FILE_ID	SENTENCE	GENE	PHENOTYPE	GENE_ID	PHENOTYPE_ID	GENE_START_POSITION	GENE_END_POSITION	PHENOTYPE_START_POSITION	PHENOTYPE_END_POSITION	RELATION
26489614	Previous studies have reported the association of prodynorphin (PDYN) promoter polymorphism with temporal lobe epilepsy (TLE) susceptibility, but the results remain inconclusive.	PDYN	epilepsy	5173	HP_0001250	64	68	111	119	False
28769069	The remaining cases, clinically similar to XLA, are autosomal recessive agammaglobulinemia (ARA).	XLA	autosomal recessive	695	HP_0000007	43	46	52	71	False
28769069	The remaining cases, clinically similar to XLA, are autosomal recessive agammaglobulinemia (ARA).	ARA	autosomal recessive	368	HP_0000007	92	95	52	71	True
30396386	<i>Background:</i> YAP/TAZ have been reported to be highly expressed in malignant tumors.	YAP	tumors	55249	HP_0002664	19	22	82	88	False
30396386	<i>Background:</i> YAP/TAZ have been reported to be highly expressed in malignant tumors.	TAZ	tumors	25937	HP_0002664	23	26	82	88	False
30396386	This research was aimed to study the expression of TAZ/YAP protein in malignant melanoma and to investigate its relationship to the clinicopathology and prognosis of patients with malignant melanoma.	YAP	malignant melanoma	55249	HP_0002861	55	58	70	88	False
30396386	This research was aimed to study the expression of TAZ/YAP protein in malignant melanoma and to investigate its relationship to the clinicopathology and prognosis of patients with malignant melanoma.	TAZ	malignant melanoma	25937	HP_0002861	51	54	70	88	False
30396386	Relationship between TAZ/YAP and clinical data of malignant melanoma were analyzed.	YAP	malignant melanoma	55249	HP_0002861	25	28	50	68	False
30396386	Relationship between TAZ/YAP and clinical data of malignant melanoma were analyzed.	TAZ	malignant melanoma	25937	HP_0002861	21	24	50	68	False
30396386	<i>Results:</i> The number of positive cells of TAZ and YAP in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and TNM stages (P &lt;0.05), and increased with TNM staging.	YAP	malignant melanoma	55249	HP_0002861	56	59	63	81	False
30396386	<i>Results:</i> The number of positive cells of TAZ and YAP in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and TNM stages (P &lt;0.05), and increased with TNM staging.	TAZ	malignant melanoma	25937	HP_0002861	48	51	63	81	False
30396386	<i>Results:</i> The number of positive cells of TAZ and YAP in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and TNM stages (P &lt;0.05), and increased with TNM staging.	TNM	malignant melanoma	10178	HP_0002861	430	433	63	81	False
30396386	<i>Results:</i> The number of positive cells of TAZ and YAP in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and TNM stages (P &lt;0.05), and increased with TNM staging.	YAP	tumor	55249	HP_0002664	56	59	82	87	False
30396386	<i>Results:</i> The number of positive cells of TAZ and YAP in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and TNM stages (P &lt;0.05), and increased with TNM staging.	TAZ	tumor	25937	HP_0002664	48	51	82	87	False
30396386	<i>Results:</i> The number of positive cells of TAZ and YAP in malignant melanoma tumor tissues was significantly higher than that in melanocytic nevi tissues, and the expression of both proteins was positively correlated with malignant melanoma (r = 0.687, P &lt;0.01); TAZ and YAP protein expression in malignant melanoma tissue was significantly correlated with tumor thickness, invasive depth grade, lymph node metastasis and TNM stages (P &lt;0.05), and increased with TNM staging.	TNM	tumor	10178	HP_0002664	430	433	82	87	False
30396386	High expression of TAZ/YAP significantly reduced the postoperative survival rate in patients with malignant melanoma.	YAP	malignant melanoma	55249	HP_0002861	23	26	98	116	False
30396386	High expression of TAZ/YAP significantly reduced the postoperative survival rate in patients with malignant melanoma.	TAZ	malignant melanoma	25937	HP_0002861	19	22	98	116	False
30396386	<i>Conclusion:</i> TAZ/YAP is highly expressed in malignant melanoma tumor tissues.	YAP	malignant melanoma	55249	HP_0002861	23	26	50	68	False
30396386	<i>Conclusion:</i> TAZ/YAP is highly expressed in malignant melanoma tumor tissues.	TAZ	malignant melanoma	25937	HP_0002861	19	22	50	68	False
30396386	<i>Conclusion:</i> TAZ/YAP is highly expressed in malignant melanoma tumor tissues.	YAP	tumor	55249	HP_0002664	23	26	69	74	False
30396386	<i>Conclusion:</i> TAZ/YAP is highly expressed in malignant melanoma tumor tissues.	TAZ	tumor	25937	HP_0002664	19	22	69	74	False
30396386	The high expression of TAZ/YAP promotes the progression of malignant melanoma and affects the postoperative survival of patients	YAP	malignant melanoma	55249	HP_0002861	27	30	59	77	False
30396386	The high expression of TAZ/YAP promotes the progression of malignant melanoma and affects the postoperative survival of patients	TAZ	malignant melanoma	25937	HP_0002861	23	26	59	77	False
30021390	In this sense, evidence from both clinical and experimental studies indicates that EPO may reverse diabetic neuropathy through an antioxidant action by decreasing pro-inflammatory cytokines, restoring Na+/K+-ATPase activity, and blocking the generation of pro-apoptotic proteins.	EPO	neuropathy	8288	HP_0009830	83	86	108	118	False
28145425	p.(Arg320His) mutation in the KCNC1 gene in human 11p15.1 has recently been identified in patients with progressive myoclonus epilepsies, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and ataxia.	KCNC1	myoclonus	3746	HP_0001336	30	35	116	125	True
28145425	p.(Arg320His) mutation in the KCNC1 gene in human 11p15.1 has recently been identified in patients with progressive myoclonus epilepsies, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and ataxia.	KCNC1	epilepsies	3746	HP_0001250	30	35	126	136	True
28145425	p.(Arg320His) mutation in the KCNC1 gene in human 11p15.1 has recently been identified in patients with progressive myoclonus epilepsies, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and ataxia.	KCNC1	epilepsy	3746	HP_0001250	30	35	219	227	True
28145425	p.(Arg320His) mutation in the KCNC1 gene in human 11p15.1 has recently been identified in patients with progressive myoclonus epilepsies, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and ataxia.	KCNC1	ataxia	3746	HP_0001251	30	35	233	239	True
28145425	As previously observed in the mutant mouse carrying a disrupted KCNC1 gene, these findings reveal that individuals with a KCNC1 loss-of-function variant can present intellectual disability without seizure and epilepsy	KCNC1	intellectual disability	3746	HP_0001249	64	69	165	188	False
28145425	As previously observed in the mutant mouse carrying a disrupted KCNC1 gene, these findings reveal that individuals with a KCNC1 loss-of-function variant can present intellectual disability without seizure and epilepsy	KCNC1	seizure	3746	HP_0001250	64	69	197	204	True
24355597	Interestingly, REEP1 mutations have been linked to neurodegenerative disorders of upper and lower motor neurons, hereditary spastic paraplegia (HSP) and distal hereditary motor neuropathy type V (dHMN-V).	REEP1	spastic paraplegia	65055	HP_0001258	15	20	124	142	True
24355597	Interestingly, REEP1 mutations have been linked to neurodegenerative disorders of upper and lower motor neurons, hereditary spastic paraplegia (HSP) and distal hereditary motor neuropathy type V (dHMN-V).	type	spastic paraplegia	6445	HP_0001258	188	192	124	142	False
24355597	Interestingly, REEP1 mutations have been linked to neurodegenerative disorders of upper and lower motor neurons, hereditary spastic paraplegia (HSP) and distal hereditary motor neuropathy type V (dHMN-V).	REEP1	neuropathy	65055	HP_0009830	15	20	177	187	True
24355597	Interestingly, REEP1 mutations have been linked to neurodegenerative disorders of upper and lower motor neurons, hereditary spastic paraplegia (HSP) and distal hereditary motor neuropathy type V (dHMN-V).	type	neuropathy	6445	HP_0009830	188	192	177	187	False
30265712	The KSHV viral homolog of interleukin-6 gene (vIL-6) may play a significant role in tumor development and may serve as a new anti-cancer target, but its role in tumor formation is only partially understood.	vIL	cancer	7429	HP_0002664	46	49	130	136	False
30265712	The KSHV viral homolog of interleukin-6 gene (vIL-6) may play a significant role in tumor development and may serve as a new anti-cancer target, but its role in tumor formation is only partially understood.	vIL	tumor	7429	HP_0002664	46	49	84	89	False
30265712	Here, a novel animal model was used to study how vIL-6 affects tumor development.	vIL	tumor	7429	HP_0002664	49	52	63	68	False
30265712	Solid tumors developed and total tumor mass and the number of tumors were characterized.	mass	tumor	2200	HP_0002664	39	43	6	11	False
30265712	The vIL-6 gene had no significant impact on tumor mass, but significantly more tumors were detected when vIL-6 was present.	vIL	tumor	7429	HP_0002664	4	7	44	49	False
30265712	The vIL-6 gene had no significant impact on tumor mass, but significantly more tumors were detected when vIL-6 was present.	impact	tumor	55364	HP_0002664	34	40	44	49	False
30265712	The vIL-6 gene had no significant impact on tumor mass, but significantly more tumors were detected when vIL-6 was present.	mass	tumor	2200	HP_0002664	50	54	44	49	False
30265712	Significant differences in expression of B cell markers in cells from extracted tumors were detected based upon the presence of vIL-6.	vIL	tumor	7429	HP_0002664	128	131	80	85	False
30265712	B cell markers in tumor cells were also compared to the same cell type in culture, prior to xenotransplantation; B cell markers were mostly downregulated during tumor formation and these changes did not differ based upon the presence of vIL-6.	vIL	tumor	7429	HP_0002664	237	240	18	23	False
30265712	B cell markers in tumor cells were also compared to the same cell type in culture, prior to xenotransplantation; B cell markers were mostly downregulated during tumor formation and these changes did not differ based upon the presence of vIL-6.	type	tumor	6445	HP_0002664	66	70	18	23	False
30265712	These data indicate that vIL-6 plays a role in KSHV tumor formation in B cells in vivo.	vIL	tumor	7429	HP_0002664	25	28	52	57	False
29577047	The canonical Hippo tumor suppressor pathway in mammalian cells is primarily composed of the MST1/2-SAV1-LATS1/2-MOB1-YAP/TAZ cascade.	YAP	tumor	55249	HP_0002664	118	121	20	25	False
29278326	We recently found that DDHD2 is a principal triglyceride hydrolase in the central nervous system (CNS) and that genetic deletion of this enzyme in mice leads to ectopic lipid droplet (LD) accumulation in neurons throughout the brain.	DDHD2	central	23259	HP_0030645	23	28	74	81	False
29278326	We recently found that DDHD2 is a principal triglyceride hydrolase in the central nervous system (CNS) and that genetic deletion of this enzyme in mice leads to ectopic lipid droplet (LD) accumulation in neurons throughout the brain.	mice	central	23581	HP_0030645	147	151	74	81	False
29278326	We recently found that DDHD2 is a principal triglyceride hydrolase in the central nervous system (CNS) and that genetic deletion of this enzyme in mice leads to ectopic lipid droplet (LD) accumulation in neurons throughout the brain.	LD	central	7957	HP_0030645	184	186	74	81	False
28232668	We find evidence of genetic heterogeneity between the sub-phenotypes of NSOFC and among different populations.	find	heterogeneity	81501	HP_0001425	3	7	28	41	False
29101630	Biotin Thiamine responsive Basal Ganglia Disease (BTBGD) is a rare treatable autosomal recessive metabolic disorder caused by mutations in SLC19A3 gene.	SLC19A3	autosomal recessive	80704	HP_0000007	139	146	77	96	True
27899487	We compared the early transcriptome profile between DKD-resistant C57BL/6J and DKD-susceptible DBA/2J (D2) glomeruli and demonstrated a significant downregulation of essential mitochondrial genes in glomeruli from diabetic D2 mice, but not in C57BL/6J, with comparable hyperglycemia.	mice	hyperglycemia	23581	HP_0003074	226	230	269	282	False
27899487	Selective Ednra blockade or mitochondrial-targeted reactive oxygen species scavenging prevented mitochondrial oxidative stress of endothelial cells and ameliorated diabetes-induced endothelial injury, podocyte loss, albuminuria, and glomerulosclerosis.	Ednra	albuminuria	1909	HP_0012592	10	15	216	227	False
27899487	Our studies show that DKD susceptibility was linked to mitochondrial dysfunction, mediated largely by Edn1-Ednra in glomerular endothelial cells representing an early event in DKD progression, and suggest that cross talk between glomerular endothelial injury and podocytes leads to defects and depletion, albuminuria, and glomerulosclerosis	Ednra	albuminuria	1909	HP_0012592	107	112	305	316	False
27899487	Our studies show that DKD susceptibility was linked to mitochondrial dysfunction, mediated largely by Edn1-Ednra in glomerular endothelial cells representing an early event in DKD progression, and suggest that cross talk between glomerular endothelial injury and podocytes leads to defects and depletion, albuminuria, and glomerulosclerosis	Edn1	albuminuria	1906	HP_0012592	102	106	305	316	False
28940097	We also highlight NCKAP1 as another compelling candidate in a large family with autosomal dominant mild intellectual disability that fully segregates with a heterozygous truncating variant.	NCKAP1	intellectual disability	10787	HP_0001249	18	24	104	127	False
28768149	A variable-length poly-T variant in intron 6 of the TOMM40 gene, rs10524523, is associated with risk and age-of-onset of sporadic (late-onset) Alzheimer's disease.	TOMM40	sporadic	10452	HP_0003745	52	58	121	129	False
22744456	MESP2, HES7 and DUSP6 genes have been proved to be involved in the etiopathogenesis of congenital scoliosis (CS) in animal embryo studies, however, whether this association was detected in human CS patients also remains unknown.	HES7	scoliosis	84667	HP_0002650	7	11	98	107	True
22744456	MESP2, HES7 and DUSP6 genes have been proved to be involved in the etiopathogenesis of congenital scoliosis (CS) in animal embryo studies, however, whether this association was detected in human CS patients also remains unknown.	DUSP6	scoliosis	1848	HP_0002650	16	21	98	107	False
22744456	MESP2, HES7 and DUSP6 genes have been proved to be involved in the etiopathogenesis of congenital scoliosis (CS) in animal embryo studies, however, whether this association was detected in human CS patients also remains unknown.	MESP2	scoliosis	145873	HP_0002650	0	5	98	107	True
22744456	MESP2, HES7 and DUSP6 genes may not be involved in the etiopathogenesis of sporadic and non-syndromic CS in Chinese Han population	HES7	sporadic	84667	HP_0003745	7	11	75	83	False
22744456	MESP2, HES7 and DUSP6 genes may not be involved in the etiopathogenesis of sporadic and non-syndromic CS in Chinese Han population	DUSP6	sporadic	1848	HP_0003745	16	21	75	83	False
22744456	MESP2, HES7 and DUSP6 genes may not be involved in the etiopathogenesis of sporadic and non-syndromic CS in Chinese Han population	MESP2	sporadic	145873	HP_0003745	0	5	75	83	False
28760657	Mutations in the MID1 gene have been associated with the X-linked form of Opitz Syndrome, a developmental disorder characterized by midline defects and intellectual disability.	MID1	intellectual disability	4281	HP_0001249	17	21	152	175	False
28128203	Gain-of-function mutations in iRHOM2 underlie Tylosis with oesophageal cancer (TOC), characterized by palmoplantar thickening, upregulate K16 with robust downregulation of its type II keratin binding partner, K6.	iRHOM2	cancer	79651	HP_0002664	30	36	71	77	True
28128203	Gain-of-function mutations in iRHOM2 underlie Tylosis with oesophageal cancer (TOC), characterized by palmoplantar thickening, upregulate K16 with robust downregulation of its type II keratin binding partner, K6.	TOC	cancer	79651	HP_0002664	79	82	71	77	True
28128203	Gain-of-function mutations in iRHOM2 underlie Tylosis with oesophageal cancer (TOC), characterized by palmoplantar thickening, upregulate K16 with robust downregulation of its type II keratin binding partner, K6.	type	cancer	6445	HP_0002664	176	180	71	77	False
25482028	Smad4 has recently been identified as a tumor suppressor gene in a variety of cancers, yet the role of Smad4 in renal cell carcinoma (RCC) remained to be elusive.	Smad4	tumor	4089	HP_0002664	0	5	40	45	True
25482028	Smad4 has recently been identified as a tumor suppressor gene in a variety of cancers, yet the role of Smad4 in renal cell carcinoma (RCC) remained to be elusive.	RCC	tumor	7515	HP_0002664	134	137	40	45	False
25482028	Smad4 has recently been identified as a tumor suppressor gene in a variety of cancers, yet the role of Smad4 in renal cell carcinoma (RCC) remained to be elusive.	Smad4	renal cell carcinoma	4089	HP_0005584	0	5	112	132	False
25482028	Smad4 has recently been identified as a tumor suppressor gene in a variety of cancers, yet the role of Smad4 in renal cell carcinoma (RCC) remained to be elusive.	RCC	renal cell carcinoma	7515	HP_0005584	134	137	112	132	False
25482028	These results indicate that Smad4 acts as a tumor suppressor by activating FOXH1, and then suppressing the expression of estrogen receptor, in addition to tumor migration and invasion.	Smad4	tumor	4089	HP_0002664	28	33	44	49	True
25482028	These results indicate that Smad4 acts as a tumor suppressor by activating FOXH1, and then suppressing the expression of estrogen receptor, in addition to tumor migration and invasion.	FOXH1	tumor	8928	HP_0002664	75	80	44	49	True
30127791	Studies in humans with autosomal recessive CARD9 deficiency have indicated a highly specific role for this molecule in the activation of antifungal immune responses in the central nervous system, the oral mucosa, and the skin.	CARD9	autosomal recessive	64170	HP_0000007	43	48	23	42	True
30127791	Studies in humans with autosomal recessive CARD9 deficiency have indicated a highly specific role for this molecule in the activation of antifungal immune responses in the central nervous system, the oral mucosa, and the skin.	CARD9	central	64170	HP_0030645	43	48	172	179	False
30127791	Moreover, CARD9-dependent functions have recently been indicated to modulate the development of autoimmunity, inflammatory bowel diseases, and cancer.	CARD9	cancer	64170	HP_0002664	10	15	143	149	False
29469952	VLCFA-containing lipids accumulate in X-ALD patients, although the effect of ABCD1-deficiency on each lipid species in the central nervous system has not been fully characterized.	ALD	central	215	HP_0030645	40	43	123	130	False
29469952	VLCFA-containing lipids accumulate in X-ALD patients, although the effect of ABCD1-deficiency on each lipid species in the central nervous system has not been fully characterized.	ABCD1	central	215	HP_0030645	77	82	123	130	False
29295731	Tbx3, a member of the T-box family of transcription factors, contributes directly to tumor formation, migration, and invasion.	Tbx3	tumor	6926	HP_0002664	0	4	85	90	False
29295731	Tbx3 expression was positively associated with multiple tumor nodes, venous infiltration, and advanced TNM tumor stage.	Tbx3	tumor	6926	HP_0002664	0	4	56	61	False
29295731	Tbx3 expression was positively associated with multiple tumor nodes, venous infiltration, and advanced TNM tumor stage.	TNM	tumor	10178	HP_0002664	103	106	56	61	False
29084757	Defects of CIB2, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, DFNB48 and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.	CIB2	deafness	10518	HP_0000365	11	15	95	103	True
29084757	Defects of CIB2, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, DFNB48 and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.	DFNB48	deafness	10518	HP_0000365	105	111	95	103	True
29084757	Defects of CIB2, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, DFNB48 and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.	CIB2	profound	10518	HP_0012829	11	15	168	176	False
29084757	Defects of CIB2, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, DFNB48 and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.	DFNB48	profound	10518	HP_0012829	105	111	168	176	False
29084757	Defects of CIB2, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, DFNB48 and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.	CIB2	blindness	10518	HP_0000618	11	15	207	216	False
29084757	Defects of CIB2, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, DFNB48 and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.	DFNB48	blindness	10518	HP_0000618	105	111	207	216	False
29084757	We report here two new nonsense mutations (pGln12* and pTyr110*) in <i>CIB2</i> patients displaying nonsyndromic profound hearing loss, with no evidence of vestibular or retinal dysfunction.	CIB2	profound	10518	HP_0012829	71	75	113	121	False
29084757	We report here two new nonsense mutations (pGln12* and pTyr110*) in <i>CIB2</i> patients displaying nonsyndromic profound hearing loss, with no evidence of vestibular or retinal dysfunction.	CIB2	hearing loss	10518	HP_0000365	71	75	122	134	True
29084757	Also, the generated <i>CIB2</i><sup>-/-</sup> mice display an early onset profound deafness and have normal balance and retinal functions.	CIB2	deafness	10518	HP_0000365	23	27	83	91	True
29084757	Also, the generated <i>CIB2</i><sup>-/-</sup> mice display an early onset profound deafness and have normal balance and retinal functions.	mice	deafness	23581	HP_0000365	46	50	83	91	False
29084757	Also, the generated <i>CIB2</i><sup>-/-</sup> mice display an early onset profound deafness and have normal balance and retinal functions.	CIB2	profound	10518	HP_0012829	23	27	74	82	False
29084757	Also, the generated <i>CIB2</i><sup>-/-</sup> mice display an early onset profound deafness and have normal balance and retinal functions.	mice	profound	23581	HP_0012829	46	50	74	82	False
29084757	This essential role of CIB2 in mechanotransduction and cell survival that, we show, is restricted to the cochlea, probably accounts for the presence in <i>CIB2</i><sup>-/-</sup> mice and <i>CIB2</i> patients, unlike in Usher syndrome, of isolated hearing loss without balance and vision deficits	CIB2	hearing loss	10518	HP_0000365	23	27	247	259	True
29084757	This essential role of CIB2 in mechanotransduction and cell survival that, we show, is restricted to the cochlea, probably accounts for the presence in <i>CIB2</i><sup>-/-</sup> mice and <i>CIB2</i> patients, unlike in Usher syndrome, of isolated hearing loss without balance and vision deficits	mice	hearing loss	23581	HP_0000365	178	182	247	259	False
26841241	In a family with post-lingual progressive non-syndromic deafness, whole-exome sequencing of genomic DNA from five hearing-impaired relatives revealed a single variant, p.Gly488Glu (rs145970949:G&gt;A) in MYO3A, co-segregating with HL as an autosomal dominant trait.	MYO3A	deafness	53904	HP_0000365	204	209	56	64	True
30117805	Previously (Pappas et al., 2015;4:e08352), we reported that Dlx5/6-Cre mediated forebrain deletion of the DYT1 dystonia protein torsinA (Dlx-CKO) causes abnormal twisting and selective degeneration of dorsal striatal cholinergic interneurons (ChI) (Pappas et al., 2015).	DYT1	dystonia	1861	HP_0001332	106	110	111	119	True
30170380	Human bladder cancer (BCa) is one of the most commonly diagnosed malignancies worldwide.	BCa	cancer	29760	HP_0002664	22	25	14	20	True
30170380	An increasing number of studies suggest that long-noncoding RNAs (lncRNAs) play important roles in various biological processes and disease pathologies, including cancer.We analyzed the expression profiles of lncRNA, miRNA, and mRNA, along with the clinical information of BCa patients collected from the Cancer Genome Atlas database to identify lncRNA biomarkers for prognosis.	BCa	cancer	29760	HP_0002664	273	276	163	169	True
29730475	In functional assays performed with RNA knockdown, loss of STEAP3 attenuated aggressive phenotypes in glioma cells, including cell proliferation, invasion, and sphere formation in vitro and tumor growth in vivo.	STEAP3	tumor	55240	HP_0002664	59	65	190	195	False
29553832	Deficient transient receptor potential vanilloid type 4 function contributes to compromised [Ca<sup>2+</sup>]<sub>i</sub> homeostasis in human autosomal-dominant polycystic kidney disease cells	type	kidney disease	6445	HP_0000077	49	53	173	187	False
29478595	Heritability-based analyses are demonstrating strong links between migraine and other neuropsychiatric disorders and brain phenotypes, highlighting genetic links between migraine and major depressive disorder and attention-deficit hyperactivity disorder, among others.	light	hyperactivity	8740	HP_0000752	139	144	231	244	False
29174094	Tricho-hepato-enteric syndrome (SD/THE) and Multiple intestinal atresia with combined immune deficiency (MIA-CID) are autosomal recessive disorders that present immunological and gastrointestinal features.	MIA	intestinal atresia	8190	HP_0011100	105	108	53	71	False
29174094	Tricho-hepato-enteric syndrome (SD/THE) and Multiple intestinal atresia with combined immune deficiency (MIA-CID) are autosomal recessive disorders that present immunological and gastrointestinal features.	MIA	autosomal recessive	8190	HP_0000007	105	108	118	137	False
29174094	There are two different phenotypes of patients with TTC7A mutations: the severe form, caused by null mutations and leading to the classical MIA-CID; and the mild form, caused by missense mutations and leading to predominant features of VEO-IBD, less severe immunological involvement and hair abnormalities.	TTC7A	hair abnormalities	57217	HP_0001595	52	57	287	305	True
29174094	There are two different phenotypes of patients with TTC7A mutations: the severe form, caused by null mutations and leading to the classical MIA-CID; and the mild form, caused by missense mutations and leading to predominant features of VEO-IBD, less severe immunological involvement and hair abnormalities.	MIA	hair abnormalities	8190	HP_0001595	140	143	287	305	False
29174094	We expand the knowledge about TTC7A deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and MIA-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE	TTC7A	intestinal atresia	57217	HP_0011100	30	35	172	190	True
29174094	We expand the knowledge about TTC7A deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and MIA-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE	MIA	intestinal atresia	8190	HP_0011100	163	166	172	190	False
29174094	We expand the knowledge about TTC7A deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and MIA-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE	TTC7A	dental abnormalities	57217	HP_0000164	30	35	253	273	False
29174094	We expand the knowledge about TTC7A deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and MIA-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE	MIA	dental abnormalities	8190	HP_0000164	163	166	253	273	False
29174094	We expand the knowledge about TTC7A deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and MIA-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE	TTC7A	liver abnormalities	57217	HP_0001392	30	35	290	309	True
29174094	We expand the knowledge about TTC7A deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and MIA-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE	MIA	liver abnormalities	8190	HP_0001392	163	166	290	309	False
29174094	We expand the knowledge about TTC7A deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and MIA-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE	TTC7A	hypogammaglobulinemia	57217	HP_0004313	30	35	338	359	False
29174094	We expand the knowledge about TTC7A deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and MIA-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also dental abnormalities, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE	MIA	hypogammaglobulinemia	8190	HP_0004313	163	166	338	359	False
30469315	However, there is limited knowledge on the selenoprotein expression in colorectal adenoma (CRA) and colorectal cancer (CRC) patients, or the interaction with Se status levels.	CRA	cancer	51747	HP_0002664	91	94	111	117	False
30469315	<i>GPX2</i> and <i>TXNRD3</i> showed a higher expression and <i>GPX3</i>, <i>SELENOP</i>, <i>SELENOS</i>, and <i>SEPHS2</i> exhibited a lower expression in the disease tissue from adenomas and both cancer groups (<i>p</i>-values from 0.023 to &lt;0.001).	SELENOP	cancer	6414	HP_0002664	77	84	198	204	False
30469315	While there were no significant correlations with both Se status markers, <i>SELENOF</i>, <i>SELENOK</i>, and <i>TXNRD1</i> tumor tissue expression positively correlated with Se, while <i>TXNRD2</i> and <i>TXNRD3</i> negatively correlated with <i>SELENOP</i>.	SELENOP	tumor	6414	HP_0002664	247	254	124	129	False
27103084	In a recent study combining autozygome and exome analysis, a homozygous loss of function mutation in TENM3 (previously named ODZ3) was reported in two siblings with isolated bilateral colobomatous microphthalmia from a consanguineous Saudi family.	TENM3	microphthalmia	55714	HP_0000568	101	106	197	211	True
27103084	In a recent study combining autozygome and exome analysis, a homozygous loss of function mutation in TENM3 (previously named ODZ3) was reported in two siblings with isolated bilateral colobomatous microphthalmia from a consanguineous Saudi family.	ODZ3	microphthalmia	10178	HP_0000568	125	129	197	211	False
27103084	In a recent study combining autozygome and exome analysis, a homozygous loss of function mutation in TENM3 (previously named ODZ3) was reported in two siblings with isolated bilateral colobomatous microphthalmia from a consanguineous Saudi family.	TENM3	bilateral	55714	HP_0012832	101	106	174	183	False
27103084	In a recent study combining autozygome and exome analysis, a homozygous loss of function mutation in TENM3 (previously named ODZ3) was reported in two siblings with isolated bilateral colobomatous microphthalmia from a consanguineous Saudi family.	ODZ3	bilateral	10178	HP_0012832	125	129	174	183	False
27103084	Herein, we report a third patient (not related to the previously reported family) with bilateral colobomatous microphthalmia and developmental delay in whom genetic studies identified a homozygous TENM3 splicing mutation c.2968-2A&gt;T (p.Val990Cysfs*13).	TENM3	microphthalmia	55714	HP_0000568	197	202	110	124	True
27103084	Herein, we report a third patient (not related to the previously reported family) with bilateral colobomatous microphthalmia and developmental delay in whom genetic studies identified a homozygous TENM3 splicing mutation c.2968-2A&gt;T (p.Val990Cysfs*13).	TENM3	bilateral	55714	HP_0012832	197	202	87	96	False
27103084	Herein, we report a third patient (not related to the previously reported family) with bilateral colobomatous microphthalmia and developmental delay in whom genetic studies identified a homozygous TENM3 splicing mutation c.2968-2A&gt;T (p.Val990Cysfs*13).	TENM3	developmental delay	55714	HP_0001263	197	202	129	148	False
27103084	This report supports the association of TENM3 mutations with colobomatous microphthalmia and expands the phenotypic spectrum associated with mutations in this gene.	TENM3	microphthalmia	55714	HP_0000568	40	45	74	88	True
25204426	Planar cell polarity (PCP) signaling has been shown in different studies to either promote or inhibit the malignancy of breast cancer.	PCP	cancer	54858	HP_0002664	22	25	127	133	False
25204426	We thus provide evidence that PCP signaling can act in a context dependent manner to promote breast cancer progression.	PCP	cancer	54858	HP_0002664	30	33	100	106	False
25204426	We thus provide evidence that PCP signaling can act in a context dependent manner to promote breast cancer progression.	act	cancer	11332	HP_0002664	48	51	100	106	False
28332779	Sensenbrenner syndrome (cranioectodermal dysplasia, CED) is a very rare autosomal recessive ciliopathy.	CED	autosomal recessive	7040	HP_0000007	52	55	72	91	False
29774942	Gastric stump cancer (GSC) is a carcinoma arising from the remnant stomach following gastric surgery for benign or malignant disease, and is more common in men.	GSC	cancer	145258	HP_0002664	22	25	14	20	False
29774942	Gastric stump cancer (GSC) is a carcinoma arising from the remnant stomach following gastric surgery for benign or malignant disease, and is more common in men.	GSC	carcinoma	145258	HP_0030731	22	25	32	41	False
29774942	Treatments in GSC and primary gastric cancer are the same and include resection of the lesion and radical lymph node dissection.	GSC	cancer	145258	HP_0002664	14	17	38	44	False
29109381	This manuscript describes the case of a nine-year-old girl with microcephaly, mild facial dysmorphisms, epileptic seizures, and severe developmental delay, with a de novo heterozygous c.320A&gt;G [p.(His 107 Arg)] mutation in <i>TUBA1A</i> gene, and the clinical aspects and neuroimaging features of &quot;lissencephaly syndrome&quot; are summarized.	Arg	microcephaly	27	HP_0000252	208	211	64	76	False
29109381	This manuscript describes the case of a nine-year-old girl with microcephaly, mild facial dysmorphisms, epileptic seizures, and severe developmental delay, with a de novo heterozygous c.320A&gt;G [p.(His 107 Arg)] mutation in <i>TUBA1A</i> gene, and the clinical aspects and neuroimaging features of &quot;lissencephaly syndrome&quot; are summarized.	Arg	facial dysmorphisms	27	HP_0001999	208	211	83	102	False
29109381	This manuscript describes the case of a nine-year-old girl with microcephaly, mild facial dysmorphisms, epileptic seizures, and severe developmental delay, with a de novo heterozygous c.320A&gt;G [p.(His 107 Arg)] mutation in <i>TUBA1A</i> gene, and the clinical aspects and neuroimaging features of &quot;lissencephaly syndrome&quot; are summarized.	Arg	seizures	27	HP_0001250	208	211	114	122	False
29109381	This manuscript describes the case of a nine-year-old girl with microcephaly, mild facial dysmorphisms, epileptic seizures, and severe developmental delay, with a de novo heterozygous c.320A&gt;G [p.(His 107 Arg)] mutation in <i>TUBA1A</i> gene, and the clinical aspects and neuroimaging features of &quot;lissencephaly syndrome&quot; are summarized.	Arg	developmental delay	27	HP_0001263	208	211	135	154	False
28869607	Depletion of the exon 3-containing long isoform of MRPL33 (MRPL33-L) led to impaired proliferation and increased apoptosis in cancer cell lines and in a xenograft model.	MRPL33	cancer	9553	HP_0002664	51	57	126	132	False
28869607	More importantly, overexpression of MRPL33-L could increase tumorigenic potential of hnRNPK-depleted cancer cells, likely indicating that hnRNPK mediates tumorigenesis through splicing regulation of MRPL33 pre-mRNA.	MRPL33	cancer	9553	HP_0002664	36	42	101	107	False
28869607	More importantly, overexpression of MRPL33-L could increase tumorigenic potential of hnRNPK-depleted cancer cells, likely indicating that hnRNPK mediates tumorigenesis through splicing regulation of MRPL33 pre-mRNA.	hnRNPK	cancer	3190	HP_0002664	85	91	101	107	False
28869607	More importantly, overexpression of MRPL33-L could increase tumorigenic potential of hnRNPK-depleted cancer cells, likely indicating that hnRNPK mediates tumorigenesis through splicing regulation of MRPL33 pre-mRNA.	MRPL33	tumor	9553	HP_0002664	36	42	60	65	False
28869607	More importantly, overexpression of MRPL33-L could increase tumorigenic potential of hnRNPK-depleted cancer cells, likely indicating that hnRNPK mediates tumorigenesis through splicing regulation of MRPL33 pre-mRNA.	hnRNPK	tumor	3190	HP_0002664	85	91	60	65	False
28869607	Finally, we found that inclusion of MRPL33 exon 3 was promoted in human colorectal cancer tissues and this was correlated with hnRNPK levels.	MRPL33	cancer	9553	HP_0002664	36	42	83	89	False
28869607	Finally, we found that inclusion of MRPL33 exon 3 was promoted in human colorectal cancer tissues and this was correlated with hnRNPK levels.	hnRNPK	cancer	3190	HP_0002664	127	133	83	89	False
28869607	In summary, our findings underscore the biological significance of MRPL33-L and hnRNPK in the tumor formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in cancer cells	MRPL33	cancer	9553	HP_0002664	67	73	187	193	False
28869607	In summary, our findings underscore the biological significance of MRPL33-L and hnRNPK in the tumor formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in cancer cells	hnRNPK	cancer	3190	HP_0002664	80	86	187	193	False
28869607	In summary, our findings underscore the biological significance of MRPL33-L and hnRNPK in the tumor formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in cancer cells	MRPL33	tumor	9553	HP_0002664	67	73	94	99	False
28869607	In summary, our findings underscore the biological significance of MRPL33-L and hnRNPK in the tumor formation and identifies hnRNPK as a critical splicing regulator of MRPL33 pre-mRNA in cancer cells	hnRNPK	tumor	3190	HP_0002664	80	86	94	99	False
30463805	Several publications had illustrated the relationship of between CAV1 polymorphism and urinary cancer, but the results were not consistent.	CAV1	cancer	857	HP_0002664	65	69	95	101	False
30463805	Odds ratios (ORs) and 95% confidence intervals (CIs) were conducted to evaluate the overall strength of the associations in five genetic models, as well as in subgroup analyses, stratified by ethnicity, cancer type or source of control.	CIs	cancer	1154	HP_0002664	48	51	203	209	False
30463805	Odds ratios (ORs) and 95% confidence intervals (CIs) were conducted to evaluate the overall strength of the associations in five genetic models, as well as in subgroup analyses, stratified by ethnicity, cancer type or source of control.	type	cancer	6445	HP_0002664	210	214	203	209	False
30463805	In the stratified analyses by cancer types, the risk of PCa is downgrade by rs7804372 in all five genetic models.	type	cancer	6445	HP_0002664	37	41	30	36	False
30463805	In the stratified analyses by cancer types, the risk of PCa is downgrade by rs7804372 in all five genetic models.	PCa	cancer	28982	HP_0002664	56	59	30	36	False
30463805	Conclusion rs1049334 polymorphismof CAV1 upgrade the risk of urinary cancer, while rs1049337 and rs7804372 polymorphisms may act as a protector of urinary cancer.	CAV1	cancer	857	HP_0002664	36	40	69	75	False
30463805	Conclusion rs1049334 polymorphismof CAV1 upgrade the risk of urinary cancer, while rs1049337 and rs7804372 polymorphisms may act as a protector of urinary cancer.	act	cancer	11332	HP_0002664	125	128	69	75	False
27650626	A case with GAMT deficiency (homozygous c.64dupG mutation) presented with neurodevelopmental delay, rare seizures, behavioral disturbances, and mild hypotonia, posing diagnostic challenges.	GAMT	neurodevelopmental delay	2593	HP_0012758	12	16	74	98	True
27650626	A case with GAMT deficiency (homozygous c.64dupG mutation) presented with neurodevelopmental delay, rare seizures, behavioral disturbances, and mild hypotonia, posing diagnostic challenges.	GAMT	seizures	2593	HP_0001250	12	16	105	113	True
27650626	A case with GAMT deficiency (homozygous c.64dupG mutation) presented with neurodevelopmental delay, rare seizures, behavioral disturbances, and mild hypotonia, posing diagnostic challenges.	GAMT	behavioral disturbances	2593	HP_0000708	12	16	115	138	False
27650626	A case with GAMT deficiency (homozygous c.64dupG mutation) presented with neurodevelopmental delay, rare seizures, behavioral disturbances, and mild hypotonia, posing diagnostic challenges.	GAMT	mild	2593	HP_0012825	12	16	144	148	False
23261302	Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal-recessive disorder, characterized by oto-sino-pulmonary disease and situs abnormalities.	PCD	ciliary dyskinesia	352909	HP_0012265	28	31	8	26	True
23261302	Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal-recessive disorder, characterized by oto-sino-pulmonary disease and situs abnormalities.	PCD	heterogeneous	352909	HP_0001425	28	31	50	63	False
23261302	These results revealed that mutations in CCDC114 are a cause of ciliary dysmotility and PCD and further demonstrate the utility of exome sequencing to identify genetic causes in heterogeneous recessive disorders	PCD	heterogeneous	352909	HP_0001425	88	91	178	191	False
23261302	These results revealed that mutations in CCDC114 are a cause of ciliary dysmotility and PCD and further demonstrate the utility of exome sequencing to identify genetic causes in heterogeneous recessive disorders	CCDC114	heterogeneous	93233	HP_0001425	41	48	178	191	False
29659569	We found monoallelic truncating/functionally deleterious mutations in seven genes, including ATM and CHEK2, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely RAD51C, FANCD2, FANCI, CEP57 and RECQL4.	ATM	cancer	472	HP_0002664	93	96	229	235	True
29659569	We found monoallelic truncating/functionally deleterious mutations in seven genes, including ATM and CHEK2, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely RAD51C, FANCD2, FANCI, CEP57 and RECQL4.	CHEK2	cancer	11200	HP_0002664	101	106	229	235	True
29659569	We found monoallelic truncating/functionally deleterious mutations in seven genes, including ATM and CHEK2, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely RAD51C, FANCD2, FANCI, CEP57 and RECQL4.	RAD51C	cancer	5889	HP_0002664	277	283	229	235	True
29659569	We found monoallelic truncating/functionally deleterious mutations in seven genes, including ATM and CHEK2, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely RAD51C, FANCD2, FANCI, CEP57 and RECQL4.	FANCD2	cancer	2177	HP_0002664	285	291	229	235	True
29659569	We found monoallelic truncating/functionally deleterious mutations in seven genes, including ATM and CHEK2, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely RAD51C, FANCD2, FANCI, CEP57 and RECQL4.	FANCI	cancer	55215	HP_0002664	293	298	229	235	True
29659569	We found monoallelic truncating/functionally deleterious mutations in seven genes, including ATM and CHEK2, which have previously been associated with PrCa predisposition, and five new candidate PrCa associated genes involved in cancer predisposing recessive disorders, namely RAD51C, FANCD2, FANCI, CEP57 and RECQL4.	CEP57	cancer	9702	HP_0002664	300	305	229	235	True
29659569	Furthermore, using in silico pathogenicity prediction of missense variants among 18 genes associated with breast/ovarian cancer and/or Lynch syndrome, followed by KASP genotyping in 710 healthy controls, we identified &quot;likely pathogenic&quot; missense variants in ATM, BRIP1, CHEK2 and TP53.	ATM	cancer	472	HP_0002664	269	272	121	127	True
29659569	Furthermore, using in silico pathogenicity prediction of missense variants among 18 genes associated with breast/ovarian cancer and/or Lynch syndrome, followed by KASP genotyping in 710 healthy controls, we identified &quot;likely pathogenic&quot; missense variants in ATM, BRIP1, CHEK2 and TP53.	CHEK2	cancer	11200	HP_0002664	281	286	121	127	True
29659569	Furthermore, using in silico pathogenicity prediction of missense variants among 18 genes associated with breast/ovarian cancer and/or Lynch syndrome, followed by KASP genotyping in 710 healthy controls, we identified &quot;likely pathogenic&quot; missense variants in ATM, BRIP1, CHEK2 and TP53.	BRIP1	cancer	64979	HP_0002664	274	279	121	127	False
29449721	Pathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.	COCH	progressive	1690	HP_0003676	22	26	73	84	True
29449721	Pathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.	DFNA9	progressive	1690	HP_0003676	48	53	73	84	True
29449721	Pathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.	COCH	hearing loss	1690	HP_0000365	22	26	85	97	True
29449721	Pathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.	DFNA9	hearing loss	1690	HP_0000365	48	53	85	97	True
29449721	Pathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.	COCH	vestibular dysfunction	1690	HP_0001751	22	26	102	124	True
29449721	Pathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset.	DFNA9	vestibular dysfunction	1690	HP_0001751	48	53	102	124	True
29449721	Here, we describe two brothers with congenital prelingual deafness and a homozygous nonsense c.292C&gt;T(p.Arg98*) COCH variant, suggesting a loss-of-function effect.	COCH	deafness	1690	HP_0000365	115	119	58	66	True
29449721	This is the first report of autosomal recessive inheritance of cochlea-vestibular dysfunction caused by a pathogenic variant in the COCH gene.	COCH	vestibular dysfunction	1690	HP_0001751	132	136	71	93	True
29449721	This is the first report of autosomal recessive inheritance of cochlea-vestibular dysfunction caused by a pathogenic variant in the COCH gene.	COCH	autosomal recessive inheritance	1690	HP_0000007	132	136	28	59	False
29449721	An earlier onset of hearing impairment and vestibular dysfunction compared to the dominant hearing loss causing COCH variants is observed	COCH	hearing loss	1690	HP_0000365	112	116	91	103	True
29449721	An earlier onset of hearing impairment and vestibular dysfunction compared to the dominant hearing loss causing COCH variants is observed	COCH	vestibular dysfunction	1690	HP_0001751	112	116	43	65	True
26079437	These expanded roles underscore the significance of vertebrate PCP proteins as factors contributing to a number of diseases, including neural tube defects, tumor metastases, and various genetic syndromes characterized by abnormal migratory cell behaviors	PCP	neural tube defects	54858	HP_0045005	63	66	135	154	False
26079437	These expanded roles underscore the significance of vertebrate PCP proteins as factors contributing to a number of diseases, including neural tube defects, tumor metastases, and various genetic syndromes characterized by abnormal migratory cell behaviors	PCP	tumor	54858	HP_0002664	63	66	156	161	False
28459858	Liposarcoma is an often fatal cancer of fat cells.	fat	cancer	948	HP_0002664	24	27	30	36	False
28459858	The cleavage of fatty acids from acylglycerols (lipolysis) has been implicated in cancer.	fat	cancer	948	HP_0002664	16	19	82	88	False
28459858	All DAKO mice developed liposarcoma between 11 and 14 months of age.	mice	liposarcoma	23581	HP_0012034	9	13	24	35	False
28459858	No tumors occurred in single knockout or control mice.	mice	tumors	23581	HP_0002664	49	53	3	9	False
28459858	Similar changes of GPNMB and G0S2 expression were present in a human liposarcoma database.	GPNMB	liposarcoma	10457	HP_0012034	19	24	69	80	False
28459858	These results show that a previously-unknown, fully penetrant epistatic interaction between Pnpla2 and Lipe can cause liposarcoma in mice.	mice	liposarcoma	23581	HP_0012034	133	137	118	129	False
28459858	These results show that a previously-unknown, fully penetrant epistatic interaction between Pnpla2 and Lipe can cause liposarcoma in mice.	Pnpla2	liposarcoma	57104	HP_0012034	92	98	118	129	False
28459858	These results show that a previously-unknown, fully penetrant epistatic interaction between Pnpla2 and Lipe can cause liposarcoma in mice.	Lipe	liposarcoma	3991	HP_0012034	103	107	118	129	False
27567740	Recently, a missense mutation (R7S) in yet another member of this family, HSPB3, was found to cause an axonal motor neuropathy (distal hereditary motor neuropathy type 2C, dHMN2C).	HSPB3	neuropathy	8988	HP_0009830	74	79	116	126	True
27567740	Recently, a missense mutation (R7S) in yet another member of this family, HSPB3, was found to cause an axonal motor neuropathy (distal hereditary motor neuropathy type 2C, dHMN2C).	type	neuropathy	6445	HP_0009830	163	167	116	126	False
29518027	Using preclinical models, we have recently found that ELK1, a transcriptional factor that activates downstream targets, including <i>c-fos</i> proto-oncogene, induces bladder cancer outgrowth.	ELK1	cancer	2002	HP_0002664	54	58	175	181	False
29518027	Lymphovascular invasion was significantly (<i>P</i> = 0.014) more often seen in phospho-ELK1(2+) tumors (80.0%) than in phospho-ELK1(0/1+) tumors (36.0%).	ELK1	tumors	2002	HP_0002664	88	92	97	103	False
29518027	There were no statistically significant associations between phospho-ELK1 expression and tumor grade, presence of concurrent carcinoma in situ or hydronephrosis, or pN status.	ELK1	tumor	2002	HP_0002664	69	73	89	94	False
29518027	There were no statistically significant associations between phospho-ELK1 expression and tumor grade, presence of concurrent carcinoma in situ or hydronephrosis, or pN status.	ELK1	hydronephrosis	2002	HP_0000126	69	73	146	160	False
29518027	Kaplan-Meier and log-rank tests revealed that patients with phospho-ELK1(2+) tumor had marginally and significantly higher risks of disease progression (<i>P</i> = 0.055) and cancer-specific mortality (<i>P</i> = 0.008), respectively, compared to those with phospho-ELK1(0/1+) tumor.	ELK1	cancer	2002	HP_0002664	68	72	175	181	False
29518027	Kaplan-Meier and log-rank tests revealed that patients with phospho-ELK1(2+) tumor had marginally and significantly higher risks of disease progression (<i>P</i> = 0.055) and cancer-specific mortality (<i>P</i> = 0.008), respectively, compared to those with phospho-ELK1(0/1+) tumor.	ELK1	tumor	2002	HP_0002664	68	72	77	82	False
29518027	The current results thus support our previous observations in bladder cancer and further suggest that phospho-ELK1 overexpression serves as a predictor of poor prognosis in patients with UUTUC	ELK1	cancer	2002	HP_0002664	110	114	70	76	False
30454692	Brain MRI showed diffuse leukoencephalopathy, suggesting CADASIL.	CADASIL	leukoencephalopathy	4854	HP_0002352	57	64	25	44	True
28318499	Through genetic mapping of disease loci and whole-exome sequencing in four unrelated multiplex families presenting with severe AMC, we identified biallelic loss-of-function mutations in LGI4 (leucine-rich glioma-inactivated 4).	LGI4	glioma	163175	HP_0009733	186	190	205	211	False
28318499	This is consistent with previous studies reporting arthrogryposis in Lgi4-deficient mice due to peripheral hypomyelination.	Lgi4	arthrogryposis	163175	HP_0002804	69	73	51	65	True
28318499	This is consistent with previous studies reporting arthrogryposis in Lgi4-deficient mice due to peripheral hypomyelination.	mice	arthrogryposis	23581	HP_0002804	84	88	51	65	False
28981088	Mutations in heat shock transcription factor 4 (HSF4) have been associated with cataract; however, the mechanisms regarding how mutations in HSF4 cause cataract are still obscure.	HSF4	cataract	3299	HP_0000518	48	52	80	88	True
28981088	The mutant zebrafish developed an early-onset cataract with multiple developmental defects in lens.	fish	cataract	9644	HP_0000518	16	20	46	54	False
28487959	In this study, we performed exome-wide association studies(EWASs) to identify genetic variants that confer susceptibility to ischemic stroke, intracerebral hemorrhage(ICH), or subarachnoid hemorrhage(SAH).	SAH	intracerebral hemorrhage	6296	HP_0001342	203	206	143	167	False
28487959	Multivariable logistic regression analysis with adjustment for age, sex and the prevalence of hypertension and diabetes mellitus revealed that 4of these SNPs[rs3212335 of GABRB3(P=0.0036; odds ratio, 1.29), rs147783135 of TMPRSS7(P=0.0024; odds ratio, 0.37), rs2292661 of PDIA5 (P=0.0054; odds ratio, 0.35) and rs191885206 of CYP4F12 (P=0.0082; odds ratio, 2.60)] were related(P&lt;0.01) to ischemic stroke.	sex	hypertension	55558	HP_0000822	68	71	94	106	False
28487959	Multivariable logistic regression analysis with adjustment for age, sex and the prevalence of hypertension and diabetes mellitus revealed that 4of these SNPs[rs3212335 of GABRB3(P=0.0036; odds ratio, 1.29), rs147783135 of TMPRSS7(P=0.0024; odds ratio, 0.37), rs2292661 of PDIA5 (P=0.0054; odds ratio, 0.35) and rs191885206 of CYP4F12 (P=0.0082; odds ratio, 2.60)] were related(P&lt;0.01) to ischemic stroke.	TMPRSS7	hypertension	344805	HP_0000822	225	232	94	106	False
28487959	Multivariable logistic regression analysis with adjustment for age, sex and the prevalence of hypertension and diabetes mellitus revealed that 4of these SNPs[rs3212335 of GABRB3(P=0.0036; odds ratio, 1.29), rs147783135 of TMPRSS7(P=0.0024; odds ratio, 0.37), rs2292661 of PDIA5 (P=0.0054; odds ratio, 0.35) and rs191885206 of CYP4F12 (P=0.0082; odds ratio, 2.60)] were related(P&lt;0.01) to ischemic stroke.	PDIA5	hypertension	10954	HP_0000822	276	281	94	106	False
28487959	Multivariable logistic regression analysis with adjustment for age, sex and the prevalence of hypertension and diabetes mellitus revealed that 4of these SNPs[rs3212335 of GABRB3(P=0.0036; odds ratio, 1.29), rs147783135 of TMPRSS7(P=0.0024; odds ratio, 0.37), rs2292661 of PDIA5 (P=0.0054; odds ratio, 0.35) and rs191885206 of CYP4F12 (P=0.0082; odds ratio, 2.60)] were related(P&lt;0.01) to ischemic stroke.	CYP4F12	hypertension	66002	HP_0000822	330	337	94	106	False
28487959	Multivariable logistic regression analysis with adjustment for age, sex and the prevalence of hypertension revealed that rs138533962 of STYK1 (P&lt;1.0x10-23; odds ratio, 111.3) was significantly (P&lt;2.60x10-4) associated with ICH and that rs117564807 of COL17A1 (P=0.0009; odds ratio, 2.23x10-8) was significantly (P&lt;0.0010) associated with SAH.	SAH	hypertension	6296	HP_0000822	347	350	94	106	False
28487959	Multivariable logistic regression analysis with adjustment for age, sex and the prevalence of hypertension revealed that rs138533962 of STYK1 (P&lt;1.0x10-23; odds ratio, 111.3) was significantly (P&lt;2.60x10-4) associated with ICH and that rs117564807 of COL17A1 (P=0.0009; odds ratio, 2.23x10-8) was significantly (P&lt;0.0010) associated with SAH.	sex	hypertension	55558	HP_0000822	68	71	94	106	False
28487959	Multivariable logistic regression analysis with adjustment for age, sex and the prevalence of hypertension revealed that rs138533962 of STYK1 (P&lt;1.0x10-23; odds ratio, 111.3) was significantly (P&lt;2.60x10-4) associated with ICH and that rs117564807 of COL17A1 (P=0.0009; odds ratio, 2.23x10-8) was significantly (P&lt;0.0010) associated with SAH.	STYK1	hypertension	55359	HP_0000822	136	141	94	106	False
28487959	Multivariable logistic regression analysis with adjustment for age, sex and the prevalence of hypertension revealed that rs138533962 of STYK1 (P&lt;1.0x10-23; odds ratio, 111.3) was significantly (P&lt;2.60x10-4) associated with ICH and that rs117564807 of COL17A1 (P=0.0009; odds ratio, 2.23x10-8) was significantly (P&lt;0.0010) associated with SAH.	COL17A1	hypertension	1308	HP_0000822	257	264	94	106	False
27185910	Here we demonstrate that the prostate cancer cell lines LNCaP and LAPC4 display markedly different sensitivity to docetaxel with AR activation, and RNA-seq analysis of these cell lines identified KDM5D (lysine-specific demethylase 5D) encoded on the Y chromosome as a potential mediator of this sensitivity.	KDM5D	cancer	8284	HP_0002664	196	201	38	44	False
28349276	Their seizures started within the first day and could not be controlled by pyridoxine or pyridoxal-5'-phosphate (PLP) completely.	PLP	seizures	5354	HP_0001250	113	116	6	14	True
29937467	However, the negative association between 25(OH)D and GRS was modified by obesity and sun exposure.	GRS	obesity	597	HP_0001513	54	57	74	81	False
27220846	Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.	INVS	autosomal recessive	27130	HP_0000007	16	20	70	89	True
27220846	Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.	type	autosomal recessive	6445	HP_0000007	50	54	70	89	True
27220846	Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.	NPHP2	autosomal recessive	27130	HP_0000007	59	64	70	89	True
27220846	Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.	AA	autosomal recessive	7003	HP_0000007	16	18	70	89	False
27220846	Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.	INVS	chronic	27130	HP_0011010	16	20	90	97	False
27220846	Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.	type	chronic	6445	HP_0011010	50	54	90	97	False
27220846	Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.	NPHP2	chronic	27130	HP_0011010	59	64	90	97	False
27220846	Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.	AA	chronic	7003	HP_0011010	16	18	90	97	False
27220846	Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.	INVS	nephropathy	27130	HP_0000112	16	20	117	128	False
27220846	Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.	type	nephropathy	6445	HP_0000112	50	54	117	128	False
27220846	Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.	NPHP2	nephropathy	27130	HP_0000112	59	64	117	128	False
27220846	Mutation in the INVS gene causes nephronophthisis type II (NPHP2), an autosomal recessive chronic tubulointerstitial nephropathy.	AA	nephropathy	7003	HP_0000112	16	18	117	128	False
28972307	However, the significance of Brf1 overexpression in human breast cancer (HBC) remains to be investigated.	Brf1	cancer	677	HP_0002664	29	33	65	71	False
28972307	Inhibition of ER by its siRNA or tamoxifen reduces cellular levels of Brf1 and Pol III gene expression and decreases the rate of colony formation of breast cancer cells.	Brf1	cancer	677	HP_0002664	71	75	157	163	False
29547829	Pyridoxine dependent epilepsy (PDE) is a rare autosomal recessive neurometabolic disorder.	PDE	epilepsy	501	HP_0001250	31	34	21	29	True
28625504	Typical ciliopathy phenotypes (curved body shape, retinal dystrophy, coloboma, and decreased cilia) in a CRISPR/Cas9-engineered zebrafish mutant model provide additional support for ARMC9 as a ciliopathy-associated gene.	ARMC9	coloboma	80210	HP_0000589	182	187	69	77	True
28625504	Typical ciliopathy phenotypes (curved body shape, retinal dystrophy, coloboma, and decreased cilia) in a CRISPR/Cas9-engineered zebrafish mutant model provide additional support for ARMC9 as a ciliopathy-associated gene.	ARMC9	retinal dystrophy	80210	HP_0000556	182	187	50	67	True
29257344	The expression of uncarboxylated MGP (ucMGP), carboxylated MGP (cMGP), matrix metalloproteinase (MMP)13, collagen type X, collagen type II, tumor necrosis factor (TNF) and interleukin (IL)1 were detected by ELISA, immunohistochemistry, reverse transcriptionquantitative polymerase chain reaction and western blotting.	MGP	tumor	4256	HP_0002664	33	36	141	146	False
29257344	The expression of uncarboxylated MGP (ucMGP), carboxylated MGP (cMGP), matrix metalloproteinase (MMP)13, collagen type X, collagen type II, tumor necrosis factor (TNF) and interleukin (IL)1 were detected by ELISA, immunohistochemistry, reverse transcriptionquantitative polymerase chain reaction and western blotting.	type	tumor	6445	HP_0002664	115	119	141	146	False
29257344	The expression of uncarboxylated MGP (ucMGP), carboxylated MGP (cMGP), matrix metalloproteinase (MMP)13, collagen type X, collagen type II, tumor necrosis factor (TNF) and interleukin (IL)1 were detected by ELISA, immunohistochemistry, reverse transcriptionquantitative polymerase chain reaction and western blotting.	TNF	tumor	7124	HP_0002664	164	167	141	146	False
27270415	Mice with a neuronal deletion of Arv1 recapitulated the human phenotype, exhibiting seizures and a severe survival defect in adulthood.	type	seizure	6445	HP_0001250	67	71	84	91	False
27270415	Mice with a neuronal deletion of Arv1 recapitulated the human phenotype, exhibiting seizures and a severe survival defect in adulthood.	Arv1	seizure	64801	HP_0001250	33	37	84	91	True
27270415	Our data support ARV1 deficiency as a cause of autosomal recessive epileptic encephalopathy	ARV1	autosomal recessive	64801	HP_0000007	17	21	47	66	True
27102954	Previously, a homozygous missense mutation in THOC6 in the Hutterite population was reported in association with syndromic intellectual disability.	THOC6	intellectual disability	79228	HP_0001249	46	51	123	146	True
27102954	Using exome sequencing, we identified three unrelated patients with bi-allelic mutations in THOC6 associated with intellectual disability and additional clinical features.	THOC6	intellectual disability	79228	HP_0001249	92	97	114	137	True
27102954	Our results expand the mutational and clinical spectrum of this rare disease, confirm that THOC6 is an intellectual disability causing gene, while providing insight into the importance of the THO complex in neurodevelopment	THOC6	intellectual disability	79228	HP_0001249	91	96	103	126	True
30072435	Overall, 40 of the 73 ICA patients (55%) and 23 of the 56 kindreds (41%) carry mutations located in translated or untranslated exons of <i>RPSA.</i> Eleven of the 43 kindreds affected by sporadic disease (26%) carry <i>RPSA</i> mutations, whereas 12 of the 13 multiplex kindreds (92%) carry <i>RPSA</i> mutations.	RPSA	sporadic	3921	HP_0003745	139	143	187	195	False
30177815	As proof of concept, we applied CRAFT to epilepsy and predicted the tyrosine kinase receptor Csf1R as a potential therapeutic target.	Csf1R	epilepsy	1436	HP_0001250	93	98	41	49	False
30177815	The predicted effect of Csf1R blockade in attenuating epilepsy seizures was validated in three pre-clinical models of epilepsy.	Csf1R	epilepsy	1436	HP_0001250	24	29	54	62	False
30177815	The predicted effect of Csf1R blockade in attenuating epilepsy seizures was validated in three pre-clinical models of epilepsy.	Csf1R	seizures	1436	HP_0001250	24	29	63	71	False
30177815	These results highlight CRAFT as a systems-level framework for target discovery and suggest Csf1R blockade as a novel therapeutic strategy in epilepsy.	Csf1R	epilepsy	1436	HP_0001250	92	97	142	150	False
30327925	Renal manifestations of multiple myeloma (MM) including cast nephropathy, amyloidosis, and renal calcification have been widely recognized.	cast	multiple myeloma	10849	HP_0006775	56	60	24	40	False
25920810	The human KAT6A and KAT6B genes are recurrently mutated in leukemia, non-hematologic malignancies, and multiple developmental disorders displaying intellectual disability and various other abnormalities.	KAT6A	intellectual disability	7994	HP_0001249	10	15	147	170	True
25920810	The human KAT6A and KAT6B genes are recurrently mutated in leukemia, non-hematologic malignancies, and multiple developmental disorders displaying intellectual disability and various other abnormalities.	KAT6B	intellectual disability	23522	HP_0001249	20	25	147	170	True
25920810	In addition, the BRPF1 gene is mutated in childhood leukemia and adult medulloblastoma.	BRPF1	medulloblastoma	7862	HP_0002885	17	22	71	86	False
29341901	However, BMP-9 is a big protein expensive to produce that can hardly access the central nervous system.	BMP-9	central	2658	HP_0030645	9	14	80	87	False
29341901	Since it is known that the native protein, BMP-9, can act in synergy with other growth factors in the context of AD, here we study the potential synergistic effect of various combinations of SpBMP-9 with bFGF, EGF, IGF-2 or NGF on the cholinergic differentiation of human neuroblastoma cells SH-SY5Y.	BMP-9	neuroblastoma	2658	HP_0003006	43	48	272	285	False
29341901	Since it is known that the native protein, BMP-9, can act in synergy with other growth factors in the context of AD, here we study the potential synergistic effect of various combinations of SpBMP-9 with bFGF, EGF, IGF-2 or NGF on the cholinergic differentiation of human neuroblastoma cells SH-SY5Y.	act	neuroblastoma	11332	HP_0003006	54	57	272	285	False
29341901	Since it is known that the native protein, BMP-9, can act in synergy with other growth factors in the context of AD, here we study the potential synergistic effect of various combinations of SpBMP-9 with bFGF, EGF, IGF-2 or NGF on the cholinergic differentiation of human neuroblastoma cells SH-SY5Y.	EGF	neuroblastoma	1950	HP_0003006	210	213	272	285	False
29341901	Since it is known that the native protein, BMP-9, can act in synergy with other growth factors in the context of AD, here we study the potential synergistic effect of various combinations of SpBMP-9 with bFGF, EGF, IGF-2 or NGF on the cholinergic differentiation of human neuroblastoma cells SH-SY5Y.	NGF	neuroblastoma	4803	HP_0003006	224	227	272	285	False
30015928	Bone morphogenetic protein7(BMP7), a member of the BMP family of signaling molecules, has been implicated in various types of cancer, particularly prostate cancer and breast cancer.	BMP7	cancer	655	HP_0002664	30	34	128	134	False
27302160	The aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 (AIMP2) splice variant designated DX2 is induced by cigarette smoke carcinogens and is often detected in human lung cancer specimens.	AIMP2	cancer	7965	HP_0002664	77	82	192	198	False
29099273	Of the 465,447 CpG sites analyzed, 12 showed differential methylation (false discovery rate &lt;0.15), including markers within genes associated with monogenic diabetes (HNF4A) or obesity (RREB1).	RREB1	obesity	6239	HP_0001513	189	194	180	187	True
29099273	Of the 465,447 CpG sites analyzed, 12 showed differential methylation (false discovery rate &lt;0.15), including markers within genes associated with monogenic diabetes (HNF4A) or obesity (RREB1).	HNF4A	obesity	3172	HP_0001513	170	175	180	187	False
23647707	Despite this multisystemic involvement and contrasting with a cachectic appearance, the anthropometric parameters showed marked overgrowth (+4 DS), leading to diagnosis of congenital lipodystrophy, which was confirmed by the presence of the new homozygous c.259C&gt;T (p.Gln87*) mutation in the AGPAT2 gene.	AGPAT2	lipodystrophy	10555	HP_0009125	295	301	183	196	True
29757260	In the present study, we sought to identify the factors involved in the RAR&amp;alpha;-mediated transcriptional regulation of the tumor suppressor gene and the tissue factor pathway inhibitor 2 (TFPI2) in hepatocellular carcinoma (HCC).	TFPI2	tumor	7980	HP_0002664	195	200	130	135	False
29757260	In the present study, we sought to identify the factors involved in the RAR&amp;alpha;-mediated transcriptional regulation of the tumor suppressor gene and the tissue factor pathway inhibitor 2 (TFPI2) in hepatocellular carcinoma (HCC).	HCC	tumor	84668	HP_0002664	231	234	130	135	False
29757260	In the present study, we sought to identify the factors involved in the RAR&amp;alpha;-mediated transcriptional regulation of the tumor suppressor gene and the tissue factor pathway inhibitor 2 (TFPI2) in hepatocellular carcinoma (HCC).	TFPI2	hepatocellular carcinoma	7980	HP_0001402	195	200	205	229	False
29757260	In the present study, we sought to identify the factors involved in the RAR&amp;alpha;-mediated transcriptional regulation of the tumor suppressor gene and the tissue factor pathway inhibitor 2 (TFPI2) in hepatocellular carcinoma (HCC).	HCC	hepatocellular carcinoma	84668	HP_0001402	231	234	205	229	False
29757260	The musculo-aponeurotic fibrosarcoma oncogene homolog B (MAFB) significantly enhanced the activation of the TFPI2 promoter via RAR&amp;alpha; while MAFF inhibited it.	TFPI2	fibrosarcoma	7980	HP_0100244	108	113	24	36	False
29757260	The musculo-aponeurotic fibrosarcoma oncogene homolog B (MAFB) significantly enhanced the activation of the TFPI2 promoter via RAR&amp;alpha; while MAFF inhibited it.	MAFB	fibrosarcoma	9935	HP_0100244	57	61	24	36	False
29757260	The musculo-aponeurotic fibrosarcoma oncogene homolog B (MAFB) significantly enhanced the activation of the TFPI2 promoter via RAR&amp;alpha; while MAFF inhibited it.	MAFF	fibrosarcoma	23764	HP_0100244	148	152	24	36	False
29757260	These results suggest that MAFB and MAFF play critical roles in the antitumor effects of retinoids by regulating the expression of retinoid target genes such as TFPI2 and can be promising for developing therapies to combat HCC invasion	TFPI2	tumor	7980	HP_0002664	161	166	72	77	False
29757260	These results suggest that MAFB and MAFF play critical roles in the antitumor effects of retinoids by regulating the expression of retinoid target genes such as TFPI2 and can be promising for developing therapies to combat HCC invasion	HCC	tumor	84668	HP_0002664	223	226	72	77	False
29757260	These results suggest that MAFB and MAFF play critical roles in the antitumor effects of retinoids by regulating the expression of retinoid target genes such as TFPI2 and can be promising for developing therapies to combat HCC invasion	MAFB	tumor	9935	HP_0002664	27	31	72	77	False
29757260	These results suggest that MAFB and MAFF play critical roles in the antitumor effects of retinoids by regulating the expression of retinoid target genes such as TFPI2 and can be promising for developing therapies to combat HCC invasion	MAFF	tumor	23764	HP_0002664	36	40	72	77	False
24689825	Few studies have examined the roles of CRELD1 and GATA4 in cardiac abnormalities or their association with pulmonary artery histopathology.	CRELD1	cardiac abnormalities	78987	HP_0001627	39	45	59	80	True
24689825	Few studies have examined the roles of CRELD1 and GATA4 in cardiac abnormalities or their association with pulmonary artery histopathology.	GATA4	cardiac abnormalities	2626	HP_0001627	50	55	59	80	True
24689825	Children with DS have an elevated risk of pulmonary arterial hypertension (PAH).	PAH	pulmonary arterial hypertension	5053	HP_0002092	75	78	42	73	False
25265279	Downregulation of Gli1, Gli2, Gli3 and Kif7 was demonstrated in clinical samples of choriocarcinoma and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.	Kif7	choriocarcinoma	374654	HP_0100768	39	43	84	99	False
25265279	Downregulation of Gli1, Gli2, Gli3 and Kif7 was demonstrated in clinical samples of choriocarcinoma and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.	Gli1	choriocarcinoma	2735	HP_0100768	18	22	84	99	False
25265279	Downregulation of Gli1, Gli2, Gli3 and Kif7 was demonstrated in clinical samples of choriocarcinoma and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.	Gli2	choriocarcinoma	2736	HP_0100768	24	28	84	99	False
25265279	Downregulation of Gli1, Gli2, Gli3 and Kif7 was demonstrated in clinical samples of choriocarcinoma and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.	Gli3	choriocarcinoma	2737	HP_0100768	30	34	84	99	False
25265279	Ectopic expression of Kif7 in two choriocarcinoma cell lines JAR and JEG-3 led to a decrease in cell growth and increase in apoptosis demonstrated by MTT and TUNEL assays, respectively.	Kif7	choriocarcinoma	374654	HP_0100768	22	26	34	49	False
24736721	Schizophrenia (SZ) and autism spectrum disorders (ASD) are highly heritable neuropsychiatric disorders, although environmental factors, such as maternal immune activation (MIA), play a role as well.	MIA	autism	8190	HP_0000717	172	175	23	29	False
24736721	Schizophrenia (SZ) and autism spectrum disorders (ASD) are highly heritable neuropsychiatric disorders, although environmental factors, such as maternal immune activation (MIA), play a role as well.	fact	autism	11198	HP_0000717	127	131	23	29	False
30459038	Amyotrophic lateral sclerosis (ALS) is the major adult-onset motor neuron disease, and is clinically, pathologically, and genetically associated with frontotemporal dementia, the second cause of dementia in the elderly.	ALS	frontotemporal dementia	3483	HP_0002145	31	34	150	173	False
30459038	Amyotrophic lateral sclerosis (ALS) is the major adult-onset motor neuron disease, and is clinically, pathologically, and genetically associated with frontotemporal dementia, the second cause of dementia in the elderly.	call	frontotemporal dementia	1663	HP_0002145	95	99	150	173	False
30155490	miR-122, the expression of which is regulated by several transcription factors, such as HNF1A, was recently reported to be associated with type 2 diabetes (T2DM) and hepatocellular carcinoma.	HNF1A	hepatocellular carcinoma	6927	HP_0001402	88	93	166	190	False
30155490	miR-122, the expression of which is regulated by several transcription factors, such as HNF1A, was recently reported to be associated with type 2 diabetes (T2DM) and hepatocellular carcinoma.	type	hepatocellular carcinoma	6445	HP_0001402	139	143	166	190	False
30155490	miR-122, the expression of which is regulated by several transcription factors, such as HNF1A, was recently reported to be associated with type 2 diabetes (T2DM) and hepatocellular carcinoma.	miR	hepatocellular carcinoma	220972	HP_0001402	0	3	166	190	False
30155490	miR-122, the expression of which is regulated by several transcription factors, such as HNF1A, was recently reported to be associated with type 2 diabetes (T2DM) and hepatocellular carcinoma.	DM	hepatocellular carcinoma	1760	HP_0001402	158	160	166	190	False
30155490	HNF1A variants can cause diabetes and might be involved in the development of primary liver neoplasm.	HNF1A	neoplasm	6927	HP_0002664	0	5	92	100	True
30155490	Lower serum miR-122 is a unique feature of HNF1A-DM patients and might partially explain the increased risk for liver neoplasm and abnormal lipid metabolism in HNF1A-DM patients	HNF1A	neoplasm	6927	HP_0002664	43	48	118	126	True
30155490	Lower serum miR-122 is a unique feature of HNF1A-DM patients and might partially explain the increased risk for liver neoplasm and abnormal lipid metabolism in HNF1A-DM patients	miR	neoplasm	220972	HP_0002664	12	15	118	126	False
30155490	Lower serum miR-122 is a unique feature of HNF1A-DM patients and might partially explain the increased risk for liver neoplasm and abnormal lipid metabolism in HNF1A-DM patients	DM	neoplasm	1760	HP_0002664	49	51	118	126	False
28681861	We characterize MYMK-CFZS as a congenital myopathy with marked facial weakness and additional clinical and pathologic features that distinguish it from other congenital neuromuscular syndromes.	MYMK	facial weakness	389827	HP_0010628	16	20	63	78	True
28082341	It is caused by recessive mutations in <i>NBEAL2</i>, resulting in macrothrombocytopenia and myelofibrosis.	NBEAL2	macrothrombocytopenia	23218	HP_0040185	42	48	67	88	False
28082341	Though using the term gray platelets for GATA1 deficiency has been debated, a reduced number of -granules has been described for macrothrombocytopenia due to <i>GATA1</i> mutations.	GATA1	macrothrombocytopenia	2623	HP_0040185	41	46	130	151	True
30365130	Multivariable logistic regression analysis with adjustment for age and sex revealed that all 25, 28 and 65 of these SNPs were significantly associated with hypertriglyceridemia, hypoHDLcholesterolemia and hyperLDLcholesterolemia, respectively.	sex	hypertriglyceridemia	55558	HP_0002155	71	74	156	176	False
30365130	Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, EHD3, COL6A3, ZNF860CACNA1D, COL6A5, DCLRE1C, ZNF77) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, UBD, LOC105375015) for hyperLDLcholesterolemia.	LPGAT1	hypertriglyceridemia	9926	HP_0002155	358	364	311	331	False
30365130	Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, EHD3, COL6A3, ZNF860CACNA1D, COL6A5, DCLRE1C, ZNF77) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, UBD, LOC105375015) for hyperLDLcholesterolemia.	EHD3	hypertriglyceridemia	30845	HP_0002155	366	370	311	331	False
30365130	Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, EHD3, COL6A3, ZNF860CACNA1D, COL6A5, DCLRE1C, ZNF77) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, UBD, LOC105375015) for hyperLDLcholesterolemia.	COL6A3	hypertriglyceridemia	1293	HP_0002155	372	378	311	331	False
30365130	Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, EHD3, COL6A3, ZNF860CACNA1D, COL6A5, DCLRE1C, ZNF77) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, UBD, LOC105375015) for hyperLDLcholesterolemia.	COL6A5	hypertriglyceridemia	256076	HP_0002155	396	402	311	331	False
30365130	Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, EHD3, COL6A3, ZNF860CACNA1D, COL6A5, DCLRE1C, ZNF77) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, UBD, LOC105375015) for hyperLDLcholesterolemia.	DCLRE1C	hypertriglyceridemia	64421	HP_0002155	404	411	311	331	False
30365130	Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, EHD3, COL6A3, ZNF860CACNA1D, COL6A5, DCLRE1C, ZNF77) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, UBD, LOC105375015) for hyperLDLcholesterolemia.	ZNF77	hypertriglyceridemia	58492	HP_0002155	413	418	311	331	False
30365130	Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDLcholesterol, or LDLcholesterol, linkage disequilibrium of the SNPs, and results of previous genomewide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for hypertriglyceridemia, eight loci (MOB3CTMOD4, LPGAT1, EHD3, COL6A3, ZNF860CACNA1D, COL6A5, DCLRE1C, ZNF77) for hypoHDLcholesterolemia, and three loci (KIAA0319FAM65B, UBD, LOC105375015) for hyperLDLcholesterolemia.	UBD	hypertriglyceridemia	10537	HP_0002155	483	486	311	331	False
30300827	OX40 and its ligand are members of the TNF/TNF receptor superfamily, which includes various molecules influencing cellular signaling and function of both tumor and immune cells.	OX40	tumor	7293	HP_0002664	0	4	154	159	True
30300827	The ability of OX40 to promote proliferation and differentiation of activated T cells fueled present attempts to modulate this immune checkpoint to reinforce antitumor immunity.	OX40	tumor	7293	HP_0002664	15	19	162	167	True
30300827	The data presented thus not only identify the yet unknown involvement of OX40/OX40L in ALL pathophysiology and NK cell immunosurveillance but also point to the necessity to thoroughly consider the consequences of modulating the OX40/OX40L molecule system beyond its effects on T cells when developing OX40-targeting approaches for cancer immunotherapy	ALL	cancer	613	HP_0002664	87	90	331	337	True
30300827	The data presented thus not only identify the yet unknown involvement of OX40/OX40L in ALL pathophysiology and NK cell immunosurveillance but also point to the necessity to thoroughly consider the consequences of modulating the OX40/OX40L molecule system beyond its effects on T cells when developing OX40-targeting approaches for cancer immunotherapy	OX40	cancer	7293	HP_0002664	73	77	331	337	True
30220141	<b>Objective:</b> To study the association between Thymidine Phosphorylase (TYMP) genetic variation and clinical outcomes and safety of postoperative colorectal cancer (CRC) patients.	TYMP	cancer	1890	HP_0002664	76	80	161	167	False
30220141	Additionally, of the 87 postoperative tissue specimens, the results showed that the expression of TYMP in cancer tissues of the patients with CT or TT genotypes were significantly higher than those of the wild type CC genotype patients (<i>P</i>=0.019).	TYMP	cancer	1890	HP_0002664	98	102	106	112	False
30220141	Additionally, of the 87 postoperative tissue specimens, the results showed that the expression of TYMP in cancer tissues of the patients with CT or TT genotypes were significantly higher than those of the wild type CC genotype patients (<i>P</i>=0.019).	type	cancer	6445	HP_0002664	155	159	106	112	False
29452234	XRCC4 is one of the essential proteins of this pathway and single-nucleotide polymorphisms (SNPs) of this gene are reported to be associated with cancer risks.	XRCC4	cancer	7518	HP_0002664	0	5	146	152	True
22935918	To test whether this gene can confer a wide variety of psychiatric disorders, we carried out a case-control association analysis of three tagging single-nucleotide polymorphisms (rs2074896, rs2074897, and rs2074898) in the NDUFS7 gene by sequencing 330 Han Chinese patients with schizophrenia and 330 well-matched healthy controls.	NDUFS7	schizophrenia	374291	HP_0100753	223	229	279	292	False
26786290	The genes with the highest number of hypermethylated CpG sites in INRG M tumors are TERT, PCDHGA4, DLX5, and DLX6-AS1.	TERT	tumor	7015	HP_0002664	84	88	73	78	True
26786290	The genes with the highest number of hypermethylated CpG sites in INRG M tumors are TERT, PCDHGA4, DLX5, and DLX6-AS1.	DLX6	tumor	1750	HP_0002664	109	113	73	78	False
26786290	The genes with the highest number of hypermethylated CpG sites in INRG M tumors are TERT, PCDHGA4, DLX5, and DLX6-AS1.	AS	tumor	3106	HP_0002664	114	116	73	78	False
26786290	For validation, we used a set of independent tumors previously analyzed with the Illumina 27K methylation arrays, which confirmed the differentially methylated sites.	set	tumor	6418	HP_0002664	26	29	45	50	False
29724721	The second most frequently mutated gene, histone methyltransferase <i>SETD2</i>, has known roles in multiple cancers, but has not previously been strongly implicated in osteosarcoma.	SETD2	osteosarcoma	29072	HP_0002669	70	75	169	181	False
29724721	The second most frequently mutated gene, histone methyltransferase <i>SETD2</i>, has known roles in multiple cancers, but has not previously been strongly implicated in osteosarcoma.	SETD2	cancer	29072	HP_0002664	70	75	109	115	True
29724721	This study points to the likely importance of histone modifications in osteosarcoma and highlights the strong genetic similarities between human and dog osteosarcoma, suggesting that canine osteosarcoma may serve as an excellent model for developing treatment strategies in both species.<b>Significance:</b> Canine osteosarcoma genomics identify SETD2 as a possible oncogenic driver of osteosarcoma, and findings establish the canine model as a useful comparative model for the corresponding human disease.	SETD2	osteosarcoma	29072	HP_0002669	346	351	71	83	False
28137912	Our data provide <i>in vivo</i> evidence that <i>L2hgdh</i> mutation leads to L-2-HG accumulation, leukoencephalopathy, and neurodegeneration in mice, thereby offering new insights into the pathophysiology of L-2-HGA in humans	mice	leukoencephalopathy	23581	HP_0002352	145	149	99	118	False
27893709	Here, integrative genomic analysis identified MYST3 as a potential oncogene target that is frequently amplified in breast cancer.	MYST3	cancer	7994	HP_0002664	46	51	122	128	False
27893709	We found that MYST3 was amplified in 11% and/or overexpressed in 15% of breast tumors, and overexpression of MYST3 correlated with worse clinical outcome in estrogen receptor+ (ER+) breast cancers.	MYST3	cancer	7994	HP_0002664	14	19	189	195	False
27893709	We found that MYST3 was amplified in 11% and/or overexpressed in 15% of breast tumors, and overexpression of MYST3 correlated with worse clinical outcome in estrogen receptor+ (ER+) breast cancers.	MYST3	tumors	7994	HP_0002664	14	19	79	85	False
27893709	Interestingly, MYST3 depletion drastically inhibited proliferation in MYST3-high, ER+ breast cancer cells, but not in benign breast epithelial cells or in MYST3-low breast cancer cells.	MYST3	cancer	7994	HP_0002664	15	20	93	99	False
24827421	By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	VARS2	microcephaly	7407	HP_0000252	82	87	108	120	False
24827421	By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	MRC	microcephaly	4345	HP_0000252	210	213	108	120	False
24827421	By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	TARS2	microcephaly	80222	HP_0000252	264	269	108	120	False
24827421	By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	VARS2	epilepsy	7407	HP_0001250	82	87	125	133	True
24827421	By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	MRC	epilepsy	4345	HP_0001250	210	213	125	133	False
24827421	By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	TARS2	epilepsy	80222	HP_0001250	264	269	125	133	False
24827421	By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	VARS2	axial	7407	HP_0025287	82	87	302	307	False
24827421	By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	MRC	axial	4345	HP_0025287	210	213	302	307	False
24827421	By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	TARS2	axial	80222	HP_0025287	264	269	302	307	False
24827421	By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	VARS2	mitochondrial	7407	HP_0001427	82	87	177	190	False
24827421	By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	MRC	mitochondrial	4345	HP_0001427	210	213	177	190	False
24827421	By way of whole-exome sequencing, we identified a homozygous missense mutation in VARS2 in one subject with microcephaly and epilepsy associated with isolated deficiency of the mitochondrial respiratory chain (MRC) complex I and compound heterozygous mutations in TARS2 in two siblings presenting with axial hypotonia and severe psychomotor delay associated with multiple MRC defects.	TARS2	mitochondrial	80222	HP_0001427	264	269	177	190	False
24827421	Expression of the corresponding wild-type transcripts in immortalized mutant fibroblasts rescued the biochemical impairment of mitochondrial respiration and yeast modeling of the VARS2 mutation confirmed its pathogenic role.	VARS2	mitochondrial	7407	HP_0001427	179	184	127	140	False
24827421	Our study reports the first mutations in the VARS2 and TARS2 genes, which encode two mitochondrial aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial encephalopathies.	VARS2	mitochondrial	7407	HP_0001427	45	50	85	98	False
24827421	Our study reports the first mutations in the VARS2 and TARS2 genes, which encode two mitochondrial aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial encephalopathies.	TARS2	mitochondrial	80222	HP_0001427	55	60	85	98	False
24827421	Our study reports the first mutations in the VARS2 and TARS2 genes, which encode two mitochondrial aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial encephalopathies.	VARS2	encephalopathies	7407	HP_0001298	45	50	187	203	False
24827421	Our study reports the first mutations in the VARS2 and TARS2 genes, which encode two mitochondrial aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial encephalopathies.	TARS2	encephalopathies	80222	HP_0001298	55	60	187	203	False
29037804	Fluorescence in situ hybridisation (FISH) targeting specific genes has been used as an ancillary method for differential diagnosis of melanocytic tumours, but most previous studies have focused on non-acral lesions which may have genetic alterations different from acral lesions.	FISH	tumours	9644	HP_0002664	36	40	146	153	False
29037804	Fluorescence in situ hybridisation (FISH) targeting specific genes has been used as an ancillary method for differential diagnosis of melanocytic tumours, but most previous studies have focused on non-acral lesions which may have genetic alterations different from acral lesions.	FISH	acral	9644	HP_0025292	36	40	201	206	False
29037804	We evaluated use of multi-site FISH in the diagnosis of acral melanoma in a series of 82 acral melanocytic tumours.	FISH	tumours	9644	HP_0002664	31	35	107	114	False
29037804	We evaluated use of multi-site FISH in the diagnosis of acral melanoma in a series of 82 acral melanocytic tumours.	FISH	acral	9644	HP_0025292	31	35	56	61	False
29037804	In 44 primary acral melanomas, sensitivity was 70.5% (31/44) using probe set 1 alone, and 59.1% (26/44) using probe set 2 alone.	set	acral	6418	HP_0025292	73	76	14	19	False
29037804	In 44 primary acral melanomas, sensitivity was 70.5% (31/44) using probe set 1 alone, and 59.1% (26/44) using probe set 2 alone.	set	melanomas	6418	HP_0002861	73	76	20	29	False
29037804	In this study FISH exhibited sensitivity and specificity in diagnosis of acral melanoma which allows its application as an auxiliary diagnostic test in acral melanocytic tumours	FISH	acral	9644	HP_0025292	14	18	73	78	False
27143436	Despite significant progress in our understanding of hereditary neurodegenerative diseases, the list of genes associated with early-onset dementia is not yet complete.	set	neurodegenerative diseases	6418	HP_0002180	134	137	64	90	False
30030956	Hearing impairment (HI) caused by mutations in the connexin-26 gene (GJB2) accounts for the majority of cases with inherited, nonsyndromic sensorineural hearing loss.	GJB2	hearing loss	2706	HP_0000365	69	73	153	165	True
30030956	This study describes the first use of PGD for GJB2 associated non-syndromic deafness in Iran.	GJB2	deafness	2706	HP_0000365	46	50	76	84	True
30030956	This study describes the first use of PGD for GJB2 associated non-syndromic deafness in Iran.	PGD	deafness	5226	HP_0000365	38	41	76	84	False
30030956	GJB2 donor splicing site IVS1+1G&amp;gt;A mutation analysis was performed using Sanger sequencing for a total of 71 Iranian families with at least 1 deaf child diagnosed with non-syndromic deafness.	GJB2	deafness	2706	HP_0000365	0	4	189	197	True
30030956	This is the first report of a successful application of PGD for hearing loss in Iran.	PGD	hearing loss	5226	HP_0000365	56	59	64	76	False
28695418	We identified 568 proteins in the CSF of infants with spina bifida, which is the most common type of NTD.	type	spina bifida	6445	HP_0002414	93	97	54	66	False
29903538	ATP13A2 mutations are rare cause of autosomal recessive juvenile-onset Parkinson disease.	ATP13A2	autosomal recessive	23400	HP_0000007	0	7	36	55	True
22951595	We further replicated pleiotropic associations of GYS2 in a childhood obesity study (n=482) and in a gestational diabetes study (n=1710), respectively.	GYS2	obesity	2998	HP_0001513	50	54	70	77	False
30015898	While mutations in TMEM165 are known to cause human 'congenital disorders of glycosylation', a recessive autosomal metabolic disease, the potential association of this protein with human cancer development has not been explored to date.	TMEM165	cancer	55858	HP_0002664	19	26	187	193	False
30015898	In the present study, we revealed that TMEM165 is overexpressed in HCC and its depletion weakens the invasive activity of cancer cells through suppression of matrix metalloproteinase2 (MMP2) expression.	TMEM165	cancer	55858	HP_0002664	39	46	122	128	False
30015898	In the present study, we revealed that TMEM165 is overexpressed in HCC and its depletion weakens the invasive activity of cancer cells through suppression of matrix metalloproteinase2 (MMP2) expression.	HCC	cancer	84668	HP_0002664	67	70	122	128	False
30252186	Mutations in the KARS gene, which encodes both the cytosolic and mitochondrial isoform of lysyl-tRNA synthetase, cause predominantly neurological diseases that often involve deafness, but have also been linked to cardiomyopathy, developmental delay, and lactic acidosis.	KARS	deafness	3735	HP_0000365	17	21	174	182	True
30252186	Mutations in the KARS gene, which encodes both the cytosolic and mitochondrial isoform of lysyl-tRNA synthetase, cause predominantly neurological diseases that often involve deafness, but have also been linked to cardiomyopathy, developmental delay, and lactic acidosis.	KARS	cardiomyopathy	3735	HP_0001638	17	21	213	227	False
30252186	Mutations in the KARS gene, which encodes both the cytosolic and mitochondrial isoform of lysyl-tRNA synthetase, cause predominantly neurological diseases that often involve deafness, but have also been linked to cardiomyopathy, developmental delay, and lactic acidosis.	KARS	developmental delay	3735	HP_0001263	17	21	229	248	True
30252186	Mutations in the KARS gene, which encodes both the cytosolic and mitochondrial isoform of lysyl-tRNA synthetase, cause predominantly neurological diseases that often involve deafness, but have also been linked to cardiomyopathy, developmental delay, and lactic acidosis.	KARS	lactic acidosis	3735	HP_0003128	17	21	254	269	False
30728889	To date, researchers have discovered that Nrf2 deletion results in high susceptibility and severity of insults in various models of respiratory diseases, including bronchopulmonary dysplasia (BPD), respiratory infections, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), asthma, idiopathic pulmonary fibrosis (IPF), and lung cancer.	Nrf2	cancer	2551	HP_0002664	42	46	366	372	False
30728889	To date, researchers have discovered that Nrf2 deletion results in high susceptibility and severity of insults in various models of respiratory diseases, including bronchopulmonary dysplasia (BPD), respiratory infections, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), asthma, idiopathic pulmonary fibrosis (IPF), and lung cancer.	COPD	cancer	372	HP_0002664	305	309	366	372	False
26708751	We report four individuals from three unrelated families who have homozygous missense or compound heterozygous truncating mutations in UNC80 and persistent hypotonia, encephalopathy, growth failure, and severe intellectual disability.	UNC80	encephalopathy	285175	HP_0001298	135	140	167	181	True
26708751	We report four individuals from three unrelated families who have homozygous missense or compound heterozygous truncating mutations in UNC80 and persistent hypotonia, encephalopathy, growth failure, and severe intellectual disability.	UNC80	intellectual disability	285175	HP_0001249	135	140	210	233	True
30684871	Moreover, we demonstrate that TD-428, which comprises TD-106 linked to a BET inhibitor, JQ1 efficiently induce BET protein degradation in the prostate cancer cell line 22Rv1.	BET	cancer	92737	HP_0002664	73	76	151	157	False
29267478	Mutations in GJB2 or GJB6 and the mitochondrial A7445G mutation, known to be the major causes of diverse Inherited Palmoplantar Keratodermas -hearing loss syndromes were not detected by Sanger sequencing.	GJB2	hearing loss	2706	HP_0000365	13	17	142	154	True
29267478	Mutations in GJB2 or GJB6 and the mitochondrial A7445G mutation, known to be the major causes of diverse Inherited Palmoplantar Keratodermas -hearing loss syndromes were not detected by Sanger sequencing.	GJB6	hearing loss	10804	HP_0000365	21	25	142	154	True
30562637	Colorectal cancer cell lines with CHFR methylation demonstrated increased sensitivity to irinotecan.	CHFR	cancer	55743	HP_0002664	34	38	11	17	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	ATP7A	macrocephaly	538	HP_0000256	111	116	508	520	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	COG7	macrocephaly	91949	HP_0000256	230	234	508	520	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	MACS	macrocephaly	4082	HP_0000256	559	563	508	520	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	Rab	macrocephaly	3267	HP_0000256	590	593	508	520	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	RIN2	macrocephaly	54453	HP_0000256	608	612	508	520	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	TALDO1	macrocephaly	6888	HP_0000256	694	700	508	520	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	RAB6	macrocephaly	5870	HP_0000256	768	772	508	520	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	GORAB	macrocephaly	92344	HP_0000256	786	791	508	520	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	SCYL1BP1	macrocephaly	92344	HP_0000256	795	803	508	520	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	PTPN11	macrocephaly	5781	HP_0000256	953	959	508	520	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	HRas	macrocephaly	3265	HP_0000256	971	975	508	520	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	HRAS	macrocephaly	3265	HP_0000256	1000	1004	508	520	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	BRAF	macrocephaly	673	HP_0000256	1054	1058	508	520	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	KRAS	macrocephaly	3845	HP_0000256	1069	1073	508	520	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	SOS2	macrocephaly	6655	HP_0000256	1155	1159	508	520	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	SHOC2	macrocephaly	8036	HP_0000256	1200	1205	508	520	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	NRAS	macrocephaly	4893	HP_0000256	1208	1212	508	520	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	Raf-1	macrocephaly	5894	HP_0000256	1248	1253	508	520	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	RAF1	macrocephaly	5894	HP_0000256	1295	1299	508	520	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	ATP7A	scoliosis	538	HP_0002650	111	116	548	557	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	COG7	scoliosis	91949	HP_0002650	230	234	548	557	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	MACS	scoliosis	4082	HP_0002650	559	563	548	557	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	Rab	scoliosis	3267	HP_0002650	590	593	548	557	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	RIN2	scoliosis	54453	HP_0002650	608	612	548	557	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	TALDO1	scoliosis	6888	HP_0002650	694	700	548	557	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	RAB6	scoliosis	5870	HP_0002650	768	772	548	557	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	GORAB	scoliosis	92344	HP_0002650	786	791	548	557	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	SCYL1BP1	scoliosis	92344	HP_0002650	795	803	548	557	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	PTPN11	scoliosis	5781	HP_0002650	953	959	548	557	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	HRas	scoliosis	3265	HP_0002650	971	975	548	557	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	HRAS	scoliosis	3265	HP_0002650	1000	1004	548	557	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	BRAF	scoliosis	673	HP_0002650	1054	1058	548	557	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	KRAS	scoliosis	3845	HP_0002650	1069	1073	548	557	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	SOS2	scoliosis	6655	HP_0002650	1155	1159	548	557	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	SHOC2	scoliosis	8036	HP_0002650	1200	1205	548	557	False
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	NRAS	scoliosis	4893	HP_0002650	1208	1212	548	557	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	Raf-1	scoliosis	5894	HP_0002650	1248	1253	548	557	True
28409271	Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	RAF1	scoliosis	5894	HP_0002650	1295	1299	548	557	True
27819674	Metaplastic breast carcinoma is an aggressive form of invasive breast cancer with histological evidence of epithelial to mesenchymal transition (EMT).	EMT	breast carcinoma	3702	HP_0003002	145	148	12	28	False
27819674	Metaplastic breast carcinoma is an aggressive form of invasive breast cancer with histological evidence of epithelial to mesenchymal transition (EMT).	EMT	cancer	3702	HP_0002664	145	148	70	76	True
27819674	Here we show that CCN6 (WISP3), a secreted matricellular protein of the CCN (CYR61/CTGF/NOV) family, is significantly downregulated in clinical samples of human spindle cell metaplastic breast carcinoma.	CCN6	breast carcinoma	8838	HP_0003002	18	22	186	202	False
27819674	Here we show that CCN6 (WISP3), a secreted matricellular protein of the CCN (CYR61/CTGF/NOV) family, is significantly downregulated in clinical samples of human spindle cell metaplastic breast carcinoma.	WISP3	breast carcinoma	8838	HP_0003002	24	29	186	202	False
27819674	Ccn6<sup>fl/fl</sup>;MMTV-Cre mice developed invasive high grade mammary carcinomas with bona fide EMT, histologically similar to human metaplastic breast carcinomas.	EMT	breast carcinoma	3702	HP_0003002	99	102	148	164	False
27819674	Ccn6<sup>fl/fl</sup>;MMTV-Cre mice developed invasive high grade mammary carcinomas with bona fide EMT, histologically similar to human metaplastic breast carcinomas.	Ccn6	breast carcinoma	8838	HP_0003002	0	4	148	164	False
27819674	Ccn6<sup>fl/fl</sup>;MMTV-Cre mice developed invasive high grade mammary carcinomas with bona fide EMT, histologically similar to human metaplastic breast carcinomas.	mice	breast carcinoma	23581	HP_0003002	30	34	148	164	False
25964267	Erythrokeratodermia variabilis et progressiva (EKVP) is a genodermatosis with clinical and genetic heterogeneity, most often transmitted in an autosomal dominant manner, caused by mutations in GJB3 and GJB4 genes encoding connexins (Cx)31 and 30.3, respectively.	GJB3	heterogeneity	2707	HP_0001425	193	197	99	112	False
25964267	Erythrokeratodermia variabilis et progressiva (EKVP) is a genodermatosis with clinical and genetic heterogeneity, most often transmitted in an autosomal dominant manner, caused by mutations in GJB3 and GJB4 genes encoding connexins (Cx)31 and 30.3, respectively.	GJB4	heterogeneity	127534	HP_0001425	202	206	99	112	False
25964267	These results expand the genetic heterogeneity of EKVP and the human disease phenotypes associated with GJA1 mutations.	GJA1	heterogeneity	2697	HP_0001425	104	108	33	46	False
28377405	Although open hERG1 channels did not interact as strongly with <sub>1</sub> integrins as did closed channels, current flow through hERG1 channels was necessary to activate the integrin-dependent phosphorylation of Tyr<sup>397</sup> in focal adhesion kinase (FAK) in both normal and cancer cells.	FAK	cancer	5747	HP_0002664	259	262	283	289	False
28377405	In immunodeficient mice, proliferation was inhibited in breast cancer cells expressing forms of hERG1 with impaired K<sup>+</sup> flow, whereas metastasis of breast cancer cells was reduced when the hERG1/<sub>1</sub> integrin interaction was disrupted.	mice	cancer	23581	HP_0002664	19	23	63	69	False
24365204	As a result, we identified one gene set with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (GRM5), GABAergic genes (GABRB1, GABARAP) and genes located in the MHC region (HLA-C, TAP2, HIST1H1B).	set	schizophrenia	6418	HP_0100753	36	39	90	103	False
24365204	As a result, we identified one gene set with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (GRM5), GABAergic genes (GABRB1, GABARAP) and genes located in the MHC region (HLA-C, TAP2, HIST1H1B).	GRM5	schizophrenia	2915	HP_0100753	236	240	90	103	False
24365204	As a result, we identified one gene set with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (GRM5), GABAergic genes (GABRB1, GABARAP) and genes located in the MHC region (HLA-C, TAP2, HIST1H1B).	GABRB1	schizophrenia	2560	HP_0100753	260	266	90	103	False
24365204	As a result, we identified one gene set with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (GRM5), GABAergic genes (GABRB1, GABARAP) and genes located in the MHC region (HLA-C, TAP2, HIST1H1B).	GABARAP	schizophrenia	11337	HP_0100753	268	275	90	103	False
24365204	As a result, we identified one gene set with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (GRM5), GABAergic genes (GABRB1, GABARAP) and genes located in the MHC region (HLA-C, TAP2, HIST1H1B).	HLA-C	schizophrenia	3107	HP_0100753	314	319	90	103	False
24365204	As a result, we identified one gene set with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (GRM5), GABAergic genes (GABRB1, GABARAP) and genes located in the MHC region (HLA-C, TAP2, HIST1H1B).	TAP2	schizophrenia	266629	HP_0100753	321	325	90	103	False
24365204	As a result, we identified one gene set with a joint effect significantly associated with schizophrenia and gene expression profiling analysis suggested that they were mainly neuro- and immune-related genes, such as glutamatergic gene (GRM5), GABAergic genes (GABRB1, GABARAP) and genes located in the MHC region (HLA-C, TAP2, HIST1H1B).	HIST1H1B	schizophrenia	3009	HP_0100753	327	335	90	103	False
24365204	In our study, we identified a set of susceptibility genes that had been missed in single-marker GWAS, and our findings could promote the study of the genetic mechanisms in schizophrenia.	set	schizophrenia	6418	HP_0100753	30	33	172	185	False
28544463	This study also identified a de novo c.3015_3027dup frameshift mutation predicting p.Lys1010Glnfs*57 in NEFH from a CMT2 family with an atypical clinical symptom of prominent proximal weakness.	NEFH	proximal	4744	HP_0012840	104	108	175	183	False
28544463	This study also identified a de novo c.3015_3027dup frameshift mutation predicting p.Lys1010Glnfs*57 in NEFH from a CMT2 family with an atypical clinical symptom of prominent proximal weakness.	CMT2	proximal	23095	HP_0012840	116	120	175	183	False
28544463	Therefore, this study suggests that the stop loss and translational elongations by the 3' UTR of the NEFH mutations may be a relatively frequent genetic cause of axonal peripheral neuropathy with the specific characteristics of proximal dominant weakness	NEFH	proximal	4744	HP_0012840	101	105	228	236	False
28544463	Therefore, this study suggests that the stop loss and translational elongations by the 3' UTR of the NEFH mutations may be a relatively frequent genetic cause of axonal peripheral neuropathy with the specific characteristics of proximal dominant weakness	stop	proximal	4135	HP_0012840	40	44	228	236	False
24895405	BCS is an autosomal recessive generalized connective tissue disorder associated with extreme corneal thinning and a high risk of corneal rupture.	BCS	autosomal recessive	617	HP_0000007	0	3	10	29	True
24895405	Some individuals with heterozygous PRDM5 mutations demonstrate a carrier ocular phenotype, which includes a mildly reduced corneal thickness, keratoconus and blue sclera.	PRDM5	keratoconus	11107	HP_0000563	35	40	142	153	True
24895405	We hypothesized that heterozygous variants in PRDM5 and ZNF469 predispose to the development of isolated keratoconus.	ZNF469	keratoconus	84627	HP_0000563	56	62	105	116	True
24895405	We hypothesized that heterozygous variants in PRDM5 and ZNF469 predispose to the development of isolated keratoconus.	PRDM5	keratoconus	11107	HP_0000563	46	51	105	116	True
24895405	We found a significant enrichment of potentially pathologic heterozygous alleles in ZNF469 associated with the development of keratoconus (P = 0.00102) resulting in a relative risk of 12.0.	ZNF469	keratoconus	84627	HP_0000563	84	90	126	137	True
24895405	This enrichment of rare potentially pathogenic alleles in ZNF469 in 12.5% of keratoconus patients represents a significant mutational load and highlights ZNF469 as the most significant genetic factor responsible for keratoconus identified to date.	ZNF469	keratoconus	84627	HP_0000563	58	64	77	88	True
28973549	JBTS is genetically heterogeneous, however mutations in CEP290 are a common underlying cause.	CEP290	heterogeneous	80184	HP_0001425	56	62	20	33	False
30100047	After a rapid overview of current knowledge regarding somatic genomic alterations, this state-of-art addresses pathways to improve small-cell lung cancer outcome such as the targeting of DNA damage repair mechanisms firstly anti-PARPs, inhibitory molecules of EZH2, derepression of the NOTCH pathway, rovalbituzumab-tesirine, inhibition of serine/threonine Aurora A kinase, temozolomide and its dependence on methylation of the MGMT promoter.	art	cancer	181	HP_0002664	97	100	147	153	False
30100047	After a rapid overview of current knowledge regarding somatic genomic alterations, this state-of-art addresses pathways to improve small-cell lung cancer outcome such as the targeting of DNA damage repair mechanisms firstly anti-PARPs, inhibitory molecules of EZH2, derepression of the NOTCH pathway, rovalbituzumab-tesirine, inhibition of serine/threonine Aurora A kinase, temozolomide and its dependence on methylation of the MGMT promoter.	damage	cancer	51438	HP_0002664	191	197	147	153	False
30100047	After a rapid overview of current knowledge regarding somatic genomic alterations, this state-of-art addresses pathways to improve small-cell lung cancer outcome such as the targeting of DNA damage repair mechanisms firstly anti-PARPs, inhibitory molecules of EZH2, derepression of the NOTCH pathway, rovalbituzumab-tesirine, inhibition of serine/threonine Aurora A kinase, temozolomide and its dependence on methylation of the MGMT promoter.	EZH2	cancer	2146	HP_0002664	260	264	147	153	False
30100047	After a rapid overview of current knowledge regarding somatic genomic alterations, this state-of-art addresses pathways to improve small-cell lung cancer outcome such as the targeting of DNA damage repair mechanisms firstly anti-PARPs, inhibitory molecules of EZH2, derepression of the NOTCH pathway, rovalbituzumab-tesirine, inhibition of serine/threonine Aurora A kinase, temozolomide and its dependence on methylation of the MGMT promoter.	MGMT	cancer	4255	HP_0002664	428	432	147	153	True
30807555	We investigated glioma-associated oncogene protein-1 (Gli-1) expression in human esophageal carcinoma tissue and the inhibition of cyclopamine on EC9706 esophageal carcinoma cell growth.	Gli	esophageal carcinoma	2735	HP_0011459	54	57	81	101	False
30807555	We investigated glioma-associated oncogene protein-1 (Gli-1) expression in human esophageal carcinoma tissue and the inhibition of cyclopamine on EC9706 esophageal carcinoma cell growth.	Gli	glioma	2735	HP_0009733	54	57	16	22	False
30807555	MATERIAL AND METHODS Gli-1 in tumor tissue was measured by immunohistochemistry (IHC).	Gli	tumor	2735	HP_0002664	21	24	30	35	True
30807555	RESULTS Gli-1 was associated with patient age, gender, lymphatic metastasis, tumor recurrence, and stage, with significantly (P&lt;0.05) positive correlations with age, lymphatic metastasis, tumor recurrence, and stage.	Gli	tumor	2735	HP_0002664	8	11	77	82	True
30807555	CONCLUSIONS Gli-1 is highly expressed in human esophageal carcinoma, and could be a marker for use in assessing tumor stage and the deciding on treatment target	Gli	esophageal carcinoma	2735	HP_0011459	12	15	47	67	False
30807555	CONCLUSIONS Gli-1 is highly expressed in human esophageal carcinoma, and could be a marker for use in assessing tumor stage and the deciding on treatment target	Gli	tumor	2735	HP_0002664	12	15	112	117	True
30110925	Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common inherited motor and sensory neuropathy, and is caused by duplication of <i>PMP22</i>, alterations of which are a characteristic feature of demyelination.	type	neuropathy	6445	HP_0009830	28	32	91	101	False
30110925	The clinical phenotype of CMT1A is determined by the degree of axonal loss, and patients suffer from progressive muscle weakness and impaired sensation.	type	axonal loss	6445	HP_0003447	18	22	63	74	False
28432734	The presence of minor loss-of-function variants in WFS1 predicted isolated diabetes, isolated deafness, or isolated congenital cataracts without development of the full syndrome (sensitivity 100% [93%-100%]; specificity 78% [73%-82%]).	WFS1	deafness	7466	HP_0000365	51	55	94	102	True
28432734	The presence of minor loss-of-function variants in WFS1 predicted isolated diabetes, isolated deafness, or isolated congenital cataracts without development of the full syndrome (sensitivity 100% [93%-100%]; specificity 78% [73%-82%]).	minor	deafness	8013	HP_0000365	16	21	94	102	False
28432734	The presence of minor loss-of-function variants in WFS1 predicted isolated diabetes, isolated deafness, or isolated congenital cataracts without development of the full syndrome (sensitivity 100% [93%-100%]; specificity 78% [73%-82%]).	WFS1	cataracts	7466	HP_0000518	51	55	127	136	True
28432734	The presence of minor loss-of-function variants in WFS1 predicted isolated diabetes, isolated deafness, or isolated congenital cataracts without development of the full syndrome (sensitivity 100% [93%-100%]; specificity 78% [73%-82%]).	minor	cataracts	8013	HP_0000518	16	21	127	136	False
28746897	Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	mice	incoordination	23581	HP_0002311	130	134	236	250	False
28746897	Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	DAT	incoordination	6531	HP_0002311	307	310	236	250	False
28746897	Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	LMX1B	incoordination	4010	HP_0002311	312	317	236	250	False
28746897	Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	Nurr1	incoordination	4929	HP_0002311	319	324	236	250	False
28746897	Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	Pitx3	incoordination	5309	HP_0002311	326	331	236	250	False
28746897	Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	mice	stereotypy	23581	HP_0000733	130	134	255	265	False
28746897	Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	DAT	stereotypy	6531	HP_0000733	307	310	255	265	False
28746897	Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	LMX1B	stereotypy	4010	HP_0000733	312	317	255	265	False
28746897	Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	Nurr1	stereotypy	4929	HP_0000733	319	324	255	265	False
28746897	Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19months of age results in nigrostriatal hypodopaminergia associated with locomotor incoordination and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, Nurr1, Pitx3 and DJ-1 mRNA and/or protein; overproduction of -synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	Pitx3	stereotypy	5309	HP_0000733	326	331	255	265	False
28746897	The neurophenotype of these GFAP.HMOX1<sup>8.5-19m</sup> mice is highly consistent with parkinsonism and differs dramatically from the schizophrenia-like features previously documented in younger GFAP.HMOX1<sup>0-12m</sup> mice.	mice	parkinsonism	23581	HP_0001300	57	61	88	100	False
30115896	This study investigates the soluble factors released by tumor-associated dendritic cells (TADCs) responsible for increasing cancer stem cell (CSC) properties, cell mobility, and epithelial-to-mesenchymal transition (EMT).	EMT	tumor	3702	HP_0002664	216	219	56	61	True
30115896	This study investigates the soluble factors released by tumor-associated dendritic cells (TADCs) responsible for increasing cancer stem cell (CSC) properties, cell mobility, and epithelial-to-mesenchymal transition (EMT).	EMT	cancer	3702	HP_0002664	216	219	124	130	True
30115896	Dendritic cells (DCs) of colon cancer patients were collected for phenotype and CXCL1 expression by flow cytometry and Luminex assays.	CXCL1	cancer	2919	HP_0002664	80	85	31	37	False
30115896	The transcriptome of CXCL1-treated cancer cells was established by next generation sequencing.	CXCL1	cancer	2919	HP_0002664	21	26	35	41	False
30115896	Inflammatory chemokine CXCL1, present in large amounts in DCs isolated from colon cancer patients, and SW620-conditioned TADCs, enhance CSC characteristics in cancer, supported by enhanced anchorage-independent growth, CD133 expression and aldehyde dehydrogenase activity.	CXCL1	cancer	2919	HP_0002664	23	28	82	88	False
30115896	Additionally, CXCL1 increases the metastatic ability of a cancer by enhancing cell migration, matrix metalloproteinase-7 expression and EMT.	EMT	cancer	3702	HP_0002664	136	139	58	64	True
30115896	Additionally, CXCL1 increases the metastatic ability of a cancer by enhancing cell migration, matrix metalloproteinase-7 expression and EMT.	CXCL1	cancer	2919	HP_0002664	14	19	58	64	False
30115896	The enhanced CXCL1 expression in DCs is also noted in mice transplanted with colon cancer cells.	CXCL1	cancer	2919	HP_0002664	13	18	83	89	False
30115896	The enhanced CXCL1 expression in DCs is also noted in mice transplanted with colon cancer cells.	mice	cancer	23581	HP_0002664	54	58	83	89	False
30115896	Transcriptome analysis of CXCL1-treated SW620 cells indicates that CXCL1 increases potential oncogene expression in colon cancer, including <i>PTHLH</i>, <i>TYRP1</i>, <i>FOXO1</i>, <i>TCF4</i> and <i>ZNF880</i>.	CXCL1	cancer	2919	HP_0002664	26	31	122	128	False
30115896	Concurrently, CXCL1 displays a specific microRNA (miR) upregulated by the prototypical colon cancer onco-miR miR-105.	CXCL1	cancer	2919	HP_0002664	14	19	93	99	False
30115896	Concurrently, CXCL1 displays a specific microRNA (miR) upregulated by the prototypical colon cancer onco-miR miR-105.	miR	cancer	220972	HP_0002664	50	53	93	99	False
30115896	Analysis of publicly available data reveals CXCL1-driven oncogenes and miR-105 have a negative prognostic impact on the outcome of colon cancer.	CXCL1	cancer	2919	HP_0002664	44	49	137	143	False
30115896	Analysis of publicly available data reveals CXCL1-driven oncogenes and miR-105 have a negative prognostic impact on the outcome of colon cancer.	miR	cancer	220972	HP_0002664	71	74	137	143	False
30115896	Analysis of publicly available data reveals CXCL1-driven oncogenes and miR-105 have a negative prognostic impact on the outcome of colon cancer.	impact	cancer	55364	HP_0002664	106	112	137	143	False
26952864	We observed odds ratios (ORs) of 1.7-2.3 for lung cancer (LC; P=4.0  10(-4)), chronic obstructive pulmonary disease (COPD; P=9.3  10(-4)), peripheral artery disease (PAD; P=0.090) and abdominal aortic aneurysms (AAAs; P=0.12), and the variant associates strongly with the early-onset forms of LC (OR=4.49, P=2.2  10(-4)), COPD (OR=3.22, P=2.9  10(-4)), PAD (OR=3.47, P=9.2  10(-3)) and AAA (OR=6.44, P=6.3  10(-3)).	COPD	cancer	372	HP_0002664	118	122	50	56	False
26952864	We observed odds ratios (ORs) of 1.7-2.3 for lung cancer (LC; P=4.0  10(-4)), chronic obstructive pulmonary disease (COPD; P=9.3  10(-4)), peripheral artery disease (PAD; P=0.090) and abdominal aortic aneurysms (AAAs; P=0.12), and the variant associates strongly with the early-onset forms of LC (OR=4.49, P=2.2  10(-4)), COPD (OR=3.22, P=2.9  10(-4)), PAD (OR=3.47, P=9.2  10(-3)) and AAA (OR=6.44, P=6.3  10(-3)).	AAAs	cancer	8086	HP_0002664	214	218	50	56	False
26952864	We observed odds ratios (ORs) of 1.7-2.3 for lung cancer (LC; P=4.0  10(-4)), chronic obstructive pulmonary disease (COPD; P=9.3  10(-4)), peripheral artery disease (PAD; P=0.090) and abdominal aortic aneurysms (AAAs; P=0.12), and the variant associates strongly with the early-onset forms of LC (OR=4.49, P=2.2  10(-4)), COPD (OR=3.22, P=2.9  10(-4)), PAD (OR=3.47, P=9.2  10(-3)) and AAA (OR=6.44, P=6.3  10(-3)).	PAD	cancer	79665	HP_0002664	168	171	50	56	False
26952864	We observed odds ratios (ORs) of 1.7-2.3 for lung cancer (LC; P=4.0  10(-4)), chronic obstructive pulmonary disease (COPD; P=9.3  10(-4)), peripheral artery disease (PAD; P=0.090) and abdominal aortic aneurysms (AAAs; P=0.12), and the variant associates strongly with the early-onset forms of LC (OR=4.49, P=2.2  10(-4)), COPD (OR=3.22, P=2.9  10(-4)), PAD (OR=3.47, P=9.2  10(-3)) and AAA (OR=6.44, P=6.3  10(-3)).	COPD	aortic aneurysms	372	HP_0004942	118	122	196	212	False
26952864	We observed odds ratios (ORs) of 1.7-2.3 for lung cancer (LC; P=4.0  10(-4)), chronic obstructive pulmonary disease (COPD; P=9.3  10(-4)), peripheral artery disease (PAD; P=0.090) and abdominal aortic aneurysms (AAAs; P=0.12), and the variant associates strongly with the early-onset forms of LC (OR=4.49, P=2.2  10(-4)), COPD (OR=3.22, P=2.9  10(-4)), PAD (OR=3.47, P=9.2  10(-3)) and AAA (OR=6.44, P=6.3  10(-3)).	AAAs	aortic aneurysms	8086	HP_0004942	214	218	196	212	False
26952864	We observed odds ratios (ORs) of 1.7-2.3 for lung cancer (LC; P=4.0  10(-4)), chronic obstructive pulmonary disease (COPD; P=9.3  10(-4)), peripheral artery disease (PAD; P=0.090) and abdominal aortic aneurysms (AAAs; P=0.12), and the variant associates strongly with the early-onset forms of LC (OR=4.49, P=2.2  10(-4)), COPD (OR=3.22, P=2.9  10(-4)), PAD (OR=3.47, P=9.2  10(-3)) and AAA (OR=6.44, P=6.3  10(-3)).	PAD	aortic aneurysms	79665	HP_0004942	168	171	196	212	False
22659691	Image degradation by loss of higher spatial frequencies causes form-deprivation myopia (FDM) in humans and animals, and cyclical illumination (flicker) at certain frequencies may prevent FDM.	spatial	myopia	219793	HP_0000545	36	43	80	86	False
30747231	Clinical trials have revealed that inhibition of sonic Hedgehog (SHH) signaling or histone deacetylase (HDAC) holds promise as a treatment for liver cancer.	SHH	cancer	6469	HP_0002664	65	68	149	155	True
30747231	Clinical trials have revealed that inhibition of sonic Hedgehog (SHH) signaling or histone deacetylase (HDAC) holds promise as a treatment for liver cancer.	HDAC	cancer	9734	HP_0002664	104	108	149	155	False
30747231	The results revealed that the dual use of the SHH inhibitor and the HDAC inhibitor effectively synergized to inhibit proliferation, and promote apoptosis in liver cancer cells.	SHH	cancer	6469	HP_0002664	46	49	163	169	True
30747231	The results revealed that the dual use of the SHH inhibitor and the HDAC inhibitor effectively synergized to inhibit proliferation, and promote apoptosis in liver cancer cells.	HDAC	cancer	9734	HP_0002664	68	72	163	169	False
28895923	Beyond secretion, GUCY2C is a tumor suppressor universally silenced by loss of expression of its paracrine hormone during carcinogenesis.	GUCY2C	tumor	2984	HP_0002664	18	24	30	35	False
28895923	Thus, the geographic imbalance in colorectal cancer, in part, may reflect chronic exposure to ST-producing organisms that restore GUCY2C signaling silenced by hormone loss during transformation.	GUCY2C	cancer	2984	HP_0002664	130	136	45	51	False
28895923	Moreover, mice colonized with ST-producing <i>E. coli</i> exhibited a 50% reduction in carcinogen-induced colorectal tumor burden.	mice	tumor	23581	HP_0002664	10	14	117	122	False
28895923	Thus, chronic colonization with <i>ETEC</i> producing ST could contribute to endemic cancer resistance in developing countries, reinforcing a novel paradigm of colorectal cancer chemoprevention with oral GUCY2C-targeted agents	GUCY2C	cancer	2984	HP_0002664	204	210	85	91	False
23200864	By using exome and capillary sequencing, we here identify biallelic UBE3B mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels.	UBE3B	blepharophimosis	89910	HP_0000581	68	73	165	181	True
23200864	By using exome and capillary sequencing, we here identify biallelic UBE3B mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels.	UBE3B	developmental delay	89910	HP_0001263	68	73	239	258	True
23200864	By using exome and capillary sequencing, we here identify biallelic UBE3B mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels.	UBE3B	small head circumference	89910	HP_0000252	68	73	286	310	True
23200864	By using exome and capillary sequencing, we here identify biallelic UBE3B mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels.	UBE3B	facial dysmorphisms	89910	HP_0001999	68	73	312	331	True
24608572	One upregulated candidate named transmembrane protein 98 (TMEM98) was found to be overexpressed in 80 of 118 (67.80%) of patients with hepatocellular carcinoma.	TMEM98	hepatocellular carcinoma	26022	HP_0001402	58	64	135	159	False
24608572	TMEM98 mRNA in tumor tissues was significantly higher than nontumor tissues of patients with hepatocellular carcinoma (P &lt; 0.0001).	TMEM98	hepatocellular carcinoma	26022	HP_0001402	0	6	93	117	False
24608572	TMEM98 mRNA in tumor tissues was significantly higher than nontumor tissues of patients with hepatocellular carcinoma (P &lt; 0.0001).	TMEM98	tumor	26022	HP_0002664	0	6	15	20	False
24608572	Upregulation of TMEM98 was significantly correlated with advanced tumor stage (P = 0.048), high incidence of early tumor recurrence (P = 0.005), poor overall survival (P = 0.029), and poor disease-free survival (P = 0.011) of patients with hepatocellular carcinoma after hepatectomy.	TMEM98	hepatocellular carcinoma	26022	HP_0001402	16	22	240	264	False
24608572	Upregulation of TMEM98 was significantly correlated with advanced tumor stage (P = 0.048), high incidence of early tumor recurrence (P = 0.005), poor overall survival (P = 0.029), and poor disease-free survival (P = 0.011) of patients with hepatocellular carcinoma after hepatectomy.	TMEM98	tumor	26022	HP_0002664	16	22	66	71	False
24608572	Importantly, upregulation of TMEM98 mRNA in patients with hepatocellular carcinoma who received transarterial chemoembolization (TACE) treatment was significantly higher than in patients without TACE treatment (P = 0.046).	TMEM98	hepatocellular carcinoma	26022	HP_0001402	29	35	58	82	False
24608572	Importantly, upregulation of TMEM98 mRNA in patients with hepatocellular carcinoma who received transarterial chemoembolization (TACE) treatment was significantly higher than in patients without TACE treatment (P = 0.046).	TACE	hepatocellular carcinoma	6868	HP_0001402	129	133	58	82	False
24608572	In vitro and in vivo studies showed that suppression of TMEM98 in chemoresistant hepatocellular carcinoma cells restored their chemosensitivity, while forced overexpression of TMEM98 enhanced their chemoresistance.	TMEM98	hepatocellular carcinoma	26022	HP_0001402	56	62	81	105	False
24608572	The mechanism of TMEM98 in conferring chemoresistance of hepatocellular carcinoma might be possibly through activation of the AKT pathway and deactivation of p53.	TMEM98	hepatocellular carcinoma	26022	HP_0001402	17	23	57	81	False
24608572	The mechanism of TMEM98 in conferring chemoresistance of hepatocellular carcinoma might be possibly through activation of the AKT pathway and deactivation of p53.	AKT	hepatocellular carcinoma	207	HP_0001402	126	129	57	81	False
28344334	Disease associated KIF1A mutations have been associated with motor and sensory dysfunctions as well as non-syndromic intellectual disability in humans.	KIF1A	intellectual disability	547	HP_0001249	19	24	117	140	True
28801648	Primary ciliary dyskinesia (PCD) is clinically characterized by neonatal respiratory distress, chronic sinusitis, bronchiectasis and infertility, and situs inversus in 50% of the patients.	PCD	ciliary dyskinesia	352909	HP_0012265	28	31	8	26	True
28801648	Primary ciliary dyskinesia (PCD) is clinically characterized by neonatal respiratory distress, chronic sinusitis, bronchiectasis and infertility, and situs inversus in 50% of the patients.	PCD	respiratory distress	352909	HP_0002098	28	31	73	93	True
28801648	PCD is a result of mutations in genes encoding proteins involved in ciliary function, and is primarily inherited in an autosomal recessive fashion.	PCD	autosomal recessive	352909	HP_0000007	0	3	119	138	True
28801648	Diagnosis of PCD is often a challenging task due to its high clinical and genetic heterogeneities.	PCD	heterogeneities	352909	HP_0001425	13	16	82	97	False
28801648	Diagnosis of PCD is often a challenging task due to its high clinical and genetic heterogeneities.	task	heterogeneities	3777	HP_0001425	40	44	82	97	False
30561139	A 9-month-old intact crossbred female cat was presented with jaundice, intermittent anorexia and lethargy, increased hepatic enzyme activities, and hyperammonemia.	cat	hyperammonemia	847	HP_0001987	38	41	148	162	False
29196973	Moreover, the novel mutation, p.R414C, adds up to the literature for the infantile-onset form of autosomal recessive ataxia associated with SPTBN2.	SPTBN2	autosomal recessive	6712	HP_0000007	140	146	97	116	True
29196973	Moreover, the novel mutation, p.R414C, adds up to the literature for the infantile-onset form of autosomal recessive ataxia associated with SPTBN2.	SPTBN2	ataxia	6712	HP_0001251	140	146	117	123	True
29227965	For combined mothers' and fathers' attained age, 10 loci were associated (p&lt;5*10<sup>-8</sup>), including 8 previously identified for traits including survival, Alzheimer's and cardiovascular disease.	traits	cardiovascular disease	55929	HP_0001626	137	143	180	202	False
29432535	The importance of PKC enzymes in Purkinje neuron health is apparent as mutations in PRKCG (encoding PKC) cause cerebellar ataxia.	PRKCG	cerebellar ataxia	5582	HP_0001251	84	89	112	129	True
29432535	PRKCG has also been identified as an important node in ataxia gene networks more broadly, but the functional role of PKC in other forms of ataxia remains unexplored, and the mechanisms by which PKC isozymes regulate Purkinje neuron health are not well understood.	PRKCG	ataxia	5582	HP_0001251	0	5	55	61	True
29432535	Using mouse models of spinocerebellar ataxia type 1 (SCA1) and 2 (SCA2) we identify an increase in PKC-mediated substrate phosphorylation in two different forms of inherited cerebellar ataxia.	type	cerebellar ataxia	6445	HP_0001251	45	49	27	44	False
29432535	Using mouse models of spinocerebellar ataxia type 1 (SCA1) and 2 (SCA2) we identify an increase in PKC-mediated substrate phosphorylation in two different forms of inherited cerebellar ataxia.	SCA1	cerebellar ataxia	6310	HP_0001251	53	57	27	44	True
29432535	Using mouse models of spinocerebellar ataxia type 1 (SCA1) and 2 (SCA2) we identify an increase in PKC-mediated substrate phosphorylation in two different forms of inherited cerebellar ataxia.	SCA2	cerebellar ataxia	6311	HP_0001251	66	70	27	44	True
27089054	The study of the immunome of prostate cancer (PCa) and characterization of autoantibody signature from differentially reactive antigens can uncover disease stage proteins, reveal enriched networks and even expose aberrant cellular mechanisms during the disease process.	PCa	cancer	28982	HP_0002664	46	49	38	44	False
27089054	Herewith we provide a biological and pathophysiological characterization of the immunological layer of cancerous (PCa) versus benign (BPH) disease, derived from antibody profiling on protein microarrays	PCa	cancer	28982	HP_0002664	114	117	103	109	False
27380241	These disorders include cancer, bipolar disorder, schizophrenia, autism, Cri-du-chat syndrome, myopia, cortical cataract-linked Alzheimer's disease, and infectious diseases.	chat	cancer	1103	HP_0002664	80	84	24	30	False
27380241	These disorders include cancer, bipolar disorder, schizophrenia, autism, Cri-du-chat syndrome, myopia, cortical cataract-linked Alzheimer's disease, and infectious diseases.	chat	bipolar disorder	1103	HP_0007302	80	84	32	48	False
27380241	These disorders include cancer, bipolar disorder, schizophrenia, autism, Cri-du-chat syndrome, myopia, cortical cataract-linked Alzheimer's disease, and infectious diseases.	chat	schizophrenia	1103	HP_0100753	80	84	50	63	False
27380241	These disorders include cancer, bipolar disorder, schizophrenia, autism, Cri-du-chat syndrome, myopia, cortical cataract-linked Alzheimer's disease, and infectious diseases.	chat	autism	1103	HP_0000717	80	84	65	71	False
27380241	These disorders include cancer, bipolar disorder, schizophrenia, autism, Cri-du-chat syndrome, myopia, cortical cataract-linked Alzheimer's disease, and infectious diseases.	chat	myopia	1103	HP_0000545	80	84	95	101	False
27380241	These disorders include cancer, bipolar disorder, schizophrenia, autism, Cri-du-chat syndrome, myopia, cortical cataract-linked Alzheimer's disease, and infectious diseases.	chat	cataract	1103	HP_0000518	80	84	112	120	False
28500065	<i>LCAM1</i> and <i>MPDZ</i> (<i>MUPP1</i>) are the only known human gene loci associated with non-syndromic hydrocephalus.	MPDZ	hydrocephalus	84708	HP_0000238	20	24	109	122	False
28500065	Global <i>Mpdz</i> gene deletion or conditional inactivation in Nestin-positive cells led to formation of supratentorial hydrocephalus in the early postnatal period.	Mpdz	hydrocephalus	84708	HP_0000238	10	14	121	134	False
28500065	This work provides a relevant hydrocephalus mouse model and demonstrates that <i>Mpdz</i> is essential to maintain integrity of the ependyma	Mpdz	hydrocephalus	84708	HP_0000238	81	85	30	43	False
10740212	Subsequent FISH analysis with region-specific YAC clones was used to relate the phenotypic findings such as bilateral split hand formation, specific cardiac and kidney anomalies, microtia, and hypoplastic thorax more exactly to the partial trisomy of the segment 4q26-qter	FISH	bilateral	9644	HP_0012832	11	15	108	117	False
10740212	Subsequent FISH analysis with region-specific YAC clones was used to relate the phenotypic findings such as bilateral split hand formation, specific cardiac and kidney anomalies, microtia, and hypoplastic thorax more exactly to the partial trisomy of the segment 4q26-qter	FISH	microtia	9644	HP_0008551	11	15	179	187	False
27745833	This study establishes PYROXD1 variants as a cause of early-onset myopathy and uses biospecimens and cell lines, yeast, and zebrafish models to elucidate the fundamental role of PYROXD1 in skeletal muscle.	PYROXD1	myopathy	79912	HP_0003198	23	30	66	74	False
27745833	Zebrafish with ryroxD1 knock-down recapitulate features of PYROXD1 myopathy with sarcomeric disorganization, myofibrillar aggregates, and marked swimming defect.	PYROXD1	myopathy	79912	HP_0003198	59	66	67	75	False
27745833	We characterize variants in the oxidoreductase PYROXD1 as a cause of early-onset myopathy with distinctive histopathology and introduce altered redox regulation as a primary cause of congenital muscle disease	PYROXD1	myopathy	79912	HP_0003198	47	54	81	89	False
28189050	Considering the pivotal role of VDR signaling in the colon epithelium both physiologically and pathologically, the correlation between H19 and VDR signaling may have an important role in the development of colon cancer.	VDR	cancer	7421	HP_0002664	32	35	212	218	False
28189050	In this study, the correlation between H19 and vitamin D receptor (VDR) signaling and the underlying mechanisms in colon cancer were investigated both in vitro and in vivo.	VDR	cancer	7421	HP_0002664	67	70	121	127	False
21412954	Hereditary hypotrichosis simplex (HHS) is a form of nonsyndromic inherited hair loss disorders without characteristic hair shaft changes, which has marked genetic and clinical heterogeneity.	HHS	hypotrichosis	2591	HP_0001006	34	37	11	24	False
21412954	Hereditary hypotrichosis simplex (HHS) is a form of nonsyndromic inherited hair loss disorders without characteristic hair shaft changes, which has marked genetic and clinical heterogeneity.	HHS	heterogeneity	2591	HP_0001425	34	37	176	189	False
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	BUB1B	tumor	701	HP_0002664	215	220	551	556	True
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	HURP	tumor	9787	HP_0002664	222	226	551	556	False
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	NEK2	tumor	4751	HP_0002664	228	232	551	556	False
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	damage	tumor	51438	HP_0002664	239	245	551	556	False
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	PBK	tumor	55872	HP_0002664	254	257	551	556	False
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	ATRX	tumor	546	HP_0002664	294	298	551	556	True
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	beta-catenin	tumor	1499	HP_0002664	324	336	551	556	True
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	PTEN	tumor	5728	HP_0002664	366	370	551	556	True
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	mTOR	tumor	2475	HP_0002664	380	384	551	556	False
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	BUB1B	carcinomas	701	HP_0030731	215	220	431	441	False
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	HURP	carcinomas	9787	HP_0030731	222	226	431	441	False
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	NEK2	carcinomas	4751	HP_0030731	228	232	431	441	False
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	damage	carcinomas	51438	HP_0030731	239	245	431	441	False
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	PBK	carcinomas	55872	HP_0030731	254	257	431	441	False
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	ATRX	carcinomas	546	HP_0030731	294	298	431	441	False
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	beta-catenin	carcinomas	1499	HP_0030731	324	336	431	441	False
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	PTEN	carcinomas	5728	HP_0030731	366	370	431	441	True
28877067	We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage repair (PBK, -H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (beta-catenin) and PI3K signaling pathway (PTEN, phospho-mTOR) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	mTOR	carcinomas	2475	HP_0030731	380	384	431	441	False
28877067	IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, ATRX), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.	BUB1B	carcinomas	701	HP_0030731	93	98	275	285	False
28877067	IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, ATRX), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.	HURP	carcinomas	9787	HP_0030731	100	104	275	285	False
28877067	IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, ATRX), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.	NEK2	carcinomas	4751	HP_0030731	106	110	275	285	False
28877067	IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, ATRX), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.	damage	carcinomas	51438	HP_0030731	117	123	275	285	False
28877067	IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, ATRX), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.	PBK	carcinomas	55872	HP_0030731	134	137	275	285	False
28877067	IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, ATRX), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.	ATRX	carcinomas	546	HP_0030731	179	183	275	285	False
28877067	IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, ATRX), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.	beta-catenin	carcinomas	1499	HP_0030731	190	202	275	285	False
28877067	IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, BUB1B, HURP, NEK2), DNA damage proteins (PBK, -H2AX), regulators of telomeres (DAXX, ATRX), and beta-catenin revealed characteristic expression profiles enabling the distinction of carcinomas from adenomas.	DAXX	carcinomas	1616	HP_0030731	173	177	275	285	False
28877067	Angioinvasion defined as tumor cells invading through a vessel wall and intravascular tumor cells admixed with thrombus proved to be the best prognostic parameter, predicting adverse outcome in the entire cohort as well as within low-grade ACCs.	ACC	tumor	31	HP_0002664	240	243	25	30	False
28877067	Angioinvasion defined as tumor cells invading through a vessel wall and intravascular tumor cells admixed with thrombus proved to be the best prognostic parameter, predicting adverse outcome in the entire cohort as well as within low-grade ACCs.	best	tumor	7439	HP_0002664	137	141	25	30	False
28877067	Low mitotic tumor grade, Weiss score, global loss of DAXX expression, and high phospho-mTOR expression correlated with disease-free survival, but Weiss score and biomarkers failed to predict adverse outcome in low-grade disease.	DAXX	tumor	1616	HP_0002664	53	57	12	17	True
28877067	Low mitotic tumor grade, Weiss score, global loss of DAXX expression, and high phospho-mTOR expression correlated with disease-free survival, but Weiss score and biomarkers failed to predict adverse outcome in low-grade disease.	mTOR	tumor	2475	HP_0002664	87	91	12	17	False
27378689	Hypohidrotic ectodermal dysplasia (HED) results from mutation of the EDA, EDAR or EDARADD genes and is characterized by reduced or absent eccrine sweat glands, hair follicles and teeth, and defective formation of salivary, mammary and craniofacial glands.	HED	ectodermal dysplasia	1896	HP_0000968	35	38	13	33	True
27378689	Hypohidrotic ectodermal dysplasia (HED) results from mutation of the EDA, EDAR or EDARADD genes and is characterized by reduced or absent eccrine sweat glands, hair follicles and teeth, and defective formation of salivary, mammary and craniofacial glands.	EDA	ectodermal dysplasia	1896	HP_0000968	69	72	13	33	True
28229505	A recent genome-wide association study (GWAS) linked hypercalciuria and kidney stones to a claudin-14 (CLDN14) risk haplotype.	CLDN14	hypercalciuria	23562	HP_0002150	103	109	53	67	False
28229505	We hypothesized therefore that some children with hypercalciuria and kidney stones harbor a CLDN14 variant that inappropriately increases gene expression.	CLDN14	hypercalciuria	23562	HP_0002150	92	98	50	64	False
28229505	To test this hypothesis, we sequenced the CLDN14 risk haplotype in a cohort of children with idiopathic hypercalciuria and kidney stones.	CLDN14	hypercalciuria	23562	HP_0002150	42	48	104	118	False
28229505	Our data suggest that children with the INSM1 binding site within the CLDN14 risk haplotype have a higher likelihood of hypercalciuria and kidney stones.	CLDN14	hypercalciuria	23562	HP_0002150	70	76	120	134	False
28229505	Our data suggest that children with the INSM1 binding site within the CLDN14 risk haplotype have a higher likelihood of hypercalciuria and kidney stones.	INSM1	hypercalciuria	3642	HP_0002150	40	45	120	134	False
26357016	A GARP complex mutation analogous to a VPS53 allele causing progressive cerebello-cerebral atrophy type 2 (PCCA2) in humans exhibits similar, albeit weaker, phenotypes in yeast, providing mechanistic insights into disease pathogenesis.	GARP	cerebral atrophy	1258	HP_0002059	2	6	82	98	False
26357016	A GARP complex mutation analogous to a VPS53 allele causing progressive cerebello-cerebral atrophy type 2 (PCCA2) in humans exhibits similar, albeit weaker, phenotypes in yeast, providing mechanistic insights into disease pathogenesis.	VPS53	cerebral atrophy	55275	HP_0002059	39	44	82	98	True
26357016	A GARP complex mutation analogous to a VPS53 allele causing progressive cerebello-cerebral atrophy type 2 (PCCA2) in humans exhibits similar, albeit weaker, phenotypes in yeast, providing mechanistic insights into disease pathogenesis.	type	cerebral atrophy	6445	HP_0002059	99	103	82	98	False
15915442	Similarly, SEPT4 has lymphoid and non-lymphoid forms; SEPT2 has lymphoid and central nervous system (CNS) forms; and SEPT6 and SEPT9 are elevated in lymphoid tissues but both have forms that cluster away from the lymphoid forms.	SEPT2	central	23157	HP_0030645	54	59	77	84	False
15915442	Similarly, SEPT4 has lymphoid and non-lymphoid forms; SEPT2 has lymphoid and central nervous system (CNS) forms; and SEPT6 and SEPT9 are elevated in lymphoid tissues but both have forms that cluster away from the lymphoid forms.	SEPT4	central	5414	HP_0030645	11	16	77	84	False
15915442	Similarly, SEPT4 has lymphoid and non-lymphoid forms; SEPT2 has lymphoid and central nervous system (CNS) forms; and SEPT6 and SEPT9 are elevated in lymphoid tissues but both have forms that cluster away from the lymphoid forms.	SEPT6	central	23157	HP_0030645	117	122	77	84	False
15915442	Similarly, SEPT4 has lymphoid and non-lymphoid forms; SEPT2 has lymphoid and central nervous system (CNS) forms; and SEPT6 and SEPT9 are elevated in lymphoid tissues but both have forms that cluster away from the lymphoid forms.	SEPT9	central	10801	HP_0030645	127	132	77	84	False
26642364	Here, we have described a homozygous missense variant (c.602C&gt;T, p.S201F) in POPDC1, identified by whole-exome sequencing, in a family of 4 with cardiac arrhythmia and limb-girdle muscular dystrophy (LGMD).	POPDC1	cardiac arrhythmia	11149	HP_0011675	80	86	148	166	True
26642364	Our study therefore identifies POPDC1 as a disease gene causing a very rare autosomal recessive cardiac arrhythmia and LGMD, expanding the genetic causes of this heterogeneous group of inherited rare diseases	POPDC1	autosomal recessive	11149	HP_0000007	31	37	76	95	True
26642364	Our study therefore identifies POPDC1 as a disease gene causing a very rare autosomal recessive cardiac arrhythmia and LGMD, expanding the genetic causes of this heterogeneous group of inherited rare diseases	POPDC1	cardiac arrhythmia	11149	HP_0011675	31	37	96	114	True
26642364	Our study therefore identifies POPDC1 as a disease gene causing a very rare autosomal recessive cardiac arrhythmia and LGMD, expanding the genetic causes of this heterogeneous group of inherited rare diseases	POPDC1	heterogeneous	11149	HP_0001425	31	37	162	175	False
29224276	<b>Objective:</b> To investigate the significance of Twist2 in glioma and whether it is involved in the malignant transformation of glioma by epithelial-mesenchymal transition (EMT).	Twist2	glioma	117581	HP_0009733	53	59	63	69	False
29224276	<b>Objective:</b> To investigate the significance of Twist2 in glioma and whether it is involved in the malignant transformation of glioma by epithelial-mesenchymal transition (EMT).	EMT	glioma	3702	HP_0009733	177	180	63	69	False
29224276	<b>Methods:</b> Using immunohistochemical method detected the expression level of Twist2 in 60 cases of gliomas (including WHO grades ,  and , each for 20 cases) and 20 cases of non-tumor brain tissues.	Twist2	glioma	117581	HP_0009733	82	88	104	110	False
29224276	<b>Methods:</b> Using immunohistochemical method detected the expression level of Twist2 in 60 cases of gliomas (including WHO grades ,  and , each for 20 cases) and 20 cases of non-tumor brain tissues.	Twist2	tumor	117581	HP_0002664	82	88	185	190	False
29224276	Real-time fluorescence quantitative PCR and Western blot were used to detect the expression level of Twist2 mRNA and protein in 61 cases of fresh glioma tissue (WHO grade  16 cases,  21 cases,  24 cases) and 12 cases of adjacent tissues, and the expression levels of E-cadherin, N-cadherin and vimentin were also investigated in fresh glioma tissue.	Twist2	glioma	117581	HP_0009733	101	107	146	152	False
29224276	<b>Results:</b> Immunohistochemistry results showed that the percentages of Twist2 expression in glioma was 90%(54/60) compared with 30%(6/20) in non-tumor brain tissues(<i>P</i>&lt;0.01).	Twist2	glioma	117581	HP_0009733	76	82	97	103	False
29224276	<b>Results:</b> Immunohistochemistry results showed that the percentages of Twist2 expression in glioma was 90%(54/60) compared with 30%(6/20) in non-tumor brain tissues(<i>P</i>&lt;0.01).	Twist2	tumor	117581	HP_0002664	76	82	150	155	False
29224276	The percentages of Twist2 expression were 75% (15/20), 95% (19/20), and 100% (20/20) in the WHO grades,  and  gliomas, respectively.	Twist2	glioma	117581	HP_0009733	19	25	113	119	False
29224276	Real-time fluorescence quantitative PCR and Western blot showed that the expression level of Twist 2 in gliomas was significantly higher than that in para-cancerous tissues (<i>P</i>&lt;0.01), and those in WHO grades  and  gliomas were significantly higher than that in WHO grade  glioma (<i>P</i>&lt;0.01).	Twist	glioma	7291	HP_0009733	93	98	104	110	False
29224276	Detection of key protein expression in EMT by Western blot displayed that the expression of E-cadherin was negatively associated with Twist2 in glioma (<i>r</i>=-0.972, <i>P</i>&lt;0.01).	Twist2	glioma	117581	HP_0009733	134	140	144	150	False
29224276	Detection of key protein expression in EMT by Western blot displayed that the expression of E-cadherin was negatively associated with Twist2 in glioma (<i>r</i>=-0.972, <i>P</i>&lt;0.01).	EMT	glioma	3702	HP_0009733	39	42	144	150	False
29224276	The expression of N-cadherin and vimentin was positively associated with Twist2 in glioma(<i>r</i>=0.971, <i>P</i>&lt;0.01; <i>r</i>=0.968, <i>P</i>&lt;0.01).	Twist2	glioma	117581	HP_0009733	73	79	83	89	False
29224276	<b>Conclusions:</b> The expression of Twist2 in human glioma is positively correlated with the malignant grade of glioma, which may be involved in the malignant progression of glioma by EMT	Twist2	glioma	117581	HP_0009733	38	44	54	60	False
24603334	Thus, our results suggest that aberrantly expressed Aurora-C in somatic cancer cells may impair SAC by displacing the centromeric localization of CPCs.	SAC	cancer	55811	HP_0002664	96	99	72	78	False
25560175	Breast tissue and blood from patients with invasive breast cancer (n=38) and benign breast disease (n=30) were compared with those from healthy individuals (n=36), matched with the cancer patients by age at diagnosis, ethnicity, body mass index, menopausal status and familial history of cancer.	mass	cancer	2200	HP_0002664	240	244	59	65	False
25560175	Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.	IGF2	cancer	3481	HP_0002664	38	42	72	78	True
25560175	Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.	DIRAS3	cancer	9077	HP_0002664	107	113	72	78	False
25560175	Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.	DMR	cancer	91833	HP_0002664	43	46	72	78	False
25560175	Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.	GRB10	cancer	2887	HP_0002664	126	131	72	78	False
25560175	Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.	PEG3	cancer	5178	HP_0002664	144	148	72	78	False
25560175	Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of cancer patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, PEG3 DMR in 21%, MEST ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.	MEST	cancer	4232	HP_0002664	161	165	72	78	False
26928228	We found evidence for at least five independent causal variants, each associated with different phenotype sets, including estrogen receptor (ER(+) or ER(-)) and human ERBB2 (HER2(+) or HER2(-)) tumor subtypes, mammographic density and tumor grade.	ERBB2	tumor	2064	HP_0002664	167	172	194	199	True
26928228	We found evidence for at least five independent causal variants, each associated with different phenotype sets, including estrogen receptor (ER(+) or ER(-)) and human ERBB2 (HER2(+) or HER2(-)) tumor subtypes, mammographic density and tumor grade.	HER2	tumor	2064	HP_0002664	174	178	194	199	True
26928228	The best candidate causal variants for ER(-) tumors lie in four separate enhancer elements, and their risk alleles reduce expression of ESR1, RMND1 and CCDC170, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.	ESR1	tumor	2099	HP_0002664	136	140	45	50	False
26928228	The best candidate causal variants for ER(-) tumors lie in four separate enhancer elements, and their risk alleles reduce expression of ESR1, RMND1 and CCDC170, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.	best	tumor	7439	HP_0002664	4	8	45	50	False
26928228	The best candidate causal variants for ER(-) tumors lie in four separate enhancer elements, and their risk alleles reduce expression of ESR1, RMND1 and CCDC170, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.	RMND1	tumor	55005	HP_0002664	142	147	45	50	False
26928228	The best candidate causal variants for ER(-) tumors lie in four separate enhancer elements, and their risk alleles reduce expression of ESR1, RMND1 and CCDC170, whereas the risk alleles of the strongest candidates for the remaining independent causal variant disrupt a silencer element and putatively increase ESR1 and RMND1 expression.	CCDC170	tumor	80129	HP_0002664	152	159	45	50	False
25142862	Our current study found that phosphoserine aminotransferase 1 (PSAT1), an enzyme catalyzing serine biosynthesis, was significantly up-regulated in non-small cell lung cancer (NSCLC) and was involved in the regulation of E2F activity.	PSAT1	cancer	29968	HP_0002664	63	68	167	173	False
25142862	Loss- and gain-of-function experiments demonstrated that PSAT1 promoted cell cycle progression, cell proliferation and tumorigenesis.	PSAT1	tumor	29968	HP_0002664	57	62	119	124	False
25142862	Correlation analysis showed that PSAT1 expression positively correlated with the levels of phosphorylated GSK-3, cyclin D1 and phosphorylated Rb in NSCLC primary tumors.	PSAT1	tumor	29968	HP_0002664	33	38	163	168	False
21565611	Nephronophthisis (NPHP), Joubert (JBTS), and Meckel-Gruber (MKS) syndromes are autosomal-recessive ciliopathies presenting with cystic kidneys, retinal degeneration, and cerebellar/neural tube malformation.	MKS	retinal degeneration	54903	HP_0000546	60	63	144	164	False
21565611	Nephronophthisis (NPHP), Joubert (JBTS), and Meckel-Gruber (MKS) syndromes are autosomal-recessive ciliopathies presenting with cystic kidneys, retinal degeneration, and cerebellar/neural tube malformation.	tube	retinal degeneration	51175	HP_0000546	188	192	144	164	False
30506560	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	CGD	heterogeneous	1536	HP_0001425	0	3	21	34	False
30506560	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	CYBB	heterogeneous	1536	HP_0001425	111	115	21	34	False
30506560	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	CYBA	heterogeneous	1535	HP_0001425	237	241	21	34	False
30506560	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	NCF1	heterogeneous	653361	HP_0001425	258	262	21	34	False
30506560	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	NCF2	heterogeneous	4688	HP_0001425	279	283	21	34	False
30506560	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	NCF4	heterogeneous	4689	HP_0001425	303	307	21	34	False
30506560	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	CGD	autosomal recessive	1536	HP_0000007	0	3	176	195	False
30506560	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	CYBB	autosomal recessive	1536	HP_0000007	111	115	176	195	False
30506560	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	CYBA	autosomal recessive	1535	HP_0000007	237	241	176	195	True
30506560	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	NCF1	autosomal recessive	653361	HP_0000007	258	262	176	195	True
30506560	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	NCF2	autosomal recessive	4688	HP_0000007	279	283	176	195	True
30506560	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA (OMIM #608508), NCF1 (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	NCF4	autosomal recessive	4689	HP_0000007	303	307	176	195	True
30506560	In this study, we evaluated the clinical, laboratory and genetic findings and the prognostic effects of molecular inheritance of our 24 CGD cases (14 XR, 10 autosomal recessive-AR).	CGD	autosomal recessive	1536	HP_0000007	136	139	157	176	False
29536528	Prostate cancer (PCa) is the most common cancer among men.	PCa	cancer	28982	HP_0002664	17	20	9	15	False
29536528	Metabolic syndrome (MeS) is associated with increased PCa aggressiveness and recurrence.	PCa	aggressiveness	28982	HP_0000718	54	57	58	72	False
29536528	Moreover, CLCA2 depletion in PCa cells injected subcutaneously in MeS mice increased the circulating tumor cells foci compared to control.	PCa	tumor	28982	HP_0002664	29	32	101	106	False
29536528	Moreover, CLCA2 depletion in PCa cells injected subcutaneously in MeS mice increased the circulating tumor cells foci compared to control.	mice	tumor	23581	HP_0002664	70	74	101	106	False
29536528	Moreover, CLCA2 depletion in PCa cells injected subcutaneously in MeS mice increased the circulating tumor cells foci compared to control.	CLCA2	tumor	9635	HP_0002664	10	15	101	106	False
30111766	RESULTS Circ-CFH expression was significantly upregulated in glioma tissue and was correlated with tumor grade.	CFH	tumor	3075	HP_0002664	13	16	99	104	False
28029652	A putative tumor suppressor BLU mapped on the chromosomal 3p21 region, is frequently lost in human tumors including nasopharyngeal carcinoma (NPC).	BLU	tumor	51364	HP_0002664	28	31	11	16	False
28029652	To explore the underlying mechanism of tumor suppression by BLU, its potential to promote apoptosis induced by TRAIL, an effector molecule elaborated by natural killer-T (NKT) cells was investigated.	BLU	tumor	51364	HP_0002664	60	63	39	44	False
28029652	To explore the underlying mechanism of tumor suppression by BLU, its potential to promote apoptosis induced by TRAIL, an effector molecule elaborated by natural killer-T (NKT) cells was investigated.	TRAIL	tumor	8743	HP_0002664	111	116	39	44	False
28029652	In conclusion, BLU suppressed tumor formation by strengthening the antitumor immunity	BLU	tumor	51364	HP_0002664	15	18	30	35	False
26073781	Genome-wide association studies have identified SNPs near ZNF365 at 10q21.2 that are associated with both breast cancer risk and mammographic density.	ZNF365	cancer	22891	HP_0002664	58	64	113	119	False
26073781	There was weaker evidence for iCHAV4, located 5' of ADO, associated only with ER-positive breast cancer (OR = 0.93 [0.90-0.96]).	ADO	cancer	84890	HP_0002664	52	55	97	103	False
26073781	Chromosome conformation capture analysis showed that iCHAV2 interacts with the ZNF365 and NRBF2 (more than 600 kb away) promoters in normal and cancerous breast epithelial cells.	ZNF365	cancer	22891	HP_0002664	79	85	144	150	False
26073781	Chromosome conformation capture analysis showed that iCHAV2 interacts with the ZNF365 and NRBF2 (more than 600 kb away) promoters in normal and cancerous breast epithelial cells.	NRBF2	cancer	29982	HP_0002664	90	95	144	150	False
26073781	Luciferase assays did not identify SNPs that affect transactivation of ZNF365, but identified a protective haplotype in iCHAV2, associated with silencing of the NRBF2 promoter, implicating this gene in the etiology of breast cancer.	ZNF365	cancer	22891	HP_0002664	71	77	225	231	False
26073781	Luciferase assays did not identify SNPs that affect transactivation of ZNF365, but identified a protective haplotype in iCHAV2, associated with silencing of the NRBF2 promoter, implicating this gene in the etiology of breast cancer.	NRBF2	cancer	29982	HP_0002664	161	166	225	231	False
29073238	Reproductive aging phenotypes, including age at menarche (AM) and age at natural menopause (ANM), are well-established risk factors for breast cancer.	ANM	cancer	7138	HP_0002664	92	95	143	149	False
29073238	Using data from the Women's Circle of Health Study (WCHS) of 1,307 European-American (EA) and 1,365 African-American (AA) breast cancer cases and controls, we aimed to replicate 53 earlier GWAS variants for AM and ANM in AA and EA groups and to perform analyses on total and net reproductive lifespan (TRLS; NRLS).	ANM	cancer	7138	HP_0002664	214	217	129	135	False
29073238	Using data from the Women's Circle of Health Study (WCHS) of 1,307 European-American (EA) and 1,365 African-American (AA) breast cancer cases and controls, we aimed to replicate 53 earlier GWAS variants for AM and ANM in AA and EA groups and to perform analyses on total and net reproductive lifespan (TRLS; NRLS).	net	cancer	2004	HP_0002664	275	278	129	135	False
30205301	The studied CVD biomarkers include AXL receptor tyrosine kinase, apolipoproteins, cholesterol, C-reactive protein (CRP), D-dimer, fibrinogen (Fib), glucose, insulin, interleukins, lipoproteins, myoglobin, N-terminal pro-B-type natriuretic peptide (BNP), tumor necrosis factor alpha (TNF-) and troponins (Tns) on electrochemical transduction format.	AXL	tumor	558	HP_0002664	35	38	254	259	False
30205301	The studied CVD biomarkers include AXL receptor tyrosine kinase, apolipoproteins, cholesterol, C-reactive protein (CRP), D-dimer, fibrinogen (Fib), glucose, insulin, interleukins, lipoproteins, myoglobin, N-terminal pro-B-type natriuretic peptide (BNP), tumor necrosis factor alpha (TNF-) and troponins (Tns) on electrochemical transduction format.	CRP	tumor	1401	HP_0002664	115	118	254	259	False
30205301	The studied CVD biomarkers include AXL receptor tyrosine kinase, apolipoproteins, cholesterol, C-reactive protein (CRP), D-dimer, fibrinogen (Fib), glucose, insulin, interleukins, lipoproteins, myoglobin, N-terminal pro-B-type natriuretic peptide (BNP), tumor necrosis factor alpha (TNF-) and troponins (Tns) on electrochemical transduction format.	Fib	tumor	2091	HP_0002664	142	145	254	259	False
30205301	The studied CVD biomarkers include AXL receptor tyrosine kinase, apolipoproteins, cholesterol, C-reactive protein (CRP), D-dimer, fibrinogen (Fib), glucose, insulin, interleukins, lipoproteins, myoglobin, N-terminal pro-B-type natriuretic peptide (BNP), tumor necrosis factor alpha (TNF-) and troponins (Tns) on electrochemical transduction format.	Tns	tumor	7145	HP_0002664	305	308	254	259	False
30004071	Superficial CD34-positive fibroblastic tumor is a recently described soft-tissue tumor entity.	CD34	tumor	947	HP_0002664	12	16	39	44	False
30004071	A 48 year-old-male presented with a gradually increasing soft-tissue mass in his right forearm of 2 years' duration, along with multiple subcutaneous soft-tissue nodular lesions, and reminiscent of lipomas over his body.	mass	lipomas	2200	HP_0012032	69	73	198	205	False
30004071	Microscopic sections showed a circumscribed tumor in the dermis and subcutaneous fat, composed of spindle cells, inflammatory cells, including lymphocytes, plasma cells, and eosinophils, along with interspersed markedly pleomorphic giant cells containing moderate-to-abundant &quot;glassy&quot; cytoplasm, vesicular nuclei, exhibiting prominent nucleoli, and intranuclear pseudoinclusions.	fat	tumor	948	HP_0002664	81	84	44	49	False
30004071	By immunohistochemistry, the tumor cells were diffusely positive for CD34 while negative for cytokeratin (CK), pan CK (AE1/AE3), S100 protein, CD30, and CD31.	CD34	tumor	947	HP_0002664	69	73	29	34	False
30004071	MIB1/Ki-67 was low and highlighted 4%-5% tumor nuclei.	Ki	tumor	10197	HP_0002664	5	7	41	46	False
30004071	Diagnosis of superficial CD34-positive fibroblastic tumor was offered.	CD34	tumor	947	HP_0002664	25	29	52	57	False
30231971	Squamous cell carcinoma (SCC) can progress to malignant metastatic cancer, including an aggressive subtype known as spindle cell carcinoma (spSCC). spSCC formation involves epithelial-to-mesenchymal transition (EMT), yet the molecular basis of this event remains unknown.	SCC	cancer	6317	HP_0002664	25	28	67	73	False
30231971	Squamous cell carcinoma (SCC) can progress to malignant metastatic cancer, including an aggressive subtype known as spindle cell carcinoma (spSCC). spSCC formation involves epithelial-to-mesenchymal transition (EMT), yet the molecular basis of this event remains unknown.	EMT	cancer	3702	HP_0002664	211	214	67	73	True
30231971	Here, we show that human spSCC tumours also feature strong nuclear localisation of YAP and overexpression of activated YAP (NLS-YAP-5SA) with Keratin-5 (K5-CreERt) is sufficient to induce rapid formation of both SCC and spSCC in mice.	SCC	tumours	6317	HP_0002664	27	30	31	38	False
30231971	Here, we show that human spSCC tumours also feature strong nuclear localisation of YAP and overexpression of activated YAP (NLS-YAP-5SA) with Keratin-5 (K5-CreERt) is sufficient to induce rapid formation of both SCC and spSCC in mice.	YAP	tumours	55249	HP_0002664	83	86	31	38	False
30231971	Here, we show that human spSCC tumours also feature strong nuclear localisation of YAP and overexpression of activated YAP (NLS-YAP-5SA) with Keratin-5 (K5-CreERt) is sufficient to induce rapid formation of both SCC and spSCC in mice.	mice	tumours	23581	HP_0002664	229	233	31	38	False
30231971	spSCC tumours arise at sites of epithelial scratch wounding, where tumour-initiating epithelial cells undergo EMT to generate spSCC.	SCC	tumours	6317	HP_0002664	2	5	6	13	False
30231971	spSCC tumours arise at sites of epithelial scratch wounding, where tumour-initiating epithelial cells undergo EMT to generate spSCC.	EMT	tumours	3702	HP_0002664	110	113	6	13	True
30231971	spSCC tumours arise at sites of epithelial scratch wounding, where tumour-initiating epithelial cells undergo EMT to generate spSCC.	SCC	tumour	6317	HP_0002664	2	5	67	73	False
30231971	spSCC tumours arise at sites of epithelial scratch wounding, where tumour-initiating epithelial cells undergo EMT to generate spSCC.	EMT	tumour	3702	HP_0002664	110	113	67	73	True
28663096	Eight different SRD5A2 mutations were detected in 15 patients with posterior hypospadias (60%, 15/25), including six previously described mutations (p.Q6X, Q71X, p.L20P, p.G203S, p.R227Q, and p.R246Q) and two novel mutations (p.G196R and p.L73Pfs<sup></sup>17).	SRD5A2	hypospadias	6716	HP_0000047	16	22	77	88	True
28663096	Our data suggest that mutations of the SRD5A2 gene are the main causes of posterior hypospadias and seem to affect the semen quality of adult patients, whereas mutations in AR and HSD17B3 gene were rare in these hypospadias patients.	SRD5A2	hypospadias	6716	HP_0000047	39	45	84	95	True
28663096	Our data suggest that mutations of the SRD5A2 gene are the main causes of posterior hypospadias and seem to affect the semen quality of adult patients, whereas mutations in AR and HSD17B3 gene were rare in these hypospadias patients.	HSD17B3	hypospadias	3293	HP_0000047	180	187	84	95	False
28208713	Before and after eight weeks daily treatment with six capsules of F&amp;amp;V juice concentrate or placebo, peripheral blood gene expression (microarray, quantitative polymerase chain reaction (qPCR)), plasma tumour necrosis factor (TNF) (enzyme-linked immunosorbent assay (ELISA)), body composition (Dual-energy X-ray absorptiometry (DEXA)) and lipid profiles were assessed.	TNF	tumour	7124	HP_0002664	233	236	209	215	False
26002316	In this study, we investigated the expression of JIP3 in temporal lobe epilepsy (TLE) and in a kainic acid (KA)-induced mouse model of epileptic seizures, and determined whether down-regulation of JIP3 can decrease susceptibility to seizures and neuron damage induced by KA.	JIP3	epilepsy	23162	HP_0001250	49	53	71	79	False
26002316	In this study, we investigated the expression of JIP3 in temporal lobe epilepsy (TLE) and in a kainic acid (KA)-induced mouse model of epileptic seizures, and determined whether down-regulation of JIP3 can decrease susceptibility to seizures and neuron damage induced by KA.	damage	epilepsy	51438	HP_0001250	253	259	71	79	False
26002316	In this study, we investigated the expression of JIP3 in temporal lobe epilepsy (TLE) and in a kainic acid (KA)-induced mouse model of epileptic seizures, and determined whether down-regulation of JIP3 can decrease susceptibility to seizures and neuron damage induced by KA.	JIP3	seizures	23162	HP_0001250	49	53	145	153	False
26002316	In this study, we investigated the expression of JIP3 in temporal lobe epilepsy (TLE) and in a kainic acid (KA)-induced mouse model of epileptic seizures, and determined whether down-regulation of JIP3 can decrease susceptibility to seizures and neuron damage induced by KA.	damage	seizures	51438	HP_0001250	253	259	145	153	False
26002316	We found that JIP3 was markedly increased in TLE patients and a mouse model of epileptic seizures; mice underexpressing JIP3 through lentivirus bearing LV-Letm1-RNAi showed decreased susceptibility, delayed first seizure and decreased seizure duration response to the epileptogenic properties of KA.	JIP3	seizures	23162	HP_0001250	14	18	89	97	False
26002316	We found that JIP3 was markedly increased in TLE patients and a mouse model of epileptic seizures; mice underexpressing JIP3 through lentivirus bearing LV-Letm1-RNAi showed decreased susceptibility, delayed first seizure and decreased seizure duration response to the epileptogenic properties of KA.	mice	seizures	23581	HP_0001250	99	103	89	97	False
26002316	We found that JIP3 was markedly increased in TLE patients and a mouse model of epileptic seizures; mice underexpressing JIP3 through lentivirus bearing LV-Letm1-RNAi showed decreased susceptibility, delayed first seizure and decreased seizure duration response to the epileptogenic properties of KA.	JIP3	seizure	23162	HP_0001250	14	18	213	220	False
26002316	We found that JIP3 was markedly increased in TLE patients and a mouse model of epileptic seizures; mice underexpressing JIP3 through lentivirus bearing LV-Letm1-RNAi showed decreased susceptibility, delayed first seizure and decreased seizure duration response to the epileptogenic properties of KA.	mice	seizure	23581	HP_0001250	99	103	213	220	False
26002316	Subsequently, a decreased activation of JNK following seizure induction was observed in mice underexpressing JIP3, which also exhibited less neuronal apoptosis in the CA3 region of the hippocampus, as assessed three days after KA administration.	JIP3	seizure	23162	HP_0001250	109	113	54	61	False
26002316	Subsequently, a decreased activation of JNK following seizure induction was observed in mice underexpressing JIP3, which also exhibited less neuronal apoptosis in the CA3 region of the hippocampus, as assessed three days after KA administration.	JNK	seizure	5599	HP_0001250	40	43	54	61	False
26002316	Subsequently, a decreased activation of JNK following seizure induction was observed in mice underexpressing JIP3, which also exhibited less neuronal apoptosis in the CA3 region of the hippocampus, as assessed three days after KA administration.	mice	seizure	23581	HP_0001250	88	92	54	61	False
26002316	We also found that mice underexpressing JIP3 exhibited a delayed pentylenetetrazole (PTZ)-induced kindling seizure process	JIP3	seizure	23162	HP_0001250	40	44	107	114	False
26002316	We also found that mice underexpressing JIP3 exhibited a delayed pentylenetetrazole (PTZ)-induced kindling seizure process	mice	seizure	23581	HP_0001250	19	23	107	114	False
29978618	This disease is an autosomal recessive disorder, and the gene CSTB, which encodes cystatin B, a cysteine protease inhibitor, is the only gene known to be associated with ULD.	CSTB	autosomal recessive	1476	HP_0000007	62	66	19	38	True
27908734	However, the biological function and mechanism of TPI1 in cancer remain largely unknown.	TPI1	cancer	7167	HP_0002664	50	54	58	64	False
27908734	In this study, we have found that TPI1 expression was greatly decreased in clinical HCC samples, positively correlated with overall survival, and negatively associated with histological differentiation, tumor size and organ metastasis.	TPI1	tumor	7167	HP_0002664	34	38	203	208	False
27908734	In this study, we have found that TPI1 expression was greatly decreased in clinical HCC samples, positively correlated with overall survival, and negatively associated with histological differentiation, tumor size and organ metastasis.	HCC	tumor	84668	HP_0002664	84	87	203	208	False
27908734	Moreover, overexpression of TPI1 led to slowed tumor growth and decreased tumor weight invivo.	TPI1	tumor	7167	HP_0002664	28	32	47	52	False
27908734	Therefore, our data suggested that TPI1 functioned as a tumor suppressor in HCC and might serve as a potential therapeutic target for the treatment of HCC	TPI1	tumor	7167	HP_0002664	35	39	56	61	False
27908734	Therefore, our data suggested that TPI1 functioned as a tumor suppressor in HCC and might serve as a potential therapeutic target for the treatment of HCC	HCC	tumor	84668	HP_0002664	76	79	56	61	False
29209896	BRAF mutations occur in about 40-45% of all papillary thyroid carcinomas (PTCs) and of which 99.7% is the BRAFV600E mutation.	PTC	papillary thyroid carcinomas	8030	HP_0002895	74	77	44	72	False
29209896	A simultaneous increase in serum thyroid-stimulating hormone (TSH) in response to hypothyroidism (common in autoimmune diseases such as Hashimoto's thyroiditis) would cause senescent tumor cells to overcome OIS and proceed towards malignancy, hence showing the importance of TSH/TSHR signaling in the development of PTCs.	TSHR	hypothyroidism	7253	HP_0000821	279	283	82	96	True
29209896	A simultaneous increase in serum thyroid-stimulating hormone (TSH) in response to hypothyroidism (common in autoimmune diseases such as Hashimoto's thyroiditis) would cause senescent tumor cells to overcome OIS and proceed towards malignancy, hence showing the importance of TSH/TSHR signaling in the development of PTCs.	PTC	hypothyroidism	8030	HP_0000821	316	319	82	96	False
29209896	A simultaneous increase in serum thyroid-stimulating hormone (TSH) in response to hypothyroidism (common in autoimmune diseases such as Hashimoto's thyroiditis) would cause senescent tumor cells to overcome OIS and proceed towards malignancy, hence showing the importance of TSH/TSHR signaling in the development of PTCs.	TSHR	tumor	7253	HP_0002664	279	283	183	188	False
29209896	A simultaneous increase in serum thyroid-stimulating hormone (TSH) in response to hypothyroidism (common in autoimmune diseases such as Hashimoto's thyroiditis) would cause senescent tumor cells to overcome OIS and proceed towards malignancy, hence showing the importance of TSH/TSHR signaling in the development of PTCs.	PTC	tumor	8030	HP_0002664	316	319	183	188	False
16783572	We confirmed the association between DGCR2 and schizophrenia through individual genotyping of 1,400 subjects.	DGCR2	schizophrenia	9993	HP_0100753	37	42	47	60	False
16783572	In a gene expression analysis the risk allele of a coding SNP associated with schizophrenia was found to be associated with a reduced expression of DGCR2.	DGCR2	schizophrenia	9993	HP_0100753	148	153	78	91	False
16783572	The genetic and functional evidences here reported suggest a possible role of the DGCR2 gene in the pathology of schizophrenia and also in the therapeutic effects of antipsychotic drugs	DGCR2	schizophrenia	9993	HP_0100753	82	87	113	126	False
28135245	Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease with a strong genetic component characterized by autoantibody production and a type I interferon signature.	type	heterogeneous	6445	HP_0001425	152	156	40	53	False
29330049	PHF8 knockdown inhibits proliferation and promotes the apoptosis of ALL cells invitro as well as attenuates tumor growth invivo.	PHF8	tumor	23133	HP_0002664	0	4	109	114	False
28965845	Only overexpression of LAT induced a reduction of brain proliferating cells and concomitant microcephaly.	LAT	microcephaly	83985	HP_0000252	23	26	92	104	False
25973542	Here we identify a set of genes that is highly expressed in breast cancer bone metastasis and activated by ZEB1.	ZEB1	cancer	6935	HP_0002664	107	111	67	73	False
25973542	Here we identify a set of genes that is highly expressed in breast cancer bone metastasis and activated by ZEB1.	set	cancer	6418	HP_0002664	19	22	67	73	False
25973542	We here demonstrate that the expression of ZEB1 and BMP-inhibitors is correlated with bone metastasis, but not with brain or lung metastasis of breast cancer patients.	ZEB1	cancer	6935	HP_0002664	43	47	151	157	False
25973542	These findings suggest that ZEB1 is not only driving EMT, but also contributes to the formation of osteolytic bone metastases in breast cancer.	EMT	cancer	3702	HP_0002664	53	56	136	142	True
25973542	These findings suggest that ZEB1 is not only driving EMT, but also contributes to the formation of osteolytic bone metastases in breast cancer.	ZEB1	cancer	6935	HP_0002664	28	32	136	142	False
21195649	Cystinosis is an autosomal recessive lysosomal storage disease caused by mutations in CTNS.	CTNS	autosomal recessive	1497	HP_0000007	86	90	17	36	True
24743044	We recently demonstrated that SIRT1 is upregulated in melanoma and its inhibition by a small-molecule, tenovin-1, inhibits cell proliferation and clonogenic survival of melanoma cells, possibly via activating p53.	SIRT1	melanoma	23411	HP_0002861	30	35	54	62	False
24743044	Here, we employed a gel free quantitative proteomics approach to identify the downstream effectors and targets of SIRT1 in melanoma.	SIRT1	melanoma	23411	HP_0002861	114	119	123	131	False
24743044	The qRT-PCR and immunoblot analyses showed that tenovin-1 inhibition of SIRT1 resulted in a downregulation of BUB3, BUB1 and BUBR1 in multiple melanoma cell lines.	SIRT1	melanoma	23411	HP_0002861	72	77	143	151	False
24743044	The qRT-PCR and immunoblot analyses showed that tenovin-1 inhibition of SIRT1 resulted in a downregulation of BUB3, BUB1 and BUBR1 in multiple melanoma cell lines.	BUB3	melanoma	9184	HP_0002861	110	114	143	151	False
24743044	The qRT-PCR and immunoblot analyses showed that tenovin-1 inhibition of SIRT1 resulted in a downregulation of BUB3, BUB1 and BUBR1 in multiple melanoma cell lines.	BUB1	melanoma	699	HP_0002861	116	120	143	151	False
24743044	The qRT-PCR and immunoblot analyses showed that tenovin-1 inhibition of SIRT1 resulted in a downregulation of BUB3, BUB1 and BUBR1 in multiple melanoma cell lines.	BUBR1	melanoma	701	HP_0002861	125	130	143	151	False
24835313	Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, SERPINF1, BMP1, WNT1, FKBP10).	CRTAP	autosomal recessive	10491	HP_0000007	133	138	99	118	True
24835313	Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, SERPINF1, BMP1, WNT1, FKBP10).	LEPRE1	autosomal recessive	64175	HP_0000007	140	146	99	118	True
24835313	Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, SERPINF1, BMP1, WNT1, FKBP10).	PPIB	autosomal recessive	5479	HP_0000007	148	152	99	118	True
24835313	Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, SERPINF1, BMP1, WNT1, FKBP10).	SERPINF1	autosomal recessive	5176	HP_0000007	162	170	99	118	True
24835313	Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, SERPINF1, BMP1, WNT1, FKBP10).	BMP1	autosomal recessive	649	HP_0000007	172	176	99	118	True
24835313	Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, SERPINF1, BMP1, WNT1, FKBP10).	WNT1	autosomal recessive	7471	HP_0000007	178	182	99	118	True
24835313	Several gene encoding proteins related to collagen metabolism have been described in some cases of autosomal recessive OI (including CRTAP, LEPRE1, PPIB, FKBP65, SERPINF1, BMP1, WNT1, FKBP10).	FKBP10	autosomal recessive	60681	HP_0000007	184	190	99	118	True
24835313	Recently, TMEM38B, a gene that encodes TRIC-B, a monovalent cation-specific channel involved in calcium flux from intracellular stores and in cell differentiation, has been associated with autosomal recessive OI.	TMEM38B	autosomal recessive	55151	HP_0000007	10	17	189	208	True
24835313	Recently, TMEM38B, a gene that encodes TRIC-B, a monovalent cation-specific channel involved in calcium flux from intracellular stores and in cell differentiation, has been associated with autosomal recessive OI.	TRIC-B	autosomal recessive	55151	HP_0000007	39	45	189	208	True
30075571	Altered ERCC1 expression or function is closely associated with cancer development and progression.	ERCC1	cancer	2067	HP_0002664	8	13	64	70	False
30075571	This study determined the association of ERCC1 expression with survivin expression, clinicopathological characteristics, and survival of esophageal squamous cell carcinoma (ESCC) patients after postoperative concurrent chemoradiotherapy.Tissue specimens from 102 resected ESCC patients were acquired for immunohistochemical analysis of ERCC1 and survivin protein expression.ERCC1 expression was detected in 62.7% of ESCC tissues and in 9.8% of normal squamous epithelium tissues (P&lt;.01), while survivin expression was detected in 60.8% of ESCC tissues and in 19.6% of normal squamous epithelia (P&lt;.01).	ERCC1	squamous cell carcinoma	2067	HP_0002860	41	46	148	171	False
30075571	This study determined the association of ERCC1 expression with survivin expression, clinicopathological characteristics, and survival of esophageal squamous cell carcinoma (ESCC) patients after postoperative concurrent chemoradiotherapy.Tissue specimens from 102 resected ESCC patients were acquired for immunohistochemical analysis of ERCC1 and survivin protein expression.ERCC1 expression was detected in 62.7% of ESCC tissues and in 9.8% of normal squamous epithelium tissues (P&lt;.01), while survivin expression was detected in 60.8% of ESCC tissues and in 19.6% of normal squamous epithelia (P&lt;.01).	survivin	squamous cell carcinoma	332	HP_0002860	63	71	148	171	False
30075571	ERCC1 overexpression associated with advanced tumor clinical stage and lymph node metastasis (P&lt;.05), but not with tumor size, depth of invasion, or differentiation (P&gt;.05).	ERCC1	tumor	2067	HP_0002664	0	5	46	51	False
30075571	Multivariate analysis data revealed that ERCC1 and survivin protein expression were independent predictors of overall survival of ESCC patients after chemotherapy and/or radiotherapy (P&lt;.05).ERCC1 overexpression is an important phenotype that is associated with ESCC lymph node metastasis and advanced tumor clinical stages.	ERCC1	tumor	2067	HP_0002664	41	46	307	312	False
30075571	Multivariate analysis data revealed that ERCC1 and survivin protein expression were independent predictors of overall survival of ESCC patients after chemotherapy and/or radiotherapy (P&lt;.05).ERCC1 overexpression is an important phenotype that is associated with ESCC lymph node metastasis and advanced tumor clinical stages.	survivin	tumor	332	HP_0002664	51	59	307	312	False
29747823	The accuracy of this mouse model was emphasized by the finding that various central nervous system and noncentral nervous system tissues from PD patients manifested similar GM1 deficiency as the B4galnt1<sup>+/-</sup> mouse.	B4galnt1	central	2583	HP_0030645	195	203	76	83	False
28415684	Here we show that linc-NeD125, which we previously characterized as a neuronal-induced lncRNA, is significantly overexpressed in Group 4 medulloblastomas (G4 MBs), the largest and least well characterized molecular MB subgroup.	MBs	medulloblastomas	4659	HP_0002885	158	161	137	153	False
21464332	Gabapentin (GBP; Neurontin) and pregabalin (PGB; Lyrica, S-(+)-3-isobutylgaba) are used clinically to treat several disorders associated with excessive or inappropriate excitability, including epilepsy; pain from diabetic neuropathy, postherpetic neuralgia, and fibromyalgia; and generalized anxiety disorder.	GBP	epilepsy	3030	HP_0001250	12	15	193	201	True
21464332	Gabapentin (GBP; Neurontin) and pregabalin (PGB; Lyrica, S-(+)-3-isobutylgaba) are used clinically to treat several disorders associated with excessive or inappropriate excitability, including epilepsy; pain from diabetic neuropathy, postherpetic neuralgia, and fibromyalgia; and generalized anxiety disorder.	GBP	neuropathy	3030	HP_0009830	12	15	222	232	True
29652635	Furthermore, we show that increased FAR2 expression in human patients is associated with diabetic nephropathy, lupus nephritis, and IgA nephropathy.	FAR2	nephropathy	55711	HP_0000112	36	40	98	109	False
29652635	Furthermore, we show that increased FAR2 expression in human patients is associated with diabetic nephropathy, lupus nephritis, and IgA nephropathy.	IgA	nephropathy	973	HP_0000112	132	135	98	109	False
26855150	Cytochrome P450 3A5 (CYP3A5) metabolizes these compounds in tumors of the exocrine-like subtype, and pharmacological or short hairpin RNA (shRNA)-mediated CYP3A5 inhibition sensitizes tumor cells to these drugs.	CYP3A5	tumors	1577	HP_0002664	21	27	60	66	False
26855150	Cytochrome P450 3A5 (CYP3A5) metabolizes these compounds in tumors of the exocrine-like subtype, and pharmacological or short hairpin RNA (shRNA)-mediated CYP3A5 inhibition sensitizes tumor cells to these drugs.	CYP3A5	tumor	1577	HP_0002664	21	27	184	189	False
26855150	These findings designate CYP3A5 as a predictor of therapy response and as a tumor cell-autonomous detoxification mechanism that must be overcome to prevent drug resistance	CYP3A5	tumor	1577	HP_0002664	25	31	76	81	False
29901133	No pathogenic mutations were detected in PAX6, FOXC1 or PITX2 in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.	PAX6	sporadic	5080	HP_0003745	41	45	89	97	False
29901133	No pathogenic mutations were detected in PAX6, FOXC1 or PITX2 in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.	FOXC1	sporadic	2296	HP_0003745	47	52	89	97	False
29901133	No pathogenic mutations were detected in PAX6, FOXC1 or PITX2 in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.	PITX2	sporadic	5308	HP_0003745	56	61	89	97	False
29901133	No pathogenic mutations were detected in PAX6, FOXC1 or PITX2 in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.	PAX6	heterogeneity	5080	HP_0001425	41	45	154	167	False
29901133	No pathogenic mutations were detected in PAX6, FOXC1 or PITX2 in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.	FOXC1	heterogeneity	2296	HP_0001425	47	52	154	167	True
29901133	No pathogenic mutations were detected in PAX6, FOXC1 or PITX2 in the only patient with a sporadic form of aniridialike phenotype, confirming the genetic heterogeneity associated with this disease.	PITX2	heterogeneity	5308	HP_0001425	56	61	154	167	True
22561202	6q14 deletions have been associated with intellectual disability and a distinct pattern of minor anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal tip, anteverted nares, long philtrum, and thin upper lip.	minor	intellectual disability	8013	HP_0001249	91	96	41	64	False
22561202	6q14 deletions have been associated with intellectual disability and a distinct pattern of minor anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal tip, anteverted nares, long philtrum, and thin upper lip.	tip	intellectual disability	81533	HP_0001249	200	203	41	64	False
22561202	6q14 deletions have been associated with intellectual disability and a distinct pattern of minor anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal tip, anteverted nares, long philtrum, and thin upper lip.	minor	upslanted palpebral fissures	8013	HP_0000582	91	96	118	146	False
22561202	6q14 deletions have been associated with intellectual disability and a distinct pattern of minor anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal tip, anteverted nares, long philtrum, and thin upper lip.	tip	upslanted palpebral fissures	81533	HP_0000582	200	203	118	146	False
22561202	6q14 deletions have been associated with intellectual disability and a distinct pattern of minor anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal tip, anteverted nares, long philtrum, and thin upper lip.	minor	epicanthal folds	8013	HP_0000286	91	96	152	168	False
22561202	6q14 deletions have been associated with intellectual disability and a distinct pattern of minor anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal tip, anteverted nares, long philtrum, and thin upper lip.	tip	epicanthal folds	81533	HP_0000286	200	203	152	168	False
22561202	6q14 deletions have been associated with intellectual disability and a distinct pattern of minor anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal tip, anteverted nares, long philtrum, and thin upper lip.	minor	short nose	8013	HP_0003196	91	96	172	182	False
22561202	6q14 deletions have been associated with intellectual disability and a distinct pattern of minor anomalies, including upslanted palpebral fissures with epicanthal folds, a short nose with broad nasal tip, anteverted nares, long philtrum, and thin upper lip.	tip	short nose	81533	HP_0003196	200	203	172	182	False
22561202	Possible candidate genes in 6q14 for intellectual disability might be FILIP1, MYO6, HTR1B, and SNX14	FILIP1	intellectual disability	27145	HP_0001249	70	76	37	60	False
22561202	Possible candidate genes in 6q14 for intellectual disability might be FILIP1, MYO6, HTR1B, and SNX14	MYO6	intellectual disability	4646	HP_0001249	78	82	37	60	False
22561202	Possible candidate genes in 6q14 for intellectual disability might be FILIP1, MYO6, HTR1B, and SNX14	HTR1B	intellectual disability	3351	HP_0001249	84	89	37	60	False
29116080	Spinocerebellar ataxia type 5 (SCA5) is a neurodegenerative disease caused by mutations in the cytoskeletal protein -III-spectrin.	type	ataxia	6445	HP_0001251	23	27	16	22	False
29116080	Spinocerebellar ataxia type 5 (SCA5) is a neurodegenerative disease caused by mutations in the cytoskeletal protein -III-spectrin.	SCA5	ataxia	6712	HP_0001251	31	35	16	22	True
29116080	Spinocerebellar ataxia type 5 (SCA5) is a neurodegenerative disease caused by mutations in the cytoskeletal protein -III-spectrin.	type	neurodegenerative disease	6445	HP_0002180	23	27	42	67	False
29116080	Spinocerebellar ataxia type 5 (SCA5) is a neurodegenerative disease caused by mutations in the cytoskeletal protein -III-spectrin.	SCA5	neurodegenerative disease	6712	HP_0002180	31	35	42	67	False
30171257	Anaplastic thyroid cancer (ATC) is associated with poor prognosis and is often untreatable.	ATC	cancer	472	HP_0002664	27	30	19	25	True
30171257	The abnormal regulation of miR-483 may play an important role in tumorigenesis, and Par3 is known to regulate cell polarity, cell migration, and cell division.	miR	tumor	220972	HP_0002664	27	30	65	70	False
30171257	The abnormal regulation of miR-483 may play an important role in tumorigenesis, and Par3 is known to regulate cell polarity, cell migration, and cell division.	Par3	tumor	2151	HP_0002664	84	88	65	70	False
30171257	Tumor proliferation promoted by the regulation of miRNA expression can be regulated in thyroid cancer by upregulating transforming growth factor-1 (TGF-1), which is thought to interact with Pard3.	Pard3	cancer	56288	HP_0002664	192	197	95	101	False
30171257	Tumor proliferation promoted by the regulation of miRNA expression can be regulated in thyroid cancer by upregulating transforming growth factor-1 (TGF-1), which is thought to interact with Pard3.	miR	cancer	220972	HP_0002664	50	53	95	101	False
30171257	When compared with adjacent non-tumor tissues, we found that miR-483 was upregulated and Pard3 was downregulated in 80 thyroid tumor samples.	Pard3	tumor	56288	HP_0002664	89	94	32	37	False
30171257	When compared with adjacent non-tumor tissues, we found that miR-483 was upregulated and Pard3 was downregulated in 80 thyroid tumor samples.	miR	tumor	220972	HP_0002664	61	64	32	37	False
27763569	The purpose of this study was to evaluate the association of the hepatic lipase (LIPC) rs493258 polymorphism and susceptibility to age-related macular degeneration (AMD).	LIPC	macular degeneration	3990	HP_0000608	81	85	143	163	False
29374341	In Chinese siblings with late-onset cblC, the main clinic manifestation and abnormal radioimaging were cognitive decline and cerebral atrophy respectively.	cblC	cerebral atrophy	23624	HP_0002059	36	40	125	141	False
30388826	Fungal immunomodulatory protein from <i>Nectria haematococca</i> (FIP-nha) has potential as a lung cancer therapeutic; as such, illuminating its anti-tumor mechanism is expected to facilitate novel treatment options.	FIP	cancer	7392	HP_0002664	66	69	99	105	False
30388826	Fungal immunomodulatory protein from <i>Nectria haematococca</i> (FIP-nha) has potential as a lung cancer therapeutic; as such, illuminating its anti-tumor mechanism is expected to facilitate novel treatment options.	FIP	tumor	7392	HP_0002664	66	69	150	155	False
30388826	Thus, we comprehensively revealed the anti-tumor mechanism of FIP-nha, which inhibits tumor growth by modulating PI3K/Akt-regulated cell cycle arrest, autophagy, and apoptosis, and provided the basis for further application of fungal immunomodulatory proteins, especially FIP-nha	FIP	tumor	7392	HP_0002664	62	65	43	48	False
30388826	Thus, we comprehensively revealed the anti-tumor mechanism of FIP-nha, which inhibits tumor growth by modulating PI3K/Akt-regulated cell cycle arrest, autophagy, and apoptosis, and provided the basis for further application of fungal immunomodulatory proteins, especially FIP-nha	Akt	tumor	207	HP_0002664	118	121	43	48	True
30025107	The hallmarks of this disease are macular drusen, RPE alterations, and geographic atrophy (GA).	RPE	geographic atrophy	6120	HP_0031609	50	53	71	89	False
29152796	Seborrhoeic Dermatitis (SD) is a common inflammatory skin disease that presents as itchy, flaking skin in the seborrhoeic areas.	SD	flaking skin	5905	HP_0040189	24	26	90	102	False
28481869	GATA3, a critical transcription factor involved in the development of the mammary gland, also plays important roles in mammary tumorigenesis by regulating transcription in coordination with two essential DNA repair factors, PARP1 and BRCA1.	PARP1	tumor	142	HP_0002664	224	229	127	132	False
28481869	GATA3, a critical transcription factor involved in the development of the mammary gland, also plays important roles in mammary tumorigenesis by regulating transcription in coordination with two essential DNA repair factors, PARP1 and BRCA1.	GATA3	tumor	2625	HP_0002664	0	5	127	132	False
28481869	However, whether and how GATA3 participates in the process of DNA repair, which is often associated with tumorigenesis, has not been investigated.	GATA3	tumor	2625	HP_0002664	25	30	105	110	False
28481869	In addition, through data mining analysis, we observed an extremely strong correlation between the expression levels of GATA3 and CtIP in paratumors, but the correlation turned insignificant in mammary tumors.	GATA3	tumors	2625	HP_0002664	120	125	142	148	False
28481869	In addition, through data mining analysis, we observed an extremely strong correlation between the expression levels of GATA3 and CtIP in paratumors, but the correlation turned insignificant in mammary tumors.	CtIP	tumors	5932	HP_0002664	130	134	142	148	False
28481869	Using vectors encoding GATA3 with mutations frequently occurring in mammary tumors, we found that several mutations on GATA3 led to a dysregulation of CtIP, and therefore HR repair.	GATA3	tumors	2625	HP_0002664	23	28	76	82	False
28481869	Using vectors encoding GATA3 with mutations frequently occurring in mammary tumors, we found that several mutations on GATA3 led to a dysregulation of CtIP, and therefore HR repair.	CtIP	tumors	5932	HP_0002664	151	155	76	82	False
28481869	In summary, our data delineates the regulatory mechanisms of GATA3 in DNA DSB repair and strongly suggests that it might act as a tumor suppressor by promoting CtIP expression and HR to stabilize genomes	GATA3	tumor	2625	HP_0002664	61	66	130	135	False
28481869	In summary, our data delineates the regulatory mechanisms of GATA3 in DNA DSB repair and strongly suggests that it might act as a tumor suppressor by promoting CtIP expression and HR to stabilize genomes	CtIP	tumor	5932	HP_0002664	160	164	130	135	False
28233610	Here, we applied next-generation sequencing in 89 patients with a clinical diagnosis of distal renal tubular acidosis, analyzing the prevalence of genetic defects in SLC4A1, ATP6V0A4, and ATP6V1B1 genes and the clinical phenotype.	SLC4A1	distal renal tubular acidosis	6521	HP_0008341	166	172	88	117	True
28233610	Here, we applied next-generation sequencing in 89 patients with a clinical diagnosis of distal renal tubular acidosis, analyzing the prevalence of genetic defects in SLC4A1, ATP6V0A4, and ATP6V1B1 genes and the clinical phenotype.	ATP6V0A4	distal renal tubular acidosis	50617	HP_0008341	174	182	88	117	True
28233610	Here, we applied next-generation sequencing in 89 patients with a clinical diagnosis of distal renal tubular acidosis, analyzing the prevalence of genetic defects in SLC4A1, ATP6V0A4, and ATP6V1B1 genes and the clinical phenotype.	ATP6V1B1	distal renal tubular acidosis	525	HP_0008341	188	196	88	117	False
28890319	Using human neuroblastoma SH-SY5Y cells, we found that the neuroprotective function of CHRNA7 is blocked by CHRNA7 knockdown using RNA interference.	CHRNA7	neuroblastoma	1139	HP_0003006	87	93	12	25	False
29667444	PM were loaded with a siRNA against AKT2, an important oncogene involved in breast cancer tumorigenesis, with a special role in CSC malignancy.	AKT2	cancer	208	HP_0002664	36	40	83	89	False
29667444	PM were loaded with a siRNA against AKT2, an important oncogene involved in breast cancer tumorigenesis, with a special role in CSC malignancy.	AKT2	tumor	208	HP_0002664	36	40	90	95	False
29667444	Efficacy of siAKT2-PM was validated in CSC isolated from two breast cancer cell lines: MCF-7 and Triple Negative MDA-MB-231 corresponding to an aggressive subtype of breast cancer.	AKT2	cancer	208	HP_0002664	14	18	68	74	False
29667444	These results prompt AKT2 inhibition as a powerful therapeutic target against CSC and pave the way to the appearance of more effective nanomedicine-based gene therapies aimed to prevent CSC-related tumor recurrence	AKT2	tumor	208	HP_0002664	21	25	198	203	False
29269878	This contributes to the intrinsic aggressiveness of these cells by upregulating Rab27-dependent recycling of the transmembrane matrix metalloprotease, MT1-MMP to promote invasive behaviour leading to basement membrane disruption.	MT1-MMP	aggressiveness	4323	HP_0000718	151	158	34	48	False
28456383	Spinal muscular atrophy (SMA) refers to a group of disorders affecting lower motor neurons.	SMA	muscular atrophy	6606	HP_0003202	25	28	7	23	True
29054568	A combination of familial and population based sequencing studies, and genome wide association studies (GWAS) have identified a range of genetic susceptibility alleles for EOC comprising rare but highly penetrant genes (e.g. BRCA1, BRCA2) that are responsible for familial clustering of ovarian cancer cases; more moderate penetrance susceptibility genes (e.g. BRIP1, RAD51C/D, MSH6); and multiple common but low penetrance susceptibility alleles identified by GWAS.	BRCA1	cancer	672	HP_0002664	225	230	295	301	True
29054568	A combination of familial and population based sequencing studies, and genome wide association studies (GWAS) have identified a range of genetic susceptibility alleles for EOC comprising rare but highly penetrant genes (e.g. BRCA1, BRCA2) that are responsible for familial clustering of ovarian cancer cases; more moderate penetrance susceptibility genes (e.g. BRIP1, RAD51C/D, MSH6); and multiple common but low penetrance susceptibility alleles identified by GWAS.	BRCA2	cancer	675	HP_0002664	232	237	295	301	True
29054568	A combination of familial and population based sequencing studies, and genome wide association studies (GWAS) have identified a range of genetic susceptibility alleles for EOC comprising rare but highly penetrant genes (e.g. BRCA1, BRCA2) that are responsible for familial clustering of ovarian cancer cases; more moderate penetrance susceptibility genes (e.g. BRIP1, RAD51C/D, MSH6); and multiple common but low penetrance susceptibility alleles identified by GWAS.	BRIP1	cancer	64979	HP_0002664	361	366	295	301	False
29054568	A combination of familial and population based sequencing studies, and genome wide association studies (GWAS) have identified a range of genetic susceptibility alleles for EOC comprising rare but highly penetrant genes (e.g. BRCA1, BRCA2) that are responsible for familial clustering of ovarian cancer cases; more moderate penetrance susceptibility genes (e.g. BRIP1, RAD51C/D, MSH6); and multiple common but low penetrance susceptibility alleles identified by GWAS.	MSH6	cancer	2956	HP_0002664	378	382	295	301	True
29054568	Identifying genetic risk alleles for ovarian cancer has had a significant impact on disease prevention strategies; for example it is now routine clinical practice for individuals with germline BRCA1 and BRCA2 mutations to undergo risk reducing salpingo-oophorectomy.	BRCA1	cancer	672	HP_0002664	193	198	45	51	True
29054568	Identifying genetic risk alleles for ovarian cancer has had a significant impact on disease prevention strategies; for example it is now routine clinical practice for individuals with germline BRCA1 and BRCA2 mutations to undergo risk reducing salpingo-oophorectomy.	BRCA2	cancer	675	HP_0002664	203	208	45	51	True
29054568	Identifying genetic risk alleles for ovarian cancer has had a significant impact on disease prevention strategies; for example it is now routine clinical practice for individuals with germline BRCA1 and BRCA2 mutations to undergo risk reducing salpingo-oophorectomy.	impact	cancer	55364	HP_0002664	74	80	45	51	False
26547929	MicroRNA-9 (miR-9) dysregulation is implicated in a variety of human malignancies including hepatocellular carcinoma (HCC), but its role remains contradictory.	HCC	hepatocellular carcinoma	84668	HP_0001402	118	121	92	116	False
26547929	In this study, we explored the expression and methylation status of miR-9 in HCC samples, as well as the tumor-related functions of miR-9 in vitro.	HCC	tumor	84668	HP_0002664	77	80	105	110	False
26547929	Mechanically, miR-9 plays a tumor suppressive role partially through a functional miR-9/IGF2BP1/AKT&amp;ERK axis.	IGF2BP1	tumor	10642	HP_0002664	88	95	28	33	False
26547929	Our study suggests that miR-9 functions as a tumor suppressor in HCC progression by inhibiting a series of target genes, including the newly validated miR-9/IGF2BP1/AKT&amp;ERK axis, thus providing potential therapeutic targets and novel prognostic biomarkers for HCC patients.	HCC	tumor	84668	HP_0002664	65	68	45	50	False
26547929	Our study suggests that miR-9 functions as a tumor suppressor in HCC progression by inhibiting a series of target genes, including the newly validated miR-9/IGF2BP1/AKT&amp;ERK axis, thus providing potential therapeutic targets and novel prognostic biomarkers for HCC patients.	IGF2BP1	tumor	10642	HP_0002664	157	164	45	50	False
28557061	Of all the movement disorders, myoclonus is the most difficult to encapsulate into any simple framework.	simple	movement disorders	9516	HP_0100022	87	93	11	29	True
28557061	Of all the movement disorders, myoclonus is the most difficult to encapsulate into any simple framework.	simple	myoclonus	9516	HP_0001336	87	93	31	40	False
28557061	In dogs, myotonia is associated with mutations in CLCN1.	CLCN1	myotonia	1180	HP_0002486	50	55	9	17	True
29359854	Biotinidase (BTD) deficiency is a rare autosomal recessive metabolic disease, which develops neurological and cutaneous symptoms because of the impaired biotin recycling.	BTD	autosomal recessive	686	HP_0000007	13	16	39	58	True
29359854	Fatigue, hypotonia, proximal muscular weakness, hearing deficits, rash and respiratory problems are common clinical phenotype of our patients.	type	proximal	6445	HP_0012840	121	125	20	28	False
29070483	Mutations in MYH2 are associated with skeletal myopathies, characterized by ophthalmoplegia.	MYH	skeletal myopathies	4595	HP_0003756	13	16	38	57	False
29070483	Mutations in MYH2 are associated with skeletal myopathies, characterized by ophthalmoplegia.	MYH	ophthalmoplegia	4595	HP_0000602	13	16	76	91	False
29070483	Mutations in MYH3 and MYH8 are associated with distal arthrogryposis syndromes.	MYH	distal	4595	HP_0012839	13	16	47	53	False
29070483	Mutations in MYH3 and MYH8 are associated with distal arthrogryposis syndromes.	MYH	arthrogryposis	4595	HP_0002804	13	16	54	68	False
29070483	Mutations in MYH7 are associated with not only skeletal muscle diseases, such as Laing distal myopathy and myosin storage myopathy, but also hypertrophic cardiomyopathy.	MYH	distal	4595	HP_0012839	13	16	87	93	False
29070483	Mutations in MYH7 are associated with not only skeletal muscle diseases, such as Laing distal myopathy and myosin storage myopathy, but also hypertrophic cardiomyopathy.	MYH	myopathy	4595	HP_0003198	13	16	94	102	False
27766406	To further characterize CD164 as a potential biomarker for malignant CD4<sup>+</sup> T cells, CD164<sup>+</sup> and CD164<sup>-</sup>CD4<sup>+</sup> T cells isolated from patients with high-circulating tumor burden, B2 stage, and medium/low tumor burden, B1-B0 stage, were assessed for the expression of genes reported to differentiate SS from normal controls, and associated with malignancy and poor prognosis.	B1	tumor	27241	HP_0002664	255	257	202	207	False
27766406	CD164 was co-expressed with KIR3DL2 on circulating CD4<sup>+</sup> T cells from high tumor burden SS patients, further providing strong support for CD164 as a disease relevant surface biomarker	KIR3DL2	tumor	3812	HP_0002664	28	35	85	90	False
28267080	Blood and tissue samples from 48 osteosarcoma patients were obtained, and the following polymorphisms were analyzed; SLC19A1 80G&gt;A, DHFR 829C&gt;T, MTHFR 677C&gt;T, MTHFR 1298A&gt;C, and ATIC 347C&gt;G.	SLC19A1	osteosarcoma	6573	HP_0002669	117	124	33	45	False
28267080	Blood and tissue samples from 48 osteosarcoma patients were obtained, and the following polymorphisms were analyzed; SLC19A1 80G&gt;A, DHFR 829C&gt;T, MTHFR 677C&gt;T, MTHFR 1298A&gt;C, and ATIC 347C&gt;G.	DHFR	osteosarcoma	1719	HP_0002669	135	139	33	45	False
28267080	Blood and tissue samples from 48 osteosarcoma patients were obtained, and the following polymorphisms were analyzed; SLC19A1 80G&gt;A, DHFR 829C&gt;T, MTHFR 677C&gt;T, MTHFR 1298A&gt;C, and ATIC 347C&gt;G.	MTHFR	osteosarcoma	4524	HP_0002669	151	156	33	45	False
28267080	Blood and tissue samples from 48 osteosarcoma patients were obtained, and the following polymorphisms were analyzed; SLC19A1 80G&gt;A, DHFR 829C&gt;T, MTHFR 677C&gt;T, MTHFR 1298A&gt;C, and ATIC 347C&gt;G.	ATIC	osteosarcoma	471	HP_0002669	190	194	33	45	False
28267080	Even though the role of single nucleotide polymorphisms of ATIC in chemotherapy-induced tumor necrosis has not been investigated yet, the ATIC 347C&gt;G polymorphism may influence the levels of adenosine after MTX treatment, which may affect the histologic response of osteosarcoma.	MTX	osteosarcoma	4580	HP_0002669	210	213	269	281	False
28267080	Even though the role of single nucleotide polymorphisms of ATIC in chemotherapy-induced tumor necrosis has not been investigated yet, the ATIC 347C&gt;G polymorphism may influence the levels of adenosine after MTX treatment, which may affect the histologic response of osteosarcoma.	ATIC	osteosarcoma	471	HP_0002669	59	63	269	281	False
28267080	Even though the role of single nucleotide polymorphisms of ATIC in chemotherapy-induced tumor necrosis has not been investigated yet, the ATIC 347C&gt;G polymorphism may influence the levels of adenosine after MTX treatment, which may affect the histologic response of osteosarcoma.	MTX	tumor	4580	HP_0002664	210	213	88	93	False
28267080	Even though the role of single nucleotide polymorphisms of ATIC in chemotherapy-induced tumor necrosis has not been investigated yet, the ATIC 347C&gt;G polymorphism may influence the levels of adenosine after MTX treatment, which may affect the histologic response of osteosarcoma.	ATIC	tumor	471	HP_0002664	59	63	88	93	False
29620212	The incidence of thyroid cancer has increased the past few decades, the most frequent type has been identified to be the papillary thyroid carcinoma (PTC).	type	cancer	6445	HP_0002664	86	90	25	31	False
29620212	The incidence of thyroid cancer has increased the past few decades, the most frequent type has been identified to be the papillary thyroid carcinoma (PTC).	PTC	cancer	8030	HP_0002664	150	153	25	31	False
29620212	The incidence of thyroid cancer has increased the past few decades, the most frequent type has been identified to be the papillary thyroid carcinoma (PTC).	type	papillary thyroid carcinoma	6445	HP_0002895	86	90	121	148	False
29620212	The incidence of thyroid cancer has increased the past few decades, the most frequent type has been identified to be the papillary thyroid carcinoma (PTC).	PTC	papillary thyroid carcinoma	8030	HP_0002895	150	153	121	148	False
29620212	Overexpression of LARP7 inhibited the proliferation and increased the radioiodine uptake ability of PTC cells invitro and inhibited the tumor growth invivo.	PTC	tumor	8030	HP_0002664	100	103	137	142	False
29620212	Overexpression of LARP7 inhibited the proliferation and increased the radioiodine uptake ability of PTC cells invitro and inhibited the tumor growth invivo.	LARP	tumor	23367	HP_0002664	18	22	137	142	False
29620212	In conclusion, LARP7 may act as a tumor suppressor in PTC by inhibiting the SHH signaling pathway and may be a promising therapeutic target in patients with PTC	PTC	tumor	8030	HP_0002664	54	57	34	39	False
29620212	In conclusion, LARP7 may act as a tumor suppressor in PTC by inhibiting the SHH signaling pathway and may be a promising therapeutic target in patients with PTC	LARP	tumor	23367	HP_0002664	15	19	34	39	False
29620212	In conclusion, LARP7 may act as a tumor suppressor in PTC by inhibiting the SHH signaling pathway and may be a promising therapeutic target in patients with PTC	SHH	tumor	6469	HP_0002664	76	79	34	39	True
29620212	In conclusion, LARP7 may act as a tumor suppressor in PTC by inhibiting the SHH signaling pathway and may be a promising therapeutic target in patients with PTC	act	tumor	11332	HP_0002664	25	28	34	39	False
27553092	-Ureidopropionase deficiency is a rare autosomal recessive disease affecting the last step of pyrimidine degradation, and it is caused by a mutation in the UPB1 gene.	step	autosomal recessive	84867	HP_0000007	87	91	40	59	False
27553092	-Ureidopropionase deficiency is a rare autosomal recessive disease affecting the last step of pyrimidine degradation, and it is caused by a mutation in the UPB1 gene.	UPB1	autosomal recessive	51733	HP_0000007	157	161	40	59	True
29643508	Although genes that are essential for cortical developmental expansion have been identified from the genetics of human primary microcephaly (a disorder associated with reduced brain size and intellectual disability) <sup>1</sup> , studies of these genes in mice, which have a smooth cortex that is one thousand times smaller than the cortex of humans, have provided limited insight.	mice	microcephaly	23581	HP_0000252	257	261	127	139	False
29643508	Although genes that are essential for cortical developmental expansion have been identified from the genetics of human primary microcephaly (a disorder associated with reduced brain size and intellectual disability) <sup>1</sup> , studies of these genes in mice, which have a smooth cortex that is one thousand times smaller than the cortex of humans, have provided limited insight.	mice	intellectual disability	23581	HP_0001249	257	261	191	214	False
29643508	Mutations in abnormal spindle-like microcephaly-associated (ASPM), the most common recessive microcephaly gene, reduce cortical volume by at least 50% in humans<sup>2-4</sup>, but have little effect on the brains of mice<sup>5-9</sup>; this probably reflects evolutionarily divergent functions of ASPM<sup>10,11</sup>.	mice	microcephaly	23581	HP_0000252	216	220	35	47	False
29643508	Mutations in abnormal spindle-like microcephaly-associated (ASPM), the most common recessive microcephaly gene, reduce cortical volume by at least 50% in humans<sup>2-4</sup>, but have little effect on the brains of mice<sup>5-9</sup>; this probably reflects evolutionarily divergent functions of ASPM<sup>10,11</sup>.	ASPM	microcephaly	259266	HP_0000252	60	64	35	47	True
29643508	Aspm knockout ferrets exhibit severe microcephaly (25-40% decreases in brain weight), reflecting reduced cortical surface area without significant change in cortical thickness, as has been found in human patients<sup>3,4</sup>, suggesting that loss of 'cortical units' has occurred.	Aspm	microcephaly	259266	HP_0000252	0	4	37	49	True
28731174	Non-small cell lung cancer (NSCLC) is the most common type of lung cancer.	type	cancer	6445	HP_0002664	54	58	20	26	False
28731174	Furthermore, LHX3 is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (ADC) patients, but is not associated with overall survival of squamous cell carcinoma (SCC) patients (n=524, p=0.27).	LHX3	lung adenocarcinoma	8022	HP_0030078	13	17	153	172	False
28731174	Furthermore, LHX3 is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (ADC) patients, but is not associated with overall survival of squamous cell carcinoma (SCC) patients (n=524, p=0.27).	ADC	lung adenocarcinoma	113451	HP_0030078	174	177	153	172	False
28731174	Furthermore, LHX3 is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (ADC) patients, but is not associated with overall survival of squamous cell carcinoma (SCC) patients (n=524, p=0.27).	SCC	lung adenocarcinoma	6317	HP_0030078	261	264	153	172	False
28731174	Furthermore, LHX3 is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (ADC) patients, but is not associated with overall survival of squamous cell carcinoma (SCC) patients (n=524, p=0.27).	LHX3	squamous cell carcinoma	8022	HP_0002860	13	17	236	259	False
28731174	Furthermore, LHX3 is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (ADC) patients, but is not associated with overall survival of squamous cell carcinoma (SCC) patients (n=524, p=0.27).	ADC	squamous cell carcinoma	113451	HP_0002860	174	177	236	259	False
28731174	Furthermore, LHX3 is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in lung adenocarcinoma (ADC) patients, but is not associated with overall survival of squamous cell carcinoma (SCC) patients (n=524, p=0.27).	SCC	squamous cell carcinoma	6317	HP_0002860	261	264	236	259	False
28731174	Further functional studies show that forced expression of LHX3 in lung cancer cells obviously promotes cell proliferation and invasion, whereas inhibits cell apoptosis.	LHX3	cancer	8022	HP_0002664	58	62	71	77	False
25997889	Broad GNAS methylation abnormalities are also observed in most sporadic PHP1B (sporPHP1B) cases.	GNAS	sporadic	2778	HP_0003745	6	10	63	71	True
25997889	We now investigated 23 Japanese sporPHP1B cases, who presented with hypocalcemia, hyperphosphatemia, elevated PTH levels, and occasionally with TSH elevations and mild AHO features.	PTH	hypocalcemia	5741	HP_0002901	110	113	68	80	True
25997889	We now investigated 23 Japanese sporPHP1B cases, who presented with hypocalcemia, hyperphosphatemia, elevated PTH levels, and occasionally with TSH elevations and mild AHO features.	PTH	hyperphosphatemia	5741	HP_0002905	110	113	82	99	True
30279180	Mutation of aspartic acid 378 of hnRNPDL to either asparagine or histidine has been associated with limb girdle muscular dystrophy.	hnRNPDL	limb girdle muscular dystrophy	9987	HP_0006785	33	40	100	130	True
28792508	Here, we tested the DCTN1 protein-coding exons in 510 sporadic ALS patients in whom SOD1, TARDBP, FUS, and C9orf72 genes were screened before.	ALS	sporadic	3483	HP_0003745	63	66	54	62	False
28792508	Here, we tested the DCTN1 protein-coding exons in 510 sporadic ALS patients in whom SOD1, TARDBP, FUS, and C9orf72 genes were screened before.	DCTN1	sporadic	1639	HP_0003745	20	25	54	62	False
28792508	Here, we tested the DCTN1 protein-coding exons in 510 sporadic ALS patients in whom SOD1, TARDBP, FUS, and C9orf72 genes were screened before.	SOD1	sporadic	6647	HP_0003745	84	88	54	62	False
28792508	Here, we tested the DCTN1 protein-coding exons in 510 sporadic ALS patients in whom SOD1, TARDBP, FUS, and C9orf72 genes were screened before.	TARDBP	sporadic	23435	HP_0003745	90	96	54	62	False
28792508	Here, we tested the DCTN1 protein-coding exons in 510 sporadic ALS patients in whom SOD1, TARDBP, FUS, and C9orf72 genes were screened before.	FUS	sporadic	2521	HP_0003745	98	101	54	62	False
28792508	Here, we tested the DCTN1 protein-coding exons in 510 sporadic ALS patients in whom SOD1, TARDBP, FUS, and C9orf72 genes were screened before.	C9orf72	sporadic	203228	HP_0003745	107	114	54	62	False
28792508	Our results suggested that variants in DCTN1 are not common risk factors for Chinese sporadic ALS and that the frequency of variants of unknown significance in the cohort study was 0.39%	ALS	sporadic	3483	HP_0003745	94	97	85	93	False
28792508	Our results suggested that variants in DCTN1 are not common risk factors for Chinese sporadic ALS and that the frequency of variants of unknown significance in the cohort study was 0.39%	DCTN1	sporadic	1639	HP_0003745	39	44	85	93	False
25351776	We analyzed, by conventional and molecular cytogenetics, 19 novel SRY-negative unrelated 46,XX subjects both familial and sporadic, with isolated DSD.	SRY	sporadic	6736	HP_0003745	66	69	122	130	False
25351776	A further XX male, ascertained because of intellectual disability, carried a de novo cryptic duplication at Xq27.1, involving SOX3.	cryptic	intellectual disability	55997	HP_0001249	85	92	42	65	False
25351776	A further XX male, ascertained because of intellectual disability, carried a de novo cryptic duplication at Xq27.1, involving SOX3.	SOX3	intellectual disability	6658	HP_0001249	126	130	42	65	True
28870817	Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	PKD	paroxysmal dyskinesias	5587	HP_0007166	83	86	59	81	False
28870817	Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	ICCA	paroxysmal dyskinesias	112476	HP_0007166	211	215	59	81	True
28870817	Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	FHM	paroxysmal dyskinesias	773	HP_0007166	258	261	59	81	False
28870817	Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	type	paroxysmal dyskinesias	6445	HP_0007166	262	266	59	81	False
28870817	Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	PKD	epilepsy	5587	HP_0001250	83	86	129	137	False
28870817	Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	ICCA	epilepsy	112476	HP_0001250	211	215	129	137	True
28870817	Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	FHM	epilepsy	773	HP_0001250	258	261	129	137	True
28870817	Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	type	epilepsy	6445	HP_0001250	262	266	129	137	False
28870817	Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	PKD	episodic	5587	HP_0025303	83	86	319	327	False
28870817	Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	ICCA	episodic	112476	HP_0025303	211	215	319	327	False
28870817	Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	FHM	episodic	773	HP_0025303	258	261	319	327	False
28870817	Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	type	episodic	6445	HP_0025303	262	266	319	327	False
28870817	Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	PKD	ataxia	5587	HP_0001251	83	86	328	334	False
28870817	Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	ICCA	ataxia	112476	HP_0001251	211	215	328	334	True
28870817	Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	FHM	ataxia	773	HP_0001251	258	261	328	334	True
28870817	Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (PKD) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (ICCA), a form of familial hemiplegic migraine (FHM type 4), paroxysmal benign torticollis of childhood, and episodic ataxia.	type	ataxia	6445	HP_0001251	262	266	328	334	False
22753417	Hyperekplexia or startle disease is characterized by an exaggerated startle response, evoked by tactile or auditory stimuli, producing hypertonia and apnea episodes.	tactile	hypertonia	10225	HP_0001276	96	103	135	145	False
29317515	Clear cell renal cell carcinoma (ccRCC) is an heterogeneous tumour at architectural, cellular and molecular level, a reason why the 2014 International Society of Urological Pathology consensus recommended wide sampling of RCC masses to include at least 1 block/cm of tumour together with perpendicular sections of the tumour/perinephric fat interface and the tumour/renal sinus interface.	RCC	heterogeneous	7515	HP_0001425	35	38	46	59	False
29317515	Clear cell renal cell carcinoma (ccRCC) is an heterogeneous tumour at architectural, cellular and molecular level, a reason why the 2014 International Society of Urological Pathology consensus recommended wide sampling of RCC masses to include at least 1 block/cm of tumour together with perpendicular sections of the tumour/perinephric fat interface and the tumour/renal sinus interface.	fat	heterogeneous	948	HP_0001425	337	340	46	59	False
29317515	Clear cell renal cell carcinoma (ccRCC) is an heterogeneous tumour at architectural, cellular and molecular level, a reason why the 2014 International Society of Urological Pathology consensus recommended wide sampling of RCC masses to include at least 1 block/cm of tumour together with perpendicular sections of the tumour/perinephric fat interface and the tumour/renal sinus interface.	RCC	tumour	7515	HP_0002664	35	38	60	66	False
29317515	Clear cell renal cell carcinoma (ccRCC) is an heterogeneous tumour at architectural, cellular and molecular level, a reason why the 2014 International Society of Urological Pathology consensus recommended wide sampling of RCC masses to include at least 1 block/cm of tumour together with perpendicular sections of the tumour/perinephric fat interface and the tumour/renal sinus interface.	fat	tumour	948	HP_0002664	337	340	60	66	False
29317515	We observed the presence of the mutation at pH1047R of <i>PIK3CA</i> gene in five samples of the tumour, while the remaining 15 samples did not show any mutation at <i>PIK3CA</i> or any other investigated gene.	PIK3CA	tumour	5290	HP_0002664	58	64	97	103	True
29317515	There is a great need to develop novel RCC sampling strategies to overcome tumour heterogeneity prior to define precision oncology strategies	RCC	tumour	7515	HP_0002664	39	42	75	81	False
29317515	There is a great need to develop novel RCC sampling strategies to overcome tumour heterogeneity prior to define precision oncology strategies	great	tumour	122042	HP_0002664	11	16	75	81	False
29317515	There is a great need to develop novel RCC sampling strategies to overcome tumour heterogeneity prior to define precision oncology strategies	RCC	heterogeneity	7515	HP_0001425	39	42	82	95	False
29317515	There is a great need to develop novel RCC sampling strategies to overcome tumour heterogeneity prior to define precision oncology strategies	great	heterogeneity	122042	HP_0001425	11	16	82	95	False
30113427	Twenty-two previously identified pancreatic cancer risk genes and 337 germline variants were identified from 97 informative studies that met our inclusion criteria.	met	cancer	4233	HP_0002664	137	140	44	50	True
30694044	To investigate the direct effects of this SNP in the heterogeneous cellular context of the brain, we generated humanized transgenic mice using a design that maximized the local transcriptional landscape of the human HTR1A gene while also controlling for effects of genomic insertion location.	mice	heterogeneous	23581	HP_0001425	132	136	53	66	False
30694044	To investigate the direct effects of this SNP in the heterogeneous cellular context of the brain, we generated humanized transgenic mice using a design that maximized the local transcriptional landscape of the human HTR1A gene while also controlling for effects of genomic insertion location.	HTR1A	heterogeneous	3350	HP_0001425	216	221	53	66	False
29961928	Humans who carry HNF1B mutations develop heterogeneous renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, renal hypoplasia, and renal interstitial fibrosis.	HNF1B	heterogeneous	6928	HP_0001425	17	22	41	54	False
29961928	Humans who carry HNF1B mutations develop heterogeneous renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, renal hypoplasia, and renal interstitial fibrosis.	HNF1B	renal agenesis	6928	HP_0000104	17	22	150	164	True
29961928	Humans who carry HNF1B mutations develop heterogeneous renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, renal hypoplasia, and renal interstitial fibrosis.	HNF1B	renal hypoplasia	6928	HP_0000089	17	22	166	182	True
29961928	Humans who carry HNF1B mutations develop heterogeneous renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, renal hypoplasia, and renal interstitial fibrosis.	HNF1B	renal interstitial fibrosis	6928	HP_0005576	17	22	188	215	False
26188004	For individual RP patients, our study may help to predict time-courses for Pde6a-related retinal degeneration and thereby facilitate the definition of a window-of-opportunity for clinical interventions.	Pde6a	retinal degeneration	5145	HP_0000546	75	80	89	109	False
30022764	Pompe disease, also called type II glycogen storage disease, is a rare autosomal recessive inherited disease caused by the storage of glycogen in lysosome due to acid -glucosidase (GAA) deficiency, with the most severe conditions in the skeletal muscle, the myocardium, and the smooth muscle.	type	autosomal recessive	6445	HP_0000007	27	31	71	90	True
30022764	Pompe disease, also called type II glycogen storage disease, is a rare autosomal recessive inherited disease caused by the storage of glycogen in lysosome due to acid -glucosidase (GAA) deficiency, with the most severe conditions in the skeletal muscle, the myocardium, and the smooth muscle.	GAA	autosomal recessive	2548	HP_0000007	182	185	71	90	True
21818352	We examined the effects of a mutation in the Sh3pxd2b gene (Sh3pxd2b(nee)) on the progression of otitis media and hearing impairment at various developmental stages.	Sh3pxd2b	hearing impairment	285590	HP_0000365	45	53	114	132	False
26035073	To date, the genetic alteration of SASS6 has not been reported in human cancers.	SASS6	cancer	163786	HP_0002664	35	40	72	78	False
26035073	In the present study, we examined whether SASS6 expression is abnormally regulated in colorectal cancers (CRCs).	SASS6	cancer	163786	HP_0002664	42	47	97	103	False
26035073	Next, using DLD-1 colon cancer cells inducibly expressing SASS6, SASS6 overexpression was shown to induce centrosome amplification, mitotic abnormalities such as chromosomal misalignment and lagging chromosome, and chromosomal numerical changes.	SASS6	cancer	163786	HP_0002664	58	63	24	30	False
26035073	Next, using DLD-1 colon cancer cells inducibly expressing SASS6, SASS6 overexpression was shown to induce centrosome amplification, mitotic abnormalities such as chromosomal misalignment and lagging chromosome, and chromosomal numerical changes.	DLD	cancer	1738	HP_0002664	12	15	24	30	False
26035073	SASS6 upregulation in colon cancer was also revealed in the Cancer Genome Atlas (TCGA) data and was shown to be an independent predictor of poor survival (multivariate analysis: hazard ratio, 2.805; 95% confidence interval, 1.2447.512; P=0.0112).	SASS6	cancer	163786	HP_0002664	0	5	28	34	False
26035073	Finally, further analysis of the TCGA data demonstrated SASS6 upregulation in a modest manner in 8 of 11 cancer types other than colon cancer, and SASS6 upregulation was found to be associated with a poor survival outcome in patients with kidney renal cell carcinoma and lung adenocarcinoma.	SASS6	cancer	163786	HP_0002664	56	61	105	111	False
26035073	Finally, further analysis of the TCGA data demonstrated SASS6 upregulation in a modest manner in 8 of 11 cancer types other than colon cancer, and SASS6 upregulation was found to be associated with a poor survival outcome in patients with kidney renal cell carcinoma and lung adenocarcinoma.	type	cancer	6445	HP_0002664	112	116	105	111	False
26035073	Finally, further analysis of the TCGA data demonstrated SASS6 upregulation in a modest manner in 8 of 11 cancer types other than colon cancer, and SASS6 upregulation was found to be associated with a poor survival outcome in patients with kidney renal cell carcinoma and lung adenocarcinoma.	SASS6	lung adenocarcinoma	163786	HP_0030078	56	61	271	290	False
26035073	Finally, further analysis of the TCGA data demonstrated SASS6 upregulation in a modest manner in 8 of 11 cancer types other than colon cancer, and SASS6 upregulation was found to be associated with a poor survival outcome in patients with kidney renal cell carcinoma and lung adenocarcinoma.	type	lung adenocarcinoma	6445	HP_0030078	112	116	271	290	False
26035073	Our present findings revealed that the upregulation of SASS6 expression is involved in the pathogenesis of CRC and is associated with a poor prognosis among patients with colon cancer.	SASS6	cancer	163786	HP_0002664	55	60	177	183	False
27737959	Here, we report that biallelic mutations in NCAPD2, NCAPH, or NCAPD3, encoding subunits of these complexes, cause microcephaly.	NCAPD2	microcephaly	9918	HP_0000252	44	50	114	126	False
27737959	Here, we report that biallelic mutations in NCAPD2, NCAPH, or NCAPD3, encoding subunits of these complexes, cause microcephaly.	NCAPH	microcephaly	23397	HP_0000252	52	57	114	126	False
27737959	Here, we report that biallelic mutations in NCAPD2, NCAPH, or NCAPD3, encoding subunits of these complexes, cause microcephaly.	NCAPD3	microcephaly	23310	HP_0000252	62	68	114	126	True
29161404	Mutations in a proline-rich-repeat region (PRR) of UBQLN2 cause amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD); however, neither the normal functions of the PRR nor impacts of ALS-associated mutations within it are well understood.	PRR	frontotemporal dementia	10159	HP_0002145	43	46	100	123	False
29161404	Mutations in a proline-rich-repeat region (PRR) of UBQLN2 cause amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD); however, neither the normal functions of the PRR nor impacts of ALS-associated mutations within it are well understood.	UBQLN2	frontotemporal dementia	29978	HP_0002145	51	57	100	123	True
29161404	Mutations in a proline-rich-repeat region (PRR) of UBQLN2 cause amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD); however, neither the normal functions of the PRR nor impacts of ALS-associated mutations within it are well understood.	ALS	frontotemporal dementia	3483	HP_0002145	95	98	100	123	False
29021214	Recently, we identified disease-linked mutations in the <i>CCNF</i> gene, which encodes the cyclin F protein, in cohorts of patients with familial and sporadic ALS and frontotemporal dementia (FTD) (Williams KL <i>et al</i> 2016 <i>Nat.	ALS	sporadic	3483	HP_0003745	160	163	151	159	False
29021214	Recently, we identified disease-linked mutations in the <i>CCNF</i> gene, which encodes the cyclin F protein, in cohorts of patients with familial and sporadic ALS and frontotemporal dementia (FTD) (Williams KL <i>et al</i> 2016 <i>Nat.	ALS	frontotemporal dementia	3483	HP_0002145	160	163	168	191	False
27588451	Cone-rod degeneration (CRD) belongs to the disease spectrum of retinal degenerations, a group of hereditary disorders characterized by an extreme clinical and genetic heterogeneity.	CRD	retinal degenerations	1406	HP_0000546	23	26	63	84	False
27588451	Cone-rod degeneration (CRD) belongs to the disease spectrum of retinal degenerations, a group of hereditary disorders characterized by an extreme clinical and genetic heterogeneity.	rod	retinal degenerations	9735	HP_0000546	5	8	63	84	False
27588451	Cone-rod degeneration (CRD) belongs to the disease spectrum of retinal degenerations, a group of hereditary disorders characterized by an extreme clinical and genetic heterogeneity.	CRD	heterogeneity	1406	HP_0001425	23	26	167	180	False
27588451	Cone-rod degeneration (CRD) belongs to the disease spectrum of retinal degenerations, a group of hereditary disorders characterized by an extreme clinical and genetic heterogeneity.	rod	heterogeneity	9735	HP_0001425	5	8	167	180	False
27588451	It mainly differentiates from other retinal dystrophies, and in particular from the more frequent disease retinitis pigmentosa, because cone photoreceptors degenerate at a higher rate than rod photoreceptors, causing severe deficiency of central vision.	rod	retinal dystrophies	9735	HP_0000556	189	192	36	55	False
27588451	In addition to CRD, these three individuals had hearing loss or hearing deficit.	CRD	hearing loss	1406	HP_0000365	15	18	48	60	True
27588451	Interaction studies also showed that CEP78 binds to FAM161A, another ciliary protein associated with retinal degeneration.	CEP78	retinal degeneration	84131	HP_0000546	37	42	101	121	True
27588451	Interaction studies also showed that CEP78 binds to FAM161A, another ciliary protein associated with retinal degeneration.	FAM161A	retinal degeneration	84140	HP_0000546	52	59	101	121	False
27588451	Altogether, our data strongly suggest that mutations in CEP78 cause a previously undescribed clinical entity of a ciliary nature characterized by blindness and deafness but clearly distinct from Usher syndrome, a condition for which visual impairment is due to retinitis pigmentosa.	CEP78	blindness	84131	HP_0000618	56	61	146	155	False
27588451	Altogether, our data strongly suggest that mutations in CEP78 cause a previously undescribed clinical entity of a ciliary nature characterized by blindness and deafness but clearly distinct from Usher syndrome, a condition for which visual impairment is due to retinitis pigmentosa.	CEP78	deafness	84131	HP_0000365	56	61	160	168	True
27588451	Altogether, our data strongly suggest that mutations in CEP78 cause a previously undescribed clinical entity of a ciliary nature characterized by blindness and deafness but clearly distinct from Usher syndrome, a condition for which visual impairment is due to retinitis pigmentosa.	CEP78	visual impairment	84131	HP_0000505	56	61	233	250	True
23063620	We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus, dextrocardia, or transposition of the great arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous Megf8.	great	dysmorphic facies	122042	HP_0001999	162	167	51	68	False
23063620	We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus, dextrocardia, or transposition of the great arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous Megf8.	Megf8	dysmorphic facies	1954	HP_0001999	273	278	51	68	False
23063620	We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus, dextrocardia, or transposition of the great arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous Megf8.	great	dextrocardia	122042	HP_0001651	162	167	124	136	False
23063620	We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus, dextrocardia, or transposition of the great arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous Megf8.	Megf8	dextrocardia	1954	HP_0001651	273	278	124	136	True
23063620	We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus, dextrocardia, or transposition of the great arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous Megf8.	great	cardiac abnormalities	122042	HP_0001627	162	167	186	207	False
23063620	We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus, dextrocardia, or transposition of the great arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the orthologous Megf8.	Megf8	cardiac abnormalities	1954	HP_0001627	273	278	186	207	True
24849935	Bardet-Biedl syndrome (BBS) is a rare ciliopathy disorder that is clinically and genetically heterogeneous with 18 known genes.	BBS	heterogeneous	583	HP_0001425	23	26	93	106	False
24849935	This result represents another indication for the genetic heterogeneity of BBS and extends the mutational spectrum of the disease by introducing nine novel mutations in five BBS genes.	BBS	heterogeneity	583	HP_0001425	75	78	58	71	False
25732731	In this study, we show that the presentation of a MHC class II-restricted model Ag (male, DBY) released by dying tumor cells may last more than 4 wk.	DBY	tumor	8653	HP_0002664	90	93	113	118	False
25732731	To avoid this artifactual early priming of the host precluding the study of the interactions between the immune system and tumors at the steady state, we generated a cell line expressing the DBY Ag in an inducible manner.	DBY	tumor	8653	HP_0002664	191	194	123	128	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	ACAD8	kyphoscoliosis	27034	HP_0002751	30	35	401	415	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	ACADSB	kyphoscoliosis	36	HP_0002751	85	91	401	415	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	SCAD	kyphoscoliosis	35	HP_0002751	129	133	401	415	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	AUH	kyphoscoliosis	549	HP_0002751	148	151	401	415	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	DHCR7	kyphoscoliosis	1717	HP_0002751	192	197	401	415	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	HMGCS2	kyphoscoliosis	3158	HP_0002751	228	234	401	415	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	HSD17B10	kyphoscoliosis	3028	HP_0002751	291	299	401	415	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	FKBP14	kyphoscoliosis	55033	HP_0002751	353	359	401	415	True
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	ROGDI	kyphoscoliosis	79641	HP_0002751	457	462	401	415	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	ACAD8	myopathy	27034	HP_0003198	30	35	417	425	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	ACADSB	myopathy	36	HP_0003198	85	91	417	425	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	SCAD	myopathy	35	HP_0003198	129	133	417	425	True
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	AUH	myopathy	549	HP_0003198	148	151	417	425	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	DHCR7	myopathy	1717	HP_0003198	192	197	417	425	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	HMGCS2	myopathy	3158	HP_0003198	228	234	417	425	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	HSD17B10	myopathy	3028	HP_0003198	291	299	417	425	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	FKBP14	myopathy	55033	HP_0003198	353	359	417	425	True
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	ROGDI	myopathy	79641	HP_0003198	457	462	417	425	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	ACAD8	hearing loss	27034	HP_0000365	30	35	431	443	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	ACADSB	hearing loss	36	HP_0000365	85	91	431	443	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	SCAD	hearing loss	35	HP_0000365	129	133	431	443	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	AUH	hearing loss	549	HP_0000365	148	151	431	443	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	DHCR7	hearing loss	1717	HP_0000365	192	197	431	443	True
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	HMGCS2	hearing loss	3158	HP_0000365	228	234	431	443	False
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	HSD17B10	hearing loss	3028	HP_0000365	291	299	431	443	True
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	FKBP14	hearing loss	55033	HP_0000365	353	359	431	443	True
25111118	The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), ACADSB (short-chain acyl-CoA dehydrogenase (SCAD) deficiency), AUH (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), HMGCS2 (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), HSD17B10 (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss; EDSKMH) and ROGDI (Kohlschtter-Tnz syndrome).	ROGDI	hearing loss	79641	HP_0000365	457	462	431	443	False
28505344	Recent studies have suggested possible therapeutic targets for some patients with early-onset glaucoma based on the molecular and cellular events caused by MYOC, OPTN and TBK1 mutations.	MYOC	glaucoma	4653	HP_0000501	156	160	94	102	True
28505344	Recent studies have suggested possible therapeutic targets for some patients with early-onset glaucoma based on the molecular and cellular events caused by MYOC, OPTN and TBK1 mutations.	OPTN	glaucoma	10133	HP_0000501	162	166	94	102	True
28505344	Recent studies have suggested possible therapeutic targets for some patients with early-onset glaucoma based on the molecular and cellular events caused by MYOC, OPTN and TBK1 mutations.	TBK1	glaucoma	29110	HP_0000501	171	175	94	102	False
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	ABCA1	glaucoma	19	HP_0000501	136	141	60	68	False
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	AFAP1	glaucoma	60312	HP_0000501	143	148	60	68	False
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	GMDS	glaucoma	2762	HP_0000501	150	154	60	68	False
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	PMM2	glaucoma	5373	HP_0000501	156	160	60	68	False
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	TGFBR3	glaucoma	7049	HP_0000501	162	168	60	68	False
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	FNDC3B	glaucoma	64778	HP_0000501	170	176	60	68	False
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	ARHGEF12	glaucoma	23365	HP_0000501	178	186	60	68	False
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	GAS7	glaucoma	8522	HP_0000501	188	192	60	68	False
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	FOXC1	glaucoma	2296	HP_0000501	194	199	60	68	True
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	ATXN2	glaucoma	6311	HP_0000501	201	206	60	68	False
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	TXNRD2	glaucoma	10587	HP_0000501	208	214	60	68	False
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	EPDR1	glaucoma	54749	HP_0000501	255	260	60	68	False
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	CHAT	glaucoma	1103	HP_0000501	262	266	60	68	False
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	GLIS3	glaucoma	169792	HP_0000501	268	273	60	68	True
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	FERMT2	glaucoma	10979	HP_0000501	275	281	60	68	False
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	DPM2	glaucoma	8818	HP_0000501	283	287	60	68	False
28505344	Recent GWAS completed for three types of common adult-onset glaucoma have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, TGFBR3, FNDC3B, ARHGEF12, GAS7, FOXC1, ATXN2, TXNRD2); PACG (primary angle-closure glaucoma (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	CACNA1A	glaucoma	773	HP_0000501	338	345	60	68	False
28505344	In total sixteen genomic regions have been associated with POAG (including the normal tension glaucoma (NTG) subgroup), 8 with PACG and 2 with XFS.	NTG	glaucoma	9968	HP_0000501	104	107	94	102	False
30291284	Here, we demonstrate that transgenic targeting of OGG1 to mitochondria confers significant protection from diet-induced obesity, insulin resistance, and adipose tissue inflammation.	OGG1	obesity	4968	HP_0001513	50	54	120	127	False
27993705	Patients with mutations in ZNF711 all present with mild to moderate ID and poor speech accompanied by additional features in some patients, including autistic features and mild facial dysmorphisms, suggesting that ZNF711 mutations cause non-syndromic ID	ZNF711	mild	7552	HP_0012825	27	33	51	55	False
27993705	Patients with mutations in ZNF711 all present with mild to moderate ID and poor speech accompanied by additional features in some patients, including autistic features and mild facial dysmorphisms, suggesting that ZNF711 mutations cause non-syndromic ID	ZNF711	facial dysmorphisms	7552	HP_0001999	27	33	177	196	True
30808755	The brains of <i>Ube3b</i><sup>-/-</sup> mice had hypoplasia of the corpus callosum, enlarged ventricles, and decreased thickness of the somatosensory cortex.	Ube3b	hypoplasia of the corpus callosum	89910	HP_0002079	17	22	50	83	True
30808755	The brains of <i>Ube3b</i><sup>-/-</sup> mice had hypoplasia of the corpus callosum, enlarged ventricles, and decreased thickness of the somatosensory cortex.	mice	hypoplasia of the corpus callosum	23581	HP_0002079	41	45	50	83	False
30808755	The brains of <i>Ube3b</i><sup>-/-</sup> mice had hypoplasia of the corpus callosum, enlarged ventricles, and decreased thickness of the somatosensory cortex.	Ube3b	enlarged ventricles	89910	HP_0002119	17	22	85	104	True
30808755	The brains of <i>Ube3b</i><sup>-/-</sup> mice had hypoplasia of the corpus callosum, enlarged ventricles, and decreased thickness of the somatosensory cortex.	mice	enlarged ventricles	23581	HP_0002119	41	45	85	104	False
30504766	Palatable foods (fat and sweet) induce hyperphagia, and facilitate the development of obesity.	fat	hyperphagia	948	HP_0002591	17	20	39	50	False
30504766	Palatable foods (fat and sweet) induce hyperphagia, and facilitate the development of obesity.	fat	obesity	948	HP_0001513	17	20	86	93	False
30504766	Here we show that adipocyte OGT is essential for high fat diet-induced hyperphagia, but is dispensable for baseline food intake.	fat	hyperphagia	948	HP_0002591	54	57	71	82	False
30504766	Here we show that adipocyte OGT is essential for high fat diet-induced hyperphagia, but is dispensable for baseline food intake.	OGT	hyperphagia	8473	HP_0002591	28	31	71	82	False
30504766	Adipocyte OGT stimulates hyperphagia by transcriptional activation of de novo lipid desaturation and accumulation of N-arachidonyl ethanolamine (AEA), an endogenous appetite-inducing cannabinoid (CB).	OGT	hyperphagia	8473	HP_0002591	10	13	25	36	False
30504766	Pharmacological manipulation of peripheral CB1 signaling regulates hyperphagia in an adipocyte OGT-dependent manner.	OGT	hyperphagia	8473	HP_0002591	95	98	67	78	False
30504766	These findings define adipocyte OGT as a fat sensor that regulates peripheral lipid signals, and uncover an unexpected adipose-to-brain axis to induce hyperphagia and obesity	fat	hyperphagia	948	HP_0002591	41	44	151	162	False
30504766	These findings define adipocyte OGT as a fat sensor that regulates peripheral lipid signals, and uncover an unexpected adipose-to-brain axis to induce hyperphagia and obesity	OGT	hyperphagia	8473	HP_0002591	32	35	151	162	False
30223116	Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) is a potential target in Alzheimer's disease (AD) because of the established correlation between its over-expression and generation of neurofibrillary tangles (NFT) as well as the accumulation of amyloid plaques.	Dyrk1A	neurofibrillary tangles	1859	HP_0002185	63	69	206	229	False
28361972	Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant, late-onset muscle disorder characterized by ptosis, swallowing difficulties, proximal limb weakness and nuclear aggregates in skeletal muscles.	OPMD	ptosis	8106	HP_0000508	36	40	112	118	True
28361972	Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant, late-onset muscle disorder characterized by ptosis, swallowing difficulties, proximal limb weakness and nuclear aggregates in skeletal muscles.	OPMD	swallowing difficulties	8106	HP_0002015	36	40	120	143	True
28752900	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease.	ALS	neurodegenerative disease	3483	HP_0002180	31	34	47	72	False
28752900	Progressive and systemic loss of motor neurons with gliosis in the central nervous system (CNS) is a neuropathological hallmark of ALS.	ALS	central	3483	HP_0030645	131	134	67	74	False
26840709	Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, MAPK1, STAT3, RAF1, and JAK1 might be associated with the development of lung adenocarcinoma.	PRIM1	lung adenocarcinoma	5557	HP_0030078	58	63	144	163	False
26840709	Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, MAPK1, STAT3, RAF1, and JAK1 might be associated with the development of lung adenocarcinoma.	MCM3	lung adenocarcinoma	4172	HP_0030078	65	69	144	163	False
26840709	Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, MAPK1, STAT3, RAF1, and JAK1 might be associated with the development of lung adenocarcinoma.	MAPK1	lung adenocarcinoma	5594	HP_0030078	71	76	144	163	False
26840709	Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, MAPK1, STAT3, RAF1, and JAK1 might be associated with the development of lung adenocarcinoma.	STAT3	lung adenocarcinoma	6774	HP_0030078	78	83	144	163	False
26840709	Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, MAPK1, STAT3, RAF1, and JAK1 might be associated with the development of lung adenocarcinoma.	RAF1	lung adenocarcinoma	5894	HP_0030078	85	89	144	163	False
26840709	Our findings suggest that DEGs encoding subunits of NADH, PRIM1, MCM3, MAPK1, STAT3, RAF1, and JAK1 might be associated with the development of lung adenocarcinoma.	JAK1	lung adenocarcinoma	3716	HP_0030078	95	99	144	163	False
29503125	Disorders of sex development comprise a heterogeneous group of congenital conditions associated with atypical development of internal and external genitalia.	sex	heterogeneous	55558	HP_0001425	13	16	40	53	False
27983999	Our study indicates the novel WDR73 p.W371G missense mutation causes infantile onset intellectual disability and cerebellar hypoplasia in recessive mode of inheritance.	WDR73	intellectual disability	84942	HP_0001249	30	35	85	108	True
27983999	Our study indicates the novel WDR73 p.W371G missense mutation causes infantile onset intellectual disability and cerebellar hypoplasia in recessive mode of inheritance.	WDR73	cerebellar hypoplasia	84942	HP_0001321	30	35	113	134	False
27983999	Our study indicates the novel WDR73 p.W371G missense mutation causes infantile onset intellectual disability and cerebellar hypoplasia in recessive mode of inheritance.	WDR73	mode of inheritance	84942	HP_0000005	30	35	148	167	False
27983999	Our findings imply that microcephaly is a variable phenotype in WDR73-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease	WDR73	microcephaly	84942	HP_0000252	64	69	24	36	True
27983999	Our findings imply that microcephaly is a variable phenotype in WDR73-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease	type	microcephaly	6445	HP_0000252	56	60	24	36	False
27983999	Our findings imply that microcephaly is a variable phenotype in WDR73-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease	WDR73	intellectual disability	84942	HP_0001249	64	69	134	157	True
27983999	Our findings imply that microcephaly is a variable phenotype in WDR73-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease	type	intellectual disability	6445	HP_0001249	56	60	134	157	False
27983999	Our findings imply that microcephaly is a variable phenotype in WDR73-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease	WDR73	cerebellar hypoplasia	84942	HP_0001321	64	69	162	183	False
27983999	Our findings imply that microcephaly is a variable phenotype in WDR73-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease	type	cerebellar hypoplasia	6445	HP_0001321	56	60	162	183	False
29043394	Through biological and in silico analyses, our study suggests an association between SIX1/EYA1 mutations and cardiovascular malformations, SIX1/EYA1 mutations might be partially responsible for CTDs	SIX1	cardiovascular malformations	6495	HP_0030680	85	89	109	137	False
29043394	Through biological and in silico analyses, our study suggests an association between SIX1/EYA1 mutations and cardiovascular malformations, SIX1/EYA1 mutations might be partially responsible for CTDs	EYA1	cardiovascular malformations	2138	HP_0030680	90	94	109	137	False
28925718	Two pairwise genetic interactions (B cell lymphocyte kinase (BLK) rs13277113,B cell scaffold protein with ankyrin repeats 1 (BANK1) rs3733197and BLK rs13277113 membrane metalloendopeptidase like 1 (MMEL1)/ tumor necrosis factor receptor superfamily member 14 (TNFRSF14) rs3890745) have been demonstrated in determining susceptibility to rheumatoid arthritis (RA) without replication, thus this study was performed to examine whether abovementioned genetic polymorphisms were associated with RA and further tests were performed to see whether aforementioned genetic interactions existed in RA among Chinese population.	BLK	tumor	640	HP_0002664	61	64	206	211	False
28925718	Two pairwise genetic interactions (B cell lymphocyte kinase (BLK) rs13277113,B cell scaffold protein with ankyrin repeats 1 (BANK1) rs3733197and BLK rs13277113 membrane metalloendopeptidase like 1 (MMEL1)/ tumor necrosis factor receptor superfamily member 14 (TNFRSF14) rs3890745) have been demonstrated in determining susceptibility to rheumatoid arthritis (RA) without replication, thus this study was performed to examine whether abovementioned genetic polymorphisms were associated with RA and further tests were performed to see whether aforementioned genetic interactions existed in RA among Chinese population.	BANK1	tumor	55024	HP_0002664	125	130	206	211	False
28925718	Two pairwise genetic interactions (B cell lymphocyte kinase (BLK) rs13277113,B cell scaffold protein with ankyrin repeats 1 (BANK1) rs3733197and BLK rs13277113 membrane metalloendopeptidase like 1 (MMEL1)/ tumor necrosis factor receptor superfamily member 14 (TNFRSF14) rs3890745) have been demonstrated in determining susceptibility to rheumatoid arthritis (RA) without replication, thus this study was performed to examine whether abovementioned genetic polymorphisms were associated with RA and further tests were performed to see whether aforementioned genetic interactions existed in RA among Chinese population.	MMEL1	tumor	79258	HP_0002664	198	203	206	211	True
28925718	Two pairwise genetic interactions (B cell lymphocyte kinase (BLK) rs13277113,B cell scaffold protein with ankyrin repeats 1 (BANK1) rs3733197and BLK rs13277113 membrane metalloendopeptidase like 1 (MMEL1)/ tumor necrosis factor receptor superfamily member 14 (TNFRSF14) rs3890745) have been demonstrated in determining susceptibility to rheumatoid arthritis (RA) without replication, thus this study was performed to examine whether abovementioned genetic polymorphisms were associated with RA and further tests were performed to see whether aforementioned genetic interactions existed in RA among Chinese population.	TNFRSF14	tumor	8764	HP_0002664	260	268	206	211	False
28512252	Loss of ZBTB18 contributes to the aggressive phenotype of glioblastoma through regulation of poor prognosis-associated signatures.	ZBTB18	glioblastoma	10472	HP_0012174	8	14	58	70	False
28512252	Restitution of ZBTB18 expression reverses the phenotype and impairs tumor-forming ability.	ZBTB18	tumor	10472	HP_0002664	15	21	68	73	False
28512252	These results indicate that ZBTB18 functions as a tumor suppressor in GBM through the regulation of genes associated with phenotypically aggressive properties.<b>Implications:</b> This study characterizes the role of the putative tumor suppressor ZBTB18 and its regulation by promoter hypermethylation, which appears to be a common mechanism to silence ZBTB18 in the mesenchymal subtype of GBM and provides a new mechanistic opportunity to specifically target this tumor subclass.	ZBTB18	tumor	10472	HP_0002664	28	34	50	55	False
27640307	We identified a recurrent de novo ATAD3A c.1582C&gt;T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy.	ATAD3A	developmental delay	55210	HP_0001263	34	40	170	189	True
27640307	We identified a recurrent de novo ATAD3A c.1582C&gt;T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy.	ATAD3A	optic atrophy	55210	HP_0000648	34	40	202	215	True
27640307	We identified a recurrent de novo ATAD3A c.1582C&gt;T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy.	ATAD3A	neuropathy	55210	HP_0009830	34	40	224	234	True
27640307	We identified a recurrent de novo ATAD3A c.1582C&gt;T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy.	ATAD3A	cardiomyopathy	55210	HP_0001638	34	40	253	267	True
30738487	As a potential target for cancer treatment, the C-Myc high expresses abnormally in a variety of solid tumors and hematological malignancies in humans.	C-Myc	cancer	4609	HP_0002664	48	53	26	32	True
30738487	As a potential target for cancer treatment, the C-Myc high expresses abnormally in a variety of solid tumors and hematological malignancies in humans.	C-Myc	tumors	4609	HP_0002664	48	53	102	108	True
29108898	Since platelet-mediated clot formation is a key event in several fatal diseases, such as myocardial infarction, stroke and pulmonary embolism, understanding TYMP in depth may lead to uncovering novel mechanisms in the development of cardiovascular diseases.	TYMP	pulmonary embolism	1890	HP_0002204	157	161	123	141	False
29108898	Since platelet-mediated clot formation is a key event in several fatal diseases, such as myocardial infarction, stroke and pulmonary embolism, understanding TYMP in depth may lead to uncovering novel mechanisms in the development of cardiovascular diseases.	TYMP	cardiovascular diseases	1890	HP_0001626	157	161	233	256	False
29108898	In this review article, we summarize the discovery of TYMP and the potential molecular mechanisms of TYMP involved in the development of various diseases, especially cardiovascular diseases.	TYMP	cardiovascular diseases	1890	HP_0001626	54	58	166	189	False
28535045	Chemical inhibition of epigenetic regulatory proteins BrdT and Brd4 is emerging as a promising therapeutic strategy in contraception, cancer, and heart disease.	BrdT	cancer	676	HP_0002664	54	58	134	140	False
28535045	Chemical inhibition of epigenetic regulatory proteins BrdT and Brd4 is emerging as a promising therapeutic strategy in contraception, cancer, and heart disease.	Brd4	cancer	23476	HP_0002664	63	67	134	140	False
20850505	In a large Scottish pedigree, a balanced translocation t (1;11)(q42.1;q14.3) disrupting the DISC1 and DISC2 genes segregates with major mental illness, including schizophrenia and depression.	DISC1	schizophrenia	27185	HP_0100753	92	97	162	175	False
20850505	A frame-shift carboxyl-terminal deletion was reported in DISC1 in an American family with schizophrenia, but subsequently found in two controls.	DISC1	schizophrenia	27185	HP_0100753	57	62	90	103	False
29901129	Schwartz-Jampel syndrome type 1 (SJS1) is a rare autosomal recessive disease caused by mutations in the gene heparan sulfate proteoglycan 2 (HSPG2; also known as basement membranespecific heparin sulfate).	type	autosomal recessive	6445	HP_0000007	25	29	49	68	True
29901129	Schwartz-Jampel syndrome type 1 (SJS1) is a rare autosomal recessive disease caused by mutations in the gene heparan sulfate proteoglycan 2 (HSPG2; also known as basement membranespecific heparin sulfate).	SJS1	autosomal recessive	3339	HP_0000007	33	37	49	68	True
29901129	Schwartz-Jampel syndrome type 1 (SJS1) is a rare autosomal recessive disease caused by mutations in the gene heparan sulfate proteoglycan 2 (HSPG2; also known as basement membranespecific heparin sulfate).	HSPG2	autosomal recessive	3339	HP_0000007	141	146	49	68	True
29901129	The key clinical features of the patient with SJS1 included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the face and limbs; barely discernible kyphosis was also noted.	SJS1	short stature	3339	HP_0004322	46	50	60	73	True
29901129	The key clinical features of the patient with SJS1 included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the face and limbs; barely discernible kyphosis was also noted.	face	short stature	2178	HP_0004322	164	168	60	73	True
29901129	The key clinical features of the patient with SJS1 included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the face and limbs; barely discernible kyphosis was also noted.	SJS1	contractures	3339	HP_0001371	46	50	81	93	True
29901129	The key clinical features of the patient with SJS1 included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the face and limbs; barely discernible kyphosis was also noted.	face	contractures	2178	HP_0001371	164	168	81	93	False
29901129	The key clinical features of the patient with SJS1 included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the face and limbs; barely discernible kyphosis was also noted.	SJS1	myotonia	3339	HP_0002486	46	50	114	122	True
29901129	The key clinical features of the patient with SJS1 included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the face and limbs; barely discernible kyphosis was also noted.	face	myotonia	2178	HP_0002486	164	168	114	122	False
29901129	The key clinical features of the patient with SJS1 included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the face and limbs; barely discernible kyphosis was also noted.	SJS1	kyphosis	3339	HP_0002808	46	50	199	207	True
29901129	The key clinical features of the patient with SJS1 included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the face and limbs; barely discernible kyphosis was also noted.	face	kyphosis	2178	HP_0002808	164	168	199	207	False
29901129	The family members harboring 1 heterozygous mutation in HSPG2 did not exhibit any skeletal abnormalities.	HSPG2	skeletal abnormalities	3339	HP_0000924	56	61	82	104	True
30765526	These mice displayed hypertension, hyperkalemia, hyperactive NCC, and other features fully recapitulating human and mouse models of PHAII caused by gain-of-function WNK4.	WNK4	hypertension	65266	HP_0000822	165	169	21	33	True
30765526	These mice displayed hypertension, hyperkalemia, hyperactive NCC, and other features fully recapitulating human and mouse models of PHAII caused by gain-of-function WNK4.	mice	hypertension	23581	HP_0000822	6	10	21	33	False
30765526	These mice displayed hypertension, hyperkalemia, hyperactive NCC, and other features fully recapitulating human and mouse models of PHAII caused by gain-of-function WNK4.	WNK4	hyperkalemia	65266	HP_0002153	165	169	35	47	True
30765526	These mice displayed hypertension, hyperkalemia, hyperactive NCC, and other features fully recapitulating human and mouse models of PHAII caused by gain-of-function WNK4.	mice	hyperkalemia	23581	HP_0002153	6	10	35	47	False
27507850	In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by CCND1/CDK6-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of EGFR in patient HNSCC samples.	EGFR	tumor	1956	HP_0002664	183	187	33	38	True
27507850	In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by CCND1/CDK6-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of EGFR in patient HNSCC samples.	CCND1	tumor	595	HP_0002664	87	92	33	38	True
27507850	In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by CCND1/CDK6-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of EGFR in patient HNSCC samples.	CDK6	tumor	1021	HP_0002664	93	97	33	38	False
27507850	In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by CCND1/CDK6-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of EGFR in patient HNSCC samples.	EGFR	retinoblastoma	1956	HP_0009919	183	187	50	64	False
27507850	In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by CCND1/CDK6-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of EGFR in patient HNSCC samples.	CCND1	retinoblastoma	595	HP_0009919	87	92	50	64	False
27507850	In addition, inactivation of the tumor suppressor retinoblastoma 1 (RB1), reflected by CCND1/CDK6-inactivating phosphorylation of RB1 at T356, inversely correlated with expression of EGFR in patient HNSCC samples.	CDK6	retinoblastoma	1021	HP_0009919	93	97	50	64	False
29844574	We noted that Sirtuin 1 (SIRT1) is overexpressed in HPV-infected cervical cancer cells and hypothesized that SIRT1 counteracts antiviral immunity.	SIRT1	cancer	23411	HP_0002664	25	30	74	80	False
29844574	Here, we found that cervical cancer cells undergo massive death by SIRT1 knockdown, but this effect is reversed by SIRT1 restoration.	SIRT1	cancer	23411	HP_0002664	67	72	29	35	False
29844574	Interestingly, pyroptotic death signaling in SIRT1-knocked-down cells was transmitted to nave cervical cancer cells, which was mediated by extracellular vesicles carrying AIM2 inflammasome proteins.	SIRT1	cancer	23411	HP_0002664	45	50	104	110	False
29844574	Interestingly, pyroptotic death signaling in SIRT1-knocked-down cells was transmitted to nave cervical cancer cells, which was mediated by extracellular vesicles carrying AIM2 inflammasome proteins.	AIM2	cancer	9447	HP_0002664	172	176	104	110	False
29844574	Furthermore, the growth of cervical cancer xenografts was significantly inhibited by either SIRT1-targeting siRNAs or SIRT1-knockdown-derived extracellular vesicles.	SIRT1	cancer	23411	HP_0002664	92	97	36	42	False
29844574	Immunohistochemical analyses showed that SIRT1 expression correlated with poor clinical outcomes in cervical cancer.	SIRT1	cancer	23411	HP_0002664	41	46	109	115	False
29844574	In conclusion, SIRT1 enabled HPV-infected cervical cancer cells to continue growing by nullifying AIM2 inflammasome-mediated immunity.	SIRT1	cancer	23411	HP_0002664	15	20	51	57	False
29844574	In conclusion, SIRT1 enabled HPV-infected cervical cancer cells to continue growing by nullifying AIM2 inflammasome-mediated immunity.	AIM2	cancer	9447	HP_0002664	98	102	51	57	False
29844574	Without SIRT1, cervical cancer cells could no longer survive because of the derepression of the AIM2 inflammasome.	SIRT1	cancer	23411	HP_0002664	8	13	24	30	False
29844574	Without SIRT1, cervical cancer cells could no longer survive because of the derepression of the AIM2 inflammasome.	AIM2	cancer	9447	HP_0002664	96	100	24	30	False
30667376	Genetic sequencing confirmed a homozygous R565Q missense mutation in the catalytic domain of PDE6C, a cone-specific phototransduction enzyme associated with achromatopsia in humans.	PDE6C	achromatopsia	5146	HP_0011516	93	98	157	170	False
29559246	The subcapsular mass-forming tumor was composed of poorly differentiated tumor cells arranged in small vague glandular or slit-lumen nests, and focally fused or anastomosing large trabecular patterns within the prominent fibrotic stroma.	mass	tumor	2200	HP_0002664	16	20	29	34	False
29559246	The tumor cells with immunoreactivity to CK7, CK19, Cam5.2, COX2, EMA, BCL-2, MOC-31 and AE1/AE3, supported a diagnosis of intrahepatic cholangiocarcinoma.	COX2	tumor	140909	HP_0002664	60	64	4	9	False
29559246	The tumor cells with immunoreactivity to CK7, CK19, Cam5.2, COX2, EMA, BCL-2, MOC-31 and AE1/AE3, supported a diagnosis of intrahepatic cholangiocarcinoma.	EMA	tumor	2108	HP_0002664	66	69	4	9	False
29559246	The tumor cells with immunoreactivity to CK7, CK19, Cam5.2, COX2, EMA, BCL-2, MOC-31 and AE1/AE3, supported a diagnosis of intrahepatic cholangiocarcinoma.	BCL-2	tumor	596	HP_0002664	71	76	4	9	True
25464848	Disruption of Sema3C induced apoptosis of GSCs, but not NPCs or NSTCs, and suppressed tumor growth in orthotopic models of glioblastoma.	Sema3C	tumor	10512	HP_0002664	14	20	86	91	True
25464848	Disruption of Sema3C induced apoptosis of GSCs, but not NPCs or NSTCs, and suppressed tumor growth in orthotopic models of glioblastoma.	Sema3C	glioblastoma	10512	HP_0012174	14	20	123	135	False
25464848	Our study supports the targeting of Sema3C to break this GSC-specific autocrine/paracrine loop in order to improve glioblastoma treatment, potentially with a high therapeutic index.	Sema3C	glioblastoma	10512	HP_0012174	36	42	115	127	False
27730671	Appraisal of the present case against previously reported patients indicate that EXPH5 mutations result in a distinctive skin fragility phenotype, with minimal blistering compared with other forms of basal EBS	EXPH5	skin fragility	23086	HP_0001030	81	86	121	135	True
29265763	Brain malformations described in association with 22q11.2 deletion syndrome include polymicrogyria, cerebellar hypoplasia, megacisterna magna, and agenesis of the corpus callosum (ACC), although these are rare.	ACC	polymicrogyria	31	HP_0002126	180	183	84	98	False
29265763	Brain malformations described in association with 22q11.2 deletion syndrome include polymicrogyria, cerebellar hypoplasia, megacisterna magna, and agenesis of the corpus callosum (ACC), although these are rare.	ACC	cerebellar hypoplasia	31	HP_0001321	180	183	100	121	False
29265763	Brain malformations described in association with 22q11.2 deletion syndrome include polymicrogyria, cerebellar hypoplasia, megacisterna magna, and agenesis of the corpus callosum (ACC), although these are rare.	ACC	agenesis of the corpus callosum	31	HP_0001274	180	183	147	178	False
29265763	Although the patient showed cardiac anomalies, which is one of the typical symptoms of 22q11.2 deletion syndrome, her rather severe phenotype and atypical face prompted us to search for additional pathogenic mutations.	face	cardiac anomalies	2178	HP_0001627	155	159	28	45	True
26173643	Noonan syndrome (NS), the commonest RASopathy, is genetically heterogeneous and caused by functional dysregulation of signal transducers and regulatory proteins with roles in the RAS/extracellular signal-regulated kinase (ERK) signal transduction pathway.	ERK	heterogeneous	2048	HP_0001425	222	225	62	75	False
29338044	To investigate the mechanism by which the -crystallin mutations Cryaa-R49C and Cryab-R120G lead to cataract formation, we determined whether these mutations cause an altered expression of specific transcripts in the lens at an early postnatal age by RNA-seq analysis.	Cryaa	cataract	1409	HP_0000518	65	70	100	108	True
29338044	To investigate the mechanism by which the -crystallin mutations Cryaa-R49C and Cryab-R120G lead to cataract formation, we determined whether these mutations cause an altered expression of specific transcripts in the lens at an early postnatal age by RNA-seq analysis.	Cryab	cataract	1410	HP_0000518	80	85	100	108	True
29338044	Taken together, these findings offer additional insight into the early transcriptional changes caused by Cryaa and Cryab mutations associated with autosomal dominant human cataracts, and indicate that the transcript levels of certain genes are affected by the expression of mutant -crystallin in vivo	Cryaa	cataracts	1409	HP_0000518	105	110	172	181	True
29338044	Taken together, these findings offer additional insight into the early transcriptional changes caused by Cryaa and Cryab mutations associated with autosomal dominant human cataracts, and indicate that the transcript levels of certain genes are affected by the expression of mutant -crystallin in vivo	Cryab	cataracts	1410	HP_0000518	115	120	172	181	True
28328135	Since the original description of the IARS2-related cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.	IARS2	cataracts	55699	HP_0000518	38	43	52	61	True
28328135	Since the original description of the IARS2-related cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.	IARS2	neuropathy	55699	HP_0009830	38	43	98	108	True
28328135	Since the original description of the IARS2-related cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.	IARS2	hearing loss	55699	HP_0000365	38	43	124	136	True
28328135	Since the original description of the IARS2-related cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.	IARS2	skeletal dysplasia	55699	HP_0002652	38	43	138	156	True
28328135	Here, we report on a female Danish patient with a novel homozygous IARS2 mutation, p.Gly874Arg, who presented at birth with bilateral hip dislocation and short stature.	IARS2	short stature	55699	HP_0004322	67	72	154	167	True
28328135	Here, we report on a female Danish patient with a novel homozygous IARS2 mutation, p.Gly874Arg, who presented at birth with bilateral hip dislocation and short stature.	hip	short stature	64399	HP_0004322	134	137	154	167	False
28328135	At 3 months, additional dysmorphic features were noted and at 18 months her radiographic skeletal abnormalities were suggestive of an underlying spondyloepimetaphyseal dysplasia (SEMD).	SEMD	skeletal abnormalities	10371	HP_0000924	179	183	89	111	True
28328135	At 3 months, additional dysmorphic features were noted and at 18 months her radiographic skeletal abnormalities were suggestive of an underlying spondyloepimetaphyseal dysplasia (SEMD).	SEMD	spondyloepimetaphyseal dysplasia	10371	HP_0002651	179	183	145	177	False
28328135	We present her clinical features and particularly highlight her skeletal findings, which confirm the presence of a primary SEMD skeletal dysplasia in a growing list of mitochondrial-related disorders including CAGSSS, CODAS, EVEN-PLUS, and X-linked SEMD-MR syndromes	SEMD	skeletal dysplasia	10371	HP_0002652	123	127	128	146	True
28328135	We present her clinical features and particularly highlight her skeletal findings, which confirm the presence of a primary SEMD skeletal dysplasia in a growing list of mitochondrial-related disorders including CAGSSS, CODAS, EVEN-PLUS, and X-linked SEMD-MR syndromes	MR	skeletal dysplasia	4306	HP_0002652	254	256	128	146	False
30736903	The study was conducted to determine the effect of DHA on the distribution of apelin and apelin receptor (APJ) in the central nervous system in 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP)-induced PD model.	apelin	central	8862	HP_0030645	78	84	118	125	False
30736903	The study was conducted to determine the effect of DHA on the distribution of apelin and apelin receptor (APJ) in the central nervous system in 1-methyl-4-phenyl-1, 2, 3, 6 tetrahydropyridine (MPTP)-induced PD model.	APJ	central	187	HP_0030645	106	109	118	125	False
29179176	Chorea-acanthocytosis (ChAc), a neurodegenerative disease, results from loss-of-function-mutations of the chorein-encoding gene VPS13A.	ChAc	neurodegenerative disease	23230	HP_0002180	23	27	32	57	False
29179176	Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and lip biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.	lip	movement disorder	23049	HP_0100022	157	160	44	61	False
29179176	Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and lip biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.	lip	chorea	23049	HP_0002072	157	160	72	78	False
29179176	Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and lip biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.	lip	parkinsonism	23049	HP_0001300	157	160	80	92	False
29179176	Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and lip biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.	lip	dystonia	23049	HP_0001332	157	160	94	102	False
29179176	Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and lip biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.	lip	tongue protrusion	23049	HP_0010808	157	160	104	121	False
29179176	Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and lip biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.	lip	dysarthria	23049	HP_0001260	157	160	123	133	False
29179176	Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and lip biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.	lip	dysphagia	23049	HP_0002015	157	160	135	144	False
29179176	Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and lip biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.	lip	seizures	23049	HP_0001250	157	160	241	249	False
29179176	Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and lip biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.	lip	cognitive impairment	23049	HP_0100543	157	160	251	271	False
29179176	Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, dystonia, tongue protrusion, dysarthria, dysphagia, tongue and lip biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.	lip	behavioral changes	23049	HP_0000708	157	160	277	295	False
29179176	Chorein, SGK1, ORAI1 and SOCE further confer survival of tumor cells.	SGK1	tumor	6446	HP_0002664	9	13	57	62	False
29179176	Chorein, SGK1, ORAI1 and SOCE further confer survival of tumor cells.	ORAI1	tumor	84876	HP_0002664	15	20	57	62	False
28716533	Mutations in UBQLN2 have been associated with rare cases of X-linked juvenile and adult forms of amyotrophic lateral sclerosis (ALS) and ALS linked to frontotemporal dementia (FTD).	UBQLN2	frontotemporal dementia	29978	HP_0002145	13	19	151	174	True
28716533	Mutations in UBQLN2 have been associated with rare cases of X-linked juvenile and adult forms of amyotrophic lateral sclerosis (ALS) and ALS linked to frontotemporal dementia (FTD).	ALS	frontotemporal dementia	3483	HP_0002145	128	131	151	174	False
28716533	Here, we report 1 known (c.1489C&gt;T, p.Pro497Ser, P497S) and 3 novel (c.1481C&gt;T, p.Pro494Leu, P494L; c.1498C&gt;T, p.Pro500Ser, P500S; and c.1516C&gt;G, p.Pro506Ala, P506A) missense mutations in the PXX domain of UBQLN2 in familial motor neuron diseases including ALS and spastic paraplegia (SP).	UBQLN2	spastic paraplegia	29978	HP_0001258	218	224	277	295	False
28716533	Here, we report 1 known (c.1489C&gt;T, p.Pro497Ser, P497S) and 3 novel (c.1481C&gt;T, p.Pro494Leu, P494L; c.1498C&gt;T, p.Pro500Ser, P500S; and c.1516C&gt;G, p.Pro506Ala, P506A) missense mutations in the PXX domain of UBQLN2 in familial motor neuron diseases including ALS and spastic paraplegia (SP).	ALS	spastic paraplegia	3483	HP_0001258	269	272	277	295	False
28716533	A novel missense mutation (c.1462G&gt;A, p.Ala488Thr, A488T) adjacent to this hotspot UBQLN2 domain was identified in a sporadic case of ALS.	UBQLN2	sporadic	29978	HP_0003745	86	92	120	128	False
28716533	A novel missense mutation (c.1462G&gt;A, p.Ala488Thr, A488T) adjacent to this hotspot UBQLN2 domain was identified in a sporadic case of ALS.	ALS	sporadic	3483	HP_0003745	137	140	120	128	False
27065468	The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (MDS) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy.	MDS	progressive	5048	HP_0003676	131	134	233	244	False
27065468	The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (MDS) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy.	MDS	ophthalmoplegia	5048	HP_0000602	131	134	254	269	False
27065468	The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (MDS) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy.	MDS	ataxia	5048	HP_0001251	131	134	271	277	True
27065468	The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (MDS) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy.	MDS	neuropathy	5048	HP_0009830	131	134	278	288	False
27065468	The resulting loss of cellular respiration ultimately induces mitochondrial genetic diseases, including mtDNA depletion syndromes (MDS) such as Alpers or early infantile hepatocerebral syndromes, and mtDNA deletion disorders such as progressive external ophthalmoplegia, ataxia-neuropathy, or mitochondrial neurogastrointestinal encephalomyopathy.	MDS	mitochondrial	5048	HP_0001427	131	134	62	75	False
28737756	Zinc finger protein 687 (ZNF687), identified as a C2H2 zinc finger protein, has been found to be mutated and upregulated in giant cell tumor of bone and acute myeloid leukemia, suggesting an oncogenic role for ZNF687 in cancer.	ZNF687	tumor	57592	HP_0002664	25	31	135	140	False
28737756	Zinc finger protein 687 (ZNF687), identified as a C2H2 zinc finger protein, has been found to be mutated and upregulated in giant cell tumor of bone and acute myeloid leukemia, suggesting an oncogenic role for ZNF687 in cancer.	ZNF687	cancer	57592	HP_0002664	25	31	220	226	False
28737756	However, the clinical significance and precise role of ZNF687 in cancer progression are largely unknown.	ZNF687	cancer	57592	HP_0002664	55	61	65	71	False
28737756	Herein, we report that ZNF687 was markedly upregulated in hepatocellular carcinoma (HCC) cell lines and HCC tissues, and was significantly correlated with relapse-free survival in HCC.	ZNF687	hepatocellular carcinoma	57592	HP_0001402	23	29	58	82	False
28737756	Herein, we report that ZNF687 was markedly upregulated in hepatocellular carcinoma (HCC) cell lines and HCC tissues, and was significantly correlated with relapse-free survival in HCC.	HCC	hepatocellular carcinoma	84668	HP_0001402	84	87	58	82	False
28737756	ZNF687 overexpression greatly enhanced HCC cell capability for tumorsphere formation, invasion and chemoresistance in vitro, whereas inhibiting ZNF687 reduced these capabilities and inhibited HCC cell tumorigenic capability in vivo.	ZNF687	tumor	57592	HP_0002664	0	6	63	68	False
28737756	ZNF687 overexpression greatly enhanced HCC cell capability for tumorsphere formation, invasion and chemoresistance in vitro, whereas inhibiting ZNF687 reduced these capabilities and inhibited HCC cell tumorigenic capability in vivo.	HCC	tumor	84668	HP_0002664	39	42	63	68	False
28737756	Importantly, extreme limiting dilution analysis revealed that even 1  10<sup>2</sup> ZNF687-transduced cells could form tumors in vivo, indicating that ZNF687 contributes to HCC recurrence.	ZNF687	tumor	57592	HP_0002664	86	92	121	126	False
28737756	Importantly, extreme limiting dilution analysis revealed that even 1  10<sup>2</sup> ZNF687-transduced cells could form tumors in vivo, indicating that ZNF687 contributes to HCC recurrence.	HCC	tumor	84668	HP_0002664	175	178	121	126	False
26548497	FGD is a heterogeneous disorder for which causal mutations have been identified in MC2R, MRAP, MCM4 and TXNRD2.	MRAP	heterogeneous	56246	HP_0001425	89	93	9	22	False
26548497	FGD is a heterogeneous disorder for which causal mutations have been identified in MC2R, MRAP, MCM4 and TXNRD2.	MCM4	heterogeneous	4173	HP_0001425	95	99	9	22	False
28334746	In the present article, we describe an infant who smelt of ketones during examination and who was diagnosed with transient NDM caused by a ZFP57 mutation, accompanied by ketoacidosis.	ZFP57	ketoacidosis	346171	HP_0001993	139	144	170	182	False
29734195	Mutations of the CYP21A2 gene encoding adrenal 21-hydroxylase cause congenital adrenal hyperplasia (CAH).	CYP21A2	adrenal hyperplasia	1589	HP_0008221	17	24	79	98	True
29734195	Mutations affecting both alleles of TNXB cause a severe, autosomal recessive form of Ehlers-Danlos syndrome (EDS).	TNXB	autosomal recessive	7148	HP_0000007	36	40	57	76	True
29734195	Rarely, patients with severe, salt-wasting CAH have deletions of CYP21A2 that extend into TNXB, resulting in a &quot;contiguous gene syndrome&quot; consisting of CAH and EDS.	CYP21A2	contiguous gene syndrome	1589	HP_0001466	65	72	117	141	False
29734195	Rarely, patients with severe, salt-wasting CAH have deletions of CYP21A2 that extend into TNXB, resulting in a &quot;contiguous gene syndrome&quot; consisting of CAH and EDS.	TNXB	contiguous gene syndrome	7148	HP_0001466	90	94	117	141	False
21855232	These tumors often exhibit a plasmablastic morphology, a finding which prompted our interest in looking for ALK fusions in plasma cell neoplasms.	ALK	tumors	238	HP_0002664	108	111	6	12	True
21855232	These tumors often exhibit a plasmablastic morphology, a finding which prompted our interest in looking for ALK fusions in plasma cell neoplasms.	ALK	neoplasms	238	HP_0002664	108	111	135	144	True
21855232	We studied 46 cases of extramedullary plasmacytoma by immunostaining with anti-ALK antibody and fluorescence in situ hybridization (FISH) analysis using an ALK break-apart probe and found one case to be ALK protein-positive and demonstrated the disruption of the ALK gene in this case.	ALK	plasmacytoma	238	HP_0011857	79	82	38	50	False
21855232	We studied 46 cases of extramedullary plasmacytoma by immunostaining with anti-ALK antibody and fluorescence in situ hybridization (FISH) analysis using an ALK break-apart probe and found one case to be ALK protein-positive and demonstrated the disruption of the ALK gene in this case.	FISH	plasmacytoma	9644	HP_0011857	132	136	38	50	False
21855232	This finding expands the lists of the ALK-positive tumors, and ALK-positive extramedullary plasmacytoma may benefit from the treatment of ALK inhibitor in the future	ALK	tumors	238	HP_0002664	38	41	51	57	True
21855232	This finding expands the lists of the ALK-positive tumors, and ALK-positive extramedullary plasmacytoma may benefit from the treatment of ALK inhibitor in the future	ALK	plasmacytoma	238	HP_0011857	38	41	91	103	False
27711207	We hypothesized that newly identified genetic risk factors for the general African American population could also impact laboratory biomarkers known to contribute to the clinical disease expression of SCA, including variants influencing the white blood cell count and the development of albuminuria and abnormal glomerular filtration rate.	impact	albuminuria	55364	HP_0012592	114	120	287	298	False
27711207	The APOL1 G1 polymorphism, an identified risk factor for non-diabetic renal disease, was associated with albuminuria.	APOL1	albuminuria	8542	HP_0012592	4	9	105	116	False
28690296	However, the prevalence and spectrum of NKX2-5 mutations associated with sporadic DCM remain to be evaluated.	NKX2-5	sporadic	1482	HP_0003745	40	46	73	81	False
28690296	In this study, the coding regions and flanking introns of the NKX2-5 gene, which encodes a cardiac transcription factor pivotal for cardiac development and structural remodeling, were sequenced in 210 unrelated patients with sporadic adult-onset DCM.	NKX2-5	sporadic	1482	HP_0003745	62	68	225	233	False
28690296	As a result, two novel heterozygous NKX2-5 mutations, p.R139W and p.E167X, were identified in 2 unrelated patients with sporadic adult-onset DCM, with a mutational prevalence of approximately 0.95%.	NKX2-5	sporadic	1482	HP_0003745	36	42	120	128	False
28690296	This study is the first to associate NKX2-5 loss-of-function mutations with enhanced susceptibility to sporadic DCM, which provides novel insight into the molecular etiology underpinning DCM, and suggests the potential implications for the genetic counseling and personalized treatment of the DCM patients	NKX2-5	sporadic	1482	HP_0003745	37	43	103	111	False
27634344	Congenital myasthenic syndromes (CMS) are a heterogeneous group of genetic disorders.	CMS	heterogeneous	23607	HP_0001425	33	36	44	57	False
27634344	We present a comprehensive description of the heterogeneous clinical features of the CMS caused by the homozygous 1267delG mutation in the AChR  subunit in nine members of two large Gipsy kindreds.	CMS	heterogeneous	23607	HP_0001425	85	88	46	59	False
25091416	Whole-genome sequencing documented two rare truncating variants in DOCK6, a gene associated with a type of autosomal recessive AOS that recurrently features periventricular calcification and impaired neurodevelopment.	DOCK6	autosomal recessive	57572	HP_0000007	67	72	107	126	True
29567476	Here, we report that TRIP13 is highly overexpressed in multiple lung adenocarcinoma cell lines and tumor tissues.	TRIP13	lung adenocarcinoma	9319	HP_0030078	21	27	64	83	False
29567476	Here, we report that TRIP13 is highly overexpressed in multiple lung adenocarcinoma cell lines and tumor tissues.	TRIP13	tumor	9319	HP_0002664	21	27	99	104	True
29567476	Clinically, TRIP13 expression is positively associated with tumor size, T-stage, and N-stage, and Kaplan-Meier analysis revealed that heightened TRIP13 expression is associated with lower overall survival.	TRIP13	tumor	9319	HP_0002664	12	18	60	65	True
29567476	TRIP13 promotes lung adenocarcinoma cell proliferation, clonogenicity, and migration while inhibiting apoptosis and G2/M phase shift invitro.	TRIP13	lung adenocarcinoma	9319	HP_0030078	0	6	16	35	False
29567476	Accordingly, TRIP13-silenced xenograft tumors displayed significant growth inhibition invivo.	TRIP13	tumor	9319	HP_0002664	13	19	39	44	True
29567476	In conclusion, heightened TRIP13 expression appears to promote lung adenocarcinoma tumor progression and displays potential as a therapeutic target or biomarker for lung adenocarcinoma	TRIP13	lung adenocarcinoma	9319	HP_0030078	26	32	63	82	False
29567476	In conclusion, heightened TRIP13 expression appears to promote lung adenocarcinoma tumor progression and displays potential as a therapeutic target or biomarker for lung adenocarcinoma	TRIP13	tumor	9319	HP_0002664	26	32	83	88	True
24485798	The molecular signatures unique to primary and metastatic LMSs may aid in understanding tumor progression in this cancer and in providing a molecular basis for prognostic studies and therapeutic target discovery.	aid	tumor	57379	HP_0002664	67	70	88	93	False
24485798	The molecular signatures unique to primary and metastatic LMSs may aid in understanding tumor progression in this cancer and in providing a molecular basis for prognostic studies and therapeutic target discovery.	aid	cancer	57379	HP_0002664	67	70	114	120	False
30365080	Prostate cancer (PCa) is one of the most common types of cancer in the urinary system in men.	PCa	cancer	28982	HP_0002664	17	20	9	15	False
26990554	In addition, the tested peptides inhibited lung colonization after intranasal inoculation of mice with S. pneumoniae.	mice	pneumonia	23581	HP_0002090	93	97	106	115	False
29771335	Here, we showed that the homeostatic synaptic downscaling is absent in the hippocampal neurons of Fmr1 KO mice, the mouse model of the most common inherited autism, fragile X syndrome (FXS).	Fmr1	autism	2332	HP_0000717	98	102	157	163	True
29771335	Here, we showed that the homeostatic synaptic downscaling is absent in the hippocampal neurons of Fmr1 KO mice, the mouse model of the most common inherited autism, fragile X syndrome (FXS).	mice	autism	23581	HP_0000717	106	110	157	163	False
29771335	We found that the impaired homeostatic synaptic downscaling in Fmr1 KO neurons is caused by loss-of-function dephosphorylation of an epilepsy-associated ubiquitin E3 ligase, neural precursor cell expressed developmentally down-regulated gene 4-2, Nedd4-2.	Fmr1	epilepsy	2332	HP_0001250	63	67	133	141	True
29771335	We found that the impaired homeostatic synaptic downscaling in Fmr1 KO neurons is caused by loss-of-function dephosphorylation of an epilepsy-associated ubiquitin E3 ligase, neural precursor cell expressed developmentally down-regulated gene 4-2, Nedd4-2.	Nedd4-2	epilepsy	23327	HP_0001250	247	254	133	141	True
29771335	Such dephosphorylation of Nedd4-2 is surprisingly caused by abnormally stable tumor suppressor p53 and subsequently destabilized kinase Akt.	Nedd4-2	tumor	23327	HP_0002664	26	33	78	83	False
26323472	In infants and children, it can lead to serious and permanent damage to the central nervous system, which leads to the manifesting mental retardation.	damage	central	51438	HP_0030645	62	68	76	83	False
27799525	The tumor cells resembled pro-B cells, and were CD19<sup>+</sup>IgM<sup>-</sup>IgD<sup>-</sup>CD93<sup>+</sup>CD43<sup>+</sup>CD21<sup>-</sup>CD23<sup>-</sup>VpreB<sup>+</sup>CXCR4<sup>+</sup> Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.	Rag1	tumor	5896	HP_0002664	319	323	4	9	True
27799525	The tumor cells resembled pro-B cells, and were CD19<sup>+</sup>IgM<sup>-</sup>IgD<sup>-</sup>CD93<sup>+</sup>CD43<sup>+</sup>CD21<sup>-</sup>CD23<sup>-</sup>VpreB<sup>+</sup>CXCR4<sup>+</sup> Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.	Rag2	tumor	5897	HP_0002664	325	329	4	9	True
27799525	The tumor cells resembled pro-B cells, and were CD19<sup>+</sup>IgM<sup>-</sup>IgD<sup>-</sup>CD93<sup>+</sup>CD43<sup>+</sup>CD21<sup>-</sup>CD23<sup>-</sup>VpreB<sup>+</sup>CXCR4<sup>+</sup> Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.	Vpreb1	tumor	7441	HP_0002664	337	343	4	9	False
27799525	The tumor cells resembled pro-B cells, and were CD19<sup>+</sup>IgM<sup>-</sup>IgD<sup>-</sup>CD93<sup>+</sup>CD43<sup>+</sup>CD21<sup>-</sup>CD23<sup>-</sup>VpreB<sup>+</sup>CXCR4<sup>+</sup> Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.	Vpreb3	tumor	29802	HP_0002664	345	351	4	9	False
27799525	The tumor cells resembled pro-B cells, and were CD19<sup>+</sup>IgM<sup>-</sup>IgD<sup>-</sup>CD93<sup>+</sup>CD43<sup>+</sup>CD21<sup>-</sup>CD23<sup>-</sup>VpreB<sup>+</sup>CXCR4<sup>+</sup> Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.	Igll1	tumor	3543	HP_0002664	357	362	4	9	True
27799525	The tumor cells resembled pro-B cells, and were CD19<sup>+</sup>IgM<sup>-</sup>IgD<sup>-</sup>CD93<sup>+</sup>CD43<sup>+</sup>CD21<sup>-</sup>CD23<sup>-</sup>VpreB<sup>+</sup>CXCR4<sup>+</sup> Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and Igll1 We confirmed RAG1 expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.	RAG1	tumor	5896	HP_0002664	376	380	4	9	True
28656064	Through epigenomic study of a colon cancer cell line pair (HCT116 and DKO), we identified <i>JPH3</i> as a methylated novel tumor suppressor gene (TSG) candidate at 16q24.	TSG	cancer	57045	HP_0002664	147	150	36	42	False
28656064	Through epigenomic study of a colon cancer cell line pair (HCT116 and DKO), we identified <i>JPH3</i> as a methylated novel tumor suppressor gene (TSG) candidate at 16q24.	TSG	tumor	57045	HP_0002664	147	150	124	129	False
28656064	Thus, <i>JPH3</i> was identified as a novel TSG methylated in colorectal and gastric tumors which promotes mitochondrial-mediated apoptosis, also as a potential metastasis and survival biomarker for digestive cancers	TSG	cancer	57045	HP_0002664	44	47	209	215	False
28656064	Thus, <i>JPH3</i> was identified as a novel TSG methylated in colorectal and gastric tumors which promotes mitochondrial-mediated apoptosis, also as a potential metastasis and survival biomarker for digestive cancers	TSG	tumor	57045	HP_0002664	44	47	85	90	False
26091610	We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor 2 subunit (CHRNB2) found in patients with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).	CHRNB2	nocturnal	1141	HP_0025301	162	168	212	221	False
26091610	We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor 2 subunit (CHRNB2) found in patients with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).	lobe	nocturnal	84335	HP_0025301	230	234	212	221	False
26091610	We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor 2 subunit (CHRNB2) found in patients with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).	CHRNB2	epilepsy	1141	HP_0001250	162	168	235	243	True
26091610	We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor 2 subunit (CHRNB2) found in patients with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).	lobe	epilepsy	84335	HP_0001250	230	234	235	243	False
26091610	To confirm that V286L-TG rats exhibit seizures similar to those observed in humans, gene expression patterns and behavioral phenotypes were analyzed.	type	seizures	6445	HP_0001250	129	133	38	46	False
26091610	This seizure type is similar to &quot;paroxysmal arousals&quot; that are observed in human ADNFLE.	type	seizure	6445	HP_0001250	13	17	5	12	False
29261713	Although the pathophysiological mechanisms that underlie this entity remain unknown, the fact that epilepsy can affect cardiac function is not surprising.	fact	epilepsy	11198	HP_0001250	89	93	99	107	False
28953230	Agonistic antibodies, which bind specifically to death receptor 5 (DR5), can trigger apoptosis in tumor cells through the extrinsic pathway.	DR5	tumor	8795	HP_0002664	67	70	98	103	True
28953230	After screening for agonism in a cell-viability assay in vitro, a novel DR5-specific scFv antibody TR2-3 was isolated, which inhibited COLO205 and MDA-MB-231 tumor cell growth without any cross-linking agents.	DR5	tumor	8795	HP_0002664	72	75	158	163	True
28953230	After screening for agonism in a cell-viability assay in vitro, a novel DR5-specific scFv antibody TR2-3 was isolated, which inhibited COLO205 and MDA-MB-231 tumor cell growth without any cross-linking agents.	TR2	tumor	7181	HP_0002664	99	102	158	163	False
28953230	The activity of TR2-3 in inducing apoptosis in cancer cells was evaluated by using an Annexin V-PE apoptosis detection kit in combination with flow cytometry and the Hoechst 33342 and propidium iodide double staining analysis.	TR2	cancer	7181	HP_0002664	16	19	47	53	False
28953230	The activity of TR2-3 in inducing apoptosis in cancer cells was evaluated by using an Annexin V-PE apoptosis detection kit in combination with flow cytometry and the Hoechst 33342 and propidium iodide double staining analysis.	kit	cancer	3815	HP_0002664	119	122	47	53	True
28953230	Furthermore, TR2-3 suppressed the tumor growth significantly in the xenograft model.	TR2	tumor	7181	HP_0002664	13	16	34	39	False
28953230	Taken together, these data suggest that TR2-3 exhibited potent antitumor activity both in vitro and in vivo.	TR2	tumor	7181	HP_0002664	40	43	67	72	False
29104277	RT-PCR analysis showed that the overall transcriptional activity of the main HS biosynthesis-involved genes (<i>EXT1</i>, <i>EXT2</i>, <i>NDST1</i>, <i>NDST2</i>, <i>GLCE</i>, <i>HS2ST1</i>, <i>HS3ST1</i>, <i>HS3ST2</i>, <i>HS6ST1</i>, <i>HS6ST2</i>, <i>SULF1</i>, <i>SULF2</i>, <i>HPSE</i>) was decreased by 1.5-2-fold in Grade II-III glioma (<i>p</i> &lt; 0.01) and by 3-fold in Grade IV glioma (glioblastoma multiforme, GBM) (<i>p</i> &lt; 0.05), as compared with the para-tumourous tissue.	HPSE	glioma	10855	HP_0009733	282	286	336	342	False
29104277	RT-PCR analysis showed that the overall transcriptional activity of the main HS biosynthesis-involved genes (<i>EXT1</i>, <i>EXT2</i>, <i>NDST1</i>, <i>NDST2</i>, <i>GLCE</i>, <i>HS2ST1</i>, <i>HS3ST1</i>, <i>HS3ST2</i>, <i>HS6ST1</i>, <i>HS6ST2</i>, <i>SULF1</i>, <i>SULF2</i>, <i>HPSE</i>) was decreased by 1.5-2-fold in Grade II-III glioma (<i>p</i> &lt; 0.01) and by 3-fold in Grade IV glioma (glioblastoma multiforme, GBM) (<i>p</i> &lt; 0.05), as compared with the para-tumourous tissue.	HPSE	tumour	10855	HP_0002664	282	286	476	482	False
29104277	Heparanase (<i>HPSE</i>) expression was identified in 50% of GBM tumours by immunostaining, and was characterised by a high intratumoural heterogeneity of the presence of the HPSE protein.	HPSE	tumours	10855	HP_0002664	15	19	65	72	False
29104277	Heparanase (<i>HPSE</i>) expression was identified in 50% of GBM tumours by immunostaining, and was characterised by a high intratumoural heterogeneity of the presence of the HPSE protein.	HPSE	heterogeneity	10855	HP_0001425	15	19	138	151	False
29104277	Heparanase (<i>HPSE</i>) expression was identified in 50% of GBM tumours by immunostaining, and was characterised by a high intratumoural heterogeneity of the presence of the HPSE protein.	HPSE	tumour	10855	HP_0002664	15	19	129	135	False
30242258	We show that tumour cells specifically induce Notch2 activity in mesenchymal stromal cells (MSCs) required for the transcription of the complement factor C1q.	Notch2	tumour	4853	HP_0002664	46	52	13	19	False
30242258	Notch2 activation in the microenvironment is a pre-requisite for the activation of canonical Wnt signalling in tumour cells	Notch2	tumour	4853	HP_0002664	0	6	111	117	False
27927781	Elevated serum PTH concentrations in primary and secondary hyperparathyroidism have been associated with bone disease, hypertension, and in some studies, cardiovascular mortality.	PTH	hyperparathyroidism	5741	HP_0000843	15	18	59	78	False
27927781	Elevated serum PTH concentrations in primary and secondary hyperparathyroidism have been associated with bone disease, hypertension, and in some studies, cardiovascular mortality.	PTH	hypertension	5741	HP_0000822	15	18	119	131	False
24459106	In a family with sensory neuropathy with loss of pain perception and destruction of the pedal skeleton we report a missense mutation in a highly conserved amino acid residue of atlastin GTPase 3 (ATL3), an endoplasmic reticulum-shaping GTPase.	ATL3	neuropathy	25923	HP_0009830	196	200	25	35	True
24459106	ATL3 is a paralogue of ATL1, a membrane curvature-generating molecule that is involved in spastic paraplegia and hereditary sensory neuropathy.	ATL3	neuropathy	25923	HP_0009830	0	4	132	142	True
24459106	ATL3 is a paralogue of ATL1, a membrane curvature-generating molecule that is involved in spastic paraplegia and hereditary sensory neuropathy.	ATL1	neuropathy	51062	HP_0009830	23	27	132	142	True
30181549	Further experiments demonstrated that the MYEOV ceRNA sequestered miR-30c-2-3p from binding its targets TGFBR2 and USP15 mRNAs, which in turn leading to constitutive activation of TGF- signaling and tumor progression in NSCLC.	MYEOV	tumor	26579	HP_0002664	42	47	200	205	False
30181549	Further experiments demonstrated that the MYEOV ceRNA sequestered miR-30c-2-3p from binding its targets TGFBR2 and USP15 mRNAs, which in turn leading to constitutive activation of TGF- signaling and tumor progression in NSCLC.	miR	tumor	220972	HP_0002664	66	69	200	205	False
30181549	Further experiments demonstrated that the MYEOV ceRNA sequestered miR-30c-2-3p from binding its targets TGFBR2 and USP15 mRNAs, which in turn leading to constitutive activation of TGF- signaling and tumor progression in NSCLC.	TGFBR2	tumor	7048	HP_0002664	104	110	200	205	True
30181549	Further experiments demonstrated that the MYEOV ceRNA sequestered miR-30c-2-3p from binding its targets TGFBR2 and USP15 mRNAs, which in turn leading to constitutive activation of TGF- signaling and tumor progression in NSCLC.	USP15	tumor	9958	HP_0002664	115	120	200	205	False
10633131	Previously, the combination of hypoparathyroidism, deafness, and renal dysplasia has been proposed to represent a specific syndrome (MIM 146255) under the acronym HDR.	MIM	hypoparathyroidism	9788	HP_0000829	133	136	31	49	False
10633131	Previously, the combination of hypoparathyroidism, deafness, and renal dysplasia has been proposed to represent a specific syndrome (MIM 146255) under the acronym HDR.	HDR	hypoparathyroidism	2625	HP_0000829	163	166	31	49	True
10633131	Previously, the combination of hypoparathyroidism, deafness, and renal dysplasia has been proposed to represent a specific syndrome (MIM 146255) under the acronym HDR.	MIM	deafness	9788	HP_0000365	133	136	51	59	False
10633131	Previously, the combination of hypoparathyroidism, deafness, and renal dysplasia has been proposed to represent a specific syndrome (MIM 146255) under the acronym HDR.	HDR	deafness	2625	HP_0000365	163	166	51	59	True
10633131	Previously, the combination of hypoparathyroidism, deafness, and renal dysplasia has been proposed to represent a specific syndrome (MIM 146255) under the acronym HDR.	MIM	renal dysplasia	9788	HP_0000110	133	136	65	80	False
10633131	Previously, the combination of hypoparathyroidism, deafness, and renal dysplasia has been proposed to represent a specific syndrome (MIM 146255) under the acronym HDR.	HDR	renal dysplasia	2625	HP_0000110	163	166	65	80	True
10633131	Hemizygosity of the distal region, designated HDR1, can cause hypoparathyroidism and in addition sensorineuronal deafness and renal dysplasia/insufficiency or a subset of this triad	HDR	hypoparathyroidism	2625	HP_0000829	46	49	62	80	True
10633131	Hemizygosity of the distal region, designated HDR1, can cause hypoparathyroidism and in addition sensorineuronal deafness and renal dysplasia/insufficiency or a subset of this triad	HDR	deafness	2625	HP_0000365	46	49	113	121	True
10633131	Hemizygosity of the distal region, designated HDR1, can cause hypoparathyroidism and in addition sensorineuronal deafness and renal dysplasia/insufficiency or a subset of this triad	HDR	renal dysplasia	2625	HP_0000110	46	49	126	141	True
29653487	Solute carrier family 34 member 2 (SLC34A2) is a well-known sodium-dependent phosphate transporter that has recently been linked to cancer development.	SLC34A2	cancer	10568	HP_0002664	35	42	132	138	False
29387864	RNA sequencing transcriptome analysis revealed that inflammatory mediators such as tumor necrosis factor (TNF)- suppressed expression of R-spondin-1 (Rspo1, a critical growth factor for intestinal epithelial cells) in Sirt6-silenced YAMC cells <i>in vitro</i>.	Sirt6	tumor	51548	HP_0002664	219	224	83	88	False
29387864	RNA sequencing transcriptome analysis revealed that inflammatory mediators such as tumor necrosis factor (TNF)- suppressed expression of R-spondin-1 (Rspo1, a critical growth factor for intestinal epithelial cells) in Sirt6-silenced YAMC cells <i>in vitro</i>.	TNF	tumor	7124	HP_0002664	106	109	83	88	False
29387864	RNA sequencing transcriptome analysis revealed that inflammatory mediators such as tumor necrosis factor (TNF)- suppressed expression of R-spondin-1 (Rspo1, a critical growth factor for intestinal epithelial cells) in Sirt6-silenced YAMC cells <i>in vitro</i>.	Rspo1	tumor	284654	HP_0002664	151	156	83	88	True
28052027	On these bases, we investigated whether the ligation of ER by a selective agonist, the 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN), could impact HL tumor growth.	impact	tumor	55364	HP_0002664	140	146	150	155	False
28052027	In nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice engrafted with HL cells, ER activation by DPN was able to reduce lymphoma growth up to 60% and this associated with the induction of tumor cell autophagy.	mice	tumor	23581	HP_0002664	64	68	203	208	False
28052027	After ER activation, both DRAM2 and protein 1 light chain 3 (LC3), a key actor in the autophagosome formation, strictly interacted each other and localized at mitochondrial level.Altogether these results suggest that targeting ER with selective agonists might affect HL cell proliferation and tumor growth via a mechanism that brings into play DRAM2-dependent autophagic cascade	DRAM2	tumor	128338	HP_0002664	27	32	295	300	False
28052027	After ER activation, both DRAM2 and protein 1 light chain 3 (LC3), a key actor in the autophagosome formation, strictly interacted each other and localized at mitochondrial level.Altogether these results suggest that targeting ER with selective agonists might affect HL cell proliferation and tumor growth via a mechanism that brings into play DRAM2-dependent autophagic cascade	light	tumor	8740	HP_0002664	47	52	295	300	False
29779043	Loss of GLIS3 function in humans and mice leads to the development of several pathologies, including neonatal diabetes and congenital hypothyroidism, polycystic kidney disease, and infertility.	GLIS3	hypothyroidism	169792	HP_0000821	8	13	134	148	True
29779043	Loss of GLIS3 function in humans and mice leads to the development of several pathologies, including neonatal diabetes and congenital hypothyroidism, polycystic kidney disease, and infertility.	mice	hypothyroidism	23581	HP_0000821	37	41	134	148	False
29779043	Single nucleotide polymorphisms in GLIS3 genes have been associated with increased risk of several diseases, including type 1 and type 2 diabetes, glaucoma, and neurological disorders.	GLIS3	glaucoma	169792	HP_0000501	35	40	147	155	True
29779043	Single nucleotide polymorphisms in GLIS3 genes have been associated with increased risk of several diseases, including type 1 and type 2 diabetes, glaucoma, and neurological disorders.	type	glaucoma	6445	HP_0000501	119	123	147	155	False
28302382	In humans, heterozygous mutations in NKX2.5 result in congenital heart defects (CHDs).	NKX2.5	congenital heart defects	1482	HP_0001627	37	43	54	78	True
28302382	NKX2.5-R142C is a mutation that was reported to be associated with atrial septal defect (ASD) and atrioventricular (AV) block in 13-patients from one family.	NKX2.5	atrial septal defect	1482	HP_0001631	0	6	67	87	True
28602620	We identified integrin 7 (ITGA7) as a major laminin receptor in GSCs and in primary high-grade glioma specimens.	ITGA7	glioma	3679	HP_0009733	27	32	96	102	False
28602620	Analyses of mRNA profiles in comprehensive datasets revealed that high ITGA7 expression negatively correlated with survival of patients with both low- and high-grade glioma.	ITGA7	glioma	3679	HP_0009733	71	76	166	172	False
28602620	We also found that targeting of ITGA7 by RNAi or blocking mAbs impaired laminin-induced signaling, and it led to a significant delay in tumor engraftment plus a strong reduction in tumor size and invasion.	ITGA7	tumor	3679	HP_0002664	32	37	136	141	False
28602620	Our data, therefore, highlight ITGA7 as a glioblastoma biomarker and candidate therapeutic target	ITGA7	glioblastoma	3679	HP_0012174	31	36	42	54	False
30078471	Differently from other digestive malignancies, gastric cancer (GC) carcinogenesis seems more heterogeneous and unclear.	GC	cancer	2638	HP_0002664	63	65	55	61	False
30078471	Differently from other digestive malignancies, gastric cancer (GC) carcinogenesis seems more heterogeneous and unclear.	GC	heterogeneous	2638	HP_0001425	63	65	93	106	False
30078471	This entails failing in identification of reliable serum tumor markers for screening early GC (EGC) as well as persisting ominous prognosis of this disease.	GC	tumor	2638	HP_0002664	91	93	57	62	False
30078471	In the case of GC, in fact, several cytological and molecular works have already demonstrated GJ to be an interesting biological material for improving clinicopathologic and prognostic knowledge of this cancer.	GC	cancer	2638	HP_0002664	15	17	203	209	False
30078471	In the case of GC, in fact, several cytological and molecular works have already demonstrated GJ to be an interesting biological material for improving clinicopathologic and prognostic knowledge of this cancer.	fact	cancer	11198	HP_0002664	22	26	203	209	False
28053051	Mutations in peripherin 2 (PRPH2), also known as retinal degeneration slow/RDS, lead to various retinal degenerations including retinitis pigmentosa (RP) and macular/pattern dystrophy (MD/PD).	PRPH2	retinal degeneration	5961	HP_0000546	27	32	49	69	True
28053051	We asked whether ROM1 could modify the phenotype of a PRPH2 mutation associated with a high degree of intrafamilial phenotypic heterogeneity: Y141C.	PRPH2	heterogeneity	5961	HP_0001425	54	59	127	140	False
28053051	We asked whether ROM1 could modify the phenotype of a PRPH2 mutation associated with a high degree of intrafamilial phenotypic heterogeneity: Y141C.	ROM1	heterogeneity	6094	HP_0001425	17	21	127	140	False
29735674	Like other macular degenerations, pathogenesis within the retinal pigment epithelium (RPE) appears to contribute to the loss of photoreceptors from the central retina.	RPE	macular degenerations	6120	HP_0000608	86	89	11	32	False
28600779	Two of these genes were independently mutated in more than one family with similar phenotypes, which substantiates their link to human disease (AKAP6 in intellectual disability and UBR4 in early dementia).	AKAP6	intellectual disability	9472	HP_0001249	144	149	153	176	False
28600779	Two of these genes were independently mutated in more than one family with similar phenotypes, which substantiates their link to human disease (AKAP6 in intellectual disability and UBR4 in early dementia).	UBR4	intellectual disability	23352	HP_0001249	181	185	153	176	False
24346768	Three predicted driver genes (CDKN2A, AKT1, RNF139) were found common in these three cancers by comparative analysis.	CDKN2A	cancer	1029	HP_0002664	30	36	85	91	True
24346768	Three predicted driver genes (CDKN2A, AKT1, RNF139) were found common in these three cancers by comparative analysis.	AKT1	cancer	207	HP_0002664	38	42	85	91	True
24346768	Three predicted driver genes (CDKN2A, AKT1, RNF139) were found common in these three cancers by comparative analysis.	RNF139	cancer	11236	HP_0002664	44	50	85	91	True
30778726	Very recently, PUS7 mutations were reported to cause intellectual disability with growth retardation.	PUS7	intellectual disability	54517	HP_0001249	15	19	53	76	False
30778726	We describe two families in which two different homozygous PUS7 mutations (missense and frameshift deletion) segregate with a phenotype comprising intellectual disability and progressive microcephaly.	PUS7	intellectual disability	54517	HP_0001249	59	63	147	170	False
30778726	We describe two families in which two different homozygous PUS7 mutations (missense and frameshift deletion) segregate with a phenotype comprising intellectual disability and progressive microcephaly.	PUS7	microcephaly	54517	HP_0000252	59	63	187	199	False
29107665	In vitro head and neck cancer studies have demonstrated that epidermal growth factor receptor kinase substrate 8 (Eps8) overexpression contributes to squamous carcinogenesis.	Eps8	cancer	2059	HP_0002664	114	118	23	29	False
29107665	Oral squamous cell carcinoma studies have correlated Eps8 expression with metastatic disease and poor prognosis.	Eps8	squamous cell carcinoma	2059	HP_0002860	53	57	5	28	False
29107665	We then correlated our findings with clinicopathologic data including tumor-node-metastasis stage, p16 status, age, sex, and smoking and alcohol history.	sex	tumor	55558	HP_0002664	116	119	70	75	False
29107665	In conclusion, our data offer in vivo support that, in HNSCCs, Eps8 is involved in tumor invasion but not necessarily the development of regional LN metastasis.	Eps8	tumor	2059	HP_0002664	63	67	83	88	False
29107665	The association between low Eps8 expression and p16<sup>+</sup> HNSCCs suggests that alternative signaling pathways may be used for their tumorigenesis	Eps8	tumor	2059	HP_0002664	28	32	138	143	False
27764096	Age-related hearing impairment (ARHI), one of the most common sensory disorders, can be mitigated, but not cured or eliminated.	ARHI	hearing impairment	9077	HP_0000365	32	36	12	30	False
27764096	The latter SNP lies just outside exon 8 and is highly correlated (r2 = 0.96) with the missense SNP rs5756795 in exon 7 of TRIOBP, a gene previously associated with prelingual nonsyndromic hearing loss.	TRIOBP	hearing loss	11078	HP_0000365	122	128	188	200	True
27764096	We also tested variants within exons of 132 other previously-identified hearing loss genes, and identified two common additional significant SNPs: rs2877561 (synonymous change in ILDR1, p = 6.2x10-5), which replicated in the UK Biobank (p = 0.00057), and had a significant GERA SRT (p = 0.00019) and speech discrimination score (SDS; p = 0.0019); and rs9493627 (missense change in EYA4, p = 0.00011) which replicated in the UK Biobank (p = 0.0095), other GERA groups (p = 0.0080), and had a consistent significant result for SRT (p = 0.041) and suggestive result for SDS (p = 0.081).	ILDR1	hearing loss	286676	HP_0000365	179	184	72	84	True
27764096	We also tested variants within exons of 132 other previously-identified hearing loss genes, and identified two common additional significant SNPs: rs2877561 (synonymous change in ILDR1, p = 6.2x10-5), which replicated in the UK Biobank (p = 0.00057), and had a significant GERA SRT (p = 0.00019) and speech discrimination score (SDS; p = 0.0019); and rs9493627 (missense change in EYA4, p = 0.00011) which replicated in the UK Biobank (p = 0.0095), other GERA groups (p = 0.0080), and had a consistent significant result for SRT (p = 0.041) and suggestive result for SDS (p = 0.081).	SDS	hearing loss	51119	HP_0000365	329	332	72	84	False
27764096	We also tested variants within exons of 132 other previously-identified hearing loss genes, and identified two common additional significant SNPs: rs2877561 (synonymous change in ILDR1, p = 6.2x10-5), which replicated in the UK Biobank (p = 0.00057), and had a significant GERA SRT (p = 0.00019) and speech discrimination score (SDS; p = 0.0019); and rs9493627 (missense change in EYA4, p = 0.00011) which replicated in the UK Biobank (p = 0.0095), other GERA groups (p = 0.0080), and had a consistent significant result for SRT (p = 0.041) and suggestive result for SDS (p = 0.081).	EYA4	hearing loss	2070	HP_0000365	381	385	72	84	True
26542286	Primary creatine disorders are inherited as autosomal recessive (mutations affecting GATM [for glycine-amidinotransferase, mitochondrial]) and GAMT genes) or X-linked (SLC6A8 gene) traits.	GAMT	autosomal recessive	2593	HP_0000007	143	147	44	63	True
26542286	Primary creatine disorders are inherited as autosomal recessive (mutations affecting GATM [for glycine-amidinotransferase, mitochondrial]) and GAMT genes) or X-linked (SLC6A8 gene) traits.	SLC6A8	autosomal recessive	6535	HP_0000007	168	174	44	63	False
26542286	Primary creatine disorders are inherited as autosomal recessive (mutations affecting GATM [for glycine-amidinotransferase, mitochondrial]) and GAMT genes) or X-linked (SLC6A8 gene) traits.	GATM	autosomal recessive	2628	HP_0000007	85	89	44	63	True
29372391	Mutations in ganglioside-induced differentiation-associated-protein 1 (GDAP1) have been associated with both subtypes of Charcot-Marie-Tooth (CMT) disease, autosomal recessive (CMT4A and AR-CMT2K) and autosomal dominant (AD-CMT2K).	GDAP1	autosomal recessive	54332	HP_0000007	71	76	156	175	True
29372391	Mutations in ganglioside-induced differentiation-associated-protein 1 (GDAP1) have been associated with both subtypes of Charcot-Marie-Tooth (CMT) disease, autosomal recessive (CMT4A and AR-CMT2K) and autosomal dominant (AD-CMT2K).	CMT4A	autosomal recessive	54332	HP_0000007	177	182	156	175	True
29372391	Mutations in ganglioside-induced differentiation-associated-protein 1 (GDAP1) have been associated with both subtypes of Charcot-Marie-Tooth (CMT) disease, autosomal recessive (CMT4A and AR-CMT2K) and autosomal dominant (AD-CMT2K).	AR	autosomal recessive	231	HP_0000007	187	189	156	175	False
29372391	Three families (families 1, 2 and 3) were found to have an autosomal recessive (AR) pattern of inheritance while family 4 displayed an autosomal dominant (AD) mode of inheritance.	AR	autosomal recessive	231	HP_0000007	80	82	59	78	False
29372391	Three families (families 1, 2 and 3) were found to have an autosomal recessive (AR) pattern of inheritance while family 4 displayed an autosomal dominant (AD) mode of inheritance.	AR	mode of inheritance	231	HP_0000005	80	82	159	178	False
29372391	Electro-physiologic studies revealed an axonal type of neuropathy (AR-CMT2K and AD-CMT2K) in all affected individuals.	AR	neuropathy	231	HP_0009830	67	69	55	65	False
29372391	Our study expands the mutational spectrum of GDAP1-related CMT disease with the identification of new and unreported GDAP1 variants and demonstrates the predominance of the axonal form of neuropathy in CMT disease associated with GDAP1.	GDAP1	neuropathy	54332	HP_0009830	45	50	188	198	True
30465257	Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegenerative diseases that overlap in their clinical presentation, pathology and genetics, and likely represent a spectrum of one underlying disease.	ALS	frontotemporal dementia	3483	HP_0002145	31	34	40	63	False
27612429	Recent evidence suggests that ARS genes may participate in a wide array of cellular processes, and may contribute to the pathology of autoimmune disease, cancer, and other diseases.	ARS	cancer	57152	HP_0002664	30	33	154	160	False
27612429	Several studies have suggested a role for the glutamyl prolyl tRNA synthetase (EPRS) in breast cancers, although none has identified any underlying mechanism about how EPRS contributes to carcinogenesis.	EPRS	cancer	2058	HP_0002664	79	83	95	101	False
27612429	In this study, we identified EPRS as upregulated in estrogen receptor positive (ER+) human breast tumors in the TCGA and METABRIC cohorts, with copy number gains in nearly 50% of samples in both datasets.	EPRS	tumors	2058	HP_0002664	29	33	98	104	False
27612429	EPRS expression is associated with reduced overall survival in patients with ER+ tumors in TCGA and METABRIC datasets.	EPRS	tumors	2058	HP_0002664	0	4	81	87	False
27612429	We demonstrated the necessity of EPRS for proliferation of tamoxifen-resistant ER+ breast cancer, but not ER- breast cancer cells.	EPRS	cancer	2058	HP_0002664	33	37	90	96	False
27612429	Finally, we constructed a causal gene network based on over 2500 ER+ breast tumor samples to build up an EPRS-estrogen signaling pathway.	EPRS	tumor	2058	HP_0002664	105	109	76	81	False
27612429	EPRS and its regulated estrogenic gene network may offer a promising alternative approach to target ER+ breast cancers that are refractory to current anti-estrogens	EPRS	cancer	2058	HP_0002664	0	4	111	117	False
27113481	A total of nine non-coding variants on 11q13.5 predispose men to prostate cancer (PrCa). rs200331695 within the EMSY intron is associated with aggressive PrCa and two high linkage disequilibrium (LD) groups of single-nucleotide polymorphisms (SNPs) in the intergenic region are associated with PrCa death.	men	cancer	8178	HP_0002664	58	61	74	80	False
27113481	A total of nine non-coding variants on 11q13.5 predispose men to prostate cancer (PrCa). rs200331695 within the EMSY intron is associated with aggressive PrCa and two high linkage disequilibrium (LD) groups of single-nucleotide polymorphisms (SNPs) in the intergenic region are associated with PrCa death.	EMSY	cancer	56946	HP_0002664	112	116	74	80	False
27113481	The results were validated in a second tumor set (n=41), in lymphoblastoid cell lines (LCLs) (n=38), and using the GTEx Portal.	set	tumor	6418	HP_0002664	45	48	39	44	False
27113481	The high LD SNPs (rs143975731, rs12277366, rs2155225, and rs2155222) were associated with DGAT2 expression in both tumors sets (screening P=0.035-0.043; validation P=0.005-0.018).	set	tumors	6418	HP_0002664	122	125	115	121	False
27113481	The high LD SNPs (rs143975731, rs12277366, rs2155225, and rs2155222) were associated with DGAT2 expression in both tumors sets (screening P=0.035-0.043; validation P=0.005-0.018).	DGAT2	tumors	84649	HP_0002664	90	95	115	121	False
27113481	The findings indicate the functionality of the PrCa death-predisposing SNPs rs143975731, rs12277366, rs2155225, and rs2155222 as DGAT2 regulators in prostate tumors.	DGAT2	tumors	84649	HP_0002664	129	134	158	164	False
25677735	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH, OMIM 225790), also known as Fowler syndrome, is a rare autosomal recessive disorder, caused by mutations in FLVCR2.	FLVCR2	hydranencephaly	55640	HP_0002324	184	190	31	46	True
25677735	Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH, OMIM 225790), also known as Fowler syndrome, is a rare autosomal recessive disorder, caused by mutations in FLVCR2.	FLVCR2	hydrocephaly	55640	HP_0000238	184	190	47	59	True
28327575	Mutations in 18 genes that encode components of GPI-anchor biogenesis result in a phenotypic spectrum that includes learning disability, epilepsy, microcephaly, congenital malformations and mild dysmorphic features.	GPI	epilepsy	10007	HP_0001250	48	51	137	145	False
28327575	Mutations in 18 genes that encode components of GPI-anchor biogenesis result in a phenotypic spectrum that includes learning disability, epilepsy, microcephaly, congenital malformations and mild dysmorphic features.	GPI	microcephaly	10007	HP_0000252	48	51	147	159	False
27488440	Overexpression of LOXL2 and SERPINH1 was observed in clinical specimens of lung cancer and fibrotic lesions.	LOXL2	cancer	4017	HP_0002664	18	23	80	86	False
27488440	Overexpression of LOXL2 and SERPINH1 was observed in clinical specimens of lung cancer and fibrotic lesions.	SERPINH1	cancer	871	HP_0002664	28	36	80	86	False
27488440	Downregulation of miR-29a caused overexpression of LOXL2 and SERPINH1 in lung cancer and IPF, suggesting that these genes are involved in the pathogenesis of these two diseases	LOXL2	cancer	4017	HP_0002664	51	56	78	84	False
27488440	Downregulation of miR-29a caused overexpression of LOXL2 and SERPINH1 in lung cancer and IPF, suggesting that these genes are involved in the pathogenesis of these two diseases	SERPINH1	cancer	871	HP_0002664	61	69	78	84	False
24898506	These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	CDSN	autosomal recessive	1041	HP_0000007	97	101	221	240	True
24898506	These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	APCDD1	autosomal recessive	147495	HP_0000007	103	109	221	240	True
24898506	These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	SNRPE	autosomal recessive	6635	HP_0000007	114	119	221	240	False
24898506	These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	DSG4	autosomal recessive	147409	HP_0000007	192	196	221	240	True
24898506	These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	LIPH	autosomal recessive	200879	HP_0000007	198	202	221	240	True
24898506	These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	LPAR6	autosomal recessive	10161	HP_0000007	207	212	221	240	True
24898506	These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	type	autosomal recessive	6445	HP_0000007	298	302	221	240	True
24898506	These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	CDSN	hypotrichosis	1041	HP_0001006	97	101	155	168	True
24898506	These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	APCDD1	hypotrichosis	147495	HP_0001006	103	109	155	168	True
24898506	These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	SNRPE	hypotrichosis	6635	HP_0001006	114	119	155	168	True
24898506	These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	DSG4	hypotrichosis	147409	HP_0001006	192	196	155	168	True
24898506	These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	LIPH	hypotrichosis	200879	HP_0001006	198	202	155	168	True
24898506	These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	LPAR6	hypotrichosis	10161	HP_0001006	207	212	155	168	True
24898506	These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, APCDD1 and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and LPAR6 for the autosomal recessive forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	type	hypotrichosis	6445	HP_0001006	298	302	155	168	False
30589983	Smad3, a major transcription factor in transforming growth factor- (TGF-) signaling, plays critical roles in both tumor-suppressive and pro-oncogenic functions.	Smad3	tumor	4088	HP_0002664	0	5	116	121	False
30589983	However, recent discoveries of Smad3-interacting molecules that preferentially bind phosphorylated Smad3 linker serine/threonine residues have shown a multitude of signal transductions that either enhance or suppress TGF- responses associated with Smad3 turnover or cancer progression.	Smad3	cancer	4088	HP_0002664	31	36	267	273	False
23020131	Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated melanoma line (P&lt;0.001).	GNPAT	melanoma	8443	HP_0002861	47	52	198	206	False
23020131	Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated melanoma line (P&lt;0.001).	SUMO1	melanoma	7341	HP_0002861	54	59	198	206	False
23020131	Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated melanoma line (P&lt;0.001).	SPINT2	melanoma	10653	HP_0002861	61	67	198	206	False
23020131	Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated melanoma line (P&lt;0.001).	FLI1	melanoma	2313	HP_0002861	69	73	198	206	False
23020131	Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated melanoma line (P&lt;0.001).	SSX1	melanoma	6756	HP_0002861	79	83	198	206	False
23020131	Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, FLI1, and SSX1) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated melanoma line (P&lt;0.001).	BRAF	melanoma	673	HP_0002861	185	189	198	206	True
23020131	Our findings indicate that GNPAT, SUMO1, SPINT2, FLI1, and SSX1 play critical roles in synergy with inflammation pathways in modulating melanoma cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control	GNPAT	melanoma	8443	HP_0002861	27	32	136	144	False
23020131	Our findings indicate that GNPAT, SUMO1, SPINT2, FLI1, and SSX1 play critical roles in synergy with inflammation pathways in modulating melanoma cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control	SUMO1	melanoma	7341	HP_0002861	34	39	136	144	False
23020131	Our findings indicate that GNPAT, SUMO1, SPINT2, FLI1, and SSX1 play critical roles in synergy with inflammation pathways in modulating melanoma cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control	SPINT2	melanoma	10653	HP_0002861	41	47	136	144	False
23020131	Our findings indicate that GNPAT, SUMO1, SPINT2, FLI1, and SSX1 play critical roles in synergy with inflammation pathways in modulating melanoma cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control	FLI1	melanoma	2313	HP_0002861	49	53	136	144	False
23020131	Our findings indicate that GNPAT, SUMO1, SPINT2, FLI1, and SSX1 play critical roles in synergy with inflammation pathways in modulating melanoma cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control	SSX1	melanoma	6756	HP_0002861	59	63	136	144	False
27889060	Reverse phenotyping of 12 affected individuals from eight families revealed a homogeneous EOEE phenotype characterized by severe developmental delay, poor visual contact with optic atrophy, and postnatal microcephaly.	type	developmental delay	6445	HP_0001263	100	104	129	148	False
27889060	Reverse phenotyping of 12 affected individuals from eight families revealed a homogeneous EOEE phenotype characterized by severe developmental delay, poor visual contact with optic atrophy, and postnatal microcephaly.	type	optic atrophy	6445	HP_0000648	100	104	175	188	False
27889060	Reverse phenotyping of 12 affected individuals from eight families revealed a homogeneous EOEE phenotype characterized by severe developmental delay, poor visual contact with optic atrophy, and postnatal microcephaly.	type	microcephaly	6445	HP_0000252	100	104	204	216	False
26588071	Canine mast cell tumours (CMCT) are one of the most common skin tumours in dogs with a major impact on canine health.	mast	tumours	51324	HP_0002664	7	11	17	24	False
26588071	Canine mast cell tumours (CMCT) are one of the most common skin tumours in dogs with a major impact on canine health.	impact	tumours	55364	HP_0002664	93	99	17	24	False
26588071	Certain breeds have a higher risk of developing mast cell tumours, suggesting that underlying predisposing germ-line genetic factors play a role in the development of this disease.	mast	tumours	51324	HP_0002664	48	52	58	65	False
30094507	Somewhat arbitrarily, three disorders were successively put forward as the underlying cause of HIES: autosomal dominant (AD) STAT3 deficiency, the only disorder corresponding to the original definition of HIES, and autosomal recessive (AR) DOCK8 and PGM3 deficiencies, in which atopy and high serum IgE levels occur in a context of manifestations not seen in patients with typical HIES.	STAT3	autosomal recessive	6774	HP_0000007	125	130	215	234	False
30094507	Somewhat arbitrarily, three disorders were successively put forward as the underlying cause of HIES: autosomal dominant (AD) STAT3 deficiency, the only disorder corresponding to the original definition of HIES, and autosomal recessive (AR) DOCK8 and PGM3 deficiencies, in which atopy and high serum IgE levels occur in a context of manifestations not seen in patients with typical HIES.	DOCK8	autosomal recessive	81704	HP_0000007	240	245	215	234	True
30094507	Somewhat arbitrarily, three disorders were successively put forward as the underlying cause of HIES: autosomal dominant (AD) STAT3 deficiency, the only disorder corresponding to the original definition of HIES, and autosomal recessive (AR) DOCK8 and PGM3 deficiencies, in which atopy and high serum IgE levels occur in a context of manifestations not seen in patients with typical HIES.	PGM3	autosomal recessive	5238	HP_0000007	250	254	215	234	True
30219970	Small intestine neuroendocrine tumors (SI-NETs) represent the most common histotype among small intestine neoplasms, and metastatic disease is usually present at diagnosis.	SI	tumors	6490	HP_0002664	39	41	31	37	False
30219970	Small intestine neuroendocrine tumors (SI-NETs) represent the most common histotype among small intestine neoplasms, and metastatic disease is usually present at diagnosis.	NETs	tumors	11005	HP_0002664	42	46	31	37	False
30219970	Small intestine neuroendocrine tumors (SI-NETs) represent the most common histotype among small intestine neoplasms, and metastatic disease is usually present at diagnosis.	type	tumors	6445	HP_0002664	79	83	31	37	False
30219970	Small intestine neuroendocrine tumors (SI-NETs) represent the most common histotype among small intestine neoplasms, and metastatic disease is usually present at diagnosis.	SI	neoplasms	6490	HP_0002664	39	41	106	115	False
30219970	Small intestine neuroendocrine tumors (SI-NETs) represent the most common histotype among small intestine neoplasms, and metastatic disease is usually present at diagnosis.	NETs	neoplasms	11005	HP_0002664	42	46	106	115	False
30219970	Small intestine neuroendocrine tumors (SI-NETs) represent the most common histotype among small intestine neoplasms, and metastatic disease is usually present at diagnosis.	type	neoplasms	6445	HP_0002664	79	83	106	115	False
30219970	A retrospective series of 52 sporadic primary surgically resected SI-NETs, which were metastatic at diagnosis, was analyzed by high-coverage target sequencing (HCTS) for the mutational status of 57 genes and copy number status of 40 genes selected from recently published genome sequencing data.	SI	sporadic	6490	HP_0003745	66	68	29	37	False
30219970	A retrospective series of 52 sporadic primary surgically resected SI-NETs, which were metastatic at diagnosis, was analyzed by high-coverage target sequencing (HCTS) for the mutational status of 57 genes and copy number status of 40 genes selected from recently published genome sequencing data.	NETs	sporadic	11005	HP_0003745	69	73	29	37	False
30219970	Recurrent copy number variations are important events in SI-NET and SRC may represent a novel prognostic biomarker for this tumor type	SI	tumor	6490	HP_0002664	57	59	124	129	False
30219970	Recurrent copy number variations are important events in SI-NET and SRC may represent a novel prognostic biomarker for this tumor type	SRC	tumor	6714	HP_0002664	68	71	124	129	True
30219970	Recurrent copy number variations are important events in SI-NET and SRC may represent a novel prognostic biomarker for this tumor type	NET	tumor	2004	HP_0002664	60	63	124	129	False
30535804	Several mouse models have been described for this gene; mice heterozygous for loss-of-function defects display a rapidly progressive high-frequency hearing impairment.	mice	hearing impairment	23581	HP_0000365	56	60	148	166	False
30535804	Up to now ATP2B2 has only been reported as a modifier, or in a digenic mechanism with CDH23 for hearing impairment in humans.	ATP2B2	hearing impairment	493	HP_0000365	10	16	96	114	False
30535804	Up to now ATP2B2 has only been reported as a modifier, or in a digenic mechanism with CDH23 for hearing impairment in humans.	CDH23	hearing impairment	64072	HP_0000365	86	91	96	114	True
30535804	Although a digenic inheritance pattern of hearing impairment has been reported for heterozygous missense variants of ATP2B2 and CDH23, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2	ATP2B2	hearing impairment	493	HP_0000365	117	123	42	60	False
30535804	Although a digenic inheritance pattern of hearing impairment has been reported for heterozygous missense variants of ATP2B2 and CDH23, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2	CDH23	hearing impairment	64072	HP_0000365	128	133	42	60	True
30535804	Although a digenic inheritance pattern of hearing impairment has been reported for heterozygous missense variants of ATP2B2 and CDH23, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2	ATP2B2	digenic inheritance	493	HP_0010984	117	123	11	30	False
30535804	Although a digenic inheritance pattern of hearing impairment has been reported for heterozygous missense variants of ATP2B2 and CDH23, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2	CDH23	digenic inheritance	64072	HP_0010984	128	133	11	30	False
27834349	Eleven (79%) and five (36%) of fourteen keratinizing squamous cell carcinomas tested contained TP53 and CDKN2A mutations, respectively.	CDKN2A	squamous cell carcinomas	1029	HP_0002860	104	110	53	77	True
27834349	The findings indicate that although PIK3CA mutations are found in &lt;10% of vulvar squamous cell carcinomas, they may be specific for a particular pathway involving atypical verruciform lesions, which could function as either a direct precursor or a risk factor for vulvar squamous cell carcinoma.	PIK3CA	squamous cell carcinomas	5290	HP_0002860	36	42	84	108	False
27834349	The findings indicate that although PIK3CA mutations are found in &lt;10% of vulvar squamous cell carcinomas, they may be specific for a particular pathway involving atypical verruciform lesions, which could function as either a direct precursor or a risk factor for vulvar squamous cell carcinoma.	PIK3CA	squamous cell carcinoma	5290	HP_0002860	36	42	274	297	False
27834349	Whether they function as direct precursors to a less common form of squamous cell carcinoma will require further study, but carcinomas associated with these lesions might warrant testing for PIK3CA mutations to address this question	PIK3CA	squamous cell carcinoma	5290	HP_0002860	191	197	68	91	False
28778788	In this study we present the first two cases from India of a rare inborn error of metabolism manifesting as dystonia and 3-methylglutaconic aciduria and a Leigh like lesions in the brain MRI associated with SERAC1 gene mutation, a phenotype characteristic of MEGDEL syndrome.	SERAC1	dystonia	84947	HP_0001332	207	213	108	116	True
27807832	TNFAIP8 mRNA is induced by NF-kB, and overexpression of TNFAIP8 has been correlated with poor prognosis in many cancers.	TNFAIP8	cancer	25816	HP_0002664	0	7	112	118	False
27807832	TNFAIP8 mRNA is induced by NF-kB, and overexpression of TNFAIP8 has been correlated with poor prognosis in many cancers.	NF	cancer	23114	HP_0002664	27	29	112	118	False
27807832	Downregulation of TNFAIP8 expression has been associated with decreased pulmonary colonization of human tumor cells, and enhanced sensitivities of tumor xenografts to radiation and docetaxel.	TNFAIP8	tumor	25816	HP_0002664	18	25	104	109	False
27807832	Here we have investigated the effects of depletion of TNFAIP8 on the mRNA, microRNA and protein expression profiles in prostate and breast cancers and melanoma.	TNFAIP8	melanoma	25816	HP_0002861	54	61	151	159	False
27807832	Here we have investigated the effects of depletion of TNFAIP8 on the mRNA, microRNA and protein expression profiles in prostate and breast cancers and melanoma.	TNFAIP8	cancer	25816	HP_0002664	54	61	139	145	False
27807832	Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.	TNFAIP8	tumor	25816	HP_0002664	47	54	17	22	False
27807832	Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.	NF	tumor	23114	HP_0002664	279	281	17	22	False
27807832	Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.	type	tumor	6445	HP_0002664	28	32	17	22	False
27807832	Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.	FAT3	tumor	120114	HP_0002664	176	180	17	22	False
27807832	Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.	EPHA3	tumor	2042	HP_0002664	189	194	17	22	False
27807832	Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.	ACADL	tumor	33	HP_0002664	226	231	17	22	False
27807832	Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.	MET	tumor	4233	HP_0002664	294	297	17	22	True
27807832	Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.	FOXA1	tumor	3169	HP_0002664	299	304	17	22	False
27807832	Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.	KRAS	tumor	3845	HP_0002664	306	310	17	22	True
27807832	Depending on the tumor cell type, knockdown of TNFAIP8 was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, FAT3, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, FOXA1, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.	OSTF1	tumor	26578	HP_0002664	319	324	17	22	False
27807832	TNFAIP8-centric molecules were found to be predominately implicated in the hypoxia-inducible factor-1 (HIF-1) signaling pathway, and cancer and development signaling networks.	TNFAIP8	cancer	25816	HP_0002664	0	7	135	141	False
27807832	Thus TNFAIP8 seems to regulate the cell survival and cancer progression processes in a multifaceted manner.	TNFAIP8	cancer	25816	HP_0002664	5	12	53	59	False
27109000	Misregulation of vascular endothelial growth factorA (VEGFA) has been implicated in numerous types of ovarian disease, such as polycystic ovarian syndrome, ovarian hyperstimulation syndrome, endometriosis and ovarian cancer.	VEGF	ovarian disease	7422	HP_0000137	55	59	104	119	False
27109000	Misregulation of vascular endothelial growth factorA (VEGFA) has been implicated in numerous types of ovarian disease, such as polycystic ovarian syndrome, ovarian hyperstimulation syndrome, endometriosis and ovarian cancer.	VEGF	endometriosis	7422	HP_0030127	55	59	193	206	False
27109000	Misregulation of vascular endothelial growth factorA (VEGFA) has been implicated in numerous types of ovarian disease, such as polycystic ovarian syndrome, ovarian hyperstimulation syndrome, endometriosis and ovarian cancer.	VEGF	cancer	7422	HP_0002664	55	59	219	225	False
25681241	FOXRED1 encodes a complex I-specific assembly factor and mutations in this gene result in complex I deficiency, infantile onset encephalomyopathy and Leigh syndrome.	FOXRED1	infantile onset	55572	HP_0003593	0	7	112	127	False
29290793	<b>Rationale:</b> Oncogenic STAT3 signaling activation and 3p22-21.3 locus alteration are common in multiple tumors, especially carcinomas of the nasopharynx, esophagus and lung.	STAT3	tumors	6774	HP_0002664	28	33	109	115	True
29290793	<i>DLEC1</i> was frequently downregulated in ESCC, lung and NPC cell lines and primary tumors, but was readily expressed in normal tissues and immortalized normal epithelial cells, with mutations rarely detected.	DLEC1	tumors	9940	HP_0002664	3	8	87	93	True
29290793	<i>DLEC1</i> methylation was frequently detected in ESCC tumors and correlated with lymph node metastasis, tumor recurrence and progression, with <i>DLEC1</i> as the most frequently methylated among the established 3p22.2 tumor suppressors (<i>RASSF1A, PLCD1</i> and <i>ZMYND10/BLU</i>).	DLEC1	tumors	9940	HP_0002664	3	8	57	63	True
29290793	<i>DLEC1</i> methylation was frequently detected in ESCC tumors and correlated with lymph node metastasis, tumor recurrence and progression, with <i>DLEC1</i> as the most frequently methylated among the established 3p22.2 tumor suppressors (<i>RASSF1A, PLCD1</i> and <i>ZMYND10/BLU</i>).	DLEC1	tumor	9940	HP_0002664	3	8	107	112	True
30005951	Besides dramatic metabolic alterations, cancer cells display severe changes in the clock phenotype with likely consequences in tumor progression and treatment response.	clock	cancer	9575	HP_0002664	83	88	40	46	False
30005951	Besides dramatic metabolic alterations, cancer cells display severe changes in the clock phenotype with likely consequences in tumor progression and treatment response.	clock	tumor	9575	HP_0002664	83	88	127	132	False
30005951	In this study, we use a comprehensive systems-driven approach to investigate the effect of clock disruption on metabolic pathways and its impact on drug response in a cellular model of colon cancer progression.	clock	cancer	9575	HP_0002664	91	96	191	197	False
30005951	In this study, we use a comprehensive systems-driven approach to investigate the effect of clock disruption on metabolic pathways and its impact on drug response in a cellular model of colon cancer progression.	impact	cancer	55364	HP_0002664	138	144	191	197	False
30005951	A mapping of the expression data to a comprehensive genome-scale reconstruction of human metabolism allowed for the in-depth functional characterization of 24h-oscillating transcripts and pointed to a clock-driven metabolic reprogramming in tumorigenesis.	clock	tumor	9575	HP_0002664	202	207	242	247	False
30005951	We further identified a reciprocal connection of HKDC1 to the clock in the primary tumor, which is lost in the metastatic cells.	clock	tumor	9575	HP_0002664	62	67	83	88	False
30005951	We further identified a reciprocal connection of HKDC1 to the clock in the primary tumor, which is lost in the metastatic cells.	HKDC1	tumor	80201	HP_0002664	49	54	83	88	False
30005951	This work provides novel evidence regarding the complex interplay between the circadian clock and metabolic alterations in carcinogenesis and identifies new connections between both systems with pivotal roles in cancer progression and response to therapy	clock	cancer	9575	HP_0002664	88	93	212	218	False
30536551	Reliable biomarkers for renal cell carcinoma (RCC) have yet to be determined.	RCC	renal cell carcinoma	7515	HP_0005584	46	49	24	44	False
30139748	Moreover, myostatin inhibitors are known to promote muscle regeneration and ameliorate fibrosis in animal models of Duchenne muscular dystrophy (DMD), a human disease characterized by chronic muscle degeneration.	DMD	muscular dystrophy	1756	HP_0003560	145	148	125	143	True
26677943	Although mutations in the gene encoding tricellulin are known to cause deafness in humans (DFNB49) and mice, the influence of its systemic deletion in vivo remains unknown.	DFNB49	deafness	153562	HP_0000365	91	97	71	79	True
26677943	Although mutations in the gene encoding tricellulin are known to cause deafness in humans (DFNB49) and mice, the influence of its systemic deletion in vivo remains unknown.	mice	deafness	23581	HP_0000365	103	107	71	79	False
26677943	When we generated tricellulin-knockout mice (Tric(-/-)), we found an early-onset rapidly progressive hearing loss associated with the degeneration of hair cells (HCs); however, their body size and overall appearance were normal.	mice	progressive	23581	HP_0003676	39	43	89	100	False
26677943	When we generated tricellulin-knockout mice (Tric(-/-)), we found an early-onset rapidly progressive hearing loss associated with the degeneration of hair cells (HCs); however, their body size and overall appearance were normal.	Tric	progressive	153562	HP_0003676	45	49	89	100	False
26677943	When we generated tricellulin-knockout mice (Tric(-/-)), we found an early-onset rapidly progressive hearing loss associated with the degeneration of hair cells (HCs); however, their body size and overall appearance were normal.	HCs	progressive	54205	HP_0003676	162	165	89	100	False
26677943	When we generated tricellulin-knockout mice (Tric(-/-)), we found an early-onset rapidly progressive hearing loss associated with the degeneration of hair cells (HCs); however, their body size and overall appearance were normal.	mice	hearing loss	23581	HP_0000365	39	43	101	113	False
26677943	When we generated tricellulin-knockout mice (Tric(-/-)), we found an early-onset rapidly progressive hearing loss associated with the degeneration of hair cells (HCs); however, their body size and overall appearance were normal.	Tric	hearing loss	153562	HP_0000365	45	49	101	113	True
26677943	When we generated tricellulin-knockout mice (Tric(-/-)), we found an early-onset rapidly progressive hearing loss associated with the degeneration of hair cells (HCs); however, their body size and overall appearance were normal.	HCs	hearing loss	54205	HP_0000365	162	165	101	113	False
29407414	By trio exome sequencing we now identified a novel, homozygous 2kb deletion, partially affecting exon 12 in an adult female with the typical facial gestalt of 3MC syndrome and hearing loss, but without the main feature cleft lip/palate, and without intellectual disability, or short stature.	trio	hearing loss	7204	HP_0000365	3	7	176	188	False
29407414	By trio exome sequencing we now identified a novel, homozygous 2kb deletion, partially affecting exon 12 in an adult female with the typical facial gestalt of 3MC syndrome and hearing loss, but without the main feature cleft lip/palate, and without intellectual disability, or short stature.	trio	cleft lip	7204	HP_0410030	3	7	219	228	False
29407414	By trio exome sequencing we now identified a novel, homozygous 2kb deletion, partially affecting exon 12 in an adult female with the typical facial gestalt of 3MC syndrome and hearing loss, but without the main feature cleft lip/palate, and without intellectual disability, or short stature.	trio	intellectual disability	7204	HP_0001249	3	7	249	272	True
29407414	By trio exome sequencing we now identified a novel, homozygous 2kb deletion, partially affecting exon 12 in an adult female with the typical facial gestalt of 3MC syndrome and hearing loss, but without the main feature cleft lip/palate, and without intellectual disability, or short stature.	trio	short stature	7204	HP_0004322	3	7	277	290	False
28784772	The common Ser96Ala human genetic variant of HRC strongly correlates with life-threatening ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy.	HRC	ventricular arrhythmias	3270	HP_0004308	45	48	91	114	False
27642048	Mutations in subunits of mitochondrial m-AAA proteases in the inner membrane cause neurodegeneration in spinocerebellar ataxia (SCA28) and hereditary spastic paraplegia (HSP7).	SCA28	spastic paraplegia	10939	HP_0001258	128	133	150	168	False
29351619	Limb-girdle muscular dystrophy type 2D (LGMD2D) is a rare autosomal-recessive disease, affecting striated muscle, due to mutation of SGCA, the gene coding for -sarcoglycan.	type	muscular dystrophy	6445	HP_0003560	31	35	12	30	True
29351619	Limb-girdle muscular dystrophy type 2D (LGMD2D) is a rare autosomal-recessive disease, affecting striated muscle, due to mutation of SGCA, the gene coding for -sarcoglycan.	LGMD2D	muscular dystrophy	6442	HP_0003560	40	46	12	30	True
29351619	Limb-girdle muscular dystrophy type 2D (LGMD2D) is a rare autosomal-recessive disease, affecting striated muscle, due to mutation of SGCA, the gene coding for -sarcoglycan.	SGCA	muscular dystrophy	6442	HP_0003560	133	137	12	30	True
28381550	Bartter syndrome type 3 is a clinically heterogeneous hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene (<i>CLCNKB</i>), which encodes the ClC-Kb chloride channel involved in NaCl reabsorption in the renal tubule.	type	heterogeneous	6445	HP_0001425	17	21	40	53	False
28381550	Bartter syndrome type 3 is a clinically heterogeneous hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene (<i>CLCNKB</i>), which encodes the ClC-Kb chloride channel involved in NaCl reabsorption in the renal tubule.	CLCNKB	heterogeneous	1188	HP_0001425	159	165	40	53	True
28381550	Bartter syndrome type 3 is a clinically heterogeneous hereditary salt-losing tubulopathy caused by mutations of the chloride voltage-gated channel Kb gene (<i>CLCNKB</i>), which encodes the ClC-Kb chloride channel involved in NaCl reabsorption in the renal tubule.	ClC	heterogeneous	23529	HP_0001425	190	193	40	53	False
28381550	Among patients, 29.5% had a phenotype of ante/neonatal Bartter syndrome (polyhydramnios or diagnosis in the first month of life), 44.5% had classic Bartter syndrome (diagnosis during childhood, hypercalciuria, and/or polyuria), and 26.0% had Gitelman-like syndrome (fortuitous discovery of hypokalemia with hypomagnesemia and/or hypocalciuria in childhood or adulthood).	type	hypercalciuria	6445	HP_0002150	33	37	194	208	False
28381550	Among patients, 29.5% had a phenotype of ante/neonatal Bartter syndrome (polyhydramnios or diagnosis in the first month of life), 44.5% had classic Bartter syndrome (diagnosis during childhood, hypercalciuria, and/or polyuria), and 26.0% had Gitelman-like syndrome (fortuitous discovery of hypokalemia with hypomagnesemia and/or hypocalciuria in childhood or adulthood).	type	hypokalemia	6445	HP_0002900	33	37	290	301	False
28381550	Among patients, 29.5% had a phenotype of ante/neonatal Bartter syndrome (polyhydramnios or diagnosis in the first month of life), 44.5% had classic Bartter syndrome (diagnosis during childhood, hypercalciuria, and/or polyuria), and 26.0% had Gitelman-like syndrome (fortuitous discovery of hypokalemia with hypomagnesemia and/or hypocalciuria in childhood or adulthood).	type	hypomagnesemia	6445	HP_0002917	33	37	307	321	False
28381550	Among patients, 29.5% had a phenotype of ante/neonatal Bartter syndrome (polyhydramnios or diagnosis in the first month of life), 44.5% had classic Bartter syndrome (diagnosis during childhood, hypercalciuria, and/or polyuria), and 26.0% had Gitelman-like syndrome (fortuitous discovery of hypokalemia with hypomagnesemia and/or hypocalciuria in childhood or adulthood).	type	hypocalciuria	6445	HP_0003127	33	37	329	342	False
29475819	A recent syndromic condition with craniofacial dysmorphisms, comprising congenital ocular defect and neurodevelopmental delay named Helsmoortel-Van der Aa Syndrome (HVDAS) (OMIM#615873), has been described and molecularly defined, identifying pathogenic mutations in the ADNP gene (OMIM#611386) as biological cause.	Van	neurodevelopmental delay	10318	HP_0012758	144	147	101	125	False
29475819	A recent syndromic condition with craniofacial dysmorphisms, comprising congenital ocular defect and neurodevelopmental delay named Helsmoortel-Van der Aa Syndrome (HVDAS) (OMIM#615873), has been described and molecularly defined, identifying pathogenic mutations in the ADNP gene (OMIM#611386) as biological cause.	ADNP	neurodevelopmental delay	23394	HP_0012758	271	275	101	125	True
29475819	We report on two children, displaying intellectual disability (ID) and peculiar congenital eyes anomalies, both carrying a de novo nonsense mutation in the ADNP gene.	ADNP	intellectual disability	23394	HP_0001249	156	160	38	61	True
26637980	Meier-Gorlin syndrome (MGS) is a genetically heterogeneous primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: ORC1, ORC4, ORC6, CDT1, and CDC6.	ORC1	heterogeneous	10166	HP_0001425	211	215	45	58	False
26637980	Meier-Gorlin syndrome (MGS) is a genetically heterogeneous primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: ORC1, ORC4, ORC6, CDT1, and CDC6.	ORC4	heterogeneous	5000	HP_0001425	217	221	45	58	False
26637980	Meier-Gorlin syndrome (MGS) is a genetically heterogeneous primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: ORC1, ORC4, ORC6, CDT1, and CDC6.	ORC6	heterogeneous	23594	HP_0001425	223	227	45	58	False
26637980	Meier-Gorlin syndrome (MGS) is a genetically heterogeneous primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: ORC1, ORC4, ORC6, CDT1, and CDC6.	CDT1	heterogeneous	81620	HP_0001425	229	233	45	58	False
20507343	This study doubles the number of known mutations for this disorder, confirms that truncating mutations in C2orf37 are the only known cause of WSS, and suggests that mutations in this gene do not contribute significantly to cases presenting with isolated elements of WSS such as deafness and dystonia.	C2orf37	deafness	80067	HP_0000365	106	113	278	286	True
20507343	This study doubles the number of known mutations for this disorder, confirms that truncating mutations in C2orf37 are the only known cause of WSS, and suggests that mutations in this gene do not contribute significantly to cases presenting with isolated elements of WSS such as deafness and dystonia.	C2orf37	dystonia	80067	HP_0001332	106	113	291	299	True
26325687	Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder characterized by central obesity, mental impairment, rod-cone dystrophy, polydactyly, hypogonadism in males, and renal abnormalities.	BBS	autosomal recessive	583	HP_0000007	23	26	34	53	True
26325687	Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder characterized by central obesity, mental impairment, rod-cone dystrophy, polydactyly, hypogonadism in males, and renal abnormalities.	BBS	central	583	HP_0030645	23	26	80	87	False
26325687	Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder characterized by central obesity, mental impairment, rod-cone dystrophy, polydactyly, hypogonadism in males, and renal abnormalities.	BBS	obesity	583	HP_0001513	23	26	88	95	True
26325687	Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder characterized by central obesity, mental impairment, rod-cone dystrophy, polydactyly, hypogonadism in males, and renal abnormalities.	BBS	mental impairment	583	HP_0100543	23	26	97	114	False
26325687	Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder characterized by central obesity, mental impairment, rod-cone dystrophy, polydactyly, hypogonadism in males, and renal abnormalities.	BBS	polydactyly	583	HP_0010442	23	26	136	147	True
26325687	Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder characterized by central obesity, mental impairment, rod-cone dystrophy, polydactyly, hypogonadism in males, and renal abnormalities.	BBS	hypogonadism	583	HP_0000135	23	26	149	161	True
26325687	Our results indicate that BBS in Japan is genetically heterogeneous and at least partly shares genetic features with BBS in other countries.	BBS	heterogeneous	583	HP_0001425	26	29	54	67	False
28098905	The Cripto-1 (CR-1) derived EGF-CFC family was overexpressed in tumor development enhancing proliferation, epithelial-mesenchymal transition (EMT) and migration of tumor cells.	Cripto-1	tumor	6997	HP_0002664	4	12	64	69	True
28098905	The Cripto-1 (CR-1) derived EGF-CFC family was overexpressed in tumor development enhancing proliferation, epithelial-mesenchymal transition (EMT) and migration of tumor cells.	EGF	tumor	1950	HP_0002664	28	31	64	69	False
28098905	The Cripto-1 (CR-1) derived EGF-CFC family was overexpressed in tumor development enhancing proliferation, epithelial-mesenchymal transition (EMT) and migration of tumor cells.	CFC	tumor	6903	HP_0002664	32	35	64	69	False
28098905	The Cripto-1 (CR-1) derived EGF-CFC family was overexpressed in tumor development enhancing proliferation, epithelial-mesenchymal transition (EMT) and migration of tumor cells.	EMT	tumor	3702	HP_0002664	142	145	64	69	True
28098905	The Cripto-1 (CR-1) derived EGF-CFC family was overexpressed in tumor development enhancing proliferation, epithelial-mesenchymal transition (EMT) and migration of tumor cells.	CR	tumor	1604	HP_0002664	14	16	64	69	False
28098905	However, correlation between CR-1 and prostate cancer (PCa) remains still unclear.	CR	cancer	1604	HP_0002664	29	31	47	53	False
28098905	However, correlation between CR-1 and prostate cancer (PCa) remains still unclear.	PCa	cancer	28982	HP_0002664	55	58	47	53	False
28098905	Additionally, our results displayed that Licl had antitumor activity against PC-3 through the inhibition of Wnt/-catenin pathway.	PC	tumor	5420	HP_0002664	77	79	54	59	False
29453787	Thirteen patients with GRM1-positive tumors were enrolled.	GRM1	tumors	2911	HP_0002664	23	27	37	43	False
27770446	Group 1 pulmonary hypertension or pulmonary arterial hypertension (PAH) is a rare disease characterized by proliferation and occlusion of small pulmonary arterioles, leading to progressive elevation of pulmonary artery pressure and pulmonary vascular resistance, and right ventricular failure.	PAH	pulmonary arterial hypertension	5053	HP_0002092	67	70	34	65	False
27770446	Group 1 pulmonary hypertension or pulmonary arterial hypertension (PAH) is a rare disease characterized by proliferation and occlusion of small pulmonary arterioles, leading to progressive elevation of pulmonary artery pressure and pulmonary vascular resistance, and right ventricular failure.	PAH	right ventricular failure	5053	HP_0001708	67	70	267	292	False
27770446	The aetiology of PAH is heterogeneous, and genetics play an important role in some cases.	PAH	heterogeneous	5053	HP_0001425	17	20	24	37	False
27770446	PAH in children is much more heterogeneous than in adults, and can be associated with several genetic syndromes, congenital heart disease, pulmonary disease, and vascular disease.	PAH	heterogeneous	5053	HP_0001425	0	3	29	42	False
25048004	The postsynaptic density (PSD) contains a complex set of proteins of known relevance to neuropsychiatric disorders, and schizophrenia specifically.	PSD	schizophrenia	5662	HP_0100753	26	29	120	133	False
25048004	The postsynaptic density (PSD) contains a complex set of proteins of known relevance to neuropsychiatric disorders, and schizophrenia specifically.	set	schizophrenia	6418	HP_0100753	50	53	120	133	False
25048004	Both single-gene and gene-set enrichment analyses in genome-wide association data from the largest schizophrenia sample to date of 13,689 cases and 18,226 controls show significant association of HIST1H1E and MAPK3, and enrichment of our PSD proteome.	PSD	schizophrenia	5662	HP_0100753	238	241	99	112	False
25048004	Both single-gene and gene-set enrichment analyses in genome-wide association data from the largest schizophrenia sample to date of 13,689 cases and 18,226 controls show significant association of HIST1H1E and MAPK3, and enrichment of our PSD proteome.	set	schizophrenia	6418	HP_0100753	26	29	99	112	False
25048004	Both single-gene and gene-set enrichment analyses in genome-wide association data from the largest schizophrenia sample to date of 13,689 cases and 18,226 controls show significant association of HIST1H1E and MAPK3, and enrichment of our PSD proteome.	MAPK3	schizophrenia	5595	HP_0100753	209	214	99	112	False
25048004	Both single-gene and gene-set enrichment analyses in genome-wide association data from the largest schizophrenia sample to date of 13,689 cases and 18,226 controls show significant association of HIST1H1E and MAPK3, and enrichment of our PSD proteome.	HIST1H1E	schizophrenia	3008	HP_0100753	196	204	99	112	False
25048004	Taken together, our data provide robust evidence implicating PSD-associated proteins and genes in schizophrenia, and suggest that within the PSD, NMDA-interacting and endocytosis-related proteins contribute to disease pathophysiology	PSD	schizophrenia	5662	HP_0100753	61	64	98	111	False
25608039	In the present study, we characterize SIRT2 inhibition activity of the brain-permeable compound AK7 and examine the efficacy of this small molecule in models of Parkinson's disease, amyotrophic lateral sclerosis and cerebral ischemia.	SIRT2	cerebral ischemia	22933	HP_0002637	38	43	216	233	False
25608039	These findings underscore the specificity of protective effects observed here in models of Parkinson's disease, and previously in Huntington's disease, and support the development of SIRT2 inhibitors as potential therapeutics for the two neurodegenerative diseases.	SIRT2	neurodegenerative diseases	22933	HP_0002180	183	188	238	264	False
29564728	In subgroup analysis, compared with PD patients with initial symptom of tremor and HCs, the minor allele frequency of NMD3 rs34016896 in PD patients with initial symptoms of rigidity/bradykinesia was significantly lower.	NMD3	bradykinesia	51068	HP_0002067	118	122	183	195	False
29564728	In subgroup analysis, compared with PD patients with initial symptom of tremor and HCs, the minor allele frequency of NMD3 rs34016896 in PD patients with initial symptoms of rigidity/bradykinesia was significantly lower.	HCs	bradykinesia	54205	HP_0002067	83	86	183	195	False
29564728	In subgroup analysis, compared with PD patients with initial symptom of tremor and HCs, the minor allele frequency of NMD3 rs34016896 in PD patients with initial symptoms of rigidity/bradykinesia was significantly lower.	minor	bradykinesia	8013	HP_0002067	92	97	183	195	False
28690391	ANT1 is one of the nuclear genes responsible of autosomal dominant progressive external ophthalmoplegia (adPEO) with mitochondrial DNA multiple deletions.	ANT1	progressive	291	HP_0003676	0	4	67	78	True
28690391	ANT1 is one of the nuclear genes responsible of autosomal dominant progressive external ophthalmoplegia (adPEO) with mitochondrial DNA multiple deletions.	ANT1	ophthalmoplegia	291	HP_0000602	0	4	88	103	True
28690391	Further studies are needed to assess the prevalence of central neurological manifestations in ANT1 mitochondrial disease	ANT1	central	291	HP_0030645	94	98	55	62	False
29569581	All three and two patients with NKX2.1 variants had hypothyroidism and developmental delay, respectively.	NKX2.1	hypothyroidism	7080	HP_0000821	32	38	52	66	True
29569581	All three and two patients with NKX2.1 variants had hypothyroidism and developmental delay, respectively.	NKX2.1	developmental delay	7080	HP_0001263	32	38	71	90	True
28691927	Promyelocytic leukemia (PML) is a pleiotropic tumor suppressor, but its role in tumor microenvironment regulation is poorly characterized.	PML	tumor	5371	HP_0002664	24	27	46	51	False
28691927	PML is frequently downregulated in many cancer types, including lung cancer.	PML	cancer	5371	HP_0002664	0	3	40	46	False
28691927	Clinically, this PML degradation pathway is hyperactivated in lung cancer and correlates with poor prognosis.	PML	cancer	5371	HP_0002664	17	20	67	73	False
28691927	The WDR4/PML axis induces a set of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (uPAR), and serum amyloid A2 (SAA2), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung cancer models.	PML	cancer	5371	HP_0002664	9	12	265	271	False
28691927	The WDR4/PML axis induces a set of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (uPAR), and serum amyloid A2 (SAA2), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung cancer models.	WDR4	cancer	10785	HP_0002664	4	8	265	271	False
28691927	The WDR4/PML axis induces a set of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (uPAR), and serum amyloid A2 (SAA2), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung cancer models.	set	cancer	6418	HP_0002664	28	31	265	271	False
28691927	The WDR4/PML axis induces a set of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (uPAR), and serum amyloid A2 (SAA2), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung cancer models.	uPAR	cancer	5329	HP_0002664	132	136	265	271	False
28691927	The WDR4/PML axis induces a set of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (uPAR), and serum amyloid A2 (SAA2), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung cancer models.	SAA2	cancer	6289	HP_0002664	161	165	265	271	False
28691927	In xenograft and genetically engineered mouse models, the WDR4/PML axis elevates intratumoral Tregs and M2-like macrophages and reduces CD8+ T cells to promote lung tumor growth.	PML	tumor	5371	HP_0002664	63	66	86	91	False
28691927	In xenograft and genetically engineered mouse models, the WDR4/PML axis elevates intratumoral Tregs and M2-like macrophages and reduces CD8+ T cells to promote lung tumor growth.	WDR4	tumor	10785	HP_0002664	58	62	86	91	False
28691927	Our study identifies WDR4 as an oncoprotein that negatively regulates PML via ubiquitination to promote lung cancer progression by fostering an immunosuppressive and prometastatic tumor microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation	PML	tumor	5371	HP_0002664	70	73	180	185	False
28691927	Our study identifies WDR4 as an oncoprotein that negatively regulates PML via ubiquitination to promote lung cancer progression by fostering an immunosuppressive and prometastatic tumor microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation	WDR4	tumor	10785	HP_0002664	21	25	180	185	False
28691927	Our study identifies WDR4 as an oncoprotein that negatively regulates PML via ubiquitination to promote lung cancer progression by fostering an immunosuppressive and prometastatic tumor microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation	PML	cancer	5371	HP_0002664	70	73	109	115	False
28691927	Our study identifies WDR4 as an oncoprotein that negatively regulates PML via ubiquitination to promote lung cancer progression by fostering an immunosuppressive and prometastatic tumor microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation	WDR4	cancer	10785	HP_0002664	21	25	109	115	False
29361520	However, the mechanism causing SCD as a result of exercise remains unknown, but exercise-induced ventricular arrhythmias are thought to be responsible for this fatal consequence.	SCD	ventricular arrhythmias	6584	HP_0004308	31	34	97	120	False
27939639	We performed exome sequencing in a large family affected by an autosomal-dominant form of mild syndromic ID with ptosis, growth retardation, and hypotonia, and we identified an inherited 2bp deletion causing a frameshift in BRPF1 (c.1052_1053del) in five affected family members.	BRPF1	ptosis	7862	HP_0000508	225	230	113	119	True
27939639	We conclude that both genes contribute to the phenotypic severity of 3p25 deletion syndrome but that some specific features, such as ptosis and blepharophimosis, are mostly driven by BRPF1 haploinsufficiency	BRPF1	ptosis	7862	HP_0000508	183	188	133	139	True
27939639	We conclude that both genes contribute to the phenotypic severity of 3p25 deletion syndrome but that some specific features, such as ptosis and blepharophimosis, are mostly driven by BRPF1 haploinsufficiency	BRPF1	blepharophimosis	7862	HP_0000581	183	188	144	160	True
30115536	In this research, we measured the expression of UQCRC2 protein by immunohistochemistry assay in 89 paired paraffin-embedded tumor tissues and corresponding adjacent normal tissues from patients with colorectal adenocarcinoma and investigated possible correlations of UQCRC2 expression with clinicopathological parameters and prognosis.	UQCRC2	tumor	7385	HP_0002664	48	54	124	129	False
30115536	These results provided novel insights into the potential role of UQCRC2 in the tumorigenesis and progression of CRC, and revealed that UQCRC2 may serve as a new prognostic and therapeutic target in CRC	UQCRC2	tumor	7385	HP_0002664	65	71	79	84	False
30253142	Isobutyryl-CoA dehydrogenase deficiency (IBDHD) is a rare autosomal recessive metabolic disorder related to valine catabolism and results from variants in ACAD8.	ACAD8	autosomal recessive	27034	HP_0000007	155	160	58	77	True
21605995	Carnitine-acylcarnitine translocase (CACT) deficiency is a rare autosomal recessive disease of fatty acid oxidation, mainly affecting long chain fatty acid utilization.	CACT	autosomal recessive	788	HP_0000007	37	41	64	83	True
27890673	ABHD12 mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, progressive, autosomal, recessive disease.	ABHD12	hearing loss	26090	HP_0000365	0	6	78	90	True
27890673	ABHD12 mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, progressive, autosomal, recessive disease.	ABHD12	ataxia	26090	HP_0001251	0	6	92	98	True
27890673	ABHD12 mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, progressive, autosomal, recessive disease.	ABHD12	cataract	26090	HP_0000518	0	6	138	146	True
27890673	ABHD12 mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, progressive, autosomal, recessive disease.	ABHD12	progressive	26090	HP_0003676	0	6	157	168	False
25343988	In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both autosomal recessive (MESP2, DLL3, LFNG, HES7) and autosomal dominant (TBX6) inheritance.	MESP2	autosomal recessive	145873	HP_0000007	124	129	103	122	True
25343988	In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both autosomal recessive (MESP2, DLL3, LFNG, HES7) and autosomal dominant (TBX6) inheritance.	DLL3	autosomal recessive	10683	HP_0000007	131	135	103	122	True
25343988	In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both autosomal recessive (MESP2, DLL3, LFNG, HES7) and autosomal dominant (TBX6) inheritance.	LFNG	autosomal recessive	3955	HP_0000007	137	141	103	122	True
25343988	In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both autosomal recessive (MESP2, DLL3, LFNG, HES7) and autosomal dominant (TBX6) inheritance.	HES7	autosomal recessive	84667	HP_0000007	143	147	103	122	True
25343988	In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both autosomal recessive (MESP2, DLL3, LFNG, HES7) and autosomal dominant (TBX6) inheritance.	TBX6	autosomal recessive	6911	HP_0000007	173	177	103	122	True
24121706	PINK1, a mitochondrial serine/threonine kinase, is the product of a gene mutated in an autosomal recessive form of Parkinson disease.	PINK1	autosomal recessive	65018	HP_0000007	0	5	87	106	True
28244854	Recently, hepaCAM was reported to be implicated in cancer development, and many researchers investigated its biological function in the tumorigenesis of various cancers.	hepaCAM	cancer	220296	HP_0002664	10	17	51	57	False
28244854	Recently, hepaCAM was reported to be implicated in cancer development, and many researchers investigated its biological function in the tumorigenesis of various cancers.	hepaCAM	tumor	220296	HP_0002664	10	17	136	141	False
28244854	However, what kind of role hepaCAM plays in colorectal cancer (CRC) remains unknown.	hepaCAM	cancer	220296	HP_0002664	27	34	55	61	False
28244854	Furthermore, the tumorigenesis assay showed that increased expression of hepaCAM suppressed CRC tumor growth and metastasis in vivo.	hepaCAM	tumor	220296	HP_0002664	73	80	17	22	False
28242632	Response rates in both treatment arms were less than 5% in the overall population and in the liposarcoma subgroup.	arm	liposarcoma	80210	HP_0012034	33	36	93	104	False
28389692	Multisystem proteinopathy (MSP), a newly proposed syndrome including inclusion body myopathy (IBM), PDB, frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS), is mainly caused by mutation in VCP gene.	MSP	frontotemporal dementia	89782	HP_0002145	27	30	105	128	False
28389692	Multisystem proteinopathy (MSP), a newly proposed syndrome including inclusion body myopathy (IBM), PDB, frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS), is mainly caused by mutation in VCP gene.	ALS	frontotemporal dementia	3483	HP_0002145	171	174	105	128	False
28389692	Multisystem proteinopathy (MSP), a newly proposed syndrome including inclusion body myopathy (IBM), PDB, frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS), is mainly caused by mutation in VCP gene.	VCP	frontotemporal dementia	7415	HP_0002145	209	212	105	128	True
28389991	Glutaric acidemia I (GAI) is an autosomal recessive metabolic disease caused by a deficiency of glutaryl-CoA dehydrogenase enzyme (GCDH).	GCDH	autosomal recessive	2639	HP_0000007	131	135	32	51	True
28586118	A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	JAK3	cancer	3718	HP_0002664	87	91	127	133	False
28586118	A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	EYA4	cancer	2070	HP_0002664	62	66	127	133	False
28586118	A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	SOX1	cancer	6656	HP_0002664	100	104	127	133	False
28586118	A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	CSPG2	cancer	1462	HP_0002664	48	53	127	133	False
28586118	A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	HOXA9	cancer	3205	HP_0002664	68	73	127	133	False
28586118	A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	TWIST1	cancer	7291	HP_0002664	110	116	127	133	True
28586118	A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	APC	cancer	324	HP_0002664	43	46	127	133	True
28586118	A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	EPHA5	cancer	2044	HP_0002664	55	60	127	133	False
28586118	A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	IPF1	cancer	8050	HP_0002664	75	79	127	133	False
28586118	A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	ISL1	cancer	3670	HP_0002664	81	85	127	133	False
28586118	A panel of hypermethylated genes including APC, CSPG2, EPHA5, EYA4, HOXA9, IPF1, ISL1, JAK3, PITX2, SOX1, and TWIST1 predicted cancer-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	PITX2	cancer	5308	HP_0002664	93	98	127	133	False
30542730	Kruppel-like factor 9 (KLF9), a transcription factor, is critical for the inhibition of growth and development of tumors, whereas its effects in pancreatic cancer remains unclear.	KLF9	tumors	687	HP_0002664	23	27	114	120	False
30542730	Kruppel-like factor 9 (KLF9), a transcription factor, is critical for the inhibition of growth and development of tumors, whereas its effects in pancreatic cancer remains unclear.	KLF9	cancer	687	HP_0002664	23	27	156	162	False
30542730	The purpose of the present study was to investigate the expression and functional significance of KLF9 invitro, by assessing the expression of KLF9 in pancreatic cancer tissue samples and its association with the total survival of patients and clinicopathological data.	KLF9	cancer	687	HP_0002664	98	102	163	169	False
30542730	The levels of KLF9 expression in adjacent tissues and pancreatic cancer tissues were detected using immunohistochemistry.	KLF9	cancer	687	HP_0002664	14	18	65	71	False
30542730	Using western blot analyses, we assessed KLF9 expression in human pancreatic cancer cell lines.	KLF9	cancer	687	HP_0002664	41	45	77	83	False
30542730	Using flow cytometric analysis and CCK-8, we evaluated the effects of KLF9 expression on cell apoptosis, the cell cycle and proliferation of pancreatic cancer cells.	KLF9	cancer	687	HP_0002664	70	74	152	158	False
30542730	Using flow cytometric analysis and CCK-8, we evaluated the effects of KLF9 expression on cell apoptosis, the cell cycle and proliferation of pancreatic cancer cells.	CCK	cancer	885	HP_0002664	35	38	152	158	False
30542730	Our results revealed that in both tissue samples and cell lines (particularly in BxPC-3 and PANC-1 cells) of pancreatic cancer, KLF9 exhibited relatively lower expression.	KLF9	cancer	687	HP_0002664	128	132	120	126	False
30542730	In PANC-1 and BxPC-3 cells, KLF9 overexpression decreased the proliferation of pancreatic cancer cells, induced apoptosis, blocked the cell cycle at the Sphase, and inhibited the migration and invasion of tumor cells.	KLF9	cancer	687	HP_0002664	28	32	90	96	False
30542730	In PANC-1 and BxPC-3 cells, KLF9 overexpression decreased the proliferation of pancreatic cancer cells, induced apoptosis, blocked the cell cycle at the Sphase, and inhibited the migration and invasion of tumor cells.	KLF9	tumor	687	HP_0002664	28	32	206	211	False
30542730	On the whole, our findings indicated that KLF9 exhibited low expression in pancreatic cancer, and upregulation of KLF9 may inhibit the progression of pancreatic cancer.	KLF9	cancer	687	HP_0002664	42	46	86	92	False
29381780	FGF23 excess induces hypophosphatemia via impaired phosphate reabsorption in the renal proximal tubules and decreased phosphate absorption in the intestines.	FGF23	hypophosphatemia	8074	HP_0002148	0	5	21	37	True
29381780	Among these diseases, X-linked hypophosphatemia (XLH), which is caused by inactivating mutations in the phosphate-regulating endopeptidase homolog, X-linked (PHEX) gene, is the most prevalent form of genetic FGF23-related hypophosphatemic rickets.	FGF23	hypophosphatemia	8074	HP_0002148	208	213	31	47	True
29381780	Among these diseases, X-linked hypophosphatemia (XLH), which is caused by inactivating mutations in the phosphate-regulating endopeptidase homolog, X-linked (PHEX) gene, is the most prevalent form of genetic FGF23-related hypophosphatemic rickets.	XLH	hypophosphatemia	5251	HP_0002148	49	52	31	47	True
29381780	Among these diseases, X-linked hypophosphatemia (XLH), which is caused by inactivating mutations in the phosphate-regulating endopeptidase homolog, X-linked (PHEX) gene, is the most prevalent form of genetic FGF23-related hypophosphatemic rickets.	PHEX	hypophosphatemia	5251	HP_0002148	158	162	31	47	True
29381780	Another clinically relevant form of FGF23-related hypophosphatemic disease is tumor-induced osteomalacia (TIO), a paraneoplastic syndrome associated with FGF23-producing tumors.	FGF23	osteomalacia	8074	HP_0002749	36	41	92	104	True
29381780	Another clinically relevant form of FGF23-related hypophosphatemic disease is tumor-induced osteomalacia (TIO), a paraneoplastic syndrome associated with FGF23-producing tumors.	FGF23	tumor	8074	HP_0002664	36	41	78	83	False
27967828	However, HoFH is clinically heterogeneous, reflecting residual low-density lipoprotein receptor (LDLR) activity.	LDLR	heterogeneous	3949	HP_0001425	97	101	28	41	False
30569945	BACKGROUND Epigenetic modifications in host cells, like p16 ink4a methylation, have been considered as putative complementary mechanisms for cancer development.	ink4a	cancer	1029	HP_0002664	60	65	141	147	True
30569945	OBJECTIVES We hypothesised that p16 ink4a methylation might have a role in cancer development driven by HPV16, mainly in the presence of intact E1/E2 genes.	ink4a	cancer	1029	HP_0002664	36	41	75	81	True
30569945	Methylation status of the p16 ink4a promoter was assessed by methylation-specific PCR in 87 cervical specimens comprising 29 low-grade (LSIL), 41 high-grade (HSIL) lesions, and 17 cervical cancers (CC).	ink4a	cancer	1029	HP_0002664	30	35	189	195	True
30569945	FINDINGS We observed a significantly increased trend (nptrend = 0.0320) in the proportion of methylated p16 ink4a in cervical samples during cancer development.	ink4a	cancer	1029	HP_0002664	108	113	141	147	True
30569945	MAIN CONCLUSIONS There was an increase in methylation of the p16 ink4a promoter from pre-neoplastic lesions to cancer.	ink4a	cancer	1029	HP_0002664	65	70	111	117	True
26211651	In addition, polymorphisms in apoptosis-related genes such as RNF7, TULP1, and MERTK are associated with fibrosis progression, and DEPDC5 and MICA variants are associated with HCV-related hepatocellular carcinoma.	RNF7	hepatocellular carcinoma	9616	HP_0001402	62	66	188	212	False
26211651	In addition, polymorphisms in apoptosis-related genes such as RNF7, TULP1, and MERTK are associated with fibrosis progression, and DEPDC5 and MICA variants are associated with HCV-related hepatocellular carcinoma.	TULP1	hepatocellular carcinoma	7287	HP_0001402	68	73	188	212	False
26211651	In addition, polymorphisms in apoptosis-related genes such as RNF7, TULP1, and MERTK are associated with fibrosis progression, and DEPDC5 and MICA variants are associated with HCV-related hepatocellular carcinoma.	MERTK	hepatocellular carcinoma	10461	HP_0001402	79	84	188	212	False
26211651	In addition, polymorphisms in apoptosis-related genes such as RNF7, TULP1, and MERTK are associated with fibrosis progression, and DEPDC5 and MICA variants are associated with HCV-related hepatocellular carcinoma.	DEPDC5	hepatocellular carcinoma	9681	HP_0001402	131	137	188	212	False
26211651	In addition, polymorphisms in apoptosis-related genes such as RNF7, TULP1, and MERTK are associated with fibrosis progression, and DEPDC5 and MICA variants are associated with HCV-related hepatocellular carcinoma.	MICA	hepatocellular carcinoma	100507436	HP_0001402	142	146	188	212	False
28003435	To address this, we performed exome sequencing and copy number variant analysis on 1511 frozen human brains with a diagnosis of Alzheimer's disease (AD, n = 289), frontotemporal dementia/amyotrophic lateral sclerosis (FTD/ALS, n = 252), Creutzfeldt-Jakob disease (CJD, n = 239), Parkinson's disease (PD, n = 39), dementia with Lewy bodies (DLB, n = 58), other neurodegenerative, vascular, or neurogenetic disorders (n = 266), and controls with no significant neuropathology (n = 368).	CJD	frontotemporal dementia	5621	HP_0002145	264	267	163	186	False
22791528	In the last 10 years, the primary cilia machinery has been implicated in more than a dozen disorders united as ciliopathies, including skeletal dysplasias, such as Jeune syndrome and short rib-polydactyly type III.	type	skeletal dysplasias	6445	HP_0002652	205	209	135	154	False
22791528	In the last 10 years, the primary cilia machinery has been implicated in more than a dozen disorders united as ciliopathies, including skeletal dysplasias, such as Jeune syndrome and short rib-polydactyly type III.	type	polydactyly	6445	HP_0010442	205	209	193	204	False
22791528	In this review, we focus on skeletal conditions belonging to the ciliopathy group: the short rib-polydactyly group (SRPs) that includes Verma-Naumoff syndrome (SRP type III), Majewski syndrome (SRP type II), Jeune syndrome (ATD), as well as Ellis-van Creveld syndrome (EVC), the Sensenbrenner syndrome, and, finally, Weyers acrofacial dysostosis.	type	polydactyly	6445	HP_0010442	164	168	97	108	False
22791528	In this review, we focus on skeletal conditions belonging to the ciliopathy group: the short rib-polydactyly group (SRPs) that includes Verma-Naumoff syndrome (SRP type III), Majewski syndrome (SRP type II), Jeune syndrome (ATD), as well as Ellis-van Creveld syndrome (EVC), the Sensenbrenner syndrome, and, finally, Weyers acrofacial dysostosis.	SRP	polydactyly	10911	HP_0010442	116	119	97	108	False
22791528	In this review, we focus on skeletal conditions belonging to the ciliopathy group: the short rib-polydactyly group (SRPs) that includes Verma-Naumoff syndrome (SRP type III), Majewski syndrome (SRP type II), Jeune syndrome (ATD), as well as Ellis-van Creveld syndrome (EVC), the Sensenbrenner syndrome, and, finally, Weyers acrofacial dysostosis.	ATD	polydactyly	472	HP_0010442	224	227	97	108	False
22791528	In this review, we focus on skeletal conditions belonging to the ciliopathy group: the short rib-polydactyly group (SRPs) that includes Verma-Naumoff syndrome (SRP type III), Majewski syndrome (SRP type II), Jeune syndrome (ATD), as well as Ellis-van Creveld syndrome (EVC), the Sensenbrenner syndrome, and, finally, Weyers acrofacial dysostosis.	EVC	polydactyly	2121	HP_0010442	269	272	97	108	True
28577571	Mutations in four genes (LDLR, APOB, PCSK9 and LDLRAP1) account for the majority of cases with familial hypercholesterolemia.	LDLR	hypercholesterolemia	3949	HP_0003124	25	29	104	124	True
28577571	Mutations in four genes (LDLR, APOB, PCSK9 and LDLRAP1) account for the majority of cases with familial hypercholesterolemia.	APOB	hypercholesterolemia	338	HP_0003124	31	35	104	124	True
28577571	Mutations in four genes (LDLR, APOB, PCSK9 and LDLRAP1) account for the majority of cases with familial hypercholesterolemia.	PCSK9	hypercholesterolemia	255738	HP_0003124	37	42	104	124	True
28577571	Here in, we review the recent evidence of association of the genetic variants with hypercholesterolemia and the three lipid traits; total cholesterol (TC), HDL-cholesterol (HDL-C) and LDL-cholesterol (LDL-C), their biological pathways and the associated pathogenetic mechanisms.	traits	hypercholesterolemia	55929	HP_0003124	124	130	83	103	False
28577571	Nearly 80 genes involved in lipid metabolism (encoding structural components of lipoproteins, lipoprotein receptors and related proteins, enzymes, lipid transporters, lipid transfer proteins, and activators or inhibitors of protein function and gene transcription) with single nucleotide variants (SNVs) that are recognized to be associated with hypercholesterolemia and serum lipid traits in genome-wide association studies and candidate gene studies were identified.	traits	hypercholesterolemia	55929	HP_0003124	383	389	346	366	False
28169398	The gonadoblastoma gene, testis-specific protein Y-encoded (TSPY), on the Y chromosome and its X-homologue, TSPX, are cell cycle regulators and function as a proto-oncogene and a tumor suppressor respectively in human oncogenesis.	TSPY	gonadoblastoma	7258	HP_0000150	60	64	4	18	False
28169398	The gonadoblastoma gene, testis-specific protein Y-encoded (TSPY), on the Y chromosome and its X-homologue, TSPX, are cell cycle regulators and function as a proto-oncogene and a tumor suppressor respectively in human oncogenesis.	TSPX	gonadoblastoma	64061	HP_0000150	108	112	4	18	False
28169398	The gonadoblastoma gene, testis-specific protein Y-encoded (TSPY), on the Y chromosome and its X-homologue, TSPX, are cell cycle regulators and function as a proto-oncogene and a tumor suppressor respectively in human oncogenesis.	TSPY	tumor	7258	HP_0002664	60	64	179	184	False
28169398	The gonadoblastoma gene, testis-specific protein Y-encoded (TSPY), on the Y chromosome and its X-homologue, TSPX, are cell cycle regulators and function as a proto-oncogene and a tumor suppressor respectively in human oncogenesis.	TSPX	tumor	64061	HP_0002664	108	112	179	184	False
28169398	TSPY and TSPX co-localize with the endogenous AR, in the presence of ligand, on the promoters and differentially regulate the expression of the endogenous AR target genes in the androgen-responsive LNCaP prostate cancer cells.	TSPY	cancer	7258	HP_0002664	0	4	213	219	False
28169398	TSPY and TSPX co-localize with the endogenous AR, in the presence of ligand, on the promoters and differentially regulate the expression of the endogenous AR target genes in the androgen-responsive LNCaP prostate cancer cells.	TSPX	cancer	64061	HP_0002664	9	13	213	219	False
28169398	TSPY and TSPX co-localize with the endogenous AR, in the presence of ligand, on the promoters and differentially regulate the expression of the endogenous AR target genes in the androgen-responsive LNCaP prostate cancer cells.	AR	cancer	231	HP_0002664	46	48	213	219	False
28169398	Hence, TSPY and TSPX exert opposing effects on the transactivation functions of AR and AR-Vs important for various physiological and disease processes sensitive to male sex hormone actions, thereby not only affecting the pathogenesis of male-specific prostate cancer but also likely contributing to sex differences in the health and diseases of man	TSPY	cancer	7258	HP_0002664	7	11	260	266	False
28169398	Hence, TSPY and TSPX exert opposing effects on the transactivation functions of AR and AR-Vs important for various physiological and disease processes sensitive to male sex hormone actions, thereby not only affecting the pathogenesis of male-specific prostate cancer but also likely contributing to sex differences in the health and diseases of man	TSPX	cancer	64061	HP_0002664	16	20	260	266	False
28169398	Hence, TSPY and TSPX exert opposing effects on the transactivation functions of AR and AR-Vs important for various physiological and disease processes sensitive to male sex hormone actions, thereby not only affecting the pathogenesis of male-specific prostate cancer but also likely contributing to sex differences in the health and diseases of man	AR	cancer	231	HP_0002664	80	82	260	266	False
28169398	Hence, TSPY and TSPX exert opposing effects on the transactivation functions of AR and AR-Vs important for various physiological and disease processes sensitive to male sex hormone actions, thereby not only affecting the pathogenesis of male-specific prostate cancer but also likely contributing to sex differences in the health and diseases of man	sex	cancer	55558	HP_0002664	169	172	260	266	False
29523635	Currently the only established high penetrance familial melanoma genes are CDKN2A and CDK4.	CDKN2A	melanoma	1029	HP_0002861	75	81	56	64	True
29523635	Recent studies reported germline variants in POT1 in melanoma families.	POT1	melanoma	25913	HP_0002861	45	49	53	61	True
29523635	So, in conclusion, melanoma associated POT1 germline variants seem to be rare.	POT1	melanoma	25913	HP_0002861	39	43	19	27	True
28290464	Naive CD4<sup>+</sup> T cells adhere to tumor slices in proportion to the abundance of CCL18-producing macrophages.	CCL18	tumor	6362	HP_0002664	87	92	40	45	False
28290464	Moreover, adoptively transferred human naive CD4<sup>+</sup> T cells infiltrate human breast cancer orthotopic xenografts in a CCL18-dependent manner.	CCL18	cancer	6362	HP_0002664	127	132	93	99	False
28290464	In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4<sup>+</sup> T cells into tumor by knocking down the expression of PITPNM3, a CCL18 receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.	mice	tumor	23581	HP_0002664	47	51	116	121	False
28290464	In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4<sup>+</sup> T cells into tumor by knocking down the expression of PITPNM3, a CCL18 receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.	PITPNM3	tumor	83394	HP_0002664	157	164	116	121	False
28290464	In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4<sup>+</sup> T cells into tumor by knocking down the expression of PITPNM3, a CCL18 receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.	CCL18	tumor	6362	HP_0002664	168	173	116	121	False
28290464	In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4<sup>+</sup> T cells into tumor by knocking down the expression of PITPNM3, a CCL18 receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.	mice	cancer	23581	HP_0002664	47	51	16	22	False
28290464	In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4<sup>+</sup> T cells into tumor by knocking down the expression of PITPNM3, a CCL18 receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.	PITPNM3	cancer	83394	HP_0002664	157	164	16	22	False
28290464	In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4<sup>+</sup> T cells into tumor by knocking down the expression of PITPNM3, a CCL18 receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.	CCL18	cancer	6362	HP_0002664	168	173	16	22	False
28290464	Inhibiting naive CD4<sup>+</sup> T cell recruitment into tumors by interfering with PITPNM3 recognition of CCL18 may be an attractive strategy for anticancer immunotherapy	PITPNM3	tumor	83394	HP_0002664	84	91	57	62	False
28290464	Inhibiting naive CD4<sup>+</sup> T cell recruitment into tumors by interfering with PITPNM3 recognition of CCL18 may be an attractive strategy for anticancer immunotherapy	CCL18	tumor	6362	HP_0002664	107	112	57	62	False
28290464	Inhibiting naive CD4<sup>+</sup> T cell recruitment into tumors by interfering with PITPNM3 recognition of CCL18 may be an attractive strategy for anticancer immunotherapy	PITPNM3	cancer	83394	HP_0002664	84	91	151	157	False
28290464	Inhibiting naive CD4<sup>+</sup> T cell recruitment into tumors by interfering with PITPNM3 recognition of CCL18 may be an attractive strategy for anticancer immunotherapy	CCL18	cancer	6362	HP_0002664	107	112	151	157	False
29749503	The present study intended to identify the association between three severe types of gynecological cancer, specifically ovarian cancer, cervical cancer and endometrial cancer, and to identify the connective driver genes, microRNAs (miRNAs) and biological processes associated with these types of gynecological cancer.	type	cancer	6445	HP_0002664	76	80	99	105	False
29749503	In the present study, individual driver genes for each type of cancer were identified using integrated analysis of multiple microarray data.	type	cancer	6445	HP_0002664	55	59	63	69	False
29749503	Survival analysis revealed that the expression of MCM2, MMP2, COL1A1 and JUN was associated with the prognosis of the aforementioned gynecological cancer types.	type	cancer	6445	HP_0002664	154	158	147	153	False
29749503	Survival analysis revealed that the expression of MCM2, MMP2, COL1A1 and JUN was associated with the prognosis of the aforementioned gynecological cancer types.	MCM2	cancer	4176	HP_0002664	50	54	147	153	False
29749503	Survival analysis revealed that the expression of MCM2, MMP2, COL1A1 and JUN was associated with the prognosis of the aforementioned gynecological cancer types.	MMP2	cancer	4313	HP_0002664	56	60	147	153	False
29749503	Survival analysis revealed that the expression of MCM2, MMP2, COL1A1 and JUN was associated with the prognosis of the aforementioned gynecological cancer types.	COL1A1	cancer	1277	HP_0002664	62	68	147	153	True
29749503	Survival analysis revealed that the expression of MCM2, MMP2, COL1A1 and JUN was associated with the prognosis of the aforementioned gynecological cancer types.	JUN	cancer	3725	HP_0002664	73	76	147	153	False
29749503	In conclusion, the present study demonstrated a connection model across three types of gynecological cancer, which was useful in identifying potential diagnostic markers and novel therapeutic targets, in addition to in aiding the prediction of the development of cancer as it progresses	type	cancer	6445	HP_0002664	78	82	101	107	False
30139743	Up to 15% of the population have mild to moderate chronic hypomagnesemia, which is associated with type 2 diabetes mellitus, hypertension, metabolic syndrome, and chronic kidney disease.	type	hypomagnesemia	6445	HP_0002917	99	103	58	72	False
30139743	Up to 15% of the population have mild to moderate chronic hypomagnesemia, which is associated with type 2 diabetes mellitus, hypertension, metabolic syndrome, and chronic kidney disease.	type	hypertension	6445	HP_0000822	99	103	125	137	False
29437892	Growth abnormalities, motor dysfunction, hindlimb paralysis, muscle wasting, neurogenic atrophy, motor neuron degeneration, and loss of large-caliber axons in peripheral nerves occurred at an earlier age in <i>Scyl1</i>/S<i>cyl3</i> double-deficient mice than in <i>Scyl1</i>-deficient mice.	Scyl1	muscle wasting	6357	HP_0003202	210	215	61	75	False
29437892	Growth abnormalities, motor dysfunction, hindlimb paralysis, muscle wasting, neurogenic atrophy, motor neuron degeneration, and loss of large-caliber axons in peripheral nerves occurred at an earlier age in <i>Scyl1</i>/S<i>cyl3</i> double-deficient mice than in <i>Scyl1</i>-deficient mice.	mice	muscle wasting	23581	HP_0003202	250	254	61	75	False
29437892	Growth abnormalities, motor dysfunction, hindlimb paralysis, muscle wasting, neurogenic atrophy, motor neuron degeneration, and loss of large-caliber axons in peripheral nerves occurred at an earlier age in <i>Scyl1</i>/S<i>cyl3</i> double-deficient mice than in <i>Scyl1</i>-deficient mice.	Scyl1	motor neuron degeneration	6357	HP_0007373	210	215	97	122	False
29437892	Growth abnormalities, motor dysfunction, hindlimb paralysis, muscle wasting, neurogenic atrophy, motor neuron degeneration, and loss of large-caliber axons in peripheral nerves occurred at an earlier age in <i>Scyl1</i>/S<i>cyl3</i> double-deficient mice than in <i>Scyl1</i>-deficient mice.	mice	motor neuron degeneration	23581	HP_0007373	250	254	97	122	False
28289185	Oral-facial-digital syndromes (OFDS) gather rare genetic disorders characterised by facial, oral and digital abnormalities associated with a wide range of additional features (polycystic kidney disease, cerebral malformations and several others) to delineate a growing list of OFDS subtypes.	type	kidney disease	6445	HP_0000077	285	289	187	201	False
28054444	A heterozygous nonsense variant was identified in dapper, antagonist of beta-catenin, 1 (DACT1) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.	dapper	imperforate anus	51339	HP_0002023	50	56	146	162	True
28054444	A heterozygous nonsense variant was identified in dapper, antagonist of beta-catenin, 1 (DACT1) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.	beta-catenin	imperforate anus	1499	HP_0002023	72	84	146	162	False
28054444	A heterozygous nonsense variant was identified in dapper, antagonist of beta-catenin, 1 (DACT1) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.	DACT1	imperforate anus	51339	HP_0002023	89	94	146	162	True
28054444	A heterozygous nonsense variant was identified in dapper, antagonist of beta-catenin, 1 (DACT1) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.	dapper	ear anomalies	51339	HP_0000598	50	56	228	241	True
28054444	A heterozygous nonsense variant was identified in dapper, antagonist of beta-catenin, 1 (DACT1) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.	beta-catenin	ear anomalies	1499	HP_0000598	72	84	228	241	True
28054444	A heterozygous nonsense variant was identified in dapper, antagonist of beta-catenin, 1 (DACT1) via whole-exome sequencing in family members with imperforate anus, structural renal abnormalities, genitourinary anomalies, and/or ear anomalies.	DACT1	ear anomalies	51339	HP_0000598	89	94	228	241	True
28054444	The DACT1 c.1256G&gt;A;p.Trp419<sup>*</sup> variant segregated appropriately in the family consistent with an autosomal dominant mode of inheritance.	DACT1	mode of inheritance	51339	HP_0000005	4	9	129	148	False
28054444	DACT1 is a member of the Wnt-signaling pathway, and mice homozygous for null alleles display multiple congenital anomalies including absent anus with blind-ending colon and genitourinary malformations.	DACT1	absent anus	51339	HP_0002023	0	5	133	144	True
28054444	DACT1 is a member of the Wnt-signaling pathway, and mice homozygous for null alleles display multiple congenital anomalies including absent anus with blind-ending colon and genitourinary malformations.	mice	absent anus	23581	HP_0002023	52	56	133	144	False
28965985	Through gene set enrichment analysis and bi-clustering, we also found that most of the differential expressed lncRNAs were closely associated with mitochondrial functions (e.g. mitochondrion organization, P=3.2110<sup>-17</sup>; mitochondrial ATP synthesis coupled electron transport, P=1.7310<sup>-19</sup> and mitochondrial membrane organization, P=4.0410<sup>-8</sup>).	set	mitochondrial	6418	HP_0001427	13	16	147	160	False
21607584	In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.	CDC25C	cancer	995	HP_0002664	24	30	111	117	False
21607584	In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.	TLK2	cancer	11011	HP_0002664	44	48	111	117	False
21607584	In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.	SMC6L1	cancer	79677	HP_0002664	54	60	111	117	False
21607584	In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.	CDC6	cancer	990	HP_0002664	124	128	111	117	False
21607584	In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.	CDC27	cancer	996	HP_0002664	130	135	111	117	False
21607584	In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.	SUMO3	cancer	6612	HP_0002664	137	142	111	117	False
21607584	In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.	RASSF1	cancer	11186	HP_0002664	144	150	111	117	True
21607584	In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.	KIF2	cancer	3796	HP_0002664	152	156	111	117	False
21607584	In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.	CDC14A	cancer	8556	HP_0002664	162	168	111	117	False
21607584	In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.	EIF3S10	cancer	3692	HP_0002664	225	232	111	117	False
21607584	In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P&lt;0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.	CDC25A	cancer	993	HP_0002664	237	243	111	117	False
30298137	Additionally, multivariate logistic regression analysis identified that the mutant genotype of rs4148323 in the UGT1A1 gene, ABO incompatibility, G6PD deficiency, and SS genotype at rs1805173 locus of the HO-1 gene were genetic risk factors of neonatal hyperbilirubinemia.	ABO	hyperbilirubinemia	28	HP_0002904	125	128	253	271	False
30298137	Our data demonstrate that G211 mutation in the UGT1A1 gene, ABO incompatibility, G6PD deficiency, and the SS genotype of the repeats in the promoter region of the HO-1 gene are risk factors for neonatal hyperbilirubinemia in Fujian, Southeastern China	ABO	hyperbilirubinemia	28	HP_0002904	60	63	203	221	False
29335468	This phenotype is associated with increased cytosine methylation heterogeneity, but not with increased AICDA-mediated somatic mutation burden.	AICDA	heterogeneity	57379	HP_0001425	103	108	65	78	False
29335468	This phenotype is associated with increased cytosine methylation heterogeneity, but not with increased AICDA-mediated somatic mutation burden.	AICDA	somatic mutation	57379	HP_0001428	103	108	118	134	False
29335468	Reciprocally, the cytosine methylation heterogeneity characteristic of normal GC B cells is lost upon AICDA depletion.	AICDA	heterogeneity	57379	HP_0001425	102	107	39	52	False
29335468	These observations are relevant to human patients, since DLBCLs with high AICDA expression manifest increased methylation heterogeneity vs. AICDA-low DLBCLs.	AICDA	heterogeneity	57379	HP_0001425	74	79	122	135	False
29335468	Our results identify AICDA as a driver of epigenetic heterogeneity in B-cell lymphomas with potential significance for other tumors with aberrant expression of cytidine deaminases	AICDA	heterogeneity	57379	HP_0001425	21	26	53	66	False
29335468	Our results identify AICDA as a driver of epigenetic heterogeneity in B-cell lymphomas with potential significance for other tumors with aberrant expression of cytidine deaminases	AICDA	tumors	57379	HP_0002664	21	26	125	131	False
29407415	This paper deals with the molecular investigation of Waardenburg syndrome (WS) in a sample of 49 clinically diagnosed probands (most from southeastern Brazil), 24 of them having the type 1 (WS1) variant (10 familial and 14 isolated cases) and 25 being affected by the type 2 (WS2) variant (five familial and 20 isolated cases).	type	isolated cases	6445	HP_0003745	182	186	223	237	False
25220058	As in MOPDII patients, disruption of pericentrin (Pcnt) in mice caused a number of abnormalities including microcephaly, aberrant hemodynamics analyzed by in utero echocardiography, and cardiovascular anomalies; the latter being associated with mortality, as in the human condition.	Pcnt	microcephaly	5116	HP_0000252	50	54	107	119	True
25220058	As in MOPDII patients, disruption of pericentrin (Pcnt) in mice caused a number of abnormalities including microcephaly, aberrant hemodynamics analyzed by in utero echocardiography, and cardiovascular anomalies; the latter being associated with mortality, as in the human condition.	mice	microcephaly	23581	HP_0000252	59	63	107	119	False
24461433	ALG2 mutation results in a heterogeneous phenotype and care should be taken in categorization and treatment of these patients.	ALG2	heterogeneous	85365	HP_0001425	0	4	27	40	False
30306264	Although anti-myelin-associated glycoprotein (MAG) antibody neuropathy is reported as a slowly progressive disease, it can lead to significant disability and impairment of health-related quality of life (HR-QoL) and social participation.	MAG	neuropathy	2068	HP_0009830	46	49	60	70	True
30306264	Although anti-myelin-associated glycoprotein (MAG) antibody neuropathy is reported as a slowly progressive disease, it can lead to significant disability and impairment of health-related quality of life (HR-QoL) and social participation.	HR	neuropathy	55806	HP_0009830	204	206	60	70	False
30306264	The aim of this cross-sectional study was to evaluate the functioning and HR-QoL determinants in 67 patients with anti-MAG neuropathy in terms of the International Classification of Functioning, Disability, and Health (ICF).	MAG	neuropathy	2068	HP_0009830	119	122	123	133	True
30306264	The aim of this cross-sectional study was to evaluate the functioning and HR-QoL determinants in 67 patients with anti-MAG neuropathy in terms of the International Classification of Functioning, Disability, and Health (ICF).	HR	neuropathy	55806	HP_0009830	74	76	123	133	False
30306264	Furthermore, neurorehabilitation interventions aimed at improving balance and walking performance, fatigue management, and specific pain relief therapy should be considered to ameliorate participation in social life and HR-QoL in anti-MAG neuropathy patients	MAG	neuropathy	2068	HP_0009830	235	238	239	249	True
30306264	Furthermore, neurorehabilitation interventions aimed at improving balance and walking performance, fatigue management, and specific pain relief therapy should be considered to ameliorate participation in social life and HR-QoL in anti-MAG neuropathy patients	HR	neuropathy	55806	HP_0009830	220	222	239	249	False
29174093	De novo monoallelic mutations in the GNB1 gene, encoding a  subunit of heterotrimeric G proteins, cause a newly recognized disorder with the typical clinical picture of severe developmental delay/intellectual disability, hypotonia and extrapyramidal symptoms.	GNB1	developmental delay	2782	HP_0001263	37	41	177	196	True
29174093	De novo monoallelic mutations in the GNB1 gene, encoding a  subunit of heterotrimeric G proteins, cause a newly recognized disorder with the typical clinical picture of severe developmental delay/intellectual disability, hypotonia and extrapyramidal symptoms.	GNB1	intellectual disability	2782	HP_0001249	37	41	197	220	True
29174093	We describe another case of the condition with manifestations of cutaneous mastocytosis associated with a novel do novo mutation GNB1NM_001282539.1: c.230G&gt;T; p.(Gly77Val).	GNB1	cutaneous mastocytosis	2782	HP_0200151	129	133	65	87	False
30442880	BACKGROUND The distribution of fat mass and obesity-associated gene (FTO) genes rs9939609 and rs1421085 in obese and normal ethnic Mongolians was analyzed to investigate the association of FTO gene polymorphisms with obesity and metabolic syndrome in ethnic Mongolians.	fat	obesity	948	HP_0001513	31	34	44	51	False
30442880	BACKGROUND The distribution of fat mass and obesity-associated gene (FTO) genes rs9939609 and rs1421085 in obese and normal ethnic Mongolians was analyzed to investigate the association of FTO gene polymorphisms with obesity and metabolic syndrome in ethnic Mongolians.	mass	obesity	2200	HP_0001513	35	39	44	51	False
30442880	BACKGROUND The distribution of fat mass and obesity-associated gene (FTO) genes rs9939609 and rs1421085 in obese and normal ethnic Mongolians was analyzed to investigate the association of FTO gene polymorphisms with obesity and metabolic syndrome in ethnic Mongolians.	FTO	obesity	79068	HP_0001513	69	72	44	51	True
30442880	RESULTS Body mass, body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-hip ratio (WHR), SBP, DBP, FPG, triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) were higher, while HDL-C was lower in the obesity group compared with controls.	mass	obesity	2200	HP_0001513	13	17	263	270	False
30442880	RESULTS Body mass, body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-hip ratio (WHR), SBP, DBP, FPG, triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) were higher, while HDL-C was lower in the obesity group compared with controls.	hip	obesity	64399	HP_0001513	68	71	263	270	False
30442880	RESULTS Body mass, body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-hip ratio (WHR), SBP, DBP, FPG, triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) were higher, while HDL-C was lower in the obesity group compared with controls.	DBP	obesity	2638	HP_0001513	120	123	263	270	False
21824574	The pattern of inheritance is autosomal recessive, and a causative mutation is evident in the CTDP1 gene.	CTDP1	autosomal recessive	9150	HP_0000007	94	99	30	49	True
26659383	Ectodysplasin-A2 (EDA-A2) is a recently isolated member of the tumor necrosis factor superfamily that binds to X-linked ectodermal dysplasia receptor (XEDAR).	EDA-A2	tumor	1896	HP_0002664	18	24	63	68	False
26659383	Ectodysplasin-A2 (EDA-A2) is a recently isolated member of the tumor necrosis factor superfamily that binds to X-linked ectodermal dysplasia receptor (XEDAR).	XEDAR	tumor	60401	HP_0002664	151	156	63	68	False
26659383	Ectodysplasin-A2 (EDA-A2) is a recently isolated member of the tumor necrosis factor superfamily that binds to X-linked ectodermal dysplasia receptor (XEDAR).	EDA-A2	ectodermal dysplasia	1896	HP_0000968	18	24	120	140	True
26659383	Ectodysplasin-A2 (EDA-A2) is a recently isolated member of the tumor necrosis factor superfamily that binds to X-linked ectodermal dysplasia receptor (XEDAR).	XEDAR	ectodermal dysplasia	60401	HP_0000968	151	156	120	140	False
29293603	Mutations in the elongation of very long chain fatty acid 4 (ELOVL4) gene cause Stargardt macular dystrophy 3 (STGD3), a rare, juvenile-onset, autosomal dominant form of macular degeneration.	ELOVL4	macular dystrophy	6785	HP_0007754	61	67	90	107	True
29293603	Mutations in the elongation of very long chain fatty acid 4 (ELOVL4) gene cause Stargardt macular dystrophy 3 (STGD3), a rare, juvenile-onset, autosomal dominant form of macular degeneration.	STGD3	macular dystrophy	6785	HP_0007754	111	116	90	107	True
29293603	Mutations in the elongation of very long chain fatty acid 4 (ELOVL4) gene cause Stargardt macular dystrophy 3 (STGD3), a rare, juvenile-onset, autosomal dominant form of macular degeneration.	ELOVL4	macular degeneration	6785	HP_0000608	61	67	170	190	True
29293603	Mutations in the elongation of very long chain fatty acid 4 (ELOVL4) gene cause Stargardt macular dystrophy 3 (STGD3), a rare, juvenile-onset, autosomal dominant form of macular degeneration.	STGD3	macular degeneration	6785	HP_0000608	111	116	170	190	True
29293603	However, this reduction in PC-VLC-PUFA content in the all-cone retina had no impact on morphology or function and did not accelerate retinal degeneration in the R91W;Nrl-/-;Elovl4 mice.	mice	retinal degeneration	23581	HP_0000546	180	184	133	153	False
29293603	However, this reduction in PC-VLC-PUFA content in the all-cone retina had no impact on morphology or function and did not accelerate retinal degeneration in the R91W;Nrl-/-;Elovl4 mice.	Elovl4	retinal degeneration	6785	HP_0000546	173	179	133	153	True
29293603	However, this reduction in PC-VLC-PUFA content in the all-cone retina had no impact on morphology or function and did not accelerate retinal degeneration in the R91W;Nrl-/-;Elovl4 mice.	PC	retinal degeneration	5420	HP_0000546	27	29	133	153	False
29293603	However, this reduction in PC-VLC-PUFA content in the all-cone retina had no impact on morphology or function and did not accelerate retinal degeneration in the R91W;Nrl-/-;Elovl4 mice.	impact	retinal degeneration	55364	HP_0000546	77	83	133	153	False
23086420	Several myotubularins have been genetically linked to human diseases: MTM1 is mutated in the congenital myopathy X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while MTMR2 and MTMR13 are mutated in Charcot-Marie-Tooth (CMT) neuropathies.	MTM1	myopathy	4534	HP_0003198	70	74	104	112	False
23086420	Several myotubularins have been genetically linked to human diseases: MTM1 is mutated in the congenital myopathy X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while MTMR2 and MTMR13 are mutated in Charcot-Marie-Tooth (CMT) neuropathies.	MTMR14	myopathy	64419	HP_0003198	171	177	104	112	True
23086420	Several myotubularins have been genetically linked to human diseases: MTM1 is mutated in the congenital myopathy X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while MTMR2 and MTMR13 are mutated in Charcot-Marie-Tooth (CMT) neuropathies.	MTMR2	myopathy	8898	HP_0003198	246	251	104	112	False
23086420	Several myotubularins have been genetically linked to human diseases: MTM1 is mutated in the congenital myopathy X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while MTMR2 and MTMR13 are mutated in Charcot-Marie-Tooth (CMT) neuropathies.	MTMR13	myopathy	81846	HP_0003198	256	262	104	112	False
28411178	To better understand the biology of this molecularly distinct tumor subtype, we analyze the microRNA (miRNA) expression profiles of Xp11 RCC compared with normal renal parenchyma using microarray and quantitative reverse-transcription polymerase chain reaction.	RCC	tumor	7515	HP_0002664	137	140	62	67	False
28411178	To better understand the biology of this molecularly distinct tumor subtype, we analyze the microRNA (miRNA) expression profiles of Xp11 RCC compared with normal renal parenchyma using microarray and quantitative reverse-transcription polymerase chain reaction.	miR	tumor	220972	HP_0002664	102	105	62	67	False
28411178	To better understand the biology of this molecularly distinct tumor subtype, we analyze the microRNA (miRNA) expression profiles of Xp11 RCC compared with normal renal parenchyma using microarray and quantitative reverse-transcription polymerase chain reaction.	type	tumor	6445	HP_0002664	71	75	62	67	False
30415482	Congenital hypogonadotrophic hypogonadism (CHH) is a challenging inherited endocrine disorder characterised by absent or incomplete pubertal development and infertility as a result of the low action/secretion of the hypothalamic gonadotrophin-releasing hormone (GnRH).	GnRH	hypogonadism	2796	HP_0000135	262	266	29	41	True
29254845	Conversely, Th17 cells and their effector molecules interleukin 17A (IL-17A), IL-17F, interferon (IFN), tumor necrosis factor (TNF), and granulocyte-macrophage colony-stimulating factor (GM-CSF) are implicated in the pathology of rheumatoid arthritis (RA).	IFN	tumor	3439	HP_0002664	98	101	105	110	False
29254845	Conversely, Th17 cells and their effector molecules interleukin 17A (IL-17A), IL-17F, interferon (IFN), tumor necrosis factor (TNF), and granulocyte-macrophage colony-stimulating factor (GM-CSF) are implicated in the pathology of rheumatoid arthritis (RA).	TNF	tumor	7124	HP_0002664	128	131	105	110	False
29254845	Conversely, Th17 cells and their effector molecules interleukin 17A (IL-17A), IL-17F, interferon (IFN), tumor necrosis factor (TNF), and granulocyte-macrophage colony-stimulating factor (GM-CSF) are implicated in the pathology of rheumatoid arthritis (RA).	GM-CSF	tumor	1437	HP_0002664	189	195	105	110	False
29659014	To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, PTEN, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.	BRCA2	tumor	675	HP_0002664	86	91	208	213	True
29659014	To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, PTEN, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.	BRCA1	tumor	672	HP_0002664	80	85	208	213	True
29659014	To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, PTEN, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.	RAD51C	tumor	5889	HP_0002664	251	257	208	213	True
29659014	To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, PTEN, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.	ATM	tumor	472	HP_0002664	259	262	208	213	True
29659014	To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, PTEN, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.	PTEN	tumor	5728	HP_0002664	264	268	208	213	True
29659014	To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, PTEN, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.	MLH1	tumor	4292	HP_0002664	276	280	208	213	True
29659014	To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 tumor suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, PTEN, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.	ESR1	tumor	2099	HP_0002664	320	324	208	213	False
28610954	A MMP9 inhibitor significantly inhibited cell invasion and migration in ALDOA-HIF-1 axis-induced lung cancer.	MMP9	cancer	4318	HP_0002664	2	6	103	109	False
28610954	A MMP9 inhibitor significantly inhibited cell invasion and migration in ALDOA-HIF-1 axis-induced lung cancer.	ALDOA	cancer	226	HP_0002664	72	77	103	109	False
28610954	In summary, our results reveal the molecular mechanism of Aldolase A in promoting lung cancer metastasis via PHD-mediated stabilization of HIF-1 and the subsequent activation of MMP9.	MMP9	cancer	4318	HP_0002664	179	183	87	93	False
28610954	The ALDOA-HIF-1 axis may provide a new therapeutic target for metastatic lung cancer treatment	ALDOA	cancer	226	HP_0002664	4	9	79	85	False
29083325	Deficiency in Krppel-like zinc finger transcription factor GLI-similar 3 (GLIS3) in humans is associated with the development of congenital hypothyroidism.	GLIS3	hypothyroidism	169792	HP_0000821	75	80	141	155	True
29083325	However, the functions of GLIS3 in the thyroid gland and the mechanism by which GLIS3 dysfunction causes hypothyroidism are unknown.	GLIS3	hypothyroidism	169792	HP_0000821	26	31	105	119	True
29083325	Our study identifies GLIS3 as a key regulator of TSH/TSHR-mediated thyroid hormone biosynthesis and proliferation of thyroid follicular cells and uncovers a mechanism by which GLIS3 deficiency causes neonatal hypothyroidism and prevents goiter development	GLIS3	hypothyroidism	169792	HP_0000821	21	26	209	223	True
29083325	Our study identifies GLIS3 as a key regulator of TSH/TSHR-mediated thyroid hormone biosynthesis and proliferation of thyroid follicular cells and uncovers a mechanism by which GLIS3 deficiency causes neonatal hypothyroidism and prevents goiter development	TSHR	hypothyroidism	7253	HP_0000821	53	57	209	223	True
27375225	Ex vivo data showed that DHC2 expression in GBM tissue samples was associated with tumor recurrence after TMZ chemotherapy.	DHC2	tumor	79659	HP_0002664	25	29	83	88	True
24291895	Congenital muscular dystrophy with mitochondrial structural abnormalities (MIM #602541), or also called megaconial congenital muscular dystrophy, is characterized clinically by early-onset muscle wasting and severe mental retardation, and pathologically by peculiar enlarged mitochondria that are prevalent toward the periphery of the fibers but are sparse in the center on muscle biopsy.	MIM	severe	9788	HP_0012828	75	78	208	214	False
30145633	Bcl2-associated athanogene 3 (BAG3) mutations have been reported to cause the myofibrillar myopathy (MFM) which shows progressive limb muscle weakness, respiratory failure, and cardiomyopathy.	BAG3	respiratory failure	9531	HP_0002878	30	34	152	171	False
30145633	Bcl2-associated athanogene 3 (BAG3) mutations have been reported to cause the myofibrillar myopathy (MFM) which shows progressive limb muscle weakness, respiratory failure, and cardiomyopathy.	BAG3	myopathy	9531	HP_0003198	30	34	91	99	True
30145633	We aimed to find the genetic cause of Korean patients with sensory motor polyneuropathy, myopathy and rigid spine.	find	polyneuropathy	81501	HP_0001271	12	16	73	87	False
30145633	We aimed to find the genetic cause of Korean patients with sensory motor polyneuropathy, myopathy and rigid spine.	find	myopathy	81501	HP_0003198	12	16	89	97	False
30145633	We found BAG3 mutation in one patient with neuropathy, myopathy and rigid spine syndrome, and performed electrophysiological study, whole body MRI and muscle biopsy on the patient.	BAG3	myopathy	9531	HP_0003198	9	13	55	63	True
30145633	We found BAG3 mutation in one patient with neuropathy, myopathy and rigid spine syndrome, and performed electrophysiological study, whole body MRI and muscle biopsy on the patient.	BAG3	neuropathy	9531	HP_0009830	9	13	43	53	True
30145633	A de novo heterozygous p.Pro209Leu (c.626C&gt;T) mutation in BAG3 was identified in a female myopathy.	BAG3	myopathy	9531	HP_0003198	61	65	93	101	True
30145633	She showed an axonal sensory-motor polyneuropathy like Charcot-Marie-Tooth disease (CMT), myopathy, rigid spine and respiratory dysfunction; however, she did not show any cardiomyopathy, which is a common symptom in BAG3 mutation.	BAG3	polyneuropathy	9531	HP_0001271	216	220	35	49	False
30145633	She showed an axonal sensory-motor polyneuropathy like Charcot-Marie-Tooth disease (CMT), myopathy, rigid spine and respiratory dysfunction; however, she did not show any cardiomyopathy, which is a common symptom in BAG3 mutation.	BAG3	myopathy	9531	HP_0003198	216	220	90	98	True
30145633	We described a BAG3 mutation patient with atypical phenotype of CMT and myopathy, and those are expected to broaden the clinical spectrum of the disease and help to diagnose it	BAG3	myopathy	9531	HP_0003198	15	19	72	80	True
23781959	Autosomal recessive CMT cases are generally characterized by earlier onset, usually before the age of 2 or 3 years, and rapid clinical progression that results in severe polyneuropathy and more marked distal limb deformities such as pes equino-varus, claw-like hands, and often major spinal deformities.	pes	neuropathy	23481	HP_0009830	233	236	174	184	False
23781959	Autosomal recessive CMT cases are generally characterized by earlier onset, usually before the age of 2 or 3 years, and rapid clinical progression that results in severe polyneuropathy and more marked distal limb deformities such as pes equino-varus, claw-like hands, and often major spinal deformities.	pes	spinal deformities	23481	HP_0008443	233	236	284	302	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	GDAP1	autosomal recessive	54332	HP_0000007	162	167	81	100	True
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	MTMR2	autosomal recessive	8898	HP_0000007	169	174	81	100	True
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	SBF2	autosomal recessive	81846	HP_0000007	176	180	81	100	True
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	NDRG1	autosomal recessive	10397	HP_0000007	182	187	81	100	True
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	EGR2	autosomal recessive	1959	HP_0000007	189	193	81	100	True
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	PRX	autosomal recessive	25824	HP_0000007	203	206	81	100	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	FGD4	autosomal recessive	121512	HP_0000007	208	212	81	100	True
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	FIG4	autosomal recessive	9896	HP_0000007	218	222	81	100	True
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	CMT4	autosomal recessive	54332	HP_0000007	269	273	81	100	True
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	LMNA	autosomal recessive	4000	HP_0000007	280	284	81	100	True
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	MED25	autosomal recessive	55090	HP_0000007	286	291	81	100	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	HINT1	autosomal recessive	3094	HP_0000007	293	298	81	100	True
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	LRSAM1	autosomal recessive	90678	HP_0000007	307	313	81	100	True
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	NEFL	autosomal recessive	4747	HP_0000007	315	319	81	100	True
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	HSPB1	autosomal recessive	3315	HP_0000007	321	326	81	100	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	MFN2	autosomal recessive	9927	HP_0000007	331	335	81	100	True
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	GDAP1	inheritance	54332	HP_0000005	162	167	101	112	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	MTMR2	inheritance	8898	HP_0000005	169	174	101	112	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	SBF2	inheritance	81846	HP_0000005	176	180	101	112	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	NDRG1	inheritance	10397	HP_0000005	182	187	101	112	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	EGR2	inheritance	1959	HP_0000005	189	193	101	112	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	PRX	inheritance	25824	HP_0000005	203	206	101	112	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	FGD4	inheritance	121512	HP_0000005	208	212	101	112	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	FIG4	inheritance	9896	HP_0000005	218	222	101	112	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	CMT4	inheritance	54332	HP_0000005	269	273	101	112	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	LMNA	inheritance	4000	HP_0000005	280	284	101	112	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	MED25	inheritance	55090	HP_0000005	286	291	101	112	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	HINT1	inheritance	3094	HP_0000005	293	298	101	112	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	LRSAM1	inheritance	90678	HP_0000005	307	313	101	112	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	NEFL	inheritance	4747	HP_0000005	315	319	101	112	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	HSPB1	inheritance	3315	HP_0000005	321	326	101	112	False
23781959	Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive inheritance allowed the identification of many genes such as GDAP1, MTMR2, SBF2, NDRG1, EGR2, SH3TC2, PRX, FGD4, and FIG4, implicated in demyelinating forms (ARCMT1 or CMT4), and LMNA, MED25, HINT1, GDAP1, LRSAM1, NEFL, HSPB1 and MFN2 in axonal forms (ARCMT2).	MFN2	inheritance	9927	HP_0000005	331	335	101	112	False
27840944	Differentiated embryo chondrocyte expressed gene1 (Dec1), a crucial cell differentiation mediator and apoptosis inhibitor, is abundantly expressed in various types of human cancer and is associated with malignant tumor progression.	Dec1	cancer	8553	HP_0002664	52	56	174	180	False
27840944	Differentiated embryo chondrocyte expressed gene1 (Dec1), a crucial cell differentiation mediator and apoptosis inhibitor, is abundantly expressed in various types of human cancer and is associated with malignant tumor progression.	Dec1	tumor	8553	HP_0002664	52	56	214	219	False
27840944	As poor differentiation and low apoptosis are closely associated with poor survival rates and a poor response to radio/chemotherapy in patients with cancer, the prognostic value of Dec1 expression was examined in the present study and its correlation with response to temozolomide (TMZ) chemotherapy was analyzed in patients with glioma.	Dec1	cancer	8553	HP_0002664	181	185	149	155	False
27840944	As poor differentiation and low apoptosis are closely associated with poor survival rates and a poor response to radio/chemotherapy in patients with cancer, the prognostic value of Dec1 expression was examined in the present study and its correlation with response to temozolomide (TMZ) chemotherapy was analyzed in patients with glioma.	Dec1	glioma	8553	HP_0009733	181	185	330	336	False
27840944	Dec1 expression was analyzed by immunohistochemistry in 157 samples of newly diagnosed glioma and 63 recurrent glioblastoma cases that relapsed during TMZ chemotherapy.	Dec1	glioma	8553	HP_0009733	0	4	87	93	False
27840944	Dec1 expression was analyzed by immunohistochemistry in 157 samples of newly diagnosed glioma and 63 recurrent glioblastoma cases that relapsed during TMZ chemotherapy.	Dec1	glioblastoma	8553	HP_0012174	0	4	111	123	False
27840944	Dec1 expression was also compared with the apoptosis index determined by TdTmediated dUTP nick endinglabeling assay in recurrent glioblastomas.	Dec1	glioblastoma	8553	HP_0012174	0	4	131	143	False
27840944	The antiglioma effect of TMZ in nude mice xenografts with Dec1 expression was examined invivo.	Dec1	glioma	8553	HP_0009733	58	62	8	14	False
27840944	The antiglioma effect of TMZ in nude mice xenografts with Dec1 expression was examined invivo.	nude	glioma	54820	HP_0009733	32	36	8	14	False
27840944	The antiglioma effect of TMZ in nude mice xenografts with Dec1 expression was examined invivo.	mice	glioma	23581	HP_0009733	37	41	8	14	False
27840944	High expression of Dec1, which was significantly associated with high pathological tumor grade and poor response to TMZ chemotherapy, was demonstrated to be an unfavorable independent prognostic factor and predicted poor survival in patients with newly diagnosed glioma.	Dec1	tumor	8553	HP_0002664	19	23	83	88	False
27840944	High expression of Dec1, which was significantly associated with high pathological tumor grade and poor response to TMZ chemotherapy, was demonstrated to be an unfavorable independent prognostic factor and predicted poor survival in patients with newly diagnosed glioma.	Dec1	glioma	8553	HP_0009733	19	23	263	269	False
27840944	In patients with recurrent glioblastoma, there was a negative correlation between Dec1 expression and the apoptotic index.	Dec1	glioblastoma	8553	HP_0012174	82	86	27	39	False
27665865	In this study, we enrolled 16individuals affected by tooth agenesis, prevalently hypodontia, and we carried out direct Sanger sequencing of paired box9(PAX9) and Msh homeobox1(MSX1) genes in 9subjects.	PAX9	hypodontia	5083	HP_0000668	155	159	82	92	False
27665865	In this study, we enrolled 16individuals affected by tooth agenesis, prevalently hypodontia, and we carried out direct Sanger sequencing of paired box9(PAX9) and Msh homeobox1(MSX1) genes in 9subjects.	Msh	hypodontia	4488	HP_0000668	165	168	82	92	False
27665865	In this study, we enrolled 16individuals affected by tooth agenesis, prevalently hypodontia, and we carried out direct Sanger sequencing of paired box9(PAX9) and Msh homeobox1(MSX1) genes in 9subjects.	MSX1	hypodontia	4487	HP_0000668	181	185	82	92	True
27665865	Overall, our study confirmed the major role played by WNT10A in tooth agenesis and the genetic heterogeneity of this disease.	WNT10A	heterogeneity	80326	HP_0001425	54	60	95	108	False
28190459	We show that morpholino-mediated inpp5k loss of function in the zebrafish results in shortened body axis, microphthalmia with disorganized lens, microcephaly, reduced touch-evoked motility, and highly disorganized myofibers.	inpp5k	microphthalmia	51763	HP_0000568	33	39	106	120	False
28190459	We show that morpholino-mediated inpp5k loss of function in the zebrafish results in shortened body axis, microphthalmia with disorganized lens, microcephaly, reduced touch-evoked motility, and highly disorganized myofibers.	inpp5k	microcephaly	51763	HP_0000252	33	39	145	157	True
28190459	Altogether these data demonstrate that mutations in INPP5K cause a congenital muscular dystrophy syndrome with short stature, cataracts, and intellectual disability	INPP5K	muscular dystrophy	51763	HP_0003560	52	58	78	96	True
28190459	Altogether these data demonstrate that mutations in INPP5K cause a congenital muscular dystrophy syndrome with short stature, cataracts, and intellectual disability	INPP5K	short stature	51763	HP_0004322	52	58	111	124	True
28190459	Altogether these data demonstrate that mutations in INPP5K cause a congenital muscular dystrophy syndrome with short stature, cataracts, and intellectual disability	INPP5K	cataracts	51763	HP_0000518	52	58	126	135	True
28980090	Cases were reviewed for consanguinity, sex, age at onset, death, clinical findings (including spasticity, seizures, psychomotor retardation, feeding difficulties, ectopia lentis, microcephaly), laboratory findings [urinary sulfite, S-sulfocysteine (in plasma and urine), plasma cystine, total homocysteine, uric acid, and oxypurines in urine] and radiological findings (including cerebral/cerebellar atrophy, cystic white matter changes, ventriculomegaly).	sex	spasticity	55558	HP_0001257	39	42	94	104	False
28980090	Cases were reviewed for consanguinity, sex, age at onset, death, clinical findings (including spasticity, seizures, psychomotor retardation, feeding difficulties, ectopia lentis, microcephaly), laboratory findings [urinary sulfite, S-sulfocysteine (in plasma and urine), plasma cystine, total homocysteine, uric acid, and oxypurines in urine] and radiological findings (including cerebral/cerebellar atrophy, cystic white matter changes, ventriculomegaly).	sex	seizures	55558	HP_0001250	39	42	106	114	False
28980090	Cases were reviewed for consanguinity, sex, age at onset, death, clinical findings (including spasticity, seizures, psychomotor retardation, feeding difficulties, ectopia lentis, microcephaly), laboratory findings [urinary sulfite, S-sulfocysteine (in plasma and urine), plasma cystine, total homocysteine, uric acid, and oxypurines in urine] and radiological findings (including cerebral/cerebellar atrophy, cystic white matter changes, ventriculomegaly).	sex	feeding difficulties	55558	HP_0011968	39	42	141	161	False
28980090	Cases were reviewed for consanguinity, sex, age at onset, death, clinical findings (including spasticity, seizures, psychomotor retardation, feeding difficulties, ectopia lentis, microcephaly), laboratory findings [urinary sulfite, S-sulfocysteine (in plasma and urine), plasma cystine, total homocysteine, uric acid, and oxypurines in urine] and radiological findings (including cerebral/cerebellar atrophy, cystic white matter changes, ventriculomegaly).	sex	ectopia lentis	55558	HP_0001083	39	42	163	177	False
28980090	Cases were reviewed for consanguinity, sex, age at onset, death, clinical findings (including spasticity, seizures, psychomotor retardation, feeding difficulties, ectopia lentis, microcephaly), laboratory findings [urinary sulfite, S-sulfocysteine (in plasma and urine), plasma cystine, total homocysteine, uric acid, and oxypurines in urine] and radiological findings (including cerebral/cerebellar atrophy, cystic white matter changes, ventriculomegaly).	sex	microcephaly	55558	HP_0000252	39	42	179	191	False
28980090	Cases were reviewed for consanguinity, sex, age at onset, death, clinical findings (including spasticity, seizures, psychomotor retardation, feeding difficulties, ectopia lentis, microcephaly), laboratory findings [urinary sulfite, S-sulfocysteine (in plasma and urine), plasma cystine, total homocysteine, uric acid, and oxypurines in urine] and radiological findings (including cerebral/cerebellar atrophy, cystic white matter changes, ventriculomegaly).	sex	cerebellar atrophy	55558	HP_0001272	39	42	389	407	False
20549361	Malonyl coenzyme A (CoA) decarboxylase (EC 4.1.1.9, MCD) deficiency, or malonic aciduria, is a rare inborn error of metabolism characterised by a variable phenotype of developmental delay, seizures, cardiomyopathy and acidosis.	MCD	developmental delay	23417	HP_0001263	52	55	168	187	True
20549361	Malonyl coenzyme A (CoA) decarboxylase (EC 4.1.1.9, MCD) deficiency, or malonic aciduria, is a rare inborn error of metabolism characterised by a variable phenotype of developmental delay, seizures, cardiomyopathy and acidosis.	MCD	seizures	23417	HP_0001250	52	55	189	197	True
20549361	Malonyl coenzyme A (CoA) decarboxylase (EC 4.1.1.9, MCD) deficiency, or malonic aciduria, is a rare inborn error of metabolism characterised by a variable phenotype of developmental delay, seizures, cardiomyopathy and acidosis.	MCD	cardiomyopathy	23417	HP_0001638	52	55	199	213	True
20549361	This case of malonic aciduria with cardiomyopathy demonstrates improvement in cardiac function attributable to LCT-restricted/MCT-supplemented diet	LCT	cardiomyopathy	3938	HP_0001638	111	114	35	49	False
20549361	This case of malonic aciduria with cardiomyopathy demonstrates improvement in cardiac function attributable to LCT-restricted/MCT-supplemented diet	MCT	cardiomyopathy	27349	HP_0001638	126	129	35	49	False
29053855	In summary, our results reveal that rare loss-of-function variants in GABRA3 increase the risk for a varying combination of epilepsy, intellectual disability/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern	GABRA3	intellectual disability	2556	HP_0001249	70	76	134	157	False
29053855	In summary, our results reveal that rare loss-of-function variants in GABRA3 increase the risk for a varying combination of epilepsy, intellectual disability/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern	GABRA3	developmental delay	2556	HP_0001263	70	76	158	177	False
29053855	In summary, our results reveal that rare loss-of-function variants in GABRA3 increase the risk for a varying combination of epilepsy, intellectual disability/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern	GABRA3	epilepsy	2556	HP_0001250	70	76	124	132	False
30104180	Owing to the lack of universal and specific tumor markers for neuroblastoma (NB), in this prospective study, we adopted an EpCAM-independent method to detect CTCs in the peripheral blood of NB patients.	EpCAM	tumor	4072	HP_0002664	123	128	44	49	True
30104180	Owing to the lack of universal and specific tumor markers for neuroblastoma (NB), in this prospective study, we adopted an EpCAM-independent method to detect CTCs in the peripheral blood of NB patients.	per	tumor	93210	HP_0002664	170	173	44	49	False
30104180	Owing to the lack of universal and specific tumor markers for neuroblastoma (NB), in this prospective study, we adopted an EpCAM-independent method to detect CTCs in the peripheral blood of NB patients.	EpCAM	neuroblastoma	4072	HP_0003006	123	128	62	75	True
30104180	Owing to the lack of universal and specific tumor markers for neuroblastoma (NB), in this prospective study, we adopted an EpCAM-independent method to detect CTCs in the peripheral blood of NB patients.	per	neuroblastoma	93210	HP_0003006	170	173	62	75	False
23564352	We originally discovered TERE1 as a potential tumor suppressor protein based upon reduced expression in bladder and prostate cancer specimens and growth inhibition of tumor cell lines/xenografts upon ectopic expression.	TERE1	tumor	29914	HP_0002664	25	30	46	51	False
23564352	We originally discovered TERE1 as a potential tumor suppressor protein based upon reduced expression in bladder and prostate cancer specimens and growth inhibition of tumor cell lines/xenografts upon ectopic expression.	TERE1	cancer	29914	HP_0002664	25	30	125	131	False
23564352	Vitamin K-2 is involved in mitochondrial electron transport, SXR nuclear hormone receptor signaling and redox cycling: together these functions may form the basis for tumor suppressor function.	SXR	tumor	8856	HP_0002664	61	64	167	172	False
23564352	A TERE1-TBL2 complex likely functions in oxidative/nitrosative stress, lipid metabolism, and SXR signaling pathways in its role as a tumor suppressor	TERE1	tumor	29914	HP_0002664	2	7	133	138	False
23564352	A TERE1-TBL2 complex likely functions in oxidative/nitrosative stress, lipid metabolism, and SXR signaling pathways in its role as a tumor suppressor	SXR	tumor	8856	HP_0002664	93	96	133	138	False
23564352	A TERE1-TBL2 complex likely functions in oxidative/nitrosative stress, lipid metabolism, and SXR signaling pathways in its role as a tumor suppressor	TBL2	tumor	26608	HP_0002664	8	12	133	138	False
30272273	In OSCC samples, a high GLI3 expression was associated with tumour size but not with prognosis.	GLI3	tumour	2737	HP_0002664	24	28	60	66	True
27837419	The clinical history for migraine and hypertension was collected; genomic DNA was characterized for a panel of 33 SNPs encoding proteins involved in ionic transport.	act	hypertension	11332	HP_0000822	86	89	38	50	False
29185864	Molecular diagnosis is consistent with the genetic heterogeneity of the HPRT1 gene responsible for HGprt deficiency.	HGprt	heterogeneity	3251	HP_0001425	99	104	51	64	False
29185864	Molecular diagnosis is consistent with the genetic heterogeneity of the HPRT1 gene responsible for HGprt deficiency.	HPRT1	heterogeneity	3251	HP_0001425	72	77	51	64	False
26315306	Our results demonstrated that SelM may have an important role in protecting against oxidative damage in the brain of chicken, which might shed light on the role of SelM in human neurodegenerative disease.	damage	neurodegenerative disease	51438	HP_0002180	94	100	178	203	False
26315306	Our results demonstrated that SelM may have an important role in protecting against oxidative damage in the brain of chicken, which might shed light on the role of SelM in human neurodegenerative disease.	light	neurodegenerative disease	8740	HP_0002180	143	148	178	203	False
27068579	Although there are nearly 100 different causative genes identified for nonsyndromic hearing loss (NSHL), Sanger sequencing-based DNA diagnostics usually only analyses three, namely, GJB2, SLC26A4, and OTOF.	GJB2	hearing loss	2706	HP_0000365	182	186	84	96	True
27068579	Although there are nearly 100 different causative genes identified for nonsyndromic hearing loss (NSHL), Sanger sequencing-based DNA diagnostics usually only analyses three, namely, GJB2, SLC26A4, and OTOF.	SLC26A4	hearing loss	5172	HP_0000365	188	195	84	96	True
30208623	The aberrant activation of STAT3 contributes to several human diseases, particularly cancer.	STAT3	cancer	6774	HP_0002664	27	32	85	91	True
30680848	MIR22HG is an lncRNA that contributes to the initiation and progression of many human cancers, including hepatocellular carcinoma (HCC).	HCC	hepatocellular carcinoma	84668	HP_0001402	131	134	105	129	False
30680848	We report that MIR22HG was downregulated in 120 HCC samples compared with adjacent nontumor liver tissues.	HCC	tumor	84668	HP_0002664	48	51	86	91	False
25804400	Our results provide evidence that sequence variants in human SIPA1L3 cause autosomal recessive isolated CC and give new insight into the molecular pathogenesis underlying human cataracts.	SIPA1L3	cataract	23094	HP_0000518	61	68	177	185	True
25804400	Our results provide evidence that sequence variants in human SIPA1L3 cause autosomal recessive isolated CC and give new insight into the molecular pathogenesis underlying human cataracts.	SIPA1L3	autosomal recessive	23094	HP_0000007	61	68	75	94	True
25192513	Cerebellar involvement is an important feature of PMM2-CDG, the congenital muscular dystrophies due to dystroglycanopathy, and SRD5A3-CDG.	PMM2	muscular dystrophies	5373	HP_0003560	50	54	75	95	False
25192513	Cerebellar involvement is an important feature of PMM2-CDG, the congenital muscular dystrophies due to dystroglycanopathy, and SRD5A3-CDG.	SRD5A3	muscular dystrophies	79644	HP_0003560	127	133	75	95	False
29084941	TGFBR3-PLAG1 promotes a tumorigenic phenotype in vitro, and is absent in 723 other salivary gland tumors.	PLAG1	tumors	5324	HP_0002664	7	12	98	104	True
29084941	TGFBR3-PLAG1 promotes a tumorigenic phenotype in vitro, and is absent in 723 other salivary gland tumors.	TGFBR3	tumors	7049	HP_0002664	0	6	98	104	False
29084941	TGFBR3-PLAG1 promotes a tumorigenic phenotype in vitro, and is absent in 723 other salivary gland tumors.	PLAG1	tumor	5324	HP_0002664	7	12	24	29	True
29084941	TGFBR3-PLAG1 promotes a tumorigenic phenotype in vitro, and is absent in 723 other salivary gland tumors.	TGFBR3	tumor	7049	HP_0002664	0	6	24	29	False
30226971	GRACILE Syndrome, is an autosomal recessive disease presenting with growth retardation, severe lactic acidosis, Fanconi type tubulopathy, cholestasis, iron overload and early death without any dysmorphological or neurological features.	type	autosomal recessive	6445	HP_0000007	120	124	24	43	True
30226971	GRACILE Syndrome, is an autosomal recessive disease presenting with growth retardation, severe lactic acidosis, Fanconi type tubulopathy, cholestasis, iron overload and early death without any dysmorphological or neurological features.	type	lactic acidosis	6445	HP_0003128	120	124	95	110	False
28401061	Transcription factors (TFs) are major cell fate regulators frequently involved in cancer, particularly in leukemia.	fate	cancer	89885	HP_0002664	43	47	82	88	False
28401061	Transcription factors (TFs) are major cell fate regulators frequently involved in cancer, particularly in leukemia.	fact	cancer	11198	HP_0002664	14	18	82	88	False
28401061	In humans, <i>GFI1</i> mutations are associated with severe congenital neutropenia.	GFI1	neutropenia	2672	HP_0001875	14	18	71	82	True
28401061	In keeping with this key role in cell fate, <i>GFI1B</i> is emerging as a gene involved in cancer, which also includes solid tumors.	fate	cancer	89885	HP_0002664	38	42	91	97	False
28401061	In keeping with this key role in cell fate, <i>GFI1B</i> is emerging as a gene involved in cancer, which also includes solid tumors.	GFI1B	cancer	8328	HP_0002664	47	52	91	97	True
28401061	In keeping with this key role in cell fate, <i>GFI1B</i> is emerging as a gene involved in cancer, which also includes solid tumors.	fate	tumors	89885	HP_0002664	38	42	125	131	False
28401061	In keeping with this key role in cell fate, <i>GFI1B</i> is emerging as a gene involved in cancer, which also includes solid tumors.	GFI1B	tumors	8328	HP_0002664	47	52	125	131	True
28401061	In fact, abnormal activation of <i>GFI1B</i> and <i>GFI1</i> has been related to human medulloblastoma and is also likely to be relevant in blood malignancies.	GFI1B	medulloblastoma	8328	HP_0002885	35	40	87	102	False
28401061	In fact, abnormal activation of <i>GFI1B</i> and <i>GFI1</i> has been related to human medulloblastoma and is also likely to be relevant in blood malignancies.	GFI1	medulloblastoma	2672	HP_0002885	52	56	87	102	False
28401061	In fact, abnormal activation of <i>GFI1B</i> and <i>GFI1</i> has been related to human medulloblastoma and is also likely to be relevant in blood malignancies.	fact	medulloblastoma	11198	HP_0002885	3	7	87	102	False
25865301	The autosomal recessive disease propionic acidemia (PA) is an inborn error of metabolism with highly variable clinical manifestations, caused by a deficiency of propionyl-CoA carboxylase (PCC) enzyme, due to mutations in either PCCA or PCCB genes, which encode the alpha and beta subunits of the PCC enzyme, respectively.	PCCA	autosomal recessive	5095	HP_0000007	228	232	4	23	True
25865301	The autosomal recessive disease propionic acidemia (PA) is an inborn error of metabolism with highly variable clinical manifestations, caused by a deficiency of propionyl-CoA carboxylase (PCC) enzyme, due to mutations in either PCCA or PCCB genes, which encode the alpha and beta subunits of the PCC enzyme, respectively.	PCCB	autosomal recessive	5096	HP_0000007	236	240	4	23	True
28474749	Germline SMARCE1 mutations have been described in hereditary forms of this disease and more recently in small syndromic and sporadic CCM series.	SMARCE1	sporadic	6605	HP_0003745	9	16	124	132	False
28474749	The diagnostic value of SMARCE1 in distinguishing between CCM and other meningioma variants has not been yet established.	SMARCE1	meningioma	6605	HP_0002858	24	31	72	82	False
28474749	We then validated the anti-SMARCE1 antibody specificity by analyzing additional 305 pediatric and adult meningiomas of various subtypes and 15 non-meningioma clear cell tumors by SMARCE1 immunohistochemistry.	SMARCE1	meningioma	6605	HP_0002858	27	34	104	114	False
28474749	We then validated the anti-SMARCE1 antibody specificity by analyzing additional 305 pediatric and adult meningiomas of various subtypes and 15 non-meningioma clear cell tumors by SMARCE1 immunohistochemistry.	SMARCE1	tumors	6605	HP_0002664	27	34	169	175	False
27374774	We provide functional evidence to support the pathogenicity of these TMEM126B variants, including evidence of founder effects for both variants, and establish defects within this gene as a cause of complex I deficiency in association with either pure myopathy in adulthood or, in one individual, a severe multisystem presentation (chronic renal failure andcardiomyopathy) in infancy.	TMEM126B	renal failure	55863	HP_0000083	69	77	339	352	False
28436984	Mendelian randomization analyses suggest causal inverse associations, independent of body mass index (BMI), between puberty timing and risks for breast and endometrial cancers in women and prostate cancer in men.	mass	cancer	2200	HP_0002664	90	94	168	174	False
22134107	As a result, patients with LAD suffer from severe bacterial infections and impaired wound healing, accompanied by neutrophilia.	LAD	neutrophilia	1738	HP_0011897	27	30	114	126	False
29341460	In 2009, four families with a distal duplication of Xq28 not including MECP2 and mediated by low-copy repeats (LCRs) designated &quot;K&quot; and &quot;L&quot; were reported with intellectual disability and epilepsy.	MECP2	intellectual disability	4204	HP_0001249	71	76	179	202	True
29341460	In 2009, four families with a distal duplication of Xq28 not including MECP2 and mediated by low-copy repeats (LCRs) designated &quot;K&quot; and &quot;L&quot; were reported with intellectual disability and epilepsy.	MECP2	epilepsy	4204	HP_0001250	71	76	207	215	True
25954032	Adolescent idiopathic scoliosis (AIS) and pectus excavatum (PE) are common pediatric musculoskeletal disorders.	AIS	scoliosis	231	HP_0002650	33	36	22	31	False
25954032	Adolescent idiopathic scoliosis (AIS) and pectus excavatum (PE) are common pediatric musculoskeletal disorders.	AIS	pectus excavatum	231	HP_0000767	33	36	42	58	False
25954032	Microtomographic and x-ray studies revealed several hallmarks of AIS, including postnatal onset of scoliosis without malformations of vertebral units.	AIS	scoliosis	231	HP_0002650	65	68	99	108	False
26614431	The SNPs rs2124437 (RASGRP3), rs1335022 (GRIK2), rs4512367 (PREX2), rs4748011 (CCDC3), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral cancers and 500 healthy controls with a minimum of 10years of tobacco usage.	RASGRP3	cancer	25780	HP_0002664	20	27	164	170	False
26614431	The SNPs rs2124437 (RASGRP3), rs1335022 (GRIK2), rs4512367 (PREX2), rs4748011 (CCDC3), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral cancers and 500 healthy controls with a minimum of 10years of tobacco usage.	GRIK2	cancer	2901	HP_0002664	41	46	164	170	False
26614431	The SNPs rs2124437 (RASGRP3), rs1335022 (GRIK2), rs4512367 (PREX2), rs4748011 (CCDC3), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral cancers and 500 healthy controls with a minimum of 10years of tobacco usage.	PREX2	cancer	80243	HP_0002664	60	65	164	170	False
26614431	The SNPs rs2124437 (RASGRP3), rs1335022 (GRIK2), rs4512367 (PREX2), rs4748011 (CCDC3), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral cancers and 500 healthy controls with a minimum of 10years of tobacco usage.	CCDC3	cancer	83643	HP_0002664	79	84	164	170	False
26614431	The SNPs rs2124437 (RASGRP3), rs1335022 (GRIK2), rs4512367 (PREX2), rs4748011 (CCDC3), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral cancers and 500 healthy controls with a minimum of 10years of tobacco usage.	LNX1	cancer	84708	HP_0002664	102	106	164	170	False
26614431	A significant association of the SNPs in oral cancer was observed in RASGRP3 AA (rs2124437) (p&lt;0.000, OR 1.34, 95% confidence interval (CI) 1.01-1.76), GRIK2 TT (rs1335022) (p=0.008, OR 1.58, 95% CI 1.23-2.03), PREX2 CC (p=0.008, OR 1.56, 95% CI 1.15-2.1), and TT (p&lt;0.000, OR 2.77, 1.68-4.57) genotypes, whereas the heterozygous genotypes showed higher frequencies in controls, i.e., GRIK2 CT (rs1335022) (p=0.029, OR 0.68, 95% CI 0.53-0.87) and PREX2 CT (p=0.004, OR 0.49, 95% CI 0.37-0.64), indicating protection.	RASGRP3	cancer	25780	HP_0002664	69	76	46	52	False
26614431	A significant association of the SNPs in oral cancer was observed in RASGRP3 AA (rs2124437) (p&lt;0.000, OR 1.34, 95% confidence interval (CI) 1.01-1.76), GRIK2 TT (rs1335022) (p=0.008, OR 1.58, 95% CI 1.23-2.03), PREX2 CC (p=0.008, OR 1.56, 95% CI 1.15-2.1), and TT (p&lt;0.000, OR 2.77, 1.68-4.57) genotypes, whereas the heterozygous genotypes showed higher frequencies in controls, i.e., GRIK2 CT (rs1335022) (p=0.029, OR 0.68, 95% CI 0.53-0.87) and PREX2 CT (p=0.004, OR 0.49, 95% CI 0.37-0.64), indicating protection.	GRIK2	cancer	2901	HP_0002664	158	163	46	52	False
26614431	A significant association of the SNPs in oral cancer was observed in RASGRP3 AA (rs2124437) (p&lt;0.000, OR 1.34, 95% confidence interval (CI) 1.01-1.76), GRIK2 TT (rs1335022) (p=0.008, OR 1.58, 95% CI 1.23-2.03), PREX2 CC (p=0.008, OR 1.56, 95% CI 1.15-2.1), and TT (p&lt;0.000, OR 2.77, 1.68-4.57) genotypes, whereas the heterozygous genotypes showed higher frequencies in controls, i.e., GRIK2 CT (rs1335022) (p=0.029, OR 0.68, 95% CI 0.53-0.87) and PREX2 CT (p=0.004, OR 0.49, 95% CI 0.37-0.64), indicating protection.	PREX2	cancer	80243	HP_0002664	220	225	46	52	False
26751395	A rare syndromic form of intellectual disability with impaired speech was recently found associated with mutations in CHAMP1 (chromosome alignment-maintaining phosphoprotein 1), the protein product of which is directly involved in microtubule-kinetochore attachment.	CHAMP1	intellectual disability	283489	HP_0001249	118	124	25	48	True
26751395	Through whole-exome sequencing in six unrelated nonconsanguineous families having a sporadic case of intellectual disability, we identified six novel de novo truncating mutations in CHAMP1: c.1880C&gt;G p.(Ser627*), c.1489C&gt;T; p.(Arg497*), c.1876_1877delAG; p.(Ser626Leufs*4), c.1043G&gt;A; p.(Trp348*), c.1002G&gt;A; p.(Trp334*), and c.958_959delCC; p.(Pro320*).	CHAMP1	intellectual disability	283489	HP_0001249	182	188	101	124	True
26751395	Through whole-exome sequencing in six unrelated nonconsanguineous families having a sporadic case of intellectual disability, we identified six novel de novo truncating mutations in CHAMP1: c.1880C&gt;G p.(Ser627*), c.1489C&gt;T; p.(Arg497*), c.1876_1877delAG; p.(Ser626Leufs*4), c.1043G&gt;A; p.(Trp348*), c.1002G&gt;A; p.(Trp334*), and c.958_959delCC; p.(Pro320*).	CHAMP1	sporadic	283489	HP_0003745	182	188	84	92	False
26751395	These data suggest a pathogenic mechanism of the CHAMP1-associated intellectual disability syndrome mediated by direct interacting partners of CHAMP1, several of which are involved in chromo/kinetochore-related disorders.	CHAMP1	intellectual disability	283489	HP_0001249	49	55	67	90	True
30306202	Dendritic cell (DC)-based immunotherapies have been created for a broad expanse of cancers, and DC vaccines prepared with Wilms' tumor protein 1 (WT1) peptides have shown great therapeutic efficacy in these diseases.	great	tumor	122042	HP_0002664	171	176	129	134	False
30306202	Dendritic cell (DC)-based immunotherapies have been created for a broad expanse of cancers, and DC vaccines prepared with Wilms' tumor protein 1 (WT1) peptides have shown great therapeutic efficacy in these diseases.	DC	tumor	1641	HP_0002664	16	18	129	134	False
30306202	Dendritic cell (DC)-based immunotherapies have been created for a broad expanse of cancers, and DC vaccines prepared with Wilms' tumor protein 1 (WT1) peptides have shown great therapeutic efficacy in these diseases.	WT1	tumor	7490	HP_0002664	146	149	129	134	True
30306202	Dendritic cell (DC)-based immunotherapies have been created for a broad expanse of cancers, and DC vaccines prepared with Wilms' tumor protein 1 (WT1) peptides have shown great therapeutic efficacy in these diseases.	great	cancer	122042	HP_0002664	171	176	83	89	False
30306202	Dendritic cell (DC)-based immunotherapies have been created for a broad expanse of cancers, and DC vaccines prepared with Wilms' tumor protein 1 (WT1) peptides have shown great therapeutic efficacy in these diseases.	DC	cancer	1641	HP_0002664	16	18	83	89	False
30306202	Dendritic cell (DC)-based immunotherapies have been created for a broad expanse of cancers, and DC vaccines prepared with Wilms' tumor protein 1 (WT1) peptides have shown great therapeutic efficacy in these diseases.	WT1	cancer	7490	HP_0002664	146	149	83	89	True
30306202	In this paper, we report the results of a phase I/II study of a DC-based vaccination for advanced breast, ovarian, and gastric cancers, and we offer evidence that patients can be effectively vaccinated with autologous DCs pulsed with WT1 peptide.	DC	gastric cancers	1641	HP_0012126	64	66	119	134	False
30306202	In this paper, we report the results of a phase I/II study of a DC-based vaccination for advanced breast, ovarian, and gastric cancers, and we offer evidence that patients can be effectively vaccinated with autologous DCs pulsed with WT1 peptide.	WT1	gastric cancers	7490	HP_0012126	234	237	119	134	False
25683699	X-linked Myopathy with Excessive Autophagy (XMEA) affects proximal muscles of the lower extremities and follows a progressive course reminiscent of muscular dystrophy.	XMEA	muscular dystrophy	203547	HP_0003560	44	48	148	166	False
29061346	Over 140 disease-causing mutations have been described so far in GUCY2D, 88% of which cause autosomal recessive Leber congenital amaurosis (LCA) while heterozygous missense mutations cause autosomal dominant cone-rod degeneration (adCRD).	GUCY2D	autosomal recessive	3000	HP_0000007	65	71	92	111	True
29061346	Over 140 disease-causing mutations have been described so far in GUCY2D, 88% of which cause autosomal recessive Leber congenital amaurosis (LCA) while heterozygous missense mutations cause autosomal dominant cone-rod degeneration (adCRD).	LCA	autosomal recessive	1211	HP_0000007	140	143	92	111	False
29061346	Over 140 disease-causing mutations have been described so far in GUCY2D, 88% of which cause autosomal recessive Leber congenital amaurosis (LCA) while heterozygous missense mutations cause autosomal dominant cone-rod degeneration (adCRD).	CRD	autosomal recessive	1406	HP_0000007	233	236	92	111	True
29303507	Recurrence and metastasis are major challenges in the management of hepatocellular carcinoma (HCC) patients after resection.	HCC	hepatocellular carcinoma	84668	HP_0001402	94	97	68	92	False
29303507	TCIRG1 knockdown suppressed tumor cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, Snail and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.	HCC	tumor	84668	HP_0002664	67	70	28	33	False
29303507	TCIRG1 knockdown suppressed tumor cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, Snail and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.	TCIRG1	tumor	10312	HP_0002664	0	6	28	33	False
29303507	TCIRG1 knockdown suppressed tumor cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, Snail and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.	EMT	tumor	3702	HP_0002664	307	310	28	33	True
29303507	TCIRG1 knockdown suppressed tumor cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, Snail and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.	cadherin	tumor	1015	HP_0002664	334	342	28	33	False
29303507	TCIRG1 knockdown suppressed tumor cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, Snail and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.	Snail	tumor	6615	HP_0002664	369	374	28	33	False
29303507	TCIRG1 knockdown suppressed tumor cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, Snail and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.	Slug	tumor	6591	HP_0002664	379	383	28	33	True
30305727	Hsp90ab1 is upregulated in numerous solid tumors, which is thought to induce the angiogenesis and promote cancer metastasis.	Hsp90ab1	tumors	3326	HP_0002664	0	8	42	48	False
30305727	Hsp90ab1 is upregulated in numerous solid tumors, which is thought to induce the angiogenesis and promote cancer metastasis.	Hsp90ab1	cancer	3326	HP_0002664	0	8	106	112	False
30176312	Several studies have investigated single nucleotide polymorphisms (SNPs) in a number of genes associated with the susceptibility to or severity and outcome of community-acquired pneumonia (CAP), but no research has yet been conducted on the role of IRF5 gene polymorphisms in CAP.	IRF5	pneumonia	3663	HP_0002090	249	253	178	187	False
30176312	Several studies have investigated single nucleotide polymorphisms (SNPs) in a number of genes associated with the susceptibility to or severity and outcome of community-acquired pneumonia (CAP), but no research has yet been conducted on the role of IRF5 gene polymorphisms in CAP.	CAP	pneumonia	23476	HP_0002090	189	192	178	187	False
29977031	Schnyder corneal dystrophy (SCD) is a rare autosomal dominant disease in humans, characterized by abnormal deposition of cholesterol and phospholipids in cornea caused by mutations in the UbiA prenyltransferase domain containing 1 (UBIAD1) gene.	SCD	corneal dystrophy	6584	HP_0001131	28	31	9	26	False
29977031	Schnyder corneal dystrophy (SCD) is a rare autosomal dominant disease in humans, characterized by abnormal deposition of cholesterol and phospholipids in cornea caused by mutations in the UbiA prenyltransferase domain containing 1 (UBIAD1) gene.	UBIAD1	corneal dystrophy	29914	HP_0001131	232	238	9	26	True
28913623	The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include SPINK5, ERCC2, ERCC3, GTF2H5, MPLKIP, ST14, CLDN1 and MBTPS2.	SPINK5	hair abnormalities	11005	HP_0001595	106	112	79	97	True
28913623	The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include SPINK5, ERCC2, ERCC3, GTF2H5, MPLKIP, ST14, CLDN1 and MBTPS2.	ERCC2	hair abnormalities	2068	HP_0001595	114	119	79	97	True
28913623	The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include SPINK5, ERCC2, ERCC3, GTF2H5, MPLKIP, ST14, CLDN1 and MBTPS2.	ERCC3	hair abnormalities	2071	HP_0001595	121	126	79	97	True
28913623	The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include SPINK5, ERCC2, ERCC3, GTF2H5, MPLKIP, ST14, CLDN1 and MBTPS2.	GTF2H5	hair abnormalities	404672	HP_0001595	128	134	79	97	True
28913623	The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include SPINK5, ERCC2, ERCC3, GTF2H5, MPLKIP, ST14, CLDN1 and MBTPS2.	MPLKIP	hair abnormalities	136647	HP_0001595	136	142	79	97	True
28913623	The known pathogenic molecules involved in ichthyosis syndromes with prominent hair abnormalities include SPINK5, ERCC2, ERCC3, GTF2H5, MPLKIP, ST14, CLDN1 and MBTPS2.	CLDN1	hair abnormalities	9076	HP_0001595	150	155	79	97	True
29322514	A growing body of literature indicates that YY1 is overexpressed in multiple cancer types and that increased YY1 levels correlate with poor clinical outcomes in many cancers.	type	cancer	6445	HP_0002664	84	88	77	83	False
29322514	However, the role of YY1 in the promotion or suppression of tumor growth remains controversial and its regulatory effects may be tumor cell type dependent at least in experimental systems.	type	tumor	6445	HP_0002664	140	144	60	65	False
29322514	This review highlights recent advances in our understanding of regulatory insights involving YY1 function in a range of cancer types.	type	cancer	6445	HP_0002664	127	131	120	126	False
29322514	For example, YY1's roles in tumor growth involve stabilization of hypoxia-inducible factor HIF-1 in a p53 independent manner, negative regulation of miR-9 transcription, control of MYCT1 transcription, a novel miR-193a-5p-YY1-APC axis, intracellular ROS and mitochondrial superoxide generation, p53 reduction and EGFR activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving miR-7, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.	MYCT1	tumor	80177	HP_0002664	182	187	28	33	False
29322514	For example, YY1's roles in tumor growth involve stabilization of hypoxia-inducible factor HIF-1 in a p53 independent manner, negative regulation of miR-9 transcription, control of MYCT1 transcription, a novel miR-193a-5p-YY1-APC axis, intracellular ROS and mitochondrial superoxide generation, p53 reduction and EGFR activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving miR-7, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.	ROS	tumor	6098	HP_0002664	251	254	28	33	False
29322514	For example, YY1's roles in tumor growth involve stabilization of hypoxia-inducible factor HIF-1 in a p53 independent manner, negative regulation of miR-9 transcription, control of MYCT1 transcription, a novel miR-193a-5p-YY1-APC axis, intracellular ROS and mitochondrial superoxide generation, p53 reduction and EGFR activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving miR-7, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.	EGFR	tumor	1956	HP_0002664	314	318	28	33	True
29322514	For example, YY1's roles in tumor growth involve stabilization of hypoxia-inducible factor HIF-1 in a p53 independent manner, negative regulation of miR-9 transcription, control of MYCT1 transcription, a novel miR-193a-5p-YY1-APC axis, intracellular ROS and mitochondrial superoxide generation, p53 reduction and EGFR activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving miR-7, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.	miR-7	tumor	10859	HP_0002664	436	441	28	33	False
29322514	On the other hand, tumor suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor BRCA1, increased Bax transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and cdk4, reduced expression of long noncoding RNA of SOX2 overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.	BRCA1	tumor	672	HP_0002664	103	108	19	24	True
29322514	On the other hand, tumor suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor BRCA1, increased Bax transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and cdk4, reduced expression of long noncoding RNA of SOX2 overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.	Bax	tumor	581	HP_0002664	120	123	19	24	False
29322514	On the other hand, tumor suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor BRCA1, increased Bax transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and cdk4, reduced expression of long noncoding RNA of SOX2 overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.	cdk4	tumor	1019	HP_0002664	308	312	19	24	True
29322514	On the other hand, tumor suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor BRCA1, increased Bax transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and cdk4, reduced expression of long noncoding RNA of SOX2 overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.	SOX2	tumor	6657	HP_0002664	358	362	19	24	True
29322514	YY1 expression is associated with that of cancer stem cell markers SOX2, BMI1 and OCT4 across many cancers suggesting multidynamic regulatory control and groups of cancers with distinct molecular signatures.	SOX2	cancer	6657	HP_0002664	67	71	42	48	True
29322514	YY1 expression is associated with that of cancer stem cell markers SOX2, BMI1 and OCT4 across many cancers suggesting multidynamic regulatory control and groups of cancers with distinct molecular signatures.	BMI1	cancer	648	HP_0002664	73	77	42	48	False
29322514	YY1 expression is associated with that of cancer stem cell markers SOX2, BMI1 and OCT4 across many cancers suggesting multidynamic regulatory control and groups of cancers with distinct molecular signatures.	OCT4	cancer	5460	HP_0002664	82	86	42	48	False
28816234	Human autosomal recessive osteopetrosis (ARO), also known as infantile malignant osteopetrosis, is a rare genetic bone disorder that often causes death.	ARO	autosomal recessive	1588	HP_0000007	41	44	6	25	True
27312022	Mutations in CAV3 lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal myopathy and isolated hyperCKemia.	CAV3	limb girdle muscular dystrophy	859	HP_0006785	13	17	91	121	False
27312022	Mutations in CAV3 lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal myopathy and isolated hyperCKemia.	type	limb girdle muscular dystrophy	6445	HP_0006785	53	57	91	121	False
27312022	Mutations in CAV3 lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal myopathy and isolated hyperCKemia.	LGMD1C	limb girdle muscular dystrophy	859	HP_0006785	131	137	91	121	False
27312022	Mutations in CAV3 lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal myopathy and isolated hyperCKemia.	CAV3	distal	859	HP_0012839	13	17	165	171	False
27312022	Mutations in CAV3 lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal myopathy and isolated hyperCKemia.	type	distal	6445	HP_0012839	53	57	165	171	False
27312022	Mutations in CAV3 lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal myopathy and isolated hyperCKemia.	LGMD1C	distal	859	HP_0012839	131	137	165	171	False
27312022	Mutations in CAV3 lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal myopathy and isolated hyperCKemia.	CAV3	myopathy	859	HP_0003198	13	17	172	180	True
27312022	Mutations in CAV3 lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal myopathy and isolated hyperCKemia.	type	myopathy	6445	HP_0003198	53	57	172	180	True
27312022	Mutations in CAV3 lead to various neuromuscular phenotypes with partial overlap, including limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal myopathy and isolated hyperCKemia.	LGMD1C	myopathy	859	HP_0003198	131	137	172	180	True
27312022	Here we present a series of eight patients from seven families presenting with exercise intolerance and rhabdomyolysis caused by mutations in CAV3 diagnosed by next generation sequencing (NGS) (n=6).	CAV3	rhabdomyolysis	859	HP_0003201	142	146	104	118	False
27312022	This case series demonstrates that exercise intolerance, myalgia and rhabdomyolysis may be caused by CAV3 mutations and broadens the phenotypic spectrum of caveolinopathies.	CAV3	rhabdomyolysis	859	HP_0003201	101	105	69	83	False
27485451	Somatic missense mutations in the Ser/Thr protein phosphatase 2A (PP2A) A scaffold subunit gene PPP2R1A are among the few genomic alterations that occur frequently in serous endometrial carcinoma (EC) and carcinosarcoma, two clinically aggressive subtypes of uterine cancer with few therapeutic options.	PPP2R1A	endometrial carcinoma	5518	HP_0012114	97	104	175	196	False
27485451	Somatic missense mutations in the Ser/Thr protein phosphatase 2A (PP2A) A scaffold subunit gene PPP2R1A are among the few genomic alterations that occur frequently in serous endometrial carcinoma (EC) and carcinosarcoma, two clinically aggressive subtypes of uterine cancer with few therapeutic options.	PPP2R1A	cancer	5518	HP_0002664	97	104	268	274	False
27485451	Accordingly, overexpression of the A mutants in EC cells harboring wild-type PPP2R1A increased anchorage-independent growth and tumor formation, and triggered hyperphosphorylation of oncogenic PP2A-B56/B' substrates in the GSK3, Akt, and mTOR/p70S6K signaling pathways.	PPP2R1A	tumor	5518	HP_0002664	78	85	129	134	False
27485451	Accordingly, overexpression of the A mutants in EC cells harboring wild-type PPP2R1A increased anchorage-independent growth and tumor formation, and triggered hyperphosphorylation of oncogenic PP2A-B56/B' substrates in the GSK3, Akt, and mTOR/p70S6K signaling pathways.	Akt	tumor	207	HP_0002664	231	234	129	134	True
30592286	miR498 overexpression induced cell cycle arrest and apoptosis while it suppressed epithelialmesenchymal transition (EMT) in liver cancer cells.	EMT	cancer	3702	HP_0002664	118	121	132	138	True
30592286	Furthermore, ZEB2 knockdown recapitulated the inhibitory effects of miR498 overexpression in liver cancer cells.	ZEB2	cancer	9839	HP_0002664	13	17	100	106	False
30592286	ZEB2 overexpression rescued the inhibition of liver cancer cell proliferation, migration, and invasion by miR498, indicating that ZEB2 acts as a downstream effector of miR498 in liver cancer cells.	ZEB2	cancer	9839	HP_0002664	0	4	52	58	False
30592286	Thus, we demonstrated that miR498 suppresses the growth and metastasis of liver cancer cells, partly at least, by directly targeting ZEB2, suggesting that miR498 may serve as a potential biomarker for the diagnosis and therapy of liver cancer	ZEB2	cancer	9839	HP_0002664	134	138	81	87	False
25728710	In order to investigate whether somatic THPO gene mutations play a role in sporadic pediatric myeloproliferative diseases, we performed a mutation screening of a large representative cohort of pediatric acute myeloid leukemia, myeloid leukemia of Down syndrome, and juvenile myelomonocytic leukemia samples and show that gain-of-function THPO mutations are extremely rare in sporadic pediatric myeloproliferative diseases	THPO	sporadic	7066	HP_0003745	40	44	75	83	False
29861105	Here, we report bi-allelic pathogenic SPTBN4 variants (three homozygous and two compound heterozygous) that cause a severe neurological syndrome that includes congenital hypotonia, intellectual disability, and motor axonal and auditory neuropathy.	SPTBN4	intellectual disability	57731	HP_0001249	38	44	181	204	False
29407229	Their expression changes were further validated in U2OS osteosarcoma cell lines and hOB normal cell lines through quantitative PCR (qPCR) and consistent result with microarray analysis was obtained.	OS	osteosarcoma	4281	HP_0002669	53	55	56	68	False
29222009	Herein, we report 3 patients with heterozygous constitutional CDK13 mutations, who were ascertained through exome analysis of children with intellectual disability and minor anomalies, who lacked cardiac anomalies.	CDK13	intellectual disability	8621	HP_0001249	62	67	140	163	True
29222009	Herein, we report 3 patients with heterozygous constitutional CDK13 mutations, who were ascertained through exome analysis of children with intellectual disability and minor anomalies, who lacked cardiac anomalies.	minor	intellectual disability	8013	HP_0001249	168	173	140	163	False
29222009	Herein, we report 3 patients with heterozygous constitutional CDK13 mutations, who were ascertained through exome analysis of children with intellectual disability and minor anomalies, who lacked cardiac anomalies.	CDK13	cardiac anomalies	8621	HP_0001627	62	67	196	213	True
29222009	Herein, we report 3 patients with heterozygous constitutional CDK13 mutations, who were ascertained through exome analysis of children with intellectual disability and minor anomalies, who lacked cardiac anomalies.	minor	cardiac anomalies	8013	HP_0001627	168	173	196	213	False
20116044	Diamond-Blackfan anemia (DBA), an inherited bone marrow failure syndrome characterized by anemia that usually presents before the first birthday or in early childhood, is associated with birth defects and an increased risk of cancer.	DBA	cancer	6223	HP_0002664	25	28	226	232	True
29196733	Our recent determination of a microRNA (miRNA) expression signature in prostate cancer (PCa) revealed that miR-205-5p was significantly reduced in PCa tissues and that it acted as an antitumor miRNA.	PCa	cancer	28982	HP_0002664	88	91	80	86	False
29196733	Our recent determination of a microRNA (miRNA) expression signature in prostate cancer (PCa) revealed that miR-205-5p was significantly reduced in PCa tissues and that it acted as an antitumor miRNA.	miR	cancer	220972	HP_0002664	40	43	80	86	False
29196733	Our recent determination of a microRNA (miRNA) expression signature in prostate cancer (PCa) revealed that miR-205-5p was significantly reduced in PCa tissues and that it acted as an antitumor miRNA.	si	cancer	6490	HP_0002664	53	55	80	86	False
29569755	Lactate dehydrogenase-A (LDHA) can promote Warburg effect to produce lactate and Adenosine Triphosphate (ATP) in aerobic condition, which contributes to oncogenesis metastasis and drug resistance in various cancers.	LDHA	cancer	3939	HP_0002664	25	29	207	213	False
29569755	We determined that LDHA was over-expressed in GBC tumor tissues compared with normal tissues, which was also an independent prognostic factor for the overall survival of GBC patients by tissue microarrays analysis.	LDHA	tumor	3939	HP_0002664	19	23	50	55	False
29569755	Moreover, we confirmed that knockdown of LDHA could inhibit tumor growth in vivo.	LDHA	tumor	3939	HP_0002664	41	45	60	65	False
30547349	Mutation in FLNA causes a wide spectrum of disease including skeletal dysplasia, neuronal migration abnormality, cardiovascular malformation, intellectual disability and intestinal obstruction.	FLNA	skeletal dysplasia	2316	HP_0002652	12	16	61	79	True
30547349	Mutation in FLNA causes a wide spectrum of disease including skeletal dysplasia, neuronal migration abnormality, cardiovascular malformation, intellectual disability and intestinal obstruction.	FLNA	intellectual disability	2316	HP_0001249	12	16	142	165	True
30547349	Mutation in FLNA causes a wide spectrum of disease including skeletal dysplasia, neuronal migration abnormality, cardiovascular malformation, intellectual disability and intestinal obstruction.	FLNA	intestinal obstruction	2316	HP_0005214	12	16	170	192	False
30547349	Reviewing the emerging dataset, we underline this unanticipated phenotypic consequence of pathogenic FLNA mutation-associated pulmonary disease.Conclusion: From the emerging data, we suggest that while reviewing complex cases with a sustained oxygen requirement against a clincial background of cardiac concerns or intestinal obstruction to have a high index of suspicion for FLNA related pathology and to instigate early MRI brain scan and FLNA mutation analysis.	FLNA	intestinal obstruction	2316	HP_0005214	101	105	315	337	False
29314551	Sheldon-Hall syndrome (SHS) is the most common of the distal arthrogryposes (DAs), a group of disorders characterized by congenital non-progressive contractures.	SHS	contractures	10084	HP_0001371	23	26	148	160	True
29314551	Sheldon-Hall syndrome (SHS) is the most common of the distal arthrogryposes (DAs), a group of disorders characterized by congenital non-progressive contractures.	SHS	distal	10084	HP_0012839	23	26	54	60	False
29314551	Patients with SHS present with contractures of the limbs and a distinctive triangular facies with prominent nasolabial folds.	SHS	contractures	10084	HP_0001371	14	17	31	43	True
29314551	Patients with SHS present with contractures of the limbs and a distinctive triangular facies with prominent nasolabial folds.	SHS	triangular facies	10084	HP_0000325	14	17	75	92	True
29314551	MYH3 plays a pivotal role in fetal muscle development and mutations in this gene are associated with Freeman-Sheldon syndrome, distal arthrogryposis 8 (DA8), and autosomal dominant spondylocarpotarsal synostosis.	MYH3	distal	4621	HP_0012839	0	4	127	133	False
29314551	MYH3 plays a pivotal role in fetal muscle development and mutations in this gene are associated with Freeman-Sheldon syndrome, distal arthrogryposis 8 (DA8), and autosomal dominant spondylocarpotarsal synostosis.	MYH3	arthrogryposis	4621	HP_0002804	0	4	134	148	True
29314551	We report the case of a boy with a novel pathogenic MYH3 mutation, presenting with the classical clinical features of SHS in association with unilateral carpal bone fusion and multiple vertebral fusions.	SHS	vertebral fusions	10084	HP_0002948	118	121	185	202	False
29314551	We report the case of a boy with a novel pathogenic MYH3 mutation, presenting with the classical clinical features of SHS in association with unilateral carpal bone fusion and multiple vertebral fusions.	MYH3	vertebral fusions	4621	HP_0002948	52	56	185	202	True
27338644	Main subtypes of the disease are pseudohypoparathyroidism 1b (PHP1b) and pseudohypoparathyroidism 1a (PHP1a).	PHP	pseudohypoparathyroidism	6658	HP_0000852	62	65	33	57	False
27338644	Since this is an atypical but previously described rare presentation of PHP1b, we reemphasize STX16 deletions and PHP1b as a rare cause for early onset obesity and macrosomia.	PHP	macrosomia	6658	HP_0001520	72	75	164	174	False
27338644	Since this is an atypical but previously described rare presentation of PHP1b, we reemphasize STX16 deletions and PHP1b as a rare cause for early onset obesity and macrosomia.	STX16	macrosomia	8675	HP_0001520	94	99	164	174	False
27338644	Since this is an atypical but previously described rare presentation of PHP1b, we reemphasize STX16 deletions and PHP1b as a rare cause for early onset obesity and macrosomia.	PHP	obesity	6658	HP_0001513	72	75	152	159	True
27338644	Since this is an atypical but previously described rare presentation of PHP1b, we reemphasize STX16 deletions and PHP1b as a rare cause for early onset obesity and macrosomia.	STX16	obesity	8675	HP_0001513	94	99	152	159	True
30458457	BACKGROUND The present study explored the expression of coiled-coil domain-containing 34 (CCDC34) in cervical cancer (CC) and its prognostic value.	CCDC34	cancer	91057	HP_0002664	90	96	110	116	False
30458457	MATERIAL AND METHODS GEPIA and Oncomine cancer databases were mined to predict the CCDC34 differential expression level between a CC group and a normal group.	CCDC34	cancer	91057	HP_0002664	83	89	40	46	False
30458457	CD31 and vascular endothelial growth factor (VEGF) were stained to reflect tumor angiogenesis in 67 CC tissues.	VEGF	tumor	7422	HP_0002664	45	49	75	80	False
30458457	RESULTS Both GEPIA and Oncomine cancer databases mining results revealed that CCDC34 was more highly expressed in the CC group than in the normal group (all P&lt;0.05).	CCDC34	cancer	91057	HP_0002664	78	84	32	38	False
30458457	CONCLUSIONS High expression of CCDC34 is an independent unfavorable prognostic parameter for OS and DFS of CC patients, which was strongly associated with tumor angiogenesis	CCDC34	tumor	91057	HP_0002664	31	37	155	160	False
28658141	In our study, we aim to investigate whether variants of KCNA1, KCNA2, and KCNV2 genes influence susceptibility to genetic generalized epilepsies (GGEs) and the efficacy of AEDs.	KCNA2	epilepsies	3737	HP_0001250	63	68	134	144	True
28658141	In our study, we aim to investigate whether variants of KCNA1, KCNA2, and KCNV2 genes influence susceptibility to genetic generalized epilepsies (GGEs) and the efficacy of AEDs.	KCNA1	epilepsies	3736	HP_0001250	56	61	134	144	True
28658141	In our study, we aim to investigate whether variants of KCNA1, KCNA2, and KCNV2 genes influence susceptibility to genetic generalized epilepsies (GGEs) and the efficacy of AEDs.	KCNV2	epilepsies	169522	HP_0001250	74	79	134	144	False
26531332	In the case-control analysis, the rs9607195 A&gt;G on intergenic area 250kb away from the ISX gene and the rs12738007 A&gt;G on the intron of the MECR gene were the most strongly associated SNPs with the risk of schizophrenia (P=6.210(-8) , OR=0.50 and P=3.710(-7) , OR=2.39, respectively).	ISX	schizophrenia	91464	HP_0100753	91	94	213	226	False
26531332	In the case-control analysis, the rs9607195 A&gt;G on intergenic area 250kb away from the ISX gene and the rs12738007 A&gt;G on the intron of the MECR gene were the most strongly associated SNPs with the risk of schizophrenia (P=6.210(-8) , OR=0.50 and P=3.710(-7) , OR=2.39, respectively).	MECR	schizophrenia	51102	HP_0100753	147	151	213	226	False
26531332	In subsequent fine-mapping analysis, 6 SNPs of MECR were genotyped with 310 schizophrenia patients and 604 control subjects.	MECR	schizophrenia	51102	HP_0100753	47	51	76	89	False
24443915	Recently, autosomal recessive loss-of-function mutations in EXPH5 (encoding exophilin-5, also known as Slac2-b, a protein involved in intracellular vesicle transport) were identified in a new mechanobullous disease resembling a form of epidermolysis bullosa simplex (EBS).	EXPH5	autosomal recessive	23086	HP_0000007	60	65	10	29	True
24443915	Recently, autosomal recessive loss-of-function mutations in EXPH5 (encoding exophilin-5, also known as Slac2-b, a protein involved in intracellular vesicle transport) were identified in a new mechanobullous disease resembling a form of epidermolysis bullosa simplex (EBS).	Slac2-b	autosomal recessive	23086	HP_0000007	103	110	10	29	True
24443915	Here, we searched for mutations in EXPH5 in a 4-year-old white boy with EBS in whom initial Sanger sequencing of known genes implicated in intraepidermal skin fragility failed to identify pathogenic mutations.	EXPH5	skin fragility	23086	HP_0001030	35	40	154	168	True
24443915	This case represents the third pedigree with EXPH5 mutations resulting in inherited skin fragility.	EXPH5	skin fragility	23086	HP_0001030	45	50	84	98	True
30055288	Aberrant expression of different family members of the Eph/ephrin system, which comprises the Eph receptors (Ephs) and their ligands (ephrins), has been implicated in various malignancies including breast cancer.	Eph	cancer	2041	HP_0002664	55	58	205	211	False
30055288	This review reflects the existing Eph/ephrin literature while focusing on breast cancer heterogeneity.	Eph	cancer	2041	HP_0002664	34	37	81	87	False
30055288	This review reflects the existing Eph/ephrin literature while focusing on breast cancer heterogeneity.	era	cancer	2099	HP_0002664	48	51	81	87	False
30055288	This review reflects the existing Eph/ephrin literature while focusing on breast cancer heterogeneity.	Eph	heterogeneity	2041	HP_0001425	34	37	88	101	False
30055288	This review reflects the existing Eph/ephrin literature while focusing on breast cancer heterogeneity.	era	heterogeneity	2099	HP_0001425	48	51	88	101	False
30055288	Hormone positive, HER2 positive and triple negative breast cancer (TNBC) cell lines, xenografts/mutant animal models and patient samples are examined separately as, in humans, they represent entities with differences in prognosis and treatment.	HER2	cancer	2064	HP_0002664	18	22	59	65	True
30055288	EphA2, EphB4 and EphB6 are the members most extensively studied in breast cancer.	Eph	cancer	2041	HP_0002664	0	3	74	80	False
30055288	Existing research points to the potential use of various Eph/ephrin members as biomarkers for assessing prognosis and selecting the most suitable therapeutic strategies in variable clinical scenarios, also for overcoming drug resistance, in the era of breast cancer heterogeneity	Eph	cancer	2041	HP_0002664	57	60	259	265	False
30055288	Existing research points to the potential use of various Eph/ephrin members as biomarkers for assessing prognosis and selecting the most suitable therapeutic strategies in variable clinical scenarios, also for overcoming drug resistance, in the era of breast cancer heterogeneity	era	cancer	2099	HP_0002664	148	151	259	265	False
28695896	Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon cancer-associated EIF3E-RSPO2 and PTPRK-RSPO3 chromosome rearrangements in vivo.	EIF3E	cancer	3646	HP_0002664	141	146	123	129	False
28695896	Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon cancer-associated EIF3E-RSPO2 and PTPRK-RSPO3 chromosome rearrangements in vivo.	RSPO2	cancer	340419	HP_0002664	147	152	123	129	False
28695896	Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon cancer-associated EIF3E-RSPO2 and PTPRK-RSPO3 chromosome rearrangements in vivo.	PTPRK	cancer	5796	HP_0002664	157	162	123	129	False
28695896	Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon cancer-associated EIF3E-RSPO2 and PTPRK-RSPO3 chromosome rearrangements in vivo.	RSPO3	cancer	84870	HP_0002664	163	168	123	129	False
28695896	We show that both Rspo2 and Rspo3 fusion events are sufficient to initiate hyperplasia and tumour development in vivo, without additional cooperating genetic events.	Rspo2	tumour	340419	HP_0002664	18	23	91	97	False
28695896	We show that both Rspo2 and Rspo3 fusion events are sufficient to initiate hyperplasia and tumour development in vivo, without additional cooperating genetic events.	Rspo3	tumour	84870	HP_0002664	28	33	91	97	False
28695896	Altogether, our study provides direct evidence that endogenous Rspo2 and Rspo3 chromosome rearrangements can initiate and maintain tumour development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion cancers	Rspo2	cancer	340419	HP_0002664	63	68	228	234	False
28695896	Altogether, our study provides direct evidence that endogenous Rspo2 and Rspo3 chromosome rearrangements can initiate and maintain tumour development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion cancers	Rspo3	cancer	84870	HP_0002664	73	78	228	234	False
28695896	Altogether, our study provides direct evidence that endogenous Rspo2 and Rspo3 chromosome rearrangements can initiate and maintain tumour development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion cancers	Rspo2	tumour	340419	HP_0002664	63	68	131	137	False
28695896	Altogether, our study provides direct evidence that endogenous Rspo2 and Rspo3 chromosome rearrangements can initiate and maintain tumour development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion cancers	Rspo3	tumour	84870	HP_0002664	73	78	131	137	False
28391287	Biallelic pathogenic variant in AHI1 gene can cause Joubert syndrome-related disorders with oculomotor apraxia characteristics.	AHI1	oculomotor apraxia	54806	HP_0000657	32	36	92	110	True
28391287	Therefore, we concluded that AHI1 c.3257A&gt;G and NEB c.914 A&gt;G were potential causal variants in this strabismus pedigree.	AHI1	strabismus	54806	HP_0000486	29	33	107	117	True
28391287	Therefore, we concluded that AHI1 c.3257A&gt;G and NEB c.914 A&gt;G were potential causal variants in this strabismus pedigree.	NEB	strabismus	4703	HP_0000486	51	54	107	117	False
29073155	DNA was extracted from paraffin-embedded tumor specimens from the patients and peripheral blood lymphocytes from the controls and used for LMP2/LMP7 genotyping.	LMP2	tumor	5698	HP_0002664	139	143	41	46	False
29073155	DNA was extracted from paraffin-embedded tumor specimens from the patients and peripheral blood lymphocytes from the controls and used for LMP2/LMP7 genotyping.	LMP7	tumor	5696	HP_0002664	144	148	41	46	False
29073155	Moreover, LMP2 R/C+C/C genotype was associated with increased tumor invasion depth (p = 0.041).	LMP2	tumor	5698	HP_0002664	10	14	62	67	False
28526534	Our findings are both important for the differential diagnosis of patients with urea cycle disorders and also broaden the differential diagnosis of hyperammonemia associated with 3-methylglutaconic aciduria, which was earlier only reported in TMEM70 and SERAC1 defect	TMEM70	hyperammonemia	54968	HP_0001987	243	249	148	162	True
28526534	Our findings are both important for the differential diagnosis of patients with urea cycle disorders and also broaden the differential diagnosis of hyperammonemia associated with 3-methylglutaconic aciduria, which was earlier only reported in TMEM70 and SERAC1 defect	SERAC1	hyperammonemia	84947	HP_0001987	254	260	148	162	True
26791862	HGK is also involved in cancer cell migration.	HGK	cancer	9448	HP_0002664	0	3	24	30	False
30572178	We conducted further optimization of dual enzymatic inhibitions towards FGFR1 and DDR2, two important kinases in lung squamous cell carcinoma.	DDR2	squamous cell carcinoma	4921	HP_0002860	82	86	118	141	False
30572178	We conducted further optimization of dual enzymatic inhibitions towards FGFR1 and DDR2, two important kinases in lung squamous cell carcinoma.	FGFR1	squamous cell carcinoma	2260	HP_0002860	72	77	118	141	False
29397238	Atypical teratoid/rhabdoid tumors (AT/RT) and renal/extrarenal malignant rhabdoid tumors of childhood, epithelioid sarcoma and small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) represent the most commonly recognized SWI/SNF-driven neoplasms.	type	tumors	6445	HP_0002664	176	180	27	33	False
29397238	Atypical teratoid/rhabdoid tumors (AT/RT) and renal/extrarenal malignant rhabdoid tumors of childhood, epithelioid sarcoma and small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) represent the most commonly recognized SWI/SNF-driven neoplasms.	type	sarcoma	6445	HP_0100242	176	180	115	122	False
29397238	Atypical teratoid/rhabdoid tumors (AT/RT) and renal/extrarenal malignant rhabdoid tumors of childhood, epithelioid sarcoma and small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) represent the most commonly recognized SWI/SNF-driven neoplasms.	type	neoplasms	6445	HP_0002664	176	180	244	253	False
29397238	Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (SMARCB1/INI1, rarely SMARCA4) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, types 1 and 2, respectively).	type	tumors	6445	HP_0002664	278	282	56	62	False
29397238	Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (SMARCB1/INI1, rarely SMARCA4) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, types 1 and 2, respectively).	SMARCB1	tumors	6598	HP_0002664	107	114	56	62	True
29397238	Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (SMARCB1/INI1, rarely SMARCA4) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, types 1 and 2, respectively).	SMARCA4	tumors	6597	HP_0002664	128	135	56	62	False
29397238	Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (SMARCB1/INI1, rarely SMARCA4) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, types 1 and 2, respectively).	type	tumor	6445	HP_0002664	278	282	241	246	False
29397238	Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (SMARCB1/INI1, rarely SMARCA4) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, types 1 and 2, respectively).	SMARCB1	tumor	6598	HP_0002664	107	114	241	246	True
29397238	Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (SMARCB1/INI1, rarely SMARCA4) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, types 1 and 2, respectively).	SMARCA4	tumor	6597	HP_0002664	128	135	241	246	False
29397238	However, more recently, inherited SWI/SNF-deficiency has been linked to several benign syndromic tumors including a subset of familial schwannomatosis (linked to SMARCB1) and multiple meningiomas (linked to SMARCE1) as well as others.	SMARCB1	tumors	6598	HP_0002664	162	169	97	103	True
29397238	However, more recently, inherited SWI/SNF-deficiency has been linked to several benign syndromic tumors including a subset of familial schwannomatosis (linked to SMARCB1) and multiple meningiomas (linked to SMARCE1) as well as others.	SMARCE1	tumors	6605	HP_0002664	207	214	97	103	False
29397238	However, more recently, inherited SWI/SNF-deficiency has been linked to several benign syndromic tumors including a subset of familial schwannomatosis (linked to SMARCB1) and multiple meningiomas (linked to SMARCE1) as well as others.	SMARCB1	meningiomas	6598	HP_0002858	162	169	184	195	False
29397238	However, more recently, inherited SWI/SNF-deficiency has been linked to several benign syndromic tumors including a subset of familial schwannomatosis (linked to SMARCB1) and multiple meningiomas (linked to SMARCE1) as well as others.	SMARCE1	meningiomas	6605	HP_0002858	207	214	184	195	False
30015945	However, the function and mechanism underlying the action of UCA1 in papillary thyroid cancer (PTC) remains unclear.	PTC	cancer	8030	HP_0002664	95	98	87	93	False
30015945	UCA1 knockdown significantly inhibited PTC cell viability, colony formation and the bromodomain containing 4 (BRD4) expression level invitro, and retarded PTC tumor growth invivo.	PTC	tumor	8030	HP_0002664	39	42	160	165	False
30015945	UCA1 knockdown significantly inhibited PTC cell viability, colony formation and the bromodomain containing 4 (BRD4) expression level invitro, and retarded PTC tumor growth invivo.	BRD4	tumor	23476	HP_0002664	110	114	160	165	False
30015945	In the previous study, microRNA (miR)204 inhibited thyroid cancer progression and was regulated by UCA1 in other types of cancer.	miR	cancer	220972	HP_0002664	33	36	60	66	False
30541014	MATERIAL AND METHODS Human neuroblastoma SH-SY5Y cells were treated for 24 h with increasing concentrations of aggregated A (5, 15, 25, and 45 mol) with or without the ACAT1 siRNA pretreatment.	ACAT	neuroblastoma	38	HP_0003006	175	179	27	40	False
23379998	Recent advances in whole exome sequencing technology show promise for further elucidation of disease causing variants as in the recent identification of rare variants within ZNF644 segregating with pathological myopia.	ZNF644	myopia	84146	HP_0000545	174	180	211	217	True
29925042	Metastasis is the most important feature of gastric cancer (GC) and the most widely recognized reason for GC-related deaths.	GC	cancer	2638	HP_0002664	60	62	52	58	False
27329052	D-transposition of the great arteries (TGA) is one of the most common conotruncal heart defects at birth and is characterized by a discordant ventriculoarterial connection with a concordant atrioventricular connection.	great	conotruncal heart defects	122042	HP_0001710	23	28	70	95	False
27329052	The downstream pathways of Nodal-Foxh1 play a critical role not only in L-R determination in the lateral plate mesoderm but also in myocardial specification and differentiation in the AHF, suggesting that TGA is a phenotype in heterotaxia as well as the primary developmental defect of the AHF.	Nodal	heterotaxia	4838	HP_0030853	27	32	227	238	True
27329052	The downstream pathways of Nodal-Foxh1 play a critical role not only in L-R determination in the lateral plate mesoderm but also in myocardial specification and differentiation in the AHF, suggesting that TGA is a phenotype in heterotaxia as well as the primary developmental defect of the AHF.	Foxh1	heterotaxia	8928	HP_0030853	33	38	227	238	False
29494340	Backgorund: Sanjad-Sakati syndrome (SSS) is a rare autosomal recessive disease caused by a deletion mutation (155-166del) in exon 3 of the TBCE gene on chromosome 1q42-43.	TBCE	autosomal recessive	6905	HP_0000007	139	143	51	70	True
21150032	myocilin (MYOC), optineurin (OPTN), WDR36 and neurotrophin-4 (NTF4) in primary open angle glaucoma (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.	MYOC	glaucoma	4653	HP_0000501	10	14	90	98	True
21150032	myocilin (MYOC), optineurin (OPTN), WDR36 and neurotrophin-4 (NTF4) in primary open angle glaucoma (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.	OPTN	glaucoma	10133	HP_0000501	29	33	90	98	True
21150032	myocilin (MYOC), optineurin (OPTN), WDR36 and neurotrophin-4 (NTF4) in primary open angle glaucoma (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.	WDR36	glaucoma	134430	HP_0000501	36	41	90	98	True
21150032	myocilin (MYOC), optineurin (OPTN), WDR36 and neurotrophin-4 (NTF4) in primary open angle glaucoma (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.	NTF4	glaucoma	4909	HP_0000501	62	66	90	98	True
21150032	myocilin (MYOC), optineurin (OPTN), WDR36 and neurotrophin-4 (NTF4) in primary open angle glaucoma (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.	CYP1B1	glaucoma	1545	HP_0000501	110	116	90	98	True
21150032	myocilin (MYOC), optineurin (OPTN), WDR36 and neurotrophin-4 (NTF4) in primary open angle glaucoma (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.	LTBP2	glaucoma	4053	HP_0000501	121	126	90	98	True
30005870	RAB3A interacting protein (Rab3IP) has been determined to be involved in cancer progression; however, its expression pattern and function in gastric cancer remain unknown.	Rab3IP	cancer	117177	HP_0002664	27	33	73	79	False
30005870	The aim of this study was to determine the association between Rab3IP and gastric cancer, in addition to its functional role in this disease.	Rab3IP	cancer	117177	HP_0002664	63	69	82	88	False
30005870	Overexpression of Rab3IP in gastric cancer was verified at both transcriptional and translational levels.	Rab3IP	cancer	117177	HP_0002664	18	24	36	42	False
30005870	Cellular studies showed that Rab3IP could induce an aggressive phenotype in gastric cancer cells and that its expression was correlated with markers of the epithelial-mesenchymal transition (EMT).	Rab3IP	cancer	117177	HP_0002664	29	35	84	90	False
30005870	Cellular studies showed that Rab3IP could induce an aggressive phenotype in gastric cancer cells and that its expression was correlated with markers of the epithelial-mesenchymal transition (EMT).	EMT	cancer	3702	HP_0002664	191	194	84	90	True
30005870	In addition, we verified the co-expression of and interplay between Rab3IP and SSX2 during gastric cancer progression.	Rab3IP	cancer	117177	HP_0002664	68	74	99	105	False
30005870	In addition, we verified the co-expression of and interplay between Rab3IP and SSX2 during gastric cancer progression.	SSX2	cancer	6757	HP_0002664	79	83	99	105	True
30005870	Thus, these findings elucidated the central role of Rab3IP in inducing an invasive phenotype in gastric cancer cells, in addition to its involvement in EMT.	Rab3IP	cancer	117177	HP_0002664	52	58	104	110	False
30005870	Thus, these findings elucidated the central role of Rab3IP in inducing an invasive phenotype in gastric cancer cells, in addition to its involvement in EMT.	EMT	cancer	3702	HP_0002664	152	155	104	110	True
24662834	The A Desintegrin And Metalloproteinase 23 (ADAM23) gene is epigenetically silenced in different types of tumors, and silencing is often associated with advanced disease and metastasis.	ADAM23	tumors	10863	HP_0002664	44	50	106	112	False
24662834	Here, we show that invasive breast tumors exhibit significant ADAM23-ITH and that this heterogeneity is critical for tumor growth and metastasis.	ADAM23	heterogeneity	10863	HP_0001425	62	68	87	100	False
24662834	Here, we show that invasive breast tumors exhibit significant ADAM23-ITH and that this heterogeneity is critical for tumor growth and metastasis.	ADAM23	tumors	10863	HP_0002664	62	68	35	41	False
24662834	Here, we show that invasive breast tumors exhibit significant ADAM23-ITH and that this heterogeneity is critical for tumor growth and metastasis.	ADAM23	tumor	10863	HP_0002664	62	68	117	122	False
24662834	Rather, we observed that, in ADAM23-heterotypic environments, ADAM23-negative cells promote tumor growth and metastasis by enhancing the proliferation and invasion of adjacent A23-positive cells through the production ofLGI4 (Leucine-rich Glioma Inactivated 4) and nitric oxide (NO).	ADAM23	tumor	10863	HP_0002664	29	35	92	97	False
24662834	Rather, we observed that, in ADAM23-heterotypic environments, ADAM23-negative cells promote tumor growth and metastasis by enhancing the proliferation and invasion of adjacent A23-positive cells through the production ofLGI4 (Leucine-rich Glioma Inactivated 4) and nitric oxide (NO).	LGI4	tumor	163175	HP_0002664	221	225	92	97	False
29662198	Tumor-initiating cells (TIC) represent a subset of tumor cells with increased self-renewal capability.	TIC	tumor	23550	HP_0002664	24	27	51	56	False
29662198	TICs display resistance to frontline cancer treatment and retain the ability to repopulate a tumor after therapy, leading to cancer relapse.	TIC	tumor	23550	HP_0002664	0	3	93	98	False
29662198	TICs display resistance to frontline cancer treatment and retain the ability to repopulate a tumor after therapy, leading to cancer relapse.	TIC	cancer	23550	HP_0002664	0	3	37	43	False
29662198	NOTCH signaling has been identified as an important driver of the TIC population, yet mechanisms governing regulation of this pathway in cancer remain to be fully elucidated.	TIC	cancer	23550	HP_0002664	66	69	137	143	False
29662198	Here we identify a novel mechanism of NOTCH regulation and TIC induction in breast cancer via the miR-106b-25 miRNA cluster.	TIC	cancer	23550	HP_0002664	59	62	83	89	False
29662198	Here we identify a novel mechanism of NOTCH regulation and TIC induction in breast cancer via the miR-106b-25 miRNA cluster.	miR	cancer	220972	HP_0002664	98	101	83	89	False
29662198	We show that the miR-106b-25 cluster upregulates NOTCH1 in multiple breast cancer cell lines, representing both estrogen receptor (ER+) and triple negative breast cancer (TNBC) through direct repression of the E3 ubiquitin ligase, NEDD4L.	miR	cancer	220972	HP_0002664	17	20	75	81	False
29662198	We show that the miR-106b-25 cluster upregulates NOTCH1 in multiple breast cancer cell lines, representing both estrogen receptor (ER+) and triple negative breast cancer (TNBC) through direct repression of the E3 ubiquitin ligase, NEDD4L.	NOTCH1	cancer	4851	HP_0002664	49	55	75	81	True
29662198	We show that the miR-106b-25 cluster upregulates NOTCH1 in multiple breast cancer cell lines, representing both estrogen receptor (ER+) and triple negative breast cancer (TNBC) through direct repression of the E3 ubiquitin ligase, NEDD4L.	NEDD4L	cancer	23327	HP_0002664	231	237	75	81	False
29662198	We further show that upregulation of NOTCH1 is necessary for TIC induction downstream of miR-106b-25 in both ER+and TNBC breast cancer cells, and that re-expression of NEDD4L is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.	TIC	cancer	23550	HP_0002664	61	64	130	136	False
29662198	We further show that upregulation of NOTCH1 is necessary for TIC induction downstream of miR-106b-25 in both ER+and TNBC breast cancer cells, and that re-expression of NEDD4L is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.	miR	cancer	220972	HP_0002664	89	92	130	136	False
29662198	We further show that upregulation of NOTCH1 is necessary for TIC induction downstream of miR-106b-25 in both ER+and TNBC breast cancer cells, and that re-expression of NEDD4L is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.	NOTCH1	cancer	4851	HP_0002664	37	43	130	136	True
29662198	We further show that upregulation of NOTCH1 is necessary for TIC induction downstream of miR-106b-25 in both ER+and TNBC breast cancer cells, and that re-expression of NEDD4L is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction.	NEDD4L	cancer	23327	HP_0002664	170	176	130	136	False
29662198	Importantly, we demonstrate a significant positive correlation between miR-106b-25 and NOTCH1 protein, yet a significant inverse correlation between miR-106b-25 and NEDD4L mRNA in human breast cancer, suggesting a critical role for the miR106b-25/NEDD4L/NOTCH1 axis in the disease.	miR	cancer	220972	HP_0002664	71	74	193	199	False
29662198	Importantly, we demonstrate a significant positive correlation between miR-106b-25 and NOTCH1 protein, yet a significant inverse correlation between miR-106b-25 and NEDD4L mRNA in human breast cancer, suggesting a critical role for the miR106b-25/NEDD4L/NOTCH1 axis in the disease.	NOTCH1	cancer	4851	HP_0002664	87	93	193	199	True
29662198	Importantly, we demonstrate a significant positive correlation between miR-106b-25 and NOTCH1 protein, yet a significant inverse correlation between miR-106b-25 and NEDD4L mRNA in human breast cancer, suggesting a critical role for the miR106b-25/NEDD4L/NOTCH1 axis in the disease.	NEDD4L	cancer	23327	HP_0002664	165	171	193	199	False
29662198	Further, we show for the first time that NEDD4L expression alone is significantly associated with a better relapse-free prognosis for breast cancer patients.	NEDD4L	cancer	23327	HP_0002664	41	47	141	147	False
29662198	These data expand our knowledge of the mechanisms underlying NOTCH activation and TIC induction in breast cancer, and may provide new avenues for the development of therapies targeting this resistant subset of tumor cells	TIC	tumor	23550	HP_0002664	82	85	210	215	False
29662198	These data expand our knowledge of the mechanisms underlying NOTCH activation and TIC induction in breast cancer, and may provide new avenues for the development of therapies targeting this resistant subset of tumor cells	TIC	cancer	23550	HP_0002664	82	85	106	112	False
30194396	Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).	TERT	tumors	7015	HP_0002664	127	131	85	91	True
30194396	Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).	ATM	tumors	472	HP_0002664	160	163	85	91	True
30194396	Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).	traits	tumors	55929	HP_0002664	263	269	85	91	False
30194396	Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).	GREB1	tumors	9687	HP_0002664	337	342	85	91	False
30194396	Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).	MCM8	tumors	84515	HP_0002664	354	358	85	91	False
30194396	Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).	TERT	cancer	7015	HP_0002664	127	131	296	302	True
30194396	Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).	ATM	cancer	472	HP_0002664	160	163	296	302	True
30194396	Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).	traits	cancer	55929	HP_0002664	263	269	296	302	False
30194396	Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).	GREB1	cancer	9687	HP_0002664	337	342	296	302	False
30194396	Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in TERT, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related traits (endometriosis and breast cancer) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).	MCM8	cancer	84515	HP_0002664	354	358	296	302	False
24455740	This study is to investigate multiple chemotherapeutic agent- and radiation-related genetic biomarkers in locally advanced rectal cancer (LARC) patients following fluoropyrimidine-based concurrent chemoradiotherapy (CCRT) for response prediction.	LARC	cancer	6364	HP_0002664	138	142	130	136	False
24455740	We initially selected 6 fluoropyrimidine metabolism-related genes (DPYD, ORPT, TYMS, TYMP, TK1, and TK2) and 3 radiotherapy response-related genes (GLUT1, HIF-1, and HIF-2) as targets for gene expression identification in 60 LARC cancer specimens.	LARC	cancer	6364	HP_0002664	227	231	232	238	False
24455740	We initially selected 6 fluoropyrimidine metabolism-related genes (DPYD, ORPT, TYMS, TYMP, TK1, and TK2) and 3 radiotherapy response-related genes (GLUT1, HIF-1, and HIF-2) as targets for gene expression identification in 60 LARC cancer specimens.	DPYD	cancer	1806	HP_0002664	67	71	232	238	False
24455740	We initially selected 6 fluoropyrimidine metabolism-related genes (DPYD, ORPT, TYMS, TYMP, TK1, and TK2) and 3 radiotherapy response-related genes (GLUT1, HIF-1, and HIF-2) as targets for gene expression identification in 60 LARC cancer specimens.	TYMS	cancer	7298	HP_0002664	79	83	232	238	False
24455740	We initially selected 6 fluoropyrimidine metabolism-related genes (DPYD, ORPT, TYMS, TYMP, TK1, and TK2) and 3 radiotherapy response-related genes (GLUT1, HIF-1, and HIF-2) as targets for gene expression identification in 60 LARC cancer specimens.	TYMP	cancer	1890	HP_0002664	85	89	232	238	False
24455740	We initially selected 6 fluoropyrimidine metabolism-related genes (DPYD, ORPT, TYMS, TYMP, TK1, and TK2) and 3 radiotherapy response-related genes (GLUT1, HIF-1, and HIF-2) as targets for gene expression identification in 60 LARC cancer specimens.	GLUT1	cancer	6513	HP_0002664	148	153	232	238	False
24455740	After CCRT, 39 of 60 (65%) LARC patients were classified as responders (pathological tumor regression grade 2 ~ 4).	LARC	tumor	6364	HP_0002664	27	31	85	90	False
29666464	Mutations in the mitochondrial alanyl-transfer (t)RNA synthetase 2 (AARS2; OMIM 612035) have been linked to leukoencephalopathy recently.	AARS2	leukoencephalopathy	57505	HP_0002352	68	73	108	127	True
29666464	We report a case with novel AARS2 gene mutations with developed striking cerebellar atrophy and leukoencephalopathy, which helps to further understand the clinical and genetic heterogeneity of AARS2-L	AARS2	leukoencephalopathy	57505	HP_0002352	28	33	96	115	True
29666464	We report a case with novel AARS2 gene mutations with developed striking cerebellar atrophy and leukoencephalopathy, which helps to further understand the clinical and genetic heterogeneity of AARS2-L	AARS2	cerebellar atrophy	57505	HP_0001272	28	33	73	91	True
29666464	We report a case with novel AARS2 gene mutations with developed striking cerebellar atrophy and leukoencephalopathy, which helps to further understand the clinical and genetic heterogeneity of AARS2-L	AARS2	heterogeneity	57505	HP_0001425	28	33	176	189	False
27305985	In humans, narcolepsy is a sleep disorder that is characterized by sleepiness, cataplexy and rapid eye movement (REM) sleep abnormalities.	REM	narcolepsy	28954	HP_0030050	113	116	11	21	False
27305985	Essential hypersomnia (EHS) is another type of sleep disorder that is characterized by excessive daytime sleepiness without cataplexy.	type	hypersomnia	6445	HP_0100786	39	43	10	21	False
27305985	Reported susceptibility SNPs for narcolepsy in the Japanese population, CPT1B (carnitine palmitoyltransferase 1B), TRA@ (T-cell receptor alpha) and P2RY11 (purinergic receptor P2Y, G-protein coupled, 11), were found to explain 0.8% of narcolepsy onset (P<sub>whole genome without HLA-DQB1*06:02</sub>=9.74  10<sup>-2</sup>).	CPT1B	narcolepsy	1375	HP_0030050	72	77	33	43	False
29026114	Intriguingly, one of the most frequently altered genes, mutated exclusively by inactivating mutation, was LYST (10%), which may represent a novel cancer gene in chordoma.Chordoma is a rare often incurable malignant bone tumour.	LYST	tumour	1130	HP_0002664	106	110	220	226	True
29026114	Intriguingly, one of the most frequently altered genes, mutated exclusively by inactivating mutation, was LYST (10%), which may represent a novel cancer gene in chordoma.Chordoma is a rare often incurable malignant bone tumour.	LYST	chordoma	1130	HP_0010762	106	110	161	169	False
29026114	Intriguingly, one of the most frequently altered genes, mutated exclusively by inactivating mutation, was LYST (10%), which may represent a novel cancer gene in chordoma.Chordoma is a rare often incurable malignant bone tumour.	LYST	cancer	1130	HP_0002664	106	110	146	152	True
29026114	Here, the authors investigate driver mutations of sporadic chordoma in 104 cases, revealing duplications in notochordal transcription factor brachyury (T), PI3K signalling mutations, and mutations in LYST, a potential novel cancer gene in chordoma	LYST	sporadic	1130	HP_0003745	200	204	50	58	False
29026114	Here, the authors investigate driver mutations of sporadic chordoma in 104 cases, revealing duplications in notochordal transcription factor brachyury (T), PI3K signalling mutations, and mutations in LYST, a potential novel cancer gene in chordoma	LYST	chordoma	1130	HP_0010762	200	204	59	67	False
29026114	Here, the authors investigate driver mutations of sporadic chordoma in 104 cases, revealing duplications in notochordal transcription factor brachyury (T), PI3K signalling mutations, and mutations in LYST, a potential novel cancer gene in chordoma	LYST	cancer	1130	HP_0002664	200	204	224	230	True
30206173	We confirmed previous studies showing that tumor necrosis factor alpha (TNF-) induced reactivation of infectious virus, and by analyzing expression of the progenitor cell marker CD34 as well as myeloid cell differentiation markers in IE<sup>+</sup> cells after treatment with TNF-, we showed that TNF- induced transcriptional reactivation of IE gene expression independently of differentiation.	TNF	tumor	7124	HP_0002664	72	75	43	48	False
27725196	We chose to study UNCL-Sema3E rather than wild type sema3E because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.	furin	tumor	5045	HP_0002664	167	172	279	284	False
27725196	We chose to study UNCL-Sema3E rather than wild type sema3E because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.	UNCL	tumor	25972	HP_0002664	18	22	279	284	False
27725196	We chose to study UNCL-Sema3E rather than wild type sema3E because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.	Sema3E	tumor	9723	HP_0002664	23	29	279	284	False
27725196	We chose to study UNCL-Sema3E rather than wild type sema3E because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.	type	tumor	6445	HP_0002664	47	51	279	284	False
27725196	We chose to study UNCL-Sema3E rather than wild type sema3E because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.	sema3E	tumor	9723	HP_0002664	52	58	279	284	False
27725196	We chose to study UNCL-Sema3E rather than wild type sema3E because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with furin like pro-protein convertases activates signal transduction mediated by the ErbB2 receptor and can promote tumor metastasis in addition to its anti-angiogenic activity.	ErbB2	tumor	2064	HP_0002664	248	253	279	284	True
30717820	Dasatinib treatment of the mice with intrasplenic xenografts decreased tumor growth and increased survival times, compared with mice treated with vehicle only.	mice	tumor	23581	HP_0002664	27	31	71	76	False
28911200	We report a pair of siblings carrying a homozygous missense mutation p.P333L in EEF1A2 who exhibited global developmental delay, failure to thrive, dilated cardiomyopathy and epilepsy, ultimately leading to death in early childhood.	EEF1A	developmental delay	1915	HP_0001263	80	85	108	127	False
28911200	We report a pair of siblings carrying a homozygous missense mutation p.P333L in EEF1A2 who exhibited global developmental delay, failure to thrive, dilated cardiomyopathy and epilepsy, ultimately leading to death in early childhood.	EEF1A	failure to thrive	1915	HP_0001508	80	85	129	146	False
28911200	We report a pair of siblings carrying a homozygous missense mutation p.P333L in EEF1A2 who exhibited global developmental delay, failure to thrive, dilated cardiomyopathy and epilepsy, ultimately leading to death in early childhood.	EEF1A	epilepsy	1915	HP_0001250	80	85	175	183	False
28911200	EEF1A2-deficient zebrafish had skeletal muscle weakness, cardiac failure and small heads.	EEF1A	cardiac failure	1915	HP_0001635	0	5	57	72	False
29136674	Six syndromes of familial hyperparathyroidism are compared: 1) Familial hypocalciuric hypercalcemia (FHH) expresses primary hyperparathyroidism (PHPT) beginning at birth with lifelong hypercalcemia.	FHH	hyperparathyroidism	846	HP_0000843	101	104	26	45	True
29136674	Six syndromes of familial hyperparathyroidism are compared: 1) Familial hypocalciuric hypercalcemia (FHH) expresses primary hyperparathyroidism (PHPT) beginning at birth with lifelong hypercalcemia.	FHH	hypercalcemia	846	HP_0003072	101	104	86	99	True
29136674	It usually reflects biallelic inactivation of the <i>CASR.</i> 3) Multiple endocrine neoplasia type 1 (MEN1) is most frequently expressed as PHPT with asymmetric enlargement of 3-4 parathyroids.	type	neoplasia	6445	HP_0002664	95	99	85	94	False
29136674	It usually reflects biallelic inactivation of the <i>CASR.</i> 3) Multiple endocrine neoplasia type 1 (MEN1) is most frequently expressed as PHPT with asymmetric enlargement of 3-4 parathyroids.	MEN1	neoplasia	4221	HP_0002664	103	107	85	94	True
29136674	4) Multiple endocrine neoplasia type 2A from <i>RET</i> activating mutation rarely presents as familial hyperparathyroidism, because medullary thyroid cancer and pheochromocytoma are more prominent.	type	hyperparathyroidism	6445	HP_0000843	32	36	104	123	False
29136674	4) Multiple endocrine neoplasia type 2A from <i>RET</i> activating mutation rarely presents as familial hyperparathyroidism, because medullary thyroid cancer and pheochromocytoma are more prominent.	type	neoplasia	6445	HP_0002664	32	36	22	31	False
29136674	4) Multiple endocrine neoplasia type 2A from <i>RET</i> activating mutation rarely presents as familial hyperparathyroidism, because medullary thyroid cancer and pheochromocytoma are more prominent.	type	cancer	6445	HP_0002664	32	36	151	157	False
29136674	4) Multiple endocrine neoplasia type 2A from <i>RET</i> activating mutation rarely presents as familial hyperparathyroidism, because medullary thyroid cancer and pheochromocytoma are more prominent.	type	pheochromocytoma	6445	HP_0002666	32	36	162	178	False
29136674	Five of the PHPT syndromes reflect overgrowth of parathyroid tissue; in contrast, familial hypocalciuric hypercalcemia reflects dysregulation of PTH secretion with little or no parathyroid overgrowth.	PTH	hypercalcemia	5741	HP_0003072	145	148	105	118	False
30785686	From the standpoint of the phylogenetic theory of general pathology, atherosclerosis and atheromatosis of the arteries have no great future.	great	atheromatosis	122042	HP_0002635	127	132	89	102	False
26148476	Aberrant expression of receptor interacting protein kinase 4 (RIPK4), a crucial regulatory protein of Wnt/-catenin signaling, has recently been reported to be involved in several cancers.	RIPK4	cancer	54101	HP_0002664	62	67	180	186	False
26148476	Aberrant expression of receptor interacting protein kinase 4 (RIPK4), a crucial regulatory protein of Wnt/-catenin signaling, has recently been reported to be involved in several cancers.	act	cancer	11332	HP_0002664	37	40	180	186	False
26148476	Here, we report the potential clinical implication and biological functions of RIPK4 in cervical squamous cell carcinoma (CSCC).	RIPK4	squamous cell carcinoma	54101	HP_0002860	79	84	97	120	False
26148476	Knockdown of RIPK4 reduced cell migration and invasion via inhibition of Vimentin, MMP2 and Fibronectin expression in cervical cancer cells.	RIPK4	cancer	54101	HP_0002664	13	18	127	133	False
26148476	Knockdown of RIPK4 reduced cell migration and invasion via inhibition of Vimentin, MMP2 and Fibronectin expression in cervical cancer cells.	MMP2	cancer	4313	HP_0002664	83	87	127	133	False
23340767	The DFNB79 locus harbors TPRN mutations in which have been reported in a few families with deafness.	DFNB79	deafness	286262	HP_0000365	4	10	91	99	True
23340767	The DFNB79 locus harbors TPRN mutations in which have been reported in a few families with deafness.	TPRN	deafness	286262	HP_0000365	25	29	91	99	True
23340767	Four frameshift mutations in TPRN have been described to cause severe or severe-to-profound hearing loss in Moroccan and Pakistani families, and a single frameshift mutation was associated with progressive hearing loss in deaf individuals in a Dutch family.	TPRN	profound	286262	HP_0012829	29	33	83	91	False
23340767	Four frameshift mutations in TPRN have been described to cause severe or severe-to-profound hearing loss in Moroccan and Pakistani families, and a single frameshift mutation was associated with progressive hearing loss in deaf individuals in a Dutch family.	TPRN	hearing loss	286262	HP_0000365	29	33	92	104	True
23340767	Four frameshift mutations in TPRN have been described to cause severe or severe-to-profound hearing loss in Moroccan and Pakistani families, and a single frameshift mutation was associated with progressive hearing loss in deaf individuals in a Dutch family.	TPRN	progressive	286262	HP_0003676	29	33	194	205	False
25778620	Knockout of genes encoding metabotropic glutamate receptor 5 (mGluR5) or its endogenous regulators, such as Norbin, induce a schizophrenia-like phenotype in rodents, suggesting dysregulation of mGluR5 in schizophrenia.	mGluR5	schizophrenia	2915	HP_0100753	62	68	125	138	False
25778620	Human genetic and pharmacological animal studies support this hypothesis, but no studies have explored mGluR5 dysfunction at the molecular level in the postmortem schizophrenia brain.	mGluR5	schizophrenia	2915	HP_0100753	103	109	163	176	False
25778620	We assessed mGluR5 mRNA and protein levels in the dorsolateral prefrontal cortex (DLPFC) using a large cohort of schizophrenia and control subjects (n = 37/group), and additionally measured protein levels of recently discovered mGluR5 endogenous regulators, Norbin (neurochondrin), Tamalin (GRASP-1), and Preso1 (FRMPD4), which regulate mGluR5 localization, internalization and signaling.	mGluR5	schizophrenia	2915	HP_0100753	12	18	113	126	False
25778620	We assessed mGluR5 mRNA and protein levels in the dorsolateral prefrontal cortex (DLPFC) using a large cohort of schizophrenia and control subjects (n = 37/group), and additionally measured protein levels of recently discovered mGluR5 endogenous regulators, Norbin (neurochondrin), Tamalin (GRASP-1), and Preso1 (FRMPD4), which regulate mGluR5 localization, internalization and signaling.	GRASP-1	schizophrenia	56850	HP_0100753	291	298	113	126	False
25778620	We assessed mGluR5 mRNA and protein levels in the dorsolateral prefrontal cortex (DLPFC) using a large cohort of schizophrenia and control subjects (n = 37/group), and additionally measured protein levels of recently discovered mGluR5 endogenous regulators, Norbin (neurochondrin), Tamalin (GRASP-1), and Preso1 (FRMPD4), which regulate mGluR5 localization, internalization and signaling.	FRMPD4	schizophrenia	9758	HP_0100753	313	319	113	126	False
25778620	While mGluR5 mRNA expression was unchanged, mGluR5 protein levels were significantly higher in schizophrenia subjects compared to controls (total: +22%; dimer: +54%; p &lt; 0.001).	mGluR5	schizophrenia	2915	HP_0100753	6	12	95	108	False
25778620	Conversely, mGluR5 regulatory proteins were expressed at lower levels in schizophrenia subjects compared to controls (Norbin -37%, p &lt; 0.001; Tamalin -30%, p = 0.084; Preso1 -29%, p = 0.001).	mGluR5	schizophrenia	2915	HP_0100753	12	18	73	86	False
25778620	mGluR5 protein was significantly associated with mGluR5 mRNA and mGluR5 endogenous regulators in control subjects, but these associations were lost in schizophrenia subjects.	mGluR5	schizophrenia	2915	HP_0100753	0	6	151	164	False
25778620	The results from our study provide compelling evidence that mGluR5 regulation is altered in schizophrenia, likely contributing to the altered glutamatergic signaling that is associated with the disorder	mGluR5	schizophrenia	2915	HP_0100753	60	66	92	105	False
18830713	A previously reported CLCN2 gene for epilepsy was excluded as the disease-causing gene in the family by mutational analysis of all exons and exon-intron boundaries of CLCN2 and by haplotype analysis.	CLCN2	epilepsy	1181	HP_0001250	22	27	37	45	True
29730826	A frequently reported finding is that effects from common genetic variation are associated with a schizophrenia-related structural endophenotype.	find	schizophrenia	81501	HP_0100753	22	26	98	111	False
28416184	Together, our findings suggest that in CRC TIAM1 suppresses tumor progression by regulating YAP/TAZ activity	TIAM1	tumor	7074	HP_0002664	43	48	60	65	False
28416184	Together, our findings suggest that in CRC TIAM1 suppresses tumor progression by regulating YAP/TAZ activity	TAZ	tumor	25937	HP_0002664	96	99	60	65	False
28416184	Together, our findings suggest that in CRC TIAM1 suppresses tumor progression by regulating YAP/TAZ activity	YAP	tumor	55249	HP_0002664	92	95	60	65	False
29453416	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	MYH11	sporadic	4629	HP_0003745	159	164	139	147	False
29453416	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	LMOD1	sporadic	25802	HP_0003745	190	195	139	147	False
29453416	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	MYLK	sporadic	4638	HP_0003745	214	218	139	147	False
29453416	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	light	sporadic	8740	HP_0003745	227	232	139	147	False
29453416	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	MLC	sporadic	23209	HP_0003745	240	243	139	147	False
29453416	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	MYH11	autosomal recessive	4629	HP_0000007	159	164	253	272	False
29453416	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	LMOD1	autosomal recessive	25802	HP_0000007	190	195	253	272	False
29453416	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	MYLK	autosomal recessive	4638	HP_0000007	214	218	253	272	False
29453416	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	light	autosomal recessive	8740	HP_0000007	227	232	253	272	False
29453416	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	MLC	autosomal recessive	23209	HP_0000007	240	243	253	272	True
29453416	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	MYH11	inheritance	4629	HP_0000005	159	164	273	284	False
29453416	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	LMOD1	inheritance	25802	HP_0000005	190	195	273	284	False
29453416	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	MYLK	inheritance	4638	HP_0000005	214	218	273	284	False
29453416	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	light	inheritance	8740	HP_0000005	227	232	273	284	False
29453416	The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), LMOD1 (leiomodin 1) and MYLK (myosin light chain (MLC) kinase)-autosomal recessive inheritance), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	MLC	inheritance	23209	HP_0000005	240	243	273	284	False
26826034	This is especially relevant in the context of the aerobic glycolysis, also known as the Warburg effect, which is a hallmark in many types of cancer, and MPC loss of function promotes cancer growth.	type	cancer	6445	HP_0002664	132	136	141	147	False
26826034	In this review we discuss recent advances in our knowledge of the MPC, and we argue that it may offer a promising target in diseases like cancer and type 2 diabetes.	type	cancer	6445	HP_0002664	149	153	138	144	False
30071673	<i>VEGFC</i>, which is a gene encoding the ligand for the vascular endothelial growth factor receptor 3 (VEGFR3/FLT4) and important for lymph vessel development during lymphangiogenesis, has been associated with a specific subtype of primary lymphedema.	VEGFC	edema	7424	HP_0000969	3	8	247	252	True
30071673	<i>VEGFC</i>, which is a gene encoding the ligand for the vascular endothelial growth factor receptor 3 (VEGFR3/FLT4) and important for lymph vessel development during lymphangiogenesis, has been associated with a specific subtype of primary lymphedema.	VEGF	edema	7422	HP_0000969	105	109	247	252	False
30071673	Through Sanger sequencing of a proband with bilateral congenital pedal edema resembling Milroy disease, we identified a novel mutation (NM_005429.2; c.361+5G&gt;A) in <i>VEGFC</i>.	VEGFC	bilateral	7424	HP_0012832	170	175	44	53	False
30071673	Through Sanger sequencing of a proband with bilateral congenital pedal edema resembling Milroy disease, we identified a novel mutation (NM_005429.2; c.361+5G&gt;A) in <i>VEGFC</i>.	VEGFC	edema	7424	HP_0000969	170	175	71	76	True
22179838	By analyzing public data sets of gene expression in human breast cancers we observed that increased levels of transcripts encoding the planar cell polarity (PCP) proteins SCRIB and VANGL1 correlate with increased risk of patient relapse.	PCP	cancer	54858	HP_0002664	157	160	65	71	False
22179838	By analyzing public data sets of gene expression in human breast cancers we observed that increased levels of transcripts encoding the planar cell polarity (PCP) proteins SCRIB and VANGL1 correlate with increased risk of patient relapse.	SCRIB	cancer	23513	HP_0002664	171	176	65	71	False
22179838	By analyzing public data sets of gene expression in human breast cancers we observed that increased levels of transcripts encoding the planar cell polarity (PCP) proteins SCRIB and VANGL1 correlate with increased risk of patient relapse.	VANGL1	cancer	81839	HP_0002664	181	187	65	71	True
22179838	Experimentally, we found that reducing expression of SCRIB by short-hairpin RNAs (shRNAs) reduces the growth of human breast cancer cells in xenograft assays.	SCRIB	cancer	23513	HP_0002664	53	58	125	131	False
22179838	To investigate SCRIB-associated proteins that might participate in the responses of breast cancer cells to altered levels of SCRIB, we used mass spectrometry and confocal microscopy.	SCRIB	cancer	23513	HP_0002664	15	20	91	97	False
22179838	To investigate SCRIB-associated proteins that might participate in the responses of breast cancer cells to altered levels of SCRIB, we used mass spectrometry and confocal microscopy.	mass	cancer	2200	HP_0002664	140	144	91	97	False
22179838	Focusing on NOS1AP, we observed that NOS1AP colocalizes with both SCRIB and VANGL1 along cellular protrusions in metastatic breast cancer cells, but does not colocalize with either SCRIB or VANGL1 at cell junctions in normal breast cells.	SCRIB	cancer	23513	HP_0002664	66	71	131	137	False
22179838	Focusing on NOS1AP, we observed that NOS1AP colocalizes with both SCRIB and VANGL1 along cellular protrusions in metastatic breast cancer cells, but does not colocalize with either SCRIB or VANGL1 at cell junctions in normal breast cells.	VANGL1	cancer	81839	HP_0002664	76	82	131	137	True
22179838	Focusing on NOS1AP, we observed that NOS1AP colocalizes with both SCRIB and VANGL1 along cellular protrusions in metastatic breast cancer cells, but does not colocalize with either SCRIB or VANGL1 at cell junctions in normal breast cells.	NOS1AP	cancer	9722	HP_0002664	12	18	131	137	False
22179838	We investigated the effects of shRNA-mediated knockdown of NOS1AP and SCRIB in vitro, and found that reducing NOS1AP and SCRIB slows breast cancer cell migration and prevents the establishment of leading-trailing polarity.	SCRIB	cancer	23513	HP_0002664	70	75	140	146	False
22179838	We investigated the effects of shRNA-mediated knockdown of NOS1AP and SCRIB in vitro, and found that reducing NOS1AP and SCRIB slows breast cancer cell migration and prevents the establishment of leading-trailing polarity.	NOS1AP	cancer	9722	HP_0002664	59	65	140	146	False
29709443	We aimed to investigate the effect of the AS to FEZF1 gene on non-small cell lung cancer (NSCLC) development.	FEZF1	cancer	389549	HP_0002664	48	53	82	88	False
29709443	The expression level of lncRNA FEZF-AS1 and FEZF1 was determined by the quantitative Real-time PCR in 160 cases of NSCLC tissues and their adjacent non-tumour tissues.	FEZF1	tumour	389549	HP_0002664	44	49	152	158	False
29709443	By GEPIA database analysis, we also found that the expression of lncRNA FEZF-AS1 and FEZF1 were significantly higher in tumour tissues than those of the adjacent non-cancerous tissues in 969 NSCLC patients (P&lt;0.05), and lncRNA FEZF-AS1 was positively correlated with FEZF1 (r=0.90, P&lt;0.001).	FEZF1	cancer	389549	HP_0002664	85	90	166	172	False
29709443	By GEPIA database analysis, we also found that the expression of lncRNA FEZF-AS1 and FEZF1 were significantly higher in tumour tissues than those of the adjacent non-cancerous tissues in 969 NSCLC patients (P&lt;0.05), and lncRNA FEZF-AS1 was positively correlated with FEZF1 (r=0.90, P&lt;0.001).	FEZF1	tumour	389549	HP_0002664	85	90	120	126	False
30442903	However, no study has investigated the relationship between aromatase in living brains and personality traits including aggression.	traits	aggression	55929	HP_0000718	103	109	120	130	False
30442903	However, no study has investigated the relationship between aromatase in living brains and personality traits including aggression.	aromatase	aggression	1588	HP_0000718	60	69	120	130	False
30442903	Before performing PET scans, subjects answered the Buss-Perry Aggression Questionnaire and Temperament and Character Inventory to measure their aggression and personality traits, respectively.	traits	aggression	55929	HP_0000718	171	177	144	154	False
30442903	Females showed associations between aromatase levels in subcortical regions, such as the amygdala and supraoptic nucleus of the hypothalamus, and personality traits such as aggression, novelty seeking, and self-transcendence.	traits	aggression	55929	HP_0000718	158	164	173	183	False
30442903	Females showed associations between aromatase levels in subcortical regions, such as the amygdala and supraoptic nucleus of the hypothalamus, and personality traits such as aggression, novelty seeking, and self-transcendence.	aromatase	aggression	1588	HP_0000718	36	45	173	183	False
28112229	Chronic hepatitis B virus (HBV) infection is partly responsible for hepatitis, fatty liver disease and hepatocellular carcinoma (HCC).	HCC	hepatocellular carcinoma	84668	HP_0001402	129	132	103	127	False
26978485	A moderate to severe reduction (&gt;50%) in PRODH activity resulting from recessive deletions and/or missense mutations has been shown to cause type 1 hyperprolinemia (HPI).	PRODH	hyperprolinemia	5625	HP_0008358	44	49	151	166	True
26978485	A moderate to severe reduction (&gt;50%) in PRODH activity resulting from recessive deletions and/or missense mutations has been shown to cause type 1 hyperprolinemia (HPI).	type	hyperprolinemia	6445	HP_0008358	144	148	151	166	False
26978485	Here we studied the frequency of a recurrent small 22q11.2 deletion encompassing PRODH and the neighboring DGCR6 gene in three case-control studies, one comprising HPI patients (n=83), and the other two comprising autism spectrum disorder (ASD) patients (total of n=2800), analyzed with high-resolution microarrays.	PRODH	autism	5625	HP_0000717	81	86	216	222	False
26978485	Here we studied the frequency of a recurrent small 22q11.2 deletion encompassing PRODH and the neighboring DGCR6 gene in three case-control studies, one comprising HPI patients (n=83), and the other two comprising autism spectrum disorder (ASD) patients (total of n=2800), analyzed with high-resolution microarrays.	DGCR6	autism	8214	HP_0000717	107	112	216	222	False
30139517	However, the underlying mechanism of HtrA3 function is unclear in endometrial hyperplasia and cancer.	HtrA3	cancer	726	HP_0002664	37	42	94	100	False
30139517	These findings suggested that HtrA3 is an important adaptor in hypoxic regions that drives endometrial cancer development	HtrA3	cancer	726	HP_0002664	30	35	103	109	False
26073779	Primary ciliary dyskinesia (PCD) is a rare autosomal-recessive condition resulting from structural and/or functional defects of the axoneme in motile cilia and sperm flagella.	PCD	ciliary dyskinesia	352909	HP_0012265	28	31	8	26	True
28651234	Hepatocellular carcinoma (HCC) is known as a highly prevalent cancer with a poor prognosis and short survival time, despite intensive research and clinical efforts.	HCC	cancer	84668	HP_0002664	26	29	62	68	False
28651234	Here, we report that the expression of microRNA-493 (miR-493) is decreased in HCC cell lines and in tumor tissues.	HCC	tumor	84668	HP_0002664	78	81	100	105	False
28651234	Here, we report that the expression of microRNA-493 (miR-493) is decreased in HCC cell lines and in tumor tissues.	miR	tumor	220972	HP_0002664	53	56	100	105	False
28651234	Overexpression of miR-493 in HCC cells dramatically inhibited cell proliferation and colony-formation in vitro and inhibited tumor formation of HCC cell xenografts in vivo.	HCC	tumor	84668	HP_0002664	29	32	125	130	False
28651234	Overexpression of miR-493 in HCC cells dramatically inhibited cell proliferation and colony-formation in vitro and inhibited tumor formation of HCC cell xenografts in vivo.	miR	tumor	220972	HP_0002664	18	21	125	130	False
28651234	Novel targets ANTXR1 and RSPO2 were confirmed to be suppressed by miR-493 directly, and overexpression of ANTXR1 and RSPO2 could restore tumorigenesis in miR-493 treated HCC cell.	HCC	tumor	84668	HP_0002664	170	173	137	142	False
28651234	Novel targets ANTXR1 and RSPO2 were confirmed to be suppressed by miR-493 directly, and overexpression of ANTXR1 and RSPO2 could restore tumorigenesis in miR-493 treated HCC cell.	miR	tumor	220972	HP_0002664	66	69	137	142	False
28651234	Novel targets ANTXR1 and RSPO2 were confirmed to be suppressed by miR-493 directly, and overexpression of ANTXR1 and RSPO2 could restore tumorigenesis in miR-493 treated HCC cell.	ANTXR1	tumor	84168	HP_0002664	14	20	137	142	True
28651234	Novel targets ANTXR1 and RSPO2 were confirmed to be suppressed by miR-493 directly, and overexpression of ANTXR1 and RSPO2 could restore tumorigenesis in miR-493 treated HCC cell.	RSPO2	tumor	340419	HP_0002664	25	30	137	142	False
28651234	Moreover, Wnt/-catenin signaling pathway, which was reported to be activated by ANTXR1 and RSPO2, was also inhibited by miR-493 overexpression and might be involved in anti-tumor function of miR-493.	miR	tumor	220972	HP_0002664	121	124	174	179	False
28651234	Moreover, Wnt/-catenin signaling pathway, which was reported to be activated by ANTXR1 and RSPO2, was also inhibited by miR-493 overexpression and might be involved in anti-tumor function of miR-493.	ANTXR1	tumor	84168	HP_0002664	81	87	174	179	True
28651234	Moreover, Wnt/-catenin signaling pathway, which was reported to be activated by ANTXR1 and RSPO2, was also inhibited by miR-493 overexpression and might be involved in anti-tumor function of miR-493.	RSPO2	tumor	340419	HP_0002664	92	97	174	179	False
28651234	These findings suggest that miR-493 acts as a negative regulator in hepatocellular carcinoma progression and may be a potential therapeutic target for HCC	miR	hepatocellular carcinoma	220972	HP_0001402	28	31	68	92	False
27796743	We report a novel gene duplication syndrome (10q21.2q21.3 microduplication) and present a new evidence for VIPR2 duplication, as a candidate gene for autism.	VIPR2	autism	7434	HP_0000717	107	112	150	156	False
30086807	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.	WDR62	microcephaly	284403	HP_0000252	149	154	331	343	True
30086807	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.	CDK5RAP2	microcephaly	55755	HP_0000252	156	164	331	343	True
30086807	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.	ASPM	microcephaly	259266	HP_0000252	173	177	331	343	True
30086807	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.	CENPJ	microcephaly	55835	HP_0000252	179	184	331	343	True
30086807	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.	STIL	microcephaly	6491	HP_0000252	186	190	331	343	True
30086807	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.	CEP135	microcephaly	9662	HP_0000252	192	198	331	343	True
30086807	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.	CEP152	microcephaly	22995	HP_0000252	200	206	331	343	True
30086807	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.	ZNF335	microcephaly	63925	HP_0000252	208	214	331	343	True
30086807	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.	PHC1	microcephaly	1911	HP_0000252	216	220	331	343	True
30086807	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.	CDK6	microcephaly	1021	HP_0000252	222	226	331	343	True
30086807	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.	CENPE	microcephaly	1062	HP_0000252	228	233	331	343	True
30086807	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.	SASS6	microcephaly	163786	HP_0000252	235	240	331	343	True
30086807	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.	MFSD2A	microcephaly	84879	HP_0000252	242	248	331	343	True
30086807	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.	ANKLE2	microcephaly	23141	HP_0000252	250	256	331	343	True
30086807	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.	CIT	microcephaly	11113	HP_0000252	258	261	331	343	True
30086807	Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152, ZNF335, PHC1, CDK6, CENPE, SASS6, MFSD2A, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of microcephaly genetic disorder.	WDFY3	microcephaly	23001	HP_0000252	266	271	331	343	False
28632965	Familial microscopic hematuria (FMH) is associated with a genetically heterogeneous group of conditions including the collagen-IV nephropathies, the heritable C3/CFHR5 nephropathy and the glomerulopathy with fibronectin deposits.	CFHR5	heterogeneous	81494	HP_0001425	162	167	70	83	False
29330545	We identified the first de novo variant in KCNMA1 (c.2984A&gt;G (p.(N995S)))-encoding the BK channel-that causes epilepsy, but not paroxysmal dyskinesia, in two independent families.	KCNMA1	epilepsy	3778	HP_0001250	43	49	116	124	True
29330545	We identified the first de novo variant in KCNMA1 (c.2984A&gt;G (p.(N995S)))-encoding the BK channel-that causes epilepsy, but not paroxysmal dyskinesia, in two independent families.	KCNMA1	paroxysmal dyskinesia	3778	HP_0007166	43	49	134	155	True
22580995	KLLN is a p53 target gene with DNA binding function and represents a highly plausible candidate breast cancer predisposition gene.	KLLN	cancer	100144748	HP_0002664	0	4	103	109	True
22580995	A germline c.339_340delAG variant predicted to cause premature termination of the protein after 57 alternative amino acid residues was identified in 3/860 families who tested negative for BRCA1 and BRCA2 mutations and in 1/84 sporadic breast cancer cases.	BRCA1	cancer	672	HP_0002664	188	193	242	248	True
22580995	A germline c.339_340delAG variant predicted to cause premature termination of the protein after 57 alternative amino acid residues was identified in 3/860 families who tested negative for BRCA1 and BRCA2 mutations and in 1/84 sporadic breast cancer cases.	BRCA2	cancer	675	HP_0002664	198	203	242	248	True
22580995	A germline c.339_340delAG variant predicted to cause premature termination of the protein after 57 alternative amino acid residues was identified in 3/860 families who tested negative for BRCA1 and BRCA2 mutations and in 1/84 sporadic breast cancer cases.	BRCA1	sporadic	672	HP_0003745	188	193	226	234	False
22580995	A germline c.339_340delAG variant predicted to cause premature termination of the protein after 57 alternative amino acid residues was identified in 3/860 families who tested negative for BRCA1 and BRCA2 mutations and in 1/84 sporadic breast cancer cases.	BRCA2	sporadic	675	HP_0003745	198	203	226	234	False
22580995	However, the variant was also detected in 2/182 families with known BRCA1 or BRCA2 mutations and in 2/464 non-cancer controls.	BRCA1	cancer	672	HP_0002664	68	73	110	116	True
22580995	However, the variant was also detected in 2/182 families with known BRCA1 or BRCA2 mutations and in 2/464 non-cancer controls.	BRCA2	cancer	675	HP_0002664	77	82	110	116	True
22580995	Our data suggest that pathogenic mutations in KLLN are rare in breast cancer families and the c.339_340delAG variant does not represent a high-penetrance breast cancer risk allele	KLLN	cancer	100144748	HP_0002664	46	50	70	76	True
30065108	Rac1, one of the best characterized Rho GTPases, is an established effector of receptors and an important node in signaling networks crucial for tumorigenesis and metastasis.	Rho	tumor	6010	HP_0002664	36	39	145	150	False
30065108	Rac1, one of the best characterized Rho GTPases, is an established effector of receptors and an important node in signaling networks crucial for tumorigenesis and metastasis.	best	tumor	7439	HP_0002664	17	21	145	150	False
30065108	Rac1, one of the best characterized Rho GTPases, is an established effector of receptors and an important node in signaling networks crucial for tumorigenesis and metastasis.	Rac1	tumor	5879	HP_0002664	0	4	145	150	False
30065108	Rac1 hyperactivation is common in human cancer and could be the consequence of overexpression, abnormal upstream inputs, deregulated degradation, and/or anomalous intracellular localization.	Rac1	cancer	5879	HP_0002664	0	4	40	46	False
30065108	More recently, cancer-associated gain-of-function mutations in Rac1 have been identified which contribute to tumor phenotypes and confer resistance to targeted therapies.	Rac1	cancer	5879	HP_0002664	63	67	15	21	False
30065108	More recently, cancer-associated gain-of-function mutations in Rac1 have been identified which contribute to tumor phenotypes and confer resistance to targeted therapies.	Rac1	tumor	5879	HP_0002664	63	67	109	114	False
30065108	Translating our extensive knowledge in Rac pathway biochemistry into a clinical setting still remains a major challenge; nonetheless, remarkable opportunities for cancer therapeutics arise from promising lead compounds targeting Rac and its effectors	Rac	cancer	207	HP_0002664	39	42	163	169	True
30219366	Collectively, ICOSL supports the induction of durable, antigen-specific Th17/Th1-mediated immunity in vivo, establishing a vaccination platform to enhance CD4<sup>+</sup> T cell-mediated antitumor immunity and providing a crucial component of an effective cancer vaccine	ICOS	cancer	1493	HP_0002664	14	18	256	262	True
30219366	Collectively, ICOSL supports the induction of durable, antigen-specific Th17/Th1-mediated immunity in vivo, establishing a vaccination platform to enhance CD4<sup>+</sup> T cell-mediated antitumor immunity and providing a crucial component of an effective cancer vaccine	ICOS	tumor	1493	HP_0002664	14	18	191	196	True
29452776	Several studies have shown that reproductive factors, such as age at natural menopause, parity and polycystic ovarian syndrome (PCOS), may play a role in the development of heart failure.	men	heart failure	8178	HP_0001635	77	80	173	186	False
29452776	Therefore, the aim of the current study was to explore whether any reproductive factor is potentially related to heart failure in women, based on genetic similarities.	men	heart failure	8178	HP_0001635	132	135	113	126	False
29452776	However, age at menarche, gestational diabetes and PCOS were found to be genetically linked to risk factors for heart failure, such as atrial fibrillation, diabetes and smoking.	men	heart failure	8178	HP_0001635	16	19	112	125	False
29452776	Corresponding implicated genes, such as TNNI3K, ErbB3, MKL2, MTNR1B and PRKD1, may explain the associations between reproductive factors and heart failure.	TNNI3K	heart failure	51086	HP_0001635	40	46	141	154	True
29452776	Corresponding implicated genes, such as TNNI3K, ErbB3, MKL2, MTNR1B and PRKD1, may explain the associations between reproductive factors and heart failure.	ErbB3	heart failure	2065	HP_0001635	48	53	141	154	False
29452776	Corresponding implicated genes, such as TNNI3K, ErbB3, MKL2, MTNR1B and PRKD1, may explain the associations between reproductive factors and heart failure.	MTNR1B	heart failure	4544	HP_0001635	61	67	141	154	False
29452776	Corresponding implicated genes, such as TNNI3K, ErbB3, MKL2, MTNR1B and PRKD1, may explain the associations between reproductive factors and heart failure.	PRKD1	heart failure	5587	HP_0001635	72	77	141	154	False
23871722	Because of the unbalanced sex ratio (1.3-1.4 to 1) observed in intellectual disability (ID) and the identification of large ID-affected families showing X-linked segregation, much attention has been focused on the genetics of X-linked ID (XLID).	sex	intellectual disability	55558	HP_0001249	26	29	63	86	False
30424007	Here, we hypothesize that repression of transcriptional activity of forkhead box O1 (FoxO1) via histone deacetylase inhibitors (HDACi) ameliorates hyperglycemia in T2DM rats	FoxO1	hyperglycemia	2308	HP_0003074	85	90	147	160	False
28577975	Zic2 has been shown to be crucial to the progression of human cancers.	Zic2	cancer	7546	HP_0002664	0	4	62	68	True
28577975	However, its role in hepatocellular carcinoma (HCC) remains unclear.	HCC	hepatocellular carcinoma	84668	HP_0001402	47	50	21	45	False
28577975	Our data showed that Zic2 expression gradually increased from normal to cancer to metastatic tissues.	Zic2	cancer	7546	HP_0002664	21	25	72	78	True
28577975	Zic2 overexpression promoted, whereas Zic2 knockdown inhibited, cell proliferation and migration invitro as well as tumor growth and metastasis invivo.	Zic2	tumor	7546	HP_0002664	0	4	117	122	True
29845210	In the present review, 22loci of glaucoma are presented, including the relevant genes (myocilin, interleukin20 receptor subunit B, optineurin, ankyrin repeat and SOCS boxcontaining protein 10, WD repeatcontaining protein 36, EGFcontaining fibulinlike extracellular matrix protein 1, neurotrophin 4, TANKbinding kinase 1, cytochrome P450 subfamily I polypeptide 1, latent transforming growth factor  binding protein 2 and TEK tyrosine kinase endothelial) and 74other genes (including tolllike receptor 4, sine oculis homeobox Drosophila homolog of 1, doublecortinlike kinase 1, RE repeatsencoding gene, retinitis pigmentosa GTPase regulatorinteracting protein, lysyl oxidaselike protein 1, heatshock 70kDa protein 1A, baculoviral IAP repeatcontaining protein 6, 5,10methylenetetrahydrofolate reductase and nitric oxide synthase 3 and nanophthalmos1) that are more closely associated with glaucoma.	SOCS	glaucoma	1154	HP_0000501	165	169	34	42	False
29845210	In the present review, 22loci of glaucoma are presented, including the relevant genes (myocilin, interleukin20 receptor subunit B, optineurin, ankyrin repeat and SOCS boxcontaining protein 10, WD repeatcontaining protein 36, EGFcontaining fibulinlike extracellular matrix protein 1, neurotrophin 4, TANKbinding kinase 1, cytochrome P450 subfamily I polypeptide 1, latent transforming growth factor  binding protein 2 and TEK tyrosine kinase endothelial) and 74other genes (including tolllike receptor 4, sine oculis homeobox Drosophila homolog of 1, doublecortinlike kinase 1, RE repeatsencoding gene, retinitis pigmentosa GTPase regulatorinteracting protein, lysyl oxidaselike protein 1, heatshock 70kDa protein 1A, baculoviral IAP repeatcontaining protein 6, 5,10methylenetetrahydrofolate reductase and nitric oxide synthase 3 and nanophthalmos1) that are more closely associated with glaucoma.	TEK	glaucoma	7010	HP_0000501	430	433	34	42	True
29845210	In the present review, 22loci of glaucoma are presented, including the relevant genes (myocilin, interleukin20 receptor subunit B, optineurin, ankyrin repeat and SOCS boxcontaining protein 10, WD repeatcontaining protein 36, EGFcontaining fibulinlike extracellular matrix protein 1, neurotrophin 4, TANKbinding kinase 1, cytochrome P450 subfamily I polypeptide 1, latent transforming growth factor  binding protein 2 and TEK tyrosine kinase endothelial) and 74other genes (including tolllike receptor 4, sine oculis homeobox Drosophila homolog of 1, doublecortinlike kinase 1, RE repeatsencoding gene, retinitis pigmentosa GTPase regulatorinteracting protein, lysyl oxidaselike protein 1, heatshock 70kDa protein 1A, baculoviral IAP repeatcontaining protein 6, 5,10methylenetetrahydrofolate reductase and nitric oxide synthase 3 and nanophthalmos1) that are more closely associated with glaucoma.	IAP	glaucoma	961	HP_0000501	746	749	34	42	False
20335458	These experiments identify a role for mitofusins in directly regulating mitochondrial transport and offer important insight into the cell type specificity and molecular mechanisms of axonal degeneration in CMT2A and dominant optic atrophy	type	axonal degeneration	6445	HP_0040078	138	142	183	202	False
20335458	These experiments identify a role for mitofusins in directly regulating mitochondrial transport and offer important insight into the cell type specificity and molecular mechanisms of axonal degeneration in CMT2A and dominant optic atrophy	CMT2A	axonal degeneration	23095	HP_0040078	206	211	183	202	False
29786110	Gainoffunction CTTNB1 mutations are detected in bladder cancer, colorectal cancer, gastric cancer, liver cancer, lung cancer, pancreatic cancer, prostate cancer and uterine cancer, whereas lossoffunction CTNNB1 mutations are also detected in human cancer.	CTNNB1	cancer	1499	HP_0002664	208	214	58	64	True
29786110	Eradicating H.pylori and HCV is the optimal approach for the firstline prevention of gastric cancer and hepatocellular carcinoma (HCC), respectively.	HCC	cancer	84668	HP_0002664	132	135	95	101	False
29786110	Eradicating H.pylori and HCV is the optimal approach for the firstline prevention of gastric cancer and hepatocellular carcinoma (HCC), respectively.	HCC	hepatocellular carcinoma	84668	HP_0001402	132	135	106	130	False
29786110	However, catenin inhibitors may be applicable for the prevention of organ fibrosis, secondline HCC prevention and treating catenindriven cancer.	HCC	cancer	84668	HP_0002664	98	101	143	149	False
29417338	EPAC is also known for its dual role in cancer as pro- and anti-proliferative in addition to metastasis.	EPAC	cancer	10411	HP_0002664	0	4	40	46	False
29417338	Results after perturbing EPAC activity suggests its involvement in cancer cell migration, proliferation, and cytoskeleton remodeling which makes it a potential therapeutic target for cancer treatments	EPAC	cancer	10411	HP_0002664	25	29	67	73	False
29467311	These data suggest a previously unrecognized mechanism by which EBNALP coactivates transcription through subverting of EP300 and thus affects the expression of LCL genes regulated by a broad range of host TFs.<b>IMPORTANCE</b> Epstein-Barr virus was the first human DNA tumor virus discovered over 50 years ago.	EP300	tumor	2033	HP_0002664	119	124	270	275	True
29227583	The dystrobrevin-binding protein 1 (DTNBP1) gene is a candidate risk factor for schizophrenia and has been associated with cognitive ability in both patient populations and healthy controls.	DTNBP1	schizophrenia	84062	HP_0100753	36	42	80	93	False
29227583	DTNBP1 encodes dysbindin protein, which is localized to synaptic sites and is reduced in the prefrontal cortex and hippocampus of patients with schizophrenia, indicating a potential role in schizophrenia etiology.	DTNBP1	schizophrenia	84062	HP_0100753	0	6	144	157	False
29227583	DTNBP1 encodes dysbindin protein, which is localized to synaptic sites and is reduced in the prefrontal cortex and hippocampus of patients with schizophrenia, indicating a potential role in schizophrenia etiology.	dysbindin	schizophrenia	84062	HP_0100753	15	24	144	157	False
26805782	By exome sequencing, we identified three different bi-allelic truncating mutations in TANGO2 in three unrelated individuals with infancy-onset episodic metabolic crises characterized by encephalopathy, hypoglycemia, rhabdomyolysis, arrhythmias, and laboratory findings suggestive of a defect in mitochondrial fatty acid oxidation.	TANGO2	encephalopathy	128989	HP_0001298	86	92	186	200	False
26805782	By exome sequencing, we identified three different bi-allelic truncating mutations in TANGO2 in three unrelated individuals with infancy-onset episodic metabolic crises characterized by encephalopathy, hypoglycemia, rhabdomyolysis, arrhythmias, and laboratory findings suggestive of a defect in mitochondrial fatty acid oxidation.	TANGO2	hypoglycemia	128989	HP_0001943	86	92	202	214	True
26805782	By exome sequencing, we identified three different bi-allelic truncating mutations in TANGO2 in three unrelated individuals with infancy-onset episodic metabolic crises characterized by encephalopathy, hypoglycemia, rhabdomyolysis, arrhythmias, and laboratory findings suggestive of a defect in mitochondrial fatty acid oxidation.	TANGO2	rhabdomyolysis	128989	HP_0003201	86	92	216	230	True
30322610	The melanogenic activity of 6-benzylaminopurine, the compound identified as the most potent, was further verified by measuring green fluorescent protein concentration in tyrp1 a: eGFP (tyrosinase-related protein 1) zebrafish and mitfa: eGFP (microphthalmia associated transcription factor) zebrafish and antioxidative activity.	tyrp1	microphthalmia	7306	HP_0000568	170	175	242	256	False
28654546	In this study, we evaluated the possible interaction between miR-146a and one of its putative targets ribonuclease L (RNASEL) in the risk of sporadic melanoma.	miR	sporadic	220972	HP_0003745	61	64	141	149	False
28654546	In this study, we evaluated the possible interaction between miR-146a and one of its putative targets ribonuclease L (RNASEL) in the risk of sporadic melanoma.	RNASEL	sporadic	6041	HP_0003745	118	124	141	149	False
28654546	In this study, we evaluated the possible interaction between miR-146a and one of its putative targets ribonuclease L (RNASEL) in the risk of sporadic melanoma.	miR	melanoma	220972	HP_0002861	61	64	150	158	False
28654546	In this study, we evaluated the possible interaction between miR-146a and one of its putative targets ribonuclease L (RNASEL) in the risk of sporadic melanoma.	RNASEL	melanoma	6041	HP_0002861	118	124	150	158	False
28654546	Polymorphisms rs2910164 in miR-146a and rs486907 in the RNASEL gene have both independently been associated with the risk of different cancers, and an interaction between them has been observed in nonmelanoma skin cancer.	miR	melanoma	220972	HP_0002861	27	30	200	208	False
28654546	Polymorphisms rs2910164 in miR-146a and rs486907 in the RNASEL gene have both independently been associated with the risk of different cancers, and an interaction between them has been observed in nonmelanoma skin cancer.	RNASEL	melanoma	6041	HP_0002861	56	62	200	208	False
28654546	Polymorphisms rs2910164 in miR-146a and rs486907 in the RNASEL gene have both independently been associated with the risk of different cancers, and an interaction between them has been observed in nonmelanoma skin cancer.	miR	cancer	220972	HP_0002664	27	30	135	141	False
28654546	Polymorphisms rs2910164 in miR-146a and rs486907 in the RNASEL gene have both independently been associated with the risk of different cancers, and an interaction between them has been observed in nonmelanoma skin cancer.	RNASEL	cancer	6041	HP_0002664	56	62	135	141	True
28654546	The results reported in the present study suggest a sex-specific interaction between miR-146a and RNASEL genes in melanoma skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed	miR	melanoma	220972	HP_0002861	85	88	114	122	False
28654546	The results reported in the present study suggest a sex-specific interaction between miR-146a and RNASEL genes in melanoma skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed	RNASEL	melanoma	6041	HP_0002861	98	104	114	122	False
28654546	The results reported in the present study suggest a sex-specific interaction between miR-146a and RNASEL genes in melanoma skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed	sex	melanoma	55558	HP_0002861	52	55	114	122	False
28654546	The results reported in the present study suggest a sex-specific interaction between miR-146a and RNASEL genes in melanoma skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed	miR	cancer	220972	HP_0002664	85	88	128	134	False
28654546	The results reported in the present study suggest a sex-specific interaction between miR-146a and RNASEL genes in melanoma skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed	RNASEL	cancer	6041	HP_0002664	98	104	128	134	True
28654546	The results reported in the present study suggest a sex-specific interaction between miR-146a and RNASEL genes in melanoma skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed	sex	cancer	55558	HP_0002664	52	55	128	134	False
16049035	A genetically determined generalized hyperexcitability had been predicted in primarily generalized seizures, but surprisingly the first epilepsy gene discovered, CHRNA4, was in a focal (frontal lobe)-onset syndrome.	CHRNA4	seizures	1137	HP_0001250	162	168	99	107	True
16049035	A genetically determined generalized hyperexcitability had been predicted in primarily generalized seizures, but surprisingly the first epilepsy gene discovered, CHRNA4, was in a focal (frontal lobe)-onset syndrome.	lobe	seizures	84335	HP_0001250	194	198	99	107	False
16049035	A genetically determined generalized hyperexcitability had been predicted in primarily generalized seizures, but surprisingly the first epilepsy gene discovered, CHRNA4, was in a focal (frontal lobe)-onset syndrome.	CHRNA4	epilepsy	1137	HP_0001250	162	168	136	144	True
16049035	A genetically determined generalized hyperexcitability had been predicted in primarily generalized seizures, but surprisingly the first epilepsy gene discovered, CHRNA4, was in a focal (frontal lobe)-onset syndrome.	lobe	epilepsy	84335	HP_0001250	194	198	136	144	False
16049035	The reason why CHRNA4 causes focal-onset seizures is unknown.	CHRNA4	seizures	1137	HP_0001250	15	21	41	49	True
16049035	Recently, the second focal (temporal lobe)-onset epilepsy gene, LGI1 (unknown function), was discovered.	lobe	epilepsy	84335	HP_0001250	37	41	49	57	False
16049035	Recently, the second focal (temporal lobe)-onset epilepsy gene, LGI1 (unknown function), was discovered.	LGI1	epilepsy	9211	HP_0001250	64	68	49	57	True
16049035	CHRNA4 led the way to mutation identifications in 15 ion channel genes, most causing primarily generalized epilepsies.	CHRNA4	epilepsies	1137	HP_0001250	0	6	107	117	True
16049035	Mutations in the EFHC1 gene (unknown function) occur in other rare JME families, and yet in other families, associations are present between JME (or other generalized epilepsies) and single nucleotide polymorphisms in the BRD2 gene (unknown function) and the malic enzyme 2 (ME2) gene.	EFHC1	epilepsies	114327	HP_0001250	17	22	167	177	True
16049035	Mutations in the EFHC1 gene (unknown function) occur in other rare JME families, and yet in other families, associations are present between JME (or other generalized epilepsies) and single nucleotide polymorphisms in the BRD2 gene (unknown function) and the malic enzyme 2 (ME2) gene.	BRD2	epilepsies	6046	HP_0001250	222	226	167	177	False
25412178	Mutations in PINK1, a mitochondrially targeted serine/threonine kinase, cause autosomal recessive Parkinson's disease (PD).	PINK1	autosomal recessive	65018	HP_0000007	13	18	78	97	True
27838789	We describe a multigenerational Saudi family with an autosomal dominant form of hypohidrotic ectodermal dysplasia in which positional mapping and exome sequencing identified a novel variant in KDF1 that fully segregates with the phenotype.	KDF1	ectodermal dysplasia	126695	HP_0000968	193	197	93	113	False
28867142	By leveraging whole-exome sequencing data on a large family-based ASD cohort, the Simons Simplex Collection, we systematically evaluated the potential role of PMMs in autism risk.	call	autism	1663	HP_0000717	121	125	167	173	False
30360578	Data on human papillomavirus (HPV) type-specific cervical cancer risk in women living with human immunodeficiency virus (WLHIV) are needed to understand HPVHIV interaction and to inform prevention programs for this population.	type	cancer	6445	HP_0002664	35	39	58	64	False
28501927	Carriers of CT or TT genotype of CCL2 rs13900 had increased risk of hearing loss at birth and at 6months of age (aOR=3.59; p=0.028 and aOR=4.10; p=0.039, respectively).	CCL2	hearing loss	6347	HP_0000365	33	37	68	80	False
30038266	Importantly, KLF4 inhibitor Kenpaullone sensitizes breast cancer cells and xenograft tumors to Paclitaxel and improves therapeutic effects.	KLF4	cancer	9314	HP_0002664	13	17	58	64	False
30038266	Importantly, KLF4 inhibitor Kenpaullone sensitizes breast cancer cells and xenograft tumors to Paclitaxel and improves therapeutic effects.	KLF4	tumors	9314	HP_0002664	13	17	85	91	False
27277385	The condition was initially termed MACS syndrome (macrocephaly, alopecia, cutis laxa, and scoliosis), based on the clinical features of the first identified family; however, with the expansion of the clinical phenotype in additional families, it was subsequently coined RIN2 syndrome.	RIN2	scoliosis	54453	HP_0002650	270	274	90	99	True
27277385	The condition was initially termed MACS syndrome (macrocephaly, alopecia, cutis laxa, and scoliosis), based on the clinical features of the first identified family; however, with the expansion of the clinical phenotype in additional families, it was subsequently coined RIN2 syndrome.	MACS	scoliosis	4082	HP_0002650	35	39	90	99	False
27277385	Patients with RIN2 syndrome present phenotypic overlap with other conditions, including EDS (especially the dermatosparaxis and kyphoscoliosis subtypes).	RIN2	scoliosis	54453	HP_0002650	14	18	133	142	True
27277385	Besides the hallmark features, this patient also presents problems not previously associated with RIN2 syndrome, including cervical vertebral fusion, mild hearing loss, and colonic fibrosis.	RIN2	cervical vertebral fusion	54453	HP_0002949	98	102	123	148	False
27277385	Besides the hallmark features, this patient also presents problems not previously associated with RIN2 syndrome, including cervical vertebral fusion, mild hearing loss, and colonic fibrosis.	RIN2	hearing loss	54453	HP_0000365	98	102	155	167	False
28081242	Leber hereditary optic neuropathy (LHON) and dominant optic atrophy (DOA), the most common forms of hereditary optic neuropathy, are easily confused, and it is difficult to distinguish one from the other in the clinic, especially in young children.	LHON	neuropathy	100873240	HP_0009830	35	39	23	33	False
28081242	Leber hereditary optic neuropathy (LHON) and dominant optic atrophy (DOA), the most common forms of hereditary optic neuropathy, are easily confused, and it is difficult to distinguish one from the other in the clinic, especially in young children.	LHON	optic atrophy	100873240	HP_0000648	35	39	54	67	False
28081242	The present study was designed to survey the mutation spectrum of common pathogenic genes (OPA1, OPA3 and mtDNA genes) and to analyze the genotype-phenotype characteristics of Chinese patients with suspected childhood-onset hereditary optic neuropathy.	OPA1	neuropathy	9968	HP_0009830	91	95	241	251	False
28081242	The present study was designed to survey the mutation spectrum of common pathogenic genes (OPA1, OPA3 and mtDNA genes) and to analyze the genotype-phenotype characteristics of Chinese patients with suspected childhood-onset hereditary optic neuropathy.	OPA3	neuropathy	80207	HP_0009830	97	101	241	251	True
28081242	This study expanded the OPA1 mutation spectrum, and our results showed that OPA1 mutation is another common cause of childhood-onset hereditary optic neuropathy in Chinese pediatric patients, especially those with disease onset during preschool age	OPA1	neuropathy	9968	HP_0009830	24	28	150	160	False
28176809	Recessive mutations in the secreted metalloprotease ADAMTS17 cause ectopia lentis and short stature in humans with Weill-Marchesani-like syndrome and primary open angle glaucoma and ectopia lentis in dogs.	ADAMTS17	ectopia lentis	170691	HP_0001083	52	60	67	81	True
28176809	Recessive mutations in the secreted metalloprotease ADAMTS17 cause ectopia lentis and short stature in humans with Weill-Marchesani-like syndrome and primary open angle glaucoma and ectopia lentis in dogs.	ADAMTS17	short stature	170691	HP_0004322	52	60	86	99	True
28176809	Recessive mutations in the secreted metalloprotease ADAMTS17 cause ectopia lentis and short stature in humans with Weill-Marchesani-like syndrome and primary open angle glaucoma and ectopia lentis in dogs.	ADAMTS17	glaucoma	170691	HP_0000501	52	60	169	177	True
18264100	Studying consanguineous families with Ghosal hematodiaphyseal dysplasia syndrome (GHDD), a disorder of increased bone density, we identified mutations in TBXAS1, which encodes thromboxane synthase (TXAS).	TBXAS1	increased bone density	6916	HP_0011001	154	160	103	125	True
18264100	Studying consanguineous families with Ghosal hematodiaphyseal dysplasia syndrome (GHDD), a disorder of increased bone density, we identified mutations in TBXAS1, which encodes thromboxane synthase (TXAS).	TXAS	increased bone density	6916	HP_0011001	198	202	103	125	True
28496128	To explore novel molecular mechanisms underlying obesity, we applied a systems genetics framework to integrate risk genetic loci from the largest body mass index (BMI) genome-wide association studies (GWAS) meta-analysis with mRNA and microRNA profiling in adipose tissue from 200 subjects.	mass	obesity	2200	HP_0001513	151	155	49	56	False
28496128	We identified eight hub genes which likely play important roles in obesity metabolism and identified microRNAs that significantly negatively correlated with hub genes.	hub	obesity	1993	HP_0001513	20	23	67	74	False
28496128	The results indicated that increased GPD1L in adipose tissue may have a significant therapeutic potential in reducing obesity and insulin resistance	GPD1L	obesity	23171	HP_0001513	37	42	118	125	False
27442376	BEN is a primary, chronic tubulointerstitial nephritis characterized with chronic anemia, absence of edema, xantoderma, normal blood pressure and normal findings on the fundus oculi.	BEN	tubulointerstitial nephritis	9569	HP_0001970	0	3	26	54	False
29507255	The CSIRO National NBN Telehealth Trial investigated the effects of introducing at home telemonitoring of vital signs for the management of a heterogeneous group of chronically ill patients.	NBN	heterogeneous	9048	HP_0001425	19	22	142	155	False
29758293	We studied a consanguineous Pakistani family with postnatal microcephaly, orofacial dyskinesia, spastic quadriplegia and, on MRI, cortical atrophy with myelination delay, suggestive of a FOXG1-like presentation.	FOXG1	microcephaly	2290	HP_0000252	187	192	60	72	True
29758293	We studied a consanguineous Pakistani family with postnatal microcephaly, orofacial dyskinesia, spastic quadriplegia and, on MRI, cortical atrophy with myelination delay, suggestive of a FOXG1-like presentation.	FOXG1	orofacial dyskinesia	2290	HP_0002310	187	192	74	94	False
29758293	We studied a consanguineous Pakistani family with postnatal microcephaly, orofacial dyskinesia, spastic quadriplegia and, on MRI, cortical atrophy with myelination delay, suggestive of a FOXG1-like presentation.	FOXG1	spastic quadriplegia	2290	HP_0002510	187	192	96	116	False
29758293	We studied a consanguineous Pakistani family with postnatal microcephaly, orofacial dyskinesia, spastic quadriplegia and, on MRI, cortical atrophy with myelination delay, suggestive of a FOXG1-like presentation.	FOXG1	cortical atrophy	2290	HP_0002120	187	192	130	146	True
29758293	The regulation of the post-mitotic neural survival activity of TLE1 depends critically on an interaction with FOXG1, a gene shown to be involved in a postnatal microcephaly syndrome.	FOXG1	microcephaly	2290	HP_0000252	110	115	160	172	True
29758293	The regulation of the post-mitotic neural survival activity of TLE1 depends critically on an interaction with FOXG1, a gene shown to be involved in a postnatal microcephaly syndrome.	TLE1	microcephaly	7088	HP_0000252	63	67	160	172	False
27988457	Lucitanib is a small molecule inhibitor of vascular endothelial growth factor (VEGF) receptors 1 to 3 (VEGFR1 to 3), platelet derived growth factor / (PDGFR/) and FGFR1-3 tyrosine kinases and has demonstrated activity in a phase I/II clinical study, with objective RECIST responses in breast cancer patients with FGFR1 or FGF3/4/19 gene amplification, as well as in patients anticipated to benefit from anti-angiogenic agents.	VEGF	cancer	7422	HP_0002664	79	83	296	302	False
27988457	Lucitanib is a small molecule inhibitor of vascular endothelial growth factor (VEGF) receptors 1 to 3 (VEGFR1 to 3), platelet derived growth factor / (PDGFR/) and FGFR1-3 tyrosine kinases and has demonstrated activity in a phase I/II clinical study, with objective RECIST responses in breast cancer patients with FGFR1 or FGF3/4/19 gene amplification, as well as in patients anticipated to benefit from anti-angiogenic agents.	FGFR1	cancer	2260	HP_0002664	167	172	296	302	True
27988457	We report here the in vitro and in vivo antitumor activity of lucitanib in experimental models with or without FGFR1/2 amplification or mutations.	FGFR1	tumor	2260	HP_0002664	111	116	44	49	True
27988457	In cell assays, lucitanib potently inhibited the growth of tumor cell lines with amplified FGFR1 or mutated/amplified FGFR2.	FGFR1	tumor	2260	HP_0002664	91	96	59	64	True
27988457	In cell assays, lucitanib potently inhibited the growth of tumor cell lines with amplified FGFR1 or mutated/amplified FGFR2.	FGFR2	tumor	2263	HP_0002664	118	123	59	64	True
27988457	Notably, in two lung cancer models with FGFR1 amplification, the antitumor efficacy was higher, suggesting that the simultaneous inhibition of VEGF and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.	VEGF	tumor	7422	HP_0002664	143	147	69	74	False
27988457	Notably, in two lung cancer models with FGFR1 amplification, the antitumor efficacy was higher, suggesting that the simultaneous inhibition of VEGF and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.	FGFR1	tumor	2260	HP_0002664	40	45	69	74	True
27988457	Notably, in two lung cancer models with FGFR1 amplification, the antitumor efficacy was higher, suggesting that the simultaneous inhibition of VEGF and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.	VEGF	cancer	7422	HP_0002664	143	147	21	27	False
27988457	Notably, in two lung cancer models with FGFR1 amplification, the antitumor efficacy was higher, suggesting that the simultaneous inhibition of VEGF and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.	FGFR1	cancer	2260	HP_0002664	40	45	21	27	True
27988457	Similar antitumor activity was observed in FGFR2 wild-type and amplified or mutated xenograft models.	FGFR2	tumor	2263	HP_0002664	43	48	12	17	True
27422265	Peripheral neuropathy (PNP) remains one of the most frequent side-effects experienced by patients who receive these novel agents.	PNP	neuropathy	5539	HP_0009830	23	26	11	21	False
30138348	Based on our analysis of fold-change in gene expression as a function of disease stage (i.e., early vs. advanced), coupled with consideration of the known relevant functions of these genes, we focused on four candidate genes, ACSL4, GNMT, IFI27, and miR122, which are expressed stage-specifically in HCV mono- and HIV-1/HCV co-infective liver disease and are known to play a pivotal role in regulating HCV-mediated hepatocellular carcinoma (HCC).	ACSL4	hepatocellular carcinoma	2182	HP_0001402	226	231	415	439	False
30138348	Based on our analysis of fold-change in gene expression as a function of disease stage (i.e., early vs. advanced), coupled with consideration of the known relevant functions of these genes, we focused on four candidate genes, ACSL4, GNMT, IFI27, and miR122, which are expressed stage-specifically in HCV mono- and HIV-1/HCV co-infective liver disease and are known to play a pivotal role in regulating HCV-mediated hepatocellular carcinoma (HCC).	GNMT	hepatocellular carcinoma	27232	HP_0001402	233	237	415	439	False
30138348	Based on our analysis of fold-change in gene expression as a function of disease stage (i.e., early vs. advanced), coupled with consideration of the known relevant functions of these genes, we focused on four candidate genes, ACSL4, GNMT, IFI27, and miR122, which are expressed stage-specifically in HCV mono- and HIV-1/HCV co-infective liver disease and are known to play a pivotal role in regulating HCV-mediated hepatocellular carcinoma (HCC).	IFI27	hepatocellular carcinoma	3429	HP_0001402	239	244	415	439	False
30138348	Based on our analysis of fold-change in gene expression as a function of disease stage (i.e., early vs. advanced), coupled with consideration of the known relevant functions of these genes, we focused on four candidate genes, ACSL4, GNMT, IFI27, and miR122, which are expressed stage-specifically in HCV mono- and HIV-1/HCV co-infective liver disease and are known to play a pivotal role in regulating HCV-mediated hepatocellular carcinoma (HCC).	HCC	hepatocellular carcinoma	84668	HP_0001402	441	444	415	439	False
27449031	Hypermethylated in cancer 1 (HIC1) is frequently deleted or epigenetically silenced in various human cancers.	HIC1	cancer	3090	HP_0002664	29	33	19	25	False
27449031	In this study, we found that HIC1 acted as a tumor suppressor and that its expression was downregulated in UM.	HIC1	tumor	3090	HP_0002664	29	33	45	50	False
27449031	The results provide evidence that lncRNA-numb is a newly proposed tumor suppressor that is involved in HIC1-induced phenotypes.	HIC1	tumor	3090	HP_0002664	103	107	66	71	False
27449031	Taken together, our studies of UM reveal a critical role of HIC1 in the regulation of tumorigenesis, at least partly through its downstream target, lncRNA-numb, and provide a potential therapeutic target for UM	HIC1	tumor	3090	HP_0002664	60	64	86	91	False
30249986	Oxidative stress, which is induced by reactive oxygen species (ROS), causes cellular damage which contributes to the pathogenesis of neurodegenerative diseases.	ROS	neurodegenerative diseases	6098	HP_0002180	63	66	133	159	False
30249986	Oxidative stress, which is induced by reactive oxygen species (ROS), causes cellular damage which contributes to the pathogenesis of neurodegenerative diseases.	damage	neurodegenerative diseases	51438	HP_0002180	85	91	133	159	False
30249986	First, we tested whether the pretreatment of <i>Momordica charantia</i> ethanol extract (MCEE) attenuates HO-induced cell death in human neuroblastoma SK-N-MC cells.	MCEE	neuroblastoma	84693	HP_0003006	89	93	139	152	False
30249986	First, we tested whether the pretreatment of <i>Momordica charantia</i> ethanol extract (MCEE) attenuates HO-induced cell death in human neuroblastoma SK-N-MC cells.	SK	neuroblastoma	22943	HP_0003006	153	155	139	152	False
23064016	Deficiency of the extracellular matrix molecule FRAS1, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (Fras1(bl/bl)) mice.	FRAS1	bilateral	80144	HP_0012832	48	53	104	113	False
23064016	Deficiency of the extracellular matrix molecule FRAS1, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (Fras1(bl/bl)) mice.	Fras1	bilateral	80144	HP_0012832	173	178	104	113	False
23064016	Deficiency of the extracellular matrix molecule FRAS1, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (Fras1(bl/bl)) mice.	mice	bilateral	23581	HP_0012832	187	191	104	113	False
23064016	Deficiency of the extracellular matrix molecule FRAS1, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (Fras1(bl/bl)) mice.	FRAS1	renal agenesis	80144	HP_0000104	48	53	114	128	False
23064016	Deficiency of the extracellular matrix molecule FRAS1, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (Fras1(bl/bl)) mice.	Fras1	renal agenesis	80144	HP_0000104	173	178	114	128	False
23064016	Deficiency of the extracellular matrix molecule FRAS1, normally expressed by the ureteric bud, leads to bilateral renal agenesis in humans with Fraser syndrome and blebbed (Fras1(bl/bl)) mice.	mice	renal agenesis	23581	HP_0000104	187	191	114	128	False
23064016	This prevented renal agenesis in Fras1(bl/bl) mice, permitting kidney development and postnatal survival.	Fras1	renal agenesis	80144	HP_0000104	33	38	15	29	False
23064016	This prevented renal agenesis in Fras1(bl/bl) mice, permitting kidney development and postnatal survival.	mice	renal agenesis	23581	HP_0000104	46	50	15	29	False
30089113	The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.	MMP9	tumor	4318	HP_0002664	28	32	76	81	False
30089113	The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.	SERPINE2	tumor	5270	HP_0002664	34	42	76	81	False
30089113	The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.	CAV1	tumor	857	HP_0002664	44	48	76	81	False
30089113	The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.	KRT14	tumor	3861	HP_0002664	50	55	76	81	True
30089113	The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.	RASA3	tumor	22821	HP_0002664	61	66	76	81	False
30089113	The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.	PPARG	tumor	5468	HP_0002664	88	93	76	81	False
30089113	The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.	CTSE	tumor	1510	HP_0002664	101	105	76	81	False
30089113	The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.	CDK3	tumor	1018	HP_0002664	107	111	76	81	False
30089113	The enriched genes included MMP9, SERPINE2, CAV1, KRT14, and RASA3 in basal tumors, and PPARG, LY6E, CTSE, CDK3, and TBX2 in luminal tumors.	TBX2	tumor	6909	HP_0002664	117	121	76	81	False
30231359	The incidence rate of hepatocellular carcinoma (HCC) is rising.	HCC	hepatocellular carcinoma	84668	HP_0001402	48	51	22	46	False
30231359	The incidence rate of hepatocellular carcinoma (HCC) is rising.	ide	hepatocellular carcinoma	3416	HP_0001402	7	10	22	46	False
29694336	Additionally, despite GDAP1 affecting mitochondrial functionality, and hence being of great importance to cellular function, the GDAP1associated Charcot-Marie-Tooth disease is mainly characterized by axonal degeneration.	GDAP1	axonal degeneration	54332	HP_0040078	22	27	201	220	True
29694336	Additionally, despite GDAP1 affecting mitochondrial functionality, and hence being of great importance to cellular function, the GDAP1associated Charcot-Marie-Tooth disease is mainly characterized by axonal degeneration.	great	axonal degeneration	122042	HP_0040078	86	91	201	220	False
29689622	To investigate the presence of specific chromosomal and gene alterations, BAP1 protein expression, and their relationship with distant progression free survival (DPFS), we analyzed tumor samples from 63 UM patients (40 men and 23 women, with a median age of 64 years), who underwent eye enucleation by a single cancer ophthalmologist from December 2005 to June 2016.	BAP1	tumor	154043	HP_0002664	74	78	181	186	False
29689622	To investigate the presence of specific chromosomal and gene alterations, BAP1 protein expression, and their relationship with distant progression free survival (DPFS), we analyzed tumor samples from 63 UM patients (40 men and 23 women, with a median age of 64 years), who underwent eye enucleation by a single cancer ophthalmologist from December 2005 to June 2016.	men	tumor	8178	HP_0002664	219	222	181	186	False
29689622	To investigate the presence of specific chromosomal and gene alterations, BAP1 protein expression, and their relationship with distant progression free survival (DPFS), we analyzed tumor samples from 63 UM patients (40 men and 23 women, with a median age of 64 years), who underwent eye enucleation by a single cancer ophthalmologist from December 2005 to June 2016.	BAP1	cancer	154043	HP_0002664	74	78	311	317	False
29689622	To investigate the presence of specific chromosomal and gene alterations, BAP1 protein expression, and their relationship with distant progression free survival (DPFS), we analyzed tumor samples from 63 UM patients (40 men and 23 women, with a median age of 64 years), who underwent eye enucleation by a single cancer ophthalmologist from December 2005 to June 2016.	men	cancer	8178	HP_0002664	219	222	311	317	False
24413982	Spinocerebellar ataxia type 17 (SCA17) is caused by CAG repeat expansion in the TATA-box binding protein gene.	type	ataxia	6445	HP_0001251	23	27	16	22	False
24413982	Spinocerebellar ataxia type 17 (SCA17) is caused by CAG repeat expansion in the TATA-box binding protein gene.	SCA17	ataxia	6908	HP_0001251	32	37	16	22	True
30641643	Immunohistochemically, tumor cells of all cases were positive for vimentin (100.0%, 60/60), STAT6 (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, bcl-2, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-cadherin, GFAP.	STAT6	tumor	6778	HP_0002664	92	97	23	28	False
30641643	Immunohistochemically, tumor cells of all cases were positive for vimentin (100.0%, 60/60), STAT6 (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, bcl-2, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-cadherin, GFAP.	bcl-2	tumor	596	HP_0002664	189	194	23	28	True
30641643	Immunohistochemically, tumor cells of all cases were positive for vimentin (100.0%, 60/60), STAT6 (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, bcl-2, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-cadherin, GFAP.	EMA	tumor	2108	HP_0002664	196	199	23	28	False
30641643	Immunohistochemically, tumor cells of all cases were positive for vimentin (100.0%, 60/60), STAT6 (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, bcl-2, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-cadherin, GFAP.	SSTR2	tumor	6752	HP_0002664	204	209	23	28	False
30641643	Immunohistochemically, tumor cells of all cases were positive for vimentin (100.0%, 60/60), STAT6 (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, bcl-2, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-cadherin, GFAP.	cadherin	tumor	1015	HP_0002664	255	263	23	28	False
24590288	The autosomal recessive neurodegenerative disease spinal muscular atrophy (SMA) results from low levels of survival motor neuron (SMN) protein; however, it is unclear how reduced SMN promotes SMA development.	SMA	autosomal recessive	6606	HP_0000007	75	78	4	23	True
24590288	The autosomal recessive neurodegenerative disease spinal muscular atrophy (SMA) results from low levels of survival motor neuron (SMN) protein; however, it is unclear how reduced SMN promotes SMA development.	SMN	autosomal recessive	6638	HP_0000007	130	133	4	23	False
24590288	The autosomal recessive neurodegenerative disease spinal muscular atrophy (SMA) results from low levels of survival motor neuron (SMN) protein; however, it is unclear how reduced SMN promotes SMA development.	SMA	neurodegenerative disease	6606	HP_0002180	75	78	24	49	False
24590288	The autosomal recessive neurodegenerative disease spinal muscular atrophy (SMA) results from low levels of survival motor neuron (SMN) protein; however, it is unclear how reduced SMN promotes SMA development.	SMN	neurodegenerative disease	6638	HP_0002180	130	133	24	49	False
29391579	Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.	TRAPPC2	intellectual disability	6399	HP_0001249	103	110	191	214	False
29391579	Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.	TRAPPC9	intellectual disability	83696	HP_0001249	112	119	191	214	True
29391579	Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.	TRAPPC11	intellectual disability	60684	HP_0001249	124	132	191	214	True
29391579	Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.	TRAPPC2	skeletal abnormalities	6399	HP_0000924	103	110	167	189	True
29391579	Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.	TRAPPC9	skeletal abnormalities	83696	HP_0000924	112	119	167	189	True
29391579	Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.	TRAPPC11	skeletal abnormalities	60684	HP_0000924	124	132	167	189	True
29391579	Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.	TRAPPC2	speech impairment	6399	HP_0002167	103	110	216	233	False
29391579	Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.	TRAPPC9	speech impairment	83696	HP_0002167	112	119	216	233	False
29391579	Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.	TRAPPC11	speech impairment	60684	HP_0002167	124	132	216	233	True
29391579	Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.	TRAPPC2	developmental delay	6399	HP_0001263	103	110	238	257	False
29391579	Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.	TRAPPC9	developmental delay	83696	HP_0001263	112	119	238	257	True
29391579	Mutations have previously been reported in several members of the TRAPP complex of proteins, including TRAPPC2, TRAPPC9 and TRAPPC11, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and developmental delay.	TRAPPC11	developmental delay	60684	HP_0001263	124	132	238	257	True
29348788	We investigated the possible association between chemoresistance and cellular redox state regulation in patients undergoing neoadjuvant chemotherapy (NACT) for breast cancer.	NACT	cancer	284111	HP_0002664	150	154	167	173	False
29348788	In total, 53 women with primarily inoperable or inflammatory breast cancer who were treated with NACT were included in the study.	NACT	cancer	284111	HP_0002664	97	101	68	74	False
29348788	Pre-NACT core needle biopsies and postoperative tumor samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), thioredoxin (Trx), and peroxiredoxin I (Prx I).	NACT	tumor	284111	HP_0002664	4	8	48	53	False
29348788	Pre-NACT core needle biopsies and postoperative tumor samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), thioredoxin (Trx), and peroxiredoxin I (Prx I).	Nrf2	tumor	2551	HP_0002664	146	150	48	53	False
29348788	Pre-NACT core needle biopsies and postoperative tumor samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), thioredoxin (Trx), and peroxiredoxin I (Prx I).	Keap1	tumor	9817	HP_0002664	190	195	48	53	True
29348788	Pre-NACT core needle biopsies and postoperative tumor samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), thioredoxin (Trx), and peroxiredoxin I (Prx I).	Trx	tumor	7295	HP_0002664	211	214	48	53	False
29348788	Pre-NACT core needle biopsies and postoperative tumor samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), thioredoxin (Trx), and peroxiredoxin I (Prx I).	Prx	tumor	25824	HP_0002664	238	241	48	53	False
29348788	Higher pre-NACT nuclear Prx I expression predicted smaller size of a resected tumor (<i>p</i> = 0.00052; <i>r</i> = -0.550), and higher pre-NACT cytoplasmic Prx I expression predicted a lower amount of evacuated nodal metastasis (<i>p</i> = 0.0024; <i>r</i> = -0.472).	NACT	tumor	284111	HP_0002664	11	15	78	83	False
29348788	Higher pre-NACT nuclear Prx I expression predicted smaller size of a resected tumor (<i>p</i> = 0.00052; <i>r</i> = -0.550), and higher pre-NACT cytoplasmic Prx I expression predicted a lower amount of evacuated nodal metastasis (<i>p</i> = 0.0024; <i>r</i> = -0.472).	Prx	tumor	25824	HP_0002664	24	27	78	83	False
29348788	Higher pre-NACT nuclear Prx I expression predicted smaller size of a resected tumor (<i>p</i> = 0.00052; <i>r</i> = -0.550), and higher pre-NACT cytoplasmic Prx I expression predicted a lower amount of evacuated nodal metastasis (<i>p</i> = 0.0024; <i>r</i> = -0.472).	nodal	tumor	4838	HP_0002664	212	217	78	83	True
29653744	B cell-associated protein 31 (BAP31) was shown to participate in the apoptosis, and to be an immunotherapy target and a, prognostic factor for cancer, but its role in CRC has not been elucidated.	BAP31	cancer	10134	HP_0002664	30	35	143	149	False
30272267	Familial adenomatous polyposis (FAP) is an autosomal dominantinherited colorectal cancer.	FAP	cancer	2191	HP_0002664	32	35	83	89	False
29600549	Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (PKD), paroxysmal nonkinesigenic dyskinesia (PNKD), and episodic ataxia type 1 or 2.	PKD	episodic	5587	HP_0025303	113	116	168	176	False
29600549	Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (PKD), paroxysmal nonkinesigenic dyskinesia (PNKD), and episodic ataxia type 1 or 2.	PNKD	episodic	25953	HP_0025303	157	161	168	176	False
29600549	Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (PKD), paroxysmal nonkinesigenic dyskinesia (PNKD), and episodic ataxia type 1 or 2.	type	episodic	6445	HP_0025303	184	188	168	176	False
29600549	Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (PKD), paroxysmal nonkinesigenic dyskinesia (PNKD), and episodic ataxia type 1 or 2.	PKD	ataxia	5587	HP_0001251	113	116	177	183	False
29600549	Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (PKD), paroxysmal nonkinesigenic dyskinesia (PNKD), and episodic ataxia type 1 or 2.	PNKD	ataxia	25953	HP_0001251	157	161	177	183	False
29600549	Routine gene testing is not necessary to guide treatment for typical forms of paroxysmal kinesigenic dyskinesia (PKD), paroxysmal nonkinesigenic dyskinesia (PNKD), and episodic ataxia type 1 or 2.	type	ataxia	6445	HP_0001251	184	188	177	183	False
29600549	Antiepileptic drugs remain the treatment of choice for PKD and episodic ataxia type 1, benzodiazepines are often useful for PNKD, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology	PKD	episodic	5587	HP_0025303	55	58	63	71	False
29600549	Antiepileptic drugs remain the treatment of choice for PKD and episodic ataxia type 1, benzodiazepines are often useful for PNKD, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology	PNKD	episodic	25953	HP_0025303	124	128	63	71	False
29600549	Antiepileptic drugs remain the treatment of choice for PKD and episodic ataxia type 1, benzodiazepines are often useful for PNKD, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology	type	episodic	6445	HP_0025303	79	83	63	71	False
29600549	Antiepileptic drugs remain the treatment of choice for PKD and episodic ataxia type 1, benzodiazepines are often useful for PNKD, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology	PKD	ataxia	5587	HP_0001251	55	58	72	78	False
29600549	Antiepileptic drugs remain the treatment of choice for PKD and episodic ataxia type 1, benzodiazepines are often useful for PNKD, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology	PNKD	ataxia	25953	HP_0001251	124	128	72	78	False
29600549	Antiepileptic drugs remain the treatment of choice for PKD and episodic ataxia type 1, benzodiazepines are often useful for PNKD, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology	type	ataxia	6445	HP_0001251	79	83	72	78	False
26293662	Two sisters with c.137T&gt;C (p.Leu46Pro) PIGY variants had multi-system disease including dysmorphism, seizures, severe developmental delay, cataracts and early death.	PIGY	seizures	84992	HP_0001250	42	46	104	112	True
26293662	Two sisters with c.137T&gt;C (p.Leu46Pro) PIGY variants had multi-system disease including dysmorphism, seizures, severe developmental delay, cataracts and early death.	PIGY	developmental delay	84992	HP_0001263	42	46	121	140	True
26293662	Two sisters with c.137T&gt;C (p.Leu46Pro) PIGY variants had multi-system disease including dysmorphism, seizures, severe developmental delay, cataracts and early death.	PIGY	cataracts	84992	HP_0000518	42	46	142	151	True
28081727	MicroRNA-200a (miR-200a) is frequently downregulated in most cancer types and plays an important role in carcinogenesis and cancer progression.	miR	cancer	220972	HP_0002664	15	18	61	67	False
28081727	In this study, we determined that miR-200a was downregulated in hepatocellular carcinoma (HCC) tissues and cell lines, consistent with the results of our previous study.	miR	hepatocellular carcinoma	220972	HP_0001402	34	37	64	88	False
28081727	In this study, we determined that miR-200a was downregulated in hepatocellular carcinoma (HCC) tissues and cell lines, consistent with the results of our previous study.	HCC	hepatocellular carcinoma	84668	HP_0001402	90	93	64	88	False
28081727	Taken together, these data provide novel information for comprehending the tumor-suppressive role of miR-200a in HCC pathogenesis through inhibition of GAB1 translation	miR	tumor	220972	HP_0002664	101	104	75	80	False
28081727	Taken together, these data provide novel information for comprehending the tumor-suppressive role of miR-200a in HCC pathogenesis through inhibition of GAB1 translation	HCC	tumor	84668	HP_0002664	113	116	75	80	False
28081727	Taken together, these data provide novel information for comprehending the tumor-suppressive role of miR-200a in HCC pathogenesis through inhibition of GAB1 translation	GAB1	tumor	128869	HP_0002664	152	156	75	80	False
24269018	We analyzed the nucleotide repeat lengths of 6 genes (ATXN8, ATXN10, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with ALS and healthy control subjects.	ALS	sporadic	3483	HP_0003745	224	227	201	209	False
24269018	We analyzed the nucleotide repeat lengths of 6 genes (ATXN8, ATXN10, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with ALS and healthy control subjects.	ATXN8	sporadic	724066	HP_0003745	54	59	201	209	False
24269018	We analyzed the nucleotide repeat lengths of 6 genes (ATXN8, ATXN10, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with ALS and healthy control subjects.	ATXN10	sporadic	25814	HP_0003745	61	67	201	209	False
24269018	We analyzed the nucleotide repeat lengths of 6 genes (ATXN8, ATXN10, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with ALS and healthy control subjects.	PPP2R2B	sporadic	5521	HP_0003745	69	76	201	209	False
24269018	We analyzed the nucleotide repeat lengths of 6 genes (ATXN8, ATXN10, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with ALS and healthy control subjects.	NOP56	sporadic	10528	HP_0003745	78	83	201	209	False
24269018	We analyzed the nucleotide repeat lengths of 6 genes (ATXN8, ATXN10, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with ALS and healthy control subjects.	DMPK	sporadic	1760	HP_0003745	85	89	201	209	False
24269018	We analyzed the nucleotide repeat lengths of 6 genes (ATXN8, ATXN10, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred sporadic patients with ALS and healthy control subjects.	JPH3	sporadic	57338	HP_0003745	95	99	201	209	False
29680514	The increased levels of SELENBP1 and Glycogen synthase kinase 3 subunit  (GSK3) genes in contrast with reduced levels of B-cell translocation gene 1 (BTG1), human leukocyte antigen DRB1 (HLA-DRB1), heterogeneous nuclear ribonucleoprotein A3 (HNRPA3), and serine/arginine-rich splicing factor 1 (SFRS1) genes have also been reported.	SELENBP1	heterogeneous	8991	HP_0001425	24	32	200	213	False
29680514	The increased levels of SELENBP1 and Glycogen synthase kinase 3 subunit  (GSK3) genes in contrast with reduced levels of B-cell translocation gene 1 (BTG1), human leukocyte antigen DRB1 (HLA-DRB1), heterogeneous nuclear ribonucleoprotein A3 (HNRPA3), and serine/arginine-rich splicing factor 1 (SFRS1) genes have also been reported.	BTG1	heterogeneous	694	HP_0001425	152	156	200	213	False
29680514	The increased levels of SELENBP1 and Glycogen synthase kinase 3 subunit  (GSK3) genes in contrast with reduced levels of B-cell translocation gene 1 (BTG1), human leukocyte antigen DRB1 (HLA-DRB1), heterogeneous nuclear ribonucleoprotein A3 (HNRPA3), and serine/arginine-rich splicing factor 1 (SFRS1) genes have also been reported.	DRB1	heterogeneous	129831	HP_0001425	183	187	200	213	False
29680514	The increased levels of SELENBP1 and Glycogen synthase kinase 3 subunit  (GSK3) genes in contrast with reduced levels of B-cell translocation gene 1 (BTG1), human leukocyte antigen DRB1 (HLA-DRB1), heterogeneous nuclear ribonucleoprotein A3 (HNRPA3), and serine/arginine-rich splicing factor 1 (SFRS1) genes have also been reported.	HNRPA3	heterogeneous	220988	HP_0001425	244	250	200	213	False
29680514	The increased levels of SELENBP1 and Glycogen synthase kinase 3 subunit  (GSK3) genes in contrast with reduced levels of B-cell translocation gene 1 (BTG1), human leukocyte antigen DRB1 (HLA-DRB1), heterogeneous nuclear ribonucleoprotein A3 (HNRPA3), and serine/arginine-rich splicing factor 1 (SFRS1) genes have also been reported.	SFRS1	heterogeneous	6426	HP_0001425	297	302	200	213	False
29572195	Biallelic UNC80 mutations cause infantile hypotonia with psychomotor retardation and characteristic facies 2 (IHPRF2), which is characterized by hypotonia, developmental delay (DD)/intellectual disability (ID), intrauterine growth retardation, postnatal growth retardation and characteristic facial features.	UNC80	developmental delay	285175	HP_0001263	10	15	156	175	True
29572195	Biallelic UNC80 mutations cause infantile hypotonia with psychomotor retardation and characteristic facies 2 (IHPRF2), which is characterized by hypotonia, developmental delay (DD)/intellectual disability (ID), intrauterine growth retardation, postnatal growth retardation and characteristic facial features.	UNC80	intellectual disability	285175	HP_0001249	10	15	181	204	True
29572195	Furthermore, we herein summarize the genotypes and phenotypes of patients with UNC80 mutations reported in the literature, revealing that IHPRF2 is a phenotypically heterogeneous disease.	UNC80	heterogeneous	285175	HP_0001425	79	84	165	178	False
29572195	Common facial dysmorphisms include a thin upper lip, a tented upper lip, a triangular face, strabismus and microcephaly.	lip	facial dysmorphisms	23049	HP_0001999	48	51	7	26	False
29572195	Common facial dysmorphisms include a thin upper lip, a tented upper lip, a triangular face, strabismus and microcephaly.	lip	triangular face	23049	HP_0000325	48	51	75	90	False
29572195	Common facial dysmorphisms include a thin upper lip, a tented upper lip, a triangular face, strabismus and microcephaly.	lip	strabismus	23049	HP_0000486	48	51	92	102	False
29572195	Common facial dysmorphisms include a thin upper lip, a tented upper lip, a triangular face, strabismus and microcephaly.	lip	microcephaly	23049	HP_0000252	48	51	107	119	False
30247156	The underlying molecular mechanisms of age-related hearing loss (ARHL) in humans and many strains of mice have not been fully characterized.	mice	hearing loss	23581	HP_0000365	101	105	51	63	False
30247156	Raptor-cKO mice developed hearing loss considerably more slowly than WT littermates.	mice	hearing loss	23581	HP_0000365	11	15	26	38	False
30247156	Raptor-cKO mice developed hearing loss considerably more slowly than WT littermates.	Raptor	hearing loss	57521	HP_0000365	0	6	26	38	False
30247156	Conversely, Tsc1 loss led to the early-onset death of cochlear hair cells and consequently accelerated hearing loss.	Tsc1	hearing loss	7248	HP_0000365	12	16	103	115	False
29771872	Among the 363 outbreaks with a confirmed infectious etiology, 212 (58%) were caused by Cryptosporidium (which causes predominantly gastrointestinal illness), 57 (16%) by Legionella (which causes Legionnaires' disease, a severe pneumonia, and Pontiac fever, a milder illness with flu-like symptoms), and 47 (13%) by Pseudomonas (which causes folliculitis [&quot;hot tub rash&quot;] and otitis externa [&quot;swimmers' ear&quot;]).	tub	pneumonia	7275	HP_0002090	365	368	227	236	False
28377594	This study investigated the TGFBI gene mutation types in outpatients clinically diagnosed with granular corneal dystrophy (GCD) prior to phototherapeutic keratectomy (PTK), also calculated the mutation rate of subjects with normal corneas, but positive family history.	TGFBI	corneal dystrophy	7045	HP_0001131	28	33	104	121	True
28377594	This study investigated the TGFBI gene mutation types in outpatients clinically diagnosed with granular corneal dystrophy (GCD) prior to phototherapeutic keratectomy (PTK), also calculated the mutation rate of subjects with normal corneas, but positive family history.	PTK	corneal dystrophy	2185	HP_0001131	167	170	104	121	False
28377594	This study investigated the TGFBI gene mutation types in outpatients clinically diagnosed with granular corneal dystrophy (GCD) prior to phototherapeutic keratectomy (PTK), also calculated the mutation rate of subjects with normal corneas, but positive family history.	type	corneal dystrophy	6445	HP_0001131	48	52	104	121	False
30098828	High TROP2 expression plays an important role in promoting tumor development and aggressiveness, which is correlated with reduced patient survival.	TROP2	tumor	4070	HP_0002664	5	10	59	64	False
30098828	High TROP2 expression plays an important role in promoting tumor development and aggressiveness, which is correlated with reduced patient survival.	TROP2	aggressiveness	4070	HP_0000718	5	10	81	95	False
29739933	Our results demonstrate that adenomyoepitheliomas are genetically heterogeneous, and qualify mutations in HRAS, a gene whose mutations are vanishingly rare in common-type breast cancers, as likely drivers of ER-negative adenomyoepitheliomas	HRAS	heterogeneous	3265	HP_0001425	106	110	66	79	False
26251151	In an effort to identify new mutations responsible for DBA, we performed whole-exome sequencing analysis of 48 patients with no documented mutations/deletions in our first screening and identified a de novo splicing error mutation in RPL27 and a frameshift deletion in RPS27 in sporadic patients with DBA.	DBA	sporadic	6223	HP_0003745	55	58	278	286	False
26251151	In an effort to identify new mutations responsible for DBA, we performed whole-exome sequencing analysis of 48 patients with no documented mutations/deletions in our first screening and identified a de novo splicing error mutation in RPL27 and a frameshift deletion in RPS27 in sporadic patients with DBA.	RPL27	sporadic	6155	HP_0003745	234	239	278	286	False
26959537	Previous studies have demonstrated that COX15 mutations are associated with typical LS as well as fatal infantile hypertrophic cardiomyopathy.	COX15	cardiomyopathy	1355	HP_0001638	40	45	127	141	True
29121203	Targeted exome sequencing identified biallelic mutations in WDR19, encoding an IFT-A subunit previously associated with MZSDS-related chondrodysplasia, Jeune asphyxiating thoracic dysplasia and cranioectodermal dysplasia, linked to primary cilia dysfunction, and in TEKT1 which encodes tektin-1 an uncharacterized member of the tektin family, mutations of which may cause ciliary dyskinesia.	WDR19	ciliary dyskinesia	57728	HP_0012265	60	65	372	390	False
29121203	Targeted exome sequencing identified biallelic mutations in WDR19, encoding an IFT-A subunit previously associated with MZSDS-related chondrodysplasia, Jeune asphyxiating thoracic dysplasia and cranioectodermal dysplasia, linked to primary cilia dysfunction, and in TEKT1 which encodes tektin-1 an uncharacterized member of the tektin family, mutations of which may cause ciliary dyskinesia.	TEKT1	ciliary dyskinesia	83659	HP_0012265	266	271	372	390	False
29121203	Targeted exome sequencing identified biallelic mutations in WDR19, encoding an IFT-A subunit previously associated with MZSDS-related chondrodysplasia, Jeune asphyxiating thoracic dysplasia and cranioectodermal dysplasia, linked to primary cilia dysfunction, and in TEKT1 which encodes tektin-1 an uncharacterized member of the tektin family, mutations of which may cause ciliary dyskinesia.	WDR19	thoracic dysplasia	57728	HP_0006644	60	65	171	189	True
29121203	Targeted exome sequencing identified biallelic mutations in WDR19, encoding an IFT-A subunit previously associated with MZSDS-related chondrodysplasia, Jeune asphyxiating thoracic dysplasia and cranioectodermal dysplasia, linked to primary cilia dysfunction, and in TEKT1 which encodes tektin-1 an uncharacterized member of the tektin family, mutations of which may cause ciliary dyskinesia.	TEKT1	thoracic dysplasia	83659	HP_0006644	266	271	171	189	False
25434003	Mutations in components of the major spliceosome have been described in disorders with craniofacial anomalies, e.g., Nager syndrome and mandibulofacial dysostosis type Guion-Almeida.	type	mandibulofacial dysostosis	6445	HP_0005321	163	167	136	162	False
25434003	This rare condition is characterized by bilateral choanal atresia, hearing loss, cleft lip and/or palate, and other craniofacial dysmorphisms.	lip	bilateral	23049	HP_0012832	87	90	40	49	False
25434003	This rare condition is characterized by bilateral choanal atresia, hearing loss, cleft lip and/or palate, and other craniofacial dysmorphisms.	lip	choanal atresia	23049	HP_0000453	87	90	50	65	False
25434003	This rare condition is characterized by bilateral choanal atresia, hearing loss, cleft lip and/or palate, and other craniofacial dysmorphisms.	lip	hearing loss	23049	HP_0000365	87	90	67	79	False
29481978	Patients carrying homozygous WNT1 mutations have more frequent fractures while heterozygous carriers of the mutation in WNT1 gene are also found to have early onset osteoporosis.	WNT1	osteoporosis	7471	HP_0000939	29	33	165	177	True
29974186	Some RA patients are likely to increase visceral fat without obesity [Body Mass Index (BMI) 25].	fat	obesity	948	HP_0001513	49	52	61	68	False
29974186	Some RA patients are likely to increase visceral fat without obesity [Body Mass Index (BMI) 25].	Mass	obesity	2200	HP_0001513	75	79	61	68	False
29656860	Clinical features of affected individuals with LGD variants in NAA15 include variable levels of intellectual disability, delayed speech and motor milestones, and autism spectrum disorder.	NAA15	intellectual disability	80155	HP_0001249	63	68	96	119	True
29656860	Clinical features of affected individuals with LGD variants in NAA15 include variable levels of intellectual disability, delayed speech and motor milestones, and autism spectrum disorder.	NAA15	autism	80155	HP_0000717	63	68	162	168	False
29656860	Further supporting a mechanism of haploinsufficiency, individuals with copy-number variant (CNV) deletions involving NAA15 and surrounding genes can present with mild intellectual disability, mild dysmorphic features, motor delays, and decreased growth.	NAA15	intellectual disability	80155	HP_0001249	117	122	167	190	True
29656860	Further supporting a mechanism of haploinsufficiency, individuals with copy-number variant (CNV) deletions involving NAA15 and surrounding genes can present with mild intellectual disability, mild dysmorphic features, motor delays, and decreased growth.	NAA15	motor delays	80155	HP_0001270	117	122	218	230	False
30290678	The study was carried out to explore the risk stratification of the poor prognosis for patients underwent surgical treatment.60 patients diagnosed with neuroblastoma were primarily enrolled in the study from April 2008 to April 2016.	April	neuroblastoma	10541	HP_0003006	208	213	152	165	False
30290678	Clinical variables, including age, International Neuroblastoma Staging System (INSS) stage, tumor size and site, histology, and MYCN status were retrospectively analyzed, and EFS was chosen as the endpoint.The median age of patients was 8.2 months and average follow-up period was 40.28.6 months.	MYCN	tumor	4613	HP_0002664	128	132	92	97	True
30290678	Clinical variables, including age, International Neuroblastoma Staging System (INSS) stage, tumor size and site, histology, and MYCN status were retrospectively analyzed, and EFS was chosen as the endpoint.The median age of patients was 8.2 months and average follow-up period was 40.28.6 months.	EFS	tumor	10278	HP_0002664	175	178	92	97	False
30290678	Cox multifactor regression analysis revealed that age, histology and MYCN status had significant prognostic effect on event-free survival (EFS) rate for neuroblastoma patients underwent surgical treatment.In our study, we identified a series of prognostic factors including age, histology, and MYCN status predicting the prognosis of neuroblastoma patients after surgical treatment	MYCN	neuroblastoma	4613	HP_0003006	69	73	153	166	False
30290678	Cox multifactor regression analysis revealed that age, histology and MYCN status had significant prognostic effect on event-free survival (EFS) rate for neuroblastoma patients underwent surgical treatment.In our study, we identified a series of prognostic factors including age, histology, and MYCN status predicting the prognosis of neuroblastoma patients after surgical treatment	EFS	neuroblastoma	10278	HP_0003006	139	142	153	166	False
29239044	Phaeochromocytoma and paraganglioma (PHEO/PGL) are rare tumours with an estimated annual incidence of 3 per million.	per	paraganglioma	93210	HP_0002668	104	107	22	35	False
29239044	Phaeochromocytoma and paraganglioma (PHEO/PGL) are rare tumours with an estimated annual incidence of 3 per million.	per	tumours	93210	HP_0002664	104	107	56	63	False
30628714	The tumorigenesis and metastasis of tumors are associated with human collagen triple helix repeats containing 1 (CTHRC1).	CTHRC1	tumors	115908	HP_0002664	113	119	36	42	True
28373572	The K<sup>+</sup> channel KCNQ1 has been proposed as a tumor suppressor in colorectal cancer (CRC).	KCNQ1	tumor	3784	HP_0002664	26	31	55	60	True
28373572	The K<sup>+</sup> channel KCNQ1 has been proposed as a tumor suppressor in colorectal cancer (CRC).	KCNQ1	cancer	3784	HP_0002664	26	31	86	92	True
28373572	Analysis of human primary CRC tumor patient databases showed a positive correlation between KCNQ1:KCNE3 channel complex expression and disease-free survival.	KCNQ1	tumor	3784	HP_0002664	92	97	30	35	True
28373572	We conclude that the KCNQ1 ion channel is a target gene and regulator of the Wnt/-catenin pathway, and its repression leads to CRC cell proliferation, EMT, and tumorigenesis	KCNQ1	tumor	3784	HP_0002664	21	26	161	166	True
28373572	We conclude that the KCNQ1 ion channel is a target gene and regulator of the Wnt/-catenin pathway, and its repression leads to CRC cell proliferation, EMT, and tumorigenesis	EMT	tumor	3702	HP_0002664	152	155	161	166	True
30099957	The mean pulmonary arterial pressure (mPAP), right ventricular hypertrophy index (RVHI), pulmonary vascular remodeling, serum tumor necrosis factor  (TNF), and interleukin-6 (IL-6) were higher either in SI or in TI 28 and 35 days after the first MCT injection.	MCT	ventricular hypertrophy	27349	HP_0001714	248	251	51	74	False
30099957	The mean pulmonary arterial pressure (mPAP), right ventricular hypertrophy index (RVHI), pulmonary vascular remodeling, serum tumor necrosis factor  (TNF), and interleukin-6 (IL-6) were higher either in SI or in TI 28 and 35 days after the first MCT injection.	MCT	tumor	27349	HP_0002664	248	251	126	131	False
26405179	Mutations in human ADAMTSL4, encoding an ADAMTS-like protein which has been implicated in fibrillin microfibril biogenesis, cause ectopia lentis (EL) and EL et pupillae.	ADAMTSL4	ectopia lentis	54507	HP_0001083	19	27	130	144	True
28898690	LMO1 is a high-risk neuroblastoma susceptibility gene, but how LMO1 cooperates with MYCN in neuroblastoma tumorigenesis is unclear.	LMO1	neuroblastoma	4004	HP_0003006	0	4	20	33	False
28898690	LMO1 is a high-risk neuroblastoma susceptibility gene, but how LMO1 cooperates with MYCN in neuroblastoma tumorigenesis is unclear.	MYCN	neuroblastoma	4613	HP_0003006	84	88	20	33	False
28898690	develop a novel zebrafish model that elucidates a mechanism by which LMO1 and MYCN synergistically initiate neuroblastoma and contribute to metastatic disease progression	LMO1	neuroblastoma	4004	HP_0003006	69	73	108	121	False
28898690	develop a novel zebrafish model that elucidates a mechanism by which LMO1 and MYCN synergistically initiate neuroblastoma and contribute to metastatic disease progression	MYCN	neuroblastoma	4613	HP_0003006	78	82	108	121	False
30012424	By combining meta-analysis results and identification of two unrelated HCM patients with homozygous CSRP3 truncating variants, we suggest that the association of CSRP3 as a validated HCM-causing gene require additional studies and those CSRP3 variants could result in HCM with an autosomal recessive inheritance rather than with an autosomal dominant transmission as usually reported on HCM (OMIM 612124)	CSRP3	autosomal recessive	8048	HP_0000007	100	105	280	299	False
30012424	By combining meta-analysis results and identification of two unrelated HCM patients with homozygous CSRP3 truncating variants, we suggest that the association of CSRP3 as a validated HCM-causing gene require additional studies and those CSRP3 variants could result in HCM with an autosomal recessive inheritance rather than with an autosomal dominant transmission as usually reported on HCM (OMIM 612124)	CSRP3	inheritance	8048	HP_0000005	100	105	300	311	False
28739660	This study is the first to associate a component of the RAR pathway with renal agenesis in humans	RAR	renal agenesis	10966	HP_0000104	56	59	73	87	False
30156215	Next, we took epicardial fat samples from patients with valvular heart disease and non- coronary artery disease.	fat	valvular heart disease	948	HP_0001654	25	28	56	78	False
29484972	Objective Hearing loss (HL) is the most common sensory-neural defect and the most heterogeneous trait in humans, with the involvement of &gt;100 genes, which make a molecular diagnosis problematic.	HL	heterogeneous	3155	HP_0001425	24	26	82	95	False
29484972	Results Clinical evaluations suggested autosomal recessive nonsyndromic HL.	HL	autosomal recessive	3155	HP_0000007	72	74	39	58	True
29252925	Prospective outcome data on risk-reducing salpingectomy and delayed-oophorectomy for preventing ovarian cancer is lacking, and hence, this is best offered for primary prevention within the context and safe environment of a clinical trial.	best	cancer	7439	HP_0002664	142	146	104	110	False
29252925	This includes unaffected women who have completed their family and have RAD51C, RAD51D, or BRIP1 gene mutations; first-degree relatives of women with invasive epithelial ovarian cancer; BRCA mutation-negative women from high-risk breast-and-ovarian cancer or ovarian-cancer-only families.	RAD51C	cancer	5889	HP_0002664	72	78	178	184	True
29252925	This includes unaffected women who have completed their family and have RAD51C, RAD51D, or BRIP1 gene mutations; first-degree relatives of women with invasive epithelial ovarian cancer; BRCA mutation-negative women from high-risk breast-and-ovarian cancer or ovarian-cancer-only families.	RAD51D	cancer	5892	HP_0002664	80	86	178	184	True
29252925	This includes unaffected women who have completed their family and have RAD51C, RAD51D, or BRIP1 gene mutations; first-degree relatives of women with invasive epithelial ovarian cancer; BRCA mutation-negative women from high-risk breast-and-ovarian cancer or ovarian-cancer-only families.	BRIP1	cancer	64979	HP_0002664	91	96	178	184	False
29252925	In those with BRCA1, RAD51C/RAD51D/MMR mutations and the occasional families with a history of ovarian cancer in their 40s, surgery needs to be considered at younger than 45.	BRCA1	cancer	672	HP_0002664	14	19	103	109	True
29252925	In those with BRCA1, RAD51C/RAD51D/MMR mutations and the occasional families with a history of ovarian cancer in their 40s, surgery needs to be considered at younger than 45.	RAD51C	cancer	5889	HP_0002664	21	27	103	109	True
29252925	In those with BRCA1, RAD51C/RAD51D/MMR mutations and the occasional families with a history of ovarian cancer in their 40s, surgery needs to be considered at younger than 45.	RAD51D	cancer	5892	HP_0002664	28	34	103	109	True
30845641	Vegetarian and vegan diets have increased worldwide in the last decades, according to the knowledge that they might prevent coronary heart disease, cancer, and type 2 diabetes.	type	cancer	6445	HP_0002664	160	164	148	154	False
29381923	Specifically, ADHFE1, HAND2, and GNAO1 were hypermethylated and downregulated in colon cancer, suggesting that the low expression levels of these genes may be regulated by DNA hypermethylation.	ADHFE1	cancer	137872	HP_0002664	14	20	87	93	False
29381923	Specifically, ADHFE1, HAND2, and GNAO1 were hypermethylated and downregulated in colon cancer, suggesting that the low expression levels of these genes may be regulated by DNA hypermethylation.	HAND2	cancer	9464	HP_0002664	22	27	87	93	False
29381923	Specifically, ADHFE1, HAND2, and GNAO1 were hypermethylated and downregulated in colon cancer, suggesting that the low expression levels of these genes may be regulated by DNA hypermethylation.	GNAO1	cancer	2775	HP_0002664	33	38	87	93	False
22854039	Disabling mutations in the FGD1 gene cause faciogenital dysplasia (also known as Aarskog-Scott syndrome), a human X-linked developmental disorder that results in disproportionately short stature, facial, skeletal and urogenital anomalies, and in a number of cases, mild mental retardation.	FGD1	short stature	2245	HP_0004322	27	31	181	194	True
22854039	Disabling mutations in the FGD1 gene cause faciogenital dysplasia (also known as Aarskog-Scott syndrome), a human X-linked developmental disorder that results in disproportionately short stature, facial, skeletal and urogenital anomalies, and in a number of cases, mild mental retardation.	FGD1	urogenital anomalies	2245	HP_0000119	27	31	217	237	True
22854039	Disabling mutations in the FGD1 gene cause faciogenital dysplasia (also known as Aarskog-Scott syndrome), a human X-linked developmental disorder that results in disproportionately short stature, facial, skeletal and urogenital anomalies, and in a number of cases, mild mental retardation.	FGD1	mild	2245	HP_0012825	27	31	265	269	False
22854039	Two recent studies unveiled new potential functions of FGD1, in particular, its involvement in the regulation of the formation and function of invadopodia and podosomes, which are cellular structures devoted to degradation of the extracellular matrix in tumour and endothelial cells.	FGD1	tumour	2245	HP_0002664	55	59	254	260	False
29621621	Our results confirm two previous reports indicating that loss of function of a single allele of SLC6A1 causes epilepsy.	SLC6A1	epilepsy	6529	HP_0001250	96	102	110	118	True
26392535	Although clustering of missense mutations is often regarded as a hallmark of oncoproteins, we observed that a number of tumor suppressors, including FBXW7, VHL, and STK11, also showed such clustering.	FBXW7	tumor	55294	HP_0002664	149	154	120	125	False
26392535	Although clustering of missense mutations is often regarded as a hallmark of oncoproteins, we observed that a number of tumor suppressors, including FBXW7, VHL, and STK11, also showed such clustering.	VHL	tumor	7428	HP_0002664	156	159	120	125	True
26392535	Although clustering of missense mutations is often regarded as a hallmark of oncoproteins, we observed that a number of tumor suppressors, including FBXW7, VHL, and STK11, also showed such clustering.	STK11	tumor	6794	HP_0002664	165	170	120	125	True
29046478	Loss-of-function mutations of GNA11, which encodes G-protein subunit 11 (G11), a signaling partner for the calcium-sensing receptor (CaSR), result in familial hypocalciuric hypercalcemia type 2 (FHH2).	GNA11	hypercalcemia	2767	HP_0003072	30	35	175	188	True
29046478	Loss-of-function mutations of GNA11, which encodes G-protein subunit 11 (G11), a signaling partner for the calcium-sensing receptor (CaSR), result in familial hypocalciuric hypercalcemia type 2 (FHH2).	CaSR	hypercalcemia	846	HP_0003072	135	139	175	188	True
29046478	Loss-of-function mutations of GNA11, which encodes G-protein subunit 11 (G11), a signaling partner for the calcium-sensing receptor (CaSR), result in familial hypocalciuric hypercalcemia type 2 (FHH2).	type	hypercalcemia	6445	HP_0003072	189	193	175	188	False
29046478	Loss-of-function mutations of GNA11, which encodes G-protein subunit 11 (G11), a signaling partner for the calcium-sensing receptor (CaSR), result in familial hypocalciuric hypercalcemia type 2 (FHH2).	FHH2	hypercalcemia	2767	HP_0003072	197	201	175	188	True
29046478	FHH2 is characterized by hypercalcemia, inappropriately normal or raised parathyroid hormone (PTH) concentrations, and normal or low urinary calcium excretion.	FHH2	hypercalcemia	2767	HP_0003072	0	4	25	38	True
29046478	FHH2 is characterized by hypercalcemia, inappropriately normal or raised parathyroid hormone (PTH) concentrations, and normal or low urinary calcium excretion.	PTH	hypercalcemia	5741	HP_0003072	94	97	25	38	False
28534947	The review then discusses the diseases associated with ClC2, including degeneration of the retina, Sjgren's syndrome, agerelated cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.	ClC	cataracts	23529	HP_0000518	55	58	132	141	False
28534947	The review then discusses the diseases associated with ClC2, including degeneration of the retina, Sjgren's syndrome, agerelated cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.	ClC	azoospermia	23529	HP_0000027	55	58	171	182	False
28534947	The review then discusses the diseases associated with ClC2, including degeneration of the retina, Sjgren's syndrome, agerelated cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.	ClC	cancer	23529	HP_0002664	55	58	189	195	False
28534947	The review then discusses the diseases associated with ClC2, including degeneration of the retina, Sjgren's syndrome, agerelated cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.	ClC	leukoencephalopathy	23529	HP_0002352	55	58	284	303	False
28534947	The review then discusses the diseases associated with ClC2, including degeneration of the retina, Sjgren's syndrome, agerelated cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus.	ClC	epilepsy	23529	HP_0001250	55	58	305	313	True
28069802	We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.	ALK	neuroblastoma	238	HP_0003006	20	23	37	50	False
28069802	We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.	BRAF	neuroblastoma	673	HP_0003006	102	106	37	50	True
28069802	We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.	PAX3	neuroblastoma	5077	HP_0003006	195	199	37	50	False
28069802	We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.	GLI2	neuroblastoma	2736	HP_0003006	200	204	37	50	False
28069802	We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.	ALK	astrocytoma	238	HP_0009592	20	23	70	81	False
28069802	We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.	BRAF	astrocytoma	673	HP_0009592	102	106	70	81	False
28069802	We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.	PAX3	astrocytoma	5077	HP_0009592	195	199	70	81	False
28069802	We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.	GLI2	astrocytoma	2736	HP_0009592	200	204	70	81	False
28069802	We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.	ALK	rhabdomyosarcoma	238	HP_0002859	20	23	217	233	False
28069802	We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.	BRAF	rhabdomyosarcoma	673	HP_0002859	102	106	217	233	False
28069802	We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.	PAX3	rhabdomyosarcoma	5077	HP_0002859	195	199	217	233	True
28069802	We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel BRAF fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-GLI2 fusion in a rhabdomyosarcoma.	GLI2	rhabdomyosarcoma	2736	HP_0002859	200	204	217	233	False
29024210	We report a case of ALK-positive renal cell carcinoma coincident with Hodgkin lymphoma.	ALK	renal cell carcinoma	238	HP_0005584	20	23	33	53	False
29024210	The variety of growth patterns and cell features led us to speculate a possibility of ALK-positive renal cell carcinoma (ALK+RCC).	ALK	renal cell carcinoma	238	HP_0005584	86	89	99	119	False
28386063	Several known breast cancer susceptibility genes encode proteins involved in DNA damage response (DDR) and are characterized by rare loss-of-function mutations.	damage	cancer	51438	HP_0002664	81	87	21	27	False
28386063	c.7253dupT in TEX15, encoding a DDR factor important in meiosis, associated with hereditary breast cancer (p=0.018) and likely represents a Northern Finnish founder mutation.	TEX15	cancer	56154	HP_0002664	14	19	99	105	False
28386063	A deletion (c.640_644del5) in RNF168, causative for recessive RIDDLE syndrome, had high prevalence in majority of the analyzed cohorts, but did not associate with breast cancer.	RNF168	cancer	165918	HP_0002664	30	36	170	176	False
28386063	In conclusion, truncating variants in TEX15 and FANCD2 are potential breast cancer risk factors, warranting further investigations in other populations.	TEX15	cancer	56154	HP_0002664	38	43	76	82	False
28386063	In conclusion, truncating variants in TEX15 and FANCD2 are potential breast cancer risk factors, warranting further investigations in other populations.	FANCD2	cancer	2177	HP_0002664	48	54	76	82	True
30367044	The underlining mechanisms of dietary cholesterol and nonalcoholic steatohepatitis (NASH) in contributing to hepatocellular carcinoma (HCC) remain undefined.	HCC	hepatocellular carcinoma	84668	HP_0001402	135	138	109	133	False
30106120	Finally, it was observed that 4 hub genes were highly expressed in gastric cancer tissue compared with paracarcinoma tissue in the 12patients; the increased TSPAN4 was significant (&gt;5fold).	hub	cancer	1993	HP_0002664	32	35	75	81	False
30106120	Finally, it was observed that 4 hub genes were highly expressed in gastric cancer tissue compared with paracarcinoma tissue in the 12patients; the increased TSPAN4 was significant (&gt;5fold).	TSPAN4	cancer	7106	HP_0002664	159	165	75	81	False
28272472	Recessive mutations in WD repeat domain 62 (WDR62) cause microcephaly and a wide spectrum of severe brain malformations.	WDR62	microcephaly	284403	HP_0000252	44	49	57	69	True
27261776	Activation of inflammatory pathways is known to accompany development of obesity-induced non-alcoholic fatty liver disease (NAFLD), insulin resistance and type 2 diabetes.	type	obesity	6445	HP_0001513	155	159	73	80	False
27261776	Activation of inflammatory pathways is known to accompany development of obesity-induced non-alcoholic fatty liver disease (NAFLD), insulin resistance and type 2 diabetes.	fat	obesity	948	HP_0001513	103	106	73	80	False
26861296	In addition, splicing variants of CIZ1 mRNA is associated with a variety of cancers and Alzheimer's disease, and mutations of the CIZ1 gene lead to cervical dystonia.	CIZ1	cervical dystonia	25792	HP_0000473	34	38	148	165	True
30222780	ASXL1 (additional sex combs like 1) is a gene that is mutated in a number of hematological neoplasms.	sex	neoplasms	55558	HP_0002664	18	21	91	100	False
30222780	ASXL1 (additional sex combs like 1) is a gene that is mutated in a number of hematological neoplasms.	ASXL1	neoplasms	171023	HP_0002664	0	5	91	100	True
30222780	In addition, we investigated the impact of proofreading capabilities of different DNA polymerases on ASXL1 c.1934dupG somatic mutation using conventional Sanger sequencing, another common method for ASXL1 genotyping.	ASXL1	somatic mutation	171023	HP_0001428	101	106	118	134	True
30222780	In addition, we investigated the impact of proofreading capabilities of different DNA polymerases on ASXL1 c.1934dupG somatic mutation using conventional Sanger sequencing, another common method for ASXL1 genotyping.	impact	somatic mutation	55364	HP_0001428	33	39	118	134	False
30222780	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.	ASXL1	neoplasms	171023	HP_0002664	64	69	121	130	True
30222780	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.	MDS	neoplasms	5048	HP_0002664	141	144	121	130	False
30222780	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.	MPN	neoplasms	83886	HP_0002664	151	154	121	130	False
30222780	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.	TET2	neoplasms	54790	HP_0002664	217	221	121	130	True
30222780	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.	EZH2	neoplasms	2146	HP_0002664	223	227	121	130	False
30222780	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.	IDH2	neoplasms	3418	HP_0002664	229	233	121	130	True
30222780	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.	RUNX1	neoplasms	861	HP_0002664	235	240	121	130	True
30222780	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.	NRAS	neoplasms	4893	HP_0002664	242	246	121	130	True
30222780	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.	ASXL1	somatic mutation	171023	HP_0001428	64	69	86	102	True
30222780	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.	MDS	somatic mutation	5048	HP_0001428	141	144	86	102	False
30222780	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.	MPN	somatic mutation	83886	HP_0001428	151	154	86	102	False
30222780	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.	TET2	somatic mutation	54790	HP_0001428	217	221	86	102	True
30222780	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.	EZH2	somatic mutation	2146	HP_0001428	223	227	86	102	False
30222780	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.	IDH2	somatic mutation	3418	HP_0001428	229	233	86	102	False
30222780	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.	RUNX1	somatic mutation	861	HP_0001428	235	240	86	102	False
30222780	A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological neoplasms including MDS, AML, MPN and MDS/MPN and often is associated with somatic mutations of TET2, EZH2, IDH2, RUNX1, NRAS and DNMT3A.	NRAS	somatic mutation	4893	HP_0001428	242	246	86	102	True
26747400	In summary, the regulatory role of Mfsd2a deepens our knowledge of the function of the BBB, potentially contributing to the effective drug delivery in the treatments for neurodegenerative diseases, brain tumors, and life-threatening infections in the CNS.	Mfsd2a	neurodegenerative diseases	84879	HP_0002180	35	41	170	196	False
26747400	In summary, the regulatory role of Mfsd2a deepens our knowledge of the function of the BBB, potentially contributing to the effective drug delivery in the treatments for neurodegenerative diseases, brain tumors, and life-threatening infections in the CNS.	Mfsd2a	tumors	84879	HP_0002664	35	41	204	210	False
29259115	While there has been growing interest in the homodimeric gene products of CISD1 (mitoNEET) and CISD2 (NAF-1), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in cancer.	CISD1	cancer	55847	HP_0002664	74	79	203	209	False
29259115	While there has been growing interest in the homodimeric gene products of CISD1 (mitoNEET) and CISD2 (NAF-1), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in cancer.	mitoNEET	cancer	55847	HP_0002664	81	89	203	209	False
29259115	While there has been growing interest in the homodimeric gene products of CISD1 (mitoNEET) and CISD2 (NAF-1), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in cancer.	CISD2	cancer	493856	HP_0002664	95	100	203	209	False
29259115	While there has been growing interest in the homodimeric gene products of CISD1 (mitoNEET) and CISD2 (NAF-1), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in cancer.	NAF-1	cancer	493856	HP_0002664	102	107	203	209	False
29259115	While there has been growing interest in the homodimeric gene products of CISD1 (mitoNEET) and CISD2 (NAF-1), the importance of the inner mitochondrial CISD3 protein has only recently been recognized in cancer.	CISD3	cancer	284106	HP_0002664	152	157	203	209	False
29454993	Mutations in the human TRNT1 gene encoding tRNA nucleotidyltransferase (tRNA-NT), an essential enzyme responsible for addition of the CCA (cytidine-cytidine-adenosine) sequence to the 3'-termini of tRNAs, have been linked to disease phenotypes including congenital sideroblastic anemia with B-cell immunodeficiency, periodic fevers and developmental delay (SIFD) or retinitis pigmentosa with erythrocyte microcytosis.	TRNT1	developmental delay	51095	HP_0001263	23	28	336	355	True
29454993	Mutations in the human TRNT1 gene encoding tRNA nucleotidyltransferase (tRNA-NT), an essential enzyme responsible for addition of the CCA (cytidine-cytidine-adenosine) sequence to the 3'-termini of tRNAs, have been linked to disease phenotypes including congenital sideroblastic anemia with B-cell immunodeficiency, periodic fevers and developmental delay (SIFD) or retinitis pigmentosa with erythrocyte microcytosis.	CCA	developmental delay	2201	HP_0001263	134	137	336	355	False
29454993	Mutations in the human TRNT1 gene encoding tRNA nucleotidyltransferase (tRNA-NT), an essential enzyme responsible for addition of the CCA (cytidine-cytidine-adenosine) sequence to the 3'-termini of tRNAs, have been linked to disease phenotypes including congenital sideroblastic anemia with B-cell immunodeficiency, periodic fevers and developmental delay (SIFD) or retinitis pigmentosa with erythrocyte microcytosis.	TRNT1	microcytosis	51095	HP_0025066	23	28	404	416	True
29454993	Mutations in the human TRNT1 gene encoding tRNA nucleotidyltransferase (tRNA-NT), an essential enzyme responsible for addition of the CCA (cytidine-cytidine-adenosine) sequence to the 3'-termini of tRNAs, have been linked to disease phenotypes including congenital sideroblastic anemia with B-cell immunodeficiency, periodic fevers and developmental delay (SIFD) or retinitis pigmentosa with erythrocyte microcytosis.	CCA	microcytosis	2201	HP_0025066	134	137	404	416	False
28654796	Sushi repeat-containing protein X-linked 2 (SRPX2), a novel chondroitin sulfate proteoglycan, is overexpressed in human cancer.	SRPX2	cancer	27286	HP_0002664	44	49	120	126	False
28654796	Recent studies have reported that SRPX2 overexpression is observed in gastrointestinal cancer, and promotes migration and invasion of cancer cells.	SRPX2	cancer	27286	HP_0002664	34	39	87	93	False
28654796	While, the clinical significance and biological function of SRPX2 remain rarely known in hepatocellular carcinoma (HCC).	SRPX2	hepatocellular carcinoma	27286	HP_0001402	60	65	89	113	False
28654796	While, the clinical significance and biological function of SRPX2 remain rarely known in hepatocellular carcinoma (HCC).	HCC	hepatocellular carcinoma	84668	HP_0001402	115	118	89	113	False
28654796	Here, we found that the levels of SRPX2 in HCC tissues were notably overexpressed compared to non-cancerous specimens.	SRPX2	cancer	27286	HP_0002664	34	39	98	104	False
28654796	Here, we found that the levels of SRPX2 in HCC tissues were notably overexpressed compared to non-cancerous specimens.	HCC	cancer	84668	HP_0002664	43	46	98	104	False
28654796	The positive expression of SRPX2 was prominently correlated with venous infiltration and advanced TNM tumor stage.	SRPX2	tumor	27286	HP_0002664	27	32	102	107	False
28654796	The positive expression of SRPX2 was prominently correlated with venous infiltration and advanced TNM tumor stage.	TNM	tumor	10178	HP_0002664	98	101	102	107	False
23932106	Using whole-exome sequencing, we identified biallelic mutations in seizure threshold 2 (SZT2) in both affected children.	SZT2	seizure	23334	HP_0001250	88	92	67	74	True
23932106	Although the molecular role of the peroxisomal protein SZT2 in neuronal excitability and brain development remains to be defined, Szt2 has been shown to influence seizure threshold and epileptogenesis in mice, consistent with our findings in humans.	SZT2	seizure	23334	HP_0001250	55	59	163	170	True
23932106	Although the molecular role of the peroxisomal protein SZT2 in neuronal excitability and brain development remains to be defined, Szt2 has been shown to influence seizure threshold and epileptogenesis in mice, consistent with our findings in humans.	Szt2	seizure	23334	HP_0001250	130	134	163	170	True
23932106	Although the molecular role of the peroxisomal protein SZT2 in neuronal excitability and brain development remains to be defined, Szt2 has been shown to influence seizure threshold and epileptogenesis in mice, consistent with our findings in humans.	mice	seizure	23581	HP_0001250	204	208	163	170	False
23932106	We conclude that mutations in SZT2 cause a severe type of autosomal-recessive infantile encephalopathy with intractable seizures and distinct neuroradiological anomalies.	SZT2	encephalopathy	23334	HP_0001298	30	34	88	102	True
23932106	We conclude that mutations in SZT2 cause a severe type of autosomal-recessive infantile encephalopathy with intractable seizures and distinct neuroradiological anomalies.	type	encephalopathy	6445	HP_0001298	50	54	88	102	False
23932106	We conclude that mutations in SZT2 cause a severe type of autosomal-recessive infantile encephalopathy with intractable seizures and distinct neuroradiological anomalies.	SZT2	seizure	23334	HP_0001250	30	34	120	127	True
23932106	We conclude that mutations in SZT2 cause a severe type of autosomal-recessive infantile encephalopathy with intractable seizures and distinct neuroradiological anomalies.	type	seizure	6445	HP_0001250	50	54	120	127	False
30327840	Low-density lipoprotein receptor-related protein 4 (LRP4) is a multi-functional protein implicated in bone, kidney and neurological diseases including Cenani-Lenz syndactyly (CLS), sclerosteosis, osteoporosis, congenital myasthenic syndrome and myasthenia gravis.	LRP4	syndactyly	4038	HP_0001159	52	56	163	173	True
30327840	Low-density lipoprotein receptor-related protein 4 (LRP4) is a multi-functional protein implicated in bone, kidney and neurological diseases including Cenani-Lenz syndactyly (CLS), sclerosteosis, osteoporosis, congenital myasthenic syndrome and myasthenia gravis.	CLS	syndactyly	6197	HP_0001159	175	178	163	173	False
28931725	Hence, we focus on the relationship between YAP/TAZ and serine metabolism to control methylation of DNA or histone in breast cancer with LKB1 deficiency.	LKB1	cancer	6794	HP_0002664	137	141	125	131	True
28931725	We hope that our study will stimulate further studies and a new targeted therapy and early medical intervention for YAP/TAZ could be a useful option for breast cancer cases complicated with LKB1 deficiency	LKB1	cancer	6794	HP_0002664	190	194	160	166	True
28839118	We detected 11 novel mutations in <i>GJA3</i>, <i>GJA8</i>, <i>CRYAA</i>, <i>CRYBB2</i>, <i>CRYGS</i>, <i>CRYGA</i>, <i>GCNT2</i>, <i>CRYGA</i>, and <i>MIP</i>; and three previously reported cataract-causing mutations in <i>GJA8</i>, <i>CRYAA</i>, and <i>CRYBB2</i> The most commonly mutated genes were those coding for gap junctions and crystallin proteins.	gap	cataract	5921	HP_0000518	320	323	191	199	False
27108097	On the other hand, intraperitoneal administration of PQQ exerted protective effects on rats that had received rotenone injection into the medial forebrain bundle through decreasing the apomorphine-evoked rotation, inhibiting neuronal loss and TH down-regulation in SNc, increasing the antioxidative ability, and regulating intracellular expressions of Ndufs1 and Ndufs 4.	Ndufs1	neuronal loss	4719	HP_0002529	352	358	225	238	False
27108097	Overall, our results suggest that PQQ neuroprotection may be mediated by the inhibition of mitochondrial dysfunction and oxidative stress as well as by the gene modulation of Ndufs1 and Ndufs4	Ndufs1	mitochondrial dysfunction	4719	HP_0003287	175	181	91	116	True
27458054	As ubiquitination is a versatile post-translational modification that can affect target turnover, sub-cellular localisation or activity, it is likely that diverse substrates may be differentially affected by TRIM32-mediated ubiquitination, reflecting its multi-faceted roles in muscle physiology, cancer and immunity.	TRIM32	cancer	22954	HP_0002664	208	214	297	303	False
27458054	With particular relevance for muscle physiology, mutations in TRIM32 are associated with autosomal recessive Limb-Girdle Muscular Dystrophy 2H, a muscle-wasting disease with variable clinical spectrum ranging from almost asymptomatic to wheelchair-bound patients.	TRIM32	autosomal recessive	22954	HP_0000007	62	68	89	108	True
27458054	In this review, we will focus on the ability of TRIM32 to mark specific substrates for proteasomal degradation discussing how the TRIM32-proteasome axis may (i) be important for muscle homeostasis and for the pathogenesis of muscular dystrophy; and (ii) define either an oncogenic or tumour suppressive role for TRIM32 in the context of different types of cancer	TRIM32	tumour	22954	HP_0002664	48	54	284	290	False
27458054	In this review, we will focus on the ability of TRIM32 to mark specific substrates for proteasomal degradation discussing how the TRIM32-proteasome axis may (i) be important for muscle homeostasis and for the pathogenesis of muscular dystrophy; and (ii) define either an oncogenic or tumour suppressive role for TRIM32 in the context of different types of cancer	mark	tumour	4139	HP_0002664	58	62	284	290	False
29452408	The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and MAP3K1) and glaucoma-related phenotypes (FNDC3B, LMX1B and LOXL1).	MAP3K1	glaucoma	4214	HP_0000501	101	107	113	121	False
29452408	The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and MAP3K1) and glaucoma-related phenotypes (FNDC3B, LMX1B and LOXL1).	LMX1B	glaucoma	4010	HP_0000501	84	89	113	121	True
29452408	The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and MAP3K1) and glaucoma-related phenotypes (FNDC3B, LMX1B and LOXL1).	HMGA2	glaucoma	8091	HP_0000501	91	96	113	121	False
29452408	The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and MAP3K1) and glaucoma-related phenotypes (FNDC3B, LMX1B and LOXL1).	LOXL1	glaucoma	4016	HP_0000501	160	165	113	121	False
29452408	The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and MAP3K1) and glaucoma-related phenotypes (FNDC3B, LMX1B and LOXL1).	FNDC3B	glaucoma	64778	HP_0000501	142	148	113	121	False
29452408	The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and MAP3K1) and glaucoma-related phenotypes (FNDC3B, LMX1B and LOXL1).	type	glaucoma	6445	HP_0000501	135	139	113	121	False
29452408	Genetic correlation analysis revealed the relationships between POAG and systemic diseases, including type 2 diabetes and cardiovascular diseases.	type	cardiovascular diseases	6445	HP_0001626	102	106	122	145	True
16080917	Corneal changes in aniridia-related keratopathy (ARK) include peripheral pannus and epithelial abnormalities, which eventually result in corneal opacity and contribute to visual loss.	ARK	corneal opacity	558	HP_0007957	49	52	137	152	False
16080917	Corneal changes in aniridia-related keratopathy (ARK) include peripheral pannus and epithelial abnormalities, which eventually result in corneal opacity and contribute to visual loss.	ARK	visual loss	558	HP_0000572	49	52	171	182	False
16080917	The corneal abnormalities of Pax6+/- mice provide an excellent model for the corneal changes seen in PAX6+/- humans.	PAX6	corneal abnormalities	5080	HP_0000481	101	105	4	25	True
16080917	The corneal abnormalities of Pax6+/- mice provide an excellent model for the corneal changes seen in PAX6+/- humans.	Pax6	corneal abnormalities	5080	HP_0000481	29	33	4	25	True
16080917	The corneal abnormalities of Pax6+/- mice provide an excellent model for the corneal changes seen in PAX6+/- humans.	mice	corneal abnormalities	23581	HP_0000481	37	41	4	25	False
30361777	Malfunctioning of nucleoporins is well known in human malignancies, such as gene fusions of NUP214 and NUP98 in hematological neoplasms and overexpression of NUP88 in a variety of human cancers.	NUP214	neoplasms	8021	HP_0002664	92	98	126	135	True
30361777	Malfunctioning of nucleoporins is well known in human malignancies, such as gene fusions of NUP214 and NUP98 in hematological neoplasms and overexpression of NUP88 in a variety of human cancers.	NUP98	neoplasms	4928	HP_0002664	103	108	126	135	False
30361777	Malfunctioning of nucleoporins is well known in human malignancies, such as gene fusions of NUP214 and NUP98 in hematological neoplasms and overexpression of NUP88 in a variety of human cancers.	NUP88	neoplasms	4927	HP_0002664	158	163	126	135	False
29058484	Nogo-A and Nogo-C are potent Nogos that are predominantly expressed in the central nervous system.	Nogo	central	57142	HP_0030645	0	4	75	82	False
29058484	In recent years, it has been demonstrated that NgBR plays an important role in human pathophysiological processes, including lipid metabolism, angiogenesis, N-glycosylation, cell apoptosis, chemoresistance in human hepatocellular carcinoma, and epithelial-mesenchymal transition.	NgBR	hepatocellular carcinoma	116150	HP_0001402	47	51	215	239	False
26781467	Mitochondrial dysfunction and epithelial-to-mesenchymal transition (EMT) play important roles in cancer development and metastasis.	EMT	cancer	3702	HP_0002664	68	71	97	103	True
26781467	However, very little is known about the connection between mitochondrial dysfunction and EMT.	EMT	mitochondrial dysfunction	3702	HP_0003287	89	92	59	84	False
26781467	Here, we show that TUFM is downregulated in human cancer tissues.	TUFM	cancer	7284	HP_0002664	19	23	50	56	False
26781467	TUFM expression level was positively correlated with that of E-cadherin and decreased significantly during the progression of human lung cancer.	TUFM	cancer	7284	HP_0002664	0	4	137	143	False
26781467	Mechanistically, TUFM knockdown activated AMPK and phosphorylated GSK3 and increased the nuclear accumulation of -catenin, leading to the induction of EMT and increased migration and metastasis of A549 lung cancer cells.	EMT	cancer	3702	HP_0002664	153	156	209	215	True
26781467	Mechanistically, TUFM knockdown activated AMPK and phosphorylated GSK3 and increased the nuclear accumulation of -catenin, leading to the induction of EMT and increased migration and metastasis of A549 lung cancer cells.	TUFM	cancer	7284	HP_0002664	17	21	209	215	False
26781467	Mechanistically, TUFM knockdown activated AMPK and phosphorylated GSK3 and increased the nuclear accumulation of -catenin, leading to the induction of EMT and increased migration and metastasis of A549 lung cancer cells.	AMPK	cancer	5563	HP_0002664	42	46	209	215	False
26781467	Although TUFM knockdown also induced EMT of MCF7 breast cancer cells, the underlying mechanism appeared somewhat different from that in lung cancer cells.	EMT	cancer	3702	HP_0002664	37	40	56	62	True
26781467	Although TUFM knockdown also induced EMT of MCF7 breast cancer cells, the underlying mechanism appeared somewhat different from that in lung cancer cells.	TUFM	cancer	7284	HP_0002664	9	13	56	62	False
26781467	Our work identifies TUFM as a novel regulator of EMT and suggests a molecular link between mitochondrial dysfunction and EMT induction.	EMT	mitochondrial dysfunction	3702	HP_0003287	49	52	91	116	False
26781467	Our work identifies TUFM as a novel regulator of EMT and suggests a molecular link between mitochondrial dysfunction and EMT induction.	TUFM	mitochondrial dysfunction	7284	HP_0003287	20	24	91	116	False
30043672	The therapeutic strategy to recover immune function through the restoration of impaired Tregs function with the mounting evidences regarding KRAS in autoimmune mediated disorder (MS, SLE, RA, T1D) suggest as working hypothesis the direct targeting KRAS activation using cancer-derived small molecules may be clinically relevant	KRAS	cancer	3845	HP_0002664	141	145	270	276	True
30511782	Intraepithelial neoplasia in FGPs, referred to as FGP with dysplasia, is often seen in patients with familial adenomatous polyposis (FAP).	FAP	neoplasia	2191	HP_0002664	133	136	16	25	False
30511782	In sporadic FGPs, low-grade dysplasia (LGD) is rare, and high-grade dysplasia (HGD) or carcinoma arising from sporadic FGPs is extremely rare.	HGD	sporadic	3081	HP_0003745	79	82	3	11	False
30511782	In sporadic FGPs, low-grade dysplasia (LGD) is rare, and high-grade dysplasia (HGD) or carcinoma arising from sporadic FGPs is extremely rare.	HGD	carcinoma	3081	HP_0030731	79	82	87	96	False
30511782	In the present case, a sporadic FGP with LGD did not develop into invasive carcinoma, but contained foci of HGD 14 years after diagnosis.	HGD	sporadic	3081	HP_0003745	108	111	23	31	False
30511782	In the present case, a sporadic FGP with LGD did not develop into invasive carcinoma, but contained foci of HGD 14 years after diagnosis.	HGD	carcinoma	3081	HP_0030731	108	111	75	84	False
30511782	The pathological diagnosis of the resected specimen was FGP with HGD mixed in LGD, with no invasive carcinoma.	HGD	carcinoma	3081	HP_0030731	65	68	100	109	False
25331497	Excess accumulation of endogenous all-trans-retinal (atRAL) contributes to degeneration of the retinal pigment epithelium (RPE) and photoreceptor cells, and plays a role in the etiologies of age-related macular degeneration (AMD) and Stargardt's disease.	RPE	macular degeneration	6120	HP_0000608	123	126	203	223	False
29863663	We also provide an example of using the platform to screen compounds for their ability to lower Apolipoprotein B (APOB) produced from iPSC-derived hepatocytes generated from a familial hypercholesterolemia patient.	APOB	hypercholesterolemia	338	HP_0003124	114	118	185	205	True
29207197	Prostate cancer (PCa) is a leading cause of cancerassociated mortality in men; however, the factors that contribute to disease development have yet to be fully elucidated.	PCa	cancer	28982	HP_0002664	17	20	9	15	False
29207197	Prostate cancer (PCa) is a leading cause of cancerassociated mortality in men; however, the factors that contribute to disease development have yet to be fully elucidated.	men	cancer	8178	HP_0002664	75	78	9	15	False
28922417	In humans, PNKP mutations underlie the neurological disease known as MCSZ, but these individuals are not predisposed for cancer, implying effective alternative repair pathways in dividing cells.	PNKP	cancer	11284	HP_0002664	11	15	121	127	False
27499294	COQ8A (ADCK3) is a mammalian UbiB protein associated with ubiquinone (CoQ) biosynthesis and an ataxia (ARCA2) through unclear means.	COQ8A	ataxia	56997	HP_0001251	0	5	95	101	True
27499294	We show that mice lacking COQ8A develop a slowly progressive cerebellar ataxia linked to Purkinje cell dysfunction and mild exercise intolerance, recapitulating ARCA2.	mice	ataxia	23581	HP_0001251	13	17	72	78	False
27499294	We show that mice lacking COQ8A develop a slowly progressive cerebellar ataxia linked to Purkinje cell dysfunction and mild exercise intolerance, recapitulating ARCA2.	COQ8A	ataxia	56997	HP_0001251	26	31	72	78	True
29344583	However, the role of <i>RTEL1</i> mutations in other bone marrow failure (BMF) syndromes and myeloid neoplasms, and the contribution of monoallelic <i>RTEL1</i> mutations to disease development are not well defined.	BMF	neoplasms	90427	HP_0002664	74	77	101	110	False
29344583	We screened 516 patients for germline mutations in telomere-associated genes by next-generation sequencing in 2 independent cohorts; one constituting unselected patients with idiopathic BMF, unexplained cytopenia, or myeloid neoplasms (n = 457) and a second cohort comprising selected patients on the basis of the suspicion of constitutional/familial BMF (n = 59).	BMF	neoplasms	90427	HP_0002664	186	189	225	234	False
20700148	Independently, another group has recently observed SRD5A3 mutations in several families with a type 1 congenital disorder of glycosylation (CDG type Ix, OMIM 212067), mental retardation, cerebellar ataxia and eye disorders.	type	cerebellar ataxia	6445	HP_0001251	95	99	187	204	False
20700148	Independently, another group has recently observed SRD5A3 mutations in several families with a type 1 congenital disorder of glycosylation (CDG type Ix, OMIM 212067), mental retardation, cerebellar ataxia and eye disorders.	SRD5A3	cerebellar ataxia	79644	HP_0001251	51	57	187	204	False
29603594	Glioblastoma multiforme (GBM) is a highly malignant type of brain tumor found in humans.	type	tumor	6445	HP_0002664	52	56	66	71	False
29603594	Additional plasma and 52 brain tissues obtained from patients with gliomas were used to validate the association rate of serum amyloid A1 (SAA1) in different grades of gliomas and its distribution in tumors.	SAA1	tumor	6288	HP_0002664	139	143	200	205	False
29603594	Additional plasma and 52 brain tissues obtained from patients with gliomas were used to validate the association rate of serum amyloid A1 (SAA1) in different grades of gliomas and its distribution in tumors.	SAA1	gliomas	6288	HP_0009733	139	143	67	74	False
29603594	Microarray database analysis further validated the coefficient of SAA1 levels in gliomas.	SAA1	gliomas	6288	HP_0009733	66	70	81	88	False
29603594	SAA1 was identified from MS analysis, and its level was revealed to be correlated with the disease grade, clinical severity, and survival rate of patients with gliomas.	SAA1	gliomas	6288	HP_0009733	0	4	160	167	False
29603594	Magnetic resonance imaging and tumor region-specific microarray analysis identified a correlation between SAA1 and GBM cell infiltration in patients.	SAA1	tumor	6288	HP_0002664	106	110	31	36	False
29603594	In summary, our results demonstrate that SAA1 in combination with integrin V and 3 can serve as an indicator of high glioblastoma risk.	SAA1	glioblastoma	6288	HP_0012174	41	45	119	131	False
25220380	Ano1 is a Ca(2+) activated Cl(-) channel that is related to head and neck cancer, often caused by human papilloma virus (HPV) infection.	Ano1	cancer	55107	HP_0002664	0	4	74	80	False
25220380	Ano1 is a Ca(2+) activated Cl(-) channel that is related to head and neck cancer, often caused by human papilloma virus (HPV) infection.	Ano1	papilloma	55107	HP_0012740	0	4	104	113	False
25220380	Because TMC8 is required to lower cytosolic Zn(2+) concentrations by the Zn(2+) transporter ZnT-1, we hypothesize that HPV infections and cancer caused by mutations in TMC8 are related to upregulated Zn(2+)/Ca(2+) signaling and activation of Ano1.	TMC	cancer	3703	HP_0002664	8	11	138	144	False
25220380	Because TMC8 is required to lower cytosolic Zn(2+) concentrations by the Zn(2+) transporter ZnT-1, we hypothesize that HPV infections and cancer caused by mutations in TMC8 are related to upregulated Zn(2+)/Ca(2+) signaling and activation of Ano1.	Ano1	cancer	55107	HP_0002664	242	246	138	144	False
27601211	We established a genetic diagnosis in six families with autosomal recessive HSP (SPG11 in three families and TFG/SPG57, SACS and ALS2 in one family each).	SPG11	autosomal recessive	80208	HP_0000007	81	86	56	75	True
27601211	We established a genetic diagnosis in six families with autosomal recessive HSP (SPG11 in three families and TFG/SPG57, SACS and ALS2 in one family each).	TFG	autosomal recessive	10342	HP_0000007	109	112	56	75	True
27601211	We established a genetic diagnosis in six families with autosomal recessive HSP (SPG11 in three families and TFG/SPG57, SACS and ALS2 in one family each).	SPG57	autosomal recessive	10342	HP_0000007	113	118	56	75	True
27601211	We established a genetic diagnosis in six families with autosomal recessive HSP (SPG11 in three families and TFG/SPG57, SACS and ALS2 in one family each).	SACS	autosomal recessive	26278	HP_0000007	120	124	56	75	True
27601211	We established a genetic diagnosis in six families with autosomal recessive HSP (SPG11 in three families and TFG/SPG57, SACS and ALS2 in one family each).	ALS2	autosomal recessive	57679	HP_0000007	129	133	56	75	True
27601211	Patients did not present with visual impairment as observed in a previously reported SPG57 family (c.316C&gt;T (p.(Arg106Cys)) in coiled-coil domain), suggesting unique contributions of the PB1 and coiled-coil domains in TFG complex formation/function and a possible phenotype correlation to variant location.	type	visual impairment	6445	HP_0000505	272	276	30	47	False
27601211	Patients did not present with visual impairment as observed in a previously reported SPG57 family (c.316C&gt;T (p.(Arg106Cys)) in coiled-coil domain), suggesting unique contributions of the PB1 and coiled-coil domains in TFG complex formation/function and a possible phenotype correlation to variant location.	TFG	visual impairment	10342	HP_0000505	221	224	30	47	True
27601211	Patients did not present with visual impairment as observed in a previously reported SPG57 family (c.316C&gt;T (p.(Arg106Cys)) in coiled-coil domain), suggesting unique contributions of the PB1 and coiled-coil domains in TFG complex formation/function and a possible phenotype correlation to variant location.	SPG57	visual impairment	10342	HP_0000505	85	90	30	47	True
26149656	Friedreich's ataxia (FRDA), the autosomal neurodegenerative disorder is the only human disease known so far, where a large purine (GAA) repeat in the FXN gene is known to inhibit the expression of frataxin protein.	FRDA	ataxia	2395	HP_0001251	21	25	13	19	True
26149656	Friedreich's ataxia (FRDA), the autosomal neurodegenerative disorder is the only human disease known so far, where a large purine (GAA) repeat in the FXN gene is known to inhibit the expression of frataxin protein.	GAA	ataxia	2548	HP_0001251	131	134	13	19	False
26149656	Friedreich's ataxia (FRDA), the autosomal neurodegenerative disorder is the only human disease known so far, where a large purine (GAA) repeat in the FXN gene is known to inhibit the expression of frataxin protein.	FXN	ataxia	2395	HP_0001251	150	153	13	19	True
29578003	Until now, the role of VGSCs and the relationships between calmodulin (CaM)/CaM-dependent protein kinase II (CaMKII) and VGSCs in low-grade astrocytoma have not been demonstrated.	CaM	astrocytoma	889	HP_0009592	71	74	140	151	False
29578003	In our study, the protein expression of Na<sub>V</sub>1.3, Na<sub>V</sub>1.6 and CaM was significantly increased in the tumor compared to control tissue, while the level of p-CaMKII/CaMKII was significantly decreased in the tumor group as determined by Western Blotting and immunohistochemistry.	CaM	tumor	889	HP_0002664	81	84	120	125	True
29578003	Furthermore, double-labeling immunofluorescence results showed that Na<sub>V</sub>1.3/Na<sub>V</sub>1.6 and CaM co-localization was significantly increased in the tumor group compared to control tissue.	CaM	tumor	889	HP_0002664	108	111	163	168	True
29578003	This study represents the first evidence of the abnormal changes in VGSCs subtypes and CaM/CaMKII pathway in human brain low-grade astrocytoma, providing new potential targets for molecular therapies of this disease	CaM	astrocytoma	889	HP_0009592	87	90	131	142	False
27000805	We presented the significant clinical heterogeneity among three Chinese late-onset MADD patients with similar ETFDH genotype by collecting clinical information, muscle histology, and genetic analysis.	MADD	heterogeneity	2108	HP_0001425	83	87	38	51	False
27000805	We presented the significant clinical heterogeneity among three Chinese late-onset MADD patients with similar ETFDH genotype by collecting clinical information, muscle histology, and genetic analysis.	ETFDH	heterogeneity	2110	HP_0001425	110	115	38	51	False
29844572	The RANK/RANKL axis emerges as a key regulator of breast cancer initiation, progression, and metastasis.	RANK	cancer	8792	HP_0002664	4	8	57	63	False
29844572	Here we report that RANK-c transcript is expressed in 3.2% of cases in The Cancer Genome Atlas breast cancer cohort evenly between ER-positive and ER-negative cases.	RANK	cancer	8792	HP_0002664	20	24	102	108	False
29844572	Nevertheless, the ratio of RANK to RANK-c (RANK/RANK-c) is increased in ER-negative breast cancer cell lines compared to ER-positive breast cancer cell lines.	RANK	cancer	8792	HP_0002664	27	31	91	97	False
29844572	In addition, forced expression of RANK-c in ER-negative breast cancer cell lines inhibited stimuli-induced NF-B activation and attenuated migration, invasion, colony formation, and adhesion of cancer cells.	RANK	cancer	8792	HP_0002664	34	38	63	69	False
29844572	In addition, forced expression of RANK-c in ER-negative breast cancer cell lines inhibited stimuli-induced NF-B activation and attenuated migration, invasion, colony formation, and adhesion of cancer cells.	NF	cancer	23114	HP_0002664	107	109	63	69	False
29844572	The RANK-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (NF-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (TRAF2) protein interaction.	RANK	cancer	8792	HP_0002664	4	8	34	40	False
29844572	The RANK-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (NF-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (TRAF2) protein interaction.	NF	cancer	23114	HP_0002664	84	86	34	40	False
29844572	The RANK-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (NF-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (TRAF2) protein interaction.	TRAF2	cancer	10010	HP_0002664	185	190	34	40	False
29844572	The RANK-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (NF-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (TRAF2) protein interaction.	RANK	aggressiveness	8792	HP_0000718	4	8	46	60	False
29844572	The RANK-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (NF-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (TRAF2) protein interaction.	NF	aggressiveness	23114	HP_0000718	84	86	46	60	False
29844572	The RANK-c-mediated inhibition of cancer cell aggressiveness and nuclear factor-B (NF-B) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (TRAF2) protein interaction.	TRAF2	aggressiveness	10010	HP_0000718	185	190	46	60	False
29844572	Additional protein interaction characterization revealed epidermal growth factor receptor (EGFR) as a novel interacting partner for RANK-c in breast cancer cells with a negative effect on EGFR phosphorylation and EGF-dependent downstream signaling pathway activation.	RANK	cancer	8792	HP_0002664	132	136	149	155	False
29844572	Additional protein interaction characterization revealed epidermal growth factor receptor (EGFR) as a novel interacting partner for RANK-c in breast cancer cells with a negative effect on EGFR phosphorylation and EGF-dependent downstream signaling pathway activation.	EGFR	cancer	1956	HP_0002664	91	95	149	155	True
29844572	Additional protein interaction characterization revealed epidermal growth factor receptor (EGFR) as a novel interacting partner for RANK-c in breast cancer cells with a negative effect on EGFR phosphorylation and EGF-dependent downstream signaling pathway activation.	EGF	cancer	1950	HP_0002664	213	216	149	155	False
29844572	Our findings further elucidate the complex molecular biology of the RANKL/RANK system in breast cancer and provide preliminary data for RANK-c as a possible marker for disease progression and aggressiveness	RANK	cancer	8792	HP_0002664	68	72	96	102	False
30386297	Since women with breast cancer and men and women with other disorders are often treated with aromatase inhibitors (AI), these populations might be especially vulnerable to cognitive deficits due to low neuroE2 synthesis, i.e., synthesis of E2 directly within the brain.	aromatase	cancer	1588	HP_0002664	93	102	24	30	False
30386297	Since women with breast cancer and men and women with other disorders are often treated with aromatase inhibitors (AI), these populations might be especially vulnerable to cognitive deficits due to low neuroE2 synthesis, i.e., synthesis of E2 directly within the brain.	men	cancer	8178	HP_0002664	8	11	24	30	False
28901453	In this study, we investigated whether single nucleotide polymorphisms (SNPs) rs7521902, rs10859871 and rs11031006, mapping to WNT4, VEZT and FSHB genetic loci, respectively, are associated with risk for endometriosis in a Greek population.	WNT4	endometriosis	54361	HP_0030127	127	131	204	217	False
28901453	In this study, we investigated whether single nucleotide polymorphisms (SNPs) rs7521902, rs10859871 and rs11031006, mapping to WNT4, VEZT and FSHB genetic loci, respectively, are associated with risk for endometriosis in a Greek population.	VEZT	endometriosis	55591	HP_0030127	133	137	204	217	False
28901453	In this study, we investigated whether single nucleotide polymorphisms (SNPs) rs7521902, rs10859871 and rs11031006, mapping to WNT4, VEZT and FSHB genetic loci, respectively, are associated with risk for endometriosis in a Greek population.	FSHB	endometriosis	2488	HP_0030127	142	146	204	217	False
28901453	Evidence for association with endometriosis was also found for the AC genotype of the rs10859871 of VEZT.	VEZT	endometriosis	55591	HP_0030127	100	104	30	43	False
28901453	Notably, a significant difference in the distribution of the AG genotype and the minor allele A of FSHB rs11031006 SNP was found between the endometriosis patients and controls.	FSHB	endometriosis	2488	HP_0030127	99	103	141	154	False
28901453	Notably, a significant difference in the distribution of the AG genotype and the minor allele A of FSHB rs11031006 SNP was found between the endometriosis patients and controls.	minor	endometriosis	8013	HP_0030127	81	86	141	154	False
28901453	We found a genetic association between rs11031006 (FSHB) SNP and endometriosis.	FSHB	endometriosis	2488	HP_0030127	51	55	65	78	False
28901453	WNT4 and VEZT genes constitute the most consistently associated genes with endometriosis.	WNT4	endometriosis	54361	HP_0030127	0	4	75	88	False
28901453	WNT4 and VEZT genes constitute the most consistently associated genes with endometriosis.	VEZT	endometriosis	55591	HP_0030127	9	13	75	88	False
28901453	In the present study, an association of rs7521902 (WNT4) and rs10859871 (VEZT) was confirmed in women with endometriosis at the genotypic but not the allelic level	WNT4	endometriosis	54361	HP_0030127	51	55	107	120	False
28901453	In the present study, an association of rs7521902 (WNT4) and rs10859871 (VEZT) was confirmed in women with endometriosis at the genotypic but not the allelic level	VEZT	endometriosis	55591	HP_0030127	73	77	107	120	False
23454480	Here we present a novel Mks1(tm1a(EUCOMM)Wtsi) knockout mouse which accurately recapitulates the human condition, consistently developing pre-axial polydactyly, complex posterior fossa defects (including the Dandy-Walker malformation), and renal cystic dysplasia.	Mks1	axial	54903	HP_0025287	24	28	142	147	False
23454480	Here we present a novel Mks1(tm1a(EUCOMM)Wtsi) knockout mouse which accurately recapitulates the human condition, consistently developing pre-axial polydactyly, complex posterior fossa defects (including the Dandy-Walker malformation), and renal cystic dysplasia.	Mks1	polydactyly	54903	HP_0010442	24	28	148	159	True
26743054	Signs and symptoms are blisters, skin fragility, erosions hyperpigmentation, sclerodermoid plaques.	per	skin fragility	93210	HP_0001030	60	63	33	47	False
29263214	TNF-related apoptosis-inducing ligand (TRAIL) was initially described to induce apoptosis of tumor cells and/or virally infected cells, although sparing normal cells, and has been implicated in the pathogenesis of HIV disease.	TRAIL	tumor	8743	HP_0002664	39	44	93	98	False
26853090	We compare and contrast our findings with previous studies reporting on critical 1q43-q44 regions and their constituent genes associated with seizures, microcephaly, and corpus callosum abnormalities [Ballif et al., 2012; Hum Genet 131:145-156; Nagamani et al., 2012; Eur J Hum Genet 20:176-179].	find	seizures	81501	HP_0001250	28	32	142	150	False
26853090	We compare and contrast our findings with previous studies reporting on critical 1q43-q44 regions and their constituent genes associated with seizures, microcephaly, and corpus callosum abnormalities [Ballif et al., 2012; Hum Genet 131:145-156; Nagamani et al., 2012; Eur J Hum Genet 20:176-179].	find	microcephaly	81501	HP_0000252	28	32	152	164	False
26853090	We compare and contrast our findings with previous studies reporting on critical 1q43-q44 regions and their constituent genes associated with seizures, microcephaly, and corpus callosum abnormalities [Ballif et al., 2012; Hum Genet 131:145-156; Nagamani et al., 2012; Eur J Hum Genet 20:176-179].	find	corpus callosum abnormalities	81501	HP_0001273	28	32	170	199	False
30404026	The pathogenesis of hepatocellular carcinoma (HCC) is poorly understood, but recent advances in genomics have increased our understanding of the mechanisms by which hepatitis B virus, hepatitis C virus, alcohol, fatty liver disease, and other environmental factors, such as aflatoxin, cause liver cancer.	HCC	hepatocellular carcinoma	84668	HP_0001402	46	49	20	44	False
30404026	The pathogenesis of hepatocellular carcinoma (HCC) is poorly understood, but recent advances in genomics have increased our understanding of the mechanisms by which hepatitis B virus, hepatitis C virus, alcohol, fatty liver disease, and other environmental factors, such as aflatoxin, cause liver cancer.	HCC	cancer	84668	HP_0002664	46	49	297	303	False
30140948	Uterine carcinosarcoma (UCS) has been proposed as a model for epithelial-mesenchymal transition (EMT), a process characterized by a functional change facilitating migration and metastasis in many types of cancer.	EMT	cancer	3702	HP_0002664	97	100	205	211	True
30690791	Human genetic evidence demonstrates that WNT1 mutations cause osteogenesis imperfecta (OI) and early-onset osteoporosis, implicating WNT1 as a major regulator of bone metabolism.	WNT1	osteoporosis	7471	HP_0000939	41	45	107	119	True
30690791	Targeted deletion of Wnt1 in mesenchymal progenitors led to spontaneous fractures due to impaired osteoblast function and increased bone resorption, mimicking the severe OI phenotype in humans with homozygous WNT1 mutations.	WNT1	increased bone resorption	7471	HP_0002797	209	213	122	147	False
30690791	Targeted deletion of Wnt1 in mesenchymal progenitors led to spontaneous fractures due to impaired osteoblast function and increased bone resorption, mimicking the severe OI phenotype in humans with homozygous WNT1 mutations.	Wnt1	increased bone resorption	7471	HP_0002797	21	25	122	147	False
30047423	Myelodysplastic syndromes (MDS) in children and adolescents are a rare heterogeneous group of clonal stem cell disorders.	MDS	heterogeneous	5048	HP_0001425	27	30	71	84	False
24895994	Defects in Membrane Frizzled-related Protein (MFRP) cause autosomal recessive retinitis pigmentosa (RP).	MFRP	autosomal recessive	83552	HP_0000007	46	50	58	77	True
24895994	Defects in Membrane Frizzled-related Protein (MFRP) cause autosomal recessive retinitis pigmentosa (RP).	RP	autosomal recessive	100287745	HP_0000007	100	102	58	77	False
29916023	Genetic discoveries have established the importance of SETX for neural function, as recessive mutations in the SETX gene cause Ataxia with Oculomotor Apraxia type 2 (AOA2) (OMIM: 606002), which is the third most common form of recessive ataxia, after Friedreich's ataxia and Ataxia-Telangiectasia.	SETX	ataxia	23064	HP_0001251	55	59	237	243	True
29916023	Genetic discoveries have established the importance of SETX for neural function, as recessive mutations in the SETX gene cause Ataxia with Oculomotor Apraxia type 2 (AOA2) (OMIM: 606002), which is the third most common form of recessive ataxia, after Friedreich's ataxia and Ataxia-Telangiectasia.	type	ataxia	6445	HP_0001251	158	162	237	243	False
29916023	Genetic discoveries have established the importance of SETX for neural function, as recessive mutations in the SETX gene cause Ataxia with Oculomotor Apraxia type 2 (AOA2) (OMIM: 606002), which is the third most common form of recessive ataxia, after Friedreich's ataxia and Ataxia-Telangiectasia.	AOA2	ataxia	23064	HP_0001251	166	170	237	243	True
29916023	Over the last decade, altered RNA regulation and aberrant RNA-binding protein function have emerged as a central theme in motor neuron disease pathogenesis, with evidence suggesting that sporadic ALS disease pathology may overlap with the molecular pathology uncovered in familial ALS.	ALS	sporadic	3483	HP_0003745	196	199	187	195	False
29916023	Growing evidence suggests that SETX may represent an important genetic modifier locus for sporadic ALS.	SETX	sporadic	23064	HP_0003745	31	35	90	98	False
29916023	Growing evidence suggests that SETX may represent an important genetic modifier locus for sporadic ALS.	ALS	sporadic	3483	HP_0003745	99	102	90	98	False
29916023	While we do not yet know which SETX activities are most critical to neurodegeneration, our evolving understanding of SETX function will undoubtedly be crucial for not only understanding the role of SETX in ALS and ataxia disease pathogenesis, but also for delineating the mechanistic biology of fundamentally important molecular processes in the cell	SETX	ataxia	23064	HP_0001251	31	35	214	220	True
29916023	While we do not yet know which SETX activities are most critical to neurodegeneration, our evolving understanding of SETX function will undoubtedly be crucial for not only understanding the role of SETX in ALS and ataxia disease pathogenesis, but also for delineating the mechanistic biology of fundamentally important molecular processes in the cell	ALS	ataxia	3483	HP_0001251	206	209	214	220	False
24786789	Substitution of endogenous PGAM2 with an acetylation mimetic mutant K100Q reduces cellular NADPH production and inhibits cell proliferation and tumor growth.	PGAM2	tumor	5224	HP_0002664	27	32	144	149	False
24786789	These results reveal a mechanism of PGAM2 regulation and NADPH homeostasis in response to oxidative stress that impacts cell proliferation and tumor growth	PGAM2	tumor	5224	HP_0002664	36	41	143	148	False
29277318	Genetic rearrangements involving androgen-regulated transmembrane protease serine 2 (TMPRSS2) and genes from the ETS transcription factor family, most commonly ERG and ETV1, result in alteration that responsible for oncogenic activity in prostate cancer (PC).	TMPRSS2	cancer	7113	HP_0002664	85	92	247	253	False
29277318	Genetic rearrangements involving androgen-regulated transmembrane protease serine 2 (TMPRSS2) and genes from the ETS transcription factor family, most commonly ERG and ETV1, result in alteration that responsible for oncogenic activity in prostate cancer (PC).	ERG	cancer	2078	HP_0002664	160	163	247	253	False
29277318	Genetic rearrangements involving androgen-regulated transmembrane protease serine 2 (TMPRSS2) and genes from the ETS transcription factor family, most commonly ERG and ETV1, result in alteration that responsible for oncogenic activity in prostate cancer (PC).	ETV1	cancer	2115	HP_0002664	168	172	247	253	False
28803936	Addition of exogenous SLURP1 (6XHis-tagged, E. coli expressed and partially purified using Ni-ion columns) significantly suppressed the tumor necrosis factor- (TNF-)-stimulated human umbilical cord vascular endothelial cell (HUVEC) tube formation.	SLURP1	tumor	57152	HP_0002664	22	28	136	141	False
28803936	Addition of exogenous SLURP1 (6XHis-tagged, E. coli expressed and partially purified using Ni-ion columns) significantly suppressed the tumor necrosis factor- (TNF-)-stimulated human umbilical cord vascular endothelial cell (HUVEC) tube formation.	tube	tumor	51175	HP_0002664	234	238	136	141	False
28803936	Addition of exogenous SLURP1 (6XHis-tagged, E. coli expressed and partially purified using Ni-ion columns) significantly suppressed the tumor necrosis factor- (TNF-)-stimulated human umbilical cord vascular endothelial cell (HUVEC) tube formation.	TNF	tumor	7124	HP_0002664	161	164	136	141	False
28104394	The mutational analysis of the whole mitochondrial DNA revealed the presence of m.1555A&gt;G mutation in MT-RNR1 gene associated to the m.8527A&gt;G (p.M&gt;V) and the m.8392C&gt;T (p.136P&gt;S) variations in the mitochondrial MT-ATP6 gene in patient1 and his family members with variable phenotype including hearing impairment.	MT-ATP6	hearing impairment	100287745	HP_0000365	227	234	309	327	False
28837158	The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).	CDKL5	epilepsy	6792	HP_0001250	447	452	133	141	True
28837158	The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).	GABRA1	epilepsy	2554	HP_0001250	454	460	133	141	True
28837158	The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).	GABRG2	epilepsy	2566	HP_0001250	462	468	133	141	True
28837158	The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).	GRIN2B	epilepsy	2904	HP_0001250	470	476	133	141	True
28837158	The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).	KCNQ2	epilepsy	3785	HP_0001250	478	483	133	141	True
28837158	The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).	MECP2	epilepsy	4204	HP_0001250	485	490	133	141	True
28837158	The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).	PCDH19	epilepsy	57526	HP_0001250	492	498	133	141	True
28837158	The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).	SCN1A	epilepsy	6323	HP_0001250	500	505	133	141	True
28837158	The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with epilepsy-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (CDKL5, GABRA1, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, SCN1A, or SCN2A).	SCN2A	epilepsy	6326	HP_0001250	510	515	133	141	True
19587458	For instance, mutations in both BFSP1 and BFSP2 cause cataract in humans.	BFSP1	cataract	631	HP_0000518	32	37	54	62	True
19587458	For instance, mutations in both BFSP1 and BFSP2 cause cataract in humans.	BFSP2	cataract	8419	HP_0000518	42	47	54	62	True
29157486	The genetic diagnosis is difficult owing to the large genetic heterogeneity of the 6p21.3 region, which contains the CYP21A2 gene, especially with respect to the use of new-generation techniques of sequencing.	CYP21A2	heterogeneity	1589	HP_0001425	117	124	62	75	False
29046994	We measured the expression of autophagy genes in peripheral blood mononuclear cells of 20 patients with Huntington's disease (HD), 20 with spinocerebellar ataxia type 2 (SCA2), and 20 healthy individuals.	type	ataxia	6445	HP_0001251	162	166	155	161	False
29046994	We measured the expression of autophagy genes in peripheral blood mononuclear cells of 20 patients with Huntington's disease (HD), 20 with spinocerebellar ataxia type 2 (SCA2), and 20 healthy individuals.	SCA2	ataxia	6311	HP_0001251	170	174	155	161	True
30548441	Surgical tumor specimens were collected for immunohistochemical staining to evaluate B7-H5 expression.	H5	tumor	2260	HP_0002664	88	90	9	14	True
30548441	Surgical tumor specimens were collected for immunohistochemical staining to evaluate B7-H5 expression.	B7	tumor	10233	HP_0002664	85	87	9	14	False
30548441	Patients' baseline characteristics, including gender, age, tumor size, tumor location, tumor grading, clinical TNM staging, tumor infiltrating lymphocytes, CA19-9 and chemotherapy treatment, along with the subsequent follow-up data, were documented and analyzed.	TNM	tumor	10178	HP_0002664	111	114	59	64	False
30548441	When co-cultured with T cells, pancreatic cancer PC cells with high B7-H5 expression induced a more potent immune reaction, indicated by elevated cytokine release and increased proliferation of T lymphocytes compared with cells exhibiting low B7-H5 expression.	H5	cancer	2260	HP_0002664	71	73	42	48	True
30548441	When co-cultured with T cells, pancreatic cancer PC cells with high B7-H5 expression induced a more potent immune reaction, indicated by elevated cytokine release and increased proliferation of T lymphocytes compared with cells exhibiting low B7-H5 expression.	B7	cancer	10233	HP_0002664	68	70	42	48	False
30548441	Xenograft pancreatic tumors derived from high B7-H5 expression PC cells exhibited attenuated growth compared to tumors from low B7-H5 expression cells after transfusion with T lymphocytes in immune-deficient mice.	H5	tumor	2260	HP_0002664	49	51	21	26	True
30548441	Xenograft pancreatic tumors derived from high B7-H5 expression PC cells exhibited attenuated growth compared to tumors from low B7-H5 expression cells after transfusion with T lymphocytes in immune-deficient mice.	B7	tumor	10233	HP_0002664	46	48	21	26	False
30548441	Of the 136 PDAC tumor tissues, 93 (68.38%) were strong and 43 (31.62%) were weak B7-H5 expression.	H5	tumor	2260	HP_0002664	84	86	16	21	True
30548441	Of the 136 PDAC tumor tissues, 93 (68.38%) were strong and 43 (31.62%) were weak B7-H5 expression.	B7	tumor	10233	HP_0002664	81	83	16	21	False
30548441	TNM staging, tumor location and subsequent chemotherapy were also prognostic factors in these patients.	TNM	tumor	10178	HP_0002664	0	3	13	18	False
28126686	Glycogen storage disease type Ib (GSD-Ib) is characterized by impaired glucose homeostasis, neutropenia and neutrophil dysfunction.	type	neutropenia	6445	HP_0001875	25	29	92	103	False
29290614	The importance of this process is highlighted in a patient with mitochondrial disease caused by biallelic pathogenic variants in TOP3A, characterized by muscle-restricted mtDNA deletions and chronic progressive external ophthalmoplegia (CPEO) plus syndrome.	TOP3A	chronic	7156	HP_0011010	129	134	191	198	False
29290614	The importance of this process is highlighted in a patient with mitochondrial disease caused by biallelic pathogenic variants in TOP3A, characterized by muscle-restricted mtDNA deletions and chronic progressive external ophthalmoplegia (CPEO) plus syndrome.	TOP3A	progressive	7156	HP_0003676	129	134	199	210	False
29290614	The importance of this process is highlighted in a patient with mitochondrial disease caused by biallelic pathogenic variants in TOP3A, characterized by muscle-restricted mtDNA deletions and chronic progressive external ophthalmoplegia (CPEO) plus syndrome.	TOP3A	ophthalmoplegia	7156	HP_0000602	129	134	220	235	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B4GALT7	corneal clouding	11285	HP_0007957	121	128	234	250	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	XYLT1	corneal clouding	64131	HP_0007957	107	112	234	250	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	XYLT2	corneal clouding	64132	HP_0007957	114	119	234	250	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B3GALT6	corneal clouding	126792	HP_0007957	130	137	234	250	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B3GAT3	corneal clouding	26229	HP_0007957	143	149	234	250	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B4GALT7	cataracts	11285	HP_0000518	121	128	275	284	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	XYLT1	cataracts	64131	HP_0000518	107	112	275	284	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	XYLT2	cataracts	64132	HP_0000518	114	119	275	284	True
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B3GALT6	cataracts	126792	HP_0000518	130	137	275	284	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B3GAT3	cataracts	26229	HP_0000518	143	149	275	284	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B4GALT7	strabismus	11285	HP_0000486	121	128	252	262	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	XYLT1	strabismus	64131	HP_0000486	107	112	252	262	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	XYLT2	strabismus	64132	HP_0000486	114	119	252	262	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B3GALT6	strabismus	126792	HP_0000486	130	137	252	262	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B3GAT3	strabismus	26229	HP_0000486	143	149	252	262	True
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B4GALT7	nystagmus	11285	HP_0000639	121	128	264	273	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	XYLT1	nystagmus	64131	HP_0000639	107	112	264	273	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	XYLT2	nystagmus	64132	HP_0000639	114	119	264	273	True
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B3GALT6	nystagmus	126792	HP_0000639	130	137	264	273	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B3GAT3	nystagmus	26229	HP_0000639	143	149	264	273	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B4GALT7	glaucoma	11285	HP_0000501	121	128	286	294	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	XYLT1	glaucoma	64131	HP_0000501	107	112	286	294	True
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	XYLT2	glaucoma	64132	HP_0000501	114	119	286	294	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B3GALT6	glaucoma	126792	HP_0000501	130	137	286	294	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B3GAT3	glaucoma	26229	HP_0000501	143	149	286	294	True
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B4GALT7	retinal detachment	11285	HP_0000541	121	128	333	351	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	XYLT1	retinal detachment	64131	HP_0000541	107	112	333	351	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	XYLT2	retinal detachment	64132	HP_0000541	114	119	333	351	True
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B3GALT6	retinal detachment	126792	HP_0000541	130	137	333	351	False
27320698	The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (XYLT1, XYLT2, B4GALT7, B3GALT6, and B3GAT3) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	B3GAT3	retinal detachment	26229	HP_0000541	143	149	333	351	False
27320698	The corneal clouding and cataracts in this patient may thus have been caused by her B4GALT7 mutation, but the colobomas are a novel phenotypic finding.	B4GALT7	corneal clouding	11285	HP_0007957	84	91	4	20	False
27320698	The corneal clouding and cataracts in this patient may thus have been caused by her B4GALT7 mutation, but the colobomas are a novel phenotypic finding.	B4GALT7	cataracts	11285	HP_0000518	84	91	25	34	False
29655892	However, to date the genetic cause remains unknown in around 40% of SRS cases, suggesting genetic heterogeneity and involvement of other genes.	SRS	heterogeneity	10743	HP_0001425	68	71	98	111	False
29054766	However, little information is currently available on the skeletal abnormalities of PRS and the potential contribution of PAX2 mutations.	PAX2	skeletal abnormalities	5076	HP_0000924	122	126	58	80	True
29054766	This case unravels a previously unrecognized phenotype of camptodactyly due to a significant skeletal deformity of PRS with a heterogeneous PAX2 mutation of hexanucleotide duplication.	PAX2	camptodactyly	5076	HP_0012385	140	144	58	71	False
29054766	This case unravels a previously unrecognized phenotype of camptodactyly due to a significant skeletal deformity of PRS with a heterogeneous PAX2 mutation of hexanucleotide duplication.	PAX2	heterogeneous	5076	HP_0001425	140	144	126	139	False
28775359	The zinc transporter SLC39A4 influences epithelial cell morphology and migration in various cancers; however, its role in regulating cell invasion and chemotherapeutic resistance in human lung cancer is not yet clear.	SLC39A4	cancer	55630	HP_0002664	21	28	92	98	False
28775359	Here, integrated analysis of gene expression in non-small cell lung cancer revealed that SLC39A4 expression is significantly correlated with increased tumour size and regional lymph node spread, as well as shorter overall survival (OS) and disease-free survival (DFS).	SLC39A4	cancer	55630	HP_0002664	89	96	68	74	False
28775359	Here, integrated analysis of gene expression in non-small cell lung cancer revealed that SLC39A4 expression is significantly correlated with increased tumour size and regional lymph node spread, as well as shorter overall survival (OS) and disease-free survival (DFS).	SLC39A4	tumour	55630	HP_0002664	89	96	151	157	False
28775359	SLC39A4 silencing by lentivirus-mediated shRNA blocked human lung cancer cell epithelial-mesenchymal transition and metastasis in vitro and in vivo, respectively.	SLC39A4	cancer	55630	HP_0002664	0	7	66	72	False
28775359	Moreover, SLC39A4 knockdown enhanced cancer cell sensitivity to cisplatin-induced death by inhibiting stemness in lung cancer cells.	SLC39A4	cancer	55630	HP_0002664	10	17	37	43	False
28775359	Collectively, these data suggest that SLC39A4 may be a novel therapeutic target and predictive marker of tumour metastasis in non-small cell lung cancer	SLC39A4	tumour	55630	HP_0002664	38	45	105	111	False
25521980	X-linked spondylo-epiphyseal dysplasia tarda (SEDT) is an X-linked recessive, late-onset, progressive skeletal disorder characterized by mild-to-moderate short-trunked short stature.	SEDT	epiphyseal dysplasia	6399	HP_0002656	46	50	18	38	False
25521980	X-linked spondylo-epiphyseal dysplasia tarda (SEDT) is an X-linked recessive, late-onset, progressive skeletal disorder characterized by mild-to-moderate short-trunked short stature.	SEDT	short stature	6399	HP_0004322	46	50	168	181	True
26055424	We performed a clinical, neurophysiological (in vivo electroencephalography-auditory-evoked related potentials) and genetic (whole-exome sequencing) follow-up analysis of two families with known deleterious NLGN4X gene mutations (either truncating or overexpressing) present in individuals with ASD and/or with intellectual disability (ID).	NLGN4X	intellectual disability	57502	HP_0001249	207	213	311	334	True
22419069	Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, HES5, IRX1, BMP8A, GATA4, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.	DNAJA4	rhabdomyosarcoma	55466	HP_0002859	79	85	261	277	False
22419069	Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, HES5, IRX1, BMP8A, GATA4, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.	HES5	rhabdomyosarcoma	388585	HP_0002859	87	91	261	277	False
22419069	Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, HES5, IRX1, BMP8A, GATA4, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.	IRX1	rhabdomyosarcoma	79192	HP_0002859	93	97	261	277	False
22419069	Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, HES5, IRX1, BMP8A, GATA4, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.	BMP8A	rhabdomyosarcoma	353500	HP_0002859	99	104	261	277	False
22419069	Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, HES5, IRX1, BMP8A, GATA4, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.	GATA4	rhabdomyosarcoma	2626	HP_0002859	106	111	261	277	False
22419069	Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, HES5, IRX1, BMP8A, GATA4, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.	GATA6	rhabdomyosarcoma	2627	HP_0002859	113	118	261	277	False
22419069	Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, HES5, IRX1, BMP8A, GATA4, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.	ALX3	rhabdomyosarcoma	257	HP_0002859	120	124	261	277	False
22419069	Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, HES5, IRX1, BMP8A, GATA4, GATA6, ALX3, and P4HTM were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of rhabdomyosarcoma.	P4HTM	rhabdomyosarcoma	54681	HP_0002859	130	135	261	277	False
22419069	These results suggest that DNA methylation signatures may aid in the diagnosis and risk stratification of pediatric rhabdomyosarcoma and help identify new targets for therapy	aid	rhabdomyosarcoma	57379	HP_0002859	58	61	116	132	False
30513729	These effects are thought to have a significant impact upon both vascular and cerebrovascular health, ultimately with the potential to prevent cardiovascular and potentially neurodegenerative disease with a vascular component, for example vascular dementia.	impact	neurodegenerative disease	55364	HP_0002180	48	54	174	199	False
30513729	However, there is great variation in the literature due to the heterogeneous nature of the randomised controlled trials conducted.	great	heterogeneous	122042	HP_0001425	18	23	63	76	False
24488689	Genetic insights into the pathophysiology of amyotrophic lateral sclerosis (ALS) are untangling the clinical heterogeneity that may contribute to poor clinical trial outcomes and thus to a lack of effective treatments.	ALS	heterogeneity	3483	HP_0001425	76	79	109	122	False
30076115	Sickle cell disease (SCD) is one of the most common autosomal recessive diseases in humans, occurring at a frequency of 1 in 365 African-American and 1 in 50 sub-Saharan African births.	SCD	autosomal recessive	6584	HP_0000007	21	24	52	71	True
30226594	As a mitotic kinesin, kinesin family member 14 (KIF14) has been reported to serve oncogenic roles in a variety of malignancies; however, its functional role and regulatory mechanisms in colorectal cancer (CRC) remain unclear.	KIF14	cancer	9928	HP_0002664	48	53	197	203	False
30226594	In the present study, KIF14 was observed to be markedly overexpressed in CRC, and this upregulation was associated with tumor size and marker of proliferation Ki-67 immunostaining scores.	KIF14	tumor	9928	HP_0002664	22	27	120	125	False
30226594	In the present study, KIF14 was observed to be markedly overexpressed in CRC, and this upregulation was associated with tumor size and marker of proliferation Ki-67 immunostaining scores.	Ki	tumor	10197	HP_0002664	159	161	120	125	False
30226594	Collectively, the findings of the present study demonstrated the oncogenic role of KIF14 in colorectal tumorigenesis, and also revealed a complexity of regulatory mechanisms mediating KIF14 overexpression, which may provide insight for developing novel treatments for patients with CRC	KIF14	tumor	9928	HP_0002664	83	88	103	108	False
20655465	We find NF1 mutations in neuroblastoma cell lines and in primary tumors.	find	neuroblastoma	81501	HP_0003006	3	7	25	38	False
20655465	We find NF1 mutations in neuroblastoma cell lines and in primary tumors.	find	tumor	81501	HP_0002664	3	7	65	70	False
29348457	Herein, we investigated the role of LTBP3 in the distinct processes involved in cancer metastasis.	LTBP3	cancer	4054	HP_0002664	36	41	80	86	False
29348457	By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that LTBP3 is involved in the early dissemination of primary cancer cells, namely in the intravasation step of the metastatic cascade.	LTBP3	cancer	4054	HP_0002664	229	234	285	291	False
29348457	By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that LTBP3 is involved in the early dissemination of primary cancer cells, namely in the intravasation step of the metastatic cascade.	step	cancer	84867	HP_0002664	327	331	285	291	False
29348457	By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that LTBP3 is involved in the early dissemination of primary cancer cells, namely in the intravasation step of the metastatic cascade.	LTBP3	tumor	4054	HP_0002664	229	234	21	26	False
29348457	By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that LTBP3 is involved in the early dissemination of primary cancer cells, namely in the intravasation step of the metastatic cascade.	step	tumor	84867	HP_0002664	327	331	21	26	False
29348457	By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that LTBP3 is involved in the early dissemination of primary cancer cells, namely in the intravasation step of the metastatic cascade.	LTBP3	carcinomas	4054	HP_0030731	229	234	101	111	False
29348457	By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that LTBP3 is involved in the early dissemination of primary cancer cells, namely in the intravasation step of the metastatic cascade.	step	carcinomas	84867	HP_0030731	327	331	101	111	False
29348457	By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that LTBP3 is involved in the early dissemination of primary cancer cells, namely in the intravasation step of the metastatic cascade.	LTBP3	fibrosarcoma	4054	HP_0100244	229	234	124	136	False
29348457	By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 carcinomas and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that LTBP3 is involved in the early dissemination of primary cancer cells, namely in the intravasation step of the metastatic cascade.	step	fibrosarcoma	84867	HP_0100244	327	331	124	136	False
29348457	Knockdown of LTBP3 in all tested cell lines led to significant inhibition of tumor cell intravasation, but did not affect primary tumor growth.	LTBP3	tumor	4054	HP_0002664	13	18	77	82	False
29348457	LTBP3 was dispensable in the late steps of carcinoma cell metastasis that follow tumor cell intravasation, including vascular arrest, extravasation, and tissue colonization.	LTBP3	tumor	4054	HP_0002664	0	5	81	86	False
29348457	LTBP3 was dispensable in the late steps of carcinoma cell metastasis that follow tumor cell intravasation, including vascular arrest, extravasation, and tissue colonization.	step	tumor	84867	HP_0002664	34	38	81	86	False
29348457	A similar compensatory approach rescued the dampened intravasation of LTBP3-deficient HEp-3 cells, suggesting that LTBP3 regulates the induction of the intravasation-supporting angiogenic vasculature within developing primary tumors.	LTBP3	tumor	4054	HP_0002664	70	75	226	231	False
29348457	Using our recently developed microtumor model, we confirmed that LTBP3 loss resulted in the development of intratumoral vessels with an abnormal microarchitecture incompatible with efficient intravasation of HEp-3 carcinoma cells.	LTBP3	tumor	4054	HP_0002664	65	70	34	39	False
29348457	Collectively, these findings demonstrate that LTBP3 represents a novel oncotarget that has distinctive functions in the regulation of angiogenesis-dependent tumor cell intravasation, a critical process during early cancer dissemination.	LTBP3	cancer	4054	HP_0002664	46	51	215	221	False
29348457	Collectively, these findings demonstrate that LTBP3 represents a novel oncotarget that has distinctive functions in the regulation of angiogenesis-dependent tumor cell intravasation, a critical process during early cancer dissemination.	LTBP3	tumor	4054	HP_0002664	46	51	157	162	False
29348457	Our experimental data are also consistent with the survival prognostic value of LTBP3 expression in early-stage head and neck squamous cell carcinomas, further indicating a specific role for LTBP3 in cancer progression toward metastatic disease	LTBP3	cancer	4054	HP_0002664	80	85	200	206	False
29348457	Our experimental data are also consistent with the survival prognostic value of LTBP3 expression in early-stage head and neck squamous cell carcinomas, further indicating a specific role for LTBP3 in cancer progression toward metastatic disease	LTBP3	carcinomas	4054	HP_0030731	80	85	140	150	False
20950787	L371P mutation in MED17 is a founder mutation in the Caucasus Jewish community and that homozygosity for this mutation is associated with infantile cerebral and cerebellar atrophy with poor myelination	MED17	cerebellar atrophy	9440	HP_0001272	18	23	161	179	False
29956815	Kank1, an important member of the Kank gene family, plays an important role in the development of many malignant tumors.	Kank	tumors	23189	HP_0002664	0	4	113	119	False
29956815	As a brand new tumor-suppressor gene, the expression of Kank1 gene has been revealed to be downregulated or absent in many malignant tumors.	Kank	tumors	23189	HP_0002664	56	60	133	139	False
29956815	As a brand new tumor-suppressor gene, the expression of Kank1 gene has been revealed to be downregulated or absent in many malignant tumors.	Kank	tumor	23189	HP_0002664	56	60	15	20	False
29956815	However, there is no study concerning the specific role of Kank1 in the development and progression of lung cancer.	Kank	cancer	23189	HP_0002664	59	63	108	114	False
29956815	In the present study, we found that the Kankl gene was significantly downregulated in human lung cancer and lung cancer cells.	Kank	cancer	23189	HP_0002664	40	44	97	103	False
29956815	When the Kankl gene was upregulated, we found that the proliferation of lung cancer cells was significantly inhibited, the cells were arrested in the G0/G1phase, the apoptosis of cells was observed, the expression of the caspase family of genes was altered with mainly the activation of caspase-3and-9, and Bcl-2/Bax ratio was significantly imbalanced.	Kank	cancer	23189	HP_0002664	9	13	77	83	False
29956815	In addition, we also found that upregulation of the Kankl gene resulted in the inhibition of tumor cell invasion and metastasis.	Kank	tumor	23189	HP_0002664	52	56	93	98	False
29956815	Concurrently, invivo nude mice experiments also confirmed that upregulation of Kank1 expression led to reduced tumor formation in nude mice and significantly reduced tumor volume.	Kank	tumor	23189	HP_0002664	80	84	112	117	False
29956815	Concurrently, invivo nude mice experiments also confirmed that upregulation of Kank1 expression led to reduced tumor formation in nude mice and significantly reduced tumor volume.	nude	tumor	54820	HP_0002664	22	26	112	117	False
29956815	Concurrently, invivo nude mice experiments also confirmed that upregulation of Kank1 expression led to reduced tumor formation in nude mice and significantly reduced tumor volume.	mice	tumor	23581	HP_0002664	27	31	112	117	False
29956815	These results revealed that upregulation of the Kankl gene inhibited the progression of lung cancer both invitro and invivo, and its mechanism was closely related to cell apoptosis as well as tumor invasion and metastasis	Kank	tumor	23189	HP_0002664	48	52	194	199	False
29956815	These results revealed that upregulation of the Kankl gene inhibited the progression of lung cancer both invitro and invivo, and its mechanism was closely related to cell apoptosis as well as tumor invasion and metastasis	Kank	cancer	23189	HP_0002664	48	52	93	99	False
23110055	Fuchs endothelial corneal dystrophy (FECD) is the most common late-onset, vision-threatening corneal dystrophy in the United States, affecting about 4% of the population.	FECD	corneal dystrophy	1296	HP_0001131	37	41	18	35	True
23110055	Advanced FECD involves a thickening of the cornea from stromal edema and changes in Descemet membrane.	FECD	edema	1296	HP_0000969	9	13	63	68	True
25134915	Single nucleotide polymorphisms (SNPs) in WRAP53 have been associated with risk of cancer, which strengthens the role of WRAP53 in the pathogenesis of human malignancies.	WRAP53	cancer	55135	HP_0002664	42	48	83	89	True
25134915	In fact, WRAP53 has been considered as a candidate cancer susceptibility gene.	WRAP53	cancer	55135	HP_0002664	9	15	51	57	True
25134915	In fact, WRAP53 has been considered as a candidate cancer susceptibility gene.	fact	cancer	11198	HP_0002664	3	7	51	57	False
25134915	Accordingly, we performed a study to examine the association of a frequent genetic variation in WRAP53, rs2287499 (C/G), with breast cancer risk and prognosis among Iranian-Azeri population.	WRAP53	cancer	55135	HP_0002664	96	102	133	139	True
29321361	The contiguous deletion of NDP and its neighbouring genes, MAOA/B and EFHC2, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.	NDP	microcephaly	4693	HP_0000252	27	30	133	145	True
29321361	The contiguous deletion of NDP and its neighbouring genes, MAOA/B and EFHC2, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.	EFHC2	microcephaly	80258	HP_0000252	70	75	133	145	False
29321361	The contiguous deletion of NDP and its neighbouring genes, MAOA/B and EFHC2, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.	NDP	intellectual disability	4693	HP_0001249	27	30	147	170	True
29321361	The contiguous deletion of NDP and its neighbouring genes, MAOA/B and EFHC2, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.	EFHC2	intellectual disability	80258	HP_0001249	70	75	147	170	False
29321361	The contiguous deletion of NDP and its neighbouring genes, MAOA/B and EFHC2, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.	NDP	epilepsy	4693	HP_0001250	27	30	176	184	True
29321361	The contiguous deletion of NDP and its neighbouring genes, MAOA/B and EFHC2, reportedly leads to syndromic clinical features such as microcephaly, intellectual disability, and epilepsy.	EFHC2	epilepsy	80258	HP_0001250	70	75	176	184	False
29321361	This familial study demonstrates that a deficiency in one of two MAO genes may not lead to psychomotor delay, and deletion of EFHC2 may not cause epilepsy.	EFHC2	epilepsy	80258	HP_0001250	126	131	146	154	False
27058983	Locations of mutations linked to human disease, including those responsible for Southeast Asian ovalocytosis, hereditary stomatocytosis, hereditary spherocytosis, and distal renal tubular acidosis, provide molecular insights into their effect on Band 3 folding.	red	spherocytosis	8444	HP_0004444	112	115	148	161	False
27058983	Locations of mutations linked to human disease, including those responsible for Southeast Asian ovalocytosis, hereditary stomatocytosis, hereditary spherocytosis, and distal renal tubular acidosis, provide molecular insights into their effect on Band 3 folding.	red	distal renal tubular acidosis	8444	HP_0008341	112	115	167	196	False
28237967	A key aspect of several adult lung diseases, such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD), including emphysema, is aberrant tissue repair, which leads to an accumulation of damage and impaired respiratory function.	COPD	emphysema	372	HP_0002097	132	136	149	158	False
28237967	A key aspect of several adult lung diseases, such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD), including emphysema, is aberrant tissue repair, which leads to an accumulation of damage and impaired respiratory function.	damage	emphysema	51438	HP_0002097	221	227	149	158	False
28237967	In addition, we show that <i>Vangl2<sup>Lp/+</sup></i> lungs exhibit many of the hallmarks of tissue damage, including an altered macrophage population, abnormal elastin deposition and elevated levels of the elastin-modifying enzyme, <i>Mmp12</i>, all of which are observed in emphysema.	damage	emphysema	51438	HP_0002097	101	107	277	286	False
28237967	Finally, we show that PCP genes <i>VANGL2</i> and <i>SCRIB</i> are significantly downregulated in lung tissue from patients with emphysema.	PCP	emphysema	54858	HP_0002097	22	25	129	138	False
27481395	Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH).	GCS	encephalopathy	2729	HP_0001298	25	28	167	181	False
27481395	Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH).	GLDC	encephalopathy	2731	HP_0001298	111	115	167	181	True
27481395	Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH).	AMT	encephalopathy	275	HP_0001298	117	120	167	181	True
27481395	Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH).	NKH	encephalopathy	275	HP_0001298	226	229	167	181	True
27481395	Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH).	GCS	hyperglycinemia	2729	HP_0002154	25	28	209	224	False
27481395	Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH).	GLDC	hyperglycinemia	2731	HP_0002154	111	115	209	224	True
27481395	Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH).	AMT	hyperglycinemia	275	HP_0002154	117	120	209	224	True
27481395	Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH).	NKH	hyperglycinemia	275	HP_0002154	226	229	209	224	True
27287342	We tried to elucidate the role of three 3p21.3 TSGs: DLEC1, ITGA9 and MLH1, in non-small cell lung cancer (NSCLC).	DLEC1	cancer	9940	HP_0002664	53	58	99	105	True
27287342	We tried to elucidate the role of three 3p21.3 TSGs: DLEC1, ITGA9 and MLH1, in non-small cell lung cancer (NSCLC).	ITGA9	cancer	3680	HP_0002664	60	65	99	105	False
27287342	We tried to elucidate the role of three 3p21.3 TSGs: DLEC1, ITGA9 and MLH1, in non-small cell lung cancer (NSCLC).	MLH1	cancer	4292	HP_0002664	70	74	99	105	True
27287342	In case of DLEC1 and ITGA9, expression levels were decreased in 71-78% of tumor samples and significantly different between tumor and normal tissues (P=0.0001).	DLEC1	tumor	9940	HP_0002664	11	16	75	80	True
27287342	In case of DLEC1 and ITGA9, expression levels were decreased in 71-78% of tumor samples and significantly different between tumor and normal tissues (P=0.0001).	ITGA9	tumor	3680	HP_0002664	21	26	75	80	False
27287342	ITGA9 could also be regarded as a diagnostic marker differentiating NSCLC subtypes, as its expression level was significantly lower in squamous cell carcinoma (P=0.001).	ITGA9	squamous cell carcinoma	3680	HP_0002860	0	5	135	158	False
30411605	Intravascular lithotripsy (IVL) with the Shockwave system has recently been evaluated as a familiar angioplasty-balloon-based but effective technique for the management of arterial calcification.	IVL	arterial calcification	3713	HP_0003207	27	30	173	195	False
28447668	Here, we show that fine-mapping of pancreatic and testicular cancer GWAS within one of these loci (Region 2 in CLPTM1L) focuses the signal to nine highly correlated SNPs.	CLPTM1L	cancer	81037	HP_0002664	111	118	61	67	False
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	ATM	tumor	472	HP_0002664	54	57	25	30	True
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	MSH2	tumor	4436	HP_0002664	59	63	25	30	True
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	PIK3R1	tumor	5295	HP_0002664	65	71	25	30	True
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	PTCH1	tumor	5727	HP_0002664	73	78	25	30	True
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	PTEN	tumor	5728	HP_0002664	80	84	25	30	True
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	TET2	tumor	54790	HP_0002664	86	90	25	30	True
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	TSC1	tumor	7248	HP_0002664	102	106	25	30	True
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	ALK	tumor	238	HP_0002664	136	139	25	30	True
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	BCL9	tumor	607	HP_0002664	141	145	25	30	False
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	CTNNB1	tumor	1499	HP_0002664	147	153	25	30	True
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	ERBB2	tumor	2064	HP_0002664	155	160	25	30	True
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	FGFR2	tumor	2263	HP_0002664	162	167	25	30	True
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	FLT3	tumor	2322	HP_0002664	169	173	25	30	True
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	HNF1A	tumor	6927	HP_0002664	175	180	25	30	True
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	KIT	tumor	3815	HP_0002664	182	185	25	30	True
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	MTOR	tumor	2475	HP_0002664	187	191	25	30	False
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	PDGFRA	tumor	5156	HP_0002664	193	199	25	30	True
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	PPP2R1A	tumor	5518	HP_0002664	201	208	25	30	False
26626801	The 21 genes comprised 8 tumor suppressor candidates (ATM, MSH2, PIK3R1, PTCH1, PTEN, TET2, TP53, and TSC1) and 13 oncogene candidates (ALK, BCL9, CTNNB1, ERBB2, FGFR2, FLT3, HNF1A, KIT, MTOR, PDGFRA, PPP2R1A, PTPN11, and SF3B1).	PTPN11	tumor	5781	HP_0002664	210	216	25	30	True
26626801	We identified a high frequency of mutations in PTEN (50%) and genes involved in the endometrial cancer-related molecular pathway, which involves the IL-7 signaling pathway (PIK3R1, n=1; AKT2, n=1; FOXO1, n=1).	PIK3R1	cancer	5295	HP_0002664	173	179	96	102	True
26626801	We identified a high frequency of mutations in PTEN (50%) and genes involved in the endometrial cancer-related molecular pathway, which involves the IL-7 signaling pathway (PIK3R1, n=1; AKT2, n=1; FOXO1, n=1).	PTEN	cancer	5728	HP_0002664	47	51	96	102	True
26626801	We identified a high frequency of mutations in PTEN (50%) and genes involved in the endometrial cancer-related molecular pathway, which involves the IL-7 signaling pathway (PIK3R1, n=1; AKT2, n=1; FOXO1, n=1).	AKT2	cancer	208	HP_0002664	186	190	96	102	False
26626801	We identified a high frequency of mutations in PTEN (50%) and genes involved in the endometrial cancer-related molecular pathway, which involves the IL-7 signaling pathway (PIK3R1, n=1; AKT2, n=1; FOXO1, n=1).	FOXO1	cancer	2308	HP_0002664	197	202	96	102	True
26626801	We believe that this study will shed new light on fundamental aspects for understanding the molecular pathogenesis of endometrial cancer and may aid in the development of new targeted therapies.	light	cancer	8740	HP_0002664	41	46	130	136	False
26626801	We believe that this study will shed new light on fundamental aspects for understanding the molecular pathogenesis of endometrial cancer and may aid in the development of new targeted therapies.	aid	cancer	57379	HP_0002664	145	148	130	136	False
30126206	We here report that (-)-epigallocatechin gallate (EGCG) inhibited programmed cell death ligand 1 (PD-L1) expression in nonsmall-cell lung cancer cells, induced by both interferon (IFN)- and epidermal growth factor (EGF).	IFN	cancer	3439	HP_0002664	181	184	139	145	False
30126206	We here report that (-)-epigallocatechin gallate (EGCG) inhibited programmed cell death ligand 1 (PD-L1) expression in nonsmall-cell lung cancer cells, induced by both interferon (IFN)- and epidermal growth factor (EGF).	EGF	cancer	1950	HP_0002664	217	220	139	145	False
30126206	Furthermore, 0.3% GTE in drinking water reduced the average number of tumors per mouse from 4.1  0.5 to 2.6  0.4 and the percentage of PD-L1 positive cells from 9.6% to 2.9%, a decrease of 70%, in lung tumors of A/J mice given a single intraperitoneal injection of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).	per	tumors	93210	HP_0002664	77	80	70	76	False
30126206	Furthermore, 0.3% GTE in drinking water reduced the average number of tumors per mouse from 4.1  0.5 to 2.6  0.4 and the percentage of PD-L1 positive cells from 9.6% to 2.9%, a decrease of 70%, in lung tumors of A/J mice given a single intraperitoneal injection of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).	mice	tumors	23581	HP_0002664	218	222	70	76	False
30126206	In co-culture experiments using F10-OVA melanoma cells and tumor-specific CD3+ T cells, EGCG reduced <i>PD-L1</i> mRNA expression about 30% in F10-OVA cells and restored <i>interleukin-2</i> mRNA expression in tumor-specific CD3+ T cells.	per	tumor	93210	HP_0002664	16	19	59	64	False
30126206	In co-culture experiments using F10-OVA melanoma cells and tumor-specific CD3+ T cells, EGCG reduced <i>PD-L1</i> mRNA expression about 30% in F10-OVA cells and restored <i>interleukin-2</i> mRNA expression in tumor-specific CD3+ T cells.	F10	tumor	2159	HP_0002664	32	35	59	64	False
30076230	Intracerebroventricular infusion of Hm1a rescues Dravet syndrome mice from seizures and premature death.	mice	seizures	23581	HP_0001250	65	69	75	83	False
27206021	Congenital dyserythropoietic anemia type I (CDAI) is a rare autosomal recessive disease characterized by macrocytic anemia, ineffective erythropoiesis, and secondary hemochromatosis.	type	autosomal recessive	6445	HP_0000007	36	40	60	79	True
27206021	Congenital dyserythropoietic anemia type I (CDAI) is a rare autosomal recessive disease characterized by macrocytic anemia, ineffective erythropoiesis, and secondary hemochromatosis.	CDAI	autosomal recessive	146059	HP_0000007	44	48	60	79	True
27206021	Congenital dyserythropoietic anemia type I (CDAI) is a rare autosomal recessive disease characterized by macrocytic anemia, ineffective erythropoiesis, and secondary hemochromatosis.	type	ineffective erythropoiesis	6445	HP_0010972	36	40	124	150	False
27206021	Congenital dyserythropoietic anemia type I (CDAI) is a rare autosomal recessive disease characterized by macrocytic anemia, ineffective erythropoiesis, and secondary hemochromatosis.	CDAI	ineffective erythropoiesis	146059	HP_0010972	44	48	124	150	True
27206021	Main complications were due to anemia and ineffective erythropoiesis [osteoporosis (8/9, 89%), cholelithiasis (21/30, 70%), pulmonary arterial hypertension (PAH) (6/25, 24%)] and iron overload [hypothyroidism (9/24, 38%), and diabetes mellitus (6/32, 19%)].	PAH	ineffective erythropoiesis	5053	HP_0010972	157	160	42	68	False
27206021	Main complications were due to anemia and ineffective erythropoiesis [osteoporosis (8/9, 89%), cholelithiasis (21/30, 70%), pulmonary arterial hypertension (PAH) (6/25, 24%)] and iron overload [hypothyroidism (9/24, 38%), and diabetes mellitus (6/32, 19%)].	PAH	pulmonary arterial hypertension	5053	HP_0002092	157	160	124	155	False
27206021	Main complications were due to anemia and ineffective erythropoiesis [osteoporosis (8/9, 89%), cholelithiasis (21/30, 70%), pulmonary arterial hypertension (PAH) (6/25, 24%)] and iron overload [hypothyroidism (9/24, 38%), and diabetes mellitus (6/32, 19%)].	PAH	hypothyroidism	5053	HP_0000821	157	160	194	208	False
30282866	Levels of serum CysC might become elevated regardless of renal function, and CysC-eGFR might become unpredictable during the active phase of tumors.	eGFR	tumor	1956	HP_0002664	82	86	141	146	True
29749548	Given the lack of specific targeted genes and pathways known to be involved in tumour cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3hub genes (FTH1, GRM1 and DDIT3).	hub	tumour	1993	HP_0002664	305	308	79	85	False
29749548	Given the lack of specific targeted genes and pathways known to be involved in tumour cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3hub genes (FTH1, GRM1 and DDIT3).	FTH1	tumour	2495	HP_0002664	316	320	79	85	False
29749548	Given the lack of specific targeted genes and pathways known to be involved in tumour cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3hub genes (FTH1, GRM1 and DDIT3).	GRM1	tumour	2911	HP_0002664	322	326	79	85	False
29749548	Given the lack of specific targeted genes and pathways known to be involved in tumour cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3hub genes (FTH1, GRM1 and DDIT3).	DDIT3	tumour	1649	HP_0002664	331	336	79	85	True
19334086	Treacher Collins syndrome (TCS, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.	TCS	mandibulofacial dysostosis	6949	HP_0005321	27	30	63	89	False
19334086	Treacher Collins syndrome (TCS, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.	TCS	facial anomalies	6949	HP_0000271	27	30	117	133	True
19334086	Treacher Collins syndrome (TCS, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.	TCS	malar hypoplasia	6949	HP_0000272	27	30	148	164	True
19334086	Treacher Collins syndrome (TCS, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.	TCS	dysplastic ears	6949	HP_0000377	27	30	196	211	True
19334086	Treacher Collins syndrome (TCS, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.	TCS	micrognathia	6949	HP_0000347	27	30	213	225	True
19334086	Treacher Collins syndrome (TCS, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.	TCS	cleft palate	6949	HP_0000175	27	30	227	239	True
19334086	Treacher Collins syndrome (TCS, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.	TCS	deafness	6949	HP_0000365	27	30	244	252	True
19334086	Here we describe three unrelated patients showing clinical features overlapping with TCS, but who in addition have developmental delay, microcephaly and a distinct facial gestalt.	TCS	developmental delay	6949	HP_0001263	85	88	115	134	True
19334086	Here we describe three unrelated patients showing clinical features overlapping with TCS, but who in addition have developmental delay, microcephaly and a distinct facial gestalt.	TCS	microcephaly	6949	HP_0000252	85	88	136	148	False
19334086	Because of the distinct ear anomalies and the hearing loss a HOXA2 mutation was taken into account.	HOXA2	ear anomalies	3199	HP_0000598	61	66	24	37	True
19334086	Because of the distinct ear anomalies and the hearing loss a HOXA2 mutation was taken into account.	HOXA2	hearing loss	3199	HP_0000365	61	66	46	58	True
28239884	Punctate palmoplantar keratoderma type 1 (PPPK1) is a rare autosomal dominant inherited skin disease, characterized by multiple hyperkeratotic lesions on the palms and soles.	type	palmoplantar keratoderma	6445	HP_0000982	34	38	9	33	False
28771251	The 18 new diagnoses made with WGS included structural and non-exonic sequence variants not detectable with whole-exome sequencing, and confirmed recent disease associations with the genes PIGG, RNU4ATAC, TRIO, and UNC13A.ConclusionWGS as a primary clinical test provided a higher diagnostic yield than conventional genetic testing in a clinically heterogeneous cohort	PIGG	heterogeneous	54872	HP_0001425	189	193	348	361	False
28771251	The 18 new diagnoses made with WGS included structural and non-exonic sequence variants not detectable with whole-exome sequencing, and confirmed recent disease associations with the genes PIGG, RNU4ATAC, TRIO, and UNC13A.ConclusionWGS as a primary clinical test provided a higher diagnostic yield than conventional genetic testing in a clinically heterogeneous cohort	TRIO	heterogeneous	7204	HP_0001425	205	209	348	361	False
26942284	Homozygozity mapping and exome sequencing in 62 isolated individuals with early-onset parkinsonism and confirmed consanguinity followed by data mining in the exomes of 1,348 PD-affected individuals identified, in three isolated subjects, homozygous or compound heterozygous truncating mutations in vacuolar protein sorting 13C (VPS13C).	VPS13C	parkinsonism	54832	HP_0001300	328	334	86	98	True
26942284	VPS13C mutations are associated with a distinct form of early-onset parkinsonism characterized by rapid and severe disease progression and early cognitive decline; the pathological features were striking and reminiscent of diffuse Lewy body disease.	VPS13C	parkinsonism	54832	HP_0001300	0	6	68	80	True
26942284	This work suggests that loss of function of VPS13C is a cause of autosomal-recessive early-onset parkinsonism with a distinctive phenotype of rapid and severe progression	VPS13C	parkinsonism	54832	HP_0001300	44	50	97	109	True
30248162	This review goes over recent scientific progress in understanding the molecular mechanisms governing pruritus, the cross-talk between the immune and nervous systems that regulate itch, and central nervous pathways and projections affected by itch.	itch	central	83737	HP_0030645	179	183	189	196	False
28232469	Despite the identification of several oncogenic driver mutations leading to constitutive JAK-STAT activation, the cellular and molecular biology of myeloproliferative neoplasms (MPN) remains incompletely understood.	STAT	neoplasms	6646	HP_0002664	93	97	167	176	False
28232469	Despite the identification of several oncogenic driver mutations leading to constitutive JAK-STAT activation, the cellular and molecular biology of myeloproliferative neoplasms (MPN) remains incompletely understood.	MPN	neoplasms	83886	HP_0002664	178	181	167	176	False
28232469	Our results reveal a novel genetic PMF-like mouse model and identify a tumor suppressor role for <i>NOL3</i> in the pathogenesis of myeloid malignancies	PMF	tumor	5933	HP_0002664	35	38	71	76	False
27650623	Craniofrontonasal syndrome (CFNS) is a very rare genetic disorder with variable clinical phenotypes, including brachycephaly, hypertelorism, and a bifid nasal tip.	CFNS	brachycephaly	1947	HP_0000248	28	32	111	124	True
27650623	Craniofrontonasal syndrome (CFNS) is a very rare genetic disorder with variable clinical phenotypes, including brachycephaly, hypertelorism, and a bifid nasal tip.	type	brachycephaly	6445	HP_0000248	94	98	111	124	False
27650623	Craniofrontonasal syndrome (CFNS) is a very rare genetic disorder with variable clinical phenotypes, including brachycephaly, hypertelorism, and a bifid nasal tip.	CFNS	hypertelorism	1947	HP_0000316	28	32	126	139	True
27650623	Craniofrontonasal syndrome (CFNS) is a very rare genetic disorder with variable clinical phenotypes, including brachycephaly, hypertelorism, and a bifid nasal tip.	type	hypertelorism	6445	HP_0000316	94	98	126	139	False
25398945	Leber congenital amaurosis (LCA) and juvenile retinitis pigmentosa (RP) are severe hereditary diseases that causes visual impairment in infants and children.	LCA	visual impairment	1211	HP_0000505	28	31	115	132	False
25398945	Leber congenital amaurosis (LCA) and juvenile retinitis pigmentosa (RP) are severe hereditary diseases that causes visual impairment in infants and children.	RP	visual impairment	100287745	HP_0000505	68	70	115	132	False
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	VSX1	keratoconus	30813	HP_0000563	285	289	66	77	True
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	SOD1	keratoconus	6647	HP_0000563	272	276	66	77	False
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	BANP	keratoconus	54971	HP_0000563	146	150	66	77	False
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	CAST	keratoconus	10849	HP_0000563	152	156	66	77	False
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	COL4A3	keratoconus	1285	HP_0000563	158	164	66	77	False
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	COL4A4	keratoconus	1286	HP_0000563	166	172	66	77	False
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	COL5A1	keratoconus	1289	HP_0000563	174	180	66	77	True
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	FOXO1	keratoconus	2308	HP_0000563	182	187	66	77	False
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	FNDC3B	keratoconus	64778	HP_0000563	189	195	66	77	False
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	HGF	keratoconus	3569	HP_0000563	197	200	66	77	False
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	IMMP2L	keratoconus	83943	HP_0000563	220	226	66	77	False
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	MPDZ	keratoconus	84708	HP_0000563	228	232	66	77	False
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	NFIB	keratoconus	4781	HP_0000563	234	238	66	77	False
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	RAB3GAP1	keratoconus	22930	HP_0000563	240	248	66	77	False
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	RAD51	keratoconus	5888	HP_0000563	250	255	66	77	False
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	RXRA	keratoconus	6256	HP_0000563	257	261	66	77	False
29924831	In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1.	SLC4A11	keratoconus	83959	HP_0000563	263	270	66	77	False
27094817	Inherited mutations in NAA10, encoding the catalytic subunit of the major N-terminal acetylation complex NatA have been associated with diverse, syndromic X-linked recessive disorders, whereas de novo missense mutations have been reported in one male and one female individual with severe intellectual disability but otherwise unspecific phenotypes.	NAA10	intellectual disability	8260	HP_0001249	23	28	289	312	True
27094817	The core phenotype of X-linked NAA10-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.	NAA10	intellectual disability	8260	HP_0001249	31	36	148	171	True
27094817	The core phenotype of X-linked NAA10-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.	NAA10	developmental delay	8260	HP_0001263	31	36	120	139	True
27094817	The core phenotype of X-linked NAA10-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.	NAA10	postnatal growth failure	8260	HP_0008897	31	36	173	197	True
27094817	The core phenotype of X-linked NAA10-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.	NAA10	microcephaly	8260	HP_0000252	31	36	210	222	True
27094817	The core phenotype of X-linked NAA10-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.	NAA10	cardiac anomalies	8260	HP_0001627	31	36	240	257	True
28300557	These results indicated that the HFD aggravates BDE47-inhibited testosterone production through hyperinsulinemia, and the accumulation of testicular BDE47 that induces the up-regulation of DAX-1 and the subsequent down-regulation of steroidogenic proteins, i.e., StAR and 3-HSD, in Leydig cells	StAR	hyperinsulinemia	2984	HP_0000842	263	267	96	112	False
29471565	Historically classified as a subtype of hepatocellular carcinoma (HCC), FLC has a unique clinical, histological, and molecular presentation.	HCC	hepatocellular carcinoma	84668	HP_0001402	66	69	40	64	False
26947510	Peroxisome biogenesis disorders (PBD) are a heterogeneous group of disorders due to PEX genes mutations, with a broad clinical spectrum comprising severe neonatal disease to mild presentation.	PEX	heterogeneous	5251	HP_0001425	84	87	44	57	False
28327662	Mice lacking Zbtb20 in the liver exhibit hypolipidemia and reduced levels of liver triglycerides, along with impaired hepatic lipogenesis.	Zbtb20	hypolipidemia	26137	HP_0045014	13	19	41	54	False
29750778	BACKGROUND The aim of this study was to investigate the prognostic relevance of CEP55 in lung cancer (LC).	CEP55	cancer	55165	HP_0002664	80	85	94	100	False
28175314	This progressive muscle pathology resembles the muscular dystrophy phenotype in humans and mice lacking the 7 integrin.	mice	muscular dystrophy	23581	HP_0003560	91	95	48	66	False
28175314	Furthermore, Ptrh2 expression is altered in skeletal muscle of classical congenital muscular dystrophy mouse models.	Ptrh2	muscular dystrophy	51651	HP_0003560	13	18	84	102	False
28175314	Ptrh2 levels were up-regulated in dystrophin deficient mdx muscle, which correlates with the elevated levels of the 71 integrin observed in mdx muscle and Duchenne muscular dystrophy patients.	Ptrh2	muscular dystrophy	51651	HP_0003560	0	5	166	184	False
28252641	Mechanical compression induced miR-9 downregulation by DNMT3A-dependent promoter methylation in the MDA-MB-231 and BT-474 breast cancer cell lines and in cancer-associated fibroblasts.	miR	cancer	220972	HP_0002664	31	34	129	135	False
28252641	Mechanical compression induced miR-9 downregulation by DNMT3A-dependent promoter methylation in the MDA-MB-231 and BT-474 breast cancer cell lines and in cancer-associated fibroblasts.	DNMT3A	cancer	1788	HP_0002664	55	61	129	135	True
28252641	Mechanical compression induced miR-9 downregulation by DNMT3A-dependent promoter methylation in the MDA-MB-231 and BT-474 breast cancer cell lines and in cancer-associated fibroblasts.	BT	cancer	696	HP_0002664	115	117	129	135	False
30093687	Cushing's disease results from corticotroph adenomas of the pituitary that hypersecrete adrenocorticotropin (ACTH), leading to excess glucocorticoid and hypercortisolism.	ACTH	hypercortisolism	5443	HP_0003118	109	113	153	169	False
30093687	However, the major driver mutations in USP8 wild-type tumors remain elusive.	USP8	tumors	9101	HP_0002664	39	43	54	60	True
30093687	Moreover, primary corticotroph tumor cells harboring BRAF V600E are sensitive to the BRAF inhibitor vemurafenib.	BRAF	tumor	673	HP_0002664	53	57	31	36	True
26678556	Cell surface carbohydrates are important for cell migration and invasion of prostate cancer (PCa).	PCa	cancer	28982	HP_0002664	93	96	85	91	False
26678556	Accordingly, the I-branching N-acetylglucosaminyltransferase (GCNT2) converts linear i-antigen to I-branching glycan, and its expression is associated with breast cancer progression.	GCNT2	cancer	2651	HP_0002664	62	67	163	169	False
26678556	GCNT2-positive cells were significantly lesser in organ-confined disease than in that with extra-capsular extensions, and GCNT2-negative tumors were associated with significantly better prostate-specific antigen-free survival compared with GCNT2-positive tumors.	GCNT2	tumors	2651	HP_0002664	0	5	137	143	False
28469144	In a consanguineous Saudi family segregating Usher syndrome type 1 (USH1), NGS of genes for Usher syndrome, deafness and retinal dystrophy and subsequent whole-exome sequencing each failed to identify a mutation.	type	deafness	6445	HP_0000365	60	64	108	116	False
28469144	In a consanguineous Saudi family segregating Usher syndrome type 1 (USH1), NGS of genes for Usher syndrome, deafness and retinal dystrophy and subsequent whole-exome sequencing each failed to identify a mutation.	type	retinal dystrophy	6445	HP_0000556	60	64	121	138	False
30209687	Perhaps unusually for autosomal recessive diseases, heterozygotes for mutations in NPC1 manifest many biological variations.	NPC1	autosomal recessive	4864	HP_0000007	83	87	22	41	True
28537267	In addition to replicating previously reported loci, we identify five novel loci significantly associated with endometriosis risk (P&lt;5  10<sup>-8</sup>), implicating genes involved in sex steroid hormone pathways (FN1, CCDC170, ESR1, SYNE1 and FSHB).	sex	endometriosis	55558	HP_0030127	188	191	111	124	False
28537267	In addition to replicating previously reported loci, we identify five novel loci significantly associated with endometriosis risk (P&lt;5  10<sup>-8</sup>), implicating genes involved in sex steroid hormone pathways (FN1, CCDC170, ESR1, SYNE1 and FSHB).	CCDC170	endometriosis	80129	HP_0030127	223	230	111	124	False
28537267	In addition to replicating previously reported loci, we identify five novel loci significantly associated with endometriosis risk (P&lt;5  10<sup>-8</sup>), implicating genes involved in sex steroid hormone pathways (FN1, CCDC170, ESR1, SYNE1 and FSHB).	ESR1	endometriosis	2099	HP_0030127	232	236	111	124	False
28537267	In addition to replicating previously reported loci, we identify five novel loci significantly associated with endometriosis risk (P&lt;5  10<sup>-8</sup>), implicating genes involved in sex steroid hormone pathways (FN1, CCDC170, ESR1, SYNE1 and FSHB).	SYNE1	endometriosis	23345	HP_0030127	238	243	111	124	False
28537267	In addition to replicating previously reported loci, we identify five novel loci significantly associated with endometriosis risk (P&lt;5  10<sup>-8</sup>), implicating genes involved in sex steroid hormone pathways (FN1, CCDC170, ESR1, SYNE1 and FSHB).	FSHB	endometriosis	2488	HP_0030127	248	252	111	124	False
28537267	Conditional analysis identified five secondary association signals, including two at the ESR1 locus, resulting in 19 independent single nucleotide polymorphisms (SNPs) robustly associated with endometriosis, which together explain up to 5.19% of variance in endometriosis.	ESR1	endometriosis	2099	HP_0030127	89	93	193	206	False
27659325	The aim of the study was to understand the role of SLIT2-ROBO1/2-CDC42 signalling pathways in development of breast cancer (BC).	SLIT2	cancer	6586	HP_0002664	51	56	116	122	False
27659325	The aim of the study was to understand the role of SLIT2-ROBO1/2-CDC42 signalling pathways in development of breast cancer (BC).	CDC42	cancer	998	HP_0002664	65	70	116	122	False
27659325	The aim of the study was to understand the role of SLIT2-ROBO1/2-CDC42 signalling pathways in development of breast cancer (BC).	ROBO1	cancer	6091	HP_0002664	57	62	116	122	False
27659325	Significantly, higher alteration of SLIT2 locus was observed in triple negative breast cancer (TNBC) over HER2 subtype (P = 0.0014).	SLIT2	cancer	6586	HP_0002664	36	41	87	93	False
27659325	Significantly, higher alteration of SLIT2 locus was observed in triple negative breast cancer (TNBC) over HER2 subtype (P = 0.0014).	HER2	cancer	2064	HP_0002664	106	110	87	93	True
27659325	Results indicate the importance of SLIT2-ROBO1-CDC42 signalling pathway in predicting tumour progression.	SLIT2	tumour	6586	HP_0002664	35	40	86	92	False
27659325	Results indicate the importance of SLIT2-ROBO1-CDC42 signalling pathway in predicting tumour progression.	CDC42	tumour	998	HP_0002664	47	52	86	92	False
27659325	Results indicate the importance of SLIT2-ROBO1-CDC42 signalling pathway in predicting tumour progression.	ROBO1	tumour	6091	HP_0002664	41	46	86	92	False
23646827	Subsequently, we identified another homozygous variant in 2 of the 10 probands with microphthalmia we specifically screened for mutations in ALDH1A3.	ALDH1A3	microphthalmia	220	HP_0000568	141	148	84	98	True
23646827	Interestingly, the other branch of the original family was found to segregate anophthalmia/syndactyly with a novel homozygous SMOC1 variant.	SMOC1	anophthalmia	64093	HP_0000528	126	131	78	90	True
23646827	Interestingly, the other branch of the original family was found to segregate anophthalmia/syndactyly with a novel homozygous SMOC1 variant.	SMOC1	syndactyly	64093	HP_0001159	126	131	91	101	True
23646827	Our data support the very recent and independent identification of ALDH1A3 as a disease gene in microphthalmia.	ALDH1A3	microphthalmia	220	HP_0000568	67	74	96	110	True
28371479	CHIME syndrome is a rare autosomal recessive neuroectodermal disorder associated with biallelic mutations in PIGL.	PIGL	autosomal recessive	9487	HP_0000007	109	113	25	44	True
30250298	Here, we found that 15-PGDH expression was inversely correlated with ALDH1, an important cancer stem cell-associated marker indicative of poor prognosis in humans.	PGDH	cancer	26227	HP_0002664	23	27	89	95	False
30250298	Here, we found that 15-PGDH expression was inversely correlated with ALDH1, an important cancer stem cell-associated marker indicative of poor prognosis in humans.	ALDH1	cancer	216	HP_0002664	69	74	89	95	False
30250298	Moreover, we demonstrated that pharmacological inhibition of 15-PGDH enhanced CYP26A1 expression, leading to depletion of all-trans retinoic acid (ATRA) and expansion of the ALDH1-positive subset in both human PDAC cells and tumor cells of Kras<sup>LSL-G12D/+</sup>; Ptf1a<sup>Cre/+</sup> (KC) mice.	PGDH	tumor	26227	HP_0002664	64	68	225	230	False
30250298	Moreover, we demonstrated that pharmacological inhibition of 15-PGDH enhanced CYP26A1 expression, leading to depletion of all-trans retinoic acid (ATRA) and expansion of the ALDH1-positive subset in both human PDAC cells and tumor cells of Kras<sup>LSL-G12D/+</sup>; Ptf1a<sup>Cre/+</sup> (KC) mice.	ALDH1	tumor	216	HP_0002664	174	179	225	230	False
30250298	Moreover, we demonstrated that pharmacological inhibition of 15-PGDH enhanced CYP26A1 expression, leading to depletion of all-trans retinoic acid (ATRA) and expansion of the ALDH1-positive subset in both human PDAC cells and tumor cells of Kras<sup>LSL-G12D/+</sup>; Ptf1a<sup>Cre/+</sup> (KC) mice.	CYP26A1	tumor	1592	HP_0002664	78	85	225	230	False
30250298	Moreover, we demonstrated that pharmacological inhibition of 15-PGDH enhanced CYP26A1 expression, leading to depletion of all-trans retinoic acid (ATRA) and expansion of the ALDH1-positive subset in both human PDAC cells and tumor cells of Kras<sup>LSL-G12D/+</sup>; Ptf1a<sup>Cre/+</sup> (KC) mice.	mice	tumor	23581	HP_0002664	294	298	225	230	False
30250298	Finally, ATRA replacement suppressed 15-PGDH inhibition-induced tumor progression in KC mice, and ATRA treatment attenuated Aldh1 activity in tumor cells isolated from the pancreas of 15-Pgdh<sup>-/-</sup> KC mice.	PGDH	tumor	26227	HP_0002664	40	44	64	69	False
30250298	Finally, ATRA replacement suppressed 15-PGDH inhibition-induced tumor progression in KC mice, and ATRA treatment attenuated Aldh1 activity in tumor cells isolated from the pancreas of 15-Pgdh<sup>-/-</sup> KC mice.	mice	tumor	23581	HP_0002664	88	92	64	69	False
30250298	Finally, ATRA replacement suppressed 15-PGDH inhibition-induced tumor progression in KC mice, and ATRA treatment attenuated Aldh1 activity in tumor cells isolated from the pancreas of 15-Pgdh<sup>-/-</sup> KC mice.	Pgdh	tumor	26227	HP_0002664	187	191	64	69	False
30250298	Finally, ATRA replacement suppressed 15-PGDH inhibition-induced tumor progression in KC mice, and ATRA treatment attenuated Aldh1 activity in tumor cells isolated from the pancreas of 15-Pgdh<sup>-/-</sup> KC mice.	Aldh1	tumor	216	HP_0002664	124	129	64	69	False
30250298	These findings provide evidence that 15-PGDH inhibition enhances KRAS-driven tumor progression via ATRA depletion in the pancreas.	PGDH	tumor	26227	HP_0002664	40	44	77	82	False
30250298	These findings provide evidence that 15-PGDH inhibition enhances KRAS-driven tumor progression via ATRA depletion in the pancreas.	KRAS	tumor	3845	HP_0002664	65	69	77	82	True
28481029	Deregulated monoubiquitination of histone H2B (H2Bub1), mainly catalyzed by E3 ubiquitin-protein ligase RNF20/RNF40 complex, may play an important role in cancer.	RNF20	cancer	56254	HP_0002664	104	109	155	161	False
28481029	Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as CCND3, E2F1/2, HOXA1, Bcl2 modifying factor (BMF), Met, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.	CCND3	tumor	896	HP_0002664	109	114	78	83	False
28481029	Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as CCND3, E2F1/2, HOXA1, Bcl2 modifying factor (BMF), Met, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.	HOXA1	tumor	3198	HP_0002664	124	129	78	83	False
28481029	Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as CCND3, E2F1/2, HOXA1, Bcl2 modifying factor (BMF), Met, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.	Bcl2	tumor	596	HP_0002664	131	135	78	83	True
28481029	Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as CCND3, E2F1/2, HOXA1, Bcl2 modifying factor (BMF), Met, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.	BMF	tumor	90427	HP_0002664	154	157	78	83	False
28481029	Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as CCND3, E2F1/2, HOXA1, Bcl2 modifying factor (BMF), Met, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.	Met	tumor	4233	HP_0002664	160	163	78	83	True
28481029	Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as CCND3, E2F1/2, HOXA1, Bcl2 modifying factor (BMF), Met, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.	Myc	tumor	4609	HP_0002664	169	172	78	83	True
28481029	Concurrently, global transcriptional profiling analysis reveals that multiple tumor-associated genes such as CCND3, E2F1/2, HOXA1, Bcl2 modifying factor (BMF), Met, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.	cadherin	tumor	1015	HP_0002664	277	285	78	83	False
28481029	Moreover, RNF20 knockdown dramatically suppresses terminal squamous differentiation of cultured bronchial epithelial cells, and significantly enhances proliferation, migration, invasion, and cisplatin resistance of lung cancer cells.	RNF20	cancer	56254	HP_0002664	10	15	220	226	False
30521857	Biological activities of compounds 3-7 towards human cancer cells, COX-2, ROCK1, and JAK3 were evaluated	COX	cancer	1351	HP_0002664	67	70	53	59	False
30521857	Biological activities of compounds 3-7 towards human cancer cells, COX-2, ROCK1, and JAK3 were evaluated	ROCK1	cancer	6093	HP_0002664	74	79	53	59	False
30521857	Biological activities of compounds 3-7 towards human cancer cells, COX-2, ROCK1, and JAK3 were evaluated	JAK3	cancer	3718	HP_0002664	85	89	53	59	False
28423489	In the gene expression and network-level information, we revealed significant alterations of molecules related to HIF1 and metabolic pathways in the hypoxic-conditioned lung cancer cells.	HIF1	cancer	3091	HP_0002664	114	118	174	180	False
28423489	We also observed that GBE1 and HK2 are downstream of HIF1 pathway important in hypoxia-conditioned lung cancer cell.	HIF1	cancer	3091	HP_0002664	53	57	104	110	False
28423489	We also observed that GBE1 and HK2 are downstream of HIF1 pathway important in hypoxia-conditioned lung cancer cell.	GBE1	cancer	2632	HP_0002664	22	26	104	110	False
28423489	Furthermore, we used publicly available datasets to validate that the late-stage lung adenocarcinoma patients showed higher expression HK2 and GBE1 than early-stage ones.	GBE1	lung adenocarcinoma	2632	HP_0030078	143	147	81	100	False
28423489	In terms of prognostic features, a survival analysis revealed that the high GBE1 and HK2 expression group exhibited poorer survival in lung adenocarcinoma patients.	GBE1	lung adenocarcinoma	2632	HP_0030078	76	80	135	154	False
28791728	Our analyses identified 15 CpG sites within the APC 1A promoter that were significantly hypermethylated and 14 CpG loci within the NFATC1 gene body that were significantly hypomethylated (pLIS&lt;1  10<sup>-5</sup> ) in the tumours of active smokers.	APC	tumour	324	HP_0002664	48	51	227	233	True
28791728	Our analyses identified 15 CpG sites within the APC 1A promoter that were significantly hypermethylated and 14 CpG loci within the NFATC1 gene body that were significantly hypomethylated (pLIS&lt;1  10<sup>-5</sup> ) in the tumours of active smokers.	NFATC1	tumour	4772	HP_0002664	131	137	227	233	False
28791728	The APC 1A promoter was hypermethylated in 7 of 36 tumours from never-smokers (19%), 12 of 47 tumours from former smokers (26%), and 8 of 13 tumours from active smokers (62%).	APC	tumour	324	HP_0002664	4	7	51	57	True
28791728	Promoter hypermethylation was positively associated with duration of smoking (Spearman rank correlation,  = 0.26, p=0.03) and was confined to tumours, with hypermethylation never being observed in adjacent mucosa.	rank	tumour	8792	HP_0002664	87	91	145	151	False
28791728	Our findings provide exploratory evidence for hypermethylation of the key tumour suppressor gene APC being implicated in smoking-associated colorectal carcinogenesis.	APC	tumour	324	HP_0002664	97	100	74	80	True
29057908	Here, we show that ablating or silencing the transcription factor Nfix ameliorates pathology in several forms of muscular dystrophy.	Nfix	muscular dystrophy	4784	HP_0003560	66	70	113	131	False
30093605	Mutations in two genes, <i>PKD1</i> and <i>PKD2</i>, account for most cases of autosomal dominant polycystic kidney disease, one of the most common monogenetic disorders.	PKD1	kidney disease	5310	HP_0000077	27	31	109	123	True
30093605	Mutations in two genes, <i>PKD1</i> and <i>PKD2</i>, account for most cases of autosomal dominant polycystic kidney disease, one of the most common monogenetic disorders.	PKD2	kidney disease	25865	HP_0000077	43	47	109	123	False
27900010	Meningiomas may be classified as neurofibromin 2 (NF2)-associated and non-NF2 meningiomas depending on the presence or absence of molecular alterations in the <i>NF2</i> gene.	NF2	meningiomas	4771	HP_0002858	50	53	78	89	True
27900010	In humans, <i>NF2</i> is the gene responsible for the disease neurofibromatosis type II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.	NF2	neurofibromatosis	4771	HP_0001067	14	17	62	79	True
27900010	In humans, <i>NF2</i> is the gene responsible for the disease neurofibromatosis type II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.	type	neurofibromatosis	6445	HP_0001067	80	84	62	79	False
27900010	In humans, <i>NF2</i> is the gene responsible for the disease neurofibromatosis type II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.	NF2	tumors	4771	HP_0002664	14	17	131	137	True
27900010	In humans, <i>NF2</i> is the gene responsible for the disease neurofibromatosis type II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.	type	tumors	6445	HP_0002664	80	84	131	137	False
27900010	In humans, <i>NF2</i> is the gene responsible for the disease neurofibromatosis type II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.	NF2	meningioma	4771	HP_0002858	14	17	172	182	True
27900010	In humans, <i>NF2</i> is the gene responsible for the disease neurofibromatosis type II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.	type	meningioma	6445	HP_0002858	80	84	172	182	False
27900010	It was hypothesized that the whorl formation of meningiomas may occur as a result of a disturbance in the planar cell polarity (PCP) of arachnoid cells, thus, genes understood to govern PCP signaling were analyzed for alterations.	PCP	meningiomas	54858	HP_0002858	128	131	48	59	False
27900010	<i>Drosophila</i> Fat is involved in PCP, tumor suppression and Hippo (Hpo) signaling, which is associated with Mer.	PCP	tumor	54858	HP_0002664	37	40	42	47	False
27900010	<i>Drosophila</i> Fat is involved in PCP, tumor suppression and Hippo (Hpo) signaling, which is associated with Mer.	Fat	tumor	948	HP_0002664	18	21	42	47	False
28334956	PRUNE is a member of the DHH (Asp-His-His) phosphoesterase protein superfamily of molecules important for cell motility, and implicated in cancer progression.	DHH	cancer	50846	HP_0002664	25	28	139	145	True
28334956	Here we investigated multiple families from Oman, India, Iran and Italy with individuals affected by a new autosomal recessive neurodevelopmental and degenerative disorder in which the cardinal features include primary microcephaly and profound global developmental delay.	cardinal	autosomal recessive	22900	HP_0000007	185	193	107	126	False
28334956	Here we investigated multiple families from Oman, India, Iran and Italy with individuals affected by a new autosomal recessive neurodevelopmental and degenerative disorder in which the cardinal features include primary microcephaly and profound global developmental delay.	cardinal	microcephaly	22900	HP_0000252	185	193	219	231	False
28334956	Here we investigated multiple families from Oman, India, Iran and Italy with individuals affected by a new autosomal recessive neurodevelopmental and degenerative disorder in which the cardinal features include primary microcephaly and profound global developmental delay.	cardinal	profound	22900	HP_0012829	185	193	236	244	False
28334956	Here we investigated multiple families from Oman, India, Iran and Italy with individuals affected by a new autosomal recessive neurodevelopmental and degenerative disorder in which the cardinal features include primary microcephaly and profound global developmental delay.	cardinal	developmental delay	22900	HP_0001263	185	193	252	271	False
27698189	In this study, we applied this strategy to identify novel gene interactions in KRAS-mutant cancer cells.	KRAS	cancer	3845	HP_0002664	79	83	91	97	True
27698189	Silencing of FAK or LAMB3 recapitulated the synthetic lethal effects of miR-1298 expression in KRAS-driven cancer cells, whereas coexpression of both proteins was critical to rescue miR-1298-induced cell death.	FAK	cancer	5747	HP_0002664	13	16	107	113	False
27698189	Silencing of FAK or LAMB3 recapitulated the synthetic lethal effects of miR-1298 expression in KRAS-driven cancer cells, whereas coexpression of both proteins was critical to rescue miR-1298-induced cell death.	LAMB3	cancer	3914	HP_0002664	20	25	107	113	True
27698189	Silencing of FAK or LAMB3 recapitulated the synthetic lethal effects of miR-1298 expression in KRAS-driven cancer cells, whereas coexpression of both proteins was critical to rescue miR-1298-induced cell death.	KRAS	cancer	3845	HP_0002664	95	99	107	113	True
27698189	In clinical specimens, elevated LAMB3 expression correlated with poorer survival in lung cancer patients with an oncogenic KRAS gene signature, suggesting a novel candidate biomarker in this disease setting.	LAMB3	cancer	3914	HP_0002664	32	37	89	95	True
27698189	In clinical specimens, elevated LAMB3 expression correlated with poorer survival in lung cancer patients with an oncogenic KRAS gene signature, suggesting a novel candidate biomarker in this disease setting.	KRAS	cancer	3845	HP_0002664	123	127	89	95	True
27698189	Our results define a novel regulatory pathway in KRAS-driven cancers, which offers a potential therapeutic target for their eradication.	KRAS	cancer	3845	HP_0002664	49	53	61	67	True
29952944	No differences were found in age, sex, mean arterial pressure, heart rate, HDL, cirrhosis etiology, degree of alcohol consumption, encephalopathy, variceal bleeding history, or hepatocellular carcinoma between patients with or without adrenal insufficiency.	sex	encephalopathy	55558	HP_0001298	34	37	131	145	False
29952944	No differences were found in age, sex, mean arterial pressure, heart rate, HDL, cirrhosis etiology, degree of alcohol consumption, encephalopathy, variceal bleeding history, or hepatocellular carcinoma between patients with or without adrenal insufficiency.	sex	hepatocellular carcinoma	55558	HP_0001402	34	37	177	201	False
29982334	The most important finding is the recurrently mutated gene, ASXL3, which has never been reported in parathyroid tumors before.	ASXL3	tumor	80816	HP_0002664	60	65	112	117	False
29982334	Moreover, we identified two different somatic mutations in the CDC73 gene and one somatic mutation in the EZH2 gene.	CDC73	somatic mutation	79577	HP_0001428	63	68	38	54	True
29982334	Moreover, we identified two different somatic mutations in the CDC73 gene and one somatic mutation in the EZH2 gene.	EZH2	somatic mutation	2146	HP_0001428	106	110	38	54	False
29982334	The Y54X mutation in the CDC73 gene was previously identified in parathyroid carcinomas, which proved that parathyroid adenomas and carcinomas might possess similar molecular signatures.	CDC73	parathyroid carcinomas	79577	HP_0006780	25	30	65	87	True
30005391	Generalized arterial calcification of infancy (GACI), or idiopathic infantile arterial calcification, is a rare autosomal-recessive disease recognized aAs an inherited disorder characterized by severe pathologic calcification of large- and medium-sized arteries accompanied by smooth muscle cell (SMC) hyperplasia leading to vascular obstruction [1].	SMC	arterial calcification	54808	HP_0003207	297	300	12	34	False
28940506	Biallelic pathogenic variants in FBXL4 are associated with an encephalopathic mtDNA maintenance defect syndrome that is a multisystem disease characterized by lactic acidemia, developmental delay, and hypotonia.	FBXL4	lactic acidemia	26235	HP_0003128	33	38	159	174	True
28940506	Biallelic pathogenic variants in FBXL4 are associated with an encephalopathic mtDNA maintenance defect syndrome that is a multisystem disease characterized by lactic acidemia, developmental delay, and hypotonia.	FBXL4	developmental delay	26235	HP_0001263	33	38	176	195	True
28798090	Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are approved for second-line treatment of <i>EGFR</i> wild-type (<i>EGFR</i>-wt) nonsmall cell lung cancer (NSCLC).	EGFR	cancer	1956	HP_0002664	61	65	172	178	True
27064331	Chudley-McCullough syndrome (CMS) is a rare autosomal recessive disorder characterized by sensorineural deafness, agenesis of the corpus callosum, frontal polymicrogyria, interhemispheric cyst, and ventricular enlargement.	CMS	deafness	23607	HP_0000365	29	32	104	112	False
27064331	Chudley-McCullough syndrome (CMS) is a rare autosomal recessive disorder characterized by sensorineural deafness, agenesis of the corpus callosum, frontal polymicrogyria, interhemispheric cyst, and ventricular enlargement.	CMS	agenesis of the corpus callosum	23607	HP_0001274	29	32	114	145	False
27064331	The combination of sensorineural hearing loss and partial agenesis of the corpus callosum is a highly recognizable clinico-radiological entity that should prompt mutational analysis of the GPSM2 gene.	GPSM2	agenesis of the corpus callosum	29899	HP_0001274	189	194	58	89	True
27064331	The combination of sensorineural hearing loss and partial agenesis of the corpus callosum is a highly recognizable clinico-radiological entity that should prompt mutational analysis of the GPSM2 gene.	GPSM2	hearing loss	29899	HP_0000365	189	194	33	45	True
27129218	The interaction required the tumor necrosis factor receptor-associated factor domain of USP7 and the central region of UVSSA and was disrupted by an amino acid substitution in the tumor necrosis factor receptor-associated factor-binding motif of UVSSA.	UVSSA	tumor	57654	HP_0002664	119	124	29	34	False
27129218	The interaction required the tumor necrosis factor receptor-associated factor domain of USP7 and the central region of UVSSA and was disrupted by an amino acid substitution in the tumor necrosis factor receptor-associated factor-binding motif of UVSSA.	USP7	tumor	7874	HP_0002664	88	92	29	34	False
25807461	Down-regulation of PLZF has been found in various tumor cell lines.	PLZF	tumor	7704	HP_0002664	19	23	50	55	False
25807461	There has been virtually no tissue study on the expression of PLZF in prostate cancer (PCa).	PLZF	cancer	7704	HP_0002664	62	66	79	85	False
25807461	There has been virtually no tissue study on the expression of PLZF in prostate cancer (PCa).	PCa	cancer	28982	HP_0002664	87	90	79	85	False
25807461	PCa is a heterogeneous disease, most of which are indolent and non-lethal.	PCa	heterogeneous	28982	HP_0001425	0	3	9	22	False
25807461	This study aimed to investigate the expression of PLZF by immunohistochemistry in different grade as well as metastatic PCa and to correlate the alteration of PLZF expression with PCa aggressiveness.	PLZF	aggressiveness	7704	HP_0000718	50	54	184	198	False
25807461	This study aimed to investigate the expression of PLZF by immunohistochemistry in different grade as well as metastatic PCa and to correlate the alteration of PLZF expression with PCa aggressiveness.	PCa	aggressiveness	28982	HP_0000718	120	123	184	198	False
25807461	These data demonstrated that down-regulation of PLZF is an important molecular process for tumor progression and loss of PLZF expression detected by routine immunohistochemistry is a promising and valuable biomarker for PCa aggressiveness and metastasis in the personalized care of PCa.	PLZF	tumor	7704	HP_0002664	48	52	91	96	False
25807461	These data demonstrated that down-regulation of PLZF is an important molecular process for tumor progression and loss of PLZF expression detected by routine immunohistochemistry is a promising and valuable biomarker for PCa aggressiveness and metastasis in the personalized care of PCa.	PCa	tumor	28982	HP_0002664	220	223	91	96	False
25807461	These data demonstrated that down-regulation of PLZF is an important molecular process for tumor progression and loss of PLZF expression detected by routine immunohistochemistry is a promising and valuable biomarker for PCa aggressiveness and metastasis in the personalized care of PCa.	PLZF	aggressiveness	7704	HP_0000718	48	52	224	238	False
25807461	These data demonstrated that down-regulation of PLZF is an important molecular process for tumor progression and loss of PLZF expression detected by routine immunohistochemistry is a promising and valuable biomarker for PCa aggressiveness and metastasis in the personalized care of PCa.	PCa	aggressiveness	28982	HP_0000718	220	223	224	238	False
30439408	The purpose of this study is to investigate whether NTS can modulate the osteoclastogenesis induced by RANKL or cancer cells.	RANKL	cancer	8600	HP_0002664	103	108	112	118	False
30439408	The purpose of this study is to investigate whether NTS can modulate the osteoclastogenesis induced by RANKL or cancer cells.	NTS	cancer	4922	HP_0002664	52	55	112	118	False
30439408	We found that NTS inhibits RANKL- or cancer cell-mediated osteoclastogenesis via blockade of TRAF6 and NF-B activation.	RANKL	cancer	8600	HP_0002664	27	32	37	43	False
30439408	We found that NTS inhibits RANKL- or cancer cell-mediated osteoclastogenesis via blockade of TRAF6 and NF-B activation.	TRAF6	cancer	7189	HP_0002664	93	98	37	43	False
30439408	We found that NTS inhibits RANKL- or cancer cell-mediated osteoclastogenesis via blockade of TRAF6 and NF-B activation.	NF	cancer	23114	HP_0002664	103	105	37	43	False
30439408	We found that NTS inhibits RANKL- or cancer cell-mediated osteoclastogenesis via blockade of TRAF6 and NF-B activation.	NTS	cancer	4922	HP_0002664	14	17	37	43	False
28587997	Patients with adult-onset NCL may present with slowly progressive ataxia, persistent photosensitivity, and seizures without dementia or extrapyramidal findings.	NCL	seizures	4691	HP_0001250	26	29	107	115	False
28587997	Patients with adult-onset NCL may present with slowly progressive ataxia, persistent photosensitivity, and seizures without dementia or extrapyramidal findings.	NCL	ataxia	4691	HP_0001251	26	29	66	72	False
30271078	Although the expression pattern and functions of the CaSR in the colonic microenvironment are far from being completely understood, evidence has been accumulating that the CaSR might play a protective role against both colonic inflammation and colorectal cancer.	CaSR	cancer	846	HP_0002664	53	57	255	261	False
30271078	For example, CaSR agonists such as dipeptides have been suggested to reduce colonic inflammation, while dietary calcium was shown to reduce the risk of colorectal cancer.	CaSR	cancer	846	HP_0002664	13	17	163	169	False
30271078	CaSR expression is lost in colonic malignancies, indicating that the CaSR is a biomarker for colonic cancer progression.	CaSR	cancer	846	HP_0002664	0	4	101	107	False
30271078	This dual anti-inflammatory and anti-tumourigenic role of the CaSR makes it especially interesting in colitis-associated colorectal cancer.	CaSR	cancer	846	HP_0002664	62	66	132	138	False
30271078	In this review, we describe the clinical and experimental evidence for the role of the CaSR in colonic inflammation and colorectal cancer, the intracellular signalling pathways which are putatively involved in these actions, and the possibilities to exploit these actions of the CaSR for future therapies of colonic inflammation and cancer	CaSR	cancer	846	HP_0002664	87	91	131	137	False
30511553	Mucopolysaccharidosis (MPS) type I is a rare autosomal recessive disease caused by a deficiency of the lysosomal enzyme -L-iduronidase.	type	autosomal recessive	6445	HP_0000007	28	32	45	64	True
30306274	Single marker-based association tests for corneal astigmatism identified four genome-wide significant loci (P&lt;510<sup>-8</sup>) near the genes ZC3H11B (1q41), LINC00340 (6p22.3), HERC2/OCA2 (15q13.1) and NPLOC4/TSPAN10 (17q25.3).	HERC2	astigmatism	8924	HP_0000483	187	192	50	61	False
30306274	Single marker-based association tests for corneal astigmatism identified four genome-wide significant loci (P&lt;510<sup>-8</sup>) near the genes ZC3H11B (1q41), LINC00340 (6p22.3), HERC2/OCA2 (15q13.1) and NPLOC4/TSPAN10 (17q25.3).	NPLOC4	astigmatism	55666	HP_0000483	212	218	50	61	False
30306274	Three of these loci also demonstrated genome-wide significant association with refractive astigmatism: LINC00340, HERC2/OCA2 and NPLOC4/TSPAN10.	HERC2	astigmatism	8924	HP_0000483	114	119	90	101	False
30306274	Three of these loci also demonstrated genome-wide significant association with refractive astigmatism: LINC00340, HERC2/OCA2 and NPLOC4/TSPAN10.	NPLOC4	astigmatism	55666	HP_0000483	129	135	90	101	False
30306274	These loci have previously demonstrated association with axial length (ZC3H11B), myopia (NPLOC4), spherical equivalent refractive error (LINC00340) and eye colour (HERC2).	HERC2	myopia	8924	HP_0000545	164	169	81	87	True
30306274	These loci have previously demonstrated association with axial length (ZC3H11B), myopia (NPLOC4), spherical equivalent refractive error (LINC00340) and eye colour (HERC2).	NPLOC4	myopia	55666	HP_0000545	89	95	81	87	False
25122612	We used CHi-C to investigate long-range interactions at three breast cancer gene deserts mapping to 2q35, 8q24.21, and 9q31.2.	Hi	cancer	6833	HP_0002664	9	11	69	75	False
30633201	Tenascin-C (TNC), an extracellular matrix glycoprotein, has been implicated in progression of various types of cancer.	TNC	cancer	3371	HP_0002664	12	15	111	117	False
30633201	However, few reports exist on TNC expression in gastrointestinal stromal tumors (GISTs).	TNC	tumors	3371	HP_0002664	30	33	73	79	False
30633201	The high levels of TNC expression in gastric GISTs was significantly associated with tumor size (P&lt;.001), multivisceral resection (P=.006), metastasis at initial diagnosis (P=.006), mitotic count (P=.002) and NIH risk classification (P=.015).	TNC	tumor	3371	HP_0002664	19	22	85	90	False
30633201	The TNC mRNA and protein levels were found to significantly downregulated in tumors without progression compared to those tumors which occurred tumor progression during the follow-up period (P&lt;.05).	TNC	tumors	3371	HP_0002664	4	7	77	83	False
30633201	The TNC mRNA and protein levels were found to significantly downregulated in tumors without progression compared to those tumors which occurred tumor progression during the follow-up period (P&lt;.05).	TNC	tumor	3371	HP_0002664	4	7	144	149	False
30633201	As for the prognostic analysis, it revealed that tumor size, mitotic count, surgical margins, multivisceral resection, and TNC expression were independent predictors of PFS for gastric GISTs (P&lt;.05).	TNC	tumor	3371	HP_0002664	123	126	49	54	False
27427983	This work associates missense mutations in NSMCE3 with an autosomal recessive chromosome breakage syndrome that leads to defective T and B cell function and acute respiratory distress syndrome in early childhood	SMC	autosomal recessive	54808	HP_0000007	44	47	58	77	True
29730428	This protein is expressed during development of skeletal muscle, central nervous system and neural crest derivatives, and regulates expression of target genes that impact on proliferation, survival, differentiation and motility in these lineages.	impact	central	55364	HP_0030645	164	170	65	72	False
29730428	Somatic genetic rearrangements that juxtapose the PAX3 DNA binding domain to the transcriptional activation domain of other transcription factors deregulate PAX3 function and contribute to the pathogenesis of the soft tissue cancers alveolar rhabdomyosarcoma and biphenotypic sinonasal sarcoma.	PAX3	rhabdomyosarcoma	5077	HP_0002859	50	54	242	258	True
29068161	The deleted in colorectal cancer (DCC) gene encodes the netrin-1 (NTN1) receptor DCC, a transmembrane protein required for the guidance of commissural axons.	DCC	cancer	1630	HP_0002664	34	37	26	32	True
29068161	The deleted in colorectal cancer (DCC) gene encodes the netrin-1 (NTN1) receptor DCC, a transmembrane protein required for the guidance of commissural axons.	NTN1	cancer	9423	HP_0002664	66	70	26	32	False
29068161	Germline DCC mutations disrupt the development of predominantly commissural tracts in the central nervous system (CNS) and cause a spectrum of neurological disorders.	DCC	central	1630	HP_0030645	9	12	90	97	False
29380913	In recent years, genetically determined forms of microangiopathy (e.g. CADASIL, CARASIL, Trex1-related microangiopathies, CARASAL, familial forms of cerebral amyloid angiopathy or CAA) have provided interesting cellular and molecular clues to the pathogenesis of sporadic microvascular disease such as arteriolosclerosis and AD-related CAA	CADASIL	sporadic	4854	HP_0003745	71	78	263	271	False
30531685	MATERIAL AND METHODS The proliferation of prostate cancer cells was determined by CCK-8 assay.	CCK	cancer	885	HP_0002664	82	85	51	57	False
30531685	CONCLUSIONS Our findings indicate that resveratrol induces apoptosis via HIF-1/ROS/p53 signaling in prostate cancer cells and may be a useful therapeutic agent against prostate cancer	ROS	cancer	6098	HP_0002664	80	83	110	116	False
29283210	UBE2A deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.	UBE2A	intellectual disability	7319	HP_0001249	0	5	54	77	True
29283210	UBE2A deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.	UBE2A	prominent supraorbital ridges	7319	HP_0000336	0	5	152	181	True
29283210	UBE2A deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.	UBE2A	deep-set eyes	7319	HP_0000490	0	5	202	215	True
29283210	UBE2A deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.	UBE2A	large ears	7319	HP_0000400	0	5	217	227	False
29283210	UBE2A deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.	UBE2A	wide mouth	7319	HP_0000154	0	5	229	239	True
29283210	UBE2A deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.	UBE2A	hirsutism	7319	HP_0001007	0	5	266	275	True
29283210	UBE2A deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.	UBE2A	micropenis	7319	HP_0000054	0	5	277	287	True
29705860	In 20/23 cases, MDRrel BSI occurred during neutropenia.	rel	neutropenia	5966	HP_0001875	19	22	43	54	False
29705860	MDR rectal colonization occurs in 6.5% of haematological inpatients and predicts a 16% probability of MDRrel BSI, particularly during neutropenia, as well as a higher probability of unfavourable outcomes in CR-rel BSIs.	rel	neutropenia	5966	HP_0001875	105	108	134	145	False
29705860	MDR rectal colonization occurs in 6.5% of haematological inpatients and predicts a 16% probability of MDRrel BSI, particularly during neutropenia, as well as a higher probability of unfavourable outcomes in CR-rel BSIs.	CR	neutropenia	1604	HP_0001875	207	209	134	145	False
29547997	Here, we causally link a previously unreported missense mutation in TUBB2A (c.1249G&gt;A, p.D417N), encoding one of the neuron-specific -tubulin isotype II, to a disorder characterized by progressive spastic paraplegia, peripheral sensory-motor polyneuropathy and ataxia.	TUBB2A	spastic paraplegia	7280	HP_0001258	68	74	201	219	False
29547997	Here, we causally link a previously unreported missense mutation in TUBB2A (c.1249G&gt;A, p.D417N), encoding one of the neuron-specific -tubulin isotype II, to a disorder characterized by progressive spastic paraplegia, peripheral sensory-motor polyneuropathy and ataxia.	TUBB2A	ataxia	7280	HP_0001251	68	74	265	271	False
30337515	BRCT-repeat inhibitor of hTERT expression (BRIT1) is involved in the invasion of tumors.	BRIT1	tumors	79648	HP_0002664	43	48	81	87	False
28252645	We show here that HDAC11 depletion in MYCN-driven neuroblastoma cell lines strongly induces cell death, mostly mediated by apoptotic programs.	HDAC11	neuroblastoma	79885	HP_0003006	18	24	50	63	False
28252645	Our study identified a group of cell cycle-promoting genes regulated by HDAC11, being both predictors of unfavorable patient outcome and essential for tumor cell viability.	HDAC11	tumor	79885	HP_0002664	72	78	151	156	False
28252645	The data indicate a significant role of HDAC11 for mitotic cell cycle progression and survival of MYCN-amplified neuroblastoma cells, and suggests that HDAC11 could be a valuable drug target	HDAC11	neuroblastoma	79885	HP_0003006	40	46	113	126	False
30584899	After targeting to endothelial differentiation gene (Edg) family LPA receptors (LPA1, LPA2, LPA3) and non-Edg family LPA receptors (LPA4, LPA5, LPA6), LPA mediates physiological and pathological processes such as embryonic development, angiogenesis, tumor progression, fibrogenesis, wound healing, ischemia/reperfusion injury, and inflammatory reactions.	LPA	tumor	4018	HP_0002664	65	68	250	255	False
30242501	Consequently, the disruption of Ush2a in zebrafish led to a hearing impairment, like that in mammals.	Ush2a	hearing impairment	7399	HP_0000365	32	37	60	78	True
30242501	In summary, for the first time, we generated a ush2a knockout zebrafish line with auditory disorder and retinal degeneration which mimicked the symptoms of patients, and revealed that disruption of fibronectin assembly may be one of the factors underlying RP.	ush2a	retinal degeneration	7399	HP_0000546	47	52	104	124	False
28456785	Some of the RP genes are also associated with other retinal diseases, such as LCA (Leber's congenital amaurosis) and CORD (cone-rod dystrophy).	LCA	retinal diseases	1211	HP_0000479	78	81	52	68	False
26327442	Mutations in Ankyrin repeat and sterile alpha motif domain containing 6 (ANKS6) play a causative role in renal cyst formation in the PKD/Mhm(cy/+) rat model of polycystic kidney disease and in nephronophthisis in humans.	ANKS6	renal cyst	203286	HP_0000107	73	78	105	115	True
26327442	A network of protein partners of ANKS6 is emerging and their functional characterization provides important clues to understand the role of ANKS6 in renal biology and in mechanisms involved in the formation of renal cysts.	ANKS6	renal cyst	203286	HP_0000107	33	38	210	220	True
26924529	Affected individuals presented with prenatal-onset spinal muscular atrophy (SMA), multiple congenital contractures (arthrogryposis multiplex congenita), respiratory distress, and congenital bone fractures.	SMA	contractures	6606	HP_0001371	76	79	102	114	False
26924529	Affected individuals presented with prenatal-onset spinal muscular atrophy (SMA), multiple congenital contractures (arthrogryposis multiplex congenita), respiratory distress, and congenital bone fractures.	SMA	arthrogryposis	6606	HP_0002804	76	79	116	130	False
26924529	Affected individuals presented with prenatal-onset spinal muscular atrophy (SMA), multiple congenital contractures (arthrogryposis multiplex congenita), respiratory distress, and congenital bone fractures.	SMA	congenital bone fractures	6606	HP_0005855	76	79	179	204	False
29700598	A better understanding of the mechanisms coupling thermoregulation to energy homeostasis, including the involvement of thermosensitive TRPs, may uncover additional mechanisms underlying the pathogenesis of obesity and its metabolic consequences in humans, opening new strategies for the diagnosis, treatment, and prevention of this disease	TRP	obesity	7306	HP_0001513	135	138	206	213	False
17383054	There is increasing evidence of a clinical, neuropathological and genetic overlap between frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS).	ALS	frontotemporal dementia	3483	HP_0002145	155	158	90	113	False
29128060	This trend is, in part, secondary, to the growing incidence of obesity, type 2 diabetes, and metabolic syndrome.	type	obesity	6445	HP_0001513	72	76	63	70	False
26987799	The DNA damage checkpoints provide an anti-cancer barrier in diverse tumour types, however this concept has remained unexplored in prostate cancer (CaP).	damage	cancer	51438	HP_0002664	8	14	43	49	False
26987799	The DNA damage checkpoints provide an anti-cancer barrier in diverse tumour types, however this concept has remained unexplored in prostate cancer (CaP).	CaP	cancer	23476	HP_0002664	148	151	43	49	False
26987799	The DNA damage checkpoints provide an anti-cancer barrier in diverse tumour types, however this concept has remained unexplored in prostate cancer (CaP).	damage	tumour	51438	HP_0002664	8	14	69	75	False
26987799	The DNA damage checkpoints provide an anti-cancer barrier in diverse tumour types, however this concept has remained unexplored in prostate cancer (CaP).	CaP	tumour	23476	HP_0002664	148	151	69	75	False
26987799	Furthermore, targeting DNA repair defects by PARP1 inhibitors (PARPi) as a cancer treatment strategy is emerging yet requires suitable predictive biomarkers.	PARP1	cancer	142	HP_0002664	45	50	75	81	False
26987799	Furthermore, targeting DNA repair defects by PARP1 inhibitors (PARPi) as a cancer treatment strategy is emerging yet requires suitable predictive biomarkers.	men	cancer	8178	HP_0002664	87	90	75	81	False
26987799	To address these issues, we performed immunohistochemical analysis of multiple markers of DNA damage signalling, oxidative stress, DNA repair and cell cycle control pathways during progression of human prostate disease from benign hyperplasia, through intraepithelial neoplasia to CaP, complemented by genetic analyses of TMPRSS2-ERG rearrangement and NQO1, an anti-oxidant factor and p53 protector.	damage	neoplasia	51438	HP_0002664	94	100	268	277	False
26987799	To address these issues, we performed immunohistochemical analysis of multiple markers of DNA damage signalling, oxidative stress, DNA repair and cell cycle control pathways during progression of human prostate disease from benign hyperplasia, through intraepithelial neoplasia to CaP, complemented by genetic analyses of TMPRSS2-ERG rearrangement and NQO1, an anti-oxidant factor and p53 protector.	CaP	neoplasia	23476	HP_0002664	281	284	268	277	False
26987799	To address these issues, we performed immunohistochemical analysis of multiple markers of DNA damage signalling, oxidative stress, DNA repair and cell cycle control pathways during progression of human prostate disease from benign hyperplasia, through intraepithelial neoplasia to CaP, complemented by genetic analyses of TMPRSS2-ERG rearrangement and NQO1, an anti-oxidant factor and p53 protector.	NQO1	neoplasia	1728	HP_0002664	352	356	268	277	False
26987799	To address these issues, we performed immunohistochemical analysis of multiple markers of DNA damage signalling, oxidative stress, DNA repair and cell cycle control pathways during progression of human prostate disease from benign hyperplasia, through intraepithelial neoplasia to CaP, complemented by genetic analyses of TMPRSS2-ERG rearrangement and NQO1, an anti-oxidant factor and p53 protector.	men	neoplasia	8178	HP_0002664	292	295	268	277	False
26987799	The DNA damage checkpoint barrier (H2AX, pATM, p53) mechanism was activated during CaP tumorigenesis, albeit less and with delayed culmination compared to other cancers, possibly reflecting lower replication stress (slow proliferation despite cases of Rb loss and cyclin D1 overexpression) and progressive loss of ATM activator NKX3.1.	damage	cancer	51438	HP_0002664	8	14	162	168	False
26987799	The DNA damage checkpoint barrier (H2AX, pATM, p53) mechanism was activated during CaP tumorigenesis, albeit less and with delayed culmination compared to other cancers, possibly reflecting lower replication stress (slow proliferation despite cases of Rb loss and cyclin D1 overexpression) and progressive loss of ATM activator NKX3.1.	CaP	cancer	23476	HP_0002664	84	87	162	168	False
26987799	The DNA damage checkpoint barrier (H2AX, pATM, p53) mechanism was activated during CaP tumorigenesis, albeit less and with delayed culmination compared to other cancers, possibly reflecting lower replication stress (slow proliferation despite cases of Rb loss and cyclin D1 overexpression) and progressive loss of ATM activator NKX3.1.	ATM	cancer	472	HP_0002664	43	46	162	168	True
26987799	NQO1 genotypes of 390 men did not indicate predisposition to CaP, yet loss of NQO1 in CaP suggested potential progression-opposing tumour suppressor role.	CaP	tumour	23476	HP_0002664	61	64	131	137	False
26987799	NQO1 genotypes of 390 men did not indicate predisposition to CaP, yet loss of NQO1 in CaP suggested potential progression-opposing tumour suppressor role.	NQO1	tumour	1728	HP_0002664	0	4	131	137	False
26987799	NQO1 genotypes of 390 men did not indicate predisposition to CaP, yet loss of NQO1 in CaP suggested potential progression-opposing tumour suppressor role.	men	tumour	8178	HP_0002664	22	25	131	137	False
26987799	TMPRSS2-ERG rearrangement and PTEN loss, events sensitizing to PARPi, occurred frequently along with heterogeneous loss of DNA repair factors 53BP1, JMJD1C and Rev7 (all studied here for the first time in CaP) whose defects may cause resistance to PARPi.	CaP	heterogeneous	23476	HP_0001425	205	208	101	114	False
26987799	TMPRSS2-ERG rearrangement and PTEN loss, events sensitizing to PARPi, occurred frequently along with heterogeneous loss of DNA repair factors 53BP1, JMJD1C and Rev7 (all studied here for the first time in CaP) whose defects may cause resistance to PARPi.	men	heterogeneous	8178	HP_0001425	21	24	101	114	False
26987799	TMPRSS2-ERG rearrangement and PTEN loss, events sensitizing to PARPi, occurred frequently along with heterogeneous loss of DNA repair factors 53BP1, JMJD1C and Rev7 (all studied here for the first time in CaP) whose defects may cause resistance to PARPi.	PTEN	heterogeneous	5728	HP_0001425	30	34	101	114	False
26987799	TMPRSS2-ERG rearrangement and PTEN loss, events sensitizing to PARPi, occurred frequently along with heterogeneous loss of DNA repair factors 53BP1, JMJD1C and Rev7 (all studied here for the first time in CaP) whose defects may cause resistance to PARPi.	JMJD1C	heterogeneous	221037	HP_0001425	149	155	101	114	False
26987799	TMPRSS2-ERG rearrangement and PTEN loss, events sensitizing to PARPi, occurred frequently along with heterogeneous loss of DNA repair factors 53BP1, JMJD1C and Rev7 (all studied here for the first time in CaP) whose defects may cause resistance to PARPi.	Rev7	heterogeneous	10459	HP_0001425	160	164	101	114	False
30504325	Three subtypes, <i>PTPN11- , NRAS-</i>, and <i>KRAS</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with CBL syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.	NRAS	neurofibromatosis	4893	HP_0001067	29	33	194	211	False
30504325	Three subtypes, <i>PTPN11- , NRAS-</i>, and <i>KRAS</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with CBL syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.	KRAS	neurofibromatosis	3845	HP_0001067	47	51	194	211	False
30504325	Three subtypes, <i>PTPN11- , NRAS-</i>, and <i>KRAS</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with CBL syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.	CBL	neurofibromatosis	867	HP_0001067	248	251	194	211	False
30504325	Three subtypes, <i>PTPN11- , NRAS-</i>, and <i>KRAS</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with CBL syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.	type	neurofibromatosis	6445	HP_0001067	9	13	194	211	False
30504325	Three subtypes, <i>PTPN11- , NRAS-</i>, and <i>KRAS</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with CBL syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.	NRAS	tumor	4893	HP_0002664	29	33	359	364	True
30504325	Three subtypes, <i>PTPN11- , NRAS-</i>, and <i>KRAS</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with CBL syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.	KRAS	tumor	3845	HP_0002664	47	51	359	364	True
30504325	Three subtypes, <i>PTPN11- , NRAS-</i>, and <i>KRAS</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with CBL syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.	CBL	tumor	867	HP_0002664	248	251	359	364	True
30504325	Three subtypes, <i>PTPN11- , NRAS-</i>, and <i>KRAS</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in neurofibromatosis type 1 and in JMML in children with CBL syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.	type	tumor	6445	HP_0002664	9	13	359	364	False
28778787	Almost all are inherited in autosomal recessive patterns with a few exceptions such as the X-linked ALG13.	ALG13	autosomal recessive	79868	HP_0000007	100	105	28	47	False
27604489	Mucinous tubular and spindle cell carcinoma (MTSCC) is a relatively rare subtype of renal cell carcinoma (RCC) with distinctive morphologic and cytogenetic features.	RCC	renal cell carcinoma	7515	HP_0005584	106	109	84	104	False
27604489	We demonstrate the presence of either biallelic loss of Hippo pathway tumor suppressor genes (TSG) and/or evidence of alteration of Hippo pathway genes in 85% of samples.	TSG	tumor	57045	HP_0002664	94	97	70	75	False
30459815	Silencing expression of CCND1, JUN and SPP1 in the human oral cancer cell line OECM-1 confirmed that those genes play essential roles in oral cancer cell invasion.	CCND1	cancer	595	HP_0002664	24	29	62	68	True
30459815	Silencing expression of CCND1, JUN and SPP1 in the human oral cancer cell line OECM-1 confirmed that those genes play essential roles in oral cancer cell invasion.	JUN	cancer	3725	HP_0002664	31	34	62	68	False
30459815	Silencing expression of CCND1, JUN and SPP1 in the human oral cancer cell line OECM-1 confirmed that those genes play essential roles in oral cancer cell invasion.	SPP1	cancer	30827	HP_0002664	39	43	62	68	False
30459815	Analysis of clinical samples of oral cancer found a strong correlation of these genes with short survival, especially JUN expression associated with metastasis.	JUN	cancer	3725	HP_0002664	118	121	37	43	False
30459815	Our study identified a unique gene signature - CCND1, JUN and SPP1 - which may be involved in oral cancer lymph node metastasis	CCND1	cancer	595	HP_0002664	47	52	99	105	True
30459815	Our study identified a unique gene signature - CCND1, JUN and SPP1 - which may be involved in oral cancer lymph node metastasis	JUN	cancer	3725	HP_0002664	54	57	99	105	False
30459815	Our study identified a unique gene signature - CCND1, JUN and SPP1 - which may be involved in oral cancer lymph node metastasis	SPP1	cancer	30827	HP_0002664	62	66	99	105	False
26811476	Via its bipartite zona pellucida module (ZP-N/ZP-C), UMOD forms extracellular filaments that regulate kidney electrolyte balance and innate immunity, as well as protect against renal stones.	UMOD	renal stones	7369	HP_0000787	53	57	177	189	False
26811476	This arrangement is required for filament formation and is directed by an ordered ZP-N/ZP-C linker that is not observed in ZP2 but is conserved in the sequence of deafness/Crohn's disease-associated homopolymeric glycoproteins -tectorin (TECTA) and glycoprotein 2 (GP2).	TECTA	deafness	7007	HP_0000365	239	244	163	171	True
30341509	Primary hyperoxaluria type 1 (PH1) is a rare but devastating autosomal recessive inherited disease caused by mutations in gene AGXT.	type	hyperoxaluria	6445	HP_0003159	22	26	8	21	False
30341509	Primary hyperoxaluria type 1 (PH1) is a rare but devastating autosomal recessive inherited disease caused by mutations in gene AGXT.	AGXT	hyperoxaluria	189	HP_0003159	127	131	8	21	True
30341509	Primary hyperoxaluria type 1 (PH1) is a rare but devastating autosomal recessive inherited disease caused by mutations in gene AGXT.	type	autosomal recessive	6445	HP_0000007	22	26	61	80	True
30341509	Primary hyperoxaluria type 1 (PH1) is a rare but devastating autosomal recessive inherited disease caused by mutations in gene AGXT.	AGXT	autosomal recessive	189	HP_0000007	127	131	61	80	True
30690883	Increasing evidence has shown that WT1-interacting protein (WTIP) plays important roles both physiologically and pathologically in humans; however, the role of WTIP in cancer is unknown.	WT1	cancer	7490	HP_0002664	35	38	168	174	True
30690883	Increasing evidence has shown that WT1-interacting protein (WTIP) plays important roles both physiologically and pathologically in humans; however, the role of WTIP in cancer is unknown.	WTIP	cancer	126374	HP_0002664	60	64	168	174	False
30690883	Here, we investigated the role and mechanism of WTIP in cell proliferation and tumorigenesis of non-small-cell lung cancer (NSCLC).	WTIP	cancer	126374	HP_0002664	48	52	116	122	False
30690883	Here, we investigated the role and mechanism of WTIP in cell proliferation and tumorigenesis of non-small-cell lung cancer (NSCLC).	WTIP	tumor	126374	HP_0002664	48	52	79	84	False
30690883	We report that WTIP is a tumor suppressor in human NSCLC.	WTIP	tumor	126374	HP_0002664	15	19	25	30	False
30690883	Moreover, ectopic overexpression of WTIP dramatically inhibits cell proliferation and tumorigenesis invitro and invivo; conversely, depletion of WTIP expression shows the opposite effects.	WTIP	tumor	126374	HP_0002664	36	40	86	91	False
28941044	Sturge-Weber Syndrome (SWS) is a neurocutaneous disease with clinical manifestations including ocular (glaucoma), cutaneous (port-wine birthmark), neurologic (seizures), and vascular problems.	SWS	seizures	10908	HP_0001250	23	26	159	167	False
28941044	Molecular mechanisms of SWS pathogenesis are initiated by the somatic mutation in GNAQ.	SWS	somatic mutation	10908	HP_0001428	24	27	62	78	False
30472720	However, the underlying mechanisms involved in hepatocellular carcinoma (HCC) progression remain poorly understood.	HCC	hepatocellular carcinoma	84668	HP_0001402	73	76	47	71	False
28005197	Biallelic mutations in the SBF1 gene have been identified in one family with demyelinating Charcot-Marie-Tooth disease (CMT4B3) and two families with axonal neuropathy and additional neurological and skeletal features.	SBF1	neuropathy	6305	HP_0009830	27	31	157	167	True
28005197	Here we describe novel sequence variants in SBF1 (c.1168C&gt;G and c.2209_2210del) as the potential causative mutations in two siblings with severe axonal neuropathy, hearing loss, facial weakness and bulbar features.	SBF1	neuropathy	6305	HP_0009830	44	48	155	165	True
28005197	Here we describe novel sequence variants in SBF1 (c.1168C&gt;G and c.2209_2210del) as the potential causative mutations in two siblings with severe axonal neuropathy, hearing loss, facial weakness and bulbar features.	SBF1	hearing loss	6305	HP_0000365	44	48	167	179	False
28005197	Here we describe novel sequence variants in SBF1 (c.1168C&gt;G and c.2209_2210del) as the potential causative mutations in two siblings with severe axonal neuropathy, hearing loss, facial weakness and bulbar features.	SBF1	facial weakness	6305	HP_0010628	44	48	181	196	False
28005197	Our findings suggest that SBF1 mutations may cause a syndromic form of autosomal recessive axonal neuropathy (AR-CMT2) in addition to CMT4B3	SBF1	neuropathy	6305	HP_0009830	26	30	98	108	True
28005197	Our findings suggest that SBF1 mutations may cause a syndromic form of autosomal recessive axonal neuropathy (AR-CMT2) in addition to CMT4B3	SBF1	autosomal recessive	6305	HP_0000007	26	30	71	90	True
29330474	De novo FOXP1 mutations have been associated with intellectual disability (ID), motor delay, autistic features and awide spectrum of speech difficulties.	FOXP1	intellectual disability	27086	HP_0001249	8	13	50	73	True
29330474	De novo FOXP1 mutations have been associated with intellectual disability (ID), motor delay, autistic features and awide spectrum of speech difficulties.	FOXP1	motor delay	27086	HP_0001270	8	13	80	91	True
29330474	De novo FOXP1 mutations have been associated with intellectual disability (ID), motor delay, autistic features and awide spectrum of speech difficulties.	FOXP1	speech difficulties	27086	HP_0000750	8	13	134	153	True
29330474	By whole exome sequencing we identified a de novo splicing mutation in FOXP1 in a patient, initially diagnosed as C syndrome, who suffers from syndromic intellectual disability with trigonocephaly.	FOXP1	intellectual disability	27086	HP_0001249	71	76	153	176	True
29330474	By whole exome sequencing we identified a de novo splicing mutation in FOXP1 in a patient, initially diagnosed as C syndrome, who suffers from syndromic intellectual disability with trigonocephaly.	FOXP1	trigonocephaly	27086	HP_0000243	71	76	182	196	False
29330474	The patient reported here shares speech difficulties, intellectual disability and autistic features with other FOXP1 syndrome patients, and thus the diagnosis for this patient should be changed.	FOXP1	intellectual disability	27086	HP_0001249	111	116	54	77	True
29330474	The patient reported here shares speech difficulties, intellectual disability and autistic features with other FOXP1 syndrome patients, and thus the diagnosis for this patient should be changed.	FOXP1	speech difficulties	27086	HP_0000750	111	116	33	52	True
29330474	Finally, since trigonocephaly has not been previously reported in FOXP1 syndrome, it remains to be proved whether it may be associated with the FOXP1 mutation	FOXP1	trigonocephaly	27086	HP_0000243	66	71	15	29	False
28079576	The tumors were characterized by immunohistochemistry for pituitary hormones, cytokeratins, Pit-1, and the neuronal markers NeuN, neurofilaments (NFP), and MAP2.	Pit-1	tumors	6574	HP_0002664	92	97	4	10	False
28079576	The tumors were characterized by immunohistochemistry for pituitary hormones, cytokeratins, Pit-1, and the neuronal markers NeuN, neurofilaments (NFP), and MAP2.	NeuN	tumors	146713	HP_0002664	124	128	4	10	False
28079576	Double-labeling immunohistochemistry for Pit-1/GH, Pit-1/NFP, Pit-1/MAP2, and NeuN/GH was performed in 9/10 tumors.	Pit-1	tumors	6574	HP_0002664	41	46	108	114	False
28079576	Double-labeling immunohistochemistry for Pit-1/GH, Pit-1/NFP, Pit-1/MAP2, and NeuN/GH was performed in 9/10 tumors.	NeuN	tumors	146713	HP_0002664	78	82	108	114	False
28753749	The original tumor harbors mutations in PBRM1, while the second harbors mutations in KDM5C.	PBRM1	tumor	55193	HP_0002664	40	45	13	18	False
25502460	Structural rearrangements of chromosome 10 are frequently observed in glioblastoma multiforme and over 80% of tumour samples archived in the catalogue of somatic mutations in cancer database had gene copy number loss for PI4K2A which encodes phosphatidylinositol 4-kinase type IIalpha.	type	glioblastoma	6445	HP_0012174	273	277	70	82	False
25502460	Structural rearrangements of chromosome 10 are frequently observed in glioblastoma multiforme and over 80% of tumour samples archived in the catalogue of somatic mutations in cancer database had gene copy number loss for PI4K2A which encodes phosphatidylinositol 4-kinase type IIalpha.	type	tumour	6445	HP_0002664	273	277	111	117	False
25502460	Structural rearrangements of chromosome 10 are frequently observed in glioblastoma multiforme and over 80% of tumour samples archived in the catalogue of somatic mutations in cancer database had gene copy number loss for PI4K2A which encodes phosphatidylinositol 4-kinase type IIalpha.	type	cancer	6445	HP_0002664	273	277	176	182	False
25502460	This in silico study suggests that in glioblastoma multiforme, karyotypic changes have the potential to cause multiple abnormalities in sets of genes involved in phosphoinositide metabolism and this may be important for understanding drug resistance and phosphoinositide pathway redundancy in the advanced disease state.	set	glioblastoma	6418	HP_0012174	136	139	38	50	False
28562347	This study aimed to evaluate the interactions between single nucleotide polymorphisms of ERCC6 (rs1917799) and ERCC8 (rs158572 and rs158916) in gastric cancer and its precancerous diseases.	ERCC6	cancer	2074	HP_0002664	89	94	152	158	True
28562347	This study aimed to evaluate the interactions between single nucleotide polymorphisms of ERCC6 (rs1917799) and ERCC8 (rs158572 and rs158916) in gastric cancer and its precancerous diseases.	ERCC8	cancer	1161	HP_0002664	111	116	152	158	False
28562347	In situ ERCC6 and ERCC8 protein expression were detected by immunohistochemistry in 109 chronic superficial gastritis, 109 chronic atrophic gastritis and 109 gastric cancer cases.	ERCC6	cancer	2074	HP_0002664	8	13	166	172	True
28562347	In situ ERCC6 and ERCC8 protein expression were detected by immunohistochemistry in 109 chronic superficial gastritis, 109 chronic atrophic gastritis and 109 gastric cancer cases.	ERCC8	cancer	1161	HP_0002664	18	23	166	172	False
28562347	Our results demonstrated pairwise epistatic interactions between ERCC6 and ERCC8 SNPs that ERCC6 rs1917799-ERCC8 rs158572 combination was associated with decreased risk of chronic atrophic gastritis and increased risk of gastric cancer.	ERCC6	cancer	2074	HP_0002664	65	70	229	235	True
28562347	Our results demonstrated pairwise epistatic interactions between ERCC6 and ERCC8 SNPs that ERCC6 rs1917799-ERCC8 rs158572 combination was associated with decreased risk of chronic atrophic gastritis and increased risk of gastric cancer.	ERCC8	cancer	1161	HP_0002664	75	80	229	235	False
28562347	ERCC6 rs1917799 also showed a significant interaction with ERCC8 rs158916 to reduce gastric cancer risk.	ERCC6	cancer	2074	HP_0002664	0	5	92	98	True
28562347	ERCC6 rs1917799 also showed a significant interaction with ERCC8 rs158916 to reduce gastric cancer risk.	ERCC8	cancer	1161	HP_0002664	59	64	92	98	False
28562347	The expressions of ERCC6, ERCC8 and ERCC6-ERCC8 combination have similarities that higher positivity was observed in chronic superficial gastritis compared with chronic atrophic gastritis and gastric cancer.	ERCC6	cancer	2074	HP_0002664	19	24	200	206	True
28562347	The expressions of ERCC6, ERCC8 and ERCC6-ERCC8 combination have similarities that higher positivity was observed in chronic superficial gastritis compared with chronic atrophic gastritis and gastric cancer.	ERCC8	cancer	1161	HP_0002664	26	31	200	206	False
28562347	In conclusion, ERCC6 rs1917799, ERCC8 rs158572 and rs158916 demonstrated pairwise epistatic interactions to associate with chronic atrophic gastritis and gastric cancer risk.	ERCC6	cancer	2074	HP_0002664	15	20	162	168	True
28562347	In conclusion, ERCC6 rs1917799, ERCC8 rs158572 and rs158916 demonstrated pairwise epistatic interactions to associate with chronic atrophic gastritis and gastric cancer risk.	ERCC8	cancer	1161	HP_0002664	32	37	162	168	False
25510506	Urofacial syndrome (UFS) is an autosomal recessive disease with severe dysfunctional urination including urinary incontinence (UI).	UFS	autosomal recessive	60495	HP_0000007	20	23	31	50	True
22470196	Somatic defects at five loci, WT1, CTNNB1, WTX, TP53 and the imprinted 11p15 region, are implicated in Wilms tumor, the commonest childhood kidney cancer.	CTNNB1	tumor	1499	HP_0002664	35	41	109	114	True
22470196	Somatic defects at five loci, WT1, CTNNB1, WTX, TP53 and the imprinted 11p15 region, are implicated in Wilms tumor, the commonest childhood kidney cancer.	WTX	tumor	139285	HP_0002664	43	46	109	114	False
22470196	Somatic defects at five loci, WT1, CTNNB1, WTX, TP53 and the imprinted 11p15 region, are implicated in Wilms tumor, the commonest childhood kidney cancer.	CTNNB1	cancer	1499	HP_0002664	35	41	147	153	True
22470196	Somatic defects at five loci, WT1, CTNNB1, WTX, TP53 and the imprinted 11p15 region, are implicated in Wilms tumor, the commonest childhood kidney cancer.	WTX	cancer	139285	HP_0002664	43	46	147	153	False
22470196	We identified mutations of WTX in 32%, CTNNB1 in 15%, WT1 in 12% and TP53 in 5% of tumors.	CTNNB1	tumor	1499	HP_0002664	39	45	83	88	True
22470196	We identified mutations of WTX in 32%, CTNNB1 in 15%, WT1 in 12% and TP53 in 5% of tumors.	WTX	tumor	139285	HP_0002664	27	30	83	88	False
22470196	Group 1 tumors (63%) were defined as 11p15-mutant and WT1-normal; a third also had WTX mutations.	WTX	tumor	139285	HP_0002664	83	86	8	13	False
24798461	Homozygous and compound heterozygous mutations in C12orf57 have recently been described to cause an autosomal recessive syndromic form of intellectual disability, including agenesis/hypoplasia of the corpus callosum, optic coloboma, and intractable seizures.	C12orf57	intellectual disability	113246	HP_0001249	50	58	138	161	True
24798461	Homozygous and compound heterozygous mutations in C12orf57 have recently been described to cause an autosomal recessive syndromic form of intellectual disability, including agenesis/hypoplasia of the corpus callosum, optic coloboma, and intractable seizures.	C12orf57	autosomal recessive	113246	HP_0000007	50	58	100	119	True
24798461	Homozygous and compound heterozygous mutations in C12orf57 have recently been described to cause an autosomal recessive syndromic form of intellectual disability, including agenesis/hypoplasia of the corpus callosum, optic coloboma, and intractable seizures.	C12orf57	seizures	113246	HP_0001250	50	58	249	257	True
29262419	Homozygous RSPO1 mutations cause a syndrome of 46,XX disorder of sexual development (DSD), palmoplantar keratoderma (PPK), and predisposition to squamous cell carcinoma.	RSPO1	palmoplantar keratoderma	284654	HP_0000982	11	16	91	115	True
29262419	Homozygous RSPO1 mutations cause a syndrome of 46,XX disorder of sexual development (DSD), palmoplantar keratoderma (PPK), and predisposition to squamous cell carcinoma.	RSPO1	squamous cell carcinoma	284654	HP_0002860	11	16	145	168	True
29262419	Both have PPK and hearing impairment and carried a novel homozygous mutation c.332G&gt;A (p.Cys111Tyr) located in the highly conserved furin-like cysteine-rich domain-2 (FU-CRD2).	furin	hearing impairment	5045	HP_0000365	135	140	18	36	False
29262419	Both have PPK and hearing impairment and carried a novel homozygous mutation c.332G&gt;A (p.Cys111Tyr) located in the highly conserved furin-like cysteine-rich domain-2 (FU-CRD2).	FU	hearing impairment	27148	HP_0000365	170	172	18	36	False
30455801	Although isolated cases of adult PKD have been reported in Nigerians; to the best of our knowledge, this case is the first to be reported in the paediatric age group in Nigeria.	PKD	isolated cases	5587	HP_0003745	33	36	9	23	False
30455801	Although isolated cases of adult PKD have been reported in Nigerians; to the best of our knowledge, this case is the first to be reported in the paediatric age group in Nigeria.	best	isolated cases	7439	HP_0003745	77	81	9	23	False
26060908	Generalized epilepsies, particularly the idiopathic or genetic generalized epilepsies (GGEs), represent some of the most common epilepsies.	era	epilepsies	2099	HP_0001250	3	6	12	22	False
26060908	The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in SCN1A, SCN1B, GABRG2, and GABRA1.	SCN1A	epilepsies	6323	HP_0001250	275	280	110	120	True
26060908	The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in SCN1A, SCN1B, GABRG2, and GABRA1.	SCN1B	epilepsies	6324	HP_0001250	282	287	110	120	True
26060908	The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in SCN1A, SCN1B, GABRG2, and GABRA1.	GABRG2	epilepsies	2566	HP_0001250	289	295	110	120	True
26060908	The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in SCN1A, SCN1B, GABRG2, and GABRA1.	era	epilepsies	2099	HP_0001250	101	104	110	120	False
26060908	The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in SCN1A, SCN1B, GABRG2, and GABRA1.	SCN1A	seizures	6323	HP_0001250	275	280	175	183	True
26060908	The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in SCN1A, SCN1B, GABRG2, and GABRA1.	SCN1B	seizures	6324	HP_0001250	282	287	175	183	True
26060908	The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in SCN1A, SCN1B, GABRG2, and GABRA1.	GABRG2	seizures	2566	HP_0001250	289	295	175	183	True
26060908	The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in SCN1A, SCN1B, GABRG2, and GABRA1.	era	seizures	2099	HP_0001250	101	104	175	183	False
26060908	Genes for epileptic encephalopathies such as SLC2A1 were rediscovered in GGE, highlighting the biological continuum between different epilepsies.	SLC2A1	epilepsies	6513	HP_0001250	45	51	134	144	True
26060908	Genes for epileptic encephalopathies such as SLC2A1 were rediscovered in GGE, highlighting the biological continuum between different epilepsies.	SLC2A1	encephalopathies	6513	HP_0001298	45	51	20	36	True
26060908	Genome-wide studies examining common genetic risk factors identified common variants in SCN1A, indicating a convergence of shared pathophysiological pathways in various types of epilepsies.	SCN1A	epilepsies	6323	HP_0001250	88	93	178	188	True
25590583	In this work, we functionally characterize two breast cancer associated genes, the proteasome 26S subunit ATPase 3 interacting protein (PSMC3IP) and the epithelial-stromal interaction 1 (EPSTI1), to explore their potential apoptotic role in breast cancer.	PSMC3IP	cancer	29893	HP_0002664	136	143	54	60	False
25590583	In this work, we functionally characterize two breast cancer associated genes, the proteasome 26S subunit ATPase 3 interacting protein (PSMC3IP) and the epithelial-stromal interaction 1 (EPSTI1), to explore their potential apoptotic role in breast cancer.	EPSTI1	cancer	94240	HP_0002664	187	193	54	60	False
25590583	Based on the generated interaction network, we examine several apoptotic markers to determine the effect of PSMC3IP and EPSTI1 gene expression modulation in two different human breast cancer cell lines to suggest potential molecular mechanisms to unveil their role in the disease.	PSMC3IP	cancer	29893	HP_0002664	108	115	184	190	False
25590583	Based on the generated interaction network, we examine several apoptotic markers to determine the effect of PSMC3IP and EPSTI1 gene expression modulation in two different human breast cancer cell lines to suggest potential molecular mechanisms to unveil their role in the disease.	EPSTI1	cancer	94240	HP_0002664	120	126	184	190	False
25590583	Our results show that PSMC3IP and EPSTI1 are able to modulate the extrinsic apoptotic pathway in estrogen receptor positive and triple negative breast cancer cell lines, highlighting them as potential therapeutic targets.	PSMC3IP	cancer	29893	HP_0002664	22	29	151	157	False
25590583	Our results show that PSMC3IP and EPSTI1 are able to modulate the extrinsic apoptotic pathway in estrogen receptor positive and triple negative breast cancer cell lines, highlighting them as potential therapeutic targets.	EPSTI1	cancer	94240	HP_0002664	34	40	151	157	False
29742505	Mutations in the COL4A5 gene result in X-linked Alport syndrome, homozygous or compound heterozygous mutations in COL4A3 or COL4A4 are responsible for autosomal recessive Alport syndrome, and heterozygous mutations in COL4A3 or COL4A4 cause autosomal dominant Alport syndrome or benign familial hematuria.	COL4A5	autosomal recessive	1287	HP_0000007	17	23	151	170	False
29742505	Mutations in the COL4A5 gene result in X-linked Alport syndrome, homozygous or compound heterozygous mutations in COL4A3 or COL4A4 are responsible for autosomal recessive Alport syndrome, and heterozygous mutations in COL4A3 or COL4A4 cause autosomal dominant Alport syndrome or benign familial hematuria.	COL4A3	autosomal recessive	1285	HP_0000007	114	120	151	170	True
29742505	Mutations in the COL4A5 gene result in X-linked Alport syndrome, homozygous or compound heterozygous mutations in COL4A3 or COL4A4 are responsible for autosomal recessive Alport syndrome, and heterozygous mutations in COL4A3 or COL4A4 cause autosomal dominant Alport syndrome or benign familial hematuria.	COL4A4	autosomal recessive	1286	HP_0000007	124	130	151	170	True
29742505	This result suggests that COL4A3 and COL4A4 digenic mutations in cis mimicking an autosomal dominant inheritance should be considered as a novel inheritance pattern of benign familial hematuria, although the disease-causing mechanism remains unknown	COL4A3	inheritance	1285	HP_0000005	26	32	101	112	False
29742505	This result suggests that COL4A3 and COL4A4 digenic mutations in cis mimicking an autosomal dominant inheritance should be considered as a novel inheritance pattern of benign familial hematuria, although the disease-causing mechanism remains unknown	COL4A4	inheritance	1286	HP_0000005	37	43	101	112	False
29742505	This result suggests that COL4A3 and COL4A4 digenic mutations in cis mimicking an autosomal dominant inheritance should be considered as a novel inheritance pattern of benign familial hematuria, although the disease-causing mechanism remains unknown	cis	inheritance	1154	HP_0000005	65	68	101	112	False
29036958	Bartter syndrome (BS) is a hereditary condition transmitted as an autosomal recessive (Bartter type 1 to 4) or dominant trait (Bartter type 5).	type	autosomal recessive	6445	HP_0000007	95	99	66	85	True
29036958	Here we presented a case (BS type ) of a 17 years old female presented with polyhydramnios, polyuria, nephrocalcinosis and hypokalemia, which was alleviated after treatment with celecoxib and vitamin D(3).	type	polyhydramnios	6445	HP_0001561	29	33	77	91	False
29036958	Here we presented a case (BS type ) of a 17 years old female presented with polyhydramnios, polyuria, nephrocalcinosis and hypokalemia, which was alleviated after treatment with celecoxib and vitamin D(3).	type	polyuria	6445	HP_0000103	29	33	93	101	False
29036958	Here we presented a case (BS type ) of a 17 years old female presented with polyhydramnios, polyuria, nephrocalcinosis and hypokalemia, which was alleviated after treatment with celecoxib and vitamin D(3).	type	nephrocalcinosis	6445	HP_0000121	29	33	103	119	False
29036958	Here we presented a case (BS type ) of a 17 years old female presented with polyhydramnios, polyuria, nephrocalcinosis and hypokalemia, which was alleviated after treatment with celecoxib and vitamin D(3).	type	hypokalemia	6445	HP_0002900	29	33	124	135	False
30504334	Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal hematopoietic disease caused by expansion of a stem cell that harbors a somatic mutation in <i>PIGA</i> PIGA mutant blood cells are deficient in the complement regulator proteins CD55 and CD59, making them susceptible to intravascular hemolysis due to a failure to regulate the APC on erythrocytes.	APC	somatic mutation	324	HP_0001428	332	335	126	142	True
30504334	Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal hematopoietic disease caused by expansion of a stem cell that harbors a somatic mutation in <i>PIGA</i> PIGA mutant blood cells are deficient in the complement regulator proteins CD55 and CD59, making them susceptible to intravascular hemolysis due to a failure to regulate the APC on erythrocytes.	PIGA	somatic mutation	5277	HP_0001428	149	153	126	142	True
26742492	The novel potential autism susceptibility genes PTDSS1 and AREG were uncovered and warrant further genetic and functional analyses.	PTDSS1	autism	9791	HP_0000717	48	54	20	26	False
26742492	The novel potential autism susceptibility genes PTDSS1 and AREG were uncovered and warrant further genetic and functional analyses.	AREG	autism	374	HP_0000717	59	63	20	26	False
29799832	BACKGROUND Previous research found that ALG3 is associated with cervical cancer, but the role of ALG3 in breast cancer was still unknown.	ALG3	cancer	10195	HP_0002664	40	44	73	79	False
29799832	MATERIAL AND METHODS The expression of ALG3 in breast carcinoma tissues was determined by immunochemistry.	ALG3	breast carcinoma	10195	HP_0003002	39	43	47	63	False
29799832	RESULTS There was an increased expression of ALG3 in breast cancer tissues compared to normal breast tissues (p&lt;0.05).	ALG3	cancer	10195	HP_0002664	45	49	60	66	False
29799832	ALG3 expression was significantly increased in cancer samples with advanced stages (stage III/IV) compared with those in the early stages of disease (stage I/II) (p&lt;0.05).	ALG3	cancer	10195	HP_0002664	0	4	47	53	False
29799832	The staining intensity of ALG3 was significantly correlated to the tumor grade (grades 2-3 versus 1, p&lt;0.05).	ALG3	tumor	10195	HP_0002664	26	30	67	72	False
28362817	In trans-ethnic meta-analyses of U4C and UK Biobank data, we found significant associations between breast cancer risk and the expression of RCCD1 (joint p-value: 3.6x10-06) and DHODH (p-value: 7.1x10-06) in breast tissue, as well as a suggestive association for ANKLE1 (p-value: 9.3x10-05).	RCCD1	cancer	91433	HP_0002664	141	146	107	113	False
28362817	In trans-ethnic meta-analyses of U4C and UK Biobank data, we found significant associations between breast cancer risk and the expression of RCCD1 (joint p-value: 3.6x10-06) and DHODH (p-value: 7.1x10-06) in breast tissue, as well as a suggestive association for ANKLE1 (p-value: 9.3x10-05).	DHODH	cancer	1723	HP_0002664	178	183	107	113	False
28362817	In trans-ethnic meta-analyses of U4C and UK Biobank data, we found significant associations between breast cancer risk and the expression of RCCD1 (joint p-value: 3.6x10-06) and DHODH (p-value: 7.1x10-06) in breast tissue, as well as a suggestive association for ANKLE1 (p-value: 9.3x10-05).	ANKLE1	cancer	126549	HP_0002664	263	269	107	113	False
28362817	While genome-wide association studies (GWAS) have implicated RCCD1 and ANKLE1 in breast cancer risk, they have not identified the remaining three genes.	RCCD1	cancer	91433	HP_0002664	61	66	88	94	False
28362817	While genome-wide association studies (GWAS) have implicated RCCD1 and ANKLE1 in breast cancer risk, they have not identified the remaining three genes.	ANKLE1	cancer	126549	HP_0002664	71	77	88	94	False
25290684	Delayed bone age and seizure disorders were overrepresented in the TTDN1 group (P=0.009 and P=0.024, respectively), whereas some characteristic TTD clinical, laboratory, and imaging findings were absent.	TTD	seizure	404672	HP_0001250	67	70	21	28	False
29462293	Gap junction beta-1 (GJB1) gene mutations affecting the gap junction protein connexin32 (Cx32) cause the X-linked Charcot-Marie-Tooth disease (CMT1X), a common inherited neuropathy.	GJB1	neuropathy	2705	HP_0009830	21	25	170	180	True
29462293	Gap junction beta-1 (GJB1) gene mutations affecting the gap junction protein connexin32 (Cx32) cause the X-linked Charcot-Marie-Tooth disease (CMT1X), a common inherited neuropathy.	gap	neuropathy	5921	HP_0009830	56	59	170	180	False
29065434	The major question to be solved is the genetic basis of bilateral adrenal hyperplasia (BAH).	BAH	bilateral	444	HP_0012832	87	90	56	65	False
29065434	The major question to be solved is the genetic basis of bilateral adrenal hyperplasia (BAH).	BAH	adrenal hyperplasia	444	HP_0008221	87	90	66	85	False
29065434	Is BAH due to the bilateral occurrence of APCCs, to germline variants, or perhaps due to unknown serum factors? Lastly, the etiology of unsolved cases of apparently familial hyperaldosteronism remains to be discovered.	BAH	hyperaldosteronism	444	HP_0000859	3	6	174	192	False
29065434	Is BAH due to the bilateral occurrence of APCCs, to germline variants, or perhaps due to unknown serum factors? Lastly, the etiology of unsolved cases of apparently familial hyperaldosteronism remains to be discovered.	BAH	bilateral	444	HP_0012832	3	6	18	27	False
21800012	This report describes for the first time a patient with SEPT5 deficiency presenting with cortical dysplasia (polymicrogyria), developmental delay, and platelet secretion defect	SEPT5	cortical dysplasia	5413	HP_0002539	56	61	89	107	False
21800012	This report describes for the first time a patient with SEPT5 deficiency presenting with cortical dysplasia (polymicrogyria), developmental delay, and platelet secretion defect	SEPT5	developmental delay	5413	HP_0001263	56	61	126	145	False
27666723	The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in squamous cell carcinoma(SCC) of the tongue: the vascular endothelial growth factor(VEGF)C and VEGFD, which bind to the cell surface tyrosine kinase receptor VEGF receptor3(VEGFR3); CC motif chemokine receptor7(CCR7); neuropilin(NRP)1 and NRP2; and semaphorin 3E(SEMA3E).	SCC	squamous cell carcinoma	6317	HP_0002860	144	147	119	142	False
27666723	The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in squamous cell carcinoma(SCC) of the tongue: the vascular endothelial growth factor(VEGF)C and VEGFD, which bind to the cell surface tyrosine kinase receptor VEGF receptor3(VEGFR3); CC motif chemokine receptor7(CCR7); neuropilin(NRP)1 and NRP2; and semaphorin 3E(SEMA3E).	VEGF	squamous cell carcinoma	7422	HP_0002860	204	208	119	142	False
27666723	The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in squamous cell carcinoma(SCC) of the tongue: the vascular endothelial growth factor(VEGF)C and VEGFD, which bind to the cell surface tyrosine kinase receptor VEGF receptor3(VEGFR3); CC motif chemokine receptor7(CCR7); neuropilin(NRP)1 and NRP2; and semaphorin 3E(SEMA3E).	CCR7	squamous cell carcinoma	1236	HP_0002860	339	343	119	142	False
27666723	The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in squamous cell carcinoma(SCC) of the tongue: the vascular endothelial growth factor(VEGF)C and VEGFD, which bind to the cell surface tyrosine kinase receptor VEGF receptor3(VEGFR3); CC motif chemokine receptor7(CCR7); neuropilin(NRP)1 and NRP2; and semaphorin 3E(SEMA3E).	NRP	squamous cell carcinoma	4673	HP_0002860	358	361	119	142	False
27666723	The present study, therefore, aimed to evaluate the expression levels of the following growth factors and receptors in squamous cell carcinoma(SCC) of the tongue: the vascular endothelial growth factor(VEGF)C and VEGFD, which bind to the cell surface tyrosine kinase receptor VEGF receptor3(VEGFR3); CC motif chemokine receptor7(CCR7); neuropilin(NRP)1 and NRP2; and semaphorin 3E(SEMA3E).	SEMA3E	squamous cell carcinoma	9723	HP_0002860	393	399	119	142	False
28148925	Cerebral, ocular, dental, auricular, skeletal (CODAS) syndrome is a rare autosomal recessive multisystem disorder caused by mutations in LONP1.	LONP1	autosomal recessive	9361	HP_0000007	137	142	73	92	True
28148925	We performed whole-exome sequencing on a 12-year-old Japanese male with severe intellectual disability, congenital bilateral cataracts, spasticity, hypotonia with motor regression and progressive cerebellar atrophy with hyperintensity of the cerebellar cortex on T2-weighted images.	T2	intellectual disability	292	HP_0001249	263	265	79	102	False
28148925	We performed whole-exome sequencing on a 12-year-old Japanese male with severe intellectual disability, congenital bilateral cataracts, spasticity, hypotonia with motor regression and progressive cerebellar atrophy with hyperintensity of the cerebellar cortex on T2-weighted images.	T2	cataracts	292	HP_0000518	263	265	125	134	False
28148925	We performed whole-exome sequencing on a 12-year-old Japanese male with severe intellectual disability, congenital bilateral cataracts, spasticity, hypotonia with motor regression and progressive cerebellar atrophy with hyperintensity of the cerebellar cortex on T2-weighted images.	T2	bilateral	292	HP_0012832	263	265	115	124	False
28148925	We performed whole-exome sequencing on a 12-year-old Japanese male with severe intellectual disability, congenital bilateral cataracts, spasticity, hypotonia with motor regression and progressive cerebellar atrophy with hyperintensity of the cerebellar cortex on T2-weighted images.	T2	spasticity	292	HP_0001257	263	265	136	146	False
28148925	We performed whole-exome sequencing on a 12-year-old Japanese male with severe intellectual disability, congenital bilateral cataracts, spasticity, hypotonia with motor regression and progressive cerebellar atrophy with hyperintensity of the cerebellar cortex on T2-weighted images.	T2	cerebellar atrophy	292	HP_0001272	263	265	196	214	False
28346420	Cyclooxygenase (COX)-2 is upregulated in hepatocellular carcinoma (HCC).	COX	hepatocellular carcinoma	1351	HP_0001402	16	19	41	65	False
28346420	Cyclooxygenase (COX)-2 is upregulated in hepatocellular carcinoma (HCC).	HCC	hepatocellular carcinoma	84668	HP_0001402	67	70	41	65	False
28346420	Reduced representation bisulfite sequencing (RRBS) and gene expression microarrays were performed in the HCC tumor and non-HCC liver tissues to investigate the molecular mechanisms of COX-2-driven HCC.	COX	tumor	1351	HP_0002664	184	187	109	114	False
28346420	Reduced representation bisulfite sequencing (RRBS) and gene expression microarrays were performed in the HCC tumor and non-HCC liver tissues to investigate the molecular mechanisms of COX-2-driven HCC.	HCC	tumor	84668	HP_0002664	105	108	109	114	False
28346420	Bio-functional investigation revealed that LTBP1 inhibited cell proliferation in HCC cell lines, suggesting its potential role as a tumor suppressor in HCC.	HCC	tumor	84668	HP_0002664	81	84	132	137	False
28346420	Bio-functional investigation revealed that LTBP1 inhibited cell proliferation in HCC cell lines, suggesting its potential role as a tumor suppressor in HCC.	LTBP1	tumor	4052	HP_0002664	43	48	132	137	False
28346420	In conclusion, this study demonstrated for the first time that enhanced COX-2 expression in hepatocytes is sufficient to induce HCC through inducing promoter hypermethylation by reducing TET1, silencing tumor-suppressive genes and activating key oncogenic pathways.	COX	tumor	1351	HP_0002664	72	75	203	208	False
28346420	In conclusion, this study demonstrated for the first time that enhanced COX-2 expression in hepatocytes is sufficient to induce HCC through inducing promoter hypermethylation by reducing TET1, silencing tumor-suppressive genes and activating key oncogenic pathways.	HCC	tumor	84668	HP_0002664	128	131	203	208	False
28346420	In conclusion, this study demonstrated for the first time that enhanced COX-2 expression in hepatocytes is sufficient to induce HCC through inducing promoter hypermethylation by reducing TET1, silencing tumor-suppressive genes and activating key oncogenic pathways.	TET1	tumor	80312	HP_0002664	187	191	203	208	False
28302486	We investigated this issue by analyzing the expression patterns of APP, APP-processing secretases, and APP metabolites in mitochondria separated from human neuroblastoma SH-SY5Y cells and those expressing Swedish mutant APP.	APP	neuroblastoma	351	HP_0003006	67	70	156	169	False
28866396	Among all premature deaths, contributions of cerebrovascular disease (stroke), ischemic heart disease (IHD), chronic obstructive pulmonary disease (COPD), lung cancer (LC) and acute lower respiratory infections (ALRIs) were 51.70, 26.26, 11.77, 9.45 and 0.82%, respectively.	COPD	cancer	372	HP_0002664	148	152	160	166	False
30256786	Mutations in the glucosylceramidase beta (GBA) gene are strongly associated with neurodegenerative diseases marked by protein aggregation.	GBA	neurodegenerative disease	2629	HP_0002180	42	45	81	106	False
28942967	Despite significant progress, the high genetic heterogeneity of these disorders often requires large sample sizes to identify a critical mass of individuals with disease-causing mutations in a single gene.	mass	heterogeneity	2200	HP_0001425	137	141	47	60	False
28942967	By pooling genetic findings across multiple studies, we have identified six individuals with severe developmental delay (6/6), refractory seizures (5/6), and similar dysmorphic features (3/6), each harboring a de novo mutation in PPP3CA.	PPP3CA	developmental delay	5530	HP_0001263	230	236	100	119	True
28942967	By pooling genetic findings across multiple studies, we have identified six individuals with severe developmental delay (6/6), refractory seizures (5/6), and similar dysmorphic features (3/6), each harboring a de novo mutation in PPP3CA.	PPP3CA	seizures	5530	HP_0001250	230	236	138	146	True
28942967	Based on these findings, we securely implicate PPP3CA in early-onset refractory epilepsy and further support the emerging role for synaptic dysregulation in epilepsy	PPP3CA	epilepsy	5530	HP_0001250	47	53	80	88	True
27925158	The short-rib polydactyly syndromes (SRPS) are autosomal recessively inherited, genetically heterogeneous skeletal ciliopathies.	SRP	polydactyly	10911	HP_0010442	37	40	14	25	False
27925158	The short-rib polydactyly syndromes (SRPS) are autosomal recessively inherited, genetically heterogeneous skeletal ciliopathies.	SRP	heterogeneous	10911	HP_0001425	37	40	92	105	False
27925158	Characteristic findings among all forms of SRP include short horizontal ribs, short limbs and polydactyly.	SRP	polydactyly	10911	HP_0010442	43	46	94	105	False
27925158	Characteristic findings among all forms of SRP include short horizontal ribs, short limbs and polydactyly.	SRP	short limbs	10911	HP_0009826	43	46	78	89	False
28377321	Chromosomal studies for Individual 1 identified an X-chromosome deletion due to a de novo pericentric inversion; the inversion breakpoint was associated with deletion of the 5'UTR of the USP9X, a gene which has been implicated in a syndromic intellectual disability affecting females.	USP9X	intellectual disability	8239	HP_0001249	187	192	242	265	True
28377321	Haploinsufficiency of USP9X in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.	USP9X	polydactyly	8239	HP_0010442	22	27	171	182	True
28377321	Haploinsufficiency of USP9X in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.	USP9X	scoliosis	8239	HP_0002650	22	27	124	133	True
28377321	Haploinsufficiency of USP9X in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.	USP9X	dental abnormalities	8239	HP_0000164	22	27	135	155	True
28377321	Haploinsufficiency of USP9X in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.	USP9X	anal atresia	8239	HP_0002023	22	27	157	169	True
28377321	Haploinsufficiency of USP9X in females has been associated with ID and congenital malformations that include heart defects, scoliosis, dental abnormalities, anal atresia, polydactyly, Dandy Walker malformation and hypoplastic corpus callosum.	USP9X	hypoplastic corpus callosum	8239	HP_0002079	22	27	214	241	True
24172257	The results show that LEPREL1 plays an important role in eye development and homozygous loss-of-function mutation of this gene can cause severely high myopia and early-onset cataract.	LEPREL1	myopia	55214	HP_0000545	22	29	151	157	True
24172257	The results show that LEPREL1 plays an important role in eye development and homozygous loss-of-function mutation of this gene can cause severely high myopia and early-onset cataract.	LEPREL1	cataract	55214	HP_0000518	22	29	174	182	True
28542515	X-linked hearing impairment is the rarest form of genetic hearing loss (HL) and represents only a minor fraction of all cases.	minor	hearing impairment	8013	HP_0000365	98	103	9	27	False
28542515	X-linked hearing impairment is the rarest form of genetic hearing loss (HL) and represents only a minor fraction of all cases.	minor	hearing loss	8013	HP_0000365	98	103	58	70	False
28542515	Subpopulation screening of the coding exons and flanking introns of SMPX was further performed for 338 Chinese patients with nonsydromic HL by Sanger sequencing, and another two potential causative substitutions (c.238C&gt;A and c.55A&gt;G) in SMPX were identified in additional sporadic cases of congenital deafness.	SMPX	sporadic	23676	HP_0003745	68	72	279	287	False
28542515	Subpopulation screening of the coding exons and flanking introns of SMPX was further performed for 338 Chinese patients with nonsydromic HL by Sanger sequencing, and another two potential causative substitutions (c.238C&gt;A and c.55A&gt;G) in SMPX were identified in additional sporadic cases of congenital deafness.	SMPX	deafness	23676	HP_0000365	68	72	308	316	True
28542515	Collectively, this study is the first to report the role of SMPX in Chinese population and identify a novel frameshift mutation in SMPX that causes not only nonsyndromic late-onset progressive HL, but also congenital hearing impairment.	SMPX	hearing impairment	23676	HP_0000365	60	64	217	235	True
29479983	a small fraction of the breast cancer burden, mutations in the BRCA1 and BRCA2 genes are known to confer a high	BRCA1	cancer	672	HP_0002664	63	68	31	37	True
29479983	a small fraction of the breast cancer burden, mutations in the BRCA1 and BRCA2 genes are known to confer a high	BRCA2	cancer	675	HP_0002664	73	78	31	37	True
29479983	studies have shown that mutations in the CHEK2 gene are involved in breast cancer susceptibility due to its impact	CHEK2	cancer	11200	HP_0002664	41	46	75	81	True
29479983	germline mutations in CHEK2 gene (c.1100delC, R145W and I157T) in breast cancers in Rwanda.	CHEK2	cancer	11200	HP_0002664	22	27	73	79	True
29364867	Integration of cell culture genomes, transcriptomes and tumour phenotypes with functional studies and human data reveals additional widespread effects of oncogenic dosage variation on cell morphology and plasticity, histopathology and clinical outcome, with the highest Kras<sup>MUT</sup> levels underlying aggressive undifferentiated phenotypes.	Kras	tumour	3845	HP_0002664	270	274	56	62	True
29364867	Mechanistically, different oncogenic gains and dosages evolve along distinct evolutionary routes, licensed by defined allelic states and/or combinations of hallmark tumour suppressor alterations (Cdkn2a, Trp53, Tgf-pathway).	Cdkn2a	tumour	1029	HP_0002664	196	202	165	171	True
30384806	Furthermore, microRNA-22 targeted NRAS proto-oncogene, GTPase (NRAS) in breast cancer cells.	NRAS	cancer	4893	HP_0002664	34	38	79	85	True
30384806	The expression levels of NRAS in human clinical specimens were higher in breast cancer tissues when compared to normal tissues.	NRAS	cancer	4893	HP_0002664	25	29	80	86	True
30384806	Moreover, microRNA-22 sensitized breast cancer cells to paclitaxel by regulation of NRAS.	NRAS	cancer	4893	HP_0002664	84	88	40	46	True
27333991	Our data suggest that increased expressions in certain mt genes and elevated levels of ROS may potentially play a critical role in the colorectal tumors evolving from adenopolyps to malignant lesions	ROS	tumor	6098	HP_0002664	87	90	146	151	False
30727926	Furthermore, cardiovascular risk factors such hyperthyroidism, hypertension and redox homeostasis have been identified to modulate PITX2 driven gene regulatory networks.	PITX2	hyperthyroidism	5308	HP_0000836	131	136	46	61	False
30727926	Furthermore, cardiovascular risk factors such hyperthyroidism, hypertension and redox homeostasis have been identified to modulate PITX2 driven gene regulatory networks.	PITX2	hypertension	5308	HP_0000822	131	136	63	75	False
30727926	We provide herein a state-of-the-art review of the genetic bases of atrial fibrillation, our current understanding of the genetic regulatory networks involved in AF and its plausible usage for searching novel therapeutic targets	art	atrial fibrillation	181	HP_0005110	33	36	68	87	False
30615612	Phase 2 occurs postnatally through adult stages with bone marrow production of granulocyte precursors and positive selection of mutants due to chronic G-CSF therapy to reverse the severe neutropenia.	G-CSF	neutropenia	1440	HP_0001875	151	156	187	198	False
29339836	The discovery of mutations in genes encoding the metabolic enzymes isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), and fumarate hydratase (FH) has expanded our understanding not only of altered metabolic pathways but also epigenetic dysregulation in cancer.	SDH	cancer	1757	HP_0002664	124	127	265	271	False
29339836	In contrast, SDH and FH act as tumor suppressors and genomic inactivation results in succinate and fumarate accumulation, respectively.	SDH	tumor	1757	HP_0002664	13	16	31	36	False
29339836	SDH deficiency may result from germline SDHA, SDHB, SDHC, or SDHD mutations and is found in autosomal-dominant familial paraganglioma/pheochromocytoma and Carney-Stratakis syndrome, describing the combination of paraganglioma and gastrointestinal stromal tumor (GIST).	SDH	tumor	1757	HP_0002664	0	3	255	260	False
29339836	SDH deficiency may result from germline SDHA, SDHB, SDHC, or SDHD mutations and is found in autosomal-dominant familial paraganglioma/pheochromocytoma and Carney-Stratakis syndrome, describing the combination of paraganglioma and gastrointestinal stromal tumor (GIST).	SDH	pheochromocytoma	1757	HP_0002666	0	3	134	150	False
29339836	SDH deficiency may result from germline SDHA, SDHB, SDHC, or SDHD mutations and is found in autosomal-dominant familial paraganglioma/pheochromocytoma and Carney-Stratakis syndrome, describing the combination of paraganglioma and gastrointestinal stromal tumor (GIST).	SDH	paraganglioma	1757	HP_0002668	0	3	120	133	False
29339836	In contrast, patients with the non-hereditary Carney triad, including paraganglioma, GIST, and pulmonary chondroma, usually lack germline SDH mutations and instead show epigenetic SDH complex inactivation through SDHC promoter methylation.	SDH	paraganglioma	1757	HP_0002668	138	141	70	83	False
29339836	In contrast, patients with the non-hereditary Carney triad, including paraganglioma, GIST, and pulmonary chondroma, usually lack germline SDH mutations and instead show epigenetic SDH complex inactivation through SDHC promoter methylation.	SDH	pulmonary chondroma	1757	HP_0031474	138	141	95	114	False
29336840	Biallelic loss-of-function mutations in TYROBP and TREM2 cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL).	TYROBP	frontotemporal dementia	7305	HP_0002145	40	46	105	128	False
29336840	Biallelic loss-of-function mutations in TYROBP and TREM2 cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL).	TREM2	frontotemporal dementia	54209	HP_0002145	51	56	105	128	True
29336840	Biallelic loss-of-function mutations in TYROBP and TREM2 cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL).	PLOSL	frontotemporal dementia	7305	HP_0002145	232	237	105	128	False
29336840	Biallelic loss-of-function mutations in TYROBP and TREM2 cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL).	TYROBP	leukoencephalopathy	7305	HP_0002352	40	46	211	230	True
29336840	Biallelic loss-of-function mutations in TYROBP and TREM2 cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL).	TREM2	leukoencephalopathy	54209	HP_0002352	51	56	211	230	False
29336840	Biallelic loss-of-function mutations in TYROBP and TREM2 cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL).	PLOSL	leukoencephalopathy	7305	HP_0002352	232	237	211	230	True
29307790	The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).	HUWE1	intellectual disability	10075	HP_0001249	178	183	153	176	True
29307790	The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).	GRIN1	intellectual disability	114787	HP_0001249	185	190	153	176	False
29307790	The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).	EFTUD2	intellectual disability	9343	HP_0001249	267	273	153	176	True
29307790	The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).	HUWE1	mandibulofacial dysostosis	10075	HP_0005321	178	183	221	247	False
29307790	The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).	GRIN1	mandibulofacial dysostosis	114787	HP_0005321	185	190	221	247	False
29307790	The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).	EFTUD2	mandibulofacial dysostosis	9343	HP_0005321	267	273	221	247	True
29307790	The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).	HUWE1	microcephaly	10075	HP_0000252	178	183	253	265	False
29307790	The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).	GRIN1	microcephaly	114787	HP_0000252	185	190	253	265	False
29307790	The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, GRIN1), including a gene coding for mandibulofacial dysostosis with microcephaly (EFTUD2).	EFTUD2	microcephaly	9343	HP_0000252	267	273	253	265	True
29307790	Based on our findings we conclude that for new patients with Kabuki-like phenotypes it is possible to choose a specific molecular testing approach that has the highest detection rate for a given MLL2-Kabuki score, thus fostering more precise patient diagnosis and improved management in these genetically- and phenotypically heterogeneous clinical entities	MLL2	heterogeneous	9757	HP_0001425	195	199	325	338	False
27485409	3-Methylglutaconic aciduria is associated with variants in genes encoding mitochondrial inner membrane organizing determinants, including TAZ, DNAJC19, SERAC1 and QIL1/MIC13	TAZ	mitochondrial	25937	HP_0001427	138	141	74	87	False
27485409	3-Methylglutaconic aciduria is associated with variants in genes encoding mitochondrial inner membrane organizing determinants, including TAZ, DNAJC19, SERAC1 and QIL1/MIC13	DNAJC19	mitochondrial	131118	HP_0001427	143	150	74	87	False
27485409	3-Methylglutaconic aciduria is associated with variants in genes encoding mitochondrial inner membrane organizing determinants, including TAZ, DNAJC19, SERAC1 and QIL1/MIC13	SERAC1	mitochondrial	84947	HP_0001427	152	158	74	87	False
23257780	Here, we show that ethanol treatment (100 mM) promotes ROS production and oxidative stress in cancer-associated fibroblasts, which is sufficient to induce myofibroblastic differentiation.	ROS	cancer	6098	HP_0002664	55	58	94	100	False
23257780	Remarkably, our results also show that antioxidants [such as N-acetyl cysteine (NAC)] can effectively reverse or prevent ethanol-induced oxidative stress in cancer-associated fibroblasts, suggesting a novel strategy for cancer prevention.	NAC	cancer	22861	HP_0002664	80	83	157	163	True
28334751	To this end, we generated a set of melanoma and neuroblastoma cell lines stably overexpressing wild-type (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against ATP13A2.	type	melanoma	6445	HP_0002861	100	104	35	43	False
28334751	To this end, we generated a set of melanoma and neuroblastoma cell lines stably overexpressing wild-type (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against ATP13A2.	ATP13A2	melanoma	23400	HP_0002861	183	190	35	43	False
28334751	To this end, we generated a set of melanoma and neuroblastoma cell lines stably overexpressing wild-type (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against ATP13A2.	end	melanoma	2022	HP_0002861	8	11	35	43	False
28334751	To this end, we generated a set of melanoma and neuroblastoma cell lines stably overexpressing wild-type (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against ATP13A2.	type	neuroblastoma	6445	HP_0003006	100	104	48	61	False
28334751	To this end, we generated a set of melanoma and neuroblastoma cell lines stably overexpressing wild-type (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against ATP13A2.	ATP13A2	neuroblastoma	23400	HP_0003006	183	190	48	61	False
28334751	To this end, we generated a set of melanoma and neuroblastoma cell lines stably overexpressing wild-type (WT), catalytically inactive (D508N) and N-terminal mutants, or shRNA against ATP13A2.	end	neuroblastoma	2022	HP_0003006	8	11	48	61	False
30262382	Of the included 24 CNS patients with hemangioblastoma (14 intracranial and 10 spinal hemangioblastomas), 5 patients (20.8%) were diagnosed with Von Hippel-Lindau disease (VHL).	VHL	hemangioblastoma	7428	HP_0010797	171	174	37	53	True
29559740	After exclusive analysis of 10 common variations of three hearing loss-related genes, GJB2, mtDNA12srRNA and SLC26A4, a novel truncated variant of SMPX, c.87dupA (p.Gly30Argfs*12) (NCBI ClinVar Submission ID: SUB3136126), was identified by whole-exome sequencing.	GJB2	hearing loss	2706	HP_0000365	86	90	58	70	True
29559740	After exclusive analysis of 10 common variations of three hearing loss-related genes, GJB2, mtDNA12srRNA and SLC26A4, a novel truncated variant of SMPX, c.87dupA (p.Gly30Argfs*12) (NCBI ClinVar Submission ID: SUB3136126), was identified by whole-exome sequencing.	SLC26A4	hearing loss	5172	HP_0000365	109	116	58	70	True
29559740	After exclusive analysis of 10 common variations of three hearing loss-related genes, GJB2, mtDNA12srRNA and SLC26A4, a novel truncated variant of SMPX, c.87dupA (p.Gly30Argfs*12) (NCBI ClinVar Submission ID: SUB3136126), was identified by whole-exome sequencing.	SMPX	hearing loss	23676	HP_0000365	147	151	58	70	True
30579095	In order to investigate essential molecular causes for hearing loss and mutation frequency of deafness-related genes, 1315 newborns who did not pass the Newborn Hearing Screening (NHS) (audio-no-pass) and 1000 random-selected infants were subjected to detection for 101 hotspot mutations in 18 common deafness-related genes.	NHS	hearing loss	4810	HP_0000365	180	183	55	67	False
30579095	In order to investigate essential molecular causes for hearing loss and mutation frequency of deafness-related genes, 1315 newborns who did not pass the Newborn Hearing Screening (NHS) (audio-no-pass) and 1000 random-selected infants were subjected to detection for 101 hotspot mutations in 18 common deafness-related genes.	NHS	deafness	4810	HP_0000365	180	183	94	102	False
30579095	Of the genes detected out, GJB2 gene mutation was with significant difference (<sup>2</sup>=75.132, p=0.000) between audio-no-pass group (417/1315, 31.711%) and random-selected cohort (159/1000, 15.900%); c.109G&gt;A was the most common allele, as well as the only one with significantly different allele frequency (<sup>2</sup>=79.327, p=0.000) between audio-no-pass group (392/1315, 16.84%) and random-selected cohort (140/1000, 7.55%), which suggested c.109G&gt;A mutation was critical for newborns' hearing loss.	GJB2	hearing loss	2706	HP_0000365	27	31	517	529	True
28386563	The purpose of this study was to investigate whether LED light at different wavelengths affects the expression profile of 143 cancer predisposition genes in both diabetic and normal human fibroblasts.	light	cancer	8740	HP_0002664	57	62	126	132	False
28386563	The purpose of this study was to investigate whether LED light at different wavelengths affects the expression profile of 143 cancer predisposition genes in both diabetic and normal human fibroblasts.	red	cancer	8444	HP_0002664	134	137	126	132	False
30005966	We used bivariate and multivariate analyses to examine the variations in the rates of TMA complications according to sex, age, race, and comorbid conditions, including nonpalpable pedal pulses, end-stage renal disease, coronary artery disease, hypertension, smoking status, and preoperative albumin &lt;3.5mg/dL.	sex	hypertension	55558	HP_0000822	117	120	244	256	False
30005966	We used bivariate and multivariate analyses to examine the variations in the rates of TMA complications according to sex, age, race, and comorbid conditions, including nonpalpable pedal pulses, end-stage renal disease, coronary artery disease, hypertension, smoking status, and preoperative albumin &lt;3.5mg/dL.	race	hypertension	23600	HP_0000822	127	131	244	256	False
26854714	Further in vitro and in vivo results demonstrated that ALDOA was associated with proliferation and metastasis of pancreatic cancer cells.	ALDOA	cancer	226	HP_0002664	55	60	124	130	False
26854714	Moreover, ALDOA predicted poor prognosis of pancreatic cancer, partially due to its role in E-cadherin expression regulation, and the results were further validated by analysis of the correlation between ALDOA and E-cadherin expression in pancreatic cancer tissue samples.	ALDOA	cancer	226	HP_0002664	10	15	55	61	False
26854714	Mechanistically, the role of ALDOA in pancreatic cancer might attribute to its regulation of c-Myc, HIF1 and NRF2 (Nuclear Factor, Erythroid 2-Like 2), which were key regulators of glycolysis and antioxidant response control.	ALDOA	cancer	226	HP_0002664	29	34	49	55	False
26854714	Mechanistically, the role of ALDOA in pancreatic cancer might attribute to its regulation of c-Myc, HIF1 and NRF2 (Nuclear Factor, Erythroid 2-Like 2), which were key regulators of glycolysis and antioxidant response control.	c-Myc	cancer	4609	HP_0002664	93	98	49	55	True
26854714	Mechanistically, the role of ALDOA in pancreatic cancer might attribute to its regulation of c-Myc, HIF1 and NRF2 (Nuclear Factor, Erythroid 2-Like 2), which were key regulators of glycolysis and antioxidant response control.	NRF2	cancer	2551	HP_0002664	110	114	49	55	False
29742560	Keratitis-ichthyosis-deafness (KID) syndrome is a rare genodermatosis that typically results from mutations of the GJB2 gene or, less commonly, the GJB6 gene.	KID	deafness	3835	HP_0000365	31	34	21	29	False
29742560	Keratitis-ichthyosis-deafness (KID) syndrome is a rare genodermatosis that typically results from mutations of the GJB2 gene or, less commonly, the GJB6 gene.	GJB2	deafness	2706	HP_0000365	115	119	21	29	True
29742560	Keratitis-ichthyosis-deafness (KID) syndrome is a rare genodermatosis that typically results from mutations of the GJB2 gene or, less commonly, the GJB6 gene.	GJB6	deafness	10804	HP_0000365	148	152	21	29	True
29742560	Given that patients with KID syndrome are at high risk of developing squamous cell carcinoma, biopsies were performed.	KID	squamous cell carcinoma	3835	HP_0002860	25	28	69	92	False
29879625	MicroRNAs (miRNAs) are identified as key regulators in cancer initiation, progression and metastasis including gastric cancer (GC).	miR	cancer	220972	HP_0002664	11	14	55	61	False
29879625	Furthermore, lower miR-129-5p expression closely associated with tumor size and lymph node invasion and poor prognosis of GC patients.	miR	tumor	220972	HP_0002664	19	22	65	70	False
29879625	In vivo, upregulation of miR-129-5p also inhibited tumor growth.	miR	tumor	220972	HP_0002664	25	28	51	56	False
29879625	Therefore, these results indicated that miR-129-5p functioned as a tumor suppressor in GC and may be a potential target of GC treatment	miR	tumor	220972	HP_0002664	40	43	67	72	False
28938437	Recent studies indicate that such scarring has a high female propensity; females are also almost exclusively affected by endometriosis, a common sex steroid-dependent fibrotic disease.	sex	endometriosis	55558	HP_0030127	145	148	121	134	False
28938437	In response to surgical induction of endometriosis, Klf11-/- female mice develop significant fibrosis in contrast to wild-type mice.	Klf11	endometriosis	8462	HP_0030127	52	57	37	50	False
28938437	In response to surgical induction of endometriosis, Klf11-/- female mice develop significant fibrosis in contrast to wild-type mice.	mice	endometriosis	23581	HP_0030127	68	72	37	50	False
30627128	Chronic mucocutaneous candidiasis (CMC) occurs in patients with mutations in genes affecting IL-17-mediated immunity, such as <i>STAT3, AIRE, RORC, CARD9, IL12B</i>, and <i>IL12RB1</i>, or gain of function (GOF) mutations in <i>STAT1</i>.	IL-17	mucocutaneous candidiasis	3605	HP_0002728	93	98	8	33	False
30627128	Chronic mucocutaneous candidiasis (CMC) occurs in patients with mutations in genes affecting IL-17-mediated immunity, such as <i>STAT3, AIRE, RORC, CARD9, IL12B</i>, and <i>IL12RB1</i>, or gain of function (GOF) mutations in <i>STAT1</i>.	AIRE	mucocutaneous candidiasis	326	HP_0002728	136	140	8	33	True
30627128	Chronic mucocutaneous candidiasis (CMC) occurs in patients with mutations in genes affecting IL-17-mediated immunity, such as <i>STAT3, AIRE, RORC, CARD9, IL12B</i>, and <i>IL12RB1</i>, or gain of function (GOF) mutations in <i>STAT1</i>.	RORC	mucocutaneous candidiasis	6097	HP_0002728	142	146	8	33	False
30627128	Chronic mucocutaneous candidiasis (CMC) occurs in patients with mutations in genes affecting IL-17-mediated immunity, such as <i>STAT3, AIRE, RORC, CARD9, IL12B</i>, and <i>IL12RB1</i>, or gain of function (GOF) mutations in <i>STAT1</i>.	CARD9	mucocutaneous candidiasis	64170	HP_0002728	148	153	8	33	True
28774369	In this case report, a 14-month-old boy had the clinical manifestations of delayed development, unusual facies (prominent forehead, midface retraction, hypertelorism, low-set ears, upturned nose, and micrognathia), and multiple congenital malformations (including cerebral dysplasia, dislocation of the hip joint, and cryptorchidism).	hip	unusual facies	64399	HP_0001999	303	306	96	110	False
28774369	In this case report, a 14-month-old boy had the clinical manifestations of delayed development, unusual facies (prominent forehead, midface retraction, hypertelorism, low-set ears, upturned nose, and micrognathia), and multiple congenital malformations (including cerebral dysplasia, dislocation of the hip joint, and cryptorchidism).	hip	hypertelorism	64399	HP_0000316	303	306	152	165	False
28774369	In this case report, a 14-month-old boy had the clinical manifestations of delayed development, unusual facies (prominent forehead, midface retraction, hypertelorism, low-set ears, upturned nose, and micrognathia), and multiple congenital malformations (including cerebral dysplasia, dislocation of the hip joint, and cryptorchidism).	hip	low-set ears	64399	HP_0000369	303	306	167	179	False
28774369	In this case report, a 14-month-old boy had the clinical manifestations of delayed development, unusual facies (prominent forehead, midface retraction, hypertelorism, low-set ears, upturned nose, and micrognathia), and multiple congenital malformations (including cerebral dysplasia, dislocation of the hip joint, and cryptorchidism).	hip	micrognathia	64399	HP_0000347	303	306	200	212	False
21734151	We identify ZC3H14 mRNA transcripts in the human central nervous system, and we find that rodent ZC3H14 protein is expressed in hippocampal neurons and colocalizes with poly(A) RNA in neuronal cell bodies.	find	central	81501	HP_0030645	80	84	49	56	False
26725848	While a distinct set of processes drive metastasis when compared to tumorigenesis, it is yet unclear if genetic alterations in metabolic pathways are associated with metastatic progression of human cancers.	set	cancer	6418	HP_0002664	17	20	198	204	False
26725848	While a distinct set of processes drive metastasis when compared to tumorigenesis, it is yet unclear if genetic alterations in metabolic pathways are associated with metastatic progression of human cancers.	set	tumor	6418	HP_0002664	17	20	68	73	False
26725848	Here, we analyzed the mutation, copy number variation and gene expression patterns of a literature-derived model of metabolic genes associated with glycolysis (Warburg effect), fatty acid metabolism (lipogenesis, oxidation, lipolysis, esterification) and fatty acid uptake in &gt;9000 primary or metastatic tumor samples from the multi-cancer TCGA datasets.	set	cancer	6418	HP_0002664	352	355	336	342	False
26725848	Here, we analyzed the mutation, copy number variation and gene expression patterns of a literature-derived model of metabolic genes associated with glycolysis (Warburg effect), fatty acid metabolism (lipogenesis, oxidation, lipolysis, esterification) and fatty acid uptake in &gt;9000 primary or metastatic tumor samples from the multi-cancer TCGA datasets.	set	tumor	6418	HP_0002664	352	355	307	312	False
26725848	Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all tumor types, while copy number alterations in the electron transport chain gene SCO2, fatty acid uptake (CAV1, CD36) and lipogenesis (PPARA, PPARD, MLXIPL) genes were enriched in metastatic tumors.	SCO2	tumor	9997	HP_0002664	193	197	113	118	False
26725848	Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all tumor types, while copy number alterations in the electron transport chain gene SCO2, fatty acid uptake (CAV1, CD36) and lipogenesis (PPARA, PPARD, MLXIPL) genes were enriched in metastatic tumors.	CAV1	tumor	857	HP_0002664	218	222	113	118	False
26725848	Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all tumor types, while copy number alterations in the electron transport chain gene SCO2, fatty acid uptake (CAV1, CD36) and lipogenesis (PPARA, PPARD, MLXIPL) genes were enriched in metastatic tumors.	PPARA	tumor	5465	HP_0002664	247	252	113	118	False
26725848	Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all tumor types, while copy number alterations in the electron transport chain gene SCO2, fatty acid uptake (CAV1, CD36) and lipogenesis (PPARA, PPARD, MLXIPL) genes were enriched in metastatic tumors.	PPARD	tumor	5467	HP_0002664	254	259	113	118	False
26725848	Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all tumor types, while copy number alterations in the electron transport chain gene SCO2, fatty acid uptake (CAV1, CD36) and lipogenesis (PPARA, PPARD, MLXIPL) genes were enriched in metastatic tumors.	MLXIPL	tumor	51085	HP_0002664	261	267	113	118	False
26725848	Using gene expression profiles, we established a gene-signature (CAV1, CD36, MLXIPL, CPT1C, CYP2E1) that strongly associated with epithelial-mesenchymal program across multiple cancers.	CAV1	cancer	857	HP_0002664	65	69	177	183	False
26725848	Using gene expression profiles, we established a gene-signature (CAV1, CD36, MLXIPL, CPT1C, CYP2E1) that strongly associated with epithelial-mesenchymal program across multiple cancers.	MLXIPL	cancer	51085	HP_0002664	77	83	177	183	False
26725848	Using gene expression profiles, we established a gene-signature (CAV1, CD36, MLXIPL, CPT1C, CYP2E1) that strongly associated with epithelial-mesenchymal program across multiple cancers.	CPT1C	cancer	126129	HP_0002664	85	90	177	183	False
26725848	Using gene expression profiles, we established a gene-signature (CAV1, CD36, MLXIPL, CPT1C, CYP2E1) that strongly associated with epithelial-mesenchymal program across multiple cancers.	CYP2E1	cancer	1571	HP_0002664	92	98	177	183	False
26645154	On comparing Nesprin-2 and BRCA1 localization in the ovarian cancer cell lines SKOV-3 and Caov-3, Nesprin-2 and BRCA1 were localized to the NE envelope and the nucleus in SKOV-3, respectively, and to the cytoplasm in Caov-3 cells.	Nesprin-2	cancer	23224	HP_0002664	13	22	61	67	False
26645154	On comparing Nesprin-2 and BRCA1 localization in the ovarian cancer cell lines SKOV-3 and Caov-3, Nesprin-2 and BRCA1 were localized to the NE envelope and the nucleus in SKOV-3, respectively, and to the cytoplasm in Caov-3 cells.	BRCA1	cancer	672	HP_0002664	27	32	61	67	True
28678825	High mobility group box 3 (HMGB3), a member of the high-mobility group box (HMGB) family, was reported to be over-expressed in gastric carcinoma and bladder cancer.	HMGB3	cancer	3149	HP_0002664	27	32	157	163	False
28678825	qRT-PCR results showed that high expression of HMGB3 had positive correlation with serosal invasion, lymph metastasis, and tumor-node-metastasis (TNM) stage in CRC patient.	HMGB3	tumor	3149	HP_0002664	47	52	123	128	False
28678825	qRT-PCR results showed that high expression of HMGB3 had positive correlation with serosal invasion, lymph metastasis, and tumor-node-metastasis (TNM) stage in CRC patient.	TNM	tumor	10178	HP_0002664	146	149	123	128	False
28883096	Mutations affecting human COG1, COG2 and COG4-COG8 cause monogenic forms of inherited, autosomal recessive CDGs.	CDGs	autosomal recessive	5373	HP_0000007	107	111	87	106	True
28883096	Mutations affecting human COG1, COG2 and COG4-COG8 cause monogenic forms of inherited, autosomal recessive CDGs.	COG1	autosomal recessive	9382	HP_0000007	26	30	87	106	True
28883096	Mutations affecting human COG1, COG2 and COG4-COG8 cause monogenic forms of inherited, autosomal recessive CDGs.	COG2	autosomal recessive	22796	HP_0000007	32	36	87	106	True
28883096	Mutations affecting human COG1, COG2 and COG4-COG8 cause monogenic forms of inherited, autosomal recessive CDGs.	COG4	autosomal recessive	25839	HP_0000007	41	45	87	106	True
28883096	Mutations affecting human COG1, COG2 and COG4-COG8 cause monogenic forms of inherited, autosomal recessive CDGs.	COG8	autosomal recessive	84342	HP_0000007	46	50	87	106	True
24916641	A hypomorphic variant in CCDC22 was previously reported in association with a familial case of syndromic X-linked intellectual disability, which shows phenotypic overlap with RSS/3C syndrome.	CCDC22	intellectual disability	28952	HP_0001249	25	31	114	137	True
30513714	Participants were assessed for cognitive performance (Cogstate battery), dietary selenium intake (two 24-h food recalls), plasma selenium concentration, inflammatory markers (interleukin (IL)-6, -8, -10, tumor necrosis factor-alpha and adiponectin) and neurotrophic factors (brain-derived neurotrophic factor, vascular endothelial growth factor and insulin-like growth factor 1).	adiponectin	tumor	9370	HP_0002664	236	247	204	209	False
30513714	Multiple linear regression analysis revealed that plasma selenium was not associated with cognitive performance, inflammatory markers nor neurotrophic factors, independent of age, sex, body mass index (BMI), habitual physical activity, <i>APOE</i> status, education, and history of cardiovascular disease.	sex	cardiovascular disease	55558	HP_0001626	180	183	282	304	False
30513714	Multiple linear regression analysis revealed that plasma selenium was not associated with cognitive performance, inflammatory markers nor neurotrophic factors, independent of age, sex, body mass index (BMI), habitual physical activity, <i>APOE</i> status, education, and history of cardiovascular disease.	mass	cardiovascular disease	2200	HP_0001626	190	194	282	304	True
28672880	Importantly, cardiac ANKRD1 has been shown to be highly induced in various cardiomyopathies and in heart failure, although it is still unclear what impact this may have on the pathophysiology of heart failure.	ANKRD1	heart failure	27063	HP_0001635	21	27	99	112	False
28672880	Importantly, cardiac ANKRD1 has been shown to be highly induced in various cardiomyopathies and in heart failure, although it is still unclear what impact this may have on the pathophysiology of heart failure.	impact	heart failure	55364	HP_0001635	148	154	99	112	False
28040546	Small-cell gallbladder neuroendocrine carcinoma (GB-SCNEC) is a relatively rare histological type of gallbladder cancer, and the genomic landscape of GB-SCNEC is rarely considered in treatment decisions.	type	cancer	6445	HP_0002664	93	97	113	119	False
28444220	While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, ATXN2, ATXN3, ATXN7, CACNA1A and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.	ATXN1	ataxias	6310	HP_0001251	78	83	20	27	True
28444220	While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, ATXN2, ATXN3, ATXN7, CACNA1A and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.	ATXN2	ataxias	6311	HP_0001251	85	90	20	27	True
28444220	While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, ATXN2, ATXN3, ATXN7, CACNA1A and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.	ATXN3	ataxias	4287	HP_0001251	92	97	20	27	True
28444220	While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, ATXN2, ATXN3, ATXN7, CACNA1A and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.	ATXN7	ataxias	6314	HP_0001251	99	104	20	27	True
28444220	While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, ATXN2, ATXN3, ATXN7, CACNA1A and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.	CACNA1A	ataxias	773	HP_0001251	106	113	20	27	True
28444220	While polyglutamine ataxias, linked to CAG repeat expansions in genes such as ATXN1, ATXN2, ATXN3, ATXN7, CACNA1A and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.	TBP	ataxias	6908	HP_0001251	118	121	20	27	True
28444220	Clinical comparisons showed that ataxias due to channelopathies had a significantly earlier age at onset with an average of 24.6 years, versus 40.9 years for polyglutamine expansion spinocerebellar ataxias and 37.8 years for SPG7-related forms (P = 0.001).	SPG7	ataxias	6687	HP_0001251	225	229	33	40	True
28444220	Similar differences were found among a single gene group, comparing 23 patients with CACNA1A expansions (spinocerebellar ataxia 6) to 22 patients with CACNA1A point mutations, which had lower average age at onset (25.2 versus 47.3 years) with longer disease duration (18.7 versus 10.9), but lower severity indexes (0.39 versus 0.44), indicating slower progression of the disease.	CACNA1A	ataxia	773	HP_0001251	85	92	121	127	True
28444220	In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar ataxias, and confirmed CACNA1A and SPG7 as major ataxia genes.	CACNA1A	ataxias	773	HP_0001251	161	168	138	145	True
28444220	In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar ataxias, and confirmed CACNA1A and SPG7 as major ataxia genes.	SPG7	ataxias	6687	HP_0001251	173	177	138	145	True
28444220	In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar ataxias, and confirmed CACNA1A and SPG7 as major ataxia genes.	CACNA1A	ataxia	773	HP_0001251	161	168	187	193	True
28444220	In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar ataxias, and confirmed CACNA1A and SPG7 as major ataxia genes.	SPG7	ataxia	6687	HP_0001251	173	177	187	193	True
24035971	Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without MYCN amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.	MYCN	neuroblastoma	4613	HP_0003006	242	246	220	233	False
24035971	Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without MYCN amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.	MYCN	trigonocephaly	4613	HP_0000243	242	246	57	71	False
24035971	Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without MYCN amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.	MYCN	hypotelorism	4613	HP_0000601	242	246	114	126	False
24035971	Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without MYCN amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.	MYCN	micrognathia	4613	HP_0000347	242	246	158	170	True
24035971	Hereby, we describe a 18 months old girl presenting with trigonocephaly and dysmorphic facial features, including hypotelorism, broad depressed nasal bridge, micrognathia, synophrys, epicanthal folds, and with a stage 4 neuroblastoma without MYCN amplification, carrying a germline 11q deletion (11q14.1-q22.3), outside from Jacobsen syndrome and from neuroblastoma 11q critical regions.	MYCN	epicanthal folds	4613	HP_0000286	242	246	183	199	True
29880681	Similar to the human phenotype, <i>Lima1</i>-deficient mice displayed reduced cholesterol absorption and were resistant to diet-induced hypercholesterolemia.	Lima1	hypercholesterolemia	51474	HP_0003124	35	40	136	156	False
29880681	Similar to the human phenotype, <i>Lima1</i>-deficient mice displayed reduced cholesterol absorption and were resistant to diet-induced hypercholesterolemia.	mice	hypercholesterolemia	23581	HP_0003124	55	59	136	156	False
27373049	TCS has a variable phenotype with typical clinical characteristics including downward-slant of palpebral fissure, malar hypoplasia, mandibular hypoplasia and microtia.	TCS	malar hypoplasia	6949	HP_0000272	0	3	114	130	True
27373049	TCS has a variable phenotype with typical clinical characteristics including downward-slant of palpebral fissure, malar hypoplasia, mandibular hypoplasia and microtia.	TCS	mandibular hypoplasia	6949	HP_0000347	0	3	132	153	True
27373049	TCS has a variable phenotype with typical clinical characteristics including downward-slant of palpebral fissure, malar hypoplasia, mandibular hypoplasia and microtia.	TCS	microtia	6949	HP_0008551	0	3	158	166	True
29626191	Neurofibromatosis type 2 (NF2) is a tumor-forming disease of the nervous system caused by deletion or by loss-of-function mutations in NF2, encoding the tumor suppressing protein neurofibromin 2 (also known as schwannomin or merlin).	type	tumor	6445	HP_0002664	18	22	36	41	False
29626191	Neurofibromatosis type 2 (NF2) is a tumor-forming disease of the nervous system caused by deletion or by loss-of-function mutations in NF2, encoding the tumor suppressing protein neurofibromin 2 (also known as schwannomin or merlin).	merlin	tumor	4771	HP_0002664	225	231	36	41	True
29626191	The correlation of the tumor-suppressive function and conformation (open or closed) of neurofibromin 2 has been subject to much speculation, often based on extrapolation from other ERM proteins, and controversy.	ERM	tumor	2119	HP_0002664	181	184	23	28	False
28901661	Mutations in the D40/KNL1/CASC5 gene, which was initially characterized as a gene involved in chromosomal translocation in leukemia and as a member of the cancer/testis gene family, was later found to encode a kinetochore protein essential for mitotic cell division and to cause MCPH4.	MCPH4	cancer	22995	HP_0002664	279	284	155	161	False
27292112	Mutations of FIG4 result in the inherited disorders Charcot-Marie-Tooth disease type 4J, Yunis-Varn syndrome, and polymicrogyria with seizures.	FIG4	seizures	9896	HP_0001250	13	17	135	143	True
27292112	Mutations of FIG4 result in the inherited disorders Charcot-Marie-Tooth disease type 4J, Yunis-Varn syndrome, and polymicrogyria with seizures.	type	seizures	6445	HP_0001250	80	84	135	143	False
29944916	Both patients presented the cardinal features of the disease including microcephaly, congenital cataract and postnatal growth failure.	cardinal	microcephaly	22900	HP_0000252	28	36	71	83	False
29944916	Both patients presented the cardinal features of the disease including microcephaly, congenital cataract and postnatal growth failure.	cardinal	cataract	22900	HP_0000518	28	36	96	104	False
29944916	Both patients presented the cardinal features of the disease including microcephaly, congenital cataract and postnatal growth failure.	cardinal	postnatal growth failure	22900	HP_0008897	28	36	109	133	False
27216551	Spastic paraplegia (SPG) type 28 is an autosomal recessive SPG caused by mutations in the DDHD1 gene.	SPG	autosomal recessive	55764	HP_0000007	20	23	39	58	True
27216551	Spastic paraplegia (SPG) type 28 is an autosomal recessive SPG caused by mutations in the DDHD1 gene.	type	autosomal recessive	6445	HP_0000007	25	29	39	58	True
27216551	Spastic paraplegia (SPG) type 28 is an autosomal recessive SPG caused by mutations in the DDHD1 gene.	DDHD1	autosomal recessive	80821	HP_0000007	90	95	39	58	True
27216551	We examined a Japanese 54-years-old male patient with autosomal recessive SPG.	SPG	autosomal recessive	55764	HP_0000007	74	77	54	73	True
27216551	Through the examination of 48 candidate genes known to be responsible for autosomal recessive SPG, we identified a novel homozygous 4-bp deletion, c.914_917delGTAA, p.Ser305Ilefs*2 in exon2 of the DDHD1 gene encoding phosphatidic acid-preferring phospholipase A1 (PA-PLA1).	SPG	autosomal recessive	55764	HP_0000007	94	97	74	93	True
27216551	Through the examination of 48 candidate genes known to be responsible for autosomal recessive SPG, we identified a novel homozygous 4-bp deletion, c.914_917delGTAA, p.Ser305Ilefs*2 in exon2 of the DDHD1 gene encoding phosphatidic acid-preferring phospholipase A1 (PA-PLA1).	DDHD1	autosomal recessive	80821	HP_0000007	197	202	74	93	True
27216551	Through the examination of 48 candidate genes known to be responsible for autosomal recessive SPG, we identified a novel homozygous 4-bp deletion, c.914_917delGTAA, p.Ser305Ilefs*2 in exon2 of the DDHD1 gene encoding phosphatidic acid-preferring phospholipase A1 (PA-PLA1).	PA-PLA1	autosomal recessive	80821	HP_0000007	264	271	74	93	True
28446062	Insufficient signaling through one or more of these metabolite-sensing GPCRs likely contributes to human diseases such as asthma, food allergies, type 1 and type 2 diabetes, hepatic steatosis, cardiovascular disease, and inflammatory bowel diseases	type	steatosis	6445	HP_0001397	146	150	182	191	False
28446062	Insufficient signaling through one or more of these metabolite-sensing GPCRs likely contributes to human diseases such as asthma, food allergies, type 1 and type 2 diabetes, hepatic steatosis, cardiovascular disease, and inflammatory bowel diseases	type	cardiovascular disease	6445	HP_0001626	146	150	193	215	True
29534959	Single large-scale mitochondrial DNA deletions disorders are classified into three main phenotypes with frequent clinical overlap: Pearson marrow-pancreas syndrome (PMS), Kearns-Sayre syndrome (KSS) and chronic progressive external ophtalmoplegia (PEO).	PMS	chronic	5933	HP_0011010	165	168	203	210	False
29534959	Single large-scale mitochondrial DNA deletions disorders are classified into three main phenotypes with frequent clinical overlap: Pearson marrow-pancreas syndrome (PMS), Kearns-Sayre syndrome (KSS) and chronic progressive external ophtalmoplegia (PEO).	PMS	progressive	5933	HP_0003676	165	168	211	222	False
26295479	The sterile alpha motif (SAM) domain of the protein ANKS6, a protein-protein interaction domain, is responsible for autosomal dominant polycystic kidney disease.	ANKS6	kidney disease	203286	HP_0000077	52	57	146	160	True
26841242	Patients with autosomal dominant vibratory urticaria have localized hives and systemic manifestations in response to dermal vibration, with coincident degranulation of mast cells and increased histamine levels in serum.	mast	urticaria	51324	HP_0001025	168	172	43	52	False
26841242	We identified a previously unknown missense substitution in ADGRE2 (also known as EMR2), which was predicted to result in the replacement of cysteine with tyrosine at amino acid position 492 (p.C492Y), as the only nonsynonymous variant cosegregating with vibratory urticaria in two large kindreds.	ADGRE2	urticaria	30817	HP_0001025	60	66	265	274	True
29240685	Instead, biallelic mutations have been associated with afibrinogenemia/severe hypofibrinogenemia, i.e., the severest forms of fibrinogen deficiency, affecting approximately 1-2 cases per million people.	per	hypofibrinogenemia	93210	HP_0011900	183	186	78	96	False
28915070	Primary ciliary dyskinesia (PCD) is a genetic disorder causing chronic oto-sino-pulmonary disease.	PCD	ciliary dyskinesia	352909	HP_0012265	28	31	8	26	True
28915070	Lastly, a syndromic form of PCD with retinal degeneration results in normal ciliary ultrastructure through mutations in the RPGR gene.	PCD	retinal degeneration	352909	HP_0000546	28	31	37	57	False
28915070	Lastly, a syndromic form of PCD with retinal degeneration results in normal ciliary ultrastructure through mutations in the RPGR gene.	RPGR	retinal degeneration	6103	HP_0000546	124	128	37	57	True
29408916	Constitutive activation of interferon signaling pathways has been reported in colorectal cancer (CRC), leading to a strong CD8+ T cell response through stimulation of NLRC5 expression.	NLRC5	cancer	84166	HP_0002664	167	172	89	95	False
29408916	Logistic regression analysis adjusted for age and gender reported a moderate association between rectal cancer risk and two NLRC5 SNPs, rs1684575 T&gt;G (OR: 1.60, 95% CI: 1.13-2.27, recessive model) and rs3751710 (OR: 0.70, 95% CI: 0.51-0.96, dominant model).	NLRC5	cancer	84166	HP_0002664	124	129	104	110	False
28803404	Single-gene variant analysis showed significant associations of the TT genotype of CYP1A1 and the rare GG genotype of ERCC2 with bladder cancer susceptibility (OR=1.34, 95% CI 1.22-1.40, P&lt;0.0001).	ERCC2	cancer	2068	HP_0002664	118	123	137	143	True
28803404	Single-gene variant analysis showed significant associations of the TT genotype of CYP1A1 and the rare GG genotype of ERCC2 with bladder cancer susceptibility (OR=1.34, 95% CI 1.22-1.40, P&lt;0.0001).	CYP1A1	cancer	1543	HP_0002664	83	89	137	143	False
29984231	All these findings implied the important roles of FBP1 expression in lung cancer development and progression and the potential use of the methylation status detected in FBP1 promoter region as a novel predictor for prognosis and therapeutic target for NSCLC patients	FBP1	cancer	2203	HP_0002664	50	54	74	80	False
30560086	Ectopically injected human cancer cell lines develop into tumors in SCID pigs, thus providing a human-sized <i>in vivo</i> model for evaluating imaging methods to improve cancer detection and therapeutic research and development.	pigs	cancer	94005	HP_0002664	73	77	27	33	False
30560086	Ectopically injected human cancer cell lines develop into tumors in SCID pigs, thus providing a human-sized <i>in vivo</i> model for evaluating imaging methods to improve cancer detection and therapeutic research and development.	pigs	tumors	94005	HP_0002664	73	77	58	64	False
30560086	Humanization of SCID pigs would thus provide a valuable model system for researchers to study interactions between human tumor and human immune cells.	pigs	tumor	94005	HP_0002664	21	25	121	126	False
21184099	Three affected individuals from a small Bedouin clan presented with failure to thrive, hyponatremic dehydration and hyperkalemia with isolated sweat salt wasting.	clan	failure to thrive	58484	HP_0001508	48	52	68	85	True
21184099	Three affected individuals from a small Bedouin clan presented with failure to thrive, hyponatremic dehydration and hyperkalemia with isolated sweat salt wasting.	clan	hyperkalemia	58484	HP_0002153	48	52	116	128	False
24252256	We present a young boy whose mild ataxia and abnormal eye movements repeatedly deteriorated with fever, making him unable to sit or walk during fever episodes.	sit	ataxia	55733	HP_0001251	125	128	34	40	False
24252256	We present a young boy whose mild ataxia and abnormal eye movements repeatedly deteriorated with fever, making him unable to sit or walk during fever episodes.	sit	abnormal eye movements	55733	HP_0000496	125	128	45	67	True
24252256	This family demonstrates phenotypic variability of FGF14 deletions (SCA 27), fever sensitivity of ataxia and the added value of SNP-array analysis in making a diagnosis	sit	ataxia	55733	HP_0001251	86	89	98	104	False
24252256	This family demonstrates phenotypic variability of FGF14 deletions (SCA 27), fever sensitivity of ataxia and the added value of SNP-array analysis in making a diagnosis	FGF14	ataxia	2259	HP_0001251	51	56	98	104	True
29927686	Late onset of clinical symptoms in hepatocellular carcinoma (HCC) results in late diagnosis and poor disease outcome.	HCC	hepatocellular carcinoma	84668	HP_0001402	61	64	35	59	False
29927686	We used the Illumina HumanMethylation450 BeadChip microarray to test whether white blood cell DNA, an easily accessible source of DNA, exhibits site-specific changes in DNA methylation in blood of diagnosed HCC patients (post-diagnostic, 24 cases, 24 controls) and in prospectively collected blood specimens of HCC patients who were cancer-free at blood collection (pre-diagnostic, 21 cases, 21 controls).	HCC	cancer	84668	HP_0002664	207	210	333	339	False
29927686	We established for the first time 9 probes that could distinguish HBV-negative cirrhotic patients who subsequently developed HCC from those who stayed cancer-free.	HCC	cancer	84668	HP_0002664	125	128	151	157	False
29314300	At surgery, the mass was located within the epineurium, could be bluntly dissected from the nerve fascicles, and was suspected to be a schwannoma.	mass	schwannoma	2200	HP_0100008	16	20	135	145	False
29314300	The tumor cells expressed MUC4, GLUT-1, and vimentin and were negative for S-100 protein, epithelial membrane antigen, smooth muscle actin, desmin, claudin-1, neurofilament and SOX10.	MUC4	tumor	4585	HP_0002664	26	30	4	9	False
29314300	Fluorescence in situ hybridization, with a break-apart probe strategy, demonstrated FUS rearrangement, consistent in this morphological context with the low-grade fibromyxoid sarcoma-associated FUS-CREB3L2 or FUS-CREB3L1 fusions.	FUS	sarcoma	2521	HP_0100242	84	87	175	182	False
30544479	To retrospectively analyze and quantitatively correlate UGT1A1 (bilirubin UDP- glucuronosyltransferase gene) genotypes and unconjugated hyperbilirubinemia (UCH) phenotypes among Chinese children.We retrospectively reviewed UCH patients, quantitatively analyzed genotype-phenotype correlation by comparing with healthy controls.	type	hyperbilirubinemia	6445	HP_0002904	113	117	136	154	False
30544479	Pfam database, SWISS-model, and Pymol were used for UGT1A1 protein domain analysis and protein modeling for assessing the effect of novel missense variants on protein structure.Seventy four cases, including 21 prolonged unconjugated hyperbilirubinemia (PUCH), 30 Gilbert syndrome (GS), 22 Crigler-Najjar syndrome type II (CNS-II), and 1 Crigler-Najjar syndrome type I (CNS-I) phenotypes were analyzed.	type	hyperbilirubinemia	6445	HP_0002904	313	317	233	251	False
28990958	The quality of care for LTC residents with COPD is heterogeneous in regard to both the facility and the patient.	COPD	heterogeneous	372	HP_0001425	43	47	51	64	False
27997051	Although AEBP1 immunoreactivity was almost absent in neurons containing neurofibrillary tangles, AEBP1 was highly expressed in neurons with pretangles and in the tau-immunopositive, dystrophic neurites of senile plaques.	AEBP1	neurofibrillary tangles	165	HP_0002185	9	14	72	95	False
27997051	Although AEBP1 immunoreactivity was almost absent in neurons containing neurofibrillary tangles, AEBP1 was highly expressed in neurons with pretangles and in the tau-immunopositive, dystrophic neurites of senile plaques.	tau	neurofibrillary tangles	4137	HP_0002185	162	165	72	95	True
29625811	The genetic testing revealed a de novo heterozygous mutation of c.2452G&gt;A (p.Glu818Lys) in the ATP1A3 gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.	ATP1A3	ataxia	478	HP_0001251	100	106	183	189	True
29625811	The genetic testing revealed a de novo heterozygous mutation of c.2452G&gt;A (p.Glu818Lys) in the ATP1A3 gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.	pes	ataxia	23481	HP_0001251	202	205	183	189	False
29625811	The genetic testing revealed a de novo heterozygous mutation of c.2452G&gt;A (p.Glu818Lys) in the ATP1A3 gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.	ATP1A3	optic atrophy	478	HP_0000648	100	106	213	226	True
29625811	The genetic testing revealed a de novo heterozygous mutation of c.2452G&gt;A (p.Glu818Lys) in the ATP1A3 gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.	pes	optic atrophy	23481	HP_0000648	202	205	213	226	False
29625811	The genetic testing revealed a de novo heterozygous mutation of c.2452G&gt;A (p.Glu818Lys) in the ATP1A3 gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.	ATP1A3	hearing loss	478	HP_0000365	100	106	246	258	True
29625811	The genetic testing revealed a de novo heterozygous mutation of c.2452G&gt;A (p.Glu818Lys) in the ATP1A3 gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.	pes	hearing loss	23481	HP_0000365	202	205	246	258	False
29625811	The genetic testing revealed a de novo heterozygous mutation of c.2452G&gt;A (p.Glu818Lys) in the ATP1A3 gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.	ATP1A3	areflexia	478	HP_0001284	100	106	191	200	True
29625811	The genetic testing revealed a de novo heterozygous mutation of c.2452G&gt;A (p.Glu818Lys) in the ATP1A3 gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.	pes	areflexia	23481	HP_0001284	202	205	191	200	False
27148972	LTBP4 was identified as a genetic modifier of muscular dystrophy in mice and humans.	mice	muscular dystrophy	23581	HP_0003560	68	72	46	64	False
27148972	LTBP4 was identified as a genetic modifier of muscular dystrophy in mice and humans.	LTBP4	muscular dystrophy	8425	HP_0003560	0	5	46	64	False
27148972	An in-frame insertion polymorphism in the murine Ltbp4 gene associates with partial protection against muscular dystrophy.	Ltbp4	muscular dystrophy	8425	HP_0003560	49	54	103	121	False
27148972	In humans, nonsynonymous single nucleotide polymorphisms in LTBP4 associate with prolonged ambulation in Duchenne muscular dystrophy.	LTBP4	muscular dystrophy	8425	HP_0003560	60	65	114	132	False
27148972	To better understand LTBP4 and its role in modifying muscular dystrophy, we created transgenic mice overexpressing the protective murine allele of LTBP4 specifically in mature myofibers using the human skeletal actin promoter.	mice	muscular dystrophy	23581	HP_0003560	95	99	53	71	False
27148972	To better understand LTBP4 and its role in modifying muscular dystrophy, we created transgenic mice overexpressing the protective murine allele of LTBP4 specifically in mature myofibers using the human skeletal actin promoter.	LTBP4	muscular dystrophy	8425	HP_0003560	21	26	53	71	False
27148972	In order to assess the effects of LTBP4 in muscular dystrophy, LTBP4 overexpressing mice were bred to mdx mice, a model of Duchenne muscular dystrophy.	mice	muscular dystrophy	23581	HP_0003560	84	88	43	61	False
27148972	In order to assess the effects of LTBP4 in muscular dystrophy, LTBP4 overexpressing mice were bred to mdx mice, a model of Duchenne muscular dystrophy.	LTBP4	muscular dystrophy	8425	HP_0003560	34	39	43	61	False
29016863	Our findings enlarge the spectrum of tubulinopathies and emphasize that mutations of TUBB6 should be considered in patients with congenital non-progressive facial palsy.	TUBB6	facial palsy	84617	HP_0010628	85	90	156	168	False
30015830	Direct sequencing revealed a G to T transition (c.886G&gt;T) in exon 9 of the fourpointone, ezrin, radixin, moesin domaincontaining 7 (FRMD7) gene, which resulted in a conservative substitution of glycine to cysteine at codon 296 (p.G296C), leading to idiopathic congenital nystagmus in the two affected brothers.	FRMD7	nystagmus	90167	HP_0000639	138	143	277	286	True
30015830	c.886G&gt;T is a novel idiopathic congenital nystagmusinducing mutation in the FRMD7 gene.	FRMD7	nystagmus	90167	HP_0000639	80	85	45	54	True
26077881	The findings in this study expand our understanding of SRPS locus heterogeneity and demonstrate the importance of DYNC2LI1 in dynein-2 complex stability, cilium function, Hedgehog regulation and skeletogenesis.	DYNC2LI1	heterogeneity	51626	HP_0001425	114	122	66	79	False
28346042	However, the prognostic value of ALDH5A1 in ovarian cancer remains unclear.	ALDH5A1	cancer	7915	HP_0002664	33	40	52	58	False
28346042	The aim of this study was to explore the relationship between ALDH5A1 and the prognosis of patients with ovarian cancer (OC).	ALDH5A1	cancer	7915	HP_0002664	62	69	113	119	False
28346042	In survival analyses, we found that ALDH5A1 was positively linked to prognosis in patients with OC, particularly in those with serous ovarian cancer (SOC).	ALDH5A1	cancer	7915	HP_0002664	36	43	142	148	False
28346042	In survival analyses, we found that ALDH5A1 was positively linked to prognosis in patients with OC, particularly in those with serous ovarian cancer (SOC).	SOC	cancer	91544	HP_0002664	150	153	142	148	False
28523428	The Glis3 mutant mice have been characterized for their propensity to develop congenital hypothyroidism, polycystic kidney disease, and some types of cancer.	Glis3	hypothyroidism	169792	HP_0000821	4	9	89	103	True
28523428	The Glis3 mutant mice have been characterized for their propensity to develop congenital hypothyroidism, polycystic kidney disease, and some types of cancer.	mice	hypothyroidism	23581	HP_0000821	17	21	89	103	False
28523428	The Glis3 mutant mice have been characterized for their propensity to develop congenital hypothyroidism, polycystic kidney disease, and some types of cancer.	Glis3	cancer	169792	HP_0002664	4	9	150	156	False
28523428	The Glis3 mutant mice have been characterized for their propensity to develop congenital hypothyroidism, polycystic kidney disease, and some types of cancer.	mice	cancer	23581	HP_0002664	17	21	150	156	False
27486776	Bardet-Biedl syndrome (BBS) is a defining ciliopathy, notable for extensive allelic and genetic heterogeneity, almost all of which has been identified through sequencing.	BBS	heterogeneity	583	HP_0001425	23	26	96	109	False
27753269	We describe three consanguineous Indian families with a distinct form of spondyloepiphyseal dysplasia (SED Omani type).	type	spondyloepiphyseal dysplasia	6445	HP_0002655	113	117	73	101	False
23932364	The Rb tumor suppressor gene performs a critical role in controlling cell proliferation and tumorigenesis; it recruits HDAC1 protein into the E2F complexes to repress transcription.	HDAC1	tumor	3065	HP_0002664	119	124	7	12	False
23932364	In this study, we demonstrate that SNIP1, RB and HDAC1 were significantly expressed in same lung cancer tissues in a tissue microarray (TMA) containing 300 non-small cell lung cancers (NSCLC).	HDAC1	cancer	3065	HP_0002664	49	54	97	103	False
23932364	In this study, we demonstrate that SNIP1, RB and HDAC1 were significantly expressed in same lung cancer tissues in a tissue microarray (TMA) containing 300 non-small cell lung cancers (NSCLC).	SNIP1	cancer	79753	HP_0002664	35	40	97	103	False
23932364	High expression level of SNIP1 in tumor patients was significantly correlated with poor prognosis in NSCLC (log-rank P for OS = 0.01, log-rank P for DFS = 0.001).	SNIP1	tumor	79753	HP_0002664	25	30	34	39	False
23932364	Knockdown of SNIP1 reduced colony formation ability of lung cancer cells.	SNIP1	cancer	79753	HP_0002664	13	18	60	66	False
23932364	These findings may indicate the involvement of SNIP1 in progression of lung cancer by regulating the RB/HDAC1 interaction	HDAC1	cancer	3065	HP_0002664	104	109	76	82	False
23932364	These findings may indicate the involvement of SNIP1 in progression of lung cancer by regulating the RB/HDAC1 interaction	SNIP1	cancer	79753	HP_0002664	47	52	76	82	False
22363784	Biallelic GIPC3 mutations have recently been reported to cause autosomal recessive nonsyndromic sensorineural hearing loss.	GIPC3	hearing loss	126326	HP_0000365	10	15	110	122	True
22363784	Thus we conclude that the hearing loss in the family described in this report is caused by a novel missense mutation in GIPC3.	GIPC3	hearing loss	126326	HP_0000365	120	125	26	38	True
29052317	Joubert syndrome exhibits genetic heterogeneity, with mutations identified in more than 30 genes, including INPP5E, a gene encoding inositol polyphosphate 5-phosphatase E, which is important in the development and stability of the primary cilium.	INPP5E	heterogeneity	23203	HP_0001425	108	114	34	47	False
30700765	In humans, recessive and dominant ALPL mutations cause hypophosphatasia (HPP), a metabolic bone disease with highly heterogeneous clinical manifestations, ranging from lethal perinatal hypomineralization to a relatively mild dental disease.	ALPL	heterogeneous	249	HP_0001425	34	38	116	129	False
24459086	WTX is also known as a tumor suppressor gene, and somatic mutations in that gene have been identified in Wilms tumors.	WTX	tumor	139285	HP_0002664	0	3	23	28	False
25333908	The trichorhinophalangeal syndrome is a rare genetic syndrome with characteristic craniofacial and skeletal abnormalities including hip pathology in variable manifestation.	hip	skeletal abnormalities	64399	HP_0000924	132	135	99	121	False
29881486	However autosomal recessive inheritance with mutation in the SLC34A2 gene is suspected	SLC34A2	autosomal recessive inheritance	10568	HP_0000007	61	68	8	39	True
28334780	Biallelic loss-of-function mutations in the RNA-binding protein EIF4A3 cause Richieri-Costa-Pereira syndrome (RCPS), an autosomal recessive condition mainly characterized by craniofacial and limb malformations.	EIF4A3	autosomal recessive	9775	HP_0000007	64	70	120	139	True
28334780	Eif4a3 haploinsufficient embryos presented altered mandibular process fusion and micrognathia, thus recapitulating the most penetrant phenotypes of the syndrome.	Eif4a3	micrognathia	9775	HP_0000347	0	6	81	93	True
27903752	Global gene expression profiling studies were carried out using cancer cells and surrogate tissues, such as whole blood and skin, to identify genes that are modulated by BET family proteins.	BET	cancer	92737	HP_0002664	170	173	64	70	False
27903752	Candidate markers were further characterized for concentration- and time-dependent responses to the BET inhibitor ABBV-075 in vitro and in vivo HEXIM1 was found to be the only gene that exhibited robust and consistent modulation by BET inhibitors across multiple cancer indications and surrogate tissues.	BET	cancer	92737	HP_0002664	100	103	263	269	False
27903752	Candidate markers were further characterized for concentration- and time-dependent responses to the BET inhibitor ABBV-075 in vitro and in vivo HEXIM1 was found to be the only gene that exhibited robust and consistent modulation by BET inhibitors across multiple cancer indications and surrogate tissues.	HEXIM1	cancer	10614	HP_0002664	144	150	263	269	False
27903752	Markers such as SERPINI1, ZCCHC24, and ZMYND8 were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.	BET	cancer	92737	HP_0002664	83	86	105	111	False
27903752	Markers such as SERPINI1, ZCCHC24, and ZMYND8 were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.	SERPINI1	cancer	5274	HP_0002664	16	24	105	111	False
27903752	Markers such as SERPINI1, ZCCHC24, and ZMYND8 were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.	ZCCHC24	cancer	219654	HP_0002664	26	33	105	111	False
27903752	Markers such as SERPINI1, ZCCHC24, and ZMYND8 were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.	ZMYND8	cancer	23613	HP_0002664	39	45	105	111	False
27903752	Markers such as SERPINI1, ZCCHC24, and ZMYND8 were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.	BET	tumors	92737	HP_0002664	83	86	137	143	False
27903752	Markers such as SERPINI1, ZCCHC24, and ZMYND8 were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.	SERPINI1	tumors	5274	HP_0002664	16	24	137	143	False
27903752	Markers such as SERPINI1, ZCCHC24, and ZMYND8 were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.	ZCCHC24	tumors	219654	HP_0002664	26	33	137	143	False
27903752	Markers such as SERPINI1, ZCCHC24, and ZMYND8 were modulated by ABBV-075 and other BET inhibitors across cancer cell lines and xenograft tumors but not in blood and skin.	ZMYND8	tumors	23613	HP_0002664	39	45	137	143	False
27903752	Significant downregulation of c-Myc, a well-publicized target of BET inhibitors, was largely restricted to hematologic cancer cell lines.	BET	cancer	92737	HP_0002664	65	68	119	125	False
27903752	Significant downregulation of c-Myc, a well-publicized target of BET inhibitors, was largely restricted to hematologic cancer cell lines.	c-Myc	cancer	4609	HP_0002664	30	35	119	125	True
27618447	We identified 30 new blood pressure- or hypertension-associated genetic regions in the general population, including 3 rare missense variants in RBM47, COL21A1 and RRAS with larger effects (&gt;1.5 mm Hg/allele) than common variants.	RBM47	hypertension	54502	HP_0000822	145	150	40	52	False
27618447	We identified 30 new blood pressure- or hypertension-associated genetic regions in the general population, including 3 rare missense variants in RBM47, COL21A1 and RRAS with larger effects (&gt;1.5 mm Hg/allele) than common variants.	COL21A1	hypertension	81578	HP_0000822	152	159	40	52	False
27618447	We identified 30 new blood pressure- or hypertension-associated genetic regions in the general population, including 3 rare missense variants in RBM47, COL21A1 and RRAS with larger effects (&gt;1.5 mm Hg/allele) than common variants.	RRAS	hypertension	6237	HP_0000822	164	168	40	52	False
27618447	Our data extend the spectrum of allelic variation underlying blood pressure traits and hypertension, provide new insights into the pathophysiology of hypertension and indicate new targets for clinical intervention	traits	hypertension	55929	HP_0000822	76	82	87	99	False
24888247	Polymorphisms in the genes encoding carbamoyl-phosphate synthase 1 (CPS1) and N-acetylglutamate synthase (NAGS) were recently reported to be risk factors for the development of hyperammonemia during valproic acid-based therapy.	CPS1	hyperammonemia	1589	HP_0001987	68	72	177	191	False
24888247	Polymorphisms in the genes encoding carbamoyl-phosphate synthase 1 (CPS1) and N-acetylglutamate synthase (NAGS) were recently reported to be risk factors for the development of hyperammonemia during valproic acid-based therapy.	NAGS	hyperammonemia	162417	HP_0001987	106	110	177	191	True
24888247	This study aimed to examine the influence of patient characteristics, including polymorphisms in CPS1 4217C&gt;A and NAGS -3064C&gt;A, on the development of hyperammonemia in Japanese pediatric epilepsy patients.	CPS1	epilepsy	1589	HP_0001250	97	101	194	202	False
24888247	This study aimed to examine the influence of patient characteristics, including polymorphisms in CPS1 4217C&gt;A and NAGS -3064C&gt;A, on the development of hyperammonemia in Japanese pediatric epilepsy patients.	NAGS	epilepsy	162417	HP_0001250	117	121	194	202	True
24888247	This study aimed to examine the influence of patient characteristics, including polymorphisms in CPS1 4217C&gt;A and NAGS -3064C&gt;A, on the development of hyperammonemia in Japanese pediatric epilepsy patients.	CPS1	hyperammonemia	1589	HP_0001987	97	101	157	171	False
24888247	This study aimed to examine the influence of patient characteristics, including polymorphisms in CPS1 4217C&gt;A and NAGS -3064C&gt;A, on the development of hyperammonemia in Japanese pediatric epilepsy patients.	NAGS	hyperammonemia	162417	HP_0001987	117	121	157	171	True
24888247	With regard to the CPS1 4217C&gt;A polymorphism, we did not observe a significant association with the development of hyperammonemia.	CPS1	hyperammonemia	1589	HP_0001987	19	23	118	132	False
24888247	In conclusion, CPS1 4217C&gt;A polymorphism may not be associated with the development of hyperammonemia in Japanese population	CPS1	hyperammonemia	1589	HP_0001987	15	19	90	104	False
29859855	A large, complex, and robust gene network containing well-known lung cancer-related genes, including EGFR and TERT, was identified from combined gene lists for lung adenocarcinoma.	EGFR	cancer	1956	HP_0002664	101	105	69	75	True
29859855	A large, complex, and robust gene network containing well-known lung cancer-related genes, including EGFR and TERT, was identified from combined gene lists for lung adenocarcinoma.	TERT	cancer	7015	HP_0002664	110	114	69	75	True
29859855	A large, complex, and robust gene network containing well-known lung cancer-related genes, including EGFR and TERT, was identified from combined gene lists for lung adenocarcinoma.	EGFR	lung adenocarcinoma	1956	HP_0030078	101	105	160	179	False
29859855	A large, complex, and robust gene network containing well-known lung cancer-related genes, including EGFR and TERT, was identified from combined gene lists for lung adenocarcinoma.	TERT	lung adenocarcinoma	7015	HP_0030078	110	114	160	179	False
29635281	Genome-wide association studies (GWAS) have identified 13 susceptibility loci for renal cell carcinoma (RCC).	RCC	renal cell carcinoma	7515	HP_0005584	104	107	82	102	False
29635281	In this study, we focused on 127 significantly mutated genes from The Cancer Genome Atlas (TCGA) Pan-Cancer Analysis across 12 major cancer sites to identify potential genetic variants predictive of RCC risk and clinical outcomes.	RCC	cancer	7515	HP_0002664	199	202	133	139	False
29635281	Cis-eQTL was observed for several SNPs in blood/transformed fibroblasts but not in RCC tumor tissues.	RCC	tumor	7515	HP_0002664	83	86	87	92	False
26850260	The human Shwachman-Diamond syndrome (SDS) is an autosomal recessive disease caused by mutations in a highly conserved ribosome assembly factor SBDS.	SDS	autosomal recessive	51119	HP_0000007	38	41	49	68	True
26850260	The human Shwachman-Diamond syndrome (SDS) is an autosomal recessive disease caused by mutations in a highly conserved ribosome assembly factor SBDS.	SBDS	autosomal recessive	51119	HP_0000007	144	148	49	68	True
30270440	The impact of NOX2 and ROS on cancer development is only partly explored.	NOX2	cancer	1536	HP_0002664	14	18	30	36	False
30270440	The impact of NOX2 and ROS on cancer development is only partly explored.	ROS	cancer	6098	HP_0002664	23	26	30	36	False
30270440	The impact of NOX2 and ROS on cancer development is only partly explored.	impact	cancer	55364	HP_0002664	4	10	30	36	False
30270440	Recent research published in the Journal of Pathology showed that genetic depletion of any of the NOX2 subunits Cyba, Cybb, Ncf1, Ncf2 and Ncf4 reduced the formation of lung metastases following intravenous injection of murine tumor cells.	NOX2	tumor	1536	HP_0002664	98	102	227	232	False
30270440	Recent research published in the Journal of Pathology showed that genetic depletion of any of the NOX2 subunits Cyba, Cybb, Ncf1, Ncf2 and Ncf4 reduced the formation of lung metastases following intravenous injection of murine tumor cells.	Cyba	tumor	1535	HP_0002664	112	116	227	232	False
30270440	Recent research published in the Journal of Pathology showed that genetic depletion of any of the NOX2 subunits Cyba, Cybb, Ncf1, Ncf2 and Ncf4 reduced the formation of lung metastases following intravenous injection of murine tumor cells.	Cybb	tumor	1536	HP_0002664	118	122	227	232	False
30270440	Recent research published in the Journal of Pathology showed that genetic depletion of any of the NOX2 subunits Cyba, Cybb, Ncf1, Ncf2 and Ncf4 reduced the formation of lung metastases following intravenous injection of murine tumor cells.	Ncf1	tumor	653361	HP_0002664	124	128	227	232	False
30270440	Recent research published in the Journal of Pathology showed that genetic depletion of any of the NOX2 subunits Cyba, Cybb, Ncf1, Ncf2 and Ncf4 reduced the formation of lung metastases following intravenous injection of murine tumor cells.	Ncf2	tumor	4688	HP_0002664	130	134	227	232	False
30270440	Recent research published in the Journal of Pathology showed that genetic depletion of any of the NOX2 subunits Cyba, Cybb, Ncf1, Ncf2 and Ncf4 reduced the formation of lung metastases following intravenous injection of murine tumor cells.	Ncf4	tumor	4689	HP_0002664	139	143	227	232	False
30270440	These findings, together with the role of NOX2 in maintaining self-tolerance, imply that NOX2 is a targetable immune checkpoint in cancer.	NOX2	cancer	1536	HP_0002664	42	46	131	137	False
30194038	Developmental and epileptic encephalopathy with hypsarrhythmia is present in most patients with SLC35A2 variants, and is drug-resistant in the majority of cases.	SLC35A2	encephalopathy	7355	HP_0001298	96	103	28	42	True
30194038	Developmental and epileptic encephalopathy with hypsarrhythmia is present in most patients with SLC35A2 variants, and is drug-resistant in the majority of cases.	SLC35A2	hypsarrhythmia	7355	HP_0002521	96	103	48	62	True
29321482	Epidermal growth factor receptor (EGFR) mutation is prevalently expressed in lung adenocarcinoma cases and acts as one of the major driving oncogenes.	EGFR	lung adenocarcinoma	1956	HP_0030078	34	38	77	96	False
29321482	EGFR tyrosine kinase inhibitors (TKIs) have been used in patients with EGFR-mutant as an effective targeted therapy in lung adenocarcinoma, but drug resistance and tumor recurrence inevitably occurs.	EGFR	lung adenocarcinoma	1956	HP_0030078	0	4	119	138	False
29321482	EGFR tyrosine kinase inhibitors (TKIs) have been used in patients with EGFR-mutant as an effective targeted therapy in lung adenocarcinoma, but drug resistance and tumor recurrence inevitably occurs.	EGFR	tumor	1956	HP_0002664	0	4	164	169	True
29321482	Recently, Yes-associate protein (YAP) has been reported to promote multiple cancer cell properties, such as promoting cell proliferation, epithelial-mesenchymal transition and drug resistance.	Yes	cancer	7525	HP_0002664	10	13	76	82	False
29321482	Recently, Yes-associate protein (YAP) has been reported to promote multiple cancer cell properties, such as promoting cell proliferation, epithelial-mesenchymal transition and drug resistance.	YAP	cancer	55249	HP_0002664	33	36	76	82	False
29321482	This study investigated the roles of YAP in TKI-resistant lung adenocarcinoma.	YAP	lung adenocarcinoma	55249	HP_0030078	37	40	58	77	False
29321482	With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in nude mice and Moreover, combined EGFR TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.	EGFR	tumor	1956	HP_0002664	166	170	119	124	True
29321482	With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in nude mice and Moreover, combined EGFR TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.	YAP	tumor	55249	HP_0002664	13	16	119	124	False
29321482	With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in nude mice and Moreover, combined EGFR TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.	nude	tumor	54820	HP_0002664	133	137	119	124	False
29321482	With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in nude mice and Moreover, combined EGFR TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.	mice	tumor	23581	HP_0002664	138	142	119	124	False
29321482	With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in nude mice and Moreover, combined EGFR TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.	EGFR	cancer	1956	HP_0002664	166	170	234	240	True
29321482	With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in nude mice and Moreover, combined EGFR TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.	YAP	cancer	55249	HP_0002664	13	16	234	240	False
29321482	With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in nude mice and Moreover, combined EGFR TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.	nude	cancer	54820	HP_0002664	133	137	234	240	False
29321482	With reduced YAP expression using shRNA or YAP inhibitors, TKI-resistant cells become TKI-sensitive. reduced xenograft tumor size in nude mice and Moreover, combined EGFR TKI and a YAP inhibitor, statin, prolonged survival among lung cancer patients analyzed by Taiwan National Health Insurance Research database.	mice	cancer	23581	HP_0002664	138	142	234	240	False
29202552	Mucopolysaccharidosis VI (MPS-VI) is an infrequent autosomal recessive disorder caused by mutations in ARSB gene and deficiency in lysosomal enzyyme ARSB activities subsequently.	ARSB	autosomal recessive	411	HP_0000007	103	107	51	70	True
29202552	Here we report a novel missense mutation in ARSB gene that is inherited as an autosomal recessive mode and probably explain the clinical status of the proband.	ARSB	autosomal recessive	411	HP_0000007	44	48	78	97	True
29957841	Our previous studies reported gastric cancer cells are insensitive to TRAIL.	TRAIL	cancer	8743	HP_0002664	70	75	38	44	False
29957841	However, whether -elemene could enhance anti-cancer effects of TRAIL on gastric cancer cells is unknown.	TRAIL	cancer	8743	HP_0002664	64	69	46	52	False
29957841	In our present study, -elemene prevented gastric cancer cell viability in dose-dependent manner, and when combined with TRAIL, obviously inhibited proliferation and promoted apoptosis in gastric cancer cells.	TRAIL	cancer	8743	HP_0002664	121	126	50	56	False
29957841	Our results suggest that -elemene increases the sensitivity of gastric cancer cells to TRAIL partially by promoting the formation of DISC in lipid rafts	TRAIL	cancer	8743	HP_0002664	88	93	72	78	False
27421018	Obesity causes several chronic diseases, including cardiovascular and respiratory diseases, osteoarthritis, hypertension, stroke, type II diabetes, obstructive sleep apnea, and several types of cancer.	type	obstructive sleep apnea	6445	HP_0002870	130	134	148	171	False
27421018	Obesity causes several chronic diseases, including cardiovascular and respiratory diseases, osteoarthritis, hypertension, stroke, type II diabetes, obstructive sleep apnea, and several types of cancer.	type	cancer	6445	HP_0002664	130	134	194	200	False
27421018	Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.	LEP	obesity	3952	HP_0001513	106	109	87	94	True
27421018	Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.	POMC	obesity	5443	HP_0001513	117	121	87	94	True
27421018	Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.	PCSK1	obesity	5122	HP_0001513	123	128	87	94	True
27421018	Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.	FTO	obesity	79068	HP_0001513	130	133	87	94	True
27421018	Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.	GNPDA2	obesity	132789	HP_0001513	147	153	87	94	False
27421018	Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.	TMEM18	obesity	129787	HP_0001513	155	161	87	94	False
27421018	Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.	BDNF	obesity	627	HP_0001513	175	179	87	94	True
27421018	Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.	ETV5	obesity	2119	HP_0001513	181	185	87	94	False
27421018	Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.	SEC16B	obesity	89866	HP_0001513	201	207	87	94	False
27421018	Previous genome-wide association studies have identified several genes associated with obesity, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, SEC16B, SIM1, and TNKS/MSRA.	SIM1	obesity	6492	HP_0001513	209	213	87	94	True
29953855	We previously identified a set of the most frequently mutated cytoskeleton- and extracellular matrix-related proteins (CECMPs) in numerous cancer datasets.	set	cancer	6418	HP_0002664	27	30	139	145	False
29953855	In this report, we used a bioinformatics approach to assess the impact of amino acid (AA) substitutions on the sensitivity of CECMPs to the ST14 protease (matriptase I), a transmembrane serine protease previously implicated in cancer development.	impact	cancer	55364	HP_0002664	64	70	227	233	False
30815010	Patients exhibit a variety of symptoms predominantly linked to the function of FMRP protein in the nervous system like autistic behavior and mild-to-severe intellectual disability.	FMRP	intellectual disability	2332	HP_0001249	79	83	156	179	True
30815010	Fragile-X (FraX) individuals also display cellular and morphological traits including branched dendritic spines, large ears, and macroorchidism.	traits	large ears	55929	HP_0000400	69	75	113	123	False
26490186	The TBX5 variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of GATA4 (IVS4+5G&gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.	GATA4	tricuspid atresia	2626	HP_0011662	150	155	94	111	False
26490186	The TBX5 variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of GATA4 (IVS4+5G&gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.	TBX5	tricuspid atresia	6910	HP_0011662	4	8	94	111	False
26490186	The TBX5 variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of GATA4 (IVS4+5G&gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.	GATA4	atrioventricular septal defect	2626	HP_0006695	150	155	276	306	True
26490186	The TBX5 variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of GATA4 (IVS4+5G&gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.	TBX5	atrioventricular septal defect	6910	HP_0006695	4	8	276	306	True
26490186	The TBX5 variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of GATA4 (IVS4+5G&gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.	GATA4	psychomotor delay	2626	HP_0001263	150	155	311	328	True
26490186	The TBX5 variation p.Pro108Thr, located in the T-box domain, was identified in a patient with tricuspid atresia, an exon-intron boundary variation of GATA4 (IVS4+5G&gt;A) was detected in a Tetralogy of Fallot patient and an 8p23 microdeletion was detected in one patient with atrioventricular septal defect and psychomotor delay.	TBX5	psychomotor delay	6910	HP_0001263	4	8	311	328	False
27618552	Furthermore, we identified the activity of nitric oxide synthase 2 (NOS2, also known as iNOS) originating from the glioma cells as a driving stimulus in the control of microglial caspase-3 activity.	NOS2	glioma	339345	HP_0009733	68	72	115	121	False
27618552	Furthermore, we identified the activity of nitric oxide synthase 2 (NOS2, also known as iNOS) originating from the glioma cells as a driving stimulus in the control of microglial caspase-3 activity.	iNOS	glioma	51477	HP_0009733	88	92	115	121	False
27618552	Repression of glioma NOS2 expression in vivo led to a reduction in both microglia recruitment and tumor expansion, whereas depletion of microglial caspase-3 gene promoted tumor growth.	NOS2	tumor	339345	HP_0002664	21	25	98	103	False
27618552	Repression of glioma NOS2 expression in vivo led to a reduction in both microglia recruitment and tumor expansion, whereas depletion of microglial caspase-3 gene promoted tumor growth.	NOS2	glioma	339345	HP_0009733	21	25	14	20	False
27618552	Our results provide evidence that inhibition of the denitrosylation of S-nitrosylated procaspase-3 mediated by the redox protein Trx2 is a part of the microglial pro-tumoral activation pathway initiated by glioma cancer cells	Trx2	tumor	9757	HP_0002664	129	133	166	171	False
27618552	Our results provide evidence that inhibition of the denitrosylation of S-nitrosylated procaspase-3 mediated by the redox protein Trx2 is a part of the microglial pro-tumoral activation pathway initiated by glioma cancer cells	Trx2	glioma	9757	HP_0009733	129	133	206	212	False
27618552	Our results provide evidence that inhibition of the denitrosylation of S-nitrosylated procaspase-3 mediated by the redox protein Trx2 is a part of the microglial pro-tumoral activation pathway initiated by glioma cancer cells	Trx2	cancer	9757	HP_0002664	129	133	213	219	False
29909407	Weight gain and growth failure, the hallmarks of hypercortisolism in pediatrics, may be inconsistent, especially in ACTH-independent forms of CS.	ACTH	hypercortisolism	5443	HP_0003118	116	120	49	65	False
29909407	Primary pigmented nodular adrenocortical disease (PPNAD) is the rarest form of ACTH-independent CS, and can be associated with endocrine and nonendocrine tumors, forming the Carney complex (CNC).	ACTH	tumors	5443	HP_0002664	79	83	154	160	False
29103025	Cervical cancer is the fourth most common malignancy among women worldwide, and continued research to discover biomarkers or therapeutic targets will aid early diagnosis and treatment of this cancer.	aid	cancer	57379	HP_0002664	150	153	9	15	False
29103025	We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, SYCP2, KIF4A, PRC1, TOP2A, LAMP3, KIF20A, MCM2, and APOBEC3B.	SPARCL1	cancer	8404	HP_0002664	101	108	81	87	False
29103025	We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, SYCP2, KIF4A, PRC1, TOP2A, LAMP3, KIF20A, MCM2, and APOBEC3B.	SYCP2	cancer	10388	HP_0002664	110	115	81	87	False
29103025	We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, SYCP2, KIF4A, PRC1, TOP2A, LAMP3, KIF20A, MCM2, and APOBEC3B.	KIF4A	cancer	24137	HP_0002664	117	122	81	87	False
29103025	We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, SYCP2, KIF4A, PRC1, TOP2A, LAMP3, KIF20A, MCM2, and APOBEC3B.	PRC1	cancer	9055	HP_0002664	124	128	81	87	False
29103025	We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, SYCP2, KIF4A, PRC1, TOP2A, LAMP3, KIF20A, MCM2, and APOBEC3B.	TOP2A	cancer	7153	HP_0002664	130	135	81	87	True
29103025	We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, SYCP2, KIF4A, PRC1, TOP2A, LAMP3, KIF20A, MCM2, and APOBEC3B.	LAMP3	cancer	27074	HP_0002664	137	142	81	87	False
29103025	We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, SYCP2, KIF4A, PRC1, TOP2A, LAMP3, KIF20A, MCM2, and APOBEC3B.	KIF20A	cancer	10112	HP_0002664	144	150	81	87	False
29103025	We have identified nine genes of interest that appear to be involved in cervical cancer development: SPARCL1, SYCP2, KIF4A, PRC1, TOP2A, LAMP3, KIF20A, MCM2, and APOBEC3B.	MCM2	cancer	4176	HP_0002664	152	156	81	87	False
29103025	Furthermore, gene ontology (GO) and co-expression analysis of these differentially expressed genes indicated that SPARCL1 may play a core role in cervical cancer development.	SPARCL1	cancer	8404	HP_0002664	114	121	155	161	False
29103025	Further, we analyzed the expression of these nine genes during the progression of cervical cancer, and found that SPARCL1 is also related to precancerous lesions and migration processes during cervical cancer pathogenesis.	SPARCL1	cancer	8404	HP_0002664	114	121	91	97	False
29103025	Finally, we validated these observations by investigating SPARCL1 expression in cervical cancer tissue and serum samples.	SPARCL1	cancer	8404	HP_0002664	58	65	89	95	False
29103025	The diagnostic specificity of serum SPARCL1 in cervical cancer occurrence was also compared with other high incidence diseases.	SPARCL1	cancer	8404	HP_0002664	36	43	56	62	False
29103025	All of these data indicate that SPARCL1 may be a novel cancer predictive marker and a potential therapeutic target for tumor development and progression in cervical cancer	SPARCL1	cancer	8404	HP_0002664	32	39	55	61	False
29103025	All of these data indicate that SPARCL1 may be a novel cancer predictive marker and a potential therapeutic target for tumor development and progression in cervical cancer	SPARCL1	tumor	8404	HP_0002664	32	39	119	124	False
26855408	Megaconial congenital muscular dystrophy is a disease caused by pathogenic mutations in the gene encoding choline kinase beta (CHKB).	CHKB	muscular dystrophy	1120	HP_0003560	127	131	22	40	True
29859466	Most of the available anticancer drugs are designed to act on specific targets by altering the activity of involved transporters and genes.	act	cancer	11332	HP_0002664	55	58	26	32	False
29859466	The literature supports the evidence of natural compounds exhibiting antioxidant, antimitotic, anti-inflammatory, antibiotic as well as anticancer activity.	act	cancer	11332	HP_0002664	147	150	140	146	False
29859466	In this review, we have selected marine sponges as a prolific source of bioactive compounds which can be explored for their possible use in cancer and have tried to link their role in cancer pathway.	act	cancer	11332	HP_0002664	75	78	140	146	False
29859466	We used Cytoscape network analysis and Search tool for retrieval of interacting genes/ proteins (STRING) to study the possible interactions to show the links between the antioxidants, antibiotics, anti-inflammatory and antimitotic agents and their targets for their possible use in cancer.	act	cancer	11332	HP_0002664	73	76	282	288	False
29798143	<b>Objective:</b>To investigate the expression and significance of CTHRC1 in patients with papillary thyroid cancinoma.<b>Method:</b>We collected 63 specimens of papillary thyroid carcinoma tissue with 36 specimens of the adjacent normal thyroid tissue and 23 specimens of thyroid nodular goiter.	CTHRC1	papillary thyroid carcinoma	115908	HP_0002895	67	73	162	189	False
29798143	The correlations between the expressions of CTHRC1 with clinicopathologic features,E-cadherin and Vimentin expression were analyzed.<b>Result:</b>CTHRC1 protein expression levels in papillary thyroid carcinoma tissue were significantly higher than those in adjacent normal thyroid tissue and benign disease(<i>P</i>&lt;0.01);CTHRC1 expression was significantly correlated with lymph node metastases(<i>P</i>&lt;0.05).	CTHRC1	papillary thyroid carcinoma	115908	HP_0002895	44	50	182	209	False
29798143	The correlations between the expressions of CTHRC1 with clinicopathologic features,E-cadherin and Vimentin expression were analyzed.<b>Result:</b>CTHRC1 protein expression levels in papillary thyroid carcinoma tissue were significantly higher than those in adjacent normal thyroid tissue and benign disease(<i>P</i>&lt;0.01);CTHRC1 expression was significantly correlated with lymph node metastases(<i>P</i>&lt;0.05).	cadherin	papillary thyroid carcinoma	1015	HP_0002895	85	93	182	209	False
27906773	Aminoacyl-tRNA synthetase complex (ARS)-interacting multifunctional protein 1 (AIMP1) is a cytokine that is known to amplify the actions of tumor necrosis factor- and to be involved in microglial activation and neuronal death.	ARS	tumor	57152	HP_0002664	35	38	140	145	False
27906773	Aminoacyl-tRNA synthetase complex (ARS)-interacting multifunctional protein 1 (AIMP1) is a cytokine that is known to amplify the actions of tumor necrosis factor- and to be involved in microglial activation and neuronal death.	AIMP1	tumor	9255	HP_0002664	79	84	140	145	False
27089179	Uveal melanomas are molecularly distinct from cutaneous melanomas and lack mutations in BRAF, NRAS, KIT, and NF1.	BRAF	cutaneous melanomas	673	HP_0012056	88	92	46	65	False
27089179	Uveal melanomas are molecularly distinct from cutaneous melanomas and lack mutations in BRAF, NRAS, KIT, and NF1.	NRAS	cutaneous melanomas	4893	HP_0012056	94	98	46	65	True
27089179	Uveal melanomas are molecularly distinct from cutaneous melanomas and lack mutations in BRAF, NRAS, KIT, and NF1.	KIT	cutaneous melanomas	3815	HP_0012056	100	103	46	65	False
29179235	A novel hereditary disorder encompassing high blood Mn levels, dystonia, polycythemia, distinctive T1 hyperintense signals in the basal ganglia on magnetic resonance imaging (MRI) brain, and chronic liver disease was recently described.	T1	dystonia	921	HP_0001332	99	101	63	71	False
29179235	A novel hereditary disorder encompassing high blood Mn levels, dystonia, polycythemia, distinctive T1 hyperintense signals in the basal ganglia on magnetic resonance imaging (MRI) brain, and chronic liver disease was recently described.	T1	polycythemia	921	HP_0001901	99	101	73	85	False
29179235	The older brother presented with progressive gait difficulties, hypotonia, intermittent dystonia, polycythemia, and characteristic T1-hyperintense lesions on MRI brain.	T1	dystonia	921	HP_0001332	131	133	88	96	False
29179235	The older brother presented with progressive gait difficulties, hypotonia, intermittent dystonia, polycythemia, and characteristic T1-hyperintense lesions on MRI brain.	T1	polycythemia	921	HP_0001901	131	133	98	110	False
26376857	A heterozygous mutation (c.643C&gt;A; p.Q215X) in the monocarboxylate transporter 12-encoding gene MCT12 (also known as SLC16A12) that mediates creatine transport was recently identified as the cause of a syndrome with juvenile cataracts, microcornea, and glucosuria in a single family.	MCT12	cataracts	387700	HP_0000518	99	104	228	237	True
26376857	A heterozygous mutation (c.643C&gt;A; p.Q215X) in the monocarboxylate transporter 12-encoding gene MCT12 (also known as SLC16A12) that mediates creatine transport was recently identified as the cause of a syndrome with juvenile cataracts, microcornea, and glucosuria in a single family.	SLC16A12	cataracts	387700	HP_0000518	120	128	228	237	True
26376857	A heterozygous mutation (c.643C&gt;A; p.Q215X) in the monocarboxylate transporter 12-encoding gene MCT12 (also known as SLC16A12) that mediates creatine transport was recently identified as the cause of a syndrome with juvenile cataracts, microcornea, and glucosuria in a single family.	MCT12	microcornea	387700	HP_0000482	99	104	239	250	True
26376857	A heterozygous mutation (c.643C&gt;A; p.Q215X) in the monocarboxylate transporter 12-encoding gene MCT12 (also known as SLC16A12) that mediates creatine transport was recently identified as the cause of a syndrome with juvenile cataracts, microcornea, and glucosuria in a single family.	SLC16A12	microcornea	387700	HP_0000482	120	128	239	250	True
26834157	JAK2V617F(+) myeloproliferative neoplasms (MPNs) frequently progress into leukemias, but the factors driving this process are not understood.	MPN	neoplasms	83886	HP_0002664	43	46	32	41	False
26834157	JAK2V617F(+) myeloproliferative neoplasms (MPNs) frequently progress into leukemias, but the factors driving this process are not understood.	act	neoplasms	11332	HP_0002664	94	97	32	41	False
29670289	Mutations in SAMHD1 are implicated in cancer development and in a severe congenital inflammatory disease known as Aicardi-Goutires syndrome.	SAMHD1	cancer	25939	HP_0002664	13	19	38	44	False
29670289	The mechanism by which SAMHD1 protects against cancer and chronic inflammation is unknown.	SAMHD1	cancer	25939	HP_0002664	23	29	47	53	False
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	EPG5	intellectual disability	57724	HP_0001249	176	180	342	365	True
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	SNX14	intellectual disability	57231	HP_0001249	283	288	342	365	False
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	SPG11	intellectual disability	80208	HP_0001249	426	431	342	365	True
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	SPG15	intellectual disability	23503	HP_0001249	433	438	342	365	True
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	SPG49	intellectual disability	113612	HP_0001249	443	448	342	365	True
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	ZFYVE26	intellectual disability	23503	HP_0001249	466	473	342	365	True
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	TECPR2	intellectual disability	9895	HP_0001249	478	484	342	365	True
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	EPG5	cerebellar ataxia	57724	HP_0001251	176	180	320	337	False
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	SNX14	cerebellar ataxia	57231	HP_0001251	283	288	320	337	True
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	SPG11	cerebellar ataxia	80208	HP_0001251	426	431	320	337	True
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	SPG15	cerebellar ataxia	23503	HP_0001251	433	438	320	337	True
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	SPG49	cerebellar ataxia	113612	HP_0001251	443	448	320	337	False
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	ZFYVE26	cerebellar ataxia	23503	HP_0001251	466	473	320	337	True
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	TECPR2	cerebellar ataxia	9895	HP_0001251	478	484	320	337	True
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	EPG5	spastic paraplegia	57724	HP_0001258	176	180	406	424	False
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	SNX14	spastic paraplegia	57231	HP_0001258	283	288	406	424	False
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	SPG11	spastic paraplegia	80208	HP_0001258	426	431	406	424	True
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	SPG15	spastic paraplegia	23503	HP_0001258	433	438	406	424	True
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	SPG49	spastic paraplegia	113612	HP_0001258	443	448	406	424	True
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	ZFYVE26	spastic paraplegia	23503	HP_0001258	466	473	406	424	True
26715604	Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: EPG5-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, SNX14-associated autosomal-recessive cerebellar ataxia and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG11, ZFYVE26 and TECPR2 mutations, respectively.	TECPR2	spastic paraplegia	9895	HP_0001258	478	484	406	424	True
26578791	Whereas the majority of mammalian cells carry no more than two centrosomes per cell, exceptions to this rule apply in certain specialized tissues and in select disease states, including cancer.	per	cancer	93210	HP_0002664	75	78	186	192	False
27062609	In addition to a FOXG1 mutation in a patient with all core features of the congenital variant of RTT, we identified a missense (p.Ser240Thr) in CDKL5 in a patient who appeared to be seizure free.	RTT	seizure	4204	HP_0001250	97	100	182	189	True
27062609	In addition to a FOXG1 mutation in a patient with all core features of the congenital variant of RTT, we identified a missense (p.Ser240Thr) in CDKL5 in a patient who appeared to be seizure free.	CDKL5	seizure	6792	HP_0001250	144	149	182	189	True
27062609	In addition to a FOXG1 mutation in a patient with all core features of the congenital variant of RTT, we identified a missense (p.Ser240Thr) in CDKL5 in a patient who appeared to be seizure free.	FOXG1	seizure	2290	HP_0001250	17	22	182	189	True
27062609	Finally, exome sequencing enabled us to characterize a heterozygous de novo missense (p.Val408Ala) in KCNA2 encoding the potassium channel Kv 1.2 in a girl with infantile-onset seizures variant of RTT.	RTT	seizure	4204	HP_0001250	197	200	177	184	True
27062609	Finally, exome sequencing enabled us to characterize a heterozygous de novo missense (p.Val408Ala) in KCNA2 encoding the potassium channel Kv 1.2 in a girl with infantile-onset seizures variant of RTT.	KCNA2	seizure	3737	HP_0001250	102	107	177	184	True
27062609	Our study expands the genetic heterogeneity of RTT and RTT-like phenotypes.	RTT	heterogeneity	4204	HP_0001425	47	50	30	43	False
28368009	Basic immunological assessments have confirmed that this strain of human CD3 EDG-replaced mice are entirely immune competent, and we have also demonstrated that a bispecific antibody that simultaneously binds to human CD3 and a tumor-associated antigen (e.g. ERBB2 or GPC3) can be evaluated in human CD3 EDG-replaced mice engrafted with tumors.	mice	tumor	23581	HP_0002664	90	94	228	233	False
28368009	Basic immunological assessments have confirmed that this strain of human CD3 EDG-replaced mice are entirely immune competent, and we have also demonstrated that a bispecific antibody that simultaneously binds to human CD3 and a tumor-associated antigen (e.g. ERBB2 or GPC3) can be evaluated in human CD3 EDG-replaced mice engrafted with tumors.	ERBB2	tumor	2064	HP_0002664	259	264	228	233	True
28368009	Basic immunological assessments have confirmed that this strain of human CD3 EDG-replaced mice are entirely immune competent, and we have also demonstrated that a bispecific antibody that simultaneously binds to human CD3 and a tumor-associated antigen (e.g. ERBB2 or GPC3) can be evaluated in human CD3 EDG-replaced mice engrafted with tumors.	GPC3	tumor	2719	HP_0002664	268	272	228	233	True
28661420	Moreover, Adenomatous polyposis coli 2 (APC2), a tumor suppressor and a negative regulator of Wnt signaling, was found to be the direct target of miR-3648.	miR	tumor	220972	HP_0002664	146	149	49	54	False
28661420	Moreover, Adenomatous polyposis coli 2 (APC2), a tumor suppressor and a negative regulator of Wnt signaling, was found to be the direct target of miR-3648.	APC2	tumor	29882	HP_0002664	40	44	49	54	False
15073121	The expression profile of ADAMTS1-20 in human breast carcinoma was undertaken by real-time PCR using RNA isolated from malignant tumors, nonneoplastic mammary tissue, and breast cancer cell lines to identify altered regulation that may have potential pathogenetic and prognostic significance.	ADAMTS1	breast carcinoma	9510	HP_0003002	26	33	46	62	False
15073121	The expression profile of ADAMTS1-20 in human breast carcinoma was undertaken by real-time PCR using RNA isolated from malignant tumors, nonneoplastic mammary tissue, and breast cancer cell lines to identify altered regulation that may have potential pathogenetic and prognostic significance.	ADAMTS1	tumors	9510	HP_0002664	26	33	129	135	False
15073121	The expression profile of ADAMTS1-20 in human breast carcinoma was undertaken by real-time PCR using RNA isolated from malignant tumors, nonneoplastic mammary tissue, and breast cancer cell lines to identify altered regulation that may have potential pathogenetic and prognostic significance.	ADAMTS1	cancer	9510	HP_0002664	26	33	178	184	False
15073121	Our studies show that seven of the ADAMTS genes (ADAMTS1, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the tumor type or grade (Mann-Whitney U test, P &lt; 0.0001 for each gene).	ADAMTS1	breast carcinoma	9510	HP_0003002	49	56	117	133	False
15073121	Our studies show that seven of the ADAMTS genes (ADAMTS1, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the tumor type or grade (Mann-Whitney U test, P &lt; 0.0001 for each gene).	type	breast carcinoma	6445	HP_0003002	244	248	117	133	False
15073121	Our studies show that seven of the ADAMTS genes (ADAMTS1, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the tumor type or grade (Mann-Whitney U test, P &lt; 0.0001 for each gene).	ADAMTS1	heterogeneity	9510	HP_0001425	49	56	201	214	False
15073121	Our studies show that seven of the ADAMTS genes (ADAMTS1, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the tumor type or grade (Mann-Whitney U test, P &lt; 0.0001 for each gene).	type	heterogeneity	6445	HP_0001425	244	248	201	214	False
15073121	Our studies show that seven of the ADAMTS genes (ADAMTS1, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the tumor type or grade (Mann-Whitney U test, P &lt; 0.0001 for each gene).	ADAMTS1	tumor	9510	HP_0002664	49	56	238	243	False
15073121	Our studies show that seven of the ADAMTS genes (ADAMTS1, 3, 5, 8, 9, 10, and 18) are consistently down-regulated in breast carcinomas with respect to nonneoplastic mammary tissue, irrespective of the heterogeneity of the samples and the tumor type or grade (Mann-Whitney U test, P &lt; 0.0001 for each gene).	type	tumor	6445	HP_0002664	244	248	238	243	False
15073121	Conversely, ADAMTS4, 6, 14, and 20 are consistently up-regulated in breast carcinomas (P = 0.005, P &lt; 0.0001, P = 0.003, and P = 0.001, respectively).	ADAMTS4	breast carcinoma	9507	HP_0003002	12	19	68	84	False
15073121	ADAMTS15 has emerged as being an independent predictor of survival, with RNA expression levels significantly lower (P = 0.007) in grade 3 breast carcinoma compared with grade 1 and 2 breast carcinoma	ADAMTS1	breast carcinoma	9510	HP_0003002	0	7	138	154	False
29302025	Here, we identify a cause of the autosomal recessive cblC class of inborn errors of vitamin B<sub>12</sub> metabolism that we name &quot;epi-cblC&quot;.	cblC	autosomal recessive	23624	HP_0000007	53	57	33	52	False
29050118	<b>Result:</b> Three mutant genes (PTPN11 gene in chromosome 12, RIT1 gene in chromosome 1 and RAF1 gene in chromosome 3) in five cases all had been reported to be related to hypertrophic cardiomyopathy.	PTPN11	cardiomyopathy	5781	HP_0001638	35	41	188	202	True
29050118	<b>Result:</b> Three mutant genes (PTPN11 gene in chromosome 12, RIT1 gene in chromosome 1 and RAF1 gene in chromosome 3) in five cases all had been reported to be related to hypertrophic cardiomyopathy.	RIT1	cardiomyopathy	6016	HP_0001638	65	69	188	202	True
29050118	<b>Result:</b> Three mutant genes (PTPN11 gene in chromosome 12, RIT1 gene in chromosome 1 and RAF1 gene in chromosome 3) in five cases all had been reported to be related to hypertrophic cardiomyopathy.	RAF1	cardiomyopathy	5894	HP_0001638	95	99	188	202	True
29050118	The reported hypertrophic cardiomyopathy relevant genes MYPN, MYH6 and MYBP3 had also been found in case 1 and 2.	MYPN	cardiomyopathy	84665	HP_0001638	56	60	26	40	True
29050118	The reported hypertrophic cardiomyopathy relevant genes MYPN, MYH6 and MYBP3 had also been found in case 1 and 2.	MYH6	cardiomyopathy	4624	HP_0001638	62	66	26	40	True
29050118	However, case 4 had special face, low IQ, mild pulmonary artery stenosis, and only mild ventricular hypertrophy.	face	pulmonary artery stenosis	2178	HP_0004415	28	32	47	72	False
29050118	However, case 4 had special face, low IQ, mild pulmonary artery stenosis, and only mild ventricular hypertrophy.	face	ventricular hypertrophy	2178	HP_0001714	28	32	88	111	False
28430874	Consistently, SALL2 deficiency associates with neural tube defects and coloboma, a congenital eye disease.	SALL2	neural tube defects	6297	HP_0045005	14	19	47	66	False
28430874	Consistently, SALL2 deficiency associates with neural tube defects and coloboma, a congenital eye disease.	SALL2	coloboma	6297	HP_0000589	14	19	71	79	True
28430874	Relevant to cancer, clinical studies indicate that SALL2 is deregulated in various cancers and is a specific biomarker for Synovial Sarcoma.	SALL2	cancer	6297	HP_0002664	51	56	12	18	False
28430874	We specifically discuss the role of SALL2 in the regulation of cell proliferation and survival within the context of the identified target genes, its interaction with viral oncogenes, and its association with the TP53 tumor suppressor and MYC oncogene.	SALL2	tumor	6297	HP_0002664	36	41	218	223	False
28430874	We specifically discuss the role of SALL2 in the regulation of cell proliferation and survival within the context of the identified target genes, its interaction with viral oncogenes, and its association with the TP53 tumor suppressor and MYC oncogene.	MYC	tumor	4609	HP_0002664	239	242	218	223	True
28430874	Special attention is given to p53-independent SALL2 regulation of pro-apoptotic genes BAX and PMAIP1, and the implication of these findings on the apoptotic response of cancer cells to therapy.	SALL2	cancer	6297	HP_0002664	46	51	169	175	False
28430874	Special attention is given to p53-independent SALL2 regulation of pro-apoptotic genes BAX and PMAIP1, and the implication of these findings on the apoptotic response of cancer cells to therapy.	BAX	cancer	581	HP_0002664	86	89	169	175	False
28430874	Special attention is given to p53-independent SALL2 regulation of pro-apoptotic genes BAX and PMAIP1, and the implication of these findings on the apoptotic response of cancer cells to therapy.	PMAIP1	cancer	5366	HP_0002664	94	100	169	175	False
30428605	We therefore examined whether maternal or fetal folate status, together with indices of placental folate transport, were modulated by either maternal pre-pregnancy body mass index (BMI i.e., overweight: 25  BMI &lt; 30 or obesity: BMI  30 kg/m) and/or gestational diabetes mellitus (GD).	mass	obesity	2200	HP_0001513	169	173	223	230	False
30428605	Placental mRNA abundance for the folate receptor alpha (<i>FOLR1</i>) was reduced with obesity, whilst <i>DNMT1</i> was increased with raised BMI, responses that were unaffected by GD.	DNMT	obesity	1786	HP_0001513	106	110	87	94	False
29463994	The homeodomain transcription factor SIX3 was recently reported to be a negative regulator of the Wnt pathway and has an emerging role in cancer.	SIX3	cancer	6496	HP_0002664	37	41	138	144	True
30813130	The heterogeneity test, sensitivity analysis, and publication bias test was performed by Review Manager 5.3 software.Overall, 22 case-control studies with 5049 cases and 4157 controls were included in this meta-analysis, which contained 20 studies of MTHFR C677T polymorphism, 12 studies of MTHFR A1298C polymorphism and 4 studies of MTRR A66G polymorphism.	MTHFR	heterogeneity	4524	HP_0001425	251	256	4	17	False
30813130	The heterogeneity test, sensitivity analysis, and publication bias test was performed by Review Manager 5.3 software.Overall, 22 case-control studies with 5049 cases and 4157 controls were included in this meta-analysis, which contained 20 studies of MTHFR C677T polymorphism, 12 studies of MTHFR A1298C polymorphism and 4 studies of MTRR A66G polymorphism.	MTRR	heterogeneity	4552	HP_0001425	334	338	4	17	False
30602691	The lifestyle gradually transformed from Bedouin life to urban sedentary life, along with a sharp increase in obesity and other comorbidities.	sharp	obesity	23013	HP_0001513	92	97	110	117	False
28601660	SMARCA4-deficient thoracic sarcoma is a recently proposed new entity of soft tissue sarcomas with an undifferentiated round cell morphology that is diagnostically challenging.	SMARCA4	sarcoma	6597	HP_0100242	0	7	27	34	False
28601660	Further analysis revealed a reduced SMARCA4 expression and a complete loss of SMARCA2 expression in tumor cells.	SMARCA4	tumor	6597	HP_0002664	36	43	100	105	False
28601660	Further analysis revealed a reduced SMARCA4 expression and a complete loss of SMARCA2 expression in tumor cells.	SMARCA2	tumor	6595	HP_0002664	78	85	100	105	False
27449089	Previous work has demonstrated the effectiveness of inhibiting CHK1 with small-molecule inhibitors, but the role of CHK1 mediated DDR in medulloblastoma is unknown.	CHK1	medulloblastoma	1111	HP_0002885	63	67	137	152	False
27449089	CHK1, both at the mRNA and protein level, is highly expressed in medulloblastoma and elevated CHK1 expression in Group3 medulloblastoma is an adverse prognostic marker.	CHK1	medulloblastoma	1111	HP_0002885	0	4	65	80	False
27449089	Overall, our results demonstrate that small-molecule inhibition of CHK1 in combination with, cisplatin, is more advantageous than either treatment alone, especially for Group 3 medulloblastoma, and therefore this combined therapeutic approach serves as an avenue for further investigation	CHK1	medulloblastoma	1111	HP_0002885	67	71	177	192	False
30541997	Primary hyperoxaluria type 1 (PH1), a rare autosomal recessive disorder, is characterized by renal stones, nephrocalcinosis, and chronic kidney disease.	type	hyperoxaluria	6445	HP_0003159	22	26	8	21	False
30541997	Primary hyperoxaluria type 1 (PH1), a rare autosomal recessive disorder, is characterized by renal stones, nephrocalcinosis, and chronic kidney disease.	type	renal stones	6445	HP_0000787	22	26	93	105	False
30541997	Primary hyperoxaluria type 1 (PH1), a rare autosomal recessive disorder, is characterized by renal stones, nephrocalcinosis, and chronic kidney disease.	type	nephrocalcinosis	6445	HP_0000121	22	26	107	123	False
26199132	We investigated the impact of the biomarkers of S-G2-M phases of cell cycle, Aurora kinase B (AURKB) and geminin (GMNN), on disease progression in neuroblastomas.	impact	neuroblastomas	55364	HP_0003006	20	26	147	161	False
26199132	We investigated the impact of the biomarkers of S-G2-M phases of cell cycle, Aurora kinase B (AURKB) and geminin (GMNN), on disease progression in neuroblastomas.	AURKB	neuroblastomas	9212	HP_0003006	94	99	147	161	False
26199132	We investigated the impact of the biomarkers of S-G2-M phases of cell cycle, Aurora kinase B (AURKB) and geminin (GMNN), on disease progression in neuroblastomas.	GMNN	neuroblastomas	51053	HP_0003006	114	118	147	161	False
26199132	The expression of AURKB and GMNN was studied by immunostaining 84 neuroblastomas.	AURKB	neuroblastomas	9212	HP_0003006	18	23	66	80	False
26199132	The expression of AURKB and GMNN was studied by immunostaining 84 neuroblastomas.	GMNN	neuroblastomas	51053	HP_0003006	28	32	66	80	False
26199132	The PI for both markers was significantly higher in neuroblastomas from patients with unfavorable clinical (high-risk group, advanced stage, age 18 months at presentation, primary abdominal compared to extra-abdominal sites), biological (MYCN amplification, 1p deletion, 17q gain), and pathological (undifferentiated or poorly differentiated status, high mitosis-karyorrhexis index, [MKI], unfavorable histology) factors.	MYCN	neuroblastomas	4613	HP_0003006	239	243	52	66	False
26199132	Our study shows that in neuroblastomas, AURKB- or GMNN-based PI provides valuable prognostic information and high PI indicates aggressive disease	AURKB	neuroblastomas	9212	HP_0003006	40	45	24	38	False
26199132	Our study shows that in neuroblastomas, AURKB- or GMNN-based PI provides valuable prognostic information and high PI indicates aggressive disease	GMNN	neuroblastomas	51053	HP_0003006	50	54	24	38	False
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	RET	tumors	5979	HP_0002664	144	147	38	44	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	VHL	tumors	7428	HP_0002664	149	152	38	44	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	SDHAF2	tumors	54949	HP_0002664	159	165	38	44	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	SDHA	tumors	6389	HP_0002664	167	171	38	44	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	SDHB	tumors	6390	HP_0002664	173	177	38	44	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	SDHC	tumors	6391	HP_0002664	179	183	38	44	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	SDHD	tumors	6392	HP_0002664	185	189	38	44	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	TMEM127	tumors	55654	HP_0002664	191	198	38	44	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	RET	pheochromocytoma	5979	HP_0002666	144	147	46	62	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	VHL	pheochromocytoma	7428	HP_0002666	149	152	46	62	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	SDHAF2	pheochromocytoma	54949	HP_0002666	159	165	46	62	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	SDHA	pheochromocytoma	6389	HP_0002666	167	171	46	62	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	SDHB	pheochromocytoma	6390	HP_0002666	173	177	46	62	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	SDHC	pheochromocytoma	6391	HP_0002666	179	183	46	62	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	SDHD	pheochromocytoma	6392	HP_0002666	185	189	46	62	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	TMEM127	pheochromocytoma	55654	HP_0002666	191	198	46	62	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	RET	paraganglioma	5979	HP_0002668	144	147	68	81	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	VHL	paraganglioma	7428	HP_0002668	149	152	68	81	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	SDHAF2	paraganglioma	54949	HP_0002668	159	165	68	81	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	SDHA	paraganglioma	6389	HP_0002668	167	171	68	81	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	SDHB	paraganglioma	6390	HP_0002668	173	177	68	81	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	SDHC	paraganglioma	6391	HP_0002668	179	183	68	81	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	SDHD	paraganglioma	6392	HP_0002668	185	189	68	81	True
24169644	A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX.	TMEM127	paraganglioma	55654	HP_0002668	191	198	68	81	True
29170024	Within the last decade, the Bromodomain and Extra-Terminal domain family (BET) of proteins have emerged as promising drug targets in diverse clinical indications including oncology, auto-immune disease, heart failure, and male contraception.	BET	heart failure	92737	HP_0001635	74	77	203	216	False
29170024	Finally, we report that 9 retained cytotoxicity against several pediatric cancer cell lines with EC<sub>50</sub> values comparable to BET inhibitor (BETi) clinical candidates	BET	cancer	92737	HP_0002664	134	137	74	80	False
22981119	In this study, we identified a splice-site mutation (c.637+1G&gt;T) in Ca(2+)-binding protein 2 (CABP2) in three consanguineous Iranian families affected by moderate-to-severe hearing loss.	CABP2	hearing loss	51475	HP_0000365	97	102	176	188	True
22981119	We show that genetic defects in CABP2 cause moderate-to-severe sensorineural hearing impairment.	CABP2	hearing impairment	51475	HP_0000365	32	37	77	95	True
28164238	Whereas Klf13 heterozygote mice have no detectable cardiac defects, loss of a Klf13 allele in Tbx5 heterozygote mice significantly increases the penetrance of TBX5-dependent cardiac abnormalities including atrial, atrial-ventricular and ventricular septal defects.	TBX5	cardiac abnormalities	6910	HP_0001627	159	163	174	195	True
28164238	Whereas Klf13 heterozygote mice have no detectable cardiac defects, loss of a Klf13 allele in Tbx5 heterozygote mice significantly increases the penetrance of TBX5-dependent cardiac abnormalities including atrial, atrial-ventricular and ventricular septal defects.	Klf13	cardiac abnormalities	51621	HP_0001627	8	13	174	195	False
28164238	Whereas Klf13 heterozygote mice have no detectable cardiac defects, loss of a Klf13 allele in Tbx5 heterozygote mice significantly increases the penetrance of TBX5-dependent cardiac abnormalities including atrial, atrial-ventricular and ventricular septal defects.	mice	cardiac abnormalities	23581	HP_0001627	27	31	174	195	False
28164238	Whereas Klf13 heterozygote mice have no detectable cardiac defects, loss of a Klf13 allele in Tbx5 heterozygote mice significantly increases the penetrance of TBX5-dependent cardiac abnormalities including atrial, atrial-ventricular and ventricular septal defects.	Tbx5	cardiac abnormalities	6910	HP_0001627	94	98	174	195	True
30297428	We conducted a large-scale genome-wide association study of erectile dysfunction in 36,649 men in the multiethnic Kaiser Permanente Northern California Genetic Epidemiology Research in Adult Health and Aging cohort.	men	erectile dysfunction	8178	HP_0000802	91	94	60	80	False
30297428	The association replicated in the UK Biobank sample (odds ratio = 1.25, <i>P</i> = 6.8  10<sup>-14</sup>), and the effect is independent of known erectile dysfunction risk factors, including body mass index (BMI).	mass	erectile dysfunction	2200	HP_0000802	197	201	147	167	False
28332470	Rare forms of autosomal-dominant Charcot-Marie-Tooth disease (AD-CMT) may be associated with mutations in Fibulin-5 (FBLN5) as AD-CMT is genetically heterogeneous.	FBLN5	heterogeneous	10516	HP_0001425	117	122	149	162	True
29325022	Mutations of the sigma subunit of the heterotetrameric adaptor-related protein complex 2 (AP2) impair signalling of the calcium-sensing receptor (CaSR), and cause familial hypocalciuric hypercalcaemia type 3 (FHH3).	CaSR	hypercalcaemia	846	HP_0003072	147	151	187	201	True
29325022	Mutations of the sigma subunit of the heterotetrameric adaptor-related protein complex 2 (AP2) impair signalling of the calcium-sensing receptor (CaSR), and cause familial hypocalciuric hypercalcaemia type 3 (FHH3).	type	hypercalcaemia	6445	HP_0003072	202	206	187	201	False
29325022	We hypothesized that additional rare AP2 variants may also be associated with altered CaSR function and hypercalcaemia, and sought for these by analysing&gt;111995 exomes (&gt;60706 from ExAc and dbSNP, and 51289 from the Geisinger Health System-Regeneron DiscovEHR dataset, which also contains clinical data).	CaSR	hypercalcaemia	846	HP_0003072	87	91	105	119	True
29325022	This identified 11 individuals to have 9 non-synonymous AP2 variants (Arg3His, Arg15His (x3), Ala44Thr, Phe52Tyr, Arg61His, Thr112Met, Met117Ile, Glu122Gly and Glu142Lys) with 3 of the 4 individuals who had Arg15His and Met117Ile AP2 variants having mild hypercalcaemia, thereby indicating a prevalence of FHH3-associated AP2 mutations of 7.8 per 100000 individuals.	per	hypercalcaemia	93210	HP_0003072	347	350	257	271	False
25807530	Here we demonstrate association of variants in the mitochondrial asparaginyl-tRNA synthetase NARS2 with human hearing loss and Leigh syndrome.	NARS2	hearing loss	79731	HP_0000365	93	98	110	122	False
25807530	p.Asn381Ser also disrupts dimerization of NARS2, while the hearing loss p.Val213Phe variant has no effect on NARS2 oligomerization.	NARS2	hearing loss	79731	HP_0000365	42	47	59	71	False
25807530	Our findings establish lesions in NARS2 as a new cause for nonsyndromic hearing loss and Leigh syndrome.	NARS2	hearing loss	79731	HP_0000365	34	39	72	84	False
27260292	Our data confirm the genetic heterogeneity of childhood-onset pure HSP, with SPG4/SPAST and SPG3A/ATL1 being the most frequent forms.	ATL1	heterogeneity	51062	HP_0001425	98	102	29	42	True
27260292	Our data confirm the genetic heterogeneity of childhood-onset pure HSP, with SPG4/SPAST and SPG3A/ATL1 being the most frequent forms.	SPAST	heterogeneity	6683	HP_0001425	82	87	29	42	False
29196101	This study aimed to elucidate the potential functional mechanism of miR-135b-5p in migration, invasion and epithelial-to-mesenchymal transition (EMT) of pancreatic cancer cells.	miR	cancer	220972	HP_0002664	68	71	164	170	False
29196101	This study aimed to elucidate the potential functional mechanism of miR-135b-5p in migration, invasion and epithelial-to-mesenchymal transition (EMT) of pancreatic cancer cells.	EMT	cancer	3702	HP_0002664	145	148	164	170	True
29196101	By real-time PCR and analysis of GEO database, we determined the up-regulated expression of miR-135b-5p in pancreatic cancer tissues and cell lines.	miR	cancer	220972	HP_0002664	92	95	118	124	False
29196101	Functionally, Transwell assays indicated that miR-135b-5p was a promoter for migration and invasion of pancreatic cancer cells.	miR	cancer	220972	HP_0002664	46	49	114	120	False
29196101	Additionally, immunohistochemistry staining and Western blot showed that highly expressed miR-135b-5p accelerated EMT process of pancreatic cancer cells.	miR	cancer	220972	HP_0002664	90	93	140	146	False
29196101	Additionally, immunohistochemistry staining and Western blot showed that highly expressed miR-135b-5p accelerated EMT process of pancreatic cancer cells.	EMT	cancer	3702	HP_0002664	114	117	140	146	True
29196101	Furthermore, a series of experiments and rescue experiments revealed that Nuclear Receptor Subfamily 3 Group C Member 2 (NR3C2) was the target of miR-135b-5p in pancreatic cancer cells, mediating the promotion effects of miR-135b-5p on the tumor cells migration, invasion and EMT.	miR	cancer	220972	HP_0002664	146	149	172	178	False
29196101	Furthermore, a series of experiments and rescue experiments revealed that Nuclear Receptor Subfamily 3 Group C Member 2 (NR3C2) was the target of miR-135b-5p in pancreatic cancer cells, mediating the promotion effects of miR-135b-5p on the tumor cells migration, invasion and EMT.	EMT	cancer	3702	HP_0002664	276	279	172	178	True
29196101	Furthermore, a series of experiments and rescue experiments revealed that Nuclear Receptor Subfamily 3 Group C Member 2 (NR3C2) was the target of miR-135b-5p in pancreatic cancer cells, mediating the promotion effects of miR-135b-5p on the tumor cells migration, invasion and EMT.	miR	tumor	220972	HP_0002664	146	149	240	245	False
29196101	Furthermore, a series of experiments and rescue experiments revealed that Nuclear Receptor Subfamily 3 Group C Member 2 (NR3C2) was the target of miR-135b-5p in pancreatic cancer cells, mediating the promotion effects of miR-135b-5p on the tumor cells migration, invasion and EMT.	EMT	tumor	3702	HP_0002664	276	279	240	245	True
29196101	In conclusion, miR-135b-5p, maybe a novel therapeutic target for pancreatic cancer, promoted migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2	miR	cancer	220972	HP_0002664	15	18	76	82	False
29196101	In conclusion, miR-135b-5p, maybe a novel therapeutic target for pancreatic cancer, promoted migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2	EMT	cancer	3702	HP_0002664	117	120	76	82	True
28686706	However, all experimental models of electrolytic deep vein thrombosis, tissue factor-induced pulmonary embolism, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between PlgT/T mice and wild-type mice.	Plg	deep vein thrombosis	5340	HP_0002625	217	220	49	69	False
28686706	However, all experimental models of electrolytic deep vein thrombosis, tissue factor-induced pulmonary embolism, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between PlgT/T mice and wild-type mice.	mice	deep vein thrombosis	23581	HP_0002625	224	228	49	69	False
28686706	However, all experimental models of electrolytic deep vein thrombosis, tissue factor-induced pulmonary embolism, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between PlgT/T mice and wild-type mice.	Plg	pulmonary embolism	5340	HP_0002204	217	220	93	111	False
28686706	However, all experimental models of electrolytic deep vein thrombosis, tissue factor-induced pulmonary embolism, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between PlgT/T mice and wild-type mice.	mice	pulmonary embolism	23581	HP_0002204	224	228	93	111	False
28686706	Coexistence in mice of PlgT/T and Pros1E/E did not affect pulmonary embolism symptoms, compared with those in Pros1E/E mice.	Plg	pulmonary embolism	5340	HP_0002204	23	26	58	76	False
28686706	Coexistence in mice of PlgT/T and Pros1E/E did not affect pulmonary embolism symptoms, compared with those in Pros1E/E mice.	mice	pulmonary embolism	23581	HP_0002204	15	19	58	76	False
19780717	In addition, conditions such as Gitelman's syndrome, distal renal tubular acidosis and pseudohypoaldosteronism type II, as well as a mitochondrial defect associated with hypomagnesaemia, all change the renal handling of divalent cations.	type	distal renal tubular acidosis	6445	HP_0008341	111	115	53	82	False
19780717	In addition, conditions such as Gitelman's syndrome, distal renal tubular acidosis and pseudohypoaldosteronism type II, as well as a mitochondrial defect associated with hypomagnesaemia, all change the renal handling of divalent cations.	type	pseudohypoaldosteronism	6445	HP_0008242	111	115	87	110	False
29346644	Furthermore, we detected association of rs58978565 near TNR (P = 2.3  10-8), rs28368872 near ATF7IP2 (P = 2.9  10-8) and rs142450006 near MMP9 (P = 0.0006) with progression to choroidal neovascularization but not geographic atrophy.	TNR	choroidal neovascularization	7143	HP_0011506	56	59	178	206	False
29346644	Furthermore, we detected association of rs58978565 near TNR (P = 2.3  10-8), rs28368872 near ATF7IP2 (P = 2.9  10-8) and rs142450006 near MMP9 (P = 0.0006) with progression to choroidal neovascularization but not geographic atrophy.	ATF7IP2	choroidal neovascularization	80063	HP_0011506	94	101	178	206	False
29346644	Furthermore, we detected association of rs58978565 near TNR (P = 2.3  10-8), rs28368872 near ATF7IP2 (P = 2.9  10-8) and rs142450006 near MMP9 (P = 0.0006) with progression to choroidal neovascularization but not geographic atrophy.	MMP9	choroidal neovascularization	4318	HP_0011506	140	144	178	206	False
30054853	Moreover, oncogenic activation of MYC and/or loss of a MYC antagonist, results in an imbalance in the activity of the network as a whole, leading to tumor initiation, progression and maintenance	MYC	tumor	4609	HP_0002664	34	37	149	154	True
29130599	Shared facial features are a broad and wide forehead, similar shape of the eyes with long palpebral fissures, a bulbous tip of the nose and thick lips.	tip	wide forehead	81533	HP_0000337	120	123	39	52	False
29130599	Of these five genes, the brain expressed CDK5R1 gene constitutes a good candidate for the developmental delay, while the RHOT1 gene, involved in mitochondrial trafficking, might underlie the hypotonia and the excessive fatigue	CDK5R1	developmental delay	8851	HP_0001263	41	47	90	109	False
29130599	Of these five genes, the brain expressed CDK5R1 gene constitutes a good candidate for the developmental delay, while the RHOT1 gene, involved in mitochondrial trafficking, might underlie the hypotonia and the excessive fatigue	RHOT1	developmental delay	55288	HP_0001263	121	126	90	109	False
29995789	This case-control study was aimed to evaluate the influence of cytochrome P450 family 17 subfamily A member 1 (CYP17A1) gene rs743572 polymorphism for the susceptibility to endometriosis.Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to genotype rs743572 polymorphism in 143 endometriosis patients and 148 healthy controls.	CYP17A1	endometriosis	1586	HP_0030127	111	118	173	186	False
29995789	This case-control study was aimed to evaluate the influence of cytochrome P450 family 17 subfamily A member 1 (CYP17A1) gene rs743572 polymorphism for the susceptibility to endometriosis.Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to genotype rs743572 polymorphism in 143 endometriosis patients and 148 healthy controls.	act	endometriosis	11332	HP_0030127	206	209	173	186	False
29995789	But we failed to find any obvious association of rs743572 genotypes with endometriosis stages and characteristics.T allele of rs743572 polymorphism might act as a risk factor for endometriosis, although it had no effects on the disease stages and basic features	find	endometriosis	81501	HP_0030127	17	21	73	86	False
29995789	But we failed to find any obvious association of rs743572 genotypes with endometriosis stages and characteristics.T allele of rs743572 polymorphism might act as a risk factor for endometriosis, although it had no effects on the disease stages and basic features	act	endometriosis	11332	HP_0030127	102	105	73	86	False
30258207	Biallelic mutations in IBA57 cause a mitochondrial disorder with a broad phenotypic spectrum that ranges from severe intellectual disability to adolescent-onset spastic paraplegia.	IBA57	intellectual disability	200205	HP_0001249	23	28	117	140	False
30258207	Biallelic mutations in IBA57 cause a mitochondrial disorder with a broad phenotypic spectrum that ranges from severe intellectual disability to adolescent-onset spastic paraplegia.	IBA57	spastic paraplegia	200205	HP_0001258	23	28	161	179	True
12620391	Progressive rod-cone degeneration (prcd) is a canine retinal disease that maps to the centromeric end of CFA9 in a region of synteny with the distal part of HSA17q.	prcd	retinal disease	768206	HP_0000479	35	39	53	68	True
12620391	Progressive rod-cone degeneration (prcd) is a canine retinal disease that maps to the centromeric end of CFA9 in a region of synteny with the distal part of HSA17q.	end	retinal disease	2022	HP_0000479	98	101	53	68	True
30147320	Abnormal prion proteins are responsible for several fatal neurodegenerative diseases in humans and in animals, including Creutzfeldt-Jakob disease (CJD), Gerstmann-Strussler-Scheinker disease, and fatal familial insomnia.	CJD	neurodegenerative diseases	5621	HP_0002180	148	151	58	84	False
30147320	In addition, different prion mutations were suggested to play a possible role in additional phenotypes, such as Alzheimer's type pathology, spongiform encephalopathy, or frontotemporal dementia.	type	encephalopathy	6445	HP_0001298	97	101	151	165	False
30147320	In addition, different prion mutations were suggested to play a possible role in additional phenotypes, such as Alzheimer's type pathology, spongiform encephalopathy, or frontotemporal dementia.	type	frontotemporal dementia	6445	HP_0002145	97	101	170	193	False
30147320	Since prion diseases have quite heterogeneous phenotypes, a complex analysis, a combination of genetic screening, cerebrospinal fluid biomarker analysis and imaging technologies could improve the early disease diagnosis	type	heterogeneous	6445	HP_0001425	51	55	32	45	False
19236704	Corneal dystrophies may have a simple autosomal dominant, autosomal recessive or X-linked recessive Mendelian mode of inheritance.	simple	autosomal recessive	9516	HP_0000007	31	37	58	77	False
19236704	Corneal dystrophies may have a simple autosomal dominant, autosomal recessive or X-linked recessive Mendelian mode of inheritance.	simple	mode of inheritance	9516	HP_0000005	31	37	110	129	False
19236704	Different corneal dystrophies are caused by mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.	CHST6	corneal dystrophies	4166	HP_0001131	61	66	10	29	True
19236704	Different corneal dystrophies are caused by mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.	KRT3	corneal dystrophies	3850	HP_0001131	68	72	10	29	True
19236704	Different corneal dystrophies are caused by mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.	KRT12	corneal dystrophies	3859	HP_0001131	74	79	10	29	True
19236704	Different corneal dystrophies are caused by mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.	PIP5K3	corneal dystrophies	200576	HP_0001131	81	87	10	29	True
19236704	Different corneal dystrophies are caused by mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.	SLC4A11	corneal dystrophies	83959	HP_0001131	89	96	10	29	True
19236704	Different corneal dystrophies are caused by mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.	TACSTD2	corneal dystrophies	4070	HP_0001131	98	105	10	29	True
19236704	Different corneal dystrophies are caused by mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.	TGFBI	corneal dystrophies	7045	HP_0001131	107	112	10	29	True
19236704	Different corneal dystrophies are caused by mutations in the CHST6, KRT3, KRT12, PIP5K3, SLC4A11, TACSTD2, TGFBI, and UBIAD1 genes.	UBIAD1	corneal dystrophies	29914	HP_0001131	118	124	10	29	True
29475025	In the second example, Mdx mice, a model for Duchenne muscular dystrophy, were intravenously injected with AAV8-BGN.	BGN	muscular dystrophy	633	HP_0003560	112	115	54	72	False
29475025	In the second example, Mdx mice, a model for Duchenne muscular dystrophy, were intravenously injected with AAV8-BGN.	mice	muscular dystrophy	23581	HP_0003560	27	31	54	72	False
28587924	PRMT7 plays important roles in the regulation of gene expression, splicing, DNA damage, paternal imprinting, cancer and metastasis.	PRMT7	cancer	54496	HP_0002664	0	5	109	115	False
28587924	PRMT7 plays important roles in the regulation of gene expression, splicing, DNA damage, paternal imprinting, cancer and metastasis.	damage	cancer	51438	HP_0002664	80	86	109	115	False
28553959	Individuals with biallelic TRIP13 or BUB1B mutations have a high risk of embryonal tumors, and here we show that their cells display severe SAC impairment.	TRIP13	tumor	9319	HP_0002664	27	33	83	88	True
28553959	Individuals with biallelic TRIP13 or BUB1B mutations have a high risk of embryonal tumors, and here we show that their cells display severe SAC impairment.	SAC	tumor	55811	HP_0002664	140	143	83	88	False
28553959	Individuals with biallelic TRIP13 or BUB1B mutations have a high risk of embryonal tumors, and here we show that their cells display severe SAC impairment.	BUB1B	tumor	701	HP_0002664	37	42	83	88	True
28553959	MVA due to biallelic CEP57 mutations, or of unknown cause, is not associated with embryonal tumors and cells from these individuals show minimal SAC deficiency.	SAC	tumor	55811	HP_0002664	145	148	92	97	False
28553959	MVA due to biallelic CEP57 mutations, or of unknown cause, is not associated with embryonal tumors and cells from these individuals show minimal SAC deficiency.	CEP57	tumor	9702	HP_0002664	21	26	92	97	True
27529670	The extracellular matrix (ECM) is a known factor in tumor invasion, and differences in the ECM of nontumor brain and glioblastoma has been proven.	ECM	tumor	22915	HP_0002664	26	29	52	57	False
27529670	The extracellular matrix (ECM) is a known factor in tumor invasion, and differences in the ECM of nontumor brain and glioblastoma has been proven.	ECM	glioblastoma	22915	HP_0012174	26	29	117	129	False
29656859	The spontaneous mutant mouse staggerer, with an ataxic gait caused by neurodegeneration of cerebellar Purkinje cells, was discovered two decades ago to result from homozygous intragenic Rora deletions.	ago	ataxic gait	55294	HP_0002066	145	148	48	59	False
29656859	The spontaneous mutant mouse staggerer, with an ataxic gait caused by neurodegeneration of cerebellar Purkinje cells, was discovered two decades ago to result from homozygous intragenic Rora deletions.	Rora	ataxic gait	6095	HP_0002066	186	190	48	59	False
29656859	Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving RORA in 16 individuals from 13 families with variable neurodevelopmental delay and intellectual disability (ID)-associated autistic features, cerebellar ataxia, and epilepsy.	RORA	neurodevelopmental delay	6095	HP_0012758	308	312	362	386	True
29656859	Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving RORA in 16 individuals from 13 families with variable neurodevelopmental delay and intellectual disability (ID)-associated autistic features, cerebellar ataxia, and epilepsy.	RORA	intellectual disability	6095	HP_0001249	308	312	391	414	True
29656859	Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving RORA in 16 individuals from 13 families with variable neurodevelopmental delay and intellectual disability (ID)-associated autistic features, cerebellar ataxia, and epilepsy.	RORA	cerebellar ataxia	6095	HP_0001251	308	312	450	467	True
29656859	Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving RORA in 16 individuals from 13 families with variable neurodevelopmental delay and intellectual disability (ID)-associated autistic features, cerebellar ataxia, and epilepsy.	RORA	epilepsy	6095	HP_0001250	308	312	473	481	True
28752484	Small series of cases have documented the co-occurrence of ganglioneuroma with a pheochromocytoma (Pheo)/paraganglioma (PGL) component.	PGL	pheochromocytoma	6392	HP_0002666	120	123	81	97	True
28752484	Small series of cases have documented the co-occurrence of ganglioneuroma with a pheochromocytoma (Pheo)/paraganglioma (PGL) component.	PGL	paraganglioma	6392	HP_0002668	120	123	105	118	True
28752484	Mutations of the succinate dehydrogenase (SDH) complex subunits (A, B, C, D, and SDHAF2) have been implicated in predicting metastatic behavior and in identifying possible paraganglioma syndromes.	SDH	paraganglioma	1757	HP_0002668	42	45	172	185	False
28752484	One patient had a retroperitoneal composite PGL-ganglioneuroma in the setting of neurofibromatosis type 1.	PGL	neurofibromatosis	6392	HP_0001067	44	47	81	98	False
28752484	One patient had a retroperitoneal composite PGL-ganglioneuroma in the setting of neurofibromatosis type 1.	type	neurofibromatosis	6445	HP_0001067	99	103	81	98	False
26147992	Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP) are retinal degenerative diseases which cause severe retinal dystrophy affecting the photoreceptors.	LCA	retinal dystrophy	1211	HP_0000556	28	31	116	133	False
26147992	LCA is predominantly inherited as an autosomal recessive trait and contributes to 5% of all retinal dystrophies; whereas RP is inherited by all the Mendelian pattern of inheritance and both are leading causes of visual impairment in children and young adults.	LCA	autosomal recessive	1211	HP_0000007	0	3	37	56	False
26147992	LCA is predominantly inherited as an autosomal recessive trait and contributes to 5% of all retinal dystrophies; whereas RP is inherited by all the Mendelian pattern of inheritance and both are leading causes of visual impairment in children and young adults.	LCA	retinal dystrophies	1211	HP_0000556	0	3	92	111	False
26147992	LCA is predominantly inherited as an autosomal recessive trait and contributes to 5% of all retinal dystrophies; whereas RP is inherited by all the Mendelian pattern of inheritance and both are leading causes of visual impairment in children and young adults.	LCA	visual impairment	1211	HP_0000505	0	3	212	229	False
26147992	Here we have studied eleven consanguineous LCA and one autosomal recessive RP (arRP) south Indian families to know the prevalence of mutations in known genes and also to know the involvement of novel loci, if any.	LCA	autosomal recessive	1211	HP_0000007	43	46	55	74	False
28793245	It has been reported that functionally distinct cancer stem cells (CSCs) exist in human bladder cancer (BCa).	BCa	cancer	29760	HP_0002664	104	107	48	54	True
28793245	Sox2 expression is absent in normal urothelial cells, but it begins to be expressed in pre-neoplastic bladder tumors and continues to be expressed in invasive mouse BCa.	BCa	tumors	29760	HP_0002664	165	168	110	116	True
28793245	Sox2 expression is absent in normal urothelial cells, but it begins to be expressed in pre-neoplastic bladder tumors and continues to be expressed in invasive mouse BCa.	Sox2	tumors	6657	HP_0002664	0	4	110	116	True
28793245	Using s as a reporter of Sox2 transcriptional expression, we demonstrated that Sox2-expressing cells mark a subpopulation of tumor cells that fuel the growth of established BCa.	BCa	tumor	29760	HP_0002664	173	176	125	130	True
28793245	Using s as a reporter of Sox2 transcriptional expression, we demonstrated that Sox2-expressing cells mark a subpopulation of tumor cells that fuel the growth of established BCa.	Sox2	tumor	6657	HP_0002664	25	29	125	130	True
28793245	Using s as a reporter of Sox2 transcriptional expression, we demonstrated that Sox2-expressing cells mark a subpopulation of tumor cells that fuel the growth of established BCa.	mark	tumor	4139	HP_0002664	101	105	125	130	False
28793245	Ablation of Sox2-expressing cells within primary invasive BCa led to enhanced tumor regression, supporting the essential role of SOX2-positive cells in regulating BCa maintenance and progression.	BCa	tumor	29760	HP_0002664	58	61	78	83	True
28793245	Ablation of Sox2-expressing cells within primary invasive BCa led to enhanced tumor regression, supporting the essential role of SOX2-positive cells in regulating BCa maintenance and progression.	Sox2	tumor	6657	HP_0002664	12	16	78	83	True
27827380	While examining pedigrees of JEB patients with LAMA3 mutations, we observed that heterozygous carriers of functional null mutations displayed subtle enamel pitting in the absence of skin fragility or other JEB symptoms.	LAMA3	skin fragility	3910	HP_0001030	47	52	182	196	False
27827380	The reported enamel abnormality in LAMA3 mutation carriers could be attributed to a half dose effect of the laminin 3 chain (haploinsufficiency)	LAMA3	enamel abnormality	3910	HP_0000682	35	40	13	31	False
25882839	RNF170 is an endoplasmic reticulum membrane ubiquitin ligase that contributes to the ubiquitination of activated inositol 1,4,5-trisphosphate (IP3) receptors, and also, when point mutated (arginine to cysteine at position 199), causes autosomal dominant sensory ataxia (ADSA), a disease characterized by neurodegeneration in the posterior columns of the spinal cord.	ADSA	ataxia	81790	HP_0001251	270	274	262	268	False
25882839	RNF170 is an endoplasmic reticulum membrane ubiquitin ligase that contributes to the ubiquitination of activated inositol 1,4,5-trisphosphate (IP3) receptors, and also, when point mutated (arginine to cysteine at position 199), causes autosomal dominant sensory ataxia (ADSA), a disease characterized by neurodegeneration in the posterior columns of the spinal cord.	RNF170	ataxia	81790	HP_0001251	0	6	262	268	False
30209346	With alignment to T2DM susceptibility genes and deafness genes published, KCNJ11 was found to be the only overlapped gene.	KCNJ11	deafness	3767	HP_0000365	74	80	48	56	True
27662660	We evaluated the molecular heterogeneity of sCRC tumors based on simultaneous assessment of the overall GEP of both coding mRNA and non-coding RNA genes in primary sCRC tumor samples from 23 consecutive patients and their paired liver metastases.	GEP	heterogeneity	2768	HP_0001425	104	107	27	40	False
27662660	We evaluated the molecular heterogeneity of sCRC tumors based on simultaneous assessment of the overall GEP of both coding mRNA and non-coding RNA genes in primary sCRC tumor samples from 23 consecutive patients and their paired liver metastases.	GEP	tumors	2768	HP_0002664	104	107	49	55	False
27662660	We evaluated the molecular heterogeneity of sCRC tumors based on simultaneous assessment of the overall GEP of both coding mRNA and non-coding RNA genes in primary sCRC tumor samples from 23 consecutive patients and their paired liver metastases.	GEP	tumor	2768	HP_0002664	104	107	169	174	False
27662660	RHOA, SMAD2, SMAD4, SMAD5, SMAD6, BMPR1A, SMAD7 and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis	SMAD2	tumor	4087	HP_0002664	6	11	131	136	False
27662660	RHOA, SMAD2, SMAD4, SMAD5, SMAD6, BMPR1A, SMAD7 and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis	MYC	tumor	4609	HP_0002664	52	55	131	136	True
27662660	RHOA, SMAD2, SMAD4, SMAD5, SMAD6, BMPR1A, SMAD7 and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis	SMAD4	tumor	4089	HP_0002664	13	18	131	136	True
27662660	RHOA, SMAD2, SMAD4, SMAD5, SMAD6, BMPR1A, SMAD7 and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis	SMAD5	tumor	4090	HP_0002664	20	25	131	136	False
27662660	RHOA, SMAD2, SMAD4, SMAD5, SMAD6, BMPR1A, SMAD7 and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis	SMAD6	tumor	4091	HP_0002664	27	32	131	136	False
27662660	RHOA, SMAD2, SMAD4, SMAD5, SMAD6, BMPR1A, SMAD7 and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis	BMPR1A	tumor	657	HP_0002664	34	40	131	136	True
27662660	RHOA, SMAD2, SMAD4, SMAD5, SMAD6, BMPR1A, SMAD7 and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis	SMAD7	tumor	4092	HP_0002664	42	47	131	136	False
27840983	We found that RFX5 is significantly upregulated in hepatocellular carcinoma (HCC) tumors and cell lines compared with non-tumor tissues in mRNA expression levels, but it fails to induce the expression of MHCII.	RFX5	hepatocellular carcinoma	5993	HP_0001402	14	18	51	75	False
27840983	We found that RFX5 is significantly upregulated in hepatocellular carcinoma (HCC) tumors and cell lines compared with non-tumor tissues in mRNA expression levels, but it fails to induce the expression of MHCII.	HCC	hepatocellular carcinoma	84668	HP_0001402	77	80	51	75	False
27840983	We found that RFX5 is significantly upregulated in hepatocellular carcinoma (HCC) tumors and cell lines compared with non-tumor tissues in mRNA expression levels, but it fails to induce the expression of MHCII.	RFX5	tumors	5993	HP_0002664	14	18	82	88	False
27840983	We found that RFX5 is significantly upregulated in hepatocellular carcinoma (HCC) tumors and cell lines compared with non-tumor tissues in mRNA expression levels, but it fails to induce the expression of MHCII.	HCC	tumors	84668	HP_0002664	77	80	82	88	False
27840983	We found that RFX5 is significantly upregulated in hepatocellular carcinoma (HCC) tumors and cell lines compared with non-tumor tissues in mRNA expression levels, but it fails to induce the expression of MHCII.	RFX5	tumor	5993	HP_0002664	14	18	122	127	False
27840983	We found that RFX5 is significantly upregulated in hepatocellular carcinoma (HCC) tumors and cell lines compared with non-tumor tissues in mRNA expression levels, but it fails to induce the expression of MHCII.	HCC	tumor	84668	HP_0002664	77	80	122	127	False
30588709	The primary objective of the study was to estimate the maximum tolerated dose (MTD) and/or recommended phase II dose (RP2D) of oral alpelisib in patients with advanced solid tumors who had progressed despite standard therapy.	MTD	tumors	4493	HP_0002664	79	82	174	180	False
24705504	Friedreich ataxia (FRDA) is the most frequent progressive autosomal recessive disorder associated with unstable expansion of GAA trinucleotide repeats in the first intron of the FXN gene, which encodes for the mitochondrial frataxin protein.	FRDA	ataxia	2395	HP_0001251	19	23	11	17	True
24705504	Friedreich ataxia (FRDA) is the most frequent progressive autosomal recessive disorder associated with unstable expansion of GAA trinucleotide repeats in the first intron of the FXN gene, which encodes for the mitochondrial frataxin protein.	GAA	ataxia	2548	HP_0001251	125	128	11	17	False
24705504	Friedreich ataxia (FRDA) is the most frequent progressive autosomal recessive disorder associated with unstable expansion of GAA trinucleotide repeats in the first intron of the FXN gene, which encodes for the mitochondrial frataxin protein.	FXN	ataxia	2395	HP_0001251	178	181	11	17	True
28448568	The therapeutic capacity of fenretinide (N-[4-hydroxyphenyl] retinamide; 4-HPR) has been demonstrated for several conditions, including cancer, obesity, diabetes, and ocular disease.	HPR	cancer	3250	HP_0002664	75	78	136	142	False
28448568	The therapeutic capacity of fenretinide (N-[4-hydroxyphenyl] retinamide; 4-HPR) has been demonstrated for several conditions, including cancer, obesity, diabetes, and ocular disease.	HPR	obesity	3250	HP_0001513	75	78	144	151	False
28448568	For example, administration of 3-keto-HPR instead of fenretinide may be preferential if inhibition of SCD1 or DES1 activity is the goal (cancer), while MPR may be better for BCO1 modulation (carotenoid metabolism).	HPR	cancer	3250	HP_0002664	38	41	137	143	False
28448568	For example, administration of 3-keto-HPR instead of fenretinide may be preferential if inhibition of SCD1 or DES1 activity is the goal (cancer), while MPR may be better for BCO1 modulation (carotenoid metabolism).	DES1	cancer	8560	HP_0002664	110	114	137	143	False
28448568	For example, administration of 3-keto-HPR instead of fenretinide may be preferential if inhibition of SCD1 or DES1 activity is the goal (cancer), while MPR may be better for BCO1 modulation (carotenoid metabolism).	BCO1	cancer	53630	HP_0002664	174	178	137	143	False
29666474	In humans, mutations in CISD2 result in Wolfram syndrome 2, a disease in which the patients display juvenile diabetes, neuropsychiatric disorders and defective platelet aggregation.	CISD2	defective platelet aggregation	493856	HP_0003540	24	29	150	180	True
23418071	The cause was identified in only 7 patients and included methylmalonic aciduria, meningoencephalitis, perinatal hypoxic-ischemic injury, large genomic deletion on chromosome 7q21, translocase of inner mitochondrial membrane 8 homolog A (TIMM8A) mutation (Mohr-Tranebjaerg syndrome), and chromosome 2 open reading frame 37 (C2orf37) mutation (Woodhouse-Sakati syndrome).	TIMM8A	methylmalonic aciduria	1678	HP_0012120	237	243	57	79	False
23418071	The cause was identified in only 7 patients and included methylmalonic aciduria, meningoencephalitis, perinatal hypoxic-ischemic injury, large genomic deletion on chromosome 7q21, translocase of inner mitochondrial membrane 8 homolog A (TIMM8A) mutation (Mohr-Tranebjaerg syndrome), and chromosome 2 open reading frame 37 (C2orf37) mutation (Woodhouse-Sakati syndrome).	C2orf37	methylmalonic aciduria	80067	HP_0012120	323	330	57	79	False
28742274	Hemangioblastomas (HBs) are uncommon tumors characterized by the presence of inactivating alterations in the von Hippel-Lindau (VHL) gene in inherited cases and by infrequent somatic mutation in sporadic entities.	VHL	tumors	7428	HP_0002664	128	131	37	43	True
28742274	Hemangioblastomas (HBs) are uncommon tumors characterized by the presence of inactivating alterations in the von Hippel-Lindau (VHL) gene in inherited cases and by infrequent somatic mutation in sporadic entities.	VHL	somatic mutation	7428	HP_0001428	128	131	175	191	False
28742274	Hemangioblastomas (HBs) are uncommon tumors characterized by the presence of inactivating alterations in the von Hippel-Lindau (VHL) gene in inherited cases and by infrequent somatic mutation in sporadic entities.	VHL	sporadic	7428	HP_0003745	128	131	195	203	True
28742274	Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.	VHL	sporadic	7428	HP_0003745	83	86	90	98	True
28742274	Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.	PCDH9	sporadic	5101	HP_0003745	55	60	90	98	False
28742274	Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.	KLHL12	sporadic	59349	HP_0003745	62	68	90	98	False
28742274	Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.	DCAF4L1	sporadic	285429	HP_0003745	70	77	90	98	False
28742274	Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.	ZNF814	sporadic	730051	HP_0003745	108	114	90	98	False
28742274	Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.	DLG2	sporadic	2305	HP_0003745	116	120	90	98	False
28742274	Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.	RIMS1	sporadic	22999	HP_0003745	122	127	90	98	False
28742274	Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.	PNN	sporadic	5411	HP_0003745	129	132	90	98	False
28742274	Genes harboring the most significant mutations include PCDH9, KLHL12, DCAF4L1, and VHL in sporadic HBs, and ZNF814, DLG2, RIMS1, PNN, and MUC7 in familial HBs.	MUC7	sporadic	4589	HP_0003745	138	142	90	98	False
28742274	Five genes, including OTOGL, PLCB4, SCEL, THSD4, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, CWC27, and LAMA2, have CNVs in the five patients with familial HBs.	OTOGL	sporadic	283310	HP_0003745	22	27	94	102	False
28742274	Five genes, including OTOGL, PLCB4, SCEL, THSD4, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, CWC27, and LAMA2, have CNVs in the five patients with familial HBs.	PLCB4	sporadic	5332	HP_0003745	29	34	94	102	False
28742274	Five genes, including OTOGL, PLCB4, SCEL, THSD4, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, CWC27, and LAMA2, have CNVs in the five patients with familial HBs.	SCEL	sporadic	8796	HP_0003745	36	40	94	102	False
28742274	Five genes, including OTOGL, PLCB4, SCEL, THSD4, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, CWC27, and LAMA2, have CNVs in the five patients with familial HBs.	THSD4	sporadic	79875	HP_0003745	42	47	94	102	False
28742274	Five genes, including OTOGL, PLCB4, SCEL, THSD4, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, CWC27, and LAMA2, have CNVs in the five patients with familial HBs.	WWOX	sporadic	51741	HP_0003745	53	57	94	102	False
28742274	Five genes, including OTOGL, PLCB4, SCEL, THSD4, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, CWC27, and LAMA2, have CNVs in the five patients with familial HBs.	ABCA6	sporadic	23460	HP_0003745	135	140	94	102	False
28742274	Five genes, including OTOGL, PLCB4, SCEL, THSD4, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, CWC27, and LAMA2, have CNVs in the five patients with familial HBs.	CWC27	sporadic	10283	HP_0003745	142	147	94	102	False
28742274	Five genes, including OTOGL, PLCB4, SCEL, THSD4, and WWOX, have CNVs in the six patients with sporadic HBs, and three genes, including ABCA6, CWC27, and LAMA2, have CNVs in the five patients with familial HBs.	LAMA2	sporadic	3908	HP_0003745	153	158	94	102	False
29562958	Our study aimed to investigate the roles and possible regulatory mechanism of miR-1277 in the development of hepatocellular carcinoma (HCC).	HCC	hepatocellular carcinoma	84668	HP_0001402	135	138	109	133	False
28063004	Tubulin alpha 8 (TUBA8) is highly abundant in murine liver tumors suggesting a role in hepatocellular carcinoma (HCC).	TUBA8	tumors	51807	HP_0002664	17	22	59	65	False
28063004	Tubulin alpha 8 (TUBA8) is highly abundant in murine liver tumors suggesting a role in hepatocellular carcinoma (HCC).	HCC	tumors	84668	HP_0002664	113	116	59	65	False
28063004	Tubulin alpha 8 (TUBA8) is highly abundant in murine liver tumors suggesting a role in hepatocellular carcinoma (HCC).	TUBA8	hepatocellular carcinoma	51807	HP_0001402	17	22	87	111	False
28063004	Tubulin alpha 8 (TUBA8) is highly abundant in murine liver tumors suggesting a role in hepatocellular carcinoma (HCC).	HCC	hepatocellular carcinoma	84668	HP_0001402	113	116	87	111	False
27713038	High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.	NTHL1	cancer	4913	HP_0002664	143	148	107	113	True
27713038	High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.	RPS20	cancer	6224	HP_0002664	150	155	107	113	False
27713038	High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.	FANCM	cancer	57697	HP_0002664	157	162	107	113	True
27713038	High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.	FAN1	cancer	22909	HP_0002664	164	168	107	113	True
27713038	High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.	BUB1	cancer	699	HP_0002664	176	180	107	113	True
27713038	High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.	BUB3	cancer	9184	HP_0002664	182	186	107	113	True
27713038	High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.	LRP6	cancer	4040	HP_0002664	188	192	107	113	False
27713038	High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal cancer (CRC); germline mutations in NTHL1, RPS20, FANCM, FAN1, TP53, BUB1, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.	PTPN12	cancer	5782	HP_0002664	198	204	107	113	False
27713038	We found sufficient evidence for NTHL1 to be considered a CRC predisposition gene-members of 3 unrelated Dutch families were homozygous for inactivating p.Gln90Ter mutations; a Canadian woman with polyposis, CRC, and multiple tumors was reported to be heterozygous for the inactivating NTHL1 p.Gln90Ter/c.709+1G&gt;A mutations; and a man with polyposis was reported to carry p.Gln90Ter/p.Gln287Ter; whereas no inactivating homozygous or compound heterozygous mutations were detected in controls.	NTHL1	tumors	4913	HP_0002664	33	38	226	232	True
27749845	Oral and pharyngeal cancers combined were associated with loci at 6p21.32 (rs3828805, HLA-DQB1), 10q26.13 (rs201982221, LHPP) and 11p15.4 (rs1453414, OR52N2-TRIM5).	HLA-DQB1	cancer	3119	HP_0002664	86	94	20	26	False
27749845	Oral and pharyngeal cancers combined were associated with loci at 6p21.32 (rs3828805, HLA-DQB1), 10q26.13 (rs201982221, LHPP) and 11p15.4 (rs1453414, OR52N2-TRIM5).	LHPP	cancer	64077	HP_0002664	120	124	20	26	False
27749845	Oral and pharyngeal cancers combined were associated with loci at 6p21.32 (rs3828805, HLA-DQB1), 10q26.13 (rs201982221, LHPP) and 11p15.4 (rs1453414, OR52N2-TRIM5).	OR52N2	cancer	390077	HP_0002664	150	156	20	26	False
27749845	Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L).	GPN1	cancer	11321	HP_0002664	68	72	5	11	False
27749845	Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L).	LAMC3	cancer	10319	HP_0002664	97	102	5	11	False
27749845	Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L).	CDKN2B	cancer	1030	HP_0002664	159	165	5	11	True
27749845	Oral cancer was associated with two new regions, 2p23.3 (rs6547741, GPN1) and 9q34.12 (rs928674, LAMC3), and with known cancer-related loci-9p21.3 (rs8181047, CDKN2B-AS1) and 5p15.33 (rs10462706, CLPTM1L).	CLPTM1L	cancer	81037	HP_0002664	196	203	5	11	False
27749845	Oropharyngeal cancer associations were limited to the human leukocyte antigen (HLA) region, and classical HLA allele imputation showed a protective association with the class II haplotype HLA-DRB1*1301-HLA-DQA1*0103-HLA-DQB1*0603 (odds ratio (OR) = 0.59, P = 2.7  10<sup>-9</sup>).	HLA-DQB1	cancer	3119	HP_0002664	216	224	14	20	False
29601978	A better understanding of Preb gene expression, during the pathogenesis of hepatic insulin resistance, could ultimately provide new avenues for therapies for metabolic syndrome, obesity, and type-2 diabetes mellitus, disorders whose worldwide incidences are increasing drastically	Preb	obesity	10113	HP_0001513	26	30	178	185	False
29700912	The tumor-node-metastasis (TNM) classification, the presence of a mucinous component, and signet ring cells are well-known criteria for identifying patients at a high risk for recurrence and determining the therapeutic approach for early-stage colon cancer (eCC).	TNM	tumor	10178	HP_0002664	27	30	4	9	False
29700912	The tumor-node-metastasis (TNM) classification, the presence of a mucinous component, and signet ring cells are well-known criteria for identifying patients at a high risk for recurrence and determining the therapeutic approach for early-stage colon cancer (eCC).	TNM	cancer	10178	HP_0002664	27	30	250	256	False
29700912	The aims of the present study were to evaluate the relation of dysregulated MACC1, c-MET, and NM23-H1 expression with the histopathological features of tumors in recurrence formation in eCC cases.	MACC1	tumor	346389	HP_0002664	76	81	152	157	False
29700912	The aims of the present study were to evaluate the relation of dysregulated MACC1, c-MET, and NM23-H1 expression with the histopathological features of tumors in recurrence formation in eCC cases.	MET	tumor	79811	HP_0002664	85	88	152	157	False
29700912	The aims of the present study were to evaluate the relation of dysregulated MACC1, c-MET, and NM23-H1 expression with the histopathological features of tumors in recurrence formation in eCC cases.	NM23	tumor	4830	HP_0002664	94	98	152	157	True
29700912	The aims of the present study were to evaluate the relation of dysregulated MACC1, c-MET, and NM23-H1 expression with the histopathological features of tumors in recurrence formation in eCC cases.	H1	tumor	25932	HP_0002664	99	101	152	157	False
29700912	The relationship between the altered expression of MACC1, c-MET, and NM23-H1 and pathological microenvironmental features, including the presence of tumor budding and desmoplasia, were assessed.	MACC1	tumor	346389	HP_0002664	51	56	149	154	False
29700912	The relationship between the altered expression of MACC1, c-MET, and NM23-H1 and pathological microenvironmental features, including the presence of tumor budding and desmoplasia, were assessed.	MET	tumor	79811	HP_0002664	60	63	149	154	False
29700912	The relationship between the altered expression of MACC1, c-MET, and NM23-H1 and pathological microenvironmental features, including the presence of tumor budding and desmoplasia, were assessed.	NM23	tumor	4830	HP_0002664	69	73	149	154	True
29700912	The relationship between the altered expression of MACC1, c-MET, and NM23-H1 and pathological microenvironmental features, including the presence of tumor budding and desmoplasia, were assessed.	H1	tumor	25932	HP_0002664	74	76	149	154	False
29700912	In addition, the coexistence of high MACC1 and low NM23-H1 expression and tumor budding was associated with short OS (p&lt;0.001).	MACC1	tumor	346389	HP_0002664	37	42	74	79	False
29700912	In addition, the coexistence of high MACC1 and low NM23-H1 expression and tumor budding was associated with short OS (p&lt;0.001).	NM23	tumor	4830	HP_0002664	51	55	74	79	True
29700912	In addition, the coexistence of high MACC1 and low NM23-H1 expression and tumor budding was associated with short OS (p&lt;0.001).	H1	tumor	25932	HP_0002664	56	58	74	79	False
29700912	We suggest that the combination of reduced NM23-H1, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy	MACC1	tumor	346389	HP_0002664	60	65	87	92	False
29700912	We suggest that the combination of reduced NM23-H1, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy	NM23	tumor	4830	HP_0002664	43	47	87	92	True
29700912	We suggest that the combination of reduced NM23-H1, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy	H1	tumor	25932	HP_0002664	48	50	87	92	False
29700912	We suggest that the combination of reduced NM23-H1, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy	aid	tumor	57379	HP_0002664	167	170	87	92	False
29700912	We suggest that the combination of reduced NM23-H1, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy	MACC1	cancer	346389	HP_0002664	60	65	222	228	False
29700912	We suggest that the combination of reduced NM23-H1, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy	NM23	cancer	4830	HP_0002664	43	47	222	228	True
29700912	We suggest that the combination of reduced NM23-H1, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy	H1	cancer	25932	HP_0002664	48	50	222	228	False
29700912	We suggest that the combination of reduced NM23-H1, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy	aid	cancer	57379	HP_0002664	167	170	222	228	False
30618607	Deficits in miRNA biogenesis have been linked to neurological deficits in humans, and widespread changes in miRNA levels occur in epilepsy, traumatic brain injury, and in response to less dramatic brain insults in rodent models.	miR	epilepsy	220972	HP_0001250	12	15	130	138	False
30618607	Recently, microdeletions encompassing <i>MIR137HG</i>, the host gene which encodes the miRNA miR-137, have been linked to autism and intellectual disability, and genome wide association studies have linked this locus to schizophrenia.	miR	autism	220972	HP_0000717	87	90	122	128	False
30618607	Recently, microdeletions encompassing <i>MIR137HG</i>, the host gene which encodes the miRNA miR-137, have been linked to autism and intellectual disability, and genome wide association studies have linked this locus to schizophrenia.	miR	intellectual disability	220972	HP_0001249	87	90	133	156	False
28291684	To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, MAPK10, MAP3K12, MAPK3, MAPK1, MAPK7 and VEGF), were calculated.	MAPK8	cancer	5599	HP_0002664	221	226	201	207	False
28291684	To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, MAPK10, MAP3K12, MAPK3, MAPK1, MAPK7 and VEGF), were calculated.	MAPK10	cancer	5602	HP_0002664	228	234	201	207	False
28291684	To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, MAPK10, MAP3K12, MAPK3, MAPK1, MAPK7 and VEGF), were calculated.	MAP3K12	cancer	7786	HP_0002664	236	243	201	207	False
28291684	To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, MAPK10, MAP3K12, MAPK3, MAPK1, MAPK7 and VEGF), were calculated.	MAPK3	cancer	5595	HP_0002664	245	250	201	207	False
28291684	To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, MAPK10, MAP3K12, MAPK3, MAPK1, MAPK7 and VEGF), were calculated.	MAPK1	cancer	5594	HP_0002664	252	257	201	207	True
28291684	To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, MAPK10, MAP3K12, MAPK3, MAPK1, MAPK7 and VEGF), were calculated.	MAPK7	cancer	5598	HP_0002664	259	264	201	207	False
28291684	To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in cancer development (MAPK8, MAPK10, MAP3K12, MAPK3, MAPK1, MAPK7 and VEGF), were calculated.	VEGF	cancer	7422	HP_0002664	269	273	201	207	False
22907430	Motif analysis of tumor-specific methylated regions identified enrichment of binding sites for several neural cell fate-specifying transcription factors including NEUROD1, HAND1, ZNF423 and REST.	fate	tumor	89885	HP_0002664	115	119	18	23	False
22907430	Motif analysis of tumor-specific methylated regions identified enrichment of binding sites for several neural cell fate-specifying transcription factors including NEUROD1, HAND1, ZNF423 and REST.	NEUROD1	tumor	4760	HP_0002664	163	170	18	23	False
22907430	Motif analysis of tumor-specific methylated regions identified enrichment of binding sites for several neural cell fate-specifying transcription factors including NEUROD1, HAND1, ZNF423 and REST.	HAND1	tumor	9421	HP_0002664	172	177	18	23	False
22907430	Motif analysis of tumor-specific methylated regions identified enrichment of binding sites for several neural cell fate-specifying transcription factors including NEUROD1, HAND1, ZNF423 and REST.	ZNF423	tumor	23090	HP_0002664	179	185	18	23	False
22907430	We hypothesize that two potential mechanisms, loss of cell fate-determining transcription factors by methylation of their promoters and functional inactivation of their corresponding genomic-binding sites by DNA methylation, can promote a differentiation defect of neuroendocrine cells thus enhancing the ability of tumor progenitor cells to transition toward SCLC.	fate	tumor	89885	HP_0002664	59	63	316	321	False
30531691	BACKGROUND Lin28 is a gene involved in many biological processes, including development, glucose metabolism, and tumorigenesis.	Lin28	tumor	79727	HP_0002664	11	16	113	118	False
30531691	The role of c-Myc (a target gene of let-7) and the Lin28-let-7-c-Myc pathway in the growth and malignancy of thyroid cancer is unclear.	Lin28	cancer	79727	HP_0002664	51	56	117	123	False
30531691	The role of c-Myc (a target gene of let-7) and the Lin28-let-7-c-Myc pathway in the growth and malignancy of thyroid cancer is unclear.	c-Myc	cancer	4609	HP_0002664	12	17	117	123	True
30531691	The purpose of the present study was to evaluate the expression of Lin28A, let-7a, and c-Myc in human papillary thyroid carcinoma (PTC) and to investigate their potential mechanisms in the progression of PTC.	Lin28	papillary thyroid carcinoma	79727	HP_0002895	67	72	102	129	False
30531691	The purpose of the present study was to evaluate the expression of Lin28A, let-7a, and c-Myc in human papillary thyroid carcinoma (PTC) and to investigate their potential mechanisms in the progression of PTC.	c-Myc	papillary thyroid carcinoma	4609	HP_0002895	87	92	102	129	False
30531691	The purpose of the present study was to evaluate the expression of Lin28A, let-7a, and c-Myc in human papillary thyroid carcinoma (PTC) and to investigate their potential mechanisms in the progression of PTC.	PTC	papillary thyroid carcinoma	8030	HP_0002895	131	134	102	129	False
30531691	Clinically, Lin28A was linked to a higher tumor/node/metastasis stage and the presence of lymph node metastases.	Lin28	tumor	79727	HP_0002664	12	17	42	47	False
30531691	CONCLUSIONS The Lin28A/let-7a/c-Myc pathway is involved in cancer growth and malignant behavior in PTC and is a potential target for therapeutic intervention in this disease	Lin28	cancer	79727	HP_0002664	16	21	59	65	False
30531691	CONCLUSIONS The Lin28A/let-7a/c-Myc pathway is involved in cancer growth and malignant behavior in PTC and is a potential target for therapeutic intervention in this disease	c-Myc	cancer	4609	HP_0002664	30	35	59	65	True
30531691	CONCLUSIONS The Lin28A/let-7a/c-Myc pathway is involved in cancer growth and malignant behavior in PTC and is a potential target for therapeutic intervention in this disease	PTC	cancer	8030	HP_0002664	99	102	59	65	False
25899669	We report on an 8-year-old girl born to consanguineous Iraqi parents presenting with slowly progressive encephalomyopathy, severe failure to thrive, significant delays in verbal and communicative skills and bilateral retinal cherry red spots on fundoscopy.	red	failure to thrive	8444	HP_0001508	232	235	130	147	False
25899669	We report on an 8-year-old girl born to consanguineous Iraqi parents presenting with slowly progressive encephalomyopathy, severe failure to thrive, significant delays in verbal and communicative skills and bilateral retinal cherry red spots on fundoscopy.	red	bilateral	8444	HP_0012832	232	235	207	216	False
25899669	The bilateral retinal cherry red spots and failure to thrive observed in our patient are unique features, which have not been described, in previously reported patients with TTC19 mutations.	TTC19	failure to thrive	54902	HP_0001508	174	179	43	60	False
25899669	The bilateral retinal cherry red spots and failure to thrive observed in our patient are unique features, which have not been described, in previously reported patients with TTC19 mutations.	red	failure to thrive	8444	HP_0001508	29	32	43	60	False
25899669	The bilateral retinal cherry red spots and failure to thrive observed in our patient are unique features, which have not been described, in previously reported patients with TTC19 mutations.	TTC19	bilateral	54902	HP_0012832	174	179	4	13	False
25899669	The bilateral retinal cherry red spots and failure to thrive observed in our patient are unique features, which have not been described, in previously reported patients with TTC19 mutations.	red	bilateral	8444	HP_0012832	29	32	4	13	False
21035105	In mice, Sobp (also known as Jxc1) is critical for patterning of the organ of Corti; one of our patients has a subclinical cochlear hearing loss but no gross cochlear abnormalities.	mice	hearing loss	23581	HP_0000365	3	7	132	144	False
21035105	In mice, Sobp (also known as Jxc1) is critical for patterning of the organ of Corti; one of our patients has a subclinical cochlear hearing loss but no gross cochlear abnormalities.	Sobp	hearing loss	55084	HP_0000365	9	13	132	144	False
30201866	The sonic Hedgehog/GLI signaling pathway (HH) is critical for maintaining tissue polarity in development and contributes to tumor stemness.	GLI	tumor	2735	HP_0002664	19	22	124	129	True
30201866	Important factors GLI1 and GLI2 were always expressed, only exceptionally one of them was lowered, suggesting the functionality of HH in all tumors tested.	GLI	tumor	2735	HP_0002664	18	21	141	146	True
30201866	Our results recognize the sensitivity of tumor cell types to GANT61 in cell culture and support a critical role for GLI factors in tumor progression through restraining apoptosis.	GLI	tumor	2735	HP_0002664	116	119	41	46	True
30530053	Next, we show that FBXO16 functions as a tumor suppressor in GBM.	FBXO16	tumor	157574	HP_0002664	19	25	41	46	False
30262699	Review of exome sequencing data of the proband and her unaffected son for 40 known genes causing congenital nonsyndromic cataracts revealed two variants, namely c.139G&gt;A (p.Asp47Asn; D47N) in the <i>GJA8</i> gene and c.2036C&gt;T in the <i>FYCO1</i> gene to be potentially pathogenic.	son	cataract	6651	HP_0000518	66	69	121	129	False
30262699	Review of exome sequencing data of the proband and her unaffected son for 40 known genes causing congenital nonsyndromic cataracts revealed two variants, namely c.139G&gt;A (p.Asp47Asn; D47N) in the <i>GJA8</i> gene and c.2036C&gt;T in the <i>FYCO1</i> gene to be potentially pathogenic.	GJA8	cataract	2703	HP_0000518	202	206	121	129	True
30262699	The mutation c.139G&gt;A in the <i>GJA8</i> gene detected in the present study was also previously reported in Caucasian and Chinese families but with different phenotypes, i.e. nuclear and nuclear pulverulent cataracts.	GJA8	cataract	2703	HP_0000518	35	39	210	218	True
30693543	While many downstream effectors of ATR have been established, the upstream regulators of ATR and the impact of such regulation on liver cancer remain unclear.	ATR	cancer	84168	HP_0002664	35	38	136	142	True
30693543	While many downstream effectors of ATR have been established, the upstream regulators of ATR and the impact of such regulation on liver cancer remain unclear.	impact	cancer	55364	HP_0002664	101	107	136	142	False
30693543	Here we demonstrate new functions for BRUCE in ATR activation in vitro and liver tumor suppression in vivo.	ATR	tumor	84168	HP_0002664	47	50	81	86	True
30693543	Here we demonstrate new functions for BRUCE in ATR activation in vitro and liver tumor suppression in vivo.	BRUCE	tumor	57448	HP_0002664	38	43	81	86	False
30693543	The in vivo impact of BRUCE loss on liver tumorigenesis was determined using the hepatocellular carcinoma model induced by genotoxin Diethylnitrosamine.	impact	tumor	55364	HP_0002664	12	18	42	47	False
30693543	The in vivo impact of BRUCE loss on liver tumorigenesis was determined using the hepatocellular carcinoma model induced by genotoxin Diethylnitrosamine.	BRUCE	tumor	57448	HP_0002664	22	27	42	47	False
30693543	The in vivo impact of BRUCE loss on liver tumorigenesis was determined using the hepatocellular carcinoma model induced by genotoxin Diethylnitrosamine.	impact	hepatocellular carcinoma	55364	HP_0001402	12	18	81	105	False
30693543	The in vivo impact of BRUCE loss on liver tumorigenesis was determined using the hepatocellular carcinoma model induced by genotoxin Diethylnitrosamine.	BRUCE	hepatocellular carcinoma	57448	HP_0001402	22	27	81	105	False
30693543	Liver-specific knockout of murine Bruce impaired ATR activation and exacerbated inflammation, fibrosis and hepatocellular carcinoma, which exhibited a trabecular architecture, closely resembling human HCC.	ATR	hepatocellular carcinoma	84168	HP_0001402	49	52	107	131	False
30693543	Liver-specific knockout of murine Bruce impaired ATR activation and exacerbated inflammation, fibrosis and hepatocellular carcinoma, which exhibited a trabecular architecture, closely resembling human HCC.	Bruce	hepatocellular carcinoma	57448	HP_0001402	34	39	107	131	False
30693543	Liver-specific knockout of murine Bruce impaired ATR activation and exacerbated inflammation, fibrosis and hepatocellular carcinoma, which exhibited a trabecular architecture, closely resembling human HCC.	HCC	hepatocellular carcinoma	84668	HP_0001402	201	204	107	131	False
30693543	In humans, the clinical relevance of BRUCE downregulation in liver disease was found in hepatitis, cirrhosis and hepatocellular carcinoma specimens and deleterious somatic mutations of the Bruce gene was found in human hepatocellular carcinoma in TCGA database.	BRUCE	hepatocellular carcinoma	57448	HP_0001402	37	42	113	137	False
30693543	In humans, the clinical relevance of BRUCE downregulation in liver disease was found in hepatitis, cirrhosis and hepatocellular carcinoma specimens and deleterious somatic mutations of the Bruce gene was found in human hepatocellular carcinoma in TCGA database.	Bruce	hepatocellular carcinoma	57448	HP_0001402	189	194	113	137	False
30693543	Conclusion: These findings establish a new BRUCE-ATR signaling axis in accurate DNA replication and suppression of liver cancer in mice and humans and provides a clinically relevant HCC mouse model.	ATR	cancer	84168	HP_0002664	49	52	121	127	True
30693543	Conclusion: These findings establish a new BRUCE-ATR signaling axis in accurate DNA replication and suppression of liver cancer in mice and humans and provides a clinically relevant HCC mouse model.	BRUCE	cancer	57448	HP_0002664	43	48	121	127	False
30693543	Conclusion: These findings establish a new BRUCE-ATR signaling axis in accurate DNA replication and suppression of liver cancer in mice and humans and provides a clinically relevant HCC mouse model.	HCC	cancer	84668	HP_0002664	182	185	121	127	False
30693543	Conclusion: These findings establish a new BRUCE-ATR signaling axis in accurate DNA replication and suppression of liver cancer in mice and humans and provides a clinically relevant HCC mouse model.	mice	cancer	23581	HP_0002664	131	135	121	127	False
28944914	The present study screened pathogenic genes, ectodysplasinA (EDA) and lamin A/C (LMNA), in a patient with suspected syndromic hearing impairment and various other symptoms including tooth and skin abnormalities.	EDA	hearing impairment	1896	HP_0000365	62	65	127	145	False
28944914	The present study screened pathogenic genes, ectodysplasinA (EDA) and lamin A/C (LMNA), in a patient with suspected syndromic hearing impairment and various other symptoms including tooth and skin abnormalities.	LMNA	hearing impairment	4000	HP_0000365	82	86	127	145	True
28944914	The present study screened pathogenic genes, ectodysplasinA (EDA) and lamin A/C (LMNA), in a patient with suspected syndromic hearing impairment and various other symptoms including tooth and skin abnormalities.	EDA	skin abnormalities	1896	HP_0000951	62	65	193	211	True
28944914	The present study screened pathogenic genes, ectodysplasinA (EDA) and lamin A/C (LMNA), in a patient with suspected syndromic hearing impairment and various other symptoms including tooth and skin abnormalities.	LMNA	skin abnormalities	4000	HP_0000951	82	86	193	211	True
28944914	The present findings did not identify copy number variation and mutations in EDA; therefore, excluding the possibility of EDAinitiated ectodermal dysplasia syndrome.	EDA	ectodermal dysplasia	1896	HP_0000968	77	80	136	156	True
28944914	The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.	CRYM	skin abnormalities	1428	HP_0000951	122	126	274	292	False
28944914	The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.	RAB3GAP1	skin abnormalities	22930	HP_0000951	181	189	274	292	True
28944914	The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.	WNT10A	skin abnormalities	80326	HP_0000951	218	224	274	292	True
28944914	The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.	CRYM	deafness	1428	HP_0000365	122	126	241	249	True
28944914	The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.	RAB3GAP1	deafness	22930	HP_0000365	181	189	241	249	False
28944914	The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.	WNT10A	deafness	80326	HP_0000365	218	224	241	249	False
28944914	The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.	CRYM	hypogonadism	1428	HP_0000135	122	126	251	263	False
28944914	The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.	RAB3GAP1	hypogonadism	22930	HP_0000135	181	189	251	263	True
28944914	The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit1 (RAB3GAP1) and Wnt family member10A (WNT10A), implicated in deafness, hypogonadism and tooth/skin abnormalities, respectively.	WNT10A	hypogonadism	80326	HP_0000135	218	224	251	263	False
28944914	The WNT10A p.G213S mutation was confirmed to be the etiological cause of tooth agenesis and ectodermal dysplasia as previously described.	WNT10A	ectodermal dysplasia	80326	HP_0000968	4	10	92	112	True
27448281	Consistent with this pattern of activity, polr1c and polr1d homozygous mutant zebrafish exhibit cartilage hypoplasia and cranioskeletal anomalies characteristic of humans with Treacher Collins syndrome.	polr1c	skeletal anomalies	9533	HP_0000924	42	48	127	145	True
27448281	Consistent with this pattern of activity, polr1c and polr1d homozygous mutant zebrafish exhibit cartilage hypoplasia and cranioskeletal anomalies characteristic of humans with Treacher Collins syndrome.	polr1d	skeletal anomalies	51082	HP_0000924	53	59	127	145	True
27448281	More importantly, we show that genetic inhibition of tp53 can suppress neuroepithelial cell death and ameliorate the skeletal anomalies in polr1c and polr1d mutants, providing a potential avenue to prevent the pathogenesis of Treacher Collins syndrome.	polr1c	skeletal anomalies	9533	HP_0000924	139	145	117	135	True
27448281	More importantly, we show that genetic inhibition of tp53 can suppress neuroepithelial cell death and ameliorate the skeletal anomalies in polr1c and polr1d mutants, providing a potential avenue to prevent the pathogenesis of Treacher Collins syndrome.	polr1d	skeletal anomalies	51082	HP_0000924	150	156	117	135	True
28728825	Loss-of-function mutations in the human PIEZO1 gene cause autosomal recessive congenital lymphatic dysplasia.	PIEZO1	autosomal recessive	9780	HP_0000007	40	46	58	77	True
28728825	Gain-of-function mutations in the human PIEZO1 gene cause the autosomal dominant hemolytic anemia, hereditary xerocytosis (also known as dehydrated stomatocytosis).	PIEZO1	hemolytic anemia	9780	HP_0001878	40	46	81	97	True
28728825	Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis.	PIEZO2	autosomal recessive	63895	HP_0000007	40	46	61	80	True
28728825	Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis.	PIEZO2	arthrogryposis	63895	HP_0002804	40	46	147	161	True
28728825	Loss-of-function mutations in the human PIEZO2 gene cause an autosomal recessive syndrome of muscular atrophy with perinatal respiratory distress, arthrogryposis, and scoliosis.	PIEZO2	scoliosis	63895	HP_0002650	40	46	167	176	True
28728825	Gain-of-function mutations in the human PIEZO2 gene cause three clinical types of autosomal dominant distal arthrogryposis.	PIEZO2	arthrogryposis	63895	HP_0002804	40	46	108	122	True
28728825	Gain-of-function mutations in the human PIEZO2 gene cause three clinical types of autosomal dominant distal arthrogryposis.	PIEZO2	distal	63895	HP_0012839	40	46	101	107	False
26856603	Alzheimer's disease (AD) is a serious neurodegenerative disease, and microRNAs (miRNAs) have been linked to its pathogenesis.	miR	neurodegenerative disease	220972	HP_0002180	80	83	38	63	False
22645276	We therefore screened patients with hereditary PHPV, as well as bilateral optic nerve aplasia (ONA) or hypoplasia (ONH), for mutations in ATOH7.	ATOH7	bilateral	220202	HP_0012832	138	143	64	73	False
22645276	We therefore screened patients with hereditary PHPV, as well as bilateral optic nerve aplasia (ONA) or hypoplasia (ONH), for mutations in ATOH7.	ATOH7	optic nerve aplasia	220202	HP_0012521	138	143	74	93	False
22645276	We identified a homozygous ATOH7 mutation (N46H) in a large family with an autosomal recessive PHPV disease trait linked to 10q21, and a heterozygous variant (R65G, p.Arg65Gly) in one of five sporadic ONA patients.	ATOH7	autosomal recessive	220202	HP_0000007	27	32	75	94	True
22645276	We identified a homozygous ATOH7 mutation (N46H) in a large family with an autosomal recessive PHPV disease trait linked to 10q21, and a heterozygous variant (R65G, p.Arg65Gly) in one of five sporadic ONA patients.	ATOH7	sporadic	220202	HP_0003745	27	32	192	200	False
27401718	These 294 differentially expressed genes and non-coding RNA transcripts provide here a set to specifically define skull base chordomas and to identify novel and potentially important targets for diagnosis, prognosis, and therapy of this cancer.	set	cancer	6418	HP_0002664	87	90	237	243	False
27401718	These 294 differentially expressed genes and non-coding RNA transcripts provide here a set to specifically define skull base chordomas and to identify novel and potentially important targets for diagnosis, prognosis, and therapy of this cancer.	set	chordomas	6418	HP_0010762	87	90	125	134	False
30275562	In cancer, elevated XIAP expression has been associated with malignancy, poor prognosis, and treatment resistance.	XIAP	cancer	331	HP_0002664	20	24	3	9	True
30275562	XIAP has previously been proposed to promote tumor growth through suppression of autophagy.	XIAP	tumor	331	HP_0002664	0	4	45	50	True
30275562	In this study, we examined the expression of XIAP and p62, two critical mediators of autophagy, in breast and colon cancer.	XIAP	cancer	331	HP_0002664	45	49	116	122	True
30275562	We observed a negative correlation between XIAP and p62 expression in normal and cancer tissues of breast and colon, and that the ratio of XIAP and p62 expression determines the cancer phenotype.	XIAP	cancer	331	HP_0002664	43	47	81	87	True
30275562	Furthermore, XIAP enhanced cancer cell proliferation, viability, and colony formation in vitro via suppression of p62.	XIAP	cancer	331	HP_0002664	13	17	27	33	True
30275562	In addition, we demonstrated that XIAP-enhanced tumor growth is dependent on depletion of p62 in vivo.	XIAP	tumor	331	HP_0002664	34	38	48	53	True
28912174	The deregulation of its expression or activity contributes to leukemia, in which Spi1 can be either an oncogene or a tumor suppressor.	Spi1	tumor	6688	HP_0002664	81	85	117	122	False
28912174	Herein we explored whether cellular senescence, an anti-tumoral pathway that restrains cell proliferation, is a mechanism by which Spi1 limits hematopoietic cell expansion, and thus prevents the development of leukemia.	Spi1	tumor	6688	HP_0002664	131	135	56	61	False
29385671	<i>In vivo</i> tumorigenic studies confirmed that miR-612 overexpression retarded the growth of A375 xenograft tumors, which was coupled with a decline in the percentage of Ki-67-positive proliferating cells.	miR	tumors	220972	HP_0002664	50	53	111	117	False
29385671	<i>In vivo</i> tumorigenic studies confirmed that miR-612 overexpression retarded the growth of A375 xenograft tumors, which was coupled with a decline in the percentage of Ki-67-positive proliferating cells.	Ki	tumors	10197	HP_0002664	173	175	111	117	False
30481156	Context Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease caused by mutations in the tumor suppressor gene MEN1 and can be diagnosed based on clinical, familial and/or genetic criteria.	type	neoplasia	6445	HP_0002664	37	41	27	36	False
30481156	Context Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease caused by mutations in the tumor suppressor gene MEN1 and can be diagnosed based on clinical, familial and/or genetic criteria.	MEN1	neoplasia	4221	HP_0002664	45	49	27	36	True
30481156	Context Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease caused by mutations in the tumor suppressor gene MEN1 and can be diagnosed based on clinical, familial and/or genetic criteria.	type	tumor	6445	HP_0002664	37	41	111	116	False
30481156	Context Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease caused by mutations in the tumor suppressor gene MEN1 and can be diagnosed based on clinical, familial and/or genetic criteria.	MEN1	tumor	4221	HP_0002664	45	49	111	116	True
30481156	We present a family in which we found both germline and somatic mosaicism for MEN1.	MEN1	somatic mosaicism	4221	HP_0001442	78	82	56	73	False
30481156	When her brother was found to harbor the same MEN1 mutation as our proband and, around the same time, their father was diagnosed with a neuroendocrine carcinoma, this tumor was investigated for the MEN1 mutation as well.	MEN1	tumor	4221	HP_0002664	46	50	167	172	True
30481156	In the histologic biopsy of this tumor, the same MEN1 mutation was detected as previously found in his children.	MEN1	tumor	4221	HP_0002664	49	53	33	38	True
30481156	Based on the array data, we concluded that the deletion was limited to the MEN1 gene and that the father had both germline and somatic mosaicism for MEN1.	MEN1	somatic mosaicism	4221	HP_0001442	75	79	127	144	False
30481156	Conclusions To our knowledge, this is the first reported family with combined germline and somatic mosaicism for MEN1.	MEN1	somatic mosaicism	4221	HP_0001442	113	117	91	108	False
30481156	This study illustrates that germline mosaicism is important to consider in apparently sporadic de novo MEN1 mutations, because of its particular importance for genetic counseling, specifically when evaluating the risk for family members and when considering the possibility of somatic mosaicism in the parent with germline mosaicism	MEN1	somatic mosaicism	4221	HP_0001442	103	107	277	294	False
30481156	This study illustrates that germline mosaicism is important to consider in apparently sporadic de novo MEN1 mutations, because of its particular importance for genetic counseling, specifically when evaluating the risk for family members and when considering the possibility of somatic mosaicism in the parent with germline mosaicism	MEN1	sporadic	4221	HP_0003745	103	107	86	94	False
29067635	Concordant modulation of IRGs in both mice and human cells indicates that they might play important roles in regulating CHIKV replication in the central nervous system (CNS).	mice	central	23581	HP_0030645	38	42	145	152	False
21746835	The authors report here a brief summary of findings from 12 lines of genetically engineered mice that presented with autosomal recessive congenital hydrocephalus.	mice	hydrocephalus	23581	HP_0000238	92	96	148	161	False
21746835	The authors report here a brief summary of findings from 12 lines of genetically engineered mice that presented with autosomal recessive congenital hydrocephalus.	mice	autosomal recessive	23581	HP_0000007	92	96	117	136	True
21746835	This study illustrates the value of knockout mice in identifying genetic factors involved in the development of congenital hydrocephalus.	mice	hydrocephalus	23581	HP_0000238	45	49	123	136	False
21746835	For example, the cerebellar malformations observed in RIKEN 4930444A02 knockout mice show similarities to a number of developmental disorders, such as Joubert, Meckel-Gruber, and Bardet-Biedl syndromes, which involve mutations in cilia-related genes.	mice	cerebellar malformations	23581	HP_0002438	80	84	17	41	False
21746835	Even though the direct relevance of mouse models to hydrocephalus in humans remains uncertain, the high prevalence of familial patterns of inheritance for congenital hydrocephalus in humans suggests that identification of genes responsible for development of hydrocephalus in mice may lead to the identification of homologous modifier genes and susceptibility alleles in humans.	mice	hydrocephalus	23581	HP_0000238	276	280	52	65	False
29966189	It is a genetic disorder caused by a mutation in the dysferlin gene (DYSF) with an autosomal recessive mode of inheritance.	DYSF	autosomal recessive	8291	HP_0000007	69	73	83	102	True
29966189	It is a genetic disorder caused by a mutation in the dysferlin gene (DYSF) with an autosomal recessive mode of inheritance.	DYSF	mode of inheritance	8291	HP_0000005	69	73	103	122	False
29966189	In this article, we report a case of Limb-girdle muscular dystrophy type 2B with a rare homozygous duplication c.164dupA, p.(Ile57Hisfs*8) (rs863225020) in DYSF in a Saudi patient.	DYSF	muscular dystrophy	8291	HP_0003560	156	160	49	67	True
29966189	In this article, we report a case of Limb-girdle muscular dystrophy type 2B with a rare homozygous duplication c.164dupA, p.(Ile57Hisfs*8) (rs863225020) in DYSF in a Saudi patient.	type	muscular dystrophy	6445	HP_0003560	68	72	49	67	True
29925637	We demonstrated that <i>linc-ADAL</i> interacts with heterogeneous nuclear ribonucleoprotein U (hnRNPU) and insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) at distinct subcellular locations to regulate adipocyte differentiation and lipogenesis	hnRNPU	heterogeneous	3192	HP_0001425	96	102	53	66	False
29925637	We demonstrated that <i>linc-ADAL</i> interacts with heterogeneous nuclear ribonucleoprotein U (hnRNPU) and insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) at distinct subcellular locations to regulate adipocyte differentiation and lipogenesis	IGF2BP2	heterogeneous	10644	HP_0001425	161	168	53	66	False
28976792	Results We demonstrated an association between six previously published single nucleotide polymorphisms (rs15869 [ BRCA2], rs1805389 [ LIG4], rs8079544 [ TP53], rs25489 [ XRCC1], rs1673041 [ POLD1], and rs11615 [ ERCC1]) and subsequent CNS tumors in survivors of childhood cancer.	ERCC1	cancer	2067	HP_0002664	213	218	273	279	False
28976792	Results We demonstrated an association between six previously published single nucleotide polymorphisms (rs15869 [ BRCA2], rs1805389 [ LIG4], rs8079544 [ TP53], rs25489 [ XRCC1], rs1673041 [ POLD1], and rs11615 [ ERCC1]) and subsequent CNS tumors in survivors of childhood cancer.	ERCC1	tumors	2067	HP_0002664	213	218	240	246	False
28976792	Including genetic variants in a Final Model containing age at primary cancer, sex, and cranial radiation therapy dose yielded an area under the curve of 0.81 (95% CI, 0.76 to 0.86), which was superior ( P = .002) to the Clinical Model (area under the curve, 0.73; 95% CI, 0.66 to 0.80).	sex	cancer	55558	HP_0002664	78	81	70	76	False
26762690	Extensive IDS gene deletions were identified in four patients; using DNA microarray analysis two patients showed the loss of the entire AFF2 gene, and epilepsy developed in only one of them.	IDS	epilepsy	3423	HP_0001250	10	13	151	159	True
26762690	Extensive IDS gene deletions were identified in four patients; using DNA microarray analysis two patients showed the loss of the entire AFF2 gene, and epilepsy developed in only one of them.	AFF2	epilepsy	2334	HP_0001250	136	140	151	159	False
26762690	Wide allelic heterogeneity was noted, with large gene alterations (e.g. IDS/IDSP1 gene inversions, partial to extensive IDS deletions, and one chimeric IDS-IDSP1 allele) that occurred at higher frequencies than previously reported (36% vs 18.9-29%).	IDS	heterogeneity	3423	HP_0001425	72	75	13	26	False
26762690	Our findings suggest a wide allelic heterogeneity in Mexican MPSII patients; DNA microarray analysis contributes to further delineation of the resulting phenotype for IDS and neighboring loci deletions	type	heterogeneity	6445	HP_0001425	158	162	36	49	False
26762690	Our findings suggest a wide allelic heterogeneity in Mexican MPSII patients; DNA microarray analysis contributes to further delineation of the resulting phenotype for IDS and neighboring loci deletions	IDS	heterogeneity	3423	HP_0001425	167	170	36	49	False
20979188	The severe generalized lipodystrophy in this patient with progeroid features has not previously been described in other patients with MFS and FBN1 mutations.	FBN1	generalized lipodystrophy	2200	HP_0009064	142	146	11	36	False
28738459	<b>Methods:</b> A total of 3 502 school-aged children who were included in Beijing Child and Adolescent Metabolic Syndrome (BCAMS) Study were selected, and based on the age and sex specific waist circumference (WC) standards in the BCAMS study, 1 196 central obese cases and 2 306 controls were identified.	sex	central	55558	HP_0030645	177	180	251	258	False
28041644	Defects in motile cilia and sperm flagella cause primary ciliary dyskinesia (PCD), characterized by chronic airway disease, infertility, and left-right body axis disturbance.	PCD	ciliary dyskinesia	352909	HP_0012265	77	80	57	75	True
28041644	This result has clinical and genetic counseling implications for genetically unsolved male case subjects with a classic PCD phenotype that lack additional phenotypes such as intellectual disability or retinitis pigmentosa	PCD	intellectual disability	352909	HP_0001249	120	123	174	197	False
28041644	This result has clinical and genetic counseling implications for genetically unsolved male case subjects with a classic PCD phenotype that lack additional phenotypes such as intellectual disability or retinitis pigmentosa	men	intellectual disability	8178	HP_0001249	214	217	174	197	False
29775614	Herein, we newly identified that truncated form of CHL1 is produced and released from lung tumor tissue in a mouse model expressing human EML4-ALK fusion gene.	CHL1	tumor	1663	HP_0002664	51	55	91	96	False
29775614	The correlation between the tumor size and the amount of CHL1 secretion could be examined in this study, and showed a significant positive correlation in a tumor size-dependent manner.	CHL1	tumor	1663	HP_0002664	57	61	28	33	False
29775614	Considering these results, the measurement of circulating CHL1 level may contribute to assess a tumor progression in human lung tumor patients	CHL1	tumor	1663	HP_0002664	58	62	96	101	False
29944864	Circulating soluble corin has been found to be associated with various cardiovascular diseases, such as hypertension, heart failure, myocardial infarction, preeclampsia, and stroke.	corin	cardiovascular diseases	10699	HP_0001626	20	25	71	94	False
29944864	Circulating soluble corin has been found to be associated with various cardiovascular diseases, such as hypertension, heart failure, myocardial infarction, preeclampsia, and stroke.	corin	hypertension	10699	HP_0000822	20	25	104	116	False
29944864	Circulating soluble corin has been found to be associated with various cardiovascular diseases, such as hypertension, heart failure, myocardial infarction, preeclampsia, and stroke.	corin	heart failure	10699	HP_0001635	20	25	118	131	False
29944864	Circulating soluble corin has been found to be associated with various cardiovascular diseases, such as hypertension, heart failure, myocardial infarction, preeclampsia, and stroke.	corin	myocardial infarction	10699	HP_0001658	20	25	133	154	False
29944864	All these findings indicate that circulating soluble corin has the potential to be a sensitive and specific biomarker for risk prediction and prognostic assessment of cardiovascular diseases.	corin	cardiovascular diseases	10699	HP_0001626	53	58	167	190	False
29944864	To provide new ideas based on the use of corin for risk prediction, prognostic assessment, and clinical treatment of cardiovascular diseases and to promote the implementation of corin as a routine laboratory index, we summarize the latest studies of the association between corin and cardiovascular diseases in recent years and offer some prospective proposals for future research on corin in this review	corin	cardiovascular diseases	10699	HP_0001626	41	46	117	140	False
26376864	Our results indicate that gene-based meta-analysis of GWAS provides a useful strategy to find loci of interest that were not identified in standard single-marker analyses due to high allelic heterogeneity.	find	heterogeneity	81501	HP_0001425	89	93	191	204	False
27666370	We report that biallelic mutations in TBCD, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.	TBCD	cortical atrophy	6904	HP_0002120	38	42	289	305	False
27666370	We report that biallelic mutations in TBCD, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.	TBCD	microcephaly	6904	HP_0000252	38	42	334	346	True
27666370	We report that biallelic mutations in TBCD, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.	TBCD	developmental delay	6904	HP_0001263	38	42	370	389	True
27666370	We report that biallelic mutations in TBCD, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.	TBCD	intellectual disability	6904	HP_0001249	38	42	391	414	True
27666370	We report that biallelic mutations in TBCD, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.	TBCD	seizures	6904	HP_0001250	38	42	416	424	True
27666370	We report that biallelic mutations in TBCD, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.	TBCD	optic atrophy	6904	HP_0000648	38	42	426	439	True
27666370	We report that biallelic mutations in TBCD, encoding one of the five co-chaperones required for assembly and disassembly of the -tubulin heterodimer, the structural unit of microtubules, cause a disease with neurodevelopmental and neurodegenerative features characterized by early-onset cortical atrophy, secondary hypomyelination, microcephaly, thin corpus callosum, developmental delay, intellectual disability, seizures, optic atrophy, and spastic quadriplegia.	TBCD	spastic quadriplegia	6904	HP_0002510	38	42	445	465	True
27666370	Our findings establish that defective TBCD function underlies a recognizable encephalopathy and drives accelerated microtubule polymerization and enhanced microtubule stability, underscoring an additional cause of altered microtubule dynamics with impact on neuronal function and survival in the developing brain	TBCD	encephalopathy	6904	HP_0001298	38	42	77	91	True
27666370	Our findings establish that defective TBCD function underlies a recognizable encephalopathy and drives accelerated microtubule polymerization and enhanced microtubule stability, underscoring an additional cause of altered microtubule dynamics with impact on neuronal function and survival in the developing brain	impact	encephalopathy	55364	HP_0001298	248	254	77	91	False
24417797	The gene responsible for an autosomal recessive Pelizaeus-Merzbacher-like disease called HLD5 is named fam126a (also known as hyccin or drctnnb1a).	fam126a	autosomal recessive	84668	HP_0000007	103	110	28	47	True
24417797	The gene responsible for an autosomal recessive Pelizaeus-Merzbacher-like disease called HLD5 is named fam126a (also known as hyccin or drctnnb1a).	hyccin	autosomal recessive	84668	HP_0000007	126	132	28	47	True
24417797	The gene responsible for an autosomal recessive Pelizaeus-Merzbacher-like disease called HLD5 is named fam126a (also known as hyccin or drctnnb1a).	drctnnb1a	autosomal recessive	84668	HP_0000007	136	145	28	47	True
28470677	In a two-stage study, we analyzed the existing genome-wide association study dataset of 868 pancreatic cancer patients from MD Anderson Cancer Center in relation to overall survival using Cox regression.	Cox	cancer	1351	HP_0002664	188	191	103	109	False
28470677	According to The Cancer Genome Atlas data and our previous RNA-sequencing data, the mRNA expression level of PAIP2B but not NAGK, MCEE or DYSF was significantly lower in pancreatic tumors than in normal adjacent tissues.	PAIP2B	tumors	400961	HP_0002664	109	115	181	187	False
28470677	According to The Cancer Genome Atlas data and our previous RNA-sequencing data, the mRNA expression level of PAIP2B but not NAGK, MCEE or DYSF was significantly lower in pancreatic tumors than in normal adjacent tissues.	DYSF	tumors	8291	HP_0002664	138	142	181	187	False
28470677	According to The Cancer Genome Atlas data and our previous RNA-sequencing data, the mRNA expression level of PAIP2B but not NAGK, MCEE or DYSF was significantly lower in pancreatic tumors than in normal adjacent tissues.	NAGK	tumors	55577	HP_0002664	124	128	181	187	False
28470677	According to The Cancer Genome Atlas data and our previous RNA-sequencing data, the mRNA expression level of PAIP2B but not NAGK, MCEE or DYSF was significantly lower in pancreatic tumors than in normal adjacent tissues.	MCEE	tumors	84693	HP_0002664	130	134	181	187	False
28470677	Additional validation efforts and functional studies are warranted to demonstrate whether PAIP2B is a novel tumor suppressor gene and a potential therapeutic target for pancreatic cancer	PAIP2B	tumor	400961	HP_0002664	90	96	108	113	False
26023803	In vitro test on colon cancer resistant/susceptible to chemoradioterapy cells, finally prove that XRCC3 deregulation is extensively involved in the chemoresistance mechanisms.	XRCC3	cancer	7517	HP_0002664	98	103	23	29	False
28211977	Loss-of-function mutations of GATAD2B have recently been defined to cause a recognizable syndrome with intellectual disability (ID).	GATAD2B	intellectual disability	57459	HP_0001249	30	37	103	126	True
28211977	We herein report an infant with feeding difficulty, developmental delay, hypotonia, and dysmorphic features including small palpebral fissures, telecanthus, sparse hair and eyebrow, cup-shaped ears, and clinodactyly.	ears	developmental delay	2058	HP_0001263	193	197	52	71	True
28211977	We herein report an infant with feeding difficulty, developmental delay, hypotonia, and dysmorphic features including small palpebral fissures, telecanthus, sparse hair and eyebrow, cup-shaped ears, and clinodactyly.	ears	small palpebral fissures	2058	HP_0045025	193	197	118	142	False
28211977	We herein report an infant with feeding difficulty, developmental delay, hypotonia, and dysmorphic features including small palpebral fissures, telecanthus, sparse hair and eyebrow, cup-shaped ears, and clinodactyly.	ears	clinodactyly	2058	HP_0030084	193	197	203	215	False
30287627	Hereditary angioedema (HAE), due to C1-inhibitor deficiency, is a rare autosomal dominant and potentially life-threatening disease characterised by recurrent oedema attacks of skin, mucosa and viscera.	C1	angioedema	393	HP_0100665	36	38	11	21	False
30287627	Due to the rarity and the fact that symptoms of HAE imitate other forms of angioedema and other conditions, HAE may be misdiagnosed, especially in emergency settings.	fact	angioedema	11198	HP_0100665	26	30	75	85	False
21643982	To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes ATM, PPP2R1B, SDHD and CADM1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.	ATM	cancer	472	HP_0002664	172	175	86	92	True
21643982	To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes ATM, PPP2R1B, SDHD and CADM1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.	PPP2R1B	cancer	5519	HP_0002664	177	184	86	92	True
21643982	To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes ATM, PPP2R1B, SDHD and CADM1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.	SDHD	cancer	6392	HP_0002664	186	190	86	92	True
21643982	To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes ATM, PPP2R1B, SDHD and CADM1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.	CADM1	cancer	23705	HP_0002664	195	200	86	92	False
21643982	To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes ATM, PPP2R1B, SDHD and CADM1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.	ATM	neoplasia	472	HP_0002664	172	175	229	238	True
21643982	To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes ATM, PPP2R1B, SDHD and CADM1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.	PPP2R1B	neoplasia	5519	HP_0002664	177	184	229	238	True
21643982	To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes ATM, PPP2R1B, SDHD and CADM1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.	SDHD	neoplasia	6392	HP_0002664	186	190	229	238	True
21643982	To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes ATM, PPP2R1B, SDHD and CADM1 in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.	CADM1	neoplasia	23705	HP_0002664	195	200	229	238	False
21643982	The alterations of ATM and CADM1 are associated with the progression of tumor from CIN to Stage I/II, thus implying their role in early invasiveness.	ATM	tumor	472	HP_0002664	19	22	72	77	True
21643982	The alterations of ATM and CADM1 are associated with the progression of tumor from CIN to Stage I/II, thus implying their role in early invasiveness.	CADM1	tumor	23705	HP_0002664	27	32	72	77	False
26818569	Ellis-van Creveld (EVC) syndrome is a rare autosomal recessive disorder characterized by hypoplastic nails, polydactyly, and achondroplasia.	EVC	hypoplastic nails	2121	HP_0001792	19	22	89	106	True
26818569	Ellis-van Creveld (EVC) syndrome is a rare autosomal recessive disorder characterized by hypoplastic nails, polydactyly, and achondroplasia.	EVC	polydactyly	2121	HP_0010442	19	22	108	119	True
26818569	This is, to our knowledge, a most severe phenotype of EVC syndrome, illustrating that the specific pattern of EVC2 compound heterozygous mutations may cause severe developmental delay and intestinal malfunction.	EVC	developmental delay	2121	HP_0001263	54	57	164	183	False
30289875	The KEGG enrichment analysis of DEGs showed significantly enriched pathways in cancer, extracellular matrix (ECM)-receptor interaction pathway, and cyclic adenosine monophosphate (cAMP) signaling pathway.	ECM	cancer	22915	HP_0002664	109	112	79	85	False
30289875	The KEGG enrichment analysis of DEGs showed significantly enriched pathways in cancer, extracellular matrix (ECM)-receptor interaction pathway, and cyclic adenosine monophosphate (cAMP) signaling pathway.	cAMP	cancer	283489	HP_0002664	180	184	79	85	False
30251688	Duchenne muscular dystrophy (DMD) is characterized by a severe and progressive destruction of muscle fibers associated with altered Ca<sup>2+</sup> homeostasis.	DMD	muscular dystrophy	1756	HP_0003560	29	32	9	27	True
26637696	The sideroblastic anemias are a heterogeneous group of inherited and acquired disorders characterized by the presence of ring sideroblasts in the bone marrow.	red	heterogeneous	8444	HP_0001425	74	77	32	45	False
26637696	Refractory anemia with ring sideroblasts (RARS) is a myelodysplastic syndrome characterized mainly by anemia attributable to ineffective erythropoiesis.	RARS	ineffective erythropoiesis	5917	HP_0010972	42	46	125	151	False
26637696	Inhibitors of molecules of the transforming growth factor- superfamily have been shown recently to target ineffective erythropoiesis and ameliorate anemia both in animal models of myelodysplastic syndrome and in RARS patients.	RARS	ineffective erythropoiesis	5917	HP_0010972	213	217	107	133	False
30226615	The expression of DLL4 in nonsmall cell lung cancer (NSCLC) remains unclear.	DLL4	cancer	54567	HP_0002664	18	22	46	52	False
30226615	Therefore, DLL4 expression was detected in clinical specimens using quantum dots (QDs)immunohistochemistry (IHC) and lung cancer cell lines by quantitative realtime polymerase chain reaction.	DLL4	cancer	54567	HP_0002664	11	15	123	129	False
30226615	The protein levels of DLL4 were decreased in the tumor tissues of NSCLC patients and lung cancer cell lines.	DLL4	cancer	54567	HP_0002664	22	26	90	96	False
30226615	The protein levels of DLL4 were decreased in the tumor tissues of NSCLC patients and lung cancer cell lines.	DLL4	tumor	54567	HP_0002664	22	26	49	54	False
29259009	Overall, our findings establish RASSF4 as a tumor-suppressive hub in MM and provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib to treat patients with tumors exhibiting low RASSF4 expression.<b>Significance:</b> These findings provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib in patients with multiple myeloma whose tumors exhibit low RASSF4 expression.	RASSF4	tumor	54453	HP_0002664	32	38	44	49	False
29259009	Overall, our findings establish RASSF4 as a tumor-suppressive hub in MM and provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib to treat patients with tumors exhibiting low RASSF4 expression.<b>Significance:</b> These findings provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib in patients with multiple myeloma whose tumors exhibit low RASSF4 expression.	hub	tumor	1993	HP_0002664	62	65	44	49	False
29259009	Overall, our findings establish RASSF4 as a tumor-suppressive hub in MM and provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib to treat patients with tumors exhibiting low RASSF4 expression.<b>Significance:</b> These findings provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib in patients with multiple myeloma whose tumors exhibit low RASSF4 expression.	HDAC	tumor	9734	HP_0002664	138	142	44	49	False
22158612	Moreover, Reg-1 colocalizes with exostosin tumor-like 3 (EXTL3), its putative receptor, at the membrane of these cells.	EXTL3	tumor	2137	HP_0002664	58	63	44	49	False
29638194	Fasting serum tumor necrosis factor (TNF)-like antigen 1A (TL1A) and its receptor death receptor 3 (DR3), NOGO-B (reticulon 4B) and its receptor NUS1, high-sensitivity C-reactive protein (hsCRP), A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) 1, 4, 5 and interleukin (IL) 6 levels were determined.	TNF	tumor	7124	HP_0002664	37	40	14	19	False
29638194	Fasting serum tumor necrosis factor (TNF)-like antigen 1A (TL1A) and its receptor death receptor 3 (DR3), NOGO-B (reticulon 4B) and its receptor NUS1, high-sensitivity C-reactive protein (hsCRP), A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) 1, 4, 5 and interleukin (IL) 6 levels were determined.	NOGO	tumor	57142	HP_0002664	106	110	14	19	False
29638194	Fasting serum tumor necrosis factor (TNF)-like antigen 1A (TL1A) and its receptor death receptor 3 (DR3), NOGO-B (reticulon 4B) and its receptor NUS1, high-sensitivity C-reactive protein (hsCRP), A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) 1, 4, 5 and interleukin (IL) 6 levels were determined.	NUS1	tumor	116150	HP_0002664	145	149	14	19	False
29499401	Hepatocyte growth factor (HGF)/c-MET signaling plays an important role in cell proliferation, survival, migration and motility of cancer cells.	HGF	cancer	3569	HP_0002664	26	29	130	136	False
29499401	Hepatocyte growth factor (HGF)/c-MET signaling plays an important role in cell proliferation, survival, migration and motility of cancer cells.	MET	cancer	79811	HP_0002664	33	36	130	136	False
29499401	The scope of the present review is to recapitulate and review the evidence of SPINT2 participation in cancer development and progression, exploring the clinical, biological and functional descriptions of the involvement of this protein in diverse neoplasias.	SPINT2	cancer	10653	HP_0002664	78	84	102	108	False
29499401	The scope of the present review is to recapitulate and review the evidence of SPINT2 participation in cancer development and progression, exploring the clinical, biological and functional descriptions of the involvement of this protein in diverse neoplasias.	SPINT2	neoplasias	10653	HP_0002664	78	84	247	257	False
29499401	Most studies are in agreement as to the belief that, in a large range of human cancers, the SPINT2 gene promoter is frequently methylated, resulting in the epigenetic silence of this gene.	SPINT2	cancer	10653	HP_0002664	92	98	79	85	False
29499401	Functional assays indicate that SPINT2 reactivation ameliorates the malignant phenotype, specifically reducing cell viability, migration and invasion in diverse cancer cell lines.	type	cancer	6445	HP_0002664	83	87	161	167	False
29499401	Functional assays indicate that SPINT2 reactivation ameliorates the malignant phenotype, specifically reducing cell viability, migration and invasion in diverse cancer cell lines.	SPINT2	cancer	10653	HP_0002664	32	38	161	167	False
29499401	In sum, the SPINT2 gene is epigenetically silenced or downregulated in human cancers, altering the balance of HGF activation/inhibition ratio, which contributes to cancer development and progression	HGF	cancer	3569	HP_0002664	110	113	77	83	False
29499401	In sum, the SPINT2 gene is epigenetically silenced or downregulated in human cancers, altering the balance of HGF activation/inhibition ratio, which contributes to cancer development and progression	SPINT2	cancer	10653	HP_0002664	12	18	77	83	False
27866705	Here, we have identified an epileptic encephalopathy additionally featuring cerebral calcifications and coarse facial features caused by recessive loss-of-function mutations in DENND5A.	DENND5A	encephalopathy	23258	HP_0001298	177	184	38	52	True
27866705	Here, we have identified an epileptic encephalopathy additionally featuring cerebral calcifications and coarse facial features caused by recessive loss-of-function mutations in DENND5A.	DENND5A	cerebral calcifications	23258	HP_0002514	177	184	76	99	True
28802167	5'-Aza-2'-deoxycytidine (5-Aza-dC) is a demethylating drug that causes genome-wide hypomethylation resulting in the expression of several tumor suppressor genes causing growth arrest of cancer cells.	dC	tumor	1641	HP_0002664	31	33	138	143	False
28802167	5'-Aza-2'-deoxycytidine (5-Aza-dC) is a demethylating drug that causes genome-wide hypomethylation resulting in the expression of several tumor suppressor genes causing growth arrest of cancer cells.	dC	cancer	1641	HP_0002664	31	33	186	192	False
28802167	Induction of p53 by 5-Aza-dC was tested in vitro using cancer cells.	dC	cancer	1641	HP_0002664	26	28	55	61	False
28802167	Induction of p53 by 5-Aza-dC was tested in vitro using cancer cells.	p53	cancer	7157	HP_0002664	13	16	55	61	True
28802167	Further studies are warranted to dissect these mechanisms and establish 5-Aza-dC as an effective multi-module anticancer reagent	dC	cancer	1641	HP_0002664	78	80	114	120	False
26660953	In a unique case from a consanguineous union presenting with overgrowth, macrocephaly, retinal coloboma, large thumbs, severe varicose veins and learning disabilities, exome sequencing identified a homozygous nonsense FIBP variant.	FIBP	macrocephaly	9158	HP_0000256	218	222	73	85	True
26660953	In a unique case from a consanguineous union presenting with overgrowth, macrocephaly, retinal coloboma, large thumbs, severe varicose veins and learning disabilities, exome sequencing identified a homozygous nonsense FIBP variant.	FIBP	retinal coloboma	9158	HP_0000480	218	222	87	103	False
26660953	Taken together, these results suggest the implication of FIBP in a new autosomal recessive MCA.	FIBP	autosomal recessive	9158	HP_0000007	57	61	71	90	True
22366784	To identify additional prostate cancer susceptibility loci, we genotyped nine SNPs that were nominally associated with prostate cancer (P &lt; 1  10(-4)) in our previous GWAS in three independent studies of prostate cancer in Japanese men (2,557 individuals with prostate cancer (cases) and 3,003 controls).	men	cancer	8178	HP_0002664	236	239	32	38	False
22366784	In a meta-analysis of our previous GWAS and the replication studies, which included a total of 7,141 prostate cancer cases and 11,804 controls from a single ancestry group, three new loci reached genome-wide significance on chromosomes 11q12 (rs1938781; P = 1.10  10(-10); FAM111A-FAM111B), 10q26 (rs2252004; P = 1.98  10(-8)) and 3p11.2 (rs2055109; P = 3.94  10(-8)).	FAM111A	cancer	63901	HP_0002664	274	281	110	116	False
25990537	The purpose of this study was to recognize the expanded purine repeats (EPRs) in human genome and find their correlation with cancer pathogenesis.	EPRs	cancer	2058	HP_0002664	72	76	126	132	False
25990537	The purpose of this study was to recognize the expanded purine repeats (EPRs) in human genome and find their correlation with cancer pathogenesis.	find	cancer	81501	HP_0002664	98	102	126	132	False
30301191	We focused on the tumor necrosis factor (TNF) pathway and revealed upregulation of genes related to nuclear factor kappa B (NF-B) signaling and senescence-associated secretory phenotype factors.	TNF	tumor	7124	HP_0002664	41	44	18	23	False
30665488	Dear Editor, Immune-checkpoint blockade is a type of passive immunotherapy aimed at enhancing preexisting anti-tumor responses of the organism, blocking self-tolerance molecular interactions between T-lymphocytes and neoplastic cells (1,2).	type	tumor	6445	HP_0002664	45	49	111	116	False
30665488	The tumor was afterwards identified as a dMMR melanoma for an exclusive loss of Msh6 expression on IHC (Figure 1).	Msh6	tumor	2956	HP_0002664	80	84	4	9	True
28734943	More important, Col5a2 haploinsufficiency markedly increased the incidence and severity of abdominal aortic aneurysms, and caused aortic arch ruptures and dissections, indicating that 2(V) chain deficits may play roles in these pathologies in humans	Col5a2	aortic aneurysms	1290	HP_0004942	16	22	101	117	True
28734943	More important, Col5a2 haploinsufficiency markedly increased the incidence and severity of abdominal aortic aneurysms, and caused aortic arch ruptures and dissections, indicating that 2(V) chain deficits may play roles in these pathologies in humans	arch	aortic aneurysms	339487	HP_0004942	137	141	101	117	False
27607025	As a reason why the present case showed lethal phenotype despite the in-frame deletion mutation, rapid degradation of neo-synthesized 6 protein and/or impaired transport of integrin were suggested from previous reports, and the lack of localization of integrin 64 to the epidermal basement membrane resulted in skin fragility.	type	skin fragility	6445	HP_0001030	52	56	314	328	False
26300425	In clinical practices, the therapeutic outcomes and prognosis of hepatocellular carcinoma (HCC) patients with different tumor numbers after surgery are very different; however, the underlying mechanisms of the tumorigenesis and development of HCC with different tumor numbers are still not well understood.	HCC	hepatocellular carcinoma	84668	HP_0001402	91	94	65	89	False
26300425	In clinical practices, the therapeutic outcomes and prognosis of hepatocellular carcinoma (HCC) patients with different tumor numbers after surgery are very different; however, the underlying mechanisms of the tumorigenesis and development of HCC with different tumor numbers are still not well understood.	HCC	tumor	84668	HP_0002664	91	94	120	125	False
26300425	These information revealed that there might be different molecular mechanisms of the tumorigenesis and development of the HCC with single and multiple lesions.	HCC	tumor	84668	HP_0002664	122	125	85	90	False
28744922	Forty unique IFNGR1 mutations have been reported and they exert either an autosomal dominant or an autosomal recessive effect.	IFN	autosomal recessive	3439	HP_0000007	13	16	99	118	False
29100085	Here we identified six different de novo missense mutations in DHX30 in twelve unrelated individuals affected by global developmental delay (GDD), intellectual disability (ID), severe speech impairment and gait abnormalities.	DHX30	developmental delay	22907	HP_0001263	63	68	120	139	True
29100085	Here we identified six different de novo missense mutations in DHX30 in twelve unrelated individuals affected by global developmental delay (GDD), intellectual disability (ID), severe speech impairment and gait abnormalities.	DHX30	intellectual disability	22907	HP_0001249	63	68	147	170	True
29100085	Here we identified six different de novo missense mutations in DHX30 in twelve unrelated individuals affected by global developmental delay (GDD), intellectual disability (ID), severe speech impairment and gait abnormalities.	DHX30	speech impairment	22907	HP_0002167	63	68	184	201	True
29100085	Here we identified six different de novo missense mutations in DHX30 in twelve unrelated individuals affected by global developmental delay (GDD), intellectual disability (ID), severe speech impairment and gait abnormalities.	DHX30	gait abnormalities	22907	HP_0001288	63	68	206	224	True
27124303	Disruption of PHF21A has previously been implicated in the causation of intellectual disability (but not aniridia).	PHF21A	intellectual disability	51317	HP_0001249	14	20	72	95	True
28772236	These studies suggest that compound 4d behaves well in lowering body weight and maintaining energy expenditure without a chance of hyperglycaemia, 4d has strong clinical potential as an efficient GLP-1/GCGR agonist in the prevention and treatment of obesity and dyslipidemia	GCGR	obesity	2642	HP_0001513	202	206	250	257	False
28772236	These studies suggest that compound 4d behaves well in lowering body weight and maintaining energy expenditure without a chance of hyperglycaemia, 4d has strong clinical potential as an efficient GLP-1/GCGR agonist in the prevention and treatment of obesity and dyslipidemia	GLP	obesity	342096	HP_0001513	196	199	250	257	False
30642872	By 3 months, zonular fibers invariably ruptured and mice developed ectopia lentis, a hallmark of Marfan syndrome.	mice	ectopia lentis	23581	HP_0001083	52	56	67	81	False
29034896	Pathogenic sequence variants in the Sorting Nexin 10 (SNX10) gene have been associated with autosomal recessive osteopetrosis (ARO) in human.	Nexin	autosomal recessive	5270	HP_0000007	44	49	92	111	False
29034896	Pathogenic sequence variants in the Sorting Nexin 10 (SNX10) gene have been associated with autosomal recessive osteopetrosis (ARO) in human.	SNX10	autosomal recessive	29887	HP_0000007	54	59	92	111	True
29034896	Pathogenic sequence variants in the Sorting Nexin 10 (SNX10) gene have been associated with autosomal recessive osteopetrosis (ARO) in human.	ARO	autosomal recessive	1588	HP_0000007	127	130	92	111	True
27151206	Patients with KCNK9 imprinting syndrome demonstrate congenital hypotonia, variable cleft palate, normal MRIs and EEGs, delayed development, and feeding problems.	KCNK9	cleft palate	51305	HP_0000175	14	19	83	95	True
27151206	Associated facial dysmorphic features include dolichocephaly with bitemporal narrowing, short philtrum, tented upper lip, palatal abnormalities, and small mandible.	lip	bitemporal narrowing	23049	HP_0000341	117	120	66	86	False
27151206	Associated facial dysmorphic features include dolichocephaly with bitemporal narrowing, short philtrum, tented upper lip, palatal abnormalities, and small mandible.	lip	short philtrum	23049	HP_0000322	117	120	88	102	False
27151206	Associated facial dysmorphic features include dolichocephaly with bitemporal narrowing, short philtrum, tented upper lip, palatal abnormalities, and small mandible.	lip	small mandible	23049	HP_0000347	117	120	149	163	False
27151206	Older members of a previously reported Arab-Israeli family have intellectual disability of variable severity, persistent feeding difficulties in infancy with dysphagia of liquids and dysphonia with a muffled voice in early adulthood, generalized hypotonia, weakness of proximal muscles, elongated face with narrow bitemporal diameter, and reduced facial movements.	face	intellectual disability	2178	HP_0001249	297	301	64	87	True
27151206	Older members of a previously reported Arab-Israeli family have intellectual disability of variable severity, persistent feeding difficulties in infancy with dysphagia of liquids and dysphonia with a muffled voice in early adulthood, generalized hypotonia, weakness of proximal muscles, elongated face with narrow bitemporal diameter, and reduced facial movements.	face	proximal	2178	HP_0012840	297	301	269	277	False
28814648	ZC4H2 is a small nuclear protein associated with intellectual disability and neural development in humans.	ZC4H2	intellectual disability	55906	HP_0001249	0	5	49	72	True
29401312	To better understand the molecular changes in the AH content under such conditions, we analyzed the miRNA profiles of AH samples from patients with POAG and XFG compared to non-glaucoma controls.	miR	glaucoma	220972	HP_0000501	100	103	177	185	False
29401312	While none of these miRNAs have been previously linked to glaucoma, miR-122-5p may target three glaucoma-associated genes: OPTN, TMCO1 and TGF-1.	miR	glaucoma	220972	HP_0000501	20	23	58	66	False
29401312	While none of these miRNAs have been previously linked to glaucoma, miR-122-5p may target three glaucoma-associated genes: OPTN, TMCO1 and TGF-1.	OPTN	glaucoma	10133	HP_0000501	123	127	58	66	True
29401312	While none of these miRNAs have been previously linked to glaucoma, miR-122-5p may target three glaucoma-associated genes: OPTN, TMCO1 and TGF-1.	TMCO1	glaucoma	54499	HP_0000501	129	134	58	66	False
29401312	Pathway analysis revealed that these miRNAs are involved in potential glaucoma pathways, including focal adhesion, tight junctions, and TGF- signaling.	miR	glaucoma	220972	HP_0000501	37	40	70	78	False
29401312	These miRNAs may play a role in pathways previously implicated in glaucoma and act as biomarkers for disease pathogenesis	miR	glaucoma	220972	HP_0000501	6	9	66	74	False
29401312	These miRNAs may play a role in pathways previously implicated in glaucoma and act as biomarkers for disease pathogenesis	act	glaucoma	11332	HP_0000501	79	82	66	74	False
28263981	The presynaptic cytomatrix protein Piccolo, encoded by PCLO, is frequently mutated and amplified in esophageal squamous cell carcinoma (ESCC), but its exact roles in ESCC remain unclear.	PCLO	squamous cell carcinoma	27445	HP_0002860	55	59	111	134	False
28263981	These results demonstrate that Piccolo contributes to tumor aggressiveness in ESCC, likely by stabilizing EGFR and promoting EGFR-dependent signaling.	EGFR	tumor	1956	HP_0002664	106	110	54	59	True
28263981	These results demonstrate that Piccolo contributes to tumor aggressiveness in ESCC, likely by stabilizing EGFR and promoting EGFR-dependent signaling.	EGFR	aggressiveness	1956	HP_0000718	106	110	60	74	False
26748743	Epithelial-stromal TGFBI dystrophies, macular corneal dystrophy and Schnyder corneal dystrophy (SCD) showed 100% mutation detection rates, while endothelial corneal dystrophies showed lower detection rates of 3%.	TGFBI	corneal dystrophies	7045	HP_0001131	19	24	157	176	True
26748743	Epithelial-stromal TGFBI dystrophies, macular corneal dystrophy and Schnyder corneal dystrophy (SCD) showed 100% mutation detection rates, while endothelial corneal dystrophies showed lower detection rates of 3%.	SCD	corneal dystrophies	6584	HP_0001131	96	99	157	176	False
26748743	Epithelial-stromal TGFBI dystrophies, macular corneal dystrophy and Schnyder corneal dystrophy (SCD) showed 100% mutation detection rates, while endothelial corneal dystrophies showed lower detection rates of 3%.	TGFBI	corneal dystrophy	7045	HP_0001131	19	24	46	63	True
26748743	Epithelial-stromal TGFBI dystrophies, macular corneal dystrophy and Schnyder corneal dystrophy (SCD) showed 100% mutation detection rates, while endothelial corneal dystrophies showed lower detection rates of 3%.	SCD	corneal dystrophy	6584	HP_0001131	96	99	46	63	False
29416026	Here we show that mitochondrial Sirtuin5 (SIRT5), which mediates lysine desuccinylation, deglutarylation, and demalonylation, plays a role in colorectal cancer (CRC) glutamine metabolic rewiring.	SIRT5	cancer	23408	HP_0002664	42	47	153	159	False
28122307	Hepatocellular carcinoma related protein 1 (HCRP1), which is essential for internalization and degradation of ubiquitinated membrane receptors, is downregulated in several tumors and strongly affects the outcomes of cancer patients.	HCRP1	tumors	137492	HP_0002664	44	49	172	178	False
28122307	Hepatocellular carcinoma related protein 1 (HCRP1), which is essential for internalization and degradation of ubiquitinated membrane receptors, is downregulated in several tumors and strongly affects the outcomes of cancer patients.	HCRP1	cancer	137492	HP_0002664	44	49	216	222	False
28122307	It is reported the expression of HCRP1 is inversely related to epidermal growth factor receptor (EGFR) in breast cancer and lead to resistance to cetuximab in ovarian cancer.	HCRP1	cancer	137492	HP_0002664	33	38	113	119	False
28122307	It is reported the expression of HCRP1 is inversely related to epidermal growth factor receptor (EGFR) in breast cancer and lead to resistance to cetuximab in ovarian cancer.	EGFR	cancer	1956	HP_0002664	97	101	113	119	True
28122307	HCRP1 expression was significantly related to age (P=0.017), pathological grade (P=0.003), tumor encapsulation (P=0.037), recurrence (P=0.039) and death (P=0.015), but unrelated to cirrhosis (P=0.216), tumor size (P=0.273), and distant metastasis (P=0.554).	HCRP1	tumor	137492	HP_0002664	0	5	91	96	False
29605155	Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease, characterized genetically by a disproportionately large contribution of rare genetic variation.	ALS	neurodegenerative disease	3483	HP_0002180	31	34	49	74	False
28782656	PKD1 and PKD2 germline mutations are found in patients with autosomal dominant polycystic kidney disease (ADPKD).	PKD2	kidney disease	25865	HP_0000077	9	13	90	104	False
28698647	Prostate cancer is the most common cancer among western men, with a significant mortality and morbidity reported for advanced metastatic disease.	men	cancer	8178	HP_0002664	56	59	9	15	False
28698647	By analysing prostate cancer bone metastases using high density microarrays, we found a common genomic copy number loss at 6q16.1-16.2, containing the FBXL4 gene, which was confirmed in larger series of bone metastases by fluorescence in situ hybridisation (FISH).	FBXL4	cancer	26235	HP_0002664	151	156	22	28	False
28698647	By analysing prostate cancer bone metastases using high density microarrays, we found a common genomic copy number loss at 6q16.1-16.2, containing the FBXL4 gene, which was confirmed in larger series of bone metastases by fluorescence in situ hybridisation (FISH).	FISH	cancer	9644	HP_0002664	258	262	22	28	False
28698647	Loss of FBXL4 was also detected in primary tumours and it was highly associated with prognostic factors including high Gleason score, clinical stage, prostate-specific antigen (PSA) and extent of disease, as well as poor patient survival, suggesting that FBXL4 loss contributes to prostate cancer progression.	FBXL4	cancer	26235	HP_0002664	8	13	290	296	False
28698647	Loss of FBXL4 was also detected in primary tumours and it was highly associated with prognostic factors including high Gleason score, clinical stage, prostate-specific antigen (PSA) and extent of disease, as well as poor patient survival, suggesting that FBXL4 loss contributes to prostate cancer progression.	PSA	cancer	3818	HP_0002664	177	180	290	296	False
28698647	Loss of FBXL4 was also detected in primary tumours and it was highly associated with prognostic factors including high Gleason score, clinical stage, prostate-specific antigen (PSA) and extent of disease, as well as poor patient survival, suggesting that FBXL4 loss contributes to prostate cancer progression.	FBXL4	tumours	26235	HP_0002664	8	13	43	50	False
28698647	Loss of FBXL4 was also detected in primary tumours and it was highly associated with prognostic factors including high Gleason score, clinical stage, prostate-specific antigen (PSA) and extent of disease, as well as poor patient survival, suggesting that FBXL4 loss contributes to prostate cancer progression.	PSA	tumours	3818	HP_0002664	177	180	43	50	False
28698647	We also demonstrated that FBXL4 deletion is detectable in circulating tumour cells (CTCs), making it a potential prognostic biomarker by 'liquid biopsy'.	FBXL4	tumour	26235	HP_0002664	26	31	70	76	False
28698647	In vitro analysis showed that FBXL4 plays a role in regulating the migration and invasion of prostate cancer cells.	FBXL4	cancer	26235	HP_0002664	30	35	102	108	False
28698647	FBXL4 potentially controls cancer metastasis through regulation of ERLEC1 levels.	FBXL4	cancer	26235	HP_0002664	0	5	27	33	False
28698647	FBXL4 potentially controls cancer metastasis through regulation of ERLEC1 levels.	ERLEC1	cancer	27248	HP_0002664	67	73	27	33	False
28698647	Therefore, FBXL4 could be a potential novel prostate cancer suppressor gene, which may prevent cancer progression and metastasis through controlling cell invasion	FBXL4	cancer	26235	HP_0002664	11	16	53	59	False
29744576	Here, we summarize thecellular functions of PGRN, itsroles in the nervous system, and its link to multiple neurodegenerative diseases, with a particular focus dedicated to recent lysosome-related mechanistic developments	PGRN	neurodegenerative diseases	2896	HP_0002180	45	49	109	135	False
29322253	Our data, for the first time, functionally link Jalili syndrome gene CNNM4 to LCA gene IQCB1, providing important insights into the molecular pathogenic mechanism of retinal dystrophy in Jalili syndrome	CNNM4	retinal dystrophy	26504	HP_0000556	69	74	166	183	True
29322253	Our data, for the first time, functionally link Jalili syndrome gene CNNM4 to LCA gene IQCB1, providing important insights into the molecular pathogenic mechanism of retinal dystrophy in Jalili syndrome	IQCB1	retinal dystrophy	9657	HP_0000556	87	92	166	183	True
29322253	Our data, for the first time, functionally link Jalili syndrome gene CNNM4 to LCA gene IQCB1, providing important insights into the molecular pathogenic mechanism of retinal dystrophy in Jalili syndrome	LCA	retinal dystrophy	1211	HP_0000556	78	81	166	183	False
29909971	Mutations in PLA2G6 (PARK14) cause neurodegenerative disorders in humans, including autosomal recessive neuroaxonal dystrophy and early-onset parkinsonism.	PLA2G6	autosomal recessive	8398	HP_0000007	13	19	84	103	True
29909971	Mutations in PLA2G6 (PARK14) cause neurodegenerative disorders in humans, including autosomal recessive neuroaxonal dystrophy and early-onset parkinsonism.	PARK14	autosomal recessive	8398	HP_0000007	21	27	84	103	True
29909971	Mutations in PLA2G6 (PARK14) cause neurodegenerative disorders in humans, including autosomal recessive neuroaxonal dystrophy and early-onset parkinsonism.	PLA2G6	parkinsonism	8398	HP_0001300	13	19	142	154	True
29909971	Mutations in PLA2G6 (PARK14) cause neurodegenerative disorders in humans, including autosomal recessive neuroaxonal dystrophy and early-onset parkinsonism.	PARK14	parkinsonism	8398	HP_0001300	21	27	142	154	True
28621321	Morphologic features of YWHAE-NUTM2 high-grade endometrial stromal sarcoma may overlap with other uterine sarcoma types.	YWHAE	sarcoma	7531	HP_0100242	24	29	67	74	False
28621321	BCOR immunoexpression was studied in these tumors and their morphologic mimics to assess its diagnostic utility.	BCOR	tumors	54880	HP_0002664	0	4	43	49	False
28621321	BCOR immunohistochemical staining was performed on archival tissue from 28 high-grade endometrial stromal sarcomas with classic morphology (20 YWHAE-NUTM2, 5 ZC3H7B-BCOR, 3 BCOR-ZC3H7B), 3 high-grade endometrial stromal sarcomas with unusual morphology and unknown gene rearrangement status, 66 low-grade endometrial stromal sarcomas, 21 endometrial stromal nodules, 38 uterine leiomyosarcomas, and 19 uterine leiomyomas.	YWHAE	sarcoma	7531	HP_0100242	143	148	106	113	False
28621321	BCOR immunohistochemical staining was performed on archival tissue from 28 high-grade endometrial stromal sarcomas with classic morphology (20 YWHAE-NUTM2, 5 ZC3H7B-BCOR, 3 BCOR-ZC3H7B), 3 high-grade endometrial stromal sarcomas with unusual morphology and unknown gene rearrangement status, 66 low-grade endometrial stromal sarcomas, 21 endometrial stromal nodules, 38 uterine leiomyosarcomas, and 19 uterine leiomyomas.	ZC3H7B	sarcoma	23264	HP_0100242	158	164	106	113	False
28621321	BCOR immunohistochemical staining was performed on archival tissue from 28 high-grade endometrial stromal sarcomas with classic morphology (20 YWHAE-NUTM2, 5 ZC3H7B-BCOR, 3 BCOR-ZC3H7B), 3 high-grade endometrial stromal sarcomas with unusual morphology and unknown gene rearrangement status, 66 low-grade endometrial stromal sarcomas, 21 endometrial stromal nodules, 38 uterine leiomyosarcomas, and 19 uterine leiomyomas.	BCOR	sarcoma	54880	HP_0100242	0	4	106	113	False
28621321	Strong diffuse nuclear BCOR staining (defined as &gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.	YWHAE	sarcoma	7531	HP_0100242	135	140	178	185	False
28621321	Strong diffuse nuclear BCOR staining (defined as &gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.	BCOR	sarcoma	54880	HP_0100242	23	27	178	185	False
28621321	Strong diffuse nuclear BCOR staining (defined as &gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.	FISH	sarcoma	9644	HP_0100242	260	264	178	185	False
28621321	Strong diffuse nuclear BCOR staining (defined as &gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.	YWHAE	tumors	7531	HP_0002664	135	140	309	315	False
28621321	Strong diffuse nuclear BCOR staining (defined as &gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.	BCOR	tumors	54880	HP_0002664	23	27	309	315	False
28621321	Strong diffuse nuclear BCOR staining (defined as &gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.	FISH	tumors	9644	HP_0002664	260	264	309	315	False
28621321	Strong diffuse nuclear BCOR staining (defined as &gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.	YWHAE	tumor	7531	HP_0002664	135	140	60	65	False
28621321	Strong diffuse nuclear BCOR staining (defined as &gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.	BCOR	tumor	54880	HP_0002664	23	27	60	65	False
28621321	Strong diffuse nuclear BCOR staining (defined as &gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic YWHAE-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.	FISH	tumor	9644	HP_0002664	260	264	60	65	False
28621321	Diffuse BCOR staining was strong in three and weak in one BCOR-rearranged high-grade endometrial stromal sarcoma while absent in the remaining four BCOR-rearranged tumors.	BCOR	sarcoma	54880	HP_0100242	8	12	105	112	False
28621321	Diffuse BCOR staining was strong in three and weak in one BCOR-rearranged high-grade endometrial stromal sarcoma while absent in the remaining four BCOR-rearranged tumors.	BCOR	tumors	54880	HP_0002664	8	12	164	170	False
28621321	BCOR staining was weakly positive in &lt;5% of tumor cells in 4 of 66 (6%) low-grade endometrial stromal sarcomas and 1 of 18 (6%) endometrial stromal nodules and weakly to moderately positive in &lt;5-40% of tumor cells in 6 of 31 (19%) leiomyosarcomas.	BCOR	sarcoma	54880	HP_0100242	0	4	105	112	False
28621321	BCOR staining was weakly positive in &lt;5% of tumor cells in 4 of 66 (6%) low-grade endometrial stromal sarcomas and 1 of 18 (6%) endometrial stromal nodules and weakly to moderately positive in &lt;5-40% of tumor cells in 6 of 31 (19%) leiomyosarcomas.	BCOR	tumor	54880	HP_0002664	0	4	47	52	False
28621321	No BCOR staining was seen in the remaining low-grade endometrial stromal sarcomas, endometrial stromal nodules, leiomyosarcomas, or any of the leiomyomas.	BCOR	sarcoma	54880	HP_0100242	3	7	73	80	False
28621321	BCOR immunohistochemical staining is a highly sensitive marker for YWHAE-NUTM2 high-grade endometrial stromal sarcoma with both classic and unusual morphology and identifies a subset of high-grade endometrial stromal sarcoma with BCOR alterations, including BCOR rearrangement and internal tandem duplication	YWHAE	sarcoma	7531	HP_0100242	67	72	110	117	False
28621321	BCOR immunohistochemical staining is a highly sensitive marker for YWHAE-NUTM2 high-grade endometrial stromal sarcoma with both classic and unusual morphology and identifies a subset of high-grade endometrial stromal sarcoma with BCOR alterations, including BCOR rearrangement and internal tandem duplication	BCOR	sarcoma	54880	HP_0100242	0	4	110	117	False
29845554	Since diffuse hepatic hemangiomatosis (DHH) is an extremely rare disease especially in adults, the etiology and natural course of adult-onset DHH has not been well understood.	DHH	hemangiomatosis	50846	HP_0007461	39	42	22	37	False
29845554	She presented with mild abdominal distension and laboratory findings revealed thrombocytopenia and abnormal coagulation, indicating disseminated intravascular coagulation (DIC).	DIC	abdominal distension	1468	HP_0003270	172	175	24	44	False
22961547	In this work, we report a new progressive myoclonus epilepsy associated with Lafora bodies, early-onset Lafora body disease, map its locus to chromosome 4q21.21, identify its gene and mutation and characterize the relationship of its gene product with laforin and malin.	malin	myoclonus	378884	HP_0001336	264	269	42	51	True
22961547	In this work, we report a new progressive myoclonus epilepsy associated with Lafora bodies, early-onset Lafora body disease, map its locus to chromosome 4q21.21, identify its gene and mutation and characterize the relationship of its gene product with laforin and malin.	malin	epilepsy	378884	HP_0001250	264	269	52	60	True
24597975	Recently, loss-of-function mutations in BCAP31 were reported in association with severe developmental delay, deafness and dystonia.	BCAP31	developmental delay	10134	HP_0001263	40	46	88	107	True
24597975	Recently, loss-of-function mutations in BCAP31 were reported in association with severe developmental delay, deafness and dystonia.	BCAP31	deafness	10134	HP_0000365	40	46	109	117	True
24597975	Recently, loss-of-function mutations in BCAP31 were reported in association with severe developmental delay, deafness and dystonia.	BCAP31	dystonia	10134	HP_0001332	40	46	122	130	True
24597975	Remarkably, a patient with an isolated deletion at the 3'-end of SLC6A8 had a similar severe phenotype as seen in BCAP31 deficiency but without deafness.	BCAP31	deafness	10134	HP_0000365	114	120	144	152	True
24597975	Remarkably, a patient with an isolated deletion at the 3'-end of SLC6A8 had a similar severe phenotype as seen in BCAP31 deficiency but without deafness.	SLC6A8	deafness	6535	HP_0000365	65	71	144	152	False
28749373	The RS-MC was also validated against measurements and simulations in heterogeneous phantoms created by placing lung or bone slabs in a water phantom.	RS	heterogeneous	5308	HP_0001425	4	6	69	82	True
28749373	The RS-MC algorithm demonstrated improved dosimetric accuracy over the RS-PBA in the presence of homogenous, heterogeneous and anthropomorphic phantoms.	RS	heterogeneous	5308	HP_0001425	4	6	109	122	True
28749373	For complex disease sites like breast, head and neck, and lung cancer, the RS-MC algorithm will provide significantly more accurate treatment planning	RS	cancer	5308	HP_0002664	75	77	63	69	False
30507891	For diagnosis of central nervous system degeneration in adolescents with bulbar symptoms, great attention should be paid to JALS	great	central nervous system degeneration	122042	HP_0007009	90	95	17	52	False
30134806	Numerous studies have recently demonstrated that HDAC6 expression and activity are increased in kidney disease, such as autosomal dominant polycystic kidney disease (ADPKD), renal fibrosis, and acute kidney injury (AKI), among others.	HDAC6	kidney disease	10013	HP_0000077	49	54	96	110	False
30134806	Numerous studies have recently demonstrated that HDAC6 expression and activity are increased in kidney disease, such as autosomal dominant polycystic kidney disease (ADPKD), renal fibrosis, and acute kidney injury (AKI), among others.	HDAC6	renal fibrosis	10013	HP_0030760	49	54	174	188	False
30134806	In fact, HDAC6 inhibitors effectively limit the progression of kidney diseases, suggesting that targeting HDAC6 may provide a novel treatment approach.	HDAC6	kidney disease	10013	HP_0000077	9	14	63	77	False
30134806	In fact, HDAC6 inhibitors effectively limit the progression of kidney diseases, suggesting that targeting HDAC6 may provide a novel treatment approach.	fact	kidney disease	11198	HP_0000077	3	7	63	77	False
30134806	Here, we discuss the unique function of HDAC6 and recapitulate the alluring potential of its inhibitors in kidney diseases	HDAC6	kidney disease	10013	HP_0000077	40	45	107	121	False
27966653	In A549 lung cancer cells, which endogenously express CXCR1, the depletion of REEP5 and REEP6 significantly reduced growth and invasion by downregulating IL-8-stimulated ERK phosphorylation, actin polymerization and the expression of genes related to metastasis.	CXCR1	cancer	3577	HP_0002664	54	59	13	19	False
27966653	In A549 lung cancer cells, which endogenously express CXCR1, the depletion of REEP5 and REEP6 significantly reduced growth and invasion by downregulating IL-8-stimulated ERK phosphorylation, actin polymerization and the expression of genes related to metastasis.	REEP5	cancer	7905	HP_0002664	78	83	13	19	False
27966653	In A549 lung cancer cells, which endogenously express CXCR1, the depletion of REEP5 and REEP6 significantly reduced growth and invasion by downregulating IL-8-stimulated ERK phosphorylation, actin polymerization and the expression of genes related to metastasis.	REEP6	cancer	92840	HP_0002664	88	93	13	19	False
27966653	In A549 lung cancer cells, which endogenously express CXCR1, the depletion of REEP5 and REEP6 significantly reduced growth and invasion by downregulating IL-8-stimulated ERK phosphorylation, actin polymerization and the expression of genes related to metastasis.	IL-8	cancer	3576	HP_0002664	154	158	13	19	False
27966653	In A549 lung cancer cells, which endogenously express CXCR1, the depletion of REEP5 and REEP6 significantly reduced growth and invasion by downregulating IL-8-stimulated ERK phosphorylation, actin polymerization and the expression of genes related to metastasis.	ERK	cancer	2048	HP_0002664	170	173	13	19	False
29505555	Three loci with high mutation frequencies, the 138665410 FOXL2 gene variant, the 23862952 MYH6 gene variant, and the 71098693 HYDIN gene variant were found to be significantly associated with sporadic ASD (P&lt;0.05); variants in FOXL2 and MYH6 were found in patients with isolated, sporadic ASD (P&lt;510^-4).	FOXL2	sporadic	668	HP_0003745	57	62	192	200	False
29505555	Three loci with high mutation frequencies, the 138665410 FOXL2 gene variant, the 23862952 MYH6 gene variant, and the 71098693 HYDIN gene variant were found to be significantly associated with sporadic ASD (P&lt;0.05); variants in FOXL2 and MYH6 were found in patients with isolated, sporadic ASD (P&lt;510^-4).	MYH6	sporadic	4624	HP_0003745	90	94	192	200	False
29505555	Three loci with high mutation frequencies, the 138665410 FOXL2 gene variant, the 23862952 MYH6 gene variant, and the 71098693 HYDIN gene variant were found to be significantly associated with sporadic ASD (P&lt;0.05); variants in FOXL2 and MYH6 were found in patients with isolated, sporadic ASD (P&lt;510^-4).	HYDIN	sporadic	54768	HP_0003745	126	131	192	200	False
29505555	CONCLUSIONS This was the first study that demonstrated variants in FOXL2 and HYDIN associated with sporadic ASD, and supported the use of WES and bioinformatics analysis to identify disease-associated mutations	FOXL2	sporadic	668	HP_0003745	67	72	99	107	False
29505555	CONCLUSIONS This was the first study that demonstrated variants in FOXL2 and HYDIN associated with sporadic ASD, and supported the use of WES and bioinformatics analysis to identify disease-associated mutations	HYDIN	sporadic	54768	HP_0003745	77	82	99	107	False
29726012	However, the associations between RAD50 germline mutations and the survival and risk of breast cancer have not been fully elucidated.	RAD50	cancer	10111	HP_0002664	34	39	95	101	True
29726012	Here, we aimed to investigate the clinical impact of RAD50 germline mutations in a large cohort of unselected breast cancer patients.	RAD50	cancer	10111	HP_0002664	53	58	117	123	True
29726012	Here, we aimed to investigate the clinical impact of RAD50 germline mutations in a large cohort of unselected breast cancer patients.	impact	cancer	55364	HP_0002664	43	49	117	123	False
29726012	In our study, RAD50 germline mutations were determined using next-generation sequencing in 7657 consecutive unselected breast cancer patients without BRCA1/2 mutations.	RAD50	cancer	10111	HP_0002664	14	19	126	132	True
29726012	Our study suggested that RAD50 germline mutations are not associated with an increased risk of breast cancer, but patients with RAD50 germline mutations have unfavourable survival compared to patients without these mutations	RAD50	cancer	10111	HP_0002664	25	30	102	108	True
28359976	We found that hypermethylation of TRIM36 and reduced gene expression was prevalent in several types of human cancers.	TRIM36	cancer	55521	HP_0002664	34	40	109	115	False
27206850	We identified a new susceptibility locus for bladder cancer at 5q12.3, located in the intron of CWC27 (rs2042329), that was significantly associated with disease risk (OR = 1.40; P = 4.61  10(-11)).	CWC27	cancer	10283	HP_0002664	96	101	53	59	False
27206850	The rs2042329 risk allele was also related to significantly increased expression levels of CWC27 mRNA and protein in bladder cancer tissues from Chinese patients.	CWC27	cancer	10283	HP_0002664	91	96	125	131	False
27206850	Additional functional analyses suggested that CWC27 played an oncogenic role in bladder cancer by inducing cell proliferation and suppressing apoptosis.	CWC27	cancer	10283	HP_0002664	46	51	88	94	False
29426275	Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (SEF) are rare tumors with distinct sets of morphological features, both characterized by MUC4 immunoreactivity.	SEF	sarcoma	54756	HP_0100242	79	82	22	29	False
29426275	Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (SEF) are rare tumors with distinct sets of morphological features, both characterized by MUC4 immunoreactivity.	MUC4	sarcoma	4585	HP_0100242	168	172	22	29	False
29426275	Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (SEF) are rare tumors with distinct sets of morphological features, both characterized by MUC4 immunoreactivity.	SEF	tumors	54756	HP_0002664	79	82	93	99	False
29426275	Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (SEF) are rare tumors with distinct sets of morphological features, both characterized by MUC4 immunoreactivity.	MUC4	tumors	4585	HP_0002664	168	172	93	99	False
29426275	In the largest study of hybrid LGFMS-SEF tumors to date, all cases exhibited FUS rearrangements, a similar genetic profile to LGFMS.	SEF	tumors	54756	HP_0002664	37	40	41	47	False
29426275	In the largest study of hybrid LGFMS-SEF tumors to date, all cases exhibited FUS rearrangements, a similar genetic profile to LGFMS.	FUS	tumors	2521	HP_0002664	77	80	41	47	False
29426275	Fusion gene detection using a next-generation sequencing-based anchored multiplex PCR technique (Archer FusionPlex Sarcoma Panel) was performed on both the primary renal tumor that showed the morphology of a LGFMS, and a cervical metastasis that showed the morphology of SEF.	SEF	tumor	54756	HP_0002664	271	274	170	175	False
28486105	An oncogenic role for CHD4, a NuRD component, is defined for initiating and supporting tumor suppressor gene (TSG) silencing in human colorectal cancer.	CHD4	tumor	1108	HP_0002664	22	26	87	92	False
28486105	An oncogenic role for CHD4, a NuRD component, is defined for initiating and supporting tumor suppressor gene (TSG) silencing in human colorectal cancer.	TSG	tumor	57045	HP_0002664	110	113	87	92	False
28486105	An oncogenic role for CHD4, a NuRD component, is defined for initiating and supporting tumor suppressor gene (TSG) silencing in human colorectal cancer.	CHD4	cancer	1108	HP_0002664	22	26	145	151	False
28486105	An oncogenic role for CHD4, a NuRD component, is defined for initiating and supporting tumor suppressor gene (TSG) silencing in human colorectal cancer.	TSG	cancer	57045	HP_0002664	110	113	145	151	False
28486105	CHD4 knockdown activates silenced TSGs, revealing their role for blunting colorectal cancer cell proliferation, invasion, and metastases.	CHD4	cancer	1108	HP_0002664	0	4	85	91	False
28486105	CHD4 knockdown activates silenced TSGs, revealing their role for blunting colorectal cancer cell proliferation, invasion, and metastases.	TSG	cancer	57045	HP_0002664	34	37	85	91	False
28357685	This is supported by the fact that the myeloid neoplasms with genetic predisposition represent a new category in the revised 2016 World Health Organization classification.	fact	neoplasms	11198	HP_0002664	25	29	47	56	False
29891926	Fanconi anemia (FA) is a rare disease characterized by bone marrow failure, developmental abnormalities, and increased cancer risk that is caused by defective repair of DNA interstrand crosslinks (ICLs).	FA	cancer	2395	HP_0002664	16	18	119	125	False
28960803	We present two new cases of Warsaw Breakage Syndrome (WABS), an autosomal recessive cohesinopathy, in sisters aged 13 and 11 years who both had compound heterozygous mutations in DDX11.	WABS	autosomal recessive	1663	HP_0000007	54	58	64	83	True
28960803	The sisters reported here display the distinguishing clinical features of WABS: pre- and post-natal growth restriction, microcephaly, intellectual disability, sensorineural hearing loss with cochlear abnormalities, and facial dysmorphic features.	WABS	microcephaly	1663	HP_0000252	74	78	120	132	True
28960803	The sisters reported here display the distinguishing clinical features of WABS: pre- and post-natal growth restriction, microcephaly, intellectual disability, sensorineural hearing loss with cochlear abnormalities, and facial dysmorphic features.	WABS	intellectual disability	1663	HP_0001249	74	78	134	157	True
28960803	The sisters reported here display the distinguishing clinical features of WABS: pre- and post-natal growth restriction, microcephaly, intellectual disability, sensorineural hearing loss with cochlear abnormalities, and facial dysmorphic features.	WABS	hearing loss	1663	HP_0000365	74	78	173	185	True
27288692	As a result, 14 SNPs had a significant odds ratio (OR) for lung cancer risk with P FDR &lt; 0.05, of which rs3115672 in MSH5 (OR = 1.20, 95% CI = 1.14-1.27) and rs114596632 in GTF2H4 (OR = 1.19, 95% CI = 1.12-1.25) at 6q21.33 were the most statistically significant (P combined = 3.9910(-11) and P combined = 5.4010(-10), respectively).	MSH5	cancer	4439	HP_0002664	120	124	64	70	False
27288692	As a result, 14 SNPs had a significant odds ratio (OR) for lung cancer risk with P FDR &lt; 0.05, of which rs3115672 in MSH5 (OR = 1.20, 95% CI = 1.14-1.27) and rs114596632 in GTF2H4 (OR = 1.19, 95% CI = 1.12-1.25) at 6q21.33 were the most statistically significant (P combined = 3.9910(-11) and P combined = 5.4010(-10), respectively).	GTF2H4	cancer	2968	HP_0002664	176	182	64	70	False
29789714	Recent studies indicated that the estrogen receptor beta (ER) could affect the progression of prostate and bladder tumors, however, its roles in the renal cell carcinoma (RCC), remain to be elucidated.	RCC	tumors	7515	HP_0002664	172	175	116	122	False
29789714	Recent studies indicated that the estrogen receptor beta (ER) could affect the progression of prostate and bladder tumors, however, its roles in the renal cell carcinoma (RCC), remain to be elucidated.	RCC	renal cell carcinoma	7515	HP_0005584	172	175	150	170	False
19463982	Bowen-Conradi syndrome (BCS) is an autosomal-recessive disorder characterized by severely impaired prenatal and postnatal growth, profound psychomotor retardation, and death in early childhood.	BCS	profound	617	HP_0012829	24	27	130	138	False
28111185	In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral anophthalmia, and bifid and broad nasal tip) in whom two novel FREM1 mutations (c.305A&gt;G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.	FREM1	hypertelorism	158326	HP_0000316	204	209	115	128	True
28111185	In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral anophthalmia, and bifid and broad nasal tip) in whom two novel FREM1 mutations (c.305A&gt;G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.	tip	hypertelorism	81533	HP_0000316	181	184	115	128	False
28111185	In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral anophthalmia, and bifid and broad nasal tip) in whom two novel FREM1 mutations (c.305A&gt;G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.	FREM1	unilateral	158326	HP_0012833	204	209	130	140	False
28111185	In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral anophthalmia, and bifid and broad nasal tip) in whom two novel FREM1 mutations (c.305A&gt;G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.	tip	unilateral	81533	HP_0012833	181	184	130	140	False
28111185	In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral anophthalmia, and bifid and broad nasal tip) in whom two novel FREM1 mutations (c.305A&gt;G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.	FREM1	anophthalmia	158326	HP_0000528	204	209	141	153	True
28111185	In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, unilateral anophthalmia, and bifid and broad nasal tip) in whom two novel FREM1 mutations (c.305A&gt;G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.	tip	anophthalmia	81533	HP_0000528	181	184	141	153	False
27573165	Recently a homozygous mutation, Gly372Ser, in the TIMM50 gene, was reported in an abstract form, in three sibs who suffered from intractable epilepsy and developmental delay accompanied by 3-methylglutaconic aciduria.	TIMM50	epilepsy	92609	HP_0001250	50	56	141	149	False
27573165	Recently a homozygous mutation, Gly372Ser, in the TIMM50 gene, was reported in an abstract form, in three sibs who suffered from intractable epilepsy and developmental delay accompanied by 3-methylglutaconic aciduria.	TIMM50	developmental delay	92609	HP_0001263	50	56	154	173	True
27573165	Given the phenotypic similarity, we conclude that missense mutations in TIMM50 are likely manifesting by severe intellectual disability and epilepsy accompanied by 3-methylglutaconic aciduria and variable mitochondrial complex V deficiency.	TIMM50	epilepsy	92609	HP_0001250	72	78	140	148	False
27573165	Given the phenotypic similarity, we conclude that missense mutations in TIMM50 are likely manifesting by severe intellectual disability and epilepsy accompanied by 3-methylglutaconic aciduria and variable mitochondrial complex V deficiency.	TIMM50	intellectual disability	92609	HP_0001249	72	78	112	135	True
26280109	Our results indicate that the protein expression level of dCK in pancreatic cancer tissue is a good predictor of PFS, and thus dCK may be the best biomarker of dFdC sensitivity in pancreatic cancer patients treated with dFdC, although other proteins would also contribute to dFdC-sensitivity at the cellular level in vivo and in vitro.	dCK	cancer	1633	HP_0002664	58	61	76	82	False
26280109	Our results indicate that the protein expression level of dCK in pancreatic cancer tissue is a good predictor of PFS, and thus dCK may be the best biomarker of dFdC sensitivity in pancreatic cancer patients treated with dFdC, although other proteins would also contribute to dFdC-sensitivity at the cellular level in vivo and in vitro.	best	cancer	7439	HP_0002664	142	146	76	82	False
27996048	The aberrant glucose metabolism is one of the hallmarks of cancer cells, and as a branch of glucose metabolism, hexosamine biosynthesis pathway (HBP) has been reported to play a critical role in the insulin resistance and progression of cancer.	HBP	cancer	566	HP_0002664	145	148	59	65	False
27996048	Glutamine:fructose-6-phosphate amidotransferase (GFAT1) is the rate-limiting enzyme of the HBP; nevertheless, the prognostic value of GFAT1 in pancreatic cancer remains elusive.	HBP	cancer	566	HP_0002664	91	94	154	160	False
27996048	Glutamine:fructose-6-phosphate amidotransferase (GFAT1) is the rate-limiting enzyme of the HBP; nevertheless, the prognostic value of GFAT1 in pancreatic cancer remains elusive.	GFAT1	cancer	2673	HP_0002664	49	54	154	160	False
27996048	In this study, we found that the expression of GFAT1 was increased in pancreatic cancer samples compared to peri-tumor tissues.	GFAT1	cancer	2673	HP_0002664	47	52	81	87	False
27996048	In this study, we found that the expression of GFAT1 was increased in pancreatic cancer samples compared to peri-tumor tissues.	GFAT1	tumor	2673	HP_0002664	47	52	113	118	False
27996048	High expression of GFAT1 was positively associated with lymph node metastasis, pTNM stage and shorter overall survival (OS) in pancreatic cancer patients.	GFAT1	cancer	2673	HP_0002664	19	24	138	144	False
27996048	GFAT1 was identified as an independent prognosticator for OS, and combining GFAT1 expression with pTNM stage generated a predictive nomogram, which showed better prognostic efficiency for OS in patients with pancreatic cancer.	GFAT1	cancer	2673	HP_0002664	0	5	219	225	False
27996048	In summary, high GFAT1 expression is identified as an independent predictor of adverse clinical outcome in our small number of pancreatic cancer patients, and the practical prognostic nomogram model may help clinicians in decision making and the design of clinical studies	GFAT1	cancer	2673	HP_0002664	17	22	138	144	False
29130579	We used exome sequencing to study the molecular basis of disease in an 11-year-old female patient who suffered from growth retardation, global developmental delay with absent speech acquisition, agenesis of corpus callosum and paucity of white matter, sensorineural deafness, retinitis pigmentosa, vertebral anomalies, patent ductus arteriosus, and facial dysmorphism reminiscent of STAR syndrome, a suspected ciliopathy.	STAR	developmental delay	2984	HP_0001263	383	387	143	162	False
29130579	We used exome sequencing to study the molecular basis of disease in an 11-year-old female patient who suffered from growth retardation, global developmental delay with absent speech acquisition, agenesis of corpus callosum and paucity of white matter, sensorineural deafness, retinitis pigmentosa, vertebral anomalies, patent ductus arteriosus, and facial dysmorphism reminiscent of STAR syndrome, a suspected ciliopathy.	STAR	deafness	2984	HP_0000365	383	387	266	274	False
29130579	We used exome sequencing to study the molecular basis of disease in an 11-year-old female patient who suffered from growth retardation, global developmental delay with absent speech acquisition, agenesis of corpus callosum and paucity of white matter, sensorineural deafness, retinitis pigmentosa, vertebral anomalies, patent ductus arteriosus, and facial dysmorphism reminiscent of STAR syndrome, a suspected ciliopathy.	STAR	retinitis pigmentosa	2984	HP_0000510	383	387	276	296	False
29130579	We used exome sequencing to study the molecular basis of disease in an 11-year-old female patient who suffered from growth retardation, global developmental delay with absent speech acquisition, agenesis of corpus callosum and paucity of white matter, sensorineural deafness, retinitis pigmentosa, vertebral anomalies, patent ductus arteriosus, and facial dysmorphism reminiscent of STAR syndrome, a suspected ciliopathy.	STAR	vertebral anomalies	2984	HP_0003468	383	387	298	317	False
29130579	We used exome sequencing to study the molecular basis of disease in an 11-year-old female patient who suffered from growth retardation, global developmental delay with absent speech acquisition, agenesis of corpus callosum and paucity of white matter, sensorineural deafness, retinitis pigmentosa, vertebral anomalies, patent ductus arteriosus, and facial dysmorphism reminiscent of STAR syndrome, a suspected ciliopathy.	STAR	facial dysmorphism	2984	HP_0001999	383	387	349	367	False
28755528	Triple-negative breast cancer (TNBC), lacking the steroid hormone receptors ER and PR and the oncoprotein HER2, is characterized by its aggressive pattern and insensitivity to endocrine and HER2-directed therapy.	HER2	cancer	2064	HP_0002664	106	110	23	29	True
28755528	Human kallikrein-related peptidases KLK1-15 provide a rich source of serine protease-type biomarkers associated with tumor growth and cancer progression for a variety of malignant diseases.	KLK1	cancer	3816	HP_0002664	36	40	134	140	False
28755528	Human kallikrein-related peptidases KLK1-15 provide a rich source of serine protease-type biomarkers associated with tumor growth and cancer progression for a variety of malignant diseases.	KLK1	tumor	3816	HP_0002664	36	40	117	122	False
28755528	In this study, recombinant KLK4 protein was generated and affinity-purified KLK4-directed polyclonal antibody pAb587 established to allow localization of KLK4 protein expression in tumor cell lines and archived formalin-fixed, paraffin-embedded TNBC tumor tissue specimens.	KLK4	tumor	9622	HP_0002664	27	31	181	186	False
28755528	For this, KLK4 protein expression was assessed by immunohistochemistry in primary tumor tissue sections (tissue microarrays) of 188 TNBC patients, mainly treated with anthracycline- or CMF-based polychemotherapy.	KLK4	tumor	9622	HP_0002664	10	14	82	87	False
28755528	KLK4 protein is localized in the cytoplasm of tumor and stroma cells.	KLK4	tumor	9622	HP_0002664	0	4	46	51	False
28755528	In this patient cohort, elevated stroma cell KLK4 expression, but not tumor cell KLK4 expression, is predictive for poor disease-free survival by univariate analysis (hazard ratio: 2.26, p=0.001) and multivariable analysis (hazard ratio: 2.12, p&lt;0.01).	KLK4	tumor	9622	HP_0002664	45	49	70	75	False
26886902	The patient together with her younger brother was diagnosed at the age of 5 years with familial congenital hypopituitarism, due to homozygous mutation c.150delA in PROP1 gene.	PROP1	hypopituitarism	5626	HP_0040075	164	169	107	122	True
26886902	Due to evolving hypopituitarism, she was replaced with thyroxine (from age 5), hydrocortisone (from age 13), GH (from age 13 until 17), and sex steroids in adolescence and adulthood.	sex	hypopituitarism	55558	HP_0040075	140	143	16	31	False
29636477	Deregulation of the phosphoinositide 3-kinase (PI3K) pathway contributes to the development and progression of tumors.	PI3K	tumors	5290	HP_0002664	47	51	111	117	True
29636477	Here, we determine that somatic mutations in PIK3CA (44%), PIK3R1 (17%), AKT3 (15%), and PTEN (12%) are prevalent and diverse in Chinese breast cancer patients, with 60 novel mutations identified.	PIK3CA	cancer	5290	HP_0002664	45	51	144	150	True
29636477	Here, we determine that somatic mutations in PIK3CA (44%), PIK3R1 (17%), AKT3 (15%), and PTEN (12%) are prevalent and diverse in Chinese breast cancer patients, with 60 novel mutations identified.	PIK3R1	cancer	5295	HP_0002664	59	65	144	150	True
29636477	Here, we determine that somatic mutations in PIK3CA (44%), PIK3R1 (17%), AKT3 (15%), and PTEN (12%) are prevalent and diverse in Chinese breast cancer patients, with 60 novel mutations identified.	AKT3	cancer	10000	HP_0002664	73	77	144	150	False
29636477	Here, we determine that somatic mutations in PIK3CA (44%), PIK3R1 (17%), AKT3 (15%), and PTEN (12%) are prevalent and diverse in Chinese breast cancer patients, with 60 novel mutations identified.	PTEN	cancer	5728	HP_0002664	89	93	144	150	True
29636477	A high proportion of tumors harbors multiple mutations, especially PIK3CA plus PIK3R1 mutations (9.0%).	PIK3CA	tumors	5290	HP_0002664	67	73	21	27	True
29636477	A high proportion of tumors harbors multiple mutations, especially PIK3CA plus PIK3R1 mutations (9.0%).	PIK3R1	tumors	5295	HP_0002664	79	85	21	27	True
29636477	Collectively, these findings advance our understanding of PI3K impactful mutations in breast cancer and have important implications for PI3K-targeted therapy in precision oncology	PI3K	cancer	5290	HP_0002664	58	62	93	99	True
29304371	We observed a higher rate of individuals with a history of high blood pressure among affected versus healthy individuals carrying ANGPTL6 variants, suggesting that ANGPTL6 could trigger cerebrovascular lesions when combined with other risk factors such as hypertension.	ANGPTL6	hypertension	83854	HP_0000822	130	137	256	268	True
25111227	Mutations in the ubiquitously expressed pre-mRNA processing factors 3, 8, and 31 (PRPF3, PRPF8, and PRPF31) cause nonsyndromic dominant retinitis pigmentosa in humans, an inherited retinal degeneration.	PRPF3	retinal degeneration	9129	HP_0000546	82	87	181	201	False
25111227	Mutations in the ubiquitously expressed pre-mRNA processing factors 3, 8, and 31 (PRPF3, PRPF8, and PRPF31) cause nonsyndromic dominant retinitis pigmentosa in humans, an inherited retinal degeneration.	PRPF8	retinal degeneration	10594	HP_0000546	89	94	181	201	True
28524599	As E<sub>3</sub> is modulated by cellular signalling and linked to various types of cancer, we anticipate that E<sub>3</sub> contributes to environmentally tuned REST function and may have a broad range of clinical implications	REST	cancer	5978	HP_0002664	164	168	85	91	True
29429788	We present a case of myoclonus-dystonia syndrome illustrated by three videos in which we found a novel SGCE mutation.	SGCE	myoclonus	8910	HP_0001336	103	107	21	30	True
28295819	Germ cell tumors (GCT) are a rare form of childhood cancer that originate from the primordial germ cell.	GCT	tumors	25797	HP_0002664	18	21	10	16	False
28295819	Germ cell tumors (GCT) are a rare form of childhood cancer that originate from the primordial germ cell.	GCT	cancer	25797	HP_0002664	18	21	52	58	False
28295819	A variant in BAK1 (rs210138) was positively associated with GCT (OR [95% CI]: 1.70 [1.32, 2.18]), with a strong estimated effect for testis tumors (OR [95% CI]: 3.31 [1.89, 5.79]).	GCT	tumors	25797	HP_0002664	60	63	140	146	False
28295819	A variant in BAK1 (rs210138) was positively associated with GCT (OR [95% CI]: 1.70 [1.32, 2.18]), with a strong estimated effect for testis tumors (OR [95% CI]: 3.31 [1.89, 5.79]).	BAK1	tumors	578	HP_0002664	13	17	140	146	False
28056232	<b>Objective:</b> To investigate the genotype-phenotype correlation in Chinese familial hypertrophic cardiomyopathy (HCM )focusing on the cardiac troponin C gene TNNC1 c.	TNNC1	cardiomyopathy	7137	HP_0001638	162	167	101	115	True
28056232	The proband carried the two kinds of mutations and expressed various clinical manifestations of heart failure and had history of ventricular tachycardia, paraxial atrial fibrillation, pacemaker implantation, electrocardiogram showed right bundle branch block and echocardiography examination evidenced thickened interventricular septum (23.3 mm) and apex and reduced wall motion of these segments.	apex	ventricular tachycardia	328	HP_0004756	350	354	129	152	False
29531337	Biallelic mutations in NDUFAF6 have been identified as responsible for cases of autosomal recessive Leigh syndrome associated with mitochondrial complex I deficiency.	NDUFAF6	autosomal recessive	137682	HP_0000007	23	30	80	99	False
27585752	Besides, previous evidence suggested that AHI1 expression was changed in schizophrenia patients.	AHI1	schizophrenia	54806	HP_0100753	42	46	73	86	False
27585752	Furthermore, association signal between AHI1 variants and schizophrenia has been reported in several European samples.	AHI1	schizophrenia	54806	HP_0100753	40	44	58	71	False
27585752	In the present study, we first analyzed two expression quantitative trait loci (eQTL) datasets in healthy individuals and investigated the associations of eQTL of AHI1 with schizophrenia in independent European samples.	AHI1	schizophrenia	54806	HP_0100753	163	167	173	186	False
27585752	These results suggested that AHI1 is likely a risk gene for schizophrenia, at least in European populations.	AHI1	schizophrenia	54806	HP_0100753	29	33	60	73	False
30362319	the Partner and localizer of BRCA2 (PALB2) gene and risk of breast cancer.	BRCA2	cancer	675	HP_0002664	29	34	67	73	True
30362319	the Partner and localizer of BRCA2 (PALB2) gene and risk of breast cancer.	PALB2	cancer	79728	HP_0002664	36	41	67	73	True
30362319	the association between SNPs in the PALB2 gene and the susceptibility to breast cancer.	PALB2	cancer	79728	HP_0002664	36	41	80	86	True
30362319	Conclusions: The current meta-analysis shows the associations between five SNPs of PALB2 and breast cancer risk	PALB2	cancer	79728	HP_0002664	83	88	100	106	True
26546829	Familial hypercholesterolemia is usually due to loss-of-function mutations in LDLR, the gene coding for low density lipoprotein receptor and genes encoding for proteins that interact with the receptor: APOB, PCSK9 and LDLRAP1.	LDLR	hypercholesterolemia	3949	HP_0003124	78	82	9	29	True
26546829	Familial hypercholesterolemia is usually due to loss-of-function mutations in LDLR, the gene coding for low density lipoprotein receptor and genes encoding for proteins that interact with the receptor: APOB, PCSK9 and LDLRAP1.	APOB	hypercholesterolemia	338	HP_0003124	202	206	9	29	True
26546829	Familial hypercholesterolemia is usually due to loss-of-function mutations in LDLR, the gene coding for low density lipoprotein receptor and genes encoding for proteins that interact with the receptor: APOB, PCSK9 and LDLRAP1.	PCSK9	hypercholesterolemia	255738	HP_0003124	208	213	9	29	True
26546829	Monogenic hypertriglyceridemia is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg LPL, APOC2, APOA5, LMF1, GPIHBP1).	LPL	hypertriglyceridemia	4023	HP_0002155	134	137	10	30	True
26546829	Monogenic hypertriglyceridemia is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg LPL, APOC2, APOA5, LMF1, GPIHBP1).	APOC2	hypertriglyceridemia	344	HP_0002155	139	144	10	30	True
26546829	Monogenic hypertriglyceridemia is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg LPL, APOC2, APOA5, LMF1, GPIHBP1).	APOA5	hypertriglyceridemia	116519	HP_0002155	146	151	10	30	False
26546829	Monogenic hypertriglyceridemia is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg LPL, APOC2, APOA5, LMF1, GPIHBP1).	LMF1	hypertriglyceridemia	64788	HP_0002155	153	157	10	30	True
26546829	Monogenic hypertriglyceridemia is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg LPL, APOC2, APOA5, LMF1, GPIHBP1).	GPIHBP1	hypertriglyceridemia	338328	HP_0002155	159	166	10	30	True
26546829	Conversely familial hypobetalipoproteinemia is caused by inactivation of the PCSK9 gene which increases the number of LDL receptors and decreases plasma cholesterol.	PCSK9	hypobetalipoproteinemia	255738	HP_0003563	77	82	20	43	False
30180205	Transcriptomic analysis revealed significant alterations in a number of genes associated with autism, such as adsl, mbd5, shank3, and tsc1b.	adsl	autism	158	HP_0000717	110	114	94	100	True
30180205	Transcriptomic analysis revealed significant alterations in a number of genes associated with autism, such as adsl, mbd5, shank3, and tsc1b.	mbd5	autism	55777	HP_0000717	116	120	94	100	False
30180205	Transcriptomic analysis revealed significant alterations in a number of genes associated with autism, such as adsl, mbd5, shank3, and tsc1b.	shank3	autism	85358	HP_0000717	122	128	94	100	True
17616665	The signaling of DNA damage and replication stress involves a multitude of proteins, including the kinases ataxia-telangiectasia mutated (ATM) and ATM and Rad3-related (ATR), and proteins with BRCA1 COOH-terminal (BRCT) domains.	damage	ataxia	51438	HP_0001251	21	27	107	113	False
17616665	The signaling of DNA damage and replication stress involves a multitude of proteins, including the kinases ataxia-telangiectasia mutated (ATM) and ATM and Rad3-related (ATR), and proteins with BRCA1 COOH-terminal (BRCT) domains.	ATM	ataxia	472	HP_0001251	138	141	107	113	True
17616665	The signaling of DNA damage and replication stress involves a multitude of proteins, including the kinases ataxia-telangiectasia mutated (ATM) and ATM and Rad3-related (ATR), and proteins with BRCA1 COOH-terminal (BRCT) domains.	ATR	ataxia	84168	HP_0001251	169	172	107	113	False
17616665	The signaling of DNA damage and replication stress involves a multitude of proteins, including the kinases ataxia-telangiectasia mutated (ATM) and ATM and Rad3-related (ATR), and proteins with BRCA1 COOH-terminal (BRCT) domains.	BRCA1	ataxia	672	HP_0001251	193	198	107	113	False
17616665	Here, we show that breast-ovarian cancer susceptibility 1 (BRCA1) interacts directly with ATR-interacting protein (ATRIP), an obligate partner of ATR.	ATR	cancer	84168	HP_0002664	90	93	34	40	True
17616665	Here, we show that breast-ovarian cancer susceptibility 1 (BRCA1) interacts directly with ATR-interacting protein (ATRIP), an obligate partner of ATR.	BRCA1	cancer	672	HP_0002664	59	64	34	40	True
28856687	Familial clustering of schizophrenia (SCZ), bipolar disorder (BPD), and major depressive disorder (MDD) was systematically reported (Aukes et al, Genet Med 2012, 14, 338-341) and convergent evidence from genetics, symptomatology, and psychopharmacology imply that there are intrinsic connections between these three major psychiatric disorders, for example, any two or even three of these disorders could co-exist in some families.	Med	bipolar disorder	1298	HP_0007302	152	155	44	60	False
29804124	MATERIAL AND METHODS We analyzed BC microarray studies GSE37751, GSE7390, and GSE21653 to investigate the expression of FGF5 gene between BC patients and their normal counterparts and the relationship between FGF5 expression and age, tumor size, histopathological grading, estrogen receptors, clinical risk group according to St Gallen criteria, clinical risk group according to NPI criteria, clinical risk group according to Veridex signature, distant metastasis-free survival (DMFS), time to distant metastasis (TDM), disease-free survival (DFS), and overall survival (OS) of BC patients.	FGF5	tumor	2250	HP_0002664	120	124	234	239	False
29804124	MATERIAL AND METHODS We analyzed BC microarray studies GSE37751, GSE7390, and GSE21653 to investigate the expression of FGF5 gene between BC patients and their normal counterparts and the relationship between FGF5 expression and age, tumor size, histopathological grading, estrogen receptors, clinical risk group according to St Gallen criteria, clinical risk group according to NPI criteria, clinical risk group according to Veridex signature, distant metastasis-free survival (DMFS), time to distant metastasis (TDM), disease-free survival (DFS), and overall survival (OS) of BC patients.	NPI	tumor	9509	HP_0002664	379	382	234	239	False
29804124	BC patients in the FGF5 low-expression group were correlated with better clinical characteristics, including tumor size, histopathological grading, estrogen receptors, clinical risk group according to St Gallen criteria, NPI criteria and Veridex signature, DMFS, TDM, and DFS compared with those in the FGF5 high-expression cohort.	FGF5	tumor	2250	HP_0002664	19	23	109	114	False
29804124	BC patients in the FGF5 low-expression group were correlated with better clinical characteristics, including tumor size, histopathological grading, estrogen receptors, clinical risk group according to St Gallen criteria, NPI criteria and Veridex signature, DMFS, TDM, and DFS compared with those in the FGF5 high-expression cohort.	NPI	tumor	9509	HP_0002664	221	224	109	114	False
29768408	Here, we identified three families with mutations in ADD3, encoding for adducin-, with intellectual disability, microcephaly, cataracts and skeletal defects.	ADD3	intellectual disability	120	HP_0001249	53	57	88	111	False
29768408	Here, we identified three families with mutations in ADD3, encoding for adducin-, with intellectual disability, microcephaly, cataracts and skeletal defects.	ADD3	microcephaly	120	HP_0000252	53	57	113	125	True
29768408	Here, we identified three families with mutations in ADD3, encoding for adducin-, with intellectual disability, microcephaly, cataracts and skeletal defects.	ADD3	cataracts	120	HP_0000518	53	57	127	136	False
29768408	In one of the families with additional cardiomyopathy and steroid-resistant nephrotic syndrome (SRNS), we found a homozygous variant in KAT2B, encoding the lysine acetyltransferase 2B, with impact on KAT2B protein levels in patient fibroblasts, suggesting that this second mutation might contribute to the increased disease spectrum.	KAT2B	cardiomyopathy	8850	HP_0001638	136	141	39	53	False
29768408	In one of the families with additional cardiomyopathy and steroid-resistant nephrotic syndrome (SRNS), we found a homozygous variant in KAT2B, encoding the lysine acetyltransferase 2B, with impact on KAT2B protein levels in patient fibroblasts, suggesting that this second mutation might contribute to the increased disease spectrum.	impact	cardiomyopathy	55364	HP_0001638	190	196	39	53	False
29292077	Fragile X syndrome (FXS), the leading cause of inherited forms of mental retardation and autism, is caused by the transcriptional silencing of fmr1 encoding the fragile X mental retardation protein (FMRP).	fmr1	autism	2332	HP_0000717	143	147	89	95	True
29292077	Fragile X syndrome (FXS), the leading cause of inherited forms of mental retardation and autism, is caused by the transcriptional silencing of fmr1 encoding the fragile X mental retardation protein (FMRP).	FMRP	autism	2332	HP_0000717	199	203	89	95	True
29356994	Gorlin syndrome is a rare multisystem inherited disorder which can predispose to basal cell carcinomas (BCCs), childhood medulloblastomas in addition to various developmental abnormalities; the majority of cases are due to mutations in the PTCH1 gene.	PTCH1	basal cell carcinomas	5727	HP_0002671	240	245	81	102	True
29356994	Gorlin syndrome is a rare multisystem inherited disorder which can predispose to basal cell carcinomas (BCCs), childhood medulloblastomas in addition to various developmental abnormalities; the majority of cases are due to mutations in the PTCH1 gene.	PTCH1	medulloblastomas	5727	HP_0002885	240	245	121	137	True
29356994	Certain phenotypic features have been identified as being more prevalent in individuals with a SUFU mutation such as childhood medulloblastoma, infundibulocystic BCCs and trichoepitheliomas.	SUFU	medulloblastoma	51684	HP_0002885	95	99	127	142	True
29356994	Certain phenotypic features have been identified as being more prevalent in individuals with a SUFU mutation such as childhood medulloblastoma, infundibulocystic BCCs and trichoepitheliomas.	SUFU	trichoepitheliomas	51684	HP_0025367	95	99	171	189	False
29356994	Recently hamartomatous skin lesions have also been noted in families with childhood medulloblastoma, a &quot;Gorlin like&quot; phenotype and a SUFU mutation.	SUFU	medulloblastoma	51684	HP_0002885	143	147	84	99	True
27650539	Expression of miR-17-92a miRNAs caused decreased cell proliferation, reduced activation of AKT and MAP kinases, delayed tumorigenicity and reduced tumor growth in animals.	AKT	tumor	207	HP_0002664	91	94	120	125	True
27650539	Expression of miR-17-92a miRNAs improved sensitivity of androgen dependent LNCaP 104-S prostate cancer cells to anti-androgen drug Casodex, AKT inhibitor MK-2206 2HCl, and docetaxel.	AKT	cancer	207	HP_0002664	140	143	96	102	True
30098109	Aberrant expression of TRIM-containing protein 44 (TRIM44) acts as a promoter in multiple cancers.	TRIM	cancer	50852	HP_0002664	23	27	90	96	False
30098109	Here, we investigated the biological functions and clinical significance of TRIM44 in human esophageal cancer (HEC).	TRIM	cancer	50852	HP_0002664	76	80	103	109	False
30098109	Here, we investigated the biological functions and clinical significance of TRIM44 in human esophageal cancer (HEC).	HEC	cancer	10403	HP_0002664	111	114	103	109	False
29801756	Recently, mutations of DNAJC12 gene were reported to be associated with early-onset parkinsonism, progressive neurodevelopmental delay, and dystonia in several unrelated pedigrees.	DNAJC12	parkinsonism	56521	HP_0001300	23	30	84	96	True
29801756	Recently, mutations of DNAJC12 gene were reported to be associated with early-onset parkinsonism, progressive neurodevelopmental delay, and dystonia in several unrelated pedigrees.	DNAJC12	neurodevelopmental delay	56521	HP_0012758	23	30	110	134	True
29801756	This study aimed to evaluate DNAJC12 coding mutations in sporadic Chinese Han patients with Parkinson's disease (PD) and test whether an age-of-onset effect exists.	DNAJC12	sporadic	56521	HP_0003745	29	36	57	65	False
29892959	Identification of this mutation reveals the allelic heterogeneity of RDH5 in patients with RP phenotype.	RDH5	heterogeneity	5959	HP_0001425	69	73	52	65	False
25791755	Next-generation sequencing (NGS) of the genetic information of cancer cells has revolutionized the field of cancer biology, including prostate cancer (PCa).	PCa	cancer	28982	HP_0002664	151	154	63	69	False
25791755	With its highly heterogeneous nature, PCa continues to pose a tremendous challenge in terms of diagnosis and prognosis.	PCa	heterogeneous	28982	HP_0001425	38	41	16	29	False
26164209	To investigate this mechanism, we developed a novel uterine sarcoma tissue-derived orthotopic and metastatic model in KSN nude mice using a green fluorescent protein stably expressed uterine sarcoma cell line, MES-SA.	nude	sarcoma	54820	HP_0100242	122	126	60	67	False
26164209	To investigate this mechanism, we developed a novel uterine sarcoma tissue-derived orthotopic and metastatic model in KSN nude mice using a green fluorescent protein stably expressed uterine sarcoma cell line, MES-SA.	mice	sarcoma	23581	HP_0100242	127	131	60	67	False
26164209	Microarray analysis between orthotopic tumors with high and low metastatic potentials revealed differential expression of genes related to cell proliferation and migration (TNNT1, COL1A2, and ZIC1).	TNNT1	tumors	7138	HP_0002664	173	178	39	45	False
26164209	Microarray analysis between orthotopic tumors with high and low metastatic potentials revealed differential expression of genes related to cell proliferation and migration (TNNT1, COL1A2, and ZIC1).	COL1A2	tumors	1278	HP_0002664	180	186	39	45	False
26164209	Microarray analysis between orthotopic tumors with high and low metastatic potentials revealed differential expression of genes related to cell proliferation and migration (TNNT1, COL1A2, and ZIC1).	ZIC1	tumors	7545	HP_0002664	192	196	39	45	False
29309307	ACTB-GLI1 fusions have been reported as the pathognomonic genetic abnormality defining an unusual subset of actin-positive, perivascular myoid tumors, known as &quot;pericytoma with the t(7;12) translocation.&quot; In addition, GLI1 oncogenic activation through a related MALAT1-GLI1 gene fusion has been recently reported in 2 unrelated gastric tumors, namely plexiform fibromyxoma and gastroblastoma.	GLI1	tumors	2735	HP_0002664	5	9	143	149	True
29309307	ACTB-GLI1 fusions have been reported as the pathognomonic genetic abnormality defining an unusual subset of actin-positive, perivascular myoid tumors, known as &quot;pericytoma with the t(7;12) translocation.&quot; In addition, GLI1 oncogenic activation through a related MALAT1-GLI1 gene fusion has been recently reported in 2 unrelated gastric tumors, namely plexiform fibromyxoma and gastroblastoma.	ACTB	tumors	60	HP_0002664	0	4	143	149	True
29309307	Our findings open new opportunities for targeted therapy, as tumors with GLI1 oncogenic activation, and subsequent PTCH1 overexpression, might be sensitive to sonic hedgehog pathway inhibitors	GLI1	tumors	2735	HP_0002664	73	77	61	67	True
29309307	Our findings open new opportunities for targeted therapy, as tumors with GLI1 oncogenic activation, and subsequent PTCH1 overexpression, might be sensitive to sonic hedgehog pathway inhibitors	PTCH1	tumors	5727	HP_0002664	115	120	61	67	True
29333002	In the present article, we review current evidence supporting the role of SPL in thymic egress, inflammation, and cancer.	SPL	cancer	8879	HP_0002664	74	77	114	120	False
29538454	Likewise, HCV replication is severely impaired within hepatocellular carcinoma (HCC) tissue in vivo, but the mechanisms responsible for this restriction are presently unknown.	HCC	hepatocellular carcinoma	84668	HP_0001402	80	83	54	78	False
29538454	Here, we identify tumor-associated calcium signal transducer 2 (TACSTD2), one of the most downregulated genes in primary HCC tissue, as a host factor that interacts with CLDN1 and OCLN and regulates their cellular localization.	CLDN1	tumor	9076	HP_0002664	170	175	18	23	False
29538454	Here, we identify tumor-associated calcium signal transducer 2 (TACSTD2), one of the most downregulated genes in primary HCC tissue, as a host factor that interacts with CLDN1 and OCLN and regulates their cellular localization.	OCLN	tumor	100506658	HP_0002664	180	184	18	23	False
29538454	Here, we identify tumor-associated calcium signal transducer 2 (TACSTD2), one of the most downregulated genes in primary HCC tissue, as a host factor that interacts with CLDN1 and OCLN and regulates their cellular localization.	HCC	tumor	84668	HP_0002664	121	124	18	23	False
29538454	Here, we identify tumor-associated calcium signal transducer 2 (TACSTD2), one of the most downregulated genes in primary HCC tissue, as a host factor that interacts with CLDN1 and OCLN and regulates their cellular localization.	TACSTD2	tumor	4070	HP_0002664	64	71	18	23	False
26822478	By demonstrating that MT-bound Tau inhibits the Eg5 kinesin and cell mitosis, our work provides a new framework to consider the role of Tau in neurodegenerative diseases.	Tau	neurodegenerative diseases	4137	HP_0002180	31	34	143	169	False
29878199	The patients' phenotype consisted of amelogenesis imperfecta, skeletal dysplasia, and decreased bone mineral density compatible with osteoporosis.	type	skeletal dysplasia	6445	HP_0002652	19	23	62	80	False
23599270	Using homozygosity mapping followed by exome sequencing, we identified a Thr224Asn mutation in the VPS45 gene in infants from consanguineous families who suffered from life-threatening neutropenia, which was refractory to granulocyte CSF, from defective platelet aggregation and myelofibrosis.	VPS45	neutropenia	11311	HP_0001875	99	104	185	196	True
23599270	Using homozygosity mapping followed by exome sequencing, we identified a Thr224Asn mutation in the VPS45 gene in infants from consanguineous families who suffered from life-threatening neutropenia, which was refractory to granulocyte CSF, from defective platelet aggregation and myelofibrosis.	VPS45	defective platelet aggregation	11311	HP_0003540	99	104	244	274	False
23599270	This is the first report of a Vps45-related disease in humans, manifesting by neutropenia, thrombasthenia, myelofibrosis, and progressive bone marrow failure	Vps45	neutropenia	11311	HP_0001875	30	35	78	89	True
29802988	Recent studies in RAS wild-type (WT) metastatic colorectal cancer (mCRC) suggest that the survival benefits of therapy using anti-epidermal growth factor receptor (anti-EGFR) and anti-vascular endothelial growth factor (anti-VEGF) antibodies combined with chemotherapy are maximized when the anti-EGFR antibody is given as first-line, followed by subsequent anti-VEGF antibody therapy.	EGFR	cancer	1956	HP_0002664	169	173	59	65	True
29802988	Recent studies in RAS wild-type (WT) metastatic colorectal cancer (mCRC) suggest that the survival benefits of therapy using anti-epidermal growth factor receptor (anti-EGFR) and anti-vascular endothelial growth factor (anti-VEGF) antibodies combined with chemotherapy are maximized when the anti-EGFR antibody is given as first-line, followed by subsequent anti-VEGF antibody therapy.	VEGF	cancer	7422	HP_0002664	225	229	59	65	False
27266643	Chylomicron retention disease (CRD) is a rare autosomal recessive hereditary hypocholesterolemic disorder.	CRD	autosomal recessive	1406	HP_0000007	31	34	46	65	True
27928161	KCNB1 mutations are known to cause early-onset infantile epilepsy.	KCNB1	epilepsy	3745	HP_0001250	0	5	57	65	True
27928161	Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&gt;C, p.V378L) KCNB1 mutation in a patient with global developmental delay, intellectual disability, severe speech impairment, but no episode of epilepsy until the lastly examined age of 6 years old.	KCNB1	epilepsy	3745	HP_0001250	93	98	223	231	True
27928161	Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&gt;C, p.V378L) KCNB1 mutation in a patient with global developmental delay, intellectual disability, severe speech impairment, but no episode of epilepsy until the lastly examined age of 6 years old.	KCNB1	developmental delay	3745	HP_0001263	93	98	133	152	True
27928161	Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&gt;C, p.V378L) KCNB1 mutation in a patient with global developmental delay, intellectual disability, severe speech impairment, but no episode of epilepsy until the lastly examined age of 6 years old.	KCNB1	intellectual disability	3745	HP_0001249	93	98	154	177	True
27928161	Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&gt;C, p.V378L) KCNB1 mutation in a patient with global developmental delay, intellectual disability, severe speech impairment, but no episode of epilepsy until the lastly examined age of 6 years old.	KCNB1	speech impairment	3745	HP_0002167	93	98	186	203	True
29985992	Taken together, we show here that mutations leading either to BCL11B haploinsufficiency or to a truncated BCL11B protein clinically cause a non-syndromic neurodevelopmental delay.	BCL11B	developmental delay	64919	HP_0001263	62	68	159	178	True
25706356	Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (ALP), severe developmental delay, intellectual disability, and seizures.	ALP	hyperphosphatasia	80150	HP_0003155	170	173	16	33	False
25706356	Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (ALP), severe developmental delay, intellectual disability, and seizures.	ALP	autosomal recessive	80150	HP_0000007	170	173	77	96	False
25706356	Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (ALP), severe developmental delay, intellectual disability, and seizures.	ALP	developmental delay	80150	HP_0001263	170	173	183	202	False
25706356	Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (ALP), severe developmental delay, intellectual disability, and seizures.	ALP	intellectual disability	80150	HP_0001249	170	173	204	227	False
25706356	Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (ALP), severe developmental delay, intellectual disability, and seizures.	ALP	seizures	80150	HP_0001250	170	173	233	241	False
25706356	We performed whole-exome sequencing of a patient with severe intellectual disability, distinctive facial appearance, fragile nails, and persistent increased serum levels of ALP.	ALP	intellectual disability	80150	HP_0001249	173	176	61	84	False
25706356	We performed whole-exome sequencing of a patient with severe intellectual disability, distinctive facial appearance, fragile nails, and persistent increased serum levels of ALP.	ALP	fragile nails	80150	HP_0001808	173	176	117	130	False
25706356	Nonsynonymous changes or frameshift mutations in PIGL have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.	PIGL	autosomal recessive	9487	HP_0000007	49	53	115	134	True
25706356	Nonsynonymous changes or frameshift mutations in PIGL have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.	PIGL	intellectual disability	9487	HP_0001249	49	53	246	269	True
25706356	Nonsynonymous changes or frameshift mutations in PIGL have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.	PIGL	colobomas	9487	HP_0000589	49	53	161	170	True
25706356	Nonsynonymous changes or frameshift mutations in PIGL have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.	PIGL	congenital heart defects	9487	HP_0001627	49	53	172	196	True
25706356	Nonsynonymous changes or frameshift mutations in PIGL have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities.	PIGL	migratory	9487	HP_0025279	49	53	210	219	False
29506883	In the present case, magnetic resonance imaging (MRI) obtained during infancy revealed symmetric lesions in the substantia nigra of a patient with Leigh syndrome with an NDUFA1 mutation; lesions of the bilateral putamen and brainstem were subsequently observed.	NDUFA1	bilateral	4694	HP_0012832	170	176	202	211	False
24325915	Triple-negative (TN) breast cancer is an aggressive subtype of breast cancer associated with a unique set of epidemiologic and genetic risk factors.	set	cancer	6418	HP_0002664	102	105	28	34	False
24325915	Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	PTHLH	cancer	5744	HP_0002664	317	322	28	34	False
24325915	Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	LGR6	cancer	59352	HP_0002664	63	67	28	34	False
24325915	Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	MDM4	cancer	4194	HP_0002664	69	73	28	34	False
24325915	Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	CASP8	cancer	841	HP_0002664	75	80	28	34	True
24325915	Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	ESR1	cancer	2099	HP_0002664	113	117	28	34	False
24325915	Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	TOX3	cancer	27324	HP_0002664	119	123	28	34	False
24325915	Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	RALY	cancer	22913	HP_0002664	134	138	28	34	False
24325915	Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	PEX14	cancer	5195	HP_0002664	245	250	28	34	False
24325915	Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	ADAM29	cancer	11086	HP_0002664	268	274	28	34	False
24325915	Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	EBF1	cancer	1879	HP_0002664	276	280	28	34	False
24325915	Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	TCF7L2	cancer	6934	HP_0002664	282	288	28	34	False
24325915	Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	NTN4	cancer	8079	HP_0002664	324	328	28	34	False
24325915	Associations with TN breast cancer were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, ESR1, TOX3, 19p13.1, RALY), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, EBF1, TCF7L2, 11q13.1, 11q24.3, 12p13.1, PTHLH, NTN4, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	BRCA2	cancer	675	HP_0002664	337	342	28	34	True
24325915	Further, two SNPs independent of previously reported signals in ESR1 [rs12525163 odds ratio (OR) = 1.15, P = 4.9  10(-) (4)] and 19p13.1 (rs1864112 OR = 0.84, P = 1.8  10(-) (9)) were associated with TN breast cancer.	ESR1	cancer	2099	HP_0002664	64	68	212	218	False
30106970	Succinate dehydrogenase subunit B and D (SDHB and SDHD) mutations represent the most frequent cause of hereditary pheochromocytoma and paraganglioma (PPGL).	SDHB	paraganglioma	6390	HP_0002668	41	45	135	148	True
30106970	Succinate dehydrogenase subunit B and D (SDHB and SDHD) mutations represent the most frequent cause of hereditary pheochromocytoma and paraganglioma (PPGL).	SDHD	paraganglioma	6392	HP_0002668	50	54	135	148	True
30106970	Succinate dehydrogenase subunit B and D (SDHB and SDHD) mutations represent the most frequent cause of hereditary pheochromocytoma and paraganglioma (PPGL).	PGL	paraganglioma	6392	HP_0002668	151	154	135	148	True
30106970	In SDHB-related syndrome, PPGL maintenance seems to be reduced compared to SDHD (p = 0.04 vs 0.95) due to higher probability of tumor cell regression in SDHB vs SDHD (p = 0.87 vs 0.00).	SDHB	tumor	6390	HP_0002664	3	7	128	133	True
30106970	In SDHB-related syndrome, PPGL maintenance seems to be reduced compared to SDHD (p = 0.04 vs 0.95) due to higher probability of tumor cell regression in SDHB vs SDHD (p = 0.87 vs 0.00).	SDHD	tumor	6392	HP_0002664	75	79	128	133	True
30106970	In SDHB-related syndrome, PPGL maintenance seems to be reduced compared to SDHD (p = 0.04 vs 0.95) due to higher probability of tumor cell regression in SDHB vs SDHD (p = 0.87 vs 0.00).	PGL	tumor	6392	HP_0002664	27	30	128	133	True
30106970	However, when SDHB-tumors give rise to metastases, metastatic cells are able to thrive with decreased probability of regression compared with SDHD counterparts (p = 0.17 vs 0.89).	SDHB	tumor	6390	HP_0002664	14	18	19	24	True
30106970	However, when SDHB-tumors give rise to metastases, metastatic cells are able to thrive with decreased probability of regression compared with SDHD counterparts (p = 0.17 vs 0.89).	SDHD	tumor	6392	HP_0002664	142	146	19	24	True
30106970	These findings align with data suggesting that SDHD-related PPGL require less genetic events for tumor initiation and maintenance compared to those related to SDHB, but fail to initiate biology that promotes metastatic spread and metastatic cell survival in host tissues.	SDHB	tumor	6390	HP_0002664	159	163	97	102	True
30106970	These findings align with data suggesting that SDHD-related PPGL require less genetic events for tumor initiation and maintenance compared to those related to SDHB, but fail to initiate biology that promotes metastatic spread and metastatic cell survival in host tissues.	SDHD	tumor	6392	HP_0002664	47	51	97	102	True
30106970	These findings align with data suggesting that SDHD-related PPGL require less genetic events for tumor initiation and maintenance compared to those related to SDHB, but fail to initiate biology that promotes metastatic spread and metastatic cell survival in host tissues.	PGL	tumor	6392	HP_0002664	61	64	97	102	True
30106970	By contrast, the higher number of genetic abnormalities required for tumor initiation and maintenance in SDHB PPGL result in a lower penetrance of PGL, but when cells give rise to metastases they are assumed to be better adapted to sustain survival.	SDHB	tumor	6390	HP_0002664	105	109	69	74	True
30106970	By contrast, the higher number of genetic abnormalities required for tumor initiation and maintenance in SDHB PPGL result in a lower penetrance of PGL, but when cells give rise to metastases they are assumed to be better adapted to sustain survival.	PGL	tumor	6392	HP_0002664	111	114	69	74	True
26358778	Moreover, overexpression of mutant but not normal CCDC174 in neuroblastoma cells caused rapid apoptosis.	CCDC174	neuroblastoma	51244	HP_0003006	50	57	61	74	False
28713988	The present study demonstrated that coronin 3 is significantly upregulated in clinical primary hepatocellular carcinoma (HCC) samples by reverse transcriptionquantitative polymerase chain reaction (RTqPCR) and immunohistochemical staining.	HCC	hepatocellular carcinoma	84668	HP_0001402	121	124	95	119	False
28713988	In conclusion, these results indicated that coronin3 is significantly dysregulated in HCC tumor tissues, and may exert its function via regulating G6PC3 expression.	HCC	tumor	84668	HP_0002664	86	89	90	95	False
30151890	CDCA7, a new member of the cell division cycle associated family of genes, is involved in embryonic development and dysregulated in various types of human cancer.	CDCA7	cancer	83879	HP_0002664	0	5	155	161	False
30151890	Importantly, depletion of CDCA7 strongly reduced the tumorigenicity and distant colonization capacities of TNBC cells in vivo.	CDCA7	tumor	83879	HP_0002664	26	31	53	58	False
30151890	Furthermore, CDCA7 increased the expression of EZH2, a marker of aggressive breast cancer that is involved in tumor progression, by enhancing the transcriptional activity of its promoter.	CDCA7	cancer	83879	HP_0002664	13	18	83	89	False
30151890	Furthermore, CDCA7 increased the expression of EZH2, a marker of aggressive breast cancer that is involved in tumor progression, by enhancing the transcriptional activity of its promoter.	EZH2	cancer	2146	HP_0002664	47	51	83	89	False
30151890	Furthermore, CDCA7 increased the expression of EZH2, a marker of aggressive breast cancer that is involved in tumor progression, by enhancing the transcriptional activity of its promoter.	CDCA7	tumor	83879	HP_0002664	13	18	110	115	False
30151890	Furthermore, CDCA7 increased the expression of EZH2, a marker of aggressive breast cancer that is involved in tumor progression, by enhancing the transcriptional activity of its promoter.	EZH2	tumor	2146	HP_0002664	47	51	110	115	False
30092201	We show that signaling through herpes virus entry mediator (HVEM), a member of the tumor necrosis factor (TNF) receptor superfamily, in ILC3 is important for host defense against oral infection with the bacterial pathogen Yersinia enterocolitica.	HVEM	tumor	8764	HP_0002664	60	64	83	88	False
30092201	We show that signaling through herpes virus entry mediator (HVEM), a member of the tumor necrosis factor (TNF) receptor superfamily, in ILC3 is important for host defense against oral infection with the bacterial pathogen Yersinia enterocolitica.	TNF	tumor	7124	HP_0002664	106	109	83	88	False
29552027	In parallel, we recently reported that <i>Cc2d1a</i>-deficient mice present with cognitive and social deficits, hyperactivity and anxiety.	mice	hyperactivity	23581	HP_0000752	63	67	112	125	False
29552027	We generated <i>Cc2d1b</i> knockout (KO), <i>Cc2d1a/1b</i> double heterozygous and double KO mice, then performed behavioral studies to analyze learning and memory, social interactions, anxiety, and hyperactivity.	mice	hyperactivity	23581	HP_0000752	93	97	199	212	False
25599650	Both display heterotaxy, cardiopulmonary malformations and cystic kidneys, a syndrome also characteristic of mutations in Invs and Nphp3, the other known components of the IC.	Invs	cystic kidneys	27130	HP_0000107	122	126	59	73	True
25599650	Both display heterotaxy, cardiopulmonary malformations and cystic kidneys, a syndrome also characteristic of mutations in Invs and Nphp3, the other known components of the IC.	Nphp3	cystic kidneys	27031	HP_0000107	131	136	59	73	True
30559292	Mutations in the gene encoding CCT (<i>PCYT1A</i>) cause three distinct pathologies in humans: lipodystrophy, spondylometaphyseal dysplasia with cone-rod dystrophy (SMD-CRD), and isolated retinal dystrophy.	PC	lipodystrophy	5420	HP_0009125	40	42	96	109	False
30559292	Mutations in the gene encoding CCT (<i>PCYT1A</i>) cause three distinct pathologies in humans: lipodystrophy, spondylometaphyseal dysplasia with cone-rod dystrophy (SMD-CRD), and isolated retinal dystrophy.	PC	spondylometaphyseal dysplasia	5420	HP_0002657	40	42	111	140	False
30559292	Mutations in the gene encoding CCT (<i>PCYT1A</i>) cause three distinct pathologies in humans: lipodystrophy, spondylometaphyseal dysplasia with cone-rod dystrophy (SMD-CRD), and isolated retinal dystrophy.	PC	retinal dystrophy	5420	HP_0000556	40	42	189	206	False
29108267	Down regulation of Protein Kinase D1 (PrKD1), a novel serine threonine kinase, in prostate, gastric, breast and colon cancers in humans leads to disease progression.	PrKD1	cancer	5587	HP_0002664	38	43	118	124	False
29108267	While the down regulation of PrKD1 by DNA methylation in gastric cancer and by nuclear beta-catenin in colon cancer has been shown, the regulatory mechanisms in other cancers are unknown.	PrKD1	cancer	5587	HP_0002664	29	34	65	71	False
29108267	While the down regulation of PrKD1 by DNA methylation in gastric cancer and by nuclear beta-catenin in colon cancer has been shown, the regulatory mechanisms in other cancers are unknown.	beta-catenin	cancer	1499	HP_0002664	87	99	65	71	True
29108267	Because we had demonstrated that PrKD1 is the only known kinase to phosphorylate threonine 120 (T120) of beta-catenin in prostate cancer resulting in increased nuclear beta-catenin, we explored the role of beta-catenin in gene regulation of <i>PrKD1</i>.	PrKD1	cancer	5587	HP_0002664	33	38	130	136	False
29108267	Because we had demonstrated that PrKD1 is the only known kinase to phosphorylate threonine 120 (T120) of beta-catenin in prostate cancer resulting in increased nuclear beta-catenin, we explored the role of beta-catenin in gene regulation of <i>PrKD1</i>.	beta-catenin	cancer	1499	HP_0002664	105	117	130	136	True
29108267	<i>In silico</i> human gene expression analysis confirmed the down regulation of PrKD1 in metastatic prostate cancer correlated inversely with the expression of MAX, but not MYC, and positively with MXD1, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates <i>PrKD1</i> gene expression.	PrKD1	cancer	5587	HP_0002664	81	86	110	116	False
29108267	<i>In silico</i> human gene expression analysis confirmed the down regulation of PrKD1 in metastatic prostate cancer correlated inversely with the expression of MAX, but not MYC, and positively with MXD1, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates <i>PrKD1</i> gene expression.	MYC	cancer	4609	HP_0002664	174	177	110	116	True
29108267	<i>In silico</i> human gene expression analysis confirmed the down regulation of PrKD1 in metastatic prostate cancer correlated inversely with the expression of MAX, but not MYC, and positively with MXD1, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates <i>PrKD1</i> gene expression.	MAX	cancer	4149	HP_0002664	161	164	110	116	True
29108267	<i>In silico</i> human gene expression analysis confirmed the down regulation of PrKD1 in metastatic prostate cancer correlated inversely with the expression of MAX, but not MYC, and positively with MXD1, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates <i>PrKD1</i> gene expression.	MXD1	cancer	4084	HP_0002664	199	203	110	116	False
28053981	Muscarinic acetylcholine receptor M3 (CHRM3) was reported as a key receptor in different cancer types.	CHRM3	cancer	1131	HP_0002664	38	43	89	95	False
28053981	<i>CHRM3</i> is located at 1q42-43 which was reported to associate with bladder cancer.	CHRM3	cancer	1131	HP_0002664	3	8	80	86	False
28053981	Our study attempted to delineate whether genetic variants of <i>CHRM3</i> contribute to bladder cancer in Chinese Han population in south Taiwan.	CHRM3	cancer	1131	HP_0002664	64	69	96	102	False
28053981	Five haplotypes (GTTAT, ATTGT, GCTAC, ACTAC, and ACCAC) were found significantly associated with low <i>CHRM3</i> mRNA level and contributed to increased susceptibility of bladder cancer in Kaohsiung city after rigid 10000 consecutive permutation tests.	CHRM3	cancer	1131	HP_0002664	104	109	180	186	False
28053981	To our knowledge, this is the first genetic association study that reveals the genetic contribution of <i>CHRM3</i> gene in bladder cancer etiology	CHRM3	cancer	1131	HP_0002664	106	111	132	138	False
26711644	Hepatocellular carcinoma (HCC) is an aggressive and deadly cancer.	HCC	cancer	84668	HP_0002664	26	29	59	65	False
26711644	Considering the genetic heterogeneity of HCC, four datasets from four studies consisting of 15 pairs of HCC and adjacent normal samples were analyzed.	HCC	heterogeneity	84668	HP_0001425	41	44	24	37	False
28669978	BACKGROUND Latent transforming growth factor b binding protein 2 (LTBP2) is proven to be associated with ECM and involved in the advancement of several kinds of cancer.	LTBP2	cancer	4053	HP_0002664	66	71	161	167	False
28669978	BACKGROUND Latent transforming growth factor b binding protein 2 (LTBP2) is proven to be associated with ECM and involved in the advancement of several kinds of cancer.	ECM	cancer	22915	HP_0002664	105	108	161	167	False
28720310	Preclinical studies have demonstrated that EMP2 is associated with disease prognosis in a number of human cancers, including glioblastoma.	EMP2	glioblastoma	2013	HP_0012174	43	47	125	137	False
28720310	Preclinical studies have demonstrated that EMP2 is associated with disease prognosis in a number of human cancers, including glioblastoma.	EMP2	cancer	2013	HP_0002664	43	47	106	112	False
28720310	The four large extracellular domains of EMP2 and its association with the extracellular matrix makes it an attractive target for future cancer therapies.	EMP2	cancer	2013	HP_0002664	40	44	136	142	False
28720310	Translational research suggests that EMP2 may be targeted with antibodies to improve tumor control and survival in a variety of murine models and cancer types.	EMP2	cancer	2013	HP_0002664	37	41	146	152	False
28720310	Translational research suggests that EMP2 may be targeted with antibodies to improve tumor control and survival in a variety of murine models and cancer types.	EMP2	tumor	2013	HP_0002664	37	41	85	90	False
27193597	Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).	type	obesity	6445	HP_0001513	139	143	186	193	False
27193597	Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).	ERAP2	obesity	64167	HP_0001513	166	171	186	193	False
27193597	Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).	PIK3C2A	obesity	5286	HP_0001513	94	101	186	193	False
27193597	Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).	RBMS1	obesity	5937	HP_0001513	103	108	186	193	False
27193597	Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).	UFSP1	obesity	402682	HP_0001513	110	115	186	193	False
27193597	Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).	SNX17	obesity	9784	HP_0001513	159	164	186	193	False
27193597	Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).	FN3KRP	obesity	79672	HP_0001513	173	179	186	193	False
27193597	Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).	POMC	obesity	5443	HP_0001513	200	204	186	193	True
27193597	Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. PIK3C2A, RBMS1, UFSP1), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, ERAP2, FN3KRP), and obesity (e.g. POMC, CPEB4).	CPEB4	obesity	80315	HP_0001513	206	211	186	193	False
28810294	<b>Methods:</b> The fallopian tubes in 58 cases of pelvic HGSC (54 cases of ovarian primary, 3 cases of tubal primary, 1 case of peritoneum) and 25 cases of pelvic non-HGSC (5 cases of ovarian low-grade serous cancer, 9 cases of endometrioid cancer, and 11 cases of clear cell ovary carcinoma) were collected from June 2015 to December 2016, and serially examined under light microscope (SEE-FIM protocol).	light	cancer	8740	HP_0002664	370	375	210	216	False
28810294	<b>Methods:</b> The fallopian tubes in 58 cases of pelvic HGSC (54 cases of ovarian primary, 3 cases of tubal primary, 1 case of peritoneum) and 25 cases of pelvic non-HGSC (5 cases of ovarian low-grade serous cancer, 9 cases of endometrioid cancer, and 11 cases of clear cell ovary carcinoma) were collected from June 2015 to December 2016, and serially examined under light microscope (SEE-FIM protocol).	tube	cancer	51175	HP_0002664	30	34	210	216	False
28810294	The continuum of epithelial changes in the process of serous neoplasia including p53 signature, STIL, STIC and invasive carcinoma was identified in 8 cases of pelvic HGSC.	STIL	neoplasia	6491	HP_0002664	96	100	61	70	False
28810294	Correct classification of HGSC may have potential impacts for cancer prevention and improve our understanding of ovarian serous carcinogenesis	act	cancer	11332	HP_0002664	53	56	62	68	False
23174333	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	SDHA	tumor	6389	HP_0002664	147	151	12	17	True
23174333	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	SDHB	tumor	6390	HP_0002664	153	157	12	17	True
23174333	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	SDHC	tumor	6391	HP_0002664	159	163	12	17	True
23174333	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	SDHD	tumor	6392	HP_0002664	165	169	12	17	True
23174333	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	SDHA	paraganglioma	6389	HP_0002668	147	151	255	268	True
23174333	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	SDHB	paraganglioma	6390	HP_0002668	153	157	255	268	True
23174333	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	SDHC	paraganglioma	6391	HP_0002668	159	163	255	268	True
23174333	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	SDHD	paraganglioma	6392	HP_0002668	165	169	255	268	True
23174333	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	SDHA	pheochromocytomas	6389	HP_0002666	147	151	269	286	True
23174333	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	SDHB	pheochromocytomas	6390	HP_0002666	153	157	269	286	True
23174333	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	SDHC	pheochromocytomas	6391	HP_0002666	159	163	269	286	True
23174333	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	SDHD	pheochromocytomas	6392	HP_0002666	165	169	269	286	True
23174333	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	SDHA	renal cell carcinomas	6389	HP_0005584	147	151	307	328	True
23174333	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	SDHB	renal cell carcinomas	6390	HP_0005584	153	157	307	328	True
23174333	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	SDHC	renal cell carcinomas	6391	HP_0005584	159	163	307	328	True
23174333	An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (SDHA, SDHB, SDHC, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	SDHD	renal cell carcinomas	6392	HP_0005584	165	169	307	328	True
28471035	Hereditary sensory and autonomic neuropathies (HSAN) type II are characterized by autosomal recessive inheritance, onset at birth and self-mutilating behavior.	type	autosomal recessive	6445	HP_0000007	53	57	82	101	True
28471035	Hereditary sensory and autonomic neuropathies (HSAN) type II are characterized by autosomal recessive inheritance, onset at birth and self-mutilating behavior.	type	inheritance	6445	HP_0000005	53	57	102	113	False
30513730	The fatty acid (FA) composition of red blood cell (RBC) membrane phospholipids of cancer patients can reflect tumor status, dietary intakes, and cancer type or therapy.	red	cancer	8444	HP_0002664	35	38	82	88	False
30513730	The fatty acid (FA) composition of red blood cell (RBC) membrane phospholipids of cancer patients can reflect tumor status, dietary intakes, and cancer type or therapy.	type	cancer	6445	HP_0002664	152	156	82	88	False
30513730	The fatty acid (FA) composition of red blood cell (RBC) membrane phospholipids of cancer patients can reflect tumor status, dietary intakes, and cancer type or therapy.	fat	cancer	948	HP_0002664	4	7	82	88	False
30513730	The fatty acid (FA) composition of red blood cell (RBC) membrane phospholipids of cancer patients can reflect tumor status, dietary intakes, and cancer type or therapy.	red	tumor	8444	HP_0002664	35	38	110	115	False
30513730	The fatty acid (FA) composition of red blood cell (RBC) membrane phospholipids of cancer patients can reflect tumor status, dietary intakes, and cancer type or therapy.	type	tumor	6445	HP_0002664	152	156	110	115	False
30513730	The fatty acid (FA) composition of red blood cell (RBC) membrane phospholipids of cancer patients can reflect tumor status, dietary intakes, and cancer type or therapy.	fat	tumor	948	HP_0002664	4	7	110	115	False
30513730	The adjusted Analysis of Covariance Test (ANCOVA) model revealed cancer patients to have a lower relative percentage of saturated fatty acids (SFA) (C16:0 (5.7%); C18:0 (15.9%)), and higher monounsaturated fatty acids (MUFA) (9c-C18:1 (12.9%) and 11c-C18:1 (54.5%)), compared to controls.	red	cancer	8444	HP_0002664	272	275	65	71	False
30513730	The adjusted Analysis of Covariance Test (ANCOVA) model revealed cancer patients to have a lower relative percentage of saturated fatty acids (SFA) (C16:0 (5.7%); C18:0 (15.9%)), and higher monounsaturated fatty acids (MUFA) (9c-C18:1 (12.9%) and 11c-C18:1 (54.5%)), compared to controls.	fat	cancer	948	HP_0002664	130	133	65	71	False
28120165	Acad10 mice accumulate excess abdominal adipose tissue, develop an early inflammatory liver process, exhibit fasting rhabdomyolysis, and have abnormal skeletal muscle mitochondria.	mice	rhabdomyolysis	23581	HP_0003201	7	11	117	131	False
28120165	Acad10 mice accumulate excess abdominal adipose tissue, develop an early inflammatory liver process, exhibit fasting rhabdomyolysis, and have abnormal skeletal muscle mitochondria.	Acad10	rhabdomyolysis	80724	HP_0003201	0	6	117	131	False
29068691	Herein, we performed comparative quantitative proteomics on whole plasma sampled from patients with stable angina (NMI), acute myocardial infarction (MI), and healthy control subjects (Ctrl).	NMI	myocardial infarction	9111	HP_0001658	115	118	127	148	False
29068691	Herein, we performed comparative quantitative proteomics on whole plasma sampled from patients with stable angina (NMI), acute myocardial infarction (MI), and healthy control subjects (Ctrl).	Ctrl	myocardial infarction	1506	HP_0001658	185	189	127	148	False
28941661	A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in SLC26A2 (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive type 4 in SLC26A4 (~500 mutations, 203 point mutations).	SLC26A2	deafness	1836	HP_0000365	160	167	312	320	True
28941661	A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in SLC26A2 (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive type 4 in SLC26A4 (~500 mutations, 203 point mutations).	SLC26A3	deafness	1811	HP_0000365	244	251	312	320	False
28941661	A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in SLC26A2 (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive type 4 in SLC26A4 (~500 mutations, 203 point mutations).	type	deafness	6445	HP_0000365	341	345	312	320	False
28941661	A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in SLC26A2 (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive type 4 in SLC26A4 (~500 mutations, 203 point mutations).	SLC26A4	deafness	5172	HP_0000365	351	358	312	320	True
28941661	A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in SLC26A2 (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive type 4 in SLC26A4 (~500 mutations, 203 point mutations).	SLC26A2	autosomal recessive	1836	HP_0000007	160	167	321	340	True
28941661	A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in SLC26A2 (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive type 4 in SLC26A4 (~500 mutations, 203 point mutations).	SLC26A3	autosomal recessive	1811	HP_0000007	244	251	321	340	True
28941661	A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in SLC26A2 (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive type 4 in SLC26A4 (~500 mutations, 203 point mutations).	type	autosomal recessive	6445	HP_0000007	341	345	321	340	True
28941661	A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in SLC26A2 (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or deafness autosomal recessive type 4 in SLC26A4 (~500 mutations, 203 point mutations).	SLC26A4	autosomal recessive	5172	HP_0000007	351	358	321	340	True
28739378	Carney triad (CT) is a very rare disease with synchronous or metachronous occurrence of at least three different tumor entities; gastric gastrointestinal stromal tumor (GIST), paraganglioma (PGL), and pulmonary chondroma.	PGL	tumor	6392	HP_0002664	191	194	113	118	True
28739378	Carney triad (CT) is a very rare disease with synchronous or metachronous occurrence of at least three different tumor entities; gastric gastrointestinal stromal tumor (GIST), paraganglioma (PGL), and pulmonary chondroma.	PGL	paraganglioma	6392	HP_0002668	191	194	176	189	True
28739378	Carney triad (CT) is a very rare disease with synchronous or metachronous occurrence of at least three different tumor entities; gastric gastrointestinal stromal tumor (GIST), paraganglioma (PGL), and pulmonary chondroma.	PGL	pulmonary chondroma	6392	HP_0031474	191	194	201	220	False
28739378	Another disease that shares two of the tumor components of CT, namely GIST and PGL is the Carney-Stratakis syndrome (CSS) or dyad.	PGL	tumor	6392	HP_0002664	79	82	39	44	True
28739378	There is only partial overlap between the two conditions (there are a few patients with CT that have SDH subunit mutations) but both lead to increased methylation of the entire genome in the tumors associated with them.	SDH	tumor	1757	HP_0002664	101	104	191	196	False
28739378	Other tumors (outside CT and CSS) that have SDH deficiency are associated with increased methylation of the entire genome, but only in CT there is site-specific methylation of the SDHC gene.	SDH	tumor	1757	HP_0002664	44	47	6	11	False
26991507	This includes the first two genes linked to recessively inherited isolated dystonia, that is, HPCA (hippocalcin) and COL6A3 (collagen VI alpha 3).	HPCA	dystonia	773	HP_0001332	94	98	75	83	True
26991507	This includes the first two genes linked to recessively inherited isolated dystonia, that is, HPCA (hippocalcin) and COL6A3 (collagen VI alpha 3).	COL6A3	dystonia	1293	HP_0001332	117	123	75	83	True
26991507	The novel myoclonus-dystonia genes KCTD17 and CACNA1B also implicate abnormal calcium signaling in dystonia.	KCTD17	dystonia	79734	HP_0001332	35	41	20	28	True
26991507	The novel myoclonus-dystonia genes KCTD17 and CACNA1B also implicate abnormal calcium signaling in dystonia.	CACNA1B	dystonia	774	HP_0001332	46	53	20	28	True
26991507	The newly reported myoclonus-dystonia gene, RELN, plays also a role in the formation of brain structures.	RELN	dystonia	5649	HP_0001332	44	48	29	37	False
26991507	Defects in neurodevelopment likewise seem to be a recurrent scheme underpinning mainly complex dystonias, for example those attributable to biallelic mutations in GCH1, TH, SPR, or to heterozygous TUBB4A mutations.	GCH1	dystonia	2643	HP_0001332	163	167	95	103	True
26991507	Defects in neurodevelopment likewise seem to be a recurrent scheme underpinning mainly complex dystonias, for example those attributable to biallelic mutations in GCH1, TH, SPR, or to heterozygous TUBB4A mutations.	SPR	dystonia	6869	HP_0001332	173	176	95	103	False
26991507	Defects in neurodevelopment likewise seem to be a recurrent scheme underpinning mainly complex dystonias, for example those attributable to biallelic mutations in GCH1, TH, SPR, or to heterozygous TUBB4A mutations.	TUBB4A	dystonia	10382	HP_0001332	197	203	95	103	True
30006060	Alazami syndrome (AS) (MIM# 615071) is an autosomal recessive microcephalic primordial dwarfism (PD) with recognizable facial features and severe intellectual disability due to depletion or loss of function variants in LARP7.	MIM	autosomal recessive	9788	HP_0000007	23	26	42	61	False
30006060	Alazami syndrome (AS) (MIM# 615071) is an autosomal recessive microcephalic primordial dwarfism (PD) with recognizable facial features and severe intellectual disability due to depletion or loss of function variants in LARP7.	LARP7	autosomal recessive	51574	HP_0000007	219	224	42	61	True
30006060	Alazami syndrome (AS) (MIM# 615071) is an autosomal recessive microcephalic primordial dwarfism (PD) with recognizable facial features and severe intellectual disability due to depletion or loss of function variants in LARP7.	MIM	intellectual disability	9788	HP_0001249	23	26	146	169	False
30006060	Alazami syndrome (AS) (MIM# 615071) is an autosomal recessive microcephalic primordial dwarfism (PD) with recognizable facial features and severe intellectual disability due to depletion or loss of function variants in LARP7.	LARP7	intellectual disability	51574	HP_0001249	219	224	146	169	True
30006060	By comparing these two additional cases with those previously reported, we strengthen the key features of AS: severe growth restriction, severe intellectual disability and some distinguishing facial features such as broad nose, malar hypoplasia, wide mouth, full lips and abnormally set teeth.	set	intellectual disability	6418	HP_0001249	283	286	144	167	True
30006060	By comparing these two additional cases with those previously reported, we strengthen the key features of AS: severe growth restriction, severe intellectual disability and some distinguishing facial features such as broad nose, malar hypoplasia, wide mouth, full lips and abnormally set teeth.	set	malar hypoplasia	6418	HP_0000272	283	286	228	244	False
30006060	By comparing these two additional cases with those previously reported, we strengthen the key features of AS: severe growth restriction, severe intellectual disability and some distinguishing facial features such as broad nose, malar hypoplasia, wide mouth, full lips and abnormally set teeth.	set	wide mouth	6418	HP_0000154	283	286	246	256	True
25921236	A third proband was doubly heterozygous for inherited rare variants in additional components of complex I, NDUFAF2 and NDUFB9, confirming that Histiocytoid CM is genetically heterogeneous.	NDUFAF2	heterogeneous	91942	HP_0001425	107	114	174	187	False
25921236	A third proband was doubly heterozygous for inherited rare variants in additional components of complex I, NDUFAF2 and NDUFB9, confirming that Histiocytoid CM is genetically heterogeneous.	NDUFB9	heterogeneous	4715	HP_0001425	119	125	174	187	False
24056535	Mutations in filamin A (FLNA) or ADP-ribosylation factor guanine nucleotide-exchange factor 2 (ARFGEF2) cause periventricular nodular heterotopia, but most patients with this malformation do not have a known aetiology.	FLNA	heterotopia	2316	HP_0002282	24	28	134	145	True
24056535	Mutations in filamin A (FLNA) or ADP-ribosylation factor guanine nucleotide-exchange factor 2 (ARFGEF2) cause periventricular nodular heterotopia, but most patients with this malformation do not have a known aetiology.	ADP	heterotopia	23038	HP_0002282	33	36	134	145	False
24056535	Mutations in filamin A (FLNA) or ADP-ribosylation factor guanine nucleotide-exchange factor 2 (ARFGEF2) cause periventricular nodular heterotopia, but most patients with this malformation do not have a known aetiology.	ARFGEF2	heterotopia	10564	HP_0002282	95	102	134	145	True
24056535	Using whole exome sequencing in 14 patients with isolated periventricular nodular heterotopia but no copy number variants, we identified one patient with periventricular nodular heterotopia, developmental delay and epilepsy and a de novo missense mutation in the chromosome 6 open reading frame 70 (C6orf70) gene, mapping in the minimal critical deleted region.	C6orf70	heterotopia	55780	HP_0002282	299	306	82	93	True
24056535	Using whole exome sequencing in 14 patients with isolated periventricular nodular heterotopia but no copy number variants, we identified one patient with periventricular nodular heterotopia, developmental delay and epilepsy and a de novo missense mutation in the chromosome 6 open reading frame 70 (C6orf70) gene, mapping in the minimal critical deleted region.	C6orf70	epilepsy	55780	HP_0001250	299	306	215	223	True
24056535	Using whole exome sequencing in 14 patients with isolated periventricular nodular heterotopia but no copy number variants, we identified one patient with periventricular nodular heterotopia, developmental delay and epilepsy and a de novo missense mutation in the chromosome 6 open reading frame 70 (C6orf70) gene, mapping in the minimal critical deleted region.	C6orf70	developmental delay	55780	HP_0001263	299	306	191	210	True
24056535	Silencing of C6orf70 in the developing rat neocortex produced periventricular nodular heterotopia that was rescued by concomitant expression of wild-type human C6orf70 protein.	C6orf70	heterotopia	55780	HP_0002282	13	20	86	97	True
24056535	Silencing of the contiguous Phf10 or Dll1 genes only produced slightly delayed migration but not periventricular nodular heterotopia.	Phf10	heterotopia	55274	HP_0002282	28	33	121	132	False
24056535	Silencing of the contiguous Phf10 or Dll1 genes only produced slightly delayed migration but not periventricular nodular heterotopia.	Dll1	heterotopia	28514	HP_0002282	37	41	121	132	False
24056535	Our data suggest that, of the genes within this minimal critical region, C6orf70 plays a major role in the control of neuronal migration and its haploinsufficiency or mutation causes periventricular nodular heterotopia.	C6orf70	heterotopia	55780	HP_0002282	73	80	207	218	True
28776571	Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.	CDKN2A	tumor	1029	HP_0002664	27	33	213	218	True
28776571	Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.	CCND1	tumor	595	HP_0002664	35	40	213	218	True
28776571	Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.	CCNE1	tumor	898	HP_0002664	42	47	213	218	False
28776571	Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.	EGFR	tumor	1956	HP_0002664	49	53	213	218	True
28776571	Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.	EPHA3	tumor	2042	HP_0002664	55	60	213	218	False
28776571	Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.	EPHB1	tumor	2047	HP_0002664	62	67	213	218	False
28776571	Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.	FGFR1	tumor	2260	HP_0002664	69	74	213	218	True
28776571	Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.	JUN	tumor	3725	HP_0002664	76	79	213	218	False
28776571	Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.	RET	tumor	5979	HP_0002664	91	94	213	218	True
28776571	Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.	KIT	tumor	3815	HP_0002664	148	151	213	218	True
28776571	Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.	BRAF	tumor	673	HP_0002664	164	168	213	218	True
28776571	Focal alterations affected CDKN2A, CCND1, CCNE1, EGFR, EPHA3, EPHB1, FGFR1, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, BRAF, NTRK2 were seen in G3 compared with the G1 tumor areas.	NTRK2	tumor	4915	HP_0002664	170	175	213	218	False
28776571	TRIO and RICTOR co-amplification was seen in 8 (44%) G3 and 1 (10%) G1 myxofibrosarcomas and RICTOR amplification alone in 4 (40%) G1 myxofibrosarcomas.	RICTOR	sarcomas	253260	HP_0100242	9	15	80	88	False
26411452	Genome-wide association studies have identified genomic loci, whose single-nucleotide polymorphisms (SNPs) predispose to prostate cancer (PCa).	PCa	cancer	28982	HP_0002664	138	141	130	136	False
26411452	The expression of MLPH in primary prostate tumors was significantly lower in those with the G compared with the T allele and correlated significantly with AR protein.	MLPH	tumors	79083	HP_0002664	18	22	43	49	False
26411452	Higher melanophilin level in prostate tissue of patients with a favorable PCa risk profile points out a tumor-suppressive effect.	PCa	tumor	28982	HP_0002664	74	77	104	109	False
21615728	Hyperpolarization-activated cyclic nucleotide-gated channels (HCN) can act as pacemakers in the brain making them strong candidates for driving aberrant hypersynchronous network activity seen in epilepsy.	act	epilepsy	11332	HP_0001250	18	21	195	203	False
21615728	However, only recently have genetic studies demonstrated sequence variation in HCN1 and HCN2 genes associated with human epilepsy.	HCN1	epilepsy	348980	HP_0001250	79	83	121	129	True
21615728	However, only recently have genetic studies demonstrated sequence variation in HCN1 and HCN2 genes associated with human epilepsy.	HCN2	epilepsy	610	HP_0001250	88	92	121	129	False
21615728	These include a triple proline deletion in HCN2 that increases channel function and occurs more often in patients with febrile seizure syndromes.	HCN2	seizure	610	HP_0001250	43	47	127	134	False
30324244	Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique EWSR1-FLI1 translocation.	EWSR1	sarcoma	2130	HP_0100242	93	98	8	15	True
30324244	Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique EWSR1-FLI1 translocation.	FLI1	sarcoma	2314	HP_0100242	99	103	8	15	False
30324244	Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique EWSR1-FLI1 translocation.	EWSR1	tumor	2130	HP_0002664	93	98	45	50	True
30324244	Ewing's sarcoma is an aggressive mesenchymal tumor characterized by the presence of a unique EWSR1-FLI1 translocation.	FLI1	tumor	2314	HP_0002664	99	103	45	50	False
30324244	In conclusion, we successfully established a novel Ewing's sarcoma cell line, NCC-ES1-C1, from primary tumor tissue.	C1	sarcoma	393	HP_0100242	86	88	59	66	False
30324244	In conclusion, we successfully established a novel Ewing's sarcoma cell line, NCC-ES1-C1, from primary tumor tissue.	C1	tumor	393	HP_0002664	86	88	103	108	False
29621546	We found that KLK10 was significantly overexpressed in tissues of pancreatic intraepithelial neoplasia (PanIN) and PDAC from Pdx1-Cre; LSL-Kras<sup>G12D/+</sup> mice (KC) and Pdx1-Cre; LSL-Kras<sup>G12D/+</sup>; LSL-Trp53<sup>R172H/+</sup> mice (KPC) by immunohistochemical analysis.	KLK10	neoplasia	5655	HP_0002664	14	19	93	102	False
29621546	We found that KLK10 was significantly overexpressed in tissues of pancreatic intraepithelial neoplasia (PanIN) and PDAC from Pdx1-Cre; LSL-Kras<sup>G12D/+</sup> mice (KC) and Pdx1-Cre; LSL-Kras<sup>G12D/+</sup>; LSL-Trp53<sup>R172H/+</sup> mice (KPC) by immunohistochemical analysis.	mice	neoplasia	23581	HP_0002664	161	165	93	102	False
27818272	After its downregulation in neuroblastoma cells and in brains of Tspan3-deficient mice, ADAM10 and APP levels appeared unaltered possibly due to a compensatory increase in the expression of Tspans 5 and 7, respectively.	ADAM10	neuroblastoma	102	HP_0003006	88	94	28	41	False
27818272	After its downregulation in neuroblastoma cells and in brains of Tspan3-deficient mice, ADAM10 and APP levels appeared unaltered possibly due to a compensatory increase in the expression of Tspans 5 and 7, respectively.	APP	neuroblastoma	351	HP_0003006	99	102	28	41	False
27818272	After its downregulation in neuroblastoma cells and in brains of Tspan3-deficient mice, ADAM10 and APP levels appeared unaltered possibly due to a compensatory increase in the expression of Tspans 5 and 7, respectively.	Tspan3	neuroblastoma	10099	HP_0003006	65	71	28	41	False
27818272	After its downregulation in neuroblastoma cells and in brains of Tspan3-deficient mice, ADAM10 and APP levels appeared unaltered possibly due to a compensatory increase in the expression of Tspans 5 and 7, respectively.	mice	neuroblastoma	23581	HP_0003006	82	86	28	41	False
27761175	We report a case of a 33 month-old male referred for developmental delay that was found to have an Xp21.2 duplication containing IL1RAPL1 and multiple midline brain malformations	IL1RAPL1	developmental delay	11141	HP_0001263	129	137	53	72	False
28646536	Cystinuria is a heterogeneous, rare but important cause of inherited kidney stone disease due to mutations in 2 genes: SLC3A1 and SLC7A9.	SLC3A1	heterogeneous	6519	HP_0001425	119	125	16	29	False
28646536	Cystinuria is a heterogeneous, rare but important cause of inherited kidney stone disease due to mutations in 2 genes: SLC3A1 and SLC7A9.	SLC7A9	heterogeneous	11136	HP_0001425	130	136	16	29	False
28646536	We report 83 patients affected by cystinuria: 44 presented prenatally with a HEC (HEC group) and 39 with a classical postnatal form (CC group).	HEC	cystinuria	10403	HP_0003131	77	80	34	44	False
28646536	This study shows a relationship between genotype and the clinical form of cystinuria, suggesting that only the patients with the most severe mutations presented with an HEC.	HEC	cystinuria	10403	HP_0003131	169	172	74	84	False
29499418	The percentage of autosomal recessive forms due to mutations in BMP1, FKBP10, LEPRE1, SERPINF1, and WNT1 was unusually high (48%).	BMP1	autosomal recessive	649	HP_0000007	64	68	18	37	True
29499418	The percentage of autosomal recessive forms due to mutations in BMP1, FKBP10, LEPRE1, SERPINF1, and WNT1 was unusually high (48%).	FKBP10	autosomal recessive	60681	HP_0000007	70	76	18	37	True
29499418	The percentage of autosomal recessive forms due to mutations in BMP1, FKBP10, LEPRE1, SERPINF1, and WNT1 was unusually high (48%).	LEPRE1	autosomal recessive	64175	HP_0000007	78	84	18	37	True
29499418	The percentage of autosomal recessive forms due to mutations in BMP1, FKBP10, LEPRE1, SERPINF1, and WNT1 was unusually high (48%).	SERPINF1	autosomal recessive	5176	HP_0000007	86	94	18	37	True
29499418	The percentage of autosomal recessive forms due to mutations in BMP1, FKBP10, LEPRE1, SERPINF1, and WNT1 was unusually high (48%).	WNT1	autosomal recessive	7471	HP_0000007	100	104	18	37	True
30552303	In contrast, among the factors supporting the resistance in men can be an elevated concentration of MP-TF which, together with the coexistence of hypertriglyceridemia, may constitute an important mechanism of resistance to clopidogrel	men	hypertriglyceridemia	8178	HP_0002155	60	63	146	166	False
30552303	In contrast, among the factors supporting the resistance in men can be an elevated concentration of MP-TF which, together with the coexistence of hypertriglyceridemia, may constitute an important mechanism of resistance to clopidogrel	TF	hypertriglyceridemia	7018	HP_0002155	103	105	146	166	False
28814763	We demonstrate spatial genomic heterogeneity in more than 75% of patients, including inactivation of CDKN2C and TP53, and mutations affecting mitogen-activated protein kinase genes.	spatial	heterogeneity	219793	HP_0001425	15	22	31	44	False
28814763	We demonstrate spatial genomic heterogeneity in more than 75% of patients, including inactivation of CDKN2C and TP53, and mutations affecting mitogen-activated protein kinase genes.	CDKN2C	heterogeneity	1031	HP_0001425	101	107	31	44	False
28814763	We show that the extent of spatial heterogeneity is positively associated with the size of biopsied focal lesions consistent with regional outgrowth of advanced clones.	spatial	heterogeneity	219793	HP_0001425	27	34	35	48	False
28814763	Here, the authors use multi-region sequencing in patient samples to analyse spatial clonal architecture and heterogeneity, providing novel insight into multiple myeloma progression and evolution	spatial	heterogeneity	219793	HP_0001425	76	83	108	121	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	ACTN1	autosomal recessive	87	HP_0000007	92	97	346	365	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	DCAF5	autosomal recessive	8816	HP_0000007	99	104	346	365	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	EXD2	autosomal recessive	55218	HP_0000007	106	110	346	365	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	GALNTL1	autosomal recessive	57452	HP_0000007	112	119	346	365	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	ERH	autosomal recessive	2079	HP_0000007	121	124	346	365	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	SLC39A9	autosomal recessive	55334	HP_0000007	126	133	346	365	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	PLEKHD1	autosomal recessive	400224	HP_0000007	135	142	346	365	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	CCDC177	autosomal recessive	56936	HP_0000007	144	151	346	365	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	KIAA0247	autosomal recessive	9766	HP_0000007	153	161	346	365	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	SRSF5	autosomal recessive	6430	HP_0000007	177	182	346	365	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	SLC10A1	autosomal recessive	6554	HP_0000007	184	191	346	365	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	SMOC1	autosomal recessive	64093	HP_0000007	193	198	346	365	True
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	SLC8A3	autosomal recessive	6547	HP_0000007	200	206	346	365	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	SYNJ2BP	autosomal recessive	55333	HP_0000007	225	232	346	365	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	COX16	autosomal recessive	51241	HP_0000007	218	223	346	365	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	ADAM21	autosomal recessive	8747	HP_0000007	208	214	346	365	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	ACTN1	macrothrombocytopenia	87	HP_0040185	92	97	462	483	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	DCAF5	macrothrombocytopenia	8816	HP_0040185	99	104	462	483	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	EXD2	macrothrombocytopenia	55218	HP_0040185	106	110	462	483	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	GALNTL1	macrothrombocytopenia	57452	HP_0040185	112	119	462	483	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	ERH	macrothrombocytopenia	2079	HP_0040185	121	124	462	483	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	SLC39A9	macrothrombocytopenia	55334	HP_0040185	126	133	462	483	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	PLEKHD1	macrothrombocytopenia	400224	HP_0040185	135	142	462	483	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	CCDC177	macrothrombocytopenia	56936	HP_0040185	144	151	462	483	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	KIAA0247	macrothrombocytopenia	9766	HP_0040185	153	161	462	483	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	SRSF5	macrothrombocytopenia	6430	HP_0040185	177	182	462	483	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	SLC10A1	macrothrombocytopenia	6554	HP_0040185	184	191	462	483	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	SMOC1	macrothrombocytopenia	64093	HP_0040185	193	198	462	483	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	SLC8A3	macrothrombocytopenia	6547	HP_0040185	200	206	462	483	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	SYNJ2BP	macrothrombocytopenia	55333	HP_0040185	225	232	462	483	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	COX16	macrothrombocytopenia	51241	HP_0040185	218	223	462	483	False
24357125	Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, EXD2, GALNTL1, ERH, SLC39A9, PLEKHD1, CCDC177, KIAA0247, LOC100289511, SRSF5, SLC10A1, SMOC1, SLC8A3, ADAM21P1, COX16, SYNJ2BP, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	ADAM21	macrothrombocytopenia	8747	HP_0040185	208	214	462	483	False
25617527	LETM1 protein was detected in 107 TNBC, 42 ductal carcinoma in situ (DCIS) and 65 adjacent non-tumor breast tissues using immunohistochemical (IHC) staining.	LETM1	tumor	3954	HP_0002664	0	5	95	100	True
25617527	The strongly positive rate of LETM1 in TNBC was 69.2% (74/107), which was significantly higher than in both DCIS 35.7% (15/42) and adjacent non-tumor tissues 12.3% (8/65).	LETM1	tumor	3954	HP_0002664	30	35	144	149	True
28368018	Here we show in a child with microthrombocytopenia, eosinophilia and inflammatory disease, a homozygous frameshift mutation in ARPC1B (p.Val91Trpfs*30).	ARPC1B	eosinophilia	10095	HP_0001880	127	133	52	64	False
28368018	Thus loss of ARPC1B produces a unique set of platelet abnormalities, and is associated with haematopoietic/immune symptoms affecting cell lineages where this isoform predominates.	ARPC1B	platelet abnormalities	10095	HP_0001872	13	19	45	67	True
27746184	Therefore, we evaluated the roles of CSNK2A1, SIRT6, and phosphorylated SIRT6 and their relationships in breast carcinoma.	CSNK2A1	breast carcinoma	1459	HP_0003002	37	44	105	121	False
27746184	Therefore, we evaluated the roles of CSNK2A1, SIRT6, and phosphorylated SIRT6 and their relationships in breast carcinoma.	SIRT6	breast carcinoma	51548	HP_0003002	46	51	105	121	False
27746184	Inhibition of CSNK2A1 decreased the proliferative and invasive activity of cancer cells.	CSNK2A1	cancer	1459	HP_0002664	14	21	75	81	False
27746184	Knockdown of SIRT6 decreased the proliferation and invasiveness of cancer cells.	SIRT6	cancer	51548	HP_0002664	13	18	67	73	False
27746184	This study demonstrates that CSNK2A1 and SIRT6 are indicators of poor prognosis for breast carcinomas and that CSNK2A1-mediated phosphorylation of SIRT6 might be involved in the progression of breast carcinoma	CSNK2A1	breast carcinoma	1459	HP_0003002	29	36	84	100	False
27746184	This study demonstrates that CSNK2A1 and SIRT6 are indicators of poor prognosis for breast carcinomas and that CSNK2A1-mediated phosphorylation of SIRT6 might be involved in the progression of breast carcinoma	SIRT6	breast carcinoma	51548	HP_0003002	41	46	84	100	False
29074724	Knock-in of nonphosphorylatable PRPS1/2 mutants, which have uninhibited activity, in brain tumor cells under energy stress exhausts cellular ATP and NADPH and increases reactive oxygen species levels, thereby promoting cell apoptosis.	PRPS1	tumor	5631	HP_0002664	32	37	91	96	False
29074724	Our findings highlight the significance of recalibrating tumor cell metabolism by fine-tuning nucleotide and NAD synthesis in tumor growth.<b>Significance:</b> Our findings elucidate an instrumental function of AMPK in direct regulation of nucleic acid and NAD synthesis in tumor cells in response to energy stress.	AMPK	tumor	5563	HP_0002664	211	215	57	62	False
29074724	AMPK phosphorylates PRPS1/2, converts PRPS1/2 hexamers to monomers, and inhibits PRPS1/2 activity and subsequent nucleotide and NAD synthesis to maintain tumor cell growth and survival.	AMPK	tumor	5563	HP_0002664	0	4	154	159	False
29074724	AMPK phosphorylates PRPS1/2, converts PRPS1/2 hexamers to monomers, and inhibits PRPS1/2 activity and subsequent nucleotide and NAD synthesis to maintain tumor cell growth and survival.	PRPS1	tumor	5631	HP_0002664	20	25	154	159	False
29146900	Surprisingly, germline variants in SAMD9 or SAMD9L were present in 17% of primary MDS patients, and these variants were routinely lost in the tumor cells by chromosomal deletions (e.g., monosomy 7) or copy number neutral loss of heterozygosity (CN-LOH).	MDS	tumor	5048	HP_0002664	82	85	142	147	False
29146900	Surprisingly, germline variants in SAMD9 or SAMD9L were present in 17% of primary MDS patients, and these variants were routinely lost in the tumor cells by chromosomal deletions (e.g., monosomy 7) or copy number neutral loss of heterozygosity (CN-LOH).	SAMD9	tumor	54809	HP_0002664	35	40	142	147	True
24670872	In zebrafish, downregulation of slc7a14 expression leads to an abnormal eye phenotype and defective light-induced locomotor response.	slc7a14	abnormal eye	57709	HP_0000478	32	39	63	75	True
24670872	Furthermore, targeted knockout of Slc7a14 in mice results in retinal degeneration with abnormal ERG response.	Slc7a14	retinal degeneration	57709	HP_0000546	34	41	61	81	True
24670872	Furthermore, targeted knockout of Slc7a14 in mice results in retinal degeneration with abnormal ERG response.	mice	retinal degeneration	23581	HP_0000546	45	49	61	81	False
24670872	Furthermore, targeted knockout of Slc7a14 in mice results in retinal degeneration with abnormal ERG response.	ERG	retinal degeneration	2078	HP_0000546	96	99	61	81	False
29785007	Germline CHEK2 mutations confer increased cancer risk, for breast and other types, which is variable depending on the specific mutation.	CHEK2	cancer	11200	HP_0002664	9	14	42	48	True
29785007	The present study aimed to molecularly define and determine the contribution of two rare, apparently novel CHEK2 LGRs, among Greek breast cancer patients.	CHEK2	cancer	11200	HP_0002664	107	112	138	144	True
21965325	Consistent with our description of this pathway and the phenotype of patients with FGD1 mutations, mice with a targeted deletion of Mlk3 displayed multiple skeletal defects, including dental abnormalities, deficient calvarial mineralization, and reduced bone mass.	FGD1	dental abnormalities	2245	HP_0000164	83	87	184	204	True
21965325	Consistent with our description of this pathway and the phenotype of patients with FGD1 mutations, mice with a targeted deletion of Mlk3 displayed multiple skeletal defects, including dental abnormalities, deficient calvarial mineralization, and reduced bone mass.	mice	dental abnormalities	23581	HP_0000164	99	103	184	204	False
21965325	Consistent with our description of this pathway and the phenotype of patients with FGD1 mutations, mice with a targeted deletion of Mlk3 displayed multiple skeletal defects, including dental abnormalities, deficient calvarial mineralization, and reduced bone mass.	Mlk3	dental abnormalities	4296	HP_0000164	132	136	184	204	False
30201903	Recent studies have examined the intrinsic antitumor activity of melatonin in various cancers, including hepatocellular carcinoma (HCC), the primary life-threatening malignancy in both sexes in Taiwan.	HCC	hepatocellular carcinoma	84668	HP_0001402	131	134	105	129	False
28343629	OTUD6B encodes a member of the ovarian tumor domain (OTU)-containing subfamily of deubiquitinating enzymes.	OTUD6B	tumor	51633	HP_0002664	0	6	39	44	False
28343629	Herein, we report biallelic pathogenic variants in OTUD6B in 12 individuals from 6 independent families with an intellectual disability syndrome associated with seizures and dysmorphic features.	OTUD6B	intellectual disability	51633	HP_0001249	51	57	112	135	True
28343629	Herein, we report biallelic pathogenic variants in OTUD6B in 12 individuals from 6 independent families with an intellectual disability syndrome associated with seizures and dysmorphic features.	OTUD6B	seizures	51633	HP_0001250	51	57	161	169	True
28343629	Homozygous Otud6b knockout mice were subviable, smaller in size, and had congenital heart defects, consistent with the severity of loss-of-function variants in humans.	Otud6b	congenital heart defects	51633	HP_0001627	11	17	73	97	False
28343629	Homozygous Otud6b knockout mice were subviable, smaller in size, and had congenital heart defects, consistent with the severity of loss-of-function variants in humans.	mice	congenital heart defects	23581	HP_0001627	27	31	73	97	False
21224892	Myotonic dystrophy type 2 (DM2) is a progressive multisystem disease with muscle weakness and myotonia as main characteristics.	type	myotonia	6445	HP_0002486	19	23	94	102	True
29453415	We also demonstrate that ATP-binding cassette subfamily C member 2 (ABCC2) gene, responsible for hyperbilirubinemia, is linked to ERLIN1	ABCC2	hyperbilirubinemia	1244	HP_0002904	68	73	97	115	True
30643356	In respect to achalasia, per-oral endoscopic myotomy (POEM) which was developed in Japan, has become an alternative to the traditional Heller's myotomy.	per	achalasia	5187	HP_0002571	25	28	14	23	False
30643356	In respect to achalasia, per-oral endoscopic myotomy (POEM) which was developed in Japan, has become an alternative to the traditional Heller's myotomy.	POEM	achalasia	255743	HP_0002571	54	58	14	23	False
30643356	In regard to BE, endoscopic submucosal dissection (ESD) which is well established in Asia, is now becoming more mainstream in the West for the treatment of BE with high grade dysplasia, as well as early esophageal cancer.	ESD	cancer	2098	HP_0002664	51	54	214	220	False
30643356	Importantly, in regard to early gastric cancer and submucosal tumors (SMTs) of the stomach, ESD and full thickness resection (FTR) can excise these lesions <i>en-bloc</i> and endoscopic suturing is now used to close large defects and perforations.	per	cancer	5187	HP_0002664	234	237	40	46	False
30643356	Importantly, in regard to early gastric cancer and submucosal tumors (SMTs) of the stomach, ESD and full thickness resection (FTR) can excise these lesions <i>en-bloc</i> and endoscopic suturing is now used to close large defects and perforations.	ESD	cancer	2098	HP_0002664	92	95	40	46	False
30643356	Importantly, in regard to early gastric cancer and submucosal tumors (SMTs) of the stomach, ESD and full thickness resection (FTR) can excise these lesions <i>en-bloc</i> and endoscopic suturing is now used to close large defects and perforations.	per	tumors	5187	HP_0002664	234	237	62	68	False
30643356	Importantly, in regard to early gastric cancer and submucosal tumors (SMTs) of the stomach, ESD and full thickness resection (FTR) can excise these lesions <i>en-bloc</i> and endoscopic suturing is now used to close large defects and perforations.	ESD	tumors	2098	HP_0002664	92	95	62	68	False
29802240	BACKGROUND Hepatocellular carcinoma (HCC) is one of the most common malignancies occurring worldwide and is most frequent type of liver cancer.	HCC	cancer	84668	HP_0002664	37	40	136	142	False
29802240	BACKGROUND Hepatocellular carcinoma (HCC) is one of the most common malignancies occurring worldwide and is most frequent type of liver cancer.	type	cancer	6445	HP_0002664	122	126	136	142	False
29511671	Moreover, we found ITGA3 expression correlated with several clinicopathological features, including tumor size, lymph node metastasis, and the TNM stage.	ITGA3	tumor	3675	HP_0002664	19	24	100	105	False
29511671	Moreover, we found ITGA3 expression correlated with several clinicopathological features, including tumor size, lymph node metastasis, and the TNM stage.	TNM	tumor	10178	HP_0002664	143	146	100	105	False
29511671	However, as a classical cell surface adhesion molecule, we found ITGA3 correlated negatively with the migration and invasion of ICC cell lines, which differs from other malignant tumors.	ITGA3	tumor	3675	HP_0002664	65	70	179	184	False
29310658	Among these genes, mutations in VCP gene involve in inclusion body myopathy with Paget disease of bone and frontotemporal dementia (IBMPFD), familial amyotrophic lateral sclerosis (ALS), autism spectrum disorders (ASD), and hereditary spastic paraplegia (HSP).	VCP	frontotemporal dementia	7415	HP_0002145	32	35	107	130	True
29310658	Among these genes, mutations in VCP gene involve in inclusion body myopathy with Paget disease of bone and frontotemporal dementia (IBMPFD), familial amyotrophic lateral sclerosis (ALS), autism spectrum disorders (ASD), and hereditary spastic paraplegia (HSP).	IBMPFD	frontotemporal dementia	7415	HP_0002145	132	138	107	130	True
29310658	Among these genes, mutations in VCP gene involve in inclusion body myopathy with Paget disease of bone and frontotemporal dementia (IBMPFD), familial amyotrophic lateral sclerosis (ALS), autism spectrum disorders (ASD), and hereditary spastic paraplegia (HSP).	VCP	autism	7415	HP_0000717	32	35	187	193	False
29310658	Among these genes, mutations in VCP gene involve in inclusion body myopathy with Paget disease of bone and frontotemporal dementia (IBMPFD), familial amyotrophic lateral sclerosis (ALS), autism spectrum disorders (ASD), and hereditary spastic paraplegia (HSP).	IBMPFD	autism	7415	HP_0000717	132	138	187	193	False
25807459	Missense mutations in the human GPI biosynthesis enzyme pigv are associated with a multiple congenital malformation syndrome with a high frequency of Hirschsprung disease and renal anomalies.	GPI	renal anomalies	10007	HP_0000077	32	35	175	190	False
25807459	Missense mutations in the human GPI biosynthesis enzyme pigv are associated with a multiple congenital malformation syndrome with a high frequency of Hirschsprung disease and renal anomalies.	pigv	renal anomalies	55650	HP_0000077	56	60	175	190	False
29281825	Focal cortical dysplasia (FCD) and hemimegalencephaly (HME) are epileptogenic neurodevelopmentalmalformations caused by mutations in mTOR pathway genes.	HME	cortical dysplasia	4321	HP_0002539	55	58	6	24	False
29281825	Focal cortical dysplasia (FCD) and hemimegalencephaly (HME) are epileptogenic neurodevelopmentalmalformations caused by mutations in mTOR pathway genes.	mTOR	cortical dysplasia	2475	HP_0002539	134	138	6	24	True
29281825	Focal cortical dysplasia (FCD) and hemimegalencephaly (HME) are epileptogenic neurodevelopmentalmalformations caused by mutations in mTOR pathway genes.	HME	hemimegalencephaly	4321	HP_0007206	55	58	35	53	False
29281825	Focal cortical dysplasia (FCD) and hemimegalencephaly (HME) are epileptogenic neurodevelopmentalmalformations caused by mutations in mTOR pathway genes.	mTOR	hemimegalencephaly	2475	HP_0007206	134	138	35	53	True
29596833	Congenital heart defects represent a characteristic part of several genetic syndromes associated with chromosomal abnormalities such as 22q11.2 deletion syndrome; many genes located in this locus, mainly TBX1, are candidate genes for congenital heart defects.	TBX1	congenital heart defects	6899	HP_0001627	204	208	234	258	True
29596833	In our cohort of 27 subjects with congenital heart defect, both karyotype analysis and Fluorescence in situ hybridization (FISH) were performed.	FISH	congenital heart defect	9644	HP_0001627	123	127	34	57	False
29471829	In fact, cells which simultaneously express both sets of markers have the highest tumor initiating capacity.	fact	tumor	11198	HP_0002664	3	7	82	87	False
29471829	In ALDH<sup>+</sup>CD24<sup>-</sup>CD44<sup>+</sup> BCSCs, we identified P4HA2, PTGR1 and RAB40B as potential prognostic markers, which were virtually related to the status of BCSCs and tumor growth in TNBC cells	PTGR1	tumor	22949	HP_0002664	80	85	186	191	False
29471829	In ALDH<sup>+</sup>CD24<sup>-</sup>CD44<sup>+</sup> BCSCs, we identified P4HA2, PTGR1 and RAB40B as potential prognostic markers, which were virtually related to the status of BCSCs and tumor growth in TNBC cells	RAB40B	tumor	10966	HP_0002664	90	96	186	191	False
12140191	Consistent with a conserved role for this gene in the cochlea, the genetic mapping data presented here support human TMIE as the gene affected at DFNB6, a non-syndromic hearing loss locus.	TMIE	hearing loss	259236	HP_0000365	117	121	169	181	True
12140191	Consistent with a conserved role for this gene in the cochlea, the genetic mapping data presented here support human TMIE as the gene affected at DFNB6, a non-syndromic hearing loss locus.	DFNB6	hearing loss	9381	HP_0000365	146	151	169	181	True
18348268	This study supports heterogeneity for CDPX1-like phenotypes and sorting these out will help to define the biological pathway and genetic contributors	CDPX1	heterogeneity	415	HP_0001425	38	43	20	33	False
23335591	Over the past decade, the genetic basis of several forms of autosomal recessive SCD cases has been solved with the identification of four causative genes (DLL3, MESP2, LFNG and HES7).	SCD	autosomal recessive	6584	HP_0000007	80	83	60	79	True
23335591	Over the past decade, the genetic basis of several forms of autosomal recessive SCD cases has been solved with the identification of four causative genes (DLL3, MESP2, LFNG and HES7).	DLL3	autosomal recessive	10683	HP_0000007	155	159	60	79	True
23335591	Over the past decade, the genetic basis of several forms of autosomal recessive SCD cases has been solved with the identification of four causative genes (DLL3, MESP2, LFNG and HES7).	MESP2	autosomal recessive	145873	HP_0000007	161	166	60	79	True
23335591	Over the past decade, the genetic basis of several forms of autosomal recessive SCD cases has been solved with the identification of four causative genes (DLL3, MESP2, LFNG and HES7).	LFNG	autosomal recessive	3955	HP_0000007	168	172	60	79	True
23335591	Over the past decade, the genetic basis of several forms of autosomal recessive SCD cases has been solved with the identification of four causative genes (DLL3, MESP2, LFNG and HES7).	HES7	autosomal recessive	84667	HP_0000007	177	181	60	79	True
25111228	Mutations in the gene encoding the single transmembrane receptor multiple epidermal growth factor-like domain 10 (MEGF10) cause an autosomal recessive congenital muscle disease in humans.	MEGF10	autosomal recessive	84466	HP_0000007	114	120	131	150	True
25111228	Although mammalian MEGF10 is expressed in the central nervous system as well as in skeletal muscle, patients carrying mutations in MEGF10 do not show symptoms of central nervous system dysfunction.	MEGF10	central	84466	HP_0030645	19	25	46	53	False
25111228	The histological and behavioral abnormalities seen in the affected flies set the stage for further studies examining the signaling pathway modulated by MEGF10/Drpr in muscle, as well as assessing the effects of genetic and/or pharmacological manipulations on the observed muscle defects.	MEGF10	behavioral abnormalities	84466	HP_0000708	152	158	21	45	False
25111228	The histological and behavioral abnormalities seen in the affected flies set the stage for further studies examining the signaling pathway modulated by MEGF10/Drpr in muscle, as well as assessing the effects of genetic and/or pharmacological manipulations on the observed muscle defects.	set	behavioral abnormalities	6418	HP_0000708	73	76	21	45	False
29634879	Kindler syndrome is a rare, autosomal recessive genodermatosis, caused by mutations in the FERMT1 gene.	FERMT1	autosomal recessive	55612	HP_0000007	91	97	28	47	True
29122497	Defects in ISC biogenesis lead to multiple mitochondrial dysfunction syndromes including: ISCA2 with infantile onset leukodystrophy.	ISCA2	mitochondrial dysfunction	122961	HP_0003287	90	95	43	68	False
28757574	Animal models of viral-associated blood-brain barrier (BBB) disruption and experimental cerebral malaria (ECM) have identified perforin as critical for inducing pathologic central nervous system CNS vascular permeability.	ECM	central	22915	HP_0030645	106	109	172	179	False
26420843	Vestibular sensory-evoked potentials demonstrate severe to profound vestibular deficits in Dfnb31(neo/neo) and Dfnb31(wi/wi) mice.	mice	profound	23581	HP_0012829	125	129	59	67	False
26420843	Because Dfnb31(wi/wi) and Dfnb31(neo/neo) mice faithfully recapitulate hearing and vision symptoms in patients, our findings of vestibular dysfunction in these Dfnb31 mutants raise the question of whether DFNB31-deficient patients may acquire vestibular as well as hearing and vision loss.	find	vestibular dysfunction	81501	HP_0001751	116	120	128	150	False
26420843	Because Dfnb31(wi/wi) and Dfnb31(neo/neo) mice faithfully recapitulate hearing and vision symptoms in patients, our findings of vestibular dysfunction in these Dfnb31 mutants raise the question of whether DFNB31-deficient patients may acquire vestibular as well as hearing and vision loss.	mice	vestibular dysfunction	23581	HP_0001751	42	46	128	150	False
26010722	Biological relationships among these mutated genes were mined using Ingenuity Pathway Analysis, and the results demonstrated that top two networks with highest scores were highly associated with cancer and hematological diseases, indicating that the mutated genes identified by our method were highly relevant to MDS.	MDS	cancer	5048	HP_0002664	313	316	195	201	False
26010722	The results indicated two mutated driver pathways are important for the pathogenesis of MDS: pathway in cancer and in regulation of actin cytoskeleton.	MDS	cancer	5048	HP_0002664	88	91	104	110	False
25091424	Mutations in eight of them (PDSS1, PDSS2, COQ2, COQ4, COQ6, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.	PDSS1	heterogeneous	23590	HP_0001425	28	33	120	133	False
25091424	Mutations in eight of them (PDSS1, PDSS2, COQ2, COQ4, COQ6, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.	PDSS2	heterogeneous	57107	HP_0001425	35	40	120	133	False
25091424	Mutations in eight of them (PDSS1, PDSS2, COQ2, COQ4, COQ6, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.	COQ2	heterogeneous	27235	HP_0001425	42	46	120	133	False
25091424	Mutations in eight of them (PDSS1, PDSS2, COQ2, COQ4, COQ6, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.	COQ4	heterogeneous	51117	HP_0001425	48	52	120	133	False
25091424	Mutations in eight of them (PDSS1, PDSS2, COQ2, COQ4, COQ6, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.	COQ6	heterogeneous	51004	HP_0001425	54	58	120	133	False
25091424	Mutations in eight of them (PDSS1, PDSS2, COQ2, COQ4, COQ6, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.	COQ9	heterogeneous	57017	HP_0001425	78	82	120	133	False
25091424	In primary forms treatment can stop the progression of both SRNS and encephalopathy, hence the critical importance of a prompt diagnosis.	stop	encephalopathy	4135	HP_0001298	31	35	69	83	False
29581481	BMPR1B is known to be responsible for autosomal dominant brachydactyly and autosomal recessive acromesomelic chondrodysplasia.	BMPR1B	brachydactyly	658	HP_0001156	0	6	57	70	True
29581481	BMPR1B is known to be responsible for autosomal dominant brachydactyly and autosomal recessive acromesomelic chondrodysplasia.	BMPR1B	autosomal recessive	658	HP_0000007	0	6	75	94	True
29989649	Analysis using Gene Set Enrichment Analysis (GSEA) software revealed significant enrichment for 197proteins from the CM of lung cancer samples in maternalplacental interface expression profiles for a midterm placenta with strong invasiveness relative to RNA expression profiles for a human fullterm placenta after delivery.	Set	cancer	6418	HP_0002664	20	23	129	135	False
27353389	A mutation of Lrrc6 has been identified in human patients with primary ciliary dyskinesia (PCD).	Lrrc6	ciliary dyskinesia	23639	HP_0012265	14	19	71	89	True
27353389	A mutation of Lrrc6 has been identified in human patients with primary ciliary dyskinesia (PCD).	PCD	ciliary dyskinesia	352909	HP_0012265	91	94	71	89	True
27353389	Mutant mice lacking Lrrc6 show typical PCD defects such as hydrocephalus and laterality defects.	mice	hydrocephalus	23581	HP_0000238	7	11	59	72	False
27353389	Mutant mice lacking Lrrc6 show typical PCD defects such as hydrocephalus and laterality defects.	Lrrc6	hydrocephalus	23639	HP_0000238	20	25	59	72	False
27353389	Mutant mice lacking Lrrc6 show typical PCD defects such as hydrocephalus and laterality defects.	PCD	hydrocephalus	352909	HP_0000238	39	42	59	72	False
26202106	Progressive retinal atrophy (PRA) is the collective name of a class of hereditary retinal dystrophies in the dog and is often described as the equivalent of retinitis pigmentosa in humans.	PRA	retinal atrophy	6277	HP_0001105	29	32	12	27	False
26202106	Progressive retinal atrophy (PRA) is the collective name of a class of hereditary retinal dystrophies in the dog and is often described as the equivalent of retinitis pigmentosa in humans.	PRA	retinal dystrophies	6277	HP_0000556	29	32	82	101	False
26202106	PRA is characterized by visual impairment due to degeneration of the photoreceptors in the retina, usually leading to blindness.	PRA	visual impairment	6277	HP_0000505	0	3	24	41	False
26202106	PRA is characterized by visual impairment due to degeneration of the photoreceptors in the retina, usually leading to blindness.	PRA	blindness	6277	HP_0000618	0	3	118	127	False
26202106	PRA has been reported in dogs from more than 100 breeds and can be genetically heterogeneous both between and within breeds.	PRA	heterogeneous	6277	HP_0001425	0	3	79	92	False
26202106	The study indicated genetic heterogeneity as the mutation was present in all PRA-affected individuals in one large family of Shelties, whereas some other cases in the studied Sheltie population were not associated with this CNGA1 mutation.	PRA	heterogeneity	6277	HP_0001425	77	80	28	41	False
26202106	The study indicated genetic heterogeneity as the mutation was present in all PRA-affected individuals in one large family of Shelties, whereas some other cases in the studied Sheltie population were not associated with this CNGA1 mutation.	CNGA1	heterogeneity	1259	HP_0001425	224	229	28	41	False
28777934	Here, we report that variants in TRAPPC12 result in progressive childhood encephalopathy.	TRAPPC12	encephalopathy	51112	HP_0001298	33	41	74	88	True
29423809	While the varied landscapes of mutations driving common cancer types such as lung, breast, and colorectal cancer have been comprehensively charted, the genetic underpinnings of many rare cancers remain poorly defined.	type	cancer	6445	HP_0002664	63	67	56	62	False
29423809	Here we describe the approaches and methods used to identify SMARCA4 mutations, which drive development of the rare ovarian cancer, small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), and point to the broader relevance of this paradigm for future research in rare cancers	SMARCA4	cancer	6597	HP_0002664	61	68	124	130	False
29423809	Here we describe the approaches and methods used to identify SMARCA4 mutations, which drive development of the rare ovarian cancer, small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), and point to the broader relevance of this paradigm for future research in rare cancers	type	cancer	6445	HP_0002664	181	185	124	130	False
30029432	Taking advantage of the homogeneous and heterogeneous electrochemical biosensors, a simple, sensitive, and selective electrochemical biosensor is constructed by combining entropy-driven amplification (EDA) with DNA walker.	simple	heterogeneous	9516	HP_0001425	84	90	40	53	True
30029432	Taking advantage of the homogeneous and heterogeneous electrochemical biosensors, a simple, sensitive, and selective electrochemical biosensor is constructed by combining entropy-driven amplification (EDA) with DNA walker.	EDA	heterogeneous	1896	HP_0001425	201	204	40	53	True
30592012	Transmissible spongiform encephalopathies, characterized by long incubation periods and spongiform changes associated with neuronal loss in the brain, have been described in several mammalian species appearing either naturally (scrapie in sheep and goats, bovine spongiform encephalopathy in cattle, chronic wasting disease in cervids, Creutzfeldt-Jakob disease in humans) or by experimental transmission studies (scrapie in mice and hamsters).	mice	encephalopathy	23581	HP_0001298	425	429	274	288	False
30592012	Transmissible spongiform encephalopathies, characterized by long incubation periods and spongiform changes associated with neuronal loss in the brain, have been described in several mammalian species appearing either naturally (scrapie in sheep and goats, bovine spongiform encephalopathy in cattle, chronic wasting disease in cervids, Creutzfeldt-Jakob disease in humans) or by experimental transmission studies (scrapie in mice and hamsters).	mice	encephalopathies	23581	HP_0001298	425	429	25	41	False
30592012	Transmissible spongiform encephalopathies, characterized by long incubation periods and spongiform changes associated with neuronal loss in the brain, have been described in several mammalian species appearing either naturally (scrapie in sheep and goats, bovine spongiform encephalopathy in cattle, chronic wasting disease in cervids, Creutzfeldt-Jakob disease in humans) or by experimental transmission studies (scrapie in mice and hamsters).	mice	neuronal loss	23581	HP_0002529	425	429	123	136	False
21416382	Posterior microphthalmos (PM) is a relatively infrequent type of microphthalmos where posterior segment is predominantly affected with normal anterior segment measurements.	type	microphthalmos	6445	HP_0000568	57	61	10	24	False
12642876	Liver cancer is very common worldwide and the rates of hepatocellular carcinoma (HCC) have increased by over 70% in the last 2 decades in the US.	HCC	cancer	84668	HP_0002664	81	84	6	12	False
12642876	Liver cancer is very common worldwide and the rates of hepatocellular carcinoma (HCC) have increased by over 70% in the last 2 decades in the US.	HCC	hepatocellular carcinoma	84668	HP_0001402	81	84	55	79	False
12642876	We present the cloning and characterization of a novel gene, CRG-L2 (Cancer related gene-Liver 2), which displays high expression in murine and human hepatocellular carcinomas.	CRG-L2	hepatocellular carcinoma	342035	HP_0001402	61	67	150	174	False
12642876	Using in situ hybridization, we show that CRG-L2 mRNA levels are increased early during the development of liver tumors in C3H/HeJ mice, and that in normal tissues CRG-L2 mRNA is restricted to the murine testis and human placenta.	CRG-L2	tumors	342035	HP_0002664	42	48	113	119	False
12642876	Using in situ hybridization, we show that CRG-L2 mRNA levels are increased early during the development of liver tumors in C3H/HeJ mice, and that in normal tissues CRG-L2 mRNA is restricted to the murine testis and human placenta.	mice	tumors	23581	HP_0002664	131	135	113	119	False
12642876	Its restricted expression in normal tissues and unique early upregulation during tumor development make CRG-L2 an excellent candidate as a new clinical marker of HCC	CRG-L2	tumor	342035	HP_0002664	104	110	81	86	False
26680691	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	CGD	heterogeneous	1536	HP_0001425	0	3	21	34	False
26680691	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	CYBB	heterogeneous	1536	HP_0001425	111	115	21	34	False
26680691	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	CYBA	heterogeneous	1535	HP_0001425	222	226	21	34	False
26680691	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	NCF1	heterogeneous	653361	HP_0001425	228	232	21	34	False
26680691	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	NCF2	heterogeneous	4688	HP_0001425	234	238	21	34	False
26680691	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	NCF4	heterogeneous	4689	HP_0001425	243	247	21	34	False
26680691	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	CGD	autosomal recessive	1536	HP_0000007	0	3	161	180	False
26680691	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	CYBB	autosomal recessive	1536	HP_0000007	111	115	161	180	False
26680691	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	CYBA	autosomal recessive	1535	HP_0000007	222	226	161	180	True
26680691	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	NCF1	autosomal recessive	653361	HP_0000007	228	232	161	180	True
26680691	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	NCF2	autosomal recessive	4688	HP_0000007	234	238	161	180	True
26680691	CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the CYBA, NCF1, NCF2, or NCF4 genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	NCF4	autosomal recessive	4689	HP_0000007	243	247	161	180	True
29445841	In human, PDC deficiency leads to severe neurodevelopmental delay and progressive neurodegeneration.	PDC	neurodevelopmental delay	25953	HP_0012758	10	13	41	65	False
29445841	In human, PDC deficiency leads to severe neurodevelopmental delay and progressive neurodegeneration.	PDC	progressive neurodegeneration	25953	HP_0002344	10	13	70	99	False
30661749	T cell-related encephalopathy (CRES) syndrome may occur concomitantly.	CRES	encephalopathy	10047	HP_0001298	31	35	15	29	False
29339498	This mutation was also found in a second unrelated family with the same clinical phenotype, while no germline or somatic <i>MAFA</i> mutations were identified in nine patients with sporadic insulinomatosis.	MAFA	sporadic	10219	HP_0003745	124	128	181	189	False
26820484	Membrane transporters (such as ABCs, SLCs and ATPases) act in carcinogenesis and chemoresistance development, but their relevance for prognosis of epithelial ovarian cancer (EOC) remains poorly understood.	act	cancer	11332	HP_0002664	55	58	166	172	False
26820484	Membrane transporters (such as ABCs, SLCs and ATPases) act in carcinogenesis and chemoresistance development, but their relevance for prognosis of epithelial ovarian cancer (EOC) remains poorly understood.	SLC	cancer	6366	HP_0002664	37	40	166	172	False
22147650	Prion proteins (PRNP and PRND), known mostly for its involvement in neurodegenerative spongiform encephalopathies, have been recently demonstrated to be involved in resistance to apoptosis, tumorigenesis, proliferation, and metastasis.	PRNP	encephalopathies	5621	HP_0001298	16	20	97	113	True
22147650	Prion proteins (PRNP and PRND), known mostly for its involvement in neurodegenerative spongiform encephalopathies, have been recently demonstrated to be involved in resistance to apoptosis, tumorigenesis, proliferation, and metastasis.	PRND	encephalopathies	23627	HP_0001298	25	29	97	113	False
22147650	Prion proteins (PRNP and PRND), known mostly for its involvement in neurodegenerative spongiform encephalopathies, have been recently demonstrated to be involved in resistance to apoptosis, tumorigenesis, proliferation, and metastasis.	PRNP	tumor	5621	HP_0002664	16	20	190	195	False
22147650	Prion proteins (PRNP and PRND), known mostly for its involvement in neurodegenerative spongiform encephalopathies, have been recently demonstrated to be involved in resistance to apoptosis, tumorigenesis, proliferation, and metastasis.	PRND	tumor	23627	HP_0002664	25	29	190	195	False
22147650	PRNP and PRND are significantly over-expressed in osteosarcoma.	PRNP	osteosarcoma	5621	HP_0002669	0	4	50	62	False
22147650	PRNP and PRND are significantly over-expressed in osteosarcoma.	PRND	osteosarcoma	23627	HP_0002669	9	13	50	62	False
22147650	PRNP and PRND appear involved with some important genes related to tumorigenesis and apoptosis.	PRNP	tumor	5621	HP_0002664	0	4	67	72	False
22147650	PRNP and PRND appear involved with some important genes related to tumorigenesis and apoptosis.	PRND	tumor	23627	HP_0002664	9	13	67	72	False
28657137	A single family with an autosomal recessive form of OFCS and a homozygous missense mutation in PAX1 gene has been described.	PAX1	autosomal recessive	5075	HP_0000007	95	99	24	43	True
28657137	This report provides evidence that bi-allelic null PAX1 mutations may lead to a multi-system autosomal recessive disorders, where SCID might represent the main feature	PAX1	autosomal recessive	5075	HP_0000007	51	55	93	112	True
24024198	Here, we report two novel GUCA1A (the gene for guanylate cyclase activating protein 1) mutations identified in unrelated Spanish families affected by autosomal dominant retinal degeneration (adRD) with cone and rod involvement.	GUCA1A	retinal degeneration	2978	HP_0000546	26	32	169	189	True
24024198	Here, we report two novel GUCA1A (the gene for guanylate cyclase activating protein 1) mutations identified in unrelated Spanish families affected by autosomal dominant retinal degeneration (adRD) with cone and rod involvement.	rod	retinal degeneration	9735	HP_0000546	211	214	169	189	False
30093657	We show that an inhaled PI3K inhibitor improves survival rates following S. pneumoniae infection in wild-type mice and in mice with activated PI3K.	mice	pneumonia	23581	HP_0002090	111	115	77	86	False
24135068	In a patient with clinical features of BOR syndrome, such as hearing loss, preauricular fistulas and facial dysmorphisms, but no renal anomalies, neither sequencing of the 3 genes linked to BOR syndrome nor array comparative genomic hybridization and MLPA were able to uncover a causative mutation.	BOR	hearing loss	55143	HP_0000365	39	42	61	73	False
24135068	In a patient with clinical features of BOR syndrome, such as hearing loss, preauricular fistulas and facial dysmorphisms, but no renal anomalies, neither sequencing of the 3 genes linked to BOR syndrome nor array comparative genomic hybridization and MLPA were able to uncover a causative mutation.	BOR	preauricular fistulas	55143	HP_0004467	39	42	75	96	False
24135068	In a patient with clinical features of BOR syndrome, such as hearing loss, preauricular fistulas and facial dysmorphisms, but no renal anomalies, neither sequencing of the 3 genes linked to BOR syndrome nor array comparative genomic hybridization and MLPA were able to uncover a causative mutation.	BOR	facial dysmorphisms	55143	HP_0001999	39	42	101	120	False
24135068	In a patient with clinical features of BOR syndrome, such as hearing loss, preauricular fistulas and facial dysmorphisms, but no renal anomalies, neither sequencing of the 3 genes linked to BOR syndrome nor array comparative genomic hybridization and MLPA were able to uncover a causative mutation.	BOR	renal anomalies	55143	HP_0000077	39	42	129	144	False
23828044	A branch-site mutation in the human gene encoding assembly factor NUBPL has recently been associated with mitochondrial encephalopathy and complex I deficiency in seven independent cases.	NUBPL	encephalopathy	80224	HP_0001298	66	71	120	134	False
26640080	Using whole-exome sequencing, we identified a homozygous acceptor splice-site mutation in intron 6 of the KATNB1 gene in a patient from a consanguineous Turkish family who presented with congenital microcephaly, lissencephaly, short stature, polysyndactyly, and dental abnormalities.	KATNB1	microcephaly	10300	HP_0000252	106	112	198	210	True
26640080	Using whole-exome sequencing, we identified a homozygous acceptor splice-site mutation in intron 6 of the KATNB1 gene in a patient from a consanguineous Turkish family who presented with congenital microcephaly, lissencephaly, short stature, polysyndactyly, and dental abnormalities.	KATNB1	lissencephaly	10300	HP_0001339	106	112	212	225	True
26640080	Using whole-exome sequencing, we identified a homozygous acceptor splice-site mutation in intron 6 of the KATNB1 gene in a patient from a consanguineous Turkish family who presented with congenital microcephaly, lissencephaly, short stature, polysyndactyly, and dental abnormalities.	KATNB1	short stature	10300	HP_0004322	106	112	227	240	False
26640080	Using whole-exome sequencing, we identified a homozygous acceptor splice-site mutation in intron 6 of the KATNB1 gene in a patient from a consanguineous Turkish family who presented with congenital microcephaly, lissencephaly, short stature, polysyndactyly, and dental abnormalities.	KATNB1	dental abnormalities	10300	HP_0000164	106	112	262	282	False
26640080	Homozygous and compound heterozygous mutations in KATNB1 have very recently been described as a cause of microcephaly with brain malformations and seizures.	KATNB1	microcephaly	10300	HP_0000252	50	56	105	117	True
26640080	Homozygous and compound heterozygous mutations in KATNB1 have very recently been described as a cause of microcephaly with brain malformations and seizures.	KATNB1	seizures	10300	HP_0001250	50	56	147	155	True
26640080	We extend the KATNB1 associated phenotype by describing a syndrome characterized by primordial dwarfism, lissencephaly, polysyndactyly, and dental anomalies, which is caused by a homozygous truncating KATNB1 mutation	KATNB1	lissencephaly	10300	HP_0001339	14	20	105	118	True
26640080	We extend the KATNB1 associated phenotype by describing a syndrome characterized by primordial dwarfism, lissencephaly, polysyndactyly, and dental anomalies, which is caused by a homozygous truncating KATNB1 mutation	KATNB1	dwarfism	10300	HP_0003510	14	20	95	103	False
26640080	We extend the KATNB1 associated phenotype by describing a syndrome characterized by primordial dwarfism, lissencephaly, polysyndactyly, and dental anomalies, which is caused by a homozygous truncating KATNB1 mutation	KATNB1	dental anomalies	10300	HP_0000164	14	20	140	156	False
26251042	Ectopic expression of Cx31 in mouse skin results in skin abnormalities resembling human EKV.	EKV	skin abnormalities	2707	HP_0000951	88	91	52	70	True
28033303	One presently identified eQTL for the PEX6 gene was rs10948059, which had been associated with prostate cancer from previous association studies.	PEX6	cancer	5190	HP_0002664	38	42	104	110	False
28033303	The results imply that variants associated with prostate cancer can be identified through expressional change in the PEX6 gene, but not in the overlapped glycine N-methyltransferase gene which had been considered as a candidate gene.Further studies are required to understand their underlying mechanisms for the strong eQTLs for the SNHG5 and PEX6 genes	PEX6	cancer	5190	HP_0002664	117	121	57	63	False
29376577	Citrin deficiency is an autosomal recessive metabolic disorder, which is caused by pathogenic mutations in the SLC25A13 gene on chromosome 7q21.3, as the causative gene that encodes the liver type aspartate/glutamate carrier isoform 2 (AGC2).	SLC25A13	autosomal recessive	10165	HP_0000007	111	119	24	43	True
29376577	Citrin deficiency is an autosomal recessive metabolic disorder, which is caused by pathogenic mutations in the SLC25A13 gene on chromosome 7q21.3, as the causative gene that encodes the liver type aspartate/glutamate carrier isoform 2 (AGC2).	type	autosomal recessive	6445	HP_0000007	192	196	24	43	True
27449533	We report a girl with consanguineous parents presenting as collodion baby with contractures of the great joints and palmoplantar hyperlinearity.	great	contractures	122042	HP_0001371	99	104	79	91	False
24535756	Testing for high-risk (hr) types of human papillomavirus (HPV) is highly sensitive as a screening test of high-grade cervical intraepithelial neoplastic (CIN2/3) disease, the precursor of cervical cancer.	type	cancer	6445	HP_0002664	27	31	197	203	False
28687971	We identified 16 of 53 participants (30%) with a pathogenic (P) or likely pathogenic (LP) variant that may be related to their hereditary pancreatic cancer predisposition; seven had mutations in genes associated with well-known cancer syndromes (13%) [ATM (2), BRCA2 (3), MSH2 (1), MSH6 (1)].	BRCA2	cancer	675	HP_0002664	261	266	149	155	True
28687971	We identified 16 of 53 participants (30%) with a pathogenic (P) or likely pathogenic (LP) variant that may be related to their hereditary pancreatic cancer predisposition; seven had mutations in genes associated with well-known cancer syndromes (13%) [ATM (2), BRCA2 (3), MSH2 (1), MSH6 (1)].	MSH2	cancer	4436	HP_0002664	272	276	149	155	True
28687971	We identified 16 of 53 participants (30%) with a pathogenic (P) or likely pathogenic (LP) variant that may be related to their hereditary pancreatic cancer predisposition; seven had mutations in genes associated with well-known cancer syndromes (13%) [ATM (2), BRCA2 (3), MSH2 (1), MSH6 (1)].	MSH6	cancer	2956	HP_0002664	282	286	149	155	True
28173120	To better understand the biological role of this factor, we generated Tmem70-deficient mice and found that the homozygous Tmem70-/- knockouts exhibited profound growth retardation and embryonic lethality at 9.5 days post coitum.	Tmem70	profound	54968	HP_0012829	70	76	152	160	False
28173120	To better understand the biological role of this factor, we generated Tmem70-deficient mice and found that the homozygous Tmem70-/- knockouts exhibited profound growth retardation and embryonic lethality at 9.5 days post coitum.	mice	profound	23581	HP_0012829	87	91	152	160	False
30582655	To decipher a mechanism for this, we previously generated a mathematical model of how estrogen-mediated upregulation of the transcription factor, E2F6, upregulates the ovarian cancer stem/initiating cell marker, c-Kit, by epigenetic silencing the tumor suppressor miR-193a, and a competing endogenous (ceRNA) mechanism.	c-Kit	cancer	3815	HP_0002664	212	217	176	182	True
30582655	To decipher a mechanism for this, we previously generated a mathematical model of how estrogen-mediated upregulation of the transcription factor, E2F6, upregulates the ovarian cancer stem/initiating cell marker, c-Kit, by epigenetic silencing the tumor suppressor miR-193a, and a competing endogenous (ceRNA) mechanism.	c-Kit	tumor	3815	HP_0002664	212	217	247	252	True
30582655	Interestingly, ChIP-PCR and bisulphite pyrosequencing showed that E2F6 also epigenetically suppresses miR-193a, through recruitment of EZH2, and by a complex ceRNA mechanism in ovarian cancer cell lines.	EZH2	cancer	2146	HP_0002664	135	139	185	191	False
30582655	Importantly, cell line and animal experiments both confirmed that E2F6 promotes ovarian cancer stemness, whereas E2F6 or EZH2 depletion derepressed miR-193a, which opposes cancer stemness, by alleviating DNA methylation and repressive chromatin.	EZH2	cancer	2146	HP_0002664	121	125	88	94	False
29198720	Using exome sequencing in a multiplex family and three simplex case subjects with an atypical association of LCA with early-onset hearing loss, we identified two heterozygous mutations affecting Arg391 in -tubulin 4B isotype-encoding (TUBB4B).	LCA	hearing loss	1211	HP_0000365	109	112	130	142	False
29198720	Using exome sequencing in a multiplex family and three simplex case subjects with an atypical association of LCA with early-onset hearing loss, we identified two heterozygous mutations affecting Arg391 in -tubulin 4B isotype-encoding (TUBB4B).	TUBB4B	hearing loss	10383	HP_0000365	236	242	130	142	False
30564368	Murine double minute 2 (MDM2) is the E3 ubiquitin ligase of the tumor suppressor gene, p53, and inhibition of MDM2 can suppress tumor cell growth.	MDM2	tumor	4193	HP_0002664	24	28	64	69	True
26100624	Study of RetGC1 regulation in vitro and its association with fluorescently tagged GCAP in transfected cells showed that R822P substitution in the cyclase dimerization domain causing congenital early onset blindness disrupted RetGC1 ability to bind GCAP but did not eliminate its affinity for another photoreceptor-specific protein, retinal degeneration 3 (RD3).	GCAP	blindness	2978	HP_0000618	82	86	205	214	False
26100624	Study of RetGC1 regulation in vitro and its association with fluorescently tagged GCAP in transfected cells showed that R822P substitution in the cyclase dimerization domain causing congenital early onset blindness disrupted RetGC1 ability to bind GCAP but did not eliminate its affinity for another photoreceptor-specific protein, retinal degeneration 3 (RD3).	GCAP	retinal degeneration	2978	HP_0000546	82	86	332	352	True
25857301	Among the proteins enriched in LO, cytokeratin 18 (CK18) was one of the most abundant (within the top 5th percentile) and was used to develop an assay to detect LO in the circulation and tissues of mice and patients with prostate cancer.	mice	cancer	23581	HP_0002664	198	202	230	236	False
25857301	These observations indicate that LO represent a discrete EV type that may play a distinct role in tumor progression and that may be a source of cancer-specific markers	type	cancer	6445	HP_0002664	60	64	144	150	False
25857301	These observations indicate that LO represent a discrete EV type that may play a distinct role in tumor progression and that may be a source of cancer-specific markers	type	tumor	6445	HP_0002664	60	64	98	103	False
28425625	Squamous cell carcinoma (SCC) is the most common cancer of the equine eye, frequently originating at the limbus, with the potential to invade the cornea, cause visual impairment, and result in loss of the eye.	SCC	cancer	6317	HP_0002664	25	28	49	55	False
28425625	Squamous cell carcinoma (SCC) is the most common cancer of the equine eye, frequently originating at the limbus, with the potential to invade the cornea, cause visual impairment, and result in loss of the eye.	SCC	visual impairment	6317	HP_0000505	25	28	160	177	False
28425625	Pedigree analysis in the Haflinger breed supports a simple recessive mode of inheritance and a genome-wide association study (N=23) identified a 1.5 Mb locus on ECA12 significantly associated with limbal SCC (P<sub>corrected</sub> = 0.04).	SCC	mode of inheritance	6317	HP_0000005	206	209	69	88	False
28425625	Pedigree analysis in the Haflinger breed supports a simple recessive mode of inheritance and a genome-wide association study (N=23) identified a 1.5 Mb locus on ECA12 significantly associated with limbal SCC (P<sub>corrected</sub> = 0.04).	simple	mode of inheritance	9516	HP_0000005	52	58	69	88	False
28425625	Furthermore, in humans xeroderma pigmentosum complementation group E, a disease characterized by sun sensitivity and increased risk of cutaneous SCC and melanomas, is explained by mutations in DDB2.	SCC	melanomas	6317	HP_0002861	145	148	153	162	False
28425625	Furthermore, in humans xeroderma pigmentosum complementation group E, a disease characterized by sun sensitivity and increased risk of cutaneous SCC and melanomas, is explained by mutations in DDB2.	DDB2	melanomas	1643	HP_0002861	193	197	153	162	True
28655712	Alterations in <i>MEK1/2</i> occur in cancers, both in the treatment-nave state and following targeted therapies, most notably BRAF and MEK inhibitors in <i>BRAF</i>-V600E-mutant melanoma and colorectal cancer.	BRAF	cancer	673	HP_0002664	128	132	38	44	True
28655712	This work highlights the importance of classifying mutations based on structural and phenotypic consequences, both in terms of pathway signaling output and response to pharmacologic inhibition.<b>Implications:</b> This study suggests that alternate modes of target inhibition, such as ERK inhibition, will be required to effectively treat tumors harboring these MEK1/2-resistant alleles.	ERK	tumors	2048	HP_0002664	285	288	339	345	False
26909801	Primary ciliary dyskinesia (PCD) is a recessively inherited disease that leads to chronic respiratory disorders owing to impaired mucociliary clearance.	PCD	ciliary dyskinesia	352909	HP_0012265	28	31	8	26	True
22752289	A majority of the familial breast cancer cases are not explained by mutations in the best-known high susceptibility genes BRCA1 and BRCA2.	best	cancer	7439	HP_0002664	85	89	34	40	False
22752289	A majority of the familial breast cancer cases are not explained by mutations in the best-known high susceptibility genes BRCA1 and BRCA2.	BRCA1	cancer	672	HP_0002664	122	127	34	40	True
25640947	Deleted in lung and esophageal cancer 1 (DLEC1) is a tumor suppressor gene with reduced transcriptional activity and promoter hypermethylation in various cancers, including colorectal cancer.	DLEC1	cancer	9940	HP_0002664	41	46	31	37	True
25640947	Deleted in lung and esophageal cancer 1 (DLEC1) is a tumor suppressor gene with reduced transcriptional activity and promoter hypermethylation in various cancers, including colorectal cancer.	DLEC1	tumor	9940	HP_0002664	41	46	53	58	True
26892341	RFT1-congenital disorder of glycosylation (CDG) syndrome, a recessive N-glycosylation disorder caused by mutation in the RFT1 gene, is a very rare subtype of CDG syndrome associated with deafness, developmental delay, and non-specific epilepsy.	RFT1	deafness	91869	HP_0000365	0	4	187	195	True
26892341	RFT1-congenital disorder of glycosylation (CDG) syndrome, a recessive N-glycosylation disorder caused by mutation in the RFT1 gene, is a very rare subtype of CDG syndrome associated with deafness, developmental delay, and non-specific epilepsy.	RFT1	developmental delay	91869	HP_0001263	0	4	197	216	True
26892341	RFT1-congenital disorder of glycosylation (CDG) syndrome, a recessive N-glycosylation disorder caused by mutation in the RFT1 gene, is a very rare subtype of CDG syndrome associated with deafness, developmental delay, and non-specific epilepsy.	RFT1	epilepsy	91869	HP_0001250	0	4	235	243	True
30036796	To further explore this, we investigated the associations of peripheral GR-1<sub>F</sub> methylation (52 CpGs) with the cortisol stress response (Trier Social Stress Test) and with childhood trauma in three independent studies (total N=241) including healthy controls, patients with schizophrenia and bipolar disorder and unaffected siblings of patients with one of these disorders.	GR	schizophrenia	2908	HP_0100753	72	74	285	298	False
28067412	Although CHH and other skeletal dysplasias caused by mutations in RMRP or POP1 are commonly cited as ribosomal biogenesis disorders, recent studies question this assumption.	POP1	skeletal dysplasia	11149	HP_0002652	74	78	23	41	False
30079398	Alterations of its normal function may contribute to two different phenotypes: juvenile amyotrophic lateral sclerosis (ALS 16) and distal hereditary motor neuropathies (dHMN).	ALS	distal	3483	HP_0012839	119	122	131	137	False
27164068	According to the Ottawa Heart Genomics Study genome-wide association study, a recent research identified that Q688 spastic paraplegia 7 (SPG7) variant is associated with CAD as it bypasses the regulation of tyrosine phosphorylation of AFG3L2 and enhances the processing and maturation of SPG7 protein.	CAD	spastic paraplegia	1677	HP_0001258	170	173	115	133	False
27164068	According to the Ottawa Heart Genomics Study genome-wide association study, a recent research identified that Q688 spastic paraplegia 7 (SPG7) variant is associated with CAD as it bypasses the regulation of tyrosine phosphorylation of AFG3L2 and enhances the processing and maturation of SPG7 protein.	SPG7	spastic paraplegia	6687	HP_0001258	137	141	115	133	True
27164068	According to the Ottawa Heart Genomics Study genome-wide association study, a recent research identified that Q688 spastic paraplegia 7 (SPG7) variant is associated with CAD as it bypasses the regulation of tyrosine phosphorylation of AFG3L2 and enhances the processing and maturation of SPG7 protein.	AFG3L2	spastic paraplegia	10939	HP_0001258	235	241	115	133	False
30486759	This is the first study to investigate the effect of vitamin D receptor ( VDR) gene single-nucleotide polymorphisms on the clinicopathologic features of papillary thyroid cancer in Turkey.	VDR	cancer	7421	HP_0002664	74	77	171	177	False
30486759	VDR gene polymorphisms BsmI, ApaI, and TaqI did not differ between the papillary thyroid cancer group and control group (p&gt;0.05, each).	VDR	cancer	7421	HP_0002664	0	3	89	95	False
30486759	The VDR gene FokI CT/TT genotype was associated with an increased papillary thyroid cancer risk (CT vs CC: odds ratio=1.71, 95% confidence interval=1.15-2.76, p=0.028; TT vs CC: odds ratio=2.44, 95% confidence interval=1.29-4.62, p=0.005; CT/TT vs CC: odds ratio=1.88, 95% confidence interval=1.20-2.96, p=0.006; CT/CC vs TT: odds ratio=1.80, 95% confidence interval=1.05-3.20, p=0.041).	VDR	cancer	7421	HP_0002664	4	7	84	90	False
30486759	VDR gene FokI T allele and TT genotype correlated with aggressiveness of papillary thyroid cancer; thus, FokI could be useful as a poor prognostic factor to assess the high risk of papillary thyroid cancer	VDR	cancer	7421	HP_0002664	0	3	91	97	False
30486759	VDR gene FokI T allele and TT genotype correlated with aggressiveness of papillary thyroid cancer; thus, FokI could be useful as a poor prognostic factor to assess the high risk of papillary thyroid cancer	VDR	aggressiveness	7421	HP_0000718	0	3	55	69	False
28526779	We report ten new patients from eight unrelated kindreds with DGKE nephropathy.	DGKE	nephropathy	8526	HP_0000112	62	66	67	78	False
28526779	In conclusion, we did not observe a clear genotype-phenotype correlation in patients with DGKE nephropathy, suggesting additional factors mediating phenotypic heterogeneity.	DGKE	nephropathy	8526	HP_0000112	90	94	95	106	False
28526779	In conclusion, we did not observe a clear genotype-phenotype correlation in patients with DGKE nephropathy, suggesting additional factors mediating phenotypic heterogeneity.	DGKE	heterogeneity	8526	HP_0001425	90	94	159	172	False
27798098	Among these, heterozygous mutations in NOBOX, a homeobox gene encoding a transcription factor expressed specifically by oocyte and granulosa cells within the ovary, have been reported in 6% of women with sporadic POI.	NOBOX	sporadic	135935	HP_0003745	39	44	205	213	False
29341862	To address this gap, we performed a longitudinal exome-wide association study to identify susceptibility loci for obesity and MetS in a Japanese population.	gap	obesity	5921	HP_0001513	16	19	114	121	False
29341862	The association of single nucleotide polymorphisms (SNPs) with body mass index (BMI) or the prevalence of obesity and MetS was examined in a generalized estimating equation model.	mass	obesity	2200	HP_0001513	68	72	106	113	False
29666340	The student's t-test was used to compare FOXP1 expression in the tumour and the adjacent normal tissues.	FOXP1	tumour	27086	HP_0002664	41	46	65	71	True
29666340	There was a significantly higher expression level of FOXP1 in the tumour than in the adjacent normal tissue (0.0052  0.0021 vs 0.0027  0.0018, P &lt; 0.001).	FOXP1	tumour	27086	HP_0002664	53	58	66	72	True
29666340	Patients with genotype AA were found to have remarkably higher FOXP1 expression in the tumour than those with genotype CC (P = 0.01).	FOXP1	tumour	27086	HP_0002664	63	68	87	93	True
22936811	We also functionally characterized two CaBP4 mutants that are associated with a congenital variant of human night blindness and other closely related nonstationary retinal diseases.	CaBP4	blindness	57010	HP_0000618	39	44	114	123	False
22936811	We also functionally characterized two CaBP4 mutants that are associated with a congenital variant of human night blindness and other closely related nonstationary retinal diseases.	CaBP4	retinal diseases	57010	HP_0000479	39	44	164	180	True
27767079	Moreover, we show that over-expression of PNPLA8 dramatically decreases hepatic steatosis through increased autophagy in hepatocytes of HFD-fed mice.	mice	steatosis	23581	HP_0001397	144	148	80	89	False
27767079	Moreover, we show that over-expression of PNPLA8 dramatically decreases hepatic steatosis through increased autophagy in hepatocytes of HFD-fed mice.	PNPLA8	steatosis	50640	HP_0001397	42	48	80	89	False
29084003	Furthermore, we identified some potential lung cancer driver genes, such as TBX2, MCM4, SLC2A1, BIRC5, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.	TBX2	cancer	6909	HP_0002664	76	80	47	53	False
29084003	Furthermore, we identified some potential lung cancer driver genes, such as TBX2, MCM4, SLC2A1, BIRC5, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.	MCM4	cancer	4173	HP_0002664	82	86	47	53	True
29084003	Furthermore, we identified some potential lung cancer driver genes, such as TBX2, MCM4, SLC2A1, BIRC5, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.	SLC2A1	cancer	6513	HP_0002664	88	94	47	53	False
29084003	Furthermore, we identified some potential lung cancer driver genes, such as TBX2, MCM4, SLC2A1, BIRC5, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.	BIRC5	cancer	332	HP_0002664	96	101	47	53	False
29084003	Furthermore, we identified some potential lung cancer driver genes, such as TBX2, MCM4, SLC2A1, BIRC5, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.	CDC20	cancer	991	HP_0002664	107	112	47	53	False
28384236	Complete identification of genes related to one type of cancer facilitates earlier diagnosis and effective treatments.	type	cancer	6445	HP_0002664	48	52	56	62	False
28739921	Malfunction of mutant AIPL1 proteins triggers a severe form of Leber congenital amaurosis and leads to blindness.	AIPL1	blindness	23746	HP_0000618	22	27	103	112	True
30272645	Familial hypercholesterolemia (FH) is mostly caused by low-density lipoprotein receptor (LDLR) mutations and results in an increased risk of early-onset cardiovascular disease due to marked elevation of LDL cholesterol (LDL-C) in blood.	LDLR	hypercholesterolemia	3949	HP_0003124	89	93	9	29	True
30272645	Familial hypercholesterolemia (FH) is mostly caused by low-density lipoprotein receptor (LDLR) mutations and results in an increased risk of early-onset cardiovascular disease due to marked elevation of LDL cholesterol (LDL-C) in blood.	LDLR	cardiovascular disease	3949	HP_0001626	89	93	153	175	True
30272645	Statins are the first line of lipid-lowering drugs for treating FH and other types of hypercholesterolemia, but new approaches are emerging, in particular PCSK9 antibodies, which are now being tested in clinical trials.	PCSK9	hypercholesterolemia	255738	HP_0003124	155	160	86	106	True
29445180	Here, we determine that non-canonical IKK-RelB pathway activation of KRAS-mutant tumor cells mediates MPE development and this is fueled by host-provided interleukin IL-1.	KRAS	tumor	3845	HP_0002664	70	74	82	87	True
29445180	Here, we determine that non-canonical IKK-RelB pathway activation of KRAS-mutant tumor cells mediates MPE development and this is fueled by host-provided interleukin IL-1.	RelB	tumor	5971	HP_0002664	43	47	82	87	False
29445180	Indeed, IKK is required for the MPE-competence of KRAS-mutant tumor cells by activating non-canonical NF-B signaling.	KRAS	tumor	3845	HP_0002664	51	55	63	68	True
29445180	Indeed, IKK is required for the MPE-competence of KRAS-mutant tumor cells by activating non-canonical NF-B signaling.	NF	tumor	23114	HP_0002664	103	105	63	68	False
29445180	Importantly, IL-1-mediated NF-B induction in KRAS-mutant tumor cells, as well as their resulting MPE-competence, can only be blocked by co-inhibition of both KRAS and IKK, a strategy that overcomes drug resistance to individual treatments.	KRAS	tumor	3845	HP_0002664	47	51	59	64	True
29445180	Importantly, IL-1-mediated NF-B induction in KRAS-mutant tumor cells, as well as their resulting MPE-competence, can only be blocked by co-inhibition of both KRAS and IKK, a strategy that overcomes drug resistance to individual treatments.	NF	tumor	23114	HP_0002664	28	30	59	64	False
29445180	Hence we show that mutant KRAS facilitates IKK-mediated responsiveness of tumor cells to host IL-1, thereby establishing a host-to-tumor signaling circuit that culminates in inflammatory MPE development and drug resistance	KRAS	tumor	3845	HP_0002664	26	30	75	80	True
29945973	Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a neurodegenerative disease that is caused by mutations in the <i>SACS</i> gene.	ARSACS	ataxia	26278	HP_0001251	59	65	28	34	True
28687526	Heterozygous missense mutations in ANK3 have been associated with autism spectrum disorder.	ANK3	autism	288	HP_0000717	35	39	66	72	False
26340902	We use the BMI- and obesity-associated FTO locus as a subject as it poses an illustrative example on the value of these resources.	FTO	obesity	79068	HP_0001513	39	42	20	27	True
23561899	Crizotinib is a small orally-administered ALK inhibitor for patients with non-small cell lung cancer with EML4-ALK rearrangement (echinoderm microtubule-associated protein-like 4 and anaplastic lymphoma kinase).	ALK	cancer	238	HP_0002664	42	45	94	100	True
23561899	Crizotinib is a small orally-administered ALK inhibitor for patients with non-small cell lung cancer with EML4-ALK rearrangement (echinoderm microtubule-associated protein-like 4 and anaplastic lymphoma kinase).	EML4	cancer	27436	HP_0002664	106	110	94	100	False
24463884	Mutations in the photoreceptor tetraspanin gene peripherin-2/retinal degeneration slow (PRPH2/RDS) cause both rod- and cone-dominant diseases.	RDS	retinal degeneration	5961	HP_0000546	94	97	61	81	True
24463884	Mutations in the photoreceptor tetraspanin gene peripherin-2/retinal degeneration slow (PRPH2/RDS) cause both rod- and cone-dominant diseases.	rod	retinal degeneration	9735	HP_0000546	110	113	61	81	False
24463884	Here we took advantage of a transgenic mouse line expressing an RDS mutant (R172W) known to cause macular degeneration (MD) in humans.	RDS	macular degeneration	5961	HP_0000608	64	67	98	118	True
24463884	Fundus imaging demonstrated that R172W mice developed severe clinical signs of disease nearly identical to those seen in human MD patients, including retinal degeneration, retinal pigment epithlium (RPE) defects and loss of the choriocapillaris.	mice	retinal degeneration	23581	HP_0000546	39	43	150	170	False
24463884	Fundus imaging demonstrated that R172W mice developed severe clinical signs of disease nearly identical to those seen in human MD patients, including retinal degeneration, retinal pigment epithlium (RPE) defects and loss of the choriocapillaris.	RPE	retinal degeneration	6120	HP_0000546	199	202	150	170	False
30261661	Fc-gamma receptor-IIb (FcRIIb) and its ligand are reported to be associated with obesity and type 2 diabetes mellitus (T2DM).	gamma	obesity	9913	HP_0001513	3	8	82	89	False
30261661	Fc-gamma receptor-IIb (FcRIIb) and its ligand are reported to be associated with obesity and type 2 diabetes mellitus (T2DM).	type	obesity	6445	HP_0001513	94	98	82	89	False
30702631	A risk score of 4, 4, 6, 6, 7, or 6 was assigned to diabetes, baseline estimated GFR&lt;45mL/min/1.73m, hypertension, repeated contrast exposure, congestive heart failure, and persistent renal injury (defined as an elevation of serum creatinine 25% at 3 months), respectively.	GFR	hypertension	9771	HP_0000822	81	84	108	120	False
30702631	A risk score of 4, 4, 6, 6, 7, or 6 was assigned to diabetes, baseline estimated GFR&lt;45mL/min/1.73m, hypertension, repeated contrast exposure, congestive heart failure, and persistent renal injury (defined as an elevation of serum creatinine 25% at 3 months), respectively.	GFR	congestive heart failure	9771	HP_0001635	81	84	150	174	False
28930697	We investigate the association of MUC1 with castration-resistant prostate cancer (CRPC), bone metastasis, and PC recurrence.	MUC1	cancer	4582	HP_0002664	34	38	74	80	False
29141310	A case with GABRB3 (C.905A&gt;G) had seizure controlled for 3 mouths.	GABRB3	seizure	2562	HP_0001250	12	18	37	44	True
29141310	A case with ARX (C.700G&gt;A) had seizure controlled for 6 mouths.	ARX	seizure	10054	HP_0001250	12	15	34	41	False
29742177	Downregulation of -actinin-1 in E-cadherin expressing basal-like breast cancer cells demonstrate that -actinin-1-assembled actin fibers destabilize E-cadherin-based adhesions.	cadherin	cancer	1015	HP_0002664	35	43	73	79	False
29742177	Taken together, these results indicate that increased -actinin-1 expression destabilizes E-cadherin-based adhesions, which is likely to promote the migratory potential of breast cancer cells.	cadherin	cancer	1015	HP_0002664	92	100	179	185	False
23894477	Since microtubule severing is an important cellular mechanism of which malfunctions result in serious diseases such as spastic paraplegia, Alzheimer's disease and cell cycle related disorders, identification of KATNB1 transcriptional regulation is crucial in understanding the coordination of microtubule severing activity by different proteins in the cells.	KATNB1	paraplegia	10300	HP_0010550	211	217	127	137	False
29031008	TRAPPC9 gene mutations have been linked recently to autosomal recessive mental retardation 13 (MRT13; MIM#613192) with only eight families reported world-wide.	MRT13	autosomal recessive	83696	HP_0000007	95	100	52	71	True
29031008	TRAPPC9 gene mutations have been linked recently to autosomal recessive mental retardation 13 (MRT13; MIM#613192) with only eight families reported world-wide.	TRAPPC9	autosomal recessive	83696	HP_0000007	0	7	52	71	True
29031008	Mutations in TRAPPC9 should be considered in non-syndromic autosomal recessive intellectual disability with severe speech disorder	TRAPPC9	autosomal recessive	83696	HP_0000007	13	20	59	78	True
29031008	Mutations in TRAPPC9 should be considered in non-syndromic autosomal recessive intellectual disability with severe speech disorder	TRAPPC9	intellectual disability	83696	HP_0001249	13	20	79	102	True
29044474	We confirmed that this nonsense MYO6 mutation segregated with deafness in this family.	MYO6	deafness	4646	HP_0000365	32	36	62	70	True
29044474	In conclusion, we described a novel nonsense MYO6 mutation that was responsible for the hearing loss in a Brazilian family.	MYO6	hearing loss	4646	HP_0000365	45	49	88	100	True
30320371	Helicaselike transcription factor (HLTF) has been identified as a tumor suppressor gene.	HLTF	tumor	6596	HP_0002664	36	40	67	72	False
30320371	The hypermethylation of HTLF is frequently observed in various types of cancer, including colorectal cancer(CRC).	HTLF	cancer	3344	HP_0002664	24	28	72	78	False
29951696	Polymorphisms in the MED13L gene have been linked to congenital heart anomalies and intellectual disabilities.	MED13L	intellectual disabilities	23389	HP_0001249	21	27	84	109	True
29109788	Our data indicate that 5-hmC might serve as a metastasis marker for cancer and that the decreased expression of LSH is likely one of the mechanisms of genome instability underlying 5-hmC loss in cancer	LSH	cancer	3070	HP_0002664	112	115	68	74	False
27751317	Genetic workup confirmed the clinical diagnosis of camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome CACP syndrome and also revealed a rare mutation in the causative gene	CACP	camptodactyly	10216	HP_0012385	101	105	51	64	True
30723593	Indeed, we have previously reported that a vaccine comprises allogeneic murine embryonic stem cells (ESCs) and murine fibroblasts expressing GM-CSF (to amplify immune responses) successfully blocks the outgrowth of an implantable cancer (Lewis lung carcinoma; LLC) and lung tumors generated in mice using a combination of a mutagen followed by chronic pulmonary inflammation.	GM-CSF	tumors	1437	HP_0002664	141	147	274	280	False
30723593	Indeed, we have previously reported that a vaccine comprises allogeneic murine embryonic stem cells (ESCs) and murine fibroblasts expressing GM-CSF (to amplify immune responses) successfully blocks the outgrowth of an implantable cancer (Lewis lung carcinoma; LLC) and lung tumors generated in mice using a combination of a mutagen followed by chronic pulmonary inflammation.	mice	tumors	23581	HP_0002664	294	298	274	280	False
30723593	Indeed, we have previously reported that a vaccine comprises allogeneic murine embryonic stem cells (ESCs) and murine fibroblasts expressing GM-CSF (to amplify immune responses) successfully blocks the outgrowth of an implantable cancer (Lewis lung carcinoma; LLC) and lung tumors generated in mice using a combination of a mutagen followed by chronic pulmonary inflammation.	GM-CSF	cancer	1437	HP_0002664	141	147	230	236	False
30723593	Indeed, we have previously reported that a vaccine comprises allogeneic murine embryonic stem cells (ESCs) and murine fibroblasts expressing GM-CSF (to amplify immune responses) successfully blocks the outgrowth of an implantable cancer (Lewis lung carcinoma; LLC) and lung tumors generated in mice using a combination of a mutagen followed by chronic pulmonary inflammation.	mice	cancer	23581	HP_0002664	294	298	230	236	False
30723593	Examination of tumor-infiltrating immune cells from mice vaccinated with the GM-CSF-expressing exosomes showed robust tumor-reactive CD8<sup>+</sup> T effector responses, Th1 cytokine responses, and higher CD8<sup>+</sup> T effector/CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> T regulatory cell ratio in the tumors.	GM-CSF	tumors	1437	HP_0002664	77	83	313	319	False
30723593	Examination of tumor-infiltrating immune cells from mice vaccinated with the GM-CSF-expressing exosomes showed robust tumor-reactive CD8<sup>+</sup> T effector responses, Th1 cytokine responses, and higher CD8<sup>+</sup> T effector/CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> T regulatory cell ratio in the tumors.	mice	tumors	23581	HP_0002664	52	56	313	319	False
30723593	Examination of tumor-infiltrating immune cells from mice vaccinated with the GM-CSF-expressing exosomes showed robust tumor-reactive CD8<sup>+</sup> T effector responses, Th1 cytokine responses, and higher CD8<sup>+</sup> T effector/CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> T regulatory cell ratio in the tumors.	GM-CSF	tumor	1437	HP_0002664	77	83	15	20	False
30723593	Examination of tumor-infiltrating immune cells from mice vaccinated with the GM-CSF-expressing exosomes showed robust tumor-reactive CD8<sup>+</sup> T effector responses, Th1 cytokine responses, and higher CD8<sup>+</sup> T effector/CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> T regulatory cell ratio in the tumors.	mice	tumor	23581	HP_0002664	52	56	15	20	False
30262717	Importantly, the role of sexual dimorphism in the genetic regulation of obesity and body fat distribution was also reported in a few studies.	fat	obesity	948	HP_0001513	89	92	72	79	False
25620207	Keppen-Lubinsky syndrome (KPLBS) is a rare disease mainly characterized by severe developmental delay and intellectual disability, microcephaly, large prominent eyes, a narrow nasal bridge, a tented upper lip, a high palate, an open mouth, tightly adherent skin, an aged appearance, and severe generalized lipodystrophy.	lip	developmental delay	23049	HP_0001263	205	208	82	101	False
25620207	Keppen-Lubinsky syndrome (KPLBS) is a rare disease mainly characterized by severe developmental delay and intellectual disability, microcephaly, large prominent eyes, a narrow nasal bridge, a tented upper lip, a high palate, an open mouth, tightly adherent skin, an aged appearance, and severe generalized lipodystrophy.	lip	intellectual disability	23049	HP_0001249	205	208	106	129	False
25620207	Keppen-Lubinsky syndrome (KPLBS) is a rare disease mainly characterized by severe developmental delay and intellectual disability, microcephaly, large prominent eyes, a narrow nasal bridge, a tented upper lip, a high palate, an open mouth, tightly adherent skin, an aged appearance, and severe generalized lipodystrophy.	lip	microcephaly	23049	HP_0000252	205	208	131	143	False
25620207	Keppen-Lubinsky syndrome (KPLBS) is a rare disease mainly characterized by severe developmental delay and intellectual disability, microcephaly, large prominent eyes, a narrow nasal bridge, a tented upper lip, a high palate, an open mouth, tightly adherent skin, an aged appearance, and severe generalized lipodystrophy.	lip	prominent eyes	23049	HP_0000520	205	208	151	165	False
25620207	Keppen-Lubinsky syndrome (KPLBS) is a rare disease mainly characterized by severe developmental delay and intellectual disability, microcephaly, large prominent eyes, a narrow nasal bridge, a tented upper lip, a high palate, an open mouth, tightly adherent skin, an aged appearance, and severe generalized lipodystrophy.	lip	high palate	23049	HP_0000218	205	208	212	223	False
26212640	The tumor suppressor gene TP53 is mutated exclusively with the HYDIN, KRAS, and PTEN genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.	HYDIN	tumor	54768	HP_0002664	63	68	4	9	False
26212640	The tumor suppressor gene TP53 is mutated exclusively with the HYDIN, KRAS, and PTEN genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.	KRAS	tumor	3845	HP_0002664	70	74	4	9	True
26212640	The tumor suppressor gene TP53 is mutated exclusively with the HYDIN, KRAS, and PTEN genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.	PTEN	tumor	5728	HP_0002664	80	84	4	9	True
26212640	The tumor suppressor gene TP53 is mutated exclusively with the HYDIN, KRAS, and PTEN genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.	HYDIN	cancer	54768	HP_0002664	63	68	133	139	False
26212640	The tumor suppressor gene TP53 is mutated exclusively with the HYDIN, KRAS, and PTEN genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.	KRAS	cancer	3845	HP_0002664	70	74	133	139	True
26212640	The tumor suppressor gene TP53 is mutated exclusively with the HYDIN, KRAS, and PTEN genes in large intestine, lung, and endometrial cancers respectively, indicating that TP53 takes part in different signaling pathways in different cancers.	PTEN	cancer	5728	HP_0002664	80	84	133	139	True
30041243	The revision was based on data accumulated since the 2008 WHO classification of MDS, much of which relates to new molecular genetic information about these neoplasms.	MDS	neoplasms	5048	HP_0002664	80	83	156	165	False
28490573	In ALS, motor neuron degeneration first becomes evident at the motor nerve terminals in neuromuscular junctions (NMJs), the cholinergic synapse between motor neuron and skeletal muscle; degeneration then progresses proximally, implicating the NMJ as a therapeutic target.	ALS	motor neuron degeneration	3483	HP_0007373	3	6	8	33	False
23586047	Further inference was found in the tumor suppression gene, p53, with a new hypothesis of including the bovine PKM2 pathways for targeting the glycolysis preference in many types of cancerous cells, consistent with quantum metabolism models.	PKM2	tumor	5315	HP_0002664	110	114	35	40	False
24697219	EEF1A2 gene is highly expressed in the central nervous system and Eef1a2 knockout mice show the neuronal degeneration.	Eef1a2	central	1917	HP_0030645	66	72	39	46	False
24697219	EEF1A2 gene is highly expressed in the central nervous system and Eef1a2 knockout mice show the neuronal degeneration.	mice	central	23581	HP_0030645	82	86	39	46	False
24697219	EEF1A2 gene is highly expressed in the central nervous system and Eef1a2 knockout mice show the neuronal degeneration.	EEF1A2	central	1917	HP_0030645	0	6	39	46	False
29864623	There is growing evidence shown that microRNAs (miRNAs) are associated with cancer and can play a role in human cancers as oncogenes or tumor suppressor genes.	miR	cancer	220972	HP_0002664	48	51	76	82	False
29864623	There is growing evidence shown that microRNAs (miRNAs) are associated with cancer and can play a role in human cancers as oncogenes or tumor suppressor genes.	miR	tumor	220972	HP_0002664	48	51	136	141	False
29864623	MicroRNA-214 (miR-214) shows carcinogenesis in various tumor types, but little is known about biological functions of miR-214 in esophageal squamous cell carcinoma (ESCC).	miR	tumor	220972	HP_0002664	14	17	55	60	False
29864623	MicroRNA-214 (miR-214) shows carcinogenesis in various tumor types, but little is known about biological functions of miR-214 in esophageal squamous cell carcinoma (ESCC).	miR	squamous cell carcinoma	220972	HP_0002860	14	17	140	163	False
29864623	In addition, the expression of miR-214 inhibited proliferation of ESCC cells in vitro and inhibit the growth of xenograft tumor in vivo.	miR	tumor	220972	HP_0002664	31	34	122	127	False
29864623	The results show miR-214 serve as a tumor promoter regulating cells migration, invasion and apoptosis in ESCC.	miR	tumor	220972	HP_0002664	17	20	36	41	False
29864623	In summary, these results suggest that miR-214 serves as tumor promoter to promote proliferation, migration, invasion and inhibit apoptosis of ESCC cells by targeting LZTS1 via PI3K/AKT/mTOR signaling pathway.	miR	tumor	220972	HP_0002664	39	42	57	62	False
29864623	In summary, these results suggest that miR-214 serves as tumor promoter to promote proliferation, migration, invasion and inhibit apoptosis of ESCC cells by targeting LZTS1 via PI3K/AKT/mTOR signaling pathway.	LZTS1	tumor	11178	HP_0002664	167	172	57	62	True
23946133	This study was undertaken to investigate the prevalence of sequence variants in LCA5 in patients with Leber congenital amaurosis (LCA), early-onset retinal dystrophy (EORD), and autosomal recessive retinitis pigmentosa (arRP); to delineate the ocular phenotypes; and to provide an overview of all published LCA5 variants in an online database.	LCA5	retinal dystrophy	167691	HP_0000556	80	84	148	165	False
23946133	This study was undertaken to investigate the prevalence of sequence variants in LCA5 in patients with Leber congenital amaurosis (LCA), early-onset retinal dystrophy (EORD), and autosomal recessive retinitis pigmentosa (arRP); to delineate the ocular phenotypes; and to provide an overview of all published LCA5 variants in an online database.	LCA	retinal dystrophy	1211	HP_0000556	130	133	148	165	False
23946133	This study was undertaken to investigate the prevalence of sequence variants in LCA5 in patients with Leber congenital amaurosis (LCA), early-onset retinal dystrophy (EORD), and autosomal recessive retinitis pigmentosa (arRP); to delineate the ocular phenotypes; and to provide an overview of all published LCA5 variants in an online database.	LCA5	autosomal recessive	167691	HP_0000007	80	84	178	197	True
23946133	This study was undertaken to investigate the prevalence of sequence variants in LCA5 in patients with Leber congenital amaurosis (LCA), early-onset retinal dystrophy (EORD), and autosomal recessive retinitis pigmentosa (arRP); to delineate the ocular phenotypes; and to provide an overview of all published LCA5 variants in an online database.	LCA	autosomal recessive	1211	HP_0000007	130	133	178	197	False
23946133	Mutations in LCA5 are a rare cause of childhood retinal dystrophy accounting for 2% of disease in this cohort, and the majority of LCA5 mutations are likely null.	LCA5	retinal dystrophy	167691	HP_0000556	13	17	48	65	False
30565239	One hundred and forty-eight CTLA4 mutation carriers have been reported; patients showed hypogammaglobulinemia, recurrent infectious diseases, various autoimmune diseases, and lymphocytic infiltration into multiple organs.	CTLA4	hypogammaglobulinemia	1493	HP_0004313	28	33	88	109	True
28939041	The overexpression of PARIS selectively leads to the loss of dopaminergic neurons (DN) and mitochondrial abnormalities in the substantia nigra (SN) of Parkinson's disease (PD) models.	PARIS	mitochondrial	155061	HP_0001427	22	27	91	104	False
28939041	The overexpression of PARIS selectively leads to the loss of dopaminergic neurons (DN) and mitochondrial abnormalities in the substantia nigra (SN) of Parkinson's disease (PD) models.	SN	mitochondrial	7857	HP_0001427	144	146	91	104	False
25255716	Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disease of the cerebellum caused by a polyglutamine-repeat expansion in the protein ATXN1.	type	ataxia	6445	HP_0001251	23	27	16	22	False
25255716	Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disease of the cerebellum caused by a polyglutamine-repeat expansion in the protein ATXN1.	SCA1	ataxia	6310	HP_0001251	31	35	16	22	True
25255716	Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disease of the cerebellum caused by a polyglutamine-repeat expansion in the protein ATXN1.	ATXN1	ataxia	6310	HP_0001251	165	170	16	22	True
28298625	Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in FAM20A, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.	FAM20A	nephrocalcinosis	54757	HP_0000121	112	118	140	156	True
28298625	Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in FAM20A, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.	type	nephrocalcinosis	6445	HP_0000121	212	216	140	156	False
28298625	Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in FAM20A, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.	FAM20A	nephrolithiasis	54757	HP_0000787	112	118	158	173	False
28298625	Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in FAM20A, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.	type	nephrolithiasis	6445	HP_0000787	212	216	158	173	False
28298625	Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in FAM20A, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.	FAM20A	gingival fibromatosis	54757	HP_0000169	112	118	218	239	False
28298625	Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in FAM20A, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.	type	gingival fibromatosis	6445	HP_0000169	212	216	218	239	False
28298625	Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in FAM20A, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.	FAM20A	dental abnormalities	54757	HP_0000164	112	118	250	270	True
28298625	Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in FAM20A, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.	type	dental abnormalities	6445	HP_0000164	212	216	250	270	False
28298625	Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in FAM20A, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.	FAM20A	hypodontia	54757	HP_0000668	112	118	282	292	False
28298625	Enamel-renal-gingival syndrome (ERGS; OMIM #204690), a rare autosomal recessive disorder caused by mutations in FAM20A, is characterized by nephrocalcinosis, nephrolithiasis, amelogenesis imperfecta, hypoplastic type, gingival fibromatosis and other dental abnormalities, including hypodontia and unerupted teeth with large dental follicles.	type	hypodontia	6445	HP_0000668	212	216	282	292	False
29637450	To explore the relationship between NF2 promoter gene mutation and the risk of medulloblastomas (MBs).	MBs	medulloblastomas	4659	HP_0002885	97	100	79	95	False
29484414	However, few studies are available on the expression and clinical significance of Raf1 in nonsmall cell lung cancer (NSCLC).	Raf1	cancer	5894	HP_0002664	82	86	110	116	True
29484414	Signicant associations between Raf1 expression and invasion and metastasis capability in lung cancer A549 and H1299 cell lines were identied.	Raf1	cancer	5894	HP_0002664	32	36	95	101	True
29339485	In a mouse model of colitis-associated colon cancer (CAC), urine level of D2HG during colitis correlates positively with subsequent polyp counts and severity of dysplasia.	CAC	cancer	788	HP_0002664	53	56	45	51	False
29339485	The colonic expression of D2HGDH is decreased in ulcerative colitis (UC) patients at baseline who progress to cancer.	D2HGDH	cancer	728294	HP_0002664	26	32	110	116	False
29339485	Our study identifies urine D2HG and tissue D2HGDH expression as biomarkers to identify patients at risk for progressing from colitis to cancer.	D2HGDH	cancer	728294	HP_0002664	43	49	136	142	False
29165358	Thus, it is clear that a more complex genetic network of cancer-associated genes than previously hypothesized is involved in BCC carcinogenesis, with a potential impact on the development of new molecular targeted therapies.	impact	cancer	55364	HP_0002664	162	168	57	63	False
30185235	Pediatric refractory epilepsy is a broad phenotypic spectrum with great genetic heterogeneity.	great	epilepsy	122042	HP_0001250	66	71	21	29	False
30185235	Pediatric refractory epilepsy is a broad phenotypic spectrum with great genetic heterogeneity.	great	heterogeneity	122042	HP_0001425	66	71	80	93	False
30185235	Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.	SCN8A	epilepsy	6334	HP_0001250	77	82	47	55	True
30185235	Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.	CACNA1A	epilepsy	773	HP_0001250	84	91	47	55	True
30185235	Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.	GABRB3	epilepsy	2562	HP_0001250	93	99	47	55	True
30185235	Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.	GABRA1	epilepsy	2554	HP_0001250	101	107	47	55	True
30185235	Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.	IQSEC2	epilepsy	23096	HP_0001250	109	115	47	55	True
30185235	Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.	TSC1	epilepsy	7248	HP_0001250	117	121	47	55	True
30185235	Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.	VRK2	epilepsy	7444	HP_0001250	123	127	47	55	False
30185235	Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.	ATP1A2	epilepsy	477	HP_0001250	129	135	47	55	True
30185235	Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.	PCDH19	epilepsy	57526	HP_0001250	137	143	47	55	True
30185235	Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.	SLC9A6	epilepsy	10479	HP_0001250	145	151	47	55	True
30185235	Other novel mutations detected in unclassified epilepsy patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, TSC1, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.	CHD2	epilepsy	1106	HP_0001250	156	160	47	55	True
29562234	Proteomic analysis of 12 tumours from an mTOR-driven hepatocellular carcinoma mouse model revealed that NME1 and NME2, the only known mammalian histidine kinases, were upregulated.	mTOR	tumours	2475	HP_0002664	41	45	25	32	False
29562234	Proteomic analysis of 12 tumours from an mTOR-driven hepatocellular carcinoma mouse model revealed that NME1 and NME2, the only known mammalian histidine kinases, were upregulated.	NME1	tumours	4830	HP_0002664	104	108	25	32	True
29562234	Proteomic analysis of 12 tumours from an mTOR-driven hepatocellular carcinoma mouse model revealed that NME1 and NME2, the only known mammalian histidine kinases, were upregulated.	NME2	tumours	4831	HP_0002664	113	117	25	32	False
29562234	Proteomic analysis of 12 tumours from an mTOR-driven hepatocellular carcinoma mouse model revealed that NME1 and NME2, the only known mammalian histidine kinases, were upregulated.	mTOR	hepatocellular carcinoma	2475	HP_0001402	41	45	53	77	False
29562234	Proteomic analysis of 12 tumours from an mTOR-driven hepatocellular carcinoma mouse model revealed that NME1 and NME2, the only known mammalian histidine kinases, were upregulated.	NME1	hepatocellular carcinoma	4830	HP_0001402	104	108	53	77	False
29562234	Proteomic analysis of 12 tumours from an mTOR-driven hepatocellular carcinoma mouse model revealed that NME1 and NME2, the only known mammalian histidine kinases, were upregulated.	NME2	hepatocellular carcinoma	4831	HP_0001402	113	117	53	77	False
29562234	Conversely, expression of the putative histidine phosphatase LHPP was downregulated specifically in the tumours.	LHPP	tumours	64077	HP_0002664	61	65	104	111	False
29562234	Sustained, hepatic expression of LHPP in the hepatocellular carcinoma mouse model reduced tumour burden and prevented the loss of liver function.	LHPP	hepatocellular carcinoma	64077	HP_0001402	33	37	45	69	False
29562234	Sustained, hepatic expression of LHPP in the hepatocellular carcinoma mouse model reduced tumour burden and prevented the loss of liver function.	LHPP	tumour	64077	HP_0002664	33	37	90	96	False
29562234	Finally, in patients with hepatocellular carcinoma, low expression of LHPP correlated with increased tumour severity and reduced overall survival.	LHPP	hepatocellular carcinoma	64077	HP_0001402	70	74	26	50	False
29562234	Finally, in patients with hepatocellular carcinoma, low expression of LHPP correlated with increased tumour severity and reduced overall survival.	LHPP	tumour	64077	HP_0002664	70	74	101	107	False
29562234	Thus, LHPP is a protein histidine phosphatase and tumour suppressor, suggesting that deregulated histidine phosphorylation is oncogenic	LHPP	tumour	64077	HP_0002664	6	10	50	56	False
23812039	Nuclear receptor small heterodimer partner (SHP/Nr0b2) is a hepatic tumor suppressor and a critical regulator of liver function.	SHP	tumor	8431	HP_0002664	44	47	68	73	False
25142535	We report on the case of a 77-year-old male with genetically proven spinocerebellar ataxia type 31 (SCA31) who had dystonia.	type	ataxia	6445	HP_0001251	91	95	84	90	False
25142535	We report on the case of a 77-year-old male with genetically proven spinocerebellar ataxia type 31 (SCA31) who had dystonia.	SCA31	ataxia	146227	HP_0001251	100	105	84	90	True
25142535	We report on the case of a 77-year-old male with genetically proven spinocerebellar ataxia type 31 (SCA31) who had dystonia.	type	dystonia	6445	HP_0001332	91	95	115	123	False
25142535	We report on the case of a 77-year-old male with genetically proven spinocerebellar ataxia type 31 (SCA31) who had dystonia.	SCA31	dystonia	146227	HP_0001332	100	105	115	123	False
25142535	On the basis of his symptoms, we diagnosed him as spinocerebellar degeneration (SCD), and prescribed taltirelin hydrate.	SCD	spinocerebellar degeneration	6584	HP_0002503	80	83	50	78	False
25142535	And left hallux moved involuntarily toward the top surface of the foot at rest, that is dystonia.	rest	dystonia	5978	HP_0001332	74	78	88	96	False
25142535	Previously there have been no reports of SCA31 associated with dystonia.	SCA31	dystonia	146227	HP_0001332	41	46	63	71	False
25142535	Our case report support clinical heterogeneity of SCA31, and highlight the importance of considering this type in patients with dystonia and ataxia.	type	ataxia	6445	HP_0001251	106	110	141	147	False
25142535	Our case report support clinical heterogeneity of SCA31, and highlight the importance of considering this type in patients with dystonia and ataxia.	SCA31	ataxia	146227	HP_0001251	50	55	141	147	True
25142535	Our case report support clinical heterogeneity of SCA31, and highlight the importance of considering this type in patients with dystonia and ataxia.	type	dystonia	6445	HP_0001332	106	110	128	136	False
25142535	Our case report support clinical heterogeneity of SCA31, and highlight the importance of considering this type in patients with dystonia and ataxia.	SCA31	dystonia	146227	HP_0001332	50	55	128	136	False
25142535	Our case report support clinical heterogeneity of SCA31, and highlight the importance of considering this type in patients with dystonia and ataxia.	type	heterogeneity	6445	HP_0001425	106	110	33	46	False
25142535	Our case report support clinical heterogeneity of SCA31, and highlight the importance of considering this type in patients with dystonia and ataxia.	SCA31	heterogeneity	146227	HP_0001425	50	55	33	46	False
25142535	Patients with the combination of dystonia and ataxia and a family history of a neurodegenerative disorder should be tested for SCA31.	SCA31	ataxia	146227	HP_0001251	127	132	46	52	True
25142535	Patients with the combination of dystonia and ataxia and a family history of a neurodegenerative disorder should be tested for SCA31.	SCA31	dystonia	146227	HP_0001332	127	132	33	41	False
28463998	Infantile cerebellar-retinal degeneration associated with mutations in the mitochondrial aconitase 2 gene (ACO2) has been recently described as a neurodegenerative disease of autosomal recessive inheritance.	ACO2	neurodegenerative disease	50	HP_0002180	107	111	146	171	False
28463998	Infantile cerebellar-retinal degeneration associated with mutations in the mitochondrial aconitase 2 gene (ACO2) has been recently described as a neurodegenerative disease of autosomal recessive inheritance.	ACO2	autosomal recessive inheritance	50	HP_0000007	107	111	175	206	True
12827610	PKP1 and PKP3 immunoreactivity was inversely correlated with tumor histological grade and was observed only in tumors that did not metastasize.	PKP1	tumor	5317	HP_0002664	0	4	61	66	False
12827610	PKP1 and PKP3 immunoreactivity was inversely correlated with tumor histological grade and was observed only in tumors that did not metastasize.	PKP3	tumor	11187	HP_0002664	9	13	61	66	False
12827610	In contrast, strong PKP2 immunoreactivity was observed in 85.7% of metastatic tumors.	PKP2	tumor	5318	HP_0002664	20	24	78	83	False
12827610	Interestingly, patients with tumors in which PKP1 and PKP3 immunoreactivity was reduced or absent exhibited local recurrences or metastases, or both, as well as poor survival.	PKP1	tumor	5317	HP_0002664	45	49	29	34	False
12827610	Interestingly, patients with tumors in which PKP1 and PKP3 immunoreactivity was reduced or absent exhibited local recurrences or metastases, or both, as well as poor survival.	PKP3	tumor	11187	HP_0002664	54	58	29	34	False
12827610	Although the 4 PKPs displayed different levels and patterns of subcellular distribution in tumors, there was a positive correlation between immunoreactivity for PKP2 and PKP3, as well as for PKP2 and p0071, suggesting possible functional similarities associated with differentiation, tumor growth, and disease prognosis.	PKP2	tumor	5318	HP_0002664	161	165	91	96	False
12827610	Although the 4 PKPs displayed different levels and patterns of subcellular distribution in tumors, there was a positive correlation between immunoreactivity for PKP2 and PKP3, as well as for PKP2 and p0071, suggesting possible functional similarities associated with differentiation, tumor growth, and disease prognosis.	PKP3	tumor	11187	HP_0002664	170	174	91	96	False
23479141	Limb girdle muscular dystrophy type 2G (LGMD2G) is caused by mutations in the telethonin gene.	type	muscular dystrophy	6445	HP_0003560	31	35	12	30	True
23479141	Limb girdle muscular dystrophy type 2G (LGMD2G) is caused by mutations in the telethonin gene.	LGMD2G	muscular dystrophy	8557	HP_0003560	41	47	12	30	True
23479141	Limb girdle muscular dystrophy type 2G (LGMD2G) is caused by mutations in the telethonin gene.	telethonin	muscular dystrophy	8557	HP_0003560	79	89	12	30	True
23708190	Although some causative genes have been identified, little progress has been made in identifying genes in which low-penetrance susceptibility variants occur in the majority of sporadic CHM cases.	CHM	sporadic	1121	HP_0003745	185	188	176	184	False
23708190	To identify common genetic variants associated with sporadic non-syndromic CHM in Han Chinese populations, we performed a multistage genome-wide association study (GWAS) in a total of 4,225 CHM cases and 5,112 non-CHM controls.	CHM	sporadic	1121	HP_0003745	75	78	52	60	False
26225770	Previous studies have shown that c-MET is overexpressed in cases of aggressive bladder cancer (BCa).	MET	cancer	79811	HP_0002664	35	38	87	93	False
26225770	Previous studies have shown that c-MET is overexpressed in cases of aggressive bladder cancer (BCa).	BCa	cancer	29760	HP_0002664	95	98	87	93	True
30486375	In pulmonary arterial hypertension (PAH), lung-angioproliferation leads to increased pulmonary vascular resistance, while simultaneous myocardial microvessel loss contributes to right ventricular (RV) failure.	PAH	pulmonary arterial hypertension	5053	HP_0002092	36	39	3	34	False
28095295	Osteopetrosis (OPT) is a rare skeletal disorder with phenotypic and genotypic heterogeneity: a variety of clinical features besides the bony defect may be present, and at least ten different genes are known to be involved in the disease pathogenesis.	OPT	heterogeneity	51430	HP_0001425	15	18	78	91	False
28095295	In the framework of this heterogeneity, we report the clinical description of a neonate, first child of consanguineous parents, who had osteoclast-rich osteopetrosis and bone marrow failure in early life, but no other usual classical features of infantile malignant OPT, such as visual or hearing impairments.	OPT	heterogeneity	51430	HP_0001425	266	269	25	38	False
28095295	In the framework of this heterogeneity, we report the clinical description of a neonate, first child of consanguineous parents, who had osteoclast-rich osteopetrosis and bone marrow failure in early life, but no other usual classical features of infantile malignant OPT, such as visual or hearing impairments.	OPT	hearing impairments	51430	HP_0000365	266	269	289	308	False
30285736	Pulmonary veno-occlusive disease (PVOD) is a rare and fatal cause of pulmonary arterial hypertension (PAH).	PAH	pulmonary arterial hypertension	5053	HP_0002092	102	105	69	100	False
30285736	Different from other types of PAH, PVOD patients have a dismal prognosis because of the progressive nature of pulmonary vascular involvement and fatal pulmonary edema induced by PAH-targeted drugs.	PAH	pulmonary edema	5053	HP_0100598	30	33	151	166	False
30285736	In a recent article published in the journal, Yang and his colleagues found pulmonary edema was not demonstrated in 2 of the 6 PVOD patients injected with prostacyclin analogues (a kind of PAH-targeted drug).	PAH	pulmonary edema	5053	HP_0100598	189	192	76	91	False
30285736	Here, we reported a sporadic PVOD patient evidenced by pathology and EIF2AK4 biallelic mutation.	EIF2AK4	sporadic	440275	HP_0003745	69	76	20	28	False
26429724	These mice develop prostate tumors similar to a subset of poor outcome, treatment-associated human PC tumors.	mice	tumors	23581	HP_0002664	6	10	28	34	False
26429724	Correlation analysis using microarray data from (TRAMP  PWK/PhJ) F2 prostate tumors identified 35 metastasis-associated transcripts within the two loci.	TRAMP	tumors	8718	HP_0002664	49	54	78	84	False
30054562	In this study, we reported the identification of Calcium Binding Protein 39-Like (CAB39L) as a novel regulator of tumor metabolism in GC.	CAB39L	tumor	81617	HP_0002664	82	88	114	119	False
30054562	Functional studies suggested that CAB39L functions as a tumor suppressor, as overexpression of CAB39L elicited suppression of multiple cancer phenotypes both in GC cells and an orthotopic mouse model; whilst its knockdown promoted tumorigenesis.	CAB39L	cancer	81617	HP_0002664	34	40	135	141	False
30054562	Functional studies suggested that CAB39L functions as a tumor suppressor, as overexpression of CAB39L elicited suppression of multiple cancer phenotypes both in GC cells and an orthotopic mouse model; whilst its knockdown promoted tumorigenesis.	CAB39L	tumor	81617	HP_0002664	34	40	56	61	False
30054562	LKB1-AMPK activation in GC cell lines was tumor suppressive, as metformin (an AMPK activator) inhibited GC cell growth in the CAB39L-silenced cells.	CAB39L	tumor	81617	HP_0002664	126	132	42	47	False
30054562	LKB1-AMPK activation in GC cell lines was tumor suppressive, as metformin (an AMPK activator) inhibited GC cell growth in the CAB39L-silenced cells.	LKB1	tumor	6794	HP_0002664	0	4	42	47	True
30054562	LKB1-AMPK activation in GC cell lines was tumor suppressive, as metformin (an AMPK activator) inhibited GC cell growth in the CAB39L-silenced cells.	AMPK	tumor	5563	HP_0002664	5	9	42	47	False
30054562	Moreover, knockdown of LKB1 reversed growth inhibitory effect of CAB39L, indicating that tumor suppression by CAB39L depended on LKB1-AMPK.	CAB39L	tumor	81617	HP_0002664	65	71	89	94	False
30054562	Moreover, knockdown of LKB1 reversed growth inhibitory effect of CAB39L, indicating that tumor suppression by CAB39L depended on LKB1-AMPK.	LKB1	tumor	6794	HP_0002664	23	27	89	94	True
30054562	Moreover, knockdown of LKB1 reversed growth inhibitory effect of CAB39L, indicating that tumor suppression by CAB39L depended on LKB1-AMPK.	AMPK	tumor	5563	HP_0002664	134	138	89	94	False
30054562	Our data demonstrate that CAB39L is a novel tumor suppressor which suppresses tumorigenesis by promoting LKB1-AMPK-PGC1 axis, thereby preventing a metabolic shift that drives carcinogenesis.	CAB39L	tumor	81617	HP_0002664	26	32	44	49	False
30054562	Our data demonstrate that CAB39L is a novel tumor suppressor which suppresses tumorigenesis by promoting LKB1-AMPK-PGC1 axis, thereby preventing a metabolic shift that drives carcinogenesis.	LKB1	tumor	6794	HP_0002664	105	109	44	49	True
30054562	Our data demonstrate that CAB39L is a novel tumor suppressor which suppresses tumorigenesis by promoting LKB1-AMPK-PGC1 axis, thereby preventing a metabolic shift that drives carcinogenesis.	AMPK	tumor	5563	HP_0002664	110	114	44	49	False
28817240	Hyperphosphatasia with mental retardation syndrome (HPMRS) is caused by mutations in PIGV and includes hyperphosphatasia as a diagnostic hallmark.	PIGV	hyperphosphatasia	55650	HP_0003155	85	89	103	120	True
28332095	Among others, an immature subpopulation of self-renewing and therapy-resistant tumor cells-often referred to as glioblastoma stem-like cells (GSCs)-has been shown to contribute to disease recurrence.	has	glioblastoma	3036	HP_0012174	148	151	112	124	False
28332095	Among others, an immature subpopulation of self-renewing and therapy-resistant tumor cells-often referred to as glioblastoma stem-like cells (GSCs)-has been shown to contribute to disease recurrence.	GSC	glioblastoma	145258	HP_0012174	142	145	112	124	False
28332095	Among others, an immature subpopulation of self-renewing and therapy-resistant tumor cells-often referred to as glioblastoma stem-like cells (GSCs)-has been shown to contribute to disease recurrence.	has	tumor	3036	HP_0002664	148	151	79	84	False
28332095	Among others, an immature subpopulation of self-renewing and therapy-resistant tumor cells-often referred to as glioblastoma stem-like cells (GSCs)-has been shown to contribute to disease recurrence.	GSC	tumor	145258	HP_0002664	142	145	79	84	False
28332095	by reactivating pre-existing anti-tumor immune responses against GSC antigens.	GSC	tumor	145258	HP_0002664	65	68	34	39	False
28332095	In summary, we identified novel immunogenic proteins, which frequently induce tumor-specific Tcell responses in GBM patients and were also detected in vitro in therapy-resistant quiescent, slow-cycling GSCs.	GSC	tumor	145258	HP_0002664	203	206	78	83	False
26556829	Besides, we screened for all the known genes related to axonal autosomal recessive Charcot-Marie-Tooth disease (CMT2A2/HMSN2A2/MFN2, CMT2B1/LMNA, CMT2B2/MED25, CMT2B5/NEFL, ARCMT2F/dHMN2B/HSPB1, CMT2K/GDAP1, CMT2P/LRSAM1, CMT2R/TRIM2, CMT2S/IGHMBP2, CMT2T/HSJ1, CMTRID/COX6A1, ARAN-NM/HINT and GAN/GAN), for the genes related to autosomal recessive hereditary spastic paraplegia with thin corpus callosum and axonal peripheral neuropathy (SPG7/PGN, SPG15/ZFYVE26, SPG21/ACP33, SPG35/FA2H, SPG46/GBA2, SPG55/C12orf65 and SPG56/CYP2U1), as well as for the causative gene of peripheral neuropathy with or without agenesis of the corpus callosum (SLC12A6).	SLC12A6	autosomal recessive	9990	HP_0000007	643	650	63	82	True
26556829	Besides, we screened for all the known genes related to axonal autosomal recessive Charcot-Marie-Tooth disease (CMT2A2/HMSN2A2/MFN2, CMT2B1/LMNA, CMT2B2/MED25, CMT2B5/NEFL, ARCMT2F/dHMN2B/HSPB1, CMT2K/GDAP1, CMT2P/LRSAM1, CMT2R/TRIM2, CMT2S/IGHMBP2, CMT2T/HSJ1, CMTRID/COX6A1, ARAN-NM/HINT and GAN/GAN), for the genes related to autosomal recessive hereditary spastic paraplegia with thin corpus callosum and axonal peripheral neuropathy (SPG7/PGN, SPG15/ZFYVE26, SPG21/ACP33, SPG35/FA2H, SPG46/GBA2, SPG55/C12orf65 and SPG56/CYP2U1), as well as for the causative gene of peripheral neuropathy with or without agenesis of the corpus callosum (SLC12A6).	SLC12A6	neuropathy	9990	HP_0009830	643	650	427	437	True
26556829	An additional locus for autosomal recessive Charcot-Marie-Tooth disease type 2H on chromosome 8q13-21.1 was excluded by linkage analysis.	type	autosomal recessive	6445	HP_0000007	72	76	24	43	True
28844659	Transplantation of rod photoreceptors, derived either from neonatal retinae or pluripotent stem cells (PSCs), can restore rod-mediated visual function in murine models of inherited blindness.	rod	blindness	9735	HP_0000618	19	22	181	190	False
28204981	Objective clinical response was 19% (one confirmed partial response (PR) in small cell lung cancer (SCLC) and two unconfirmed); stable disease (SD) was 6% for a disease control rate (DCR) of 25%.	DCR	cancer	51181	HP_0002664	183	186	92	98	False
30272319	Estrogens and estrogen receptors (ERs), such as ER and ER, prolactin (PRL) and prolactin receptor (PRLR) have been reported to be involved in the physiopathology of uterine cervical cancer (UCC).	PRL	cancer	5617	HP_0002664	72	75	184	190	False
30272319	The results revealed that ER, ER, PRLR and Ki67 expression levels were increased during the progression of cancer.	PRL	cancer	5617	HP_0002664	36	39	109	115	False
29305977	Typical HHT clinical features are mucocutaneous telangiectases, arteriovenous malformations, spontaneous and recurrent epistaxis, as well as gastrointestinal bleedings.	HHT	arteriovenous malformations	94	HP_0100026	8	11	64	91	True
29317335	Four established melanoma susceptibility genes achieved nominal statistical significance, MC1R (p=.0014), MITF (p=.0165) BRCA2 (p=.0206), and MTAP (p=.0393).	MITF	melanoma	4286	HP_0002861	108	112	17	25	True
29317335	Four established melanoma susceptibility genes achieved nominal statistical significance, MC1R (p=.0014), MITF (p=.0165) BRCA2 (p=.0206), and MTAP (p=.0393).	BRCA2	melanoma	675	HP_0002861	125	130	17	25	True
29317335	Four established melanoma susceptibility genes achieved nominal statistical significance, MC1R (p=.0014), MITF (p=.0165) BRCA2 (p=.0206), and MTAP (p=.0393).	MTAP	melanoma	4507	HP_0002861	148	152	17	25	False
29317335	We also observed a suggestive association for FANCA (p=.002), a gene previously implicated in melanoma survival.	FANCA	melanoma	2175	HP_0002861	46	51	96	104	False
29317335	Although MC1R carriers were represented proportionally among the four molecular tumor subtypes, these individuals accounted for 69% of ultraviolet (UV) radiation mutational signatures among triple-wild type tumors (p=.040), highlighting the increased sensitivity to UV exposure among individuals with loss-of-function variants in MC1R	type	tumor	6445	HP_0002664	89	93	80	85	False
25361962	Jeune asphyxiating thoracic dystrophy (JATD) is a skeletal dysplasia characterized by a small thoracic cage and a range of skeletal and extra-skeletal anomalies.	cage	skeletal dysplasia	168400	HP_0002652	103	107	50	68	False
25361962	Inhibition of the CEP120 ortholog in zebrafish produced pleiotropic phenotypes characteristic of cilia defects including abnormal body curvature, hydrocephalus, otolith defects and abnormal renal, head and craniofacial development.	CEP120	hydrocephalus	153241	HP_0000238	18	24	146	159	True
24766809	Mice carrying kinase-dead CLP1 also displayed microcephaly and reduced cortical brain volume due to the enhanced cell death of neuronal progenitors that is associated with reduced numbers of cortical neurons.	CLP1	microcephaly	10978	HP_0000252	26	30	46	58	True
24655110	GRACILE syndrome is a rare autosomal recessive disease characterized by fetal growth retardation, Fanconi type aminoaciduria, cholestasis, iron overload, profound lactic acidosis, and early death.	type	autosomal recessive	6445	HP_0000007	106	110	27	46	True
24655110	GRACILE syndrome is a rare autosomal recessive disease characterized by fetal growth retardation, Fanconi type aminoaciduria, cholestasis, iron overload, profound lactic acidosis, and early death.	type	profound	6445	HP_0012829	106	110	154	162	False
24655110	GRACILE syndrome is a rare autosomal recessive disease characterized by fetal growth retardation, Fanconi type aminoaciduria, cholestasis, iron overload, profound lactic acidosis, and early death.	type	lactic acidosis	6445	HP_0003128	106	110	163	178	False
24655110	GRACILE syndrome is a rare autosomal recessive disease characterized by fetal growth retardation, Fanconi type aminoaciduria, cholestasis, iron overload, profound lactic acidosis, and early death.	type	aminoaciduria	6445	HP_0003355	106	110	111	124	False
24655110	Mitochondrial disorders are an extremely heterogeneous group of diseases sharing, in common, the fact that they all ultimately impair the function of the mitochondrial respiratory chain.	fact	heterogeneous	11198	HP_0001425	97	101	41	54	False
29101791	We generated calpain-1 knockout Townes sickle (SSCKO) mice to investigate the role of calpain-1 in steady state and hypoxia/reoxygenation (H/R)-induced sickle platelet activation and aggregation, clot retraction, and pulmonary arterial hypertension.	mice	pulmonary arterial hypertension	23581	HP_0002092	54	58	217	248	False
27323939	Focal epilepsies, where seizures initiate in spatially limited networks, are the most frequent epilepsy type, accounting for two-thirds of patients.	type	epilepsies	6445	HP_0001250	104	108	6	16	False
27323939	Focal epilepsies, where seizures initiate in spatially limited networks, are the most frequent epilepsy type, accounting for two-thirds of patients.	type	seizures	6445	HP_0001250	104	108	24	32	False
27323939	Focal epilepsies, where seizures initiate in spatially limited networks, are the most frequent epilepsy type, accounting for two-thirds of patients.	type	epilepsy	6445	HP_0001250	104	108	95	103	False
27323939	Brain somatic mutations in the gene encoding mTOR (MTOR) have recently been linked to focal cortical dysplasia and other associated brain pathologies including hemimegalencephaly.	mTOR	cortical dysplasia	2475	HP_0002539	45	49	92	110	True
27323939	Brain somatic mutations in the gene encoding mTOR (MTOR) have recently been linked to focal cortical dysplasia and other associated brain pathologies including hemimegalencephaly.	MTOR	cortical dysplasia	2475	HP_0002539	51	55	92	110	True
27323939	Brain somatic mutations in the gene encoding mTOR (MTOR) have recently been linked to focal cortical dysplasia and other associated brain pathologies including hemimegalencephaly.	mTOR	hemimegalencephaly	2475	HP_0007206	45	49	160	178	True
27323939	Brain somatic mutations in the gene encoding mTOR (MTOR) have recently been linked to focal cortical dysplasia and other associated brain pathologies including hemimegalencephaly.	MTOR	hemimegalencephaly	2475	HP_0007206	51	55	160	178	True
28011715	Ectodermal dysplasia-9 (ED-9) is a congenital condition characterized by hypotrichosis and nail dystrophy without other disorders, and Hoxc13 is a pathogenic gene for ED-9.	nail	hypotrichosis	51744	HP_0001006	91	95	73	86	False
28011715	Ectodermal dysplasia-9 (ED-9) is a congenital condition characterized by hypotrichosis and nail dystrophy without other disorders, and Hoxc13 is a pathogenic gene for ED-9.	Hoxc13	hypotrichosis	3229	HP_0001006	135	141	73	86	True
19235036	We evaluated the association between dietary and supplemental zinc and prostate cancer within the VITamins And Lifestyle (VITAL) cohort, a study specifically designed to evaluate the impact of dietary supplements and cancer risk.	impact	cancer	55364	HP_0002664	183	189	80	86	False
19235036	We evaluated the association between dietary and supplemental zinc and prostate cancer within the VITamins And Lifestyle (VITAL) cohort, a study specifically designed to evaluate the impact of dietary supplements and cancer risk.	men	cancer	8178	HP_0002664	55	58	80	86	False
19235036	Of 35,242 men who completed the baseline dietary and supplemental questionnaire, 832 men developed invasive prostate cancers between October 2000 and December 2004.	men	cancer	8178	HP_0002664	10	13	117	123	False
19235036	Ten-year average intake of supplemental zinc was not associated with a reduced prostate cancer risk overall (adjusted hazard ratio (HR) = 0.82 (95% confidence interval (CI) 0.58-1.14) for &gt;15 mg/day vs. nonuse, P for trend = 0.44); however, risk of advanced prostate cancer (regionally invasive or distant metastatic, n = 123) decreased with greater intake of supplemental zinc (adjusted HR = 0.34, 95% CI = 0.13-1.09 for 10-yr average intake &gt; 15 mg/day vs. nonuse, P for trend = 0.04).	men	cancer	8178	HP_0002664	33	36	88	94	False
28285769	By whole-exome sequencing, recessive protein-truncating mutations in CWC27 were found in seven unrelated families that show a range of clinical phenotypes, including retinal degeneration, brachydactyly, craniofacial abnormalities, short stature, and neurological defects.	CWC27	retinal degeneration	10283	HP_0000546	69	74	166	186	False
28285769	By whole-exome sequencing, recessive protein-truncating mutations in CWC27 were found in seven unrelated families that show a range of clinical phenotypes, including retinal degeneration, brachydactyly, craniofacial abnormalities, short stature, and neurological defects.	CWC27	brachydactyly	10283	HP_0001156	69	74	188	201	True
28285769	By whole-exome sequencing, recessive protein-truncating mutations in CWC27 were found in seven unrelated families that show a range of clinical phenotypes, including retinal degeneration, brachydactyly, craniofacial abnormalities, short stature, and neurological defects.	CWC27	short stature	10283	HP_0004322	69	74	231	244	True
28285769	Remarkably, variable expressivity of the human phenotype can be recapitulated in Cwc27 mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout mice while mice with a partial loss-of-function allele mimic the isolated retinal degeneration phenotype.	Cwc27	retinal degeneration	10283	HP_0000546	81	86	266	286	False
28285769	Remarkably, variable expressivity of the human phenotype can be recapitulated in Cwc27 mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout mice while mice with a partial loss-of-function allele mimic the isolated retinal degeneration phenotype.	mice	retinal degeneration	23581	HP_0000546	192	196	266	286	False
28285769	Remarkably, variable expressivity of the human phenotype can be recapitulated in Cwc27 mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout mice while mice with a partial loss-of-function allele mimic the isolated retinal degeneration phenotype.	Cwc27	variable expressivity	10283	HP_0003828	81	86	12	33	False
28285769	Remarkably, variable expressivity of the human phenotype can be recapitulated in Cwc27 mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout mice while mice with a partial loss-of-function allele mimic the isolated retinal degeneration phenotype.	mice	variable expressivity	23581	HP_0003828	192	196	12	33	False
29047041	The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.	PRPS1	neuropathy	5631	HP_0009830	21	26	70	80	True
29047041	The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.	type	neuropathy	6445	HP_0009830	81	85	70	80	False
29047041	The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.	CMTX5	neuropathy	5631	HP_0009830	89	94	70	80	True
29047041	The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.	Arts	neuropathy	5414	HP_0009830	117	121	70	80	False
29047041	The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.	PRPS1	deafness	5631	HP_0000365	21	26	141	149	True
29047041	The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.	type	deafness	6445	HP_0000365	81	85	141	149	False
29047041	The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.	CMTX5	deafness	5631	HP_0000365	89	94	141	149	True
29047041	The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.	Arts	deafness	5414	HP_0000365	117	121	141	149	False
29047041	The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.	PRPS1	cancer	5631	HP_0002664	21	26	160	166	False
29047041	The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.	type	cancer	6445	HP_0002664	81	85	160	166	False
29047041	The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.	CMTX5	cancer	5631	HP_0002664	89	94	160	166	False
29047041	The mutations in the PRPS1 gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), PRS super activity, Arts syndrome, X-linked deafness-1, breast cancer, and colorectal cancer.	Arts	cancer	5414	HP_0002664	117	121	160	166	False
29522511	Exome sequencing of superior coloboma patients identified rare variants in a Bone Morphogenetic Protein (Bmp) receptor (BMPR1A) and T-box transcription factor (TBX2).	BMPR1A	coloboma	657	HP_0000589	120	126	29	37	False
29522511	Exome sequencing of superior coloboma patients identified rare variants in a Bone Morphogenetic Protein (Bmp) receptor (BMPR1A) and T-box transcription factor (TBX2).	TBX2	coloboma	6909	HP_0000589	160	164	29	37	False
29522511	Together, our findings explain the existence of superior coloboma, a congenital ocular anomaly resulting from aberrant morphogenesis of a developmental structure	find	coloboma	81501	HP_0000589	14	18	57	65	False
30412119	Clinicopathologic features such as menarche age, body mass index, personal cancer history, grade, and histologic type were compared between the 2 groups.	mass	cancer	2200	HP_0002664	54	58	75	81	False
30412119	Clinicopathologic features such as menarche age, body mass index, personal cancer history, grade, and histologic type were compared between the 2 groups.	type	cancer	6445	HP_0002664	113	117	75	81	False
30412119	Univariate (Pearson Chi-squared test, Fisher exact test, T test, Wilcoxon rank sum test, logistic regression) statistics and stepwise multivariate logistic regression were used to identify factors associated with PFH in the analysis.Among young patients with EC, the PFH group had younger age-of-onset age of endometrial cancer (40 years) (odds ratio [OR] = 2.21, 95% confidence interval [95% CI]: 1.01-4.82) than the NFH group.	rank	cancer	8792	HP_0002664	74	78	321	327	False
30412119	Colorectal, lung, endometrial, breast, and hepatocellular carcinoma accounted for 58.6% of all cancer types among 1st- and 2nd-degree relatives.	type	cancer	6445	HP_0002664	102	106	95	101	False
30412119	Colorectal, lung, endometrial, breast, and hepatocellular carcinoma accounted for 58.6% of all cancer types among 1st- and 2nd-degree relatives.	type	hepatocellular carcinoma	6445	HP_0001402	102	106	43	67	False
24859618	In severe bilateral cases (anophthalmia or severe microphthalmia) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in SOX2 or OTX2 being the most common.	SOX2	microphthalmia	6657	HP_0000568	198	202	50	64	True
24859618	In severe bilateral cases (anophthalmia or severe microphthalmia) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in SOX2 or OTX2 being the most common.	OTX2	microphthalmia	5015	HP_0000568	206	210	50	64	True
24859618	In severe bilateral cases (anophthalmia or severe microphthalmia) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in SOX2 or OTX2 being the most common.	SOX2	anophthalmia	6657	HP_0000528	198	202	27	39	True
24859618	In severe bilateral cases (anophthalmia or severe microphthalmia) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in SOX2 or OTX2 being the most common.	OTX2	anophthalmia	5015	HP_0000528	206	210	27	39	True
28104793	The nonsense mutation and loss of protein of Rab23 has been associated with neural tube defect in mice and aberrant expression in various diseases in human such as neural system, breast, visceral, and cutaneous tumor.	Rab23	neural tube defect	51715	HP_0045005	45	50	76	94	True
28104793	The nonsense mutation and loss of protein of Rab23 has been associated with neural tube defect in mice and aberrant expression in various diseases in human such as neural system, breast, visceral, and cutaneous tumor.	mice	neural tube defect	23581	HP_0045005	98	102	76	94	False
28104793	The nonsense mutation and loss of protein of Rab23 has been associated with neural tube defect in mice and aberrant expression in various diseases in human such as neural system, breast, visceral, and cutaneous tumor.	Rab23	tumor	51715	HP_0002664	45	50	211	216	False
28104793	The nonsense mutation and loss of protein of Rab23 has been associated with neural tube defect in mice and aberrant expression in various diseases in human such as neural system, breast, visceral, and cutaneous tumor.	mice	tumor	23581	HP_0002664	98	102	211	216	False
28104793	In this review, we give a brief review on the functions of Rab23, summarize the involvement of Rab23 in genetic research, membrane trafficking, and potential autophagy pathway, especially focus on tumor promotion, disease pathogenesis, and discuss the possible underlying mechanisms that are regulated by Rab23	Rab23	tumor	51715	HP_0002664	59	64	197	202	False
29045821	MiR-93-5p has been previously found to be associated with gastric cancer (GC) tumorigenesis; however, the current understanding of its function in this context remains largely incomplete.	GC	cancer	2638	HP_0002664	74	76	66	72	False
29045821	MiR-93-5p has been previously found to be associated with gastric cancer (GC) tumorigenesis; however, the current understanding of its function in this context remains largely incomplete.	GC	tumor	2638	HP_0002664	74	76	78	83	False
29045821	MiR-93-5p upregulation was also shown to inhibit the expression of two well-characterized Hippo pathway regulators, protocadherin Fat 4 (FAT4), and large tumor suppressors 2 (LATS2), at both the mRNA and protein level.	Fat	tumor	948	HP_0002664	130	133	154	159	False
29045821	MiR-93-5p upregulation was also shown to inhibit the expression of two well-characterized Hippo pathway regulators, protocadherin Fat 4 (FAT4), and large tumor suppressors 2 (LATS2), at both the mRNA and protein level.	FAT4	tumor	79633	HP_0002664	137	141	154	159	True
29045821	MiR-93-5p upregulation was also shown to inhibit the expression of two well-characterized Hippo pathway regulators, protocadherin Fat 4 (FAT4), and large tumor suppressors 2 (LATS2), at both the mRNA and protein level.	LATS2	tumor	26524	HP_0002664	175	180	154	159	False
17245537	Corticosteroid-binding globulin (SERPINA6) deficiency is an extremely rare hereditary disorder characterized by reduced corticosteroid-binding capacity with normal or low plasma corticosteroid-binding globulin concentration, and normal or low basal cortisol levels associated with hypo-/hypertension and muscle fatigue.	SERPINA6	hypertension	866	HP_0000822	33	41	287	299	True
25638162	We found that the expression of Sgo1 mRNA was relatively low in normal tissues, but was upregulated in 82% of hepatocellular carcinoma (HCC), and correlated with elevated alpha-fetoprotein and early disease onset of HCC.	Sgo1	hepatocellular carcinoma	151648	HP_0001402	32	36	110	134	False
25638162	We found that the expression of Sgo1 mRNA was relatively low in normal tissues, but was upregulated in 82% of hepatocellular carcinoma (HCC), and correlated with elevated alpha-fetoprotein and early disease onset of HCC.	HCC	hepatocellular carcinoma	84668	HP_0001402	136	139	110	134	False
23918659	Mutations in Vps33 isoforms cause pigment dilution in mice (Vps33a, buff) and Drosophila (car) and the neurogenic arthrogryposis, renal dysfunction and cholestasis syndrome in humans (ARC1, VPS33B).	mice	arthrogryposis	23581	HP_0002804	54	58	114	128	False
23918659	Mutations in Vps33 isoforms cause pigment dilution in mice (Vps33a, buff) and Drosophila (car) and the neurogenic arthrogryposis, renal dysfunction and cholestasis syndrome in humans (ARC1, VPS33B).	Vps33a	arthrogryposis	65082	HP_0002804	60	66	114	128	False
23918659	Mutations in Vps33 isoforms cause pigment dilution in mice (Vps33a, buff) and Drosophila (car) and the neurogenic arthrogryposis, renal dysfunction and cholestasis syndrome in humans (ARC1, VPS33B).	car	arthrogryposis	1525	HP_0002804	90	93	114	128	False
23918659	Mutations in Vps33 isoforms cause pigment dilution in mice (Vps33a, buff) and Drosophila (car) and the neurogenic arthrogryposis, renal dysfunction and cholestasis syndrome in humans (ARC1, VPS33B).	VPS33B	arthrogryposis	26276	HP_0002804	190	196	114	128	True
23918659	Mutations in Vps33 isoforms cause pigment dilution in mice (Vps33a, buff) and Drosophila (car) and the neurogenic arthrogryposis, renal dysfunction and cholestasis syndrome in humans (ARC1, VPS33B).	ARC	arthrogryposis	8996	HP_0002804	184	187	114	128	False
29849040	In addition, p-BS/GS can occur as a result of other inherited diseases such as cystic fibrosis, autosomal dominant hypocalcemia, Dent disease, or congenital chloride diarrhea (CCD).	CCD	hypocalcemia	860	HP_0002901	176	179	115	127	False
28031293	Usher syndrome (USH) is the most common cause of inherited deaf-blindness, manifested as USH1, USH2 and USH3 clinical types.	USH2	blindness	7399	HP_0000618	95	99	64	73	True
28031293	Usher syndrome (USH) is the most common cause of inherited deaf-blindness, manifested as USH1, USH2 and USH3 clinical types.	USH3	blindness	7401	HP_0000618	104	108	64	73	True
30015619	Abnormalities in nucleic acid processing are associated with the development of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).	ALS	frontotemporal dementia	3483	HP_0002145	111	114	120	143	False
30015619	Mutations in <i>Matrin 3</i> (<i>MATR3</i>), a poorly understood DNA- and RNA-binding protein, cause familial ALS/FTD, and MATR3 pathology is a feature of sporadic disease, suggesting that MATR3 dysfunction is integrally linked to ALS pathogenesis.	ALS	sporadic	3483	HP_0003745	110	113	155	163	False
30015619	Mutations in <i>Matrin 3</i> (<i>MATR3</i>), a poorly understood DNA- and RNA-binding protein, cause familial ALS/FTD, and MATR3 pathology is a feature of sporadic disease, suggesting that MATR3 dysfunction is integrally linked to ALS pathogenesis.	MATR3	sporadic	9782	HP_0003745	33	38	155	163	False
30015619	Our findings offer a foundation for understanding MATR3-related neurodegeneration and how nucleic acid binding functions, localization, and pathogenic mutations drive sporadic and familial disease	MATR3	sporadic	9782	HP_0003745	50	55	167	175	False
27239697	To examine the pathomechanisms of early craniofacial and dental abnormalities, we analyzed mice with an MLII patient mutation that mimic the clinical and biochemical symptoms of MLII patients.	mice	dental abnormalities	23581	HP_0000164	91	95	57	77	False
29391407	The molecular chaperone Hsp90 is overexpressed in prostate cancer (PCa) and is responsible for the folding, stabilization and maturation of multiple oncoproteins, which are implicated in PCa progression.	Hsp90	cancer	3320	HP_0002664	24	29	59	65	False
29391407	The molecular chaperone Hsp90 is overexpressed in prostate cancer (PCa) and is responsible for the folding, stabilization and maturation of multiple oncoproteins, which are implicated in PCa progression.	PCa	cancer	28982	HP_0002664	67	70	59	65	False
29859207	We have recently demonstrated that DNA damage signaling from DNA double-strand breaks (DSBs) promotes PD-L1 upregulation in cancer cells.	damage	cancer	51438	HP_0002664	39	45	124	130	False
28877251	In the present study, we used a custom-made TES panel to identify the genetic defect of a four-generation Chinese family with bilateral pulverulent nuclear cataracts.	TES	cataract	26136	HP_0000518	44	47	156	164	False
28877251	In the present study, we used a custom-made TES panel to identify the genetic defect of a four-generation Chinese family with bilateral pulverulent nuclear cataracts.	TES	bilateral	26136	HP_0012832	44	47	126	135	False
26685052	We present a case of a patient with long-standing hyperpigmented macules and erythematous papules over his chest, abdomen, back and arms, suggestive of Dowling-Degos disease (DDD).	arms	hyperpigmented macules	57498	HP_0001034	132	136	50	72	False
26685052	We present a case of a patient with long-standing hyperpigmented macules and erythematous papules over his chest, abdomen, back and arms, suggestive of Dowling-Degos disease (DDD).	arms	erythematous papules	57498	HP_0030350	132	136	77	97	False
26685052	In addition, there were hyperkeratotic papules, alternating red and white nail-bed discolouration, and V-shaped nail notching consistent with Darier disease (DD).	red	hyperkeratotic papules	8444	HP_0045059	60	63	24	46	False
26685052	In addition, there were hyperkeratotic papules, alternating red and white nail-bed discolouration, and V-shaped nail notching consistent with Darier disease (DD).	nail	hyperkeratotic papules	51744	HP_0045059	74	78	24	46	False
28947093	An underdeveloped or impaired immune response in young children is associated with increased susceptibility to Streptococcus pneumonia (Spn) infections.	Spn	pneumonia	10522	HP_0002090	136	139	125	134	False
20005768	The aim of this study was to examine the Kif2a expression and its role in tumor progression, invasion and metastasis in squamous cell carcinoma of the oral tongue (SCCOT).	Kif2a	tumor	3796	HP_0002664	41	46	74	79	False
20005768	Immunohistochemistry was used to observe the Kif2a expression and its correlation with clinicopathologic factors in oral tongue cancer.	Kif2a	cancer	3796	HP_0002664	45	50	128	134	False
20005768	The immunohistochemistry showed that Kif2a expression was stronger in oral tongue cancer tissues than in paired adjacent tissues (P&lt;0.01), and the higher expression of Kif2a was also significantly associated with lymph node metastasis (P&lt;0.01), tumor clinical stage (P&lt;0.01).	Kif2a	tumor	3796	HP_0002664	37	42	251	256	False
20005768	The immunohistochemistry showed that Kif2a expression was stronger in oral tongue cancer tissues than in paired adjacent tissues (P&lt;0.01), and the higher expression of Kif2a was also significantly associated with lymph node metastasis (P&lt;0.01), tumor clinical stage (P&lt;0.01).	Kif2a	cancer	3796	HP_0002664	37	42	82	88	False
28334762	Congenital erythropoietic porphyria (CEP) is an inborn error of heme biosynthesis characterized by uroporphyrinogen III synthase (UROS) deficiency resulting in deleterious porphyrin accumulation in blood cells responsible for hemolytic anemia and cutaneous photosensitivity.	UROS	cutaneous photosensitivity	7390	HP_0000992	130	134	247	273	True
28334762	Finally, we show evidence that abnormal protein homeostasis is a prevalent mechanism responsible for UROS deficiency and that modulators of UROS proteolysis such as proteasome inhibitors or chemical chaperones may represent an attractive therapeutic option to reduce porphyrin accumulation and prevent skin photosensitivity in CEP patients when the genotype includes a missense variant	UROS	skin photosensitivity	7390	HP_0000992	101	105	302	323	True
28686853	These subjects share a set of common facial features that include a prominent maxilla and upper lip that readily reveal the upper gingiva, widely spaced teeth, and a broad nasal tip.	set	widely spaced teeth	6418	HP_0000687	23	26	139	158	False
28686853	These subjects share a set of common facial features that include a prominent maxilla and upper lip that readily reveal the upper gingiva, widely spaced teeth, and a broad nasal tip.	lip	widely spaced teeth	23049	HP_0000687	96	99	139	158	False
27589347	Similarly, homozygous loss-of-function mutations in CYP26B1, one of the major RA-metabolizing enzymes, cause advanced bone age, premature epiphyseal fusion, and craniosynostosis.	CYP26B1	craniosynostosis	56603	HP_0001363	52	59	161	177	True
28920921	The short-limbed dwarfism metaphyseal chondrodysplasia type Schmid (MCDS) is linked to mutations in type X collagen, which increase ER stress by inducing misfolding of the mutant protein and subsequently disrupting hypertrophic chondrocyte differentiation.	type	short-limbed dwarfism	6445	HP_0008873	55	59	4	25	False
28920921	In MCDS mice expressing the Col10a1.pN617K mutation, CBZ reduced the MCDS-associated expansion of the growth plate hypertrophic zone, attenuated enhanced expression of ER stress markers such as Bip and Atf4, increased bone growth, and reduced skeletal dysplasia.	mice	skeletal dysplasia	23581	HP_0002652	8	12	243	261	False
28920921	In MCDS mice expressing the Col10a1.pN617K mutation, CBZ reduced the MCDS-associated expansion of the growth plate hypertrophic zone, attenuated enhanced expression of ER stress markers such as Bip and Atf4, increased bone growth, and reduced skeletal dysplasia.	Bip	skeletal dysplasia	3309	HP_0002652	194	197	243	261	False
28920921	In MCDS mice expressing the Col10a1.pN617K mutation, CBZ reduced the MCDS-associated expansion of the growth plate hypertrophic zone, attenuated enhanced expression of ER stress markers such as Bip and Atf4, increased bone growth, and reduced skeletal dysplasia.	Atf4	skeletal dysplasia	468	HP_0002652	202	206	243	261	False
22196487	We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	ARX	epileptic encephalopathies	10054	HP_0200134	173	176	116	142	False
22196487	We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	CDKL5	epileptic encephalopathies	6792	HP_0200134	211	216	116	142	True
22196487	We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	STXBP1	epileptic encephalopathies	6812	HP_0200134	247	253	116	142	True
22196487	We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	SLC25A22	epileptic encephalopathies	79751	HP_0200134	292	300	116	142	True
22196487	We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	SPTAN1	epileptic encephalopathies	6709	HP_0200134	333	339	116	142	True
22196487	We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	MAGI2	epileptic encephalopathies	9863	HP_0200134	418	423	116	142	False
22196487	We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	PNKP	epileptic encephalopathies	11284	HP_0200134	464	468	116	142	True
22196487	We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	type	epileptic encephalopathies	6445	HP_0200134	495	499	116	142	False
22196487	We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	SCN1A	epileptic encephalopathies	6323	HP_0200134	512	517	116	142	True
22196487	We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	PCDH19	epileptic encephalopathies	57526	HP_0200134	538	544	116	142	False
22196487	We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset epileptic encephalopathies: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (CDKL5), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic -spectrin-1 (SPTAN1), phospholipase C1 (PLC1), membrane-associated guanylate kinase inverted-2 (MAGI2), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1 subunit (SCN1A), protocadherin 19 (PCDH19), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	PNPO	epileptic encephalopathies	55163	HP_0200134	591	595	116	142	True
29229831	Having used a similar strategy for the in silico evaluation of 150 mutations of <i>CYP21A2</i>, the disease-causing gene in congenital adrenal hyperplasia, we now provide a full structural explanation for the clinical severity of AME resulting from each known <i>HSD11B2</i> missense mutation.	HSD11B2	adrenal hyperplasia	3291	HP_0008221	263	270	135	154	False
28195350	Various genes (eg, SPG7, SYNE1, PNPLA6) traditionally rooted in either the ataxia or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one end of the disease continuum and hereditary spastic paraplegia on the other.	SPG7	ataxia	6687	HP_0001251	19	23	75	81	True
28195350	Various genes (eg, SPG7, SYNE1, PNPLA6) traditionally rooted in either the ataxia or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one end of the disease continuum and hereditary spastic paraplegia on the other.	SYNE1	ataxia	23345	HP_0001251	25	30	75	81	True
28195350	Various genes (eg, SPG7, SYNE1, PNPLA6) traditionally rooted in either the ataxia or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one end of the disease continuum and hereditary spastic paraplegia on the other.	PNPLA6	ataxia	10908	HP_0001251	32	38	75	81	True
28195350	Various genes (eg, SPG7, SYNE1, PNPLA6) traditionally rooted in either the ataxia or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one end of the disease continuum and hereditary spastic paraplegia on the other.	end	ataxia	2022	HP_0001251	184	187	75	81	False
28195350	Other genes such as GBA2 and KIF1C were almost simultaneously published as both a hereditary spastic paraplegia and an ataxia gene.	GBA2	ataxia	57704	HP_0001251	20	24	119	125	True
28195350	Other genes such as GBA2 and KIF1C were almost simultaneously published as both a hereditary spastic paraplegia and an ataxia gene.	KIF1C	ataxia	10749	HP_0001251	29	34	119	125	True
27480663	Recessive mutations in BRAT1 cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.	BRAT1	rigidity	221927	HP_0002063	23	28	51	59	True
27480663	Recessive mutations in BRAT1 cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.	BRAT1	multifocal	221927	HP_0030651	23	28	64	74	False
27480663	Recessive mutations in BRAT1 cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.	BRAT1	seizure	221927	HP_0001250	23	28	75	82	True
27480663	Recessive mutations in BRAT1 cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.	BRAT1	microcephaly	221927	HP_0000252	23	28	131	143	True
27480663	Recessive mutations in BRAT1 cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.	BRAT1	hypertonia	221927	HP_0001276	23	28	145	155	True
27480663	Recessive mutations in BRAT1 cause lethal neonatal rigidity and multifocal seizure syndrome, a phenotype characterized by neonatal microcephaly, hypertonia, and refractory epilepsy with premature death by age 2 years.	BRAT1	epilepsy	221927	HP_0001250	23	28	172	180	True
27480663	Here, we report two affected siblings with compound heterozygous truncating mutations in BRAT1 and intra-familial phenotypic heterogeneity, with a less severe disease course in the female sibling.	BRAT1	heterogeneity	221927	HP_0001425	89	94	125	138	False
27480663	This phenotypic variability should be taken into account when treating patients with BRAT1-associated neurodegenerative disease.	BRAT1	neurodegenerative disease	221927	HP_0002180	85	90	102	127	False
27480663	Mildly affected individuals with BRAT1 mutations show that BRAT1 must be considered as a cause in childhood refractory epilepsy and microcephaly with survival beyond infancy.	BRAT1	microcephaly	221927	HP_0000252	33	38	132	144	True
27480663	Mildly affected individuals with BRAT1 mutations show that BRAT1 must be considered as a cause in childhood refractory epilepsy and microcephaly with survival beyond infancy.	BRAT1	epilepsy	221927	HP_0001250	33	38	119	127	True
29959922	However, the role of circRNAs in age-related cataract (ARC), the leading cause of visual impairment worldwide, is still unknown.	ARC	cataract	8996	HP_0000518	55	58	45	53	False
29959922	However, the role of circRNAs in age-related cataract (ARC), the leading cause of visual impairment worldwide, is still unknown.	ARC	visual impairment	8996	HP_0000505	55	58	82	99	False
27924851	DLX3 mutations have been found to be responsible for Tricho-Dento-Osseous (TDO) syndrome, characterized by kinky hair, thin-pitted enamel and increased bone density.	DLX3	increased bone density	1747	HP_0011001	0	4	142	164	True
27924851	DLX3 mutations have been found to be responsible for Tricho-Dento-Osseous (TDO) syndrome, characterized by kinky hair, thin-pitted enamel and increased bone density.	TDO	increased bone density	6999	HP_0011001	75	78	142	164	False
27924851	DLX3 mutations have been found to be responsible for Tricho-Dento-Osseous (TDO) syndrome, characterized by kinky hair, thin-pitted enamel and increased bone density.	act	increased bone density	11332	HP_0011001	94	97	142	164	False
27924851	Here we show that the DLX3 mutation (c.533A&gt;G; Q178R) attenuates osteogenic potential and senescence of bone mesenchymal stem cells (BMSCs) isolated from a TDO patient, providing a molecular explanation for abnormal increased bone density.	DLX3	increased bone density	1747	HP_0011001	22	26	220	242	True
27924851	Here we show that the DLX3 mutation (c.533A&gt;G; Q178R) attenuates osteogenic potential and senescence of bone mesenchymal stem cells (BMSCs) isolated from a TDO patient, providing a molecular explanation for abnormal increased bone density.	TDO	increased bone density	6999	HP_0011001	160	163	220	242	False
30537159	In this study, we found that LASS2 protein level was positively related to InternationalFederationof Gynecology and Obstetrics (FIGO) stage and LASS2-negative tumors showed significant association with longer disease-free survival (DFS) and overall survival (OS) in ovarian cancer patients.	LASS2	tumors	29956	HP_0002664	29	34	161	167	False
30537159	In this study, we found that LASS2 protein level was positively related to InternationalFederationof Gynecology and Obstetrics (FIGO) stage and LASS2-negative tumors showed significant association with longer disease-free survival (DFS) and overall survival (OS) in ovarian cancer patients.	LASS2	cancer	29956	HP_0002664	29	34	276	282	False
30537159	The heterogeneous expression of LASS2 had been exhibited in diverse ovarian cancer cells.	LASS2	cancer	29956	HP_0002664	32	37	76	82	False
30537159	The heterogeneous expression of LASS2 had been exhibited in diverse ovarian cancer cells.	LASS2	heterogeneous	29956	HP_0001425	32	37	4	17	False
30537159	A significantly lower messenger RNA (mRNA) and protein level of LASS2 was seen in 3AO cell compared with those in other types of ovarian cancer cells.	LASS2	cancer	29956	HP_0002664	64	69	137	143	False
30537159	The oncogenic capacity of LASS2 in ovarian cancer may be mediated by increased expression of YAP/TAZ.	LASS2	cancer	29956	HP_0002664	26	31	43	49	False
26138355	Missense mutations in SCN2A (p.Leu1342Pro) and KCNQ2 (p.Ala306Thr) were found in two patients with no history of epilepsy before the onset of ISs.	SCN2A	epilepsy	6326	HP_0001250	22	27	113	121	True
26138355	Missense mutations in SCN2A (p.Leu1342Pro) and KCNQ2 (p.Ala306Thr) were found in two patients with no history of epilepsy before the onset of ISs.	KCNQ2	epilepsy	3785	HP_0001250	47	52	113	121	True
28144995	In this study, we describe the phenotypic spectrum of distal hereditary motor neuropathy caused by mutations in the small heat shock proteins HSPB1 and HSPB8 and investigate the functional consequences of newly discovered variants.	HSPB1	distal	3315	HP_0012839	142	147	54	60	False
28144995	In this study, we describe the phenotypic spectrum of distal hereditary motor neuropathy caused by mutations in the small heat shock proteins HSPB1 and HSPB8 and investigate the functional consequences of newly discovered variants.	HSPB8	distal	26353	HP_0012839	152	157	54	60	False
28144995	In this study, we describe the phenotypic spectrum of distal hereditary motor neuropathy caused by mutations in the small heat shock proteins HSPB1 and HSPB8 and investigate the functional consequences of newly discovered variants.	HSPB1	neuropathy	3315	HP_0009830	142	147	78	88	True
28144995	In this study, we describe the phenotypic spectrum of distal hereditary motor neuropathy caused by mutations in the small heat shock proteins HSPB1 and HSPB8 and investigate the functional consequences of newly discovered variants.	HSPB8	neuropathy	26353	HP_0009830	152	157	78	88	True
28144995	Among 510 unrelated patients with distal motor neuropathy, we identified mutations in HSPB1 (28 index patients/510; 5.5%) and HSPB8 (four index patients/510; 0.8%) genes.	HSPB1	distal	3315	HP_0012839	86	91	34	40	False
28144995	Among 510 unrelated patients with distal motor neuropathy, we identified mutations in HSPB1 (28 index patients/510; 5.5%) and HSPB8 (four index patients/510; 0.8%) genes.	HSPB8	distal	26353	HP_0012839	126	131	34	40	False
28144995	Among 510 unrelated patients with distal motor neuropathy, we identified mutations in HSPB1 (28 index patients/510; 5.5%) and HSPB8 (four index patients/510; 0.8%) genes.	HSPB1	neuropathy	3315	HP_0009830	86	91	47	57	True
28144995	Among 510 unrelated patients with distal motor neuropathy, we identified mutations in HSPB1 (28 index patients/510; 5.5%) and HSPB8 (four index patients/510; 0.8%) genes.	HSPB8	neuropathy	26353	HP_0009830	126	131	47	57	True
28144995	We demonstrate that HSPB1 and HSPB8 mutations are a major cause of inherited motor axonal neuropathy.	HSPB1	neuropathy	3315	HP_0009830	20	25	90	100	True
28144995	We demonstrate that HSPB1 and HSPB8 mutations are a major cause of inherited motor axonal neuropathy.	HSPB8	neuropathy	26353	HP_0009830	30	35	90	100	True
28089576	Mutations in the Pejvakin (Pjvk) gene cause autosomal recessive hearing loss DFNB59 with audiological features of auditory neuropathy spectrum disorder (ANSD) or cochlear dysfunction.	Pjvk	autosomal recessive	494513	HP_0000007	27	31	44	63	True
28089576	Mutations in the Pejvakin (Pjvk) gene cause autosomal recessive hearing loss DFNB59 with audiological features of auditory neuropathy spectrum disorder (ANSD) or cochlear dysfunction.	Pjvk	hearing loss	494513	HP_0000365	27	31	64	76	True
28089576	Mutations in the Pejvakin (Pjvk) gene cause autosomal recessive hearing loss DFNB59 with audiological features of auditory neuropathy spectrum disorder (ANSD) or cochlear dysfunction.	Pjvk	neuropathy	494513	HP_0009830	27	31	123	133	False
28089576	Here, we demonstrate that mice with conditional ablation of the Pjvk gene in all sensory hair cells or only in outer hair cells (OHCs) show similar auditory phenotypes with early-onset profound hearing loss.	Pjvk	hearing loss	494513	HP_0000365	64	68	194	206	True
28089576	Here, we demonstrate that mice with conditional ablation of the Pjvk gene in all sensory hair cells or only in outer hair cells (OHCs) show similar auditory phenotypes with early-onset profound hearing loss.	mice	hearing loss	23581	HP_0000365	26	30	194	206	False
28089576	Here, we demonstrate that mice with conditional ablation of the Pjvk gene in all sensory hair cells or only in outer hair cells (OHCs) show similar auditory phenotypes with early-onset profound hearing loss.	Pjvk	profound	494513	HP_0012829	64	68	185	193	False
28089576	Here, we demonstrate that mice with conditional ablation of the Pjvk gene in all sensory hair cells or only in outer hair cells (OHCs) show similar auditory phenotypes with early-onset profound hearing loss.	mice	profound	23581	HP_0012829	26	30	185	193	False
28089576	By contrast, loss of Pjvk in adult OHCs causes a slowly progressive hearing loss associated with OHC degeneration and delayed loss of inner hair cells (IHCs), indicating a primary role for pejvakin in regulating OHC function and survival.	Pjvk	hearing loss	494513	HP_0000365	21	25	68	80	True
28506993	Finally, we reveal that papillary craniopharyngioma (PCP), a benign human pituitary tumour harbouring <i>BRAF p.V600E</i> also contains Sox2<sup>+</sup> cells with sustained proliferative capacity and disrupted pituitary differentiation.	PCP	craniopharyngioma	54858	HP_0030062	53	56	34	51	False
28506993	Finally, we reveal that papillary craniopharyngioma (PCP), a benign human pituitary tumour harbouring <i>BRAF p.V600E</i> also contains Sox2<sup>+</sup> cells with sustained proliferative capacity and disrupted pituitary differentiation.	PCP	tumour	54858	HP_0002664	53	56	84	90	False
28977530	Although PABPN1 plays a critical role in the regulation of RNA processing, mutation of the gene encoding this ubiquitously expressed RNA binding protein causes a specific form of muscular dystrophy termed oculopharyngeal muscular dystrophy (OPMD).	PABPN1	muscular dystrophy	8106	HP_0003560	9	15	179	197	False
28977530	Although PABPN1 plays a critical role in the regulation of RNA processing, mutation of the gene encoding this ubiquitously expressed RNA binding protein causes a specific form of muscular dystrophy termed oculopharyngeal muscular dystrophy (OPMD).	OPMD	muscular dystrophy	8106	HP_0003560	241	245	179	197	False
28977530	The MATR3 gene is mutated in a form of distal myopathy and amyotrophic lateral sclerosis (ALS).	MATR3	distal	9782	HP_0012839	4	9	39	45	False
28977530	The MATR3 gene is mutated in a form of distal myopathy and amyotrophic lateral sclerosis (ALS).	ALS	distal	3483	HP_0012839	90	93	39	45	False
28977530	The MATR3 gene is mutated in a form of distal myopathy and amyotrophic lateral sclerosis (ALS).	MATR3	myopathy	9782	HP_0003198	4	9	46	54	False
28977530	The MATR3 gene is mutated in a form of distal myopathy and amyotrophic lateral sclerosis (ALS).	ALS	myopathy	3483	HP_0003198	90	93	46	54	False
29452367	Here we report a patient with a congenital syndrome consisting of severe global developmental delay, microcephaly, heart defects, failure to thrive and liver disease with a previously unreported homozygous NM_015352.1: c.485C&gt;T variant (p.Ser162Leu) in POFUT1 detected by exome sequencing.	POFUT1	developmental delay	23509	HP_0001263	256	262	80	99	False
29452367	Here we report a patient with a congenital syndrome consisting of severe global developmental delay, microcephaly, heart defects, failure to thrive and liver disease with a previously unreported homozygous NM_015352.1: c.485C&gt;T variant (p.Ser162Leu) in POFUT1 detected by exome sequencing.	POFUT1	microcephaly	23509	HP_0000252	256	262	101	113	False
29452367	Here we report a patient with a congenital syndrome consisting of severe global developmental delay, microcephaly, heart defects, failure to thrive and liver disease with a previously unreported homozygous NM_015352.1: c.485C&gt;T variant (p.Ser162Leu) in POFUT1 detected by exome sequencing.	POFUT1	failure to thrive	23509	HP_0001508	256	262	130	147	False
29452367	These results suggest that this N-glycan of POFUT1 is not required for its proper enzymatic function, and that the p.Ser162Leu mutation of POFUT1 likely causes global developmental delay, microcephaly with vascular and cardiac defects	POFUT1	developmental delay	23509	HP_0001263	44	50	167	186	False
29452367	These results suggest that this N-glycan of POFUT1 is not required for its proper enzymatic function, and that the p.Ser162Leu mutation of POFUT1 likely causes global developmental delay, microcephaly with vascular and cardiac defects	POFUT1	microcephaly	23509	HP_0000252	44	50	188	200	False
26099505	Also as pro-angiogenic inducer, the role of HMGB1 in different redox states has never been defined in tumour angiogenesis.	HMGB1	tumour	3146	HP_0002664	44	49	102	108	False
26099505	Functional inhibition of HMGB1 and its receptors abrogated HMGB1-induced angiogenic properties of ECs co-cultured with tumour cells.	HMGB1	tumour	3146	HP_0002664	25	30	119	125	False
26099505	HMGB1 orchestrates the key events of tumour angiogenesis, migration of ECs and their induction to secrete VEGF-A, by adopting distinct redox states.	HMGB1	tumour	3146	HP_0002664	0	5	37	43	False
26099505	HMGB1 orchestrates the key events of tumour angiogenesis, migration of ECs and their induction to secrete VEGF-A, by adopting distinct redox states.	VEGF-A	tumour	7422	HP_0002664	106	112	37	43	False
30071039	Several advances have been made in the treatment of HER2-positive breast cancer, yet issues of resistance and poor response to therapy remains prevalent.	HER2	cancer	2064	HP_0002664	52	56	73	79	True
28436964	We find that SWELL1-mediated VRAC is augmented in hypertrophic murine and human adipocytes in the setting of obesity.	SWELL1	obesity	56262	HP_0001513	13	19	109	116	False
28436964	We find that SWELL1-mediated VRAC is augmented in hypertrophic murine and human adipocytes in the setting of obesity.	find	obesity	81501	HP_0001513	3	7	109	116	False
28545977	Glutaric aciduria type I (GA-I) is a rare organic aciduria caused by the autosomal recessive inherited deficiency of glutaryl-CoA dehydrogenase (GCDH).	type	organic aciduria	6445	HP_0001992	18	22	42	58	False
28545977	Glutaric aciduria type I (GA-I) is a rare organic aciduria caused by the autosomal recessive inherited deficiency of glutaryl-CoA dehydrogenase (GCDH).	GCDH	organic aciduria	2639	HP_0001992	145	149	42	58	True
28545977	Glutaric aciduria type I (GA-I) is a rare organic aciduria caused by the autosomal recessive inherited deficiency of glutaryl-CoA dehydrogenase (GCDH).	GA	organic aciduria	27165	HP_0001992	26	28	42	58	False
28545977	Glutaric aciduria type I (GA-I) is a rare organic aciduria caused by the autosomal recessive inherited deficiency of glutaryl-CoA dehydrogenase (GCDH).	type	autosomal recessive	6445	HP_0000007	18	22	73	92	True
28545977	Glutaric aciduria type I (GA-I) is a rare organic aciduria caused by the autosomal recessive inherited deficiency of glutaryl-CoA dehydrogenase (GCDH).	GCDH	autosomal recessive	2639	HP_0000007	145	149	73	92	True
28545977	Glutaric aciduria type I (GA-I) is a rare organic aciduria caused by the autosomal recessive inherited deficiency of glutaryl-CoA dehydrogenase (GCDH).	GA	autosomal recessive	27165	HP_0000007	26	28	73	92	False
27177047	Auditory neuropathy is a type of hearing loss that constitutes a change in the conduct of the auditory stimulus by the involvement of inner hair cells or auditory nerve synapses.	type	neuropathy	6445	HP_0009830	25	29	9	19	False
27177047	Auditory neuropathy is a type of hearing loss that constitutes a change in the conduct of the auditory stimulus by the involvement of inner hair cells or auditory nerve synapses.	type	hearing loss	6445	HP_0000365	25	29	33	45	False
27177047	At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.	OTOF	neuropathy	9381	HP_0009830	144	148	61	71	False
27177047	At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.	PJVK	neuropathy	494513	HP_0009830	215	219	61	71	False
27177047	At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.	DIAPH3	neuropathy	81624	HP_0009830	351	357	61	71	False
27177047	At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.	OTOF	autosomal recessive	9381	HP_0000007	144	148	160	179	True
27177047	At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.	PJVK	autosomal recessive	494513	HP_0000007	215	219	160	179	True
27177047	At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.	DIAPH3	autosomal recessive	81624	HP_0000007	351	357	160	179	False
27177047	At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.	OTOF	inheritance	9381	HP_0000005	144	148	264	275	False
27177047	At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.	PJVK	inheritance	494513	HP_0000005	215	219	264	275	False
27177047	At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.	DIAPH3	inheritance	81624	HP_0000005	351	357	264	275	False
27177047	At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.	OTOF	deafness	9381	HP_0000365	144	148	110	118	True
27177047	At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.	PJVK	deafness	494513	HP_0000365	215	219	110	118	True
27177047	At present, four loci associated with nonsyndromic auditory neuropathy have been mapped: Autosomal recessive deafness9 [DFNB9; the otoferlin (OTOF) gene] and autosomal recessive deafness59 [DFNB59; the pejvakin (PJVK) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous3 (DIAPH3) gene]; and AUNX1, linked to chromosomeX.	DIAPH3	deafness	81624	HP_0000365	351	357	110	118	True
27177047	OTOF gene mutations exert a significant role in auditory neuropathy.	OTOF	neuropathy	9381	HP_0009830	0	4	57	67	False
27177047	The identification of genetic alterations responsible for auditory neuropathy is one of the challenges contributing to understand the molecular bases of the different phenotypes of hearing loss.	type	neuropathy	6445	HP_0009830	172	176	67	77	False
27177047	The identification of genetic alterations responsible for auditory neuropathy is one of the challenges contributing to understand the molecular bases of the different phenotypes of hearing loss.	type	hearing loss	6445	HP_0000365	172	176	181	193	False
27177047	Thus, the present study aimed to investigate molecular changes in the OTOF gene in patients with auditory neuropathy, and to develop a DNA chip for the molecular diagnosis of auditory neuropathy using mass spectrometry for genotyping.	OTOF	neuropathy	9381	HP_0009830	70	74	106	116	False
27177047	Thus, the present study aimed to investigate molecular changes in the OTOF gene in patients with auditory neuropathy, and to develop a DNA chip for the molecular diagnosis of auditory neuropathy using mass spectrometry for genotyping.	chip	neuropathy	10273	HP_0009830	139	143	106	116	True
27177047	Thus, the present study aimed to investigate molecular changes in the OTOF gene in patients with auditory neuropathy, and to develop a DNA chip for the molecular diagnosis of auditory neuropathy using mass spectrometry for genotyping.	mass	neuropathy	2200	HP_0009830	201	205	106	116	True
27177047	Genetic alterations were investigated in 47patients with hearing loss and clinical diagnosis of auditory neuropathy, and the c.35delG mutation in the GJB2 gene was identified in three homozygous patients, and the heterozygous parents of one of these cases.	GJB2	neuropathy	2706	HP_0009830	151	155	106	116	False
27177047	Genetic alterations were investigated in 47patients with hearing loss and clinical diagnosis of auditory neuropathy, and the c.35delG mutation in the GJB2 gene was identified in three homozygous patients, and the heterozygous parents of one of these cases.	GJB2	hearing loss	2706	HP_0000365	151	155	58	70	True
27508411	WWS is a multigenic disorder characterised by muscular dystrophy as well as brain and eye anomalies.	WWS	muscular dystrophy	55906	HP_0003560	0	3	46	64	False
27520484	Further, exposure to the Notch signaling inhibitor and gene silencing studies showed that Notch signaling inhibition or silencing Nothc4/Dll3 decreased endothelial markers and function of tumor-derived endothelial cells under chemotherapy treatment, which may be through VEGFR3.	VEGF	tumor	7422	HP_0002664	271	275	188	193	False
27520484	Thus, our findings demonstrate that chemotherapy induces functional tumor-derived endothelial microvessels by mediating Notch signaling and VEGF signaling, and may provide new targets for anti-angiogenesis therapy in breast cancer	VEGF	tumor	7422	HP_0002664	140	144	68	73	False
29526753	Microfibrillar-associated protein 5 (MFAP5) is a component of extracellular elastic microfibril which has been confirmed to function in tissue development and cancer progression.	MFAP5	cancer	8076	HP_0002664	37	42	159	165	False
29526753	But the role of MFAP5 in breast cancer remains unclear.	MFAP5	cancer	8076	HP_0002664	16	21	32	38	False
29526753	The present study demonstrated that MFAP5 was up-regulated in breast cancers compared with that in normal breast tissues, and further increased in breast cancer bone metastasis.	MFAP5	cancer	8076	HP_0002664	36	41	69	75	False
29526753	Functionally, MFAP5 overexpression accelerated breast cancer cell proliferation and migration, while an opposite effect was observed when MFAP5 was knocked down.	MFAP5	cancer	8076	HP_0002664	14	19	54	60	False
29526753	These findings may provide a better understanding about the mechanism of breast cancer and suggest that MFAP5 may be a potential prognostic biomarker and therapeutic target for breast cancer, especially for bone metastasis of breast cancer	MFAP5	cancer	8076	HP_0002664	104	109	80	86	False
29391521	To date, over 150 disease-associated variants in CRB1 have been described, resulting in a range of retinal disease phenotypes including Leber congenital amaurosis and retinitis pigmentosa.	CRB1	retinal disease	23418	HP_0000479	49	53	99	114	True
29391521	We performed a retrospective review of electronic patient records to identify patients with macular dystrophy due to bi-allelic variants in CRB1.	CRB1	macular dystrophy	23418	HP_0007754	140	144	92	109	False
30048532	The main objective of this study is to provide a brief version of the Spanish translation of the PIP, across a sample consisting of 465 main familial caregivers (85.2% female, n = 396) between 27 and 67 years old ([Formula: see text] = 44.13; SD = 5.35) of paediatric patients between 9 and 18 years old ([Formula: see text] = 12.10, SD = 2.20; 56.8% men, n = 264) diagnosed with diabetes mellitus type I (20.9% of the sample; n = 97), short stature (32.5% of the sample; n = 151), or a chronic respiratory disease (asthma, cystic fibrosis, bronchiolitis obliterans and bronchiectasis) (46.6% of the sample; n = 217).	PIP	short stature	5304	HP_0004322	97	100	436	449	False
30048532	The main objective of this study is to provide a brief version of the Spanish translation of the PIP, across a sample consisting of 465 main familial caregivers (85.2% female, n = 396) between 27 and 67 years old ([Formula: see text] = 44.13; SD = 5.35) of paediatric patients between 9 and 18 years old ([Formula: see text] = 12.10, SD = 2.20; 56.8% men, n = 264) diagnosed with diabetes mellitus type I (20.9% of the sample; n = 97), short stature (32.5% of the sample; n = 151), or a chronic respiratory disease (asthma, cystic fibrosis, bronchiolitis obliterans and bronchiectasis) (46.6% of the sample; n = 217).	men	short stature	8178	HP_0004322	351	354	436	449	False
30048532	The main objective of this study is to provide a brief version of the Spanish translation of the PIP, across a sample consisting of 465 main familial caregivers (85.2% female, n = 396) between 27 and 67 years old ([Formula: see text] = 44.13; SD = 5.35) of paediatric patients between 9 and 18 years old ([Formula: see text] = 12.10, SD = 2.20; 56.8% men, n = 264) diagnosed with diabetes mellitus type I (20.9% of the sample; n = 97), short stature (32.5% of the sample; n = 151), or a chronic respiratory disease (asthma, cystic fibrosis, bronchiolitis obliterans and bronchiectasis) (46.6% of the sample; n = 217).	type	short stature	6445	HP_0004322	398	402	436	449	False
30701745	Family hyperaldosteronism type I (glucocorticoids-remediable hyperaldosteronism) is a rare form of symptomatic arterial hypertension (AH), which often leads to the development of cerebrovascular complications.	type	hyperaldosteronism	6445	HP_0000859	26	30	7	25	False
29992558	Only a few genes, including SMARCA4, SMO, ZNF44 and CHD2, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this tumor.	SMARCA4	tumor	6597	HP_0002664	28	35	175	180	False
29992558	Only a few genes, including SMARCA4, SMO, ZNF44 and CHD2, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this tumor.	SMO	tumor	54498	HP_0002664	37	40	175	180	False
29992558	Only a few genes, including SMARCA4, SMO, ZNF44 and CHD2, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this tumor.	ZNF44	tumor	51710	HP_0002664	42	47	175	180	False
29992558	Only a few genes, including SMARCA4, SMO, ZNF44 and CHD2, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this tumor.	CHD2	tumor	1106	HP_0002664	52	56	175	180	False
29973584	Large-scale tumor sequencing has revolutionized the identification of somatic driver alterations but has had limited impact on the identification of cancer predisposition genes (CPGs).	impact	cancer	55364	HP_0002664	117	123	149	155	False
29973584	Large-scale tumor sequencing has revolutionized the identification of somatic driver alterations but has had limited impact on the identification of cancer predisposition genes (CPGs).	impact	tumor	55364	HP_0002664	117	123	12	17	False
29973584	Applied to ~10,000 tumor exomes the approach identifies known and putative CPGs - including the chromatin modifier NSD1 -that contribute to cancer through a combination of rare germline variants and somatic loss-of-heterozygosity (LOH).	NSD1	cancer	64324	HP_0002664	115	119	141	147	True
29973584	Applied to ~10,000 tumor exomes the approach identifies known and putative CPGs - including the chromatin modifier NSD1 -that contribute to cancer through a combination of rare germline variants and somatic loss-of-heterozygosity (LOH).	NSD1	tumor	64324	HP_0002664	115	119	19	24	True
27389535	Using a proteomics screen, we now show that the mitochondrial unfoldase-peptidase complex ClpXP associates with the oncoprotein survivin and the respiratory chain Complex II subunit succinate dehydrogenase B (SDHB) in mitochondria of tumor cells.	survivin	tumor	332	HP_0002664	128	136	234	239	False
27389535	Using a proteomics screen, we now show that the mitochondrial unfoldase-peptidase complex ClpXP associates with the oncoprotein survivin and the respiratory chain Complex II subunit succinate dehydrogenase B (SDHB) in mitochondria of tumor cells.	SDHB	tumor	6390	HP_0002664	209	213	234	239	True
27389535	Using a proteomics screen, we now show that the mitochondrial unfoldase-peptidase complex ClpXP associates with the oncoprotein survivin and the respiratory chain Complex II subunit succinate dehydrogenase B (SDHB) in mitochondria of tumor cells.	ClpX	tumor	10845	HP_0002664	90	94	234	239	False
27389535	Deregulated mitochondrial respiration induced by ClpXP targeting causes oxidative stress, which in turn reduces tumor cell proliferation, suppresses cell motility, and abolishes metastatic dissemination in vivo.	ClpX	tumor	10845	HP_0002664	49	53	112	117	False
27389535	ClpP is universally overexpressed in primary and metastatic human cancer, correlating with shortened patient survival.	ClpP	cancer	8192	HP_0002664	0	4	66	72	False
27389535	Therefore, tumors exploit ClpXP-directed proteostasis to maintain mitochondrial bioenergetics, buffer oxidative stress, and enable metastatic competence.	ClpX	tumor	10845	HP_0002664	26	30	11	16	False
30624777	However, the exact compounds of areca nut causing oral cancer remain unproven.	nut	cancer	256646	HP_0002664	38	41	55	61	False
30624777	We found that NOTCH1 regulates TP53 expression from NOTCH1 knockdown oral cancer cells.	NOTCH1	cancer	4851	HP_0002664	14	20	74	80	True
26782618	Occult macular dystrophy (OMD) is an inherited macular disease characterized by progressive visual decline with the absence of visible retinal abnormalities.	OMD	macular dystrophy	4958	HP_0007754	26	29	7	24	False
28752220	Therefore, hypertrophic cardiomyopathy and tubulopathy may not be considered as constant features of MRPS22.	MRPS22	cardiomyopathy	56945	HP_0001638	101	107	24	38	True
27493007	The genetic study by panels of known genes associated with tubulointerstitial disease allowed us to discover autosomal dominant distal renal tubular acidosis associated with a de novo mutation in exon 14 of the SLC4A1 gene, which would have been impossible to diagnose clinically due to the advanced nature of the kidney disease when it was discovered	SLC4A1	distal	6521	HP_0012839	211	217	128	134	False
27493007	The genetic study by panels of known genes associated with tubulointerstitial disease allowed us to discover autosomal dominant distal renal tubular acidosis associated with a de novo mutation in exon 14 of the SLC4A1 gene, which would have been impossible to diagnose clinically due to the advanced nature of the kidney disease when it was discovered	SLC4A1	renal tubular acidosis	6521	HP_0001947	211	217	135	157	True
28610891	Mucolipidosis type IV (MLIV) is a lysosomal storage disease exhibiting progressive intellectual disability, motor impairment, and premature death.	type	intellectual disability	6445	HP_0001249	14	18	83	106	False
28610891	Mucolipidosis type IV (MLIV) is a lysosomal storage disease exhibiting progressive intellectual disability, motor impairment, and premature death.	MLIV	intellectual disability	57192	HP_0001249	23	27	83	106	True
28610891	Several studies have demonstrated that N-butyldeoxynojirimycin (NB-DNJ, also known as miglustat), an inhibitor of the enzyme glucosylceramide synthase (GCS), successfully delays the onset of motor deficits, improves longevity, and rescues some of the cerebellar abnormalities (e.g., Purkinje cell death) seen in another lysosomal disease known as Niemann-Pick type C (NPC).	type	cerebellar abnormalities	6445	HP_0001317	360	364	251	275	False
28610891	Several studies have demonstrated that N-butyldeoxynojirimycin (NB-DNJ, also known as miglustat), an inhibitor of the enzyme glucosylceramide synthase (GCS), successfully delays the onset of motor deficits, improves longevity, and rescues some of the cerebellar abnormalities (e.g., Purkinje cell death) seen in another lysosomal disease known as Niemann-Pick type C (NPC).	GCS	cerebellar abnormalities	2729	HP_0001317	152	155	251	275	False
29486327	The fat mass and obesity-associated (FTO) gene is tightly related to body weight and fat mass, and plays a pivotal role in regulating lipid accumulation in hepatocytes.	fat	obesity	948	HP_0001513	4	7	17	24	False
29486327	The fat mass and obesity-associated (FTO) gene is tightly related to body weight and fat mass, and plays a pivotal role in regulating lipid accumulation in hepatocytes.	mass	obesity	2200	HP_0001513	8	12	17	24	False
29486327	The fat mass and obesity-associated (FTO) gene is tightly related to body weight and fat mass, and plays a pivotal role in regulating lipid accumulation in hepatocytes.	FTO	obesity	79068	HP_0001513	37	40	17	24	True
28031292	Mutations in the DNAJB2 gene lead to inherited neuropathies such as Charcot-Marie-Tooth type-2, distal hereditary motor neuropathies, spinal muscular atrophy with parkinsonism and the later stages can resemble amyotrophic lateral sclerosis.	DNAJB2	parkinsonism	3300	HP_0001300	17	23	163	175	False
29253764	Minichromosome maintenance protein 5 (MCM5) has been suggested overexpressed in cervical cancer, but the clinical value and biological function of MCM5 in cervical cancer is still unknown.	MCM5	cancer	4174	HP_0002664	38	42	89	95	False
29253764	In our study, MCM5 mRNA and protein were significantly overexpressed in cervical cancer tissues and cell lines compared with normal cervical tissues and cell lines, and were obviously increased in cervical adenocarcinoma tissues and cell lines in comparison to cervical squamous cell carcinoma tissues and cell lines.	MCM5	cancer	4174	HP_0002664	14	18	81	87	False
29253764	In our study, MCM5 mRNA and protein were significantly overexpressed in cervical cancer tissues and cell lines compared with normal cervical tissues and cell lines, and were obviously increased in cervical adenocarcinoma tissues and cell lines in comparison to cervical squamous cell carcinoma tissues and cell lines.	MCM5	squamous cell carcinoma	4174	HP_0002860	14	18	270	293	False
28121444	A set of ten plasma and serum samples from subjects with multiple sclerosis, narcolepsy, and without any disease diagnosis were profiled on a peptide array representing the whole proteome, hosting 2.2 million 12-mer peptides with a six amino acid lateral shift.	set	narcolepsy	6418	HP_0030050	2	5	77	87	False
28121444	The presented workflow employed three different peptide microarray formats to discover and resolve the epitopes of human autoantibodies and revealed two potentially new autoantigens: MAP3K7 in multiple sclerosis and NRXN1 in narcolepsy.	MAP3K7	narcolepsy	6885	HP_0030050	183	189	225	235	False
28121444	The presented workflow employed three different peptide microarray formats to discover and resolve the epitopes of human autoantibodies and revealed two potentially new autoantigens: MAP3K7 in multiple sclerosis and NRXN1 in narcolepsy.	NRXN1	narcolepsy	9378	HP_0030050	216	221	225	235	False
26214590	Inactivating NF1 mutations were present in 46% of melanomas expressing wild-type BRAF and RAS, occurred in older patients and showed a distinct pattern of co-mutation with other RASopathy genes, particularly RASA2.	BRAF	melanomas	673	HP_0002861	81	85	50	59	True
26835907	CSD refers to an intractable diarrhea of intrauterine onset with high fecal sodium loss.	CSD	intrauterine onset	51380	HP_0003577	0	3	41	59	False
26835907	CSD is clinically and genetically heterogeneous.	CSD	heterogeneous	51380	HP_0001425	0	3	34	47	False
26835907	A syndromic form of CSD features choanal and intestinal atresias as well as recurrent corneal erosions.	CSD	intestinal atresias	51380	HP_0011100	20	23	45	64	False
26835907	It is autosomal recessively inherited, and caused by SPINT2 mutations.	SPINT2	autosomal recessive	10653	HP_0000007	53	59	6	25	True
26835907	The nonsyndromic form of CSD can be caused by dominant activating mutations in GUCY2C, encoding intestinal receptor guanylate cyclase C (GC-C), and by autosomal recessive SLC9A3 loss-of-function mutations.	CSD	autosomal recessive	51380	HP_0000007	25	28	151	170	False
26835907	The nonsyndromic form of CSD can be caused by dominant activating mutations in GUCY2C, encoding intestinal receptor guanylate cyclase C (GC-C), and by autosomal recessive SLC9A3 loss-of-function mutations.	GUCY2C	autosomal recessive	2984	HP_0000007	79	85	151	170	True
26835907	The nonsyndromic form of CSD can be caused by dominant activating mutations in GUCY2C, encoding intestinal receptor guanylate cyclase C (GC-C), and by autosomal recessive SLC9A3 loss-of-function mutations.	SLC9A3	autosomal recessive	6550	HP_0000007	171	177	151	170	True
30125602	However, unconditioned NRGS mice developed less clinically relevant disease, with CDXs forming solid tumors throughout the body, whereas unconditioned NRG mice were incapable of efficiently supporting PDX or human hematopoietic stem cell engraftment.	mice	tumors	23581	HP_0002664	28	32	101	107	False
30213139	The formation of neurofibrillary tangles (NFT) and its precursor tau oligomers have been suggested as main cause of neuronal degeneration because of a direct correlation of their density to the degree of dementia.	tau	neurofibrillary tangles	4137	HP_0002185	65	68	17	40	True
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	SNCA	autosomal recessive	6622	HP_0000007	180	184	280	299	False
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	LRRK2	autosomal recessive	120892	HP_0000007	173	178	280	299	False
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	VPS35	autosomal recessive	55737	HP_0000007	186	191	280	299	False
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	GCH1	autosomal recessive	2643	HP_0000007	193	197	280	299	True
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	ATXN2	autosomal recessive	6311	HP_0000007	199	204	280	299	False
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	DNAJC13	autosomal recessive	23317	HP_0000007	206	213	280	299	False
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	TMEM230	autosomal recessive	29058	HP_0000007	215	222	280	299	False
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	GIGYF2	autosomal recessive	26058	HP_0000007	224	230	280	299	False
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	HTRA2	autosomal recessive	27429	HP_0000007	232	237	280	299	True
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	RIC3	autosomal recessive	79608	HP_0000007	239	243	280	299	False
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	EIF4G1	autosomal recessive	1981	HP_0000007	245	251	280	299	False
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	UCHL1	autosomal recessive	7345	HP_0000007	253	258	280	299	True
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	CHCHD2	autosomal recessive	51142	HP_0000007	260	266	280	299	False
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	GBA	autosomal recessive	2629	HP_0000007	272	275	280	299	True
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	PRKN	autosomal recessive	5071	HP_0000007	318	322	280	299	True
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	PINK1	autosomal recessive	65018	HP_0000007	324	329	280	299	True
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	ATP13A2	autosomal recessive	23400	HP_0000007	336	343	280	299	True
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	PLA2G6	autosomal recessive	8398	HP_0000007	345	351	280	299	True
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	FBXO7	autosomal recessive	25793	HP_0000007	353	358	280	299	True
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	DNAJC6	autosomal recessive	9829	HP_0000007	360	366	280	299	True
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	SYNJ1	autosomal recessive	8867	HP_0000007	368	373	280	299	True
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	SPG11	autosomal recessive	80208	HP_0000007	375	380	280	299	True
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	VPS13C	autosomal recessive	54832	HP_0000007	382	388	280	299	True
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	PODXL	autosomal recessive	5420	HP_0000007	390	395	280	299	False
30245141	We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, GIGYF2, HTRA2, RIC3, EIF4G1, UCHL1, CHCHD2, and GBA; or autosomal recessive (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, PLA2G6, FBXO7, DNAJC6, SYNJ1, SPG11, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	PTRHD1	autosomal recessive	391356	HP_0000007	401	407	280	299	False
17804352	In 2005, CLTC clients were significantly more likely to have chronic conditions, including hypertension, chronic obstructive pulmonary disease, Alzheimer's disease, arthritis, diabetes, and renal failure (all p &lt; 0.05).	CLTC	hypertension	1213	HP_0000822	9	13	91	103	False
17804352	In 2005, CLTC clients were significantly more likely to have chronic conditions, including hypertension, chronic obstructive pulmonary disease, Alzheimer's disease, arthritis, diabetes, and renal failure (all p &lt; 0.05).	CLTC	renal failure	1213	HP_0000083	9	13	190	203	False
30158849	Homozygous null mutation of tumor suppressor <i>WWOX/Wwox</i> gene leads to severe neural diseases, metabolic disorders and early death in the newborns of humans, mice and rats.	WWOX	tumor	51741	HP_0002664	48	52	28	33	True
30158849	Homozygous null mutation of tumor suppressor <i>WWOX/Wwox</i> gene leads to severe neural diseases, metabolic disorders and early death in the newborns of humans, mice and rats.	Wwox	tumor	51741	HP_0002664	53	57	28	33	True
30158849	Homozygous null mutation of tumor suppressor <i>WWOX/Wwox</i> gene leads to severe neural diseases, metabolic disorders and early death in the newborns of humans, mice and rats.	mice	tumor	23581	HP_0002664	163	167	28	33	False
30158849	<i>In vitro</i> analysis revealed that knockdown of WWOX protein in neuroblastoma cells results in aggregation of TRAPPC6A, TIAF1, amyloid , and Tau in a sequential manner.	WWOX	neuroblastoma	51741	HP_0003006	52	56	68	81	False
30158849	<i>In vitro</i> analysis revealed that knockdown of WWOX protein in neuroblastoma cells results in aggregation of TRAPPC6A, TIAF1, amyloid , and Tau in a sequential manner.	TIAF1	neuroblastoma	9220	HP_0003006	125	130	68	81	False
30158849	<i>In vitro</i> analysis revealed that knockdown of WWOX protein in neuroblastoma cells results in aggregation of TRAPPC6A, TIAF1, amyloid , and Tau in a sequential manner.	Tau	neuroblastoma	4137	HP_0003006	147	150	68	81	False
30158849	<i>In vitro</i> analysis revealed that knockdown of WWOX protein in neuroblastoma cells results in aggregation of TRAPPC6A, TIAF1, amyloid , and Tau in a sequential manner.	APP	neuroblastoma	351	HP_0003006	116	119	68	81	False
27345729	Hennekam lymphangiectasia-lymphedema syndrome is an autosomal recessive disorder, with 25% of patients having mutations in CCBE1.	CCBE1	autosomal recessive	147372	HP_0000007	123	128	52	71	True
22786707	These clinical and imaging findings are unlike that of any recognized severe forms of microcephaly which is believed to be a new microcephalic primordial dwarfism (MPD) with developmental brain malformations with most probably autosomal recessive inheritance based on consanguinity and similarly affected male and female sibs	MPD	microcephaly	4597	HP_0000252	164	167	86	98	False
22786707	These clinical and imaging findings are unlike that of any recognized severe forms of microcephaly which is believed to be a new microcephalic primordial dwarfism (MPD) with developmental brain malformations with most probably autosomal recessive inheritance based on consanguinity and similarly affected male and female sibs	MPD	autosomal recessive	4597	HP_0000007	164	167	227	246	False
22786707	These clinical and imaging findings are unlike that of any recognized severe forms of microcephaly which is believed to be a new microcephalic primordial dwarfism (MPD) with developmental brain malformations with most probably autosomal recessive inheritance based on consanguinity and similarly affected male and female sibs	MPD	inheritance	4597	HP_0000005	164	167	247	258	False
24430573	Biallelic mutations in the YARS2 gene encoding mitochondrial tyrosyl-tRNA synthetase cause myopathy, lactic acidosis, and sideroblastic anemia 2 (MLASA2), a type of mitochondrial disease.	YARS2	lactic acidosis	51067	HP_0003128	27	32	101	116	True
24430573	Biallelic mutations in the YARS2 gene encoding mitochondrial tyrosyl-tRNA synthetase cause myopathy, lactic acidosis, and sideroblastic anemia 2 (MLASA2), a type of mitochondrial disease.	type	lactic acidosis	6445	HP_0003128	157	161	101	116	False
23544012	Common genetic variants contribute to the observed variation in breast cancer risk for BRCA2 mutation carriers; those known to date have all been found through population-based genome-wide association studies (GWAS).	BRCA2	cancer	675	HP_0002664	87	92	71	77	True
23544012	To comprehensively identify breast cancer risk modifying loci for BRCA2 mutation carriers, we conducted a deep replication of an ongoing GWAS discovery study.	BRCA2	cancer	675	HP_0002664	66	71	35	41	True
23544012	DNA samples from 3,881 breast cancer affected and 4,330 unaffected BRCA2 mutation carriers from 47 studies belonging to the Consortium of Investigators of Modifiers of BRCA1/2 were genotyped and available for analysis.	BRCA2	cancer	675	HP_0002664	67	72	30	36	True
23544012	DNA samples from 3,881 breast cancer affected and 4,330 unaffected BRCA2 mutation carriers from 47 studies belonging to the Consortium of Investigators of Modifiers of BRCA1/2 were genotyped and available for analysis.	BRCA1	cancer	672	HP_0002664	168	173	30	36	True
23544012	We replicated previously reported breast cancer susceptibility alleles in these BRCA2 mutation carriers and for several regions (including FGFR2, MAP3K1, CDKN2A/B, and PTHLH) identified SNPs that have stronger evidence of association than those previously published.	BRCA2	cancer	675	HP_0002664	80	85	41	47	True
23544012	We replicated previously reported breast cancer susceptibility alleles in these BRCA2 mutation carriers and for several regions (including FGFR2, MAP3K1, CDKN2A/B, and PTHLH) identified SNPs that have stronger evidence of association than those previously published.	FGFR2	cancer	2263	HP_0002664	139	144	41	47	True
23544012	We replicated previously reported breast cancer susceptibility alleles in these BRCA2 mutation carriers and for several regions (including FGFR2, MAP3K1, CDKN2A/B, and PTHLH) identified SNPs that have stronger evidence of association than those previously published.	MAP3K1	cancer	4214	HP_0002664	146	152	41	47	True
23544012	We replicated previously reported breast cancer susceptibility alleles in these BRCA2 mutation carriers and for several regions (including FGFR2, MAP3K1, CDKN2A/B, and PTHLH) identified SNPs that have stronger evidence of association than those previously published.	PTHLH	cancer	5744	HP_0002664	168	173	41	47	False
23544012	This SNP was not associated with breast cancer risk either in the general population or in BRCA1 mutation carriers.	BRCA1	cancer	672	HP_0002664	91	96	40	46	True
23544012	The locus lies within a region containing TFAP2A, which encodes a transcriptional activation protein that interacts with several tumor suppressor genes.	TFAP2A	tumor	7020	HP_0002664	42	48	129	134	True
23544012	This report identifies the first breast cancer risk locus specific to a BRCA2 mutation background.	BRCA2	cancer	675	HP_0002664	72	77	40	46	True
23544012	This comprehensive update of novel and previously reported breast cancer susceptibility loci contributes to the establishment of a panel of SNPs that modify breast cancer risk in BRCA2 mutation carriers.	BRCA2	cancer	675	HP_0002664	179	184	66	72	True
29777712	In the present study, our results indicated that SPOP expression was significantly downregulated in HCC and was associated with tumor size, differentiation and metastasis.	HCC	tumor	84668	HP_0002664	100	103	128	133	False
29777712	In the present study, our results indicated that SPOP expression was significantly downregulated in HCC and was associated with tumor size, differentiation and metastasis.	SPOP	tumor	8405	HP_0002664	49	53	128	133	False
24777537	Mutations in LIAS have been identified that result in a variant form of nonketotic hyperglycinemia with early-onset convulsions combined with a defect in mitochondrial energy metabolism with encephalopathy and cardiomyopathy.	LIAS	encephalopathy	11019	HP_0001298	13	17	191	205	True
24777537	Mutations in LIAS have been identified that result in a variant form of nonketotic hyperglycinemia with early-onset convulsions combined with a defect in mitochondrial energy metabolism with encephalopathy and cardiomyopathy.	LIAS	cardiomyopathy	11019	HP_0001638	13	17	210	224	True
26518168	Trichothiodystrophy (TTD), also known as sulfur-deficient brittle hair syndrome, is a rare autosomal recessive multisystem disorder, which manifests with brittle hair, mental retardation, ichthyosis and decreased fertility.	TTD	autosomal recessive	404672	HP_0000007	21	24	91	110	True
26518168	Trichothiodystrophy (TTD), also known as sulfur-deficient brittle hair syndrome, is a rare autosomal recessive multisystem disorder, which manifests with brittle hair, mental retardation, ichthyosis and decreased fertility.	TTD	brittle hair	404672	HP_0002299	21	24	58	70	True
29521944	The major categories of pancreatic neuroendocrine tumor (PanNET) are well-differentiated NET and poorly differentiated neuroendocrine carcinoma.	NET	tumor	2004	HP_0002664	60	63	50	55	False
29521944	Sequencing of these tumors has identified multiple important genes in the pathogenesis of PanNETs, such as DAXX/ATRX, MEN1, TP53, RB, and mTOR pathway genes.	NET	tumor	2004	HP_0002664	93	96	20	25	False
29521944	Sequencing of these tumors has identified multiple important genes in the pathogenesis of PanNETs, such as DAXX/ATRX, MEN1, TP53, RB, and mTOR pathway genes.	DAXX	tumor	1616	HP_0002664	107	111	20	25	True
29521944	Sequencing of these tumors has identified multiple important genes in the pathogenesis of PanNETs, such as DAXX/ATRX, MEN1, TP53, RB, and mTOR pathway genes.	MEN1	tumor	4221	HP_0002664	118	122	20	25	True
29521944	Sequencing of these tumors has identified multiple important genes in the pathogenesis of PanNETs, such as DAXX/ATRX, MEN1, TP53, RB, and mTOR pathway genes.	mTOR	tumor	2475	HP_0002664	138	142	20	25	False
29521944	Our data support that high-grade progression in PanNETs may be the result of the progressive accumulation of genetic changes (CNVs and point mutational changes) within the body of the tumor.	NET	tumor	2004	HP_0002664	51	54	184	189	False
29659833	Mutations in IFT172 lead to diseases ranging from isolated retinal degeneration to severe syndromic ciliopathies.	IFT172	retinal degeneration	26160	HP_0000546	13	19	59	79	True
29659833	In this study, we created a mouse model of IFT172-associated retinal degeneration to investigate the ocular disease mechanism.	IFT172	retinal degeneration	26160	HP_0000546	43	49	61	81	True
29659833	We investigated molecular mechanisms of degeneration and show that IFT172 protein reduction leads to mislocalization of specific photoreceptor outersegment (OS) proteins (RHO, RP1, IFT139), aberrant light-driven translocation of alpha transducin and altered localization of glioma-associated oncogene family member 1 (GLI1).	IFT172	glioma	26160	HP_0009733	67	73	274	280	False
29659833	We investigated molecular mechanisms of degeneration and show that IFT172 protein reduction leads to mislocalization of specific photoreceptor outersegment (OS) proteins (RHO, RP1, IFT139), aberrant light-driven translocation of alpha transducin and altered localization of glioma-associated oncogene family member 1 (GLI1).	RHO	glioma	6010	HP_0009733	171	174	274	280	False
29659833	We investigated molecular mechanisms of degeneration and show that IFT172 protein reduction leads to mislocalization of specific photoreceptor outersegment (OS) proteins (RHO, RP1, IFT139), aberrant light-driven translocation of alpha transducin and altered localization of glioma-associated oncogene family member 1 (GLI1).	IFT139	glioma	79809	HP_0009733	181	187	274	280	False
29659833	We investigated molecular mechanisms of degeneration and show that IFT172 protein reduction leads to mislocalization of specific photoreceptor outersegment (OS) proteins (RHO, RP1, IFT139), aberrant light-driven translocation of alpha transducin and altered localization of glioma-associated oncogene family member 1 (GLI1).	GLI1	glioma	2735	HP_0009733	318	322	274	280	False
29659833	This mouse model exhibits key features of the retinal phenotype observed in patients with IFT172-associated blindness and can be used for in vivo testing of ciliopathy therapies	IFT172	blindness	26160	HP_0000618	90	96	108	117	True
30115683	Both RPE65 isomerase of the visual cycle and the rhodopsin visual pigment have recently been identified as critical players in mediating light-induced retinal degeneration.	RPE	retinal degeneration	6120	HP_0000546	5	8	151	171	False
30115683	Both RPE65 isomerase of the visual cycle and the rhodopsin visual pigment have recently been identified as critical players in mediating light-induced retinal degeneration.	light	retinal degeneration	8740	HP_0000546	137	142	151	171	False
18306244	Mutation analysis of the NDUFA11 is warranted in isolated complex I deficiency presenting with infantile lactic acidemia or encephalocardiomyopathy	NDUFA11	lactic acidemia	126328	HP_0003128	25	32	105	120	False
30465166	CYP21A2 defects result in congenital adrenal hyperplasia (CAH), an autosomal recessive disorder characterized by impaired adrenal steroidogenesis.	CYP21A2	adrenal hyperplasia	1589	HP_0008221	0	7	37	56	True
29901224	The search for clinically relevant molecular markers in classical Hodgkin lymphoma (cHL) is hampered by the histopathological complexity of the disease, resulting from the admixture of a small number of neoplastic Hodgkin and Reed-Sternberg (H-RS) cells with an abundant and heterogeneous microenvironment.	cHL	heterogeneous	91851	HP_0001425	84	87	275	288	False
29901224	The search for clinically relevant molecular markers in classical Hodgkin lymphoma (cHL) is hampered by the histopathological complexity of the disease, resulting from the admixture of a small number of neoplastic Hodgkin and Reed-Sternberg (H-RS) cells with an abundant and heterogeneous microenvironment.	RS	heterogeneous	5308	HP_0001425	244	246	275	288	True
29901224	We reinforce the potential of CASP3 as an interesting target to be explored in adult and pediatric cHL, and alert for its dual biological role in H-RS cells and tumor microenvironment	cHL	tumor	91851	HP_0002664	99	102	161	166	False
29901224	We reinforce the potential of CASP3 as an interesting target to be explored in adult and pediatric cHL, and alert for its dual biological role in H-RS cells and tumor microenvironment	CASP3	tumor	836	HP_0002664	30	35	161	166	False
29901224	We reinforce the potential of CASP3 as an interesting target to be explored in adult and pediatric cHL, and alert for its dual biological role in H-RS cells and tumor microenvironment	RS	tumor	5308	HP_0002664	148	150	161	166	False
28657129	However, Pdha1<sup>f/Y;</sup> Cnp<sup>Cre/+</sup> mice showed reduced fiber density and signs of axonal degeneration in both sciatic and optic nerves from 6 months of age.	Pdha1	axonal degeneration	5160	HP_0040078	9	14	97	116	False
28657129	However, Pdha1<sup>f/Y;</sup> Cnp<sup>Cre/+</sup> mice showed reduced fiber density and signs of axonal degeneration in both sciatic and optic nerves from 6 months of age.	mice	axonal degeneration	23581	HP_0040078	50	54	97	116	False
29259035	In conclusion, our research results strongly recommend combination analysis of cytoplasmic and nuclear girdin for a precise prognostic prediction in breast cancer.-Zhang, H., Yu, F., Qin, F., Shao, Y., Chong, W., Guo, Z., Liu, X., Fu, L., Gu, F., Ma, Y.	Qin	cancer	2290	HP_0002664	183	186	156	162	False
23387289	VSX1 remains as the best characterised keratoconus gene but only accounts for rare cases.	best	keratoconus	7439	HP_0000563	20	24	39	50	True
23387289	Family-based studies have recently led to the identification of the MIR184 gene for keratoconus with cataract and to the DOCK9 gene in a family with isolated keratoconus.	DOCK9	keratoconus	23348	HP_0000563	121	126	84	95	False
23387289	Family-based studies have recently led to the identification of the MIR184 gene for keratoconus with cataract and to the DOCK9 gene in a family with isolated keratoconus.	DOCK9	cataract	23348	HP_0000518	121	126	101	109	False
23387289	Numerous other linkages have been reported and new sequencing technologies are set to rapidly expand the number of identified keratoconus genes in these regions.	set	keratoconus	6418	HP_0000563	79	82	126	137	False
23387289	Similarly, recent genome-wide association studies in case-controlled cohorts have identified common variations in and around HGF, RAB3GAP1 and LOX as candidate risk factors for keratoconus.	HGF	keratoconus	3569	HP_0000563	125	128	177	188	False
23387289	Similarly, recent genome-wide association studies in case-controlled cohorts have identified common variations in and around HGF, RAB3GAP1 and LOX as candidate risk factors for keratoconus.	RAB3GAP1	keratoconus	22930	HP_0000563	130	138	177	188	False
23387289	Similarly, recent genome-wide association studies in case-controlled cohorts have identified common variations in and around HGF, RAB3GAP1 and LOX as candidate risk factors for keratoconus.	LOX	keratoconus	4015	HP_0000563	143	146	177	188	False
28391250	Vitamin-B<sub>6</sub>-dependent epilepsies are a heterogenous group of treatable disorders due to mutations in several genes (<i>ALDH7A1, PNPO, ALPL</i> or <i>ALDH4A1</i>).	PNPO	epilepsies	55163	HP_0001250	138	142	32	42	True
28391250	In neonatal seizures, defects in <i>ALDH7A1 and PNPO</i> explain a major fraction of cases.	PNPO	seizures	55163	HP_0001250	48	52	12	20	True
27759029	These results suggest (i) apparent allelic heterogeneity in CFB and genetic heterogeneity in SLC44A4 across different ethnic groups; (ii) shared ulcerative colitis genetic etiological factors among Asians; and finally (iii) re-exploration of GWAS findings together with high-density genotyping/sequencing and trans-ethnic fine mapping approaches may help identify shared and population-specific risk variants and enable to explain missing disease heritability	CFB	heterogeneity	629	HP_0001425	60	63	43	56	False
27759029	These results suggest (i) apparent allelic heterogeneity in CFB and genetic heterogeneity in SLC44A4 across different ethnic groups; (ii) shared ulcerative colitis genetic etiological factors among Asians; and finally (iii) re-exploration of GWAS findings together with high-density genotyping/sequencing and trans-ethnic fine mapping approaches may help identify shared and population-specific risk variants and enable to explain missing disease heritability	SLC44A4	heterogeneity	80736	HP_0001425	93	100	43	56	False
27793028	In this study, a TF-cascade-targeted strategy aiming to disrupt tumor blood vessels was developed by combination of TF-targeted HMME-loaded drug delivery system and PDT.	TF	tumor	7018	HP_0002664	17	19	64	69	False
27793028	PDT is a promising new modality in the treatment of cancers, which employs the interaction between a tumor-localizing photosensitizer and light of an appropriate wavelength to bring about ROS-induced cell death.	light	tumor	8740	HP_0002664	138	143	101	106	False
27793028	PDT is a promising new modality in the treatment of cancers, which employs the interaction between a tumor-localizing photosensitizer and light of an appropriate wavelength to bring about ROS-induced cell death.	ROS	tumor	6098	HP_0002664	188	191	101	106	False
27793028	In vivo multispectral fluorescent imaging, the EGFP-EGF1 conjugated nanoparticles showed significantly higher accumulation in tumor tissues than non-conjugated ones.	EGF1	tumor	85476	HP_0002664	52	56	126	131	False
27793028	Tumor tissue slides further presented that EGFP-EGF1 conjugated nanoparticles showed significantly higher accumulation in tumor vasculature than non-conjugated ones.	EGF1	tumor	85476	HP_0002664	48	52	122	127	False
27793028	In vivo imaging, ex vivo imaging and tumor tissue slides showed that PDT further contribute EGFP-EGF1-NP accumulation in tumor.	EGF1	tumor	85476	HP_0002664	97	101	37	42	False
27793028	In vivo imaging, ex vivo imaging and tumor tissue slides showed that PDT further contribute EGFP-EGF1-NP accumulation in tumor.	NP	tumor	4860	HP_0002664	102	104	37	42	True
27793028	These promising results indicated that PDT enhanced EGFP-EGF1modified PEG-PLGA nanoparticle accumulation in tumor vaculature.	EGF1	tumor	85476	HP_0002664	57	61	108	113	False
27793028	A combination of both EGFP-EGF1 modification and PDT provided a positive feed-back target effect to tumor vessels and might have a great potential for tumor therapy	EGF1	tumor	85476	HP_0002664	27	31	100	105	False
27793028	A combination of both EGFP-EGF1 modification and PDT provided a positive feed-back target effect to tumor vessels and might have a great potential for tumor therapy	great	tumor	122042	HP_0002664	131	136	100	105	False
24386311	In breast cancer, EMT facilitates invasion of surrounding tissues and correlates closely with cancer metastasis and relapse.	EMT	cancer	3702	HP_0002664	18	21	10	16	True
24386311	We found previously that the candidate tumor suppressor CLCA2 is expressed in differentiated, growth-arrested mammary epithelial cells but is downregulated during tumor progression and EMT.	EMT	tumor	3702	HP_0002664	185	188	39	44	True
24386311	We found previously that the candidate tumor suppressor CLCA2 is expressed in differentiated, growth-arrested mammary epithelial cells but is downregulated during tumor progression and EMT.	CLCA2	tumor	9635	HP_0002664	56	61	39	44	False
24386311	We show here that another member of the CLCA gene family, CLCA4, is expressed in mammary epithelial cells and is similarly downregulated in breast tumors and in breast cancer cell lines.	CLCA4	cancer	22802	HP_0002664	58	63	168	174	False
24386311	We show here that another member of the CLCA gene family, CLCA4, is expressed in mammary epithelial cells and is similarly downregulated in breast tumors and in breast cancer cell lines.	CLCA4	tumor	22802	HP_0002664	58	63	147	152	False
24386311	Clinically, low expression of CLCA4 signaled lower relapse-free survival in basal and luminal B breast cancers.	CLCA4	cancer	22802	HP_0002664	30	35	103	109	False
30232607	All tumors were positive for AE1-AE3, CK18, PAX 8, antimitochondrial antigen, and SDHB.	AE1	tumors	6521	HP_0002664	29	32	4	10	False
30232607	All tumors were positive for AE1-AE3, CK18, PAX 8, antimitochondrial antigen, and SDHB.	AE3	tumors	6508	HP_0002664	33	36	4	10	False
30232607	All tumors were positive for AE1-AE3, CK18, PAX 8, antimitochondrial antigen, and SDHB.	SDH	tumors	1757	HP_0002664	82	85	4	10	False
30232607	HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), TFE3 and TFEB RCC, SDH-deficient RCC, and eosinophilic solid and cystic RCC	TFE3	tumors	7030	HP_0002664	210	214	142	148	True
30232607	HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), TFE3 and TFEB RCC, SDH-deficient RCC, and eosinophilic solid and cystic RCC	TFEB	tumors	7942	HP_0002664	219	223	142	148	False
30232607	HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), TFE3 and TFEB RCC, SDH-deficient RCC, and eosinophilic solid and cystic RCC	SDH	tumors	1757	HP_0002664	229	232	142	148	False
30232607	HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), TFE3 and TFEB RCC, SDH-deficient RCC, and eosinophilic solid and cystic RCC	RCC	tumors	7515	HP_0002664	204	207	142	148	False
30232607	HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), TFE3 and TFEB RCC, SDH-deficient RCC, and eosinophilic solid and cystic RCC	TFE3	renal cell carcinoma	7030	HP_0005584	210	214	182	202	True
30232607	HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), TFE3 and TFEB RCC, SDH-deficient RCC, and eosinophilic solid and cystic RCC	TFEB	renal cell carcinoma	7942	HP_0005584	219	223	182	202	False
30232607	HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), TFE3 and TFEB RCC, SDH-deficient RCC, and eosinophilic solid and cystic RCC	SDH	renal cell carcinoma	1757	HP_0005584	229	232	182	202	False
30232607	HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe renal cell carcinoma (RCC), TFE3 and TFEB RCC, SDH-deficient RCC, and eosinophilic solid and cystic RCC	RCC	renal cell carcinoma	7515	HP_0005584	204	207	182	202	False
29648643	Human-induced neuronal progenitor cells (iNPCs) carrying dominant and recessive GARS mutations showed alterations of mitochondrial proteins, which were more prominent in iNPCs with dominant, neuropathy-causing mutations.	GARS	neuropathy	2617	HP_0009830	80	84	191	201	True
29648643	Our data suggest that altered mitochondria-associated endoplasmic reticulum (ER) membranes (MAM) may be important disease mechanisms leading to neuropathy in this condition	MAM	neuropathy	6445	HP_0009830	92	95	144	154	False
28874563	Elucidating the exact relationship between these two enzymes when they methylate two distinct sites of the same substrate may aid in developing therapeutics aimed at reducing PRMT5/7 activity in cancer and other diseases	PRMT5	cancer	10419	HP_0002664	175	180	195	201	False
28874563	Elucidating the exact relationship between these two enzymes when they methylate two distinct sites of the same substrate may aid in developing therapeutics aimed at reducing PRMT5/7 activity in cancer and other diseases	aid	cancer	57379	HP_0002664	126	129	195	201	False
26578640	Disorders of signalling of various paracrine factors (FGFs, BMPs, WNTs, PTHrP/IHH, and CNP/NPR2) or genetic defects affecting cartilage extracellular matrix usually cause disproportionate short stature.	NPR2	short stature	10641	HP_0004322	91	95	188	201	False
27193124	Here, we have performed a prospective nationwide genetic association study using the Human Exome BeadChip and identified gene variants in encoding dynactin 4 (DCTN4), retinoic acid early transcript 1E (RAET1E), and V-akt murine thymoma viral oncogene homolog 3 (AKT3) to be associated with unfavourable outcome in patients with pneumococcal meningitis.	DCTN4	meningitis	51164	HP_0001287	159	164	341	351	False
27193124	Here, we have performed a prospective nationwide genetic association study using the Human Exome BeadChip and identified gene variants in encoding dynactin 4 (DCTN4), retinoic acid early transcript 1E (RAET1E), and V-akt murine thymoma viral oncogene homolog 3 (AKT3) to be associated with unfavourable outcome in patients with pneumococcal meningitis.	RAET1E	meningitis	135250	HP_0001287	202	208	341	351	False
27193124	Here, we have performed a prospective nationwide genetic association study using the Human Exome BeadChip and identified gene variants in encoding dynactin 4 (DCTN4), retinoic acid early transcript 1E (RAET1E), and V-akt murine thymoma viral oncogene homolog 3 (AKT3) to be associated with unfavourable outcome in patients with pneumococcal meningitis.	akt	meningitis	207	HP_0001287	217	220	341	351	False
27193124	Here, we have performed a prospective nationwide genetic association study using the Human Exome BeadChip and identified gene variants in encoding dynactin 4 (DCTN4), retinoic acid early transcript 1E (RAET1E), and V-akt murine thymoma viral oncogene homolog 3 (AKT3) to be associated with unfavourable outcome in patients with pneumococcal meningitis.	AKT3	meningitis	10000	HP_0001287	262	266	341	351	False
27193124	No clinical replication cohort is available, so we validated the role of one of these targets, AKT3, in a pneumococcal meningitis mouse model.	AKT3	meningitis	10000	HP_0001287	95	99	119	129	False
29159890	Our report of variant in ARMC9 Leading to Joubert syndrome phenotype (JS30), elucidates the genetic heterogeneity of Joubert syndrome, and expands the gene list for ciliopathies	ARMC9	heterogeneity	80210	HP_0001425	25	30	100	113	False
29718273	Although humans with X-linked hypophosphatemia (XLH) and the Hyp mouse, a murine homolog of XLH, are known to develop degenerative joint disease, the exact mechanism that drives the osteoarthritis (OA) phenotype remains unclear.	XLH	hypophosphatemia	5251	HP_0002148	48	51	30	46	True
29718273	Although humans with X-linked hypophosphatemia (XLH) and the Hyp mouse, a murine homolog of XLH, are known to develop degenerative joint disease, the exact mechanism that drives the osteoarthritis (OA) phenotype remains unclear.	Hyp	hypophosphatemia	5251	HP_0002148	61	64	30	46	True
29718273	Although humans with X-linked hypophosphatemia (XLH) and the Hyp mouse, a murine homolog of XLH, are known to develop degenerative joint disease, the exact mechanism that drives the osteoarthritis (OA) phenotype remains unclear.	XLH	degenerative joint disease	5251	HP_0002758	48	51	118	144	True
29718273	Although humans with X-linked hypophosphatemia (XLH) and the Hyp mouse, a murine homolog of XLH, are known to develop degenerative joint disease, the exact mechanism that drives the osteoarthritis (OA) phenotype remains unclear.	Hyp	degenerative joint disease	5251	HP_0002758	61	64	118	144	True
29513714	Molecular biomarkers in blood are needed to aid the early diagnosis and clinical assessment of glioblastoma (GBM).	aid	glioblastoma	57379	HP_0012174	44	47	95	107	False
29513714	The plasma concentrations of LRG1, CRP, and C9 showed significant positive correlations with tumor size (R2 = 0.534, 0.495, and 0.452, respectively)	LRG1	tumor	116844	HP_0002664	29	33	93	98	False
29513714	The plasma concentrations of LRG1, CRP, and C9 showed significant positive correlations with tumor size (R2 = 0.534, 0.495, and 0.452, respectively)	CRP	tumor	1401	HP_0002664	35	38	93	98	False
29361540	Mutations of <i>MYO7A</i>/<i>Myo7a</i> have been implicated in inherited deafness in both humans and mice.	Myo7a	deafness	4647	HP_0000365	29	34	73	81	True
29361540	Mutations of <i>MYO7A</i>/<i>Myo7a</i> have been implicated in inherited deafness in both humans and mice.	MYO7A	deafness	4647	HP_0000365	16	21	73	81	True
30150420	There are several genetic mutations that lead to ALS development, such as chromosome 9 hexanucleotide repeat 72 (C9ORF72), transactive response DNA-binding protein (TARDBP), superoxide dismutase 1 (SOD1) and fused in sarcoma (FUS).	ALS	sarcoma	3483	HP_0100242	49	52	217	224	False
30150420	There are several genetic mutations that lead to ALS development, such as chromosome 9 hexanucleotide repeat 72 (C9ORF72), transactive response DNA-binding protein (TARDBP), superoxide dismutase 1 (SOD1) and fused in sarcoma (FUS).	C9ORF72	sarcoma	203228	HP_0100242	113	120	217	224	False
30150420	There are several genetic mutations that lead to ALS development, such as chromosome 9 hexanucleotide repeat 72 (C9ORF72), transactive response DNA-binding protein (TARDBP), superoxide dismutase 1 (SOD1) and fused in sarcoma (FUS).	TARDBP	sarcoma	23435	HP_0100242	165	171	217	224	False
30150420	There are several genetic mutations that lead to ALS development, such as chromosome 9 hexanucleotide repeat 72 (C9ORF72), transactive response DNA-binding protein (TARDBP), superoxide dismutase 1 (SOD1) and fused in sarcoma (FUS).	SOD1	sarcoma	6647	HP_0100242	198	202	217	224	False
30150420	There are several genetic mutations that lead to ALS development, such as chromosome 9 hexanucleotide repeat 72 (C9ORF72), transactive response DNA-binding protein (TARDBP), superoxide dismutase 1 (SOD1) and fused in sarcoma (FUS).	FUS	sarcoma	2521	HP_0100242	226	229	217	224	False
30075559	The successful therapeutic use of anti-TNF biological agents in patients with ankylosing spondylitis (AS) indicates that tumor necrosis factor- (TNF-) and tumor necrosis factor receptor (TNFR) genes are involved in the pathogenesis of AS.	TNF	tumor	7124	HP_0002664	39	42	121	126	False
29857823	This study aimed to investigate PAX2 expression in tamoxifen resistant (TAM-R) and tamoxifen sensitive (TAM-S) breast carcinoma patients and analyze its correlation with clinicopathological characteristics and survival.	PAX2	breast carcinoma	5076	HP_0003002	32	36	111	127	False
29857823	Immunohistochemical analysis was performed to evaluate PAX2 protein expression in 36 TAM-R and 36 TAM-S formalin-fixed paraffin-embedded (FFPE) breast tumor tissues.	PAX2	tumor	5076	HP_0002664	55	59	151	156	False
29857823	Our data suggested that high expression of PAX2 could be associated with better survival in estrogen receptor positive tamoxifen-treated breast carcinoma patients	PAX2	breast carcinoma	5076	HP_0003002	43	47	137	153	False
29901136	The present study aimed to identify novel intervertebral disc degeneration (IDD)associated long noncoding (lnc)RNAs and genes.	IDD	intervertebral disc degeneration	1299	HP_0008419	76	79	42	74	False
29021137	Mice genetically deficient in DDB2 exhibited increased susceptibility to colon tumor development in a manner associated with higher abundance of the Wnt receptor-expressing cells and greater activation of the downstream Wnt pathway.	DDB2	tumor	1643	HP_0002664	30	34	79	84	True
29021137	Our results identify DDB2 as both a partner and regulator of Wnt signaling, with an important role in suppressing colon cancer development.	DDB2	cancer	1643	HP_0002664	21	25	120	126	True
30519476	Risdiplam (RG7916; RO7034067) is an orally administered, small-molecule <i>SMN2</i> pre-mRNA splicing modifier that distributes into the central nervous system (CNS) and peripheral tissues.	SMN	central	6638	HP_0030645	75	78	137	144	False
24831815	In an unrelated sporadic case of CGHT, we identified a 1.3 Mb cryptic deletion of chr17q24.2-q24.3 encompassing ABCA5 and found that ABCA5 levels are dramatically reduced throughout patient hair follicles.	ABCA5	sporadic	23461	HP_0003745	112	117	16	24	False
24831815	In an unrelated sporadic case of CGHT, we identified a 1.3 Mb cryptic deletion of chr17q24.2-q24.3 encompassing ABCA5 and found that ABCA5 levels are dramatically reduced throughout patient hair follicles.	cryptic	sporadic	55997	HP_0003745	62	69	16	24	False
28456592	The aim of this study was to look for genetic causes of Currarino Syndrome in sporadic patients after ruling out other causes, like chromosome aberrations, disease-causing variants in possible MNX1 cooperating transcription factors and aberrant methylation in the promoter of the MNX1 gene.	MNX1	sporadic	3110	HP_0003745	193	197	78	86	False
29117357	To investigate genetic predispositions for MYCN-amplified neuroblastoma, we performed a meta-analysis of three genome-wide association studies totaling 615 MYCN-amplified high-risk neuroblastoma cases and 1869 MYCN-nonamplified non-high-risk neuroblastoma cases as controls using a fixed-effects model with inverse variance weighting.	MYCN	neuroblastoma	4613	HP_0003006	43	47	58	71	False
29117357	We identified a novel locus at 3p21.31 indexed by the single nucleotide polymorphism (SNP) rs80059929 (odds ratio [OR] = 2.95, 95% confidence interval [CI] = 2.17 to 4.02, Pmeta = 6.4710-12) associated with MYCN-amplified neuroblastoma, which was replicated in 127 MYCN-amplified cases and 254 non-high-risk controls (OR=2.30, 95% CI=1.12 to 4.69, Preplication = .02).	MYCN	neuroblastoma	4613	HP_0003006	210	214	225	238	False
29117357	To confirm this signal is exclusive to MYCN-amplified tumors, we performed a second meta-analysis comparing 728 MYCN-nonamplified high-risk patients to identical controls.	MYCN	tumors	4613	HP_0002664	39	43	54	60	True
29117357	Additionally, the previously reported LMO1 neuroblastoma risk locus was statistically significant only in patients with MYCN-nonamplified high-risk tumors (OR=0.63, 95% CI=0.53 to 0.75, Pmeta = 1.5110-8; Pmeta = .95).	MYCN	neuroblastoma	4613	HP_0003006	120	124	43	56	False
29117357	Additionally, the previously reported LMO1 neuroblastoma risk locus was statistically significant only in patients with MYCN-nonamplified high-risk tumors (OR=0.63, 95% CI=0.53 to 0.75, Pmeta = 1.5110-8; Pmeta = .95).	LMO1	neuroblastoma	4004	HP_0003006	38	42	43	56	False
29117357	Additionally, the previously reported LMO1 neuroblastoma risk locus was statistically significant only in patients with MYCN-nonamplified high-risk tumors (OR=0.63, 95% CI=0.53 to 0.75, Pmeta = 1.5110-8; Pmeta = .95).	MYCN	tumors	4613	HP_0002664	120	124	148	154	True
29117357	Additionally, the previously reported LMO1 neuroblastoma risk locus was statistically significant only in patients with MYCN-nonamplified high-risk tumors (OR=0.63, 95% CI=0.53 to 0.75, Pmeta = 1.5110-8; Pmeta = .95).	LMO1	tumors	4004	HP_0002664	38	42	148	154	True
29117357	Our results indicate that common genetic variation predisposes to different neuroblastoma genotypes, including the likelihood of somatic MYCN-amplification	MYCN	neuroblastoma	4613	HP_0003006	137	141	76	89	False
29625052	Twenty-one genes showed single or cross-cancer associations, including novel associations of SDHA in melanoma and PALB2 in stomach adenocarcinoma.	SDHA	cancer	6389	HP_0002664	93	97	40	46	True
29625052	Twenty-one genes showed single or cross-cancer associations, including novel associations of SDHA in melanoma and PALB2 in stomach adenocarcinoma.	PALB2	cancer	79728	HP_0002664	114	119	40	46	True
29625052	Twenty-one genes showed single or cross-cancer associations, including novel associations of SDHA in melanoma and PALB2 in stomach adenocarcinoma.	SDHA	melanoma	6389	HP_0002861	93	97	101	109	False
29625052	Twenty-one genes showed single or cross-cancer associations, including novel associations of SDHA in melanoma and PALB2 in stomach adenocarcinoma.	PALB2	melanoma	79728	HP_0002861	114	119	101	109	True
29625052	The 659 predisposition variants and 18 additional large deletions in tumor suppressors, including ATM, BRCA1, and NF1, showed low gene expression and frequent (43%) loss of heterozygosity or biallelic two-hit events.	ATM	tumor	472	HP_0002664	98	101	69	74	True
29625052	The 659 predisposition variants and 18 additional large deletions in tumor suppressors, including ATM, BRCA1, and NF1, showed low gene expression and frequent (43%) loss of heterozygosity or biallelic two-hit events.	BRCA1	tumor	672	HP_0002664	103	108	69	74	True
27236917	We describe a neurological disorder with epilepsy and prominent choreoathetosis caused by biallelic pathogenic variants in FRRS1L, which encodes an AMPA receptor outer-core protein.	FRRS1L	epilepsy	23732	HP_0001250	123	129	41	49	True
28379297	Here, we hypothesize that PYCR1 might be a novel prognostic biomarker and therapeutic target for breast cancer.	PYCR1	cancer	5831	HP_0002664	26	31	104	110	False
28379297	In this study, breast cancer tissue samples were obtained from Zhejiang University (ZJU set).	set	cancer	6418	HP_0002664	88	91	22	28	False
28379297	The prognostic significance and performance of PYCR1 mRNA were validated on 13 worldwide independent microarray data sets, composed of 2500 assessable breast cancer cases.	PYCR1	cancer	5831	HP_0002664	47	52	158	164	False
28379297	The prognostic significance and performance of PYCR1 mRNA were validated on 13 worldwide independent microarray data sets, composed of 2500 assessable breast cancer cases.	set	cancer	6418	HP_0002664	117	120	158	164	False
28379297	Our findings revealed that both PYCR1 mRNA and protein expression were significantly associated with tumor size, grade and invasive molecular subtypes of breast cancers.	PYCR1	cancer	5831	HP_0002664	32	37	161	167	False
28379297	Our findings revealed that both PYCR1 mRNA and protein expression were significantly associated with tumor size, grade and invasive molecular subtypes of breast cancers.	PYCR1	tumor	5831	HP_0002664	32	37	101	106	False
28379297	Independent and pooled analyses verified that higher PYCR1 mRNA levels were significantly associated with poor survival of breast cancer patients, regardless of estrogen receptor (ER) status.	PYCR1	cancer	5831	HP_0002664	53	58	130	136	False
28379297	For in vitro studies, inhibition of PYCR1 by small-hairpin RNA significantly reduced the growth and invasion capabilities of the cells, while enhancing the cytotoxicity of doxorubicin in breast cancer cell lines MCF-7 (ER positive) and MDA-MB-231 (ER negative).	PYCR1	cancer	5831	HP_0002664	36	41	194	200	False
28379297	Further population study also validated that chemotherapy significantly improved survival in early-stage breast cancer patients with low PYCR1 expression levels.	PYCR1	cancer	5831	HP_0002664	137	142	112	118	False
28379297	Therefore, PYCR1 might serve as a prognostic biomaker for either ER-positive or ER-negative breast cancer subtypes and can also be a potential target for breast cancer therapy	PYCR1	cancer	5831	HP_0002664	11	16	99	105	False
25927284	Functional loss of expression of breast cancer susceptibility gene 1(BRCA1) has been implicated in genomic instability and cancer progression.	BRCA1	cancer	672	HP_0002664	69	74	40	46	True
25927284	There is emerging evidence that BRCA1 gene product (BRCA1) also plays a role in cancer cell migration.	BRCA1	cancer	672	HP_0002664	32	37	80	86	True
25927284	We performed a quantitative proteomics study of EOC patient tumor tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (CAPN1, 14-3-3, CAPG, PFN1, SPTBN1, CFN1) associated with loss of BRCA1 function.	BRCA1	tumor	672	HP_0002664	258	263	60	65	True
25927284	We performed a quantitative proteomics study of EOC patient tumor tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (CAPN1, 14-3-3, CAPG, PFN1, SPTBN1, CFN1) associated with loss of BRCA1 function.	CAPN1	tumor	823	HP_0002664	193	198	60	65	False
25927284	We performed a quantitative proteomics study of EOC patient tumor tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (CAPN1, 14-3-3, CAPG, PFN1, SPTBN1, CFN1) associated with loss of BRCA1 function.	CAPG	tumor	822	HP_0002664	208	212	60	65	False
25927284	We performed a quantitative proteomics study of EOC patient tumor tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (CAPN1, 14-3-3, CAPG, PFN1, SPTBN1, CFN1) associated with loss of BRCA1 function.	PFN1	tumor	5216	HP_0002664	214	218	60	65	False
25927284	We performed a quantitative proteomics study of EOC patient tumor tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (CAPN1, 14-3-3, CAPG, PFN1, SPTBN1, CFN1) associated with loss of BRCA1 function.	SPTBN1	tumor	6711	HP_0002664	220	226	60	65	False
25927284	By immunohistochemistry of ovarian tumors with BRCA1(+/+) and BRCA1(null) status, we further verified our proteomic-based finding of elevated PFN1 expression associated with BRCA1 deficiency.	BRCA1	tumor	672	HP_0002664	47	52	35	40	True
25927284	By immunohistochemistry of ovarian tumors with BRCA1(+/+) and BRCA1(null) status, we further verified our proteomic-based finding of elevated PFN1 expression associated with BRCA1 deficiency.	PFN1	tumor	5216	HP_0002664	142	146	35	40	False
25927284	Finally, we established a causal link between PFN1 and BRCA1-induced changes in cell migration thus uncovering a novel mechanistic basis for BRCA1-dependent regulation of ovarian cancer cell migration.	BRCA1	cancer	672	HP_0002664	55	60	179	185	True
25927284	Finally, we established a causal link between PFN1 and BRCA1-induced changes in cell migration thus uncovering a novel mechanistic basis for BRCA1-dependent regulation of ovarian cancer cell migration.	PFN1	cancer	5216	HP_0002664	46	50	179	185	False
29100091	However, the pathophysiological mechanisms leading to bilateral kidney agenesis (BKA) remain largely elusive.	BKA	bilateral	51077	HP_0012832	81	84	54	63	False
29100091	Whole-exome or targeted exome sequencing of 183 unrelated familial and/or severe CAKUT-affected case subjects, including 54 fetuses with BKA, led to the identification of 16 heterozygous variants in GREB1L (growth regulation by estrogen in breast cancer 1-like), a gene reported as a target of retinoic acid signaling.	BKA	cancer	51077	HP_0002664	137	140	247	253	False
29100091	Whole-exome or targeted exome sequencing of 183 unrelated familial and/or severe CAKUT-affected case subjects, including 54 fetuses with BKA, led to the identification of 16 heterozygous variants in GREB1L (growth regulation by estrogen in breast cancer 1-like), a gene reported as a target of retinoic acid signaling.	GREB1L	cancer	80000	HP_0002664	199	205	247	253	False
28720665	Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.<b>Results:</b> One of the 11 tumors was found to carry a known cancer-predisposing somatic mutation in <i>IDH1</i> A variant in <i>GOT2</i>, c.357A&gt;T, found in a patient with multiple tumors, was associated with higher tumor mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.	GOT2	tumors	2806	HP_0002664	239	243	137	143	False
28720665	Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.<b>Results:</b> One of the 11 tumors was found to carry a known cancer-predisposing somatic mutation in <i>IDH1</i> A variant in <i>GOT2</i>, c.357A&gt;T, found in a patient with multiple tumors, was associated with higher tumor mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.	GOT2	cancer	2806	HP_0002664	239	243	171	177	False
28720665	Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.<b>Results:</b> One of the 11 tumors was found to carry a known cancer-predisposing somatic mutation in <i>IDH1</i> A variant in <i>GOT2</i>, c.357A&gt;T, found in a patient with multiple tumors, was associated with higher tumor mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.	GOT2	somatic mutation	2806	HP_0001428	239	243	191	207	False
28720665	Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.<b>Results:</b> One of the 11 tumors was found to carry a known cancer-predisposing somatic mutation in <i>IDH1</i> A variant in <i>GOT2</i>, c.357A&gt;T, found in a patient with multiple tumors, was associated with higher tumor mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.	GOT2	tumor	2806	HP_0002664	239	243	330	335	False
28720665	Array methylation-based analysis uncovered a somatic epigenetic mutation in <i>SDHC</i> in a patient with multiple pheochromocytomas and a gastrointestinal stromal tumor.	SDH	pheochromocytomas	1757	HP_0002666	79	82	115	132	False
28720665	Array methylation-based analysis uncovered a somatic epigenetic mutation in <i>SDHC</i> in a patient with multiple pheochromocytomas and a gastrointestinal stromal tumor.	SDH	tumor	1757	HP_0002664	79	82	164	169	False
27203443	Surprisingly, either silencing miR-126-3p by LNA-antimiR or overexpressing miR-126-3p by miRNA mimic repressed laser-induced choroidal neovascularization.	miR	choroidal neovascularization	220972	HP_0011506	31	34	125	153	False
29401583	The oncogenic potential of ASS1 in terms of prognosis and cancer metastasis in arginine prototrophic gastric cancer (GC) remains unclear at present.	ASS1	cancer	445	HP_0002664	27	31	58	64	False
29401583	We identify differentially expressed proteins in microdissected GC tumor cells relative to adjacent nontumor epithelia by isobaric mass tag for relative and absolute quantitation proteomics analysis.	mass	tumor	2200	HP_0002664	131	135	67	72	False
29401583	ASS1 was highly expressed in GC and positively correlated with GC aggressiveness and poor outcome.	ASS1	aggressiveness	445	HP_0000718	0	4	66	80	False
29401583	Depletion of ASS1 led to inhibition of tumor growth and decreased cell invasion via induction of autophagy-lysosome machinery, resulting in degradation of active -catenin, Snail, and Twist.	ASS1	tumor	445	HP_0002664	13	17	39	44	False
29401583	Depletion of ASS1 led to inhibition of tumor growth and decreased cell invasion via induction of autophagy-lysosome machinery, resulting in degradation of active -catenin, Snail, and Twist.	Snail	tumor	6615	HP_0002664	173	178	39	44	False
29401583	Depletion of ASS1 led to inhibition of tumor growth and decreased cell invasion via induction of autophagy-lysosome machinery, resulting in degradation of active -catenin, Snail, and Twist.	Twist	tumor	7291	HP_0002664	184	189	39	44	True
29401583	Ectopic expression of ASS1 in GC cells reversed these effects and protected cancer cells from chemotherapy drug-induced apoptosis via activation of the AKT-mammalian target of rapamycin signaling pathway.	ASS1	cancer	445	HP_0002664	22	26	76	82	False
29401583	Ectopic expression of ASS1 in GC cells reversed these effects and protected cancer cells from chemotherapy drug-induced apoptosis via activation of the AKT-mammalian target of rapamycin signaling pathway.	AKT	cancer	207	HP_0002664	152	155	76	82	True
27447970	NSUN2 is a RNA methyltransferase that has been shown to be implicated in development of human cancer.	NSUN2	cancer	54888	HP_0002664	0	5	94	100	True
27447970	However, the functional role of NSUN2, mechanism of NSUN2 overexpression and its association with clinicopathologic features in breast cancer remain unclear.	NSUN2	cancer	54888	HP_0002664	32	37	135	141	True
27447970	To investigate alterations in the expression and functional role of NSUN2 in breast cancer, NSUN2 expression was assessed in breast cancer cells and tissues obtained from cancers at different American Joint Committee on Cancer (AJCC) stages, and its functions were investigated using breast cancer cells.	NSUN2	cancer	54888	HP_0002664	68	73	84	90	True
27447970	NSUN2 expression was shown to be significantly higher in breast cancer cells and tissues than in normal breast epithelial cells and tissues, at both mRNA and protein levels.	NSUN2	cancer	54888	HP_0002664	0	5	64	70	True
27447970	Our results demonstrated that the overall expression of NSUN2 significantly correlated with clinical stage (P=0.027), tumor classification (P=0.012), pathological differentiation (P=0.023), as well as with the expression levels of estrogen receptor (P&lt;0.001), progesterone receptor (P=0.001), and Ki-67 (P&lt;0.001).	NSUN2	tumor	54888	HP_0002664	56	61	118	123	True
27447970	Our results demonstrated that the overall expression of NSUN2 significantly correlated with clinical stage (P=0.027), tumor classification (P=0.012), pathological differentiation (P=0.023), as well as with the expression levels of estrogen receptor (P&lt;0.001), progesterone receptor (P=0.001), and Ki-67 (P&lt;0.001).	Ki	tumor	10197	HP_0002664	300	302	118	123	False
27447970	Our findings provide a unique insight into the roles and effects of NSUN2 overexpression in breast cancer cells, and highlight the necessity of the investigation of novel therapeutic targets, such as NSUN2, for the improvement of breast cancer treatments	NSUN2	cancer	54888	HP_0002664	68	73	99	105	True
26206859	The pH-sensing receptor ovarian cancer G protein-coupled receptor 1 (OGR1; GPR68) is expressed in the gut.	OGR1	cancer	8111	HP_0002664	69	73	32	38	False
26206859	The pH-sensing receptor ovarian cancer G protein-coupled receptor 1 (OGR1; GPR68) is expressed in the gut.	GPR68	cancer	8111	HP_0002664	75	80	32	38	False
12382951	In a previous report, we described the clinical and radiographical features of three related subjects with the disease and suggest that due to the unusual combination of limb defects and to its phenotypic similarity with the limb malformative pattern induced by disrupting the Hoxd13 gene in mouse, the triphalangeal thumb-brachyectrodactyly syndrome might be caused by mutations in a HOX gene.	Hoxd13	triphalangeal thumb	3239	HP_0001199	277	283	303	322	False
12382951	In a previous report, we described the clinical and radiographical features of three related subjects with the disease and suggest that due to the unusual combination of limb defects and to its phenotypic similarity with the limb malformative pattern induced by disrupting the Hoxd13 gene in mouse, the triphalangeal thumb-brachyectrodactyly syndrome might be caused by mutations in a HOX gene.	Hoxd13	ectrodactyly	3239	HP_0100257	277	283	329	341	False
30315939	Mutations in COL4A1 have been reported in schizencephaly and porencephaly combined with microbleeds or calcifications, often associated with ocular and renal abnormalities, myopathy, elevated creatine kinase levels and haemolytic anaemia.	COL4A1	schizencephaly	1282	HP_0010636	13	19	42	56	True
30315939	Mutations in COL4A1 have been reported in schizencephaly and porencephaly combined with microbleeds or calcifications, often associated with ocular and renal abnormalities, myopathy, elevated creatine kinase levels and haemolytic anaemia.	COL4A1	myopathy	1282	HP_0003198	13	19	173	181	False
30315939	In this study, we aimed to clarify the phenotypic spectrum of COL4A1/A2 mutations in the context of cortical malformations that include schizencephaly, polymicrogyria and/or heterotopia	COL4A1	schizencephaly	1282	HP_0010636	62	68	136	150	True
30315939	In this study, we aimed to clarify the phenotypic spectrum of COL4A1/A2 mutations in the context of cortical malformations that include schizencephaly, polymicrogyria and/or heterotopia	COL4A1	polymicrogyria	1282	HP_0002126	62	68	152	166	True
27528030	To elucidate the underlying molecular mechanisms of tamoxifen resistance, we performed a systematic analysis of miRNA-mediated gene regulation in three clinically-relevant tamoxifen-resistant breast cancer cell lines (TamRs) compared to their parental tamoxifen-sensitive cell line.	miR	cancer	220972	HP_0002664	112	115	199	205	False
27528030	Finally, we show that a combination of 2 miRNAs (miR-190b and miR-516a-5p) exhibiting altered expression in TamR cell lines were predictive of treatment outcome in a cohort of ER+ breast cancer patients receiving adjuvant tamoxifen mono-therapy.	miR	cancer	220972	HP_0002664	41	44	187	193	False
28179590	We identified 22 genes including APC, KRAS, TP53, GNAS, NRAS, SMAD4, ARID2, and PIK3CA with non-silent mutations in the cancer Census Genes.	APC	cancer	324	HP_0002664	33	36	120	126	True
28179590	We identified 22 genes including APC, KRAS, TP53, GNAS, NRAS, SMAD4, ARID2, and PIK3CA with non-silent mutations in the cancer Census Genes.	KRAS	cancer	3845	HP_0002664	38	42	120	126	True
28179590	We identified 22 genes including APC, KRAS, TP53, GNAS, NRAS, SMAD4, ARID2, and PIK3CA with non-silent mutations in the cancer Census Genes.	GNAS	cancer	2778	HP_0002664	50	54	120	126	True
28179590	We identified 22 genes including APC, KRAS, TP53, GNAS, NRAS, SMAD4, ARID2, and PIK3CA with non-silent mutations in the cancer Census Genes.	NRAS	cancer	4893	HP_0002664	56	60	120	126	True
28179590	We identified 22 genes including APC, KRAS, TP53, GNAS, NRAS, SMAD4, ARID2, and PIK3CA with non-silent mutations in the cancer Census Genes.	SMAD4	cancer	4089	HP_0002664	62	67	120	126	True
28179590	We identified 22 genes including APC, KRAS, TP53, GNAS, NRAS, SMAD4, ARID2, and PIK3CA with non-silent mutations in the cancer Census Genes.	ARID2	cancer	196528	HP_0002664	69	74	120	126	False
28179590	We identified 22 genes including APC, KRAS, TP53, GNAS, NRAS, SMAD4, ARID2, and PIK3CA with non-silent mutations in the cancer Census Genes.	PIK3CA	cancer	5290	HP_0002664	80	86	120	126	True
28179590	Five HGCAs harbored either mono-allelic (four HGCAs) or bi-allelic (one HGCA) SMAD4 mutation or 18q loss that had been known as early carcinoma-specific changes.	SMAD4	carcinoma	4089	HP_0030731	78	83	134	143	False
28179590	Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	APC	carcinoma	324	HP_0030731	76	79	58	67	True
28179590	Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	KRAS	carcinoma	3845	HP_0030731	81	85	58	67	False
28179590	Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	GNAS	carcinoma	2778	HP_0030731	96	100	58	67	False
28179590	Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	NRAS	carcinoma	4893	HP_0030731	87	91	58	67	False
28179590	Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	SMAD4	carcinoma	4089	HP_0030731	144	149	58	67	False
28179590	Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	ARID2	carcinoma	196528	HP_0030731	190	195	58	67	False
28179590	Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	MTOR	carcinoma	2475	HP_0030731	151	155	58	67	False
28179590	Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	ACVR1B	carcinoma	91	HP_0030731	157	163	58	67	False
28179590	Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	GNAQ	carcinoma	2776	HP_0030731	165	169	58	67	False
28179590	Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	ATM	carcinoma	472	HP_0030731	171	174	58	67	False
28179590	Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	CNOT1	carcinoma	23019	HP_0030731	176	181	58	67	False
28179590	Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	RET	carcinoma	5979	HP_0030731	197	200	58	67	False
28179590	Our WES data is largely matched with the earlier 'adenoma-carcinoma model' (APC, KRAS, NRAS and GNAS mutations), but there are newly identified SMAD4, MTOR, ACVR1B, GNAQ, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	MAP2K4	carcinoma	6416	HP_0030731	205	211	58	67	False
28453560	The aim of our study was to determine the impact of genetic polymorphisms in the caspase (CASP) genes on prognosis of hepatocellular carcinoma (HCC).	impact	hepatocellular carcinoma	55364	HP_0001402	42	48	118	142	False
28453560	The aim of our study was to determine the impact of genetic polymorphisms in the caspase (CASP) genes on prognosis of hepatocellular carcinoma (HCC).	CASP	hepatocellular carcinoma	10491	HP_0001402	90	94	118	142	False
28453560	The aim of our study was to determine the impact of genetic polymorphisms in the caspase (CASP) genes on prognosis of hepatocellular carcinoma (HCC).	HCC	hepatocellular carcinoma	84668	HP_0001402	144	147	118	142	False
28453560	We genotyped 7 potentially functional polymorphisms in CASP3, CASP7, CASP8, CASP9, CASP10 genes in 362 HCC patients of receiving surgical resection of HCC tumor.	CASP	tumor	10491	HP_0002664	55	59	155	160	False
28453560	We genotyped 7 potentially functional polymorphisms in CASP3, CASP7, CASP8, CASP9, CASP10 genes in 362 HCC patients of receiving surgical resection of HCC tumor.	HCC	tumor	84668	HP_0002664	103	106	155	160	False
24998186	We evaluated whether methylation of tumor-suppressor genes (TSGs) would classify non-muscle-invasive (NMI) bladder cancer subgroups and predict outcome.	NMI	cancer	9111	HP_0002664	102	105	115	121	False
24998186	We evaluated whether methylation of tumor-suppressor genes (TSGs) would classify non-muscle-invasive (NMI) bladder cancer subgroups and predict outcome.	TSG	cancer	57045	HP_0002664	60	63	115	121	False
24998186	We evaluated whether methylation of tumor-suppressor genes (TSGs) would classify non-muscle-invasive (NMI) bladder cancer subgroups and predict outcome.	NMI	tumor	9111	HP_0002664	102	105	36	41	False
24998186	We evaluated whether methylation of tumor-suppressor genes (TSGs) would classify non-muscle-invasive (NMI) bladder cancer subgroups and predict outcome.	TSG	tumor	57045	HP_0002664	60	63	36	41	False
24998186	A retrospective design included the following paraffin-embedded primary NMI tumor types (n = 251): pTa low grade (LG) (n = 79), pT1LG (n = 81), and pT1 high grade (HG) (n = 91).	NMI	tumor	9111	HP_0002664	72	75	76	81	False
24998186	A retrospective design included the following paraffin-embedded primary NMI tumor types (n = 251): pTa low grade (LG) (n = 79), pT1LG (n = 81), and pT1 high grade (HG) (n = 91).	pTa	tumor	171558	HP_0002664	99	102	76	81	False
24998186	Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.	pTa	tumor	171558	HP_0002664	98	101	113	118	False
24998186	Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.	STK11	tumor	6794	HP_0002664	174	179	113	118	True
24998186	Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.	RARB	tumor	5915	HP_0002664	15	19	113	118	False
24998186	Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.	GATA5	tumor	140628	HP_0002664	81	86	113	118	False
24998186	Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.	GSTP1	tumor	2950	HP_0002664	34	39	113	118	False
24998186	Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.	IGSF4	tumor	23705	HP_0002664	41	46	113	118	False
24998186	Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.	CADM1	tumor	23705	HP_0002664	48	53	113	118	False
24998186	Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.	PYCARD	tumor	29108	HP_0002664	56	62	113	118	False
24998186	Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.	CDH13	tumor	1012	HP_0002664	64	69	113	118	False
24998186	Methylation of RARB, CD44, PAX5A, GSTP1, IGSF4 (CADM1), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 tumors whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.	CHFR	tumor	55743	HP_0002664	154	158	113	118	False
30134235	This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, tumor suppressors (TP53, DDX3X, and MGA), the JAK/STAT cascade, and epigenetic modifiers (KMT2D, BCOR, ARID1A, and EP300).	DDX3X	tumor	1654	HP_0002664	158	163	133	138	False
30134235	This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, tumor suppressors (TP53, DDX3X, and MGA), the JAK/STAT cascade, and epigenetic modifiers (KMT2D, BCOR, ARID1A, and EP300).	MGA	tumor	8972	HP_0002664	169	172	133	138	False
30134235	This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, tumor suppressors (TP53, DDX3X, and MGA), the JAK/STAT cascade, and epigenetic modifiers (KMT2D, BCOR, ARID1A, and EP300).	KMT2D	tumor	8085	HP_0002664	223	228	133	138	False
30134235	This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, tumor suppressors (TP53, DDX3X, and MGA), the JAK/STAT cascade, and epigenetic modifiers (KMT2D, BCOR, ARID1A, and EP300).	BCOR	tumor	54880	HP_0002664	230	234	133	138	False
30134235	This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, tumor suppressors (TP53, DDX3X, and MGA), the JAK/STAT cascade, and epigenetic modifiers (KMT2D, BCOR, ARID1A, and EP300).	ARID1A	tumor	8289	HP_0002664	236	242	133	138	False
24632816	Utilizing matrix-coated polydimethylsiloxane gels to manipulate substrate compliance, we show that cdGAP, an adhesion-localized Rac1 and Cdc42 specific GTPase activating protein, is necessary for U2OS osteosarcoma cells to coordinate cell shape changes and migration as a function of extracellular matrix stiffness.	cdGAP	osteosarcoma	57514	HP_0002669	99	104	201	213	False
24632816	Utilizing matrix-coated polydimethylsiloxane gels to manipulate substrate compliance, we show that cdGAP, an adhesion-localized Rac1 and Cdc42 specific GTPase activating protein, is necessary for U2OS osteosarcoma cells to coordinate cell shape changes and migration as a function of extracellular matrix stiffness.	Rac1	osteosarcoma	5879	HP_0002669	128	132	201	213	False
24632816	Utilizing matrix-coated polydimethylsiloxane gels to manipulate substrate compliance, we show that cdGAP, an adhesion-localized Rac1 and Cdc42 specific GTPase activating protein, is necessary for U2OS osteosarcoma cells to coordinate cell shape changes and migration as a function of extracellular matrix stiffness.	Cdc42	osteosarcoma	998	HP_0002669	137	142	201	213	False
30057031	Five individuals who carry IRF2BPL nonsense variants resulting in a premature stop codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.	IRF2BPL	neurodevelopmental regression	64207	HP_0002376	27	34	104	133	True
30057031	Five individuals who carry IRF2BPL nonsense variants resulting in a premature stop codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.	stop	neurodevelopmental regression	4135	HP_0002376	78	82	104	133	False
30057031	Five individuals who carry IRF2BPL nonsense variants resulting in a premature stop codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.	IRF2BPL	progressive	64207	HP_0003676	27	34	146	157	True
30057031	Five individuals who carry IRF2BPL nonsense variants resulting in a premature stop codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.	stop	progressive	4135	HP_0003676	78	82	146	157	False
30057031	Five individuals who carry IRF2BPL nonsense variants resulting in a premature stop codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.	IRF2BPL	ataxia	64207	HP_0001251	27	34	158	164	True
30057031	Five individuals who carry IRF2BPL nonsense variants resulting in a premature stop codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.	stop	ataxia	4135	HP_0001251	78	82	158	164	False
30057031	Five individuals who carry IRF2BPL nonsense variants resulting in a premature stop codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.	IRF2BPL	seizures	64207	HP_0001250	27	34	166	174	True
30057031	Five individuals who carry IRF2BPL nonsense variants resulting in a premature stop codon display severe neurodevelopmental regression, hypotonia, progressive ataxia, seizures, and a lack of coordination.	stop	seizures	4135	HP_0001250	78	82	166	174	False
29636449	Feingold syndrome is a skeletal dysplasia caused by loss-of-function mutations of either MYCN (type 1) or MIR17HG that encodes miR-17-92 microRNAs (type 2).	MYCN	skeletal dysplasia	4613	HP_0002652	89	93	23	41	False
29636449	Feingold syndrome is a skeletal dysplasia caused by loss-of-function mutations of either MYCN (type 1) or MIR17HG that encodes miR-17-92 microRNAs (type 2).	type	skeletal dysplasia	6445	HP_0002652	95	99	23	41	False
29636449	Feingold syndrome is a skeletal dysplasia caused by loss-of-function mutations of either MYCN (type 1) or MIR17HG that encodes miR-17-92 microRNAs (type 2).	miR	skeletal dysplasia	220972	HP_0002652	127	130	23	41	False
24273071	Up to this time, only heterozygous mutations of COL9A3 gene have been reported in human and related to: (1) multiple epiphyseal dysplasia type 3, (2) susceptibility to an intervertebral disc disease, and (3) hearing loss.	COL9A3	epiphyseal dysplasia	1299	HP_0002656	48	54	117	137	True
24273071	Up to this time, only heterozygous mutations of COL9A3 gene have been reported in human and related to: (1) multiple epiphyseal dysplasia type 3, (2) susceptibility to an intervertebral disc disease, and (3) hearing loss.	type	epiphyseal dysplasia	6445	HP_0002656	138	142	117	137	False
24273071	Up to this time, only heterozygous mutations of COL9A3 gene have been reported in human and related to: (1) multiple epiphyseal dysplasia type 3, (2) susceptibility to an intervertebral disc disease, and (3) hearing loss.	COL9A3	hearing loss	1299	HP_0000365	48	54	208	220	True
24273071	Up to this time, only heterozygous mutations of COL9A3 gene have been reported in human and related to: (1) multiple epiphyseal dysplasia type 3, (2) susceptibility to an intervertebral disc disease, and (3) hearing loss.	type	hearing loss	6445	HP_0000365	138	142	208	220	False
24273071	Here, we describe the first autosomal recessive Stickler family due to loss of function mutations (c.1176_1198del, p.Gln393Cysfs*25) of COL9A3 gene.	COL9A3	autosomal recessive	1299	HP_0000007	136	142	28	47	False
30819650	We will also discuss emerging paradigms of the molecular and cellular pathophysiology of disease-causing ephrinB2-EphB4-RASA1 mutations, including the potential role of somatic mosaicism.	RASA1	somatic mosaicism	5921	HP_0001442	120	125	169	186	False
29512714	The tumor suppressor characteristics of cyclindependent kinase 10 (CDK10) in nasopharyngeal carcinoma and breast cancer have been previously demonstrated.	CDK10	tumor	8558	HP_0002664	68	73	4	9	False
29512714	The tumor suppressor characteristics of cyclindependent kinase 10 (CDK10) in nasopharyngeal carcinoma and breast cancer have been previously demonstrated.	CDK10	cancer	8558	HP_0002664	68	73	114	120	False
29512714	In the present study the expression status of CDK10 and its prognostic significance in gastric cancer was determined, as well as its role in cell proliferation and invasion.	CDK10	cancer	8558	HP_0002664	46	51	95	101	False
29512714	Immunoblot analysis revealed that CDK10 protein expression was notably decreased in gastric cancer compared with normal tissues.	CDK10	cancer	8558	HP_0002664	34	39	92	98	False
29512714	Immunohistochemistry demonstrated that the loss of CDK10 expression, which was observed in 50.8% of primary gastric cancer tissues (n=128), significantly correlated with advanced tumor stage (P&lt;0.001), frequent lymph node metastasis (P&lt;0.001), distant metastasis (P=0.013), tumor differentiation (P=0.004) and unfavorable overall survival (P&lt;0.001).	CDK10	tumor	8558	HP_0002664	51	56	179	184	False
29512714	Immunohistochemistry demonstrated that the loss of CDK10 expression, which was observed in 50.8% of primary gastric cancer tissues (n=128), significantly correlated with advanced tumor stage (P&lt;0.001), frequent lymph node metastasis (P&lt;0.001), distant metastasis (P=0.013), tumor differentiation (P=0.004) and unfavorable overall survival (P&lt;0.001).	CDK10	cancer	8558	HP_0002664	51	56	116	122	False
29512714	Multivariate analysis suggested that CDK10 expression may serve as an independent prognostic predictor (P=0.001) for the progression of gastric cancer.	CDK10	cancer	8558	HP_0002664	37	42	144	150	False
29512714	In addition, ectopic CDK10 expression inhibited gastric cancer cell proliferation, migration and invasion, while knockdown of CDK10 promoted these phenotypes.	CDK10	cancer	8558	HP_0002664	21	26	56	62	False
24239381	Phenotypically, bs mice exhibit nuclear cataracts and male infertility; genetic analyses assigned the bs locus to mouse chromosome 2.	mice	cataracts	23581	HP_0000518	19	23	40	49	False
24239381	Based on the function of TBC1D20 as a RABGAP and the bs cataract and testicular phenotypes, we hypothesized that mutations in TBC1D20 may contribute to Warburg micro syndrome (WARBM); WARBM constitutes a spectrum of disorders characterized by eye, brain, and endocrine abnormalities caused by mutations in RAB3GAP1, RAB3GAP2, and RAB18.	TBC1D20	cataract	128637	HP_0000518	25	32	56	64	True
24239381	Based on the function of TBC1D20 as a RABGAP and the bs cataract and testicular phenotypes, we hypothesized that mutations in TBC1D20 may contribute to Warburg micro syndrome (WARBM); WARBM constitutes a spectrum of disorders characterized by eye, brain, and endocrine abnormalities caused by mutations in RAB3GAP1, RAB3GAP2, and RAB18.	GAP	cataract	5921	HP_0000518	41	44	56	64	False
24239381	Based on the function of TBC1D20 as a RABGAP and the bs cataract and testicular phenotypes, we hypothesized that mutations in TBC1D20 may contribute to Warburg micro syndrome (WARBM); WARBM constitutes a spectrum of disorders characterized by eye, brain, and endocrine abnormalities caused by mutations in RAB3GAP1, RAB3GAP2, and RAB18.	RAB1	cataract	5861	HP_0000518	330	334	56	64	False
28328138	Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper lip, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	lip	developmental delay	23049	HP_0001263	317	320	7	26	False
28328138	Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper lip, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	lip	microcephaly	23049	HP_0000252	317	320	43	55	False
28328138	Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper lip, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	lip	progressive	23049	HP_0003676	317	320	77	88	False
28328138	Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper lip, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	lip	ataxia	23049	HP_0001251	317	320	89	95	False
28328138	Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper lip, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	lip	distal	23049	HP_0012839	317	320	97	103	False
28328138	Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper lip, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	lip	contractures	23049	HP_0001371	317	320	131	143	False
28328138	Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper lip, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	lip	neuropathy	23049	HP_0009830	317	320	172	182	False
28328138	Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper lip, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	lip	hearing loss	23049	HP_0000365	317	320	202	214	False
28328138	Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper lip, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	lip	facial dysmorphism	23049	HP_0001999	317	320	251	269	False
28328138	Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper lip, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	lip	widely spaced eyes	23049	HP_0000316	317	320	275	293	False
28328138	Global developmental delay associated with microcephaly, growth retardation, progressive ataxia, distal muscle weakness with ankle contractures, demyelinating sensorimotor neuropathy, and sensorineural hearing loss were present in all patients, while facial dysmorphism with widely spaced eyes, exotropia, thin upper lip, proximally placed thumbs, and deformities of the fingers and toes were present in some individuals.	lip	exotropia	23049	HP_0000577	317	320	295	304	False
28328138	Our findings expand the clinical phenotype and further demonstrate the clinical heterogeneity related to PTRH2 variants	PTRH2	heterogeneity	51651	HP_0001425	105	110	80	93	False
28099929	Spinal muscular atrophy (SMA) is a lethal autosomal recessive neurological disease characterized by selective degeneration of motor neurons in the spinal cord.	SMA	autosomal recessive	6606	HP_0000007	25	28	42	61	True
29246092	PAK3-related intellectual disability is caused by mutations in the gene encoding the p21-activated kinase (PAK) protein.	p21	intellectual disability	9338	HP_0001249	85	88	13	36	False
29246092	PAK3-related intellectual disability is caused by mutations in the gene encoding the p21-activated kinase (PAK) protein.	PAK3	intellectual disability	8874	HP_0001249	0	4	13	36	False
29246092	The authors report a patient with a novel PAK3 mutation, who presented with intellectual disability, severe automutilation, and epilepsy.	PAK3	intellectual disability	8874	HP_0001249	42	46	76	99	False
29246092	The authors report a patient with a novel PAK3 mutation, who presented with intellectual disability, severe automutilation, and epilepsy.	PAK3	epilepsy	8874	HP_0001250	42	46	128	136	False
29246092	This is the first case of PAK3-related intellectual disability presenting with severe self-injury with improvement following treatment.	PAK3	intellectual disability	8874	HP_0001249	26	30	39	62	False
28294290	We analyzed commonly reported European and Asian obesity-related gene variants in a Mexican-Mestizo population through each single nucleotide polymorphism (SNP) and a genetic risk score (GRS) based on 23 selected SNPs.	GRS	obesity	597	HP_0001513	187	190	49	56	False
28294290	ME attenuated the influence of APOB rs512535 and TNFA rs361525 on obesity risk in FMP.	APOB	obesity	338	HP_0001513	31	35	66	73	False
28294290	ME attenuated the influence of APOB rs512535 and TNFA rs361525 on obesity risk in FMP.	TNFA	obesity	7124	HP_0001513	49	53	66	73	False
28294290	We report associations for 6 out of 23 SNPs and for the GRS, which confer obesity risk, a novel finding for Mexican-Mestizo physically active population.	GRS	obesity	597	HP_0001513	56	59	74	81	False
30125135	Pure hair and nail ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of HOXC13 and is characterized by hypotrichosis and nail dystrophy in humans.	HOXC13	ectodermal dysplasia	3229	HP_0000968	115	121	19	39	True
30125135	Pure hair and nail ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of HOXC13 and is characterized by hypotrichosis and nail dystrophy in humans.	nail	ectodermal dysplasia	51744	HP_0000968	14	18	19	39	False
30125135	Pure hair and nail ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of HOXC13 and is characterized by hypotrichosis and nail dystrophy in humans.	HOXC13	autosomal recessive	3229	HP_0000007	115	121	57	76	True
30125135	Pure hair and nail ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of HOXC13 and is characterized by hypotrichosis and nail dystrophy in humans.	nail	autosomal recessive	51744	HP_0000007	14	18	57	76	False
30125135	Pure hair and nail ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of HOXC13 and is characterized by hypotrichosis and nail dystrophy in humans.	HOXC13	hypotrichosis	3229	HP_0001006	115	121	146	159	True
30125135	Pure hair and nail ectodermal dysplasia 9 (ECTD-9) is an autosomal recessive genetic disease caused by mutation of HOXC13 and is characterized by hypotrichosis and nail dystrophy in humans.	nail	hypotrichosis	51744	HP_0001006	14	18	146	159	False
30125135	Unlike patients with ECTD-9, Hoxc13-mutated mice and pigs do not faithfully recapitulate the phenotype of hypotrichosis, so there is a limited understanding of the molecular mechanism of Hoxc13-mediated hypotrichosis in animal models and clinically.	Hoxc13	hypotrichosis	3229	HP_0001006	29	35	106	119	True
30125135	Unlike patients with ECTD-9, Hoxc13-mutated mice and pigs do not faithfully recapitulate the phenotype of hypotrichosis, so there is a limited understanding of the molecular mechanism of Hoxc13-mediated hypotrichosis in animal models and clinically.	mice	hypotrichosis	23581	HP_0001006	44	48	106	119	False
30125135	Unlike patients with ECTD-9, Hoxc13-mutated mice and pigs do not faithfully recapitulate the phenotype of hypotrichosis, so there is a limited understanding of the molecular mechanism of Hoxc13-mediated hypotrichosis in animal models and clinically.	pigs	hypotrichosis	94005	HP_0001006	53	57	106	119	False
30125135	Here, the homozygous Hoxc13<sup>-/-</sup> rabbits showed complete loss of hair on the head and dorsum, whereas hypotrichosis in the limbs and tail were determined in the Hoxc13<sup>-/-</sup> rabbits.	Hoxc13	hypotrichosis	3229	HP_0001006	21	27	111	124	True
30125135	In addition, reduced hair follicles (HFs) while the enlarged and increased number of sebaceous glands (SGs) were also found in the Hoxc13<sup>-/-</sup> rabbits, showing that the disrupted balance between HFs and SGs may respond to hypotrichosis of ECTD-9 in an animal model and clinically.	Hoxc13	hypotrichosis	3229	HP_0001006	131	137	231	244	True
30125135	In addition, reduced hair follicles (HFs) while the enlarged and increased number of sebaceous glands (SGs) were also found in the Hoxc13<sup>-/-</sup> rabbits, showing that the disrupted balance between HFs and SGs may respond to hypotrichosis of ECTD-9 in an animal model and clinically.	SGs	hypotrichosis	2200	HP_0001006	103	106	231	244	False
30125135	Therefore, our findings demonstrate that Hoxc13<sup>-/-</sup> rabbits can be used as a model for human ECTD-9, especially to understand the pathologic mechanism of hypotrichosis.	Hoxc13	hypotrichosis	3229	HP_0001006	41	47	164	177	True
30125135	Moreover, the disrupted balance between HFs and SGs, especially in the Hoxc13<sup>-/-</sup> rabbits, can be used as an ideal animal model for dermatology ailments, such as acne and hypotrichosis, in preclinical studies.-Deng, J., Chen, M., Liu, Z., Song, Y., Sui, T., Lai, L., Li, Z.	Hoxc13	hypotrichosis	3229	HP_0001006	71	77	181	194	True
30125135	Moreover, the disrupted balance between HFs and SGs, especially in the Hoxc13<sup>-/-</sup> rabbits, can be used as an ideal animal model for dermatology ailments, such as acne and hypotrichosis, in preclinical studies.-Deng, J., Chen, M., Liu, Z., Song, Y., Sui, T., Lai, L., Li, Z.	SGs	hypotrichosis	2200	HP_0001006	48	51	181	194	False
29501609	Mutations and post-translational modifications of PLN may lead to dilated cardiomyopathy (DCM) and heart failure.	PLN	heart failure	5350	HP_0001635	50	53	99	112	True
28459465	Here, we report that the expression of the INTU gene is aberrantly elevated in human basal cell carcinoma (BCC), coinciding with increased primary cilia formation and activated hedgehog (Hh) signaling.	INTU	basal cell carcinoma	27152	HP_0002671	43	47	85	105	False
30653965	As it is currently unclear whether localized production of either H<sub>2</sub>S or GSH contributes to retinal homeostasis, we undertook a comparative analysis of CBS and CSE expression in canine, non-human primate (NHP) and human retinas to determine if these antioxidants could play a regulatory role in age-related or disease-associated retinal degeneration.	CBS	retinal degeneration	875	HP_0000546	163	166	340	360	False
28906593	Genetic mutations to a specific subset of mitochondrial Fe/S cluster delivery proteins are broadly categorized as disease-related under multiple mitochondrial dysfunction syndrome (MMDS), with symptoms indicative of a general failure of the metabolic system.	Fe	mitochondrial dysfunction	2960	HP_0003287	56	58	145	170	False
28906593	Multiple mitochondrial dysfunction syndrome 1 (MMDS1) arises as a result of the missense mutation in NFU1, an Fe/S cluster scaffold protein, which substitutes a glycine near the Fe/S cluster-binding pocket to a cysteine (p.Gly208Cys).	NFU1	mitochondrial dysfunction	27247	HP_0003287	101	105	9	34	True
28906593	Multiple mitochondrial dysfunction syndrome 1 (MMDS1) arises as a result of the missense mutation in NFU1, an Fe/S cluster scaffold protein, which substitutes a glycine near the Fe/S cluster-binding pocket to a cysteine (p.Gly208Cys).	Fe	mitochondrial dysfunction	2960	HP_0003287	110	112	9	34	False
29454536	This review highlights recent advances in understanding how the OVOL1-OVOL2 axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.	OVOL1	tumors	5017	HP_0002664	64	69	199	205	False
29454536	This review highlights recent advances in understanding how the OVOL1-OVOL2 axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.	OVOL2	tumors	58495	HP_0002664	70	75	199	205	False
29454536	This review highlights recent advances in understanding how the OVOL1-OVOL2 axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.	OVOL1	squamous cell carcinoma	5017	HP_0002860	64	69	216	239	False
29454536	This review highlights recent advances in understanding how the OVOL1-OVOL2 axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.	OVOL2	squamous cell carcinoma	58495	HP_0002860	70	75	216	239	False
29454536	This review highlights recent advances in understanding how the OVOL1-OVOL2 axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.	OVOL1	malignant melanoma	5017	HP_0002861	64	69	244	262	False
29454536	This review highlights recent advances in understanding how the OVOL1-OVOL2 axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and malignant melanoma.	OVOL2	malignant melanoma	58495	HP_0002861	70	75	244	262	False
24516401	E168d2 mice carry a frameshift mutation in the CRX activation domain, Glu168del2, which is associated with severe dominant CoRD or LCA in humans.	CRX	severe	1406	HP_0012828	47	50	107	113	False
24516401	E168d2 mice carry a frameshift mutation in the CRX activation domain, Glu168del2, which is associated with severe dominant CoRD or LCA in humans.	LCA	severe	1211	HP_0012828	131	134	107	113	False
24516401	E168d2 mice carry a frameshift mutation in the CRX activation domain, Glu168del2, which is associated with severe dominant CoRD or LCA in humans.	mice	severe	23581	HP_0012828	7	11	107	113	False
24516401	As seen in human patients, heterozygous E168d2 (&quot;E168d2/+&quot;) but not R90W (&quot;R90W/+&quot;) mice show severely impaired retinal function, while mice homozygous for either mutation are blind and undergo rapid photoreceptor degeneration.	mice	severe	23581	HP_0012828	104	108	114	120	False
28179442	Asthma is characterised by heterogeneous clinical phenotypes.	type	heterogeneous	6445	HP_0001425	55	59	27	40	False
28179442	Our objective was to determine molecular phenotypes of asthma by analysing sputum cell transcriptomics from 104 moderate-to-severe asthmatic subjects and 16 nonasthmatic subjects.After filtering on the differentially expressed genes between eosinophil- and noneosinophil-associated sputum inflammation, we used unbiased hierarchical clustering on 508 differentially expressed genes and gene set variation analysis of specific gene sets.We defined three transcriptome-associated clusters (TACs): TAC1 (characterised by immune receptors <i>IL33R</i>, <i>CCR3</i> and <i>TSLPR</i>), TAC2 (characterised by interferon-, tumour necrosis factor-- and inflammasome-associated genes) and TAC3 (characterised by genes of metabolic pathways, ubiquitination and mitochondrial function).	set	tumour	6418	HP_0002664	391	394	616	622	False
28179442	Our objective was to determine molecular phenotypes of asthma by analysing sputum cell transcriptomics from 104 moderate-to-severe asthmatic subjects and 16 nonasthmatic subjects.After filtering on the differentially expressed genes between eosinophil- and noneosinophil-associated sputum inflammation, we used unbiased hierarchical clustering on 508 differentially expressed genes and gene set variation analysis of specific gene sets.We defined three transcriptome-associated clusters (TACs): TAC1 (characterised by immune receptors <i>IL33R</i>, <i>CCR3</i> and <i>TSLPR</i>), TAC2 (characterised by interferon-, tumour necrosis factor-- and inflammasome-associated genes) and TAC3 (characterised by genes of metabolic pathways, ubiquitination and mitochondrial function).	TAC1	tumour	6863	HP_0002664	495	499	616	622	False
28179442	Our objective was to determine molecular phenotypes of asthma by analysing sputum cell transcriptomics from 104 moderate-to-severe asthmatic subjects and 16 nonasthmatic subjects.After filtering on the differentially expressed genes between eosinophil- and noneosinophil-associated sputum inflammation, we used unbiased hierarchical clustering on 508 differentially expressed genes and gene set variation analysis of specific gene sets.We defined three transcriptome-associated clusters (TACs): TAC1 (characterised by immune receptors <i>IL33R</i>, <i>CCR3</i> and <i>TSLPR</i>), TAC2 (characterised by interferon-, tumour necrosis factor-- and inflammasome-associated genes) and TAC3 (characterised by genes of metabolic pathways, ubiquitination and mitochondrial function).	TAC2	tumour	6863	HP_0002664	580	584	616	622	False
28179442	Our objective was to determine molecular phenotypes of asthma by analysing sputum cell transcriptomics from 104 moderate-to-severe asthmatic subjects and 16 nonasthmatic subjects.After filtering on the differentially expressed genes between eosinophil- and noneosinophil-associated sputum inflammation, we used unbiased hierarchical clustering on 508 differentially expressed genes and gene set variation analysis of specific gene sets.We defined three transcriptome-associated clusters (TACs): TAC1 (characterised by immune receptors <i>IL33R</i>, <i>CCR3</i> and <i>TSLPR</i>), TAC2 (characterised by interferon-, tumour necrosis factor-- and inflammasome-associated genes) and TAC3 (characterised by genes of metabolic pathways, ubiquitination and mitochondrial function).	TAC3	tumour	6866	HP_0002664	681	685	616	622	False
28179442	Our objective was to determine molecular phenotypes of asthma by analysing sputum cell transcriptomics from 104 moderate-to-severe asthmatic subjects and 16 nonasthmatic subjects.After filtering on the differentially expressed genes between eosinophil- and noneosinophil-associated sputum inflammation, we used unbiased hierarchical clustering on 508 differentially expressed genes and gene set variation analysis of specific gene sets.We defined three transcriptome-associated clusters (TACs): TAC1 (characterised by immune receptors <i>IL33R</i>, <i>CCR3</i> and <i>TSLPR</i>), TAC2 (characterised by interferon-, tumour necrosis factor-- and inflammasome-associated genes) and TAC3 (characterised by genes of metabolic pathways, ubiquitination and mitochondrial function).	type	tumour	6445	HP_0002664	46	50	616	622	False
28179442	TAC1 showed the highest enrichment of gene signatures for interleukin-13/T-helper cell type 2 (Th2) and innate lymphoid cell type 2.TAC1 had the highest sputum eosinophilia and exhaled nitric oxide fraction, and was restricted to severe asthma with oral corticosteroid dependency, frequent exacerbations and severe airflow obstruction.	TAC1	eosinophilia	6863	HP_0001880	0	4	161	173	False
28179442	TAC1 showed the highest enrichment of gene signatures for interleukin-13/T-helper cell type 2 (Th2) and innate lymphoid cell type 2.TAC1 had the highest sputum eosinophilia and exhaled nitric oxide fraction, and was restricted to severe asthma with oral corticosteroid dependency, frequent exacerbations and severe airflow obstruction.	type	eosinophilia	6445	HP_0001880	87	91	161	173	False
28179442	TAC2 showed the highest sputum neutrophilia, serum C-reactive protein levels and prevalence of eczema.	TAC2	neutrophilia	6863	HP_0011897	0	4	31	43	False
28479227	Limb girdle muscular dystrophy type 2I (LGMD2I) is a progressive disorder caused by mutations in the FuKutin-Related Protein gene (FKRP).	type	muscular dystrophy	6445	HP_0003560	31	35	12	30	True
28479227	Limb girdle muscular dystrophy type 2I (LGMD2I) is a progressive disorder caused by mutations in the FuKutin-Related Protein gene (FKRP).	LGMD2I	muscular dystrophy	79147	HP_0003560	40	46	12	30	True
28479227	Limb girdle muscular dystrophy type 2I (LGMD2I) is a progressive disorder caused by mutations in the FuKutin-Related Protein gene (FKRP).	FKRP	muscular dystrophy	79147	HP_0003560	131	135	12	30	True
28479227	LGMD2I displays clinical heterogeneity with onset of severe symptoms in early childhood to mild calf and thigh hypertrophy in the second or third decade.	LGMD2I	heterogeneity	79147	HP_0001425	0	6	25	38	True
26875496	Shh signalling from the prechordal plate and ventral midline of the diencephalon is required for appropriate division of the eyefield and forebrain, with mutation in a number of pathway components associated with Holoprosencephaly, a clinically heterogeneous developmental defect characterized by a failure of the early forebrain vesicle to divide into distinct halves.	Shh	heterogeneous	6469	HP_0001425	0	3	245	258	False
20409997	Hair-nail ectodermal dysplasia (HNED; OMIM 602032) constitutes a rare subgroup of ectodermal dysplasias characterised by onychodystrophy, hypotrichosis and brittle hair.	nail	ectodermal dysplasia	51744	HP_0000968	5	9	10	30	False
20409997	Hair-nail ectodermal dysplasia (HNED; OMIM 602032) constitutes a rare subgroup of ectodermal dysplasias characterised by onychodystrophy, hypotrichosis and brittle hair.	nail	hypotrichosis	51744	HP_0001006	5	9	138	151	False
20409997	Our study confirms linkage of a variant clinical form of hair-nail ectodermal dysplasia to chromosome 12 without any mutation in the coding sequences of the KRTHB5 gene.	nail	ectodermal dysplasia	51744	HP_0000968	62	66	67	87	False
20409997	Our study confirms linkage of a variant clinical form of hair-nail ectodermal dysplasia to chromosome 12 without any mutation in the coding sequences of the KRTHB5 gene.	KRTHB5	ectodermal dysplasia	3891	HP_0000968	157	163	67	87	True
26604137	Prostate cancer is the most common non-skin cancer in males, with a 1.5-2-fold higher incidence in African American men when compared with whites.	men	cancer	8178	HP_0002664	117	120	9	15	False
26604137	In this first whole-exome sequencing study of prostate cancer, our findings do not provide strong support for the hypothesis that NS coding variants down to 0.5-1.0% frequency have large effects on prostate cancer risk in men of African ancestry.	men	cancer	8178	HP_0002664	222	225	55	61	False
28726978	Factor VII (FVII) activating protease (FSAP) is a circulating serine protease that is likely to be involved in a number of disease conditions such as stroke, atherosclerosis, liver fibrosis, thrombosis and cancer.	FSAP	cancer	3026	HP_0002664	39	43	206	212	True
30413001	Danon disease, an X-linked dominant cardioskeletal myopathy, is caused by primary deficiency of lysosome-associated membrane protein-2 (LAMP-2).	LAMP	myopathy	27074	HP_0003198	136	140	51	59	False
28213671	Smith-Magenis syndrome (SMS), a neurodevelopmental disorder characterized by dysmorphic features, intellectual disability (ID), and sleep disturbances, results from a 17p11.2 microdeletion or a mutation in the RAI1 gene.	SMS	intellectual disability	10743	HP_0001249	24	27	98	121	True
28213671	Smith-Magenis syndrome (SMS), a neurodevelopmental disorder characterized by dysmorphic features, intellectual disability (ID), and sleep disturbances, results from a 17p11.2 microdeletion or a mutation in the RAI1 gene.	RAI1	intellectual disability	10743	HP_0001249	210	214	98	121	True
28213671	Smith-Magenis syndrome (SMS), a neurodevelopmental disorder characterized by dysmorphic features, intellectual disability (ID), and sleep disturbances, results from a 17p11.2 microdeletion or a mutation in the RAI1 gene.	SMS	sleep disturbances	10743	HP_0002360	24	27	132	150	True
28213671	Smith-Magenis syndrome (SMS), a neurodevelopmental disorder characterized by dysmorphic features, intellectual disability (ID), and sleep disturbances, results from a 17p11.2 microdeletion or a mutation in the RAI1 gene.	RAI1	sleep disturbances	10743	HP_0002360	210	214	132	150	True
29421602	Jalili syndrome (JS) is an autosomal recessive disease characterized by a combination of cone-rode retinal dytrophy (CRD) and amelogenesis imperfect (AI).	CRD	autosomal recessive	1406	HP_0000007	117	120	27	46	True
22029171	Our case presented the specific characteristics: macrocephaly, midline cleft-lip, cleft palate, polydactyly of both hands and feet but without occipitoschisis, considered as the pathognomonic sign of the syndrome.	lip	macrocephaly	23049	HP_0000256	77	80	49	61	False
22029171	Our case presented the specific characteristics: macrocephaly, midline cleft-lip, cleft palate, polydactyly of both hands and feet but without occipitoschisis, considered as the pathognomonic sign of the syndrome.	lip	cleft palate	23049	HP_0000175	77	80	82	94	False
28522832	High mobility group A2 (HMGA2) plays a crucial role in the development of cancer.	HMGA2	cancer	8091	HP_0002664	24	29	74	80	True
28522832	However, the mechanism by which HMGA2 promotes the growth of hepatocellular carcinoma (HCC) remains unclear.	HMGA2	hepatocellular carcinoma	8091	HP_0001402	32	37	61	85	False
28522832	However, the mechanism by which HMGA2 promotes the growth of hepatocellular carcinoma (HCC) remains unclear.	HCC	hepatocellular carcinoma	84668	HP_0001402	87	90	61	85	False
29142187	In Japan, 26 mutations in the ATP2A2 gene in 7 pedigrees and 19 sporadic cases with DD have been reported, among which one pedigree and one sporadic case were accompanied by neuropsychiatric symptoms.	ATP2A2	sporadic	488	HP_0003745	30	36	64	72	False
26053550	No significant associations were detected between these SNPs and schizophrenia in Han Chinese and the PGC data set.	PGC	schizophrenia	5225	HP_0100753	102	105	65	78	False
26053550	However, we observed nominal significant associations of 2 SNPs in the NDUFS1 gene and 4 SNPs in the NDUFS2 gene with early onset schizophrenia (EOS), but none of these associations survived the Bonferroni correction.	NDUFS1	schizophrenia	4719	HP_0100753	71	77	130	143	False
26053550	However, we observed nominal significant associations of 2 SNPs in the NDUFS1 gene and 4 SNPs in the NDUFS2 gene with early onset schizophrenia (EOS), but none of these associations survived the Bonferroni correction.	NDUFS2	schizophrenia	4720	HP_0100753	101	107	130	143	False
26053550	However, we observed nominal significant associations of 2 SNPs in the NDUFS1 gene and 4 SNPs in the NDUFS2 gene with early onset schizophrenia (EOS), but none of these associations survived the Bonferroni correction.	EOS	schizophrenia	64375	HP_0100753	145	148	130	143	False
28289221	B1 induced readthrough at all three nonsense codons in cultured cancer cells with <i>TP53</i> (tumor protein p53) mutations, in cells from patients with nonsense mutations in the <i>TPP1</i> (tripeptidyl peptidase 1), <i>DMD</i> (dystrophin), <i>SMARCAL1</i> (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1), and <i>COL7A1</i> (collagen type VII alpha 1 chain) genes, and in an in vivo tumor xenograft model.	type	cancer	6445	HP_0002664	385	389	64	70	False
28289221	B1 induced readthrough at all three nonsense codons in cultured cancer cells with <i>TP53</i> (tumor protein p53) mutations, in cells from patients with nonsense mutations in the <i>TPP1</i> (tripeptidyl peptidase 1), <i>DMD</i> (dystrophin), <i>SMARCAL1</i> (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a-like 1), and <i>COL7A1</i> (collagen type VII alpha 1 chain) genes, and in an in vivo tumor xenograft model.	type	tumor	6445	HP_0002664	385	389	95	100	False
28969390	Using exome sequencing, we identified dominant mutations in DNM1L on chromosome 12p11.21 in three large families with isolated optic atrophy, including the two families that defined the OPA5 locus on chromosome 19q12.1-13.1, the existence of which is denied by the present study.	DNM1L	optic atrophy	10059	HP_0000648	60	65	127	140	True
25703721	Recessive variants located in the ligand-binding domain (LBD) of NR2E3 cause enhanced short wavelength sensitive- (S-) cone syndrome (ESCS), a retinal degeneration characterized by an excess of S-cones and non-functional rods.	rod	retinal degeneration	9735	HP_0000546	221	224	143	163	False
27740521	Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor.	HCC	tumor	84668	HP_0002664	26	29	74	79	False
26384305	Although Sur8 has been shown to be a scaffold protein of the Ras-ERK pathway, its interaction with other signaling pathways and its involvement in tumor malignancy has not been reported.	ERK	tumor	2048	HP_0002664	65	68	147	152	False
26384305	Although Sur8 has been shown to be a scaffold protein of the Ras-ERK pathway, its interaction with other signaling pathways and its involvement in tumor malignancy has not been reported.	Sur8	tumor	8036	HP_0002664	9	13	147	152	False
29773347	Friedreich's ataxia (FRDA) is an autosomal recessive neurodegenerative disorder resulting from reduced expression of the protein frataxin (FXN).	FRDA	ataxia	2395	HP_0001251	21	25	13	19	True
29773347	Friedreich's ataxia (FRDA) is an autosomal recessive neurodegenerative disorder resulting from reduced expression of the protein frataxin (FXN).	FXN	ataxia	2395	HP_0001251	139	142	13	19	True
29949095	In this study, we expand the genotype-phenotype repertoire of SCA13 by describing the novel KCNC3 deletion p.Pro583_Pro585del highlighting the allelic heterogeneity observed in SCA13 patients.	KCNC3	heterogeneity	3748	HP_0001425	92	97	151	164	False
29949095	In this study, we expand the genotype-phenotype repertoire of SCA13 by describing the novel KCNC3 deletion p.Pro583_Pro585del highlighting the allelic heterogeneity observed in SCA13 patients.	SCA13	heterogeneity	3748	HP_0001425	62	67	151	164	False
29949095	We characterize adult-onset, progressive clinical symptoms of two afflicted kindred and introduce the symptom of profound spasticity not previously associated with the SCA13 phenotype.	SCA13	profound	3748	HP_0012829	168	173	113	121	False
29949095	We characterize adult-onset, progressive clinical symptoms of two afflicted kindred and introduce the symptom of profound spasticity not previously associated with the SCA13 phenotype.	SCA13	spasticity	3748	HP_0001257	168	173	122	132	False
29945888	Here, we applied domain-focused CRISPR screening to human cancer cell lines to identify the transcription factor (TF) POU2F3 (POU class 2 homeobox 3; also known as SKN-1a/OCT-11) as a powerful dependency in a subset of SCLC lines.	POU2F3	cancer	25833	HP_0002664	118	124	58	64	False
29945888	Here, we applied domain-focused CRISPR screening to human cancer cell lines to identify the transcription factor (TF) POU2F3 (POU class 2 homeobox 3; also known as SKN-1a/OCT-11) as a powerful dependency in a subset of SCLC lines.	SKN	cancer	55733	HP_0002664	164	167	58	64	False
29945888	Here, we applied domain-focused CRISPR screening to human cancer cell lines to identify the transcription factor (TF) POU2F3 (POU class 2 homeobox 3; also known as SKN-1a/OCT-11) as a powerful dependency in a subset of SCLC lines.	OCT	cancer	5362	HP_0002664	171	174	58	64	False
29945888	An analysis of human SCLC specimens revealed that POU2F3 is expressed exclusively in variant SCLC tumors that lack expression of neuroendocrine markers and instead express markers of a chemosensory lineage known as tuft cells.	POU2F3	tumor	25833	HP_0002664	50	56	98	103	False
29945888	Moreover, we show that most SCLC tumors can be classified into one of three lineages based on the expression of POU2F3, ASCL1, or NEUROD1.	POU2F3	tumor	25833	HP_0002664	112	118	33	38	False
29945888	Moreover, we show that most SCLC tumors can be classified into one of three lineages based on the expression of POU2F3, ASCL1, or NEUROD1.	ASCL1	tumor	429	HP_0002664	120	125	33	38	True
28315782	We investigated the effects of heightened levels of COMT on dopamine-regulated motor behaviors and molecular alterations in a mouse model of dyskinesia.	COMT	dyskinesia	1312	HP_0100660	52	56	141	151	False
28315782	l-DOPA-induced dyskinesia was exacerbated in TG mice without altering l-DOPA motor efficacy as determined by contralateral rotations or motor coordination.	mice	dyskinesia	23581	HP_0100660	48	52	15	25	False
28315782	Inductions of FosB and phospho-acetylated histone 3 (molecular correlates of dyskinesia) were potentiated in the lesioned striatum of TG mice compared with their WT littermates.	mice	dyskinesia	23581	HP_0100660	137	141	77	87	False
28315782	Inductions of FosB and phospho-acetylated histone 3 (molecular correlates of dyskinesia) were potentiated in the lesioned striatum of TG mice compared with their WT littermates.	FosB	dyskinesia	2354	HP_0100660	14	18	77	87	False
28315782	Our results demonstrate that human COMT overexpression confers a heightened susceptibility to l-DOPA-induced dyskinesia and alters molecular and neurochemical responses in the lesioned striatum of mice	COMT	dyskinesia	1312	HP_0100660	35	39	109	119	False
26771056	A previous study recently described two consanguineous families in which homozygous mutations of MCM9 were responsible for POI and short stature.	MCM9	short stature	254394	HP_0004322	97	101	131	144	True
28398482	In humans, CERKL mutations cause widespread retinal degeneration: early dysfunction and loss of rod and cone photoreceptors in the outer retina and, progressively, death of cells in the inner retina.	CERKL	retinal degeneration	375298	HP_0000546	11	16	44	64	False
28398482	In humans, CERKL mutations cause widespread retinal degeneration: early dysfunction and loss of rod and cone photoreceptors in the outer retina and, progressively, death of cells in the inner retina.	rod	retinal degeneration	9735	HP_0000546	96	99	44	64	False
29293945	We aimed to test effects of such gCNVs on the risk of lung cancer and chronic obstructive pulmonary disease (COPD).	COPD	cancer	372	HP_0002664	109	113	59	65	False
29293945	Genomic imbalance of lung cancer was determined by the array comparative genomic hybridization (aCGH), and common gCNVs at these imbalance regions were genotyped in lung cancer-based and COPD-based retrospective studies.	COPD	cancer	372	HP_0002664	187	191	26	32	False
29293945	The CNVR_3425.1, overlapping the chr16q24.1 with genomic imbalance, was significantly associated with increased risks of lung cancer (OR = 1.76; 95% CI = 1.46-2.11) and COPD (OR = 1.98; 95% CI = 1.57-2.51).	COPD	cancer	372	HP_0002664	169	173	126	132	False
29293945	The increase copy of CNVR_3425.1 forms a new additional truncated FOXF1 adjacent non-coding developmental regulatory RNA (FENDRR) sequences comparing the gene promoter and perturbs the transcriptional factors (TFs) binding to the original FENDRR promoter and further downregulates FENDRR, a long intergenic non-coding RNA (lincRNA) that functions to inhibit lung cancer by affecting expressions of an abundant number of genes, including the tumor suppressor FOXF1.	FOXF1	tumor	2294	HP_0002664	66	71	441	446	False
29293945	The increase copy of CNVR_3425.1 forms a new additional truncated FOXF1 adjacent non-coding developmental regulatory RNA (FENDRR) sequences comparing the gene promoter and perturbs the transcriptional factors (TFs) binding to the original FENDRR promoter and further downregulates FENDRR, a long intergenic non-coding RNA (lincRNA) that functions to inhibit lung cancer by affecting expressions of an abundant number of genes, including the tumor suppressor FOXF1.	FOXF1	cancer	2294	HP_0002664	66	71	363	369	False
29293945	These findings suggested the CNVR_3425.1 to be a possibly predictive biomarker for the risk of lung cancer and COPD, and targeted molecular therapy pertaining to FENDRR upregulation may be a valuable pathway to fight two diseases	COPD	cancer	372	HP_0002664	111	115	100	106	False
29215551	Aim of this study was to analyze the CMG2 mRNA and protein expression in soft tissue sarcoma and their association with patient outcome.	CMG2	sarcoma	118429	HP_0100242	37	41	85	92	True
29215551	CMG2 mRNA was measured in 121 tumor samples of soft tissue sarcoma patients using quantitative real-time PCR.	CMG2	sarcoma	118429	HP_0100242	0	4	59	66	True
29215551	CMG2 mRNA was measured in 121 tumor samples of soft tissue sarcoma patients using quantitative real-time PCR.	CMG2	tumor	118429	HP_0002664	0	4	30	35	True
29215551	CMG2 protein was evaluated in 52 tumor samples by ELISA.	CMG2	tumor	118429	HP_0002664	0	4	33	38	True
29215551	Low CMG2 mRNA expression was correlated with a worsened patients' disease-specific survival in Kaplan-Meier analyses (mean patient survival was 25 vs. 96 months; <i>p</i> = 0.013), especially in high-stage tumors.	CMG2	tumor	118429	HP_0002664	4	8	206	211	True
29215551	A decreased CMG2 expression is a negative prognostic factor for soft tissue sarcoma patients.	CMG2	sarcoma	118429	HP_0100242	12	16	76	83	True
29215551	CMG2 may be an interesting candidate gene for the further exploration of soft tissue sarcoma genesis and progression	CMG2	sarcoma	118429	HP_0100242	0	4	85	92	True
29215551	CMG2 may be an interesting candidate gene for the further exploration of soft tissue sarcoma genesis and progression	genesis	sarcoma	27022	HP_0100242	93	100	85	92	False
30136158	Whole exome sequencing in triple negative breast cancer cases (n=8) and targeted sequencing in healthy controls (n=48) revealed BRIP1 rs552752779 (MAF: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), ERBB2 rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), MSH6 rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.	BRIP1	cancer	64979	HP_0002664	132	137	49	55	False
30136158	Whole exome sequencing in triple negative breast cancer cases (n=8) and targeted sequencing in healthy controls (n=48) revealed BRIP1 rs552752779 (MAF: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), ERBB2 rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), MSH6 rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.	MAF	cancer	4094	HP_0002664	151	154	49	55	False
30136158	Whole exome sequencing in triple negative breast cancer cases (n=8) and targeted sequencing in healthy controls (n=48) revealed BRIP1 rs552752779 (MAF: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), ERBB2 rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), MSH6 rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.	ERBB2	cancer	2064	HP_0002664	202	207	49	55	True
30136158	Whole exome sequencing in triple negative breast cancer cases (n=8) and targeted sequencing in healthy controls (n=48) revealed BRIP1 rs552752779 (MAF: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), ERBB2 rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), MSH6 rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.	ERCC2	cancer	2068	HP_0002664	273	278	49	55	True
30136158	Whole exome sequencing in triple negative breast cancer cases (n=8) and targeted sequencing in healthy controls (n=48) revealed BRIP1 rs552752779 (MAF: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), ERBB2 rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), MSH6 rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.	MSH6	cancer	2956	HP_0002664	345	349	49	55	True
27693232	Germline de novo truncating variants in ASXL1 and ASXL3 have been respectively implicated in causing Bohring-Opitz and Bainbridge-Ropers syndromes, which result in overlapping features of severe intellectual disability and dysmorphic features.	ASXL1	intellectual disability	171023	HP_0001249	40	45	195	218	True
27693232	Germline de novo truncating variants in ASXL1 and ASXL3 have been respectively implicated in causing Bohring-Opitz and Bainbridge-Ropers syndromes, which result in overlapping features of severe intellectual disability and dysmorphic features.	ASXL3	intellectual disability	80816	HP_0001249	50	55	195	218	True
27693232	Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.	ASXL1	macrocephaly	171023	HP_0000256	150	155	189	201	False
27693232	Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.	ASXL2	macrocephaly	55252	HP_0000256	118	123	189	201	True
27693232	Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.	ASXL3	macrocephaly	80816	HP_0000256	161	166	189	201	False
27693232	Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.	ASXL1	intellectual disabilities	171023	HP_0001249	150	155	272	297	True
27693232	Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.	ASXL2	intellectual disabilities	55252	HP_0001249	118	123	272	297	True
27693232	Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities.	ASXL3	intellectual disabilities	80816	HP_0001249	161	166	272	297	True
28703219	Furthermore, we identified specific variants of DTC that have different effects according to cancer type or ethnicity.	type	cancer	6445	HP_0002664	100	104	93	99	False
29899297	Pre-treatment testing of the localized cutaneous tumor lesion on a lymphoid amplicon panel demonstrated an <i>MYD88</i> p.L265P mutation.	MYD88	tumor	4615	HP_0002664	110	115	49	54	True
28530155	To examine if CRC patients have altered decorin levels, expression of decorin and its target genes, Met and vascular endothelial growth factor A (VEGFA), were analyzed in their tumors.	Met	tumors	4233	HP_0002664	100	103	177	183	True
28530155	To examine if CRC patients have altered decorin levels, expression of decorin and its target genes, Met and vascular endothelial growth factor A (VEGFA), were analyzed in their tumors.	VEGFA	tumors	7422	HP_0002664	146	151	177	183	False
28530155	Compared to normal tissues, decorin expression was reduced in CRC patients' tumors, while there were increased Met and VEGFA levels.	Met	tumors	4233	HP_0002664	111	114	76	82	True
28530155	Compared to normal tissues, decorin expression was reduced in CRC patients' tumors, while there were increased Met and VEGFA levels.	VEGFA	tumors	7422	HP_0002664	119	124	76	82	False
28530155	Several therapeutic strategies expressing GM-CSF have been employed in clinical trials for treating metastatic colorectal cancer.	GM-CSF	cancer	1437	HP_0002664	42	48	122	128	False
18180767	Association between autism and single-nucleotide polymorphisms in SLC25A12 has been reported in various studies.	SLC25A12	autism	8604	HP_0000717	66	74	20	26	False
18180767	These fetal structures generate regions with abnormal activity in autism, including the dorsolateral prefrontal cortex (BA46), the pars opercularis of the inferior frontal cortex and the fusiform gyrus.	pars	autism	2058	HP_0000717	131	135	66	72	False
18180767	Our findings suggest that SLC25A12 overexpression may be involved in the pathophysiology of autism, modifying neuronal networks in specific subregions, such as the dorsolateral prefrontal cortex and fusiform gyrus, at both pre- and postnatal stages	SLC25A12	autism	8604	HP_0000717	26	34	92	98	False
28073926	Renpenning syndrome is a group of X-linked intellectual disability syndromes caused by mutations in human polyglutamine-binding protein 1 (PQBP1) gene.	PQBP1	intellectual disability	10084	HP_0001249	139	144	43	66	True
29886046	Clinical presentation of COX deficiency is heterogeneous ranging from mild to severe neuromuscular diseases.	COX	heterogeneous	1351	HP_0001425	25	28	43	56	True
26381604	Patients with ORC1 and ORC4 mutations appear to have the most severe short stature and microcephaly.	ORC1	short stature	10166	HP_0004322	14	18	69	82	False
26381604	Patients with ORC1 and ORC4 mutations appear to have the most severe short stature and microcephaly.	ORC4	short stature	5000	HP_0004322	23	27	69	82	True
26381604	Patients with ORC1 and ORC4 mutations appear to have the most severe short stature and microcephaly.	ORC1	microcephaly	10166	HP_0000252	14	18	87	99	False
26381604	Patients with ORC1 and ORC4 mutations appear to have the most severe short stature and microcephaly.	ORC4	microcephaly	5000	HP_0000252	23	27	87	99	True
28841361	Although p53R2 has been linked to human cancer, its role in cervical cancer remains unknown.	p53	cancer	7157	HP_0002664	9	12	40	46	True
28841361	In this study, we investigated the expression and clinical significance of p53R2 in early-stage cervical cancer.	p53	cancer	7157	HP_0002664	75	78	105	111	True
28841361	p53R2 expression is significantly upregulated at both mRNA and protein levels in cervical cancer cells and tissues, compared with that in matched normal cervical cells and tissues, respectively.	p53	cancer	7157	HP_0002664	0	3	90	96	True
28841361	p53R2 overexpression is associated with increased risk of pelvic lymph node metastasis (PLNM, p = 0.001) and cancer relapse (p = 0.009).	p53	cancer	7157	HP_0002664	0	3	109	115	True
28841361	Patients with high p53R2 expression have a shorter overall survival (OS) and disease-free survival (DFS). p53R2 is an independent factor for predicting OS and DFS of cervical cancer patients.	p53	cancer	7157	HP_0002664	19	22	175	181	True
28841361	We further show that p53R2 is important for oncogenic growth, migration and invasion in cervical cancer cells.	p53	cancer	7157	HP_0002664	21	24	97	103	True
28841361	In conclusion, our study demonstrates for the first time that p53R2 protein is overexpressed in early-stage cervical cancer and unravels some unconventional oncogenic functions of p53R2. p53R2 may be a useful prognostic biomarker and therapeutic target for cervical cancer	p53	cancer	7157	HP_0002664	62	65	117	123	True
28634653	Exposure to BMAA has been implicated in the development of neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD) and Parkinson's disease (PD).	ALS	neurodegenerative diseases	3483	HP_0002180	127	130	59	85	False
30500808	Moreover, we demonstrated that ERG and FLI1 expression is downregulated in ECs within tumors by soluble factors enriched in the tumor microenvironment.	ERG	tumor	2078	HP_0002664	31	34	86	91	False
30500808	Moreover, we demonstrated that ERG and FLI1 expression is downregulated in ECs within tumors by soluble factors enriched in the tumor microenvironment.	FLI1	tumor	2313	HP_0002664	39	43	86	91	False
30626716	Here, we report a reduction of histone deacetylase 3 (HDAC3) protein amounts in eutopic endometrium of infertile women with endometriosis compared to a control group.	HDAC3	endometriosis	8841	HP_0030127	54	59	124	137	False
30626716	Reduction of <i>HDAC3</i> abrogated decidualization in a primary culture of human endometrial stromal cells (hESCs) similar to that observed in infertile patients with endometriosis.	HDAC3	endometriosis	8841	HP_0030127	16	21	168	181	False
30626716	Collectively, we found attenuation of HDAC3 and overexpression of collagen type I in the eutopic endometrium of infertile patients with endometriosis.	HDAC3	endometriosis	8841	HP_0030127	38	43	136	149	False
30626716	Collectively, we found attenuation of HDAC3 and overexpression of collagen type I in the eutopic endometrium of infertile patients with endometriosis.	type	endometriosis	6445	HP_0030127	75	79	136	149	False
22261332	Chmp1A functions as a tumor suppressor gene and has been reported in pancreatic tumor cells.	Chmp1A	tumor	5119	HP_0002664	0	6	22	27	False
22261332	Here, we examined the expression level of Chmp1A in human RCC tissues and renal tumor cells by real-time quantitative RT-PCR and western blot.	RCC	tumor	7515	HP_0002664	58	61	80	85	False
22261332	Here, we examined the expression level of Chmp1A in human RCC tissues and renal tumor cells by real-time quantitative RT-PCR and western blot.	Chmp1A	tumor	5119	HP_0002664	42	48	80	85	False
22261332	We found that the expression level of Chmp1A is significantly lower in RCC tissues and renal tumor cells compared with adjacent non-tumorous tissues and normal renal cells.	RCC	tumor	7515	HP_0002664	71	74	93	98	False
22261332	We found that the expression level of Chmp1A is significantly lower in RCC tissues and renal tumor cells compared with adjacent non-tumorous tissues and normal renal cells.	Chmp1A	tumor	5119	HP_0002664	38	44	93	98	False
22261332	Additionally, inhibition of Chmp1A expression by shRNA induced tumor formation in normal renal cells.	Chmp1A	tumor	5119	HP_0002664	28	34	63	68	False
22261332	However, inhibition of Chmp1A did not significantly affect tumor cell proliferation in vitro and tumor progression in vivo.	Chmp1A	tumor	5119	HP_0002664	23	29	59	64	False
22261332	Interestingly, overexpression of Chmp1A using a eukaryotic plasmid inhibited the proliferation of renal tumor cells in vitro and the growth of renal tumor in vivo.	Chmp1A	tumor	5119	HP_0002664	33	39	104	109	False
22261332	Thus, our results demonstrate that Chmp1A functions as a tumor suppressor gene in renal cells and may be a useful target for treatment of RCC	Chmp1A	tumor	5119	HP_0002664	35	41	57	62	False
30204612	Subsequent mutation analyses identified tumor-associated calcium signal transducer 2 (TACSTD2; former name, M1S1) as the gene responsible for GDLD.	TACSTD2	tumor	4070	HP_0002664	86	93	40	45	False
27034204	Fourteen single-nucleotide polymorphisms (SNPs) in three genes were genotyped by the TaqMan method using the real-time PCR system.ResultsThree SNPs GRM6-rs11746675, GRM6-rs2067011, and GRM6-rs2645339 were associated with high myopia (odds ratio (OR)=0.74, P=0.003; OR=0.78, P=0.018; and OR=0.78, P=0.023; respectively).	GRM6	myopia	2916	HP_0000545	148	152	226	232	True
27034204	The genetic model analysis found that GRM6-rs11746675 and GRM6-rs2067011 were suggestively associated with high myopia in the recessive model (OR=0.54, P=0.004; OR=0.52, P=0.003; respectively).	GRM6	myopia	2916	HP_0000545	38	42	112	118	True
27034204	Haplotype GAT for GRM6 markers rs2067011-rs2645339-rs762724 showed significance (P=0.0239), but such association did not remain significant after multiple testing corrections.ConclusionsOur data suggested that genetic variants in GRM6 are associated with high myopia.	GRM6	myopia	2916	HP_0000545	18	22	260	266	True
27034204	Haplotype GAT for GRM6 markers rs2067011-rs2645339-rs762724 showed significance (P=0.0239), but such association did not remain significant after multiple testing corrections.ConclusionsOur data suggested that genetic variants in GRM6 are associated with high myopia.	GAT	myopia	10249	HP_0000545	10	13	260	266	False
27034204	The mechanism of GRM6 in the development of high myopia need to be further investigated.	GRM6	myopia	2916	HP_0000545	17	21	49	55	True
28408481	These inhibitors, coupled with targeted knockdown of Hhat and Porcn, reveal the essential functions of fatty acylation of secreted morphogens in a wide variety of human tumors	Hhat	tumor	55733	HP_0002664	53	57	169	174	False
28408481	These inhibitors, coupled with targeted knockdown of Hhat and Porcn, reveal the essential functions of fatty acylation of secreted morphogens in a wide variety of human tumors	Porcn	tumor	64840	HP_0002664	62	67	169	174	True
27406698	Our exome analysis indicated the proband as a compound heterozygote for two missense variants in the TECPR2 gene according to a recessive mode of inheritance.	TECPR2	mode of inheritance	9895	HP_0000005	101	107	138	157	False
27406698	The TECPR2 gene has been reported as a positive regulator of autophagy which is an essential mechanism for maintaining neuron homeostasis and survival and plays a key role in major adult and pediatric neurodegenerative diseases.	TECPR2	neurodegenerative diseases	9895	HP_0002180	4	10	201	227	False
28901390	In this study, we found that tumor suppressor candidate3(TUSC3) was downregulated in temozolomide-resistant U87MG cells(U87MG-res cells) and its restoration sensitized U87MG-res cells to temozolomide.	TUSC3	tumor	7991	HP_0002664	59	64	29	34	False
28901390	miR132 was upregulated in the U87MG-res cells and its overexpression induced temozolomide resistance and the formation of cancer stem cell phenotypes in the U87MG cells.	miR	cancer	220972	HP_0002664	0	3	123	129	False
28901390	Thus, our data indicate that miR-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting TUSC3 in glioblastoma	TUSC3	cancer	7991	HP_0002664	140	145	99	105	False
28901390	Thus, our data indicate that miR-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting TUSC3 in glioblastoma	miR	cancer	220972	HP_0002664	29	32	99	105	False
29898953	Myotonic dystrophy 1 (DM1) is a multisystem disorder primarily affecting the central nervous system, heart and skeletal muscle.	DM1	central	1760	HP_0030645	22	25	77	84	False
29319775	Primary hyperoxaluria (PH) is a very rare genetic disorder; it is characterized by total or partial deficiency of the enzymes related to the metabolism of glyoxylate, with an overproduction of calcium oxalate that is deposited in different organs, mainly the kidney, leading to recurrent lithiasis, nephrocalcinosis and end stage renal disease (ESRD).	end	hyperoxaluria	2022	HP_0003159	320	323	8	21	False
29319775	Primary hyperoxaluria (PH) is a very rare genetic disorder; it is characterized by total or partial deficiency of the enzymes related to the metabolism of glyoxylate, with an overproduction of calcium oxalate that is deposited in different organs, mainly the kidney, leading to recurrent lithiasis, nephrocalcinosis and end stage renal disease (ESRD).	end	nephrocalcinosis	2022	HP_0000121	320	323	299	315	False
29319775	We present two cases of patients with a history of renal lithiasis who were diagnosed with primary hyperoxaluria in the post-transplant period, manifested by early graft failure, with evidence of calcium oxalate crystals in renal biopsy, hyperoxaluria, hyperoxalemia, and genetic test compatible; they were managed with proper diet, abundant oral liquids, pyridoxine, hydrochlorothiazide and potassium citrate; however, they had slow but progressive deterioration of their grafts function until they reached end-stage chronic renal disease	end	hyperoxaluria	2022	HP_0003159	508	511	99	112	False
25872961	Mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase (HMGCL) deficiency is an autosomal recessive disorder affecting the leucine catabolic pathway and ketone body synthesis, and is clinically characterized by metabolic crises with hypoketotic hypoglycemia, metabolic acidosis and hyperammonemia.	HMGCL	hypoglycemia	3155	HP_0001943	52	57	241	253	True
25872961	Mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase (HMGCL) deficiency is an autosomal recessive disorder affecting the leucine catabolic pathway and ketone body synthesis, and is clinically characterized by metabolic crises with hypoketotic hypoglycemia, metabolic acidosis and hyperammonemia.	HMGCL	hyperammonemia	3155	HP_0001987	52	57	278	292	True
28884119	This study investigated the role of potassium channel gene <i>(KCNQ5)</i> polymorphisms in high myopia.	KCNQ5	myopia	56479	HP_0000545	63	68	96	102	False
28884119	Five tag single-nucleotide polymorphisms (SNPs) of <i>KCNQ5</i> were genotyped, and association testing with high myopia was conducted using logistic regression analysis adjusted for sex and age to give <i>P</i><sub>asym</sub> values, and multiple comparisons were corrected by permutation test to give <i>P</i><sub>emp</sub> values.	KCNQ5	myopia	56479	HP_0000545	54	59	114	120	False
28884119	Five tag single-nucleotide polymorphisms (SNPs) of <i>KCNQ5</i> were genotyped, and association testing with high myopia was conducted using logistic regression analysis adjusted for sex and age to give <i>P</i><sub>asym</sub> values, and multiple comparisons were corrected by permutation test to give <i>P</i><sub>emp</sub> values.	sex	myopia	55558	HP_0000545	183	186	114	120	False
28884119	The SNP rs7744813, previously shown to be associated with refractive error and myopia in two GWAS, showed an odds ratio of 0.75 (95% CI 0.63-0.90; <i>P</i><sub>emp</sub> = 0.0058) for the minor allele.	minor	myopia	8013	HP_0000545	188	193	79	85	False
28884119	Our data support the involvement of <i>KCNQ5</i> gene polymorphisms in the genetic susceptibility to high myopia and further exploration of <i>KCNQ5</i> as a risk factor for high myopia	KCNQ5	myopia	56479	HP_0000545	39	44	106	112	False
27230853	The phenotypic spectrum related to PEX10 mutations includes slowly progressive, syndromic recessive ataxia.	PEX1	ataxia	5189	HP_0001251	35	39	100	106	True
25943428	DNA samples from eight families with autosomal recessive retinal dystrophies were subjected to genome wide homozygosity mapping (seven by SNP arrays and one by STR markers) and genes comprised within the detected homozygous regions were analyzed by Sanger sequencing.	STR	retinal dystrophies	6779	HP_0000556	160	163	57	76	False
25943428	DNA samples from eight families with autosomal recessive retinal dystrophies were subjected to genome wide homozygosity mapping (seven by SNP arrays and one by STR markers) and genes comprised within the detected homozygous regions were analyzed by Sanger sequencing.	STR	autosomal recessive	6779	HP_0000007	160	163	37	56	False
28680084	Screening the PANK2 gene in the patients as well as their unaffected family members revealed a functional single nucleotide variation, perfectly segregating in the patient's family in an autosomal recessive mode of inheritance.	PANK2	autosomal recessive	80025	HP_0000007	14	19	187	206	True
28680084	Screening the PANK2 gene in the patients as well as their unaffected family members revealed a functional single nucleotide variation, perfectly segregating in the patient's family in an autosomal recessive mode of inheritance.	PANK2	mode of inheritance	80025	HP_0000005	14	19	207	226	False
29372689	Our case-control study investigates the possible association between seven DPYD gene polymophisms (rs1801267, rs72547602, rs1801160, rs3918290, rs1801159, rs1801158, rs1801265) and risk of colorectal cancer (CRC).	DPYD	cancer	1806	HP_0002664	75	79	200	206	False
29372689	The present study suggests that the SNP rs1801160 and the &quot;IISt&quot; haplotype in the DPYD gene may also have a role in colorectal cancer risk	DPYD	cancer	1806	HP_0002664	92	96	137	143	False
30361054	Familial amyloid polyneuropathy (FAP) is a rare autosomal dominant disorder characterized by amyloid accumulation in the peripheral nerves and other organs, including the heart, kidney, and eyes.	FAP	peripheral	2191	HP_0030646	33	36	121	131	False
30361054	Familial amyloid polyneuropathy (FAP) is a rare autosomal dominant disorder characterized by amyloid accumulation in the peripheral nerves and other organs, including the heart, kidney, and eyes.	FAP	neuropathy	2191	HP_0009830	33	36	21	31	False
27392078	Crisponi syndrome (CS)/cold-induced sweating syndrome type 1 (CISS1) is a very rare autosomal-recessive disorder characterized by a complex phenotype with high neonatal lethality, associated with the following main clinical features: hyperthermia and feeding difficulties in the neonatal period, scoliosis, and paradoxical sweating induced by cold since early childhood.	type	hyperthermia	6445	HP_0001945	54	58	234	246	False
27392078	Crisponi syndrome (CS)/cold-induced sweating syndrome type 1 (CISS1) is a very rare autosomal-recessive disorder characterized by a complex phenotype with high neonatal lethality, associated with the following main clinical features: hyperthermia and feeding difficulties in the neonatal period, scoliosis, and paradoxical sweating induced by cold since early childhood.	CISS1	hyperthermia	9244	HP_0001945	62	67	234	246	True
27392078	Crisponi syndrome (CS)/cold-induced sweating syndrome type 1 (CISS1) is a very rare autosomal-recessive disorder characterized by a complex phenotype with high neonatal lethality, associated with the following main clinical features: hyperthermia and feeding difficulties in the neonatal period, scoliosis, and paradoxical sweating induced by cold since early childhood.	type	feeding difficulties	6445	HP_0011968	54	58	251	271	False
27392078	Crisponi syndrome (CS)/cold-induced sweating syndrome type 1 (CISS1) is a very rare autosomal-recessive disorder characterized by a complex phenotype with high neonatal lethality, associated with the following main clinical features: hyperthermia and feeding difficulties in the neonatal period, scoliosis, and paradoxical sweating induced by cold since early childhood.	CISS1	feeding difficulties	9244	HP_0011968	62	67	251	271	True
27392078	Crisponi syndrome (CS)/cold-induced sweating syndrome type 1 (CISS1) is a very rare autosomal-recessive disorder characterized by a complex phenotype with high neonatal lethality, associated with the following main clinical features: hyperthermia and feeding difficulties in the neonatal period, scoliosis, and paradoxical sweating induced by cold since early childhood.	type	scoliosis	6445	HP_0002650	54	58	296	305	True
27392078	Crisponi syndrome (CS)/cold-induced sweating syndrome type 1 (CISS1) is a very rare autosomal-recessive disorder characterized by a complex phenotype with high neonatal lethality, associated with the following main clinical features: hyperthermia and feeding difficulties in the neonatal period, scoliosis, and paradoxical sweating induced by cold since early childhood.	CISS1	scoliosis	9244	HP_0002650	62	67	296	305	True
27392078	Although these data further support the pathogenic role of KLHL7 mutations in a CS/CISS1-like phenotype, they do not explain all their clinical manifestations and highlight the high phenotypic heterogeneity associated with mutations in KLHL7.	type	heterogeneity	6445	HP_0001425	99	103	193	206	False
27392078	Although these data further support the pathogenic role of KLHL7 mutations in a CS/CISS1-like phenotype, they do not explain all their clinical manifestations and highlight the high phenotypic heterogeneity associated with mutations in KLHL7.	CISS1	heterogeneity	9244	HP_0001425	83	88	193	206	False
27392078	Although these data further support the pathogenic role of KLHL7 mutations in a CS/CISS1-like phenotype, they do not explain all their clinical manifestations and highlight the high phenotypic heterogeneity associated with mutations in KLHL7.	KLHL7	heterogeneity	55975	HP_0001425	59	64	193	206	False
29431240	It has been reported that N-myc downstream regulated gene 1 (NDRG1) is related to the prognosis of non-small cell lung cancer (NSCLC), and associated with c-Myc degradation in NSCLC cell lines.	N-myc	cancer	4613	HP_0002664	26	31	119	125	True
29431240	It has been reported that N-myc downstream regulated gene 1 (NDRG1) is related to the prognosis of non-small cell lung cancer (NSCLC), and associated with c-Myc degradation in NSCLC cell lines.	NDRG1	cancer	10397	HP_0002664	61	66	119	125	False
29431240	It has been reported that N-myc downstream regulated gene 1 (NDRG1) is related to the prognosis of non-small cell lung cancer (NSCLC), and associated with c-Myc degradation in NSCLC cell lines.	c-Myc	cancer	4609	HP_0002664	155	160	119	125	True
29431240	However, the relationship of NDRG1 to prognosis or c-Myc expression in lung adenocarcinoma has not been well clarified.	NDRG1	lung adenocarcinoma	10397	HP_0030078	29	34	71	90	False
29431240	However, the relationship of NDRG1 to prognosis or c-Myc expression in lung adenocarcinoma has not been well clarified.	c-Myc	lung adenocarcinoma	4609	HP_0030078	51	56	71	90	False
29431240	The present study was designed to investigate the prognostic significance of NDRG1 and/or c-Myc expression in lung adenocarcinoma using immunohistochemistry with a tissue microarray.	NDRG1	lung adenocarcinoma	10397	HP_0030078	77	82	110	129	False
29431240	The present study was designed to investigate the prognostic significance of NDRG1 and/or c-Myc expression in lung adenocarcinoma using immunohistochemistry with a tissue microarray.	c-Myc	lung adenocarcinoma	4609	HP_0030078	90	95	110	129	False
29431240	We examined 184 lung adenocarcinomas and observed low expression of NDRG1 in adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA), whereas high expression of NDRG1 was seen in invasive adenocarcinoma.	NDRG1	lung adenocarcinoma	10397	HP_0030078	68	73	16	35	False
29431240	We examined 184 lung adenocarcinomas and observed low expression of NDRG1 in adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA), whereas high expression of NDRG1 was seen in invasive adenocarcinoma.	AIS	lung adenocarcinoma	231	HP_0030078	101	104	16	35	False
29431240	We examined 184 lung adenocarcinomas and observed low expression of NDRG1 in adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA), whereas high expression of NDRG1 was seen in invasive adenocarcinoma.	MIA	lung adenocarcinoma	8190	HP_0030078	145	148	16	35	False
24518672	Primary ciliary dyskinesia (PCD) is an inherited chronic respiratory obstructive disease with randomized body laterality and infertility, resulting from cilia and sperm dysmotility.	PCD	ciliary dyskinesia	352909	HP_0012265	28	31	8	26	True
24518672	PCD is characterized by clinical variability and extensive genetic heterogeneity, associated with different cilia ultrastructural defects and mutations identified in &gt;20 genes.	PCD	heterogeneity	352909	HP_0001425	0	3	67	80	False
29046115	However, activated T cells and B cells secrete pro-osteoclastogenic factors including receptor activator of Nuclear factor-kappaB (NF-kB) ligand (RANKL), Interleukin (IL)-17A, and tumor necrosis factor (TNF)- promoting bone loss in inflammatory states such as rheumatoid arthritis.	RANKL	tumor	8600	HP_0002664	146	151	180	185	False
29046115	However, activated T cells and B cells secrete pro-osteoclastogenic factors including receptor activator of Nuclear factor-kappaB (NF-kB) ligand (RANKL), Interleukin (IL)-17A, and tumor necrosis factor (TNF)- promoting bone loss in inflammatory states such as rheumatoid arthritis.	TNF	tumor	7124	HP_0002664	203	206	180	185	False
29046115	T cell-produced TNF and IL-17A further contribute to bone loss in hyperparathyroidism, while T cell production of the anabolic Wingless integration site (Wnt) ligand, Wnt10b, promotes bone formation in response to anabolic parathyroid hormone and the immunomodulatory costimulation inhibitor cytotoxic T lymphocyte-associated protein-4-IgG (abatacept).	TNF	hyperparathyroidism	7124	HP_0000843	16	19	66	85	False
29046115	T cell-produced TNF and IL-17A further contribute to bone loss in hyperparathyroidism, while T cell production of the anabolic Wingless integration site (Wnt) ligand, Wnt10b, promotes bone formation in response to anabolic parathyroid hormone and the immunomodulatory costimulation inhibitor cytotoxic T lymphocyte-associated protein-4-IgG (abatacept).	Wnt10b	hyperparathyroidism	7480	HP_0000843	167	173	66	85	False
26683626	The transcriptional coactivator peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1) has been linked to multiple neurological and psychiatric disorders including schizophrenia, but its involvement in the pathophysiology of these disorders is unclear.	gamma	schizophrenia	9913	HP_0100753	75	80	187	200	False
26683626	The transcriptional coactivator peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1) has been linked to multiple neurological and psychiatric disorders including schizophrenia, but its involvement in the pathophysiology of these disorders is unclear.	PGC	schizophrenia	5225	HP_0100753	102	105	187	200	False
26683626	We measured the mRNA expression of PGC-1 and these transcripts in postmortem cortical tissue from control and schizophrenia patients and found a reduction in PGC-1-dependent transcripts without a change in PGC-1.	PGC	schizophrenia	5225	HP_0100753	35	38	111	124	False
26683626	While control subjects with high PGC-1 expression exhibited high PV and Nefh expression, schizophrenia subjects with high PGC-1 expression did not, suggesting dissociation between PGC-1 expression and these targets in schizophrenia.	PGC	schizophrenia	5225	HP_0100753	33	36	90	103	False
26683626	While control subjects with high PGC-1 expression exhibited high PV and Nefh expression, schizophrenia subjects with high PGC-1 expression did not, suggesting dissociation between PGC-1 expression and these targets in schizophrenia.	Nefh	schizophrenia	4744	HP_0100753	73	77	90	103	False
26683626	NRF-1 mRNA expression was reduced in schizophrenia, and its transcript levels predicted that of PGC-1-dependent targets in schizophrenia.	PGC	schizophrenia	5225	HP_0100753	96	99	37	50	False
26683626	NRF-1 mRNA expression was reduced in schizophrenia, and its transcript levels predicted that of PGC-1-dependent targets in schizophrenia.	NRF	schizophrenia	55922	HP_0100753	0	3	37	50	False
26683626	Interestingly, the positive correlation between PGC-1 and PV, Syt2, or Cplx1 expression was lost in schizophrenia patients with low NRF-1 expression, suggesting that NRF-1 is a critical predictor of these genes in disease.	PGC	schizophrenia	5225	HP_0100753	48	51	101	114	False
26683626	Interestingly, the positive correlation between PGC-1 and PV, Syt2, or Cplx1 expression was lost in schizophrenia patients with low NRF-1 expression, suggesting that NRF-1 is a critical predictor of these genes in disease.	Syt2	schizophrenia	127833	HP_0100753	63	67	101	114	False
26683626	Interestingly, the positive correlation between PGC-1 and PV, Syt2, or Cplx1 expression was lost in schizophrenia patients with low NRF-1 expression, suggesting that NRF-1 is a critical predictor of these genes in disease.	Cplx1	schizophrenia	10815	HP_0100753	72	77	101	114	False
26683626	Interestingly, the positive correlation between PGC-1 and PV, Syt2, or Cplx1 expression was lost in schizophrenia patients with low NRF-1 expression, suggesting that NRF-1 is a critical predictor of these genes in disease.	NRF	schizophrenia	55922	HP_0100753	133	136	101	114	False
26683626	These data suggest that schizophrenia involves a disruption in PGC-1 and/or NRF-1-associated transcriptional programs in the cortex and that approaches to enhance the activity of PGC-1 or transcriptional regulators like NRF-1 should be considered with the goal of restoring normal gene programs and improving cortical function	PGC	schizophrenia	5225	HP_0100753	63	66	24	37	False
26683626	These data suggest that schizophrenia involves a disruption in PGC-1 and/or NRF-1-associated transcriptional programs in the cortex and that approaches to enhance the activity of PGC-1 or transcriptional regulators like NRF-1 should be considered with the goal of restoring normal gene programs and improving cortical function	NRF	schizophrenia	55922	HP_0100753	77	80	24	37	False
26960553	Serine biosynthesis defects result from deficiencies in PGDH, PSAT, or PSP and have a broad phenotypic spectrum ranging from Neu-Laxova syndrome, a lethal multiple congenital anomaly disease at the severe end to a childhood disease with intellectual disability at the mild end, with infantile growth deficiency, and severe neurological manifestations as an intermediate phenotype.	PGDH	intellectual disability	26227	HP_0001249	56	60	237	260	True
26960553	Serine biosynthesis defects result from deficiencies in PGDH, PSAT, or PSP and have a broad phenotypic spectrum ranging from Neu-Laxova syndrome, a lethal multiple congenital anomaly disease at the severe end to a childhood disease with intellectual disability at the mild end, with infantile growth deficiency, and severe neurological manifestations as an intermediate phenotype.	PSP	intellectual disability	140683	HP_0001249	71	74	237	260	False
26960553	Serine biosynthesis defects result from deficiencies in PGDH, PSAT, or PSP and have a broad phenotypic spectrum ranging from Neu-Laxova syndrome, a lethal multiple congenital anomaly disease at the severe end to a childhood disease with intellectual disability at the mild end, with infantile growth deficiency, and severe neurological manifestations as an intermediate phenotype.	end	intellectual disability	2022	HP_0001249	205	208	237	260	False
26960553	The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, seizures, contractures, hypertonia, distinctive facial features, and a homozygous mutation in PSAT1.	PSAT1	microcephaly	29968	HP_0000252	182	187	49	61	True
26960553	The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, seizures, contractures, hypertonia, distinctive facial features, and a homozygous mutation in PSAT1.	PSAT1	seizures	29968	HP_0001250	182	187	88	96	True
26960553	The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, seizures, contractures, hypertonia, distinctive facial features, and a homozygous mutation in PSAT1.	PSAT1	contractures	29968	HP_0001371	182	187	98	110	True
26960553	The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, seizures, contractures, hypertonia, distinctive facial features, and a homozygous mutation in PSAT1.	PSAT1	hypertonia	29968	HP_0001276	182	187	112	122	True
26960553	The third subject was an infant with growth deficiency, microcephaly, ichthyotic skin lesions, anemia, hypertonia, distinctive facial features, low serine and glycine in plasma and CSF, and a novel homozygous mutation in PHGDH gene.	PHGDH	microcephaly	26227	HP_0000252	221	226	56	68	True
26960553	The third subject was an infant with growth deficiency, microcephaly, ichthyotic skin lesions, anemia, hypertonia, distinctive facial features, low serine and glycine in plasma and CSF, and a novel homozygous mutation in PHGDH gene.	PHGDH	hypertonia	26227	HP_0001276	221	226	103	113	True
26960553	The third subject was an infant with growth deficiency, microcephaly, ichthyotic skin lesions, anemia, hypertonia, distinctive facial features, low serine and glycine in plasma and CSF, and a novel homozygous mutation in PHGDH gene.	PHGDH	anemia	26227	HP_0001903	221	226	95	101	True
28774589	Using whole-exome sequencing in four probands with undiagnosed skin hyperkeratosis/ichthyosis, we identified compound heterozygosity for mutations in KDSR, encoding an enzyme in the de novo synthesis pathway of ceramides.	KDSR	hyperkeratosis	2531	HP_0000962	150	154	68	82	True
29710722	Growing evidence suggests that mitochondrial dysfunction is an early event in sporadic Alzheimer's disease (AD), but the impact of mitochondrial dysfunction on the transition from healthy aging to AD remains elusive.	impact	sporadic	55364	HP_0003745	121	127	78	86	False
29117186	The high-risk HPV types (HR HPV) account for approximately 5% of the global burden of cancer and thus cause high morbidity and mortality.	type	cancer	6445	HP_0002664	18	22	86	92	False
30013442	To our knowledge, no study investigates the association of genetic variant distributions of WW domain-containing oxidoreductase (WWOX) gene with development of invasive cancer, clinicopathologic variables and patient survival in uterine cervical cancer for Taiwanese women.	WWOX	cancer	51741	HP_0002664	129	133	169	175	True
30013442	We therefore conducted this study to explore the clinical involvements of WWOX single nucleotide polymorphisms (SNPs) in cervical cancer.	WWOX	cancer	51741	HP_0002664	74	78	130	136	True
30013442	The results revealed that only WWOX SNP rs3764340 was associated between patients with cervical invasive cancer and normal controls among 5 WWOX genetic variants.	WWOX	cancer	51741	HP_0002664	31	35	105	111	True
30013442	Cervical cancer patients with genotypes GA/AA in WWOX SNP rs12918952 were associated with parametrium invasion and pelvic lymph node metastasis.	WWOX	cancer	51741	HP_0002664	49	53	9	15	True
30013442	In conclusion, Taiwanese women with CG/GG in WWOX SNP rs3764340 are susceptible to cervical invasive cancer.	WWOX	cancer	51741	HP_0002664	45	49	101	107	True
27007844	Individuals with PTCHD1 deletion show symptoms of ADHD, sleep disruption, hypotonia, aggression, ASD, and ID.	PTCHD1	aggression	139411	HP_0000718	17	23	85	95	False
27007844	TRN-restricted deletion of Ptchd1 leads to attention deficits and hyperactivity, both of which are rescued by pharmacological augmentation of SK channel activity.	Ptchd1	hyperactivity	139411	HP_0000752	27	33	66	79	False
27007844	TRN-restricted deletion of Ptchd1 leads to attention deficits and hyperactivity, both of which are rescued by pharmacological augmentation of SK channel activity.	TRN	hyperactivity	3842	HP_0000752	0	3	66	79	False
27007844	Global Ptchd1 deletion recapitulates learning impairment, hyper-aggression, and motor defects, all of which are insensitive to SK pharmacological targeting and not found in the TRN-restricted deletion mouse.	Ptchd1	aggression	139411	HP_0000718	7	13	64	74	False
27007844	Global Ptchd1 deletion recapitulates learning impairment, hyper-aggression, and motor defects, all of which are insensitive to SK pharmacological targeting and not found in the TRN-restricted deletion mouse.	TRN	aggression	3842	HP_0000718	177	180	64	74	False
26685157	In a patient with Leigh-like syndrome presenting with leukodystrophy and severe epilepsy, we identified a homozygous splice site mutation in COX8A, which codes for the ubiquitously expressed isoform of subunit VIII, the smallest nuclear-encoded subunit of complex IV.	COX8A	epilepsy	1351	HP_0001250	141	146	80	88	True
26685157	In a patient with Leigh-like syndrome presenting with leukodystrophy and severe epilepsy, we identified a homozygous splice site mutation in COX8A, which codes for the ubiquitously expressed isoform of subunit VIII, the smallest nuclear-encoded subunit of complex IV.	VIII	epilepsy	1351	HP_0001250	210	214	80	88	True
30504367	Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic cancer, including KRAS and inactivation of tumor suppressors, such as TP53, SMAD4 and CDKN2A.	KRAS	cancer	3845	HP_0002664	169	173	151	157	True
30504367	Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic cancer, including KRAS and inactivation of tumor suppressors, such as TP53, SMAD4 and CDKN2A.	SMAD4	cancer	4089	HP_0002664	227	232	151	157	True
30504367	Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic cancer, including KRAS and inactivation of tumor suppressors, such as TP53, SMAD4 and CDKN2A.	KRAS	tumor	3845	HP_0002664	169	173	194	199	True
30504367	Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic cancer, including KRAS and inactivation of tumor suppressors, such as TP53, SMAD4 and CDKN2A.	SMAD4	tumor	4089	HP_0002664	227	232	194	199	True
30504367	However, siRNA-based therapeutics face important challenges, including rapid serum degradation, poor tumor cell uptake and cellular uptake, leading to off-target effects.	face	tumor	2178	HP_0002664	34	38	101	106	True
30504367	Therefore, there is a great need for the development of safe and effective nanoparticles for better tumor-specific delivery of anti-cancer therapeutics.	great	cancer	122042	HP_0002664	22	27	132	138	False
30504367	Therefore, there is a great need for the development of safe and effective nanoparticles for better tumor-specific delivery of anti-cancer therapeutics.	great	tumor	122042	HP_0002664	22	27	100	105	False
30732133	In the present study, we evaluated the association of SENPs polymorphism with susceptibility as well as clinicopathologic features and patients' response of breast cancer (BC) in a Chinese population.We genotyped SENP1 (rs61918808), SENP2 (rs6762208), SENP7 (rs61697963) by sequencing in a case-control study including 210 BC patients and 225 healthy volunteers.	SENP1	cancer	29843	HP_0002664	213	218	164	170	False
30732133	In the present study, we evaluated the association of SENPs polymorphism with susceptibility as well as clinicopathologic features and patients' response of breast cancer (BC) in a Chinese population.We genotyped SENP1 (rs61918808), SENP2 (rs6762208), SENP7 (rs61697963) by sequencing in a case-control study including 210 BC patients and 225 healthy volunteers.	SENP2	cancer	59343	HP_0002664	233	238	164	170	False
30732133	In the present study, we evaluated the association of SENPs polymorphism with susceptibility as well as clinicopathologic features and patients' response of breast cancer (BC) in a Chinese population.We genotyped SENP1 (rs61918808), SENP2 (rs6762208), SENP7 (rs61697963) by sequencing in a case-control study including 210 BC patients and 225 healthy volunteers.	SENP7	cancer	57337	HP_0002664	252	257	164	170	False
26771602	Dihydropyrimidinase (DHP) deficiency is an autosomal recessive disease caused by mutations in the DPYS gene.	DPYS	autosomal recessive	1807	HP_0000007	98	102	43	62	True
28650469	Sonic Hedgehog (SHH) signaling at primary cilia drives the proliferation and progression of a subset of medulloblastomas, the most common malignant paediatric brain tumor.	SHH	medulloblastomas	6469	HP_0002885	16	19	104	120	False
28650469	Sonic Hedgehog (SHH) signaling at primary cilia drives the proliferation and progression of a subset of medulloblastomas, the most common malignant paediatric brain tumor.	SHH	tumor	6469	HP_0002664	16	19	165	170	True
28650469	However, the role INPP5E plays in cancer is unknown and the contribution of PI3-kinase signaling to cilia function is little characterized.	INPP5E	cancer	23203	HP_0002664	18	24	34	40	False
28650469	However, the role INPP5E plays in cancer is unknown and the contribution of PI3-kinase signaling to cilia function is little characterized.	PI3	cancer	5266	HP_0002664	76	79	34	40	False
28650469	Here, we reveal INPP5E promotes SHH signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized PI3-kinase signaling axis that maintains primary cilia on tumor cells.	SHH	tumor	6469	HP_0002664	32	35	178	183	True
28650469	Here, we reveal INPP5E promotes SHH signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized PI3-kinase signaling axis that maintains primary cilia on tumor cells.	INPP5E	tumor	23203	HP_0002664	16	22	178	183	False
28650469	Here, we reveal INPP5E promotes SHH signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized PI3-kinase signaling axis that maintains primary cilia on tumor cells.	PI3	tumor	5266	HP_0002664	120	123	178	183	False
28650469	Here, we reveal INPP5E promotes SHH signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized PI3-kinase signaling axis that maintains primary cilia on tumor cells.	SHH	medulloblastoma	6469	HP_0002885	32	35	53	68	False
28650469	Here, we reveal INPP5E promotes SHH signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized PI3-kinase signaling axis that maintains primary cilia on tumor cells.	INPP5E	medulloblastoma	23203	HP_0002885	16	22	53	68	False
28650469	Here, we reveal INPP5E promotes SHH signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized PI3-kinase signaling axis that maintains primary cilia on tumor cells.	PI3	medulloblastoma	5266	HP_0002885	120	123	53	68	False
28650469	Conditional deletion of Inpp5e in a murine model of constitutively active Smoothened-driven medulloblastoma slowed tumor progression, suppressed cell proliferation, reduced SHH signaling and promoted tumor cell cilia loss.	SHH	tumor	6469	HP_0002664	173	176	115	120	True
28650469	Conditional deletion of Inpp5e in a murine model of constitutively active Smoothened-driven medulloblastoma slowed tumor progression, suppressed cell proliferation, reduced SHH signaling and promoted tumor cell cilia loss.	Inpp5e	tumor	23203	HP_0002664	24	30	115	120	False
28650469	Conditional deletion of Inpp5e in a murine model of constitutively active Smoothened-driven medulloblastoma slowed tumor progression, suppressed cell proliferation, reduced SHH signaling and promoted tumor cell cilia loss.	SHH	medulloblastoma	6469	HP_0002885	173	176	92	107	False
28650469	Conditional deletion of Inpp5e in a murine model of constitutively active Smoothened-driven medulloblastoma slowed tumor progression, suppressed cell proliferation, reduced SHH signaling and promoted tumor cell cilia loss.	Inpp5e	medulloblastoma	23203	HP_0002885	24	30	92	107	False
28650469	The number of PtdIns(3,4,5)P<sub>3</sub>/pAKT/pGSK3-positive cilia was increased in cultured Inpp5e-null tumor cells relative to controls.	Inpp5e	tumor	23203	HP_0002664	94	100	106	111	False
28650469	PI3-kinase inhibition or expression of wild-type, but not catalytically inactive HA-INPP5E partially rescued cilia loss in Inpp5e-null tumor cells in vitro.	INPP5E	tumor	23203	HP_0002664	84	90	135	140	False
28650469	PI3-kinase inhibition or expression of wild-type, but not catalytically inactive HA-INPP5E partially rescued cilia loss in Inpp5e-null tumor cells in vitro.	PI3	tumor	5266	HP_0002664	0	3	135	140	False
28650469	PI3-kinase inhibition or expression of wild-type, but not catalytically inactive HA-INPP5E partially rescued cilia loss in Inpp5e-null tumor cells in vitro.	Inpp5e	tumor	23203	HP_0002664	123	129	135	140	False
28650469	INPP5E mRNA and copy number were reduced in human SHH medulloblastoma compared to other molecular subtypes and consistent with the murine model, reduced INPP5E was associated with improved overall survival.	SHH	medulloblastoma	6469	HP_0002885	50	53	54	69	False
28650469	INPP5E mRNA and copy number were reduced in human SHH medulloblastoma compared to other molecular subtypes and consistent with the murine model, reduced INPP5E was associated with improved overall survival.	INPP5E	medulloblastoma	23203	HP_0002885	0	6	54	69	False
28650469	Therefore our study identifies a compartmentalized PtdIns(3,4,5)P<sub>3</sub>/AKT/GSK3 signaling axis at cilia in SHH-dependent medulloblastoma that is regulated by INPP5E to maintain tumor cell cilia, promote SHH signaling and thereby medulloblastoma progression	SHH	tumor	6469	HP_0002664	115	118	185	190	True
28650469	Therefore our study identifies a compartmentalized PtdIns(3,4,5)P<sub>3</sub>/AKT/GSK3 signaling axis at cilia in SHH-dependent medulloblastoma that is regulated by INPP5E to maintain tumor cell cilia, promote SHH signaling and thereby medulloblastoma progression	INPP5E	tumor	23203	HP_0002664	166	172	185	190	False
28650469	Therefore our study identifies a compartmentalized PtdIns(3,4,5)P<sub>3</sub>/AKT/GSK3 signaling axis at cilia in SHH-dependent medulloblastoma that is regulated by INPP5E to maintain tumor cell cilia, promote SHH signaling and thereby medulloblastoma progression	SHH	medulloblastoma	6469	HP_0002885	115	118	129	144	False
28650469	Therefore our study identifies a compartmentalized PtdIns(3,4,5)P<sub>3</sub>/AKT/GSK3 signaling axis at cilia in SHH-dependent medulloblastoma that is regulated by INPP5E to maintain tumor cell cilia, promote SHH signaling and thereby medulloblastoma progression	INPP5E	medulloblastoma	23203	HP_0002885	166	172	129	144	False
24078084	Patients with HCP show &lt;50% of normal activity and those with the rare autosomal recessive harderoporphyria accumulate harderoporphyrinogen, an intermediate porphyrin of the CPOX reaction.	HCP	autosomal recessive	259	HP_0000007	14	17	74	93	False
24078084	Patients with HCP show &lt;50% of normal activity and those with the rare autosomal recessive harderoporphyria accumulate harderoporphyrinogen, an intermediate porphyrin of the CPOX reaction.	CPOX	autosomal recessive	1371	HP_0000007	177	181	74	93	False
29518248	Recessively inherited, pathogenic defects in LonP1 have been previously reported to underlie cerebral, ocular, dental, auricular and skeletal anomalies (CODAS) syndrome, a complex multisystemic and developmental disorder.	LonP1	skeletal anomalies	9361	HP_0000924	45	50	133	151	True
29518248	We have applied whole exome sequencing to a patient with congenital lactic acidosis, muscle weakness, profound deficiencies in mitochondrial oxidative phosphorylation associated with loss of mtDNA copy number and MRI abnormalities consistent with Leigh syndrome, identifying biallelic variants in the LONP1 (NM_004793.3) gene; c.1693T&gt;C predicting p.(Tyr565His) and c.2197G&gt;A predicting p.(Glu733Lys); no evidence of the classical skeletal or dental defects observed in CODAS syndrome patients were noted in our patient.	LONP1	acidosis	9361	HP_0001941	301	306	75	83	False
29238041	In this work we investigated the role of forkhead box O1 (FoxO1) in the transcriptional regulation in macrophages, which affects the anti-tumor functions of tumor-associated macrophages (TAMs).	FoxO1	tumor	2308	HP_0002664	58	63	138	143	True
29238041	First, we showed that TAMs expressed reduced levels of FoxO1, which was associated with their protumoral M2 polarization state.	FoxO1	tumor	2308	HP_0002664	55	60	97	102	True
29238041	The suppression of FoxO1 expression in TAM was induced by the hypoxic condition in the tumor microenviroment.	FoxO1	tumor	2308	HP_0002664	19	24	87	92	True
29238041	Furthermore, we used FoxO1 conditional knockout mice to show that FoxO1 deficiency in myeloid cells exacerbates tumor growth.	FoxO1	tumor	2308	HP_0002664	21	26	112	117	True
29238041	Furthermore, we used FoxO1 conditional knockout mice to show that FoxO1 deficiency in myeloid cells exacerbates tumor growth.	mice	tumor	23581	HP_0002664	48	52	112	117	False
29238041	These results demonstrate that the protumoral property of TAMs is induced by the hypoxia-triggered FoxO1 deficiency, which could be a potential target of novel anti-tumor therapies	FoxO1	tumor	2308	HP_0002664	99	104	38	43	True
24843229	Limb-girdle muscular dystrophies (LGMD) are a highly heterogeneous group of muscle disorders, which first affect the voluntary muscles of the hip and shoulder areas.	hip	muscular dystrophies	64399	HP_0003560	142	145	12	32	False
24843229	Limb-girdle muscular dystrophies (LGMD) are a highly heterogeneous group of muscle disorders, which first affect the voluntary muscles of the hip and shoulder areas.	hip	heterogeneous	64399	HP_0001425	142	145	53	66	False
24843229	The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	LGMD2	autosomal recessive	825	HP_0000007	31	36	4	23	True
24843229	The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	telethonin	autosomal recessive	8557	HP_0000007	187	197	4	23	True
24843229	The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	TRIM32	autosomal recessive	22954	HP_0000007	208	214	4	23	True
24843229	The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	FKRP	autosomal recessive	79147	HP_0000007	225	229	4	23	True
24843229	The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	POMT1	autosomal recessive	10585	HP_0000007	256	261	4	23	True
24843229	The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	POMT2	autosomal recessive	29954	HP_0000007	312	317	4	23	True
24843229	The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	TRAPPC11	autosomal recessive	60684	HP_0000007	404	412	4	23	True
24843229	The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	GMPPB	autosomal recessive	29925	HP_0000007	423	428	4	23	True
24843229	The autosomal recessive forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C ( sarcoglycan), LGMD2D ( sarcoglycan), LGMD2E ( sarcoglycan), LGMD2F ( sarcoglycan), LGMD2G (telethonin), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	ISPD	autosomal recessive	729920	HP_0000007	439	443	4	23	True
29525180	In this study, we conducted targeted sequencing in 246 clinically heterogeneous patients, mainly with early-onset and/or familial neurodegenerative dementia, using a custom-designed next-generation sequencing panel covering 27 genes known to harbor mutations that can cause different types of dementia, in addition to the detection of C9orf72 repeat expansions.	C9orf72	heterogeneous	203228	HP_0001425	335	342	66	79	False
29525180	In this study, we conducted targeted sequencing in 246 clinically heterogeneous patients, mainly with early-onset and/or familial neurodegenerative dementia, using a custom-designed next-generation sequencing panel covering 27 genes known to harbor mutations that can cause different types of dementia, in addition to the detection of C9orf72 repeat expansions.	type	heterogeneous	6445	HP_0001425	284	288	66	79	False
29309627	The insulin-secreting pancreatic neuroendocrine tumors, insulinomas, characterized by increased pancreatic islet -cell proliferation, express the phosphorylated isoform of the -cell differentiation factor HLXB9 that interacts with NONO/p54NRB, a survival factor.	HLXB9	tumors	3110	HP_0002664	207	212	48	54	True
29309627	The insulin-secreting pancreatic neuroendocrine tumors, insulinomas, characterized by increased pancreatic islet -cell proliferation, express the phosphorylated isoform of the -cell differentiation factor HLXB9 that interacts with NONO/p54NRB, a survival factor.	NONO	tumors	4841	HP_0002664	233	237	48	54	False
29309627	The insulin-secreting pancreatic neuroendocrine tumors, insulinomas, characterized by increased pancreatic islet -cell proliferation, express the phosphorylated isoform of the -cell differentiation factor HLXB9 that interacts with NONO/p54NRB, a survival factor.	HLXB9	insulinomas	3110	HP_0012197	207	212	56	67	False
29309627	The insulin-secreting pancreatic neuroendocrine tumors, insulinomas, characterized by increased pancreatic islet -cell proliferation, express the phosphorylated isoform of the -cell differentiation factor HLXB9 that interacts with NONO/p54NRB, a survival factor.	NONO	insulinomas	4841	HP_0012197	233	237	56	67	False
29309627	Also, two somatic heterozygous NONO mutations were found in endocrine-related tumors, p.H146R (parathyroid) and p.R293H (small intestine neuroendocrine tumor).	NONO	tumors	4841	HP_0002664	31	35	78	84	False
29309627	Also, two somatic heterozygous NONO mutations were found in endocrine-related tumors, p.H146R (parathyroid) and p.R293H (small intestine neuroendocrine tumor).	NONO	tumor	4841	HP_0002664	31	35	152	157	False
29309627	Overall, our results highlight the importance of HLXB9 in conditions of -cell excess (insulinomas) and in conditions of -cell loss or dysfunction (diabetes).	HLXB9	insulinomas	3110	HP_0012197	49	54	87	98	False
29309627	Our studies implicate therapeutic strategies for either reducing -cell proliferation in insulinomas or alleviating normal -cell deficiency in diabetes through the modulation of HLXB9 phosphorylation	HLXB9	insulinomas	3110	HP_0012197	179	184	89	100	False
25008864	The major histocompatibility complex (MHC) region on chromosome 6p21.3 is suspected to host susceptibility loci for HIV-related Kaposi's sarcoma (HIV-KS).	KS	sarcoma	80781	HP_0100242	150	152	137	144	False
25264125	The genes HLA complex P5 (HCP5), spermatogenesis associated 2 (SPATA2), tumour necrosis factor alpha-induced protein 3 (TNFAIP3), TNFAIP3-interacting protein 1 (TNIP1) and the component of oligomeric Golgi complex 6 (COG6) were reported to be associated with psoriasis in western populations by genome-wide association studies.	SPATA2	tumour	9825	HP_0002664	63	69	72	78	False
25264125	The genes HLA complex P5 (HCP5), spermatogenesis associated 2 (SPATA2), tumour necrosis factor alpha-induced protein 3 (TNFAIP3), TNFAIP3-interacting protein 1 (TNIP1) and the component of oligomeric Golgi complex 6 (COG6) were reported to be associated with psoriasis in western populations by genome-wide association studies.	TNFAIP3	tumour	7128	HP_0002664	120	127	72	78	False
25264125	The genes HLA complex P5 (HCP5), spermatogenesis associated 2 (SPATA2), tumour necrosis factor alpha-induced protein 3 (TNFAIP3), TNFAIP3-interacting protein 1 (TNIP1) and the component of oligomeric Golgi complex 6 (COG6) were reported to be associated with psoriasis in western populations by genome-wide association studies.	TNIP1	tumour	10318	HP_0002664	161	166	72	78	False
25264125	The genes HLA complex P5 (HCP5), spermatogenesis associated 2 (SPATA2), tumour necrosis factor alpha-induced protein 3 (TNFAIP3), TNFAIP3-interacting protein 1 (TNIP1) and the component of oligomeric Golgi complex 6 (COG6) were reported to be associated with psoriasis in western populations by genome-wide association studies.	COG6	tumour	57511	HP_0002664	217	221	72	78	False
27270838	Our study demonstrated that AURKA rs1047972 TT and (CC+CT) genotypes were significantly associated with an increased risk of gastric cancer.	AURKA	cancer	6790	HP_0002664	28	33	135	141	False
27270838	Our study demonstrated that AURKA rs1047972 TT and (CC+CT) genotypes were significantly associated with an increased risk of gastric cancer.	type	cancer	6445	HP_0002664	65	69	135	141	False
26792177	The mutation (p.Trp211Arg), which segregates with a disease phenotype characterized by either isolated IIP/IPF, or IPF associated with lung adenocarcinoma, is located in the carbohydrate recognition domain (CRD) of SP-A1 and involves a residue invariant throughout evolution, not only in SP-A1, but also in its close paralog SP-A2 and other CRD-containing proteins.	CRD	lung adenocarcinoma	1406	HP_0030078	207	210	135	154	False
26792177	Overall, this first report of a germline molecular defect in SFTPA1 unveils the key role of SP-A1 in the occurrence of several chronic respiratory diseases, ranging from severe respiratory insufficiency occurring early in life to the association of lung fibrosis and cancer in adult patients.	SFTPA1	cancer	653509	HP_0002664	61	67	267	273	False
30344797	In this study, we aimed to assess the independent prognostic value of miR-361-3p in terms of overall survival (OS) and recurrence-free survival (RFS) in cervical cancer, as well as its possible regulative network.	miR	cancer	220972	HP_0002664	70	73	162	168	False
28690234	Epilepsy with mental retardation limited to females (EFMR) is a syndrome characterized by early onset heat-sensitive epilepsy of infancy or early childhood and generally limited to females, which previously reported that the cadherin gene superfamily subtype protocadherin 19 (PCDH19) gene is its pathogenic gene.	EFMR	epilepsy	57526	HP_0001250	53	57	117	125	True
28690234	Epilepsy with mental retardation limited to females (EFMR) is a syndrome characterized by early onset heat-sensitive epilepsy of infancy or early childhood and generally limited to females, which previously reported that the cadherin gene superfamily subtype protocadherin 19 (PCDH19) gene is its pathogenic gene.	cadherin	epilepsy	1015	HP_0001250	225	233	117	125	False
28690234	Epilepsy with mental retardation limited to females (EFMR) is a syndrome characterized by early onset heat-sensitive epilepsy of infancy or early childhood and generally limited to females, which previously reported that the cadherin gene superfamily subtype protocadherin 19 (PCDH19) gene is its pathogenic gene.	PCDH19	epilepsy	57526	HP_0001250	277	283	117	125	True
28690234	Cognitive impairment or autism-like performance were often identified in these patients, hematuria metabolic diseases screening was normal, no abnormal MRI imaging of the head, and de novo PCDH19 gene mutations were found in their epilepsy gene chip sequencing.	PCDH19	epilepsy	57526	HP_0001250	189	195	231	239	True
28690234	Cognitive impairment or autism-like performance were often identified in these patients, hematuria metabolic diseases screening was normal, no abnormal MRI imaging of the head, and de novo PCDH19 gene mutations were found in their epilepsy gene chip sequencing.	chip	epilepsy	10273	HP_0001250	245	249	231	239	True
28690234	Cognitive impairment or autism-like performance were often identified in these patients, hematuria metabolic diseases screening was normal, no abnormal MRI imaging of the head, and de novo PCDH19 gene mutations were found in their epilepsy gene chip sequencing.	PCDH19	autism	57526	HP_0000717	189	195	24	30	False
28690234	Cognitive impairment or autism-like performance were often identified in these patients, hematuria metabolic diseases screening was normal, no abnormal MRI imaging of the head, and de novo PCDH19 gene mutations were found in their epilepsy gene chip sequencing.	chip	autism	10273	HP_0000717	245	249	24	30	False
30342424	Their phosphorylation activity has also linked them to the development of neurodegenerative diseases like Alzheimer's disease, amyotrophic lateral sclerosis or spinocerebellar ataxia type 11.	type	neurodegenerative diseases	6445	HP_0002180	183	187	74	100	False
30342424	Their phosphorylation activity has also linked them to the development of neurodegenerative diseases like Alzheimer's disease, amyotrophic lateral sclerosis or spinocerebellar ataxia type 11.	type	ataxia	6445	HP_0001251	183	187	176	182	False
30342424	The final analysis of all this information led us to propose TTBK1 as a new target for the treatment of neurodegenerative diseases and its selective inhibitors as potential effective drugs for the treatment of these severe unmet disorders	TTBK1	neurodegenerative diseases	84630	HP_0002180	61	66	104	130	False
30732125	Ltd), a vascular endothelial growth factor receptor 2 (VEGFR-2) tyrosine kinase inhibitor, has been proven to be safe and to significantly prolong survival in advanced chemotherapy-refractory gastric cancer.	end	cancer	2022	HP_0002664	17	20	200	206	True
25277197	Finally, we demonstrate that TRPS1 expression is elevated in luminal breast cancer cells and luminal breast cancer tissues as compared with other breast cancer subtypes.	TRPS1	cancer	7227	HP_0002664	29	34	76	82	True
25277197	Overall, our study proposes that TRPS1 acts as a central hub in the control of cell cycle and proliferation during cancer development.	TRPS1	cancer	7227	HP_0002664	33	38	115	121	True
25277197	Overall, our study proposes that TRPS1 acts as a central hub in the control of cell cycle and proliferation during cancer development.	hub	cancer	1993	HP_0002664	57	60	115	121	False
24942156	Patients with physical findings suggestive of Treacher Collins syndrome (TCS) or mandibulofacial dysostosis (MFD) and macrocytic anemia diagnostic of Diamond-Blackfan anemia (DBA) have been reported.	TCS	mandibulofacial dysostosis	6949	HP_0005321	73	76	81	107	False
24942156	Patients with physical findings suggestive of Treacher Collins syndrome (TCS) or mandibulofacial dysostosis (MFD) and macrocytic anemia diagnostic of Diamond-Blackfan anemia (DBA) have been reported.	DBA	mandibulofacial dysostosis	6223	HP_0005321	175	178	81	107	False
24942156	We conclude that the phenotype combining features of TCS with DBA is genetically heterogeneous.	TCS	heterogeneous	6949	HP_0001425	53	56	81	94	False
24942156	We conclude that the phenotype combining features of TCS with DBA is genetically heterogeneous.	DBA	heterogeneous	6223	HP_0001425	62	65	81	94	False
28572511	We report a new (fifth) patient with the cblJ disorder who presented at 7 days of age with poor feeding, hypotonia, methylmalonic aciduria, and elevated plasma homocysteine and harbored the mutations c.1667_1668delAG [p.Glu556Glyfs*27] and c.1295G&gt;A [p.Arg432Gln] in the <i>ABCD4</i> gene.	ABCD4	methylmalonic aciduria	5826	HP_0012120	277	282	116	138	True
27643693	The Aicardi-Goutires syndrome (AGS) was first described in 1984, and over the following years was defined by the clinical and radiological features of an early onset, severe, neurologic disorder with intracranial calcification, leukoencephalopathy, and cerebral atrophy, usually associated with a cerebrospinal fluid (CSF) pleocytosis and elevated CSF interferon  activity.	AGS	intracranial calcification	182	HP_0002514	32	35	201	227	False
27643693	The Aicardi-Goutires syndrome (AGS) was first described in 1984, and over the following years was defined by the clinical and radiological features of an early onset, severe, neurologic disorder with intracranial calcification, leukoencephalopathy, and cerebral atrophy, usually associated with a cerebrospinal fluid (CSF) pleocytosis and elevated CSF interferon  activity.	AGS	leukoencephalopathy	182	HP_0002352	32	35	229	248	False
27643693	The Aicardi-Goutires syndrome (AGS) was first described in 1984, and over the following years was defined by the clinical and radiological features of an early onset, severe, neurologic disorder with intracranial calcification, leukoencephalopathy, and cerebral atrophy, usually associated with a cerebrospinal fluid (CSF) pleocytosis and elevated CSF interferon  activity.	AGS	cerebral atrophy	182	HP_0002059	32	35	254	270	False
28931550	The importance of Akt actions in human physiology is strengthened by the rarity of modifying mutations in their genes and by the devastating impact caused by these mutations on growth and development and in disorders such as cancer.	Akt	cancer	207	HP_0002664	18	21	225	231	True
28931550	The importance of Akt actions in human physiology is strengthened by the rarity of modifying mutations in their genes and by the devastating impact caused by these mutations on growth and development and in disorders such as cancer.	act	cancer	11332	HP_0002664	22	25	225	231	False
29367767	BBN tumors showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), Kmt2d (70%), and Kmt2c (90%) mutations by exome sequencing, similar to human MIBC.	Kmt2d	cancer	8085	HP_0002664	127	132	53	59	False
29367767	BBN tumors showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), Kmt2d (70%), and Kmt2c (90%) mutations by exome sequencing, similar to human MIBC.	Kmt2c	cancer	58508	HP_0002664	144	149	53	59	False
29367767	BBN tumors showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), Kmt2d (70%), and Kmt2c (90%) mutations by exome sequencing, similar to human MIBC.	Kmt2d	tumors	8085	HP_0002664	127	132	4	10	False
29367767	BBN tumors showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), Kmt2d (70%), and Kmt2c (90%) mutations by exome sequencing, similar to human MIBC.	Kmt2c	tumors	58508	HP_0002664	144	149	4	10	False
26076463	In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.	ALX4	polydactyly	60529	HP_0010442	19	23	120	131	False
26076463	In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.	mice	polydactyly	23581	HP_0010442	14	18	120	131	False
26076463	In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.	ALX4	alopecia	60529	HP_0001596	19	23	228	236	True
26076463	In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.	mice	alopecia	23581	HP_0001596	14	18	228	236	False
26076463	In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.	ALX4	craniosynostosis	60529	HP_0001363	19	23	246	262	True
26076463	In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.	mice	craniosynostosis	23581	HP_0001363	14	18	246	262	False
26076463	In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.	ALX4	hypertelorism	60529	HP_0000316	19	23	264	277	True
26076463	In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.	mice	hypertelorism	23581	HP_0000316	14	18	264	277	False
26076463	In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.	ALX4	hypogonadism	60529	HP_0000135	19	23	330	342	True
26076463	In humans and mice ALX4 mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, hypogonadism, and body agenesis.	mice	hypogonadism	23581	HP_0000135	14	18	330	342	False
30281617	Recently, defects of ZBTB20, a BTB and zinc finger domain containing transcriptional repressor, have been implicated in a wide range of neurodevelopmental disorders, including intellectual disability and autism.	ZBTB20	intellectual disability	26137	HP_0001249	21	27	176	199	True
30281617	Recently, defects of ZBTB20, a BTB and zinc finger domain containing transcriptional repressor, have been implicated in a wide range of neurodevelopmental disorders, including intellectual disability and autism.	ZBTB20	autism	26137	HP_0000717	21	27	204	210	True
30281617	Two ZBTB20 single nucleotide variants, located at the N-terminal and central regions of the protein and potentially conferring autism risk, altered dendritic spine morphology.	ZBTB20	autism	26137	HP_0000717	4	10	127	133	True
30281617	In contrast, a single nucleotide variant identified in patients with intellectual disability and located at the C-terminus of ZBTB20 affected dendritic arborization and dendritic length but had no effect on dendritic spine morphology.	ZBTB20	intellectual disability	26137	HP_0001249	126	132	69	92	True
29691940	Mutations in CASK cause a wide spectrum of phenotypes in humans ranging from mild X-linked intellectual disability to a severe microcephaly (MC) and pontocerebellar hypoplasia syndrome.	CASK	intellectual disability	8573	HP_0001249	13	17	91	114	True
29691940	Mutations in CASK cause a wide spectrum of phenotypes in humans ranging from mild X-linked intellectual disability to a severe microcephaly (MC) and pontocerebellar hypoplasia syndrome.	CASK	microcephaly	8573	HP_0000252	13	17	127	139	True
29372690	This study aims to determine the association between FGF10 (rs4415084 C&gt;T), FGFR2 (rs2981582 C&gt;T) and MAP3K1 (rs889312 A&gt;C) gene polymorphisms and breast cancer, to analyse the discriminative ability of each SNP and to test the accuracy of the predictive breast cancer risk model which includes all SNPs.	FGF10	cancer	2255	HP_0002664	53	58	163	169	False
29372690	This study aims to determine the association between FGF10 (rs4415084 C&gt;T), FGFR2 (rs2981582 C&gt;T) and MAP3K1 (rs889312 A&gt;C) gene polymorphisms and breast cancer, to analyse the discriminative ability of each SNP and to test the accuracy of the predictive breast cancer risk model which includes all SNPs.	FGFR2	cancer	2263	HP_0002664	79	84	163	169	True
29372690	This study aims to determine the association between FGF10 (rs4415084 C&gt;T), FGFR2 (rs2981582 C&gt;T) and MAP3K1 (rs889312 A&gt;C) gene polymorphisms and breast cancer, to analyse the discriminative ability of each SNP and to test the accuracy of the predictive breast cancer risk model which includes all SNPs.	MAP3K1	cancer	4214	HP_0002664	108	114	163	169	True
29372690	We have revealed significant association of FGFR2 and MAP3K1 polymorphisms with breast cancer.	FGFR2	cancer	2263	HP_0002664	44	49	87	93	True
29372690	We have revealed significant association of FGFR2 and MAP3K1 polymorphisms with breast cancer.	MAP3K1	cancer	4214	HP_0002664	54	60	87	93	True
29372690	The Random Forest algorithm selected FGFR2, MAP3K1 and age as important breast cancer predictors.	FGFR2	cancer	2263	HP_0002664	37	42	79	85	True
29372690	The Random Forest algorithm selected FGFR2, MAP3K1 and age as important breast cancer predictors.	MAP3K1	cancer	4214	HP_0002664	44	50	79	85	True
30257380	Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast cancer (TNBC) cells and increase the expression of epithelial-mesenchymal transition (EMT) related transcription factor ZEB1, while had no effect on Snail, Slug or Twist.	EMT	cancer	3702	HP_0002664	198	201	112	118	True
30257380	Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast cancer (TNBC) cells and increase the expression of epithelial-mesenchymal transition (EMT) related transcription factor ZEB1, while had no effect on Snail, Slug or Twist.	ZEB1	cancer	6935	HP_0002664	232	236	112	118	False
30257380	Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast cancer (TNBC) cells and increase the expression of epithelial-mesenchymal transition (EMT) related transcription factor ZEB1, while had no effect on Snail, Slug or Twist.	Snail	cancer	6615	HP_0002664	261	266	112	118	False
30257380	Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast cancer (TNBC) cells and increase the expression of epithelial-mesenchymal transition (EMT) related transcription factor ZEB1, while had no effect on Snail, Slug or Twist.	Slug	cancer	6591	HP_0002664	268	272	112	118	True
29293510	The objective of this study was to investigate the safety and the tolerability of combined cellular immunotherapy with low-dose cyclophosphamide (CPA) in patients with advanced solid tumors.	CPA	tumors	1357	HP_0002664	146	149	183	189	False
29293510	This study targeted a novel tumor-associated antigen, ring finger protein 43 (RNF43).	RNF43	tumor	54894	HP_0002664	78	83	28	33	True
29293510	Eligible patients were resistant to standard therapy, HLA-A*24:02- or A*02:01-positive and exhibiting high RNF43 expression in their tumor cells.	RNF43	tumor	54894	HP_0002664	107	112	133	138	True
29293510	We successfully showed that the combination of immune cell therapy and CPA was safe, might induce tumor-specific immune responses and clinical efficacy, and was accompanied by a decreased ratio of Tregs in patients with RNF43-positive advanced solid tumors	CPA	tumor	1357	HP_0002664	71	74	98	103	False
29293510	We successfully showed that the combination of immune cell therapy and CPA was safe, might induce tumor-specific immune responses and clinical efficacy, and was accompanied by a decreased ratio of Tregs in patients with RNF43-positive advanced solid tumors	RNF43	tumor	54894	HP_0002664	220	225	98	103	True
29753921	De novo variants of ASH1L, which encodes a histone methyltransferase, have been reported in a few patients with intellectual disability and autistic features.	ASH1L	intellectual disability	55870	HP_0001249	20	25	112	135	True
29753921	Here, we identified a novel de novo frame-shift variant, c.2422_2423delAAinsT which predicts p.(Lys808TyrfsTer40), in ASH1L in a patient with multiple congenital anomalies (MCA), fine motor developmental delay, learning difficulties, attention deficit hyperactivity disorder, sleep apnea, and scoliosis.	ASH1L	developmental delay	55870	HP_0001263	118	123	190	209	True
29753921	Here, we identified a novel de novo frame-shift variant, c.2422_2423delAAinsT which predicts p.(Lys808TyrfsTer40), in ASH1L in a patient with multiple congenital anomalies (MCA), fine motor developmental delay, learning difficulties, attention deficit hyperactivity disorder, sleep apnea, and scoliosis.	ASH1L	sleep apnea	55870	HP_0010535	118	123	276	287	False
29753921	Here, we identified a novel de novo frame-shift variant, c.2422_2423delAAinsT which predicts p.(Lys808TyrfsTer40), in ASH1L in a patient with multiple congenital anomalies (MCA), fine motor developmental delay, learning difficulties, attention deficit hyperactivity disorder, sleep apnea, and scoliosis.	ASH1L	scoliosis	55870	HP_0002650	118	123	293	302	False
29753921	Our report provides further evidence to support loss-of-function alterations of ASH1L as causative for an emergent neurodevelopmental syndrome characterized by MCA, intellectual disability, and behavioral problems, and further delineates this genetic disorder	ASH1L	intellectual disability	55870	HP_0001249	80	85	165	188	True
29753921	Our report provides further evidence to support loss-of-function alterations of ASH1L as causative for an emergent neurodevelopmental syndrome characterized by MCA, intellectual disability, and behavioral problems, and further delineates this genetic disorder	ASH1L	behavioral problems	55870	HP_0000708	80	85	194	213	True
25875328	Mutations in the CPA6 gene have been identified in patients with temporal lobe epilepsy and febrile seizures.	CPA6	epilepsy	1548	HP_0001250	17	21	79	87	False
25875328	Mutations in the CPA6 gene have been identified in patients with temporal lobe epilepsy and febrile seizures.	CPA6	seizures	1548	HP_0001250	17	21	100	108	False
25875328	In the present study, we screened for CPA6 mutations in patients with juvenile myoclonic epilepsy and identified two novel missense mutations: Arg36His and Asn271Ser.	CPA6	epilepsy	1548	HP_0001250	38	42	89	97	False
25875328	Our experiments demonstrate that these mutations in CPA6 are deleterious and provide further evidence for the involvement of CPA6 mutations in the predisposition for several types of epilepsy.	CPA6	epilepsy	1548	HP_0001250	52	56	183	191	False
30310141	We first develop a doxycycline-inducible cell line expressing GFP-tagged cytoplasmic TDP-43 protein (iGFP-NLSm) as a cell-based system to screen and identify seeding activity of human brain-derived pathological TDP-43 isolated from sporadic FTLD-TDP and familial cases with Granulin (FTLD-TDP-GRN) or C9orf72 repeat expansion mutations (FTLD-TDP-C9+).	TDP-43	sporadic	23435	HP_0003745	85	91	232	240	False
30310141	We first develop a doxycycline-inducible cell line expressing GFP-tagged cytoplasmic TDP-43 protein (iGFP-NLSm) as a cell-based system to screen and identify seeding activity of human brain-derived pathological TDP-43 isolated from sporadic FTLD-TDP and familial cases with Granulin (FTLD-TDP-GRN) or C9orf72 repeat expansion mutations (FTLD-TDP-C9+).	C9orf72	sporadic	203228	HP_0003745	301	308	232	240	False
29272104	Friedreich's ataxia (FA) is an autosomal recessive disease caused by an intronic GAA triplet expansion in the FXN gene, leading to reduced expression of the mitochondrial protein frataxin.	GAA	ataxia	2548	HP_0001251	81	84	13	19	False
29272104	Friedreich's ataxia (FA) is an autosomal recessive disease caused by an intronic GAA triplet expansion in the FXN gene, leading to reduced expression of the mitochondrial protein frataxin.	FXN	ataxia	2395	HP_0001251	110	113	13	19	True
29272104	Friedreich's ataxia (FA) is an autosomal recessive disease caused by an intronic GAA triplet expansion in the FXN gene, leading to reduced expression of the mitochondrial protein frataxin.	GAA	autosomal recessive	2548	HP_0000007	81	84	31	50	True
29272104	Friedreich's ataxia (FA) is an autosomal recessive disease caused by an intronic GAA triplet expansion in the FXN gene, leading to reduced expression of the mitochondrial protein frataxin.	FXN	autosomal recessive	2395	HP_0000007	110	113	31	50	True
29096595	In proximal renal tubules, FGF23 suppresses the membrane expression of the sodium-phosphate cotransporters Npt2a and Npt2c which mediate urinary reabsorption of filtered phosphate.	FGF23	proximal	8074	HP_0012840	27	32	3	11	False
29096595	In addition, FGF23 suppresses proximal tubular expression of 1-hydroxylase, the key enzyme responsible for vitamin D hormone production.	FGF23	proximal	8074	HP_0012840	13	18	30	38	False
29096595	In distal renal tubules, FGF23 signaling activates with-no-lysine kinase 4, leading to increased renal tubular reabsorption of calcium and sodium.	FGF23	distal	8074	HP_0012839	25	30	3	9	False
29669843	Previous investigations have demonstrated that single nucleotide polymorphisms (SNPs) of NER pathway genes were associated with various types of cancer.	NER	cancer	7376	HP_0002664	89	92	145	151	False
29669843	However, there was no research elucidating the genetic association of entire NER pathway with ovarian cancer susceptibility.	NER	cancer	7376	HP_0002664	77	80	102	108	False
29669843	Therefore, we conducted genotyping for 17 SNPs of six NER core genes (<i>XPA, XPC, XPG, ERCC1, ERCC2</i>, and <i>ERCC4</i>) in 89 ovarian cancer cases and 356 cancer-free controls.	NER	cancer	7376	HP_0002664	54	57	138	144	False
29669843	Therefore, we conducted genotyping for 17 SNPs of six NER core genes (<i>XPA, XPC, XPG, ERCC1, ERCC2</i>, and <i>ERCC4</i>) in 89 ovarian cancer cases and 356 cancer-free controls.	XPC	cancer	7508	HP_0002664	78	81	138	144	True
29669843	Therefore, we conducted genotyping for 17 SNPs of six NER core genes (<i>XPA, XPC, XPG, ERCC1, ERCC2</i>, and <i>ERCC4</i>) in 89 ovarian cancer cases and 356 cancer-free controls.	ERCC1	cancer	2067	HP_0002664	88	93	138	144	False
29669843	The result showed that both <i>ERCC1</i> rs11615 and <i>XPC</i> rs2228000 were significantly associated with reduced risk of ovarian cancer under dominant genetic model (adjusted OR = 0.35, 95% CI = 0.20-0.61, <i>P</i>=0.0002 and adjusted OR = 0.49, 95% CI = 0.30-0.81, <i>P</i>=0.005 respectively).	XPC	cancer	7508	HP_0002664	56	59	133	139	True
29669843	The result showed that both <i>ERCC1</i> rs11615 and <i>XPC</i> rs2228000 were significantly associated with reduced risk of ovarian cancer under dominant genetic model (adjusted OR = 0.35, 95% CI = 0.20-0.61, <i>P</i>=0.0002 and adjusted OR = 0.49, 95% CI = 0.30-0.81, <i>P</i>=0.005 respectively).	ERCC1	cancer	2067	HP_0002664	31	36	133	139	False
29669843	In addition, <i>XPC</i> rs2228001 and <i>ERCC2</i> rs238406 had statistically significant association with the increased risk of ovarian cancer under dominant genetic model (adjusted OR = 1.72, 95% CI = 1.02-2.92, <i>P</i>=0.043 and adjusted OR = 2.07, 95% CI = 1.07-4.01, <i>P</i>=0.032 respectively).	XPC	cancer	7508	HP_0002664	16	19	137	143	True
29669843	<i>ERCC1</i> rs3212986 were related with the increased risk of ovarian cancer under recessive model (adjusted OR = 2.40, 95% CI = 1.30-4.44, <i>P</i>=0.005).	ERCC1	cancer	2067	HP_0002664	3	8	71	77	False
29669843	In conclusion, our results indicated that <i>ERCC1, XPC</i> and <i>ERCC2</i> might influence ovarian cancer susceptibility.	XPC	cancer	7508	HP_0002664	52	55	101	107	True
29669843	In conclusion, our results indicated that <i>ERCC1, XPC</i> and <i>ERCC2</i> might influence ovarian cancer susceptibility.	ERCC1	cancer	2067	HP_0002664	45	50	101	107	False
22383991	Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cancer.	BRCA2	cancer	675	HP_0002664	68	73	164	170	True
22383991	Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cancer.	BRIP1	cancer	64979	HP_0002664	75	80	164	170	False
22383991	Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cancer.	PALB2	cancer	79728	HP_0002664	82	87	164	170	True
22383991	Some of the genes causing the Fanconi anemia (FA) syndrome, such as BRCA2, BRIP1, PALB2, and RAD51C, are associated with high or moderate risk of developing breast cancer.	RAD51C	cancer	5889	HP_0002664	93	99	164	170	True
22383991	Very recently, SLX4 has been established as a new FA gene raising the question of its implication in breast cancer risk.	SLX4	cancer	84464	HP_0002664	15	19	108	114	True
22383991	This study aimed at answering this question sequencing the entire coding region of SLX4 in 526 familial breast cancer cases from Italy.	SLX4	cancer	84464	HP_0002664	83	87	111	117	True
22383991	Our results indicate that testing for SLX4 germline mutations is unlikely to be relevant for the identification of individuals at risk of breast cancer, at least in the Italian population	SLX4	cancer	84464	HP_0002664	38	42	145	151	True
29925788	To personalize nutrition, the purpose of this study was to examine five key genes in the folate metabolism pathway, and dietary parameters and related interactive parameters as predictors of colorectal cancer (CRC) by measuring the healthy eating index (HEI) in multiethnic families.	era	cancer	2099	HP_0002664	154	157	202	208	False
29925788	We then constructed predictive generalized regression (GR) modeling with a supervised machine learning validation procedure with the target variable (cancer status) being specified to validate the results to allow enhanced prediction and reproducibility.	era	cancer	2099	HP_0002664	34	37	150	156	False
29925788	Additional predictors included age, as well as gender and the interaction of <i>MTHFR</i> 677 with overweight status (measured by body mass index) in predicting CRC, with the cancer group having more men and overweight cases.	mass	cancer	2200	HP_0002664	135	139	175	181	False
29925788	Additional predictors included age, as well as gender and the interaction of <i>MTHFR</i> 677 with overweight status (measured by body mass index) in predicting CRC, with the cancer group having more men and overweight cases.	men	cancer	8178	HP_0002664	200	203	175	181	False
29925788	Additional predictors included age, as well as gender and the interaction of <i>MTHFR</i> 677 with overweight status (measured by body mass index) in predicting CRC, with the cancer group having more men and overweight cases.	era	cancer	2099	HP_0002664	65	68	175	181	False
30249491	Some aspects of the disease are now well known, such as nephrocalcinosis and craniosynostosis, related to the natural course of the disease, which persisted despite the ERT.	ERT	craniosynostosis	1999	HP_0001363	169	172	77	93	False
30249491	Some aspects of the disease are now well known, such as nephrocalcinosis and craniosynostosis, related to the natural course of the disease, which persisted despite the ERT.	ERT	nephrocalcinosis	1999	HP_0000121	169	172	56	72	False
27048600	We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in CSNK2A1, the gene encoding CK2, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory () and two catalytic ( and/or ') subunits.	CSNK2A1	intellectual disability	1459	HP_0001249	412	419	56	79	False
27048600	We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in CSNK2A1, the gene encoding CK2, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory () and two catalytic ( and/or ') subunits.	CSNK2A1	developmental delay	1459	HP_0001263	412	419	80	99	False
27048600	We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in CSNK2A1, the gene encoding CK2, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory () and two catalytic ( and/or ') subunits.	CSNK2A1	behavioral problems	1459	HP_0000708	412	419	231	250	False
27048600	We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in CSNK2A1, the gene encoding CK2, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory () and two catalytic ( and/or ') subunits.	CSNK2A1	microcephaly	1459	HP_0000252	412	419	280	292	False
27048600	We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in CSNK2A1, the gene encoding CK2, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory () and two catalytic ( and/or ') subunits.	CSNK2A1	pachygyria	1459	HP_0001302	412	419	294	304	False
26915689	Deafness genes, which harbor pathogenic mutations that have been identified in families with hereditary hearing loss, are commonly expressed in the auditory end organ or the cochlea and may contribute to normal hearing function, yet some of the mouse models carrying these mutations fail to recapitulate the hearing loss phenotype.	end	hearing loss	2022	HP_0000365	157	160	104	116	False
26915689	In this study, we find that distinct expression patterns of those deafness genes in the cochlea of a non-human primate, the common marmoset (Callithrix jacchus).	find	deafness	81501	HP_0000365	18	22	66	74	False
26915689	The deafness genes GJB3, CRYM, GRHL2, DFNA5, and ATP6B1 were expressed in marmoset cochleae in patterns different from those in mouse cochleae.	GJB3	deafness	2707	HP_0000365	19	23	4	12	True
26915689	The deafness genes GJB3, CRYM, GRHL2, DFNA5, and ATP6B1 were expressed in marmoset cochleae in patterns different from those in mouse cochleae.	CRYM	deafness	1428	HP_0000365	25	29	4	12	True
26915689	The deafness genes GJB3, CRYM, GRHL2, DFNA5, and ATP6B1 were expressed in marmoset cochleae in patterns different from those in mouse cochleae.	GRHL2	deafness	79977	HP_0000365	31	36	4	12	True
26915689	The deafness genes GJB3, CRYM, GRHL2, DFNA5, and ATP6B1 were expressed in marmoset cochleae in patterns different from those in mouse cochleae.	ATP6B1	deafness	525	HP_0000365	49	55	4	12	True
26915689	Of note, all those genes are causative for progressive hearing loss in humans, but not in mice.	mice	hearing loss	23581	HP_0000365	90	94	55	67	False
26915689	The other tested genes, including the deafness gene COCH, in which mutation recapitulates deafness in mice, were expressed in a similar manner in both species.	mice	deafness	23581	HP_0000365	102	106	38	46	False
26915689	The other tested genes, including the deafness gene COCH, in which mutation recapitulates deafness in mice, were expressed in a similar manner in both species.	COCH	deafness	1690	HP_0000365	52	56	38	46	True
17668385	BRWD3 is therefore a new gene implicated in the etiology of XLMR associated with macrocephaly and may cause disease by altering intracellular signaling pathways affecting cellular proliferation	BRWD3	macrocephaly	254065	HP_0000256	0	5	81	93	True
27976805	Mutations in CRLF1 have been associated with autosomal recessive Crisponi or cold-induced sweating syndrome type 1 (CS/CISS1), which among other symptoms also manifests with early onset feeding difficulties.	CRLF1	autosomal recessive	9244	HP_0000007	13	18	45	64	True
27976805	Mutations in CRLF1 have been associated with autosomal recessive Crisponi or cold-induced sweating syndrome type 1 (CS/CISS1), which among other symptoms also manifests with early onset feeding difficulties.	type	autosomal recessive	6445	HP_0000007	108	112	45	64	True
27976805	Mutations in CRLF1 have been associated with autosomal recessive Crisponi or cold-induced sweating syndrome type 1 (CS/CISS1), which among other symptoms also manifests with early onset feeding difficulties.	CRLF1	feeding difficulties	9244	HP_0011968	13	18	186	206	True
27976805	Mutations in CRLF1 have been associated with autosomal recessive Crisponi or cold-induced sweating syndrome type 1 (CS/CISS1), which among other symptoms also manifests with early onset feeding difficulties.	type	feeding difficulties	6445	HP_0011968	108	112	186	206	False
29133631	Leber's hereditary optic neuropathy (LHON) is a common inherited mitochondrial disorder that is characterized by the degeneration of the optic nerves, leading to vision loss.	LHON	neuropathy	100873240	HP_0009830	37	41	25	35	False
29233839	The Wnt/beta-catenin pathway can be activated in both benign and malignant tumors by <i>CTNNB1</i> mutations and by <i>ZNRF3</i> inactivation in adrenal cancer (ACC).	ACC	tumors	31	HP_0002664	161	164	75	81	False
29233839	The Wnt/beta-catenin pathway can be activated in both benign and malignant tumors by <i>CTNNB1</i> mutations and by <i>ZNRF3</i> inactivation in adrenal cancer (ACC).	ACC	cancer	31	HP_0002664	161	164	153	159	False
29251941	Mucopolysaccharidosis Type IIIA (MPSIIIA), also known as Sanfilippo A syndrome, is an inherited neurodegenerative disease caused by mutations in the lysosomal enzyme, N-sulfoglucosamine sulfohydrolase (SGSH), also known as sulfamidase.	Type	neurodegenerative disease	6445	HP_0002180	22	26	96	121	False
29251941	Mucopolysaccharidosis Type IIIA (MPSIIIA), also known as Sanfilippo A syndrome, is an inherited neurodegenerative disease caused by mutations in the lysosomal enzyme, N-sulfoglucosamine sulfohydrolase (SGSH), also known as sulfamidase.	SGSH	neurodegenerative disease	6448	HP_0002180	202	206	96	121	False
29307797	Non-alcoholic steatohepatitis (NASH) is commonly associated with obesity, type 2 diabetes, and/or hypertriglyceridemia, while alcoholic steatohepatitis (ASH) is associated with alcohol abuse.	type	obesity	6445	HP_0001513	74	78	65	72	False
29307797	Non-alcoholic steatohepatitis (NASH) is commonly associated with obesity, type 2 diabetes, and/or hypertriglyceridemia, while alcoholic steatohepatitis (ASH) is associated with alcohol abuse.	type	hypertriglyceridemia	6445	HP_0002155	74	78	98	118	False
29307797	Both NASH and ASH patients can develop cirrhosis and hepatocellular carcinoma (HCC) if left untreated.	HCC	hepatocellular carcinoma	84668	HP_0001402	79	82	53	77	False
25473808	Cilia play essential roles in normal human development and health; cilia dysfunction results in diseases such as primary ciliary dyskinesia (PCD).	PCD	ciliary dyskinesia	352909	HP_0012265	141	144	121	139	True
25473808	We present the native 3D structures of normal and PCD-causing RSPH1-mutant human respiratory cilia in unprecedented detail; this allows comparisons of cilia structure across evolutionarily distant species and reveals the previously unknown primary defect and the heterogeneous secondary defects in RSPH1-mutant cilia.	PCD	heterogeneous	352909	HP_0001425	50	53	263	276	False
25473808	We present the native 3D structures of normal and PCD-causing RSPH1-mutant human respiratory cilia in unprecedented detail; this allows comparisons of cilia structure across evolutionarily distant species and reveals the previously unknown primary defect and the heterogeneous secondary defects in RSPH1-mutant cilia.	RSPH1	heterogeneous	89765	HP_0001425	62	67	263	276	False
25473808	Our data provide evidence for structural and functional heterogeneity in radial spokes, suggest a mechanism for the milder RSPH1 PCD phenotype and demonstrate that cryo-electron tomography can be applied to human disease by directly imaging patient samples.	PCD	heterogeneity	352909	HP_0001425	129	132	56	69	False
25473808	Our data provide evidence for structural and functional heterogeneity in radial spokes, suggest a mechanism for the milder RSPH1 PCD phenotype and demonstrate that cryo-electron tomography can be applied to human disease by directly imaging patient samples.	RSPH1	heterogeneity	89765	HP_0001425	123	128	56	69	False
29660846	The classical mammalian isoforms of PLD are PLD1 and PLD2, and the levels of both mRNA were higher at the primary tumor sites than in normal kidney tissues.	PLD1	tumor	5589	HP_0002664	44	48	114	119	False
29660846	The classical mammalian isoforms of PLD are PLD1 and PLD2, and the levels of both mRNA were higher at the primary tumor sites than in normal kidney tissues.	PLD2	tumor	5338	HP_0002664	53	57	114	119	False
29660846	Notably, shRNA-mediated knockdown of PLD2 suppressed the growth and invasion of tumors in nude mouse xenograft models.	PLD2	tumor	5338	HP_0002664	37	41	80	85	False
29660846	Notably, shRNA-mediated knockdown of PLD2 suppressed the growth and invasion of tumors in nude mouse xenograft models.	nude	tumor	54820	HP_0002664	90	94	80	85	False
29660846	As for genes relating to the tumor invasion of PLD2, we found that angiogenin (ANG) was positively regulated by PLD2.	PLD2	tumor	5338	HP_0002664	47	51	29	34	False
29660846	As for genes relating to the tumor invasion of PLD2, we found that angiogenin (ANG) was positively regulated by PLD2.	ANG	tumor	283	HP_0002664	79	82	29	34	False
29660846	In fact, the expression levels of ANG were elevated in tumor tissues as compared with normal kidney and the inhibition of ANG activity with a neutralizing antibody significantly suppressed tumor invasion.	ANG	tumor	283	HP_0002664	34	37	55	60	False
29660846	In fact, the expression levels of ANG were elevated in tumor tissues as compared with normal kidney and the inhibition of ANG activity with a neutralizing antibody significantly suppressed tumor invasion.	fact	tumor	11198	HP_0002664	3	7	55	60	False
30097493	Partial loss-of-function variants in the TREM2 immune receptor are associated with increased risk for Alzheimer's disease (AD) and other forms of neurodegenerative disease, but the molecular bases for these connections are unknown.	TREM2	neurodegenerative disease	54209	HP_0002180	41	46	146	171	True
25569091	The patients were classified according to the presence of significant coronary atherosclerosis (CAS) and history of myocardial infarction (MI).	CAS	myocardial infarction	9564	HP_0001658	96	99	116	137	False
28777491	Horstick et al. (2013) previously reported a homozygous p.Trp284Ser variant in STAC3 as the cause of Native American myopathy (NAM) in 5 Lumbee Native American families with congenital hypotonia and weakness, cleft palate, short stature, ptosis, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH).	STAC3	cleft palate	246329	HP_0000175	79	84	209	221	True
28777491	Horstick et al. (2013) previously reported a homozygous p.Trp284Ser variant in STAC3 as the cause of Native American myopathy (NAM) in 5 Lumbee Native American families with congenital hypotonia and weakness, cleft palate, short stature, ptosis, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH).	STAC3	short stature	246329	HP_0004322	79	84	223	236	True
28777491	Horstick et al. (2013) previously reported a homozygous p.Trp284Ser variant in STAC3 as the cause of Native American myopathy (NAM) in 5 Lumbee Native American families with congenital hypotonia and weakness, cleft palate, short stature, ptosis, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH).	STAC3	ptosis	246329	HP_0000508	79	84	238	244	True
28777491	Horstick et al. (2013) previously reported a homozygous p.Trp284Ser variant in STAC3 as the cause of Native American myopathy (NAM) in 5 Lumbee Native American families with congenital hypotonia and weakness, cleft palate, short stature, ptosis, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH).	STAC3	kyphoscoliosis	246329	HP_0002751	79	84	246	260	True
30030762	In gastrointestinal tumors, FEZF1 plays an oncogenic role through DNA demethylation.	FEZF1	tumors	389549	HP_0002664	28	33	20	26	False
30030762	However, the role of FEZF1 in the prognosis of human glioma prognosis remains unclear.	FEZF1	glioma	389549	HP_0009733	21	26	53	59	False
30030762	In this research, we discovered that FEZF1 was significantly increased in glioma tissues in contrast to normal brain tissues (NBTs; P&lt;0.05).	FEZF1	glioma	389549	HP_0009733	37	42	74	80	False
30030762	Furthermore, a high level of FEZF1 in patients with glioma acted as an independent biomarker to predict reduced survival (P=0.026).	FEZF1	glioma	389549	HP_0009733	29	34	52	58	False
30030762	In an in vitro experiment, FEZF1 can promote the proliferation, migration, and invasion of glioma cells and inhibit cell apoptosis by activating Akt-ERK pathway.	FEZF1	glioma	389549	HP_0009733	27	32	91	97	False
30030762	In an in vitro experiment, FEZF1 can promote the proliferation, migration, and invasion of glioma cells and inhibit cell apoptosis by activating Akt-ERK pathway.	Akt	glioma	207	HP_0009733	145	148	91	97	False
30030762	In an in vitro experiment, FEZF1 can promote the proliferation, migration, and invasion of glioma cells and inhibit cell apoptosis by activating Akt-ERK pathway.	ERK	glioma	2048	HP_0009733	149	152	91	97	False
30132828	Previous reports have identified SLC6A1 variants in patients with generalized epilepsies, such as myoclonic-atonic epilepsy and childhood absence epilepsy.	SLC6A1	epilepsies	6529	HP_0001250	33	39	78	88	True
30132828	Previous reports have identified SLC6A1 variants in patients with generalized epilepsies, such as myoclonic-atonic epilepsy and childhood absence epilepsy.	SLC6A1	epilepsy	6529	HP_0001250	33	39	115	123	True
30132828	The purpose of this study was to determine the incidence of SLC6A1 variants in 460 unselected epilepsy patients and to evaluate the impact of the identified variants on -aminobutyric acid (GABA)transport.	SLC6A1	epilepsy	6529	HP_0001250	60	66	94	102	True
30132828	The purpose of this study was to determine the incidence of SLC6A1 variants in 460 unselected epilepsy patients and to evaluate the impact of the identified variants on -aminobutyric acid (GABA)transport.	impact	epilepsy	55364	HP_0001250	132	138	94	102	False
30132828	Targeted resequencing was used to screen 460 unselected epilepsy patients for variants in SLC6A1.	SLC6A1	epilepsy	6529	HP_0001250	90	96	56	64	True
30132828	These findings demonstrate that SLC6A1 is an important contributor to childhood epilepsy and that reduced GAT-1 function is a common consequence of epilepsy-causing SLC6A1 variants	SLC6A1	epilepsy	6529	HP_0001250	32	38	80	88	True
30132828	These findings demonstrate that SLC6A1 is an important contributor to childhood epilepsy and that reduced GAT-1 function is a common consequence of epilepsy-causing SLC6A1 variants	GAT	epilepsy	10249	HP_0001250	106	109	80	88	False
26399219	Epithelial-mesenchymal transition (EMT) is a process whereby epithelial cells assume mesenchymal characteristics to facilitate cancer metastasis.	EMT	cancer	3702	HP_0002664	35	38	127	133	True
26399219	However, EMT also contributes to the initiation and development of primary tumors.	EMT	tumors	3702	HP_0002664	9	12	75	81	True
26399219	Prior studies that explored the hypothesis that EMT gene variants contribute to epithelial ovarian carcinoma (EOC) risk have been based on small sample sizes and none have sought replication in an independent population.	EMT	ovarian carcinoma	3702	HP_0025318	48	51	91	108	False
29190522	The diagnosis of acquired chronic dysimmune neuropathies (CDN) like chronic inflammatory demyelinating polyneuropathy (CIDP), Lewis-Sumner Syndrome (LSS) or multifocal motor neuropathy (MMN) can be challenging.	CDN	multifocal	30833	HP_0030651	58	61	157	167	False
29190522	The diagnosis of acquired chronic dysimmune neuropathies (CDN) like chronic inflammatory demyelinating polyneuropathy (CIDP), Lewis-Sumner Syndrome (LSS) or multifocal motor neuropathy (MMN) can be challenging.	LSS	multifocal	4047	HP_0030651	149	152	157	167	False
29190522	The diagnosis of acquired chronic dysimmune neuropathies (CDN) like chronic inflammatory demyelinating polyneuropathy (CIDP), Lewis-Sumner Syndrome (LSS) or multifocal motor neuropathy (MMN) can be challenging.	CDN	neuropathy	30833	HP_0009830	58	61	107	117	False
29190522	The diagnosis of acquired chronic dysimmune neuropathies (CDN) like chronic inflammatory demyelinating polyneuropathy (CIDP), Lewis-Sumner Syndrome (LSS) or multifocal motor neuropathy (MMN) can be challenging.	LSS	neuropathy	4047	HP_0009830	149	152	107	117	False
28963677	The current study aims to investigate the biological roles and clinical significance of HCRP1 in human gastric cancer.	HCRP1	cancer	137492	HP_0002664	88	93	111	117	False
28963677	The expression pattern of HCRP1 in gastric cancer tissue and adjacent non-cancerous tissue was detected by immunohistochemistry.	HCRP1	cancer	137492	HP_0002664	26	31	43	49	False
28963677	HCRP1 downregulation was found in 57 of 137 human gastric cancer samples and correlated with advanced TNM stage, positive nodal status, and relapse.	HCRP1	cancer	137492	HP_0002664	0	5	58	64	False
28963677	HCRP1 downregulation was found in 57 of 137 human gastric cancer samples and correlated with advanced TNM stage, positive nodal status, and relapse.	TNM	cancer	10178	HP_0002664	102	105	58	64	False
28963677	HCRP1 downregulation was found in 57 of 137 human gastric cancer samples and correlated with advanced TNM stage, positive nodal status, and relapse.	nodal	cancer	4838	HP_0002664	122	127	58	64	True
28963677	In conclusion, our results suggest that HCRP1 downregulation might serve as an indicator for poor prognosis in gastric cancer patients.	HCRP1	cancer	137492	HP_0002664	40	45	119	125	False
28687524	His facial features included a high anterior hairline, small eyes with narrowed palpebral fissures, a bulbous nasal tip with a short columella, and a large mouth with a thin upper vermilion, and small chin.	tip	short columella	81533	HP_0002000	116	119	127	142	False
28687524	His facial features included a high anterior hairline, small eyes with narrowed palpebral fissures, a bulbous nasal tip with a short columella, and a large mouth with a thin upper vermilion, and small chin.	tip	large mouth	81533	HP_0000154	116	119	150	161	False
28687524	De novo missense and frameshift mutations and deletions involving TBL1XR1 have been described in patients with intellectual disability and autism, but without any of the dysmorphic findings or malformations associated with Pierpont syndrome, implying a mutation-specific mechanism for the pathogenicity of p.Tyr446Cys.	TBL1XR1	intellectual disability	79718	HP_0001249	66	73	111	134	True
28687524	De novo missense and frameshift mutations and deletions involving TBL1XR1 have been described in patients with intellectual disability and autism, but without any of the dysmorphic findings or malformations associated with Pierpont syndrome, implying a mutation-specific mechanism for the pathogenicity of p.Tyr446Cys.	TBL1XR1	autism	79718	HP_0000717	66	73	139	145	False
28687524	His distinctive facial and digital features are further evidence that p.Tyr446Cys results in a clinically recognizable, syndromic form of intellectual disability in contrast to other TBL1XR1 mutations	TBL1XR1	intellectual disability	79718	HP_0001249	183	190	138	161	True
29408595	The roles of STX3 in human breast cancer remains elusive.	STX3	cancer	6809	HP_0002664	13	17	34	40	False
29408595	Here we report that STX3 acts as an oncogenic protein in human breast cancer.	STX3	cancer	6809	HP_0002664	20	24	70	76	False
29408595	We analyzed the expression of STX3 in 148 patients with breast cancer.	STX3	cancer	6809	HP_0002664	30	34	63	69	False
29408595	The mRNA and protein levels of STX3 are significantly up-regulated in human breast cancer compared with matched adjacent non-cancer tissues.	STX3	cancer	6809	HP_0002664	31	35	83	89	False
29408595	The up-regulation of STX3 is correlated with high disease stage and predicts overall and disease-free survival in patients with breast cancer.	STX3	cancer	6809	HP_0002664	21	25	135	141	False
29408595	Lentivirus-mediated knockdown of STX3 represses in vitro proliferation and colony formation and in vivo growth of breast cancer cells, whereas STX3 overexpression promotes the growth of breast cancer cells in vitro and in vivo.	STX3	cancer	6809	HP_0002664	33	37	121	127	False
29408595	We find that STX3 promotes the proliferation of breast cancer cells by increasing the activation of the Akt-mTOR signaling, and Akt inhibitor Ipatasertib or MK-2206 represses STX3 effects on the growth of breast cancer cells.	STX3	cancer	6809	HP_0002664	13	17	55	61	False
29408595	We find that STX3 promotes the proliferation of breast cancer cells by increasing the activation of the Akt-mTOR signaling, and Akt inhibitor Ipatasertib or MK-2206 represses STX3 effects on the growth of breast cancer cells.	find	cancer	81501	HP_0002664	3	7	55	61	False
29408595	We find that STX3 promotes the proliferation of breast cancer cells by increasing the activation of the Akt-mTOR signaling, and Akt inhibitor Ipatasertib or MK-2206 represses STX3 effects on the growth of breast cancer cells.	Akt	cancer	207	HP_0002664	104	107	55	61	True
29408595	We find that STX3 promotes the proliferation of breast cancer cells by increasing the activation of the Akt-mTOR signaling, and Akt inhibitor Ipatasertib or MK-2206 represses STX3 effects on the growth of breast cancer cells.	mTOR	cancer	2475	HP_0002664	108	112	55	61	False
29408595	We find that STX3 promotes the proliferation of breast cancer cells by increasing the activation of the Akt-mTOR signaling, and Akt inhibitor Ipatasertib or MK-2206 represses STX3 effects on the growth of breast cancer cells.	MK	cancer	4192	HP_0002664	157	159	55	61	False
29408595	Therefore, STX3 promotes the growth of breast cancer cells by regulating the PTEN-PI3K-Akt-mTOR signaling	STX3	cancer	6809	HP_0002664	11	15	46	52	False
29408595	Therefore, STX3 promotes the growth of breast cancer cells by regulating the PTEN-PI3K-Akt-mTOR signaling	Akt	cancer	207	HP_0002664	87	90	46	52	True
29408595	Therefore, STX3 promotes the growth of breast cancer cells by regulating the PTEN-PI3K-Akt-mTOR signaling	mTOR	cancer	2475	HP_0002664	91	95	46	52	False
29408595	Therefore, STX3 promotes the growth of breast cancer cells by regulating the PTEN-PI3K-Akt-mTOR signaling	PTEN	cancer	5728	HP_0002664	77	81	46	52	True
29408595	Therefore, STX3 promotes the growth of breast cancer cells by regulating the PTEN-PI3K-Akt-mTOR signaling	PI3K	cancer	5290	HP_0002664	82	86	46	52	True
28154168	Two common <i>POLG</i> mutations usually found <i>in cis</i> in patients primarily with progressive external ophthalmoplegia generate T251I and P587L amino acid substitutions.	POLG	progressive	5428	HP_0003676	14	18	88	99	True
28036274	Furthermore, we identified several unreported tissue-specific TFs that may contribute to breast cancer, including ATOH8, DMRT2, TBX15 and ZNF367.	ATOH8	cancer	84913	HP_0002664	114	119	96	102	False
28036274	Furthermore, we identified several unreported tissue-specific TFs that may contribute to breast cancer, including ATOH8, DMRT2, TBX15 and ZNF367.	DMRT2	cancer	10655	HP_0002664	121	126	96	102	False
28036274	Furthermore, we identified several unreported tissue-specific TFs that may contribute to breast cancer, including ATOH8, DMRT2, TBX15 and ZNF367.	TBX15	cancer	6913	HP_0002664	128	133	96	102	False
29215294	Herein, we designed a retro-inverso isomer of <sup>L</sup>c(LyP-1), termed <sup>D</sup>c(LyP-1), expecting to inspire brain metastatic tumor targeted drug delivery.	LyP	tumor	4068	HP_0002664	60	63	135	140	True
29215294	Further, <sup>L</sup>c(LyP-1) modified PEG-PLA micelles displayed much higher in vivo distribution in brain metastatic tumor than <sup>D</sup>c(LyP-1).	LyP	tumor	4068	HP_0002664	23	26	119	124	True
29215294	All results suggested that <sup>L</sup>c(LyP-1) had a better performance than <sup>D</sup>c(LyP-1) in brain metastatic tumor-targeted drug delivery	LyP	tumor	4068	HP_0002664	41	44	119	124	True
30500452	Vascular endothelial cell damage is related to many vascular diseases, including cardiovascular disease (CVD).	damage	cardiovascular disease	51438	HP_0001626	26	32	81	103	False
30500452	Reactive oxygen species (ROS) play a vital role in the pathogenesis of many cardiovascular diseases.	ROS	cardiovascular disease	6098	HP_0001626	25	28	76	98	False
29325615	This chapter focuses on the current data covering the etiology and epidemiology, clinical presentation, and pathogenesis of four monogenic forms of isolated dystonia: DYT-TOR1A, DYT-THAP1, DYT-GCH1, and DYT-GNAL	TOR1A	dystonia	1861	HP_0001332	171	176	157	165	True
29325615	This chapter focuses on the current data covering the etiology and epidemiology, clinical presentation, and pathogenesis of four monogenic forms of isolated dystonia: DYT-TOR1A, DYT-THAP1, DYT-GCH1, and DYT-GNAL	THAP1	dystonia	55145	HP_0001332	182	187	157	165	True
29325615	This chapter focuses on the current data covering the etiology and epidemiology, clinical presentation, and pathogenesis of four monogenic forms of isolated dystonia: DYT-TOR1A, DYT-THAP1, DYT-GCH1, and DYT-GNAL	GCH1	dystonia	2643	HP_0001332	193	197	157	165	True
24812430	Several candidate genes for obesity and T2D (e.g., IRS1 and VEGFA) were differentially expressed in discordant twins.	IRS1	obesity	3667	HP_0001513	51	55	28	35	False
24812430	Several candidate genes for obesity and T2D (e.g., IRS1 and VEGFA) were differentially expressed in discordant twins.	VEGFA	obesity	7422	HP_0001513	60	65	28	35	False
25965574	TAF12, NFYC, and RAD54L co-located on human chromosome 1p32-35.3 and mouse chromosome 4qD1-D3 were identified as oncogenes that are gained in tumors in both species and required for disease initiation and progression.	NFYC	tumors	4802	HP_0002664	7	11	142	148	False
25965574	TAF12, NFYC, and RAD54L co-located on human chromosome 1p32-35.3 and mouse chromosome 4qD1-D3 were identified as oncogenes that are gained in tumors in both species and required for disease initiation and progression.	RAD54L	tumors	8438	HP_0002664	17	23	142	148	True
29183715	Sjgren-Larsson syndrome (SLS) is a rare autosomal recessive disorder characterized by ichthyosis, spasticity and intellectual disability.	SLS	spasticity	224	HP_0001257	26	29	99	109	True
29183715	Sjgren-Larsson syndrome (SLS) is a rare autosomal recessive disorder characterized by ichthyosis, spasticity and intellectual disability.	SLS	intellectual disability	224	HP_0001249	26	29	114	137	True
27120127	Primary ciliary dyskinesia (PCD) is an autosomal recessive disease characterized by chronic respiratory infections of the upper and lower airways, hypofertility, and, in approximately half of the cases, situs inversus.	PCD	ciliary dyskinesia	352909	HP_0012265	28	31	8	26	True
27120127	Primary ciliary dyskinesia (PCD) is an autosomal recessive disease characterized by chronic respiratory infections of the upper and lower airways, hypofertility, and, in approximately half of the cases, situs inversus.	PCD	autosomal recessive	352909	HP_0000007	28	31	39	58	True
26929355	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting motor neurons that leads to progressive paralysis of skeletal muscle.	ALS	neurodegenerative disease	3483	HP_0002180	31	34	41	66	False
28442722	In order to expand the mutation spectrum of the causative genes in Chinese adult population, we investigated three genes, SLC39A5, LEPREL1 and LRPAP1, in a cohort of 187 independent Chinese patients with high myopia.	SLC39A5	myopia	283375	HP_0000545	122	129	209	215	True
28442722	In order to expand the mutation spectrum of the causative genes in Chinese adult population, we investigated three genes, SLC39A5, LEPREL1 and LRPAP1, in a cohort of 187 independent Chinese patients with high myopia.	LEPREL1	myopia	55214	HP_0000545	131	138	209	215	True
28442722	In order to expand the mutation spectrum of the causative genes in Chinese adult population, we investigated three genes, SLC39A5, LEPREL1 and LRPAP1, in a cohort of 187 independent Chinese patients with high myopia.	LRPAP1	myopia	4043	HP_0000545	143	149	209	215	True
28442722	Our findings will not only augment the mutation spectrum of these three genes, but also provide insights of the contribution of these genes to adult high myopia in Chinese.	find	myopia	81501	HP_0000545	4	8	154	160	False
24865954	The importance of mitochondria for white matter is best exemplified in a group of defects of the mitochondria oxidative metabolism called mitochondria leukoencephalopathies or encephalomyopathies.	best	leukoencephalopathies	7439	HP_0002352	51	55	151	172	False
28916654	DICER1 is an RNase III endoribonuclease central to miRNA biogenesis, and germline <i>DICER1</i> mutations result in a cancer predisposition syndrome, associated with an increased risk of many tumor types.	DICER1	cancer	23405	HP_0002664	0	6	118	124	True
28916654	DICER1 is an RNase III endoribonuclease central to miRNA biogenesis, and germline <i>DICER1</i> mutations result in a cancer predisposition syndrome, associated with an increased risk of many tumor types.	DICER1	tumor	23405	HP_0002664	0	6	192	197	True
28916654	Here, we show that biallelic <i>Dicer1</i> deletion with <i>aP2-Cre</i> drives aggressive and metastatic angiosarcoma independent of other genetically engineered oncogenes or tumor suppressor loss.	Dicer1	angiosarcoma	23405	HP_0200058	32	38	105	117	False
28916654	Here, we show that biallelic <i>Dicer1</i> deletion with <i>aP2-Cre</i> drives aggressive and metastatic angiosarcoma independent of other genetically engineered oncogenes or tumor suppressor loss.	Dicer1	tumor	23405	HP_0002664	32	38	175	180	True
28916654	Angiosarcomas in <i>aP2-Cre;Dicer1<sup>Flox/-</sup></i> mice histologically and genetically resemble human angiosarcoma.	Dicer1	angiosarcoma	23405	HP_0200058	28	34	107	119	False
28916654	Angiosarcomas in <i>aP2-Cre;Dicer1<sup>Flox/-</sup></i> mice histologically and genetically resemble human angiosarcoma.	mice	angiosarcoma	23581	HP_0200058	56	60	107	119	False
28916654	Angiosarcomas in <i>aP2-Cre;Dicer1<sup>Flox/-</sup></i> mice histologically and genetically resemble human angiosarcoma.	Dicer1	sarcoma	23405	HP_0100242	28	34	5	12	True
28916654	Angiosarcomas in <i>aP2-Cre;Dicer1<sup>Flox/-</sup></i> mice histologically and genetically resemble human angiosarcoma.	mice	sarcoma	23581	HP_0100242	56	60	5	12	False
28916654	These studies illustrate that Dicer1 can function as a traditional loss-of-function tumor suppressor gene, and they provide a fully penetrant animal model for the study of angiosarcoma development and metastasis.	Dicer1	angiosarcoma	23405	HP_0200058	30	36	172	184	False
28916654	These studies illustrate that Dicer1 can function as a traditional loss-of-function tumor suppressor gene, and they provide a fully penetrant animal model for the study of angiosarcoma development and metastasis.	Dicer1	tumor	23405	HP_0002664	30	36	84	89	True
27736906	HIV-1 transgenic mice on the FVB/NJ background (TgFVB) represent a validated model of HIV-associated nephropathy (HIVAN).	mice	nephropathy	23581	HP_0000112	17	21	101	112	False
27736906	A major susceptibility locus, HIVAN1, was previously mapped to chromosome 3A1-A3 in a cross between TgFVB and CAST/EiJ (CAST) strains, and introgression of a 51.9 Mb segment encompassing HIVAN1 from CAST into TgFVB resulted in accelerated development of nephropathy.	CAST	nephropathy	10849	HP_0000112	110	114	254	265	False
27736906	Of these, Frem1, Foxo1, and Setd7 have been implicated in the pathogenesis of nephropathy.	Frem1	nephropathy	158326	HP_0000112	10	15	78	89	False
27736906	Of these, Frem1, Foxo1, and Setd7 have been implicated in the pathogenesis of nephropathy.	Foxo1	nephropathy	2308	HP_0000112	17	22	78	89	False
27736906	Of these, Frem1, Foxo1, and Setd7 have been implicated in the pathogenesis of nephropathy.	Setd7	nephropathy	80854	HP_0000112	28	33	78	89	False
30173437	Idiopathic hypogonadotropic hypogonadism (IHH) is often caused by hyposecretion of gonadotropin and consequently affects male fertility.	IHH	hypogonadism	3549	HP_0000135	42	45	28	40	False
30256478	Therefore, quantification of glioma extracellular pH (pHe) is of crucial importance.	pH	glioma	5053	HP_0009733	50	52	29	35	False
30256478	This study is focused on the application of the YbHPDO3A (ytterbium 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane) probe for in vivo glioma pHe quantification using chemical exchange saturation transfer (CEST)-MRI and its correlation with tumor metabolism assessed by immunohistochemistry.	pH	glioma	5053	HP_0009733	149	151	142	148	False
30256478	This study is focused on the application of the YbHPDO3A (ytterbium 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane) probe for in vivo glioma pHe quantification using chemical exchange saturation transfer (CEST)-MRI and its correlation with tumor metabolism assessed by immunohistochemistry.	pH	tumor	5053	HP_0002664	149	151	248	253	False
30256478	In vivo MRI sequences consisted of T<sub>2w</sub> for tumor localization, T<sub>2w</sub> * to assess YbHPDO3A biodistribution by exploiting its magnetic susceptibility effect and CEST for glioma pHe mapping.	pH	glioma	5053	HP_0009733	195	197	188	194	False
30256478	In vivo MRI sequences consisted of T<sub>2w</sub> for tumor localization, T<sub>2w</sub> * to assess YbHPDO3A biodistribution by exploiting its magnetic susceptibility effect and CEST for glioma pHe mapping.	pH	tumor	5053	HP_0002664	195	197	54	59	False
30256478	These immunohistochemical results are consistent with our pHe mapping (Pearson correlation coefficient&gt;0.70) and provide evidence for the feasibility of the CEST-MRI method with the YbHPDO3A probe for glioma pHe quantification at 4.7T.	pH	glioma	5053	HP_0009733	58	60	206	212	False
29725255	<b>Methods</b>: Analysis of publicly available microarray data of oral SCC revealed that AMACR was significantly upregulated in tumor tissue compared with normal mucosa.	AMACR	tumor	23600	HP_0002664	89	94	128	133	False
29725255	<b>Methods</b>: Analysis of publicly available microarray data of oral SCC revealed that AMACR was significantly upregulated in tumor tissue compared with normal mucosa.	SCC	tumor	6317	HP_0002664	71	74	128	133	False
29725255	<b>Results</b>: AMACR overexpression was significantly associated with advanced tumor status (<i>P</i>=0.001), advanced nodal status (<i>P</i>=0.036), increased vascular invasion (<i>P</i>=0.026) and increased perineural invasion (<i>P</i>=0.004).	AMACR	tumor	23600	HP_0002664	16	21	80	85	False
29725255	<b>Results</b>: AMACR overexpression was significantly associated with advanced tumor status (<i>P</i>=0.001), advanced nodal status (<i>P</i>=0.036), increased vascular invasion (<i>P</i>=0.026) and increased perineural invasion (<i>P</i>=0.004).	nodal	tumor	4838	HP_0002664	120	125	80	85	True
30375717	Analyses of our original miRNA expression signatures indicated that both strands of miR-144 (miR-144-5p, the passenger strand; miR-144-3p, the guide strand) showed decreased expression in cancer tissues.	miR	cancer	220972	HP_0002664	25	28	188	194	False
30375717	Functional assays revealed that ectopic expression of miR-144-5p and miR-144-3p significantly blocked the malignant abilities of LUSQ cells, eg, cancer cell proliferation, migration, and invasion.	miR	cancer	220972	HP_0002664	54	57	145	151	False
30170832	Mutations in SPRTN cause premature ageing and liver cancer in humans and mice; thus, defective DPC repair has great clinical ramifications.	SPRTN	cancer	83932	HP_0002664	13	18	52	58	True
30170832	Mutations in SPRTN cause premature ageing and liver cancer in humans and mice; thus, defective DPC repair has great clinical ramifications.	mice	cancer	23581	HP_0002664	73	77	52	58	False
30170832	Mutations in SPRTN cause premature ageing and liver cancer in humans and mice; thus, defective DPC repair has great clinical ramifications.	great	cancer	122042	HP_0002664	110	115	52	58	False
30170832	Finally, we will discuss the impact of faulty DPC repair on disease and cancer therapy	impact	cancer	55364	HP_0002664	29	35	72	78	False
30362313	PAX6 expression and molecular mechanisms by which PAX6 modifies the migration capacity of breast cancer cells	PAX6	cancer	5080	HP_0002664	0	4	97	103	True
23339187	Blocking the expression of PAK1, DIAPH2, and RDX significantly inhibits breast cancer cell migration induced by let-7b repression.	PAK1	cancer	5585	HP_0002664	27	31	79	85	False
23339187	Blocking the expression of PAK1, DIAPH2, and RDX significantly inhibits breast cancer cell migration induced by let-7b repression.	DIAPH2	cancer	1730	HP_0002664	33	39	79	85	False
23339187	Blocking the expression of PAK1, DIAPH2, and RDX significantly inhibits breast cancer cell migration induced by let-7b repression.	RDX	cancer	5962	HP_0002664	45	48	79	85	False
29421438	However, the role of FUZ in tumor biology remains poorly studied.	FUZ	tumor	80199	HP_0002664	21	24	28	33	False
29421438	Our purpose of this study is to discover the physiological effects and mechanism of FUZ in non-small-cell lung cancer (NSCLC) in vitro.	FUZ	cancer	80199	HP_0002664	84	87	111	117	False
30388513	Here we discuss the heterogeneity of T-bet expressing B cells and related cells	bet	heterogeneity	92737	HP_0001425	39	42	20	33	False
29080269	A total of 3128 people participated and were divided into 5 groups: healthy controls, natural clearance, chronic hepatitis B(CHB), liver cirrhosis and hepatocellular carcinoma (HCC).	HCC	hepatocellular carcinoma	84668	HP_0001402	177	180	151	175	False
29346610	The mutations in both LIPH and LPAR6/P2RY5 are responsible for autosomal recessive woolly hair with or without hypotrichosis (ARWH/HT).	LIPH	hypotrichosis	200879	HP_0001006	22	26	111	124	True
29346610	The mutations in both LIPH and LPAR6/P2RY5 are responsible for autosomal recessive woolly hair with or without hypotrichosis (ARWH/HT).	LIPH	autosomal recessive	200879	HP_0000007	22	26	63	82	True
30482341	Identifying the central and peripheral vestibular mechanisms responsible for pathology can aid in management of SRC.	SRC	peripheral	6714	HP_0030646	112	115	28	38	False
30482341	Identifying the central and peripheral vestibular mechanisms responsible for pathology can aid in management of SRC.	aid	peripheral	57379	HP_0030646	91	94	28	38	False
30482341	The most common vestibular disturbances after SRC include benign paroxysmal positional vertigo, vestibulo-ocular reflex impairment, visual motion sensitivity, and balance impairment.	SRC	vertigo	6714	HP_0002321	46	49	87	94	False
29040572	Here, we conducted whole-exome sequencing of patients with optic atrophy and other neurological signs of mitochondriopathy and identified 17 individuals from 13 unrelated families with recessive mutations in FDXR, encoding the mitochondrial membrane-associated flavoprotein ferrodoxin reductase required for electron transport from NADPH to cytochrome P450.	FDXR	optic atrophy	2232	HP_0000648	208	212	59	72	True
29040572	Moreover, we found that mice carrying a spontaneous mutation allelic to the most common mutation found in patients displayed progressive gait abnormalities and vision loss, in addition to biochemical defects consistent with the major clinical features of the disease.	mice	vision loss	23581	HP_0000572	24	28	160	171	False
29040572	Taken together, these data provide the first demonstration that germline, hypomorphic mutations in FDXR cause a novel mitochondriopathy and optic atrophy in humans	FDXR	optic atrophy	2232	HP_0000648	99	103	140	153	True
25198130	Here we used an integrative strategy to examine the hypothesis that genetic variants at FOXA1/2 binding elements may be associated with sexual dimorphism of hepatocellular carcinoma (HCC) risk.	FOXA1	hepatocellular carcinoma	3169	HP_0001402	88	93	157	181	False
25198130	Here we used an integrative strategy to examine the hypothesis that genetic variants at FOXA1/2 binding elements may be associated with sexual dimorphism of hepatocellular carcinoma (HCC) risk.	sex	hepatocellular carcinoma	55558	HP_0001402	136	139	157	181	False
25198130	Here we used an integrative strategy to examine the hypothesis that genetic variants at FOXA1/2 binding elements may be associated with sexual dimorphism of hepatocellular carcinoma (HCC) risk.	HCC	hepatocellular carcinoma	84668	HP_0001402	183	186	157	181	False
25198130	Moreover, results from our real-time quantitative polymerase chain reaction (qPCR) using 72 normal liver tissues adjacent to the tumors showed that SERPINA6 expression was significantly different among different genotypes of this variant (GG versus CC: P = 0.032; Group test: P = 0.060).	SERPINA6	tumors	866	HP_0002664	148	156	129	135	False
29891935	Functional studies support intraocular pressure-related influences of FMNL2 and LMX1B, with certain Lmx1b mutations causing high IOP and glaucoma resembling POAG in mice.	FMNL2	glaucoma	114793	HP_0000501	70	75	137	145	False
29891935	Functional studies support intraocular pressure-related influences of FMNL2 and LMX1B, with certain Lmx1b mutations causing high IOP and glaucoma resembling POAG in mice.	LMX1B	glaucoma	4010	HP_0000501	80	85	137	145	True
29891935	Functional studies support intraocular pressure-related influences of FMNL2 and LMX1B, with certain Lmx1b mutations causing high IOP and glaucoma resembling POAG in mice.	Lmx1b	glaucoma	4010	HP_0000501	100	105	137	145	True
24781758	The AP4B1-associated phenotype has previously been assigned to spastic paraplegia-47.	AP4B1	spastic paraplegia	10717	HP_0001258	4	9	63	81	True
29298444	She manifested macrocephaly, preaxial polysyndactyly, psychomotor developmental delay, cerebral cavernous malformations, and glucose intolerance due to a 6.2-Mb deletion of 7p14.1p12.3 which included GLI3, GCK, and CCM2.	GLI	macrocephaly	2735	HP_0000256	200	203	15	27	False
29298444	She manifested macrocephaly, preaxial polysyndactyly, psychomotor developmental delay, cerebral cavernous malformations, and glucose intolerance due to a 6.2-Mb deletion of 7p14.1p12.3 which included GLI3, GCK, and CCM2.	GCK	macrocephaly	5871	HP_0000256	206	209	15	27	False
29298444	She manifested macrocephaly, preaxial polysyndactyly, psychomotor developmental delay, cerebral cavernous malformations, and glucose intolerance due to a 6.2-Mb deletion of 7p14.1p12.3 which included GLI3, GCK, and CCM2.	GLI	developmental delay	2735	HP_0001263	200	203	66	85	False
29298444	She manifested macrocephaly, preaxial polysyndactyly, psychomotor developmental delay, cerebral cavernous malformations, and glucose intolerance due to a 6.2-Mb deletion of 7p14.1p12.3 which included GLI3, GCK, and CCM2.	GCK	developmental delay	5871	HP_0001263	206	209	66	85	False
29298444	We summarize the phenotypic extent of GLI2/3 syndromes in the literature and determine that these 2 syndromes manifest opposite features to a certain extent, such as midface hypoplasia or macrocephaly, and anterior or posterior side of polydactyly.	GLI	macrocephaly	2735	HP_0000256	38	41	188	200	False
29298444	We summarize the phenotypic extent of GLI2/3 syndromes in the literature and determine that these 2 syndromes manifest opposite features to a certain extent, such as midface hypoplasia or macrocephaly, and anterior or posterior side of polydactyly.	GLI	polydactyly	2735	HP_0010442	38	41	236	247	True
25909288	OGFOD1 knockdown in MDA-MB-231 breast cancer cells significantly impeded cell proliferation and resulted in the accumulation of G1 and G2/M cells by decreasing the mRNA levels of G1/S transition- and G2/M-related transcription factors and their target genes.	OGFOD1	cancer	55239	HP_0002664	0	6	38	44	False
25909288	We also confirmed that OGFOD1 is highly expressed in breast cancer tissues by bioinformatic analysis and immunohistochemistry.	OGFOD1	cancer	55239	HP_0002664	23	29	60	66	False
25909288	Thus, we propose that OGFOD1 is required for breast cancer cell proliferation and is associated with poor prognosis in breast cancer.	OGFOD1	cancer	55239	HP_0002664	22	28	52	58	False
30532139	Spinocerebellar ataxia type 11 (SCA11) is a rare, dominantly inherited human ataxia characterized by atrophy of Purkinje neurons in the cerebellum.	type	ataxia	6445	HP_0001251	23	27	16	22	False
30532139	Spinocerebellar ataxia type 11 (SCA11) is a rare, dominantly inherited human ataxia characterized by atrophy of Purkinje neurons in the cerebellum.	SCA11	ataxia	146057	HP_0001251	32	37	16	22	True
28328130	Auriculocondylar syndrome, mainly characterized by micrognathia, small mandibular condyle, and question mark ears, is a rare disease segregating in an autosomal dominant pattern in the majority of the families reported in the literature.	mark	micrognathia	4139	HP_0000347	104	108	51	63	False
28328130	Auriculocondylar syndrome, mainly characterized by micrognathia, small mandibular condyle, and question mark ears, is a rare disease segregating in an autosomal dominant pattern in the majority of the families reported in the literature.	ears	micrognathia	2058	HP_0000347	109	113	51	63	False
28328130	Auriculocondylar syndrome, mainly characterized by micrognathia, small mandibular condyle, and question mark ears, is a rare disease segregating in an autosomal dominant pattern in the majority of the families reported in the literature.	mark	small mandibular condyle	4139	HP_0007628	104	108	65	89	False
28328130	Auriculocondylar syndrome, mainly characterized by micrognathia, small mandibular condyle, and question mark ears, is a rare disease segregating in an autosomal dominant pattern in the majority of the families reported in the literature.	ears	small mandibular condyle	2058	HP_0007628	109	113	65	89	False
28328130	In order to address these questions, we searched for alterations in PLCB4, GNAI3, and EDN1 in patients with typical Auriculocondylar syndrome (n=3), Pierre Robin sequence-plus (n=3), micrognathia with additional craniofacial malformations (n=4), or non-specific auricular dysplasia (n=1), which could represent subtypes of Auriculocondylar syndrome.	PLCB4	micrognathia	5332	HP_0000347	68	73	187	199	True
28328130	In order to address these questions, we searched for alterations in PLCB4, GNAI3, and EDN1 in patients with typical Auriculocondylar syndrome (n=3), Pierre Robin sequence-plus (n=3), micrognathia with additional craniofacial malformations (n=4), or non-specific auricular dysplasia (n=1), which could represent subtypes of Auriculocondylar syndrome.	GNAI3	micrognathia	2773	HP_0000347	75	80	187	199	True
28328130	In order to address these questions, we searched for alterations in PLCB4, GNAI3, and EDN1 in patients with typical Auriculocondylar syndrome (n=3), Pierre Robin sequence-plus (n=3), micrognathia with additional craniofacial malformations (n=4), or non-specific auricular dysplasia (n=1), which could represent subtypes of Auriculocondylar syndrome.	EDN1	micrognathia	1906	HP_0000347	86	90	187	199	True
29727687	The clinical presentation was severe, early-onset, progressive SMA-like motor neuronopathy, cerebellar atrophy, and in one affected individual, congenital fractures of the long bones.	SMA	cerebellar atrophy	6606	HP_0001272	63	66	92	110	False
29727687	In summary, we show that variants in EXOSC9 result in a neurological syndrome combining cerebellar atrophy and spinal motoneuronopathy, thus expanding the list of human exosomopathies	EXOSC9	cerebellar atrophy	5393	HP_0001272	37	43	88	106	True
29670100	A pathogenic R474Q mutation of LGI1, which does not exceptionallyaffect either the secretion or the ADAM22 binding, is located in the LGI1-LGI1 interface and disrupts the higher-order assembly of the LGI1-ADAM22 complex in vitro and in a mouse model for familial epilepsy.	LGI1	epilepsy	9211	HP_0001250	31	35	264	272	True
29670100	A pathogenic R474Q mutation of LGI1, which does not exceptionallyaffect either the secretion or the ADAM22 binding, is located in the LGI1-LGI1 interface and disrupts the higher-order assembly of the LGI1-ADAM22 complex in vitro and in a mouse model for familial epilepsy.	ADAM22	epilepsy	53616	HP_0001250	101	107	264	272	True
29907571	Here, we investigated whether synonymous changes could affect expression of the potassium voltage-gated channel subfamily H member 2 (<i>KCNH2</i>) gene, encoding the human ether-a-go-go-related gene (hERG) ion channel, which is linked to hereditary cardiac arrhythmia.	hERG	cardiac arrhythmia	3757	HP_0011675	201	205	250	268	True
29503225	Here, we assessed the effect of paired tumor-associated and normal lung tissue mesenchymal stem cells (MSCs) on the growth and dissemination of primary human lung carcinoma cells isolated from the same patients.	MSC	tumor	9242	HP_0002664	103	106	39	44	False
29503225	We show that the tumor microenvironment modulates MSC gene expression and identify a four-gene MSC signature that is functionally implicated in promoting metastasis.	MSC	tumor	9242	HP_0002664	50	53	17	22	False
29503225	We also demonstrate that tumor-associated MSCs induce the expression of genes associated with an aggressive phenotype in primary lung cancer cells and selectively promote their dissemination rather than local growth.	MSC	cancer	9242	HP_0002664	42	45	134	140	False
29503225	We also demonstrate that tumor-associated MSCs induce the expression of genes associated with an aggressive phenotype in primary lung cancer cells and selectively promote their dissemination rather than local growth.	MSC	tumor	9242	HP_0002664	42	45	25	30	False
28051077	We aimed to identify the genetic cause of the devastating neurodegenerative disease amyotrophic lateral sclerosis (ALS) in a German family with two affected individuals, and to assess the prevalence of variants in the identified risk gene, FIG4, in a central European ALS cohort.	ALS	neurodegenerative disease	3483	HP_0002180	115	118	58	83	False
28051077	We aimed to identify the genetic cause of the devastating neurodegenerative disease amyotrophic lateral sclerosis (ALS) in a German family with two affected individuals, and to assess the prevalence of variants in the identified risk gene, FIG4, in a central European ALS cohort.	FIG4	neurodegenerative disease	9896	HP_0002180	240	244	58	83	True
28051077	Additionally, novel or rare heterozygous FIG4 missense variants predicted to be deleterious were detected in five sporadic ALS patients revealing an overall FIG4 variant frequency of 3% in our cohort.	ALS	sporadic	3483	HP_0003745	123	126	114	122	False
28051077	Additionally, novel or rare heterozygous FIG4 missense variants predicted to be deleterious were detected in five sporadic ALS patients revealing an overall FIG4 variant frequency of 3% in our cohort.	FIG4	sporadic	9896	HP_0003745	41	45	114	122	False
28051077	Four of six variants identified were previously associated with ALS or the motor and sensory neuropathy Charcot-Marie-Tooth disease type 4J (CMT4J), whereas two variants were novel.	ALS	neuropathy	3483	HP_0009830	64	67	93	103	False
28051077	Four of six variants identified were previously associated with ALS or the motor and sensory neuropathy Charcot-Marie-Tooth disease type 4J (CMT4J), whereas two variants were novel.	type	neuropathy	6445	HP_0009830	132	136	93	103	False
28051077	Four of six variants identified were previously associated with ALS or the motor and sensory neuropathy Charcot-Marie-Tooth disease type 4J (CMT4J), whereas two variants were novel.	CMT4J	neuropathy	9896	HP_0009830	141	146	93	103	True
29217762	Here we report that UBE3A ubiquitylates and triggers degradation of the tumor-suppressive sirtuin SIRT6 in hepatocellular carcinoma.	UBE3A	tumor	7337	HP_0002664	20	25	72	77	False
29217762	Here we report that UBE3A ubiquitylates and triggers degradation of the tumor-suppressive sirtuin SIRT6 in hepatocellular carcinoma.	SIRT6	tumor	51548	HP_0002664	98	103	72	77	False
29217762	Here we report that UBE3A ubiquitylates and triggers degradation of the tumor-suppressive sirtuin SIRT6 in hepatocellular carcinoma.	UBE3A	hepatocellular carcinoma	7337	HP_0001402	20	25	107	131	False
29217762	Here we report that UBE3A ubiquitylates and triggers degradation of the tumor-suppressive sirtuin SIRT6 in hepatocellular carcinoma.	SIRT6	hepatocellular carcinoma	51548	HP_0001402	98	103	107	131	False
29217762	In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated tumorigenesis.	UBE3A	tumor	7337	HP_0002664	118	123	133	138	False
29217762	In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated tumorigenesis.	SIRT6	tumor	51548	HP_0002664	45	50	133	138	False
29217762	In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated tumorigenesis.	ANXA2	tumor	302	HP_0002664	94	99	133	138	False
29217762	In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated tumorigenesis.	UBE3A	hepatocellular carcinoma	7337	HP_0001402	118	123	19	43	False
29217762	In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated tumorigenesis.	SIRT6	hepatocellular carcinoma	51548	HP_0001402	45	50	19	43	False
29217762	In mouse models of hepatocellular carcinoma, SIRT6 downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated tumorigenesis.	ANXA2	hepatocellular carcinoma	302	HP_0001402	94	99	19	43	False
29217762	Furthermore, in clinical specimens, increased UBE3A levels correlated with reduced SIRT6 levels and elevated ANXA2 levels in increasing tumor grades.	UBE3A	tumor	7337	HP_0002664	46	51	136	141	False
29217762	Furthermore, in clinical specimens, increased UBE3A levels correlated with reduced SIRT6 levels and elevated ANXA2 levels in increasing tumor grades.	SIRT6	tumor	51548	HP_0002664	83	88	136	141	False
29217762	Furthermore, in clinical specimens, increased UBE3A levels correlated with reduced SIRT6 levels and elevated ANXA2 levels in increasing tumor grades.	ANXA2	tumor	302	HP_0002664	109	114	136	141	False
29217762	Overall, our findings show how the tumor suppressor SIRT6 is regulated in hepatocellular carcinoma and establish the mechanism underlying UBE3A-mediated tumorigenesis in this disease.<b>Significance:</b> These findings provide mechanistic insights into regulation of the tumor suppressive sirtuin SIRT6 and its implications for the development of hepatocellular carcinoma.	UBE3A	tumor	7337	HP_0002664	138	143	35	40	False
29217762	Overall, our findings show how the tumor suppressor SIRT6 is regulated in hepatocellular carcinoma and establish the mechanism underlying UBE3A-mediated tumorigenesis in this disease.<b>Significance:</b> These findings provide mechanistic insights into regulation of the tumor suppressive sirtuin SIRT6 and its implications for the development of hepatocellular carcinoma.	SIRT6	tumor	51548	HP_0002664	52	57	35	40	False
29217762	Overall, our findings show how the tumor suppressor SIRT6 is regulated in hepatocellular carcinoma and establish the mechanism underlying UBE3A-mediated tumorigenesis in this disease.<b>Significance:</b> These findings provide mechanistic insights into regulation of the tumor suppressive sirtuin SIRT6 and its implications for the development of hepatocellular carcinoma.	UBE3A	hepatocellular carcinoma	7337	HP_0001402	138	143	74	98	False
29217762	Overall, our findings show how the tumor suppressor SIRT6 is regulated in hepatocellular carcinoma and establish the mechanism underlying UBE3A-mediated tumorigenesis in this disease.<b>Significance:</b> These findings provide mechanistic insights into regulation of the tumor suppressive sirtuin SIRT6 and its implications for the development of hepatocellular carcinoma.	SIRT6	hepatocellular carcinoma	51548	HP_0001402	52	57	74	98	False
30333494	Chemotherapy and radiation not only trigger cancer cell apoptosis but also damage stromal cells in the tumour microenvironment (TME), inducing a senescence-associated secretory phenotype (SASP) characterized by chronic secretion of diverse soluble factors.	damage	cancer	51438	HP_0002664	75	81	44	50	False
30333494	Chemotherapy and radiation not only trigger cancer cell apoptosis but also damage stromal cells in the tumour microenvironment (TME), inducing a senescence-associated secretory phenotype (SASP) characterized by chronic secretion of diverse soluble factors.	type	cancer	6445	HP_0002664	182	186	44	50	False
30333494	Chemotherapy and radiation not only trigger cancer cell apoptosis but also damage stromal cells in the tumour microenvironment (TME), inducing a senescence-associated secretory phenotype (SASP) characterized by chronic secretion of diverse soluble factors.	damage	tumour	51438	HP_0002664	75	81	103	109	False
30333494	Chemotherapy and radiation not only trigger cancer cell apoptosis but also damage stromal cells in the tumour microenvironment (TME), inducing a senescence-associated secretory phenotype (SASP) characterized by chronic secretion of diverse soluble factors.	type	tumour	6445	HP_0002664	182	186	103	109	False
30333494	DNA damage causes SPINK1 expression by engaging NF-B and C/EBP, while paracrine SPINK1 promotes cancer cell aggressiveness particularly chemoresistance.	damage	cancer	51438	HP_0002664	4	10	97	103	False
30333494	DNA damage causes SPINK1 expression by engaging NF-B and C/EBP, while paracrine SPINK1 promotes cancer cell aggressiveness particularly chemoresistance.	SPINK1	cancer	6690	HP_0002664	18	24	97	103	True
30333494	DNA damage causes SPINK1 expression by engaging NF-B and C/EBP, while paracrine SPINK1 promotes cancer cell aggressiveness particularly chemoresistance.	NF	cancer	23114	HP_0002664	48	50	97	103	False
30333494	Strikingly, SPINK1 reprograms the expression profile of cancer cells, causing prominent epithelial-endothelial transition (EET), a phenotypic switch mediated by EGFR signaling but hitherto rarely reported for a SASP factor.	SPINK1	cancer	6690	HP_0002664	12	18	56	62	True
30333494	Strikingly, SPINK1 reprograms the expression profile of cancer cells, causing prominent epithelial-endothelial transition (EET), a phenotypic switch mediated by EGFR signaling but hitherto rarely reported for a SASP factor.	EGFR	cancer	1956	HP_0002664	161	165	56	62	True
30333494	In vivo, SPINK1 is expressed in the stroma of solid tumours and is routinely detectable in peripheral blood of cancer patients after chemotherapy.	SPINK1	cancer	6690	HP_0002664	9	15	111	117	True
30333494	In vivo, SPINK1 is expressed in the stroma of solid tumours and is routinely detectable in peripheral blood of cancer patients after chemotherapy.	SPINK1	tumour	6690	HP_0002664	9	15	52	58	True
30262533	We report the case of a patient with <i>PIGT</i> mutations who experienced recurrent aseptic meningitis 121 times over 16 years before developing paroxysmal nocturnal haemoglobinuria (PNH).	PIGT	paroxysmal nocturnal haemoglobinuria	51604	HP_0004818	40	44	146	182	True
29668979	Mutations in bestrophin-1 (BEST1) are associated with distinct retinopathies, notably three forms with autosomal dominant inheritance and one condition with an autosomal recessive mode of transmission.	BEST1	autosomal recessive	7439	HP_0000007	27	32	160	179	True
29668979	Although heterozygous missense mutations in BEST1 reveal dominant-negative effects in patients with autosomal dominant Best disease (BD), heterozygous mutations associated with autosomal recessive bestrophinopathy (ARB) display no disease phenotype.	BEST1	autosomal recessive	7439	HP_0000007	44	49	177	196	True
29668979	Although heterozygous missense mutations in BEST1 reveal dominant-negative effects in patients with autosomal dominant Best disease (BD), heterozygous mutations associated with autosomal recessive bestrophinopathy (ARB) display no disease phenotype.	Best	autosomal recessive	7439	HP_0000007	119	123	177	196	True
29668979	Taken together, our data provide insight into the molecular pathways of dominantly and recessively acting BEST1 missense mutations suggesting that the site of subcellular protein quality control as well as the rate and degree of mutant protein degradation are ultimately responsible for the distinct retinal disease phenotypes in BD and ARB	BEST1	retinal disease	7439	HP_0000479	106	111	300	315	True
28973536	However, the inherent susceptibility of these tissues to SCO1 mutations and the clinical heterogeneity observed across SCO1 pedigrees remain poorly understood phenomena.	SCO1	heterogeneity	6341	HP_0001425	57	61	89	102	True
28973536	Lethality was observed in both models due to a combined COX and copper deficiency that resulted in a dilated cardiomyopathy.	COX	cardiomyopathy	1351	HP_0001638	56	59	109	123	True
28973536	CTR1 was similarly mislocalized to the cytosol in the heart of knockin mice carrying a homozygous G115S substitution in Sco1, which in humans causes a hypertrophic cardiomyopathy.	mice	cardiomyopathy	23581	HP_0001638	71	75	164	178	False
28973536	CTR1 was similarly mislocalized to the cytosol in the heart of knockin mice carrying a homozygous G115S substitution in Sco1, which in humans causes a hypertrophic cardiomyopathy.	Sco1	cardiomyopathy	6341	HP_0001638	120	124	164	178	True
28973536	CTR1 was similarly mislocalized to the cytosol in the heart of knockin mice carrying a homozygous G115S substitution in Sco1, which in humans causes a hypertrophic cardiomyopathy.	CTR1	cardiomyopathy	1317	HP_0001638	0	4	164	178	False
25189544	Identification of novel genetic and epigenetic alterations is required for optimal stratification of patients with hepatocellular carcinoma (HCC) at risk for recurrence and adverse prognosis.	HCC	hepatocellular carcinoma	84668	HP_0001402	141	144	115	139	False
25189544	PDSS2 is a putative tumor suppressor, and promoter hypermethylation is a key regulatory mechanism in HCC.	HCC	tumor	84668	HP_0002664	101	104	20	25	False
25189544	PDSS2 is a putative tumor suppressor, and promoter hypermethylation is a key regulatory mechanism in HCC.	PDSS2	tumor	57107	HP_0002664	0	5	20	25	False
26026368	Overexpression of Phgdh in CK5-positive cell lineages, and differential protein isoform expression, was additionally found in other tissues and cancer types, suggesting that overexpression of Phgdh is generally associated with CK5 cells, and that oncogenic function may be determined by isoform expression.	Phgdh	cancer	26227	HP_0002664	18	23	144	150	False
30451843	Here, we show that tamoxifen, a well-known drug used against breast cancer, rescues the phenotype of Mtm1-deficient mice.	Mtm1	cancer	4534	HP_0002664	101	105	68	74	True
30788347	Necropsy revealed extensive granulomatous pneumonia, from which Mtb was isolated and identified as a member of LAM3/F11 lineage; a common lineage found in humans in South Africa.	Mtb	pneumonia	54892	HP_0002090	64	67	42	51	False
28345816	We found that rs1042752-located in the 3'-UTR of POU2AF1, which plays a vital role in lymphomagenesis-was significantly associated with lymphoma risk in a case-control study with 793 patients and 939 controls.	POU2AF1	lymphoma	5450	HP_0002665	49	56	86	94	False
28345816	We found that rs1042752-located in the 3'-UTR of POU2AF1, which plays a vital role in lymphomagenesis-was significantly associated with lymphoma risk in a case-control study with 793 patients and 939 controls.	was	lymphoma	7454	HP_0002665	102	105	86	94	True
29537328	It has been proposed that transcobalamin 2 (TCN2) and the transcobalamin 2 receptor (TCN2R) are associated with idiopathic recurrent spontaneous abortion (RSA).	TCN2	spontaneous abortion	6948	HP_0005268	44	48	133	153	False
27871432	Mutations in the PGAP2 gene cause hyperphosphatasia mental retardation syndrome-3.	PGAP2	hyperphosphatasia	27315	HP_0003155	17	22	34	51	True
29874194	Results Our cohort consisted mostly of children and displayed a wide phenotypic variability in the presenting symptoms ranging from hypoglycemic seizures at the severe end of the spectrum to insidious hyperpigmentation and delayed development.	end	seizures	2022	HP_0001250	168	171	145	153	True
29735526	Targeted expression of a human NGLY1 transgene to tissues involved in ecdysteroidogenesis, <i>e.g.</i>, prothoracic gland, also partially rescues global developmental delay in mutant homozygotes.	NGLY1	developmental delay	55768	HP_0001263	31	36	153	172	True
29735526	Finally, the proteasome inhibitor bortezomib is a potent enhancer of global developmental delay in our fly model, evidence of a defective proteasome &quot;bounce-back&quot; response that is also observed in nematode and cellular models of NGLY1 Deficiency.	NGLY1	developmental delay	55768	HP_0001263	239	244	76	95	True
27486783	Primary ciliary dyskinesia (PCD) is an autosomal-recessive disease due to functional or ultra-structural defects of motile cilia.	PCD	ciliary dyskinesia	352909	HP_0012265	28	31	8	26	True
29417940	An early intervention using biomarkers to predict acute myocardial infarction (AMI) will effectively reduce global heart attack incidence, particularly among high-risk patients with type 2 diabetes mellitus (T2DM).	type	myocardial infarction	6445	HP_0001658	182	186	56	77	False
30293388	<b>Objective:</b> To investigate the expression of granulocyte-colony stimulating factor receptor (G-CSFR) in a mouse model of colitis-associated cancer (CAC), and the roles of G-CSFR positive immune cells in the development of CAC.	CAC	cancer	788	HP_0002664	154	157	146	152	False
30293388	<b>Objective:</b> To investigate the expression of granulocyte-colony stimulating factor receptor (G-CSFR) in a mouse model of colitis-associated cancer (CAC), and the roles of G-CSFR positive immune cells in the development of CAC.	CSFR	cancer	1436	HP_0002664	101	105	146	152	False
28612833	The majority of causative genetic variants identified thus far are inherited in an autosomal recessive manner and impact key cellular pathways such as mitosis, DNA damage response and repair, apoptosis and splicing.	impact	autosomal recessive	55364	HP_0000007	114	120	83	102	False
28612833	The majority of causative genetic variants identified thus far are inherited in an autosomal recessive manner and impact key cellular pathways such as mitosis, DNA damage response and repair, apoptosis and splicing.	damage	autosomal recessive	51438	HP_0000007	164	170	83	102	False
28612833	Here, we report a novel donor splice site variant in the G-patch domain and KOW motifs (GPKOW) gene (NG_021310.2:g.6126G&gt;A, NM_015698.4:c.331+5G&gt;A) that segregates with affected and carrier status in a multigenerational family with an X-linked perinatal lethal condition characterized by severe microcephaly and intrauterine growth restriction (IUGR).	GPKOW	microcephaly	27238	HP_0000252	88	93	301	313	True
28612833	Here, we report a novel donor splice site variant in the G-patch domain and KOW motifs (GPKOW) gene (NG_021310.2:g.6126G&gt;A, NM_015698.4:c.331+5G&gt;A) that segregates with affected and carrier status in a multigenerational family with an X-linked perinatal lethal condition characterized by severe microcephaly and intrauterine growth restriction (IUGR).	GPKOW	severe	27238	HP_0012828	88	93	294	300	False
28612833	Here, we report a novel donor splice site variant in the G-patch domain and KOW motifs (GPKOW) gene (NG_021310.2:g.6126G&gt;A, NM_015698.4:c.331+5G&gt;A) that segregates with affected and carrier status in a multigenerational family with an X-linked perinatal lethal condition characterized by severe microcephaly and intrauterine growth restriction (IUGR).	GPKOW	intrauterine growth restriction	27238	HP_0001511	88	93	318	349	True
28612833	Based on our and published data we propose that the GPKOW gene is essential for fetal development and when disrupted, leads to a severe, male-lethal phenotype characterised by microcephaly and IUGR	GPKOW	microcephaly	27238	HP_0000252	52	57	176	188	True
28612833	Based on our and published data we propose that the GPKOW gene is essential for fetal development and when disrupted, leads to a severe, male-lethal phenotype characterised by microcephaly and IUGR	type	microcephaly	6445	HP_0000252	154	158	176	188	False
28612833	Based on our and published data we propose that the GPKOW gene is essential for fetal development and when disrupted, leads to a severe, male-lethal phenotype characterised by microcephaly and IUGR	GPKOW	severe	27238	HP_0012828	52	57	129	135	False
28612833	Based on our and published data we propose that the GPKOW gene is essential for fetal development and when disrupted, leads to a severe, male-lethal phenotype characterised by microcephaly and IUGR	type	severe	6445	HP_0012828	154	158	129	135	False
29952426	However, the ectopic expression of FSHR was recently discovered in intra-tumoral blood vessels endothelia and/or in tumoral cells of many extra-gonadal human tumors (particularly in endocrine tumours).	FSHR	tumors	2492	HP_0002664	35	39	158	164	False
29952426	However, the ectopic expression of FSHR was recently discovered in intra-tumoral blood vessels endothelia and/or in tumoral cells of many extra-gonadal human tumors (particularly in endocrine tumours).	FSHR	tumours	2492	HP_0002664	35	39	192	199	False
29952426	However, the ectopic expression of FSHR was recently discovered in intra-tumoral blood vessels endothelia and/or in tumoral cells of many extra-gonadal human tumors (particularly in endocrine tumours).	FSHR	tumor	2492	HP_0002664	35	39	73	78	False
29952426	The paper reviews the data concerning the appearance of ectopic FSHR in particular human neoplasms.	FSHR	neoplasms	2492	HP_0002664	64	68	89	98	False
29952426	The possible involvement of FSHR in tumor progression and the use of FSHR examination for diagnostic purposes is also reviewed.	FSHR	tumor	2492	HP_0002664	28	32	36	41	False
29866822	Activating mutations in the KIT or PDGFRA receptor tyrosine kinases are hallmarks of gastrointestinal stromal tumor (GIST).	KIT	tumor	3815	HP_0002664	28	31	110	115	True
29866822	Activating mutations in the KIT or PDGFRA receptor tyrosine kinases are hallmarks of gastrointestinal stromal tumor (GIST).	PDGFRA	tumor	5156	HP_0002664	35	41	110	115	True
30332805	A principal feature of AD is the presence of neurofibrillary tangles (NFT) induced by the aberrant phosphorylation of the microtubule-associated protein tau in the brains of affected individuals.	tau	neurofibrillary tangles	4137	HP_0002185	153	156	45	68	True
24702957	Here we describe two unrelated individuals with infantile-onset epilepsy and abnormalities of brain morphology, harboring de novo variants that affect adjacent amino acids in a beta-tubulin gene TUBB2A.	TUBB2A	epilepsy	7280	HP_0001250	195	201	64	72	True
27666198	Nagashima-type palmoplantar keratosis (NPPK) is an autosomal recessive form of palmoplantar keratoderma (PPK), which is caused by mutations in the SERPINB7 gene.	SERPINB7	palmoplantar keratosis	8710	HP_0000972	147	155	15	37	False
27666198	Nagashima-type palmoplantar keratosis (NPPK) is an autosomal recessive form of palmoplantar keratoderma (PPK), which is caused by mutations in the SERPINB7 gene.	SERPINB7	autosomal recessive	8710	HP_0000007	147	155	51	70	True
27666198	Nagashima-type palmoplantar keratosis (NPPK) is an autosomal recessive form of palmoplantar keratoderma (PPK), which is caused by mutations in the SERPINB7 gene.	SERPINB7	palmoplantar keratoderma	8710	HP_0000982	147	155	79	103	True
27624628	We report the association of many previously unreported variants with retinal disease, as well as new disease phenotypes associated with known genes, including the first association of the SLC24A1 gene with retinitis pigmentosa.	SLC24A1	retinal disease	9187	HP_0000479	189	196	70	85	True
30632664	Birt-Hogg-Dub (BHD) syndrome is a rare genetic disorder characterized by cutaneous fibrofolliculomas, pulmonary cysts and renal cell carcinomas.	BHD	renal cell carcinomas	201163	HP_0005584	16	19	123	144	True
30128822	Nuclear respiratory factor 1 (NRF1) transcription factor has recently been shown to control breast cancer progression.	NRF1	cancer	4779	HP_0002664	30	34	99	105	False
30128822	However, mechanistic aspects by which NRF1 may contribute to susceptibility to different breast tumor subtypes are still not fully understood.	NRF1	tumor	4779	HP_0002664	38	42	96	101	False
30128822	Since transcriptional control of NRF1 seems to be dependent on epidermal growth factor receptor signaling, herein, we investigated the role of NRF1 in estrogen receptor/progesterone receptor negative, but human epidermal growth factor receptor 2-positive (ER/PR -ve HER2 +ve) breast cancer.	NRF1	cancer	4779	HP_0002664	33	37	283	289	False
30128822	Since transcriptional control of NRF1 seems to be dependent on epidermal growth factor receptor signaling, herein, we investigated the role of NRF1 in estrogen receptor/progesterone receptor negative, but human epidermal growth factor receptor 2-positive (ER/PR -ve HER2 +ve) breast cancer.	HER2	cancer	2064	HP_0002664	266	270	283	289	True
30128822	We found that both mRNA and protein levels of NRF1 and its transcriptional activity were significantly higher in ER/PR-ve HER2+ve breast cancer samples compared to normal breast tissues.	NRF1	cancer	4779	HP_0002664	46	50	139	145	False
30128822	We found that both mRNA and protein levels of NRF1 and its transcriptional activity were significantly higher in ER/PR-ve HER2+ve breast cancer samples compared to normal breast tissues.	HER2	cancer	2064	HP_0002664	123	127	139	145	True
30128822	This was consistent with our observation of higher NRF1 protein expression in the experimental model of HER2+ breast cancer brain metastasis.	NRF1	cancer	4779	HP_0002664	51	55	117	123	False
30128822	This was consistent with our observation of higher NRF1 protein expression in the experimental model of HER2+ breast cancer brain metastasis.	HER2	cancer	2064	HP_0002664	104	108	117	123	True
30128822	To identify network-based pathways involved in the susceptibility to the ER/PR-ve HER2+ve breast cancer subtype, the NRF1 transcriptional regulatory genome-wide landscape was analyzed using the approach consisting of a systematic integration of ChIP DNA-seq, RNA-Microarray, NRF1 protein-DNA motif binding, signal pathway analysis, and Bayesian machine learning.	NRF1	cancer	4779	HP_0002664	119	123	99	105	False
30128822	To identify network-based pathways involved in the susceptibility to the ER/PR-ve HER2+ve breast cancer subtype, the NRF1 transcriptional regulatory genome-wide landscape was analyzed using the approach consisting of a systematic integration of ChIP DNA-seq, RNA-Microarray, NRF1 protein-DNA motif binding, signal pathway analysis, and Bayesian machine learning.	HER2	cancer	2064	HP_0002664	83	87	99	105	True
30128822	To identify network-based pathways involved in the susceptibility to the ER/PR-ve HER2+ve breast cancer subtype, the NRF1 transcriptional regulatory genome-wide landscape was analyzed using the approach consisting of a systematic integration of ChIP DNA-seq, RNA-Microarray, NRF1 protein-DNA motif binding, signal pathway analysis, and Bayesian machine learning.	ChIP	cancer	10273	HP_0002664	247	251	99	105	False
30128822	Our findings show that a high percentage of known HER2+ breast cancer susceptibility genes, including EGFR, IGFR, and E2F1, are under transcriptional control of NRF1.	NRF1	cancer	4779	HP_0002664	161	165	63	69	False
30128822	Our findings show that a high percentage of known HER2+ breast cancer susceptibility genes, including EGFR, IGFR, and E2F1, are under transcriptional control of NRF1.	HER2	cancer	2064	HP_0002664	50	54	63	69	True
30128822	Our findings show that a high percentage of known HER2+ breast cancer susceptibility genes, including EGFR, IGFR, and E2F1, are under transcriptional control of NRF1.	EGFR	cancer	1956	HP_0002664	102	106	63	69	True
30128822	Our findings show that a high percentage of known HER2+ breast cancer susceptibility genes, including EGFR, IGFR, and E2F1, are under transcriptional control of NRF1.	IGFR	cancer	3480	HP_0002664	108	112	63	69	False
30128822	Our findings show that a high percentage of known HER2+ breast cancer susceptibility genes, including EGFR, IGFR, and E2F1, are under transcriptional control of NRF1.	E2F1	cancer	1869	HP_0002664	118	122	63	69	False
30128822	Promoters of several genes from the KEGG HER2+ breast cancer pathway and 11 signaling pathways linked to 6 hallmarks of cancer contain the NRF1 motif.	NRF1	cancer	4779	HP_0002664	139	143	54	60	False
30128822	Promoters of several genes from the KEGG HER2+ breast cancer pathway and 11 signaling pathways linked to 6 hallmarks of cancer contain the NRF1 motif.	HER2	cancer	2064	HP_0002664	41	45	54	60	True
30128822	By pathway analysis, key breast cancer hallmark genes of epithelial-mesenchymal transition, stemness, cell apoptosis, cell cycle regulation, chromosomal integrity, and DNA damage/repair were highly enriched with NRF1 motifs.	NRF1	cancer	4779	HP_0002664	212	216	32	38	False
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	NRF1	cancer	4779	HP_0002664	76	80	470	476	False
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	HER2	cancer	2064	HP_0002664	505	509	470	476	True
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	FGFR1	cancer	2260	HP_0002664	136	141	470	476	True
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	E2F1	cancer	1869	HP_0002664	183	187	470	476	False
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	IGF1R	cancer	3480	HP_0002664	143	148	470	476	False
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	SHC2	cancer	25759	HP_0002664	208	212	470	476	False
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	PI3K	cancer	5290	HP_0002664	227	231	470	476	True
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	mTOR	cancer	2475	HP_0002664	236	240	470	476	False
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	PIK3CD	cancer	5293	HP_0002664	259	265	470	476	False
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	GRB2	cancer	2885	HP_0002664	214	218	470	476	False
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	MAPK1	cancer	5594	HP_0002664	220	225	470	476	True
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	WNT7B	cancer	7477	HP_0002664	314	319	470	476	False
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	PIK3R1	cancer	5295	HP_0002664	267	273	470	476	True
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	PIK3R3	cancer	8503	HP_0002664	275	281	470	476	False
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	RPS6KB2	cancer	6199	HP_0002664	283	290	470	476	False
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	GSK3B	cancer	2932	HP_0002664	333	338	470	476	False
30128822	In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-SHC2, GRB2, MAPK1; PI3K-AKT-mTOR signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-WNT7B, DLV1, DLV2, GSK3B, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast cancer cells, were associated with HER2-amplified breast cancer.	DDB2	cancer	1643	HP_0002664	350	354	470	476	True
30128822	Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and MAPK1, low or no change in E2F1 and FGFR1, and high or no change in PIK3R3.	NRF1	cancer	4779	HP_0002664	134	138	85	91	False
30128822	Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and MAPK1, low or no change in E2F1 and FGFR1, and high or no change in PIK3R3.	HER2	cancer	2064	HP_0002664	64	68	85	91	True
30128822	Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and MAPK1, low or no change in E2F1 and FGFR1, and high or no change in PIK3R3.	FGFR1	cancer	2260	HP_0002664	245	250	85	91	True
30128822	Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and MAPK1, low or no change in E2F1 and FGFR1, and high or no change in PIK3R3.	E2F1	cancer	1869	HP_0002664	236	240	85	91	False
30128822	Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and MAPK1, low or no change in E2F1 and FGFR1, and high or no change in PIK3R3.	MAPK1	cancer	5594	HP_0002664	209	214	85	91	True
30128822	Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and MAPK1, low or no change in E2F1 and FGFR1, and high or no change in PIK3R3.	PIK3R3	cancer	8503	HP_0002664	277	283	85	91	False
30128822	Machine learning search further revealed that the likelihood of HER2-positive breast cancer is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and MAPK1, low or no change in E2F1 and FGFR1, and high or no change in PIK3R3.	GSK3B	cancer	2932	HP_0002664	198	203	85	91	False
30128822	In summary, our findings suggest novel roles of NRF1 and its regulatory networks in susceptibility to the ER/PR-ve HER2+ve aggressive breast cancer subtype.	NRF1	cancer	4779	HP_0002664	48	52	143	149	False
30128822	In summary, our findings suggest novel roles of NRF1 and its regulatory networks in susceptibility to the ER/PR-ve HER2+ve aggressive breast cancer subtype.	HER2	cancer	2064	HP_0002664	116	120	143	149	True
30128822	Clinical confirmation of our machine learned Bayesian networks will have significant impact on our understanding of the role of NRF1 as a valuable biomarker for breast cancer diagnosis and prognosis as well as provide strong rationale for future studies to develop NRF1 signaling-based therapeutics to target HER2+ breast cancer	NRF1	cancer	4779	HP_0002664	128	132	168	174	False
30128822	Clinical confirmation of our machine learned Bayesian networks will have significant impact on our understanding of the role of NRF1 as a valuable biomarker for breast cancer diagnosis and prognosis as well as provide strong rationale for future studies to develop NRF1 signaling-based therapeutics to target HER2+ breast cancer	HER2	cancer	2064	HP_0002664	309	313	168	174	True
28993958	Hypomorphic IKBKG mutations in males are typically associated with anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID).	IKBKG	ectodermal dysplasia	8517	HP_0000968	12	17	78	98	True
28993958	Hypomorphic IKBKG mutations in males are typically associated with anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID).	EDA	ectodermal dysplasia	1896	HP_0000968	122	125	78	98	True
28993958	As rare polymorphisms have been described in IKBKG and polygenic inheritance remains an option in the presented case, this study emphasizes the need for thorough functional and genetic evaluation when encountering and interpreting suspected disease-causing NEMO-ID variants	IKBKG	polygenic inheritance	8517	HP_0010982	45	50	55	76	False
28993958	As rare polymorphisms have been described in IKBKG and polygenic inheritance remains an option in the presented case, this study emphasizes the need for thorough functional and genetic evaluation when encountering and interpreting suspected disease-causing NEMO-ID variants	NEMO	polygenic inheritance	8517	HP_0010982	257	261	55	76	False
25340510	We recently reported that centrosomal protein 164 (CEP164) regulates both cilia and the DNA damage response in the autosomal recessive polycystic kidney disease nephronophthisis.	CEP164	autosomal recessive	22897	HP_0000007	51	57	115	134	True
25340510	We recently reported that centrosomal protein 164 (CEP164) regulates both cilia and the DNA damage response in the autosomal recessive polycystic kidney disease nephronophthisis.	damage	autosomal recessive	51438	HP_0000007	92	98	115	134	False
24390428	Treatment of tumor cells with the inhibitor GSK2830371 increases phosphorylation of Wip1 substrates and causes growth inhibition in both hematopoietic tumor cell lines and Wip1-amplified breast tumor cells harboring wild-type TP53.	Wip1	tumor	8493	HP_0002664	84	88	13	18	True
29523295	SNORD115 abnormalities with varying downstream multigene involvement would account for catatonia across the life span within some subtypes of autism spectrum disorders, schizophrenia, bipolar and major depressive disorder, psychosis, genetic disorders, and in immune disorders such as anti-N-methyl-d-aspartate receptor (NMDAR) antibody encephalitis as well as the susceptibility to the neuroleptic malignant syndrome (NMS) if environmentally triggered.	NMS	autism	129521	HP_0000717	419	422	142	148	False
29523295	SNORD115 abnormalities with varying downstream multigene involvement would account for catatonia across the life span within some subtypes of autism spectrum disorders, schizophrenia, bipolar and major depressive disorder, psychosis, genetic disorders, and in immune disorders such as anti-N-methyl-d-aspartate receptor (NMDAR) antibody encephalitis as well as the susceptibility to the neuroleptic malignant syndrome (NMS) if environmentally triggered.	NMS	schizophrenia	129521	HP_0100753	419	422	169	182	False
29523295	SNORD115 abnormalities with varying downstream multigene involvement would account for catatonia across the life span within some subtypes of autism spectrum disorders, schizophrenia, bipolar and major depressive disorder, psychosis, genetic disorders, and in immune disorders such as anti-N-methyl-d-aspartate receptor (NMDAR) antibody encephalitis as well as the susceptibility to the neuroleptic malignant syndrome (NMS) if environmentally triggered.	NMS	psychosis	129521	HP_0000709	419	422	223	232	False
29523295	SNORD115 abnormalities with varying downstream multigene involvement would account for catatonia across the life span within some subtypes of autism spectrum disorders, schizophrenia, bipolar and major depressive disorder, psychosis, genetic disorders, and in immune disorders such as anti-N-methyl-d-aspartate receptor (NMDAR) antibody encephalitis as well as the susceptibility to the neuroleptic malignant syndrome (NMS) if environmentally triggered.	NMS	encephalitis	129521	HP_0002383	419	422	337	349	False
29523295	Dysfunction of SNORD115-PBRM1 connecting with SMARCA2 as well as other proven schizophrenia-associated genes might explain why traditionally catatonia has been classified with schizophrenia.	PBRM1	schizophrenia	55193	HP_0100753	24	29	78	91	False
29523295	Dysfunction of SNORD115-PBRM1 connecting with SMARCA2 as well as other proven schizophrenia-associated genes might explain why traditionally catatonia has been classified with schizophrenia.	SMARCA2	schizophrenia	6595	HP_0100753	46	53	78	91	False
29523295	SNORD115-TAF1 and SNORD-DPM2 dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-RALGPS1 suggest links to both anti-NMDAR encephalitis and the proven predisposing catatonic SHANK3 gene.	TAF1	encephalitis	6872	HP_0002383	9	13	206	218	False
29523295	SNORD115-TAF1 and SNORD-DPM2 dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-RALGPS1 suggest links to both anti-NMDAR encephalitis and the proven predisposing catatonic SHANK3 gene.	DPM2	encephalitis	8818	HP_0002383	24	28	206	218	False
29523295	SNORD115-TAF1 and SNORD-DPM2 dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-RALGPS1 suggest links to both anti-NMDAR encephalitis and the proven predisposing catatonic SHANK3 gene.	RALGPS1	encephalitis	9649	HP_0002383	165	172	206	218	False
29523295	SNORD115-TAF1 and SNORD-DPM2 dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-RALGPS1 suggest links to both anti-NMDAR encephalitis and the proven predisposing catatonic SHANK3 gene.	NMS	encephalitis	129521	HP_0002383	128	131	206	218	False
29523295	SNORD115-TAF1 and SNORD-DPM2 dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in NMS, while abnormalities of SNORD115-RALGPS1 suggest links to both anti-NMDAR encephalitis and the proven predisposing catatonic SHANK3 gene.	SHANK3	encephalitis	85358	HP_0002383	257	263	206	218	False
28439028	Hereditary sensory and autonomic neuropathy type III, or familial dysautonomia [FD; Online Mendelian Inheritance in Man (OMIM) 223900], affects the development and long-term viability of neurons in the peripheral nervous system (PNS) and retina.	type	neuropathy	6445	HP_0009830	44	48	33	43	False
23911318	These data suggest AMPD2-related PCH as a potentially treatable early-onset neurodegenerative disease.	AMPD2	neurodegenerative disease	271	HP_0002180	19	24	76	101	False
28262687	IGSF1 (Immunoglobulin Superfamily 1) gene defects cause central hypothyroidism and macroorchidism.	IGSF1	hypothyroidism	3547	HP_0000821	0	5	64	78	True
28262687	IGSF1 (Immunoglobulin Superfamily 1) gene defects cause central hypothyroidism and macroorchidism.	IGSF1	macroorchidism	3547	HP_0000053	0	5	83	97	False
28262687	IGSF1 (Immunoglobulin Superfamily 1) gene defects cause central hypothyroidism and macroorchidism.	IGSF1	central	3547	HP_0030645	0	5	56	63	False
28262687	Based on a patient with a full deletion of IGSF1 clinically followed from neonate to adulthood, we investigated a common pituitary origin for hypothyroidism and macroorchidism, and the role of IGSF1 as regulator of pituitary hormone secretion.	IGSF1	hypothyroidism	3547	HP_0000821	43	48	142	156	True
28262687	Based on a patient with a full deletion of IGSF1 clinically followed from neonate to adulthood, we investigated a common pituitary origin for hypothyroidism and macroorchidism, and the role of IGSF1 as regulator of pituitary hormone secretion.	IGSF1	macroorchidism	3547	HP_0000053	43	48	161	175	False
28262687	In conclusion, two relevant molecular mechanisms linked to central hypothyroidism and macroorchidism in IGSF1 deficiency are identified, revealing IGSF1 as an important regulator of TGF/Activin pathways in the pituitary	IGSF1	hypothyroidism	3547	HP_0000821	104	109	67	81	True
28262687	In conclusion, two relevant molecular mechanisms linked to central hypothyroidism and macroorchidism in IGSF1 deficiency are identified, revealing IGSF1 as an important regulator of TGF/Activin pathways in the pituitary	IGSF1	macroorchidism	3547	HP_0000053	104	109	86	100	False
28262687	In conclusion, two relevant molecular mechanisms linked to central hypothyroidism and macroorchidism in IGSF1 deficiency are identified, revealing IGSF1 as an important regulator of TGF/Activin pathways in the pituitary	IGSF1	central	3547	HP_0030645	104	109	59	66	False
28475458	In this study, we present a male child demonstrating recurrent febrile episodes, spasticity, and basal ganglia calcification suggestive of Aicardi-Goutires syndrome, who carries the same Arg822Gln mutation in IFIH1 previously associated with SMS.	IFIH1	basal ganglia calcification	64135	HP_0002135	210	215	97	124	True
28475458	In this study, we present a male child demonstrating recurrent febrile episodes, spasticity, and basal ganglia calcification suggestive of Aicardi-Goutires syndrome, who carries the same Arg822Gln mutation in IFIH1 previously associated with SMS.	SMS	basal ganglia calcification	10743	HP_0002135	243	246	97	124	False
28475458	In this study, we present a male child demonstrating recurrent febrile episodes, spasticity, and basal ganglia calcification suggestive of Aicardi-Goutires syndrome, who carries the same Arg822Gln mutation in IFIH1 previously associated with SMS.	IFIH1	spasticity	64135	HP_0001257	210	215	81	91	True
28475458	In this study, we present a male child demonstrating recurrent febrile episodes, spasticity, and basal ganglia calcification suggestive of Aicardi-Goutires syndrome, who carries the same Arg822Gln mutation in IFIH1 previously associated with SMS.	SMS	spasticity	10743	HP_0001257	243	246	81	91	False
28954601	Human placenta-derived mesenchymal stem cell (hPMSC) transplantation has a potential to restore ovarian dysfunction associated with premature ovarian failure (POF), while the exact function of the Treg cells in the transplantation still needs to be further investigated.	POF	premature ovarian failure	1730	HP_0008209	159	162	132	157	True
28492237	We discover that proline catabolism via proline dehydrogenase (Prodh) supports growth of breast cancer cells in 3D culture.	Prodh	cancer	5625	HP_0002664	63	68	96	102	False
28492237	In particular, we find that PRODH expression and proline catabolism is increased in metastases compared to primary breast cancers of patients and mice.	find	cancer	81501	HP_0002664	18	22	122	128	False
28492237	In particular, we find that PRODH expression and proline catabolism is increased in metastases compared to primary breast cancers of patients and mice.	PRODH	cancer	5625	HP_0002664	28	33	122	128	False
26979803	To test whether these risk SNPs regulate their target genes through long-range chromatin interactions, we applied capture-based 3C sequencing technology to investigate possible cis-interactions at ten prostate cancer risk loci in six cell lines.	cis	cancer	1154	HP_0002664	177	180	210	216	False
26979803	This study identifies a set of candidate genes and their potential regulatory variants, and provides additional evidence showing the role of long-range chromatin interactions in prostate cancer etiology	set	cancer	6418	HP_0002664	24	27	187	193	False
28218467	PhIP-induced skin tumors were subjected to mutation screening, which identified genetic changes in Hras (7/40, 17.5%) and Tp53 (2/40, 5%), but not in Ctnnb1, a commonly mutated gene in PhIP-induced colon tumors.	PhIP	tumors	55023	HP_0002664	0	4	18	24	False
28218467	PhIP-induced skin tumors were subjected to mutation screening, which identified genetic changes in Hras (7/40, 17.5%) and Tp53 (2/40, 5%), but not in Ctnnb1, a commonly mutated gene in PhIP-induced colon tumors.	Hras	tumors	3265	HP_0002664	99	103	18	24	True
28218467	PhIP-induced skin tumors were subjected to mutation screening, which identified genetic changes in Hras (7/40, 17.5%) and Tp53 (2/40, 5%), but not in Ctnnb1, a commonly mutated gene in PhIP-induced colon tumors.	Ctnnb1	tumors	1499	HP_0002664	150	156	18	24	True
28218467	Despite the absence of Ctnnb1 mutations, -catenin was overexpressed in nuclear and plasma membrane fractions from PhIP-induced skin tumors, coinciding with loss of p120-catenin from the plasma membrane, and the appearance of multiple p120-catenin-associated bands in the nuclear extracts.	PhIP	tumors	55023	HP_0002664	115	119	133	139	False
28218467	Despite the absence of Ctnnb1 mutations, -catenin was overexpressed in nuclear and plasma membrane fractions from PhIP-induced skin tumors, coinciding with loss of p120-catenin from the plasma membrane, and the appearance of multiple p120-catenin-associated bands in the nuclear extracts.	Ctnnb1	tumors	1499	HP_0002664	23	29	133	139	True
28218467	Real-time RT-PCR revealed that p120-catenin isoforms 1 and 4 were upregulated in PhIP-induced skin tumors, whereas p120-catenin isoform 3 was expressed uniformly, compared with adjacent normal-looking tissue.	PhIP	tumors	55023	HP_0002664	81	85	99	105	False
28218467	Co-immunoprecipitation experiments identified associations of -catenin with p120-catenin isoforms in PhIP-induced skin tumors and human cancer cell lines.	PhIP	tumors	55023	HP_0002664	102	106	120	126	False
28218467	Co-immunoprecipitation experiments identified associations of -catenin with p120-catenin isoforms in PhIP-induced skin tumors and human cancer cell lines.	PhIP	cancer	55023	HP_0002664	102	106	137	143	False
28696035	The clinical presentation of both patients was initially thought to be suggestive of Lin-Gettig syndrome (LGS), a multiple malformation syndrome associated with craniosynostosis that was initially reported in two brothers in 1990, with a third patient reported in 2003.	LGS	craniosynostosis	2131	HP_0001363	106	109	161	177	False
28696035	We show that craniosynostosis, which has not been previously reported in association with KAT6B mutations, may be part of the genitopatellar/Say Barber Biesecker Young Simpson spectrum.	KAT6B	craniosynostosis	23522	HP_0001363	90	95	13	29	False
26109344	To identify potential biological differences by race among Luminal A breast cancers, gene expression data from 108 CAU and 57 AA breast tumors were analyzed.	race	cancer	23600	HP_0002664	48	52	76	82	False
26109344	To identify potential biological differences by race among Luminal A breast cancers, gene expression data from 108 CAU and 57 AA breast tumors were analyzed.	race	tumors	23600	HP_0002664	48	52	136	142	False
26109344	Six genes (ACOX2, MUC1, CRYBB2, PSPH, SQLE, TYMS) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR &lt;0.8, HR &gt;1.25).	race	cancer	23600	HP_0002664	83	87	111	117	False
26109344	Six genes (ACOX2, MUC1, CRYBB2, PSPH, SQLE, TYMS) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR &lt;0.8, HR &gt;1.25).	ACOX2	cancer	8309	HP_0002664	11	16	111	117	False
26109344	Six genes (ACOX2, MUC1, CRYBB2, PSPH, SQLE, TYMS) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR &lt;0.8, HR &gt;1.25).	MUC1	cancer	4582	HP_0002664	18	22	111	117	False
26109344	Six genes (ACOX2, MUC1, CRYBB2, PSPH, SQLE, TYMS) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR &lt;0.8, HR &gt;1.25).	CRYBB2	cancer	1415	HP_0002664	24	30	111	117	False
26109344	Six genes (ACOX2, MUC1, CRYBB2, PSPH, SQLE, TYMS) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR &lt;0.8, HR &gt;1.25).	PSPH	cancer	5723	HP_0002664	32	36	111	117	False
26109344	Six genes (ACOX2, MUC1, CRYBB2, PSPH, SQLE, TYMS) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR &lt;0.8, HR &gt;1.25).	SQLE	cancer	6713	HP_0002664	38	42	111	117	False
26109344	Six genes (ACOX2, MUC1, CRYBB2, PSPH, SQLE, TYMS) were differentially expressed by race among Luminal A breast cancers and were associated with survival (HR &lt;0.8, HR &gt;1.25).	TYMS	cancer	7298	HP_0002664	44	48	111	117	False
26109344	For all six genes, tumors in AA had higher expression of poor prognosis genes (CRYBB2, PSPH, SQLE, TYMS) and lower expression of good prognosis genes (ACOX2, MUC1).	ACOX2	tumors	8309	HP_0002664	151	156	19	25	False
26109344	For all six genes, tumors in AA had higher expression of poor prognosis genes (CRYBB2, PSPH, SQLE, TYMS) and lower expression of good prognosis genes (ACOX2, MUC1).	MUC1	tumors	4582	HP_0002664	158	162	19	25	False
26109344	For all six genes, tumors in AA had higher expression of poor prognosis genes (CRYBB2, PSPH, SQLE, TYMS) and lower expression of good prognosis genes (ACOX2, MUC1).	CRYBB2	tumors	1415	HP_0002664	79	85	19	25	False
26109344	For all six genes, tumors in AA had higher expression of poor prognosis genes (CRYBB2, PSPH, SQLE, TYMS) and lower expression of good prognosis genes (ACOX2, MUC1).	PSPH	tumors	5723	HP_0002664	87	91	19	25	False
26109344	For all six genes, tumors in AA had higher expression of poor prognosis genes (CRYBB2, PSPH, SQLE, TYMS) and lower expression of good prognosis genes (ACOX2, MUC1).	SQLE	tumors	6713	HP_0002664	93	97	19	25	False
26109344	For all six genes, tumors in AA had higher expression of poor prognosis genes (CRYBB2, PSPH, SQLE, TYMS) and lower expression of good prognosis genes (ACOX2, MUC1).	TYMS	tumors	7298	HP_0002664	99	103	19	25	False
26109344	Some of these differences (CRYBB2 and PSPH) may exist from the earliest stages of tumor development, or may even precede malignancy	CRYBB2	tumor	1415	HP_0002664	27	33	82	87	False
26109344	Some of these differences (CRYBB2 and PSPH) may exist from the earliest stages of tumor development, or may even precede malignancy	PSPH	tumor	5723	HP_0002664	38	42	82	87	False
28098859	Williams-Beuren syndrome (WBS, no.OMIM 194050) is a rare multisystem genetic disorder caused by a microdeletion on chromosome7q11.23 and characterized by cardiovascular malformations, mental retardation, and a specific facial dysmorphism.	WBS	cardiovascular malformations	2006	HP_0030680	26	29	156	184	True
28098859	Williams-Beuren syndrome (WBS, no.OMIM 194050) is a rare multisystem genetic disorder caused by a microdeletion on chromosome7q11.23 and characterized by cardiovascular malformations, mental retardation, and a specific facial dysmorphism.	WBS	facial dysmorphism	2006	HP_0001999	26	29	221	239	True
28098859	Recently, we reported that a series of nonHodgkin's lymphoma occurs in children with WBS and thus hypothesized that a predisposition to cancer may be associated with this genetic disorder.	WBS	cancer	2006	HP_0002664	86	89	137	143	False
27809291	Metastatic bone disease has a major impact on morbidity of breast cancer (BC) patients.	impact	cancer	55364	HP_0002664	36	42	66	72	False
27809291	Alterations in mTOR signaling are involved both in cancer progression and in osteoclast differentiation.	mTOR	cancer	2475	HP_0002664	15	19	51	57	False
29054762	miRNAs are a kind of endogenous non-coding small RNAs, which involved in occurrence and development of multi cancer, including miR-34a.	miR	cancer	220972	HP_0002664	0	3	109	115	False
29054762	However, the relationship between miR-34a and luteolin's susceptibility to cancer cells still remains unclear.	miR	cancer	220972	HP_0002664	34	37	75	81	False
29054762	Retrospectively study revealed that miR-34a expression was downregulated in human primary GC tissues compared with non-tumor tissues and low miR-34a expression was associated with a significantly shorter overall survival and disease-free survival.	miR	tumor	220972	HP_0002664	36	39	119	124	False
29054762	On the other hand, miR-34a inhibitor could partly counter the anticancer effect of luteolin.	miR	cancer	220972	HP_0002664	19	22	66	72	False
29054762	Therefore, our findings firstly suggested that miR-34a could modulate the susceptibility of gastric cancer cell to luteolin via targeting HK1, potentially benefiting GC patients' treatment in the future	miR	cancer	220972	HP_0002664	47	50	100	106	False
29958137	Salivary gland tumor (SGT) is a rare tumor type, which exhibits broad-spectrum phenotypic, biological, and clinical heterogeneity.	SGT	tumor	6449	HP_0002664	22	25	15	20	False
29958137	Salivary gland tumor (SGT) is a rare tumor type, which exhibits broad-spectrum phenotypic, biological, and clinical heterogeneity.	type	tumor	6445	HP_0002664	43	47	15	20	False
29958137	Salivary gland tumor (SGT) is a rare tumor type, which exhibits broad-spectrum phenotypic, biological, and clinical heterogeneity.	SGT	heterogeneity	6449	HP_0001425	22	25	116	129	False
29958137	Salivary gland tumor (SGT) is a rare tumor type, which exhibits broad-spectrum phenotypic, biological, and clinical heterogeneity.	type	heterogeneity	6445	HP_0001425	43	47	116	129	False
29958137	We have deleted two major tumor suppressors, Pten, a negative regulator of the PI3K pathway, and Smad4, the central signaling mediator of TGF pathway, in the murine salivary gland.	Pten	tumor	5728	HP_0002664	45	49	26	31	True
29958137	We have deleted two major tumor suppressors, Pten, a negative regulator of the PI3K pathway, and Smad4, the central signaling mediator of TGF pathway, in the murine salivary gland.	Smad4	tumor	4089	HP_0002664	97	102	26	31	True
29958137	Our results have shown that deletion of either Pten or Smad4 in murine salivary gland resulted in pleomorphic adenomas, the most common tumor in human SGT patients.	SGT	tumor	6449	HP_0002664	151	154	136	141	False
29958137	Our results have shown that deletion of either Pten or Smad4 in murine salivary gland resulted in pleomorphic adenomas, the most common tumor in human SGT patients.	Pten	tumor	5728	HP_0002664	47	51	136	141	True
29958137	Our results have shown that deletion of either Pten or Smad4 in murine salivary gland resulted in pleomorphic adenomas, the most common tumor in human SGT patients.	Smad4	tumor	4089	HP_0002664	55	60	136	141	True
28847716	Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c mice, and mRNA levels of Mxra7 as well as several matrix-remodeling related genes (Mmp3, Mmp13, Ecm1, Timp1) were monitored with RT-PCR.	Mxra7	corneal neovascularization	439921	HP_0011496	141	146	22	48	False
28847716	Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c mice, and mRNA levels of Mxra7 as well as several matrix-remodeling related genes (Mmp3, Mmp13, Ecm1, Timp1) were monitored with RT-PCR.	mice	corneal neovascularization	23581	HP_0011496	116	120	22	48	False
28847716	Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c mice, and mRNA levels of Mxra7 as well as several matrix-remodeling related genes (Mmp3, Mmp13, Ecm1, Timp1) were monitored with RT-PCR.	Mmp3	corneal neovascularization	4314	HP_0011496	199	203	22	48	False
28847716	Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c mice, and mRNA levels of Mxra7 as well as several matrix-remodeling related genes (Mmp3, Mmp13, Ecm1, Timp1) were monitored with RT-PCR.	Mmp13	corneal neovascularization	4322	HP_0011496	205	210	22	48	False
28847716	Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c mice, and mRNA levels of Mxra7 as well as several matrix-remodeling related genes (Mmp3, Mmp13, Ecm1, Timp1) were monitored with RT-PCR.	Ecm1	corneal neovascularization	1893	HP_0011496	212	216	22	48	False
28847716	Then the inflammatory corneal neovascularization (CorNV) model and fungal corneal infections were induced in Balb/c mice, and mRNA levels of Mxra7 as well as several matrix-remodeling related genes (Mmp3, Mmp13, Ecm1, Timp1) were monitored with RT-PCR.	Timp1	corneal neovascularization	7076	HP_0011496	218	223	22	48	False
25861810	Pathway analyses demonstrated that methylation levels associated with age and BMI are overrepresented among genes involved in cancer, type 2 diabetes and cardiovascular disease.	type	cancer	6445	HP_0002664	134	138	126	132	False
25861810	Pathway analyses demonstrated that methylation levels associated with age and BMI are overrepresented among genes involved in cancer, type 2 diabetes and cardiovascular disease.	type	cardiovascular disease	6445	HP_0001626	134	138	154	176	True
25861810	Our results highlight the impact of age, BMI and HbA1c on epigenetic variation of candidate genes for obesity, type 2 diabetes and cancer in human adipose tissue.	impact	cancer	55364	HP_0002664	26	32	131	137	False
25861810	Our results highlight the impact of age, BMI and HbA1c on epigenetic variation of candidate genes for obesity, type 2 diabetes and cancer in human adipose tissue.	type	cancer	6445	HP_0002664	111	115	131	137	False
25861810	Our results highlight the impact of age, BMI and HbA1c on epigenetic variation of candidate genes for obesity, type 2 diabetes and cancer in human adipose tissue.	impact	obesity	55364	HP_0001513	26	32	102	109	False
25861810	Our results highlight the impact of age, BMI and HbA1c on epigenetic variation of candidate genes for obesity, type 2 diabetes and cancer in human adipose tissue.	type	obesity	6445	HP_0001513	111	115	102	109	False
28369529	Structural, biophysical, and mutagenesis analyses revealed that cancer-associated mutations disrupt the SRP68-SRP72 interaction and their co-localization with ER in mammalian cells.	SRP	cancer	10911	HP_0002664	104	107	64	70	False
29112861	Although disruption of the CDKN2A (INK4A/ARF) locus has been reported in end-stage disease, information is lacking on the status of this key tumor suppressor gene in pleural lesions preceding mesothelioma.	CDKN2A	tumor	1029	HP_0002664	27	33	141	146	True
29112861	We show that hypermethylation of p16/Ink4a and p19/Arf in CNT- and asbestos-induced inflammatory lesions precedes mesothelioma; this results in silencing of Cdkn2a (Ink4a/Arf) and loss of p16 and p19 protein, consistent with epigenetic alterations playing a gatekeeper role in cancer.	Cdkn2a	cancer	1029	HP_0002664	157	163	277	283	True
30256787	The mechanistic target of rapamycin (mTOR) is an established therapeutic target in renal cell carcinoma (RCC).	mTOR	renal cell carcinoma	2475	HP_0005584	37	41	83	103	False
30256787	The mechanistic target of rapamycin (mTOR) is an established therapeutic target in renal cell carcinoma (RCC).	RCC	renal cell carcinoma	7515	HP_0005584	105	108	83	103	False
30256787	We identified six patients with metastatic RCC who initially responded to mTOR inhibitor therapy and then progressed, and had pre-treatment and post-treatment tumor samples available for analysis.	mTOR	tumor	2475	HP_0002664	74	78	159	164	False
30256787	We identified six patients with metastatic RCC who initially responded to mTOR inhibitor therapy and then progressed, and had pre-treatment and post-treatment tumor samples available for analysis.	RCC	tumor	7515	HP_0002664	43	46	159	164	False
28598419	We show that maternal COL24A1 variants have a significant genome-wide interaction with maternal pre-pregnancy overweight/obesity on PTB risk, with rs11161721 (P<sub>G  E</sub>=1.8  10<sup>-8</sup>; empirical P<sub>G  E</sub>=1.2  10<sup>-8</sup>) as the top hit.	PTB	obesity	5725	HP_0001513	132	135	121	128	False
28598419	We show that maternal COL24A1 variants have a significant genome-wide interaction with maternal pre-pregnancy overweight/obesity on PTB risk, with rs11161721 (P<sub>G  E</sub>=1.8  10<sup>-8</sup>; empirical P<sub>G  E</sub>=1.2  10<sup>-8</sup>) as the top hit.	COL24A1	obesity	255631	HP_0001513	22	29	121	128	False
28132977	This case of adult-diagnosed MTP deficiency was characterized by slowly progressive peripheral neuropathy masquerading CMT in addition to muscular symptoms.	MTP	neuropathy	4547	HP_0009830	29	32	95	105	False
28132977	This case of adult-diagnosed MTP deficiency was characterized by slowly progressive peripheral neuropathy masquerading CMT in addition to muscular symptoms.	MTP	peripheral	4547	HP_0030646	29	32	84	94	False
28132977	MTP deficiency should be considered in patients with the combination of peripheral neuropathy and recurrent rhabdomyolysis	MTP	neuropathy	4547	HP_0009830	0	3	83	93	False
28132977	MTP deficiency should be considered in patients with the combination of peripheral neuropathy and recurrent rhabdomyolysis	MTP	peripheral	4547	HP_0030646	0	3	72	82	False
27222538	We and others have recently demonstrated that c-SRC is a key mediator of growth, invasion, and metastasis, and therefore represents a promising therapeutic target in thyroid cancer.	c-SRC	cancer	6714	HP_0002664	46	51	174	180	True
27222538	We have generated four thyroid cancer cell lines with a greater than 30-fold increase in acquired resistance to the Src inhibitor dasatinib.	Src	cancer	6714	HP_0002664	116	119	31	37	True
29688779	RESULTS A nonsynonymous mutation at ovine Chr3:193,691,195, which generated a glycine-to-arginine amino acid change within the predicted Slco1b3 protein, was significantly associated with hyperbilirubinemia and predicted to be deleterious.	Slco1b3	hyperbilirubinemia	28234	HP_0002904	137	144	188	206	True
29109511	Global-genome nucleotide excision repair (GG-NER) prevents ultraviolet (UV) light-induced skin cancer by removing mutagenic cyclobutane pyrimidine dimers (CPDs).	NER	cancer	7376	HP_0002664	45	48	95	101	False
29109511	Global-genome nucleotide excision repair (GG-NER) prevents ultraviolet (UV) light-induced skin cancer by removing mutagenic cyclobutane pyrimidine dimers (CPDs).	CPD	cancer	9455	HP_0002664	155	158	95	101	False
28344074	In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, NUP205, NUP107 and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) mice and sporadic ALS patients.	ALS	sporadic	3483	HP_0003745	244	247	235	243	False
28344074	In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, NUP205, NUP107 and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) mice and sporadic ALS patients.	RanGAP1	sporadic	5905	HP_0003745	74	81	235	243	False
28344074	In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, NUP205, NUP107 and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) mice and sporadic ALS patients.	NUP205	sporadic	23165	HP_0003745	124	130	235	243	False
28344074	In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, NUP205, NUP107 and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) mice and sporadic ALS patients.	NUP107	sporadic	57122	HP_0003745	132	138	235	243	False
28344074	In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, NUP205, NUP107 and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) mice and sporadic ALS patients.	NUP50	sporadic	10762	HP_0003745	143	148	235	243	False
28344074	In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, NUP205, NUP107 and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) mice and sporadic ALS patients.	mice	sporadic	23581	HP_0003745	226	230	235	243	False
28344074	In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, NUP205, NUP107 and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) mice and sporadic ALS patients.	SOD1	sporadic	6647	HP_0003745	217	221	235	243	False
28344074	In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, NUP205, NUP107 and NUP50) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) mice and sporadic ALS patients.	Tg	sporadic	7038	HP_0003745	222	224	235	243	False
28344074	The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of ALS both in SOD1-Tg mice and human sporadic ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in C9-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention	ALS	sporadic	3483	HP_0003745	112	115	147	155	False
28344074	The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of ALS both in SOD1-Tg mice and human sporadic ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in C9-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention	mice	sporadic	23581	HP_0003745	132	136	147	155	False
28344074	The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of ALS both in SOD1-Tg mice and human sporadic ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in C9-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention	SOD1	sporadic	6647	HP_0003745	124	128	147	155	False
28344074	The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of ALS both in SOD1-Tg mice and human sporadic ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in C9-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention	Tg	sporadic	7038	HP_0003745	129	131	147	155	False
28344074	The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of ALS both in SOD1-Tg mice and human sporadic ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in C9-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention	C9	sporadic	735	HP_0003745	259	261	147	155	False
28607447	Recently, the roles of FAM83H in tumorigenesis have been interested and increased expression of FAM83H and MYC in hepatocellular carcinoma (HCC) have been reported.	FAM83H	hepatocellular carcinoma	286077	HP_0001402	23	29	114	138	False
28607447	Recently, the roles of FAM83H in tumorigenesis have been interested and increased expression of FAM83H and MYC in hepatocellular carcinoma (HCC) have been reported.	MYC	hepatocellular carcinoma	4609	HP_0001402	107	110	114	138	False
28607447	Recently, the roles of FAM83H in tumorigenesis have been interested and increased expression of FAM83H and MYC in hepatocellular carcinoma (HCC) have been reported.	HCC	hepatocellular carcinoma	84668	HP_0001402	140	143	114	138	False
28607447	Recently, the roles of FAM83H in tumorigenesis have been interested and increased expression of FAM83H and MYC in hepatocellular carcinoma (HCC) have been reported.	FAM83H	tumor	286077	HP_0002664	23	29	33	38	False
28607447	Recently, the roles of FAM83H in tumorigenesis have been interested and increased expression of FAM83H and MYC in hepatocellular carcinoma (HCC) have been reported.	MYC	tumor	4609	HP_0002664	107	110	33	38	True
28607447	Recently, the roles of FAM83H in tumorigenesis have been interested and increased expression of FAM83H and MYC in hepatocellular carcinoma (HCC) have been reported.	HCC	tumor	84668	HP_0002664	140	143	33	38	False
28607447	The expression of FAM83H is elevated in liver cancer cells, and nuclear expression of FAM83H predicted shorter survival of HCC patients.	FAM83H	cancer	286077	HP_0002664	18	24	46	52	False
28607447	The expression of FAM83H is elevated in liver cancer cells, and nuclear expression of FAM83H predicted shorter survival of HCC patients.	HCC	cancer	84668	HP_0002664	123	126	46	52	False
28607447	In hepatic tumor cells derived from Tet-O-MYC mice, the expression of mRNA and protein of FAM83H were dependent on MYC expression.	FAM83H	tumor	286077	HP_0002664	90	96	11	16	False
28607447	In hepatic tumor cells derived from Tet-O-MYC mice, the expression of mRNA and protein of FAM83H were dependent on MYC expression.	MYC	tumor	4609	HP_0002664	42	45	11	16	True
28607447	In hepatic tumor cells derived from Tet-O-MYC mice, the expression of mRNA and protein of FAM83H were dependent on MYC expression.	mice	tumor	23581	HP_0002664	46	50	11	16	False
28607447	In conclusion, we present an oncogenic role of FAM83H in liver cancer, which is closely associated with the oncogene MYC.	FAM83H	cancer	286077	HP_0002664	47	53	63	69	False
28607447	In conclusion, we present an oncogenic role of FAM83H in liver cancer, which is closely associated with the oncogene MYC.	MYC	cancer	4609	HP_0002664	117	120	63	69	True
23110775	Bartter syndrome Type IV is a rare subtype of the Bartter syndromes that leads to both severe renal salt wasting and sensorineural deafness.	Type	renal salt wasting	6445	HP_0000127	17	21	94	112	False
23110775	Bartter syndrome Type IV is a rare subtype of the Bartter syndromes that leads to both severe renal salt wasting and sensorineural deafness.	Type	deafness	6445	HP_0000365	17	21	131	139	False
23110775	This autosomal recessive disease is caused by mutations in the gene encoding barttin, BSND, an essential subunit of the ClC-K chloride channels expressed in renal and inner ear epithelia.	BSND	autosomal recessive	7809	HP_0000007	86	90	5	24	True
23110775	This autosomal recessive disease is caused by mutations in the gene encoding barttin, BSND, an essential subunit of the ClC-K chloride channels expressed in renal and inner ear epithelia.	ClC	autosomal recessive	23529	HP_0000007	120	123	5	24	True
23110775	In this study, we report the identification of the first insertion mutation, p.W102Vfs*7, in the BSND gene of a newborn girl with acute clinical symptoms including early-onset chronic renal failure.	BSND	chronic	7809	HP_0011010	97	101	176	183	False
23110775	In this study, we report the identification of the first insertion mutation, p.W102Vfs*7, in the BSND gene of a newborn girl with acute clinical symptoms including early-onset chronic renal failure.	BSND	renal failure	7809	HP_0000083	97	101	184	197	True
30303148	We report a case of 2-year old child who presented with small bone osteomyelitis involving bilateral feet and was later diagnosed to have autosomal recessive CGD due to mutation in NCF1 gene	CGD	autosomal recessive	1536	HP_0000007	158	161	138	157	False
30303148	We report a case of 2-year old child who presented with small bone osteomyelitis involving bilateral feet and was later diagnosed to have autosomal recessive CGD due to mutation in NCF1 gene	NCF1	autosomal recessive	653361	HP_0000007	181	185	138	157	True
28045043	It is highly heterogeneous, with more than 80 disease-causing genes 27 of which are known to cause autosomal dominant RP (adRP), having been identified.	adRP	heterogeneous	123	HP_0001425	122	126	13	26	False
28055971	Progression of prostate cancer (PC) to castration-recurrent growth (CRPC) remains dependent on sustained expression and transcriptional activity of the androgen receptor (AR).	AR	cancer	231	HP_0002664	171	173	24	30	False
28055971	By comparing the Src-induced AR-cistrome and/or transcriptome in LNCaP to those in CRPC and LuCaP35.1 tumors, we identified an 11-gene Src-regulated CRPC signature consisting of AR-dependent, AR binding site (ARBS)-associated genes whose expression is altered by DHT in LNCaP[Src527F] but not in LNCaP cells.	Src	tumors	6714	HP_0002664	17	20	102	108	True
28055971	By comparing the Src-induced AR-cistrome and/or transcriptome in LNCaP to those in CRPC and LuCaP35.1 tumors, we identified an 11-gene Src-regulated CRPC signature consisting of AR-dependent, AR binding site (ARBS)-associated genes whose expression is altered by DHT in LNCaP[Src527F] but not in LNCaP cells.	AR	tumors	231	HP_0002664	29	31	102	108	False
28798667	In order to provide an additional insight into its functional role we compared target gene expression levels between human neuroblastoma cells (SH-SY5Y) stably overexpressing <i>FOXP2</i> cDNA of either humans or the common chimpanzee, Rhesus monkey, and marmoset, respectively.	FOXP2	neuroblastoma	93986	HP_0003006	178	183	123	136	False
29153328	Here we find, launching from Drosophila models of amyotrophic lateral sclerosis and frontotemporal dementia, that TDP-43 impairs the induction of multiple key stress genes required to protect from disease by reducing the recruitment of the chromatin remodeler Chd1 to chromatin.	find	frontotemporal dementia	81501	HP_0002145	8	12	84	107	False
29153328	Here we find, launching from Drosophila models of amyotrophic lateral sclerosis and frontotemporal dementia, that TDP-43 impairs the induction of multiple key stress genes required to protect from disease by reducing the recruitment of the chromatin remodeler Chd1 to chromatin.	TDP-43	frontotemporal dementia	23435	HP_0002145	114	120	84	107	True
29153328	Here we find, launching from Drosophila models of amyotrophic lateral sclerosis and frontotemporal dementia, that TDP-43 impairs the induction of multiple key stress genes required to protect from disease by reducing the recruitment of the chromatin remodeler Chd1 to chromatin.	Chd1	frontotemporal dementia	1105	HP_0002145	260	264	84	107	False
29153328	Enhancing chromatin dynamics may be a treatment approach to amyotrophic lateral scleorosis (ALS)/frontotemporal dementia (FTD)	ALS	frontotemporal dementia	3483	HP_0002145	92	95	97	120	False
29915213	Our study provides further evidence for validating the role of PARS2 in the pathology of related infantile-onset encephalopathy, contributing to the phenotypic features of this condition, and providing clinical and molecular insight for the diagnosis of this disease entity	PARS2	encephalopathy	25973	HP_0001298	63	68	113	127	False
27894866	Aberrant expression of the sodium channel gene (SCN5A) has been proposed to disrupt cardiac action potential and cause human cardiac arrhythmias, but the mechanisms of SCN5A gene regulation and dysregulation still remain largely unexplored.	SCN5A	cardiac arrhythmias	6331	HP_0011675	48	53	125	144	True
30146575	We herein report the case of a 59-year-old man with anti-leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis who presented with slowly progressive cognitive impairment mimicking dementia for over 3 years and then developed seizures.	LGI1	glioma	9211	HP_0009733	92	96	70	76	False
30146575	We herein report the case of a 59-year-old man with anti-leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis who presented with slowly progressive cognitive impairment mimicking dementia for over 3 years and then developed seizures.	LGI1	encephalitis	9211	HP_0002383	92	96	107	119	False
30146575	We herein report the case of a 59-year-old man with anti-leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis who presented with slowly progressive cognitive impairment mimicking dementia for over 3 years and then developed seizures.	LGI1	seizures	9211	HP_0001250	92	96	234	242	True
30146575	Taken together, these findings indicate that anti-LGI1 encephalitis may present as slowly progressive cognitive impairment mimicking dementia and that fluctuating MRI striatal lesions may be a characteristic radiological finding of this disorder	LGI1	encephalitis	9211	HP_0002383	50	54	55	67	False
29358399	These changes were accompanied by cortical atrophy as well as increased expression of angiogenesis-related genes such as <i>Vegfa</i>, <i>Serpine1</i>, and <i>Plau</i> in CD31-positive endothelial cells.	CD31	cortical atrophy	5175	HP_0002120	171	175	34	50	False
25157627	Though KRT5 has been identified to be the causal gene of DDD, the heterogeneity of this disease was displayed: for example, POFUT1 and POGLUT1 were recently identified and confirmed to be additional pathogenic genes of DDD.	KRT5	heterogeneity	3852	HP_0001425	7	11	66	79	False
25157627	Though KRT5 has been identified to be the causal gene of DDD, the heterogeneity of this disease was displayed: for example, POFUT1 and POGLUT1 were recently identified and confirmed to be additional pathogenic genes of DDD.	POFUT1	heterogeneity	23509	HP_0001425	124	130	66	79	False
25157627	Though KRT5 has been identified to be the causal gene of DDD, the heterogeneity of this disease was displayed: for example, POFUT1 and POGLUT1 were recently identified and confirmed to be additional pathogenic genes of DDD.	POGLUT1	heterogeneity	56983	HP_0001425	135	142	66	79	False
25157627	No other novel mutation or this deletion was detected in POFUT1 in a second DDD family and a sporadic DDD case by Sanger Sequencing.	POFUT1	sporadic	23509	HP_0003745	57	63	93	101	False
29916977	Popliteal pterygium syndrome shares features with van der Woude syndrome but, in addition, is characterized by genital anomalies, syndactyly of fingers and toes, and toenail dysplasia.	van	pterygium	10318	HP_0001059	50	53	10	19	False
29916977	Popliteal pterygium syndrome shares features with van der Woude syndrome but, in addition, is characterized by genital anomalies, syndactyly of fingers and toes, and toenail dysplasia.	van	genital anomalies	10318	HP_0000078	50	53	111	128	False
29916977	Popliteal pterygium syndrome shares features with van der Woude syndrome but, in addition, is characterized by genital anomalies, syndactyly of fingers and toes, and toenail dysplasia.	van	toenail dysplasia	10318	HP_0100797	50	53	166	183	False
17490642	Mutations in both proteins cause lens cataract and careful consideration of the detail of these cataract phenotypes alerts us to several interesting features concerning the function of filensin (BFSP1) and CP49 (BFSP2) in the lens.	BFSP1	cataract	631	HP_0000518	195	200	38	46	True
17490642	Mutations in both proteins cause lens cataract and careful consideration of the detail of these cataract phenotypes alerts us to several interesting features concerning the function of filensin (BFSP1) and CP49 (BFSP2) in the lens.	BFSP2	cataract	8419	HP_0000518	212	217	38	46	True
17490642	Mutations in both proteins cause lens cataract and careful consideration of the detail of these cataract phenotypes alerts us to several interesting features concerning the function of filensin (BFSP1) and CP49 (BFSP2) in the lens.	filensin	cataract	631	HP_0000518	185	193	38	46	True
17490642	With the first filensin (BFSP1) mutation now having been reported to cause a recessive cataract phenotype, there is the suggestion that the mutation could predispose heterozygote carriers to the early onset of age-related nuclear cataract.	BFSP1	cataract	631	HP_0000518	25	30	87	95	True
17490642	With the first filensin (BFSP1) mutation now having been reported to cause a recessive cataract phenotype, there is the suggestion that the mutation could predispose heterozygote carriers to the early onset of age-related nuclear cataract.	filensin	cataract	631	HP_0000518	15	23	87	95	True
25303533	Rescue of KLHL9 expression induced proteasomal degradation of C/EBP proteins, abrogated the mesenchymal signature, and reduced tumor viability in vitro and in vivo.	KLHL9	tumor	55958	HP_0002664	10	15	127	132	False
29560513	Grossly, the neoplasm was lobulated, with a fleshy cut surface and a diameter ranging between 0.8 and 8cm (mean 3.4cm).	cut	neoplasm	1523	HP_0002664	51	54	13	21	False
29593177	This review focuses on the molecular basis of the pathogenesis of cardiac abnormality due to PRKAG2 mutation and will provide current overviews of the mechanism of glycogen regulation by AMPK.	PRKAG2	cardiac abnormality	51422	HP_0001627	93	99	66	85	True
29593177	This review focuses on the molecular basis of the pathogenesis of cardiac abnormality due to PRKAG2 mutation and will provide current overviews of the mechanism of glycogen regulation by AMPK.	AMPK	cardiac abnormality	5563	HP_0001627	187	191	66	85	False
29758292	Truncating mutations in the last and penultimate exons of the PPM1D gene were recently described as a cause for mild to severe intellectual disability in fourteen patients.	PPM1D	intellectual disability	8493	HP_0001249	62	67	127	150	True
29758292	Feeding difficulties, periods of fever and vomiting as well as a high pain threshold were described as additional characteristic features and the disorder was subsequently termed &quot;intellectual developmental disorder with gastrointestinal difficulties and high pain threshold (IDDGIP)&quot; in the OMIM database (MIM # 617450).	MIM	vomiting	9788	HP_0002013	303	306	43	51	False
29758292	While the patient showed features overlapping with the reported phenotype, such as a short stature and small hands and feet, he also presented with additional features like cleft lip and palate and an aberrant right subclavian artery.	lip	short stature	23049	HP_0004322	179	182	85	98	False
29960046	We present a 22-year old male with hypotonia, developmental delay, seizure disorder, and dysmorphic facial features who enrolled in our rare disease research center at 18 years of age, where exome sequencing revealed a novel, likely pathogenic variant in the OPHN1 gene.	OPHN1	developmental delay	4983	HP_0001263	259	264	46	65	True
29960046	We present a 22-year old male with hypotonia, developmental delay, seizure disorder, and dysmorphic facial features who enrolled in our rare disease research center at 18 years of age, where exome sequencing revealed a novel, likely pathogenic variant in the OPHN1 gene.	OPHN1	seizure	4983	HP_0001250	259	264	67	74	True
29960046	These comparisons found previously unreported commonalities between the newly identified patients, such as the presence of otitis media and the lack of genitourinary abnormalities (i.e. hypoplastic scrotum, microphallus, cryptorchidism), which had been noted to be classic features of patients with OPHN1 variants.	OPHN1	genitourinary abnormalities	4983	HP_0000119	299	304	152	179	True
29960046	These comparisons found previously unreported commonalities between the newly identified patients, such as the presence of otitis media and the lack of genitourinary abnormalities (i.e. hypoplastic scrotum, microphallus, cryptorchidism), which had been noted to be classic features of patients with OPHN1 variants.	OPHN1	hypoplastic scrotum	4983	HP_0000046	299	304	186	205	True
29960046	These comparisons found previously unreported commonalities between the newly identified patients, such as the presence of otitis media and the lack of genitourinary abnormalities (i.e. hypoplastic scrotum, microphallus, cryptorchidism), which had been noted to be classic features of patients with OPHN1 variants.	OPHN1	microphallus	4983	HP_0030260	299	304	207	219	True
30177679	In keeping with a tumor suppressive role of FBW7 in human gastric cancer, we find an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples.	Brg1	tumor	6597	HP_0002664	122	126	18	23	False
30177679	In keeping with a tumor suppressive role of FBW7 in human gastric cancer, we find an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples.	FBW7	tumor	55294	HP_0002664	44	48	18	23	False
30177679	In keeping with a tumor suppressive role of FBW7 in human gastric cancer, we find an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples.	find	tumor	81501	HP_0002664	77	81	18	23	False
30177679	In keeping with a tumor suppressive role of FBW7 in human gastric cancer, we find an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples.	Brg1	cancer	6597	HP_0002664	122	126	66	72	False
30177679	In keeping with a tumor suppressive role of FBW7 in human gastric cancer, we find an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples.	FBW7	cancer	55294	HP_0002664	44	48	66	72	False
30177679	In keeping with a tumor suppressive role of FBW7 in human gastric cancer, we find an inverse correlation between FBW7 and Brg1 expression in human gastric cancer clinical samples.	find	cancer	81501	HP_0002664	77	81	66	72	False
30177679	Mechanistically, we find that stabilization of Brg1 in gastric cancer cells suppresses E-cadherin expression, subsequently promoting gastric cancer metastasis.	Brg1	cancer	6597	HP_0002664	47	51	63	69	False
30177679	Mechanistically, we find that stabilization of Brg1 in gastric cancer cells suppresses E-cadherin expression, subsequently promoting gastric cancer metastasis.	find	cancer	81501	HP_0002664	20	24	63	69	False
30177679	Mechanistically, we find that stabilization of Brg1 in gastric cancer cells suppresses E-cadherin expression, subsequently promoting gastric cancer metastasis.	cadherin	cancer	1015	HP_0002664	89	97	63	69	False
30177679	Hence, this previously unknown FBW7/Brg1 signaling axis provides the molecular basis and the rationale to target Brg1 in FBW7-compromised human gastric cancers	Brg1	cancer	6597	HP_0002664	36	40	152	158	False
30177679	Hence, this previously unknown FBW7/Brg1 signaling axis provides the molecular basis and the rationale to target Brg1 in FBW7-compromised human gastric cancers	FBW7	cancer	55294	HP_0002664	31	35	152	158	False
29054765	Through a whole genome sequencing (WGS) analysis of the nine subjects (four lung cancer patients and five normal family members of FLC), we obtained a whole genome dataset of DNA alterations in FLC samples.	set	cancer	6418	HP_0002664	168	171	81	87	False
29054765	Subsequently, the top 12 highly mutated genes were selected for validation by polymerase chain reaction and DNA sequencing in an expanded sample set including FLC, sporadic lung cancer, and healthy population.	set	sporadic	6418	HP_0003745	145	148	164	172	False
29054765	Subsequently, the top 12 highly mutated genes were selected for validation by polymerase chain reaction and DNA sequencing in an expanded sample set including FLC, sporadic lung cancer, and healthy population.	set	cancer	6418	HP_0002664	145	148	178	184	False
29054765	Mutations of the five genes (ARHGEF5, ANKRD20A2, ZNF595, ZNF812, MYO18B) may be potential germline mutations of lung cancer.	ARHGEF5	cancer	7984	HP_0002664	29	36	117	123	False
29054765	Mutations of the five genes (ARHGEF5, ANKRD20A2, ZNF595, ZNF812, MYO18B) may be potential germline mutations of lung cancer.	ANKRD20A2	cancer	441430	HP_0002664	38	47	117	123	False
29054765	Mutations of the five genes (ARHGEF5, ANKRD20A2, ZNF595, ZNF812, MYO18B) may be potential germline mutations of lung cancer.	ZNF595	cancer	152687	HP_0002664	49	55	117	123	False
29054765	Mutations of the five genes (ARHGEF5, ANKRD20A2, ZNF595, ZNF812, MYO18B) may be potential germline mutations of lung cancer.	MYO18B	cancer	84700	HP_0002664	65	71	117	123	False
29054765	We also analyzed specific mutations within the 12 genes and found that some specific mutations within the MUC12, FOXD4L3 and FOXD4L5 genes showed higher frequencies in the samples of FLC and/or lung cancer tissue, compared with the healthy population.	MUC12	cancer	10071	HP_0002664	106	111	199	205	False
29054765	We also analyzed specific mutations within the 12 genes and found that some specific mutations within the MUC12, FOXD4L3 and FOXD4L5 genes showed higher frequencies in the samples of FLC and/or lung cancer tissue, compared with the healthy population.	FOXD4L3	cancer	286380	HP_0002664	113	120	199	205	False
29054765	We also analyzed specific mutations within the 12 genes and found that some specific mutations within the MUC12, FOXD4L3 and FOXD4L5 genes showed higher frequencies in the samples of FLC and/or lung cancer tissue, compared with the healthy population.	FOXD4L5	cancer	653427	HP_0002664	125	132	199	205	False
28419579	Alpha-1-antitrypsin deficiency (AATD) is an inherited disease characterized by emphysema and liver disease.	AAT	emphysema	5265	HP_0002097	32	35	79	88	True
26915936	Dominantly inherited digitotalar dysmorphism (DTD), which is characterised by flexion contractures of digits and 'rocker-bottom' feet due to a vertical talus, was first described in a South African family of European stock in 1972.	DTD	contractures	1728	HP_0001371	46	49	86	98	False
26915936	Dominantly inherited digitotalar dysmorphism (DTD), which is characterised by flexion contractures of digits and 'rocker-bottom' feet due to a vertical talus, was first described in a South African family of European stock in 1972.	DTD	vertical talus	1728	HP_0001838	46	49	143	157	False
26915936	Since the distal arthrogryposes (DAs) are genetically heterogeneous, an unbiased approach to mutation identification was undertaken through whole-exome next-generation sequencing of DNA from a single DTD-affected female.	DTD	heterogeneous	1728	HP_0001425	200	203	54	67	False
30641218	Recently, a few Rho GTPase activating proteins (RhoGAPs) have been identified as tumor suppressors in some human cancers.	Rho	tumor	6010	HP_0002664	16	19	81	86	False
30641218	Recently, a few Rho GTPase activating proteins (RhoGAPs) have been identified as tumor suppressors in some human cancers.	Rho	cancer	6010	HP_0002664	16	19	113	119	False
30641218	The present study aimed to explore ARHGAP17 expression in cervical cancer and the possible function in tumor progression.	ARHGAP17	tumor	55114	HP_0002664	35	43	103	108	False
30641218	The present study aimed to explore ARHGAP17 expression in cervical cancer and the possible function in tumor progression.	ARHGAP17	cancer	55114	HP_0002664	35	43	67	73	False
30641218	ARHGAP17 expression in cervical cancer cell lines was assessed by RT-PCR and Western blotting.	ARHGAP17	cancer	55114	HP_0002664	0	8	32	38	False
30641218	ARHGAP17 expression in cervical cancer tissues and normal tissues was assessed by immunohistochemistry.	ARHGAP17	cancer	55114	HP_0002664	0	8	32	38	False
30641218	Here, we showed lower expression of ARHGAP17 in cell lines and human cervical cancer samples.	ARHGAP17	cancer	55114	HP_0002664	36	44	78	84	False
30641218	Manipulation of ARHGAP17 affected cell proliferation in vitro and tumor growth in vivo.	ARHGAP17	tumor	55114	HP_0002664	16	24	66	71	False
30641218	Furthermore, the phosphorylation of AKT was enhanced in ARHGAP17 silencing cervical cancer cells.	ARHGAP17	cancer	55114	HP_0002664	56	64	84	90	False
30641218	Furthermore, the phosphorylation of AKT was enhanced in ARHGAP17 silencing cervical cancer cells.	AKT	cancer	207	HP_0002664	36	39	84	90	True
30641218	Stepwise investigations demonstrated that ARHGAP17 suppressed malignant phenotype of cervical cancer cells via inhibiting PI3K/AKT signaling pathway.	ARHGAP17	cancer	55114	HP_0002664	42	50	94	100	False
30641218	Stepwise investigations demonstrated that ARHGAP17 suppressed malignant phenotype of cervical cancer cells via inhibiting PI3K/AKT signaling pathway.	AKT	cancer	207	HP_0002664	127	130	94	100	True
30641218	These results reveal that ARHGAP17 functions as a tumor suppressor in cervical cancer that suppresses tumor growth, at least partly, through inhibition of PI3K/AKT signaling and up-regulation of P21 and P27 expression	ARHGAP17	tumor	55114	HP_0002664	26	34	50	55	False
30641218	These results reveal that ARHGAP17 functions as a tumor suppressor in cervical cancer that suppresses tumor growth, at least partly, through inhibition of PI3K/AKT signaling and up-regulation of P21 and P27 expression	AKT	tumor	207	HP_0002664	160	163	50	55	True
30641218	These results reveal that ARHGAP17 functions as a tumor suppressor in cervical cancer that suppresses tumor growth, at least partly, through inhibition of PI3K/AKT signaling and up-regulation of P21 and P27 expression	ARHGAP17	cancer	55114	HP_0002664	26	34	79	85	False
30641218	These results reveal that ARHGAP17 functions as a tumor suppressor in cervical cancer that suppresses tumor growth, at least partly, through inhibition of PI3K/AKT signaling and up-regulation of P21 and P27 expression	AKT	cancer	207	HP_0002664	160	163	79	85	True
23856421	We describe an infant with the phenotype of a congenital muscular dystrophy, with borderline microcephaly, hypotonia, camptodactyly, severe motor delay, and elevated creatine kinase.	type	microcephaly	6445	HP_0000252	36	40	93	105	False
23856421	We describe an infant with the phenotype of a congenital muscular dystrophy, with borderline microcephaly, hypotonia, camptodactyly, severe motor delay, and elevated creatine kinase.	type	camptodactyly	6445	HP_0012385	36	40	118	131	False
23856421	We describe an infant with the phenotype of a congenital muscular dystrophy, with borderline microcephaly, hypotonia, camptodactyly, severe motor delay, and elevated creatine kinase.	type	motor delay	6445	HP_0001270	36	40	140	151	False
23856421	We describe an infant with the phenotype of a congenital muscular dystrophy, with borderline microcephaly, hypotonia, camptodactyly, severe motor delay, and elevated creatine kinase.	type	muscular dystrophy	6445	HP_0003560	36	40	57	75	True
30217758	Interestingly, de novo loss-of-function and missense variants in KDM5B were identified in patients with intellectual disability (ID) and autism spectrum disorder (ASD) but also in unaffected individuals.	KDM5B	intellectual disability	10765	HP_0001249	65	70	104	127	False
30217758	Interestingly, de novo loss-of-function and missense variants in KDM5B were identified in patients with intellectual disability (ID) and autism spectrum disorder (ASD) but also in unaffected individuals.	KDM5B	autism	10765	HP_0000717	65	70	137	143	False
30217758	The c.808+1G&gt;A variant was identified in a boy with mild ID and autism traits and is associated with a significant reduced KDM5B mRNA expression without alteration of its H3K4me3 pattern.	KDM5B	autism	10765	HP_0000717	130	135	71	77	False
30217758	The c.808+1G&gt;A variant was identified in a boy with mild ID and autism traits and is associated with a significant reduced KDM5B mRNA expression without alteration of its H3K4me3 pattern.	traits	autism	55929	HP_0000717	78	84	71	77	False
30217758	Our data reinforces the recent observation that the KDM5B haploinsufficiency is not a mechanism involved in intellectual disability and that KDM5B disorder associated with LOF variants is a recessive disorder.	KDM5B	intellectual disability	10765	HP_0001249	52	57	108	131	False
26576547	Using whole-exome sequencing (WES), we identified four de novo variants in PPP2R5D in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features.	PPP2R5D	intellectual disability	5528	HP_0001249	75	82	130	153	True
26576547	Using whole-exome sequencing (WES), we identified four de novo variants in PPP2R5D in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features.	PPP2R5D	autism	5528	HP_0000717	75	82	212	218	False
26576547	Using whole-exome sequencing (WES), we identified four de novo variants in PPP2R5D in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features.	PPP2R5D	macrocephaly	5528	HP_0000256	75	82	238	250	True
26576547	Using whole-exome sequencing (WES), we identified four de novo variants in PPP2R5D in a total of seven unrelated individuals with intellectual disability (ID) and other shared clinical characteristics, including autism spectrum disorder, macrocephaly, hypotonia, seizures, and dysmorphic features.	PPP2R5D	seizures	5528	HP_0001250	75	82	263	271	True
28314892	Increased catabolite concentrations in serum are associated with several cardiovascular diseases (CVD), including heart disease, atherosclerosis, and endothelial dysfunction, as well as their risk factors, including hypertension, diabetes, obesity, and aging.	act	hypertension	11332	HP_0000822	198	201	216	228	False
28314892	Increased catabolite concentrations in serum are associated with several cardiovascular diseases (CVD), including heart disease, atherosclerosis, and endothelial dysfunction, as well as their risk factors, including hypertension, diabetes, obesity, and aging.	act	obesity	11332	HP_0001513	198	201	240	247	False
27553190	Recent studies have revealed severe cases of microcephaly resulting from human mutations in the NDE1 gene, which is involved in the regulation of cytoplasmic dynein.	NDE1	microcephaly	54820	HP_0000252	96	100	45	57	True
27553190	These results reveal that the severity of NDE1-associated microcephaly results not from defects in mitosis, but rather the inability of neural progenitors to ever reach this stage	NDE1	microcephaly	54820	HP_0000252	42	46	58	70	True
28218269	Fragile X syndrome (FXS), caused by the loss of functional FMRP, is a leading cause of autism.	FMRP	autism	2332	HP_0000717	59	63	87	93	True
28218269	Genetic reduction of Adcy1 also ameliorates autism-related symptoms including repetitive behaviour, defective social interaction and audiogenic seizures.	Adcy1	autism	107	HP_0000717	21	26	44	50	False
28218269	Genetic reduction of Adcy1 also ameliorates autism-related symptoms including repetitive behaviour, defective social interaction and audiogenic seizures.	Adcy1	seizures	107	HP_0001250	21	26	144	152	False
30707697	We recently reported a novel human phenotype resulting from a mutation in the critical coding region of the HBS1L gene characterized by facial dysmorphism, severe growth restriction, axial hypotonia, global developmental delay and retinal pigmentary deposits.	HBS1L	facial dysmorphism	10767	HP_0001999	108	113	136	154	False
30707697	We recently reported a novel human phenotype resulting from a mutation in the critical coding region of the HBS1L gene characterized by facial dysmorphism, severe growth restriction, axial hypotonia, global developmental delay and retinal pigmentary deposits.	HBS1L	axial	10767	HP_0025287	108	113	183	188	False
30707697	We recently reported a novel human phenotype resulting from a mutation in the critical coding region of the HBS1L gene characterized by facial dysmorphism, severe growth restriction, axial hypotonia, global developmental delay and retinal pigmentary deposits.	HBS1L	developmental delay	10767	HP_0001263	108	113	207	226	False
30707697	We also describe a mouse model harboring a knockdown mutation in the murine Hbs1l gene that shared several of the phenotypic elements observed in the Hbs1L-deficient human including facial dysmorphism, growth restriction and retinal deposits.	Hbs1L	facial dysmorphism	10767	HP_0001999	150	155	182	200	False
30707697	We also describe a mouse model harboring a knockdown mutation in the murine Hbs1l gene that shared several of the phenotypic elements observed in the Hbs1L-deficient human including facial dysmorphism, growth restriction and retinal deposits.	Hbs1l	facial dysmorphism	10767	HP_0001999	76	81	182	200	False
28536440	However, the relationship between MEGF10 and autism remains poorly understood.	MEGF10	autism	84466	HP_0000717	34	40	45	51	False
28536440	To investigate the role of MEGF10 variants with putative transcription regulatory function in the etiology of autism, we performed a family-based association study in 410 Chinese Han trios.	MEGF10	autism	84466	HP_0000717	27	33	110	116	False
29950560	Adult-type granulosa cell tumors of the ovary (aGCTs) are rare gynecologic malignancies that exhibit a high frequency of somatic FOXL2 c.C402G (p.Cys134Trp) mutation.	FOXL2	tumors	668	HP_0002664	129	134	26	32	False
29950560	Here we show, using whole-exome and cancer gene panel sequencing of 79 aGCTs from two independent cohorts, that truncating mutation of the histone lysine methyltransferase gene KMT2D (also known as MLL2) is a recurrent somatic event in aGCT.	KMT2D	cancer	8085	HP_0002664	177	182	36	42	False
29950560	Here we show, using whole-exome and cancer gene panel sequencing of 79 aGCTs from two independent cohorts, that truncating mutation of the histone lysine methyltransferase gene KMT2D (also known as MLL2) is a recurrent somatic event in aGCT.	MLL2	cancer	9757	HP_0002664	198	202	36	42	False
29950560	IHC detects additional non-KMT2D-mutated aGCTs with loss of nuclear KMT2D expression, suggesting that non-genetic KMT2D inactivation may occur in this tumor type.	KMT2D	tumor	8085	HP_0002664	27	32	151	156	False
29311258	cDNA-encoded FLAG-tagged human wildtype ATP6V0A2 (<i>a</i>2) and ATP6V0A4 (<i>a</i>4) subunits and their mutants, <i>a</i>2<sup>P405L</sup> (causing cutis laxa), and <i>a</i>4<sup>R449H</sup> and <i>a</i>4<sup>G820R</sup> (causing renal tubular acidosis, dRTA), were transiently expressed in HEK 293 cells.	ATP6V0A2	renal tubular acidosis	23545	HP_0001947	40	48	231	253	False
29311258	cDNA-encoded FLAG-tagged human wildtype ATP6V0A2 (<i>a</i>2) and ATP6V0A4 (<i>a</i>4) subunits and their mutants, <i>a</i>2<sup>P405L</sup> (causing cutis laxa), and <i>a</i>4<sup>R449H</sup> and <i>a</i>4<sup>G820R</sup> (causing renal tubular acidosis, dRTA), were transiently expressed in HEK 293 cells.	ATP6V0A4	renal tubular acidosis	50617	HP_0001947	65	73	231	253	True
29311258	cDNA-encoded FLAG-tagged human wildtype ATP6V0A2 (<i>a</i>2) and ATP6V0A4 (<i>a</i>4) subunits and their mutants, <i>a</i>2<sup>P405L</sup> (causing cutis laxa), and <i>a</i>4<sup>R449H</sup> and <i>a</i>4<sup>G820R</sup> (causing renal tubular acidosis, dRTA), were transiently expressed in HEK 293 cells.	HEK	renal tubular acidosis	2042	HP_0001947	292	295	231	253	False
26336158	We describe a female proband with primordial dwarfism, skeletal dysplasia, facial dysmorphism, extreme dyslipidaemic insulin resistance and fatty liver associated with a novel homozygous frameshift mutation in POC1A, predicted to affect two of the three protein products of the gene.	POC1A	skeletal dysplasia	25886	HP_0002652	210	215	55	73	False
26336158	We describe a female proband with primordial dwarfism, skeletal dysplasia, facial dysmorphism, extreme dyslipidaemic insulin resistance and fatty liver associated with a novel homozygous frameshift mutation in POC1A, predicted to affect two of the three protein products of the gene.	POC1A	facial dysmorphism	25886	HP_0001999	210	215	75	93	True
29484942	After diagnosis of granular cell tumour by core needle biopsy, the masses were excised with histopathological and immunohistochemical analysis of both specimens confirming the presence of non-malignant granular cell tumours.	mass	tumour	2200	HP_0002664	67	71	33	39	False
29986413	High-density lipoprotein (HDL) particles have experienced a turbulent decade of falling from grace with widespread demotion from the most-sought-after therapeutic target to reverse cardiovascular disease (CVD), to mere biomarker status.	era	cardiovascular disease	2099	HP_0001626	153	156	181	203	True
30700638	Imatinib is a tyrosine kinase inhibitor specific for platelet-derived growth factor receptor and is expected as a treatment option for pulmonary arterial hypertension (PAH).	PAH	pulmonary arterial hypertension	5053	HP_0002092	168	171	135	166	False
30700638	We suspected PVOD from CT characteristics and pulmonary edema after PAH-targeted vasodilator therapy, and then started oral imatinib treatment.	PAH	pulmonary edema	5053	HP_0100598	68	71	46	61	False
29359444	MAGEL2 mutations, first reported to be the cause of the Prader-Willi like syndrome with autism by Schaaf et al. (2013) Nature Genetics, 45: 1405-1408 show the wide range of phenotypic spectrum from lethal arthrogryposis multiplex congenital to autism spectrum disorder (ASD) and mild intellectual disability (ID).	MAGEL2	autism	54551	HP_0000717	0	6	88	94	True
29359444	MAGEL2 mutations, first reported to be the cause of the Prader-Willi like syndrome with autism by Schaaf et al. (2013) Nature Genetics, 45: 1405-1408 show the wide range of phenotypic spectrum from lethal arthrogryposis multiplex congenital to autism spectrum disorder (ASD) and mild intellectual disability (ID).	MAGEL2	arthrogryposis	54551	HP_0002804	0	6	205	219	True
29359444	MAGEL2 mutations, first reported to be the cause of the Prader-Willi like syndrome with autism by Schaaf et al. (2013) Nature Genetics, 45: 1405-1408 show the wide range of phenotypic spectrum from lethal arthrogryposis multiplex congenital to autism spectrum disorder (ASD) and mild intellectual disability (ID).	MAGEL2	intellectual disability	54551	HP_0001249	0	6	284	307	True
29359444	Our results indicate that MAGEL2 mutations cause multiple congenital anomalies and intellectual disability accompanied by arthrogryposis multiplex congenita and various endocrinologic abnormalities, supporting that the view that clinical phenotypes of MAGEL2 mutations are variable	MAGEL2	arthrogryposis	54551	HP_0002804	26	32	122	136	True
29359444	Our results indicate that MAGEL2 mutations cause multiple congenital anomalies and intellectual disability accompanied by arthrogryposis multiplex congenita and various endocrinologic abnormalities, supporting that the view that clinical phenotypes of MAGEL2 mutations are variable	MAGEL2	intellectual disability	54551	HP_0001249	26	32	83	106	True
29860398	Amyotrophic lateral sclerosis (ALS) is a devastating adult-onset progressive neurodegenerative disease characterized by upper and lower motoneuron degeneration.	ALS	neurodegenerative disease	3483	HP_0002180	31	34	77	102	False
29860398	The inhibition of CTGF/CCN2 with the monoclonal neutralizing antibody FG-3019 reduces fibrosis in several chronic disorders including the mdx mice, a murine model for Duchenne muscular dystrophy (DMD).	mice	muscular dystrophy	23581	HP_0003560	142	146	176	194	False
29860398	The inhibition of CTGF/CCN2 with the monoclonal neutralizing antibody FG-3019 reduces fibrosis in several chronic disorders including the mdx mice, a murine model for Duchenne muscular dystrophy (DMD).	DMD	muscular dystrophy	1756	HP_0003560	196	199	176	194	True
29311158	LncRNA <i>pancEts-1</i> promoted the growth, invasion, and metastasis of neuroblastoma cells <i>in vitro</i> and <i>in vivo</i> Mechanistically, <i>pancEts-1</i> bound to hnRNPK to facilitate its physical interaction with -catenin, whereas hnRNPK stabilized the -catenin by inhibiting proteasome-mediated degradation, resulting in transcriptional alteration of target genes associated with neuroblastoma progression.	hnRNPK	neuroblastoma	3190	HP_0003006	171	177	73	86	False
29311158	Both <i>pancEts-1</i> and <i>hnRNPK</i> were upregulated in clinical neuroblastoma tissues, and were associated with unfavorable outcome of patients.	hnRNPK	neuroblastoma	3190	HP_0003006	29	35	69	82	False
29311158	Overall, our results define an oncogenic role of <i>pancEts-1</i> in neuroblastoma progression through hnRNPK-mediated -catenin stabilization, with potential implications for the clinical therapeutics of neuroblastoma.<b>Significance:</b> These findings reveal the oncogenic functions of a long noncoding RNA in neuroblastoma progression, offering a potential target for clinical therapeutics.	hnRNPK	neuroblastoma	3190	HP_0003006	103	109	69	82	False
28678915	The expression of the ID2, PRELP and SMOC2 genes was compared between the endometrium of women without endometriosis in the proliferative phase of their menstrual cycle and the eutopic and ectopic endometrium of women with endometriosis in the proliferative phase.	PRELP	endometriosis	5549	HP_0030127	27	32	103	116	False
28678915	The expression of the ID2, PRELP and SMOC2 genes was compared between the endometrium of women without endometriosis in the proliferative phase of their menstrual cycle and the eutopic and ectopic endometrium of women with endometriosis in the proliferative phase.	SMOC2	endometriosis	64094	HP_0030127	37	42	103	116	False
28678915	The ID2 gene expression was increased in the most advanced stage of endometriosis and in ovarian endometriomas, the PRELP was more expressed in peritoneal lesions, and the SMOC2 was highly expressed in both peritoneal and endometrioma lesions.	PRELP	endometriosis	5549	HP_0030127	116	121	68	81	False
28678915	The ID2 gene expression was increased in the most advanced stage of endometriosis and in ovarian endometriomas, the PRELP was more expressed in peritoneal lesions, and the SMOC2 was highly expressed in both peritoneal and endometrioma lesions.	SMOC2	endometriosis	64094	HP_0030127	172	177	68	81	False
25339750	To identify other possible transcriptional targets of PGC-1 in neural tissue, we conducted a microarray on neuroblastoma cells overexpressing PGC-1, mined results for genes with physiological relevance to interneurons, and measured cortical gene and protein expression of these genes in mice with underexpression and overexpression of PGC-1.	PGC	neuroblastoma	5225	HP_0003006	54	57	108	121	False
25339750	To identify other possible transcriptional targets of PGC-1 in neural tissue, we conducted a microarray on neuroblastoma cells overexpressing PGC-1, mined results for genes with physiological relevance to interneurons, and measured cortical gene and protein expression of these genes in mice with underexpression and overexpression of PGC-1.	mice	neuroblastoma	23581	HP_0003006	289	293	108	121	False
30212649	Inhibitory immune receptors, such as NLRP12, dampen inflammation and are important for resolving inflammation, but their role in obesity is unknown.	NLRP12	obesity	91662	HP_0001513	37	43	129	136	False
30212649	We show that obesity in humans correlates with reduced expression of adipose tissue NLRP12.	NLRP12	obesity	91662	HP_0001513	84	90	13	20	False
30212649	Co-housing with wild-type animals, antibiotic treatment, or germ-free condition was sufficient to restrain inflammation, obesity, and insulin tolerance in Nlrp12<sup>-/-</sup> mice, implicating the microbiota.	Nlrp12	obesity	91662	HP_0001513	155	161	121	128	False
30212649	Co-housing with wild-type animals, antibiotic treatment, or germ-free condition was sufficient to restrain inflammation, obesity, and insulin tolerance in Nlrp12<sup>-/-</sup> mice, implicating the microbiota.	mice	obesity	23581	HP_0001513	176	180	121	128	False
30212649	HFD-fed Nlrp12<sup>-/-</sup> mice display dysbiosis marked by increased obesity-associated Erysipelotrichaceae, but reduced Lachnospiraceae family and the associated enzymes required for short-chain fatty acid (SCFA) synthesis.	Nlrp12	obesity	91662	HP_0001513	8	14	72	79	False
30212649	HFD-fed Nlrp12<sup>-/-</sup> mice display dysbiosis marked by increased obesity-associated Erysipelotrichaceae, but reduced Lachnospiraceae family and the associated enzymes required for short-chain fatty acid (SCFA) synthesis.	mice	obesity	23581	HP_0001513	29	33	72	79	False
30212649	These findings reveal that Nlrp12 reduces HFD-induced obesity by maintaining beneficial microbiota	Nlrp12	obesity	91662	HP_0001513	27	33	54	61	False
28892570	Biallelic DNAJC12 mutations were described in children with hyperphenylalaninemia, neurodevelopmental delay, and dystonia.	DNAJC12	hyperphenylalaninemia	56521	HP_0004923	10	17	60	81	False
28892570	Biallelic DNAJC12 mutations were described in children with hyperphenylalaninemia, neurodevelopmental delay, and dystonia.	DNAJC12	neurodevelopmental delay	56521	HP_0012758	10	17	83	107	True
28892570	Biallelic DNAJC12 mutations were described in children with hyperphenylalaninemia, neurodevelopmental delay, and dystonia.	DNAJC12	dystonia	56521	HP_0001332	10	17	113	121	True
28892570	We identified DNAJC12 homozygous null variants (c.187A&gt;T;p.K63* and c.79-2A&gt;G;p.V27Wfs*14) in two kindreds with early-onset parkinsonism.	DNAJC12	parkinsonism	56521	HP_0001300	14	21	130	142	True
28892570	Our results suggest that DNAJC12 mutations (absent in 500 early-onset patients with Parkinson's disease) rarely cause dopa-responsive nonprogressive parkinsonism in adulthood, but broaden the clinical spectrum of DNAJC12 deficiency.	DNAJC12	parkinsonism	56521	HP_0001300	25	32	149	161	True
28892570	Our results suggest that DNAJC12 mutations (absent in 500 early-onset patients with Parkinson's disease) rarely cause dopa-responsive nonprogressive parkinsonism in adulthood, but broaden the clinical spectrum of DNAJC12 deficiency.	DNAJC12	nonprogressive	56521	HP_0003680	25	32	134	148	False
28272537	Mutations in the PCYT1A gene have been recently linked to two different phenotypes: one characterized by spondylometaphyseal dysplasia and cone-rod dystrophy (SMD-CRD) and the other by congenital lipodystrophy, severe fatty liver disease, and reduced HDL cholesterol without any retinal or skeletal involvement.	PCYT1A	spondylometaphyseal dysplasia	5130	HP_0002657	17	23	105	134	True
28272537	Mutations in the PCYT1A gene have been recently linked to two different phenotypes: one characterized by spondylometaphyseal dysplasia and cone-rod dystrophy (SMD-CRD) and the other by congenital lipodystrophy, severe fatty liver disease, and reduced HDL cholesterol without any retinal or skeletal involvement.	PCYT1A	lipodystrophy	5130	HP_0009125	17	23	196	209	False
28272537	Here, we identified, by next generation sequencing, sequence variants affecting function in the PCYT1A gene in three young patients with isolated retinal dystrophy from two different Italian families.	PCYT1A	retinal dystrophy	5130	HP_0000556	96	102	146	163	True
28272537	This is the first report showing that the PCYT1A gene can be responsible for isolated forms of retinal dystrophy, particularly without any skeletal involvement, thus further expanding the phenotypic spectrum induced by mutations in this gene	PCYT1A	retinal dystrophy	5130	HP_0000556	42	48	95	112	True
28777935	We identified a highly significant enrichment of de novo variants in YWHAG, establishing their role in early-onset epilepsy, and we provide additional support for the prior assignment of SLC1A2.	set	epilepsy	6418	HP_0001250	111	114	115	123	True
28777935	We identified a highly significant enrichment of de novo variants in YWHAG, establishing their role in early-onset epilepsy, and we provide additional support for the prior assignment of SLC1A2.	SLC1A2	epilepsy	6506	HP_0001250	187	193	115	123	True
28777935	We identified a highly significant enrichment of de novo variants in YWHAG, establishing their role in early-onset epilepsy, and we provide additional support for the prior assignment of SLC1A2.	YWHAG	epilepsy	7532	HP_0001250	69	74	115	123	True
29656927	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	type	developmental delay	6445	HP_0001263	12	16	190	209	False
29656927	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	SMA	developmental delay	6606	HP_0001263	136	139	190	209	False
29656927	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	EXOSC3	developmental delay	51010	HP_0001263	100	106	190	209	True
29656927	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	SLC25A46	developmental delay	91137	HP_0001263	110	118	190	209	True
29656927	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	type	hearing impairment	6445	HP_0000365	12	16	222	240	False
29656927	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	SMA	hearing impairment	6606	HP_0000365	136	139	222	240	False
29656927	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	EXOSC3	hearing impairment	51010	HP_0000365	100	106	222	240	False
29656927	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	SLC25A46	hearing impairment	91137	HP_0000365	110	118	222	240	False
29656927	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	type	microcephaly	6445	HP_0000252	12	16	258	270	False
29656927	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	SMA	microcephaly	6606	HP_0000252	136	139	258	270	False
29656927	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	EXOSC3	microcephaly	51010	HP_0000252	100	106	258	270	True
29656927	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	SLC25A46	microcephaly	91137	HP_0000252	110	118	258	270	False
29656927	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	type	optic atrophy	6445	HP_0000648	12	16	286	299	False
29656927	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	SMA	optic atrophy	6606	HP_0000648	136	139	286	299	False
29656927	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	EXOSC3	optic atrophy	51010	HP_0000648	100	106	286	299	False
29656927	The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy.	SLC25A46	optic atrophy	91137	HP_0000648	110	118	286	299	True
29656927	Mutations with milder presentation (homozygous p.D132A/EXOSC3 or VRK1) may display additionally signs of upper motor neuron impairment, dystonia or ataxia and die at age between 5 and 18 years.	EXOSC3	ataxia	51010	HP_0001251	55	61	148	154	False
29656927	Mutations with milder presentation (homozygous p.D132A/EXOSC3 or VRK1) may display additionally signs of upper motor neuron impairment, dystonia or ataxia and die at age between 5 and 18 years.	VRK1	ataxia	7443	HP_0001251	65	69	148	154	True
29656927	Other EXOSC3 mutations and EXOSC8 cases are intermediate - SMA type 1-like presentation, spasticity (mostly in EXOSC8) and death between 3 months and 5 years.	type	spasticity	6445	HP_0001257	63	67	89	99	False
29656927	Other EXOSC3 mutations and EXOSC8 cases are intermediate - SMA type 1-like presentation, spasticity (mostly in EXOSC8) and death between 3 months and 5 years.	SMA	spasticity	6606	HP_0001257	59	62	89	99	False
29656927	Other EXOSC3 mutations and EXOSC8 cases are intermediate - SMA type 1-like presentation, spasticity (mostly in EXOSC8) and death between 3 months and 5 years.	EXOSC3	spasticity	51010	HP_0001257	6	12	89	99	True
29656927	Other EXOSC3 mutations and EXOSC8 cases are intermediate - SMA type 1-like presentation, spasticity (mostly in EXOSC8) and death between 3 months and 5 years.	EXOSC8	spasticity	11340	HP_0001257	27	33	89	99	True
23408445	The most significant association with childhood brain tumor risk was for IVS1-401G&gt;C in the AICDA gene [odds ratio (OR) = 2.8; 95% confidence interval (95%CI) = 1.25-6.46]; the polymorphism *9276A&gt;C of CASP14 was associated with decreased brain tumor risk (OR = 0.4; 95%CI = 0.19-0.95).	AICDA	tumor	57379	HP_0002664	95	100	54	59	False
23408445	The most significant association with childhood brain tumor risk was for IVS1-401G&gt;C in the AICDA gene [odds ratio (OR) = 2.8; 95% confidence interval (95%CI) = 1.25-6.46]; the polymorphism *9276A&gt;C of CASP14 was associated with decreased brain tumor risk (OR = 0.4; 95%CI = 0.19-0.95).	CASP14	tumor	23581	HP_0002664	208	214	54	59	False
23408445	We concluded that genetic polymorphisms in AICDA and CASP14 are associated with risk for brain tumor in Korean children.	AICDA	tumor	57379	HP_0002664	43	48	95	100	False
23408445	We concluded that genetic polymorphisms in AICDA and CASP14 are associated with risk for brain tumor in Korean children.	CASP14	tumor	23581	HP_0002664	53	59	95	100	False
30024674	Most often, hypogonadotropic hypogonadism is caused by disorder in secretion of gonadoliberin, the product of gene GNRH1.	GNRH1	hypogonadism	2796	HP_0000135	115	120	29	41	True
30024674	Thus, increased expression of gene GNRH1 in blood cells appears to be associated with the isolated form of hypogonadotropic hypogonadism and, in prospect, may be used as one of the disease markers	GNRH1	hypogonadism	2796	HP_0000135	35	40	124	136	True
28510328	Here, we investigated associations between genetic variants of Rho GTPases-related genes and cutaneous melanoma-specific survival (CMSS) by re-analyzing a published melanoma genome-wide association study (GWAS) and validating the results in another melanoma GWAS.	Rho	cutaneous melanoma	6010	HP_0012056	63	66	93	111	False
24782121	However, there is considerable clinical heterogeneity among patients, and the molecular basis for the evolution of immunodeficiency into MDS/AML remains unknown.	MDS	heterogeneity	5048	HP_0001425	137	140	40	53	False
26944031	Mosaicism was identified for autosomal dominant (JAG1, COL3A1), autosomal recessive (PYGM), and X-linked (PHKA2, PDHA1, OTC, and SLC6A8) disorders.	COL3A1	autosomal recessive	1281	HP_0000007	55	61	64	83	False
26944031	Mosaicism was identified for autosomal dominant (JAG1, COL3A1), autosomal recessive (PYGM), and X-linked (PHKA2, PDHA1, OTC, and SLC6A8) disorders.	PYGM	autosomal recessive	5837	HP_0000007	85	89	64	83	True
26944031	Mosaicism was identified for autosomal dominant (JAG1, COL3A1), autosomal recessive (PYGM), and X-linked (PHKA2, PDHA1, OTC, and SLC6A8) disorders.	PHKA2	autosomal recessive	5256	HP_0000007	106	111	64	83	False
26944031	Mosaicism was identified for autosomal dominant (JAG1, COL3A1), autosomal recessive (PYGM), and X-linked (PHKA2, PDHA1, OTC, and SLC6A8) disorders.	PDHA1	autosomal recessive	5160	HP_0000007	113	118	64	83	False
26944031	Mosaicism was identified for autosomal dominant (JAG1, COL3A1), autosomal recessive (PYGM), and X-linked (PHKA2, PDHA1, OTC, and SLC6A8) disorders.	OTC	autosomal recessive	5009	HP_0000007	120	123	64	83	False
26944031	Mosaicism was identified for autosomal dominant (JAG1, COL3A1), autosomal recessive (PYGM), and X-linked (PHKA2, PDHA1, OTC, and SLC6A8) disorders.	SLC6A8	autosomal recessive	6535	HP_0000007	129	135	64	83	False
30618169	Lactate dehydrogenase A (LDHA), a key enzyme in glycolysis, is highly expressed in a variety of tumors and catalyzes pyruvate to lactate.	LDHA	tumor	3939	HP_0002664	25	29	96	101	False
30618169	In the present study, we first analyzed the association and clinical significance of p53 and LDHA in breast cancer expressing wild-type p53 (wt-p53) and found that LDHA mRNA levels are negatively correlated with wt-p53 but not with mutation p53 mRNA levels, and low p53 and high LDHA expression are significantly associated with poor overall survival rates.	LDHA	cancer	3939	HP_0002664	93	97	108	114	False
30618169	Moreover, a series of LDHA gain-of-function and rescore experiments were carried out in breast cancer MCF7 cells expressing endogenous wt-p53, showing that ectopic expression of p53 decreases aerobic glycolysis, cell proliferation, migration, invasion and tumor formation of breast cancer cells and that restoration of the expression of LDHA in p53-overexpressing cells could abolish the suppressive effect of p53 on aerobic glycolysis and other malignant phenotypes.	LDHA	tumor	3939	HP_0002664	22	26	256	261	False
30618169	Moreover, a series of LDHA gain-of-function and rescore experiments were carried out in breast cancer MCF7 cells expressing endogenous wt-p53, showing that ectopic expression of p53 decreases aerobic glycolysis, cell proliferation, migration, invasion and tumor formation of breast cancer cells and that restoration of the expression of LDHA in p53-overexpressing cells could abolish the suppressive effect of p53 on aerobic glycolysis and other malignant phenotypes.	LDHA	cancer	3939	HP_0002664	22	26	95	101	False
30618169	In conclusion, our findings showed that repression of LDHA induced by wt-p53 blocks tumor growth and invasion through downregulation of aerobic glycolysis in breast cancer, providing new insights into the mechanism by which p53 contributes to the development and progression of breast cancer	LDHA	tumor	3939	HP_0002664	54	58	84	89	False
30618169	In conclusion, our findings showed that repression of LDHA induced by wt-p53 blocks tumor growth and invasion through downregulation of aerobic glycolysis in breast cancer, providing new insights into the mechanism by which p53 contributes to the development and progression of breast cancer	LDHA	cancer	3939	HP_0002664	54	58	165	171	False
28467418	Our results therefore confirm the KCNC3R423H allele as causative for SCA13, through a dominant negative effect on KCNC3WT and links with EGFR that account for dominant inheritance, congenital onset, and disease pathology	SCA13	inheritance	3748	HP_0000005	69	74	168	179	False
28467418	Our results therefore confirm the KCNC3R423H allele as causative for SCA13, through a dominant negative effect on KCNC3WT and links with EGFR that account for dominant inheritance, congenital onset, and disease pathology	KCNC3	inheritance	3748	HP_0000005	34	39	168	179	False
28467418	Our results therefore confirm the KCNC3R423H allele as causative for SCA13, through a dominant negative effect on KCNC3WT and links with EGFR that account for dominant inheritance, congenital onset, and disease pathology	EGFR	inheritance	1956	HP_0000005	137	141	168	179	False
29801399	of UNC5C gene (one of the netrin-1 receptors) in colorectal cancer patients of Kashmiri population (North India).	UNC5C	cancer	8633	HP_0002664	3	8	60	66	False
29801399	Results: UNC5C promoter hypermethylation was significantly found to be associated with colorectal cancer cases	UNC5C	cancer	8633	HP_0002664	9	14	98	104	False
28872120	We have been investigating the pancreas specific transcription factor, 1a cre-recombinase; lox-stop-lox- Kristen rat sarcoma, glycine to aspartic acid at the 12 codon (Ptf1a<sup>cre/+</sup>;LSL-Kras<sup>G12D/+</sup>) mouse strain as a model of human pancreatic cancer.	lox	sarcoma	4015	HP_0100242	91	94	117	124	False
28872120	We have been investigating the pancreas specific transcription factor, 1a cre-recombinase; lox-stop-lox- Kristen rat sarcoma, glycine to aspartic acid at the 12 codon (Ptf1a<sup>cre/+</sup>;LSL-Kras<sup>G12D/+</sup>) mouse strain as a model of human pancreatic cancer.	lox	cancer	4015	HP_0002664	91	94	261	267	False
28600480	Tumor growth in xenografts as well as EGFR signaling were assessed in HCT116 cells expressing IL17RD with either a mutant 3' untranslated region (UTR) or wild-type (WT) 3'UTR.<b>Results:</b> miR-31, miR-34a, miR-106b, and miR-193a-3p were significantly dysregulated in ulcerative colitis-neoplasia and adjacent tissue.	miR	neoplasia	220972	HP_0002664	191	194	288	297	False
28600480	Tumor growth in xenografts as well as EGFR signaling were assessed in HCT116 cells expressing IL17RD with either a mutant 3' untranslated region (UTR) or wild-type (WT) 3'UTR.<b>Results:</b> miR-31, miR-34a, miR-106b, and miR-193a-3p were significantly dysregulated in ulcerative colitis-neoplasia and adjacent tissue.	EGFR	neoplasia	1956	HP_0002664	38	42	288	297	True
28600480	Significant down-regulation of miR-193a-3p was also seen in an independent cohort of ulcerative colitis cancers.	miR	cancer	220972	HP_0002664	31	34	104	110	False
28600480	Changes in methylation of miR-193a or expression of pri-miR-193a were not observed in ulcerative colitis cancer.	miR	cancer	220972	HP_0002664	26	29	105	111	False
28600480	IL17RD expression was increased in ulcerative colitis cancers, and miR-193a-3p treatment decreased growth and EGFR signaling of HCT116 cells in xenografts expressing both IL17RD with WT 3'UTR compared with cells expressing IL17RD with mutant 3'UTR.<b>Conclusions:</b> miR-193a-3p is downregulated in ulcerative colitis neoplasia, and its loss promotes carcinogenesis through upregulation of IL17RD.	miR	cancer	220972	HP_0002664	67	70	54	60	False
28600480	IL17RD expression was increased in ulcerative colitis cancers, and miR-193a-3p treatment decreased growth and EGFR signaling of HCT116 cells in xenografts expressing both IL17RD with WT 3'UTR compared with cells expressing IL17RD with mutant 3'UTR.<b>Conclusions:</b> miR-193a-3p is downregulated in ulcerative colitis neoplasia, and its loss promotes carcinogenesis through upregulation of IL17RD.	EGFR	cancer	1956	HP_0002664	110	114	54	60	True
28600480	IL17RD expression was increased in ulcerative colitis cancers, and miR-193a-3p treatment decreased growth and EGFR signaling of HCT116 cells in xenografts expressing both IL17RD with WT 3'UTR compared with cells expressing IL17RD with mutant 3'UTR.<b>Conclusions:</b> miR-193a-3p is downregulated in ulcerative colitis neoplasia, and its loss promotes carcinogenesis through upregulation of IL17RD.	miR	neoplasia	220972	HP_0002664	67	70	319	328	False
28600480	IL17RD expression was increased in ulcerative colitis cancers, and miR-193a-3p treatment decreased growth and EGFR signaling of HCT116 cells in xenografts expressing both IL17RD with WT 3'UTR compared with cells expressing IL17RD with mutant 3'UTR.<b>Conclusions:</b> miR-193a-3p is downregulated in ulcerative colitis neoplasia, and its loss promotes carcinogenesis through upregulation of IL17RD.	EGFR	neoplasia	1956	HP_0002664	110	114	319	328	True
17467691	Duplication in LMNB1 encoding lamin B1 causes autosomal dominant leukodystrophy and mutations in LMNB2 encoding lamin B2 are associated with acquired partial lipodystrophy.	LMNB1	leukodystrophy	4001	HP_0002415	15	20	65	79	True
17467691	Duplication in LMNB1 encoding lamin B1 causes autosomal dominant leukodystrophy and mutations in LMNB2 encoding lamin B2 are associated with acquired partial lipodystrophy.	LMNB2	leukodystrophy	84823	HP_0002415	97	102	65	79	False
30007115	In vitro and invivo (a subcutaneous BALB/c nude mouse model) studies showed that exosomal ZIP4 can significantly promote pancreatic cancer growth.	ZIP4	cancer	55630	HP_0002664	91	95	133	139	False
30007115	In vitro and invivo (a subcutaneous BALB/c nude mouse model) studies showed that exosomal ZIP4 can significantly promote pancreatic cancer growth.	nude	cancer	54820	HP_0002664	44	48	133	139	False
30007115	Using clinical blood samples, we compared the diagnostic values of serum exosomal ZIP4 levels between malignant pancreatic cancer patients (n=24) and benign pancreatic disease patients (n=32, AUC=.89), and between biliary disease patients (n=32, AUC=.8112) and healthy controls (n=46, AUC=.8931).	ZIP4	cancer	55630	HP_0002664	82	86	123	129	False
30007115	In conclusion, exosomal ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer	ZIP4	cancer	55630	HP_0002664	24	28	38	44	False
26758872	Meesmann epithelial corneal dystrophy (MECD) is a rare autosomal dominant disorder caused by dominant-negative mutations within the KRT3 or KRT12 genes, which encode the cytoskeletal protein keratins K3 and K12, respectively.	KRT3	corneal dystrophy	3850	HP_0001131	132	136	20	37	True
26758872	Meesmann epithelial corneal dystrophy (MECD) is a rare autosomal dominant disorder caused by dominant-negative mutations within the KRT3 or KRT12 genes, which encode the cytoskeletal protein keratins K3 and K12, respectively.	KRT12	corneal dystrophy	3859	HP_0001131	140	145	20	37	True
26758872	Meesmann epithelial corneal dystrophy (MECD) is a rare autosomal dominant disorder caused by dominant-negative mutations within the KRT3 or KRT12 genes, which encode the cytoskeletal protein keratins K3 and K12, respectively.	K12	corneal dystrophy	3859	HP_0001131	207	210	20	37	True
26758872	Although no overt changes in corneal opacity were detected by slit-lamp examination, the corneas of homozygous mutant mice exhibited histological and ultrastructural epithelial cell fragility phenotypes.	lamp	corneal opacity	27074	HP_0007957	67	71	29	44	False
26758872	Although no overt changes in corneal opacity were detected by slit-lamp examination, the corneas of homozygous mutant mice exhibited histological and ultrastructural epithelial cell fragility phenotypes.	mice	corneal opacity	23581	HP_0007957	118	122	29	44	False
26758872	Although the most severe phenotype is observed in the homozygous mice, this model will still provide a test-bed for therapies not only for corneal dystrophies but also for other keratinopathies caused by similar mutations.	mice	corneal dystrophies	23581	HP_0001131	65	69	139	158	False
17143510	The lack of good molecular markers for diagnosis as well as treatment assessment has rendered the hepatocellular carcinoma (HCC) a major challenge in health care.	HCC	hepatocellular carcinoma	84668	HP_0001402	124	127	98	122	False
17143510	An analysis approach combing supervised significant analysis of microarray (SAM), prediction analysis of microarray (PAM), and unsupervised hierarchical cluster methodologies statistically determined 211 upregulated and 78 downregulated genes between liver cancer and non-cancer liver tissues, and demonstrated &gt; or = 93% accuracy in classifying the tissue samples.	PAM	cancer	23077	HP_0002664	117	120	257	263	False
17143510	Numerous genes found in this study were also differentially expressed in human HCC and many other human cancers including breast, prostate and lung cancers, etc., serving as tumor suppressors, promoters, prognostic markers or chemotherapy targets.	HCC	cancer	84668	HP_0002664	79	82	104	110	False
17143510	Numerous genes found in this study were also differentially expressed in human HCC and many other human cancers including breast, prostate and lung cancers, etc., serving as tumor suppressors, promoters, prognostic markers or chemotherapy targets.	HCC	tumor	84668	HP_0002664	79	82	174	179	False
30061496	PMM2-CDG is an autosomal recessive disease with a large phenotypic spectrum, and is associated with mutations in the <i>PMM2</i> gene.	PMM2	autosomal recessive	5373	HP_0000007	0	4	15	34	True
16752389	In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (COL11A2), DFNB66, and DFNB67.	DFNB53	autosomal recessive	1302	HP_0000007	218	224	58	77	True
16752389	In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (COL11A2), DFNB66, and DFNB67.	COL11A2	autosomal recessive	1302	HP_0000007	226	233	58	77	True
16752389	In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (COL11A2), DFNB66, and DFNB67.	DFNB67	autosomal recessive	222662	HP_0000007	248	254	58	77	True
16752389	In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (COL11A2), DFNB66, and DFNB67.	DFNB53	hearing loss	1302	HP_0000365	218	224	91	103	True
16752389	In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (COL11A2), DFNB66, and DFNB67.	COL11A2	hearing loss	1302	HP_0000365	226	233	91	103	True
16752389	In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci DFNB53 (COL11A2), DFNB66, and DFNB67.	DFNB67	hearing loss	222662	HP_0000365	248	254	91	103	True
16752389	Fine mapping excluded DFNB53 and subsequently homozygous mutations were identified in the lipoma HMGIC fusion partner-like 5 (LHFPL5) gene, also named tetraspan membrane protein of hair cell stereocilia (TMHS) gene, which was recently shown to be mutated in the &quot;hurry scurry&quot; mouse and in two DFNB67-linked families from Pakistan.	DFNB53	lipoma	1302	HP_0012032	22	28	90	96	False
16752389	Fine mapping excluded DFNB53 and subsequently homozygous mutations were identified in the lipoma HMGIC fusion partner-like 5 (LHFPL5) gene, also named tetraspan membrane protein of hair cell stereocilia (TMHS) gene, which was recently shown to be mutated in the &quot;hurry scurry&quot; mouse and in two DFNB67-linked families from Pakistan.	HMGIC	lipoma	8091	HP_0012032	97	102	90	96	False
16752389	Fine mapping excluded DFNB53 and subsequently homozygous mutations were identified in the lipoma HMGIC fusion partner-like 5 (LHFPL5) gene, also named tetraspan membrane protein of hair cell stereocilia (TMHS) gene, which was recently shown to be mutated in the &quot;hurry scurry&quot; mouse and in two DFNB67-linked families from Pakistan.	LHFPL5	lipoma	222662	HP_0012032	126	132	90	96	False
16752389	Fine mapping excluded DFNB53 and subsequently homozygous mutations were identified in the lipoma HMGIC fusion partner-like 5 (LHFPL5) gene, also named tetraspan membrane protein of hair cell stereocilia (TMHS) gene, which was recently shown to be mutated in the &quot;hurry scurry&quot; mouse and in two DFNB67-linked families from Pakistan.	tetraspan	lipoma	7106	HP_0012032	151	160	90	96	False
16752389	Fine mapping excluded DFNB53 and subsequently homozygous mutations were identified in the lipoma HMGIC fusion partner-like 5 (LHFPL5) gene, also named tetraspan membrane protein of hair cell stereocilia (TMHS) gene, which was recently shown to be mutated in the &quot;hurry scurry&quot; mouse and in two DFNB67-linked families from Pakistan.	TMHS	lipoma	222662	HP_0012032	204	208	90	96	False
16752389	Fine mapping excluded DFNB53 and subsequently homozygous mutations were identified in the lipoma HMGIC fusion partner-like 5 (LHFPL5) gene, also named tetraspan membrane protein of hair cell stereocilia (TMHS) gene, which was recently shown to be mutated in the &quot;hurry scurry&quot; mouse and in two DFNB67-linked families from Pakistan.	DFNB67	lipoma	222662	HP_0012032	304	310	90	96	False
28642546	Mutations in SLC4A11, a Na<sup>+</sup> dependent OH<sup>-</sup> transporter, cause congenital hereditary endothelial dystrophy (CHED) and Fuchs' endothelial corneal dystrophy (FECD), the two most common forms of endothelial degeneration.	SLC4A11	corneal dystrophy	83959	HP_0001131	13	20	157	174	True
28642546	Mutations in SLC4A11, a Na<sup>+</sup> dependent OH<sup>-</sup> transporter, cause congenital hereditary endothelial dystrophy (CHED) and Fuchs' endothelial corneal dystrophy (FECD), the two most common forms of endothelial degeneration.	CHED	corneal dystrophy	8621	HP_0001131	128	132	157	174	False
28642546	Mutations in SLC4A11, a Na<sup>+</sup> dependent OH<sup>-</sup> transporter, cause congenital hereditary endothelial dystrophy (CHED) and Fuchs' endothelial corneal dystrophy (FECD), the two most common forms of endothelial degeneration.	FECD	corneal dystrophy	1296	HP_0001131	176	180	157	174	True
27618312	Further, mice heterozygous for either Magoh or Rbm8a exhibit aberrant neurogenesis and microcephaly.	Magoh	microcephaly	4116	HP_0000252	38	43	87	99	False
27618312	Further, mice heterozygous for either Magoh or Rbm8a exhibit aberrant neurogenesis and microcephaly.	Rbm8a	microcephaly	9939	HP_0000252	47	52	87	99	False
27618312	Further, mice heterozygous for either Magoh or Rbm8a exhibit aberrant neurogenesis and microcephaly.	mice	microcephaly	23581	HP_0000252	9	13	87	99	False
27618312	Using a new conditional allele, we first show that Eif4a3 haploinsufficiency phenocopies aberrant neurogenesis and microcephaly of Magoh and Rbm8a mutant mice.	Magoh	microcephaly	4116	HP_0000252	131	136	115	127	False
27618312	Using a new conditional allele, we first show that Eif4a3 haploinsufficiency phenocopies aberrant neurogenesis and microcephaly of Magoh and Rbm8a mutant mice.	Rbm8a	microcephaly	9939	HP_0000252	141	146	115	127	False
27618312	Using a new conditional allele, we first show that Eif4a3 haploinsufficiency phenocopies aberrant neurogenesis and microcephaly of Magoh and Rbm8a mutant mice.	Eif4a3	microcephaly	9775	HP_0000252	51	57	115	127	False
27618312	Using a new conditional allele, we first show that Eif4a3 haploinsufficiency phenocopies aberrant neurogenesis and microcephaly of Magoh and Rbm8a mutant mice.	mice	microcephaly	23581	HP_0000252	154	158	115	127	False
29544710	The purpose of these recommendations is to answer the following question: in case of deeply infiltrating endometriosis associated infertility, what is the best therapeutic strategy? First-line surgery and then in vitro fertilization (IVF) in case of persistent infertility or first-line IVF, without surgery? After exhaustive literature analysis, we suggest the following recommendations: studies focusing on spontaneous fertility of infertile patients with deeply infiltrating endometriosis found spontaneous pregnancy rates about 10%.	best	endometriosis	7439	HP_0030127	155	159	105	118	False
29544710	The purpose of these recommendations is to answer the following question: in case of deeply infiltrating endometriosis associated infertility, what is the best therapeutic strategy? First-line surgery and then in vitro fertilization (IVF) in case of persistent infertility or first-line IVF, without surgery? After exhaustive literature analysis, we suggest the following recommendations: studies focusing on spontaneous fertility of infertile patients with deeply infiltrating endometriosis found spontaneous pregnancy rates about 10%.	IVF	endometriosis	6331	HP_0030127	234	237	105	118	False
29544710	Treatment should be considered in infertile women with deeply infiltrating endometriosis when they wish to conceive.	wish	endometriosis	51517	HP_0030127	99	103	75	88	False
29544710	First-line IVF is a good option in case of no operated deeply infiltrating endometriosis associated infertility.	IVF	endometriosis	6331	HP_0030127	11	14	75	88	False
29544710	The use of IVF in the indication &quot;deep infiltrating endometriosis&quot; allows satisfactory pregnancy rates without significant risk, regarding disease progression or oocyte retrieval procedure morbidity	IVF	endometriosis	6331	HP_0030127	11	14	57	70	False
25645620	AL mice showed a diabetes prevalence of 43%, whereas mice under CR and IF were completely protected against hyperglycemia.	mice	hyperglycemia	23581	HP_0003074	3	7	108	121	False
24273168	The toxic subcellular accumulation of lipids predisposes several human metabolic syndromes, including obesity, type 2 diabetes, and some forms of neurodegeneration.	type	obesity	6445	HP_0001513	111	115	102	109	False
28185376	Individuals had microcephaly, developmental delay, epilepsy, and recessive mutations in TRIT1.	TRIT1	microcephaly	54802	HP_0000252	88	93	16	28	False
28185376	Individuals had microcephaly, developmental delay, epilepsy, and recessive mutations in TRIT1.	TRIT1	developmental delay	54802	HP_0001263	88	93	30	49	True
28185376	Individuals had microcephaly, developmental delay, epilepsy, and recessive mutations in TRIT1.	TRIT1	epilepsy	54802	HP_0001250	88	93	51	59	True
25730767	Using exome sequencing, we discovered missense mutations in AFF4, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia).	AFF4	coarse facies	27125	HP_0000280	60	64	272	285	True
25730767	Using exome sequencing, we discovered missense mutations in AFF4, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia).	AFF4	obesity	27125	HP_0001513	60	64	314	321	True
25730767	Using exome sequencing, we discovered missense mutations in AFF4, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia).	AFF4	short stature	27125	HP_0004322	60	64	361	374	True
25730767	Using exome sequencing, we discovered missense mutations in AFF4, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia).	AFF4	skeletal dysplasia	27125	HP_0002652	60	64	379	397	False
22939900	One clue to this relationship has come from the elucidation of the hereditary kidney cancer gene, TRC8, which functions partly to degrade key regulators of endogenous cholesterol and lipid biosynthesis.	TRC8	cancer	11236	HP_0002664	98	102	85	91	True
12596933	the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the light sensitivity and adaptation in intact rods; 2. functional differences between GCAP1 and GCAP2 in intact rod photoreceptors; and 3. whether GCAP mutants with impaired Ca2+ binding lead to retinal disease in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies	light	retinal disease	8740	HP_0000479	75	80	267	282	False
12596933	the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the light sensitivity and adaptation in intact rods; 2. functional differences between GCAP1 and GCAP2 in intact rod photoreceptors; and 3. whether GCAP mutants with impaired Ca2+ binding lead to retinal disease in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies	GCAP1	retinal disease	2978	HP_0000479	158	163	267	282	True
12596933	the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the light sensitivity and adaptation in intact rods; 2. functional differences between GCAP1 and GCAP2 in intact rod photoreceptors; and 3. whether GCAP mutants with impaired Ca2+ binding lead to retinal disease in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies	GCAP2	retinal disease	2979	HP_0000479	168	173	267	282	True
12596933	the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the light sensitivity and adaptation in intact rods; 2. functional differences between GCAP1 and GCAP2 in intact rod photoreceptors; and 3. whether GCAP mutants with impaired Ca2+ binding lead to retinal disease in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies	GCAP	retinal disease	2978	HP_0000479	219	223	267	282	True
12596933	the quantitative aspects of the Ca2+-feedback to Ret-GCs in regulating the light sensitivity and adaptation in intact rods; 2. functional differences between GCAP1 and GCAP2 in intact rod photoreceptors; and 3. whether GCAP mutants with impaired Ca2+ binding lead to retinal disease in vivo by constitutive activation of Ret-GCs and elevation of intracellular cGMP, as predicted from in vitro studies	rod	retinal disease	9735	HP_0000479	118	121	267	282	False
27872092	The polo family serine threonine kinase Plk4 has been proposed as a therapeutic target in advanced cancers based on increased expression in primary human cancers, facilitation of tumor growth in murine xenograft models, and centrosomal amplification induced by its overexpression.	Plk4	tumor	10733	HP_0002664	40	44	179	184	False
27872092	The polo family serine threonine kinase Plk4 has been proposed as a therapeutic target in advanced cancers based on increased expression in primary human cancers, facilitation of tumor growth in murine xenograft models, and centrosomal amplification induced by its overexpression.	Plk4	cancer	10733	HP_0002664	40	44	99	105	False
27872092	Here we characterize Plk4-dependent cancer cell migration and invasion as well as local invasion and metastasis of cancer xenografts.	Plk4	cancer	10733	HP_0002664	21	25	36	42	False
27872092	Plk4 depletion suppressed cancer invasion and induced an epithelial phenotype in poorly differentiated breast cancer cells.	Plk4	cancer	10733	HP_0002664	0	4	26	32	False
27872092	In an unbiased BioID screen for Plk4 interactors, we identified members of the Arp2/3 complex and confirmed a physical and functional interaction between Plk4 and Arp2 in mediating Plk4-driven cancer cell movement.	Plk4	cancer	10733	HP_0002664	32	36	193	199	False
27872092	In an unbiased BioID screen for Plk4 interactors, we identified members of the Arp2/3 complex and confirmed a physical and functional interaction between Plk4 and Arp2 in mediating Plk4-driven cancer cell movement.	Arp2	cancer	10097	HP_0002664	79	83	193	199	False
27872092	Our results validate Plk4 as a therapeutic target in cancer patients and reveal a new role for Plk4 in regulating Arp2/3-mediated actin cytoskeletal rearrangement.	Plk4	cancer	10733	HP_0002664	21	25	53	59	False
27872092	Our results validate Plk4 as a therapeutic target in cancer patients and reveal a new role for Plk4 in regulating Arp2/3-mediated actin cytoskeletal rearrangement.	Arp2	cancer	10097	HP_0002664	114	118	53	59	False
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	ACAN	skeletal dysplasia	176	HP_0002652	22	26	68	86	True
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	FGFR3	skeletal dysplasia	2261	HP_0002652	28	33	68	86	True
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	NPR2	skeletal dysplasia	10641	HP_0002652	35	39	68	86	False
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	SHOX	skeletal dysplasia	6473	HP_0002652	45	49	68	86	False
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	GHRHR	skeletal dysplasia	2692	HP_0002652	105	110	68	86	False
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	GHR	skeletal dysplasia	2690	HP_0002652	117	120	68	86	False
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	STAT5B	skeletal dysplasia	6777	HP_0002652	122	128	68	86	False
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	IGF1	skeletal dysplasia	3479	HP_0002652	130	134	68	86	False
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	IGFALS	skeletal dysplasia	3483	HP_0002652	136	142	68	86	False
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	GH	skeletal dysplasia	2688	HP_0002652	112	114	68	86	False
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	ACAN	short stature	176	HP_0004322	22	26	326	339	True
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	FGFR3	short stature	2261	HP_0004322	28	33	326	339	True
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	NPR2	short stature	10641	HP_0004322	35	39	326	339	False
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	SHOX	short stature	6473	HP_0004322	45	49	326	339	True
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	GHRHR	short stature	2692	HP_0004322	105	110	326	339	False
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	GHR	short stature	2690	HP_0004322	117	120	326	339	True
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	STAT5B	short stature	6777	HP_0004322	122	128	326	339	True
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	IGF1	short stature	3479	HP_0004322	130	134	326	339	True
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	IGFALS	short stature	3483	HP_0004322	136	142	326	339	False
28768959	Although mutations in ACAN, FGFR3, NPR2, and SHOX typically lead to skeletal dysplasia, and mutations in GHRHR, GH1, GHR, STAT5B, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	GH	short stature	2688	HP_0004322	112	114	326	339	True
28768959	Unlike previously reported patients with ACAN mutations, our four patients with ACAN variants manifested non-specific short stature with age-appropriate or mildly delayed bone ages, and had parents of normal stature.	ACAN	short stature	176	HP_0004322	41	45	118	131	True
24022475	We describe a previously unreported syndrome characterized by secondary (post-natal) microcephaly with fronto-temporal lobe hypoplasia, multiple pituitary hormone deficiency, seizures, severe visual impairment and abnormalities of the kidneys and urinary tract in a highly consanguineous family with six affected children.	lobe	microcephaly	84335	HP_0000252	119	123	85	97	False
24022475	We describe a previously unreported syndrome characterized by secondary (post-natal) microcephaly with fronto-temporal lobe hypoplasia, multiple pituitary hormone deficiency, seizures, severe visual impairment and abnormalities of the kidneys and urinary tract in a highly consanguineous family with six affected children.	lobe	seizures	84335	HP_0001250	119	123	175	183	False
24022475	We describe a previously unreported syndrome characterized by secondary (post-natal) microcephaly with fronto-temporal lobe hypoplasia, multiple pituitary hormone deficiency, seizures, severe visual impairment and abnormalities of the kidneys and urinary tract in a highly consanguineous family with six affected children.	lobe	visual impairment	84335	HP_0000505	119	123	192	209	False
24022475	We also show expression of ARNT2 within the central nervous system, including the hypothalamus, as well as the renal tract during human embryonic development.	ARNT2	central	9915	HP_0030645	27	32	44	51	False
24022475	The progressive neurological abnormalities, congenital hypopituitarism and post-retinal visual pathway dysfunction in affected individuals demonstrates for the first time the essential role of ARNT2 in the development of the hypothalamo-pituitary axis, post-natal brain growth, and visual and renal function in humans.	ARNT2	neurological abnormalities	9915	HP_0000707	193	198	16	42	True
24022475	The progressive neurological abnormalities, congenital hypopituitarism and post-retinal visual pathway dysfunction in affected individuals demonstrates for the first time the essential role of ARNT2 in the development of the hypothalamo-pituitary axis, post-natal brain growth, and visual and renal function in humans.	ARNT2	hypopituitarism	9915	HP_0040075	193	198	55	70	True
20662849	We report an ~1.3 Mb tandem duplication at Xp11.23p11.3 in an 11-year-old boy with pleasant personality, hyperactivity, learning and visual-spatial difficulties, relative microcephaly, long face, stellate iris pattern, and periorbital fullness.	spatial	hyperactivity	219793	HP_0000752	140	147	105	118	False
20662849	We report an ~1.3 Mb tandem duplication at Xp11.23p11.3 in an 11-year-old boy with pleasant personality, hyperactivity, learning and visual-spatial difficulties, relative microcephaly, long face, stellate iris pattern, and periorbital fullness.	face	hyperactivity	2178	HP_0000752	190	194	105	118	False
20662849	We report an ~1.3 Mb tandem duplication at Xp11.23p11.3 in an 11-year-old boy with pleasant personality, hyperactivity, learning and visual-spatial difficulties, relative microcephaly, long face, stellate iris pattern, and periorbital fullness.	spatial	microcephaly	219793	HP_0000252	140	147	171	183	False
20662849	We report an ~1.3 Mb tandem duplication at Xp11.23p11.3 in an 11-year-old boy with pleasant personality, hyperactivity, learning and visual-spatial difficulties, relative microcephaly, long face, stellate iris pattern, and periorbital fullness.	face	microcephaly	2178	HP_0000252	190	194	171	183	True
28147318	KRT5 and KRT6 (KRT6A, KRT6B &amp; KRT6C) gene expression was assessed in publically available serous ovarian cancer data sets, ovarian cancer cell lines and primary serous ovarian cancer cells.	KRT6	cancer	140807	HP_0002664	9	13	109	115	False
28147318	KRT5 and KRT6 (KRT6A, KRT6B &amp; KRT6C) gene expression was assessed in publically available serous ovarian cancer data sets, ovarian cancer cell lines and primary serous ovarian cancer cells.	KRT5	cancer	3852	HP_0002664	0	4	109	115	True
28147318	Survival analyses showed that high KRT5 mRNA in stage III/IV serous ovarian cancers was significantly associated with reduced progression-free (HR 1.38, P &lt; 0.0001) and overall survival (HR 1.28, P = 0.013) whilst high KRT6 mRNA was only associated with reduced progression-free survival (HR 1.2, P = 0.031).	KRT6	cancer	140807	HP_0002664	222	226	76	82	False
28147318	Survival analyses showed that high KRT5 mRNA in stage III/IV serous ovarian cancers was significantly associated with reduced progression-free (HR 1.38, P &lt; 0.0001) and overall survival (HR 1.28, P = 0.013) whilst high KRT6 mRNA was only associated with reduced progression-free survival (HR 1.2, P = 0.031).	KRT5	cancer	3852	HP_0002664	35	39	76	82	True
28147318	KRT5 but not KRT6C mRNA expression was increased in chemotherapy resistant primary serous ovarian cancer cells compared to chemotherapy sensitive cells.	KRT6	cancer	140807	HP_0002664	13	17	98	104	False
28147318	KRT5 but not KRT6C mRNA expression was increased in chemotherapy resistant primary serous ovarian cancer cells compared to chemotherapy sensitive cells.	KRT5	cancer	3852	HP_0002664	0	4	98	104	True
30107296	Here, using a microarray screen, we found that knocking down DJ-1 in human neuroblastoma cells results in down-regulation of microRNA-221 (miR-221).	miR	neuroblastoma	220972	HP_0003006	139	142	75	88	False
30107296	Here, using a microarray screen, we found that knocking down DJ-1 in human neuroblastoma cells results in down-regulation of microRNA-221 (miR-221).	DJ-1	neuroblastoma	11315	HP_0003006	61	65	75	88	False
27581786	High expression of Chemokine receptor 4 (CXCR4) is important in tumor invasion, metastasis, drug-resistance and maintenance of stemness in non-small cell lung cancer (NSCLC).	CXCR4	tumor	7852	HP_0002664	41	46	64	69	True
27581786	High expression of Chemokine receptor 4 (CXCR4) is important in tumor invasion, metastasis, drug-resistance and maintenance of stemness in non-small cell lung cancer (NSCLC).	CXCR4	cancer	7852	HP_0002664	41	46	159	165	True
27581786	We therefore studied the molecular characteristics of drug-resistant CXCR4-positive cells on epithelial-mesenchymal transition (EMT) for the future identification of the tumor cells with the properties of both EMT and stemness.	CXCR4	tumor	7852	HP_0002664	69	74	170	175	True
27581786	We therefore studied the molecular characteristics of drug-resistant CXCR4-positive cells on epithelial-mesenchymal transition (EMT) for the future identification of the tumor cells with the properties of both EMT and stemness.	EMT	tumor	3702	HP_0002664	128	131	170	175	True
26356719	Therefore, we performed this preliminary clinical study to investigate the possible association between 2 adipokines, C1q/tumor necrosis factor-related protein-3 and -5 (CTRP-3 and CTRP-5), with lung function and other markers of inflammation in COPD.	COPD	tumor	372	HP_0002664	246	250	122	127	False
30264546	However, in hepatocellular carcinoma (HCC), the characteristics and mechanism of IDO1 expression have not been well defined.	IDO1	hepatocellular carcinoma	3620	HP_0001402	81	85	12	36	False
30264546	However, in hepatocellular carcinoma (HCC), the characteristics and mechanism of IDO1 expression have not been well defined.	HCC	hepatocellular carcinoma	84668	HP_0001402	38	41	12	36	False
30264546	In this study, IDO1 expression in tumor cells (T-IDO1) was frequently detected (109/112) by immunohistochemistry in formalin-fixed paraffin-embedded specimens from HCC patients, and the expression patterns were mostly focal (102/109).	IDO1	tumor	3620	HP_0002664	15	19	34	39	False
30264546	In this study, IDO1 expression in tumor cells (T-IDO1) was frequently detected (109/112) by immunohistochemistry in formalin-fixed paraffin-embedded specimens from HCC patients, and the expression patterns were mostly focal (102/109).	HCC	tumor	84668	HP_0002664	164	167	34	39	False
30264546	These findings indicated that T-IDO1 expression in HCC is common and is dominantly driven by the host antitumor immune response, which is a favorable prognostic factor in HCC	IDO1	tumor	3620	HP_0002664	32	36	106	111	False
30264546	These findings indicated that T-IDO1 expression in HCC is common and is dominantly driven by the host antitumor immune response, which is a favorable prognostic factor in HCC	HCC	tumor	84668	HP_0002664	51	54	106	111	False
16960806	Genetic analysis of a large Indian family with an autosomal dominant cataract phenotype allowed us to identify a novel cataract gene, CRYBA4.	CRYBA4	cataract	1413	HP_0000518	134	140	69	77	True
16960806	To date, CRYBA4 was the only gene in this cluster not associated with either human or murine cataracts.	CRYBA4	cataract	1413	HP_0000518	9	15	93	101	True
16960806	Considering that CRYBA4 associates with CRYBB2 and that the latter protein has been implicated in microphthalmia, mutational analysis of CRYBA4 was performed in 32 patients affected with microphthalmia (small eye).	CRYBA4	microphthalmia	1413	HP_0000568	17	23	98	112	False
16960806	Considering that CRYBA4 associates with CRYBB2 and that the latter protein has been implicated in microphthalmia, mutational analysis of CRYBA4 was performed in 32 patients affected with microphthalmia (small eye).	CRYBB2	microphthalmia	1415	HP_0000568	40	46	98	112	False
16960806	This is the first report linking mutations in CRYBA4 to cataractogenesis and microphthalmia	CRYBA4	cataract	1413	HP_0000518	46	52	56	64	True
28726664	Here we present a case of a 3-year-old boy with compound heterozygous missense mutations in the TMEM67 gene manifesting features of both JBTS and NPHP syndromes, with neonatal onset of end-stage renal disease (ESRD) and associated microcephaly.	TMEM67	microcephaly	91147	HP_0000252	96	102	231	243	True
30544377	Our study aimed to investigate the relationship between single nucleotide polymorphisms (SNPs) of claudin 10 (CLDN10) (rs1325774, rs7333503, rs3751334) and breast cancer and the clinical characteristics of patients.A total of 104 patients with breast cancer and 118 healthy controls were recruited in our study between 2013 and 2015.	CLDN10	cancer	9071	HP_0002664	110	116	163	169	False
30544377	The Gene Expression Profiling Interactive Analyses application (GEPIA) was used to analysis the expression of CLDN10 in breast cancer tissues and normal samples.The polymorphism of rs1325774 was significantly associated with an increased risk of breast cancer (T/G vs T/T: OR=2.073, 95% CI=1.095-3.927, P=.025).	CLDN10	cancer	9071	HP_0002664	110	116	127	133	False
30544377	The expression level of CLDN10 was reduced in breast cancer tissues compared with normal breast tissues according to the analysis of The Cancer Genome Atlas (TCGA) data through GEPIA.Our results suggest that the polymorphism of rs1325774 associate with increase the breast cancer risk.	CLDN10	cancer	9071	HP_0002664	24	30	53	59	False
26506440	De novo loss of function (LOF) mutations in the ASXL3 gene cause Bainbridge-Ropers syndrome, a severe form of intellectual disability (ID) and developmental delay, but there is evidence that they also occur in healthy individuals.	ASXL3	intellectual disability	80816	HP_0001249	48	53	110	133	True
26506440	De novo loss of function (LOF) mutations in the ASXL3 gene cause Bainbridge-Ropers syndrome, a severe form of intellectual disability (ID) and developmental delay, but there is evidence that they also occur in healthy individuals.	ASXL3	developmental delay	80816	HP_0001263	48	53	143	162	True
26446763	Indeed, patients with PCBD1 mutations were shown to suffer hypomagnesemia and MODY5-like diabetes.	PCBD1	hypomagnesemia	5092	HP_0002917	22	27	59	73	False
26446763	Indeed, patients with PCBD1 mutations were shown to suffer hypomagnesemia and MODY5-like diabetes.	MODY5	hypomagnesemia	6928	HP_0002917	78	83	59	73	False
26446763	Mutations in CNNM2 were shown to cause hypomagnesemia, seizures and intellectual disability.	CNNM2	hypomagnesemia	54805	HP_0002917	13	18	39	53	True
26446763	Mutations in CNNM2 were shown to cause hypomagnesemia, seizures and intellectual disability.	CNNM2	seizures	54805	HP_0001250	13	18	55	63	True
26446763	Mutations in CNNM2 were shown to cause hypomagnesemia, seizures and intellectual disability.	CNNM2	intellectual disability	54805	HP_0001249	13	18	68	91	True
30336550	Heritable pulmonary arterial hypertension (HPAH) is a rare but severe complication of HHT.	HHT	pulmonary arterial hypertension	94	HP_0002092	86	89	10	41	True
29402277	Primary ciliary dyskinesia (PCD) is a rare, autosomal recessive disease with abnormalities in the structure of cilia, causing impairment of muco-ciliary clearance with respiratory tract infections, heterotaxia and abnormal sperm motility with male infertility.	PCD	ciliary dyskinesia	352909	HP_0012265	28	31	8	26	True
29402277	Primary ciliary dyskinesia (PCD) is a rare, autosomal recessive disease with abnormalities in the structure of cilia, causing impairment of muco-ciliary clearance with respiratory tract infections, heterotaxia and abnormal sperm motility with male infertility.	PCD	autosomal recessive	352909	HP_0000007	28	31	44	63	True
29402277	Primary ciliary dyskinesia (PCD) is a rare, autosomal recessive disease with abnormalities in the structure of cilia, causing impairment of muco-ciliary clearance with respiratory tract infections, heterotaxia and abnormal sperm motility with male infertility.	PCD	heterotaxia	352909	HP_0030853	28	31	198	209	False
29402277	Primary ciliary dyskinesia (PCD) is a rare, autosomal recessive disease with abnormalities in the structure of cilia, causing impairment of muco-ciliary clearance with respiratory tract infections, heterotaxia and abnormal sperm motility with male infertility.	PCD	abnormal sperm motility	352909	HP_0012206	28	31	214	237	False
29402277	Here, with a comprehensive literature review, we report a couple with an infertility history of 9years and three unsuccessful IVF treatments, where male partner has Kartagener's Syndrome, a subtype of PCD, displaying recurrent respiratory infections, dextrocardia and total asthenozoospermia.	PCD	dextrocardia	352909	HP_0001651	202	205	252	264	True
29402277	Here, with a comprehensive literature review, we report a couple with an infertility history of 9years and three unsuccessful IVF treatments, where male partner has Kartagener's Syndrome, a subtype of PCD, displaying recurrent respiratory infections, dextrocardia and total asthenozoospermia.	IVF	dextrocardia	6331	HP_0001651	127	130	252	264	False
29771329	Overexpression of Pmp22 in rodent models recapitulates several aspects of neuropathy, and reduction of Pmp22 in such models results in amelioration of the neuropathy phenotype.	Pmp22	neuropathy	5827	HP_0009830	18	23	74	84	False
20622109	In this study, we examine the role of proton-sensing ovarian cancer G protein-coupled receptor 1 (OGR1) in extracellular acidification-induced regulation of cyclooxygenase (COX)-2 induction, PGI(2) production, MAPK phosphatase (MKP)-1 expression, and plasminogen activator inhibitor (PAI)-1 expression and proliferation in human aortic smooth muscle cells (AoSMCs).	OGR1	cancer	8111	HP_0002664	98	102	61	67	False
20622109	In this study, we examine the role of proton-sensing ovarian cancer G protein-coupled receptor 1 (OGR1) in extracellular acidification-induced regulation of cyclooxygenase (COX)-2 induction, PGI(2) production, MAPK phosphatase (MKP)-1 expression, and plasminogen activator inhibitor (PAI)-1 expression and proliferation in human aortic smooth muscle cells (AoSMCs).	COX	cancer	1351	HP_0002664	173	176	61	67	False
20622109	In this study, we examine the role of proton-sensing ovarian cancer G protein-coupled receptor 1 (OGR1) in extracellular acidification-induced regulation of cyclooxygenase (COX)-2 induction, PGI(2) production, MAPK phosphatase (MKP)-1 expression, and plasminogen activator inhibitor (PAI)-1 expression and proliferation in human aortic smooth muscle cells (AoSMCs).	PAI	cancer	5054	HP_0002664	284	287	61	67	False
28987323	The knock out animals were protected from HFD induced obesity, fatty liver and insulin resistance.	fat	obesity	948	HP_0001513	63	66	54	61	False
26514363	In the single-locus analysis, two variants, the NBS1 rs1805794 (OR 1.42, 95% CI 1.15-1.76, P = 0.001), and RAD54L rs1048771 (OR 1.61, 95% CI 1.17-2.22, P = 0.002) were significantly associated with glioma risk.	NBS1	glioma	9048	HP_0009733	48	52	198	204	False
26514363	In the single-locus analysis, two variants, the NBS1 rs1805794 (OR 1.42, 95% CI 1.15-1.76, P = 0.001), and RAD54L rs1048771 (OR 1.61, 95% CI 1.17-2.22, P = 0.002) were significantly associated with glioma risk.	RAD54L	glioma	8438	HP_0009733	107	113	198	204	False
25290169	Promoter CpG island hypermethylation is an important mechanism for inactivating key cellular enzymes that mediate epigenetic processes in hepatitis-related hepatocellular carcinoma (HCC).	HCC	hepatocellular carcinoma	84668	HP_0001402	182	185	156	180	False
30231346	Large granular lymphocyte (LGL) leukemia has been recognized in the World Health Organization classifications among mature T cell and natural killer cell neoplasms and is divided into three categories.	killer	neoplasms	8795	HP_0002664	142	148	154	163	True
23053991	Recently, it has been demonstrated that, mutations of LRTOMT are associated with profound nonsyndromic hearing impairment at the DFNB63 locus.	LRTOMT	hearing impairment	220074	HP_0000365	54	60	103	121	True
23053991	Recently, it has been demonstrated that, mutations of LRTOMT are associated with profound nonsyndromic hearing impairment at the DFNB63 locus.	DFNB63	hearing impairment	220074	HP_0000365	129	135	103	121	True
23053991	Recently, it has been demonstrated that, mutations of LRTOMT are associated with profound nonsyndromic hearing impairment at the DFNB63 locus.	LRTOMT	profound	220074	HP_0012829	54	60	81	89	False
23053991	Recently, it has been demonstrated that, mutations of LRTOMT are associated with profound nonsyndromic hearing impairment at the DFNB63 locus.	DFNB63	profound	220074	HP_0012829	129	135	81	89	False
23053991	The objective of this study is to evaluate the carrier frequency of c.242G&gt;A mutation in LRTOMT gene and define the contribution of this gene in the etiology of deafness in Moroccan population.	LRTOMT	deafness	220074	HP_0000365	92	98	164	172	True
23053991	Our results show that after the GJB2 gene mutation in LRTOMT gene is the second cause of congenital hearing impairment in Moroccan patients.	LRTOMT	hearing impairment	220074	HP_0000365	54	60	100	118	True
23053991	Our results show that after the GJB2 gene mutation in LRTOMT gene is the second cause of congenital hearing impairment in Moroccan patients.	GJB2	hearing impairment	2706	HP_0000365	32	36	100	118	True
28515229	Mutations in human crumbs 1 (<i>CRB1</i>) are a major cause of retinal diseases that lead to blindness.	CRB1	blindness	23418	HP_0000618	32	36	93	102	True
26777436	To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.	ALS	sporadic	3483	HP_0003745	48	51	39	47	False
26777436	To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.	SOD1	sporadic	6647	HP_0003745	170	174	39	47	False
26777436	To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.	C9orf72	sporadic	203228	HP_0003745	176	183	39	47	False
26777436	To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.	TARDBP	sporadic	23435	HP_0003745	185	191	39	47	False
26777436	To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.	FUS	sporadic	2521	HP_0003745	193	196	39	47	False
26777436	To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.	ANG	sporadic	283	HP_0003745	198	201	39	47	False
26777436	To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.	CHMP2B	sporadic	25978	HP_0003745	203	209	39	47	False
26777436	To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.	ATXN2	sporadic	6311	HP_0003745	211	216	39	47	False
26777436	To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.	NIPA1	sporadic	123606	HP_0003745	218	223	39	47	False
26777436	To dissect the genetic architecture of sporadic ALS, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, C9orf72, TARDBP, FUS, ANG, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.	SMN1	sporadic	6606	HP_0003745	225	229	39	47	False
29302927	It is characterized by hyperkeratotic follicular papules coalescing into orange-red scaly plaques, islands of sparing, and palmoplantar keratoderma.	red	palmoplantar keratoderma	8444	HP_0000982	80	83	123	147	False
24711380	Erbin(-/-) mice rapidly develop decompensated cardiac hypertrophy, and following severe pressure overload all Erbin(-/-) mice died from heart failure.	Erbin	heart failure	55914	HP_0001635	0	5	136	149	False
24711380	Erbin(-/-) mice rapidly develop decompensated cardiac hypertrophy, and following severe pressure overload all Erbin(-/-) mice died from heart failure.	mice	heart failure	23581	HP_0001635	11	15	136	149	False
17377520	PITPNM3, known as a human homologue of the Drosophila retinal degeneration B (rdgB), lacks the N-terminal PIT domain needed for transport of phospholipids, renewal of photoreceptors membrane and providing the electroretinogram (ERG) response to light.	PITPNM3	retinal degeneration	83394	HP_0000546	0	7	54	74	True
17377520	PITPNM3, known as a human homologue of the Drosophila retinal degeneration B (rdgB), lacks the N-terminal PIT domain needed for transport of phospholipids, renewal of photoreceptors membrane and providing the electroretinogram (ERG) response to light.	rdgB	retinal degeneration	9600	HP_0000546	78	82	54	74	False
17377520	PITPNM3, known as a human homologue of the Drosophila retinal degeneration B (rdgB), lacks the N-terminal PIT domain needed for transport of phospholipids, renewal of photoreceptors membrane and providing the electroretinogram (ERG) response to light.	ERG	retinal degeneration	2078	HP_0000546	228	231	54	74	False
27557495	Polo-Like Kinase 1 (PLK1), a serine-threonine kinase that is often overexpressed across multiple tumor types, is one of the key regulators of CIN and is considered as a potential therapeutic target.	PLK1	tumor	5347	HP_0002664	20	24	97	102	False
27557495	Rather than directly inhibiting PLK1, we found that inhibition of PP2A causes selective lethality to PLK1-overexpressing breast, pancreatic, ovarian, glioblastoma, and prostate cancer cells.	PLK1	glioblastoma	5347	HP_0012174	32	36	150	162	False
27557495	Rather than directly inhibiting PLK1, we found that inhibition of PP2A causes selective lethality to PLK1-overexpressing breast, pancreatic, ovarian, glioblastoma, and prostate cancer cells.	PLK1	cancer	5347	HP_0002664	32	36	177	183	False
29849566	Our study showed that targeted NGS is an effective tool for diagnosis of genetic deafness and that p.G141R in <i>ILDR1</i> may be a relatively frequent mutation for DFNB42 in Chinese Hans	DFNB42	deafness	286676	HP_0000365	165	171	81	89	True
29556354	Genetic modification of a human prostate cancer cell line to induce miR-101 and suppress CENPF decreased cell migration and invasion.	CENPF	cancer	1063	HP_0002664	89	94	41	47	False
29556354	Genetic modification of a human prostate cancer cell line to induce miR-101 and suppress CENPF decreased cell migration and invasion.	miR	cancer	220972	HP_0002664	68	71	41	47	False
29556354	As prostate cancer xenografts in mice, these cells had decreased visibility on diffusion weighted MRI and decreased perfusion, which correlated with immunostaining showing decreased cell density and proliferation.	mice	cancer	23581	HP_0002664	33	37	12	18	False
26578234	In a bone metastasis model, mice treated with ZOL+US had osteolytic lesions that were 58% smaller than those of ZOL-treated animals as well as a reduced skeletal tumor burden.	mice	tumor	23581	HP_0002664	28	32	162	167	False
26578234	Additionally, US forced the penetration of ZOL within tumors, as demonstrated by the intratumoral accumulation of unprenylated Rap1A, a surrogate marker of ZOL antitumor activity.	Rap1A	tumor	5906	HP_0002664	127	132	54	59	False
29351440	Previously, we demonstrated that several common pathological gene regulatory programs such as innate inflammatory and profibrotic transcriptional networks were shared by COPD and heart failure.	COPD	heart failure	372	HP_0001635	170	174	179	192	False
21493627	Meckel syndrome (MKS) is an embryonic lethal, autosomal recessive disorder characterized by polycystic kidney disease, central nervous system defects, polydactyly and liver fibrosis.	MKS	polydactyly	54903	HP_0010442	17	20	151	162	True
21493627	However, mutation screening of these genes revealed two mutated alleles in only just over half of our MKS cohort (46 families), suggesting an even greater level of genetic heterogeneity.	MKS	heterogeneity	54903	HP_0001425	102	105	172	185	False
21493627	The fetus inherited an additional likely pathogenic novel missense change to a second MKS gene, CEP290; p.R2210C, suggesting oligogenic inheritance in this disorder	MKS	oligogenic inheritance	54903	HP_0010983	86	89	125	147	False
21493627	The fetus inherited an additional likely pathogenic novel missense change to a second MKS gene, CEP290; p.R2210C, suggesting oligogenic inheritance in this disorder	CEP290	oligogenic inheritance	80184	HP_0010983	96	102	125	147	False
29061647	Pyridoxine-dependent epilepsy (PDE) is a rare disease characterized by mutations in the lysine degradation gene <i>ALDH7A1</i> leading to recurrent neonatal seizures, which are uniquely alleviated by high doses of pyridoxine or pyridoxal 5'-phosphate (vitamin B6 vitamers).	PDE	epilepsy	501	HP_0001250	31	34	21	29	True
29061647	Pyridoxine-dependent epilepsy (PDE) is a rare disease characterized by mutations in the lysine degradation gene <i>ALDH7A1</i> leading to recurrent neonatal seizures, which are uniquely alleviated by high doses of pyridoxine or pyridoxal 5'-phosphate (vitamin B6 vitamers).	PDE	seizures	501	HP_0001250	31	34	157	165	True
29061647	Over 60 years after the initial description of PDE, we report the first animal model for this disease: an aldh7a1-null zebrafish (<i>Danio rerio</i>) displaying deficient lysine metabolism and spontaneous and recurrent seizures in the larval stage (10 days postfertilization).	PDE	seizures	501	HP_0001250	47	50	219	227	True
29061647	Over 60 years after the initial description of PDE, we report the first animal model for this disease: an aldh7a1-null zebrafish (<i>Danio rerio</i>) displaying deficient lysine metabolism and spontaneous and recurrent seizures in the larval stage (10 days postfertilization).	aldh7a1	seizures	501	HP_0001250	106	113	219	227	True
29061647	Remarkably, as is the case in human PDE, the seizures show an almost immediate sensitivity to pyridoxine and pyridoxal 5'-phosphate, with a resulting extension of the life span.	PDE	seizures	501	HP_0001250	36	39	45	53	True
29061647	Impaired lysine degradation with accumulation of PDE biomarkers, B6 deficiency, and low -aminobutyric acid levels were observed in the <i>aldh7a1</i><sup>-/-</sup> larvae, which may play a significant role in the seizure phenotype and PDE pathogenesis.	PDE	seizure	501	HP_0001250	49	52	214	221	True
29061647	Impaired lysine degradation with accumulation of PDE biomarkers, B6 deficiency, and low -aminobutyric acid levels were observed in the <i>aldh7a1</i><sup>-/-</sup> larvae, which may play a significant role in the seizure phenotype and PDE pathogenesis.	aldh7a1	seizure	501	HP_0001250	139	146	214	221	True
29061647	This novel model provides valuable insights into PDE pathophysiology; further research may offer new opportunities for drug discovery to control seizure activity and improve neurodevelopmental outcomes for PDE	PDE	seizure	501	HP_0001250	49	52	145	152	True
29914902	After 1year, because of worsening in spatial orientation and the onset of dressing apraxia, he was referred to our memory clinic.	spatial	apraxia	219793	HP_0002186	38	45	84	91	False
27861128	Mutations in the homeobox gene SHOX cause SHOX deficiency, a condition with clinical manifestations ranging from short stature without dysmorphic signs to severe mesomelic skeletal dysplasia.	SHOX	short stature	6473	HP_0004322	31	35	113	126	True
27861128	Mutations in the homeobox gene SHOX cause SHOX deficiency, a condition with clinical manifestations ranging from short stature without dysmorphic signs to severe mesomelic skeletal dysplasia.	SHOX	skeletal dysplasia	6473	HP_0002652	31	35	172	190	False
29864493	Elevated cytokines, such as interferon (IFN)-, interleukin (IL)-6 and tumor necrosis factor  decreased to normal levels after splenectomy whereas IL-10 remained high.	IFN	tumor	3439	HP_0002664	40	43	71	76	False
29443088	In addition to describing how to perform the EEG-ECG recordings, we also detail methods to quantify the resulting data for seizures, EEG spectral power, cardiac function, and heart rate variability, which we demonstrate in an example experiment using a mouse with epilepsy due to Kcna1 gene deletion.	Kcna1	epilepsy	3736	HP_0001250	280	285	264	272	True
29443088	In addition to describing how to perform the EEG-ECG recordings, we also detail methods to quantify the resulting data for seizures, EEG spectral power, cardiac function, and heart rate variability, which we demonstrate in an example experiment using a mouse with epilepsy due to Kcna1 gene deletion.	Kcna1	seizures	3736	HP_0001250	280	285	123	131	True
29071511	The most common and severe form, primary hyperoxaluria Type I, is due to the deficit of liver peroxisomal alanine/glyoxylate aminotransferase (AGT).	Type	hyperoxaluria	6445	HP_0003159	55	59	41	54	False
29071511	The most common and severe form, primary hyperoxaluria Type I, is due to the deficit of liver peroxisomal alanine/glyoxylate aminotransferase (AGT).	AGT	hyperoxaluria	189	HP_0003159	143	146	41	54	True
29071511	Primary hyperoxaluria Type II and primary hyperoxaluria Type III are due to the deficit of glyoxylate reductase/hydroxypyruvate reductase (GRHPR) and 4-hydroxy-2-oxoglutarate aldolase (HOGA1), respectively.	Type	hyperoxaluria	6445	HP_0003159	22	26	8	21	False
29071511	Primary hyperoxaluria Type II and primary hyperoxaluria Type III are due to the deficit of glyoxylate reductase/hydroxypyruvate reductase (GRHPR) and 4-hydroxy-2-oxoglutarate aldolase (HOGA1), respectively.	GRHPR	hyperoxaluria	9380	HP_0003159	139	144	8	21	True
29071511	Primary hyperoxaluria Type II and primary hyperoxaluria Type III are due to the deficit of glyoxylate reductase/hydroxypyruvate reductase (GRHPR) and 4-hydroxy-2-oxoglutarate aldolase (HOGA1), respectively.	HOGA1	hyperoxaluria	112817	HP_0003159	185	190	8	21	True
30429449	BACKGROUND RET rearrangements have been reported in 30% of papillary thyroid carcinomas and 1-2% of non-small cell lung cancer (NSCLC).	RET	papillary thyroid carcinomas	5979	HP_0002895	11	14	59	87	False
30429449	BACKGROUND RET rearrangements have been reported in 30% of papillary thyroid carcinomas and 1-2% of non-small cell lung cancer (NSCLC).	RET	cancer	5979	HP_0002664	11	14	120	126	True
30429449	In these tumors, RET gene fusion product provides a constitutively active tyrosine kinase (TKR), leading to uncontrolled cellular proliferation, differentiation, and migration.	RET	tumors	5979	HP_0002664	17	20	9	15	True
30429449	In these tumors, RET gene fusion product provides a constitutively active tyrosine kinase (TKR), leading to uncontrolled cellular proliferation, differentiation, and migration.	TKR	tumors	8277	HP_0002664	91	94	9	15	False
30429449	In this investigation we assessed the positivity rate of RET gene rearrangement in primary and metastatic non-small cell lung cancer and explored their relationships.	RET	cancer	5979	HP_0002664	57	60	126	132	True
30429449	The RET rearrangement uniformity in metastatic lymph nodes and tumor specimens were contrasted and the relationships between RET rearrangement and patients' clinical features were investigated.	RET	tumor	5979	HP_0002664	4	7	63	68	True
30429449	RESULTS For those 384 cases, 7 (1.82%) cases had tumors with identified RET rearrangement.	RET	tumors	5979	HP_0002664	72	75	49	55	True
30429449	Among the 246 paired cases, 3 (1.22%) cases of primary tumor had identified RET rearrangement and 2 (0.81%) cases of metastases had identified RET rearrangement.	RET	tumor	5979	HP_0002664	76	79	55	60	True
30429449	CONCLUSIONS The results of this research indicate that the metastases of non-small cell lung cancer can predict RET rearrangement of the primary tumor tissue in the majority of cases.	RET	cancer	5979	HP_0002664	112	115	93	99	True
30429449	CONCLUSIONS The results of this research indicate that the metastases of non-small cell lung cancer can predict RET rearrangement of the primary tumor tissue in the majority of cases.	RET	tumor	5979	HP_0002664	112	115	145	150	True
30429449	Testing for RET rearrangement in metastases can be used as an alternative to testing of primary tumor tissue if it is inaccessible	RET	tumor	5979	HP_0002664	12	15	96	101	True
29409816	RAD51C and RAD51D have been defined as susceptibility genes for hereditary breast and ovarian cancer syndrome in several studies.	RAD51D	cancer	5892	HP_0002664	11	17	94	100	True
29409816	RAD51C and RAD51D have been defined as susceptibility genes for hereditary breast and ovarian cancer syndrome in several studies.	RAD51C	cancer	5889	HP_0002664	0	6	94	100	True
29409816	The RAD51C pathogenic variant c.404G&gt;A was identified in a breast and ovarian cancer family (0.7%), while the RAD51D pathogenic variant c.694C&gt;T was described in an ovarian cancer family (1.3%).	RAD51D	cancer	5892	HP_0002664	115	121	83	89	True
29409816	The RAD51C pathogenic variant c.404G&gt;A was identified in a breast and ovarian cancer family (0.7%), while the RAD51D pathogenic variant c.694C&gt;T was described in an ovarian cancer family (1.3%).	RAD51C	cancer	5889	HP_0002664	4	10	83	89	True
29409816	These results increase our knowledge about the RAD51C and RAD51D mutation spectrum and support the notion that these genes should be included in the gene panel testing performed on patients with hereditary breast and ovarian cancer syndrome	RAD51D	cancer	5892	HP_0002664	58	64	225	231	True
29409816	These results increase our knowledge about the RAD51C and RAD51D mutation spectrum and support the notion that these genes should be included in the gene panel testing performed on patients with hereditary breast and ovarian cancer syndrome	RAD51C	cancer	5889	HP_0002664	47	53	225	231	True
26918822	Heterotaxy, a birth defect involving left-right patterning defects, and primary ciliary dyskinesia (PCD), a sinopulmonary disease with dyskinetic/immotile cilia in the airway are seemingly disparate diseases.	PCD	ciliary dyskinesia	352909	HP_0012265	100	103	80	98	True
28662356	A protective effect was observed for the fetal NOG1 SNP on cleft palate only, opposite in direction to the effect on CLO.	NOG1	cleft palate	23560	HP_0000175	47	51	59	71	False
28427240	Here, we examined the effects of UBE2T on the progression of gastric cancer.	UBE2T	cancer	29089	HP_0002664	33	38	69	75	True
28427240	UBE2T was highly expressed in gastric tumors and gastric cancer cells.	UBE2T	cancer	29089	HP_0002664	0	5	57	63	True
28427240	UBE2T was highly expressed in gastric tumors and gastric cancer cells.	UBE2T	tumors	29089	HP_0002664	0	5	38	44	True
28427240	siRNA-mediated suppression of UBE2T inhibited gastric cancer cell proliferation and colony formation by promoting cell cycle arrest at G2/M phase and increasing apoptosis.	UBE2T	cancer	29089	HP_0002664	30	35	54	60	True
28427240	Suppression of UBE2T also attenuated the invasive and metastatic abilities of gastric cancer cells by altering expression of epithelial-mesenchymal transition (EMT)-related factors.	UBE2T	cancer	29089	HP_0002664	15	20	86	92	True
28427240	Suppression of UBE2T also attenuated the invasive and metastatic abilities of gastric cancer cells by altering expression of epithelial-mesenchymal transition (EMT)-related factors.	EMT	cancer	3702	HP_0002664	160	163	86	92	True
28427240	A xenograft model in which nude mice were injected with UBE2T knockdown human gastric cancer cells confirmed that suppression of UBE2T also decreased tumor formation and growth in vivo.	UBE2T	cancer	29089	HP_0002664	56	61	86	92	True
28427240	A xenograft model in which nude mice were injected with UBE2T knockdown human gastric cancer cells confirmed that suppression of UBE2T also decreased tumor formation and growth in vivo.	nude	cancer	54820	HP_0002664	27	31	86	92	False
28427240	A xenograft model in which nude mice were injected with UBE2T knockdown human gastric cancer cells confirmed that suppression of UBE2T also decreased tumor formation and growth in vivo.	mice	cancer	23581	HP_0002664	32	36	86	92	False
28427240	A xenograft model in which nude mice were injected with UBE2T knockdown human gastric cancer cells confirmed that suppression of UBE2T also decreased tumor formation and growth in vivo.	UBE2T	tumor	29089	HP_0002664	56	61	150	155	True
28427240	A xenograft model in which nude mice were injected with UBE2T knockdown human gastric cancer cells confirmed that suppression of UBE2T also decreased tumor formation and growth in vivo.	nude	tumor	54820	HP_0002664	27	31	150	155	False
28427240	A xenograft model in which nude mice were injected with UBE2T knockdown human gastric cancer cells confirmed that suppression of UBE2T also decreased tumor formation and growth in vivo.	mice	tumor	23581	HP_0002664	32	36	150	155	False
28427240	These results suggest that UBE2T plays a critical role in gastric cancer, and that it may serve as a useful prognostic biomarker and therapeutic target in gastric cancer patients	UBE2T	cancer	29089	HP_0002664	27	32	66	72	True
30613837	The 2016 revised World Health Organization (WHO) classification of lymphoid neoplasms included the category of high-grade B cell lymphomas (HGBLs) with combined MYC and BCL2 and/or BCL6 rearrangements (double-hit, DH).	MYC	neoplasms	4609	HP_0002664	161	164	76	85	True
30613837	The 2016 revised World Health Organization (WHO) classification of lymphoid neoplasms included the category of high-grade B cell lymphomas (HGBLs) with combined MYC and BCL2 and/or BCL6 rearrangements (double-hit, DH).	BCL2	neoplasms	596	HP_0002664	169	173	76	85	True
30613837	The 2016 revised World Health Organization (WHO) classification of lymphoid neoplasms included the category of high-grade B cell lymphomas (HGBLs) with combined MYC and BCL2 and/or BCL6 rearrangements (double-hit, DH).	BCL6	neoplasms	604	HP_0002664	181	185	76	85	True
28972077	Ancestor tumor clones evolved into three subclonal clades: clade1 fostered metastatic subclones that carried metastatic features of <i>PIK3CA</i> and <i>ARHGAP26</i> point mutations as well as chr13 arm-level deletion, clade2 owned branch-specific <i>JAK1</i> mutations and <i>PTEN</i> deletion, and clade3 was found in two vertical distribution samples below the primary tumor area, highlighting the fact that it is possible for PMME to disseminate by the submucosal longitudinal lymphatic route at an early stage of metastasis.	arm	tumor	80210	HP_0002664	199	202	9	14	False
28972077	Ancestor tumor clones evolved into three subclonal clades: clade1 fostered metastatic subclones that carried metastatic features of <i>PIK3CA</i> and <i>ARHGAP26</i> point mutations as well as chr13 arm-level deletion, clade2 owned branch-specific <i>JAK1</i> mutations and <i>PTEN</i> deletion, and clade3 was found in two vertical distribution samples below the primary tumor area, highlighting the fact that it is possible for PMME to disseminate by the submucosal longitudinal lymphatic route at an early stage of metastasis.	fact	tumor	11198	HP_0002664	401	405	9	14	False
28972077	These findings facilitate interpretation of the genetic essence of this rare melanoma subtype as well as the pattern of cancer evolution, thus reinforcing the therapeutic challenges associated with PMME.<b>Significance:</b> This study highlights the use of multiregion exome sequencing and whole genome SNP array genotyping to comprehensively characterize the genetic landscape of a rare type of esophogeal melanoma.	type	cancer	6445	HP_0002664	89	93	120	126	False
28485764	5-20% of melanoma families have germline mutations in the CDKN2A gene.	CDKN2A	melanoma	1029	HP_0002861	58	64	9	17	True
28485764	Swedish CDKN2A mutation carriers have a young median age of onset of melanoma, increased risks of multiple primary melanoma and of tobacco-associated cancers in respiratory and upper digestive tissues, and also worse survival compared to non-carriers.	CDKN2A	melanoma	1029	HP_0002861	8	14	69	77	True
28485764	In a few (non-Swedish) melanoma families, mutations in other genes have been found, including CDK4, TERT, POT1, ACD and TERF2IP.	CDK4	melanoma	1019	HP_0002861	94	98	23	31	True
28485764	In a few (non-Swedish) melanoma families, mutations in other genes have been found, including CDK4, TERT, POT1, ACD and TERF2IP.	TERT	melanoma	7015	HP_0002861	100	104	23	31	True
28485764	In a few (non-Swedish) melanoma families, mutations in other genes have been found, including CDK4, TERT, POT1, ACD and TERF2IP.	POT1	melanoma	25913	HP_0002861	106	110	23	31	True
28485764	In a few (non-Swedish) melanoma families, mutations in other genes have been found, including CDK4, TERT, POT1, ACD and TERF2IP.	ACD	melanoma	65057	HP_0002861	112	115	23	31	True
28485764	In some families with multiple cases of uveal and cutaneous melanoma (including a few Swedish families), mutations in the BAP1 gene have been found.	BAP1	melanoma	154043	HP_0002861	122	126	60	68	False
28485764	In genes that regulate cellular pigmentation pathways, including MC1R, ASIP, IRF4, TYR, TYRP1 and OCA, there are different common variants that determine complexion traits, and those variants are also associated with different risks of melanoma.	ASIP	melanoma	56288	HP_0002861	71	75	236	244	False
28485764	In genes that regulate cellular pigmentation pathways, including MC1R, ASIP, IRF4, TYR, TYRP1 and OCA, there are different common variants that determine complexion traits, and those variants are also associated with different risks of melanoma.	IRF4	melanoma	3662	HP_0002861	77	81	236	244	False
28485764	In genes that regulate cellular pigmentation pathways, including MC1R, ASIP, IRF4, TYR, TYRP1 and OCA, there are different common variants that determine complexion traits, and those variants are also associated with different risks of melanoma.	TYR	melanoma	7299	HP_0002861	83	86	236	244	True
28485764	In genes that regulate cellular pigmentation pathways, including MC1R, ASIP, IRF4, TYR, TYRP1 and OCA, there are different common variants that determine complexion traits, and those variants are also associated with different risks of melanoma.	traits	melanoma	55929	HP_0002861	165	171	236	244	False
28485764	Individuals with known mutations in tumor suppressor genes such as CDKN2A and BAP1 require, in addition, follow up for other cancers	CDKN2A	tumor	1029	HP_0002664	67	73	36	41	True
28485764	Individuals with known mutations in tumor suppressor genes such as CDKN2A and BAP1 require, in addition, follow up for other cancers	BAP1	tumor	154043	HP_0002664	78	82	36	41	False
26033187	uPA may enhance the migratory and invasive capabilities of endometrial tumor cells by the phosphorylation of ERK1/2, Akt and p38 molecules.	uPA	tumor	5328	HP_0002664	0	3	71	76	False
26033187	uPA may enhance the migratory and invasive capabilities of endometrial tumor cells by the phosphorylation of ERK1/2, Akt and p38 molecules.	Akt	tumor	207	HP_0002664	117	120	71	76	True
26033187	uPA is a dysregulated gene involved in the tumorigenesis, bio-pathological features and outcomes of EEC. uPA may be a potential molecule and target for the detection and treatment of EEC.	uPA	tumor	5328	HP_0002664	0	3	43	48	False
28576945	Thus, research directed at expanding our current understanding of transcriptional corepressors could impact the future development of new cancer diagnostics, prognostics, and therapies.	impact	cancer	55364	HP_0002664	101	107	138	144	False
28576945	Importantly, the role of CtBP1 overexpression in adult tissues in promoting the progression of multiple cancer types through their ability to modulate the transcription of developmental genes ectopically is explored.	CtBP1	cancer	1487	HP_0002664	25	30	104	110	True
28576945	CtBP1 overexpression is known to be protumorigenic and affects the regulation of gene networks associated with &quot;cancer hallmarks&quot; and malignant behavior, including increased cell survival, proliferation, migration, invasion, and the epithelial-mesenchymal transition.	CtBP1	cancer	1487	HP_0002664	0	5	117	123	True
28576945	CtBP1 overexpression is known to be protumorigenic and affects the regulation of gene networks associated with &quot;cancer hallmarks&quot; and malignant behavior, including increased cell survival, proliferation, migration, invasion, and the epithelial-mesenchymal transition.	CtBP1	tumor	1487	HP_0002664	0	5	39	44	True
28576945	As a transcriptional regulator of broad developmental processes capable of promoting malignant growth in adult tissues, therapeutically targeting the CtBP1 corepressor has the potential to be an effective method for the treatment of diverse tumor types.	CtBP1	tumor	1487	HP_0002664	150	155	241	246	True
28434238	We included 7 consecutive patients with LP with typical intracranial calcifications out of 16 patients with ECM1 mutations and investigated the semiologic features, ictal and interictal EEG findings, and long-term prognosis of epilepsy in this genodermatosis.	ECM1	epilepsy	1893	HP_0001250	108	112	227	235	True
28434238	Four of them had seizures (57.1%), and focal seizures with motionless staring were the most common seizure phenotype, originating from bilateral mesial temporal areas, but interictal spikes were scant.	staring	seizures	9810	HP_0001250	70	77	17	25	False
28434238	Four of them had seizures (57.1%), and focal seizures with motionless staring were the most common seizure phenotype, originating from bilateral mesial temporal areas, but interictal spikes were scant.	staring	seizure	9810	HP_0001250	70	77	99	106	False
28434238	Four of them had seizures (57.1%), and focal seizures with motionless staring were the most common seizure phenotype, originating from bilateral mesial temporal areas, but interictal spikes were scant.	staring	bilateral	9810	HP_0012832	70	77	135	144	False
26351325	Furthermore, in vitro inhibition of cancer-derived BMP4 noncanonical signals results in an increase of chemosensitivity in a colorectal cancer cell line.	BMP4	cancer	652	HP_0002664	51	55	36	42	False
21292309	We have previously identified a novel zinc finger protein, glial cell line-derived neurotrophic factor-inducible zinc finger protein 1 (GZF1), whose expression was induced in the human neuroblastoma cell line TGW expressing RET by GDNF stimulation and was also detected in mouse metanephric kidney.	GDNF	neuroblastoma	2668	HP_0003006	231	235	185	198	True
21292309	We have previously identified a novel zinc finger protein, glial cell line-derived neurotrophic factor-inducible zinc finger protein 1 (GZF1), whose expression was induced in the human neuroblastoma cell line TGW expressing RET by GDNF stimulation and was also detected in mouse metanephric kidney.	RET	neuroblastoma	5979	HP_0003006	224	227	185	198	True
21292309	We have previously identified a novel zinc finger protein, glial cell line-derived neurotrophic factor-inducible zinc finger protein 1 (GZF1), whose expression was induced in the human neuroblastoma cell line TGW expressing RET by GDNF stimulation and was also detected in mouse metanephric kidney.	GZF1	neuroblastoma	64412	HP_0003006	136	140	185	198	False
21292309	We also evaluated GZF1 expression in various kidney diseases including membranous nephropathy, minimal change nephrotic syndrome with or without acute kidney injury, immunoglobulin A nephropathy, diabetic nephropathy, acute tubular necrosis, and antineutrophil cytoplasmic antibody-related glomerulonephritis.	GZF1	membranous nephropathy	64412	HP_0012578	18	22	71	93	False
21292309	In addition, GZF1 expression was undetectable or very low in most cases of renal cell carcinomas and Wilms tumors.	GZF1	renal cell carcinomas	64412	HP_0005584	13	17	75	96	False
21292309	In addition, GZF1 expression was undetectable or very low in most cases of renal cell carcinomas and Wilms tumors.	GZF1	tumors	64412	HP_0002664	13	17	107	113	False
28924745	Genetic studies have identified a homozygous truncation mutation in Trak1 that causes hypertonia in mice.	Trak1	hypertonia	22906	HP_0001276	68	73	86	96	True
28924745	Moreover, elevated Trak1 protein expression is associated with several types of cancers and variants in Trak1 are linked to childhood absence epilepsy in humans.	Trak1	epilepsy	22906	HP_0001250	19	24	142	150	True
28924745	We found that hypertonia-associated mutation impairs Trak1 mitochondrial localization and its ability to facilitate mitochondrial tethering and fusion.	Trak1	hypertonia	22906	HP_0001276	53	58	14	24	True
28924745	Our findings uncover a novel function of Trak1 as a regulator of mitochondrial fusion and provide evidence linking dysregulated mitochondrial dynamics to hypertonia pathogenesis	Trak1	hypertonia	22906	HP_0001276	41	46	154	164	True
29161432	Homozygous, loss of function variants in PROKR2 was initially implicated in autosomal recessive IGD; however, most IGD-associated PROKR2 variants are heterozygous.	PROKR2	autosomal recessive	128674	HP_0000007	41	47	76	95	True
26988419	Finally, we show that inhibition of SMYD2 cooperates with standard chemotherapy to treat PDAC cells and tumors.	SMYD2	tumors	56950	HP_0002664	36	41	104	110	False
26988419	These findings uncover a pivotal role for SMYD2 in promoting pancreatic cancer.	SMYD2	cancer	56950	HP_0002664	42	47	72	78	False
29317501	CHIP plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive type 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.	CHIP	neurodegenerative disease	10273	HP_0002180	0	4	48	73	False
29317501	CHIP plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive type 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.	type	neurodegenerative disease	6445	HP_0002180	157	161	48	73	False
29317501	CHIP plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive type 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.	CHIP	autosomal recessive	10273	HP_0000007	0	4	137	156	True
29317501	CHIP plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive type 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.	type	autosomal recessive	6445	HP_0000007	157	161	137	156	True
29317501	CHIP plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive type 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.	CHIP	ataxia	10273	HP_0001251	0	4	130	136	True
29317501	CHIP plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia autosomal recessive type 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.	type	ataxia	6445	HP_0001251	157	161	130	136	False
26497552	In order to determine the role of Flii during carcinogenesis, squamous cell carcinomas (SCCs) were induced in Flii heterozygous (Flii+/-), wild-type and Flii overexpressing (FliiTg/Tg) mice by intradermal injection of 3-methylcholanthrene (MCA).	Flii	squamous cell carcinomas	2314	HP_0002860	34	38	62	86	False
26497552	In order to determine the role of Flii during carcinogenesis, squamous cell carcinomas (SCCs) were induced in Flii heterozygous (Flii+/-), wild-type and Flii overexpressing (FliiTg/Tg) mice by intradermal injection of 3-methylcholanthrene (MCA).	mice	squamous cell carcinomas	23581	HP_0002860	185	189	62	86	False
26497552	In order to determine the role of Flii during carcinogenesis, squamous cell carcinomas (SCCs) were induced in Flii heterozygous (Flii+/-), wild-type and Flii overexpressing (FliiTg/Tg) mice by intradermal injection of 3-methylcholanthrene (MCA).	SCC	squamous cell carcinomas	6317	HP_0002860	88	91	62	86	False
26497552	Flii was highly expressed in human SCC biopsies particularly by the invading cells at the tumor edge.	Flii	tumor	2314	HP_0002664	0	4	90	95	False
26497552	Flii was highly expressed in human SCC biopsies particularly by the invading cells at the tumor edge.	SCC	tumor	6317	HP_0002664	35	38	90	95	False
26497552	In contrast Flii+/- mice had significantly smaller tumors that were less invasive.	Flii	tumor	2314	HP_0002664	12	16	51	56	False
26497552	In contrast Flii+/- mice had significantly smaller tumors that were less invasive.	mice	tumor	23581	HP_0002664	20	24	51	56	False
26497552	Intradermal injection of Flii neutralizing antibodies during SCC initiation and progression significantly reduced the size of the tumors and, in vitro, decreased cellular sphere formation and invasion.	Flii	tumor	2314	HP_0002664	25	29	130	135	False
26497552	Intradermal injection of Flii neutralizing antibodies during SCC initiation and progression significantly reduced the size of the tumors and, in vitro, decreased cellular sphere formation and invasion.	SCC	tumor	6317	HP_0002664	61	64	130	135	False
26497552	Analysis of the tumors from the Flii overexpressing mice showed reduced caspase I and annexin V expression suggesting Flii may negatively regulate apoptosis within these tumors.	Flii	tumor	2314	HP_0002664	32	36	16	21	False
26497552	Analysis of the tumors from the Flii overexpressing mice showed reduced caspase I and annexin V expression suggesting Flii may negatively regulate apoptosis within these tumors.	mice	tumor	23581	HP_0002664	52	56	16	21	False
26497552	These studies therefore suggest that Flii enhances SCC tumor progression by decreasing apoptosis and enhancing tumor cell invasion.	Flii	tumor	2314	HP_0002664	37	41	55	60	False
26497552	These studies therefore suggest that Flii enhances SCC tumor progression by decreasing apoptosis and enhancing tumor cell invasion.	SCC	tumor	6317	HP_0002664	51	54	55	60	False
28376086	The mitochondrial protein SLC25A46 has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.	SLC25A46	optic atrophy	91137	HP_0000648	26	34	157	170	True
28376086	The mitochondrial protein SLC25A46 has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.	type	optic atrophy	6445	HP_0000648	192	196	157	170	False
28376086	The mitochondrial protein SLC25A46 has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.	SLC25A46	ataxia	91137	HP_0001251	26	34	238	244	True
28376086	The mitochondrial protein SLC25A46 has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.	type	ataxia	6445	HP_0001251	192	196	238	244	False
28376086	The mitochondrial protein SLC25A46 has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.	SLC25A46	cerebellar hypoplasia	91137	HP_0001321	26	34	272	293	False
28376086	The mitochondrial protein SLC25A46 has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.	type	cerebellar hypoplasia	6445	HP_0001321	192	196	272	293	False
28376086	Mutant mice manifest the main clinical features identified in patients, including ataxia, optic atrophy and cerebellar hypoplasia, which were completely rescued by expression of the human ortholog.	mice	optic atrophy	23581	HP_0000648	7	11	90	103	False
28376086	Mutant mice manifest the main clinical features identified in patients, including ataxia, optic atrophy and cerebellar hypoplasia, which were completely rescued by expression of the human ortholog.	mice	ataxia	23581	HP_0001251	7	11	82	88	False
28376086	Mutant mice manifest the main clinical features identified in patients, including ataxia, optic atrophy and cerebellar hypoplasia, which were completely rescued by expression of the human ortholog.	mice	cerebellar hypoplasia	23581	HP_0001321	7	11	108	129	False
22488736	He has similar clinical findings, including mild facial dysmorphisms and intellectual disability, as other individuals with much larger deletions of the terminus of the long arm of chromosome 14.	arm	mild	80210	HP_0012825	174	177	44	48	False
22488736	He has similar clinical findings, including mild facial dysmorphisms and intellectual disability, as other individuals with much larger deletions of the terminus of the long arm of chromosome 14.	arm	facial dysmorphisms	80210	HP_0001999	174	177	49	68	True
22488736	He has similar clinical findings, including mild facial dysmorphisms and intellectual disability, as other individuals with much larger deletions of the terminus of the long arm of chromosome 14.	arm	intellectual disability	80210	HP_0001249	174	177	73	96	True
27359054	Here we found that perilipin-1 (PLIN1) mRNA expression is significantly downregulated in human breast cancer.	PLIN1	cancer	5346	HP_0002664	32	37	102	108	False
27359054	Further Cox proportional hazard models analysis revealed that the reduced expression of PLIN1 is an independent predictor of overall survival in estrogen receptor positive (p &lt; 0.0001, HR = 0.87, 95% CI = 0.81-0.92, N = 3,600) and luminal A-subtype (p = 0.02, HR = 0.88, 95% CI = 0.78-0.98, N = 1,469) breast cancer patients.	PLIN1	cancer	5346	HP_0002664	88	93	312	318	False
27359054	Further Cox proportional hazard models analysis revealed that the reduced expression of PLIN1 is an independent predictor of overall survival in estrogen receptor positive (p &lt; 0.0001, HR = 0.87, 95% CI = 0.81-0.92, N = 3,600) and luminal A-subtype (p = 0.02, HR = 0.88, 95% CI = 0.78-0.98, N = 1,469) breast cancer patients.	Cox	cancer	1351	HP_0002664	8	11	312	318	False
27359054	We also demonstrated that the exogenous expression of PLIN1 in human breast cancer MCF-7 and MDA-MB-231 cells significantly inhibits cell proliferation, migration, invasion and in vivo tumorigenesis in mice.	PLIN1	cancer	5346	HP_0002664	54	59	76	82	False
27359054	Together, these data provide novel insights into a prognostic significance of PLIN1 in human breast cancer and reveal a potentially new gene therapy target for breast cancer	PLIN1	cancer	5346	HP_0002664	78	83	100	106	False
30100179	In 2003, a new syndrome was described in the Sephardi Jewish population, named progressive cerebello-cerebral atrophy (PCCA) based on the typical neuroradiological findings.	PCCA	cerebral atrophy	5095	HP_0002059	119	123	101	117	True
19526372	The membrane-type frizzled-related protein (MFRP) is the only gene so far reported implicated in autosomal recessive, non-syndromic and syndromic forms of PM.	MFRP	autosomal recessive	83552	HP_0000007	44	48	97	116	True
19526372	To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.	MFRP	microphthalmia	83552	HP_0000568	76	80	236	250	True
19526372	To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.	CHX10	microphthalmia	338917	HP_0000568	114	119	236	250	True
19526372	To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.	OPA1	microphthalmia	9968	HP_0000568	121	125	236	250	False
19526372	To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.	MITF	microphthalmia	4286	HP_0000568	127	131	236	250	True
19526372	To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.	CRYBB1	microphthalmia	1414	HP_0000568	139	145	236	250	False
19526372	To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.	CRYBA4	microphthalmia	1413	HP_0000568	152	158	236	250	False
19526372	To identify the disease-causing defect in these families, we first analysed MFRP gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and NNO2) previously implicated in different forms of microphthalmia.	NNO2	microphthalmia	83552	HP_0000568	186	190	236	250	True
30426231	Interestingly, dysregulated expression of KDM4 members is involved in the progression of several cancer types and plays a role in the DNA damage response; however, the gene expression profile and the importance of KDM4 members in CLL are still unknown.	damage	cancer	51438	HP_0002664	138	144	97	103	False
28455959	Great progress has been achieved in the study of the role of TGF- signaling in triggering epithelial-mesenchymal transition (EMT) in a variety of cancers; however, the regulation of TGF- signaling during EMT in mammary tumor metastasis has not been completely defined.	EMT	tumor	3702	HP_0002664	126	129	221	226	True
28455959	Great progress has been achieved in the study of the role of TGF- signaling in triggering epithelial-mesenchymal transition (EMT) in a variety of cancers; however, the regulation of TGF- signaling during EMT in mammary tumor metastasis has not been completely defined.	EMT	cancer	3702	HP_0002664	126	129	147	153	True
28455959	In the present study, we demonstrated that OVOL2, a zinc finger transcription factor, inhibits TGF- signaling-induced EMT in mouse and human mammary tumor cells, as well as in mouse tumor models.	EMT	tumor	3702	HP_0002664	119	122	150	155	True
28455959	In the present study, we demonstrated that OVOL2, a zinc finger transcription factor, inhibits TGF- signaling-induced EMT in mouse and human mammary tumor cells, as well as in mouse tumor models.	OVOL2	tumor	58495	HP_0002664	43	48	150	155	False
28455959	Data from the Oncomine databases indicated a strong negative relationship between OVOL2 expression and breast cancer progression.	OVOL2	cancer	58495	HP_0002664	82	87	110	116	False
28455959	The modulation of these molecular processes may represent a strategy for inhibiting breast cancer invasion by restoring OVOL2 expression	OVOL2	cancer	58495	HP_0002664	120	125	91	97	False
28935222	We evaluated the genetic impact of the amyotrophic lateral sclerosis (ALS) risk gene never in mitosis gene a-related kinase 1 (NEK1) in a Belgian cohort of 278 patients with ALS (n= 245) or ALS with frontotemporal dementia (ALS-FTD, n= 33) and 609 control individuals.	impact	frontotemporal dementia	55364	HP_0002145	25	31	200	223	False
28935222	We evaluated the genetic impact of the amyotrophic lateral sclerosis (ALS) risk gene never in mitosis gene a-related kinase 1 (NEK1) in a Belgian cohort of 278 patients with ALS (n= 245) or ALS with frontotemporal dementia (ALS-FTD, n= 33) and 609 control individuals.	ALS	frontotemporal dementia	3483	HP_0002145	70	73	200	223	False
28935222	We evaluated the genetic impact of the amyotrophic lateral sclerosis (ALS) risk gene never in mitosis gene a-related kinase 1 (NEK1) in a Belgian cohort of 278 patients with ALS (n= 245) or ALS with frontotemporal dementia (ALS-FTD, n= 33) and 609 control individuals.	NEK1	frontotemporal dementia	4750	HP_0002145	127	131	200	223	False
29740943	It is dominated by cerebellar ataxia and susceptible to stresses that act as factors provoking disease onset or episodes of rapid neurological deterioration possibly leading to death.	act	cerebellar ataxia	11332	HP_0001251	70	73	19	36	False
28254648	Recently mutations in the CASPR/CNTN1 complex have been associated with similar severe phenotypes and CNTNAP1 gene mutations, causing loss of the CASPR protein, were shown to cause severe, prenatal onset arthrogryposis multiplex congenita in four unrelated families.	CASPR	arthrogryposis	8506	HP_0002804	26	31	204	218	True
28254648	Recently mutations in the CASPR/CNTN1 complex have been associated with similar severe phenotypes and CNTNAP1 gene mutations, causing loss of the CASPR protein, were shown to cause severe, prenatal onset arthrogryposis multiplex congenita in four unrelated families.	CNTNAP1	arthrogryposis	8506	HP_0002804	102	109	204	218	True
28254648	Recently mutations in the CASPR/CNTN1 complex have been associated with similar severe phenotypes and CNTNAP1 gene mutations, causing loss of the CASPR protein, were shown to cause severe, prenatal onset arthrogryposis multiplex congenita in four unrelated families.	CASPR	prenatal onset	8506	HP_0003577	26	31	189	203	False
28254648	Recently mutations in the CASPR/CNTN1 complex have been associated with similar severe phenotypes and CNTNAP1 gene mutations, causing loss of the CASPR protein, were shown to cause severe, prenatal onset arthrogryposis multiplex congenita in four unrelated families.	CNTNAP1	prenatal onset	8506	HP_0003577	102	109	189	203	False
28254648	Here we report a consanguineous Arab family from Qatar with three children having an early lethal form of arthrogryposis multiplex congenita and a novel frameshift mutation in CNTNAP1.	CNTNAP1	arthrogryposis	8506	HP_0002804	176	183	106	120	True
28254648	We further expand the existing CNTNAP1-associated phenotype to include profound cerebral and cerebellar atrophy	CNTNAP1	profound	8506	HP_0012829	31	38	71	79	False
28155967	Diabetes is a metabolic disorder characterized by hyperglycemia and associated with microvascular and macrovascular syndromes mediated by mast cells.	mast	hyperglycemia	51324	HP_0003074	138	142	50	63	False
28719596	We investigated the impact of these polymorphisms on the clinical outcome of 103 patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with a platinum compound, fluorouracil and cetuximab as palliative first-line therapy.	impact	squamous cell carcinoma	55364	HP_0002860	20	26	119	142	False
29414779	Neurturin (NRTN) provides trophic support to neurons and is considered a therapeutic agent for neurodegenerative diseases, such as Parkinson's disease.	NRTN	neurodegenerative diseases	4902	HP_0002180	11	15	95	121	False
25863124	Small cell lung cancer (SCLC) is the most aggressive type of lung cancer.	type	cancer	6445	HP_0002664	53	57	16	22	False
25863124	In particular, the TMEM132D, SPTA1 and VPS13B genes were commonly mutated in both early and late stage tumors, primary tumors and metastases, and tumors before and after chemotherapy, as in the case of the TP53 and RB1 genes.	TMEM132D	tumors	121256	HP_0002664	19	27	103	109	False
25863124	In particular, the TMEM132D, SPTA1 and VPS13B genes were commonly mutated in both early and late stage tumors, primary tumors and metastases, and tumors before and after chemotherapy, as in the case of the TP53 and RB1 genes.	SPTA1	tumors	6708	HP_0002664	29	34	103	109	False
25863124	In particular, the TMEM132D, SPTA1 and VPS13B genes were commonly mutated in both early and late stage tumors, primary tumors and metastases, and tumors before and after chemotherapy, as in the case of the TP53 and RB1 genes.	VPS13B	tumors	157680	HP_0002664	39	45	103	109	False
27851961	Here, we show that high levels of the actin cytoskeleton-associated protein WIP (WASP-interacting protein) correlates with tumor growth, both of which are linked to the tumor-initiating cell phenotype.	WIP	tumor	7456	HP_0002664	76	79	123	128	True
27851961	We find that WIP controls tumor growth by boosting signals that stabilize the YAP/TAZ complex via a mechanism mediated by the endocytic/endosomal system.	WIP	tumor	7456	HP_0002664	13	16	26	31	True
27851961	We find that WIP controls tumor growth by boosting signals that stabilize the YAP/TAZ complex via a mechanism mediated by the endocytic/endosomal system.	find	tumor	81501	HP_0002664	3	7	26	31	False
27851961	This close biochemical relationship indicates an oncogenic role for WIP in the physiology of cancer pathology by increasing YAP/TAZ stability	WIP	cancer	7456	HP_0002664	68	71	93	99	True
26310313	Genome-wide association studies have identified loci at 15q25 (IREB2) and 4q22 (FAM13A), associated with lung cancer (LC) and chronic obstructive pulmonary disease (COPD).	IREB2	cancer	3658	HP_0002664	63	68	110	116	False
26310313	Genome-wide association studies have identified loci at 15q25 (IREB2) and 4q22 (FAM13A), associated with lung cancer (LC) and chronic obstructive pulmonary disease (COPD).	FAM13A	cancer	10144	HP_0002664	80	86	110	116	False
26310313	Genome-wide association studies have identified loci at 15q25 (IREB2) and 4q22 (FAM13A), associated with lung cancer (LC) and chronic obstructive pulmonary disease (COPD).	COPD	cancer	372	HP_0002664	165	169	110	116	False
25277027	Melanogenesis genes tyrosinase, tyrosinase-related protein 1, Hermansky-Pudlak Syndrome 3, premelanosome protein and dopachrome tautomerase were upregulated, as was the melanogenesis-controlling transcription factor, microphthalmia-associated transcription factor (MITF).	MITF	microphthalmia	4286	HP_0000568	265	269	217	231	True
25853559	Genetic variation in the TMC6/TMC8 region has been linked to beta-type HPV infection and squamous cell carcinoma of the skin, cervical cancer, HPV persistence and progression to cervical cancer.	TMC6	cancer	11322	HP_0002664	25	29	135	141	True
25853559	Genetic variation in the TMC6/TMC8 region has been linked to beta-type HPV infection and squamous cell carcinoma of the skin, cervical cancer, HPV persistence and progression to cervical cancer.	TMC8	cancer	147138	HP_0002664	30	34	135	141	True
25853559	Genetic variation in the TMC6/TMC8 region has been linked to beta-type HPV infection and squamous cell carcinoma of the skin, cervical cancer, HPV persistence and progression to cervical cancer.	TMC6	squamous cell carcinoma of the skin	11322	HP_0006739	25	29	89	124	False
25853559	Genetic variation in the TMC6/TMC8 region has been linked to beta-type HPV infection and squamous cell carcinoma of the skin, cervical cancer, HPV persistence and progression to cervical cancer.	TMC8	squamous cell carcinoma of the skin	147138	HP_0006739	30	34	89	124	False
25853559	Here, we have tested the hypothesis that the common TMC8 SNP rs7208422 is associated with high-risk HPV infection and risk of head and neck squamous cell carcinoma (HNSCC).	TMC8	squamous cell carcinoma	147138	HP_0002860	52	56	140	163	True
28566226	X-linked retinitis pigmentosa (XLRP) caused by mutations in the RPGR gene is an early onset and severe cause of blindness.	RPGR	blindness	6103	HP_0000618	64	68	112	121	True
27129268	Recent studies have linked mutations in the SLC24A4 (NCKX4) and SLC24A5 (NCKX5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (OCA6), respectively.	SLC24A4	albinism	123041	HP_0001022	44	51	151	159	False
27129268	Recent studies have linked mutations in the SLC24A4 (NCKX4) and SLC24A5 (NCKX5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (OCA6), respectively.	NCKX4	albinism	123041	HP_0001022	53	58	151	159	False
27129268	Recent studies have linked mutations in the SLC24A4 (NCKX4) and SLC24A5 (NCKX5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (OCA6), respectively.	SLC24A5	albinism	283652	HP_0001022	64	71	151	159	False
27129268	Recent studies have linked mutations in the SLC24A4 (NCKX4) and SLC24A5 (NCKX5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (OCA6), respectively.	OCA6	albinism	283652	HP_0001022	161	165	151	159	False
27129268	Recent studies have linked mutations in the SLC24A4 (NCKX4) and SLC24A5 (NCKX5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (OCA6), respectively.	NCKX	albinism	9187	HP_0001022	73	77	151	159	False
27129268	We also analyzed two mutations in a Drosophila NCKX gene that have been reported to result in an increased susceptibility for seizures, and found that both resulted in mutant proteins with significantly reduced but observable NCKX activity.	NCKX	seizures	9187	HP_0001250	47	51	126	134	False
27233227	To our knowledge, this is one of the first reports on isolated mild ventricular hypertrophy due to ACAD9 mutation in a family with moderate symptoms during adolescence.	ACAD9	ventricular hypertrophy	28976	HP_0001714	99	104	68	91	False
14719106	Subsequent quantitative PCR experiments confirmed that PRDX4, CKS2, MAGED2, and an EST (GenBank accession number BF696304) were expressed at significantly higher levels in tumors with metastasis.	PRDX4	tumors	10549	HP_0002664	55	60	172	178	False
14719106	Subsequent quantitative PCR experiments confirmed that PRDX4, CKS2, MAGED2, and an EST (GenBank accession number BF696304) were expressed at significantly higher levels in tumors with metastasis.	CKS2	tumors	1164	HP_0002664	62	66	172	178	False
14719106	Subsequent quantitative PCR experiments confirmed that PRDX4, CKS2, MAGED2, and an EST (GenBank accession number BF696304) were expressed at significantly higher levels in tumors with metastasis.	MAGED2	tumors	10916	HP_0002664	68	74	172	178	False
14719106	Subsequent quantitative PCR experiments confirmed that PRDX4, CKS2, MAGED2, and an EST (GenBank accession number BF696304) were expressed at significantly higher levels in tumors with metastasis.	EST	tumors	1326	HP_0002664	83	86	172	178	True
27995510	A growing body of clinical literature emphasizes the impact of cerebral edema in early brain injury following aneurysmal subarachnoid hemorrhage (aSAH).	impact	cerebral edema	55364	HP_0002181	53	59	63	77	False
27995510	A growing body of clinical literature emphasizes the impact of cerebral edema in early brain injury following aneurysmal subarachnoid hemorrhage (aSAH).	aSAH	cerebral edema	427	HP_0002181	146	150	63	77	False
27995510	Although cerebral edema is not a universal feature of aSAH, it portends a poor clinical course, with quantitative analysis revealing a direct correlation between cerebral edema and poor outcome, including mortality and cognitive deficits.	aSAH	cerebral edema	427	HP_0002181	54	58	9	23	False
27995510	Here, we review these cellular and molecular mechanisms of global cerebral edema formation in aSAH.	aSAH	cerebral edema	427	HP_0002181	94	98	66	80	False
27995510	Given the importance of edema to the outcome of patients with aSAH and its status as a highly modifiable pathological process, a better understanding of cerebral edema in aSAH promises to hasten the development of medical therapies to improve outcomes in this frequently devastating disease	aSAH	cerebral edema	427	HP_0002181	62	66	153	167	False
27995510	Given the importance of edema to the outcome of patients with aSAH and its status as a highly modifiable pathological process, a better understanding of cerebral edema in aSAH promises to hasten the development of medical therapies to improve outcomes in this frequently devastating disease	aSAH	edema	427	HP_0000969	62	66	24	29	True
25907251	Based on the elastic net, 33 genes out of 1381 genes related to bladder cancer were selected.	net	cancer	2004	HP_0002664	21	24	72	78	False
25907251	This study indicates that the elastic net has a higher capacity than the Lasso and boosting for the prediction of survival time in bladder cancer patients.	net	cancer	2004	HP_0002664	38	41	139	145	False
29538625	De novo heterozygous mutations in STXBP1/Munc18-1 cause early infantile epileptic encephalopathies (EIEE4, OMIM #612164) characterized by infantile epilepsy, developmental delay, intellectual disability, and can include autistic features.	STXBP1	epileptic encephalopathies	6812	HP_0200134	34	40	72	98	True
29538625	De novo heterozygous mutations in STXBP1/Munc18-1 cause early infantile epileptic encephalopathies (EIEE4, OMIM #612164) characterized by infantile epilepsy, developmental delay, intellectual disability, and can include autistic features.	STXBP1	epilepsy	6812	HP_0001250	34	40	148	156	True
29538625	De novo heterozygous mutations in STXBP1/Munc18-1 cause early infantile epileptic encephalopathies (EIEE4, OMIM #612164) characterized by infantile epilepsy, developmental delay, intellectual disability, and can include autistic features.	STXBP1	developmental delay	6812	HP_0001263	34	40	158	177	True
29538625	De novo heterozygous mutations in STXBP1/Munc18-1 cause early infantile epileptic encephalopathies (EIEE4, OMIM #612164) characterized by infantile epilepsy, developmental delay, intellectual disability, and can include autistic features.	STXBP1	intellectual disability	6812	HP_0001249	34	40	179	202	True
29538625	We characterized the cellular deficits for an allelic series of seven STXBP1 mutations and developed four mouse models that recapitulate the abnormal EEG activity and cognitive aspects of human STXBP1-encephalopathy.	STXBP1	encephalopathy	6812	HP_0001298	70	76	201	215	True
29538625	Together, these cellular studies suggest that impaired protein stability and STXBP1 haploinsufficiency explain STXBP1-encephalopathy and that, therefore, Stxbp1+/- mice provide a valid mouse model.	STXBP1	encephalopathy	6812	HP_0001298	77	83	118	132	True
29538625	Together, these cellular studies suggest that impaired protein stability and STXBP1 haploinsufficiency explain STXBP1-encephalopathy and that, therefore, Stxbp1+/- mice provide a valid mouse model.	Stxbp1	encephalopathy	6812	HP_0001298	154	160	118	132	True
29538625	Together, these cellular studies suggest that impaired protein stability and STXBP1 haploinsufficiency explain STXBP1-encephalopathy and that, therefore, Stxbp1+/- mice provide a valid mouse model.	mice	encephalopathy	23581	HP_0001298	164	168	118	132	False
29538625	Simultaneous video and EEG recordings revealed that Stxbp1+/- mice with different genomic backgrounds recapitulate the seizure/spasm phenotype observed in humans, characterized by myoclonic jerks and spike-wave discharges that were suppressed by the antiepileptic drug levetiracetam.	Stxbp1	seizure	6812	HP_0001250	52	58	119	126	True
29538625	Simultaneous video and EEG recordings revealed that Stxbp1+/- mice with different genomic backgrounds recapitulate the seizure/spasm phenotype observed in humans, characterized by myoclonic jerks and spike-wave discharges that were suppressed by the antiepileptic drug levetiracetam.	mice	seizure	23581	HP_0001250	62	66	119	126	False
29538625	Stxbp1+/- mice showed impaired cognitive performance, hyperactivity and anxiety-like behaviour, without altered social behaviour.	Stxbp1	hyperactivity	6812	HP_0000752	0	6	54	67	True
29538625	Stxbp1+/- mice showed impaired cognitive performance, hyperactivity and anxiety-like behaviour, without altered social behaviour.	mice	hyperactivity	23581	HP_0000752	10	14	54	67	False
29538625	Taken together, these data demonstrate the construct, face and predictive validity of Stxbp1+/- mice and point to protein instability, haploinsufficiency and imbalanced excitation in neocortex, as the underlying mechanism of STXBP1-encephalopathy.	STXBP1	encephalopathy	6812	HP_0001298	225	231	232	246	True
29538625	Taken together, these data demonstrate the construct, face and predictive validity of Stxbp1+/- mice and point to protein instability, haploinsufficiency and imbalanced excitation in neocortex, as the underlying mechanism of STXBP1-encephalopathy.	Stxbp1	encephalopathy	6812	HP_0001298	86	92	232	246	True
29538625	Taken together, these data demonstrate the construct, face and predictive validity of Stxbp1+/- mice and point to protein instability, haploinsufficiency and imbalanced excitation in neocortex, as the underlying mechanism of STXBP1-encephalopathy.	mice	encephalopathy	23581	HP_0001298	96	100	232	246	False
29538625	Taken together, these data demonstrate the construct, face and predictive validity of Stxbp1+/- mice and point to protein instability, haploinsufficiency and imbalanced excitation in neocortex, as the underlying mechanism of STXBP1-encephalopathy.	face	encephalopathy	2178	HP_0001298	54	58	232	246	False
29511670	Primary ciliary dyskinesia (PCD) is a clinical rare peculiar disorder, mainly featured by respiratory infection, tympanitis, nasosinusitis, and male infertility.	PCD	ciliary dyskinesia	352909	HP_0012265	28	31	8	26	True
27476655	In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.	ARCN1	facial dysmorphisms	372	HP_0001999	260	265	92	111	False
27476655	In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.	delta	facial dysmorphisms	5694	HP_0001999	302	307	92	111	False
27476655	In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.	ARCN1	micrognathia	372	HP_0000347	260	265	120	132	True
27476655	In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.	delta	micrognathia	5694	HP_0000347	302	307	120	132	False
27476655	In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.	ARCN1	rhizomelic shortening	372	HP_0008905	260	265	134	155	True
27476655	In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.	delta	rhizomelic shortening	5694	HP_0008905	302	307	134	155	False
27476655	In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.	ARCN1	dwarfism	372	HP_0003510	260	265	171	179	False
27476655	In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.	delta	dwarfism	5694	HP_0003510	302	307	171	179	False
27476655	In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.	ARCN1	mild	372	HP_0012825	260	265	185	189	False
27476655	In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.	delta	mild	5694	HP_0012825	302	307	185	189	False
27476655	In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.	ARCN1	developmental delay	372	HP_0001263	260	265	190	209	False
27476655	In this article, we report a clinically recognizable craniofacial disorder characterized by facial dysmorphisms, severe micrognathia, rhizomelic shortening, microcephalic dwarfism, and mild developmental delay due to loss-of-function heterozygous mutations in ARCN1, which encodes the coatomer subunit delta of COPI.	delta	developmental delay	5694	HP_0001263	302	307	190	209	False
26872363	The significance of the ubiquitin-proteasome system (UPS) for protein degradation has been highlighted in the context of neurodegenerative diseases, including retinal dystrophies.	UPS	neurodegenerative diseases	3145	HP_0002180	53	56	121	147	False
26872363	The significance of the ubiquitin-proteasome system (UPS) for protein degradation has been highlighted in the context of neurodegenerative diseases, including retinal dystrophies.	UPS	retinal dystrophies	3145	HP_0000556	53	56	159	178	False
26425700	Candidate markers were identified by bisulfite conversion-based genome-wide methylation screening of lung tissue from lung cancer, fibrotic ILD, and COPD. cfDNA from 400l serum (n=204) served to test the diagnostic performance of these markers.	COPD	cancer	372	HP_0002664	149	153	123	129	False
26425700	Cancer was distinguished from ILD with a specificity of 88%, (95%CI: 0.57-1), and COPD from cancer with a specificity of 88% (95%CI: 0.64-0.97).	COPD	cancer	372	HP_0002664	82	86	92	98	False
30542737	Phosphatase and tensin homolog (PTEN) is a wellknown tumor suppressor and serves a vital role in cancer progression.	PTEN	cancer	5728	HP_0002664	32	36	98	104	True
30542737	Phosphatase and tensin homolog (PTEN) is a wellknown tumor suppressor and serves a vital role in cancer progression.	PTEN	tumor	5728	HP_0002664	32	36	54	59	True
28106506	The tumor necrosis factor (TNF) family ligand ectodysplasin A (EDA) is produced as 2 full-length splice variants, EDA1 and EDA2, that bind to EDA receptor (EDAR) and X-linked EDA receptor (XEDAR/EDA2R), respectively.	TNF	tumor	7124	HP_0002664	27	30	4	9	False
28106506	The tumor necrosis factor (TNF) family ligand ectodysplasin A (EDA) is produced as 2 full-length splice variants, EDA1 and EDA2, that bind to EDA receptor (EDAR) and X-linked EDA receptor (XEDAR/EDA2R), respectively.	EDA	tumor	1896	HP_0002664	63	66	4	9	False
28106506	Inactivating mutations in Eda or Edar cause hypohidrotic ectodermal dysplasia (HED), a condition characterized by malformations of the teeth, hair and glands, with milder deficiencies affecting only the teeth.	Eda	ectodermal dysplasia	1896	HP_0000968	26	29	57	77	True
28106506	Inactivating mutations in Eda or Edar cause hypohidrotic ectodermal dysplasia (HED), a condition characterized by malformations of the teeth, hair and glands, with milder deficiencies affecting only the teeth.	HED	ectodermal dysplasia	1896	HP_0000968	79	82	57	77	True
28801086	The patient had a history of severe neonatal jaundice, hemolytic crisis with rhabdomyolysis triggered by febrile viral infections, dysarthria, and intellectual disability during early childhood.	red	neonatal jaundice	8444	HP_0006579	98	101	36	53	False
28801086	The patient had a history of severe neonatal jaundice, hemolytic crisis with rhabdomyolysis triggered by febrile viral infections, dysarthria, and intellectual disability during early childhood.	red	dysarthria	8444	HP_0001260	98	101	131	141	False
28801086	The patient had a history of severe neonatal jaundice, hemolytic crisis with rhabdomyolysis triggered by febrile viral infections, dysarthria, and intellectual disability during early childhood.	red	intellectual disability	8444	HP_0001249	98	101	147	170	False
29727689	We conducted a cis-expression quantitative trait loci (cis-eQTL) analysis using normal or tumor breast transcriptome data from the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC), The Cancer Genome Atlas (TCGA), and the Genotype-Tissue Expression (GTEx) project.	cis	tumor	1154	HP_0002664	15	18	90	95	False
29727689	Furthermore, we performed invitro assays in breast cancer cell lines, and our results indicated that DCLRE1B, MRPS30, and ATG10 played a vital role in breast tumorigenesis via certain disruption of cell behaviors.	DCLRE1B	cancer	64858	HP_0002664	102	109	52	58	False
29727689	Furthermore, we performed invitro assays in breast cancer cell lines, and our results indicated that DCLRE1B, MRPS30, and ATG10 played a vital role in breast tumorigenesis via certain disruption of cell behaviors.	MRPS30	cancer	10884	HP_0002664	111	117	52	58	False
29727689	Furthermore, we performed invitro assays in breast cancer cell lines, and our results indicated that DCLRE1B, MRPS30, and ATG10 played a vital role in breast tumorigenesis via certain disruption of cell behaviors.	ATG10	cancer	83734	HP_0002664	123	128	52	58	False
29727689	Furthermore, we performed invitro assays in breast cancer cell lines, and our results indicated that DCLRE1B, MRPS30, and ATG10 played a vital role in breast tumorigenesis via certain disruption of cell behaviors.	DCLRE1B	tumor	64858	HP_0002664	102	109	159	164	False
29727689	Furthermore, we performed invitro assays in breast cancer cell lines, and our results indicated that DCLRE1B, MRPS30, and ATG10 played a vital role in breast tumorigenesis via certain disruption of cell behaviors.	MRPS30	tumor	10884	HP_0002664	111	117	159	164	False
29727689	Furthermore, we performed invitro assays in breast cancer cell lines, and our results indicated that DCLRE1B, MRPS30, and ATG10 played a vital role in breast tumorigenesis via certain disruption of cell behaviors.	ATG10	tumor	83734	HP_0002664	123	128	159	164	False
29762087	Among the available genomic studies, the key findings in Africa were variants in GATA4 (P193H), MTHFR 677TT, and MTHFR 1298CC that were associated with atrial septal defect, ventricular septal defect (VSD), Tetralogy of Fallot (TOF), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.	GATA4	atrial septal defect	2626	HP_0001631	81	86	152	172	True
29762087	Among the available genomic studies, the key findings in Africa were variants in GATA4 (P193H), MTHFR 677TT, and MTHFR 1298CC that were associated with atrial septal defect, ventricular septal defect (VSD), Tetralogy of Fallot (TOF), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.	MTHFR	atrial septal defect	4524	HP_0001631	96	101	152	172	False
29762087	Among the available genomic studies, the key findings in Africa were variants in GATA4 (P193H), MTHFR 677TT, and MTHFR 1298CC that were associated with atrial septal defect, ventricular septal defect (VSD), Tetralogy of Fallot (TOF), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.	TOF	atrial septal defect	55079	HP_0001631	228	231	152	172	False
29762087	Among the available genomic studies, the key findings in Africa were variants in GATA4 (P193H), MTHFR 677TT, and MTHFR 1298CC that were associated with atrial septal defect, ventricular septal defect (VSD), Tetralogy of Fallot (TOF), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.	GATA4	ventricular septal defect	2626	HP_0001629	81	86	174	199	True
29762087	Among the available genomic studies, the key findings in Africa were variants in GATA4 (P193H), MTHFR 677TT, and MTHFR 1298CC that were associated with atrial septal defect, ventricular septal defect (VSD), Tetralogy of Fallot (TOF), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.	MTHFR	ventricular septal defect	4524	HP_0001629	96	101	174	199	False
29762087	Among the available genomic studies, the key findings in Africa were variants in GATA4 (P193H), MTHFR 677TT, and MTHFR 1298CC that were associated with atrial septal defect, ventricular septal defect (VSD), Tetralogy of Fallot (TOF), and patent ductus arteriosus phenotypes and 22q.11 deletion, which is associated with TOF.	TOF	ventricular septal defect	55079	HP_0001629	228	231	174	199	False
26220971	Homozygous recessive mutations in either EFEMP2 (encoding fibulin-4) or FBLN5 (encoding fibulin-5), critical genes for elastogenesis, lead to autosomal recessive cutis laxa types 1B and 1A, respectively.	EFEMP2	autosomal recessive	30008	HP_0000007	41	47	142	161	True
26220971	Homozygous recessive mutations in either EFEMP2 (encoding fibulin-4) or FBLN5 (encoding fibulin-5), critical genes for elastogenesis, lead to autosomal recessive cutis laxa types 1B and 1A, respectively.	FBLN5	autosomal recessive	10516	HP_0000007	72	77	142	161	True
27261254	Mutations in ST3GAL5, which codes for an enzyme early in brain ganglioside biosynthesis, result in an early-onset seizure disorder with profound motor and cognitive decay, whereas mutations in B4GALNT1, a gene encoding a later step, result in hereditary spastic paraplegia accompanied by intellectual deficits.	ST3GAL5	seizure	8869	HP_0001250	13	20	114	121	True
27261254	Mutations in ST3GAL5, which codes for an enzyme early in brain ganglioside biosynthesis, result in an early-onset seizure disorder with profound motor and cognitive decay, whereas mutations in B4GALNT1, a gene encoding a later step, result in hereditary spastic paraplegia accompanied by intellectual deficits.	B4GALNT1	seizure	2583	HP_0001250	193	201	114	121	False
27261254	Mutations in ST3GAL5, which codes for an enzyme early in brain ganglioside biosynthesis, result in an early-onset seizure disorder with profound motor and cognitive decay, whereas mutations in B4GALNT1, a gene encoding a later step, result in hereditary spastic paraplegia accompanied by intellectual deficits.	step	seizure	84867	HP_0001250	227	231	114	121	False
25462154	Charcot-Marie-Tooth disease type 4B2 with early-onset glaucoma (CMT4B2, OMIM 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder.	type	heterogeneous	6445	HP_0001425	28	32	102	115	False
25462154	Charcot-Marie-Tooth disease type 4B2 with early-onset glaucoma (CMT4B2, OMIM 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder.	CMT4B2	heterogeneous	81846	HP_0001425	64	70	102	115	True
25462154	Charcot-Marie-Tooth disease type 4B2 with early-onset glaucoma (CMT4B2, OMIM 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder.	MIM	heterogeneous	9788	HP_0001425	73	76	102	115	False
25462154	Charcot-Marie-Tooth disease type 4B2 with early-onset glaucoma (CMT4B2, OMIM 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder.	type	glaucoma	6445	HP_0000501	28	32	54	62	False
25462154	Charcot-Marie-Tooth disease type 4B2 with early-onset glaucoma (CMT4B2, OMIM 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder.	CMT4B2	glaucoma	81846	HP_0000501	64	70	54	62	True
25462154	Charcot-Marie-Tooth disease type 4B2 with early-onset glaucoma (CMT4B2, OMIM 604563) is a genetically-heterogeneous childhood-onset neuromuscular disorder.	MIM	glaucoma	9788	HP_0000501	73	76	54	62	False
29712898	Here we show that a series of transcription factors, including C/EBP, GCM1, and GATA1, could act as potential modulators of histone methylation in tumor cells.	GCM1	tumor	8521	HP_0002664	71	75	148	153	False
29712898	Here we show that a series of transcription factors, including C/EBP, GCM1, and GATA1, could act as potential modulators of histone methylation in tumor cells.	GATA1	tumor	2623	HP_0002664	81	86	148	153	True
29712898	Here we show that a series of transcription factors, including C/EBP, GCM1, and GATA1, could act as potential modulators of histone methylation in tumor cells.	act	tumor	11332	HP_0002664	45	48	148	153	False
29712898	Of note, C/EBP, an independent prognostic factor for patients with ovarian cancer, mediates an important mechanism through which epigenetic enzyme modifies groups of functionally related genes in a context-dependent manner.	act	cancer	11332	HP_0002664	44	47	76	82	False
29712898	By recruiting the methyltransferase DOT1L, C/EBP can maintain an open chromatin state by H3K79 methylation of multiple drug-resistance genes, thereby augmenting the chemoresistance of tumor cells.	DOT1L	tumor	84444	HP_0002664	36	41	185	190	False
30180950	Upregulated LINC00963 led to elevated expression of NACC1 through inhibiting miR-608, which consequently promoted melanoma malignant progression.	miR	melanoma	220972	HP_0002861	77	80	114	122	False
30180950	Upregulated LINC00963 led to elevated expression of NACC1 through inhibiting miR-608, which consequently promoted melanoma malignant progression.	NACC1	melanoma	112939	HP_0002861	52	57	114	122	False
30180950	Taken together, our results illustrated that LINC00963-miR-608-NACC1 pathway might be a potential target for melanoma therapy	miR	melanoma	220972	HP_0002861	55	58	109	117	False
30180950	Taken together, our results illustrated that LINC00963-miR-608-NACC1 pathway might be a potential target for melanoma therapy	NACC1	melanoma	112939	HP_0002861	63	68	109	117	False
28271496	Mutations in NOTCH3 causes cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a hereditary cerebrovascular disease that leads to ischemic strokes and dementia, but in which migraine is often present, sometimes long before the onset of other symptoms.	NOTCH3	leukoencephalopathy	4854	HP_0002352	13	19	98	117	True
28271496	Mutations in NOTCH3 causes cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a hereditary cerebrovascular disease that leads to ischemic strokes and dementia, but in which migraine is often present, sometimes long before the onset of other symptoms.	CADASIL	leukoencephalopathy	4854	HP_0002352	119	126	98	117	True
27900359	Although homozygous inactivation of <i>CHEK2</i> in mice led to cancers in multiple organs, accumulation of additional human cases is needed to establish its pathogenic role in humans	mice	cancer	23581	HP_0002664	52	56	64	70	False
24120487	Walker-Warburg syndrome (WWS) is a severe muscular dystrophy with eye and brain malformations.	WWS	muscular dystrophy	55906	HP_0003560	25	28	42	60	False
24120487	The disease family of muscular dystrophy-dystroglycanopathy (MDDG) contains a spectrum of severe to mild disorders, designated as MDDG type A to C.	type	muscular dystrophy	6445	HP_0003560	135	139	22	40	True
24120487	Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.	type	muscular dystrophies	6445	HP_0003560	120	124	140	160	True
24120487	Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.	POMT1	muscular dystrophies	10585	HP_0003560	13	18	140	160	True
24120487	Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.	POMT2	muscular dystrophies	29954	HP_0003560	20	25	140	160	True
24120487	Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.	POMGNT1	muscular dystrophies	55624	HP_0003560	27	34	140	160	True
24120487	Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.	FKTN	muscular dystrophies	2218	HP_0003560	36	40	140	160	True
24120487	Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.	FKRP	muscular dystrophies	79147	HP_0003560	42	46	140	160	True
24120487	Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.	GMPPB	muscular dystrophies	29925	HP_0003560	55	60	140	160	True
24120487	Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.	COL4A1	muscular dystrophies	1282	HP_0003560	72	78	140	160	True
24120487	Mutations in POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE, GMPPB, TMEM5 and COL4A1 and ISPD lead to a wide spectrum of phenotypes of congenital muscular dystrophies with or without eye and brain abnormalities.	ISPD	muscular dystrophies	729920	HP_0003560	83	87	140	160	True
24120487	Patients with WWS frequently demonstrate a complete lack of psychomotor development, severe eye malformations, cobblestone lissencephaly and a hypoplastic cerebellum and brainstem, seizures, hydrocephalus and poor prognosis.	WWS	hypoplastic cerebellum	55906	HP_0001321	14	17	143	165	False
24120487	Patients with WWS frequently demonstrate a complete lack of psychomotor development, severe eye malformations, cobblestone lissencephaly and a hypoplastic cerebellum and brainstem, seizures, hydrocephalus and poor prognosis.	WWS	seizures	55906	HP_0001250	14	17	181	189	True
24120487	Patients with WWS frequently demonstrate a complete lack of psychomotor development, severe eye malformations, cobblestone lissencephaly and a hypoplastic cerebellum and brainstem, seizures, hydrocephalus and poor prognosis.	WWS	hydrocephalus	55906	HP_0000238	14	17	191	204	False
30542706	Gastrointestinal stromal tumors (GISTs) are the most common type of mesenchymal tumor of the digestive tract.	type	tumors	6445	HP_0002664	60	64	25	31	False
30542706	Gastrointestinal stromal tumors (GISTs) are the most common type of mesenchymal tumor of the digestive tract.	type	tumor	6445	HP_0002664	60	64	80	85	False
30542706	Dysregulated miRNAs are involved in various types of human disease, including cancer.	type	cancer	6445	HP_0002664	44	48	78	84	False
30542706	Dysregulated miRNAs are involved in various types of human disease, including cancer.	miR	cancer	220972	HP_0002664	13	16	78	84	False
25666713	Here, we utilized the CRISPR-Cas9 system to generate Kcnj13 mutant mice by zygote injection to verify the pathogenic role of human KCNJ13, mutations of which are thought to cause Leber congenital amaurosis (LCA), an early-onset form of blindness.	era	blindness	2099	HP_0000618	47	50	236	245	False
25666713	Here, we utilized the CRISPR-Cas9 system to generate Kcnj13 mutant mice by zygote injection to verify the pathogenic role of human KCNJ13, mutations of which are thought to cause Leber congenital amaurosis (LCA), an early-onset form of blindness.	Kcnj13	blindness	3769	HP_0000618	53	59	236	245	False
25666713	Here, we utilized the CRISPR-Cas9 system to generate Kcnj13 mutant mice by zygote injection to verify the pathogenic role of human KCNJ13, mutations of which are thought to cause Leber congenital amaurosis (LCA), an early-onset form of blindness.	mice	blindness	23581	HP_0000618	67	71	236	245	False
25666713	Here, we utilized the CRISPR-Cas9 system to generate Kcnj13 mutant mice by zygote injection to verify the pathogenic role of human KCNJ13, mutations of which are thought to cause Leber congenital amaurosis (LCA), an early-onset form of blindness.	KCNJ13	blindness	3769	HP_0000618	131	137	236	245	False
25666713	Here, we utilized the CRISPR-Cas9 system to generate Kcnj13 mutant mice by zygote injection to verify the pathogenic role of human KCNJ13, mutations of which are thought to cause Leber congenital amaurosis (LCA), an early-onset form of blindness.	LCA	blindness	1211	HP_0000618	207	210	236	245	False
24027063	PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts) is a recently described autosomal-recessive neurodegenerative disease caused by mutations in the --hydrolase domain-containing 12 gene (ABHD12).	ABHD12	hearing loss	26090	HP_0000365	220	226	23	35	True
24027063	PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts) is a recently described autosomal-recessive neurodegenerative disease caused by mutations in the --hydrolase domain-containing 12 gene (ABHD12).	ABHD12	ataxia	26090	HP_0001251	220	226	37	43	True
24027063	PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts) is a recently described autosomal-recessive neurodegenerative disease caused by mutations in the --hydrolase domain-containing 12 gene (ABHD12).	ABHD12	cataracts	26090	HP_0000518	220	226	71	80	True
24027063	PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataracts) is a recently described autosomal-recessive neurodegenerative disease caused by mutations in the --hydrolase domain-containing 12 gene (ABHD12).	ABHD12	neurodegenerative disease	26090	HP_0002180	220	226	126	151	False
24027063	The possible involvement of haploinsufficiency for GINS1, a DNA replication complex protein, in the short stature of the patient and her mother requires further studies.	GINS1	short stature	9837	HP_0004322	51	56	100	113	False
30478051	Here, we sought to find lncRNAs differentially regulated in cancer cells resistant to either TNF-related apoptosis-inducing ligand (TRAIL) or the Mcl-1 inhibitor UMI-77, agents that act through the extrinsic and intrinsic apoptotic pathways, respectively.	find	cancer	81501	HP_0002664	19	23	60	66	False
30478051	Here, we sought to find lncRNAs differentially regulated in cancer cells resistant to either TNF-related apoptosis-inducing ligand (TRAIL) or the Mcl-1 inhibitor UMI-77, agents that act through the extrinsic and intrinsic apoptotic pathways, respectively.	TNF	cancer	7124	HP_0002664	93	96	60	66	False
30478051	Here, we sought to find lncRNAs differentially regulated in cancer cells resistant to either TNF-related apoptosis-inducing ligand (TRAIL) or the Mcl-1 inhibitor UMI-77, agents that act through the extrinsic and intrinsic apoptotic pathways, respectively.	TRAIL	cancer	8743	HP_0002664	132	137	60	66	False
30478051	Here, we sought to find lncRNAs differentially regulated in cancer cells resistant to either TNF-related apoptosis-inducing ligand (TRAIL) or the Mcl-1 inhibitor UMI-77, agents that act through the extrinsic and intrinsic apoptotic pathways, respectively.	Mcl-1	cancer	4170	HP_0002664	146	151	60	66	False
30478051	Here, we sought to find lncRNAs differentially regulated in cancer cells resistant to either TNF-related apoptosis-inducing ligand (TRAIL) or the Mcl-1 inhibitor UMI-77, agents that act through the extrinsic and intrinsic apoptotic pathways, respectively.	act	cancer	11332	HP_0002664	182	185	60	66	False
30478051	Additionally, c-Myc was demonstrated to drive OVAAL transcription, indicating a positive feedback loop between c-Myc and OVAAL in controlling tumor growth.	c-Myc	tumor	4609	HP_0002664	14	19	142	147	True
30478051	Taken together, these results reveal that OVAAL contributes to the survival of cancer cells through dual mechanisms controlling RAF/MEK/ERK signaling and p27-mediated cell senescence	p27	cancer	5715	HP_0002664	154	157	79	85	False
29328371	Despite extensive research on cancer stem cells in colorectal cancer, the impact of stem cell markers on patient survival remains unclear, particularly in those with distant metastasis.	impact	cancer	55364	HP_0002664	74	80	30	36	False
29328371	In this study, we focused on colon cancer with peritoneal metastasis and investigated the association between the expression of CD133, aldehyde dehydrogenase-1(ALDH1) and leucine-rich repeating G-protein coupled receptor-5(Lgr5), and disease prognosis.	ALDH1	cancer	216	HP_0002664	161	166	35	41	False
29328371	In this study, we focused on colon cancer with peritoneal metastasis and investigated the association between the expression of CD133, aldehyde dehydrogenase-1(ALDH1) and leucine-rich repeating G-protein coupled receptor-5(Lgr5), and disease prognosis.	Lgr5	cancer	8549	HP_0002664	225	229	35	41	False
29328371	The expression of CD133, ALDH1 and Lgr5 was found to be positive in 55.6, 47.2 and 78.9% of the primary tumour samples, respectively.	ALDH1	tumour	216	HP_0002664	25	30	104	110	False
29328371	The expression of CD133, ALDH1 and Lgr5 was found to be positive in 55.6, 47.2 and 78.9% of the primary tumour samples, respectively.	Lgr5	tumour	8549	HP_0002664	35	39	104	110	False
25357075	Mutations in the membrane frizzled-related protein (MFRP/Mfrp) gene, specifically expressed in the retinal pigment epithelium (RPE) and ciliary body, cause nanophthalmia or posterior microphthalmia with retinitis pigmentosa in humans, and photoreceptor degeneration in mice.	MFRP	microphthalmia	83552	HP_0000568	52	56	183	197	True
25357075	Mutations in the membrane frizzled-related protein (MFRP/Mfrp) gene, specifically expressed in the retinal pigment epithelium (RPE) and ciliary body, cause nanophthalmia or posterior microphthalmia with retinitis pigmentosa in humans, and photoreceptor degeneration in mice.	Mfrp	microphthalmia	83552	HP_0000568	57	61	183	197	True
25357075	Mutations in the membrane frizzled-related protein (MFRP/Mfrp) gene, specifically expressed in the retinal pigment epithelium (RPE) and ciliary body, cause nanophthalmia or posterior microphthalmia with retinitis pigmentosa in humans, and photoreceptor degeneration in mice.	RPE	microphthalmia	6120	HP_0000568	127	130	183	197	False
25357075	Mutations in the membrane frizzled-related protein (MFRP/Mfrp) gene, specifically expressed in the retinal pigment epithelium (RPE) and ciliary body, cause nanophthalmia or posterior microphthalmia with retinitis pigmentosa in humans, and photoreceptor degeneration in mice.	mice	microphthalmia	23581	HP_0000568	269	273	183	197	False
25357075	In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).	Mfrp	retinal degeneration	83552	HP_0000546	3	7	107	127	True
25357075	In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).	Rpe65	retinal degeneration	6121	HP_0000546	171	176	107	127	False
25357075	In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).	Lrat	retinal degeneration	9227	HP_0000546	178	182	107	127	False
25357075	In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).	Rgr	retinal degeneration	5995	HP_0000546	184	187	107	127	True
25357075	In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).	Pde6a	retinal degeneration	5145	HP_0000546	209	214	107	127	False
25357075	In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).	Guca1b	retinal degeneration	2979	HP_0000546	216	222	107	127	False
25357075	In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).	Rgs9	retinal degeneration	388531	HP_0000546	224	228	107	127	False
25357075	In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).	Rpgrip1	retinal degeneration	57096	HP_0000546	269	276	107	127	True
25357075	In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to retinal degeneration, including those involved in visual cycle (Rpe65, Lrat, Rgr), phototransduction (Pde6a, Guca1b, Rgs9), and photoreceptor disc morphogenesis (Rpgrip1 and Fscn2).	Fscn2	retinal degeneration	25794	HP_0000546	281	286	107	127	False
25357075	Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in Mfrprd6 eyes by 17-fold.	Mfrp	microphthalmia	83552	HP_0000568	125	129	80	94	True
25357075	Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in Mfrprd6 eyes by 17-fold.	Prss56	microphthalmia	646960	HP_0000568	15	21	80	94	True
25357075	Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in Mfrprd6 eyes by 17-fold.	Mfrp	glaucoma	83552	HP_0000501	125	129	60	68	True
25357075	Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in Mfrprd6 eyes by 17-fold.	Prss56	glaucoma	646960	HP_0000501	15	21	60	68	True
25357075	Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in Mfrprd6 eyes by 17-fold.	Mfrp	myopia	83552	HP_0000545	125	129	99	105	False
25357075	Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior microphthalmia and myopia, were increased in Mfrprd6 eyes by 17-fold.	Prss56	myopia	646960	HP_0000545	15	21	99	105	False
28877460	Interestingly, heterogeneous nuclear RNA (hnRNA) for insulin and INS-IGF2, both originating from the INS promoter, were essentially undetectable in T1D pancreata, arguing for a silent INSpromoter.	INS	heterogeneous	3630	HP_0001425	65	68	15	28	False
28877460	Interestingly, heterogeneous nuclear RNA (hnRNA) for insulin and INS-IGF2, both originating from the INS promoter, were essentially undetectable in T1D pancreata, arguing for a silent INSpromoter.	IGF2	heterogeneous	3481	HP_0001425	69	73	15	28	True
29321360	Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.	van	autosomal recessive	10318	HP_0000007	6	9	33	52	False
29321360	Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.	PAP	autosomal recessive	50807	HP_0000007	244	247	33	52	False
29321360	Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.	van	skeletal dysplasia	10318	HP_0002652	6	9	53	71	False
29321360	Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.	PAP	skeletal dysplasia	50807	HP_0002652	244	247	53	71	False
29321360	Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.	van	short ribs	10318	HP_0000773	6	9	147	157	False
29321360	Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.	PAP	short ribs	50807	HP_0000773	244	247	147	157	False
29321360	Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.	van	short limbs	10318	HP_0009826	6	9	159	170	False
29321360	Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.	PAP	short limbs	50807	HP_0009826	244	247	159	170	False
29321360	Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.	van	dysplastic nails	10318	HP_0002164	6	9	172	188	False
29321360	Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.	PAP	dysplastic nails	50807	HP_0002164	244	247	172	188	False
29321360	Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.	van	cardiovascular malformations	10318	HP_0030680	6	9	190	218	False
29321360	Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.	PAP	cardiovascular malformations	50807	HP_0030680	244	247	190	218	False
29321360	Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.	van	axial	10318	HP_0025287	6	9	225	230	False
29321360	Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.	PAP	axial	50807	HP_0025287	244	247	225	230	False
29321360	Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.	van	polydactyly	10318	HP_0010442	6	9	231	242	False
29321360	Ellis-van Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, short ribs, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (PAP) (bilateral) of hands and feet.	PAP	polydactyly	50807	HP_0010442	244	247	231	242	False
29321360	This study reports first case of variants in the genes causing EvC syndrome and profound deafness in the same family	EvC	profound	2121	HP_0012829	63	66	80	88	False
29321360	This study reports first case of variants in the genes causing EvC syndrome and profound deafness in the same family	EvC	deafness	2121	HP_0000365	63	66	89	97	False
28980703	Further, high IRAK1 expression level was correlated with higher tumor stage, lymph node metastasis, myometrial invasion, and lower survival rate.	IRAK1	tumor	3654	HP_0002664	14	19	64	69	False
28980703	These collective data indicated that IRAK1 overexpression promotes EC tumorigenesis by activating mitotic cell cycle and cell division pathways, and IRAK1 may serve as a promising therapeutic strategy for EC	IRAK1	tumor	3654	HP_0002664	37	42	70	75	False
27007659	Two rare pathogenic variants were identified in the COL15A1 gene: one in a sporadic case and another was found to segregate in a family with six affected individuals with CD.	COL15A1	sporadic	1306	HP_0003745	52	59	75	83	False
25010494	Absence epilepsy (AE) is a common type of genetic generalized epilepsy (GGE), particularly in children.	type	epilepsy	6445	HP_0001250	34	38	8	16	False
25010494	Absence epilepsy (AE) is a common type of genetic generalized epilepsy (GGE), particularly in children.	era	epilepsy	2099	HP_0001250	53	56	8	16	False
25010494	By creating new Pcnxl2 frameshift alleles using TALEN mutagenesis, we show that Pcnxl2 deficiency is responsible for mitigating the seizure phenotype - making Pcnxl2 the first known modifier gene for absence seizures in any species.	type	seizures	6445	HP_0001250	145	149	208	216	False
25010494	By creating new Pcnxl2 frameshift alleles using TALEN mutagenesis, we show that Pcnxl2 deficiency is responsible for mitigating the seizure phenotype - making Pcnxl2 the first known modifier gene for absence seizures in any species.	type	seizure	6445	HP_0001250	145	149	132	139	False
25010494	Together these new findings expand our knowledge of how natural variation modulates seizures, and highlights the feasibility of characterizing and validating modifiers in mouse strains and substrains in the post-genome sequence era.	era	seizures	2099	HP_0001250	228	231	84	92	False
23307924	These findings implicate for the first time perturbed TGF- signaling in the genesis of retinal dystrophies, support the study of related morphogenetic genes for comparable roles in retinal disease and may offer additional therapeutic opportunities for genetically heterogeneous disorders presently only treatable with gene therapy	genesis	retinal dystrophies	27022	HP_0000556	77	84	88	107	False
23307924	These findings implicate for the first time perturbed TGF- signaling in the genesis of retinal dystrophies, support the study of related morphogenetic genes for comparable roles in retinal disease and may offer additional therapeutic opportunities for genetically heterogeneous disorders presently only treatable with gene therapy	genesis	retinal disease	27022	HP_0000479	77	84	182	197	False
23307924	These findings implicate for the first time perturbed TGF- signaling in the genesis of retinal dystrophies, support the study of related morphogenetic genes for comparable roles in retinal disease and may offer additional therapeutic opportunities for genetically heterogeneous disorders presently only treatable with gene therapy	genesis	heterogeneous	27022	HP_0001425	77	84	265	278	False
28874354	Here, we show that TILs from mice deleted in protocadherin-18 had enhanced antitumor activity and that coblockade of PD-1 and protocadherin-18 in wild-type mice significantly enhanced TIL effector phase function.	mice	tumor	23581	HP_0002664	29	33	79	84	False
30619852	Despite their clinical heterogeneity, which remains an open question, laminopathies are commonly caused by mutations in the LMNA gene, encoding the nuclear proteins Lamin A and C.	LMNA	heterogeneity	4000	HP_0001425	124	128	23	36	True
30051404	Pulmonary arterial hypertension (PAH) is a progressive disease characterised by increased pulmonary vascular resistance and pulmonary artery remodelling as result of increased vascular tone and vascular cell proliferation, respectively.	PAH	increased pulmonary vascular resistance	5053	HP_0005317	33	36	80	119	False
21738669	Progressive retinal atrophy (PRA) in dogs, the canine equivalent of retinitis pigmentosa (RP) in humans, is characterised by vision loss due to degeneration of the photoreceptor cells in the retina, eventually leading to complete blindness.	PRA	retinal atrophy	6277	HP_0001105	29	32	12	27	False
21738669	Progressive retinal atrophy (PRA) in dogs, the canine equivalent of retinitis pigmentosa (RP) in humans, is characterised by vision loss due to degeneration of the photoreceptor cells in the retina, eventually leading to complete blindness.	PRA	blindness	6277	HP_0000618	29	32	230	239	False
21738669	This variant was present in 56% of PRA cases and 87% of obligate carriers, and displayed a recessive mode of inheritance with full penetrance within those lineages in which it segregated.	PRA	mode of inheritance	6277	HP_0000005	35	38	101	120	False
21738669	A large proportion of cases (approximately 44%) remain unexplained, indicating that PRA in this breed is genetically heterogeneous and caused by at least three mutations.	PRA	heterogeneous	6277	HP_0001425	84	87	117	130	False
21738669	SLC4A3 is important for retinal function and has not previously been associated with spontaneously occurring retinal degenerations in any other species, including humans	SLC4A3	retinal degenerations	6508	HP_0000546	0	6	109	130	False
28444691	COG5-CDG (COG5 subunit deficiency) is a multisystem disease with dysmorphic features, intellectual disability of variable degree, seizures, acquired microcephaly, sensory defects and autistic behavior.	COG5	intellectual disability	10466	HP_0001249	0	4	86	109	True
28444691	COG5-CDG (COG5 subunit deficiency) is a multisystem disease with dysmorphic features, intellectual disability of variable degree, seizures, acquired microcephaly, sensory defects and autistic behavior.	COG5	seizures	10466	HP_0001250	0	4	130	138	False
28444691	COG5-CDG (COG5 subunit deficiency) is a multisystem disease with dysmorphic features, intellectual disability of variable degree, seizures, acquired microcephaly, sensory defects and autistic behavior.	COG5	microcephaly	10466	HP_0000252	0	4	149	161	False
28663568	We identified 52 variants contributing to obesity in 2% of cases including multiple novel variants in GNAS, which were sometimes found with accelerated growth rather than short stature as described previously.	GNAS	obesity	2778	HP_0001513	102	106	42	49	True
28663568	We identified 52 variants contributing to obesity in 2% of cases including multiple novel variants in GNAS, which were sometimes found with accelerated growth rather than short stature as described previously.	GNAS	short stature	2778	HP_0004322	102	106	171	184	True
28663568	Further validation in cohorts with severe obesity and engineering the variants in model organisms will be needed to explore whether human variants in ANGPTL6 and other genes that lead to obesity when deleted in mice, do contribute to obesity.	ANGPTL6	obesity	83854	HP_0001513	150	157	42	49	False
28663568	Further validation in cohorts with severe obesity and engineering the variants in model organisms will be needed to explore whether human variants in ANGPTL6 and other genes that lead to obesity when deleted in mice, do contribute to obesity.	mice	obesity	23581	HP_0001513	211	215	42	49	False
26881841	Usher syndrome type III (USH3A) is an autosomal recessive disorder caused by mutations in clarin-1 (CLRN1) gene, leading to progressive retinal degeneration and sensorineural deafness.	type	retinal degeneration	6445	HP_0000546	15	19	136	156	False
26881841	Usher syndrome type III (USH3A) is an autosomal recessive disorder caused by mutations in clarin-1 (CLRN1) gene, leading to progressive retinal degeneration and sensorineural deafness.	USH3A	retinal degeneration	7401	HP_0000546	25	30	136	156	False
26881841	Usher syndrome type III (USH3A) is an autosomal recessive disorder caused by mutations in clarin-1 (CLRN1) gene, leading to progressive retinal degeneration and sensorineural deafness.	CLRN1	retinal degeneration	7401	HP_0000546	100	105	136	156	False
26881841	Usher syndrome type III (USH3A) is an autosomal recessive disorder caused by mutations in clarin-1 (CLRN1) gene, leading to progressive retinal degeneration and sensorineural deafness.	type	deafness	6445	HP_0000365	15	19	175	183	False
26881841	Usher syndrome type III (USH3A) is an autosomal recessive disorder caused by mutations in clarin-1 (CLRN1) gene, leading to progressive retinal degeneration and sensorineural deafness.	USH3A	deafness	7401	HP_0000365	25	30	175	183	True
26881841	Usher syndrome type III (USH3A) is an autosomal recessive disorder caused by mutations in clarin-1 (CLRN1) gene, leading to progressive retinal degeneration and sensorineural deafness.	CLRN1	deafness	7401	HP_0000365	100	105	175	183	True
29620629	In the PPI network, 2 clusters of VTE genes, including ribosomal protein family genes and NADH family-ubiquinol-cytochrome genes, were identified, such as ribosomal protein L9 (RPL9), RPL5, RPS20, RPL23, and tumor protein p53 (TP53).The nod-like receptor signaling pathway, ribosomal protein family genes, such as RPL9, RPL5, RPS20, and RPL23, and DEG of TP53 may have the potential to be used as targets for diagnosis and treatment of VTE	RPL9	tumor	6133	HP_0002664	177	181	208	213	False
29620629	In the PPI network, 2 clusters of VTE genes, including ribosomal protein family genes and NADH family-ubiquinol-cytochrome genes, were identified, such as ribosomal protein L9 (RPL9), RPL5, RPS20, RPL23, and tumor protein p53 (TP53).The nod-like receptor signaling pathway, ribosomal protein family genes, such as RPL9, RPL5, RPS20, and RPL23, and DEG of TP53 may have the potential to be used as targets for diagnosis and treatment of VTE	RPL5	tumor	6125	HP_0002664	184	188	208	213	True
29620629	In the PPI network, 2 clusters of VTE genes, including ribosomal protein family genes and NADH family-ubiquinol-cytochrome genes, were identified, such as ribosomal protein L9 (RPL9), RPL5, RPS20, RPL23, and tumor protein p53 (TP53).The nod-like receptor signaling pathway, ribosomal protein family genes, such as RPL9, RPL5, RPS20, and RPL23, and DEG of TP53 may have the potential to be used as targets for diagnosis and treatment of VTE	RPS20	tumor	6224	HP_0002664	190	195	208	213	False
29620629	In the PPI network, 2 clusters of VTE genes, including ribosomal protein family genes and NADH family-ubiquinol-cytochrome genes, were identified, such as ribosomal protein L9 (RPL9), RPL5, RPS20, RPL23, and tumor protein p53 (TP53).The nod-like receptor signaling pathway, ribosomal protein family genes, such as RPL9, RPL5, RPS20, and RPL23, and DEG of TP53 may have the potential to be used as targets for diagnosis and treatment of VTE	RPL23	tumor	9349	HP_0002664	197	202	208	213	False
28623007	Three neurodegenerative diseases [Amyotrophic Lateral Sclerosis (ALS), Parkinson's disease (PD) and Alzheimer's disease (AD)] have many characteristics like pathological mechanisms and genes.	ALS	neurodegenerative diseases	3483	HP_0002180	65	68	6	32	False
28623007	We will systematically examine seven genes (CHN1, MDH1, PCP4, RTN1, SLC14A1, SNAP25 and VSNL1) that are altered in the three neurodegenerative diseases.	CHN1	neurodegenerative diseases	1123	HP_0002180	44	48	125	151	False
28623007	We will systematically examine seven genes (CHN1, MDH1, PCP4, RTN1, SLC14A1, SNAP25 and VSNL1) that are altered in the three neurodegenerative diseases.	MDH1	neurodegenerative diseases	4190	HP_0002180	50	54	125	151	False
28623007	We will systematically examine seven genes (CHN1, MDH1, PCP4, RTN1, SLC14A1, SNAP25 and VSNL1) that are altered in the three neurodegenerative diseases.	PCP4	neurodegenerative diseases	5121	HP_0002180	56	60	125	151	False
28623007	We will systematically examine seven genes (CHN1, MDH1, PCP4, RTN1, SLC14A1, SNAP25 and VSNL1) that are altered in the three neurodegenerative diseases.	RTN1	neurodegenerative diseases	6252	HP_0002180	62	66	125	151	False
28623007	We will systematically examine seven genes (CHN1, MDH1, PCP4, RTN1, SLC14A1, SNAP25 and VSNL1) that are altered in the three neurodegenerative diseases.	SLC14A1	neurodegenerative diseases	6563	HP_0002180	68	75	125	151	False
28623007	We will systematically examine seven genes (CHN1, MDH1, PCP4, RTN1, SLC14A1, SNAP25 and VSNL1) that are altered in the three neurodegenerative diseases.	SNAP25	neurodegenerative diseases	6616	HP_0002180	77	83	125	151	False
28623007	We will systematically examine seven genes (CHN1, MDH1, PCP4, RTN1, SLC14A1, SNAP25 and VSNL1) that are altered in the three neurodegenerative diseases.	VSNL1	neurodegenerative diseases	7447	HP_0002180	88	93	125	151	False
28766361	Introduction Despite some new treatment possibilities, the improvement in survival rate for hepatocellular carcinoma (HCC) patients is still poor due to late diagnosis.	HCC	hepatocellular carcinoma	84668	HP_0001402	118	121	92	116	False
28766361	The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.	HCC	squamous cell carcinoma	84668	HP_0002860	298	301	189	212	False
28766361	The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.	Glypican	squamous cell carcinoma	2817	HP_0002860	152	160	189	212	False
28766361	The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.	CSTB	squamous cell carcinoma	1476	HP_0002860	182	186	189	212	False
28766361	The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.	SCCA1	squamous cell carcinoma	6317	HP_0002860	224	229	189	212	False
28766361	The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.	HGF	squamous cell carcinoma	3569	HP_0002860	261	264	189	212	False
28766361	The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.	ALC	squamous cell carcinoma	55821	HP_0002860	346	349	189	212	False
28766361	The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.	HCC	tumour	84668	HP_0002664	298	301	279	285	False
28766361	The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.	Glypican	tumour	2817	HP_0002664	152	160	279	285	False
28766361	The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.	CSTB	tumour	1476	HP_0002664	182	186	279	285	False
28766361	The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.	SCCA1	tumour	6317	HP_0002664	224	229	279	285	False
28766361	The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.	HGF	tumour	3569	HP_0002664	261	264	279	285	False
28766361	The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), Glypican-3 (GP3), Cystatin B (CSTB), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (ALC) using imaging techniques (MSCT and MRI) as reference standards.	ALC	tumour	55821	HP_0002664	346	349	279	285	False
28766361	The 'best' combination of tumour markers in our study includes all tested markers with AUC of 0.967.	best	tumour	7439	HP_0002664	5	9	26	32	False
28766361	Conclusion While novel diagnostic tumour markers are urgently needed, the examined potential tumour markers, with the exception of PIVKAII seem to be inadequate for diagnosing HCC in ALC.	HCC	tumour	84668	HP_0002664	176	179	34	40	False
28766361	Conclusion While novel diagnostic tumour markers are urgently needed, the examined potential tumour markers, with the exception of PIVKAII seem to be inadequate for diagnosing HCC in ALC.	ALC	tumour	55821	HP_0002664	183	186	34	40	False
28766361	Furthermore, probably the future is in finding the best optimal combination of tumour markers for diagnosing HCC based on cost-effectiveness	HCC	tumour	84668	HP_0002664	109	112	79	85	False
28766361	Furthermore, probably the future is in finding the best optimal combination of tumour markers for diagnosing HCC based on cost-effectiveness	best	tumour	7439	HP_0002664	51	55	79	85	False
28303930	Glioblastoma (GBM) is the most prevalent and lethal type of primary malignant brain tumour.	type	tumour	6445	HP_0002664	52	56	84	90	False
28303930	We found that miR-UL112-3p expression was significantly elevated in GBM, and its expression levels were highly associated with glioma size, differentiation, WHO stage and the overall and disease-free survival of patients.	miR	glioma	220972	HP_0009733	14	17	127	133	False
17982252	The dopamine hypothesis of schizophrenia is based on the fact that all common treatments involve antidopaminergic mechanisms and genes such as DRD2, DRD3, DARPP-32, BDNF or COMT are closely related to dopaminergic system functioning.	fact	schizophrenia	11198	HP_0100753	57	61	27	40	False
17982252	The dopamine hypothesis of schizophrenia is based on the fact that all common treatments involve antidopaminergic mechanisms and genes such as DRD2, DRD3, DARPP-32, BDNF or COMT are closely related to dopaminergic system functioning.	DRD2	schizophrenia	1813	HP_0100753	143	147	27	40	False
17982252	The dopamine hypothesis of schizophrenia is based on the fact that all common treatments involve antidopaminergic mechanisms and genes such as DRD2, DRD3, DARPP-32, BDNF or COMT are closely related to dopaminergic system functioning.	DRD3	schizophrenia	1814	HP_0100753	149	153	27	40	False
17982252	The dopamine hypothesis of schizophrenia is based on the fact that all common treatments involve antidopaminergic mechanisms and genes such as DRD2, DRD3, DARPP-32, BDNF or COMT are closely related to dopaminergic system functioning.	DARPP-32	schizophrenia	84152	HP_0100753	155	163	27	40	False
17982252	The dopamine hypothesis of schizophrenia is based on the fact that all common treatments involve antidopaminergic mechanisms and genes such as DRD2, DRD3, DARPP-32, BDNF or COMT are closely related to dopaminergic system functioning.	BDNF	schizophrenia	627	HP_0100753	165	169	27	40	False
17982252	The dopamine hypothesis of schizophrenia is based on the fact that all common treatments involve antidopaminergic mechanisms and genes such as DRD2, DRD3, DARPP-32, BDNF or COMT are closely related to dopaminergic system functioning.	COMT	schizophrenia	1312	HP_0100753	173	177	27	40	True
17982252	The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).	SLC1A6	schizophrenia	6511	HP_0100753	203	209	32	45	False
17982252	The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).	SLC1A2	schizophrenia	6506	HP_0100753	211	217	32	45	False
17982252	The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).	GRIN1	schizophrenia	114787	HP_0100753	218	223	32	45	False
17982252	The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).	GRIN2A	schizophrenia	2903	HP_0100753	225	231	32	45	False
17982252	The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).	GRIA1	schizophrenia	2890	HP_0100753	233	238	32	45	False
17982252	The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).	NRG1	schizophrenia	3084	HP_0100753	240	244	32	45	False
17982252	The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).	ErbB4	schizophrenia	2066	HP_0100753	246	251	32	45	False
17982252	The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).	DTNBP1	schizophrenia	84062	HP_0100753	253	259	32	45	False
17982252	The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).	GRM3	schizophrenia	2913	HP_0100753	275	279	32	45	False
27863507	Mutations in the gene encoding the nuclear matrix protein Matrin 3 have been found in familial cases of ALS, as well as autosomal dominant distal myopathy with vocal cord and pharyngeal weakness.	ALS	distal	3483	HP_0012839	104	107	139	145	False
27863507	Mutations in the gene encoding the nuclear matrix protein Matrin 3 have been found in familial cases of ALS, as well as autosomal dominant distal myopathy with vocal cord and pharyngeal weakness.	ALS	myopathy	3483	HP_0003198	104	107	146	154	False
27863507	We previously found that spinal cord and muscle, organs involved in either ALS or distal myopathy, have relatively lower levels of Matrin 3 compared to the brain and other peripheral organs in the murine system.	ALS	distal	3483	HP_0012839	75	78	82	88	False
27863507	We previously found that spinal cord and muscle, organs involved in either ALS or distal myopathy, have relatively lower levels of Matrin 3 compared to the brain and other peripheral organs in the murine system.	ALS	myopathy	3483	HP_0003198	75	78	89	97	False
27593185	The purpose of this study was to explore the use of iterative decomposition of water and fat with echo asymmetry and least-squares estimation Carr-Purcell-Meiboom-Gill (IDEAL-CPMG) to simultaneously measure skeletal muscle apparent fat fraction and water T<sub>2</sub> (T<sub>2,w</sub>) in patients with Duchenne muscular dystrophy (DMD).	fat	muscular dystrophy	948	HP_0003560	89	92	313	331	False
27593185	The purpose of this study was to explore the use of iterative decomposition of water and fat with echo asymmetry and least-squares estimation Carr-Purcell-Meiboom-Gill (IDEAL-CPMG) to simultaneously measure skeletal muscle apparent fat fraction and water T<sub>2</sub> (T<sub>2,w</sub>) in patients with Duchenne muscular dystrophy (DMD).	DMD	muscular dystrophy	1756	HP_0003560	333	336	313	331	True
25645914	Mutations in LEPREL1, the gene encoding prolyl 3-hydroxylase-2 (P3H2), have recently been identified in individuals with recessively inherited nonsyndromic severe myopia.	LEPREL1	myopia	55214	HP_0000545	13	20	163	169	True
25645914	In this study, differences in prolyl 3-hydroxylation were screened in eye tissues from P3h2-null (P3h2(n/n)) and wild-type mice to seek tissue-specific effects due the lack of P3H2 activity on post-translational collagen chemistry that could explain myopia.	mice	myopia	23581	HP_0000545	123	127	250	256	False
25645914	In this study, differences in prolyl 3-hydroxylation were screened in eye tissues from P3h2-null (P3h2(n/n)) and wild-type mice to seek tissue-specific effects due the lack of P3H2 activity on post-translational collagen chemistry that could explain myopia.	type	myopia	6445	HP_0000545	118	122	250	256	False
29411334	Across the years the CCNs have been increasingly implicated in the development of obesity, diabetes and its complications.	CCNs	obesity	81669	HP_0001513	21	25	82	89	False
29411334	Key steps where CCNs may play a pathogenic metabolic role include: (i) obesity and insulin resistance, where CCN2 inhibits fat cell differentiation in vitro and CCN3 may induce obesity and insulin resistance; (ii) elevated blood glucose levels to diabetes mellitus onset, where CCN2 may contribute to pancreatic beta cell and islet function; and (iii) in diabetes complications, such as nephropathy, retinopathy, liver disease (NAFLD/NASH), CVD and diabetes with heart failure.	CCNs	obesity	81669	HP_0001513	16	20	71	78	False
29411334	Key steps where CCNs may play a pathogenic metabolic role include: (i) obesity and insulin resistance, where CCN2 inhibits fat cell differentiation in vitro and CCN3 may induce obesity and insulin resistance; (ii) elevated blood glucose levels to diabetes mellitus onset, where CCN2 may contribute to pancreatic beta cell and islet function; and (iii) in diabetes complications, such as nephropathy, retinopathy, liver disease (NAFLD/NASH), CVD and diabetes with heart failure.	CCN2	obesity	1490	HP_0001513	109	113	71	78	False
29411334	Key steps where CCNs may play a pathogenic metabolic role include: (i) obesity and insulin resistance, where CCN2 inhibits fat cell differentiation in vitro and CCN3 may induce obesity and insulin resistance; (ii) elevated blood glucose levels to diabetes mellitus onset, where CCN2 may contribute to pancreatic beta cell and islet function; and (iii) in diabetes complications, such as nephropathy, retinopathy, liver disease (NAFLD/NASH), CVD and diabetes with heart failure.	fat	obesity	948	HP_0001513	123	126	71	78	False
29411334	Key steps where CCNs may play a pathogenic metabolic role include: (i) obesity and insulin resistance, where CCN2 inhibits fat cell differentiation in vitro and CCN3 may induce obesity and insulin resistance; (ii) elevated blood glucose levels to diabetes mellitus onset, where CCN2 may contribute to pancreatic beta cell and islet function; and (iii) in diabetes complications, such as nephropathy, retinopathy, liver disease (NAFLD/NASH), CVD and diabetes with heart failure.	CCN3	obesity	5361	HP_0001513	161	165	71	78	False
25865492	Here, we report mutations in PYCR2, which encodes an enzyme in the proline biosynthesis pathway, as the cause of a unique syndrome characterized by postnatal microcephaly, hypomyelination, and reduced cerebral white-matter volume.	PYCR2	microcephaly	29920	HP_0000252	29	34	158	170	True
25865492	Here, we report mutations in PYCR2, which encodes an enzyme in the proline biosynthesis pathway, as the cause of a unique syndrome characterized by postnatal microcephaly, hypomyelination, and reduced cerebral white-matter volume.	PYCR2	hypomyelination	29920	HP_0003429	29	34	172	187	True
25865492	Morpholino-based knockdown of a zebrafish PYCR2 ortholog, pycr1b, recapitulated the human microcephaly phenotype, which was rescued by wild-type human PYCR2 mRNA, but not by mutant mRNAs, further supporting the pathogenicity of the identified variants.	PYCR2	microcephaly	29920	HP_0000252	42	47	90	102	True
24508273	MAX which was involved in small cell lung cancer pathway was a hub gene unique to T2D (OR=1.2, P=0.006) but not in CAD.	CAD	cancer	1677	HP_0002664	115	118	42	48	False
24508273	MAX which was involved in small cell lung cancer pathway was a hub gene unique to T2D (OR=1.2, P=0.006) but not in CAD.	hub	cancer	1993	HP_0002664	63	66	42	48	False
27966543	Since RAPSN-associated limb-girdle type CMS was only manifested in AK9 homozygous variant carriers, the disease phenotype was of digenic inheritance, and was determined by the novel disease modifier AK9 which provides NTPs for N-glycosylation.	CMS	digenic inheritance	23607	HP_0010984	40	43	129	148	False
27966543	Since RAPSN-associated limb-girdle type CMS was only manifested in AK9 homozygous variant carriers, the disease phenotype was of digenic inheritance, and was determined by the novel disease modifier AK9 which provides NTPs for N-glycosylation.	type	digenic inheritance	6445	HP_0010984	35	39	129	148	False
27966543	Since RAPSN-associated limb-girdle type CMS was only manifested in AK9 homozygous variant carriers, the disease phenotype was of digenic inheritance, and was determined by the novel disease modifier AK9 which provides NTPs for N-glycosylation.	RAPSN	digenic inheritance	5913	HP_0010984	6	11	129	148	False
27966543	Since RAPSN-associated limb-girdle type CMS was only manifested in AK9 homozygous variant carriers, the disease phenotype was of digenic inheritance, and was determined by the novel disease modifier AK9 which provides NTPs for N-glycosylation.	AK9	digenic inheritance	221264	HP_0010984	67	70	129	148	False
23011062	Physical deconditioning is associated with the development of chronic diseases, including type 2 diabetes and cardiovascular disease.	type	cardiovascular disease	6445	HP_0001626	90	94	110	132	True
29519717	Mutations in CHCHD2 and CHCHD10 were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM).	CHCHD2	neurodegenerative diseases	51142	HP_0002180	13	19	78	104	False
29519717	Mutations in CHCHD2 and CHCHD10 were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM).	CHCHD10	neurodegenerative diseases	400916	HP_0002180	24	31	78	104	True
29519717	Mutations in CHCHD2 and CHCHD10 were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM).	CHCHD2	frontotemporal dementia	51142	HP_0002145	13	19	171	194	False
29519717	Mutations in CHCHD2 and CHCHD10 were recently reported in a broad spectrum of neurodegenerative diseases, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM).	CHCHD10	frontotemporal dementia	400916	HP_0002145	24	31	171	194	True
29519717	None of the patients showed CHCHD2 mutations, whereas 1 sporadic MM patient carried a homozygous Pro96Thr substitution in CHCHD10.	CHCHD2	sporadic	51142	HP_0003745	28	34	56	64	False
29519717	None of the patients showed CHCHD2 mutations, whereas 1 sporadic MM patient carried a homozygous Pro96Thr substitution in CHCHD10.	CHCHD10	sporadic	400916	HP_0003745	122	129	56	64	False
30209139	Primary ciliary dyskinesia (PCD) can manifest in the neonatal period with severe respiratory distress.	PCD	ciliary dyskinesia	352909	HP_0012265	28	31	8	26	True
30209139	We describe a child with PCD who presented at term with severe neonatal respiratory distress, persistent right upper lobe collapse and failure to thrive who underwent lobectomy prior to the diagnosis of PCD at the age of 3 years.	PCD	failure to thrive	352909	HP_0001508	25	28	135	152	False
30209139	We describe a child with PCD who presented at term with severe neonatal respiratory distress, persistent right upper lobe collapse and failure to thrive who underwent lobectomy prior to the diagnosis of PCD at the age of 3 years.	lobe	failure to thrive	84335	HP_0001508	117	121	135	152	False
27925179	NEK2 overexpression promotes tumorigenesis and is associated with poor prognosis in several cancers.	NEK2	cancer	4751	HP_0002664	0	4	92	98	False
27925179	NEK2 overexpression promotes tumorigenesis and is associated with poor prognosis in several cancers.	NEK2	tumor	4751	HP_0002664	0	4	29	34	False
27925179	Increased NEK2 expression during the late pathological stage has been detected in the Oncomine liver dataset and hepatocellular carcinoma (HCC) specimens.	NEK2	hepatocellular carcinoma	4751	HP_0001402	10	14	113	137	False
27925179	Increased NEK2 expression during the late pathological stage has been detected in the Oncomine liver dataset and hepatocellular carcinoma (HCC) specimens.	HCC	hepatocellular carcinoma	84668	HP_0001402	139	142	113	137	False
27925179	However, the precise roles and mechanisms of NEK2 in liver cancer progression remain largely unknown.	NEK2	cancer	4751	HP_0002664	45	49	59	65	False
27925179	Results from the current study showed that NEK2 mediates tumor growth, metastasis and angiogenesis in vivo.	NEK2	tumor	4751	HP_0002664	43	47	57	62	False
27925179	Moreover, NEK2 mediated liver cancer cell migration via pAKT/NF-B signaling and matrix metalloproteinase (MMP) activation.	NEK2	cancer	4751	HP_0002664	10	14	30	36	False
27925179	Moreover, NEK2 mediated liver cancer cell migration via pAKT/NF-B signaling and matrix metalloproteinase (MMP) activation.	AKT	cancer	207	HP_0002664	57	60	30	36	True
27925179	Moreover, NEK2 mediated liver cancer cell migration via pAKT/NF-B signaling and matrix metalloproteinase (MMP) activation.	NF	cancer	23114	HP_0002664	61	63	30	36	False
30683880	We also found that multiple cancers are genetically correlated with non-cancer traits including smoking, psychiatric diseases and metabolic characteristics.	traits	cancer	55929	HP_0002664	79	85	28	34	False
30137666	Wnt transgenic mice provide convincing evidence that Wnt signaling is involved in breast cancer initiation and progression, which is further strengthened by observations on human clinical breast cancer patients and studies on in vitro cultured human breast cancer cells.	mice	cancer	23581	HP_0002664	15	19	89	95	False
30320381	In the present study, western blotting was used to verified the expression of Tlymphocyte CaSR and pathway proteins, including phosphorylated extracellular signalregulated kinase (PERK)1/2 and phosphorylated cJun Nterminal kinase (PJNK), and used cytometric bead array to detect the secretion of interleukin (IL)4, IL6, IL10 and tumor necrosis factor (TNF) in AMI onset, the results demonstrated that they were all increased.	CaSR	tumor	846	HP_0002664	91	95	338	343	False
30320381	In the present study, western blotting was used to verified the expression of Tlymphocyte CaSR and pathway proteins, including phosphorylated extracellular signalregulated kinase (PERK)1/2 and phosphorylated cJun Nterminal kinase (PJNK), and used cytometric bead array to detect the secretion of interleukin (IL)4, IL6, IL10 and tumor necrosis factor (TNF) in AMI onset, the results demonstrated that they were all increased.	TNF	tumor	7124	HP_0002664	361	364	338	343	False
22201925	Until recently, four loci (DFN2, DFN3, DFN4, and DFN6) had been implicated in nonsyndromic X-linked hearing loss; however, a new classification (DFNX1-5) has been proposed to reduce confusion in the terminology.	DFN2	hearing loss	5631	HP_0000365	27	31	100	112	True
22201925	Until recently, four loci (DFN2, DFN3, DFN4, and DFN6) had been implicated in nonsyndromic X-linked hearing loss; however, a new classification (DFNX1-5) has been proposed to reduce confusion in the terminology.	DFN3	hearing loss	5456	HP_0000365	33	37	100	112	True
22201925	Until recently, four loci (DFN2, DFN3, DFN4, and DFN6) had been implicated in nonsyndromic X-linked hearing loss; however, a new classification (DFNX1-5) has been proposed to reduce confusion in the terminology.	DFN6	hearing loss	23676	HP_0000365	49	53	100	112	True
22201925	Until recently, four loci (DFN2, DFN3, DFN4, and DFN6) had been implicated in nonsyndromic X-linked hearing loss; however, a new classification (DFNX1-5) has been proposed to reduce confusion in the terminology.	DFNX1	hearing loss	5631	HP_0000365	145	150	100	112	True
22201925	In addition to the POU3F4 gene, which was the first gene identified as causing nonsyndromic X-linked hearing loss, a second gene, PRPS1, has recently been identified to be the causative gene of DFNX1 (DFN2).	DFN2	hearing loss	5631	HP_0000365	201	205	101	113	True
22201925	In addition to the POU3F4 gene, which was the first gene identified as causing nonsyndromic X-linked hearing loss, a second gene, PRPS1, has recently been identified to be the causative gene of DFNX1 (DFN2).	POU3F4	hearing loss	5456	HP_0000365	19	25	101	113	True
22201925	In addition to the POU3F4 gene, which was the first gene identified as causing nonsyndromic X-linked hearing loss, a second gene, PRPS1, has recently been identified to be the causative gene of DFNX1 (DFN2).	PRPS1	hearing loss	5631	HP_0000365	130	135	101	113	True
22201925	In addition to the POU3F4 gene, which was the first gene identified as causing nonsyndromic X-linked hearing loss, a second gene, PRPS1, has recently been identified to be the causative gene of DFNX1 (DFN2).	DFNX1	hearing loss	5631	HP_0000365	194	199	101	113	True
28582508	Functional studies have elucidated the role of the mammalian target of rapamycin (mTOR) pathway in breast carcinogenesis, but to date, there is a paucity of data on its contribution to breast cancer risk in women of African ancestry.	mTOR	cancer	2475	HP_0002664	82	86	192	198	False
28582508	We examined 47628 SNPs in 61 mTOR pathway genes in the genome wide association study of breast cancer in the African Diaspora study (The Root consortium), which included 3686 participants (1657 cases).	mTOR	cancer	2475	HP_0002664	29	33	95	101	False
28582508	The mTOR pathway was significantly associated with overall and estrogen receptor-negative (ER-) breast cancer risk (P = 0.003 and 0.03, respectively).	mTOR	cancer	2475	HP_0002664	4	8	103	109	False
28582508	PRKAG3 (Padj = 0.0018) and RPS6KA3 (Padj = 0.061) were the leading genes for the associations with overall breast cancer risk and ER- breast cancer risk, respectively.	RPS6KA3	cancer	6197	HP_0002664	27	34	114	120	False
28582508	PRKAG3 (Padj = 0.0018) and RPS6KA3 (Padj = 0.061) were the leading genes for the associations with overall breast cancer risk and ER- breast cancer risk, respectively.	PRKAG3	cancer	53632	HP_0002664	0	6	114	120	False
28582508	These results provide new insights on the biological relevance of the mTOR pathway in breast cancer progression and underscore the need for more genetic epidemiology studies of breast cancer in the African Diaspora	mTOR	cancer	2475	HP_0002664	70	74	93	99	False
30069007	Polo-like kinase 1 (Plk1) is overexpressed in a wide spectrum of human tumors, being frequently considered as an oncogene and an attractive cancer target.	Plk1	tumors	5347	HP_0002664	20	24	71	77	False
30069007	Polo-like kinase 1 (Plk1) is overexpressed in a wide spectrum of human tumors, being frequently considered as an oncogene and an attractive cancer target.	Plk1	cancer	5347	HP_0002664	20	24	140	146	False
30069007	In vivo, Plk1 overexpression prevents the development of Kras-induced and Her2-induced mammary gland tumors, in the presence of increased rates of chromosome instability.	Plk1	tumors	5347	HP_0002664	9	13	101	107	False
30069007	In vivo, Plk1 overexpression prevents the development of Kras-induced and Her2-induced mammary gland tumors, in the presence of increased rates of chromosome instability.	Kras	tumors	3845	HP_0002664	57	61	101	107	True
30069007	In vivo, Plk1 overexpression prevents the development of Kras-induced and Her2-induced mammary gland tumors, in the presence of increased rates of chromosome instability.	Her2	tumors	2064	HP_0002664	74	78	101	107	True
30069007	In patients, Plk1 overexpression correlates with improved survival in specific breast cancer subtypes.	Plk1	cancer	5347	HP_0002664	13	17	86	92	False
30069007	Therefore, despite the therapeutic benefits of inhibiting Plk1 due to its essential role in tumor cell cycles, Plk1 overexpression has tumor-suppressive properties by perturbing mitotic progression and cytokinesis	Plk1	tumor	5347	HP_0002664	58	62	92	97	False
22527681	At least 36 different forms of ADCA are known, 20 autosomal-recessive, two X-linked, and several forms of ataxia associated with mitochondrial defects are known to date.	ADCA	ataxia	5173	HP_0001251	31	35	106	112	True
22527681	Exome and targeted sequencing has recently identified four new genes causing ataxia: TGM6, ANO10, SYT14, and rundataxin.	TGM6	ataxia	343641	HP_0001251	85	89	77	83	True
22527681	Exome and targeted sequencing has recently identified four new genes causing ataxia: TGM6, ANO10, SYT14, and rundataxin.	ANO10	ataxia	55129	HP_0001251	91	96	77	83	True
22527681	Exome and targeted sequencing has recently identified four new genes causing ataxia: TGM6, ANO10, SYT14, and rundataxin.	SYT14	ataxia	255928	HP_0001251	98	103	77	83	True
29544897	In light of more and more evidence point to the importance of Kindlin family members in normal development and human diseases especially in cancers, we aim to portrait the profile of Kindlins in the regulation of embryonic development and cancer progression.	light	cancer	8740	HP_0002664	3	8	140	146	False
29352327	LIMKs and SSH promote cancer cell invasion and metastasis and represent novel anti-cancer targets.	LIM	cancer	10611	HP_0002664	0	3	22	28	False
29352327	However, little is known regarding LIMK/cofilin and SSH in human colorectal cancer (CRC).	LIM	cancer	10611	HP_0002664	35	38	76	82	False
29352327	We show that active cofilin, LIMK1, LIMK2, and SSH1 are overexpressed in human CRC and are associated with tumor progression parameters.	LIM	tumor	10611	HP_0002664	29	32	107	112	False
29352327	We show that active cofilin, LIMK1, LIMK2, and SSH1 are overexpressed in human CRC and are associated with tumor progression parameters.	SSH1	tumor	54434	HP_0002664	47	51	107	112	False
29352327	In addition, immunofluorescence analysis showed increased expression of active cofilin, LIMK1, LIMK2, and SSH1 in HT29 colon cancer cells resistant to 5-fluorouracil compared to parental HT29 cells.	LIM	cancer	10611	HP_0002664	88	91	125	131	False
29352327	In addition, immunofluorescence analysis showed increased expression of active cofilin, LIMK1, LIMK2, and SSH1 in HT29 colon cancer cells resistant to 5-fluorouracil compared to parental HT29 cells.	SSH1	cancer	54434	HP_0002664	106	110	125	131	False
29352327	Our results suggest that F-actin regulators LIMK/cofilin pathway and SSH1 are associated with CRC progression and chemoresistance representing promising tumor biomarkers and therapeutic targets in CRC	LIM	tumor	10611	HP_0002664	44	47	153	158	False
29352327	Our results suggest that F-actin regulators LIMK/cofilin pathway and SSH1 are associated with CRC progression and chemoresistance representing promising tumor biomarkers and therapeutic targets in CRC	SSH1	tumor	54434	HP_0002664	69	73	153	158	False
29016847	The most likely causal variant identified was a novel missense variant in the X-linked GRIA3 gene, which has been implicated in intellectual disability.	GRIA3	intellectual disability	2892	HP_0001249	87	92	128	151	True
29958946	The schizophrenia-associated gene GRIN2A (glutamate ionotropic receptor NMDA type subunit 2a) codes for a protein subunit of the NMDA (N-methyl-D-aspartate) receptor that underlies central aspects of human cognition.	GRIN2A	schizophrenia	2903	HP_0100753	34	40	4	17	False
29958946	The schizophrenia-associated gene GRIN2A (glutamate ionotropic receptor NMDA type subunit 2a) codes for a protein subunit of the NMDA (N-methyl-D-aspartate) receptor that underlies central aspects of human cognition.	type	schizophrenia	6445	HP_0100753	77	81	4	17	False
29958946	The results also suggest that some schizophrenia-related alleles may be subject to cognitive tradeoffs involving both positive and negative effects on psychological phenotypes, which may help to explain the maintenance of psychiatric-disorder risk alleles in human populations	type	schizophrenia	6445	HP_0100753	170	174	35	48	False
29728556	The aim of this study was to investigate the expression of the long intergenic non-protein coding RNA 665 (LINC00665) gene and the cell cycle in hepatocellular carcinoma (HCC) using database analysis including The Cancer Genome Atlas (TCGA), the Gene Expression Omnibus (GEO), and quantitative real-time polymerase chain reaction (qPCR).	HCC	hepatocellular carcinoma	84668	HP_0001402	171	174	145	169	False
29728556	RESULTS Overexpression of LINC00665 in patients with HCC was significantly associated with gender, tumor grade, stage, and tumor cell type.	HCC	tumor	84668	HP_0002664	53	56	99	104	False
29893028	The aim this study was to investigate the prevalence of single nucleotide polymorphisms in LEP gene (LEP 3'UTR A/C, -2548G/A) and LEPR (K109R and Q223R) and their association with Leptin level and obesity.	LEP	obesity	3952	HP_0001513	91	94	198	205	True
29893028	The K109R polymorphism was associated with obesity (P=.025) and seems to significantly decrease the LEP levels (P&lt;.001).	LEP	obesity	3952	HP_0001513	102	105	43	50	True
29893028	Concerning LEP G2548A polymorphism, our results showed that the OR of obesity associated with 2548 AA/GG was 1.87[1.106-2.78] P=.028 vs 1.41[1.035-1.85] P=.045 for 223AA/GG polymorphism.	LEP	obesity	3952	HP_0001513	11	14	70	77	True
23977260	Progressive retinal atrophy (PRA) is the canine equivalent of retinitis pigmentosa (RP).	PRA	retinal atrophy	6277	HP_0001105	29	32	12	27	False
23977260	CNGB1 mutations are one cause of autosomal recessive RP making the CNGB1 mutant dog a valuable large animal model of the condition	CNGB1	autosomal recessive	1258	HP_0000007	0	5	33	52	True
25574029	The 1p breakpoint disrupts the 5' UTR of AHDC1, which encodes AT-hook DNA-binding motif containing-1 protein, and AHDC1-truncating mutations have recently been described in a syndrome that includes developmental delay, but not congenital heart disease [Xia, F., Bainbridge, M.N., Tan, T.Y., Wangler, M.F., Scheuerle, A.E., Zackai, E.H., Harr, M.H., Sutton, V.R., Nalam, R.L., Zhu, W. et al. (2014) De Novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea.	AHDC1	developmental delay	27245	HP_0001263	41	46	198	217	True
25574029	The 1p breakpoint disrupts the 5' UTR of AHDC1, which encodes AT-hook DNA-binding motif containing-1 protein, and AHDC1-truncating mutations have recently been described in a syndrome that includes developmental delay, but not congenital heart disease [Xia, F., Bainbridge, M.N., Tan, T.Y., Wangler, M.F., Scheuerle, A.E., Zackai, E.H., Harr, M.H., Sutton, V.R., Nalam, R.L., Zhu, W. et al. (2014) De Novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea.	AHDC1	language delay	27245	HP_0000750	41	46	477	491	False
25574029	The 1p breakpoint disrupts the 5' UTR of AHDC1, which encodes AT-hook DNA-binding motif containing-1 protein, and AHDC1-truncating mutations have recently been described in a syndrome that includes developmental delay, but not congenital heart disease [Xia, F., Bainbridge, M.N., Tan, T.Y., Wangler, M.F., Scheuerle, A.E., Zackai, E.H., Harr, M.H., Sutton, V.R., Nalam, R.L., Zhu, W. et al. (2014) De Novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea.	AHDC1	sleep apnea	27245	HP_0010535	41	46	508	519	True
25574029	Matr3(Gt-ex13) homozygotes are early embryo lethal, but Matr3(Gt-ex13) heterozygotes exhibit incompletely penetrant BAV, CoA and PDA phenotypes similar to those in the human proband, as well as ventricular septal defect (VSD) and double-outlet right ventricle (DORV).	Matr3	ventricular septal defect	9782	HP_0001629	0	5	194	219	False
28591699	Leiomyoma of deep soft tissue is a rare type of benign smooth muscle tumor that mostly occurs in the retroperitoneum or abdominal cavity of women, and about which very little genetic information exists.	type	tumor	6445	HP_0002664	40	44	69	74	False
28591699	G-banding showed that three tumors carried rearrangements of the long arm of chromosome 12, three others had 8q rearrangements, the 7th tumor had deletion of the long arm of chromosome 7, del(7)(q22), and the 8th had aberrations of chromosome bands 3q21~23 and 11q21~22.	arm	tumor	80210	HP_0002664	70	73	28	33	False
28591699	In the leiomyomas with 12q rearrangements, both HMGA2 and PLAG1 were expressed whereas in the tumors with 8q aberrations, only PLAG1 was expressed.	HMGA2	tumor	8091	HP_0002664	48	53	94	99	True
28591699	In the leiomyomas with 12q rearrangements, both HMGA2 and PLAG1 were expressed whereas in the tumors with 8q aberrations, only PLAG1 was expressed.	PLAG1	tumor	5324	HP_0002664	58	63	94	99	True
28591699	In two tumors with 12q rearrangements, RPSAP52 on 12q14.3 was fused with non-coding RNA (accession number XR_944195) from 14q32.2 or ZFP36L1 from14q24.1.	ZFP36L1	tumor	677	HP_0002664	133	140	7	12	False
28591699	In a tumor with inv(12), exon 3 of HMGA2 was fused to a sequence in intron 1 of the CRADD gene from 12q22.	HMGA2	tumor	8091	HP_0002664	35	40	5	10	True
28591699	In a tumor with inv(12), exon 3 of HMGA2 was fused to a sequence in intron 1 of the CRADD gene from 12q22.	CRADD	tumor	8738	HP_0002664	84	89	5	10	False
29376860	As an important multifunctional protein involved in regulation of mitochondrial metabolism, CHCHD2 was identified as a causative gene for Parkinson's disease (PD), yet the relationship between CHCHD2 and neurodegenerative dementia is not well understood.	CHCHD2	mitochondrial	51142	HP_0001427	92	98	66	79	False
29899443	We obtained cryo-electron microscopy structures of an activated filament that is allosterically induced by citrate (ACC-citrate), and an inactivated filament form that results from binding of the BRCT domains of the breast cancer type 1 susceptibility protein (BRCA1).	type	cancer	6445	HP_0002664	230	234	223	229	False
29899443	We obtained cryo-electron microscopy structures of an activated filament that is allosterically induced by citrate (ACC-citrate), and an inactivated filament form that results from binding of the BRCT domains of the breast cancer type 1 susceptibility protein (BRCA1).	BRCA1	cancer	672	HP_0002664	261	266	223	229	True
30272371	Sonic hedgehog (SHH) signaling is an important promotor of desmoplasia, a critical feature in pancreatic cancer stromal reactions involving the activation of pancreatic stellate cells(PSCs).	SHH	cancer	6469	HP_0002664	16	19	105	111	True
30272371	The present study investigated the association between Gremlin1 and SHH, and the effect of Gremlin1 in pancreatic cancer.	SHH	cancer	6469	HP_0002664	69	72	116	122	True
30272371	Primary human PSCs and pancreatic cancer cell lines were exposed to SHH, cyclopamine, GLI family zinc finger-1(Gli-1) small interfering RNA (siRNA), and Gremlin1 siRNA to examine their associations and effects using an MTT assay, reverse transcription-quantitative polymerase chain reaction analysis, western blot analysis, and migration or invasion assays.	SHH	cancer	6469	HP_0002664	68	71	34	40	True
30272371	Primary human PSCs and pancreatic cancer cell lines were exposed to SHH, cyclopamine, GLI family zinc finger-1(Gli-1) small interfering RNA (siRNA), and Gremlin1 siRNA to examine their associations and effects using an MTT assay, reverse transcription-quantitative polymerase chain reaction analysis, western blot analysis, and migration or invasion assays.	GLI	cancer	2735	HP_0002664	86	89	34	40	True
30272371	Primary human PSCs and pancreatic cancer cell lines were exposed to SHH, cyclopamine, GLI family zinc finger-1(Gli-1) small interfering RNA (siRNA), and Gremlin1 siRNA to examine their associations and effects using an MTT assay, reverse transcription-quantitative polymerase chain reaction analysis, western blot analysis, and migration or invasion assays.	Gli	cancer	2735	HP_0002664	112	115	34	40	True
30272371	In a screen of pancreatic cancer cell lines, AsPC-1 and BxPC-3 cells expressed high levels of Gremlin1, but only AsPC-1 cells exhibited a high expression level of SHH.	SHH	cancer	6469	HP_0002664	164	167	26	32	True
30272371	Based on the data from the present study, it was concluded that an abnormal expression level of Gremlin1 in pancreatic cancer was induced by SHH signaling, and that the overexpression of Gremlin1 enabled pancreatic cancer progression	SHH	cancer	6469	HP_0002664	142	145	120	126	True
30314295	Molecular genetic tests for episodic ataxia type 2 (EA2) usually target only the specific calcium channel gene (<i>CACNA1A</i>) that is known to cause EA2.	type	episodic	6445	HP_0025303	44	48	28	36	False
30314295	Molecular genetic tests for episodic ataxia type 2 (EA2) usually target only the specific calcium channel gene (<i>CACNA1A</i>) that is known to cause EA2.	type	ataxia	6445	HP_0001251	44	48	37	43	False
30314295	Here we present a case of a proband with a complex episodic ataxias (EA)/seizure phenotype with an EA-affected father; and an unaffected mother, all negative for <i>CACNA1A</i> gene mutations.	type	episodic	6445	HP_0025303	86	90	51	59	False
30314295	Here we present a case of a proband with a complex episodic ataxias (EA)/seizure phenotype with an EA-affected father; and an unaffected mother, all negative for <i>CACNA1A</i> gene mutations.	type	ataxia	6445	HP_0001251	86	90	60	66	False
30314295	Here we present a case of a proband with a complex episodic ataxias (EA)/seizure phenotype with an EA-affected father; and an unaffected mother, all negative for <i>CACNA1A</i> gene mutations.	type	seizure	6445	HP_0001250	86	90	73	80	False
30314295	The trio was studied by whole-exome sequencing to identify candidate genes responsible for causing the complex EA/seizure phenotype.	type	seizure	6445	HP_0001250	127	131	114	121	False
30314295	The trio was studied by whole-exome sequencing to identify candidate genes responsible for causing the complex EA/seizure phenotype.	trio	seizure	7204	HP_0001250	4	8	114	121	True
30314295	While the <i>SCN2A</i> variant is likely to be causal for episodic ataxia, each variant may potentially contribute to the phenotypes observed in this family.	type	episodic	6445	HP_0025303	127	131	58	66	False
30314295	While the <i>SCN2A</i> variant is likely to be causal for episodic ataxia, each variant may potentially contribute to the phenotypes observed in this family.	type	ataxia	6445	HP_0001251	127	131	67	73	False
29287625	These results imply that PPI might be modulated by four genotypes - COMT rs4680 (primarily in males), GRIK3 rs1027599, TCF4 rs9960767, and PRODH rs385440 - indicating a role of these gene variations in the development of early information processing deficits in schizophrenia.	COMT	schizophrenia	1312	HP_0100753	68	72	262	275	True
29287625	These results imply that PPI might be modulated by four genotypes - COMT rs4680 (primarily in males), GRIK3 rs1027599, TCF4 rs9960767, and PRODH rs385440 - indicating a role of these gene variations in the development of early information processing deficits in schizophrenia.	GRIK3	schizophrenia	2899	HP_0100753	102	107	262	275	False
29287625	These results imply that PPI might be modulated by four genotypes - COMT rs4680 (primarily in males), GRIK3 rs1027599, TCF4 rs9960767, and PRODH rs385440 - indicating a role of these gene variations in the development of early information processing deficits in schizophrenia.	TCF4	schizophrenia	6934	HP_0100753	119	123	262	275	False
29287625	These results imply that PPI might be modulated by four genotypes - COMT rs4680 (primarily in males), GRIK3 rs1027599, TCF4 rs9960767, and PRODH rs385440 - indicating a role of these gene variations in the development of early information processing deficits in schizophrenia.	PRODH	schizophrenia	5625	HP_0100753	139	144	262	275	True
26965286	80.5% of luminal-type tumours developed bone metastasis as opposed to 41.7% of basal and 55.6% of HER2-like tumours.	HER2	tumours	2064	HP_0002664	101	105	23	30	True
26965286	A novel 15-gene signature identified 82.4% of the tumours with bone metastasis, 85.2% of the tumours which had bone metastasis as first site of metastasis and 100% of the ones with bone metastasis only (p 9.99e-09), in the training set.	set	tumours	6418	HP_0002664	235	238	51	58	False
26965286	In the independent dataset, 81.2% of the positive tested tumours had known metastatic disease to the bone (p 4.28e-10).	set	tumours	6418	HP_0002664	23	26	58	65	False
26965286	The expression levels of the up-regulated genes (NAT1, BBS1 and PH-4) were also found to be correlated to epithelial to mesenchymal transition status of the tumour.	BBS1	tumour	582	HP_0002664	55	59	157	163	False
26965286	The expression levels of the up-regulated genes (NAT1, BBS1 and PH-4) were also found to be correlated to epithelial to mesenchymal transition status of the tumour.	NAT1	tumour	1982	HP_0002664	49	53	157	163	False
25569086	To identify tumor suppressor genes (TSGs) silenced by hypermethylation and discover new epigenetic biomarkers for early cancer detection.	TSG	tumor	57045	HP_0002664	36	39	12	17	False
25569086	To identify tumor suppressor genes (TSGs) silenced by hypermethylation and discover new epigenetic biomarkers for early cancer detection.	TSG	cancer	57045	HP_0002664	36	39	120	126	False
25569086	ADAMTS18, located at 16q23.1, has been reported to be a critical TSG in multiple primary tumors; however, this has not yet been verified in clear cell renal cell carcinoma (ccRCC).	TSG	tumor	57045	HP_0002664	65	68	89	94	False
25569086	ADAMTS18, located at 16q23.1, has been reported to be a critical TSG in multiple primary tumors; however, this has not yet been verified in clear cell renal cell carcinoma (ccRCC).	ADAMTS18	tumor	170692	HP_0002664	0	8	89	94	False
25569086	ADAMTS18, located at 16q23.1, has been reported to be a critical TSG in multiple primary tumors; however, this has not yet been verified in clear cell renal cell carcinoma (ccRCC).	TSG	clear cell renal cell carcinoma	57045	HP_0006770	65	68	140	171	False
25569086	ADAMTS18, located at 16q23.1, has been reported to be a critical TSG in multiple primary tumors; however, this has not yet been verified in clear cell renal cell carcinoma (ccRCC).	ADAMTS18	clear cell renal cell carcinoma	170692	HP_0006770	0	8	140	171	False
25569086	MSP was further performed for 101 ccRCC primary tumors and 20 adjacent normal tissues.	MSP	tumor	89782	HP_0002664	0	3	48	53	False
25569086	Furthermore, the methylation status of ADAMTS18 was not significantly associated with gender, age, location, tumor diameter, pathological stage, nuclear grade or short-term DFS in patients with ccRCC (p &gt; 0.05).	ADAMTS18	tumor	170692	HP_0002664	39	47	109	114	False
25569086	The ADAMTS18 gene is often down-regulated by hypermethylation in ccRCC-derived cell lines and primary tumors, indicating its critical role as a TSG in ccRCC.	TSG	tumor	57045	HP_0002664	144	147	102	107	False
25569086	The ADAMTS18 gene is often down-regulated by hypermethylation in ccRCC-derived cell lines and primary tumors, indicating its critical role as a TSG in ccRCC.	ADAMTS18	tumor	170692	HP_0002664	4	12	102	107	False
25569086	We conclude that ADAMTS18 gene hypermethylation may be involved in the tumorigenesis of ccRCC and may serve as a novel biomarker for this disease.	ADAMTS18	tumor	170692	HP_0002664	17	25	71	76	False
25109669	Episodic ataxia type 2 (EA2) is an autosomal dominant disorder associated with attacks of ataxia that are typically precipitated by stress, ethanol, caffeine or exercise.	type	ataxia	6445	HP_0001251	16	20	9	15	False
25109669	Episodic ataxia type 2 (EA2) is an autosomal dominant disorder associated with attacks of ataxia that are typically precipitated by stress, ethanol, caffeine or exercise.	EA2	ataxia	773	HP_0001251	24	27	9	15	True
25109669	Thus, it is possible that subtle dysfunction arising from multiple cell types is necessary for the expression of certain ataxia syndromes.	type	ataxia	6445	HP_0001251	72	76	121	127	False
30041579	In patients compared to controls, there was an increase of IgG reactivity against zinc finger protein 688 (ZNF688), early B cell factor 2 (EBF2), crystallin, alpha B (CRYAB) and tumor necrosis factor receptor superfamily member 13C (TNFRSF13C).	ZNF688	tumor	146542	HP_0002664	107	113	178	183	False
30041579	In patients compared to controls, there was an increase of IgG reactivity against zinc finger protein 688 (ZNF688), early B cell factor 2 (EBF2), crystallin, alpha B (CRYAB) and tumor necrosis factor receptor superfamily member 13C (TNFRSF13C).	EBF2	tumor	64641	HP_0002664	139	143	178	183	False
30041579	In patients compared to controls, there was an increase of IgG reactivity against zinc finger protein 688 (ZNF688), early B cell factor 2 (EBF2), crystallin, alpha B (CRYAB) and tumor necrosis factor receptor superfamily member 13C (TNFRSF13C).	CRYAB	tumor	1410	HP_0002664	167	172	178	183	False
30041579	In patients compared to controls, there was an increase of IgG reactivity against zinc finger protein 688 (ZNF688), early B cell factor 2 (EBF2), crystallin, alpha B (CRYAB) and tumor necrosis factor receptor superfamily member 13C (TNFRSF13C).	TNFRSF13C	tumor	115650	HP_0002664	233	242	178	183	True
30661349	The results showed that the concentration of inflammatory cytokines [interleukin 1 (IL1) and tumor necrosis factor  (TNF-)], myeloperoxidase (MPO) activity in the lung tissue and blood, protein abundance of toll-like receptor 4 (TLR4), nuclear factor B (NF-B, p65), phosphorylated p65 (p-p65), inhibitor B (IB), and phosphorylated IB (p-IB), and relative mRNA expression of genes associated with inflammation, such as TLR4, NF-B, IL1, interleukin 6 (IL6), and TNF-, were significantly upregulated in the LPS group compared to the PBS group.	LPS	tumor	3664	HP_0002664	521	524	95	100	False
30661349	The results showed that the concentration of inflammatory cytokines [interleukin 1 (IL1) and tumor necrosis factor  (TNF-)], myeloperoxidase (MPO) activity in the lung tissue and blood, protein abundance of toll-like receptor 4 (TLR4), nuclear factor B (NF-B, p65), phosphorylated p65 (p-p65), inhibitor B (IB), and phosphorylated IB (p-IB), and relative mRNA expression of genes associated with inflammation, such as TLR4, NF-B, IL1, interleukin 6 (IL6), and TNF-, were significantly upregulated in the LPS group compared to the PBS group.	MPO	tumor	4353	HP_0002664	146	149	95	100	False
30661349	The results showed that the concentration of inflammatory cytokines [interleukin 1 (IL1) and tumor necrosis factor  (TNF-)], myeloperoxidase (MPO) activity in the lung tissue and blood, protein abundance of toll-like receptor 4 (TLR4), nuclear factor B (NF-B, p65), phosphorylated p65 (p-p65), inhibitor B (IB), and phosphorylated IB (p-IB), and relative mRNA expression of genes associated with inflammation, such as TLR4, NF-B, IL1, interleukin 6 (IL6), and TNF-, were significantly upregulated in the LPS group compared to the PBS group.	TLR4	tumor	7099	HP_0002664	233	237	95	100	False
30661349	The results showed that the concentration of inflammatory cytokines [interleukin 1 (IL1) and tumor necrosis factor  (TNF-)], myeloperoxidase (MPO) activity in the lung tissue and blood, protein abundance of toll-like receptor 4 (TLR4), nuclear factor B (NF-B, p65), phosphorylated p65 (p-p65), inhibitor B (IB), and phosphorylated IB (p-IB), and relative mRNA expression of genes associated with inflammation, such as TLR4, NF-B, IL1, interleukin 6 (IL6), and TNF-, were significantly upregulated in the LPS group compared to the PBS group.	NF	tumor	23114	HP_0002664	121	123	95	100	False
29529029	Uncorrected refractive errors constitute the most common cause of vision loss and second leading cause of blindness worldwide.	act	blindness	11332	HP_0000618	16	19	106	115	False
29529029	We have previously identified a role for the secreted serine protease PRSS56 in ocular size determination and PRSS56 variants have been implicated in the etiology of both hyperopia and myopia, highlighting its importance in refractive development.	PRSS56	hyperopia	646960	HP_0000540	70	76	171	180	True
29529029	We have previously identified a role for the secreted serine protease PRSS56 in ocular size determination and PRSS56 variants have been implicated in the etiology of both hyperopia and myopia, highlighting its importance in refractive development.	act	hyperopia	11332	HP_0000540	228	231	171	180	False
29529029	We have previously identified a role for the secreted serine protease PRSS56 in ocular size determination and PRSS56 variants have been implicated in the etiology of both hyperopia and myopia, highlighting its importance in refractive development.	PRSS56	myopia	646960	HP_0000545	70	76	185	191	False
29529029	We have previously identified a role for the secreted serine protease PRSS56 in ocular size determination and PRSS56 variants have been implicated in the etiology of both hyperopia and myopia, highlighting its importance in refractive development.	act	myopia	11332	HP_0000545	228	231	185	191	False
29529029	Here, we use a combination of genetic mouse models to demonstrate that Prss56 mutations leading to reduced ocular size and hyperopia act via a loss of function mechanism.	Prss56	hyperopia	646960	HP_0000540	71	77	123	132	True
29529029	Here, we use a combination of genetic mouse models to demonstrate that Prss56 mutations leading to reduced ocular size and hyperopia act via a loss of function mechanism.	act	hyperopia	11332	HP_0000540	133	136	123	132	False
29529029	Finally, we demonstrate that genetic inactivation of Prss56 rescues axial elongation in a mouse model of myopia caused by a null mutation in Egr1.	Prss56	myopia	646960	HP_0000545	53	59	105	111	False
29529029	Finally, we demonstrate that genetic inactivation of Prss56 rescues axial elongation in a mouse model of myopia caused by a null mutation in Egr1.	act	myopia	11332	HP_0000545	39	42	105	111	False
29529029	Overall, our findings identify PRSS56 as a potential therapeutic target for modulating ocular growth aimed at preventing or slowing down myopia, which is reaching epidemic proportions	PRSS56	myopia	646960	HP_0000545	31	37	137	143	False
29891662	Here, we report that hypoxia-inducible factor (HIF-1) and cancer-associated fibroblasts (CAFs)-secreted TGF-2 converge to activate the expression of hedgehog transcription factor GLI2 in CSCs, resulting in increased stemness/dedifferentiation and intrinsic resistance to chemotherapy.	GLI2	cancer	2736	HP_0002664	181	185	59	65	True
29891662	Genetic or small-molecule inhibitor-based ablation of HIF-1/TGF-2-mediated GLI2 signaling effectively reversed the chemoresistance caused by the tumor microenvironment.	GLI2	tumor	2736	HP_0002664	77	81	147	152	True
29891662	Importantly, high expression levels of HIF-1/TGF-2/GLI2 correlated robustly with the patient relapse following chemotherapy, highlighting a potential biomarker and therapeutic target for chemoresistance in colorectal cancer.	GLI2	cancer	2736	HP_0002664	53	57	219	225	True
26866375	Autosomal recessive ataxias are a clinically diverse group of syndromes that in some cases are caused by mutations in genes with roles in the DNA damage response, transcriptional regulation or mitochondrial function.	damage	ataxias	51438	HP_0001251	146	152	20	27	False
26975038	Moreover, CpG island methylation status of HACE1, a candidate tumor-suppressor gene, was determined in ANKL samples.	HACE1	tumor	57531	HP_0002664	43	48	62	67	True
23424626	Our most significant AM association was upstream of RSF1, a gene implicated in ovarian and breast cancers (rs11604207, p=1.610).	RSF1	cancer	51773	HP_0002664	52	56	98	104	False
29279458	Primary macronodular adrenal hyperplasia (PMAH), also known in the past as bilateral macronodular adrenalhyperplasia or adrenocorticotropin (ACTH)-independent macronodular adrenal hyperplasia, is a rare type of Cushing's syndrome (CS) and is associated with bilateralenlargement of the adrenal glands.	ACTH	adrenal hyperplasia	5443	HP_0008221	141	145	21	40	False
29279458	Primary macronodular adrenal hyperplasia (PMAH), also known in the past as bilateral macronodular adrenalhyperplasia or adrenocorticotropin (ACTH)-independent macronodular adrenal hyperplasia, is a rare type of Cushing's syndrome (CS) and is associated with bilateralenlargement of the adrenal glands.	type	adrenal hyperplasia	6445	HP_0008221	203	207	21	40	False
29279458	Primary macronodular adrenal hyperplasia (PMAH), also known in the past as bilateral macronodular adrenalhyperplasia or adrenocorticotropin (ACTH)-independent macronodular adrenal hyperplasia, is a rare type of Cushing's syndrome (CS) and is associated with bilateralenlargement of the adrenal glands.	ACTH	bilateral	5443	HP_0012832	141	145	75	84	False
29279458	Primary macronodular adrenal hyperplasia (PMAH), also known in the past as bilateral macronodular adrenalhyperplasia or adrenocorticotropin (ACTH)-independent macronodular adrenal hyperplasia, is a rare type of Cushing's syndrome (CS) and is associated with bilateralenlargement of the adrenal glands.	type	bilateral	6445	HP_0012832	203	207	75	84	False
29279458	Autosomal dominant inheritance of AIMAH was confirmed by genotypes of one family member.	type	inheritance	6445	HP_0000005	61	65	19	30	False
29279458	In addition, haploid clone of tumor DNA was confirmed by germline mutation and somaticmutation, which suggested the pathogenic mechanism of &quot;two-hit-model.&quot; ARMC5 was the causative gene of AIMAH pedigrees.	ARMC5	tumor	79798	HP_0002664	167	172	30	35	True
29541951	Anti-PUF60 antibodies were also observed in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and Sjgren's syndrome (SS) patients at a positive rate of 17.3, 14.5, and 10.1% respectively.	PUF60	rheumatoid arthritis	22827	HP_0001370	5	10	80	100	False
27765924	However, analogous advanced treatments are not available for patients with lung squamous cell carcinoma (lung SCC).	SCC	squamous cell carcinoma	6317	HP_0002860	110	113	80	103	False
27765924	It is well known that miR-145-5p (the guide strand) functions as a tumor suppressor in several types of cancer.	miR	tumor	220972	HP_0002664	22	25	67	72	False
27765924	It is well known that miR-145-5p (the guide strand) functions as a tumor suppressor in several types of cancer.	miR	cancer	220972	HP_0002664	22	25	104	110	False
27765924	However, the impact of miR-145-3p (the passenger strand) on cancer cells is still ambiguous.	miR	cancer	220972	HP_0002664	23	26	60	66	False
27765924	However, the impact of miR-145-3p (the passenger strand) on cancer cells is still ambiguous.	impact	cancer	55364	HP_0002664	13	19	60	66	False
27765924	Expression levels of miR-145-5p and miR-145-3p were markedly reduced in cancer tissues, and ectopic expression of these miRNAs inhibited cancer cell aggressiveness, suggesting that both miR-145-3p as well as miR-145-5p acted as antitumor miRNAs.	miR	tumor	220972	HP_0002664	21	24	232	237	False
27765924	Expression levels of miR-145-5p and miR-145-3p were markedly reduced in cancer tissues, and ectopic expression of these miRNAs inhibited cancer cell aggressiveness, suggesting that both miR-145-3p as well as miR-145-5p acted as antitumor miRNAs.	miR	cancer	220972	HP_0002664	21	24	72	78	False
27765924	Expression levels of miR-145-5p and miR-145-3p were markedly reduced in cancer tissues, and ectopic expression of these miRNAs inhibited cancer cell aggressiveness, suggesting that both miR-145-3p as well as miR-145-5p acted as antitumor miRNAs.	miR	aggressiveness	220972	HP_0000718	21	24	149	163	False
27765924	Taken together, both strands of miR-145, miR-145-5p and miR-145-3p are functional and play pivotal roles as antitumor miRNAs in lung SCC	miR	tumor	220972	HP_0002664	32	35	112	117	False
28765946	Plant homeo domain finger protein 8 (PHF8), as an oncogene, has been highlighted in cancer development and progression.	PHF8	cancer	23133	HP_0002664	37	41	84	90	False
28765946	The results demonstrated that the expression of PHF8 was significantly increased in tumor tissues from patients with CRC and was correlated with tumornodemetastasis stage.	PHF8	tumor	23133	HP_0002664	48	52	84	89	False
28765946	Invitro and invivo experiments revealed that PHF8 accelerated cancer cell growth and migration, confirming the oncogenic role of PHF8 in human CRC.	PHF8	cancer	23133	HP_0002664	47	51	64	70	False
30068520	During drug discovery efforts targeting inhibition of cytochrome P450 11B2 (CYP11B2)-mediated production of aldosterone as a therapeutic approach for the treatment of chronic kidney disease and hypertension, (<i>S</i>)-6-(5-fluoro-4-(1-hydroxyethyl)pyridin-3-yl)-3,4-dihydro-1,8-naphthyridine-1(<i>2H</i>)-carboxamide (1) was identified as a potent and selective inhibitor of CYP11B2.	CYP11B2	hypertension	1585	HP_0000822	76	83	194	206	True
29124833	Our findings support the recently proposed concept of 3'UTR-encoded &quot;cryptic amyloidogenic elements.&quot; Together with a previous report on an aggregation-prone REEP1 deletion variant in distal hereditary motor neuropathy, they also suggest that toxic gain of REEP1 function, rather than loss-of-function as relevant for HSP, specifically affects lower motor neurons.	REEP1	neuropathy	65055	HP_0009830	168	173	218	228	True
24677762	Biallelic mutations in FKBP14 cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by progressive kyphoscoliosis, myopathy, and hearing loss.	FKBP14	progressive	55033	HP_0003676	23	29	102	113	False
24677762	Biallelic mutations in FKBP14 cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by progressive kyphoscoliosis, myopathy, and hearing loss.	FKBP14	kyphoscoliosis	55033	HP_0002751	23	29	114	128	True
24677762	Biallelic mutations in FKBP14 cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by progressive kyphoscoliosis, myopathy, and hearing loss.	FKBP14	myopathy	55033	HP_0003198	23	29	130	138	True
24677762	Biallelic mutations in FKBP14 cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by progressive kyphoscoliosis, myopathy, and hearing loss.	FKBP14	hearing loss	55033	HP_0000365	23	29	144	156	True
24677762	We recently identified a 42-year-old man with severe kyphoscoliosis, restrictive/obstructive lung disease, short stature, mild hearing loss, decreased muscle mass, and a dissection of the celiac artery at age 41.	mass	kyphoscoliosis	2200	HP_0002751	158	162	53	67	True
24677762	We recently identified a 42-year-old man with severe kyphoscoliosis, restrictive/obstructive lung disease, short stature, mild hearing loss, decreased muscle mass, and a dissection of the celiac artery at age 41.	mass	hearing loss	2200	HP_0000365	158	162	127	139	True
24677762	We recently identified a 42-year-old man with severe kyphoscoliosis, restrictive/obstructive lung disease, short stature, mild hearing loss, decreased muscle mass, and a dissection of the celiac artery at age 41.	mass	short stature	2200	HP_0004322	158	162	107	120	True
26637975	The disease phenotype comprises characteristic circumferential skin creases accompanied by intellectual disability, a cleft palate, short stature, and dysmorphic features.	type	intellectual disability	6445	HP_0001249	17	21	91	114	False
26637975	The disease phenotype comprises characteristic circumferential skin creases accompanied by intellectual disability, a cleft palate, short stature, and dysmorphic features.	type	cleft palate	6445	HP_0000175	17	21	118	130	False
26637975	The disease phenotype comprises characteristic circumferential skin creases accompanied by intellectual disability, a cleft palate, short stature, and dysmorphic features.	type	short stature	6445	HP_0004322	17	21	132	145	False
28805828	CRISPR-Cas9 knockout in zebrafish and mice recapitulated the human phenotype of primary microcephaly and resulted in early lethality.	mice	microcephaly	23581	HP_0000252	38	42	88	100	False
27767175	When stratified by tumor histology, three SNPs (ENO1 rs2274971A&gt;G, PFKM rs11168417C&gt;T, and PDK2 rs3785921G&gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas PFKP rs1132173C&gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.	ENO1	tumor	2023	HP_0002664	48	52	19	24	False
27767175	When stratified by tumor histology, three SNPs (ENO1 rs2274971A&gt;G, PFKM rs11168417C&gt;T, and PDK2 rs3785921G&gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas PFKP rs1132173C&gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.	PFKM	tumor	5213	HP_0002664	72	76	19	24	False
27767175	When stratified by tumor histology, three SNPs (ENO1 rs2274971A&gt;G, PFKM rs11168417C&gt;T, and PDK2 rs3785921G&gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas PFKP rs1132173C&gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.	PFKP	tumor	5214	HP_0002664	215	219	19	24	False
27767175	When stratified by tumor histology, three SNPs (ENO1 rs2274971A&gt;G, PFKM rs11168417C&gt;T, and PDK2 rs3785921G&gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas PFKP rs1132173C&gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.	PDK2	tumor	5164	HP_0002664	101	105	19	24	False
27767175	When stratified by tumor histology, three SNPs (ENO1 rs2274971A&gt;G, PFKM rs11168417C&gt;T, and PDK2 rs3785921G&gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas PFKP rs1132173C&gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.	ENO1	squamous cell carcinoma	2023	HP_0002860	48	52	182	205	False
27767175	When stratified by tumor histology, three SNPs (ENO1 rs2274971A&gt;G, PFKM rs11168417C&gt;T, and PDK2 rs3785921G&gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas PFKP rs1132173C&gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.	PFKM	squamous cell carcinoma	5213	HP_0002860	72	76	182	205	False
27767175	When stratified by tumor histology, three SNPs (ENO1 rs2274971A&gt;G, PFKM rs11168417C&gt;T, and PDK2 rs3785921G&gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas PFKP rs1132173C&gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.	PFKP	squamous cell carcinoma	5214	HP_0002860	215	219	182	205	False
27767175	When stratified by tumor histology, three SNPs (ENO1 rs2274971A&gt;G, PFKM rs11168417C&gt;T, and PDK2 rs3785921G&gt;A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas PFKP rs1132173C&gt;T exhibited a significant association with survival outcomes only in adenocarcinoma.	PDK2	squamous cell carcinoma	5164	HP_0002860	101	105	182	205	False
23620518	Perturbation of MAM function has previously been suggested in Alzheimer's disease (AD) as shown in fibroblasts from AD patients and a neuroblastoma cell line containing familial presenilin-2 AD mutation.	MAM	neuroblastoma	6445	HP_0003006	16	19	134	147	False
28942965	C1QBP deficiency represents an important mitochondrial disorder associated with a clinical spectrum ranging from infantile lactic acidosis to childhood (cardio)myopathy and late-onset progressive external ophthalmoplegia	C1QBP	myopathy	708	HP_0003198	0	5	160	168	True
28942965	C1QBP deficiency represents an important mitochondrial disorder associated with a clinical spectrum ranging from infantile lactic acidosis to childhood (cardio)myopathy and late-onset progressive external ophthalmoplegia	C1QBP	progressive	708	HP_0003676	0	5	184	195	False
29370225	We genotyped a set of mitochondrial SNPs using Illumina HumanExome arrays and tested for association in the Swedish schizophrenia sample (N&gt; 10,000).	set	schizophrenia	6418	HP_0100753	15	18	116	129	False
29370225	We conducted the largest association study of mitochondrial DNA variants and schizophrenia but did not find an association that survived multiple testing correction.	find	schizophrenia	81501	HP_0100753	103	107	77	90	False
24853665	Several recent studies applied targeted genome enrichment (TGE) and massively parallel sequencing (MPS) to simultaneously screen a large set of known hearing loss (HL) genes.	TGE	hearing loss	7053	HP_0000365	59	62	150	162	False
24853665	Several recent studies applied targeted genome enrichment (TGE) and massively parallel sequencing (MPS) to simultaneously screen a large set of known hearing loss (HL) genes.	set	hearing loss	6418	HP_0000365	137	140	150	162	False
24853665	To evaluate the effectiveness of TGE and MPS on screening sporadic NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in GJB2, MT-RNR1, and SLC26A4 genes.	TGE	sporadic	7053	HP_0003745	33	36	58	66	False
24853665	To evaluate the effectiveness of TGE and MPS on screening sporadic NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in GJB2, MT-RNR1, and SLC26A4 genes.	GJB2	sporadic	2706	HP_0003745	196	200	58	66	False
24853665	To evaluate the effectiveness of TGE and MPS on screening sporadic NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in GJB2, MT-RNR1, and SLC26A4 genes.	MT	sporadic	27349	HP_0003745	202	204	58	66	False
24853665	To evaluate the effectiveness of TGE and MPS on screening sporadic NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in GJB2, MT-RNR1, and SLC26A4 genes.	RNR1	sporadic	4929	HP_0003745	205	209	58	66	True
24853665	To evaluate the effectiveness of TGE and MPS on screening sporadic NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in GJB2, MT-RNR1, and SLC26A4 genes.	SLC26A4	sporadic	5172	HP_0003745	215	222	58	66	False
21376300	We hypothesized that de novo mutations (DNMs) in synaptic genes explain an important fraction of sporadic NSID cases.	DNM	sporadic	1759	HP_0003745	40	43	97	105	False
21376300	Sequencing these four genes in 50 additional sporadic cases of NSID identified a second DNM in GRIN1 (c.1679_1681dup/p.Ser560dup).	DNM	sporadic	1759	HP_0003745	88	91	45	53	False
21376300	Sequencing these four genes in 50 additional sporadic cases of NSID identified a second DNM in GRIN1 (c.1679_1681dup/p.Ser560dup).	GRIN1	sporadic	114787	HP_0003745	95	100	45	53	False
28795510	CNGB3 encoding the beta subunit of the cyclic nucleotide-gated ion channel in cone photoreceptors is the major achromatopsia gene.	CNGB3	achromatopsia	54714	HP_0011516	0	5	111	124	True
28795510	Here, we present a comprehensive spectrum of CNGB3 mutations and their prevalence in a cohort of 1074 independent families clinically diagnosed with achromatopsia.	CNGB3	achromatopsia	54714	HP_0011516	45	50	149	162	True
27712600	Empty spiracles homeobox 2 (EMX2) is a homeodomain-containing transcription factor that plays an essential role in tumorigenesis.	EMX2	tumor	2018	HP_0002664	28	32	115	120	False
27712600	However, to the best of our knowledge, the role of EMX2 in human colorectal cancer (CRC) is still unclear.	EMX2	cancer	2018	HP_0002664	51	55	76	82	False
27712600	However, to the best of our knowledge, the role of EMX2 in human colorectal cancer (CRC) is still unclear.	best	cancer	7439	HP_0002664	16	20	76	82	False
27712600	Overexpression of EMX2 significantly inhibited the proliferation in vitro and CRC tumor growth in nude mice.	EMX2	tumor	2018	HP_0002664	18	22	82	87	False
27712600	Overexpression of EMX2 significantly inhibited the proliferation in vitro and CRC tumor growth in nude mice.	nude	tumor	54820	HP_0002664	98	102	82	87	False
27712600	Taken together, our study demonstrates that EMX2 inhibits proliferation and tumorigenesis through inactivation of the Wnt/-catenin pathway in CRC cells.	EMX2	tumor	2018	HP_0002664	44	48	76	81	False
28252048	Despite promising therapeutic avenues, there is currently no effective treatment for Duchenne muscular dystrophy (DMD), a lethal monogenic disorder caused by the loss of the large cytoskeletal protein, dystrophin.	DMD	muscular dystrophy	1756	HP_0003560	114	117	94	112	True
30082721	Our results reveal that current SZ diagnoses aggregate over at least two disease subtypes: one part resembles high intelligence and bipolar disorder (BIP), while the other part is a cognitive disorder that is independent of BIP	BIP	bipolar disorder	3309	HP_0007302	150	153	132	148	False
26929985	These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and VAX2 genes (P&lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&lt;0.05).	IRX1	tumor	79192	HP_0002664	148	152	83	88	False
26929985	These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and VAX2 genes (P&lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&lt;0.05).	VAX2	tumor	25806	HP_0002664	157	161	83	88	False
26929985	These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and VAX2 genes (P&lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&lt;0.05).	INSRR	tumor	3645	HP_0002664	290	295	83	88	False
26929985	These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and VAX2 genes (P&lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&lt;0.05).	PRDM14	tumor	63978	HP_0002664	297	303	83	88	False
26929985	These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and VAX2 genes (P&lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&lt;0.05).	VSX1	tumor	30813	HP_0002664	305	309	83	88	False
26929985	These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and VAX2 genes (P&lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&lt;0.05).	TFAP2b	tumor	7021	HP_0002664	311	317	83	88	False
26929985	These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and VAX2 genes (P&lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&lt;0.05).	PRRX1	tumor	5396	HP_0002664	319	324	83	88	False
26929985	These analyses revealed significantly higher methylation frequencies in high-grade tumors relative to low-intermediate-grade tumors for the ATP5G2, IRX1 and VAX2 genes (P&lt;0.05), and similarly significant increases in mean levels of methylation in high-grade tumors for the ATP5G2, VAX2, INSRR, PRDM14, VSX1, TFAP2b, PRRX1, and HIST1H4F genes (P&lt;0.05).	HIST1H4F	tumor	8361	HP_0002664	330	338	83	88	False
30123056	In 128 female patients of the recruited UCC cohort, patients who carried at least one deletion allele of <i>DRD2</i> rs1799732 showed a higher incidence of having an invasive stage (AOR=2.585, 95% CI: 1.066~6.264, <i>p</i>=0.032) and a large tumor (AOR=2.778, 95% CI: 1.146~6.735, <i>p</i>=0.021).	DRD2	tumor	1813	HP_0002664	108	112	242	247	False
30123056	Further analyses of The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets revealed correlations of the expression of DRD2 with an invasive tumor, tumor metastasis, and the lower survival rate in patients with UCC.	DRD2	tumor	1813	HP_0002664	137	141	159	164	False
30115383	A growing number of studies has suggested that long non-coding RNAs (lncRNAs) exert essential roles in the development and progression of hepatocellular carcinoma (HCC).	HCC	hepatocellular carcinoma	84668	HP_0001402	164	167	138	162	False
30115383	SBF2-AS1 knockdown could inhibit the proliferation of HCC cells and attenuate the development of HCC tumor invivo.	HCC	tumor	84668	HP_0002664	54	57	101	106	False
30115383	SBF2-AS1 knockdown could inhibit the proliferation of HCC cells and attenuate the development of HCC tumor invivo.	SBF2	tumor	81846	HP_0002664	0	4	101	106	False
29892902	Mutations in the KIF5A showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy type 2 (CMT2).	KIF5A	spastic paraplegia	3798	HP_0001258	17	22	73	91	True
29892902	Mutations in the KIF5A showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy type 2 (CMT2).	type	spastic paraplegia	6445	HP_0001258	150	154	73	91	False
29892902	Mutations in the KIF5A showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy type 2 (CMT2).	CMT2	spastic paraplegia	23095	HP_0001258	158	162	73	91	False
29892902	Mutations in the KIF5A showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy type 2 (CMT2).	KIF5A	peripheral	3798	HP_0030646	17	22	128	138	False
29892902	Mutations in the KIF5A showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy type 2 (CMT2).	type	peripheral	6445	HP_0030646	150	154	128	138	False
29892902	Mutations in the KIF5A showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy type 2 (CMT2).	CMT2	peripheral	23095	HP_0030646	158	162	128	138	False
29892902	Mutations in the KIF5A showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy type 2 (CMT2).	KIF5A	neuropathy	3798	HP_0009830	17	22	139	149	True
29892902	Mutations in the KIF5A showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy type 2 (CMT2).	type	neuropathy	6445	HP_0009830	150	154	139	149	False
29892902	Mutations in the KIF5A showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth peripheral neuropathy type 2 (CMT2).	CMT2	neuropathy	23095	HP_0009830	158	162	139	149	True
29892902	The p.Arg204Trp mutation was identified from a CMT2 patient with additional complex phenotypes of HSP, ataxia, fatigability and pyramidal sign, but the p.Arg280His and p.Leu588Pro mutations were identified in each axonal CMT2 patient.	type	ataxia	6445	HP_0001251	89	93	103	109	False
29892902	The p.Arg204Trp mutation was identified from a CMT2 patient with additional complex phenotypes of HSP, ataxia, fatigability and pyramidal sign, but the p.Arg280His and p.Leu588Pro mutations were identified in each axonal CMT2 patient.	CMT2	ataxia	23095	HP_0001251	47	51	103	109	False
29892902	As the first report in Korea, this study identified three KIF5A mutations as the underlying cause of axonal peripheral neuropathy with or without the HSP phenotype.	KIF5A	peripheral	3798	HP_0030646	58	63	108	118	False
29892902	As the first report in Korea, this study identified three KIF5A mutations as the underlying cause of axonal peripheral neuropathy with or without the HSP phenotype.	type	peripheral	6445	HP_0030646	159	163	108	118	False
29892902	As the first report in Korea, this study identified three KIF5A mutations as the underlying cause of axonal peripheral neuropathy with or without the HSP phenotype.	KIF5A	neuropathy	3798	HP_0009830	58	63	119	129	True
29892902	As the first report in Korea, this study identified three KIF5A mutations as the underlying cause of axonal peripheral neuropathy with or without the HSP phenotype.	type	neuropathy	6445	HP_0009830	159	163	119	129	False
28749476	WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (PSEN1, PSEN2), lysosomal (CTSF, 7-exon macro-deletion) and cholesterol homeostasis pathways (CYP27A1).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly sporadic FTD.	PSEN1	sporadic	5663	HP_0003745	111	116	329	337	True
28749476	WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (PSEN1, PSEN2), lysosomal (CTSF, 7-exon macro-deletion) and cholesterol homeostasis pathways (CYP27A1).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly sporadic FTD.	PSEN2	sporadic	5664	HP_0003745	118	123	329	337	False
28749476	WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (PSEN1, PSEN2), lysosomal (CTSF, 7-exon macro-deletion) and cholesterol homeostasis pathways (CYP27A1).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly sporadic FTD.	CTSF	sporadic	8722	HP_0003745	137	141	329	337	False
28749476	WES also unraveled pathogenic mutations in genes not commonly linked to FTD, including mutations in Alzheimer (PSEN1, PSEN2), lysosomal (CTSF, 7-exon macro-deletion) and cholesterol homeostasis pathways (CYP27A1).ConclusionOur unbiased approach reveals a wide genetic spectrum underlying clinical FTD, including 11% of seemingly sporadic FTD.	CYP27A1	sporadic	1593	HP_0003745	204	211	329	337	False
25310821	Hirschsprung disease (HSCR) is a congenital and heterogeneous disorder characterized by the absence of intramural nervous plexuses along variable lengths of the hindgut.	HSCR	heterogeneous	1910	HP_0001425	22	26	48	61	True
25310821	To discover additional risk loci, we performed a GWAS of 123 sporadic HSCR patients and 432 unaffected controls using a large-scale platform with coverage of over 1 million polymorphic markers.	HSCR	sporadic	1910	HP_0003745	70	74	61	69	False
25869670	Consistent with a role in transition zone function, mutation of mouse Tmem231 disrupts the localization of proteins including Arl13b and Inpp5e to cilia, resulting in phenotypes characteristic of MKS such as polydactyly and kidney cysts.	MKS	polydactyly	54903	HP_0010442	196	199	208	219	True
25869670	Consistent with a role in transition zone function, mutation of mouse Tmem231 disrupts the localization of proteins including Arl13b and Inpp5e to cilia, resulting in phenotypes characteristic of MKS such as polydactyly and kidney cysts.	Tmem231	polydactyly	79583	HP_0010442	70	77	208	219	True
25869670	Consistent with a role in transition zone function, mutation of mouse Tmem231 disrupts the localization of proteins including Arl13b and Inpp5e to cilia, resulting in phenotypes characteristic of MKS such as polydactyly and kidney cysts.	Arl13b	polydactyly	200894	HP_0010442	126	132	208	219	True
25869670	Consistent with a role in transition zone function, mutation of mouse Tmem231 disrupts the localization of proteins including Arl13b and Inpp5e to cilia, resulting in phenotypes characteristic of MKS such as polydactyly and kidney cysts.	Inpp5e	polydactyly	23203	HP_0010442	137	143	208	219	False
25869670	Consistent with a role in transition zone function, mutation of mouse Tmem231 disrupts the localization of proteins including Arl13b and Inpp5e to cilia, resulting in phenotypes characteristic of MKS such as polydactyly and kidney cysts.	type	polydactyly	6445	HP_0010442	172	176	208	219	False
29478601	The congenital myasthenic syndromes (CMS) are heterogeneous disorders in which the safety margin of neuromuscular transmission is compromised by one or more specific mechanisms.	CMS	heterogeneous	23607	HP_0001425	37	40	46	59	False
26654129	The Nodal co-receptor Cripto is expressed transiently during normal germ cell development and is ectopically expressed in non-seminomas that arise from germ cell neoplasia in situ, suggesting that its aberrant expression may underlie germ cell dysregulation and hence germ cell cancer.	Nodal	neoplasia	4838	HP_0002664	4	9	162	171	True
26654129	The Nodal co-receptor Cripto is expressed transiently during normal germ cell development and is ectopically expressed in non-seminomas that arise from germ cell neoplasia in situ, suggesting that its aberrant expression may underlie germ cell dysregulation and hence germ cell cancer.	Cripto	neoplasia	6997	HP_0002664	22	28	162	171	True
26654129	The Nodal co-receptor Cripto is expressed transiently during normal germ cell development and is ectopically expressed in non-seminomas that arise from germ cell neoplasia in situ, suggesting that its aberrant expression may underlie germ cell dysregulation and hence germ cell cancer.	Nodal	cancer	4838	HP_0002664	4	9	278	284	True
26654129	The Nodal co-receptor Cripto is expressed transiently during normal germ cell development and is ectopically expressed in non-seminomas that arise from germ cell neoplasia in situ, suggesting that its aberrant expression may underlie germ cell dysregulation and hence germ cell cancer.	Cripto	cancer	6997	HP_0002664	22	28	278	284	True
26654129	Here we investigated methylation of the Cripto promoter in mouse germ cells and human germ cell cancer and correlated this with the level of CRIPTO protein expression.	Cripto	cancer	6997	HP_0002664	40	46	96	102	True
26654129	Here we investigated methylation of the Cripto promoter in mouse germ cells and human germ cell cancer and correlated this with the level of CRIPTO protein expression.	CRIPTO	cancer	6997	HP_0002664	141	147	96	102	True
26654129	CRIPTO protein was strongly expressed in germ cell neoplasia in situ along with embryonal carcinoma, yolk sac tumor and seminomas.	CRIPTO	neoplasia	6997	HP_0002664	0	6	51	60	True
26654129	CRIPTO protein was strongly expressed in germ cell neoplasia in situ along with embryonal carcinoma, yolk sac tumor and seminomas.	sac	neoplasia	55811	HP_0002664	106	109	51	60	False
26654129	CRIPTO protein was strongly expressed in germ cell neoplasia in situ along with embryonal carcinoma, yolk sac tumor and seminomas.	CRIPTO	tumor	6997	HP_0002664	0	6	110	115	True
26654129	CRIPTO protein was strongly expressed in germ cell neoplasia in situ along with embryonal carcinoma, yolk sac tumor and seminomas.	sac	tumor	55811	HP_0002664	106	109	110	115	False
26654129	Further, cleaved CRIPTO was detected in media from seminoma and embryonal carcinoma cell lines, suggesting that cleaved CRIPTO may provide diagnostic indication of germ cell cancer.	CRIPTO	cancer	6997	HP_0002664	17	23	174	180	True
26654129	Accordingly, CRIPTO was detectable in serum from 6/15 patients with embryonal carcinoma, 5/15 patients with seminoma, 4/5 patients with germ cell neoplasia in situ cells only and in 1/15 control patients.	CRIPTO	neoplasia	6997	HP_0002664	13	19	146	155	True
26654129	These findings suggest that CRIPTO expression may be a useful serological marker for diagnostic and/or prognostic purposes during germ cell cancer management.	CRIPTO	cancer	6997	HP_0002664	28	34	140	146	True
28422131	The encoded protein, complexin 1, is crucially involved in neuronal synaptic regulation, and homozygous Cplx1 knockout mice have the earliest known onset of ataxia seen in a mouse model.	Cplx1	ataxia	10815	HP_0001251	104	109	157	163	False
28422131	The encoded protein, complexin 1, is crucially involved in neuronal synaptic regulation, and homozygous Cplx1 knockout mice have the earliest known onset of ataxia seen in a mouse model.	mice	ataxia	23581	HP_0001251	119	123	157	163	False
28422131	Recently, a homozygous truncating variant in CPLX1 was suggested to be causative for migrating epilepsy and structural brain abnormalities.	CPLX1	epilepsy	10815	HP_0001250	45	50	95	103	True
28422131	However, the currently limited knowledge on CPLX1 suggests that loss of complexin 1 function may lead to a complex but variable clinical phenotype, and our findings encourage further investigations of CPLX1 in patients with ID, developmental delay and myoclonic epilepsy to unravel the phenotypic spectrum of carriers of CPLX1 variants	CPLX1	developmental delay	10815	HP_0001263	44	49	228	247	True
28422131	However, the currently limited knowledge on CPLX1 suggests that loss of complexin 1 function may lead to a complex but variable clinical phenotype, and our findings encourage further investigations of CPLX1 in patients with ID, developmental delay and myoclonic epilepsy to unravel the phenotypic spectrum of carriers of CPLX1 variants	CPLX1	epilepsy	10815	HP_0001250	44	49	262	270	True
26573920	Hereditary sensory and autonomic neuropathy 1 (HSAN1) is an autosomal dominant disorder that can be caused by variants in SPTLC1 or SPTLC2, encoding subunits of serine palmitoyl-CoA transferase.	HSAN1	neuropathy	10558	HP_0009830	47	52	33	43	True
26573920	Hereditary sensory and autonomic neuropathy 1 (HSAN1) is an autosomal dominant disorder that can be caused by variants in SPTLC1 or SPTLC2, encoding subunits of serine palmitoyl-CoA transferase.	SPTLC1	neuropathy	10558	HP_0009830	122	128	33	43	True
26573920	Hereditary sensory and autonomic neuropathy 1 (HSAN1) is an autosomal dominant disorder that can be caused by variants in SPTLC1 or SPTLC2, encoding subunits of serine palmitoyl-CoA transferase.	SPTLC2	neuropathy	9517	HP_0009830	132	138	33	43	True
26573920	Sequencing of SPTLC2 should be considered in all patients presenting with mild late-onset sensory-predominant small or large fiber neuropathy.	SPTLC2	neuropathy	9517	HP_0009830	14	20	131	141	True
30483049	Today, more than a dozen human CaM missense mutations have been described, all found in patients with severe cardiac arrhythmias.	CaM	cardiac arrhythmias	889	HP_0011675	31	34	109	128	False
30483049	However, sequencing of large human cohorts reveals a cumulative frequency of additional rare CaM mutations that raise the possibility of CaM variants not exclusively causing severe cardiac arrhythmias.	CaM	cardiac arrhythmias	889	HP_0011675	93	96	181	200	False
28778786	CDK5RAP2 gene encodes a centrosomal protein, highly expressed in fetal brain and essentially indispensable for its normal development, as biallelic mutations in it lead to primary microcephaly (MCPH).	CDK5RAP2	microcephaly	55755	HP_0000252	0	8	180	192	True
30481057	Pathogenic mutations have been identified in the TIMM8A (DDP) and DNAJC19 (TIMM14) genes and are linked to Mohr-Tranebjrg syndrome and dilated cardiomyopathy syndrome (with and without ataxia), respectively.	TIMM8A	ataxia	1678	HP_0001251	49	55	186	192	False
30481057	Pathogenic mutations have been identified in the TIMM8A (DDP) and DNAJC19 (TIMM14) genes and are linked to Mohr-Tranebjrg syndrome and dilated cardiomyopathy syndrome (with and without ataxia), respectively.	DDP	ataxia	1678	HP_0001251	57	60	186	192	False
30481057	Pathogenic mutations have been identified in the TIMM8A (DDP) and DNAJC19 (TIMM14) genes and are linked to Mohr-Tranebjrg syndrome and dilated cardiomyopathy syndrome (with and without ataxia), respectively.	DNAJC19	ataxia	131118	HP_0001251	66	73	186	192	True
30481057	Pathogenic mutations have been identified in the TIMM8A (DDP) and DNAJC19 (TIMM14) genes and are linked to Mohr-Tranebjrg syndrome and dilated cardiomyopathy syndrome (with and without ataxia), respectively.	TIMM14	ataxia	131118	HP_0001251	75	81	186	192	True
28038461	Homeobox A11 (HOXA11) is one of the hypermethylated genes in breast cancer and its function in breast tumorigenesis remains elusive.	HOXA11	cancer	3207	HP_0002664	14	20	68	74	False
28038461	Homeobox A11 (HOXA11) is one of the hypermethylated genes in breast cancer and its function in breast tumorigenesis remains elusive.	HOXA11	tumor	3207	HP_0002664	14	20	102	107	False
28038461	In this study, we analyzed the methylation status of HOXA11 in 264 paired breast cancer and normal tissue as well as in matched serum samples by MethyLight assay.	HOXA11	cancer	3207	HP_0002664	53	59	81	87	False
28038461	Further, the function of HOXA11 in breast tumorigenesis was analyzed by cell proliferation and migration assays.	HOXA11	tumor	3207	HP_0002664	25	31	42	47	False
28038461	We found that HOXA11 was hypermethylated in cancer tissues (45.08%), especially in invasive ductal carcinomas (P&lt;0.001), patients with a family history of cancer (P=0.033), cases with metastatic lymph nodes (P=0.004) and P53 positive group (P=0.017).	HOXA11	cancer	3207	HP_0002664	14	20	44	50	False
28038461	In conclusion, the hypermethylation of HOXA11 is an independent prognostic biomarker in breast cancer.	HOXA11	cancer	3207	HP_0002664	39	45	95	101	False
28038461	Additionally, HOXA11 can be a potential tumor suppressor	HOXA11	tumor	3207	HP_0002664	14	20	40	45	False
30368514	Abnormalities in these pathways cause autosomal dominant polycystic kidney disease (ADPKD) and naevoid basal cell carcinoma syndrome (NBCCS) respectively.	NBCCS	kidney disease	5727	HP_0000077	134	139	68	82	True
30368514	Abnormalities in these pathways cause autosomal dominant polycystic kidney disease (ADPKD) and naevoid basal cell carcinoma syndrome (NBCCS) respectively.	NBCCS	basal cell carcinoma	5727	HP_0002671	134	139	103	123	True
26197217	Two additional mutations linked to different forms of retinal dystrophies were identified in two families: a known frameshift deletion in RPGR, a gene responsible for X-linked retinitis pigmentosa and p.Ser163Arg in C1QTNF5 associated with Late-Onset Retinal Degeneration.	RPGR	retinal dystrophies	6103	HP_0000556	138	142	54	73	True
26197217	Two additional mutations linked to different forms of retinal dystrophies were identified in two families: a known frameshift deletion in RPGR, a gene responsible for X-linked retinitis pigmentosa and p.Ser163Arg in C1QTNF5 associated with Late-Onset Retinal Degeneration.	C1QTNF5	retinal dystrophies	83552	HP_0000556	216	223	54	73	True
26197217	This study allowed the identification of the genetic cause of the retinal dystrophy and the establishment of a correct diagnosis in four families, including a large heterozygous deletion in PRPF31, typically considered one of the pitfalls of this method.	PRPF31	retinal dystrophy	26121	HP_0000556	190	196	66	83	True
27060890	This report identifies the implication of IFT57 in human pathology and highlights the first description of a ciliary transport defect in OFDS, extending the genetic heterogeneity of this subgroup of ciliopathies	IFT57	heterogeneity	55081	HP_0001425	42	47	165	178	False
22994209	Although ABCD1 is responsible for X-linked adrenoleukodystrophy (X-ALD), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, liver dysfunction, cholestasis and early infantile death.	ABCD1	liver dysfunction	215	HP_0001410	9	14	233	250	False
22994209	Although ABCD1 is responsible for X-linked adrenoleukodystrophy (X-ALD), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, liver dysfunction, cholestasis and early infantile death.	adrenoleukodystrophy	liver dysfunction	215	HP_0001410	43	63	233	250	False
22994209	Although ABCD1 is responsible for X-linked adrenoleukodystrophy (X-ALD), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, liver dysfunction, cholestasis and early infantile death.	ALD	liver dysfunction	215	HP_0001410	67	70	233	250	False
22994209	Although ABCD1 is responsible for X-linked adrenoleukodystrophy (X-ALD), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, liver dysfunction, cholestasis and early infantile death.	ABCD1	cholestasis	215	HP_0001396	9	14	252	263	False
22994209	Although ABCD1 is responsible for X-linked adrenoleukodystrophy (X-ALD), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, liver dysfunction, cholestasis and early infantile death.	adrenoleukodystrophy	cholestasis	215	HP_0001396	43	63	252	263	False
22994209	Although ABCD1 is responsible for X-linked adrenoleukodystrophy (X-ALD), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, liver dysfunction, cholestasis and early infantile death.	ALD	cholestasis	215	HP_0001396	67	70	252	263	False
28754672	Here we find that a lymphocyte lineage-restricted transcription factor, Spi-B, is frequently expressed in human lung cancer tissues.	find	cancer	81501	HP_0002664	8	12	117	123	False
28754672	Here we find that a lymphocyte lineage-restricted transcription factor, Spi-B, is frequently expressed in human lung cancer tissues.	Spi-B	cancer	6689	HP_0002664	72	77	117	123	True
28754672	The Spi-B-expressing cancer cells coexpressed vimentin but repressed E-cadherin and exhibited invasive behavior.	Spi-B	cancer	6689	HP_0002664	4	9	21	27	True
28754672	The Spi-B-expressing cancer cells coexpressed vimentin but repressed E-cadherin and exhibited invasive behavior.	cadherin	cancer	1015	HP_0002664	71	79	21	27	False
28754672	Increased Spi-B expression was associated with tumor grade, lymphatic metastasis, and short overall survival.	Spi-B	tumor	6689	HP_0002664	10	15	47	52	True
28754672	These data suggest that Spi-B participates in mesenchymal invasion, linking epithelial cancer metastasis with a lymphatic transcriptional program.	Spi-B	cancer	6689	HP_0002664	24	29	87	93	True
27541164	TBC1D24-related disorders include a wide phenotypic ranging from mild to lethal seizure disorders, non-syndromic deafness, and composite syndromes such as DOORS (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures).	TBC1D24	seizure	57465	HP_0001250	0	7	80	87	True
27541164	TBC1D24-related disorders include a wide phenotypic ranging from mild to lethal seizure disorders, non-syndromic deafness, and composite syndromes such as DOORS (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures).	TBC1D24	deafness	57465	HP_0000365	0	7	113	121	True
27541164	Here, we present a familial case of a lethal early-onset epileptic encephalopathy, associated with two novel compound heterozygous missense variants on the TBC1D24 gene, which were detected by exome sequencing.	TBC1D24	encephalopathy	57465	HP_0001298	156	163	67	81	True
28213878	Norepinephrine transporter (NET) transfection leads to significant uptake of iodine-131-labeled metaiodobenzylguanidine (<sup>131</sup>I-MIBG) in non-neuroendocrine tumors.	NET	tumors	2004	HP_0002664	28	31	165	171	False
28213878	We evaluated the uptake and efflux of <sup>131</sup>I-MIBG both in vitro and in vivo in mice bearing transfected tumors.	mice	tumors	23581	HP_0002664	88	92	113	119	False
28213878	In vivo experiments were performed in nude mice bearing transfected tumors; results revealed that NET-VMAT2-coexpressing tumors had longer <sup>131</sup>I-MIBG retention time than NET-expressing tumors.	NET	tumors	2004	HP_0002664	98	101	68	74	False
28213878	In vivo experiments were performed in nude mice bearing transfected tumors; results revealed that NET-VMAT2-coexpressing tumors had longer <sup>131</sup>I-MIBG retention time than NET-expressing tumors.	VMAT2	tumors	6571	HP_0002664	102	107	68	74	False
28213878	In vivo experiments were performed in nude mice bearing transfected tumors; results revealed that NET-VMAT2-coexpressing tumors had longer <sup>131</sup>I-MIBG retention time than NET-expressing tumors.	mice	tumors	23581	HP_0002664	43	47	68	74	False
28213878	In vivo experiments were performed in nude mice bearing transfected tumors; results revealed that NET-VMAT2-coexpressing tumors had longer <sup>131</sup>I-MIBG retention time than NET-expressing tumors.	nude	tumors	54820	HP_0002664	38	42	68	74	False
28213878	In vivo experiments were performed in nude mice bearing transfected tumors; results revealed that NET-VMAT2-coexpressing tumors had longer <sup>131</sup>I-MIBG retention time than NET-expressing tumors.	per	tumors	93210	HP_0002664	10	13	68	74	False
28213878	Meanwhile, NET-VMAT2-coexpressing and NET-expressing tumors displayed 0.54% and 0.19%, respectively, of the injected dose per gram of tissue 24 h after <sup>131</sup>I-MIBG administration.	NET	tumors	2004	HP_0002664	11	14	53	59	False
28213878	Meanwhile, NET-VMAT2-coexpressing and NET-expressing tumors displayed 0.54% and 0.19%, respectively, of the injected dose per gram of tissue 24 h after <sup>131</sup>I-MIBG administration.	VMAT2	tumors	6571	HP_0002664	15	20	53	59	False
28213878	Meanwhile, NET-VMAT2-coexpressing and NET-expressing tumors displayed 0.54% and 0.19%, respectively, of the injected dose per gram of tissue 24 h after <sup>131</sup>I-MIBG administration.	per	tumors	93210	HP_0002664	122	125	53	59	False
